Citrus Sinensis ID: 016085

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-----
Protein Sequence
MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccHHHHHHHHccccHHHHccccEEEccccccEEEEEEEEEccccccccccccEEEEEEEEccccEEEEEEEEcccccEEEEEEcccccHHHHHHHHHHHHcccccEEEEcccccccHHHHHHHHHHHHHHHHHHHccccEEcccccccccccccccccEEEEccccccccccccccEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHcccccccccccHHHHHccccccccccccccccccccccccccccHHHHccccHHHHHcccHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccHHHccHHHcccccccccccccccccEEccccccccEEEEEEEEcccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEHHHHccccccHHHHHHHHHHHHHHHHHHHHHHcEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccHHHHccccHHHHHHHcHHHHHHHcHHHcc
Coil and Loop (DISEMBL)
mystgmapalavakpedddvmivdklpakpdddddampvdklpEEINEMKIKGERVEKEMEATvvdgngteTGHIIVTTiggrngqpkqTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTmrlldhpnvhysrasqrmpLIYVKLYTYQICRALAYIhggigvchrdikpqnllvnphthqvklcdfgsakvlvkgepnisyicsryyrapelifgateyttAVDIWSVGCVLAELllgqplfpgesgVDQLVEIIKVLGtptreeikcmnpnytefkfpqikahpwhkifhkrmppeAVDLVSRLLqyspnlrctaleacihpffdelrdpnarlpngrpfpplfnfkpqelKGASKELLSKLIpeharkqcpflgf
Flexible Loop (DISEMBL)
mystgmapalavakpedddvMIVDKlpakpdddddampvdklpEEINemkikgerveKEMEatvvdgngteTGHIIVttiggrngqpKQTISYMAERVVGQGSFGIVFQAKCLETGETVaikkvlqdkryknrelqtmrlldhpnvhysrasqrMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSklipeharkqcpflgf
Low Complexity Region (SEG)
MYSTGMAPALAVAKPEDDDVMIvdklpakpdddddampvdklpEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF
Disordered region (IsUnstruct)
****************************************************************VDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR************************************************
Disordered Region (DISOPRED)
**************************************************************************IIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC*****
Disordered Region (DISEMBL)
MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF
Disordered Region (DISPRO)
************************************************************EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	395	2.2.26 [Sep-21-2011]
Q8VZD5	410	Shaggy-related protein ki	yes	no	0.936	0.902	0.807	0.0
P43288	405	Shaggy-related protein ki	no	no	0.906	0.883	0.807	0.0
Q40518	409	Shaggy-related protein ki	N/A	no	0.916	0.885	0.789	0.0
P51137	411	Glycogen synthase kinase-	N/A	no	0.954	0.917	0.755	0.0
P43289	409	Shaggy-related protein ki	no	no	0.949	0.916	0.734	0.0
P51139	411	Glycogen synthase kinase-	N/A	no	0.913	0.878	0.779	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.949	0.912	0.731	1e-180
Q96287	472	Shaggy-related protein ki	no	no	0.881	0.737	0.727	1e-168
Q9FVS6	420	Shaggy-related protein ki	no	no	0.924	0.869	0.699	1e-166
Q39019	421	Shaggy-related protein ki	no	no	0.903	0.847	0.700	1e-165

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  674 bits (1740), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/410 (80%), Positives = 345/410 (84%), Gaps = 40/410 (9%)

Query: 23  VDKLPAKP---DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTT 79
           V  LPA        + ++  +KLPE INEMKIK +   KEMEA VVDGNGTETGHIIVTT
Sbjct: 4   VGTLPASSMATKQSNASICAEKLPEGINEMKIKDD---KEMEAAVVDGNGTETGHIIVTT 60

Query: 80  IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 139
           IGG+NGQPKQTISYMAER+VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 140 LLDHPNV----------------------------------HYSRASQRMPLIYVKLYTY 165
           LLDHPNV                                  HYSRA+QRMP+IYVKLYTY
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 225
           QICRALAYIHGG+GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
           RAPELIFGATEYTT +DIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
           CMNPNYTEFKFPQIKAHPWHKIFHKR PPEAVDLVSRLLQYSPNLR TA+EA +HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDE 360

Query: 346 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
           LRDPN RLPNGR  PPLFNFKPQELKGAS ELLSKLIP+HARKQC FL  
Sbjct: 361 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410

May mediate extracellular signals to regulate transcription in differentiating cells.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  652 bits (1683), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 319/395 (80%), Positives = 338/395 (85%), Gaps = 37/395 (9%)

Query: 35  DAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM 94
           D+  VDKLPEE+N+MKI   R +KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM
Sbjct: 14  DSTGVDKLPEEMNDMKI---RDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM 70

Query: 95  AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV-------- 146
           AERVVG GSFG+VFQAKCLETGETVAIKKVLQD+RYKNRELQTMRLLDHPNV        
Sbjct: 71  AERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFF 130

Query: 147 --------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                                     HY++ +QRMPLIYVKLYTYQI RAL+YIH  IGV
Sbjct: 131 STTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGV 190

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
           CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA
Sbjct: 191 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 250

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
           +D+WS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK
Sbjct: 251 IDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 310

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFP 360
           AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR  AL+  +HPFFDELRDPNARLPNGR  P
Sbjct: 311 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLP 370

Query: 361 PLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
           PLFNFKP ELKG   E+++KL+PEHARKQCP+LG 
Sbjct: 371 PLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  645 bits (1663), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 315/399 (78%), Positives = 334/399 (83%), Gaps = 37/399 (9%)

Query: 31  DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQT 90
           +    ++ VD+LPEE+N+M+I   R +KE+EA +VDGNGTETGHIIVTTIGGR+GQPKQT
Sbjct: 14  ESSSHSVGVDRLPEEMNDMRI---RDDKEIEAAIVDGNGTETGHIIVTTIGGRHGQPKQT 70

Query: 91  ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV---- 146
           ISYMAER+VGQGSFG+VFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV    
Sbjct: 71  ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVCLK 130

Query: 147 ------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
                                         HY++ +QRMPLI VKLYTYQI RAL+YIH 
Sbjct: 131 HCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQIFRALSYIHH 190

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 236
            IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE
Sbjct: 191 TIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           YTTA+DIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY EFKF
Sbjct: 251 YTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYNEFKF 310

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNG 356
           PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA  H FFDELRDPN RLPNG
Sbjct: 311 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAVTHAFFDELRDPNTRLPNG 370

Query: 357 RPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
           R  PPLFNFK  ELKG S E L KL+PEHARKQCP LG 
Sbjct: 371 RVLPPLFNFKAHELKGVSAENLLKLVPEHARKQCPSLGL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  643 bits (1659), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/429 (75%), Positives = 341/429 (79%), Gaps = 52/429 (12%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M S G+AP     +   D  + VD               D LPEE+++MKI+ +R   EM
Sbjct: 1   MASVGVAPTSGFREVLGDGEIGVD---------------DILPEEMSDMKIRDDR---EM 42

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVG GSFG+VFQAKCLETGETVA
Sbjct: 43  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVA 102

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNV---------------------------------- 146
           IKKVLQDKRYKNRELQTMRLLDHPNV                                  
Sbjct: 103 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIK 162

Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
           HYS+ +QRMP+IYVKLYTYQI RAL+YIH  IGVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 163 HYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 222

Query: 207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
           AKVLVKGEPNISYICSRYYRAPELIFGATEYTTA+D+WSVGCVLAELLLGQPLFPGE GV
Sbjct: 223 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGV 282

Query: 267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP EAVDLVSRLLQY
Sbjct: 283 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQY 342

Query: 327 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 386
           SPNLRC AL+   HPFFDELRDPNARLP GR  PPLFNFKP ELKG   E L KL+PEHA
Sbjct: 343 SPNLRCQALDCLTHPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEHA 402

Query: 387 RKQCPFLGF 395
           RKQCPFLG 
Sbjct: 403 RKQCPFLGL 411

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  642 bits (1656), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 315/429 (73%), Positives = 344/429 (80%), Gaps = 54/429 (12%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M S G+ P+ AV                  +   +    D+LPEE+ +MKI+ +   KEM
Sbjct: 1   MASVGIEPSAAVR-----------------ESTGNVTDADRLPEEMKDMKIQDD---KEM 40

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EAT+V+GN TETGHIIVTTIGGRNGQPKQTISYMAERVVG GSFG+VFQAKCLETGETVA
Sbjct: 41  EATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVA 100

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNV---------------------------------- 146
           IKKVLQD+RYKNRELQTMRLLDHPNV                                  
Sbjct: 101 IKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIK 160

Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
           HY++ +QRMPL+YVKLYTYQI R+L+YIH  IGVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 161 HYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 220

Query: 207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
           AKVLVKGEPNISYICSRYYRAPELIFGATEYTTA+D+WS GCVLAELLLGQPLFPGESGV
Sbjct: 221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGV 280

Query: 267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 340

Query: 327 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 386
           SPNLRC AL++ +HPFFDELRDPNARLPNGR  PPLFNFKP ELKG   E+++KL+PEHA
Sbjct: 341 SPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHA 400

Query: 387 RKQCPFLGF 395
           RKQCP+L  
Sbjct: 401 RKQCPWLSL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  640 bits (1652), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/399 (77%), Positives = 335/399 (83%), Gaps = 38/399 (9%)

Query: 31  DDDDDAMPVDKLPEEINEMKIKGERVEKEMEA-TVVDGNGTETGHIIVTTIGGRNGQPKQ 89
           D +  ++ V+KLPEE+N+MKI   R +KEMEA T+VDGNGTETGHIIVTTIGG+NGQPKQ
Sbjct: 14  DKNASSVGVEKLPEEMNDMKI---RDDKEMEAATIVDGNGTETGHIIVTTIGGKNGQPKQ 70

Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV--- 146
           TISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV   
Sbjct: 71  TISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL 130

Query: 147 -------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIH 175
                                          HY++ +QRMP+IYVKLY+YQICRALAYIH
Sbjct: 131 KHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSYQICRALAYIH 190

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 235
             IGVCHRDIKPQNLLVNPHTHQ+K+CDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT
Sbjct: 191 NSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 250

Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 295
           EYTTA+DIWS GCVL ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK
Sbjct: 251 EYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 310

Query: 296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPN 355
           FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR TALEA +HPF+D++RDPN RLPN
Sbjct: 311 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFYDDVRDPNTRLPN 370

Query: 356 GRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLG 394
           GR  PPLFNFK  ELKG   E+L KL+P HARKQC   G
Sbjct: 371 GRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQCALFG 409

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  631 bits (1628), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 313/428 (73%), Positives = 335/428 (78%), Gaps = 53/428 (12%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M + G+APA  +      DV           +   A+ VDKLP+EI  M+IK +   KEM
Sbjct: 1   MATAGVAPASGIV-----DV-----------NASSAIAVDKLPDEILGMRIKDD---KEM 41

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EA VVDGN TE GH+IVTTIGG+NGQPKQTISYMAER VGQGSFG+VFQAKCLETGETVA
Sbjct: 42  EAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVA 101

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNV---------------------------------- 146
           IKKVLQDKRYKNRELQTMRLLDHPNV                                  
Sbjct: 102 IKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIR 161

Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
           HYS+ +QRMPLIYVKLY+YQICR+LAYIH  +GV HRDIKPQNLLVNPHTHQ+KLCDFGS
Sbjct: 162 HYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGS 221

Query: 207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
           AKVLVKGEPNISYICSRYYRAPELIFGATEYT+A+DIWS GCVL ELLLGQPLFPG SGV
Sbjct: 222 AKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGV 281

Query: 267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQY
Sbjct: 282 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQY 341

Query: 327 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 386
           SPNLR TALEA +HPFFDELRDPN RLPNGR  PPLFNFK  ELKG   E+L KL+P HA
Sbjct: 342 SPNLRSTALEALVHPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPSHA 401

Query: 387 RKQCPFLG 394
           RKQC    
Sbjct: 402 RKQCSLFA 409

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  592 bits (1527), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 281/386 (72%), Positives = 315/386 (81%), Gaps = 38/386 (9%)

Query: 40  DKLPEEINEMKIKGER----VEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMA 95
           D+LP+ + EMKI+ ER     +K+ME TVV+G+GTETG +I TT+GGR+G+PKQTISYMA
Sbjct: 81  DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMA 140

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV--------- 146
           +RVVG GSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQ MRL DHPNV         
Sbjct: 141 QRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFS 200

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                    HY++ +Q MP+I+V+LYTYQICRAL Y+H  +GVC
Sbjct: 201 TTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVC 260

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRDIKPQNLLVNP THQ+K+CDFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT A+
Sbjct: 261 HRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAI 320

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIKA
Sbjct: 321 DMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKA 380

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPP 361
           HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC HPFFD+LRDPN  LPNGR  PP
Sbjct: 381 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPP 440

Query: 362 LFNFKPQELKGASKELLSKLIPEHAR 387
           LFNF  QEL GAS EL  +LIP H +
Sbjct: 441 LFNFTAQELAGASTELRQRLIPAHCQ 466

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FVS6|KSG4_ARATH Shaggy-related protein kinase delta OS=Arabidopsis thaliana GN=ASK4 PE=2 SV=1

 Score =  584 bits (1505), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 281/402 (69%), Positives = 315/402 (78%), Gaps = 37/402 (9%)

Query: 31  DDDDDAMPVDKLPEEINEMKIKGERV---EKEMEATVVDGNGTETGHIIVTTIGGRNGQP 87
           +  + +  VD L  ++ EMKI+ +     E++ E  ++DG G E GH+I TT+ GRNGQ 
Sbjct: 17  NTKNTSSSVDWLSRDMLEMKIRDKTEADEERDSEPDIIDGVGAEPGHVITTTLPGRNGQS 76

Query: 88  KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV- 146
           +QT+SY+AE VVG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LDHPNV 
Sbjct: 77  RQTVSYIAEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKNRELQIMQMLDHPNVV 136

Query: 147 ---------------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
                                             YSR +Q MPLIYVKLYTYQICR LAY
Sbjct: 137 CLKHSFYSRTENEEVYLNLVLEFVPETVNRTARSYSRMNQLMPLIYVKLYTYQICRGLAY 196

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
           +H   G+CHRDIKPQNLLVNPHTHQ+K+CDFGSAKVLVKGEPNISYICSRYYRAPELIFG
Sbjct: 197 LHNCCGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFG 256

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
           ATEYTTA+DIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE
Sbjct: 257 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 316

Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
           FKFPQIK HPWHK+F KR+PPEAVDL+ R  QYSPNLRCTA+EACIHPFFDELRDPNARL
Sbjct: 317 FKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAVEACIHPFFDELRDPNARL 376

Query: 354 PNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
           PNGRP PPLFNFKPQEL G   E + +L+PEHARKQ  F+  
Sbjct: 377 PNGRPLPPLFNFKPQELSGIPPETVDRLVPEHARKQNHFMAL 418

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39019|KSG10_ARATH Shaggy-related protein kinase kappa OS=Arabidopsis thaliana GN=ASK10 PE=2 SV=2

 Score =  581 bits (1498), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 276/394 (70%), Positives = 311/394 (78%), Gaps = 37/394 (9%)

Query: 39  VDKLPEEINEMKIKGE---RVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMA 95
           VD L  ++ E +I+ +     E++ E  ++DG G E GH+I TT+ GRNGQ +QT+SY++
Sbjct: 26  VDWLTRDLAETRIRDKVETDDERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYIS 85

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV--------- 146
           E VVG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LDHPN          
Sbjct: 86  EHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFS 145

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                     YSR +Q MPLIYVKLYTYQICRALAYIH   G+C
Sbjct: 146 RTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLC 205

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRDIKPQNLLVNPHTHQ+K+CDFGSAKVLVKGEPN+SYICSRYYRAPELIFGA+EYTTA+
Sbjct: 206 HRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAI 265

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           DIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 
Sbjct: 266 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 325

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPP 361
           HPWHK+F KR+PPEAVDL+ R  QYSPNLRCTALEACIHP FDELRDPN RLPNGRP PP
Sbjct: 326 HPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPP 385

Query: 362 LFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
           LFNFKPQEL G   E++++L+PEHARKQ  F+  
Sbjct: 386 LFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	395
296087644	412	unnamed protein product [Vitis vinifera]	0.956	0.917	0.815	0.0
359488836	416	PREDICTED: shaggy-related protein kinase	0.941	0.894	0.813	0.0
449515565	410	PREDICTED: shaggy-related protein kinase	0.911	0.878	0.860	0.0
449446680	410	PREDICTED: shaggy-related protein kinase	0.911	0.878	0.855	0.0
297811597	410	kinase family protein [Arabidopsis lyrat	0.951	0.917	0.778	0.0
22326813	410	Shaggy-related protein kinase epsilon [A	0.936	0.902	0.807	0.0
619894	409	Petunia Shaggy kinase 4 [Petunia x hybri	0.908	0.877	0.829	0.0
7573313	408	protein kinase MSK-3-like [Arabidopsis t	0.931	0.901	0.804	0.0
224068663	409	predicted protein [Populus trichocarpa]	0.916	0.885	0.817	0.0
164521171	409	serine/threonine protein kinase [Adonis	0.916	0.885	0.817	0.0

>gi|296087644|emb|CBI34900.3| unnamed protein product [Vitis vinifera]

 Score =  709 bits (1829), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/429 (81%), Positives = 363/429 (84%), Gaps = 51/429 (11%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M S G+ PA AV KP                   + M VDKLPEEINEMKI+ ++VEKEM
Sbjct: 1   MASAGIPPASAVGKP-----------------SGNTMFVDKLPEEINEMKIRDDKVEKEM 43

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA
Sbjct: 44  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 103

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNV---------------------------------- 146
           IKKVLQDKRYKNRELQTMRLLDHPN+                                  
Sbjct: 104 IKKVLQDKRYKNRELQTMRLLDHPNIVSLKHCFFSTTDKDELYLNLVLEYVPETVYRVAK 163

Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
           HYSRA+QRMPLIYVKLYTYQICRALAYIHG +GVCHRDIKPQNLLVNPH HQ+KLCDFGS
Sbjct: 164 HYSRANQRMPLIYVKLYTYQICRALAYIHGVVGVCHRDIKPQNLLVNPHIHQLKLCDFGS 223

Query: 207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
           AKVLVKGEPNISYICSRYYRAPELIFGATEYTTA+D+WSVGCVLAELLLGQPLFPGESGV
Sbjct: 224 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDMWSVGCVLAELLLGQPLFPGESGV 283

Query: 267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 284 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 343

Query: 327 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 386
           SPNLRCTALEACIHPFFDELRD N+RLPNGRP PPLFNFKPQELKGAS ELL+KLIPEHA
Sbjct: 344 SPNLRCTALEACIHPFFDELRDQNSRLPNGRPLPPLFNFKPQELKGASLELLAKLIPEHA 403

Query: 387 RKQCPFLGF 395
           RKQCPFLGF
Sbjct: 404 RKQCPFLGF 412

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488836|ref|XP_002276754.2| PREDICTED: shaggy-related protein kinase epsilon [Vitis vinifera]

 Score =  695 bits (1794), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/423 (81%), Positives = 357/423 (84%), Gaps = 51/423 (12%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M S G+ PA AV KP                   + M VDKLPEEINEMKI+ ++VEKEM
Sbjct: 1   MASAGIPPASAVGKP-----------------SGNTMFVDKLPEEINEMKIRDDKVEKEM 43

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA
Sbjct: 44  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 103

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNV---------------------------------- 146
           IKKVLQDKRYKNRELQTMRLLDHPN+                                  
Sbjct: 104 IKKVLQDKRYKNRELQTMRLLDHPNIVSLKHCFFSTTDKDELYLNLVLEYVPETVYRVAK 163

Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
           HYSRA+QRMPLIYVKLYTYQICRALAYIHG +GVCHRDIKPQNLLVNPH HQ+KLCDFGS
Sbjct: 164 HYSRANQRMPLIYVKLYTYQICRALAYIHGVVGVCHRDIKPQNLLVNPHIHQLKLCDFGS 223

Query: 207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
           AKVLVKGEPNISYICSRYYRAPELIFGATEYTTA+D+WSVGCVLAELLLGQPLFPGESGV
Sbjct: 224 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDMWSVGCVLAELLLGQPLFPGESGV 283

Query: 267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 284 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 343

Query: 327 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 386
           SPNLRCTALEACIHPFFDELRD N+RLPNGRP PPLFNFKPQELKGAS ELL+KLIPEHA
Sbjct: 344 SPNLRCTALEACIHPFFDELRDQNSRLPNGRPLPPLFNFKPQELKGASLELLAKLIPEHA 403

Query: 387 RKQ 389
           RKQ
Sbjct: 404 RKQ 406

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449515565|ref|XP_004164819.1| PREDICTED: shaggy-related protein kinase epsilon-like [Cucumis sativus]

 Score =  695 bits (1793), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/394 (86%), Positives = 347/394 (88%), Gaps = 34/394 (8%)

Query: 36  AMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMA 95
           A+  DKLPE INEMKI+ E+VEKEMEATVVDGNGTETGHIIVTTIGGRNGQ +QTISYMA
Sbjct: 17  ALFADKLPEGINEMKIRDEKVEKEMEATVVDGNGTETGHIIVTTIGGRNGQSRQTISYMA 76

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV--------- 146
           ER VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV         
Sbjct: 77  ERPVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 136

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                    HY++ASQRMPLIYVKLY YQICRALAYIHGGIGVC
Sbjct: 137 TTEKDELYLNLVLEYVPETVYRVIKHYTKASQRMPLIYVKLYAYQICRALAYIHGGIGVC 196

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA+
Sbjct: 197 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI 256

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           DIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA
Sbjct: 257 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 316

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPP 361
           HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN RLPNGRP PP
Sbjct: 317 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNTRLPNGRPLPP 376

Query: 362 LFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
           LFNFKPQELKGA+ ELLSKLIPEHARKQC FL F
Sbjct: 377 LFNFKPQELKGATLELLSKLIPEHARKQCSFLDF 410

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446680|ref|XP_004141099.1| PREDICTED: shaggy-related protein kinase epsilon-like [Cucumis sativus]

 Score =  689 bits (1778), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/394 (85%), Positives = 346/394 (87%), Gaps = 34/394 (8%)

Query: 36  AMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMA 95
           A+  DKLPE INEMKI+ E+VEKEMEATVVDGNGTETGHIIVTTIGGRNGQ +QTISYMA
Sbjct: 17  ALFADKLPEGINEMKIRDEKVEKEMEATVVDGNGTETGHIIVTTIGGRNGQSRQTISYMA 76

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV--------- 146
           ER VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV         
Sbjct: 77  ERPVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 136

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                    HY++A+QRMPLIYVKLY YQICRALAYIHGGIGVC
Sbjct: 137 TTEKDELYLNLVLEYVPETVYRVIKHYTKANQRMPLIYVKLYAYQICRALAYIHGGIGVC 196

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA+
Sbjct: 197 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI 256

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           DIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA
Sbjct: 257 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 316

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPP 361
           HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA IHPFFDELRDPN RLPNGRP PP
Sbjct: 317 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAFIHPFFDELRDPNTRLPNGRPLPP 376

Query: 362 LFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
           LFNFKPQELKGA+ ELLSKLIPEHARKQC FL F
Sbjct: 377 LFNFKPQELKGATLELLSKLIPEHARKQCSFLDF 410

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297811597|ref|XP_002873682.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297319519|gb|EFH49941.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  676 bits (1745), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/429 (77%), Positives = 351/429 (81%), Gaps = 53/429 (12%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M S G  PA +VA  + +                 ++  +KLPE INEMKIK +   KEM
Sbjct: 1   MASVGTLPASSVATKQSNA----------------SICAEKLPEGINEMKIKDD---KEM 41

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EA VVDGNGTETGHIIVTTIGG+NGQPKQTISYMAER+VGQGSFGIVFQAKCLETGETVA
Sbjct: 42  EAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVA 101

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNV---------------------------------- 146
           IKKVLQDKRYKNRELQTMRLLDHPNV                                  
Sbjct: 102 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSK 161

Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
           HYSRA+QRMP+IYVKLYTYQICRALAYIHGG+GVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 162 HYSRANQRMPMIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGS 221

Query: 207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
           AKVLVKGEPNISYICSRYYRAPELIFGATEYTTA+DIWS GCVLAELLLGQPLFPGESGV
Sbjct: 222 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGV 281

Query: 267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR PPEAVDLVSRLLQY
Sbjct: 282 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQY 341

Query: 327 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 386
           SP+LR TA+EA +HPFFDELRDPN RLPNGRP PPLFNFKPQEL GAS ELLSKLIP+HA
Sbjct: 342 SPSLRSTAMEAIVHPFFDELRDPNTRLPNGRPLPPLFNFKPQELNGASSELLSKLIPDHA 401

Query: 387 RKQCPFLGF 395
           RKQC FL  
Sbjct: 402 RKQCSFLAL 410

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|22326813|ref|NP_196968.2| Shaggy-related protein kinase epsilon [Arabidopsis thaliana] gi|46576619|sp|Q8VZD5.1|KSG5_ARATH RecName: Full=Shaggy-related protein kinase epsilon; AltName: Full=ASK-epsilon gi|18086450|gb|AAL57679.1| AT5g14640/T15N1_130 [Arabidopsis thaliana] gi|34365555|gb|AAQ65089.1| At5g14640/T15N1_130 [Arabidopsis thaliana] gi|332004674|gb|AED92057.1| Shaggy-related protein kinase epsilon [Arabidopsis thaliana]

 Score =  674 bits (1740), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/410 (80%), Positives = 345/410 (84%), Gaps = 40/410 (9%)

Query: 23  VDKLPAKP---DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTT 79
           V  LPA        + ++  +KLPE INEMKIK +   KEMEA VVDGNGTETGHIIVTT
Sbjct: 4   VGTLPASSMATKQSNASICAEKLPEGINEMKIKDD---KEMEAAVVDGNGTETGHIIVTT 60

Query: 80  IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 139
           IGG+NGQPKQTISYMAER+VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 140 LLDHPNV----------------------------------HYSRASQRMPLIYVKLYTY 165
           LLDHPNV                                  HYSRA+QRMP+IYVKLYTY
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 225
           QICRALAYIHGG+GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
           RAPELIFGATEYTT +DIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
           CMNPNYTEFKFPQIKAHPWHKIFHKR PPEAVDLVSRLLQYSPNLR TA+EA +HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDE 360

Query: 346 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
           LRDPN RLPNGR  PPLFNFKPQELKGAS ELLSKLIP+HARKQC FL  
Sbjct: 361 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|619894|emb|CAA58594.1| Petunia Shaggy kinase 4 [Petunia x hybrida]

 Score =  669 bits (1726), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 327/394 (82%), Positives = 343/394 (87%), Gaps = 35/394 (8%)

Query: 35  DAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM 94
           DAM VDKLPEEINEMKI+ ++ EKEMEA VVDGNGTE GHIIVTTIGG+NG+PKQTISYM
Sbjct: 16  DAMLVDKLPEEINEMKIRDDKAEKEMEAAVVDGNGTEKGHIIVTTIGGKNGEPKQTISYM 75

Query: 95  AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV-------- 146
           AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT+RLLDHPNV        
Sbjct: 76  AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTIRLLDHPNVVALRHCFF 135

Query: 147 --------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                                     HYS+A+Q+MP+IYVKLYTYQI RALAYIHG IGV
Sbjct: 136 STTEKDELYLNLVLEYVPETVYRVLRHYSKANQQMPMIYVKLYTYQIFRALAYIHG-IGV 194

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
           CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT A
Sbjct: 195 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTFA 254

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
           +DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK MNPNYTEFKFPQIK
Sbjct: 255 IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKSMNPNYTEFKFPQIK 314

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFP 360
           AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR TALEAC H FFDELRDP  RLPNGRP P
Sbjct: 315 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEACTHTFFDELRDPKTRLPNGRPLP 374

Query: 361 PLFNFKPQELKGASKELLSKLIPEHARKQCPFLG 394
           PLFNF+PQELKGAS +LL+KLIPEHA+KQC FLG
Sbjct: 375 PLFNFRPQELKGASADLLNKLIPEHAKKQCTFLG 408

Source: Petunia x hybrida

Species: Petunia x hybrida

Genus: Petunia

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7573313|emb|CAB87631.1| protein kinase MSK-3-like [Arabidopsis thaliana]

 Score =  666 bits (1719), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/410 (80%), Positives = 343/410 (83%), Gaps = 42/410 (10%)

Query: 23  VDKLPAKP---DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTT 79
           V  LPA        + ++  +KLPE INEMKIK +   KEMEA VVDGNGTETGHIIVTT
Sbjct: 4   VGTLPASSMATKQSNASICAEKLPEGINEMKIKDD---KEMEAAVVDGNGTETGHIIVTT 60

Query: 80  IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 139
           IGG+NGQPKQTISYMAER+VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 140 LLDHPNV----------------------------------HYSRASQRMPLIYVKLYTY 165
           LLDHPNV                                  HYSRA+QRMP+IYVKLYTY
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 225
           QICRALAYIHGG+GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
           RAPELIFGATEYTT +DIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
           CMNPNYTEFKFPQIKAHPWHKIFHKR PPEAVDLVSRLLQYSPNLR TA  A +HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTA--AIVHPFFDE 358

Query: 346 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
           LRDPN RLPNGR  PPLFNFKPQELKGAS ELLSKLIP+HARKQC FL  
Sbjct: 359 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 408

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224068663|ref|XP_002302794.1| predicted protein [Populus trichocarpa] gi|222844520|gb|EEE82067.1| predicted protein [Populus trichocarpa]

 Score =  661 bits (1706), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/399 (81%), Positives = 335/399 (83%), Gaps = 37/399 (9%)

Query: 31  DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQT 90
           D   +   VDKLPEE+N+MKI  +   KEMEA VVDGNGTETGHIIVTTIGG+NGQPKQT
Sbjct: 14  DTLGNTTGVDKLPEEMNDMKISDD---KEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQT 70

Query: 91  ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV---- 146
           ISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV    
Sbjct: 71  ISYMAERVVGHGSFGLVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK 130

Query: 147 ------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
                                         HY + SQRMPLIYVKLY YQICRALAYIH 
Sbjct: 131 HCFFSTTEKDELYLNLVLEYVPETIHRVIKHYYKMSQRMPLIYVKLYFYQICRALAYIHN 190

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 236
            IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE
Sbjct: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           YTTA+DIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF
Sbjct: 251 YTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNG 356
           PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR TALEA IHPFFDELRDPNARLPNG
Sbjct: 311 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNARLPNG 370

Query: 357 RPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
           R  PPLFNFKP ELKG   E+L KLIPEHARKQC FLG 
Sbjct: 371 RILPPLFNFKPHELKGVPVEMLVKLIPEHARKQCAFLGL 409

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|164521171|gb|ABY60447.1| serine/threonine protein kinase [Adonis aestivalis var. palaestina]

 Score =  661 bits (1706), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/399 (81%), Positives = 338/399 (84%), Gaps = 37/399 (9%)

Query: 31  DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQT 90
           D   +A   D+LPEE+N+MKI   R +KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQT
Sbjct: 14  DPTGNAGGADRLPEEMNDMKI---RDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQT 70

Query: 91  ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV---- 146
           ISYMAERVVG GSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV    
Sbjct: 71  ISYMAERVVGHGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK 130

Query: 147 ------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
                                         HY++ +QRMPLIYVKLYTYQICRALAYIHG
Sbjct: 131 HCFFSTTEKDELYLNLVLEYVPETAHRVIKHYNKMNQRMPLIYVKLYTYQICRALAYIHG 190

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 236
            IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE
Sbjct: 191 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           YTTA+DIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF
Sbjct: 251 YTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNG 356
           PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR TAL+A IHPFFDELRDP  RLPNG
Sbjct: 311 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALDALIHPFFDELRDPTTRLPNG 370

Query: 357 RPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
           R  PPLFNFKP ELKG   E+L KLIPEHARKQC FLG 
Sbjct: 371 RFLPPLFNFKPHELKGVPVEILGKLIPEHARKQCAFLGL 409

Source: Adonis aestivalis var. palaestina

Species: Adonis aestivalis

Genus: Adonis

Family: Ranunculaceae

Order: Ranunculales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	395
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.678	0.653	0.869	3.6e-176
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.681	0.664	0.833	4.2e-171
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.678	0.655	0.828	8.9e-169
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.663	0.555	0.771	4.4e-154
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.622	0.584	0.849	6.4e-153
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.612	0.594	0.839	6.4e-153
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.612	0.587	0.831	6.4e-153
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.612	0.636	0.827	4.5e-152
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.665	0.600	0.715	1.2e-136
UNIPROTKB|F1NPL8	390	GSK3B "Uncharacterized protein	0.610	0.617	0.732	2.6e-117

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1261 (449.0 bits), Expect = 3.6e-176, Sum P(2) = 3.6e-176
 Identities = 234/269 (86%), Positives = 247/269 (91%)

Query:   126 QDKRYKNRELQTM-RLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +D+ Y N  L+ +   +   + HYSRA+QRMP+IYVKLYTYQICRALAYIHGG+GVCHRD
Sbjct:   140 KDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRD 199

Query:   185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
             IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT +DIW
Sbjct:   200 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIW 259

Query:   245 SVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 304
             S GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW
Sbjct:   260 SAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 319

Query:   305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFN 364
             HKIFHKR PPEAVDLVSRLLQYSPNLR TA+EA +HPFFDELRDPN RLPNGR  PPLFN
Sbjct:   320 HKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFN 379

Query:   365 FKPQELKGASKELLSKLIPEHARKQCPFL 393
             FKPQELKGAS ELLSKLIP+HARKQC FL
Sbjct:   380 FKPQELKGASLELLSKLIPDHARKQCSFL 408

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1214 (432.4 bits), Expect = 4.2e-171, Sum P(2) = 4.2e-171
 Identities = 225/270 (83%), Positives = 243/270 (90%)

Query:   126 QDKRYKNRELQTMRLLDHPNV-HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +D+ Y N  L+ +    H  + HY++ +QRMPLIYVKLYTYQI RAL+YIH  IGVCHRD
Sbjct:   135 KDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRD 194

Query:   185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
             IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA+D+W
Sbjct:   195 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVW 254

Query:   245 SVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 304
             S GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW
Sbjct:   255 SAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 314

Query:   305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFN 364
             HKIFHKRMPPEAVDLVSRLLQYSPNLR  AL+  +HPFFDELRDPNARLPNGR  PPLFN
Sbjct:   315 HKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFN 374

Query:   365 FKPQELKGASKELLSKLIPEHARKQCPFLG 394
             FKP ELKG   E+++KL+PEHARKQCP+LG
Sbjct:   375 FKPHELKGVPLEMVAKLVPEHARKQCPWLG 404

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1215 (432.8 bits), Expect = 8.9e-169, Sum P(2) = 8.9e-169
 Identities = 223/269 (82%), Positives = 244/269 (90%)

Query:   126 QDKRYKNRELQTMRLLDHPNV-HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +D+ Y N  L+ +    H  + HY++ +QRMPL+YVKLYTYQI R+L+YIH  IGVCHRD
Sbjct:   139 KDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRD 198

Query:   185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
             IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA+D+W
Sbjct:   199 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVW 258

Query:   245 SVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 304
             S GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW
Sbjct:   259 SAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 318

Query:   305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFN 364
             HKIFHKRMPPEAVDLVSRLLQYSPNLRC AL++ +HPFFDELRDPNARLPNGR  PPLFN
Sbjct:   319 HKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFN 378

Query:   365 FKPQELKGASKELLSKLIPEHARKQCPFL 393
             FKP ELKG   E+++KL+PEHARKQCP+L
Sbjct:   379 FKPHELKGVPVEMVAKLVPEHARKQCPWL 407

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1121 (399.7 bits), Expect = 4.4e-154, Sum P(2) = 4.4e-154
 Identities = 203/263 (77%), Positives = 229/263 (87%)

Query:   126 QDKRYKNRELQTM-RLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +D+ Y N  L+ +   +   + HY++ +Q MP+I+V+LYTYQICRAL Y+H  +GVCHRD
Sbjct:   204 KDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRD 263

Query:   185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
             IKPQNLLVNP THQ+K+CDFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT A+D+W
Sbjct:   264 IKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMW 323

Query:   245 SVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 304
             S GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIKAHPW
Sbjct:   324 SGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPW 383

Query:   305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFN 364
             HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC HPFFD+LRDPN  LPNGR  PPLFN
Sbjct:   384 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFN 443

Query:   365 FKPQELKGASKELLSKLIPEHAR 387
             F  QEL GAS EL  +LIP H +
Sbjct:   444 FTAQELAGASTELRQRLIPAHCQ 466

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1174 (418.3 bits), Expect = 6.4e-153, Sum P(2) = 6.4e-153
 Identities = 209/246 (84%), Positives = 226/246 (91%)

Query:   148 YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 207
             YSR +Q MPLIYVKLYTYQICRALAYIH   G+CHRDIKPQNLLVNPHTHQ+K+CDFGSA
Sbjct:   172 YSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSA 231

Query:   208 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
             KVLVKGEPN+SYICSRYYRAPELIFGA+EYTTA+DIWS GCV+AELLLGQPLFPGESGVD
Sbjct:   232 KVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 291

Query:   268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 327
             QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDL+ R  QYS
Sbjct:   292 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYS 351

Query:   328 PNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 387
             PNLRCTALEACIHP FDELRDPN RLPNGRP PPLFNFKPQEL G   E++++L+PEHAR
Sbjct:   352 PNLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHAR 411

Query:   388 KQCPFL 393
             KQ  F+
Sbjct:   412 KQNLFM 417

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1129 (402.5 bits), Expect = 6.4e-153, Sum P(2) = 6.4e-153
 Identities = 204/243 (83%), Positives = 225/243 (92%)

Query:   147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
             HY+ ++QRMP+ YVKLYTYQI R LAYIH   GVCHRD+KPQNLLV+P THQVKLCDFGS
Sbjct:   158 HYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 217

Query:   207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
             AKVLVKGEPNISYICSRYYRAPELIFGATEYT ++DIWS GCVLAELLLGQPLFPGE+ V
Sbjct:   218 AKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSV 277

Query:   267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
             DQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQY
Sbjct:   278 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 337

Query:   327 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 386
             SP+LRCTALEAC HPFF+ELR+PNARLPNGRP PPLFNFK QEL GAS EL+++LIPEH 
Sbjct:   338 SPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELGGASMELINRLIPEHV 396

Query:   387 RKQ 389
             R+Q
Sbjct:   397 RRQ 399

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1122 (400.0 bits), Expect = 6.4e-153, Sum P(2) = 6.4e-153
 Identities = 202/243 (83%), Positives = 224/243 (92%)

Query:   147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
             HY+ ++QRMP+ YVKLYTYQI R LAYIH   GVCHRD+KPQNLLV+P THQ KLCDFGS
Sbjct:   160 HYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGS 219

Query:   207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
             AKVLVKGE NISYICSRYYRAPELIFGATEYT+++DIWS GCVLAELLLGQPLFPGE+ V
Sbjct:   220 AKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSV 279

Query:   267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
             DQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQY
Sbjct:   280 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 339

Query:   327 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 386
             SP+LRCTALEAC HPFF+ELR+PNARLPNGRP PPLFNFK QEL GAS EL+++LIPEH 
Sbjct:   340 SPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELSGASPELINRLIPEHV 398

Query:   387 RKQ 389
             R+Q
Sbjct:   399 RRQ 401

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1115 (397.6 bits), Expect = 4.5e-152, Sum P(2) = 4.5e-152
 Identities = 201/243 (82%), Positives = 224/243 (92%)

Query:   147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
             HYS A+QRMPL+YVKLY YQI R LAYIH   GVCHRD+KPQNLLV+P THQVK+CDFGS
Sbjct:   128 HYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFGS 187

Query:   207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
             AK LVKGE NISYICSR+YRAPELIFGATEYTT++DIWS GCVLAELLLGQPLFPGE+ V
Sbjct:   188 AKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247

Query:   267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
             DQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIKAHPWHKIFHKRMPPEA+D  SRLLQY
Sbjct:   248 DQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQY 307

Query:   327 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 386
             SP+LRCTALEAC HPFFDELR+PNARLPNGRPFPPLFNFK QE+ G+S EL++KLIP+H 
Sbjct:   308 SPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QEVAGSSPELVNKLIPDHI 366

Query:   387 RKQ 389
             ++Q
Sbjct:   367 KRQ 369

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1033 (368.7 bits), Expect = 1.2e-136, Sum P(2) = 1.2e-136
 Identities = 189/264 (71%), Positives = 221/264 (83%)

Query:   126 QDKRYKNRELQTM-RLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +D+ Y N  L+ +   +   +  Y++ +Q MPLIY++LYTYQICRA+ Y+H  +GVCHRD
Sbjct:   175 KDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRD 234

Query:   185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
             IKPQNLLVN  TH+VK+CDFGSAK+L+ GEPNISYICSRYYRAPELIFGATEYT+A+D+W
Sbjct:   235 IKPQNLLVNNVTHEVKICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMW 294

Query:   245 SVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 304
             SVGCV+AEL LG PLFPGE+ VDQLVEIIK+LGTP REEIK MNP Y +FKFPQIKA PW
Sbjct:   295 SVGCVMAELFLGHPLFPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPW 354

Query:   305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFN 364
             HKIF +++ PEA+DL SRLLQYSPNLRCTALEAC HPFFD+LRDP A LPNGR  PPLF+
Sbjct:   355 HKIFRRQVSPEAMDLASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFD 414

Query:   365 FKPQELKGASKELLSKLIPEHARK 388
             F  QEL GAS EL  +LIPEHARK
Sbjct:   415 FTAQELAGASVELRHRLIPEHARK 438

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|F1NPL8 GSK3B "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 965 (344.8 bits), Expect = 2.6e-117, Sum P(2) = 2.6e-117
 Identities = 178/243 (73%), Positives = 204/243 (83%)

Query:   147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
             HYSRA Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGS
Sbjct:   115 HYSRAKQTLPMIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGS 173

Query:   207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
             AK LV+GEPN+SYICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGV
Sbjct:   174 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 233

Query:   267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
             DQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y
Sbjct:   234 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 293

Query:   327 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 386
             +P  R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L S LIP HA
Sbjct:   294 TPTARLTPLEACAHSFFDELRDPNVKLPNGREKPALFNFTTQELS-SNPSLASILIPAHA 352

Query:   387 RKQ 389
             R Q
Sbjct:   353 RNQ 355

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0000320 "re-entry into mitotic cell cycle" evidence=IEA

GO:0001085 "RNA polymerase II transcription factor binding" evidence=IEA

GO:0001837 "epithelial to mesenchymal transition" evidence=IEA

GO:0001954 "positive regulation of cell-matrix adhesion" evidence=IEA

GO:0002039 "p53 binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005977 "glycogen metabolic process" evidence=IEA

GO:0006349 "regulation of gene expression by genetic imprinting" evidence=IEA

GO:0006611 "protein export from nucleus" evidence=IEA

GO:0006983 "ER overload response" evidence=IEA

GO:0007409 "axonogenesis" evidence=IEA

GO:0007520 "myoblast fusion" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0009887 "organ morphogenesis" evidence=IEA

GO:0010800 "positive regulation of peptidyl-threonine phosphorylation" evidence=IEA

GO:0016477 "cell migration" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0021766 "hippocampus development" evidence=IEA

GO:0030426 "growth cone" evidence=IEA

GO:0030529 "ribonucleoprotein complex" evidence=IEA

GO:0030877 "beta-catenin destruction complex" evidence=IEA

GO:0031333 "negative regulation of protein complex assembly" evidence=IEA

GO:0031334 "positive regulation of protein complex assembly" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0032091 "negative regulation of protein binding" evidence=IEA

GO:0032092 "positive regulation of protein binding" evidence=IEA

GO:0032855 "positive regulation of Rac GTPase activity" evidence=IEA

GO:0032886 "regulation of microtubule-based process" evidence=IEA

GO:0033138 "positive regulation of peptidyl-serine phosphorylation" evidence=IEA

GO:0034236 "protein kinase A catalytic subunit binding" evidence=IEA

GO:0035372 "protein localization to microtubule" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0043025 "neuronal cell body" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0043198 "dendritic shaft" evidence=IEA

GO:0044027 "hypermethylation of CpG island" evidence=IEA

GO:0044337 "canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process" evidence=IEA

GO:0045444 "fat cell differentiation" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0050321 "tau-protein kinase activity" evidence=IEA

GO:0051059 "NF-kappaB binding" evidence=IEA

GO:0051534 "negative regulation of NFAT protein import into nucleus" evidence=IEA

GO:0071109 "superior temporal gyrus development" evidence=IEA

GO:2000738 "positive regulation of stem cell differentiation" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.7342	0.9493	0.9168	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.8075	0.9063	0.8839	no	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.5477	0.7873	0.8036	yes	no
Q39012	KSG9_ARATH	2, ., 7, ., 1, 1, ., 1	0.7547	0.8405	0.8157	no	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.7520	0.8405	0.8058	no	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.7520	0.8405	0.8736	no	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.7005	0.9037	0.8479	no	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.5882	0.7265	0.7928	yes	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.7894	0.9164	0.8850	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6100	0.8101	0.7619	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.5675	0.7544	0.6381	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7552	0.9544	0.9172	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7313	0.9493	0.9124	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7794	0.9139	0.8783	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7091	0.8835	0.7457	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6100	0.8101	0.7619	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.8073	0.9367	0.9024	yes	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6100	0.8101	0.7619	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00020713001 SubName- Full=Chromosome chr14 scaffold_21, whole genome shotgun sequence; (409 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	395
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-120
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-85
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-81
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-76
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-75
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-73
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-70
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-70
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-69
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-68
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-67
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-67
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-66
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-64
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-63
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-62
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-61
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-60
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-57
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-57
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-56
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-54
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-54
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-54
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-53
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-53
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-51
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-51
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-50
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-50
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-49
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-49
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-49
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-48
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-47
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-47
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-47
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-46
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-44
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-44
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-43
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-43
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-43
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-42
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-42
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-42
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-41
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-40
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-39
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-39
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-36
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-35
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-35
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-33
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-32
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-31
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-30
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-30
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-28
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-28
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-28
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-27
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-26
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-26
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-26
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-25
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-25
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-24
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-24
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-24
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-23
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-23
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-20
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-20
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-18
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-18
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-17
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-16
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-16
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-12
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-12
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-11
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-07
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-06
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-06
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-06
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-06
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-06
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-06
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-06
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-06
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-05
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-05
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-04
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-04
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-04
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	0.002
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.003
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	0.004

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  356 bits (914), Expect = e-120
 Identities = 161/331 (48%), Positives = 217/331 (65%), Gaps = 39/331 (11%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV----- 146
           SY    ++G GSFG+V++A C++T E VAIKKVLQD +YKNREL  M+ L+H N+     
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126

Query: 147 --------------------------------HYSRASQRMPLIYVKLYTYQICRALAYI 174
                                           HY+R +  +PL  VKLY+YQ+CRALAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 234
           H    +CHRD+KPQNLL++P+TH +KLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
           T YTT +D+WS+GC++AE++LG P+F G+S VDQLV II+VLGTPT +++K MNPNY + 
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305

Query: 295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 354
           KFP +K     K+F K  P +A++ +S+ L+Y P  R   +EA   PFFD+LRDP  +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365

Query: 355 NG-RPFPPLFNFKPQELKGASKELLSKLIPE 384
                 P LFNF   E+K  S     K+IP+
Sbjct: 366 KYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  262 bits (672), Expect = 2e-85
 Identities = 114/333 (34%), Positives = 170/333 (51%), Gaps = 50/333 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y   + +G G++G+V  A    TG  VAIKK+      L D +   RE++ +R L H N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 147 ----------HYS--------------------RASQRMPLIYVKLYTYQICRALAYIHG 176
                                            ++ Q +   +++ + YQI R L Y+H 
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS 121

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELIF 232
              V HRD+KP N+LVN     +K+CDFG A+ +   E        Y+ +R+YRAPEL+ 
Sbjct: 122 A-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLL 179

Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNY 291
            ++ YT A+DIWSVGC+ AELL  +PLFPG   +DQL  I++VLGTP+ E++K + +   
Sbjct: 180 SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239

Query: 292 TEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
             +    P+    P  K+F     PEA+DL+ ++L + P  R TA EA  HP+  +L DP
Sbjct: 240 RNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298

Query: 350 NARLPNGRPFPPLFNFKPQELKGASKELLSKLI 382
               P  +P      F   EL   ++E L +LI
Sbjct: 299 E-DEPVAKPPFDFDFFDDDEL---TEEELKELI 327

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  249 bits (639), Expect = 5e-81
 Identities = 104/287 (36%), Positives = 158/287 (55%), Gaps = 53/287 (18%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHPN----- 145
           +G+G++G+V++A+  +TGE VA+KK+  D   +         RE+  ++ L HPN     
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 146 -VHYSRAS--------------------QRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
            V ++                         +    +K   YQ+ R LAY H    + HRD
Sbjct: 65  DVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRD 123

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAV 241
           +KPQN+L+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G+  Y+TAV
Sbjct: 124 LKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLGSKHYSTAV 180

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK-----F 296
           DIWSVGC+ AE++ G+PLFPG+S +DQL +I ++LGTPT E      P  T+       F
Sbjct: 181 DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW----PGVTKLPDYKPTF 236

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           P+       K+   R+ PE +DL+S++LQY+P  R +A EA  HP+F
Sbjct: 237 PKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  236 bits (604), Expect = 7e-76
 Identities = 106/286 (37%), Positives = 155/286 (54%), Gaps = 38/286 (13%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKN---RELQTMRLLDHPNV 146
           Y     +G+G++G+V++A+   TGE VAIKK+              RE++ ++ L+HPN+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 147 -------------------------HYSRASQR-MPLIYVKLYTYQICRALAYIHGGIGV 180
                                       +  QR +P   +K Y YQ+ + LA+ H   G+
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH-GI 119

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTT 239
            HRD+KP+NLL+N     +KL DFG A+       P   Y+ +R+YRAPEL+ G   Y+T
Sbjct: 120 LHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--YTEFKFP 297
            VDIWSVGC+ AELL  +PLFPG+S +DQL +I + LGTP  E            +F FP
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           +    P  K+F     P+A+DL+S++L Y P+ R TA +A  HP+F
Sbjct: 239 KKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  234 bits (600), Expect = 3e-75
 Identities = 105/284 (36%), Positives = 156/284 (54%), Gaps = 41/284 (14%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV---- 146
             +G+G+ GIVF+AK  ETGETVA+KKV   +          RE++ ++   HP V    
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 147 -------HYSRASQRM---------------PLIYVKLYTYQICRALAYIHGGIGVCHRD 184
                   +    + M               P   VK Y   + + +AY+H   G+ HRD
Sbjct: 66  DVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRD 124

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--ICSRYYRAPELIFGATEYTTAVD 242
           +KP NLL++     +K+ DFG A++  + EP +    + +R+YRAPEL++GA +Y   VD
Sbjct: 125 LKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVD 183

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQI 299
           +W+VGC+ AELL G PLFPGE+ ++QL  + + LGTP  E    +  + P+Y +  FP+ 
Sbjct: 184 LWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDYNKITFPES 242

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           K  P  +IF     PEA+DL+  LL Y P+ R +A EA  HP+F
Sbjct: 243 KPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  228 bits (583), Expect = 4e-73
 Identities = 95/282 (33%), Positives = 136/282 (48%), Gaps = 59/282 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNV- 146
           Y     +G+GSFG V+ A+  +TG+ VAIK +      +D+    RE++ ++ L HPN+ 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                       +   R+     + Y  QI  AL Y+H   G+ 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHS-KGIV 119

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP+N+L++   H VKL DFG A+ L  GE   +++ +  Y APE++ G   Y  AV
Sbjct: 120 HRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGKAV 177

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           DIWS+G +L ELL G+P FPG+   DQL+E+ K +G P                      
Sbjct: 178 DIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK--------------------- 213

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            P        + PEA DL+ +LL   P  R TA EA  HPFF
Sbjct: 214 -PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  222 bits (569), Expect = 2e-70
 Identities = 105/291 (36%), Positives = 149/291 (51%), Gaps = 47/291 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDH 143
           Y   + +G+G++ +V++A+  ETG  VAIKK+   +R +          RE++ ++ L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 144 PNV--------HYSRASQRMPLI------------------YVKLYTYQICRALAYIHGG 177
           PN+        H S  +     +                   +K Y     R L Y+H  
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC---SRYYRAPELIFGA 234
             + HRD+KP NLL+      +KL DFG A+    G PN        +R+YRAPEL+FGA
Sbjct: 122 -WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTRWYRAPELLFGA 177

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYT 292
             Y   VD+WSVGC+ AELLL  P  PG+S +DQL +I + LGTPT E    +   P+Y 
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237

Query: 293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           EFK       P  +IF      +A+DL+ RLL  +PN R TA +A  HP+F
Sbjct: 238 EFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  221 bits (565), Expect = 2e-70
 Identities = 86/281 (30%), Positives = 128/281 (45%), Gaps = 57/281 (20%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV--- 146
            R +G GSFG V++AK   TG+ VA+K + +            RE++ +R L HPN+   
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                                   Y      +     K    QI R L Y+H   G+ HR
Sbjct: 64  IDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS-NGIIHR 122

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAVD 242
           D+KP+N+L++     VK+ DFG AK L+K      +++ + +Y APE++ G   Y   VD
Sbjct: 123 DLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVD 181

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS+G +L ELL G+P F GE+ +DQL  I ++LG P                       
Sbjct: 182 VWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL---------------------- 219

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            + +        EA DL+ + L   P+ R TA E   HP+F
Sbjct: 220 EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  219 bits (561), Expect = 9e-69
 Identities = 106/303 (34%), Positives = 161/303 (53%), Gaps = 53/303 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRE---LQTMRLLDH 143
           Y   + +G+G++GIV++A    T E VA+KK+        D +   RE   LQ +   DH
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG--DH 66

Query: 144 PN------VHYSRASQRMPL----------------------IYVKLYTYQICRALAYIH 175
           PN      V   +A     +                      ++ +   YQ+ +AL YIH
Sbjct: 67  PNIVKLLNVI--KAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIH 124

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS------YICSRYYRAPE 229
            G  V HRD+KP N+L+N     VKL DFG A+ L + E N        Y+ +R+YRAPE
Sbjct: 125 SG-NVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182

Query: 230 LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
           ++ G+T YT  VD+WSVGC+L E+LLG+PLFPG S ++QL +II+V+G P+ E+I+ +  
Sbjct: 183 ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242

Query: 290 NYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
            +        P     P  ++   +   +A+DL+ +LL ++PN R TA EA  HP+  + 
Sbjct: 243 PFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301

Query: 347 RDP 349
            +P
Sbjct: 302 HNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  216 bits (553), Expect = 4e-68
 Identities = 100/283 (35%), Positives = 149/283 (52%), Gaps = 39/283 (13%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQ---DKRYKN---RELQTMRLLDHPNV----- 146
           VVG+G++G+V + +   TGE VAIKK  +   D+  K    RE++ +R L H N+     
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 147 --------------------HYSRASQR-MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                   AS   +P   V+ Y +Q+ +A+AY H    + HRDI
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDI 126

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLV--KGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           KP+N+LV+     +KLCDFG A+ L      P   Y+ +R+YRAPEL+ G T Y   VD+
Sbjct: 127 KPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDV 185

Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTEFKFPQIKA 301
           W++GC++AELL G+PLFPG+S +DQL  I K LG   P+ +E+   NP +    FP+   
Sbjct: 186 WAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQ 245

Query: 302 -HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                + +  ++   A+D +   L+  P  R T  E   HP+F
Sbjct: 246 PESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  216 bits (553), Expect = 2e-67
 Identities = 109/332 (32%), Positives = 172/332 (51%), Gaps = 50/332 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNV- 146
           Y     +G+G++G+V  A    TG  VAIKK+   + + +  R L+ +++L    H N+ 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 147 ----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                       +    +Q +   +++ + YQI R L YIH   
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA- 125

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELIFGA 234
            V HRD+KP NLL+N     +K+CDFG A++      +      Y+ +R+YRAPE++  +
Sbjct: 126 NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS 184

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NP---N 290
             YT A+DIWSVGC+LAE+L  +PLFPG+  + QL  I+ VLGTP++E++ C+ +    N
Sbjct: 185 KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARN 244

Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           Y +   P     PW+K+F     P+A+DL+ ++L ++P+ R T  EA  HP+ ++  DP+
Sbjct: 245 YIK-SLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS 302

Query: 351 ARLPNGRPFPPLFNFKPQELKGASKELLSKLI 382
                  PFP  F           KE L +LI
Sbjct: 303 DEPVAEEPFPFDFELFDD----LPKEKLKELI 330

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  214 bits (548), Expect = 2e-67
 Identities = 101/286 (35%), Positives = 159/286 (55%), Gaps = 46/286 (16%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL-DHPNV-- 146
           + +G G+FG V+ A+  ETGE VAIKK+ +  ++ +       RE++++R L +HPN+  
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 147 -----------HY--------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                      ++               R  +      ++   YQI + LA+IH   G  
Sbjct: 63  LKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK-HGFF 121

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP+NLLV+     VK+ DFG A+ +    P   Y+ +R+YRAPE++  +T Y++ V
Sbjct: 122 HRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPV 180

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPNYTEFKFP 297
           DIW++GC++AEL   +PLFPG S +DQL +I  VLGTPT+++     K  +     F+FP
Sbjct: 181 DIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK--LGFRFP 238

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           Q      H++      PEA+DL+  +L++ P  R TA +A  HP+F
Sbjct: 239 QFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  212 bits (543), Expect = 1e-66
 Identities = 89/285 (31%), Positives = 142/285 (49%), Gaps = 44/285 (15%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNV----- 146
           +G+G++G V++A+  +TGE VA+KK+  +   K        RE++ ++ L HPN+     
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 147 ------------------H-----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                             H           +     +K Y  Q+   L Y+H   G+ HR
Sbjct: 66  IVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS-NGILHR 124

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATEYTTAV 241
           DIK  N+L+N     +KL DFG A+   K       + + + +YR PEL+ GAT Y   V
Sbjct: 125 DIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEV 183

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQ 298
           D+WSVGC+LAEL LG+P+F G + ++QL +I ++ G+PT E    +  + P +   K  +
Sbjct: 184 DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWFENLKPKK 242

Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                  + F   + P A+DL+ +LL   P  R +A +A  H +F
Sbjct: 243 PYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  207 bits (529), Expect = 5e-64
 Identities = 110/337 (32%), Positives = 169/337 (50%), Gaps = 52/337 (15%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDHPN 145
            Y     +G G++G+V  A    +G+ VAIKK      V    +   REL+ +R   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 146 V-----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
           +                             H   + Q +   +++ + YQ+ R L YIH 
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS 125

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELI 231
              V HRD+KP NLLVN     +++ DFG A+ L             Y+ +R+YRAPEL+
Sbjct: 126 A-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183

Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 289
               EYTTA+D+WSVGC+ AE+L  + LFPG++ V QL  I+ VLG+P+ E +  +    
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243

Query: 290 --NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
              Y +   P+ +  PW KIF K   PEA+DL+S++LQ+ P  R T  +A  HPF  +  
Sbjct: 244 VRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301

Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPE 384
           DP+    +    PP F+F  + ++ + ++L   ++ E
Sbjct: 302 DPD----DEPTCPPPFDFDFEAIELSREQLKEAIVKE 334

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  206 bits (525), Expect = 2e-63
 Identities = 115/330 (34%), Positives = 172/330 (52%), Gaps = 48/330 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y+  + +G+G++GIV  AK  ET E VAIKK+        D +   RE++ +R LDH NV
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 147 ------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
                                            R+SQ +   + + + YQ+ R L YIH 
Sbjct: 67  IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 235
              V HRD+KP NLL+N +   +K+CDFG A+    KG+    Y+ +R+YRAPEL+   +
Sbjct: 127 A-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS 184

Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF 294
           EYTTA+D+WSVGC+ AELL  +PLFPG+  V QL  I ++LG+P+ E++  + N     +
Sbjct: 185 EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244

Query: 295 --KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 352
               P      + ++F     P A+DL+ ++L + P+ R T  EA  HP+   L DP+  
Sbjct: 245 IRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303

Query: 353 LPNGRPFPPLFNFKPQELKGASKELLSKLI 382
                PF   F+F+   L     E + +LI
Sbjct: 304 PVCQTPFS--FDFEEDALTE---EDIKELI 328

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  202 bits (516), Expect = 1e-62
 Identities = 94/284 (33%), Positives = 152/284 (53%), Gaps = 46/284 (16%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  +   +       RE+  ++ L+HPN+      
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 147 -------------------HY--SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                               Y  S     +    +K Y YQ+ + +AY H    V HRD+
Sbjct: 67  VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDL 125

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL++     +KL DFG A+    G P  +Y   + + +YRAPE++ G+ +Y+T VD
Sbjct: 126 KPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVD 182

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQI 299
           IWS+GC+ AE++  +PLFPG+S +DQL  I + LGTP  +    +  + P+Y    FP+ 
Sbjct: 183 IWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYKP-TFPKW 240

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                 K+    +  + +DL+S++L Y P  R +A  A  HP+F
Sbjct: 241 ARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  200 bits (511), Expect = 3e-61
 Identities = 101/301 (33%), Positives = 152/301 (50%), Gaps = 52/301 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 144
           Y     VG G++G V  A   +TG  VAIKK+ +        KR Y  REL+ ++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 145 NV-------------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
           NV                               +  +  Q++   +++   YQI R L Y
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-CQKLSDDHIQFLVYQILRGLKY 133

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
           IH   G+ HRD+KP N+ VN    ++K+ DFG A+     +    Y+ +R+YRAPE++  
Sbjct: 134 IHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLN 189

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---- 289
              Y   VDIWSVGC++AELL G+ LFPG   +DQL  I+ ++GTP  E ++ ++     
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249

Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
           NY +   PQ+    + ++F     P A+DL+ ++L   P+ R TA EA  HP+  E  DP
Sbjct: 250 NYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307

Query: 350 N 350
            
Sbjct: 308 E 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  196 bits (500), Expect = 3e-60
 Identities = 98/281 (34%), Positives = 146/281 (51%), Gaps = 43/281 (15%)

Query: 100 GQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL-DHPN------ 145
           G+G+F  V +A+  +TG+  AIK +   K +K+       RE+Q +R L  HPN      
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 146 VHYSRASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHR 183
           V + R + R+ L++                      VK Y YQ+ ++L ++H   G+ HR
Sbjct: 66  VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHR 124

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+N+L+      +KL DFGS + +    P   YI +R+YRAPE +     Y   +DI
Sbjct: 125 DIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDI 182

Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-NYTEFKFPQIKAH 302
           W+VGCV  E+L   PLFPG + +DQ+ +I  VLGTP  E +K      +  + FP  K  
Sbjct: 183 WAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGT 242

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
              K+       E +DL+ +LL Y P+ R TA +A  HP+F
Sbjct: 243 GLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  190 bits (485), Expect = 1e-57
 Identities = 106/298 (35%), Positives = 148/298 (49%), Gaps = 49/298 (16%)

Query: 99  VGQGSFGIVFQAKCLET--GETVAIKK---VLQDKRYKNRELQTMRLL----DHPN---- 145
           +GQG++GIV  A+  ET   ETVAIKK   V   K    R L+ ++LL     H N    
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 146 -----VHYS--------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                V                       R+ Q +   + + + YQI   L YIH    V
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA-NV 126

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAK----VLVKGEPNIS-YICSRYYRAPELIFGAT 235
            HRD+KP NLLVN    ++K+CDFG A+       +    ++ Y+ +R+YRAPE++    
Sbjct: 127 LHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ 185

Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 292
            YT A+D+WSVGC+LAELL  +P+F G+  VDQL +I++VLGTP  E    I        
Sbjct: 186 SYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNY 245

Query: 293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
               P I   P+  IF     P A+DL+ +LL + P  R +  EA  HP+     DP+
Sbjct: 246 IRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  187 bits (477), Expect = 7e-57
 Identities = 108/282 (38%), Positives = 159/282 (56%), Gaps = 39/282 (13%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQ---DKRYKN---RELQTMRLLDHPN----VH 147
           +VG+GS+G+V + K  ETG+ VAIKK L+   DK  K    RE++ ++ L H N    + 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 148 YSRASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHRDI 185
             R  +R+ L++                      V+ Y +QI R + + H    + HRDI
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDI 126

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
           KP+N+LV+  +  VKLCDFG A+ L   GE    Y+ +R+YRAPEL+ G T+Y  AVDIW
Sbjct: 127 KPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIW 185

Query: 245 SVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTEFKFPQIK-A 301
           +VGC++ E+L G+PLFPG+S +DQL  IIK LG   P  +EI   NP +   + P++K  
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI 245

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            P  K F K +    +DL  + L+  P+ R ++ +   H FF
Sbjct: 246 EPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  185 bits (472), Expect = 5e-56
 Identities = 98/287 (34%), Positives = 148/287 (51%), Gaps = 52/287 (18%)

Query: 101 QGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN-VHYSR--A 151
           +G++G+V++A+  +TGE VA+KK+  +K  +       RE+  +  L HPN V       
Sbjct: 15  EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV 74

Query: 152 SQRMPLIY-------------------------VKLYTYQICRALAYIHGGIGVCHRDIK 186
              +  IY                         VK    Q+   +A++H    + HRD+K
Sbjct: 75  GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLK 133

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVDI 243
             NLL+N +   +K+CDFG A+    G P   Y   + + +YRAPEL+ GA EY+TA+D+
Sbjct: 134 TSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDM 190

Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WSVGC+ AELL  +PLFPG+S +DQL +I K+LGTPT +      P ++E    + K   
Sbjct: 191 WSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPGAKKKTFT 246

Query: 304 WH-------KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            +       K     +     DL++RLL Y P  R +A +A  HP+F
Sbjct: 247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  182 bits (464), Expect = 2e-54
 Identities = 123/341 (36%), Positives = 176/341 (51%), Gaps = 54/341 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y  + V+G+GS+G+V  A    TGE VAIKK+      + D     RE++ +RLL HP++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 147 ----HYSRASQRMPL--IYV------------------------KLYTYQICRALAYIHG 176
               H      R     IYV                        + + YQ+ RAL YIH 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIF 232
              V HRD+KP+N+L N    ++K+CDFG A+V     P       Y+ +R+YRAPEL  
Sbjct: 122 A-NVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC- 178

Query: 233 GA--TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCMNP 289
           G+  ++YT A+DIWS+GC+ AE+L G+PLFPG++ V QL  I  +LGTP+ E I +  N 
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238

Query: 290 NYTEFKFPQIKAHPWHKIFHKRMP---PEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
               +     K  P    F ++ P   P A+ L+ RLL + P  R TA EA   P+F  L
Sbjct: 239 KARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296

Query: 347 RDPNARLPNGRPFPPL-FNFKPQEL-KGASKELLSKLIPEH 385
                R P+ +P   L F F+ + L K   +EL+ + I E+
Sbjct: 297 AKVE-REPSAQPITKLEFEFERRRLTKEDVRELIYREILEY 336

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  181 bits (460), Expect = 3e-54
 Identities = 99/295 (33%), Positives = 151/295 (51%), Gaps = 57/295 (19%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RE---LQTM-------RLLD 142
           +G+G++G V++A+   TG+ VA+KK   +   +       RE   LQ +       RLLD
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 143 HPNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
             +V                          +     + +P   +K + YQ+ + +A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 233
             GV HRD+KPQNLLV+     +K+ D G  +      P  SY   I + +YRAPE++ G
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
           +T Y+T VDIWSVGC+ AE+   QPLFPG+S + QL+ I K+LGTPT +      P  ++
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSK 241

Query: 294 FK----FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
            +    FPQ K     +     + PE +DL+ ++L+Y P  R +A  A  HP+FD
Sbjct: 242 LRDWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  180 bits (459), Expect = 8e-54
 Identities = 101/295 (34%), Positives = 158/295 (53%), Gaps = 41/295 (13%)

Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDH 143
           T  Y+  + VG G+FG+V  A+   TG+ VAIKK+++        +   REL+ ++ L H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 144 PNV-------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
            N+                         H    S+ +   +++ + YQI R L Y+H   
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA- 127

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEY 237
           GV HRD+KP N+L+N +   +K+CDFG A++    +P ++ Y+ +RYYRAPE++    +Y
Sbjct: 128 GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAPEIMLTWQKY 183

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 294
              VDIWS GC+ AE+L G+PLFPG+  V+Q   I  +LGTP  + I  + + N   F  
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243

Query: 295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
             P+ +  P+ + F K   P A+DL+ ++L + P  R +A EA  HP+     DP
Sbjct: 244 SLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  179 bits (455), Expect = 1e-53
 Identities = 94/281 (33%), Positives = 148/281 (52%), Gaps = 39/281 (13%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPN----VHY 148
           +G+GS+G+VF+ +  ETG+ VAIKK ++       K+   RE++ ++ L HPN    +  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 149 SRASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHRDIK 186
            R  +++ L++                      +K   +Q  +A+ + H      HRD+K
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVK 127

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEYTTAVDIWS 245
           P+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+ G T+Y   VD+W+
Sbjct: 128 PENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWA 186

Query: 246 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTEFKFPQIKA-H 302
           +GCV AELL GQPL+PG+S VDQL  I K LG   P  ++I   N  +     P+ +   
Sbjct: 187 IGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETRE 246

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           P    F   +   A+  +   LQ  P  R +  E   HP+F
Sbjct: 247 PLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  178 bits (453), Expect = 2e-53
 Identities = 101/289 (34%), Positives = 153/289 (52%), Gaps = 56/289 (19%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 147 -------------------HYSRASQR--MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                               +  AS    +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 68  IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 126

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 127 KPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 183

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK-----FP 297
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       + P  T        FP
Sbjct: 184 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTSLPDYKPSFP 239

Query: 298 QIKAHPWHKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           +     + K+    +PP   +  DL+S++L Y PN R +A  A  HPFF
Sbjct: 240 KWARQDFSKV----VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  173 bits (441), Expect = 2e-51
 Identities = 97/294 (32%), Positives = 160/294 (54%), Gaps = 43/294 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y     +G+G++G+V++A+   T ET+A+KK+  ++  +       RE+  ++ + H N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 147 ----HYSRASQRMPLIY-----------------------VKLYTYQICRALAYIHGGIG 179
                   + +R+ L++                       +K Y YQI R +AY H    
Sbjct: 64  VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-R 122

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE 236
           V HRD+KPQNLL++  T+ +KL DFG A+    G P  ++   + + +YRAPE++ G+  
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILLGSRH 180

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEF 294
           Y+T VDIWSVGC+ AE++  +PLFPG+S +D+L +I ++LGTP  E    +   P+Y   
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS- 239

Query: 295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 348
            FP+        +    + P  VDL+S++L+  P+ R TA  A  H +F +L D
Sbjct: 240 AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Length = 294

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  173 bits (440), Expect = 4e-51
 Identities = 98/289 (33%), Positives = 145/289 (50%), Gaps = 50/289 (17%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV---HYS 149
           +G+G++GIV++A+   +GE VA+KKV  D           RE+  +  L HPN+      
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 150 RASQRMPLIY-------------------------VKLYTYQICRALAYIHGGIGVCHRD 184
              + +  I+                         VK    Q+ R L Y+H    + HRD
Sbjct: 75  VVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF-IIHRD 133

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAV 241
           +K  NLL+      +K+ DFG A+    G P       + + +YRAPEL+ G T YTTA+
Sbjct: 134 LKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAI 190

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQI 299
           D+W+VGC+LAELL  +PL PG+S ++QL  II++LGTP        +  P   +F  P+ 
Sbjct: 191 DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPK- 249

Query: 300 KAHPWHKIFHKRMP--PEA-VDLVSRLLQYSPNLRCTALEACIHPFFDE 345
              P++ + HK  P   EA + L++ LL Y P  R TA EA    +F E
Sbjct: 250 --QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  169 bits (431), Expect = 4e-50
 Identities = 93/283 (32%), Positives = 154/283 (54%), Gaps = 44/283 (15%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV------- 146
           +G+G++  V++ +   TGE VA+K++  D          RE+  M+ L H N+       
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 147 ------------------HY--SRASQR-MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                              Y  +   +  +    VK +TYQ+ + +A+ H    V HRD+
Sbjct: 68  HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDL 126

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N    ++KL DFG A+    G P  ++   + + +YRAP+++ G+  Y+T++D
Sbjct: 127 KPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSID 183

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWSVGC++AE++ G+PLFPG +  DQL++I +++GTPT      ++  P Y +  FP+  
Sbjct: 184 IWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY-KPTFPRYP 242

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                ++F     P  +DL+ RLLQ +P LR +A +A  HP+F
Sbjct: 243 PQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  170 bits (432), Expect = 4e-50
 Identities = 96/290 (33%), Positives = 149/290 (51%), Gaps = 42/290 (14%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKR----YKNRELQTMRLLDHPN- 145
           +Y     +G+GS+  V++ +   TG+ VA+K++ L+ +        RE   ++ L H N 
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 146 ------VHYSRA------------SQRM---PLIY----VKLYTYQICRALAYIHGGIGV 180
                 +H  +              Q M           V+L+ +Q+ R LAY H    V
Sbjct: 66  VTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR-RV 124

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEY 237
            HRD+KPQNLL++    ++KL DFG A+   K  P+ +Y   + + +YR P+++ G+TEY
Sbjct: 125 LHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK--CMNPNYTEF 294
           +T++D+W VGC+  E+  G+PLFPG + V DQL +I +VLGTPT E       NP +  +
Sbjct: 182 STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241

Query: 295 KFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            FP     P      +    P   +L  + LQY P  R +A EA  HP+F
Sbjct: 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  169 bits (430), Expect = 1e-49
 Identities = 92/306 (30%), Positives = 143/306 (46%), Gaps = 73/306 (23%)

Query: 100 GQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNV------ 146
           G+G+FG V++A+ ++TG  VA+KK+L     K+       RE++ ++ L HPNV      
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 147 ---HYSRASQRMPLIY-------------------------VKLYTYQICRALAYIHGGI 178
                 ++ ++   +Y                         +K Y  Q+   + Y+H   
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN- 134

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------------ICSRYYR 226
            + HRDIK  N+L++ +   +K+ DFG A+      PN               + +R+YR
Sbjct: 135 HILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR 193

Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
            PEL+ G   YTTAVDIW +GCV AE+   +P+  G+S +DQL  I K+ GTPT E    
Sbjct: 194 PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETW-- 251

Query: 287 MNPNYTEFKFPQIKAHPWH---------KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 337
             P +     P       H         +    ++ PE +DL+S+LL   P  R TA +A
Sbjct: 252 --PGWR--SLP--GCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305

Query: 338 CIHPFF 343
             HP+F
Sbjct: 306 LEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  167 bits (426), Expect = 3e-49
 Identities = 95/287 (33%), Positives = 151/287 (52%), Gaps = 52/287 (18%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+      
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 147 -HYSRASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHR 183
            H   + +++ L++                      VK + +Q+ + LA+ H    V HR
Sbjct: 68  LH---SDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHR 123

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTA 240
           D+KPQNLL+N +  ++KL DFG A+    G P   Y   + + +YR P+++FGA  Y+T+
Sbjct: 124 DLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180

Query: 241 VDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEF-KF 296
           +D+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E    ++  P+Y  +  +
Sbjct: 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY 240

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           P   +     +   ++     DL+  LL  +P  R +A EA  HP+F
Sbjct: 241 PATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  169 bits (430), Expect = 5e-49
 Identities = 104/297 (35%), Positives = 149/297 (50%), Gaps = 51/297 (17%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKK---VLQD----KRYKNRELQTMRLLDHPNV-- 146
           +R +G G+FG+V+       G+ VA+KK   V Q+    KR   REL+ +    H NV  
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63

Query: 147 ---------------------------HYSRAS-QRMPLIYVKLYTYQICRALAYIHGGI 178
                                      H    S Q +   +VK++ YQI R L Y+H   
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA- 122

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-----ICSRYYRAPELIFG 233
           G+ HRDIKP NLLVN +   +K+CDFG A+V    EP+ S      + ++YYRAPE++ G
Sbjct: 123 GILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVVTQYYRAPEILMG 178

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
           +  YT+AVDIWSVGC+ AELL  + LF  +S + QL  I  +LGTP+ E ++        
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238

Query: 294 FKFPQIKAHPWHKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
                    P   + +        EAV L+ R+L + P+ R +A +A  HP+ DE R
Sbjct: 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  164 bits (417), Expect = 5e-48
 Identities = 91/301 (30%), Positives = 142/301 (47%), Gaps = 76/301 (25%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 145
           +G+G++G V++A+ L TG  VA+KKV    R             RE+  ++ L+   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 146 V-------HYSRASQRMPLIYV-------------------------KLYTYQICRALAY 173
           +       H  R  + + L  V                         K    Q+ R + +
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
           +H    + HRD+KPQN+LV     QVK+ DFG A++        S + + +YRAPE++  
Sbjct: 123 LHSH-RIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ 180

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
           ++ Y T VD+WSVGC+ AEL   +PLF G S  DQL +I  V+G P+ EE          
Sbjct: 181 SS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE---------- 229

Query: 294 FKFPQIKAHPWHKIFHKR-----------MPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             +P+  + P    F              +  E +DL+ ++L ++P+ R +A EA  HP+
Sbjct: 230 --WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Query: 343 F 343
           F
Sbjct: 287 F 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  163 bits (415), Expect = 2e-47
 Identities = 103/314 (32%), Positives = 144/314 (45%), Gaps = 74/314 (23%)

Query: 99  VGQGSFGIVFQAKCLE--TGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNV--- 146
           +G+G++G V++AK      G+  AIKK   DK           RE+  +R L H NV   
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 147 ---------------------------HYSRASQRMPL--IYVKLYTYQICRALAYIHGG 177
                                       + R ++R+ +    VK   +QI   + Y+H  
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127

Query: 178 IGVCHRDIKPQNLLV---NPHTHQVKLCDFGSA-------KVLVKGEPNISYICSRYYRA 227
             V HRD+KP N+LV    P    VK+ D G A       K L   +P +  I   +YRA
Sbjct: 128 W-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---WYRA 183

Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG---------VDQLVEIIKVLGT 278
           PEL+ GA  YT A+DIW++GC+ AELL  +P+F G             DQL  I +VLGT
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGT 243

Query: 279 PTREE---IKCMNPNY----TEFKFPQIKAHPWHKIFHKRMP--PEAVDLVSRLLQYSPN 329
           PT ++   IK M P Y     +FK     ++   K   K      +  DL+ +LL+Y P 
Sbjct: 244 PTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPT 302

Query: 330 LRCTALEACIHPFF 343
            R TA EA  HP+F
Sbjct: 303 KRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  161 bits (410), Expect = 5e-47
 Identities = 94/288 (32%), Positives = 149/288 (51%), Gaps = 53/288 (18%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLDHPNV-- 146
           +G+G++G+V++ +  +TG+ VA+KK+    R ++          RE+  ++ L HPN+  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 147 ------HYSR--------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                   SR                      Q M    VK Y YQI + + + H    V
Sbjct: 64  LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR-RV 122

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEY 237
            HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + +YRAPE++ G+  Y
Sbjct: 123 LHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFK 295
           +T VDIWS+G + AE+   +PLF G+S +DQL  I ++LGTPT +    +   P+Y    
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN-T 238

Query: 296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           FP+ K         K +  + +DL+ ++L Y P  R +A +A  HP+F
Sbjct: 239 FPKWKKGSLRSAV-KNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  163 bits (414), Expect = 5e-47
 Identities = 100/292 (34%), Positives = 148/292 (50%), Gaps = 46/292 (15%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDH------------ 143
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H            
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 144 --PNVHYSRASQ---RMPLI----------------YVKLYTYQICRALAYIHGGIGVCH 182
             P++   R       MP +                 ++   YQ+ + L YIH   G+ H
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA-GIIH 141

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVD 242
           RD+KP NL VN    ++K+ DFG A+          Y+ +R+YRAPE+I     YT  VD
Sbjct: 142 RDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMHYTQTVD 198

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFPQ 298
           IWSVGC++AE+L G+PLF G   +DQL+EI+KV GTP++E ++ +      NY + K P+
Sbjct: 199 IWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK-KLPR 257

Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
            +   +  +      P AV+++ ++L      R TA EA  HP+F+E  DP 
Sbjct: 258 FRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  162 bits (412), Expect = 1e-46
 Identities = 100/298 (33%), Positives = 149/298 (50%), Gaps = 47/298 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDHPN---- 145
           Y + + VG G++G V  A    TGE VAIKK+    Q + +  R  + + LL H      
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 146 -----VHYSRASQR--------MPLIYVKL---------------YTYQICRALAYIHGG 177
                V  S  S          MP +   L                 YQ+   L YIH  
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATE 236
            G+ HRD+KP NL VN    ++K+ DFG A+     +  ++ Y+ +R+YRAPE+I     
Sbjct: 137 -GIIHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPEVILNWMH 191

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN----PNYT 292
           Y   VDIWSVGC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +      +Y 
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYI 251

Query: 293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           +   P+     +  +F  +  P+AVDL+ ++L+   + R TA EA  HP+FD  RD +
Sbjct: 252 K-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  163 bits (412), Expect = 2e-46
 Identities = 81/322 (25%), Positives = 123/322 (38%), Gaps = 72/322 (22%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHP 144
           SY   R +G+GSFG V+ A+     + VA+K + +    K+       RE+Q +  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 145 N------------------------------VHYSRASQRMPLIYVKLYTYQICRALAYI 174
                                          +        +          QI  AL Y+
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-------SYICSRYYRA 227
           H   G+ HRDIKP+N+L++     VKL DFG AK+L              + + +  Y A
Sbjct: 118 H-SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 228 PELIFGATE--YTTAVDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTPTRE 282
           PE++ G +    +++ DIWS+G  L ELL G P F GE       Q ++II  L TP   
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233

Query: 283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                             A P      + +   A DL+ +LL   P  R ++     H  
Sbjct: 234 ----------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277

Query: 343 FDELRDPNARLPNGRPFPPLFN 364
              L+   + L +         
Sbjct: 278 LAHLKLKESDLSDLLKPDDSAP 299

Length = 384

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  157 bits (400), Expect = 3e-46
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 58/239 (24%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV------- 146
           +G+G FG V+ A+  +TG+ VAIK + ++          RE++ ++ L+HPN+       
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 147 --------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 186
                                      ++    +     QI   L Y+H   G+ HRD+K
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLK 119

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVDIWS 245
           P+N+L++    +VKL DFG +K+L   +  +  I  +  Y APE++ G   Y+   DIWS
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 246 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHP 303
           +G +L EL              +L ++I+          K +  +  +     +I  H 
Sbjct: 180 LGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  154 bits (391), Expect = 2e-44
 Identities = 85/284 (29%), Positives = 118/284 (41%), Gaps = 66/284 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNV---- 146
            ++G+GSFG V+ A   +TGE +A+K V L     +      RE++ +  L HPN+    
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 147 -HYSRASQRMPLIY-----------------------VKLYTYQICRALAYIHGGIGVCH 182
                  +    I+                       ++ YT QI   LAY+H   G+ H
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN-GIVH 124

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---YYRAPELIFGATEYTT 239
           RDIK  N+LV+     VKL DFG AK L   E        R   Y+ APE+I G  EY  
Sbjct: 125 RDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-EEYGR 182

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           A DIWS+GC + E+  G+P +         +  I   G P                 P+I
Sbjct: 183 AADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-----------------PEI 225

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
             H         +  EA D + + L+  P  R TA E   HPF 
Sbjct: 226 PEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  154 bits (390), Expect = 4e-44
 Identities = 106/284 (37%), Positives = 150/284 (52%), Gaps = 42/284 (14%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPN-VHYSR 150
           VVG+G++G+V + +  ET E VAIKK          K    REL+ +R L   N V    
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 151 ASQRMPLIY-------------------------VKLYTYQICRALAYIHGGIGVCHRDI 185
           A +R   +Y                         V+ Y YQ+ +A+ + H    + HRDI
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDI 126

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNIS-YICSRYYRAPELIFGATEYTTAVDI 243
           KP+NLL++ H   +KLCDFG A+ L +G   N + Y+ +R+YR+PEL+ GA  Y  AVD+
Sbjct: 127 KPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDM 184

Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFKFPQIKA 301
           WSVGC+L EL  GQPLFPGES +DQL  I KVLG    E++K    NP +   +FP +  
Sbjct: 185 WSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV-N 243

Query: 302 HP--WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           HP    + +   +    +DL+  LL+ +P  R    +   HP F
Sbjct: 244 HPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  152 bits (386), Expect = 5e-43
 Identities = 104/329 (31%), Positives = 159/329 (48%), Gaps = 52/329 (15%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 142

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 143 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 199

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 200 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 258

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 259 QMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 316

Query: 358 PFPPLFNFKP---QELKGASKELLSKLIP 383
           P+   F  +     E K  + + +   +P
Sbjct: 317 PYDQSFESRDLLIDEWKSLTYDEVISFVP 345

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  151 bits (382), Expect = 9e-43
 Identities = 91/300 (30%), Positives = 158/300 (52%), Gaps = 41/300 (13%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
           +Y+    +G+G++  V++ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 147 ---HYSRASQR-MPLIY----------------------VKLYTYQICRALAYIHGGIGV 180
              H    +++ + L++                      VKL+ +Q+ R L Y H    V
Sbjct: 67  VTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR-KV 125

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEY 237
            HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+++ G+T+Y
Sbjct: 126 LHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 295
           +T +D+W VGC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  N  +  + 
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242

Query: 296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPN 355
           +P+ +A   H     R+  +  +L+S+LLQ+    R +A EA  HP+F  L +   +LP+
Sbjct: 243 YPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  152 bits (385), Expect = 9e-43
 Identities = 97/306 (31%), Positives = 151/306 (49%), Gaps = 45/306 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y     VG G++G V  A      + VA+KK+      L   R   REL+ ++ + H NV
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 147 -----HYSRAS-------------------------QRMPLIYVKLYTYQICRALAYIHG 176
                 ++ A+                         Q++   +V+   YQ+ R L YIH 
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 236
             G+ HRD+KP N+ VN    ++++ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 137 A-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPEIMLNWMH 192

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           Y   VDIWSVGC++AELL G+ LFPG   +DQL  I++V+GTP+ E +K ++  +     
Sbjct: 193 YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYI 252

Query: 297 ---PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
              P +      KIF +   P A+DL+ ++L    + R +A EA  HP+F +  DP    
Sbjct: 253 QSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDE- 310

Query: 354 PNGRPF 359
           P   P+
Sbjct: 311 PEAEPY 316

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  149 bits (379), Expect = 9e-43
 Identities = 73/277 (26%), Positives = 114/277 (41%), Gaps = 60/277 (21%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRLLDHPNV------ 146
             +G+G FG V++A+   TG+ VAIK + L+ K  K     E+Q ++   HPN+      
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 147 ------------HYSRAS---------QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                         S  S         Q +    +     ++ + L Y+H   G+ HRDI
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDI 124

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWS 245
           K  N+L+     +VKL DFG +  L   +   + + + Y+ APE+I G   Y    DIWS
Sbjct: 125 KAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYDYKADIWS 182

Query: 246 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +G    EL  G+P +  E    + +  I   G P               + P        
Sbjct: 183 LGITAIELAEGKPPY-SELPPMKALFKIATNGPPG-------------LRNP-------- 220

Query: 306 KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
               ++   E  D + + LQ +P  R TA +   HPF
Sbjct: 221 ----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  151 bits (384), Expect = 1e-42
 Identities = 89/324 (27%), Positives = 152/324 (46%), Gaps = 68/324 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKK-VLQDKR---YKNRELQTMRLLDHPNV-- 146
           YM  R +G GS G+VF A   +  + VA+KK VL D +   +  RE++ +R LDH N+  
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 147 --------------------HYSRA----------------SQRMPLIYVKLYTYQICRA 170
                                 +                     +   + +L+ YQ+ R 
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRG 126

Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-------ICSR 223
           L YIH    V HRD+KP N+ +N     +K+ DFG A+++   +P+ S+       + ++
Sbjct: 127 LKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGLVTK 182

Query: 224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQL---VEIIKVLGTPT 280
           +YR+P L+     YT A+D+W+ GC+ AE+L G+PLF G   ++Q+   +E + V+    
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242

Query: 281 REEIKCMNPNYTEFKFPQIKAHPW--HKIFHKRMP---PEAVDLVSRLLQYSPNLRCTAL 335
           R E+  + P++       ++       +     +P   PEA+D + ++L ++P  R TA 
Sbjct: 243 RNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295

Query: 336 EACIHPFFDELRDPNARLPNGRPF 359
           EA +HP+      P     +  PF
Sbjct: 296 EALMHPYMSCYSCPFDEPVSLHPF 319

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  150 bits (380), Expect = 4e-42
 Identities = 100/323 (30%), Positives = 141/323 (43%), Gaps = 71/323 (21%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------------------RELQTMR 139
           +G+G++G V +A    TG+ VAIKKV +     N                   REL+ M 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 140 LLDHPNVHYSRA-------------------------SQRMPLIYVKLYTYQICRALAYI 174
            + H N+                                R+    VK    QI   L  +
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-----VLVKGEPNISYICSR------ 223
           H    + HRD+ P N+ +N      K+ DFG A+                +  R      
Sbjct: 136 HKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193

Query: 224 ----YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
               +YRAPEL+ GA +Y  AVD+WSVGC+ AELL G+PLFPGE+ +DQL  I ++LGTP
Sbjct: 194 VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTP 253

Query: 280 TRE---EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 336
             +   + K + P YTEF   + K     K        +A+DL+  LL+ +P  R +A E
Sbjct: 254 NEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309

Query: 337 ACIHPFFDELRDPNARLPNGRPF 359
           A  H +F    DP    P+  PF
Sbjct: 310 ALKHEYFKS--DPLPCDPSQLPF 330

Length = 335

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  148 bits (375), Expect = 6e-42
 Identities = 95/290 (32%), Positives = 152/290 (52%), Gaps = 42/290 (14%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 146
           SY+    +G+GS+  V++      G+ VA+K +             RE   ++ L H N+
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65

Query: 147 ---H---YSRASQRMPLIY--------------------VKLYTYQICRALAYIHGGIGV 180
              H   +++ +      Y                    V+L+ +Q+ R LAYIHG   +
Sbjct: 66  VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ-HI 124

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEY 237
            HRD+KPQNLL++ +  ++KL DFG A+   K  P+ +Y   + + +YR P+++ GAT+Y
Sbjct: 125 LHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPPDVLLGATDY 181

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN--PNYTEF 294
           ++A+DIW  GC+  E+L GQP FPG S V +QL +I  VLG PT +    ++  PNY   
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241

Query: 295 KFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            F   K      ++ +   PP+A DL S++L   P  R +A +A +HP+F
Sbjct: 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  146 bits (369), Expect = 7e-41
 Identities = 95/292 (32%), Positives = 152/292 (52%), Gaps = 43/292 (14%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPN- 145
           +Y+    +G+G++  VF+ +   T   VA+K++  +          RE+  ++ L H N 
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 146 ------VHYSRA-------------------SQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                 VH  ++                      M +  VK++ YQI R LAY H    V
Sbjct: 67  VTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR-KV 125

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEY 237
            HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+++ G++EY
Sbjct: 126 LHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--YTEFK 295
           +T +D+W VGC+  E+  G+PLFPG +  D+L  I ++LGTPT E    ++ N  +  + 
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242

Query: 296 FPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
           FP+ K  P   I H  R+  E ++L+++ LQY    R +A EA  H +F  L
Sbjct: 243 FPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  144 bits (364), Expect = 2e-40
 Identities = 91/289 (31%), Positives = 148/289 (51%), Gaps = 43/289 (14%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
           +Y+    +G+G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 147 -------HYSRA-------------------SQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                  H  R                       M +  VK++ +Q+ R L+Y H    +
Sbjct: 66  VTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR-KI 124

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEY 237
            HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+++ G+TEY
Sbjct: 125 LHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CMNPNYTEFK 295
           +T +D+W VGC+L E+  G+P+FPG +  ++L  I ++LGTPT E       N  +  + 
Sbjct: 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241

Query: 296 FPQIKAHPWHKIFH-KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           FPQ +A P   I H  R+  + +DL+S LL Y    R +A  A  H +F
Sbjct: 242 FPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  142 bits (361), Expect = 4e-39
 Identities = 97/309 (31%), Positives = 146/309 (47%), Gaps = 58/309 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKK-------VLQDKR-YKNRELQTMRLLDHP 144
           Y   + +G G+ GIV  A    TG+ VAIKK       V   KR Y  REL  M+L++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 145 NV--------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIH 175
           N+               +      M L+   L                 YQ+   + ++H
Sbjct: 76  NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 135

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 235
              G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G  
Sbjct: 136 SA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 193

Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYT 292
            Y   VDIWSVGC++ E++ G  LFPG   +DQ  +II+ LGTP+ E +  + P   NY 
Sbjct: 194 -YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYV 252

Query: 293 EFKFPQIKAHPWHKIF------------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 340
           E + P+   + + ++F            +K    +A DL+S++L   P  R +  +A  H
Sbjct: 253 ENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311

Query: 341 PFFDELRDP 349
           P+ +   DP
Sbjct: 312 PYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 8e-39
 Identities = 81/282 (28%), Positives = 123/282 (43%), Gaps = 69/282 (24%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNV---HY 148
           +G+GSFG V   +  +TG+  A+K     K+++ K   +   E   +  ++HP +   HY
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 149 S-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
           +                           R      + Y  +I  AL Y+H  +G+ +RD+
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH-SLGIIYRDL 119

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVDIW 244
           KP+N+L++   H +KL DFG AK L       +  C +  Y APE++ G   Y  AVD W
Sbjct: 120 KPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK-GYGKAVDWW 177

Query: 245 SVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 304
           S+G +L E+L G+P F  E    ++ E I                     +FP       
Sbjct: 178 SLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPLRFP------- 213

Query: 305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA-CI--HPFF 343
                + + PEA DL+S LLQ  P  R  +  A  I  HPFF
Sbjct: 214 -----EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  134 bits (339), Expect = 1e-36
 Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 69/301 (22%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV----- 146
            +G+G++G V++A+  +TGE VA+KKV  D   +       RE++ +R L+H N+     
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 147 ---------HYSRASQRMPLIY----------------------VKLYTYQICRALAYIH 175
                     + +      L++                      +K +  Q+   L Y H
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH 133

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFG 233
                 HRDIK  N+L+N +  Q+KL DFG A++    E  P  + + + +YR PEL+ G
Sbjct: 134 KK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG 191

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
              Y  A+D+WS GC+L EL   +P+F     + QL  I ++ G+P       + P+  +
Sbjct: 192 EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC----PAVWPDVIK 247

Query: 294 FKFPQIKAHPWHKIFHKRM------------PPEAVDLVSRLLQYSPNLRCTALEACIHP 341
             +       ++ +  K+             P  A+DL+  +L   P+ RCTA EA   P
Sbjct: 248 LPY-------FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300

Query: 342 F 342
           +
Sbjct: 301 W 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  130 bits (330), Expect = 5e-35
 Identities = 81/293 (27%), Positives = 129/293 (44%), Gaps = 50/293 (17%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +GQG+FG VF+A+  +T + VA+KKVL +   +       RE++ ++LL H NV      
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 147 -----------------------H-----YSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                  H      S  + +  L  +K     +   L YIH   
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN- 138

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAPELIFG 233
            + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 139 KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG 197

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCMN-PNY 291
             +Y   +D+W  GC++AE+    P+  G +   QL  I ++ G+ T E          +
Sbjct: 198 ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELF 257

Query: 292 TEFKFPQ-IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            + + PQ  K     ++      P A+DL+ +LL   P  R  A  A  H FF
Sbjct: 258 KKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  130 bits (327), Expect = 8e-35
 Identities = 92/296 (31%), Positives = 149/296 (50%), Gaps = 48/296 (16%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 146
           SY     +G+GS+  V++ K    G+ VA+K + LQ++        RE   ++ L H N+
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 147 ----HYSRASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGV 180
                     + + L++                      VKL+ +Q+ R L+YIH    +
Sbjct: 66  VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY-I 124

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEY 237
            HRD+KPQNLL++  T ++KL DFG A+   K  P+ +Y   + + +YR P+++ G+TEY
Sbjct: 125 LHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN--PNYTEF 294
           +T +D+W VGC+  E++ G   FPG   + DQL  I  VLGTP  +    ++  P++   
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241

Query: 295 KFPQIKA----HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
           +F           W+K+ +      A DL S+LLQ  P  R +A  A  H +F +L
Sbjct: 242 RFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  125 bits (316), Expect = 2e-33
 Identities = 84/283 (29%), Positives = 125/283 (44%), Gaps = 66/283 (23%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPN------- 145
           +G G+FG V+ A  L+TGE +A+K++ +QD   K       E++ + LL HPN       
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 146 -VH------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 186
            VH                       + +    +++YT Q+   LAY+H   G+ HRDIK
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIK 126

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVK-----GEPNISYICSRYYRAPELIFGAT--EYTT 239
           P N+ ++ H   +KL DFG A  L       GE   S   +  Y APE+I G     +  
Sbjct: 127 PANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGR 185

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           A DIWS+GCV+ E+  G+  +   S +D   +I+  +G          +        P I
Sbjct: 186 AADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGA--------GHK-------PPI 227

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                      ++ PE  D + R L+  P  R TA E   HPF
Sbjct: 228 PD-------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  122 bits (308), Expect = 2e-32
 Identities = 80/281 (28%), Positives = 121/281 (43%), Gaps = 64/281 (22%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVL---QDKRYK------NRELQTMRLLDHPNVH 147
            ++G GSFG V++   L+ G+  A+K+V      +  +       +E+  +  L HPN+ 
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 148 YSRASQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVC 181
               ++R                           P   ++LYT QI   L Y+H      
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR-NTV 124

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRDIK  N+LV+     VKL DFG AK +V+     S+  S Y+ APE+I     Y  A 
Sbjct: 125 HRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           DIWS+GC + E+  G+P +   S ++ +  + K+  +     I                 
Sbjct: 184 DIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI----------------- 223

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
            P H      +  EA D + + LQ  P+LR TA E   HPF
Sbjct: 224 -PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  122 bits (308), Expect = 2e-32
 Identities = 74/292 (25%), Positives = 115/292 (39%), Gaps = 90/292 (30%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN- 145
           Y   + +G+GSFG V+  +    G+   +K++       +++     E++ ++ L+HPN 
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 146 VHY---------------------------SRASQRMPL-----IYVKLYTYQICRALAY 173
           + Y                            +  +  P      +    +  Q+C AL Y
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD---WFVQLCLALKY 118

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYICSRY 224
           +H    + HRDIKPQN+ +      VKL DFG +KVL         V G P        Y
Sbjct: 119 LHS-RKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTP--------Y 168

Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y +PEL      Y    DIWS+GCVL EL   +  F GE+ + +L    K+L    + + 
Sbjct: 169 YLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KGQY 220

Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 336
             +   Y                       E  +LVS LLQ  P  R +  +
Sbjct: 221 PPIPSQY---------------------SSELRNLVSSLLQKDPEERPSIAQ 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  120 bits (303), Expect = 2e-31
 Identities = 83/286 (29%), Positives = 127/286 (44%), Gaps = 46/286 (16%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR---LL------DHPNV--- 146
           +G G++G V++A+   +G  VA+K V          L T+R   LL      DHPN+   
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 147 ----HYSRASQR-------------------------MPLIYVKLYTYQICRALAYIHGG 177
                 SR  +                          +P   +K    Q  R L ++H  
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
             + HRD+KP+N+LV     QVKL DFG A++          + + +YRAPE++  +T Y
Sbjct: 128 C-IVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST-Y 184

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
            T VD+WSVGC+ AE+   +PLF G S  DQL +I  ++G P  ++    +       F 
Sbjct: 185 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTLPRGAFS 243

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                P        +      L+  +L ++P+ R +A  A  HPFF
Sbjct: 244 PRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  119 bits (301), Expect = 3e-31
 Identities = 77/312 (24%), Positives = 124/312 (39%), Gaps = 95/312 (30%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTM-RLLDHP 144
           +   +++G+GSF  V  AK  ET +  AIK     +++++K+  Y   E + + RL  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 145 NV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
            +                           Y R    +     + Y  +I  AL Y+H   
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS-K 121

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRY---------- 224
           G+ HRD+KP+N+L++   H +K+ DFG+AKVL                            
Sbjct: 122 GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 225 -------YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKV 275
                  Y +PEL+        + D+W++GC++ ++L G+P F G +  + L   +I+K 
Sbjct: 181 SFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYLTFQKILK- 236

Query: 276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 335
                            E+ FP               PP+A DL+ +LL   P  R    
Sbjct: 237 ----------------LEYSFPPN------------FPPDAKDLIEKLLVLDPQDRLGVN 268

Query: 336 EACI----HPFF 343
           E       HPFF
Sbjct: 269 EGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  117 bits (296), Expect = 1e-30
 Identities = 84/283 (29%), Positives = 123/283 (43%), Gaps = 70/283 (24%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYK-NRELQTMRLLDHPNV------ 146
           V+GQGS G+V++ +   TG+  A+KK+     ++ R +  REL+T+R  + P V      
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 147 HYSRAS-----------------QRMPLI---YVKLYTYQICRALAYIHGGIGVCHRDIK 186
            Y                     +++  I    +     QI + L Y+H    + HRDIK
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIK 127

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTTAV 241
           P NLL+N    +VK+ DFG +KVL     N    C+ +     Y +PE I G + Y+ A 
Sbjct: 128 PSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQGES-YSYAA 181

Query: 242 DIWSVGCVLAELLLGQ-P-LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           DIWS+G  L E  LG+ P L PG+    +L++ I            C  P          
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPPP----SLP- 224

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                     +   PE  D +S  LQ  P  R +A E   HPF
Sbjct: 225 ---------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  119 bits (300), Expect = 2e-30
 Identities = 90/311 (28%), Positives = 142/311 (45%), Gaps = 63/311 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 147 ----------------------------------HYSRASQRMPLIYVKLYTYQICRALA 172
                                             H     +RM  +      YQ+   + 
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLL-----YQMLCGIK 137

Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 232
           ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 138 HLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195

Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 289
           G   Y   VDIWSVGC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   
Sbjct: 196 G-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254

Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEAC 338
           NY E + PQ     + ++F   + P           +A DL+S++L   P+ R +  EA 
Sbjct: 255 NYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313

Query: 339 IHPFFDELRDP 349
            HP+     DP
Sbjct: 314 RHPYITVWYDP 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  114 bits (287), Expect = 1e-28
 Identities = 92/306 (30%), Positives = 142/306 (46%), Gaps = 53/306 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 139 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 195

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255

Query: 295 KFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+     + K+F   + P           +A DL+S++L   P  R +  EA  HP+ 
Sbjct: 256 R-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314

Query: 344 DELRDP 349
           +   DP
Sbjct: 315 NVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  113 bits (285), Expect = 2e-28
 Identities = 89/306 (29%), Positives = 144/306 (47%), Gaps = 53/306 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 147 -------HYSRASQRMPLIYVKL----------------------YTYQICRALAYIHGG 177
                     ++ +    +Y+ +                        YQ+   + ++H  
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VDIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262

Query: 295 KFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F   + P           +A DL+S++L    + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

Query: 344 DELRDP 349
           +   DP
Sbjct: 322 NVWYDP 327

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  112 bits (281), Expect = 2e-28
 Identities = 89/289 (30%), Positives = 135/289 (46%), Gaps = 51/289 (17%)

Query: 99  VGQGSFGIVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNV-- 146
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNV  
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 147 -----HYSRASQRMPLIYV-------------------------KLYTYQICRALAYIHG 176
                  SR  +   L  V                         K   +Q+ R L ++H 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 236
              V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++  ++ 
Sbjct: 129 H-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS- 185

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           Y T VD+WSVGC+ AE+   +PLF G S VDQL +I+ V+G P  E+     P       
Sbjct: 186 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDVALPR 241

Query: 297 PQIKAHPWHKI--FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
               +     I  F   +     DL+ + L ++P  R +A  A  HP+F
Sbjct: 242 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 3e-28
 Identities = 65/194 (33%), Positives = 98/194 (50%), Gaps = 36/194 (18%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNV---HY 148
           ++G+G+FG+V++   LETG+ VAIK++ L+  + +      +E+  ++ L HPN+     
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 149 SRASQRMPLIY-----------------------VKLYTYQICRALAYIHGGIGVCHRDI 185
           S  +     I                        V +Y YQ+ + LAY+H   GV HRDI
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDI 125

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTTAVDIW 244
           K  N+L       VKL DFG A  L     +  S + + Y+ APE+I   +  +TA DIW
Sbjct: 126 KAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-SGASTASDIW 183

Query: 245 SVGCVLAELLLGQP 258
           S+GC + ELL G P
Sbjct: 184 SLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  108 bits (272), Expect = 3e-27
 Identities = 67/284 (23%), Positives = 110/284 (38%), Gaps = 67/284 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVL--QDKRYKN---RELQTMRLLDHPNV----- 146
             +G G+ G+V +     TG+ +A+K +    ++  +    REL  +   + P +     
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 147 ----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
                                        R+P   +      + + L Y+H    + HRD
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
           +KP N+LVN    Q+KLCDFG +  LV      +++ +  Y APE I G  +Y+   DIW
Sbjct: 127 VKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDYSVKSDIW 183

Query: 245 SVGCVLAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           S+G  L EL  G+  +P E+       + L  I+               P       P++
Sbjct: 184 SLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP-------PRL 224

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            +  +         P+  D V+  L   P  R +  E   HPF 
Sbjct: 225 PSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  109 bits (274), Expect = 3e-27
 Identities = 75/277 (27%), Positives = 114/277 (41%), Gaps = 60/277 (21%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN--RELQTMRLLDHPNV-------- 146
            +G+G+ G V++A    TG+ VAIKK+ L+ +  +    E+  M+   HPN+        
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 147 ---------HYSRASQRMPLIYVKLYTY----------QICRALAYIHGGIGVCHRDIKP 187
                     Y        +I                 ++ + L Y+H    V HRDIK 
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKS 144

Query: 188 QNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTAVDIWSV 246
            N+L++     VKL DFG A  L K +    S + + Y+ APE+I    +Y   VDIWS+
Sbjct: 145 DNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSL 202

Query: 247 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 306
           G +  E+  G+P +  E  +  L  I    G P    +K  NP                 
Sbjct: 203 GIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLK--NPE---------------- 240

Query: 307 IFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
               +  PE  D +++ L   P  R +A E   HPF 
Sbjct: 241 ----KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 1e-26
 Identities = 94/372 (25%), Positives = 144/372 (38%), Gaps = 106/372 (28%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDHPN------VH 147
           V+G+G+FG V+  +  +TG+  A+K + +    K  ++  +R    +L   +      ++
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67

Query: 148 YSRASQR--------MP-------LI--------YVKLYTYQICRALAYIHGGIGVCHRD 184
           YS   +         MP       LI          + Y  ++  AL  +H  +G  HRD
Sbjct: 68  YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK-LGFIHRD 126

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAK-----------------------VLVKGEPNISYIC 221
           IKP N+L++   H +KL DFG  K                       VLV+   +     
Sbjct: 127 IKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRV 185

Query: 222 SRY-------YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 274
                     Y APE++ G T Y    D WS+G +L E+L G P F  ++    L E   
Sbjct: 186 RANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT----LQE--- 237

Query: 275 VLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
                T  +I     N+ E  +FP              + PEA+DL+ RLL    +   +
Sbjct: 238 -----TYNKII----NWKESLRFPP----------DPPVSPEAIDLICRLLCDPEDRLGS 278

Query: 334 ALEACIHPFF--DELRDPNARLPNGRPFPPLF-------NF-KPQELKGASKELLSKLIP 383
             E   HPFF   +  +     P   PF P         NF   ++ K  S  L      
Sbjct: 279 FEEIKSHPFFKGIDWENLRETKP---PFVPELSSPLDTSNFDDFEDDKDLSDYLSQNSKK 335

Query: 384 EHARKQCPFLGF 395
            +  KQ  F+GF
Sbjct: 336 LNKGKQLAFVGF 347

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  106 bits (267), Expect = 1e-26
 Identities = 86/292 (29%), Positives = 127/292 (43%), Gaps = 79/292 (27%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNR------ELQTMRLLDHPNV---HY 148
           + +G++G VF AK   TG+  AIK +   D   KN+      E   +     P V   +Y
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 149 SRASQR-----------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
           S   ++                       +     ++Y  +I  AL Y+H   G+ HRD+
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDL 119

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISY--------ICSRYYRAPELIFGATE 236
           KP N+L++ + H +KL DFG +KV LV+ + N++         + +  Y APE+I G   
Sbjct: 120 KPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG- 177

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           ++  VD WS+GC+L E L+G P F GE                T EEI           F
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGE----------------TPEEI-----------F 210

Query: 297 PQIKAH--PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL---EACIHPFF 343
             I      W +     +  EA+DL+S+LL   P  R  A    E   HPFF
Sbjct: 211 QNILNGKIEWPEDVE--VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  105 bits (264), Expect = 4e-26
 Identities = 72/282 (25%), Positives = 117/282 (41%), Gaps = 64/282 (22%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHP---NV 146
           RV+G+G+FG V   +  +T +  A+K     K ++    +N   E + ++ L+HP   N+
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 147 HYS-RASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHR 183
            YS +  + M L+                       VK +  +I  AL Y+H   G+ HR
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK-GIIHR 124

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP N+L++   H V + DF  A  +       S   +  Y APE++     Y+ AVD 
Sbjct: 125 DIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDW 182

Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G    E L G+  + G S                R++I+          +P      
Sbjct: 183 WSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAKQETADV-LYP--ATW- 225

Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLR--CTALEACIHPFF 343
                      EA+D +++LL+  P  R      +   HP+F
Sbjct: 226 ---------STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  104 bits (262), Expect = 1e-25
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 74/286 (25%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNV--- 146
           + +G GSFG V   +   +G+  A+K     K+++ K+ +    E + ++ + HP +   
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                                   + R S R P    + Y  Q+  AL Y+H  + + +R
Sbjct: 67  YGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS-LDIVYR 125

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +K+ DFG AK +   +     +C +  Y APE+I     Y  AVD
Sbjct: 126 DLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIILS-KGYGKAVD 180

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
            W++G ++ E+L G P F  ++   Q+ E I          ++       + +FP     
Sbjct: 181 WWALGILIYEMLAGYPPFFDDN-PIQIYEKI----------LEG------KVRFP----- 218

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-----HPFF 343
                      P+A DL+  LLQ     R   L+  +     HP+F
Sbjct: 219 -------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  102 bits (256), Expect = 5e-25
 Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 62/228 (27%)

Query: 96  ERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            + +G+G+FG V++             VA+K + +D   +      RE + MR LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 147 --------------------------HY--SRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                      Y      + + L  +  +  QI R + Y+    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES-K 122

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------A 227
              HRD+  +N LV      VK+ DFG ++ L   +         YY+           A
Sbjct: 123 NFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVKGGKLPIRWMA 172

Query: 228 PELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
           PE +    ++T+  D+WS G +L E+  LG+  +PG S   +++E +K
Sbjct: 173 PESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 1e-24
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 39/206 (18%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV--------LQDKRYKNRELQTMRLLDHPNV--- 146
           ++G+G++G V++ K + TG  VA+K +        + D + +   L  +R    PN+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 147 ---------------HYSRASQRMPL-------IYVKLYTYQICRALAYIHGGIGVCHRD 184
                          +    S R  +        Y+ +   ++  AL YIH  +GV HRD
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHK-VGVIHRD 126

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAVDI 243
           IK  N+LV  +T  VKLCDFG A +L +      +++ + Y+ APE+I     Y T  DI
Sbjct: 127 IKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADI 185

Query: 244 WSVGCVLAELLLGQPLFPGESGVDQL 269
           WS+G  + E+  G P +   S VD  
Sbjct: 186 WSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  101 bits (254), Expect = 1e-24
 Identities = 72/284 (25%), Positives = 109/284 (38%), Gaps = 66/284 (23%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           +G G FG V   K      T A+K V          + +   E + +   +HP +     
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                   R          + Y   +  A  Y+H   G+ +RD+
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDL 119

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWS 245
           KP+NLL++     VKL DFG AK L  G+   ++  +  Y APE+I     Y  +VD WS
Sbjct: 120 KPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVDYWS 177

Query: 246 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +G +L ELL G+P F GE   D +             +I   N      +FP        
Sbjct: 178 LGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL---EFPNY------ 218

Query: 306 KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-----HPFFD 344
                 +   A DL+ +LL+ +P  R   L+  I     H +F+
Sbjct: 219 ------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  100 bits (251), Expect = 2e-24
 Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 61/227 (26%)

Query: 96  ERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            + +G+G+FG V++ K      +    VA+K + +D   +      RE + MR LDHPNV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 147 --------------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIG 179
                                      Y R ++ ++ L  +  +  QI R + Y+     
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES-KN 122

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------AP 228
             HRD+  +N LV      VK+ DFG ++ L   +         YYR           AP
Sbjct: 123 FIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRGGKLPIRWMAP 172

Query: 229 ELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
           E +    ++T+  D+WS G +L E+  LG+  +PG S  ++++E +K
Sbjct: 173 ESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 99.6 bits (249), Expect = 5e-24
 Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 50/222 (22%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN-VHY-- 148
            +G+GSFG V + +    G+ +  K++       ++K+    E+  +R L HPN V Y  
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 149 ---SRASQRMPLI---------------YVKLYTY-----------QICRALAYIHGGIG 179
               R++Q + ++                 K   Y           Q+  AL   H    
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 180 ----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIF 232
               V HRD+KP N+ ++   + VKL DFG AK+L  G  +    +Y+ + YY +PE + 
Sbjct: 127 PGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPEQLN 183

Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 274
             + Y    DIWS+GC++ EL    P F       QL   IK
Sbjct: 184 HMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 99.1 bits (247), Expect = 7e-24
 Identities = 79/282 (28%), Positives = 119/282 (42%), Gaps = 68/282 (24%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLL---DHPNV---H 147
           + +G+FG V+ AK   TG+  AIK      ++   +  N + +   ++   + P V   +
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 148 YSRASQR-----------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
           YS  S+                        +P  + K Y  ++   +  +H   G+ HRD
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRD 122

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
           IKP+NLL++   H +KL DFG ++    G  N  ++ +  Y APE I G  +     D W
Sbjct: 123 IKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGD-DKMSDWW 177

Query: 245 SVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 304
           S+GCV+ E L G P F  E+  D + + I          I     N+ E           
Sbjct: 178 SLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRI-----NWPEEVKEFCS---- 221

Query: 305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTA---LEACIHPFF 343
                    PEAVDL++RLL   P  R  A    E   HPFF
Sbjct: 222 ---------PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  100 bits (249), Expect = 8e-24
 Identities = 94/316 (29%), Positives = 140/316 (44%), Gaps = 78/316 (24%)

Query: 99  VGQGSFGIVFQAKCLETGET--VAIKKVLQD--KRYKNRELQTMRLLDHPNV-------- 146
           VG+G++G V++AK  +  +    A+K++          RE+  +R L HPNV        
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 147 ----------------------HYSRASQ------RMPLIYVKLYTYQICRALAYIHGGI 178
                                  + RAS+      ++P   VK   YQI   + Y+H   
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN- 127

Query: 179 GVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV-------LVKGEPNISYICSRYYRAP 228
            V HRD+KP N+LV    P   +VK+ D G A++       L   +P    + + +YRAP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWYRAP 184

Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLF---------PGESGVDQLVEIIKVLGTP 279
           EL+ GA  YT A+DIW++GC+ AELL  +P+F               DQL  I  V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244

Query: 280 TR---EEIKCMNPNYTEFK---------FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 327
                E+IK M  + T  K            IK    HK+   +   +A  L+ +LL   
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLLTMD 301

Query: 328 PNLRCTALEACIHPFF 343
           P  R T+ +A   P+F
Sbjct: 302 PIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 79/283 (27%), Positives = 117/283 (41%), Gaps = 70/283 (24%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDK---RYKNRELQTMRLLDHPN-VHYSRASQ 153
           +G G++G V++A+ + TGE VAIK + L+         +E+  ++   HPN V Y  +  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 154 R---------------MPLIYVKLYT----YQI---CR----ALAYIHGGIGVCHRDIKP 187
           R               +  IY          QI   CR     LAY+H   G  HRDIK 
Sbjct: 71  RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH-ETGKIHRDIKG 129

Query: 188 QNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIFGATE----YTTAV 241
            N+L+      VKL DFG +  L     +   S+I + Y+ APE+   A E    Y    
Sbjct: 130 ANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEVA--AVERKGGYDGKC 185

Query: 242 DIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
           DIW++G    EL   Q P+F         +  ++ L   ++            F  P++K
Sbjct: 186 DIWALGITAIELAELQPPMFD--------LHPMRALFLISKS----------NFPPPKLK 227

Query: 301 A-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
               W  +FH        D + + L   P  R TA +   HPF
Sbjct: 228 DKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 96.8 bits (242), Expect = 5e-23
 Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 61/220 (27%)

Query: 97  RVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
           + +G+G+FG V++      GE     VA+K + +    +       E   M+ L HPN+ 
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 147 -HYSRASQRMPLI----YVKL---------------------YTYQICRALAYIHGGIGV 180
                 +Q  PL     Y+                          QI + + Y+      
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE-SKNF 123

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------------AP 228
            HRD+  +N LV      VK+ DFG ++ + + +         YYR            AP
Sbjct: 124 VHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGGKLPIKWMAP 173

Query: 229 ELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
           E +    ++T+  D+WS G +L E+  LG+  +PG S  +
Sbjct: 174 ESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.6 bits (241), Expect = 6e-23
 Identities = 68/276 (24%), Positives = 109/276 (39%), Gaps = 59/276 (21%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNV-----HYSR 150
            +G+GS+G V++A   ETG+ VAIK V  ++  +   +E+  ++  D P +      Y +
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 151 ASQRMPLI-Y---------------------VKLYTYQICRALAYIHGGIGVCHRDIKPQ 188
            +    ++ Y                     +    YQ  + L Y+H      HRDIK  
Sbjct: 70  NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAG 128

Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTTAVDIWSVG 247
           N+L+N    Q KL DFG +  L        + I + ++ APE+I     Y    DIWS+G
Sbjct: 129 NILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLG 186

Query: 248 CVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 307
               E+  G+P +     +  +  I                P  T    P          
Sbjct: 187 ITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KPPPT-LSDP---------- 222

Query: 308 FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
             ++  PE  D V + L   P  R +A++   HPF 
Sbjct: 223 --EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 97.4 bits (242), Expect = 8e-23
 Identities = 94/314 (29%), Positives = 139/314 (44%), Gaps = 74/314 (23%)

Query: 99  VGQGSFGIVFQAKCLETGET--VAIKKVLQD--KRYKNRELQTMRLLDHPNV-------- 146
           VG+G++G V++AK  +  +    A+K++          RE+  +R L HPNV        
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 147 ----------------------HYSRASQ------RMPLIYVKLYTYQICRALAYIHGGI 178
                                  + RAS+      ++P   VK   YQI   + Y+H   
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN- 127

Query: 179 GVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV-------LVKGEPNISYICSRYYRAP 228
            V HRD+KP N+LV    P   +VK+ D G A++       L   +P    + + +YRAP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWYRAP 184

Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLF---------PGESGVDQLVEIIKVLGTP 279
           EL+ GA  YT A+DIW++GC+ AELL  +P+F               DQL  I  V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244

Query: 280 TR---EEIKCMNPNY----TEFKFPQIKAHPWHKIF--HKRMPPEAVD-LVSRLLQYSPN 329
                E+I+ M P Y     +F+          K    HK  P   V  L+ +LL   P 
Sbjct: 245 ADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303

Query: 330 LRCTALEACIHPFF 343
            R T+ +A   P+F
Sbjct: 304 KRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.1 bits (240), Expect = 9e-23
 Identities = 73/287 (25%), Positives = 110/287 (38%), Gaps = 73/287 (25%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNV- 146
           +     +G+GSFG V++A    T + VAIK +       +     +E+Q +     P + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 147 HY--------------------SRA----SQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
            Y                    S        ++   Y+     ++   L Y+H   G  H
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE-GKIH 121

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YYRAPELIFGAT 235
           RDIK  N+L++     VKL DFG     V G+   S +  R       ++ APE+I   +
Sbjct: 122 RDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFWMAPEVIKQ-S 173

Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 295
            Y    DIWS+G    EL  G+P  P  S +  +    +VL        K  NP      
Sbjct: 174 GYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL----FLIPKN-NP------ 215

Query: 296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
            P ++ + + K F         D VS  L   P  R +A E   H F
Sbjct: 216 -PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.1 bits (239), Expect = 1e-22
 Identities = 71/289 (24%), Positives = 124/289 (42%), Gaps = 69/289 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV--------LQDKRYKN--RELQTMRLLDHPNV 146
           + +G G+F   +QA+ ++TG  +A+K+V         Q++  +   +E++ M  L+HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 147 -----------HYSRASQRMP----------------LIYVKLYTYQICRALAYIHGGIG 179
                      H++   + M                  + +  YT Q+ R L+Y+H    
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN-YTEQLLRGLSYLHEN-Q 123

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-----GEPNISYICSRYYRAPELIFGA 234
           + HRD+K  NLL++    ++++ DFG+A  L       GE     + +  + APE++ G 
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG- 182

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
            +Y  + D+WSVGCV+ E+   +P +  E   + L  I K         I          
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IASATTA---- 229

Query: 295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
             P I  H         + P   D+  R L+  P  R  + E   HP F
Sbjct: 230 --PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 94.8 bits (236), Expect = 3e-22
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 41/209 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNR---ELQTMRLLDHPN 145
           +  E+ +G+G F +V++A CL  G  VA+KKV    + D + +     E+  ++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 146 V------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIH 175
           V                              H+ +  + +P   +  Y  Q+C AL ++H
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFGA 234
               + HRDIKP N+ +   T  VKL D G  +    K     S + + YY +PE I   
Sbjct: 124 SK-RIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGE 263
             Y    DIWS+GC+L E+   Q  F G+
Sbjct: 182 G-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.8 bits (228), Expect = 3e-21
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 69/286 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR------ELQTMRLLDHPNVH 147
           +++GQG+FG V+    ++TG  +A+K+V         K        E+Q ++ L H  + 
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 148 YSRASQRMPL---IYVKL-----------------------YTYQICRALAYIHGGIGVC 181
                 R      I+++                        YT QI   + Y+H  + + 
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM-IV 126

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRYYRAPELIFGATEY 237
           HRDIK  N+L +     VKL DFG++K L      G    S   + Y+ +PE+I G   Y
Sbjct: 127 HRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-Y 184

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
               D+WSVGC + E+L  +P +   +  + +  I K+   PT                P
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN---------------P 226

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           Q+ +H         + P+A + + R    +   R +A E   H F 
Sbjct: 227 QLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 91.0 bits (226), Expect = 6e-21
 Identities = 81/293 (27%), Positives = 112/293 (38%), Gaps = 82/293 (27%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNR-----ELQTMRLLDHPNV 146
           Y+  RV+G+G+FG     +  E    V  K+V L     K R     E+  + LL HPN+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 147 -----HY-----------------------SRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                H+                        +  Q      V  Y +QI  A++YIH   
Sbjct: 62  IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK-A 120

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYICSRYYRAPE 229
           G+ HRDIK  N+ +      +KL DFG +K+L         V G P        YY +PE
Sbjct: 121 GILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP--------YYMSPE 171

Query: 230 LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
           L  G  +Y    DIW++GCVL ELL  +  F         + ++          +K +  
Sbjct: 172 LCQGV-KYNFKSDIWALGCVLYELLTLKRTFDA----TNPLNLV----------VKIVQG 216

Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           NYT                      E + LV  LLQ  P  R TA E    P 
Sbjct: 217 NYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 79/288 (27%), Positives = 121/288 (42%), Gaps = 63/288 (21%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNV--HYSR 150
           +G+GS GIV  A    TG  VA+KK+  D R + R      E+  MR   HPN+   YS 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 151 -----------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 187
                                     RM    +      + +AL+++H   GV HRDIK 
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKS 143

Query: 188 QNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTAVDIWSV 246
            ++L+     +VKL DFG    + K  P   S + + Y+ APE+I     Y T VDIWS+
Sbjct: 144 DSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPYGTEVDIWSL 201

Query: 247 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 306
           G ++ E++ G+P +  E  + Q ++ I+    P  +                        
Sbjct: 202 GIMVIEMVDGEPPYFNEPPL-QAMKRIRDNLPPKLKN----------------------- 237

Query: 307 IFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 354
               ++ P     + R+L   P  R TA E   HPF  +   P++ +P
Sbjct: 238 --LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 70/289 (24%), Positives = 108/289 (37%), Gaps = 72/289 (24%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV---HYS 149
           V+G G+  +V+ A CL   E VAIK++  +K   +     +E+Q M   +HPNV   + S
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 150 RASQR-----MPLI------YVKLYTY---------------QICRALAYIHGGIGVCHR 183
                     MP +       +   +Y               ++ + L Y+H   G  HR
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-GQIHR 126

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----YICSRYYRAPELIFGATEYT 238
           DIK  N+L+      VK+ DFG +  L  G          ++ +  + APE++     Y 
Sbjct: 127 DIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 239 TAVDIWSVGCVLAELLLGQP----LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
              DIWS G    EL  G        P +     L+  ++    P+ E           F
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQN-DPPSLETGADYKKYSKSF 240

Query: 295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           +                       ++S  LQ  P+ R TA E   H FF
Sbjct: 241 R----------------------KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 85/311 (27%), Positives = 124/311 (39%), Gaps = 84/311 (27%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSR---ASQRM 155
           VGQG +G VF AK  +TGE VA+K      R K   L  +  + H  V   R    + + 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALK------RMKKSLLFKLNEVRH--VLTERDILTTTKS 60

Query: 156 PLIYVKLYTYQ----ICRALAYIHGG---------------------------------I 178
             +   LY +Q    +  A+ Y+ GG                                 +
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           G  HRD+KP+N L++   H +KL DFG +K +V      S + S  Y APE++ G   Y 
Sbjct: 121 GYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRG-KGYD 176

Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
             VD WS+GC+L E L G P F G +  +    +     T  R       P Y + +F  
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------PVYDDPRF-- 227

Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF-----DELRDPNARL 353
                        +  EA DL+++L+        +  +   HPFF     +ELR+     
Sbjct: 228 ------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKP-- 273

Query: 354 PNGRPFPPLFN 364
               PF P   
Sbjct: 274 ----PFVPELE 280

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 89.5 bits (222), Expect = 3e-20
 Identities = 81/299 (27%), Positives = 126/299 (42%), Gaps = 83/299 (27%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-------QDKRYKN------RELQTMR 139
           ++   ++G GSFG V+      +GE +A+K+V           R ++      RE+  ++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 140 LLDHPN-VHYSRAS------------------QRMPLIY-------VKLYTYQICRALAY 173
            L H N V Y  +S                    +   Y       V+ +  QI + L Y
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----------SYICSR 223
           +H   G+ HRDIK  N+LV+ +   +K+ DFG +K   K E N           S   S 
Sbjct: 122 LHNR-GIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNGARPSLQGSV 176

Query: 224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 283
           ++ APE++   T YT   DIWS+GC++ E+L G+  FP      QL  I K+        
Sbjct: 177 FWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKI-------- 224

Query: 284 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                    E   P+I ++         +  EA+D + +  +   N R TA E   HPF
Sbjct: 225 --------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 88.7 bits (220), Expect = 8e-20
 Identities = 64/200 (32%), Positives = 94/200 (47%), Gaps = 41/200 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN---- 145
           R +G GSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ L HPN    
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 146 -------------VHYSRAS-------QRMPLIYVKL--YTYQICRALAYIHGGIGVCHR 183
                        + Y   S        + PL  V++    +   + LAY+H      HR
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS-HERIHR 139

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--YTTAV 241
           DIK  N+L+      VKL DFGSA ++    P  S++ + Y+ APE+I    E  Y   V
Sbjct: 140 DIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 242 DIWSVGCVLAELLLGQ-PLF 260
           D+WS+G    EL   + PLF
Sbjct: 196 DVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 85.9 bits (213), Expect = 6e-19
 Identities = 77/284 (27%), Positives = 121/284 (42%), Gaps = 65/284 (22%)

Query: 100 GQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN-VHYSRAS 152
           G+G++G+V + + + TG  +A+K++       + KR       +MR +D P  V +  A 
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 153 QR-------MPLI-------YVKLY--------------TYQICRALAYIHGGIGVCHRD 184
            R       M ++       Y K+Y                 I +AL Y+H  + V HRD
Sbjct: 70  FREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRD 129

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE---YTTAV 241
           +KP N+L+N    QVKLCDFG +  LV           + Y APE I        Y    
Sbjct: 130 VKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKS 188

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D+WS+G  + EL  G+  FP +S             TP  +++K            Q+  
Sbjct: 189 DVWSLGITMIELATGR--FPYDS-----------WKTPF-QQLK------------QVVE 222

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
            P  ++  ++  PE  D V++ L+ +   R    E   HPFF+ 
Sbjct: 223 EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 85.2 bits (211), Expect = 8e-19
 Identities = 78/295 (26%), Positives = 126/295 (42%), Gaps = 71/295 (24%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--------LQDKRYK------NRELQTM 138
           ++   ++G+G++G V+ A  + TGE +A+K+V          D R K        E++T+
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 139 RLLDHPNVHYSRASQRMPLIY--------------------------VKLYTYQICRALA 172
           + LDH N+      +                                V+ +T Q+   LA
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV---LVKGEPNISYICSRYYRAPE 229
           Y+H   G+ HRD+K  NLLV+      K+ DFG +K    +   + N+S   S ++ APE
Sbjct: 123 YLHSK-GILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 230 LIFGATE-YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 288
           +I   ++ Y+  VDIWS+GCV+ E+  G+  +  E                  E I  M 
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE------------------EAIAAM- 221

Query: 289 PNYTEFK-FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                FK   +  A P        + P A+D ++     +P+ R TA E   HPF
Sbjct: 222 -----FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 82/283 (28%), Positives = 121/283 (42%), Gaps = 63/283 (22%)

Query: 96  ERVV-GQGSFGIVFQAKCLETGETVAIKKV-LQDKRYK---NRELQTMRLLDHPN-VHY- 148
           ERVV G+G++GIV+ A+ L T   +AIK++  +D RY    + E+     L H N V Y 
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 149 -SRASQRMPLIY--------------------------VKLYTYQICRALAYIHGGIGVC 181
            S +      I+                          +  YT QI   L Y+H    + 
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN-QIV 130

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELI-FGATEYTT 239
           HRDIK  N+LVN ++  VK+ DFG++K L    P   ++  +  Y APE+I  G   Y  
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
             DIWS+GC + E+  G+P F                       I+   P    FK    
Sbjct: 191 PADIWSLGCTIVEMATGKPPF-----------------------IELGEPQAAMFKVGMF 227

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           K HP      + +  EA + + R  +  P+ R +A +    PF
Sbjct: 228 KIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.8 bits (207), Expect = 2e-18
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 36/206 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNV 146
           Y   RVVG+G+FGIV   +     + V IK++  ++  K+       E Q ++LL HPN+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 147 -----------------HYS-----------RASQRMPLIYVKLYTYQICRALAYIHGGI 178
                             Y+           R +  +    +  +  QI  AL ++H  +
Sbjct: 62  IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL 121

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
            + HRD+K QN+L++ H   VK+ DFG +K+L       + + +  Y +PEL  G   Y 
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-KPYN 179

Query: 239 TAVDIWSVGCVLAELLLGQPLFPGES 264
              DIW++GCVL EL   +  F   +
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 83.7 bits (208), Expect = 2e-18
 Identities = 51/222 (22%), Positives = 83/222 (37%), Gaps = 68/222 (30%)

Query: 97  RVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV-- 146
           + +G+G+FG V++ K          VA+K + +D   + R     E + M+ L HPNV  
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 147 ---------------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
                                              S     + L  +  +  QI + + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------- 226
           +       HRD+  +N LV      VK+ DFG ++ +   +         YYR       
Sbjct: 121 LAS-KKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRKKTGGKL 169

Query: 227 -----APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
                APE +     +T+  D+WS G +L E+  LG   +PG
Sbjct: 170 PIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 75/281 (26%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTM-------RLLDHP--- 144
           +V+G+GSFG V  AK    G+  A+K VLQ K    K  +   M       + + HP   
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVK-VLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 145 NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
            +HYS                       +  +  P    + Y  +I  AL Y+H  + + 
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS-LNII 118

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTA 240
           +RD+KP+N+L++   H V L DFG  K  ++     S  C +  Y APE++     Y   
Sbjct: 119 YRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR-KQPYDRT 176

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT-------- 292
           VD W +G VL E+L G P F       ++ +   +L  P R     + PN +        
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPNISVSARHLLE 228

Query: 293 -------------EFKFPQIKAHP------WHKIFHKRMPP 314
                        +  F +IK H       W  + +K++ P
Sbjct: 229 GLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 58/203 (28%), Positives = 86/203 (42%), Gaps = 20/203 (9%)

Query: 154 RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 213
           R+P   +   +  + R L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+  
Sbjct: 95  RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS 153

Query: 214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
             N S++ +R Y +PE + G T YT   DIWS+G  L E+ +G+   P         E+ 
Sbjct: 154 MAN-SFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELE 207

Query: 274 KVLGTPTREEIKCMNPNYTEFKFPQ-------------IKAHPWHKIFHKRMPPEAVDLV 320
            + G P  E     +        P              I   P  K+       E  D V
Sbjct: 208 AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFV 267

Query: 321 SRLLQYSPNLRCTALEACIHPFF 343
            + L+ +P  R    E   HPF 
Sbjct: 268 DKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 84/308 (27%), Positives = 133/308 (43%), Gaps = 73/308 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNV-- 146
           +V+G+GSFG V  A+   T E  AIK + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                    + ++S R      + Y  +I   L ++H   G+ +
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK-GIIY 119

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAV 241
           RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y APE++ G  +Y  +V
Sbjct: 120 RDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESV 177

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D WS G +L E+L+GQ  F GE   D+L + I         +                  
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR----------------- 212

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-TALEACIHPFFDELRDPNARLPNGRPFP 360
            P    F + +  EA D +S+L +  P  R     +   HPFF   R  +      R  P
Sbjct: 213 -PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGIDWERLEKREIP 265

Query: 361 PLFNFKPQ 368
           P   FKP+
Sbjct: 266 P--PFKPK 271

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 42/212 (19%)

Query: 100 GQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNRE--LQTMRLL---DHPNV------- 146
           G+GS+G V++ K L   +  A+K+V L     K RE  +  +R+L   +HPN+       
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 147 ----------HYS-----------RASQRMPLIYVKLYTY--QICRALAYIHGGIGVCHR 183
                      Y+           R  +R  +   +++    Q+ R L  +H    + HR
Sbjct: 69  LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHR 127

Query: 184 DIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVD 242
           D+K  N LLV      VK+ D G +KVL K     + I + +Y APE ++    Y+   D
Sbjct: 128 DLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPYSYKSD 183

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 274
           IWS+GC+L E+    P F   S  D   ++ +
Sbjct: 184 IWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 79.9 bits (197), Expect = 6e-17
 Identities = 81/310 (26%), Positives = 121/310 (39%), Gaps = 75/310 (24%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH---PNVH-------- 147
           +G+G FG V   +   TG+  A KK L  KR K R+ + M L +      V         
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 148 -------------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                    Y+      P      Y  QI   L ++H    + +
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ-RRIVY 118

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVD 242
           RD+KP+N+L++ H + V++ D G A  L  G+       +  Y APE++ G   Y  +VD
Sbjct: 119 RDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE-VYDFSVD 176

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
            +++GC L E++ G+  F       Q  E ++      +EE+K         ++P     
Sbjct: 177 WFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRRTLE-MAVEYPD---- 219

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDPNARLPNGR 357
                   +  PEA DL   LLQ  P  R      +A E   HP F +L     RL  G 
Sbjct: 220 --------KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR--RLEAGM 269

Query: 358 PFPPLFNFKP 367
             PP   F P
Sbjct: 270 LEPP---FIP 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 79.9 bits (197), Expect = 6e-17
 Identities = 73/294 (24%), Positives = 123/294 (41%), Gaps = 72/294 (24%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQTMR------LLDHPNVH 147
           +G+G++G V++     TG T+A+K++   L + ++     EL  +       ++D     
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 148 YSRASQRMPLIYV------KLY-----------------TYQICRALAYIHGGIGVCHRD 184
           +   +  M + Y+      KLY                 TY + + L ++     + HRD
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD 128

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-----FGATEYTT 239
           +KP N+LVN +  QVKLCDFG +  LV      +  C  Y  APE I          YT 
Sbjct: 129 VKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQNPTYTV 186

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
             D+WS+G  + E+ LG+  +P E+  +   QL  I+   G P       +   Y+    
Sbjct: 187 QSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGYS---- 235

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
                             +A D V++ L   PN R T  +   HP+  + ++ +
Sbjct: 236 -----------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 80.1 bits (197), Expect = 8e-17
 Identities = 83/288 (28%), Positives = 122/288 (42%), Gaps = 63/288 (21%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNV------ 146
           +G+GS GIV  A+   +G  VA+K  + D R + R      E+  MR   H NV      
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86

Query: 147 -----------HYSRASQRMPLI-YVKLYTYQIC-------RALAYIHGGIGVCHRDIKP 187
                       + +      ++   +L   QI        +AL Y+H   GV HRDIK 
Sbjct: 87  YLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKS 145

Query: 188 QNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTAVDIWSV 246
            ++L+     +VKL DFG    + K  P   S + + Y+ APE+I   T Y T VDIWS+
Sbjct: 146 DSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPYGTEVDIWSL 203

Query: 247 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 306
           G ++ E++ G+P +  +S V  +  +        R+              P  K    HK
Sbjct: 204 GIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------PPPKLKNAHK 242

Query: 307 IFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 354
           I      P   D + R+L   P  R TA E   HPF  +   P   +P
Sbjct: 243 I-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 41/210 (19%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 144
           ++  E+ +G+G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 145 NV------------------------------HYSRASQRMPLIYVKLYTYQICRALAYI 174
           NV                              H+ +  + +P   V  Y  Q+C AL ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFG 233
           H    V HRDIKP N+ +   T  VKL D G  +    K     S + + YY +PE I  
Sbjct: 123 HSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 179

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGE 263
              Y    DIWS+GC+L E+   Q  F G+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 73/290 (25%), Positives = 117/290 (40%), Gaps = 72/290 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLLDHPNVH----- 147
           +V+G+GSFG V  A+   T E  A+K + +D   ++ +++ TM   R+L     H     
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 148 -------------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                    + + S R      + Y  +I   L ++H   G+ +
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER-GIIY 119

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAV 241
           RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y APE++     Y  AV
Sbjct: 120 RDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY-QPYGPAV 177

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D W++G +L E+L GQ  F G+   D+L                          F  I  
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGD-DEDEL--------------------------FQSILE 210

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL---EACI--HPFFDEL 346
                 + + +  EA  ++   L  +P  R   L   E  I  HPFF E+
Sbjct: 211 DEVR--YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 70/277 (25%), Positives = 109/277 (39%), Gaps = 52/277 (18%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMR-------------L 140
           +G G+ G V + K + TG  +A K V    +        RELQ M               
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 141 LDHPNV----------HYSRASQR---MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 187
           L+  N+             R  ++   +P+  +      +   L Y++    + HRDIKP
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKP 132

Query: 188 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVG 247
            N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE I G  +YT   D+WS+G
Sbjct: 133 SNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYTVKSDVWSLG 189

Query: 248 CVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 306
             + EL LG+ P        D   + + +L                     QI   P  +
Sbjct: 190 ISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQQIVQEPPPR 232

Query: 307 IFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           +     P +  D V   L   P  R T  + C  P F
Sbjct: 233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 77.8 bits (191), Expect = 3e-16
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 41/210 (19%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 144
           ++  E+ +G+G F  V++A CL   + VA+KKV    + D + +    +E+  ++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 145 NV------------------------------HYSRASQRMPLIYVKLYTYQICRALAYI 174
           NV                              ++ +  + +P   V  Y  Q+C A+ ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFG 233
           H    V HRDIKP N+ +   T  VKL D G  +    K     S + + YY +PE I  
Sbjct: 123 HSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 179

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGE 263
              Y    DIWS+GC+L E+   Q  F G+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 40/197 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN---- 145
           R +G GSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ + HPN    
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 146 -------------VHYSRAS-------QRMPL--IYVKLYTYQICRALAYIHGGIGVCHR 183
                        + Y   S        + PL  + +   T+   + LAY+H    + HR
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH-NMIHR 149

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--YTTAV 241
           DIK  N+L+     QVKL DFGSA +     P  S++ + Y+ APE+I    E  Y   V
Sbjct: 150 DIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMDEGQYDGKV 205

Query: 242 DIWSVGCVLAELLLGQP 258
           D+WS+G    EL   +P
Sbjct: 206 DVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 76/286 (26%), Positives = 112/286 (39%), Gaps = 67/286 (23%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN------ 145
           +G GSFG V+ A    T E VA+KK+    +  N       +E++ ++ L HPN      
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 146 -----------VHYSRAS-------QRMPLIYVKL--YTYQICRALAYIHGGIGVCHRDI 185
                      + Y   S        + PL  V++   T+   + LAY+H    + HRDI
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI-HRDI 147

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--YTTAVDI 243
           K  N+L+     QVKL DFGSA       P  S++ + Y+ APE+I    E  Y   VD+
Sbjct: 148 KAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 203

Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G    EL   +P     + +  L  I                    +   P ++++ 
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQNDSPTLQSNE 244

Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
           W   F           V   LQ  P  R  + E   H F    R  
Sbjct: 245 WTDSFRG--------FVDYCLQKIPQERPASAELLRHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 91/346 (26%), Positives = 141/346 (40%), Gaps = 82/346 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQD--------------KRY------------ 130
           +V+G+GSFG V  A+    GE  A+K + +D              KR             
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 131 -------KNRELQTMRLLDHPNVHYS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                  K      M  L+  ++ +  +   R  L     Y  +I   L ++H   G+ +
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK-GIIY 119

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAV 241
           RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++ G  +YT +V
Sbjct: 120 RDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG-LKYTFSV 177

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D WS G +L E+L+GQ  F G+   D+L E I+V  TP                +P+   
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP---------------HYPR--- 217

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL-EACIHPFFDELRDPNARLPNGRPFP 360
             W       +  E+ D++ +L +  P  R   +     HPFF  +   N      R   
Sbjct: 218 --W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---NWTALEKRELD 265

Query: 361 PLFNFK---PQELKGASKELLS-KLIPEHARK-------QCPFLGF 395
           P F  K   P +     +E LS K    ++ K       Q  F GF
Sbjct: 266 PPFKPKVKSPSDYSNFDREFLSEKPRLSYSDKNLIDSMDQSAFAGF 311

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 77.1 bits (190), Expect = 6e-16
 Identities = 61/193 (31%), Positives = 90/193 (46%), Gaps = 33/193 (17%)

Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--I 217
           V++Y  +I  AL ++H  +G+ +RDIK +N+L++   H V L DFG +K  +  E     
Sbjct: 107 VRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAY 164

Query: 218 SYICSRYYRAPELIFGATE-YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 276
           S+  +  Y APE+I G +  +  AVD WS+G +  ELL G   F  +   +   EI    
Sbjct: 165 SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI---- 220

Query: 277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---T 333
              +R  +K   P      FP            K M  EA D + +LL+  P  R     
Sbjct: 221 ---SRRILKSKPP------FP------------KTMSAEARDFIQKLLEKDPKKRLGANG 259

Query: 334 ALEACIHPFFDEL 346
           A E   HPFF  +
Sbjct: 260 ADEIKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 77.1 bits (190), Expect = 8e-16
 Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 49/226 (21%)

Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKG 213
           +P+   ++Y  +   AL Y+H   G+ HRD+KP NLL+    H +KL DFG +K+ L+  
Sbjct: 98  LPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSL 155

Query: 214 EPNI--------------SYIC-SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQP 258
             N+                +C +  Y APE+I     Y   VD W++G +L E L+G  
Sbjct: 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCV 214

Query: 259 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVD 318
            F G++  +   ++I        ++I    P   E                  +P +A D
Sbjct: 215 PFFGDTPEELFGQVIS-------DDI--EWPEGDE-----------------ALPADAQD 248

Query: 319 LVSRLLQYSPNLRC---TALEACIHPFFDELRDPNARLPNGRPFPP 361
           L+SRLL+ +P  R     A E   H FF  L D N  L     F P
Sbjct: 249 LISRLLRQNPLERLGTGGAFEVKQHRFFLGL-DWNGLLRQKAEFIP 293

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 40/197 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN---- 145
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN    
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 146 -------------VHYSRAS-------QRMPL--IYVKLYTYQICRALAYIHGGIGVCHR 183
                        + Y   S        + PL  + +   T+   + LAY+H    + HR
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHR 139

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--YTTAV 241
           D+K  N+L++     VKL DFGSA ++    P   ++ + Y+ APE+I    E  Y   V
Sbjct: 140 DVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 242 DIWSVGCVLAELLLGQP 258
           D+WS+G    EL   +P
Sbjct: 196 DVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.2 bits (190), Expect = 9e-16
 Identities = 75/276 (27%), Positives = 125/276 (45%), Gaps = 63/276 (22%)

Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDKRYKNRELQTMRL-------LDHP-- 144
           +V+GQGSFG VF  + +   + G+  A+K VL+    K R+    ++       ++HP  
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMK-VLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 145 -NVHYSRASQ-RMPLIY----------------------VKLYTYQICRALAYIHGGIGV 180
             +HY+  ++ ++ LI                       VK Y  ++  AL ++H  +G+
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGI 119

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATEYTT 239
            +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++     +T 
Sbjct: 120 IYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQ 177

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPT----------REEIKCMN 288
           + D WS G ++ E+L G   F G+   + +  I+K  LG P           R   K  N
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFK-RN 236

Query: 289 PNYTEFKFPQ----IKAHP------WHKIFHKRMPP 314
           P       P     IK HP      W+K++ + + P
Sbjct: 237 PANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 41/225 (18%)

Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
           H+ +   R  L   + YT ++  AL  +H    V +RD+KP+N+L++ +   + LCDFG 
Sbjct: 82  HHLQREGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLD-YQGHIALCDFGL 139

Query: 207 AKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG 265
            K+ +K +   +  C +  Y APEL+ G   YT AVD W++G +L E+L G P F  E+ 
Sbjct: 140 CKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDEN- 197

Query: 266 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 325
           V+++    K+L  P R              FP                 +A DL+  LL 
Sbjct: 198 VNEMYR--KILQEPLR--------------FPD------------GFDRDAKDLLIGLLS 229

Query: 326 YSPNLRC---TALEACIHPFFDELRDPNARLPNGRPFPPLFNFKP 367
             P  R     A E   HPFF +L     +L      PP   FKP
Sbjct: 230 RDPTRRLGYNGAQEIKNHPFFSQLS--WKKLLMKGIQPP---FKP 269

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 50/205 (24%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           VG G+FG V   +   +    A+K +       L+ +++ + E + ++ + HP +     
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                 Y R S R        Y  +I  AL Y+H    + +RD+
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH-SKEIVYRDL 127

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYYRAPELIFGATEYTT 239
           KP+N+L++   H +KL DFG AK L        G P         Y APE+I  +  +  
Sbjct: 128 KPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLAPEVI-QSKGHNK 177

Query: 240 AVDIWSVGCVLAELLLGQPLFPGES 264
           AVD W++G ++ E+L+G P F  ++
Sbjct: 178 AVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 47/204 (23%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQD--------KRYK--NRELQTMRLLDHPN-V 146
           V+G+G++G V+       G+ +A+K+V  D        K Y+    E+  ++ L H N V
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 147 HY----------------------SRASQR---MPLIYVKLYTYQICRALAYIHGGIGVC 181
            Y                      S    R   +P      YT QI   +AY+H    V 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN-CVV 124

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI-------CSRYYRAPELIFGA 234
           HRDIK  N+++ P    +KL DFG A+ L     + ++         + Y+ APE+I   
Sbjct: 125 HRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI-NE 182

Query: 235 TEYTTAVDIWSVGCVLAELLLGQP 258
           + Y    DIWS+GC + E+  G+P
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 79/309 (25%), Positives = 132/309 (42%), Gaps = 75/309 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNV-- 146
           +++G+GSFG VF A+   T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                    + ++  +  L     Y  +I   L ++H   G+ +
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK-GIVY 119

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAV 241
           RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y APE++ G  +Y T+V
Sbjct: 120 RDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSV 177

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D WS G +L E+L+GQ  F G    +              + I+  NP Y  +       
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCYPRW------- 218

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFDELRDPNARLPNGRPF 359
                     +  EA D++ +L    P  R   ++  I  HPFF E+    + L      
Sbjct: 219 ----------LTREAKDILVKLFVREPERR-LGVKGDIRQHPFFREID--WSALEEREIE 265

Query: 360 PPLFNFKPQ 368
           PP   FKP+
Sbjct: 266 PP---FKPK 271

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 73.9 bits (181), Expect = 5e-15
 Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 37/195 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVH 147
           Y   RVVG+GSFG     + + + +  A+K++   K         +E   +  + HPN+ 
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 148 YSRAS--------------------QRMPLIYVKLYT--------YQICRALAYIHGGIG 179
             + S                    Q++ L   KL+          Q+C  + +IH    
Sbjct: 62  AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-R 120

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYT 238
           V HRDIK +N+ +     +VKL DFGSA++L   G    +Y+ + YY  PE I+    Y 
Sbjct: 121 VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE-IWENMPYN 178

Query: 239 TAVDIWSVGCVLAEL 253
              DIWS+GC+L EL
Sbjct: 179 NKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 54/201 (26%), Positives = 78/201 (38%), Gaps = 45/201 (22%)

Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNI 217
            ++    Q+  AL ++H    V HRD+K  N+L+      VKL DFG SAK     +   
Sbjct: 104 QIRYVCRQMLEALNFLHSHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRD 161

Query: 218 SYICSRYYRAPELI----FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
           ++I + Y+ APE++    F    Y    DIWS+G  L EL   +P               
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--------------- 206

Query: 274 KVLGTPTREEIKCMNPNYTEFKFPQ------IKAHPWHKIFHKRMPPEAVDLVSRLLQYS 327
                P  E    +NP     K  +       +   W   F+        D +   L   
Sbjct: 207 -----PHHE----LNPMRVLLKILKSEPPTLDQPSKWSSSFN--------DFLKSCLVKD 249

Query: 328 PNLRCTALEACIHPFFDELRD 348
           P+ R TA E   HPF  +  D
Sbjct: 250 PDDRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.1 bits (182), Expect = 5e-15
 Identities = 69/281 (24%), Positives = 116/281 (41%), Gaps = 51/281 (18%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNV--HYS- 149
           ++G G+ G V++A  L T   +A+K +  D     ++    EL+ +   D P +   Y  
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 150 -----RAS--------------QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNL 190
                R S              +++P   +      + + L Y+   + + HRD+KP N+
Sbjct: 68  FFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNM 126

Query: 191 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVL 250
           LVN    QVKLCDFG +  LV      +Y+ +  Y APE I G  +Y    D+WS+G   
Sbjct: 127 LVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYGIHSDVWSLGISF 183

Query: 251 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK 310
            EL LG+  +P        +  +++L     E+             P +    + + F  
Sbjct: 184 MELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------PVLPVGQFSEKF-- 229

Query: 311 RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
                 V  +++ ++  P  R        HPF  +  D NA
Sbjct: 230 ------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 63/200 (31%), Positives = 91/200 (45%), Gaps = 40/200 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---------MRLLDHP--- 144
           +V+G+GSFG V  AK    G+  A+K VLQ K   NR+ Q          ++ + HP   
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 145 NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
            +HYS                       +  +  P    + Y  +I  AL Y+H  I + 
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS-INIV 118

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTA 240
           +RD+KP+N+L++   H V L DFG  K  +      +  C +  Y APE+I     Y   
Sbjct: 119 YRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI-RKQPYDNT 176

Query: 241 VDIWSVGCVLAELLLGQPLF 260
           VD W +G VL E+L G P F
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 74.6 bits (183), Expect = 8e-15
 Identities = 63/194 (32%), Positives = 92/194 (47%), Gaps = 34/194 (17%)

Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           V+ Y+ +I  AL ++H  +G+ +RDIK +N+L++   H V L DFG +K  +  E   +Y
Sbjct: 107 VRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTY 164

Query: 220 -IC-SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 277
             C +  Y APE+I G   +  AVD WS+G ++ ELL G   F  E   +   E+     
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV----- 219

Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC----- 332
             +R  +KC  P                  F   + PEA DL+ +LL+  P  R      
Sbjct: 220 --SRRILKCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQ 259

Query: 333 TALEACIHPFFDEL 346
            A E   HPFF  L
Sbjct: 260 GASEIKEHPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 54/172 (31%), Positives = 76/172 (44%), Gaps = 33/172 (19%)

Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICS 222
           + + L+Y+H    + HRDIKP N+L+     QVKLCDFG     V GE   S    +  +
Sbjct: 114 VLKGLSYLHSR-KIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGT 166

Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES----GVDQLVEIIKVLGT 278
            +Y APE I G   Y+   D+WS+G  L E+   +  FP E     G  +L+  I  +  
Sbjct: 167 SFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN 225

Query: 279 PT-----------REEIK-----CMNPNYTEFKFP-QIKAHPWHKIFHKRMP 313
           P             EE K     C+  + T    P  +  HPW K   K+  
Sbjct: 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 54/201 (26%)

Query: 99  VGQGSFGIVFQAKCL------ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPN--- 145
           +G+G+FG V    C        TGE VA+KK+        R   RE++ ++ L H N   
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 146 ---VHYSRASQRMPLI-----------YVK------------LYTYQICRALAYIHGGIG 179
              V YS   + + L+           Y++            LY  QIC+ + Y+ G   
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL-GSKR 128

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPELIF 232
             HRD+  +N+LV      VK+ DFG  KVL          EP  S I   ++ APE + 
Sbjct: 129 YVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI---FWYAPESL- 183

Query: 233 GATEYTTAVDIWSVGCVLAEL 253
             ++++ A D+WS G VL EL
Sbjct: 184 TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 40/210 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV--HY 148
           + +G+GSFG ++ AK     E   IK++      +++K    +E+  +  + HPN+   +
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 149 SRASQRMPLIYVKLYT--------------------------YQICRALAYIHGGIGVCH 182
           +   +   L  V  Y                            QI   L +IH    + H
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-KILH 124

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATEYTTA 240
           RDIK QN+ ++ +    KL DFG A+ L      ++Y C  + YY +PE I     Y   
Sbjct: 125 RDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-ICQNRPYNNK 182

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLV 270
            DIWS+GCVL EL   +  F G + + QLV
Sbjct: 183 TDIWSLGCVLYELCTLKHPFEGNN-LHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 83/288 (28%), Positives = 119/288 (41%), Gaps = 63/288 (21%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVHYSRAS 152
           +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  MR   H NV     S
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 153 -------------------------QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 187
                                     RM    +      + +AL+ +H   GV HRDIK 
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKS 144

Query: 188 QNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTAVDIWSV 246
            ++L+  H  +VKL DFG    + K  P   S + + Y+ APELI     Y   VDIWS+
Sbjct: 145 DSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPYGPEVDIWSL 202

Query: 247 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 306
           G ++ E++ G+P +  E               P  + +K +  N            P  K
Sbjct: 203 GIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----------PKLK 237

Query: 307 IFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 354
             HK + P     + RLL   P  R TA E   HPF  +   P+  +P
Sbjct: 238 NLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 79/289 (27%), Positives = 125/289 (43%), Gaps = 61/289 (21%)

Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 141 LDHPN-VHYSRASQRMPLIYVKL--------------------YTYQICR----ALAYIH 175
             HPN V+Y  +      ++V +                        +CR    AL ++H
Sbjct: 73  NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 132

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 234
               V HRDIK  N+L+      VKL DFG  A++  +     + + + Y+ APE++   
Sbjct: 133 SN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TR 189

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
             Y   VDIWS+G +  E++ G+P +  E+ +  L  +I   GTP             E 
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-------------EL 235

Query: 295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+            ++     D ++R L+     R +A E   HPF 
Sbjct: 236 QNPE------------KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 77/291 (26%), Positives = 124/291 (42%), Gaps = 77/291 (26%)

Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQ---------DKRYKNRELQTMRLLDHP 144
           +V+G+G +G VFQ + +   +TG+  A+K VL+         D  +   E   +  + HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 145 ---NVHYS-RASQRMPLIY----------------------VKLYTYQICRALAYIHGGI 178
              ++ Y+ +   ++ LI                          Y  +I  AL ++H   
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ-Q 119

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATEY 237
           G+ +RD+KP+N+L++   H VKL DFG  K  +         C    Y APE I   + +
Sbjct: 120 GIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE-ILMRSGH 177

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
             AVD WS+G ++ ++L G P F  E+    + +I+K          K   P Y      
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNLPPY------ 222

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 343
                         + PEA DL+ +LL+ +P+ R       A E   HPFF
Sbjct: 223 --------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 45/131 (34%), Positives = 74/131 (56%), Gaps = 9/131 (6%)

Query: 150 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 209
           + ++R+P   +   +  + R LAY+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 95  KEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 153

Query: 210 LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQ 268
           L+    N S++ +R Y +PE + G T Y+   DIWS+G  L EL +G+ P+ P ++    
Sbjct: 154 LIDSMAN-SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--- 208

Query: 269 LVEIIKVLGTP 279
             E+  + G P
Sbjct: 209 --ELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 81/305 (26%), Positives = 127/305 (41%), Gaps = 75/305 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---------MRLLDHP--- 144
           +V+G+GSFG V  AK    G   A+K VLQ K    ++ Q          ++ L HP   
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 145 NVHYS-RASQRMPLI--YV--------------------KLYTYQICRALAYIHGGIGVC 181
            +HYS + ++++  +  YV                    + Y  ++  A+ Y+H  + + 
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS-LNII 118

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTA 240
           +RD+KP+N+L++   H V L DFG  K  V+ E   S  C +  Y APE +     Y   
Sbjct: 119 YRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRT 176

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII----------------KVLGTPTREEI 284
           VD W +G VL E+L G P F     V Q+ + I                 +L     ++ 
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQ 235

Query: 285 KCMNPNYTEFKFPQIKAH------PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
           +       +F   +IK H       W  ++HKR+ P           Y+PN+   A    
Sbjct: 236 RRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITPP----------YNPNVAGPADLRH 283

Query: 339 IHPFF 343
             P F
Sbjct: 284 FDPEF 288

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 80/283 (28%), Positives = 117/283 (41%), Gaps = 72/283 (25%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNV----- 146
           +G GSFG V  AK   TGE  AIK     ++L+ K+ +   +E   +  L HP +     
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                 + R + R P    K Y  ++  A  Y+H    + +RD+
Sbjct: 86  SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDL 144

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWS 245
           KP+NLL++   H VK+ DFG AK +   +   +   +  Y APE+I  +  +  AVD W+
Sbjct: 145 KPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKGHGKAVDWWT 200

Query: 246 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +G +L E + G P F  +              TP R   K +       KFP      W 
Sbjct: 201 MGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLKFPN-----W- 237

Query: 306 KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-----HPFF 343
             F  R    A DLV  LLQ     R   L+  +     HP+F
Sbjct: 238 --FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 53/204 (25%)

Query: 97  RVVGQGSFGIVFQAKCLE-----TGETVAIKK-----VLQDKRYKNRELQTMRLLDHPNV 146
           + +G+G FG V      +     TGE VA+K        Q +    RE++ +R LDH N+
Sbjct: 10  KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 147 ----------------------------HY-SRASQRMPLIYVKLYTYQICRALAYIHGG 177
                                        Y  R   ++ L  + L++ QIC+ + Y+ G 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL-GS 127

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPEL 230
               HRD+  +N+LV      VK+ DFG AKVL +        EP  S I   +Y APE 
Sbjct: 128 QRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY-APEC 183

Query: 231 IFGATEYTTAVDIWSVGCVLAELL 254
           +  +  +++A D+WS G  L EL 
Sbjct: 184 LRTSK-FSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 55/210 (26%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLL-DHPNV----- 146
           V+G+G++G V++A+  +TG+ VAIK  + D           E   +R   +HPN+     
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 147 ------HYSRASQ-------------------------RMPLIYVKLYTYQICRALAYIH 175
                       Q                         R+   ++     +  R LAY+H
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 234
               V HRDIK QN+L+     +VKL DFG SA++        ++I + Y+ APE+I  A
Sbjct: 131 EN-KVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI--A 186

Query: 235 TE------YTTAVDIWSVGCVLAELLLGQP 258
            +      Y    D+WS+G    EL  G+P
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 78/313 (24%), Positives = 123/313 (39%), Gaps = 77/313 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL--------LDHPNV-- 146
           RV+G+G FG V   +   TG+  A KK L+ KR K R+ + M L        ++   V  
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 147 -------------------------H-YSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                                    H Y+  +          Y  +I   L  +H    +
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-RI 123

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
            +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++     YT +
Sbjct: 124 VYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KNERYTFS 181

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
            D W +GC++ E++ G+  F          E +K      REE++       E       
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERRVKEDQE------- 222

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--C---TALEACIHPFFDELRDPN-ARLP 354
                  + ++    A  +  +LL   P  R  C    A E   HPFF   R  N  RL 
Sbjct: 223 ------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF---RTANFKRLE 273

Query: 355 NGRPFPPLFNFKP 367
            G   PP   F P
Sbjct: 274 AGMLEPP---FCP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 58/197 (29%), Positives = 88/197 (44%), Gaps = 38/197 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN--RELQTMRLLDHPN- 145
           Y+  + +G+GSFG     K  E G+   IK++    +  K  +   +E+  +  + HPN 
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 146 VHYSRASQRMPLIYV--------KLYT-------------------YQICRALAYIHGGI 178
           V Y  + +    +Y+         LY                     QIC AL ++H   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR- 120

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEY 237
            + HRDIK QN+ +      +KL DFG A+VL    E   + I + YY +PE I     Y
Sbjct: 121 KILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-ICENRPY 178

Query: 238 TTAVDIWSVGCVLAELL 254
               DIW++GCVL E+ 
Sbjct: 179 NNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 85/307 (27%), Positives = 132/307 (42%), Gaps = 65/307 (21%)

Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTM 138
           G P++ +    +  +G+GS GIV  A    TG+ VA+KK+  D R + R      E+  M
Sbjct: 18  GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73

Query: 139 RLLDHPNV--HYSR-----------------------ASQRMPLIYVKLYTYQICRALAY 173
           R   H NV   Y+                           RM    +      + RAL+Y
Sbjct: 74  RDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSY 133

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIF 232
           +H   GV HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I 
Sbjct: 134 LHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI- 190

Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 292
               Y T VDIWS+G ++ E++ G+P +  E  +  +  I        R+ +        
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RDNLP------- 235

Query: 293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 352
               P++K    HK+    +    +DL   +L   P+ R TA E   HPF      P+  
Sbjct: 236 ----PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFLKLAGPPSCI 284

Query: 353 LPNGRPF 359
           +P  R +
Sbjct: 285 VPLMRQY 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 60/206 (29%), Positives = 84/206 (40%), Gaps = 49/206 (23%)

Query: 97  RVVGQGSFGIVFQAK-CLETGE--TVAIKKVLQDKRYKNREL-----QTMRLLDHPNV-- 146
           R +G+G FG V+Q        E   VA+K          RE        MR  DHP++  
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 147 -----------------------HY-SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                   Y       + L  + LY+YQ+  ALAY+       H
Sbjct: 72  LIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE-SKRFVH 130

Query: 183 RDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           RDI  +N+LV +P    VKL DFG ++ L   E    Y  S+      + APE I     
Sbjct: 131 RDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMAPESI-NFRR 184

Query: 237 YTTAVDIWSVG-CVLAELLLG-QPLF 260
           +T+A D+W  G C+   L+LG +P  
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQ 210

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.4 bits (169), Expect = 3e-13
 Identities = 70/240 (29%), Positives = 112/240 (46%), Gaps = 36/240 (15%)

Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRL 140
           G PK+   Y     +GQG+ G VF A  + TG+ VAIK++   K+ K      E+  M+ 
Sbjct: 15  GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 141 LDHPNVHYSRASQRM--PLIYVKLY-------------------TYQICR----ALAYIH 175
           L +PN+     S  +   L  V  Y                      +CR    AL ++H
Sbjct: 73  LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 234
               V HRDIK  N+L+      VKL DFG  A++  +     + + + Y+ APE++   
Sbjct: 133 AN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TR 189

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
             Y   VDIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  + ++P + +F
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSPIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 66/278 (23%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRAS-QRMP 156
           ++G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L  +  +  S  S    P
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLAL--NERIMLSLVSTGDCP 57

Query: 157 LIYVKLYTYQICRALAYI---------------HG----------------GI------G 179
            I    Y +     L++I               HG                G+       
Sbjct: 58  FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF 117

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  Y APE++     Y +
Sbjct: 118 VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDS 175

Query: 240 AVDIWSVGCVLAELLLGQ----------------------PLFPGESGVDQLVEIIKVLG 277
           + D +S+GC+L +LL G                          P     +    +  +L 
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235

Query: 278 TPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 314
                 + C+     E K  P  ++  W  +F ++ PP
Sbjct: 236 RDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 36/211 (17%)

Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           V++Y+ +I  AL ++H  +G+ +RDIK +N+L++ + H V L DFG +K   + E   +Y
Sbjct: 107 VQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAY 164

Query: 220 -ICSRY-YRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 276
             C    Y AP+++ G    +  AVD WS+G ++ ELL G   F  +   +   EI    
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI---- 220

Query: 277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---- 332
              +R  +K   P      +PQ             M   A D++ RLL   P  R     
Sbjct: 221 ---SRRILKSEPP------YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGP 259

Query: 333 -TALEACIHPFFDELR-DPNARLPNGRPFPP 361
             A E   HPFF ++  D  A      PF P
Sbjct: 260 SDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 47/229 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVH 147
           +++GQG+FG V+     +TG  +A+K+V  D               E+Q ++ L H  + 
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 148 YSRASQRMPL-----IYVKL-----------------------YTYQICRALAYIHGGIG 179
                 R P+     I+++                        YT QI   ++Y+H  + 
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM- 126

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRYYRAPELIFGAT 235
           + HRDIK  N+L +     VKL DFG++K L    + G    S   + Y+ +PE+I G  
Sbjct: 127 IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185

Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
            Y    DIWSVGC + E+L  +P +   +  + +  I K+   PT   +
Sbjct: 186 -YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.6 bits (167), Expect = 4e-13
 Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 47/235 (20%)

Query: 91  ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLL 141
           I++   +++GQG+FG V+    ++TG  +A K+V  D               E+Q ++ L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 142 DHPNV---------HYSRA----SQRMPLIYVK---------------LYTYQICRALAY 173
            H  +            +      + MP   VK                YT QI   ++Y
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRYYRAPE 229
           +H  + + HRDIK  N+L +     VKL DFG++K L    + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 230 LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           +I G   Y    D+WS+GC + E+L  +P +   +  + +  I K+   PT  ++
Sbjct: 180 VISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNPQL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 47/229 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLLDHPN-V 146
           +++G+G+FG V+     +TG  +A+K+V  D   +           E+Q ++ L H   V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 147 HY----SRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIG 179
            Y        ++   I+V+                        YT QI + ++Y+H  + 
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM- 126

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAK----VLVKGEPNISYICSRYYRAPELIFGAT 235
           + HRDIK  N+L +     VKL DFG++K    + + G    S   + Y+ +PE+I G  
Sbjct: 127 IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185

Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
            Y    D+WSV C + E+L  +P +   +  + +  I K+   PT+  +
Sbjct: 186 -YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 77/289 (26%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHP-- 144
           +++G+G+FG V   +   TG+  A+K + ++             ++R LQ  R   HP  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57

Query: 145 -NVHYS-RASQRMPLI--YV--------------------KLYTYQICRALAYIHGGIGV 180
             + YS +   R+  +  Y                     + Y  +I  AL Y+H    V
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC-DV 116

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTT 239
            +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE +    +Y  
Sbjct: 117 VYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGR 174

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           AVD W +G V+ E++ G+  F  +   ++L E+I +      EEI+              
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-------------- 213

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 343
                   F + + PEA  L++ LL+  P  R       A E   H FF
Sbjct: 214 --------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.2 bits (167), Expect = 7e-13
 Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 42/222 (18%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQ----TMRLLDHPNV------ 146
           +G+G+FG V +     +G  +A+K++    D++ + R L      MR  D P +      
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                    Y      +P   +        +AL Y+   + + H
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIH 131

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI--FGATEYTTA 240
           RD+KP N+L++ + + +KLCDFG +  LV           R Y APE I       Y   
Sbjct: 132 RDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVR 190

Query: 241 VDIWSVGCVLAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR 281
            D+WS+G  L E+  G+  +P   S  DQL +++K  G P  
Sbjct: 191 SDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 42/119 (35%), Positives = 67/119 (56%), Gaps = 4/119 (3%)

Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 226
           + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y 
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYM 169

Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 284
           +PE + G T Y+   DIWS+G  L E+ +G+ P+ P ++   +L+    V G P   E 
Sbjct: 170 SPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 59/232 (25%), Positives = 89/232 (38%), Gaps = 61/232 (26%)

Query: 99  VGQGSFGIVFQAKCLETGE---TVAIK-----KVLQDKRYKNRELQTMRLLDHPNV---- 146
           +G G+FG V +   L        VA+K      +   K+   RE   M  LDHP +    
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                 Y +  + +P+  +K   +Q+   +AY+     V HRD+
Sbjct: 63  GVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV-HRDL 121

Query: 186 KPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------------APELIF 232
             +N LLVN   HQ K+ DFG ++ L  G        S YYR            APE I 
Sbjct: 122 AARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWPLKWYAPECIN 171

Query: 233 GATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD--QLVEIIKVLGTPTR 281
               +++  D+WS G  L E    G   +    G +   ++E  + L  P  
Sbjct: 172 YGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEE 222

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 44/214 (20%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQ--DKRYKNRELQTMRLL---DHPNV--HY-- 148
           +G+GSFG+VF+          A+K++ L   ++R +   +   R+L   D   +  +Y  
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 149 ------------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
                                    +  + +P   V  +  QI   LA++H    + HRD
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRD 126

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGATEYTTA 240
           IK  NL ++ +   VK+ D G AK+L     N ++    + + YY +PEL      Y   
Sbjct: 127 IKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC-EDKPYNEK 181

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 274
            D+W++G VL E   G+  F   +    +++II+
Sbjct: 182 SDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 85/327 (25%), Positives = 134/327 (40%), Gaps = 87/327 (26%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNV-- 146
           RV+G+GSFG V  A+  E+G   A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                    + + S+R      + Y  +I  AL ++H   G+ +
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK-GIIY 119

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAV 241
           RD+K  N+L++ H    KL DFG  K  +      S  C +  Y APE I     Y  +V
Sbjct: 120 RDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPSV 177

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D W++G +L E+L G   F  E+  D L E I        +E+                 
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV----------------- 213

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--CTAL--EACI--HPFFDELRDPNARLPN 355
                ++   +  +AVD++   +  +P +R     L  E  I  HPFF EL   +    N
Sbjct: 214 -----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL---DWEKLN 265

Query: 356 GRPFPPLF-----------NFKPQELK 371
            R   P F           NF P  +K
Sbjct: 266 RRQIEPPFRPRIKSREDVSNFDPDFIK 292

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 66.4 bits (163), Expect = 2e-12
 Identities = 54/190 (28%), Positives = 80/190 (42%), Gaps = 41/190 (21%)

Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           VK    Q+  AL  +H    + H DIK +N+L +    ++ LCD+G  K  + G P    
Sbjct: 111 VKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTP---- 163

Query: 220 ICSRY-----YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 274
             S Y     Y +PE I G   Y  + D W+VG +  ELL G+   P +   D   E + 
Sbjct: 164 --SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDED---EEL- 214

Query: 275 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 334
                   +++ +     + K P          F K +   A D V  +L+Y+ N R T 
Sbjct: 215 --------DLESLLKRQ-QKKLP----------FIKNVSKNANDFVQSMLKYNINYRLTN 255

Query: 335 LEACI-HPFF 343
               I HPF 
Sbjct: 256 YNEIIKHPFL 265

Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 41/120 (34%), Positives = 61/120 (50%), Gaps = 13/120 (10%)

Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           +P  + + YT ++  AL  IH  +G  HRD+KP N+L++   H +KL DFG+    +K +
Sbjct: 139 IPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMD 193

Query: 215 PNISYICSRY-----YRAPELIF---GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
            N    C        Y +PE++    G   Y    D WSVG  L E+L+G   F  +S V
Sbjct: 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 66.7 bits (162), Expect = 2e-12
 Identities = 79/289 (27%), Positives = 126/289 (43%), Gaps = 61/289 (21%)

Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 141 LDHPN-VHYSRASQRMPLIYVKL--------------------YTYQICR----ALAYIH 175
             +PN V+Y  +      ++V +                        +CR    AL ++H
Sbjct: 73  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 234
               V HRDIK  N+L+      VKL DFG  A++  +     + + + Y+ APE++   
Sbjct: 133 SN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TR 189

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
             Y   VDIWS+G +  E++ G+P +  E+ +  L  +I   GTP     +  NP     
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-----ELQNP----- 238

Query: 295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                          +R+     D ++R L+   + R +A E   HPF 
Sbjct: 239 ---------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 72/288 (25%), Positives = 116/288 (40%), Gaps = 75/288 (26%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM----RLLD------HP--- 144
           V+G+G FG V  A+  +TGE  AIK + +       E++++    R+ +      HP   
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 145 NVH--------------YSRASQRMPLIY--------VKLYTYQICRALAYIHGGIGVCH 182
           N+               Y+     M  I+           Y   +   L Y+H    + +
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN-KIVY 124

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAV 241
           RD+K  NLL++     VK+ DFG  K  +      S  C +  + APE++   T YT AV
Sbjct: 125 RDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTRAV 182

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D W +G ++ E+L+G+  FPG+                  EE+           F  I  
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGD----------------DEEEV-----------FDSIVN 215

Query: 302 -HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 343
               +  F   +  EA+ ++ RLL+ +P  R       A +    PFF
Sbjct: 216 DEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 60/238 (25%), Positives = 83/238 (34%), Gaps = 80/238 (33%)

Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG------------SAKVLVKGEPNI 217
           A+  IH  +G  HRDIKP NLL++   H +KL DFG              ++L    P+ 
Sbjct: 113 AIDSIHK-LGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 218 SYICSR--------------------Y-------YRAPELIFGATEYTTAVDIWSVGCVL 250
                                     Y       Y APE +F  T Y    D WS+G ++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIM 229

Query: 251 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK 310
            E+L+G P F  +               P     K +N   T  +FP             
Sbjct: 230 YEMLVGYPPFCSD--------------NPQETYRKIINWKET-LQFPD----------EV 264

Query: 311 RMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFF-----DELRDPNARLPNGRPFPP 361
            + PEA DL+ RL   +          E   HPFF     + +R+  A      P  P
Sbjct: 265 PLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEHIRERPA------PIIP 316

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 80/311 (25%), Positives = 129/311 (41%), Gaps = 73/311 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMP 156
           RV+G+G FG V   +   TG+  A KK L+ KR K R+ ++M L +   +    +   + 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 157 LIYVKLYTYQICRALAYIHGG--------IG---------------------------VC 181
           L Y       +C  L  ++GG        +G                           + 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++     YT + 
Sbjct: 125 YRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSP 182

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D W++GC+L E++ GQ  F       Q  + IK      REE++ +     E        
Sbjct: 183 DWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQE-------- 222

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDPNARLPNG 356
                 + ++  P+A  L   LL   P  R       A E   HP F ++     RL  G
Sbjct: 223 -----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN--FKRLEAG 275

Query: 357 RPFPPLFNFKP 367
              PP   FKP
Sbjct: 276 MLEPP---FKP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 39/198 (19%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN 145
           +Y   RVVG+GS+G V   +    G+   IKK+       ++++   +E Q +  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 146 VHYSRAS-----------------------------QRMPLIYVKLYTYQICRALAYIHG 176
           +   R S                             + +P   V  +  QI  AL Y+H 
Sbjct: 61  IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGAT 235
              + HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY +PEL F   
Sbjct: 121 K-HILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL-FSNK 177

Query: 236 EYTTAVDIWSVGCVLAEL 253
            Y    D+W++GC + E+
Sbjct: 178 PYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (159), Expect = 8e-12
 Identities = 71/311 (22%), Positives = 120/311 (38%), Gaps = 76/311 (24%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----------LQTMRLLDHPNV-- 146
           +G+G+FG V+Q +  +T    A+K + + +    +E          L    L + P +  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 147 ---HYSRASQ---------------------RMPLIYVKLYTYQICRALAYIHGGIGVCH 182
               +   S                      R      K Y  ++  AL ++H    + +
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY-DIVY 119

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  Y APE++     YT  V
Sbjct: 120 RDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D WS+G ++ E+  G   F  E    Q+   I                 + + +FP+   
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIA----------------FGKVRFPK--- 218

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI----HPFFDELRDPNARLPNGR 357
                     +  E    V  LL  +P  R  A    +    HPFF ++ D +  L   +
Sbjct: 219 --------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI-DWDL-LSKKQ 268

Query: 358 PFPPLFNFKPQ 368
             PP   FKP 
Sbjct: 269 ITPP---FKPI 276

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 77/284 (27%), Positives = 114/284 (40%), Gaps = 73/284 (25%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNV-------- 146
           +G G++G V++A+ + TGE  AIK +     +D     +E+  M+   H N+        
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                H +       + YV   T Q    L Y+H   G  HRDI
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHSK-GKMHRDI 132

Query: 186 KPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE----YTTA 240
           K  N+L+  + H VKL DFG SA++        S+I + Y+ APE+   A E    Y   
Sbjct: 133 KGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKGGYNQL 189

Query: 241 VDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
            DIW+VG    EL  L  P+F         +  ++ L   T+          + F+ P++
Sbjct: 190 CDIWAVGITAIELAELQPPMFD--------LHPMRALFLMTK----------SNFQPPKL 231

Query: 300 KAH-PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           K    W   FH          V   L  +P  R TA +   HPF
Sbjct: 232 KDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 41/216 (18%)

Query: 82  GRNGQPKQTISYMA-ERV--VGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNR 133
                P    S    ERV  +G G+ G V++     TG   A+K +  +     +R   R
Sbjct: 62  ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR 121

Query: 134 ELQTMRLLDHPNV---H--YSRASQRMPLI-----------------YVKLYTYQICRAL 171
           E++ +R ++HPNV   H  +    +   L+                 ++     QI   +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGI 181

Query: 172 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPEL 230
           AY+H    + HRDIKP NLL+N     VK+ DFG +++L +  +P  S + +  Y +PE 
Sbjct: 182 AYLHRR-HIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPER 239

Query: 231 I-----FGATEYTTAVDIWSVGCVLAELLLGQPLFP 261
           I      GA +   A DIWS+G  + E  LG+  FP
Sbjct: 240 INTDLNHGAYD-GYAGDIWSLGVSILEFYLGR--FP 272

Length = 353

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 82/342 (23%), Positives = 136/342 (39%), Gaps = 88/342 (25%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---ELQTMRLLDHPNVHYSRASQR 154
           ++G+G+FG V +A   +  E  A+K V    +Y      E+Q M       V  +  + R
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFME-----KVRQADPADR 190

Query: 155 MPLIYVKLY-------------------------------------TYQICRALAYIHGG 177
            PL+ ++ Y                                      +Q   AL Y H  
Sbjct: 191 FPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE 250

Query: 178 IGVCHRDIKPQNLL-------VNPHTHQ--------VKLCDFGSAKVLVKGEPNISYICS 222
           + + H D+KP+N+L       V+P T++        V++CD G      +     + + +
Sbjct: 251 LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTAIVST 308

Query: 223 RYYRAPELIFG-ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT-PT 280
           R+YR+PE++ G    Y+T  D+WS+GC++ EL  G+ L+     ++ L  + K LG  P+
Sbjct: 309 RHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPS 366

Query: 281 REEIKCMNPN----YTEFKFPQIKAHPWH--KIFHKRMPPEAV------DLVSRLLQYSP 328
               +C        Y      +    P H  +I   R   E +      DL+  LL Y  
Sbjct: 367 EWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426

Query: 329 NLRCTALEACIHP----FFDELRD-PNARLPNGRPF---PPL 362
             R  A +   HP    ++ E R  PN   P+ R      P+
Sbjct: 427 QKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRPTPI 466

Length = 467

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 97/400 (24%), Positives = 149/400 (37%), Gaps = 136/400 (34%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LL---DHPNV--- 146
           +V+G+G+FG V   +  +TG+  A+K +L+ + +K  +L  ++    +L   D P V   
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 147 HYS-RASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHR 183
           +YS + +Q + LI                        + Y  +   A+  +H  +G  HR
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHR 125

Query: 184 DIKPQNLLVNPHTHQVKLCDFG------------SAKVLVKGEPNISYICSRY------- 224
           DIKP N+L++   H +KL DFG              + L++G+ N + I +R        
Sbjct: 126 DIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184

Query: 225 -----------------------------YRAPELIFGATEYTTAVDIWSVGCVLAELLL 255
                                        Y APE IF    Y    D WS+G ++ E L+
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLGAIMFECLI 243

Query: 256 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIFHKRMPP 314
           G P F  E+  +   +II                N+ E   FP    H         +  
Sbjct: 244 GWPPFCSENSHETYRKII----------------NWRETLYFPD-DIH---------LSV 277

Query: 315 EAVDLVSRLLQYSPNL--RCTALEACIHPFF-----DELRDPNARLPNGRPFPPLFN--- 364
           EA DL+ RL+  + N   R  A E   HPFF     D +R   A      PF P      
Sbjct: 278 EAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA------PFIPQLKSIT 331

Query: 365 ----FKPQELKG-----ASKELLSKLIPEHARKQCPFLGF 395
               F   EL+      A K+       E       F+G+
Sbjct: 332 DTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGY 371

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 23/168 (13%)

Query: 164 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICS 222
           T  I +AL Y+    GV HRD+KP N+L++  +  VKLCDFG +  LV  +    S  C+
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCA 178

Query: 223 RYYRAPELIFGAT---EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT- 278
            Y  APE I       +Y    D+WS+G  L EL  GQ  FP ++   +   + K+L   
Sbjct: 179 AYM-APERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEE 235

Query: 279 ----PTREE---------IKCMNPNYTEF-KFPQIKAHPWHKIFHKRM 312
               P  E            C+  ++ +  K+ ++  HP+ + +    
Sbjct: 236 PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 40/200 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY--KNRELQTM-------RLLDHP--- 144
           +V+G+GSFG V  A+  +  E     KVLQ K    K  E   M       + + HP   
Sbjct: 1   KVIGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 145 NVHYS-RASQRMPLI--YV--------------------KLYTYQICRALAYIHGGIGVC 181
            +H+S + + ++  +  Y+                    + Y  +I  AL Y+H  + + 
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIV 118

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTA 240
           +RD+KP+N+L++   H V L DFG  K  ++     S  C +  Y APE++     Y   
Sbjct: 119 YRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH-KQPYDRT 176

Query: 241 VDIWSVGCVLAELLLGQPLF 260
           VD W +G VL E+L G P F
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 41/200 (20%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL----------------- 140
           ++G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L                 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 141 -------------------LDHPNVHYSRASQRM-PLIYVKLYTYQICRALAYIHGGIGV 180
                              ++  ++HY  +   +     ++ Y  +I   L ++H    V
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF-V 118

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
            +RD+KP N+L++ H H V++ D G A    K +P+ S + +  Y APE++   T Y ++
Sbjct: 119 VYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176

Query: 241 VDIWSVGCVLAELLLGQPLF 260
            D +S+GC+L +LL G   F
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 63.6 bits (154), Expect = 2e-11
 Identities = 67/240 (27%), Positives = 113/240 (47%), Gaps = 36/240 (15%)

Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 141 LDHPN-VHYSRASQRMPLIYVKL--------------------YTYQICR----ALAYIH 175
             +PN V+Y  +      ++V +                        +CR    AL ++H
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 234
               V HRDIK  N+L+      VKL DFG  A++  +     + + + Y+ APE++   
Sbjct: 134 SN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TR 190

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
             Y   VDIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  + ++  + +F
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 68/264 (25%), Positives = 107/264 (40%), Gaps = 68/264 (25%)

Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-------KVLVK 212
            + Y  ++  A+  +H  +G  HRDIKP+N+L++   H +KL DFGSA        V  K
Sbjct: 104 AQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSK 161

Query: 213 ---GEPNISYICSRYYRAPELI-----FGATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
              G P+        Y APE++      G   Y    D WS+G +  E++ G+  F   +
Sbjct: 162 LPVGTPD--------YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213

Query: 265 GVDQLVEIIKVLGTPTREEIKCMNPNYTEF-KFPQIKAHPWHKIFHKRMPPEAVDLVSRL 323
                  I+                N+  F KFP+            ++  + +DL+  L
Sbjct: 214 SAKTYNNIM----------------NFQRFLKFPE----------DPKVSSDFLDLIQSL 247

Query: 324 LQYSPNLRCTALEACIHPFFDELRDPNAR--LPNGRPFPPLF-------NF-KPQELKGA 373
           L      R      C HPFF ++   N R  LP   PF P         NF +P++    
Sbjct: 248 LC-GQKERLGYEGLCCHPFFSKIDWNNIRNSLP---PFVPTLKSDDDTSNFDEPEKNSTR 303

Query: 374 SKELLSKLIPEH--ARKQCPFLGF 395
             +  +  +  +  + K  PF+GF
Sbjct: 304 RSQSSTTQLKPNGFSGKDLPFVGF 327

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 82/370 (22%), Positives = 135/370 (36%), Gaps = 65/370 (17%)

Query: 18  DDVMIVDKLPAKPDDDDDAMPVDKLPEEIN-----EMKIKGERVEKEMEATVVDGN---- 68
           D     D    K DD D+    D +    +     E       V +E   T    +    
Sbjct: 30  DTSDSKDTTGDKFDDCDELGDSDDVTHATDYDADEESLSPQTDVCQEPCETTSSSDPASV 89

Query: 69  -------------GTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLET 115
                        G+E G + V T  G   + K  +    + V G  + G   +   L+T
Sbjct: 90  VRMQYNILSSLTPGSE-GEVFVCTKHGDEQRKKVIV----KAVTGGKTPGR--EIDILKT 142

Query: 116 GETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIH 175
               AI  ++   R+K+     M         Y   S  +PL        ++  ALAY+H
Sbjct: 143 ISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH 202

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPEL 230
           G  G+ HRD+K +N+ ++   + V L DFG+A  L       +  C  +       +PEL
Sbjct: 203 GR-GIIHRDVKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPEL 258

Query: 231 IFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
           +     Y    DIWS G VL E+ +    LF  +         +K   +  R  I+CM  
Sbjct: 259 L-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ---------VKSSSSQLRSIIRCMQV 308

Query: 290 NYTEF-------------KFPQIKAHPWH--KIFHKRMPPEAVD-LVSRLLQYSPNLRCT 333
           +  EF             ++  +   P+    +  K      V+ L++++L +    R +
Sbjct: 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS 368

Query: 334 ALEACIHPFF 343
           A +    P F
Sbjct: 369 AQDILSLPLF 378

Length = 392

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 83/368 (22%), Positives = 147/368 (39%), Gaps = 46/368 (12%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
            YS G A     +   D D+   D   A   DDDD        + +   K K   V   +
Sbjct: 14  SYSGGAADEDLYSDISDGDLEYSDDDSASESDDDD-------DDGLIPTKQKAREVVASL 66

Query: 61  EATVVD--GNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGET 118
             TV+     G+E G + V T   + GQP   +       +GQ    ++ +A  L+    
Sbjct: 67  GYTVIKTLTPGSE-GRVFVAT---KPGQPDPVVLK-----IGQKGTTLI-EAMLLQNVNH 116

Query: 119 VAIKKVLQDKRYKNRELQTMRLLDHPN----VHYSRASQRMPLIYVKLYTYQICRALAYI 174
            ++ ++            T  +L H +     + ++ S+ +P+    +   QI   L Y+
Sbjct: 117 PSVIRMKDTLVSGA---ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 234
           H    + HRD+K +N+ +N    QV + D G+A+  V     +    +    APE +   
Sbjct: 174 HA-QRIIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLAR 230

Query: 235 TEYTTAVDIWSVGCVLAELLL----------GQPLFPGESGVDQLVEIIKVLGT-----P 279
            +Y +  DIWS G VL E+L             P    +S    L++II  L       P
Sbjct: 231 DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290

Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEAC 338
                + +   + E+   + + +  +  F +  +P +   LV ++L +   +R +A E  
Sbjct: 291 RDPGSR-LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349

Query: 339 IHPFFDEL 346
            +P F +L
Sbjct: 350 NYPMFAQL 357

Length = 357

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 81/317 (25%), Positives = 126/317 (39%), Gaps = 89/317 (28%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDH------PNV 146
           +V+G+G+FG V   K   TG+  A+K + + +  K  E    R    +L +       N+
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 147 HY------------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
           HY                        S+   R+P    + Y  ++  A+  +H  +G  H
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVH 125

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYICSRYYRAPELIF 232
           RDIKP N+L++ + H ++L DFGS   L+           G P+  YI     +A E   
Sbjct: 126 RDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YISPEILQAME--D 180

Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 292
           G   Y    D WS+G  + E+L G+  F  ES V+   +I+                N+ 
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHK 224

Query: 293 E-FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFF-----D 344
           E F+FP              +  EA DL+ RL+        R    +   HPFF     D
Sbjct: 225 EHFQFPPDVTD---------VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275

Query: 345 ELRDPNARLPNGRPFPP 361
            +R+  A      P+ P
Sbjct: 276 NIRNSTA------PYVP 286

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 40/202 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMP 156
           RV+G+G FG V   +   TG+  A K+ L+ KR K R+ ++M L +   +    +   + 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 157 LIY------------------------------------VKLYTYQICRALAYIHGGIGV 180
           L Y                                       Y  +I   L  +H     
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-NT 123

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
            +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++     YT +
Sbjct: 124 VYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NNQRYTLS 181

Query: 241 VDIWSVGCVLAELLLGQPLFPG 262
            D W +GC++ E++ GQ  F G
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 39/195 (20%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLDHPNVHY 148
           VG G++G V++A+ L TGE  A+K           ++Q + +  +E +   ++ +   + 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 149 SRASQRMPLIYV----------------KLYTYQICR----ALAYIHGGIGVCHRDIKPQ 188
           SR    + + Y                 +L    +CR     LAY+H   G  HRDIK  
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGA 135

Query: 189 NLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE----YTTAVDI 243
           N+L+  +   VKL DFG +AK+        S+I + Y+ APE+   A E    Y    DI
Sbjct: 136 NILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNGGYNQLCDI 192

Query: 244 WSVGCVLAELLLGQP 258
           W+VG    EL   QP
Sbjct: 193 WAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 39/212 (18%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHP---N 145
           +V+G+GSFG V  A+   T E  AIK + +D   ++ ++  TM   R+L     HP    
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 146 VHYS-RASQRMPLI--YV--------------------KLYTYQICRALAYIHGGIGVCH 182
           +H   +   R+  +  YV                    + Y  ++  AL ++H   GV +
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH-GVIY 119

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y APE I    EY  +V
Sbjct: 120 RDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-ILQELEYGPSV 177

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
           D W++G ++ E++ GQP F  ++  D L E I
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNE-DDLFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 66/241 (27%), Positives = 99/241 (41%), Gaps = 78/241 (32%)

Query: 156 PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG---------S 206
           P +  + Y  ++  A+  +H  +G  HRDIKP N+L++   H +KL DFG         +
Sbjct: 99  PEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHN 156

Query: 207 AKVLVKG--------EPNI-------------------------------SYICSRYYRA 227
           +K   KG        EP+                                S + +  Y A
Sbjct: 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIA 216

Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 287
           PE++     YT   D WSVG +L E+L+GQP F              +  TPT  ++K +
Sbjct: 217 PEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVI 261

Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDE 345
           N   T    PQ+K           + PEAVDL+++L   +     R  A +   HPFF E
Sbjct: 262 NWENTLHIPPQVK-----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310

Query: 346 L 346
           +
Sbjct: 311 V 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 7e-11
 Identities = 74/317 (23%), Positives = 117/317 (36%), Gaps = 99/317 (31%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNR----ELQTMRLLDHP----- 144
           +++G+G  G VF  +   TG+  A+K   K    KR K +    E + +  LDHP     
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 145 --------------------NVHYSRASQ---RMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                +      Q    +     + Y  ++  AL Y+H  +G+ 
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL-LGIV 125

Query: 182 HRDIKPQNLLVNPHTHQVKLCDF-------------------GSAKVLVKGEPNISYICS 222
           +RD+KP+N+L++   H + L DF                   GS +  V   P+ ++   
Sbjct: 126 YRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184

Query: 223 -----------RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVE 271
                        Y APE+I G   + +AVD W++G +L E+L G   F G +  +    
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSN 243

Query: 272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 331
           I+K                  E  FP              +   A DL+ +LL   P+ R
Sbjct: 244 ILK-----------------KEVTFPG----------SPPVSSSARDLIRKLLVKDPSKR 276

Query: 332 C----TALEACIHPFFD 344
                 A E   HPFF 
Sbjct: 277 LGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 82/316 (25%), Positives = 128/316 (40%), Gaps = 85/316 (26%)

Query: 97  RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHP-- 144
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57

Query: 145 -NVHYS-RASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGV 180
             + YS +   R+  +                        + Y  +I  AL Y+H    V
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTT 239
            +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE +    +Y  
Sbjct: 118 VYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGR 175

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           AVD W +G V+ E++ G+  F  +   ++L E+I +      EEI+              
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-------------- 214

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFD--ELRDPNAR 352
                   F + + PEA  L+S LL+  P  R       A E   H FF     +D   +
Sbjct: 215 --------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEK 266

Query: 353 LPNGRPFPPLFNFKPQ 368
               +  PP   FKPQ
Sbjct: 267 ----KLVPP---FKPQ 275

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 38/199 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMP 156
           RV+G+G FG V   +   TG+  A KK L+ KR K R+ + M L +   +    +   + 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 157 LIYVKLYTYQICRALAYIHGG--------IG---------------------------VC 181
           L Y       +C  L  ++GG        +G                           + 
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           +RD+KP+N+L++   H +++ D G A  + +GE     + +  Y APE+I    +YT + 
Sbjct: 125 YRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NNEKYTFSP 182

Query: 242 DIWSVGCVLAELLLGQPLF 260
           D W +GC++ E++ GQ  F
Sbjct: 183 DWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 65/245 (26%), Positives = 107/245 (43%), Gaps = 65/245 (26%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ---DKRYKNR---ELQTMRLLDHPN- 145
           Y   + +G G FG VF  K   T E    K +      +R K++   E+  MR L H N 
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 146 VHY-----SRASQRMPLIY---------------VKLY-----------TYQICRALAYI 174
           V Y     ++A+Q++ ++                 K++           T Q+  ALAY 
Sbjct: 75  VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134

Query: 175 HG------GIGVCHRDIKPQNLLVNPHTHQV----------------KLCDFGSAKVLVK 212
           H       G  V HRD+KPQN+ ++     +                K+ DFG +K +  
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI-- 192

Query: 213 GEPNISYIC--SRYYRAPELIFGATE-YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQL 269
           G  ++++ C  + YY +PEL+   T+ Y    D+W++GC++ EL  G+  F   +   QL
Sbjct: 193 GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252

Query: 270 VEIIK 274
           +  +K
Sbjct: 253 ISELK 257

Length = 1021

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 2/119 (1%)

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 225
           Q+  AL Y+H    + HRD+ P N+++     +V + DFG AK         S + +  Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
             PE++     Y    D+W+ GC+L ++   QP F   + +    +I++ +  P  E +
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 43/214 (20%)

Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
           + Y  +I  AL Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +   
Sbjct: 98  RFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTF 155

Query: 221 C-SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
           C +  Y APE +    +Y  AVD W +G V+ E++ G+  F  +   ++L E+I +    
Sbjct: 156 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM---- 209

Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TA 334
             EEI+                      F + + PEA  L++ LL+  P  R       A
Sbjct: 210 --EEIR----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 245

Query: 335 LEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQ 368
            E   H FF  +   +  +   +  PP   FKPQ
Sbjct: 246 KEVMEHRFFLSINWQD--VVQKKLLPP---FKPQ 274

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 33/209 (15%)

Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
           H  R  +++P  + + Y+ +I  AL ++H   G+ +RD+K  N+L++   H +KL D+G 
Sbjct: 86  HMQR-QRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEGH-IKLTDYGM 142

Query: 207 AKV-LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF----- 260
            K  +  G+   ++  +  Y APE++ G  +Y  +VD W++G ++ E++ G+  F     
Sbjct: 143 CKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGM 201

Query: 261 ---PGESGVDQLVEII--KVLGTPTREEIKC-------MNPNYTE-------FKFPQIKA 301
              P ++  D L ++I  K +  P    +K        +N +  E         F  IK+
Sbjct: 202 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           HP    F + +  + ++    L  Y PN+
Sbjct: 262 HP----FFRNIDWDLLEQKQVLPPYKPNI 286

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 70/316 (22%), Positives = 111/316 (35%), Gaps = 66/316 (20%)

Query: 97  RVVGQGSFG--IVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNV-- 146
            ++G+      IV  AK   T   VA+KK+  D   K        E+ T R L HPN+  
Sbjct: 4   TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 147 HYS---RASQRMPLIYV--KLYTYQICR-------------------------ALAYIHG 176
           + +     S+    +YV   L  Y  C                          AL YIH 
Sbjct: 64  YVTSFIVDSE----LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--------EPNISYICSRYYRAP 228
             G  HR +K  ++L++     V L     +  ++K         +   S + +  + +P
Sbjct: 120 -KGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 229 ELIFGATE-YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR------ 281
           E++    + Y    DI+SVG    EL  G   F        L+E  KV GT         
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLDKST 235

Query: 282 --EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
                  M+ + +  + P  +       + +         V   LQ  P  R +A +   
Sbjct: 236 YPLYEDSMSQSRSSNEHPNNRDSV-DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294

Query: 340 HPFFDELRDPNARLPN 355
           H FF + +  N  L +
Sbjct: 295 HSFFKQCKRRNTSLLD 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 43/231 (18%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP-----------NVH 147
           +G+G FG V   +   TG+  A KK L  KR K +  + M LL+             N+ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 148 YSRASQR-----MPL---------IY-----------VKLYTYQICRALAYIHGGIGVCH 182
           Y+  S+      M L         IY           V  Y+ QI   + ++H  + + +
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS-MDIVY 118

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVD 242
           RD+KP+N+L++      +L D G A  L  G+       +  Y APE I     Y+  VD
Sbjct: 119 RDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKEEPYSYPVD 176

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
            +++GC + E++ G+  F       + V   ++      +E+K  + N+TE
Sbjct: 177 WFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEHQNFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 39/211 (18%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNR--ELQTMRLLDHP----NV 146
           V+G+GSFG V  A+   T E  AIK      V+QD   +    E + + L D P     +
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 147 HYS-RASQRMPLI--YVK--------------------LYTYQICRALAYIHGGIGVCHR 183
           H   +   R+  +  YV                      Y  +I   L ++H   G+ +R
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR-GIIYR 125

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGATEYTTAVD 242
           D+K  N++++   H +K+ DFG  K  +V G    ++  +  Y APE+I     Y  +VD
Sbjct: 126 DLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-AYQPYGKSVD 183

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            W+ G +L E+L GQP F GE   D+L + I
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 26/162 (16%)

Query: 125 LQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
            QD +Y    ++ M   D  N+    ++  +P  + K YT ++  AL  IH  +G+ HRD
Sbjct: 112 FQDDKYLYMVMEYMPGGDLVNL---MSNYDVPEKWAKFYTAEVVLALDAIHS-MGLIHRD 167

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYICSRYYRAPELIF-- 232
           +KP N+L++ H H +KL DFG+   + +          G P+        Y +PE++   
Sbjct: 168 VKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD--------YISPEVLKSQ 218

Query: 233 -GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            G   Y    D WSVG  L E+L+G   F  +S V    +I+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 38/201 (18%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLLDHPN-----VHY 148
           V+G+GSFG V  A+   T E  AIK + +D   ++ +++ TM   R+L  P         
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 149 SRASQRMPLIYVKL-------------------------YTYQICRALAYIHGGIGVCHR 183
               Q M  +Y  +                         Y  +I   L ++H   G+ +R
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYR 125

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVD 242
           D+K  N++++   H +K+ DFG  K  + G       C +  Y APE+I     Y  +VD
Sbjct: 126 DLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-AYQPYGKSVD 183

Query: 243 IWSVGCVLAELLLGQPLFPGE 263
            W+ G +L E+L GQP F GE
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 48/218 (22%)

Query: 97  RVVGQGSFGIVFQAKCLETGET----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVH 147
           +V+G G+FG V++   +  GE     VAIK + ++   K       E   M  +DHP+V 
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV- 71

Query: 148 YSR-----ASQRMPLI-----------YVKL------------YTYQICRALAYIHGGIG 179
             R      S ++ LI           YV+             +  QI + ++Y+     
Sbjct: 72  -VRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE-KR 129

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATE 236
           + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     
Sbjct: 130 LVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL-HRI 187

Query: 237 YTTAVDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 271
           YT   D+WS G  + EL+  G   + G   V+   L+E
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 40/136 (29%), Positives = 74/136 (54%), Gaps = 13/136 (9%)

Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
           H  R  +++P  + + Y+ +I  AL Y+H   G+ +RD+K  N+L++   H +KL D+G 
Sbjct: 86  HMQR-QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGM 142

Query: 207 AKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF----- 260
            K  ++     S  C +  Y APE++ G  +Y  +VD W++G ++ E++ G+  F     
Sbjct: 143 CKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGS 201

Query: 261 ---PGESGVDQLVEII 273
              P ++  D L ++I
Sbjct: 202 SDNPDQNTEDYLFQVI 217

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 59.6 bits (144), Expect = 9e-10
 Identities = 47/150 (31%), Positives = 66/150 (44%), Gaps = 24/150 (16%)

Query: 148 YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 207
           Y  A + + +  +      + RA+ Y+H    + HRDIK +N+ +N H   V L DFG+A
Sbjct: 172 YLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFIN-HPGDVCLGDFGAA 229

Query: 208 KVLVKGEPNISYICSRYY--------RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPL 259
              V    N      +YY         APEL+     Y  AVDIWS G VL E+      
Sbjct: 230 CFPVDINAN------KYYGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDS 282

Query: 260 FPGESGVD-------QLVEIIKVLGTPTRE 282
              + G+D       Q+  II+  GT   E
Sbjct: 283 LFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312

Length = 391

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 44/142 (30%), Positives = 75/142 (52%), Gaps = 13/142 (9%)

Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
           H  R  +++P  + + Y  +IC AL ++H   G+ +RD+K  N+L++   H +KL D+G 
Sbjct: 86  HMQR-QRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADGH-IKLTDYGM 142

Query: 207 AKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF----- 260
            K  +      S  C +  Y APE++ G  EY  +VD W++G ++ E++ G+  F     
Sbjct: 143 CKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITD 201

Query: 261 -PGESGVDQLVEIIKVLGTPTR 281
            P  +  D L ++I  L  P R
Sbjct: 202 NPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.8 bits (142), Expect = 9e-10
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 57/205 (27%)

Query: 97  RVVGQGSFGIV----FQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPN-V 146
           RV+G+G FG V    +      TGE VA+K + ++   +N      E+  ++ L H N V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 147 HY-----SRASQRMPLI--YVKL-------------------YTYQICRALAYIHGGIGV 180
            Y      +  + + LI  YV L                   +  QIC  +AY+H    +
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYI 129

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE-----LIFGAT 235
            HRD+  +N+L++ +   VK+ DFG AK + +G          YYR  E     + + A 
Sbjct: 130 -HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDGDSPVFWYAV 179

Query: 236 E------YTTAVDIWSVGCVLAELL 254
           E      ++ A D+WS G  L ELL
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 26/162 (16%)

Query: 125 LQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
            QD RY    ++ M   D  N+    ++  +P  + + YT ++  AL  IH  +G  HRD
Sbjct: 112 FQDDRYLYMVMEYMPGGDLVNL---MSNYDVPEKWARFYTAEVVLALDAIHS-MGFIHRD 167

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYICSRYYRAPELIF-- 232
           +KP N+L++   H +KL DFG+   + K          G P+        Y +PE++   
Sbjct: 168 VKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD--------YISPEVLKSQ 218

Query: 233 -GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            G   Y    D WSVG  L E+L+G   F  +S V    +I+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 72/297 (24%), Positives = 118/297 (39%), Gaps = 68/297 (22%)

Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQT 137
           R+  P +    + E  +G G+FG V++AK  ETG  +A  KV++ K  +  E     ++ 
Sbjct: 6   RDLDPNEVWEIIGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEI 62

Query: 138 MRLLDHPNV------HYSRASQRMPLIY---------------------VKLYTYQICRA 170
           +   +HP +       Y      + + +                     +++   Q+  A
Sbjct: 63  LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA 122

Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPE 229
           L Y+H  + + HRD+K  N+L+      +KL DFG SAK +   +   S+I + Y+ APE
Sbjct: 123 LQYLHS-MKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180

Query: 230 LIFGAT----EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
           ++   T     Y    DIWS+G  L E+   +P                    P  E   
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEP--------------------PHHE--- 217

Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
            +NP     K    K+ P       +   E  D +   L   P  R +A +   HPF
Sbjct: 218 -LNPMRVLLKIA--KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 66/288 (22%), Positives = 108/288 (37%), Gaps = 81/288 (28%)

Query: 96  ERVVGQGSFGIVFQ--AKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPN 145
            R +GQGSFG+V++  AK +  GE    VAIK V ++   + R     E   M+  +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 146 V--------------------------HYSRA--------SQRMPLIYVKLYTY--QICR 169
           V                           Y R+            P    K      +I  
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 226
            +AY+       HRD+  +N +V      VK+ DFG  +       +I    + YYR   
Sbjct: 131 GMAYLAA-KKFVHRDLAARNCMVA-EDLTVKIGDFGMTR-------DIYE--TDYYRKGG 179

Query: 227 ---------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVL 276
                    APE +     +TT  D+WS G VL E+  L +  + G S  +++++ +   
Sbjct: 180 KGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFVIDG 237

Query: 277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 324
           G     E  C +      +        W   ++ +M P  +++VS L 
Sbjct: 238 GHLDLPE-NCPDKLLELMR------MCWQ--YNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 16/165 (9%)

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 184 YSFQVAKGMEFL-ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 223 RY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 278
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 293

Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 323
             +E  +   P+YT  +  Q     WH    +R  P   +LV  L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 15/168 (8%)

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           Y++Q+ R + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 179 YSFQVARGMEFL-ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 223 RY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 278
           R    + APE IF    YTT  D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288

Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP-PEAVDLVSRLLQ 325
             ++  +   P     +  +I    W     +R      V+++  LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 34/191 (17%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNV-----HY 148
           +G+GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 149 SRASQRM------------------PLIYVKLYTY--QICRALAYIHGGIGVCHRDIKPQ 188
            + ++                    P    ++ T   +I + L Y+H    + HRDIK  
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI-HRDIKAA 130

Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAVDIWSVG 247
           N+L++     VKL DFG A  L   +    +++ + ++ APE+I   + Y +  DIWS+G
Sbjct: 131 NVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKADIWSLG 188

Query: 248 CVLAELLLGQP 258
               EL  G+P
Sbjct: 189 ITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 43/214 (20%)

Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
           + Y  +I  AL Y+H G  + +RD+K +NL+++   H +K+ DFG  K  +     +   
Sbjct: 98  RFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTF 155

Query: 221 C-SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
           C +  Y APE +    +Y  AVD W +G V+ E++ G+  F  +   ++L E+I +    
Sbjct: 156 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM---- 209

Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TA 334
             E+IK                      F + +  +A  L+S LL   PN R       A
Sbjct: 210 --EDIK----------------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDA 245

Query: 335 LEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQ 368
            E   H FF  +   +    + +  PP   FKPQ
Sbjct: 246 KEIMRHSFFTGVNWQDVY--DKKLVPP---FKPQ 274

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 55.9 bits (134), Expect = 7e-09
 Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 34/191 (17%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNVHYSRAS- 152
           +G+GSFG VF+     T + VAIK + L++   +     +E+  +   D P V     S 
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 153 ----------------------QRMPLIYVKLYTY--QICRALAYIHGGIGVCHRDIKPQ 188
                                 +  PL   ++ T   +I + L Y+H    + HRDIK  
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI-HRDIKAA 130

Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEYTTAVDIWSVG 247
           N+L++ H  +VKL DFG A  L   +   + ++ + ++ APE+I   + Y +  DIWS+G
Sbjct: 131 NVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLG 188

Query: 248 CVLAELLLGQP 258
               EL  G+P
Sbjct: 189 ITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 41/199 (20%)

Query: 97  RVVGQGSFGIVFQAKCL-ETGETVAIKKVLQDKRYKNR-------ELQTMRLLDHP---N 145
           R +G GSFG V  A    E    VAIK+  + K  K +       E + +  ++HP   N
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 146 VHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
           ++ S                       R ++R P      Y  QI     Y+   + + +
Sbjct: 96  LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVY 154

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAV 241
           RD+KP+NLL++     +K+ DFG AKV+   +     +C +  Y APE++     +  A 
Sbjct: 155 RDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLNVG-HGKAA 209

Query: 242 DIWSVGCVLAELLLGQPLF 260
           D W++G  + E+L+G P F
Sbjct: 210 DWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 46/213 (21%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDH 143
           P++++    ER +G G FG V+      T + VA+K +           +E Q M+ L H
Sbjct: 4   PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60

Query: 144 PNV--HYSRASQRMPLIYV--------KLYTY-------------------QICRALAYI 174
             +   Y+  S+  P IY+         L  +                   QI   +AY+
Sbjct: 61  DKLVQLYAVCSEEEP-IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 231
                  HRD+  +N+LV  +    K+ DFG A+++   E   +   +++   + APE  
Sbjct: 120 ES-RNYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAA 176

Query: 232 -FGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
            +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 177 NYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 56.0 bits (135), Expect = 9e-09
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 46/209 (22%)

Query: 97  RVVGQGSFGIVFQAKCLETGET-----VAIKKVLQDKRYKNR-----ELQTMRLL-DHPN 145
           + +G G+FG V +A      ++     VA+K +        R     EL+ M  L +H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 146 --------------------------VHYSRASQRMPLIYVKL--YTYQICRALAYIHGG 177
                                     +++ R  +   L    L  ++YQ+ + +A++   
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGA 234
             + HRD+  +N+L+  H   VK+CDFG A+ ++     +    +R    + APE IF  
Sbjct: 161 NCI-HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218

Query: 235 TEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
             YT   D+WS G +L E+  LG   +PG
Sbjct: 219 V-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 71/281 (25%), Positives = 109/281 (38%), Gaps = 66/281 (23%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQTMRLLDHPNV------- 146
           +G G+FG V++A+  ETG  +A  KV+  K  +  E     +  +   DHPN+       
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 147 HYSR------------------ASQRMPLI--YVKLYTYQICRALAYIHGGIGVCHRDIK 186
           +Y                         PL    +++   Q   AL Y+H    + HRD+K
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLK 130

Query: 187 PQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE----YTTAV 241
             N+L       +KL DFG SAK     +   S+I + Y+ APE++   T     Y    
Sbjct: 131 AGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 189

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D+WS+G  L E+   +P                    P  E    +NP     K    K+
Sbjct: 190 DVWSLGITLIEMAQIEP--------------------PHHE----LNPMRVLLKIA--KS 223

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
            P       R   E  D + + L+ + + R T  +   HPF
Sbjct: 224 EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 45/199 (22%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVH 147
           E+V+G G FG V + +    G+    VAIK +     DK+  +   E   M   DHPN+ 
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 148 YSRA--SQRMPLIYV-------KLYTY-----------QICRALAYIHGGI------GVC 181
                 ++  P++ +        L  +           Q+   L  I  G+         
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------ICSRYYRAPELIFGAT 235
           HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I  R+  APE I    
Sbjct: 129 HRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW-TAPEAI-AYR 183

Query: 236 EYTTAVDIWSVGCVLAELL 254
           ++T+A D+WS G V+ E++
Sbjct: 184 KFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 47/216 (21%)

Query: 99  VGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKN-----RELQTMRLLDHPNV---- 146
           +G GSFG+V + +   +G     VA+K +  DK         +E   M  LDH N+    
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                                      A     +  +  Y  QI   + Y+     + HR
Sbjct: 63  GVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI-HR 121

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APELIFGATEY 237
           D+  +N+L+     +VK+ DFG  + L + E +  Y+   + +      APE +   T +
Sbjct: 122 DLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAWCAPESLRTRT-F 177

Query: 238 TTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEI 272
           + A D+W  G  L E+   G+  + G SG   L +I
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 39/211 (18%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLLDHPN-----VHY 148
           V+G+GSFG V  A+   T E  AIK + +D   ++ +++ TM   R+L            
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 149 SRASQRMPLIYVKL-------------------------YTYQICRALAYIHGGIGVCHR 183
               Q M  +Y  +                         Y  +I   L ++H   G+ +R
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYR 125

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGATEYTTAVD 242
           D+K  N++++   H +K+ DFG  K  +  G    ++  +  Y APE+I     Y  +VD
Sbjct: 126 DLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-AYQPYGKSVD 183

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 184 WWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 40/131 (30%), Positives = 69/131 (52%), Gaps = 8/131 (6%)

Query: 149 SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA- 207
           S+   R+P    + Y  ++  A+  +H  +   HRDIKP N+L++ + H ++L DFGS  
Sbjct: 93  SKFEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCL 150

Query: 208 KVLVKGEPNISY-ICSRYYRAPELIF----GATEYTTAVDIWSVGCVLAELLLGQPLFPG 262
           K++  G    S  + +  Y +PE++     G  +Y    D WS+G  + E+L G+  F  
Sbjct: 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210

Query: 263 ESGVDQLVEII 273
           ES V+   +I+
Sbjct: 211 ESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 41/131 (31%), Positives = 68/131 (51%), Gaps = 8/131 (6%)

Query: 149 SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA- 207
           S+   R+P    + Y  ++  A+  IH  +   HRDIKP N+L++ + H ++L DFGS  
Sbjct: 93  SKFEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNGH-IRLADFGSCL 150

Query: 208 KVLVKGEPNISY-ICSRYYRAPELIF----GATEYTTAVDIWSVGCVLAELLLGQPLFPG 262
           K+   G    S  + +  Y +PE++     G  +Y    D WS+G  + E+L G+  F  
Sbjct: 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210

Query: 263 ESGVDQLVEII 273
           ES V+   +I+
Sbjct: 211 ESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 53/197 (26%), Positives = 81/197 (41%), Gaps = 47/197 (23%)

Query: 154 RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 213
            +P   VK +  ++  AL  +H    VC RD+ P N+L++   H ++L  F       + 
Sbjct: 81  NIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSR---WSEV 135

Query: 214 EPNI-SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGE-SGVDQLVE 271
           E +         Y APE + G +E T A D WS+G +L ELL G+ L     SG++    
Sbjct: 136 EDSCDGEAVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT--- 191

Query: 272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 331
                              +T    P+             +  EA  L+ +LLQ++P  R
Sbjct: 192 -------------------HTTLNIPEW------------VSEEARSLLQQLLQFNPTER 220

Query: 332 CTALEACI-----HPFF 343
             A  A +     HPFF
Sbjct: 221 LGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 60/219 (27%), Positives = 89/219 (40%), Gaps = 67/219 (30%)

Query: 83  RNGQPKQTIS-------YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL 135
           R  +P   ++       +   R +  GS G VF++   +  + V +K           E 
Sbjct: 154 RGCKPPSEVAKVVAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYAS--SVHEA 211

Query: 136 QTMRLLDHPNVHYSRASQRMPLIYVK----------------LYTY-------------- 165
           + +R L HP V        + L+ V+                LYTY              
Sbjct: 212 RLLRRLSHPAV--------LALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVT 263

Query: 166 ----QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 221
               Q+  A+ YIHG  G+ HRDIK +N+LVN     + L DFG+A    +G    S+  
Sbjct: 264 AVARQLLSAIDYIHGE-GIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWST 316

Query: 222 SRYY--------RAPELIFGATEYTTAVDIWSVGCVLAE 252
             +Y         APE++ G   YT +VDIWS G V+ E
Sbjct: 317 PFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 7/104 (6%)

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---Y 219
           +TYQ+ R + ++       HRD+  +N+L+      VK+CDFG A+ ++     +S    
Sbjct: 242 FTYQVARGMEFL-ASKNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGST 299

Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
                + APE IF    YTT  D+WS G +L E+  LG   +PG
Sbjct: 300 FLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           Y++Q+ R + ++     + HRD+  +N+L++   + VK+CDFG A+ + K   +  Y+  
Sbjct: 178 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYK---DPDYVRK 232

Query: 223 RYYR------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKV 275
              R      APE IF    YTT  D+WS G +L E+  LG   +PG       V+I + 
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEE 284

Query: 276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 323
                +E  +   P Y   +   I    WH     R  P   +LV  L
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR--PTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 70/223 (31%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRL---LDHPNVH-- 147
           R++G+G  G V+ A        VA+KK+ +D       K R L+  ++   L HP +   
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 148 YSRASQR------MPLIYVKLYT-------------------------------YQICRA 170
           YS  S        MP  Y++ YT                               ++IC  
Sbjct: 68  YSICSDGDPVYYTMP--YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV----------LVKGEPNISY- 219
           + Y+H   GV HRD+KP N+L+      V L D+G+A            +   E NI Y 
Sbjct: 126 IEYVHSK-GVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 220 --------ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL 254
                   + +  Y APE + G    + + DI+++G +L ++L
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 48/220 (21%)

Query: 91  ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV- 146
           +++M E  +G G FG+V   K       VAIK + +    +     E + M  L HP + 
Sbjct: 6   LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 147 -HYSRASQRMPLIYVK-------LYTY------------------QICRALAYIHGGIGV 180
             Y   +Q+ PL  V        L  Y                   +C  + Y+      
Sbjct: 63  QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN-SF 121

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRAPELIFGA 234
            HRD+  +N LV+  T  VK+ DFG  + ++  E    Y  S        +  PE +F  
Sbjct: 122 IHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKWSPPE-VFNF 175

Query: 235 TEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII 273
           ++Y++  D+WS G ++ E+   G+  F  +S   ++VE+I
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 47/206 (22%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYKNRELQTM--RLLDHPNV--HYSR 150
            VVG G++G V++ + ++TG+  AIK   V +D+  + +    M  +   H N+  +Y  
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 151 ASQRMP---------------------LI-----------YVKLYTYQICRALAYIHGGI 178
             ++ P                     L+           ++     +I R LA++H   
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH- 140

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF---- 232
            V HRDIK QN+L+  +  +VKL DFG +  L +  G  N ++I + Y+ APE+I     
Sbjct: 141 KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDEN 198

Query: 233 GATEYTTAVDIWSVGCVLAELLLGQP 258
               Y    DIWS+G    E+  G P
Sbjct: 199 PDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 43/120 (35%), Positives = 60/120 (50%), Gaps = 8/120 (6%)

Query: 150 RASQRMPL--IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 207
           R  + +P     V L  YQI  AL  +H    + HRD+K  N+ + P T  +KL DFG +
Sbjct: 159 RLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMP-TGIIKLGDFGFS 216

Query: 208 KVL---VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
           K     V  +   S+  + YY APEL +    Y+   D+WS+G +L ELL     F G S
Sbjct: 217 KQYSDSVSLDVASSFCGTPYYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 34/191 (17%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNV-----HY 148
           +G+GSFG V++     T E VAIK + L++   +     +E+  +   D P +      Y
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 149 SRASQRM------------------PL--IYVKLYTYQICRALAYIHGGIGVCHRDIKPQ 188
            + ++                    PL   Y+     +I + L Y+H    + HRDIK  
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI-HRDIKAA 130

Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAVDIWSVG 247
           N+L++     VKL DFG A  L   +    +++ + ++ APE+I   + Y    DIWS+G
Sbjct: 131 NVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDFKADIWSLG 188

Query: 248 CVLAELLLGQP 258
               EL  G+P
Sbjct: 189 ITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 53.7 bits (129), Expect = 7e-08
 Identities = 58/243 (23%), Positives = 80/243 (32%), Gaps = 98/243 (40%)

Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH----------------THQVKL- 201
             + Y  ++  A+  +H  +G  HRDIKP N+L++                  TH  K  
Sbjct: 102 LARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160

Query: 202 ----------------------CDFGSAKVLVK------------GEPNISYICSRYYRA 227
                                 C     +   K            G PN        Y A
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIA 212

Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 287
           PE++   T YT   D WSVG +L E+L+GQP F  +              TP   ++K +
Sbjct: 213 PEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVI 257

Query: 288 NPNYTEFKFPQIKAHPWHKIFH----KRMPPEAVDLVSRLLQYSPNLRC---TALEACIH 340
           N               W    H     ++  EA DL+ RL       R     A E   H
Sbjct: 258 N---------------WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAH 301

Query: 341 PFF 343
           PFF
Sbjct: 302 PFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 54/203 (26%), Positives = 85/203 (41%), Gaps = 51/203 (25%)

Query: 97  RVVGQGSFGIV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
           R +G+G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+ 
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 147 ----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                       +  R   ++ L     Y  QIC+ + Y+ G  
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL-GSR 128

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YYRAPELI 231
              HRD+  +N+LV    HQVK+ DFG  K +   E +  Y   +       ++ APE +
Sbjct: 129 QYVHRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 232 FGATEYTTAVDIWSVGCVLAELL 254
             +  Y  A D+WS G  L ELL
Sbjct: 185 IQSKFYI-ASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 59/290 (20%), Positives = 116/290 (40%), Gaps = 72/290 (24%)

Query: 93  YMAERVVGQGSFGIVF--QAKCLETGETVAIKKVL-------QDKRYKNRELQTMRLLDH 143
           Y+ ++ +G+GSFG V+  + K     E + + K +        +    N+E Q +  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 144 PNV------------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
           P +                                    + +    V  +  Q+   + Y
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIF 232
           +H    + HRD+K +N+ +    + +K+ DFG +++L+   +   ++  + YY +PE + 
Sbjct: 122 MHQR-RILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL- 177

Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 292
               Y +  DIWS+GC+L E+      F G+   + L  +++++  PT        P+  
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIVEGPT--------PSLP 226

Query: 293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           E                     +   ++  +L   P+LR +A E   +PF
Sbjct: 227 E-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 42/198 (21%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVH 147
           E+V+G G FG V   +    G+    VAIK +     +K+ ++   E   M   DHPN+ 
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGG------IGVC 181
           +     ++  P++ V  Y                    Q+   L  I  G      +G  
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + APE I    +
Sbjct: 129 HRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAPEAI-AYRK 185

Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G V+ E++
Sbjct: 186 FTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 15/108 (13%)

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 215
           ++ Q+ + + ++       HRD+  +N+L+       K+CDFG A+        +VKG  
Sbjct: 217 FSSQVAQGMDFL-ASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNA 274

Query: 216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
            +       + APE IF    YT   D+WS G +L E+  LG+  +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 57/236 (24%), Positives = 92/236 (38%), Gaps = 76/236 (32%)

Query: 97  RVVGQGSFGIVFQAKCLE-----TGET-VAIKK-----VLQDKRYKNRELQTMRLLDHPN 145
             +G G+FG V++    +     +G   VA+K        Q+K+   +E   M   +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 146 V--------------------------HYSRASQRMPLIYVKLYTYQ--------ICRAL 171
           +                           Y R + R+      L T +        + +  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDA-RVERFGPPLLTLKELLDICLDVAKGC 119

Query: 172 AYIHGGIGVCHRDIKPQNLLVNPHTHQ----VKLCDFGSAKVLVKGEPNISYICSRYYR- 226
            Y+   +   HRD+  +N LV+   +     VK+ DFG A+ + K         S YYR 
Sbjct: 120 VYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK---------SDYYRK 169

Query: 227 -----------APE-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQL 269
                      APE L+ G   +TT  D+WS G ++ E+L LGQ  +P  +  + L
Sbjct: 170 EGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 47/190 (24%), Positives = 82/190 (43%), Gaps = 42/190 (22%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV--HYSRASQ 153
           +G G FG+V   K     + VAIK + +    ++    E + M  L HPN+   Y   ++
Sbjct: 12  LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 154 RMPLIYVK-------LYTY------------------QICRALAYIHGGIGVCHRDIKPQ 188
           + P+  V        L  Y                   +C A+ Y+    G  HRD+  +
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAAR 129

Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----APELIFGATEYTTAVDI 243
           N LV    + VK+ DFG A+ ++  +    Y  S+  +     AP  +F  + +++  D+
Sbjct: 130 NCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184

Query: 244 WSVGCVLAEL 253
           WS G ++ E+
Sbjct: 185 WSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 49.8 bits (119), Expect = 6e-07
 Identities = 53/216 (24%), Positives = 84/216 (38%), Gaps = 64/216 (29%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKK-----VLQDKRYKNRELQTMRLLDHPNVHYSRA 151
             +G+G+FG V++   L+    VA+K          KR   +E + ++  DHPN+     
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNI----- 54

Query: 152 SQRMPLIYVKLYTYQICRALAYIHGG------------------IGVC------------ 181
              + LI V +    I   +  + GG                  + +             
Sbjct: 55  ---VKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 182 ----HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-------APE- 229
               HRD+  +N LV    + +K+ DFG    + + E    Y  S   +       APE 
Sbjct: 112 KNCIHRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEA 166

Query: 230 LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGES 264
           L +G   YT+  D+WS G +L E   LG   +PG S
Sbjct: 167 LNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 41/140 (29%), Positives = 59/140 (42%), Gaps = 39/140 (27%)

Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG--------------- 205
           + Y  +   A+  IH  +G  HRDIKP NLL++   H VKL DFG               
Sbjct: 104 QFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYR 161

Query: 206 -------------------SAKVLVKGEPNISY--ICSRYYRAPELIFGATEYTTAVDIW 244
                               A+   K    ++Y  + +  Y APE +F  T Y    D W
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWW 220

Query: 245 SVGCVLAELLLGQPLFPGES 264
           S+G ++ E+L+G P F  E+
Sbjct: 221 SLGVIMYEMLIGYPPFCSET 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 49.7 bits (118), Expect = 8e-07
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 47/205 (22%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYK-NRELQTMRLLDHPN---VHYSRA 151
           +VG G++G V++ + ++TG+  AIK   V  D+  +  +E+  ++   H      +Y   
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 152 SQRMP---------------------LI-----------YVKLYTYQICRALAYIHGGIG 179
            ++ P                     LI           ++     +I R L+++H    
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-K 131

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF----G 233
           V HRDIK QN+L+  +  +VKL DFG +  L +  G  N ++I + Y+ APE+I      
Sbjct: 132 VIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDENP 189

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQP 258
              Y    D+WS+G    E+  G P
Sbjct: 190 DATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 15/108 (13%)

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 215
           ++YQ+ + ++++       HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
            +       + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 277 RLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)

Query: 157 LIYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           L Y+ L  ++YQ+   + ++     V HRD+  +N+L+      VK+CDFG A+ +++  
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLIC-EGKLVKICDFGLARDIMRDS 293

Query: 215 PNIS---YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             IS         + APE IF    YTT  D+WS G +L E+  LG   +P     +Q  
Sbjct: 294 NYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352

Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP-PEAVDLVSRLL 324
             IK          +   P +   +  +I    W + F  R    + V LV  LL
Sbjct: 353 NAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 75/313 (23%), Positives = 115/313 (36%), Gaps = 84/313 (26%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE------------------------ 134
           +G+G FG V   +   TG+  A KK L  KR K R+                        
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 135 --LQT-------MRLLDHPNVHY-----SRASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
              QT       M +++  ++ Y        +   P      YT QI   L ++H    +
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RI 118

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTT 239
            +RD+KP+N+L++   + V++ D G A  L  G+     Y  +  + APEL+ G  EY  
Sbjct: 119 IYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDF 176

Query: 240 AVDIWSVGCVLAELLLGQPLF--PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
           +VD +++G  L E++  +  F   GE          KV     ++ I   +  Y +    
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGE----------KVENKELKQRILNDSVTYPD---- 222

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-------CTALEACIHPFFDELRDPN 350
                        +  P +      LL   P  R       C  L    HP F   RD N
Sbjct: 223 -------------KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT--HPLF---RDLN 264

Query: 351 ARLPNGRPFPPLF 363
            R       PP F
Sbjct: 265 WRQLEAGMLPPPF 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 29/208 (13%)

Query: 136 QTMRLLDHPNVHYSRASQRMP---LIYVKLY--TYQICRALAYIHGGIGVCHRDIKPQNL 190
           + +R    P + YS    R+P   + +  L   TYQ+ R + Y+     + HRD+  +N+
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCI-HRDLAARNV 168

Query: 191 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-------YRAPELIFGATEYTTAVDI 243
           LV    + +K+ DFG    L +   NI Y            + APE +F    YT   D+
Sbjct: 169 LVT-ENNVMKIADFG----LARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDV 222

Query: 244 WSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           WS G ++ E+  LG   +PG   V++L +++K  G    +   C N  Y   +       
Sbjct: 223 WSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKE-GHRMDKPANCTNELYMMMR------D 274

Query: 303 PWHKI-FHKRMPPEAVDLVSRLLQYSPN 329
            WH I  H+    + V+ + R+L  + N
Sbjct: 275 CWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 79/242 (32%)

Query: 99  VGQGSFGIVFQAK-----CLETGETVAIKKVLQDKRYKN-----RELQTMRLL-DHPN-- 145
           +G+G+FG V +A+           TVA+K +  D   K+      E++ M+++  H N  
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 146 ---------------VHYSRA--------SQRMPLIYVKL-----------------YTY 165
                          V Y+          ++R P  Y                    + Y
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 225
           Q+ R + ++       HRD+  +N+LV    H +K+ DFG A+       +I +I   YY
Sbjct: 140 QVARGMEFLASK-KCIHRDLAARNVLVT-EDHVMKIADFGLAR-------DIHHI--DYY 188

Query: 226 R------------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEI 272
           R            APE +F    YT   D+WS G +L E+  LG   +PG   V++L ++
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKL 246

Query: 273 IK 274
           +K
Sbjct: 247 LK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 42/198 (21%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++V+G G FG VF+      G     VAIK +      K R     E   M    H N+ 
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
                 ++  P + +  Y                  +YQ+   L  I  G+         
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+LVN    + K+ DFG ++VL + +P  +Y  S       + APE I    +
Sbjct: 130 HRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAI-AYRK 186

Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G V+ E++
Sbjct: 187 FTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 41/140 (29%), Positives = 56/140 (40%), Gaps = 39/140 (27%)

Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN---- 216
           + Y  +   A+  IH  +G  HRDIKP NLL++   H VKL DFG    L K        
Sbjct: 104 QFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYR 161

Query: 217 --------------------------------ISYICSRYYRAPELIFGATEYTTAVDIW 244
                                            S + +  Y APE +F  T Y    D W
Sbjct: 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWW 220

Query: 245 SVGCVLAELLLGQPLFPGES 264
           S+G ++ E+L+G P F  E+
Sbjct: 221 SLGVIMYEMLIGYPPFCSET 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 66/286 (23%), Positives = 106/286 (37%), Gaps = 80/286 (27%)

Query: 97  RVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVH 147
           R++G+G FG V +A+      + + VA+K +  D    +      RE   M+  DHPNV 
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 148 -------YSRASQRMPLIYVKL-------------------------------YTYQICR 169
                   SRA  R+P+  V L                               +   I  
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 226
            + Y+       HRD+  +N ++N +   V + DFG +K +  G+         YYR   
Sbjct: 125 GMEYLSSK-NFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGD---------YYRQGC 173

Query: 227 APELIFG--ATE------YTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLG 277
           A +L     A E      YTT  D+W+ G  + E++  GQ  + G    +    +IK  G
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK--G 231

Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 323
              ++   C+   Y      ++    W      R  P    L  +L
Sbjct: 232 NRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 26/69 (37%), Positives = 37/69 (53%), Gaps = 9/69 (13%)

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY- 224
           QI  AL  +H   G+ HRD+KPQN++ +  +   K+ D G+A  L  G   I+YI   + 
Sbjct: 263 QILFALDGLHS-TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318

Query: 225 ----YRAPE 229
               Y APE
Sbjct: 319 LDPRYAAPE 327

Length = 566

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 67/277 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGET---VAIKKV-----LQDKRYKNRELQTMRLLDHPNV-- 146
           RV+G+G FG V+    +++       A+K +     L++     +E   M+   HPNV  
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 147 -------------------------HYSRASQRMP----LIYVKLYTYQICRALAYIHGG 177
                                    ++ R+    P    LI   L   Q+ + + Y+   
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL---QVAKGMEYLASK 117

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL--IFGAT 235
             V HRD+  +N +++  +  VK+ DFG A+ +   E    Y     +   +L   + A 
Sbjct: 118 KFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLPVKWMAL 171

Query: 236 E------YTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 288
           E      +TT  D+WS G +L EL+  G P +P     D  V +++  G    +   C +
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQPEYCPD 229

Query: 289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 325
           P Y      ++    WH     R  P   +LVSR+ Q
Sbjct: 230 PLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 48/189 (25%), Positives = 85/189 (44%), Gaps = 40/189 (21%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNV--HYSRAS 152
           +G G FG+V+    LE  + VAIK +    + ++ +   E Q M  L HP +   Y   +
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69

Query: 153 QRMPLIYV-------KLYTY------------------QICRALAYIHGGIGVCHRDIKP 187
           +R P+  V        L  Y                   +C  +AY+     V HRD+  
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAA 128

Query: 188 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAVDIW 244
           +N LV      VK+ DFG  + ++  +   S   +++   + +PE +F  ++Y++  D+W
Sbjct: 129 RNCLVG-ENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSFSKYSSKSDVW 185

Query: 245 SVGCVLAEL 253
           S G ++ E+
Sbjct: 186 SFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 57/218 (26%), Positives = 80/218 (36%), Gaps = 80/218 (36%)

Query: 98  VVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV- 146
            +G+G FG VF AK      E GET+ + K LQ  + +N      REL   R L H NV 
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 147 -----------HYSRASQRMPLIYVKL-----------------------------YTYQ 166
                      HY      M L Y  L                                Q
Sbjct: 72  RLLGLCREAEPHY------MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 226
           I   + ++     V HRD+  +N LV+    +VK+    S   L K   N     S YY+
Sbjct: 126 IALGMDHLSNARFV-HRDLAARNCLVSS-QREVKV----SLLSLSKDVYN-----SEYYK 174

Query: 227 -----------APELIFGATEYTTAVDIWSVGCVLAEL 253
                      APE +    +++T  D+WS G ++ E+
Sbjct: 175 LRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 24/58 (41%), Positives = 36/58 (62%), Gaps = 2/58 (3%)

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
           Y  ++  AL Y+H   G+ HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 109 YISEVALALDYLHRH-GIIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 31/104 (29%), Positives = 56/104 (53%), Gaps = 7/104 (6%)

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 132 FAWQISRGMQYL-AEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDSYVKRSKG 189

Query: 223 RY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
           R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 190 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 48/215 (22%)

Query: 97  RVVGQGSFGIVFQAKCLETGET-VAIKKVLQDKRYKN---RELQTMRLLDHPNV--HYSR 150
           R +G G FG V++   L    T VA+K +            E Q M+ L HP +   Y+ 
Sbjct: 12  RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 151 ASQRMP-------LIYVKLYTY-------------------QICRALAYI--HGGIGVCH 182
            +   P       + Y  L  Y                   Q+   +AY+     I   H
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI---H 126

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTT 239
           RD+  +N+LV  + +  K+ DFG A+V+ +     +   +++   + APE       ++ 
Sbjct: 127 RDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAAL-YNRFSI 183

Query: 240 AVDIWSVGCVLAELL-LGQPLFPGESG--VDQLVE 271
             D+WS G +L E++  G+  +PG +   V Q V+
Sbjct: 184 KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 31/102 (30%), Positives = 44/102 (43%), Gaps = 26/102 (25%)

Query: 165 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 224
            QI   + Y+       HRD+  +N LV      VK+ DFG ++ +   +         Y
Sbjct: 131 IQIAAGMEYLSSH-HFVHRDLAARNCLVGEG-LTVKISDFGLSRDIYSAD---------Y 179

Query: 225 YR------------APELI-FGATEYTTAVDIWSVGCVLAEL 253
           YR             PE I +G  ++TT  DIWS G VL E+
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 48.3 bits (115), Expect = 4e-06
 Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 50/219 (22%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK------------------------------ 122
           Y   RV+G G+ G V  AK +  GE  A+K                              
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 123 -KVLQDKRYK---NRELQTM--RLLDHPNV--------HYSRASQRMPLIYVKLYTYQIC 168
            K  +D   K   N E   M   +LD+ N           ++ ++        L   Q+ 
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 225
            A+ ++H    + HRDIK  N+L+  +   VKL DFG +K+    V  +   ++  + YY
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
            APE I+    Y+   D++S+G +L ELL  +  F GE+
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 42/199 (21%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           E V+G G FG V + +    G+    VAIK +      K R     E   M   DHPN+ 
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
           +     ++  P++ +  +                    Q+   L  I  G+         
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRAPELIFGAT 235
           HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S        + APE I    
Sbjct: 129 HRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI-AYR 186

Query: 236 EYTTAVDIWSVGCVLAELL 254
           ++T+A D+WS G V+ E++
Sbjct: 187 KFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 56/196 (28%), Positives = 86/196 (43%), Gaps = 41/196 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGET----VAIKKVLQDKRYK-NREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE     VAIK++ +    K N+E+      M  +D+P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     V 
Sbjct: 73  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLV- 131

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 132 HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI-YT 189

Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 190 HQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 52/208 (25%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRLLDHPNV----- 146
           ER +G G FG V++         VAIK +  D   K +    E+Q ++ L H ++     
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69

Query: 147 ---------------------HYSRA----SQRMP-LIYVKLYTYQICRALAYIHGGIGV 180
                                 + R+       +  LI +     Q+   +AY+      
Sbjct: 70  VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDM---ACQVAEGMAYLEEQ-NS 125

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-----VKGEPNISYICSRYYRAPELIFGAT 235
            HRD+  +N+LV       K+ DFG A+++     +  +  I Y     + APE      
Sbjct: 126 IHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPY----KWTAPEAA-SHG 179

Query: 236 EYTTAVDIWSVGCVLAELLL-GQPLFPG 262
            ++T  D+WS G +L E+   GQ  +PG
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 46/189 (24%), Positives = 71/189 (37%), Gaps = 44/189 (23%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---ELQTMRLLDHPN---------- 145
           +G+G FG V        G+ VA+K +  D         E   M  L HPN          
Sbjct: 14  IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 146 ----------------VHY--SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 187
                           V Y  SR    + L     +   +C  + Y+       HRD+  
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAA 130

Query: 188 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAVDIW 244
           +N+LV+      K+ DFG AK     E +      +    + APE +    +++T  D+W
Sbjct: 131 RNVLVS-EDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKKFSTKSDVW 183

Query: 245 SVGCVLAEL 253
           S G +L E+
Sbjct: 184 SFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 46.7 bits (111), Expect = 8e-06
 Identities = 58/239 (24%), Positives = 86/239 (35%), Gaps = 80/239 (33%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKC--LETGET---VAIKKVLQD------KRYKNREL 135
            + TI     R +G+G+FG VF  +C  LE       VA+K  L++      ++   RE 
Sbjct: 3   QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAVK-TLKETASNDARKDFEREA 59

Query: 136 QTMRLLDHPNV--HYSRASQRMPLIYVKLY------------------------------ 163
           + +    H N+   Y   ++  P I V  Y                              
Sbjct: 60  ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119

Query: 164 --------TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 215
                     QI   + Y+     V HRD+  +N LV  +   VK+ DFG ++ +     
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFV-HRDLATRNCLVG-YDLVVKIGDFGMSRDV----- 172

Query: 216 NISYICSRYYR------------APELIFGATEYTTAVDIWSVGCVLAELLL--GQPLF 260
              Y    YYR             PE I     +TT  D+WS G VL E+     QP +
Sbjct: 173 ---YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 39/138 (28%), Positives = 56/138 (40%), Gaps = 46/138 (33%)

Query: 213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 272
           G PN        Y APE++   T YT   D WSVG +L E+L+GQP F  ++ ++  +++
Sbjct: 210 GTPN--------YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV 260

Query: 273 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH----KRMPPEAVDLVSRLLQYSP 328
           I                              W    H     ++ PEA DL+ +L +  P
Sbjct: 261 IN-----------------------------WQTSLHIPPQAKLSPEASDLIIKLCR-GP 290

Query: 329 NLRC---TALEACIHPFF 343
             R     A E   HPFF
Sbjct: 291 EDRLGKNGADEIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 35/112 (31%), Positives = 51/112 (45%), Gaps = 18/112 (16%)

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVN-----PHTHQVKLCDFGSAKVLVKGEPNI--- 217
           Q+  ALA  H   G+ HRD+KPQN++V+     PH    K+ DFG   +L          
Sbjct: 87  QVLDALACAHNQ-GIVHRDLKPQNIMVSQTGVRPHA---KVLDFGIGTLLPGVRDADVAT 142

Query: 218 -----SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
                  + +  Y APE + G    T   D+++ G +  E L GQ +  G S
Sbjct: 143 LTRTTEVLGTPTYCAPEQLRGEPV-TPNSDLYAWGLIFLECLTGQRVVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 47/194 (24%), Positives = 83/194 (42%), Gaps = 37/194 (19%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPN---------- 145
           ++G+G FG V Q +   TG+ VA+K +  D   +    E   M  L H N          
Sbjct: 13  IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 146 ---------------VHYSRASQR--MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQ 188
                          V++ R   R  + +I +  ++  +   + Y+     + HRD+  +
Sbjct: 71  NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAAR 129

Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGC 248
           N+LV+      K+ DFG A+V   G  N        + APE +    ++++  D+WS G 
Sbjct: 130 NILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL-KHKKFSSKSDVWSYGV 185

Query: 249 VLAELL-LGQPLFP 261
           +L E+   G+  +P
Sbjct: 186 LLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 21/164 (12%)

Query: 124 VLQDKRYKNRELQTMRLLDHPNVHYSRASQRMP---LIYVKLYT--YQICRALAYIHGGI 178
           VL +   K    + +R    P + YS  + ++P   L +  L +  YQ+ R + Y+    
Sbjct: 95  VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK 154

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-------YRAPELI 231
            + HRD+  +N+LV    + +K+ DFG    L +   NI Y            + APE +
Sbjct: 155 CI-HRDLAARNVLVT-EDNVMKIADFG----LARDVHNIDYYKKTTNGRLPVKWMAPEAL 208

Query: 232 FGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
           F    YT   D+WS G +L E+  LG   +PG   V++L +++K
Sbjct: 209 FDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKLLK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 49/196 (25%), Positives = 78/196 (39%), Gaps = 41/196 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRAS---- 152
           +V+G G+FG V++   +  GE V I   ++  R          +LD   V     S    
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 153 ---------------QRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                          Q MP    L YV+             +  QI + ++Y+   + + 
Sbjct: 73  RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-VRLV 131

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG A++L   E        +    + A E I     +T
Sbjct: 132 HRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL-HRRFT 189

Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 190 HQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 49/205 (23%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL---DHPNV--HYSR 150
           ++G+G+FG VF+   L+    VA+K   +D  +  K + L   R+L   DHPN+      
Sbjct: 2   LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 151 ASQRMPLIYV------------------KLYTYQICR-------ALAYIHGGIGVCHRDI 185
            +QR P+  V                  +L T Q+ +        +AY+       HRD+
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK-NCIHRDL 119

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPE-LIFGATEYT 238
             +N LV    + +K+ DFG    + + E +  Y  S        + APE L +G   Y+
Sbjct: 120 AARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPEALNYG--RYS 172

Query: 239 TAVDIWSVGCVLAELL-LGQPLFPG 262
           +  D+WS G +L E   LG   +PG
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 41/188 (21%), Positives = 79/188 (42%), Gaps = 38/188 (20%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV--HYSRASQ 153
           +G G FG+V   K       VAIK + +    ++    E + M  L H  +   Y   ++
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 154 RMPLIYVKLYT-------------------------YQICRALAYIHGGIGVCHRDIKPQ 188
           + P+  V  Y                            +C  +AY+       HRD+  +
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAAR 129

Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAVDIWS 245
           N LV+     VK+ DFG ++ ++  E   S + S++   +  PE +   +++++  D+W+
Sbjct: 130 NCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLYSKFSSKSDVWA 186

Query: 246 VGCVLAEL 253
            G ++ E+
Sbjct: 187 FGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 46/205 (22%), Positives = 79/205 (38%), Gaps = 48/205 (23%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNV------- 146
           +G+G++G V++    + G   A+K +L      + E++        L +HPNV       
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 147 ----HYS------------------------RASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                             QR+    +    Y     L ++H   
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            + HRD+K  N+L+      VKL DFG SA++        + + + ++ APE+I    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 238 TTA----VDIWSVGCVLAELLLGQP 258
             +     D+WS+G    EL  G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 14/104 (13%)

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-- 223
           QI   +A+I       HRD++  N+LV+  T   K+ DFG A+++   E    Y      
Sbjct: 110 QIAEGMAFIER-KNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGA 163

Query: 224 ----YYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
                + APE I   T +T   D+WS G +L E++  G+  +PG
Sbjct: 164 KFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 43/202 (21%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNV- 146
           +V+G G+FG V++   +  GETV I    K+L +       ++       M  +DHP++ 
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV              +  QI + + Y+     + 
Sbjct: 73  RLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER-RLV 131

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG A++L   E   +    +    + A E I    ++T
Sbjct: 132 HRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH-YRKFT 189

Query: 239 TAVDIWSVGCVLAELLL--GQP 258
              D+WS G  + EL+   G+P
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 26/85 (30%), Positives = 39/85 (45%), Gaps = 23/85 (27%)

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY----RAP--------E 229
           HRD+  +N LV    + +K+ DFG ++ L        Y    YY    RAP        E
Sbjct: 153 HRDLATRNCLVGK-NYTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWE 202

Query: 230 LIFGATEYTTAVDIWSVGCVLAELL 254
            +    ++TT  D+W+ G  L E+L
Sbjct: 203 SVLL-GKFTTKSDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 34/179 (18%)

Query: 165 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 224
           YQ+ R + Y+     + HRD+  +N+LV    + +K+ DFG A+       +I +I   Y
Sbjct: 147 YQVARGMEYLASKKCI-HRDLAARNVLVT-EDNVMKIADFGLAR-------DIHHI--DY 195

Query: 225 YR------------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVE 271
           Y+            APE +F    YT   D+WS G +L E+  LG   +PG   V++L +
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFK 253

Query: 272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP-PEAVDLVSRLLQYSPN 329
           ++K  G    +   C N  Y   +        WH +  +R    + V+ + R+L  + N
Sbjct: 254 LLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDLDRILALTSN 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 15/100 (15%)

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC---- 221
           QI   ++Y+H   GV H+DI  +N +++    QVK+ D   ++ L   +    Y C    
Sbjct: 125 QIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----YHCLGDN 178

Query: 222 -SRYYR--APELIFGATEYTTAVDIWSVGCVLAELL-LGQ 257
            +R  +  A E +    EY++A D+WS G +L EL+ LGQ
Sbjct: 179 ENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 24/102 (23%)

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 225
           QI   + Y+   +   HRD+  +N LV  +   +K+ DFG ++ L  G+         YY
Sbjct: 146 QIASGMKYL-SSLNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 226 R------------APELIFGATEYTTAVDIWSVGCVLAELLL 255
           R            A E I    ++TTA D+W+ G  L E+L+
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 29/75 (38%), Positives = 39/75 (52%), Gaps = 5/75 (6%)

Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG---EPN 216
           +K    Q+   L  +H  IG+ HRDIKP+NLLV     QVK+ DFG+A  +  G    P 
Sbjct: 311 IKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPL 368

Query: 217 ISYICSRYYRAPELI 231
              +  RY    EL+
Sbjct: 369 YGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 76/326 (23%), Positives = 127/326 (38%), Gaps = 109/326 (33%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNR-------- 133
            ++ I+ + E  +GQGSFG+V++  A+ +  GE    VA+K V +    + R        
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 134 ----------------------ELQTMRLLDHPNVH-YSRA-------SQRMPLIYVK-- 161
                                  L  M L+ H ++  Y R+       +   P   ++  
Sbjct: 62  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 162 -LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
                +I   +AY++    V HRD+  +N +V  H   VK+ DFG  + + + +      
Sbjct: 122 IQMAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD------ 173

Query: 221 CSRYYR------------APELIFGATEYTTAVDIWSVGCVLAEL--LLGQPLFPGESGV 266
              YYR            APE +     +TT+ D+WS G VL E+  L  QP + G S  
Sbjct: 174 ---YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQGLSN- 227

Query: 267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
           +Q+++ +             M+  Y +         P         P    DL+    Q+
Sbjct: 228 EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQF 260

Query: 327 SPNLRCTALEAC------IHPFFDEL 346
           +P +R T LE        +HP F E+
Sbjct: 261 NPKMRPTFLEIVNLLKDDLHPSFPEV 286

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 24/100 (24%)

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 225
           Q+   +AY+     V HRD+  +N LV  +   VK+ DFG ++       NI    + YY
Sbjct: 138 QVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSR-------NI--YSADYY 186

Query: 226 RA------------PELIFGATEYTTAVDIWSVGCVLAEL 253
           +A            PE IF    YTT  D+W+ G VL E+
Sbjct: 187 KASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 35/118 (29%), Positives = 60/118 (50%), Gaps = 16/118 (13%)

Query: 165 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 224
           YQ+ R + Y+     + HRD+  +N+LV    + +K+ DFG    L +G  +I Y     
Sbjct: 141 YQVARGMEYLESRRCI-HRDLAARNVLVT-EDNVMKIADFG----LARGVHDIDYYKKTS 194

Query: 225 -------YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
                  + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L ++++
Sbjct: 195 NGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP-VEELFKLLR 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.2 bits (96), Expect = 8e-04
 Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 8/116 (6%)

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--ICSR 223
           Q+  A+ YIH    + HRDIK +N+ +N     V L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDGKIV-LGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD---QLVEIIKVL 276
              +PE++ G   Y    DIWS G +L ++L       G+ G     QL++II  L
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 50/218 (22%), Positives = 81/218 (37%), Gaps = 74/218 (33%)

Query: 99  VGQGSFGIVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNV--H 147
           +G+G+FG VF A+C     E  + +   K L++     ++   RE + + +L H ++   
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 148 YSRASQRMPLIYVKLY---------------------------------------TYQIC 168
           Y   ++  PL+ V  Y                                         QI 
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA- 227
             + Y+   +   HRD+  +N LV      VK+ DFG ++ +   +         YYR  
Sbjct: 133 SGMVYL-ASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD---------YYRVG 181

Query: 228 -----------PELIFGATEYTTAVDIWSVGCVLAELL 254
                      PE I    ++TT  DIWS G VL E+ 
Sbjct: 182 GRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 48/217 (22%), Positives = 85/217 (39%), Gaps = 48/217 (22%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLL 141
           P  + ++     +G+G++G VF+    + G   A+K +L      + E++        L 
Sbjct: 14  PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72

Query: 142 DHPNV-----------------------------------HYSRASQRMPLIYVKLYTYQ 166
           DHPNV                                    + +  +RM    +    ++
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYY 225
               L ++H    + HRD+K  N+L+      VKL DFG SA++        + + + ++
Sbjct: 133 ALMGLQHLHVNKTI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190

Query: 226 RAPELIFGA----TEYTTAVDIWSVGCVLAELLLGQP 258
            APE+I       + Y    D+WS+G    EL  G P
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 10/102 (9%)

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY- 224
           Q+   +AYI   +   HRD++  N+LV       K+ DFG A+ L++     +   +++ 
Sbjct: 110 QVAAGMAYIER-MNYIHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFP 166

Query: 225 --YRAPEL-IFGATEYTTAVDIWSVGCVLAELLL-GQPLFPG 262
             + APE  ++G   +T   D+WS G +L EL+  G+  +PG
Sbjct: 167 IKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	395
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.94
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.77
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.77
smart00090	237	RIO RIO-like kinase.	99.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.66
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.61
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.59
PRK10345	210	hypothetical protein; Provisional	99.59
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.53
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.52
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.51
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.51
PRK14879	211	serine/threonine protein kinase; Provisional	99.51
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.46
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.38
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.3
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.1
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.09
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.06
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.99
KOG1243	690	consensus Protein kinase [General function predict	98.94
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.91
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.83
COG4248	637	Uncharacterized protein with protein kinase and he	98.8
KOG3087	229	consensus Serine/threonine protein kinase [General	98.52
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.5
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.42
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.38
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.35
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.23
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.14
PRK09902	216	hypothetical protein; Provisional	98.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.94
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.83
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.82
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.8
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.67
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.64
PF01636	239	APH: Phosphotransferase enzyme family This family	97.44
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.15
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.14
KOG1235	538	consensus Predicted unusual protein kinase [Genera	96.84
KOG2270	520	consensus Serine/threonine protein kinase involved	96.61
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.55
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.49
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.49
PRK05231	319	homoserine kinase; Provisional	96.38
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.36
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.31
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.23
PLN02876	822	acyl-CoA dehydrogenase	96.21
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	95.84
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.72
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.57
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.47
PLN02236	344	choline kinase	95.18
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	95.09
PRK09550	401	mtnK methylthioribose kinase; Reviewed	94.63
PRK10593	297	hypothetical protein; Provisional	94.0
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	93.75
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.6
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	93.55
PRK10271	188	thiK thiamine kinase; Provisional	92.44
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	92.39
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	92.28
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	91.91
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.69
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	91.6
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	91.51
PRK12396	409	5-methylribose kinase; Reviewed	91.16
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	91.11
COG2334	331	Putative homoserine kinase type II (protein kinase	91.02
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	90.95
PTZ00384	383	choline kinase; Provisional	90.91
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	90.8
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	89.54
PHA03111	444	Ser/Thr kinase; Provisional	89.05
PTZ00296	442	choline kinase; Provisional	87.36

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-65  Score=470.09  Aligned_cols=318  Identities=75%  Similarity=1.229  Sum_probs=296.1

Q ss_pred             cceEEeecCCCCCCCccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCce------
Q 016085           73 GHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV------  146 (395)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni------  146 (395)
                      +.+......++.........|.-.+++|+|+||.||.|...++++.||||++.++++...+|+.+|+.++||||      
T Consensus         6 ~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~   85 (364)
T KOG0658|consen    6 GHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYF   85 (364)
T ss_pred             eeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEE
Confidence            44445555566666667778999999999999999999999999999999999999999999999999999998      


Q ss_pred             ----------------------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCc
Q 016085          147 ----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ  198 (395)
Q Consensus       147 ----------------------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~  198 (395)
                                                  .+.....+++...++.|++||++||.||| +.||+||||||.|+|+|.+.+.
T Consensus        86 f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh-~~~IcHRDIKPqNlLvD~~tg~  164 (364)
T KOG0658|consen   86 FSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH-SHGICHRDIKPQNLLVDPDTGV  164 (364)
T ss_pred             EEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH-hcCcccCCCChheEEEcCCCCe
Confidence                                        12234567788888999999999999999 7999999999999999999889


Q ss_pred             eEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 016085          199 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  278 (395)
Q Consensus       199 ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  278 (395)
                      +||||||.|+....++...++.||++|+|||.+.|...|+.+.||||.||++.||+-|++.|.|.+..+++..|++++|+
T Consensus       165 LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  165 LKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             EEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCC
Q 016085          279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRP  358 (395)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~  358 (395)
                      |+++++.+|+++|.++.+|++....|.+.+....++++.+|+.++|.++|.+|.++.|+|.||||+.+++++..++++.+
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~  324 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRP  324 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCChhhhccCCHHHHHhhchHHHhhhCCC
Q 016085          359 FPPLFNFKPQELKGASKELLSKLIPEHARKQCPF  392 (395)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (395)
                      .|++++|+..+ .+...+....++|++++.+.+.
T Consensus       325 lp~lf~f~~~e-~~~~~~~~~~l~p~~~~~~~~~  357 (364)
T KOG0658|consen  325 LPPLFNFKRAE-LGISPELVNVLIPEHLREQEKD  357 (364)
T ss_pred             CCCccCchHHH-hccchHHHHhhccHhhhhhccc
Confidence            99999999984 4789999999999999987764

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-55  Score=398.57  Aligned_cols=291  Identities=40%  Similarity=0.674  Sum_probs=243.6

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCce-------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNV-------------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni-------------------  146 (395)
                      .|...+.||+|+||.|+.|.++.+|+.||||++...      .....||+++|+.++|+||                   
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            477789999999999999999999999999988632      2344689999999999998                   


Q ss_pred             -----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc---
Q 016085          147 -----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK---  212 (395)
Q Consensus       147 -----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~---  212 (395)
                                 ..+..++.+...+++.+++||+.||.|+| +.+|+||||||.|+|++.++ .+||+|||+|+....   
T Consensus       103 iV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH-SAnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~~~~~  180 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH-SANVIHRDLKPSNLLLNADC-DLKICDFGLARYLDKFFE  180 (359)
T ss_pred             EehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh-cccccccccchhheeeccCC-CEEeccccceeeccccCc
Confidence                       11233455999999999999999999999 88999999999999999999 699999999998753   


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC-
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY-  291 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-  291 (395)
                      ....+.++.|.+|+|||+++....|+.++||||+||||.||++|++.|.|.+..+++..|+..+|+|+.+.+....... 
T Consensus       181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a  260 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA  260 (359)
T ss_pred             ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence            3445678899999999999888889999999999999999999999999999999999999999999999887665221 


Q ss_pred             --ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCChhh
Q 016085          292 --TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQE  369 (395)
Q Consensus       292 --~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (395)
                        .-...|..+..+|...|+ ..++.+.|||.+||.+||.+|+|++|+|.||||..++++...+.....+.   .   .+
T Consensus       261 r~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~---~---~~  333 (359)
T KOG0660|consen  261 RPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFD---S---FE  333 (359)
T ss_pred             HHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCc---c---cc
Confidence              112467777778888777 68999999999999999999999999999999999999977643322111   1   23


Q ss_pred             hccCCHHHHHhhchHHHhhhCCC
Q 016085          370 LKGASKELLSKLIPEHARKQCPF  392 (395)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~  392 (395)
                      .. ...+.+..++.+++..-+|-
T Consensus       334 ~~-~~~~~~r~~i~~e~~~~~~~  355 (359)
T KOG0660|consen  334 HE-LTEEELRELIYKEILDFHPD  355 (359)
T ss_pred             cc-ccHHHHHHHHHHHHHhhCcc
Confidence            33 56677777777777665554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.6e-54  Score=387.09  Aligned_cols=254  Identities=37%  Similarity=0.663  Sum_probs=221.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCce-------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV-------------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni-------------------  146 (395)
                      .|+.+.++|+|+||.||+++++.||+.||||++....      ....||+++|++|+|+|+                   
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            5889999999999999999999999999999986543      334589999999999997                   


Q ss_pred             -------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc-cCCCccc
Q 016085          147 -------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNIS  218 (395)
Q Consensus       147 -------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~-~~~~~~~  218 (395)
                             .+......++...++.|++|++.|+.|+| +.++|||||||+||||+.++ .+||||||+|+... .++..+.
T Consensus        83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH-k~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCH-KNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh-hcCeecccCChhheEEecCC-cEEeccchhhHhhcCCcchhhh
Confidence                   11233567899999999999999999999 88999999999999999988 79999999999887 5666778


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH--hhcCCCCccccC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--~~~~~~~~~~~~  296 (395)
                      ++.|++|+|||.+.|...|+.++||||+||++.||++|.+.|+|.++.+++..|++.+|.......  ...++-|....+
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            999999999999999778999999999999999999999999999999999999999998766544  455677777888


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      |..........--++++.-+.||+++||..||.+|++.+++|.|+||+.+.
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            887655433333345678999999999999999999999999999997653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-54  Score=407.80  Aligned_cols=255  Identities=39%  Similarity=0.680  Sum_probs=226.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhh-----HHHHHHHHHhcC-CCce------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-----KNRELQTMRLLD-HPNV------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~~l~~l~-h~ni------------------  146 (395)
                      ++|.++++||.|.||.||+|+.+++|+.||||.+++....     ..||+..|++|+ ||||                  
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            4799999999999999999999999999999998765332     248999999999 9998                  


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                               ....+...+++..++.|++||++||+|+| .+|+.||||||||||+.... .|||+|||+|+......+.+
T Consensus        90 E~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH-k~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev~SkpPYT  167 (538)
T KOG0661|consen   90 EFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH-KHGFFHRDLKPENILISGND-VIKIADFGLAREVRSKPPYT  167 (538)
T ss_pred             HhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH-hcCcccccCChhheEecccc-eeEecccccccccccCCCcc
Confidence                     11234678999999999999999999999 89999999999999999655 69999999999998888889


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCcccc
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFK  295 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~  295 (395)
                      .++.|++|+|||+++....|+.++|+||+|||++|+.+-++.|+|.++.+++.+|.+++|+|..+.|....  .+.-.+.
T Consensus       168 eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~  247 (538)
T KOG0661|consen  168 EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFR  247 (538)
T ss_pred             hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccC
Confidence            99999999999999988889999999999999999999999999999999999999999999988775421  2234567


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      +|+.....+...++. .+.++.+||.+||+|||.+||||.++|+||||+.-..
T Consensus       248 ~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  248 FPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             CCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence            777777777777776 8999999999999999999999999999999986543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2e-53  Score=390.96  Aligned_cols=232  Identities=32%  Similarity=0.501  Sum_probs=201.6

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCce--------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNV--------------  146 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni--------------  146 (395)
                      ....+|+++++||+|+||+||.++.+.|++.||+|++++.       .....+|..||..++||+|              
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            4456899999999999999999999999999999998654       3455689999999999998              


Q ss_pred             ------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-
Q 016085          147 ------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  213 (395)
Q Consensus       147 ------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-  213 (395)
                                  ..++..+.+++..+++|+++|+.||.||| ++|||||||||+|||||.+|| |+|+|||+|+..... 
T Consensus       102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH-~~gIiyRDlKPENILLd~~GH-i~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLH-SKGIIYRDLKPENILLDEQGH-IKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH-hCCeeeccCCHHHeeecCCCc-EEEeccccchhcccCC
Confidence                        11244678999999999999999999999 899999999999999999996 999999999966554 


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      ..+.++|||+.|||||++.+.. |+..+|||||||++|||++|.+||.+.+......+|.+.-                 
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-----------------  241 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-----------------  241 (357)
T ss_pred             CccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-----------------
Confidence            4455679999999999998875 9999999999999999999999999999888888887631                 


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC----CHHHHhcCCcccCCCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC----TALEACIHPFFDELRDPN  350 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~----t~~e~l~hp~f~~~~~~~  350 (395)
                                 ....+.-++.++++||+++|+.||++|+    .+.++.+||||..+.|..
T Consensus       242 -----------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  242 -----------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             -----------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence                       0012233789999999999999999996    578999999999998853

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-52  Score=369.45  Aligned_cols=254  Identities=39%  Similarity=0.708  Sum_probs=216.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCce------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      .+|...++||+|.||.||+|++.+||+.||||+++...      ....||++.|+.++|+||                  
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            36999999999999999999999999999999986432      234589999999999998                  


Q ss_pred             --------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cc
Q 016085          147 --------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NI  217 (395)
Q Consensus       147 --------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~  217 (395)
                              ........+....++.|+.+++.||+||| ++.|+||||||.|+|++++| .+||+|||+|+....... .+
T Consensus        82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H-~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH-SKWILHRDLKPNNLLISSDG-QLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH-hhhhhcccCCccceEEcCCC-cEEeecccchhccCCCCcccc
Confidence                    11223456788889999999999999999 88999999999999999998 799999999998865433 33


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCcccc
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFK  295 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~  295 (395)
                      ..+.|+.|+|||.+.|...|+..+|+||.|||+.||+.|.+.|+|.++.+|+..|+..+|+|..+.|..+.  ++|..+.
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            34779999999999999999999999999999999999999999999999999999999999999998765  4555444


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                        .++...... +-...+.++.||+.+||.+||.+|+|+.|+|+|+||.....+
T Consensus       240 --~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  240 --QFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             --cCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence              233333333 334568889999999999999999999999999999985433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-52  Score=396.77  Aligned_cols=256  Identities=39%  Similarity=0.652  Sum_probs=217.9

Q ss_pred             CCCccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCce------------
Q 016085           85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV------------  146 (395)
Q Consensus        85 ~~~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni------------  146 (395)
                      +.+...+.|+.+++||+|.||.||+|++..+|+.||+|++.-+.      ....||+.||++|+||||            
T Consensus       111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~  190 (560)
T KOG0600|consen  111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS  190 (560)
T ss_pred             ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence            34455667999999999999999999999999999999986543      345699999999999998            


Q ss_pred             ----------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          147 ----------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       147 ----------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                                      ......-.|++.++++|+.||+.||+||| .+||+|||||.+|||||.+| .+||+|||+|+++
T Consensus       191 ~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH-~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  191 GSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH-SRGVLHRDIKGSNILIDNNG-VLKIADFGLARFY  268 (560)
T ss_pred             ceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh-hcCeeeccccccceEEcCCC-CEEeccccceeec
Confidence                            11233457999999999999999999999 89999999999999999888 6999999999976


Q ss_pred             ccCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          211 VKGE--PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       211 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ....  ..+..+.|.+|+|||+++|...|+.++|+||+||||.||++|++.|+|.++.+|+..|++..|.|.+..|....
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            5443  46778889999999999999999999999999999999999999999999999999999999999999887322


Q ss_pred             C-CCccccCCccc-CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          289 P-NYTEFKFPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       289 ~-~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                      . .+..+. +... .+.+... ...++..+.+|+..||++||.+|.||.++|.|+||.
T Consensus       349 LP~~~~~k-p~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  349 LPHATIFK-PQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             CCcccccC-CCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            2 222222 2222 2222222 456899999999999999999999999999999993

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.3e-53  Score=380.56  Aligned_cols=257  Identities=35%  Similarity=0.574  Sum_probs=225.1

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhh------HHHHHHHHHhcCCCceE---------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY------KNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~~l~~l~h~ni~---------------  147 (395)
                      ....|..+..|++|+||.||+|+|++|++.||+|+++-++..      ..||+++|.+++|+||.               
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            345799999999999999999999999999999998755422      24899999999999981               


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  213 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-  213 (395)
                                   ...-.+++....++.++.|++.||+||| ...|+|||||++|+|++..| .+||+|||+|+.+... 
T Consensus       154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH-~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH-DNWILHRDLKTSNLLLSHKG-ILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh-hceeEecccchhheeeccCC-cEEecccchhhhhcCCc
Confidence                         1123468999999999999999999999 88999999999999999888 6999999999998655 


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCC
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY  291 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~  291 (395)
                      ...+..+.|.+|+|||+++|...|+.++|+||+|||+.||+++++.|+|....+++.+|++.+|+|++..|.-..  +..
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            335667889999999999999999999999999999999999999999999999999999999999999886432  233


Q ss_pred             ccccCCcccCCCcccccCCC-CChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      ..+.++..+...+...|... +++...+||.++|.+||.+|+||.++|+|.||.+..
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence            34667777777777777765 789999999999999999999999999999998843

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-51  Score=409.38  Aligned_cols=297  Identities=54%  Similarity=0.990  Sum_probs=258.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceEee--------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYS--------------------  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~~~--------------------  149 (395)
                      ..+|++.++||+|+||.||+|.+..+++.||||++........+|+.+|+.++|+||...                    
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            357999999999999999999999999999999998777777889999999999997210                    


Q ss_pred             -----------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          150 -----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       150 -----------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                       .....+++..++.++.||+.||.||| +.||+||||||+|||++.+++.+||+|||+|+....
T Consensus       145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH-~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH-SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence                             11345677888999999999999999 889999999999999997765799999999987765


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+++.+|.|..+.+..++++|.
T Consensus       224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~  303 (440)
T PTZ00036        224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA  303 (440)
T ss_pred             CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence            55556678899999999987766699999999999999999999999999999999999999999999999988888888


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCC-CCCCCCCCCCChhhhc
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPN-GRPFPPLFNFKPQELK  371 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  371 (395)
                      ...++.+....+...++...++++.+||.+||++||.+|+|+.|+|+||||..+.++....+. ....|++.++...++.
T Consensus       304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (440)
T PTZ00036        304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIK  383 (440)
T ss_pred             cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHh
Confidence            888888777777777888889999999999999999999999999999999998876544443 2456788999999998


Q ss_pred             cCCHHHHHhhchHHHh
Q 016085          372 GASKELLSKLIPEHAR  387 (395)
Q Consensus       372 ~~~~~~~~~~~~~~~~  387 (395)
                      ..+.+....++|....
T Consensus       384 ~~~~~~~~~~~~~~~~  399 (440)
T PTZ00036        384 EMSDACRRKIIPKCTY  399 (440)
T ss_pred             hCCHHHHHHHhhHHHH
Confidence            8888888887776443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-53  Score=393.06  Aligned_cols=231  Identities=35%  Similarity=0.517  Sum_probs=191.5

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----------hhHHHHHHHHHhcCCCceE-----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----------~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      .+.|.+.+.||+|+||.|-+|..++||+.||||++.+.+           ....+|++||++|+||||.           
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            457999999999999999999999999999999996542           1235899999999999981           


Q ss_pred             ---------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC---CCceEEeecCCccc
Q 016085          148 ---------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH---THQVKLCDFGSAKV  209 (395)
Q Consensus       148 ---------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~---~~~ikl~DFG~a~~  209 (395)
                                     .....+.+.+..-+.+++|++.|+.||| +.||+||||||+|||++.+   . .+||+|||+|+.
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH-~~GI~HRDiKPeNILl~~~~e~~-llKItDFGlAK~  328 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLH-SQGIIHRDIKPENILLSNDAEDC-LLKITDFGLAKV  328 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHH-HcCcccccCCcceEEeccCCcce-EEEecccchhhc
Confidence                           1123456777788999999999999999 8999999999999999765   4 599999999999


Q ss_pred             cccCCCcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhh
Q 016085          210 LVKGEPNISYICSRYYRAPELIFGA--TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  286 (395)
                      ...+.-..+.||||.|.|||++.+.  ..+..++|+|||||+||-+|+|.+||.+..... ...+|.+.           
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G-----------  397 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG-----------  397 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC-----------
Confidence            8877778899999999999999643  334558999999999999999999998876555 33444331           


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                         .|           .+....+..+++++++||.+||..||++|+|+.|+|+||||+...
T Consensus       398 ---~y-----------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  398 ---RY-----------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             ---cc-----------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence               11           111123345899999999999999999999999999999998654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-51  Score=395.15  Aligned_cols=227  Identities=33%  Similarity=0.535  Sum_probs=199.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCce-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNV-----------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni-----------------  146 (395)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+.       .....+|++|.+.|+||||                 
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4699999999999999999999999999999998652       3455689999999999998                 


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCc
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPN  216 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~  216 (395)
                               .+....+.+.|..++.++.||+.||.||| +.+|||||||..|+||+.+. .|||+|||+|...... +..
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH-~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH-SLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH-hcCceecccchhheeecCcC-cEEecccceeeeecCccccc
Confidence                     12345688999999999999999999999 88999999999999999887 5999999999888644 667


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      .+.||||+|+|||++... .++..+||||+||+||.||+|++||...+-.+.+..|...                 ++. 
T Consensus       176 ~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-----------------~Y~-  236 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-----------------EYS-  236 (592)
T ss_pred             ceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-----------------Ccc-
Confidence            789999999999999764 4999999999999999999999999988877887777652                 222 


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                                 +|..+|.++++||.+||..||.+|||+.++|.|+||..---+
T Consensus       237 -----------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p  278 (592)
T KOG0575|consen  237 -----------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP  278 (592)
T ss_pred             -----------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence                       344589999999999999999999999999999999554444

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-51  Score=392.24  Aligned_cols=233  Identities=30%  Similarity=0.554  Sum_probs=203.8

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhc-CCCce-------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLL-DHPNV-------------  146 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l-~h~ni-------------  146 (395)
                      ....+|..++.||.|+|++|++|+++.+++.||||++.+.       ..+..+|..+|.+| .||.|             
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            3445799999999999999999999999999999988543       24456899999999 89987             


Q ss_pred             -------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          147 -------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       147 -------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                   .++...+.+.+..+++|+.||+.||+||| ++|||||||||||||||.+++ +||+|||.|+.+...
T Consensus       150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH-~~GIIHRDlKPENILLd~dmh-ikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH-SNGIIHRDLKPENILLDKDGH-IKITDFGSAKILSPS  227 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH-hcCceeccCChhheeEcCCCc-EEEeeccccccCChh
Confidence                         22345688999999999999999999999 899999999999999999995 999999999887432


Q ss_pred             CC--------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016085          214 EP--------------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  279 (395)
Q Consensus       214 ~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  279 (395)
                      ..              ..+++||..|.+||++.... .+..+|||+||||||.|+.|.+||.+.++.-.+++|+++.   
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~---  303 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD---  303 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc---
Confidence            11              14589999999999997655 8999999999999999999999999999999999999841   


Q ss_pred             CHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCC
Q 016085          280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  352 (395)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  352 (395)
                                    +            .|+..+++.+.|||+++|..||.+|+|+.+|.+||||..+.|.+..
T Consensus       304 --------------y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw  350 (604)
T KOG0592|consen  304 --------------Y------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW  350 (604)
T ss_pred             --------------c------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence                          2            2556689999999999999999999999999999999999987644

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=361.07  Aligned_cols=228  Identities=29%  Similarity=0.482  Sum_probs=201.8

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCce--------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNV--------------  146 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni--------------  146 (395)
                      ....+|.+++.||.|+||.|.+++.+.+|..||+|++.+..       +...+|..+|+.+.||++              
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            33457999999999999999999999999999999986543       445579999999999997              


Q ss_pred             ------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          147 ------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       147 ------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                  .+.+..+++++..+++|++||+.||+||| +++|++|||||+|||||.+|+ +||+|||+|+..... 
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH-~~~iiYRDLKPENiLlD~~G~-iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH-SLDIIYRDLKPENLLLDQNGH-IKITDFGFAKRVSGR-  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH-hcCeeeccCChHHeeeccCCc-EEEEeccceEEecCc-
Confidence                        23456689999999999999999999999 899999999999999999996 999999999987443 


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                       +.+.||||.|+|||++..++ |+.++|||||||++|||+.|.+||.+.+......+|++.                 .+
T Consensus       198 -T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-----------------~v  258 (355)
T KOG0616|consen  198 -TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-----------------KV  258 (355)
T ss_pred             -EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-----------------cc
Confidence             67889999999999998765 999999999999999999999999999998888888873                 22


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                      .            +|..++.++++||+++|+.|-.+|.     ...++.+||||+.+.|.
T Consensus       259 ~------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~  306 (355)
T KOG0616|consen  259 K------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE  306 (355)
T ss_pred             c------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence            2            4455899999999999999999995     46789999999999885

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.1e-50  Score=382.72  Aligned_cols=241  Identities=32%  Similarity=0.505  Sum_probs=201.8

Q ss_pred             CccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCce-------------
Q 016085           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNV-------------  146 (395)
Q Consensus        87 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni-------------  146 (395)
                      ....++|.++++||+|+||.||+|+.+.||..||+|++++..       .....|..+|...++++|             
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            345678999999999999999999999999999999997653       344579999999999987             


Q ss_pred             -------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-
Q 016085          147 -------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  212 (395)
Q Consensus       147 -------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-  212 (395)
                                   .++.....+++..+++|+.+++.|++.|| +.|+|||||||+|+|||..|| |||+|||+|.-... 
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH-~~gyIHRDIKPdNlLiD~~GH-iKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIH-QLGYIHRDIKPDNLLIDAKGH-IKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHH-HcCcccccCChhheeecCCCC-Eeeccccccchhhhh
Confidence                         12344578999999999999999999999 899999999999999999996 99999999853211 


Q ss_pred             ---------------------C-CC------c-------------------ccccccccccccccccCCCCCCCcchHHH
Q 016085          213 ---------------------G-EP------N-------------------ISYICSRYYRAPELIFGATEYTTAVDIWS  245 (395)
Q Consensus       213 ---------------------~-~~------~-------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  245 (395)
                                           . ..      .                   .+.+|||.|||||++.++. |+..+||||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWS  373 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWS  373 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHH
Confidence                                 0 00      0                   1468999999999999876 999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhcc
Q 016085          246 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ  325 (395)
Q Consensus       246 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~  325 (395)
                      |||||||||.|.+||.+.+..+...+|+.+...               ..+|.          ...+++++.|||.+||+
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~----------~~~~s~eA~DLI~rll~  428 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPE----------EVDLSDEAKDLITRLLC  428 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCC----------cCcccHHHHHHHHHHhc
Confidence            999999999999999999999999999875211               11111          12367999999999999


Q ss_pred             CCCCCCCC---HHHHhcCCcccCCCCCCCCCCCC
Q 016085          326 YSPNLRCT---ALEACIHPFFDELRDPNARLPNG  356 (395)
Q Consensus       326 ~dP~~R~t---~~e~l~hp~f~~~~~~~~~~~~~  356 (395)
                       ||++|+.   +.||.+||||+.+.|...+...+
T Consensus       429 -d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~a  461 (550)
T KOG0605|consen  429 -DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPA  461 (550)
T ss_pred             -CHHHhcCcccHHHHhcCCccccCCcchhhcCCC
Confidence             9999985   78999999999999987665443

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-49  Score=384.68  Aligned_cols=231  Identities=29%  Similarity=0.486  Sum_probs=202.5

Q ss_pred             CccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcC-CCce------------
Q 016085           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLD-HPNV------------  146 (395)
Q Consensus        87 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~-h~ni------------  146 (395)
                      .....+|+++++||+|+||+|++|..+.+++.||||+++++.       .....|.+|+.... ||.+            
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            344568999999999999999999999999999999987753       34456888887775 9987            


Q ss_pred             -------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc-c
Q 016085          147 -------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-K  212 (395)
Q Consensus       147 -------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~-~  212 (395)
                                   ...+....+++..+++|++.|+.||.||| ++||||||||.+|||||.+|| +||+|||+|+... .
T Consensus       444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH-~~~IIYRDlKLdNiLLD~eGh-~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLH-ENGIIYRDLKLDNLLLDTEGH-VKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHH-hcCceeeecchhheEEcccCc-EEecccccccccCCC
Confidence                         23455688999999999999999999999 899999999999999999996 9999999999876 5


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      +..+.++||||.|||||++.+.. |+.++|||||||+|||||.|++||.|.+..+....|+.                 .
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~-----------------d  583 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN-----------------D  583 (694)
T ss_pred             CCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-----------------C
Confidence            56677899999999999998765 99999999999999999999999999999999888875                 1


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCH-----HHHhcCCcccCCCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFDELRDP  349 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  349 (395)
                      +..            ++..+|.++.++|+++|++||++|+.+     .++.+||||+.+.|.
T Consensus       584 ~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~  633 (694)
T KOG0694|consen  584 EVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD  633 (694)
T ss_pred             CCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence            222            344589999999999999999999864     789999999999885

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.1e-48  Score=382.60  Aligned_cols=253  Identities=36%  Similarity=0.628  Sum_probs=203.8

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHH---HHHHHHHhcC-CCc-----e----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLD-HPN-----V----------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~---~E~~~l~~l~-h~n-----i----------------  146 (395)
                      +|.|.++||+|+||.|.+|.|..|++.||||++++.+.+..   .|+.+|..|+ |.+     +                
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            69999999999999999999999999999999998877665   4788888886 322     1                


Q ss_pred             -----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC-CCCceEEeecCCccccccCC
Q 016085          147 -----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       147 -----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~-~~~~ikl~DFG~a~~~~~~~  214 (395)
                                 ........++...++.++.||+.||.+|| +.||||+|||||||||.. ....|||+|||+|....  .
T Consensus       267 fELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~-~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~--q  343 (586)
T KOG0667|consen  267 FELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH-ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES--Q  343 (586)
T ss_pred             ehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCChhheeeccCCcCceeEEecccccccC--C
Confidence                       11234567899999999999999999999 899999999999999853 33479999999997653  3


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ...+++.+++|+|||+++|.+ |+.+.||||||||++||++|.++|+|.+..+++..|++.+|.|+...+.........+
T Consensus       344 ~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff  422 (586)
T KOG0667|consen  344 RVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFF  422 (586)
T ss_pred             cceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceeh
Confidence            344888999999999999977 9999999999999999999999999999999999999999999998776443222111


Q ss_pred             cC----Ccc------------------------------cCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          295 KF----PQI------------------------------KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       295 ~~----~~~------------------------------~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .-    +..                              ....+...+...-...+.|||++||.+||.+|+|+.++|+|
T Consensus       423 ~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  423 TSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH  502 (586)
T ss_pred             hccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            11    000                              01111111111223468999999999999999999999999


Q ss_pred             CcccCCCC
Q 016085          341 PFFDELRD  348 (395)
Q Consensus       341 p~f~~~~~  348 (395)
                      |||.....
T Consensus       503 pfl~~~~~  510 (586)
T KOG0667|consen  503 PFLTGTSL  510 (586)
T ss_pred             cccccccc
Confidence            99986544

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-48  Score=359.14  Aligned_cols=257  Identities=37%  Similarity=0.717  Sum_probs=213.6

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh------hHHHHHHHHHhcCCCc-eEe----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRLLDHPN-VHY----------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~~l~~l~h~n-i~~----------------  148 (395)
                      .|..+++||+|+||+||+|+++.+|+.||+|+++-+..      ...||+.+|+.|+|+| |..                
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            58888999999999999999999999999999865432      3468999999999999 600                


Q ss_pred             ---------------ec-cC---CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          149 ---------------SR-AS---QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       149 ---------------~~-~~---~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                     .. ..   ..++...++.+++||+.||+||| ++||+||||||.||||+++| .+||+|||+|+.
T Consensus        92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H-~~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAra  169 (323)
T KOG0594|consen   92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH-SHGILHRDLKPQNLLISSSG-VLKLADFGLARA  169 (323)
T ss_pred             EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH-hCCeecccCCcceEEECCCC-cEeeeccchHHH
Confidence                           00 01   35777889999999999999999 89999999999999999988 699999999987


Q ss_pred             cccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          210 LVKG-EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       210 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ..-. ...+..++|..|+|||+++|...|+..+||||+|||++||+++++.|.|.++.+++..|++.+|+|..+.|....
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~  249 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS  249 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence            6533 335667889999999999999889999999999999999999999999999999999999999999999887543


Q ss_pred             --CCCccccCCccc-CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCC
Q 016085          289 --PNYTEFKFPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  352 (395)
Q Consensus       289 --~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  352 (395)
                        ++|.. .++... ...+... .++.+++..+++.+||+++|.+|.|+..+|.||||..+......
T Consensus       250 ~~~~~k~-~f~~~~~~~~l~~~-~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~  314 (323)
T KOG0594|consen  250 SLPDYKA-PFPKWPGPKDLSSI-LPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ  314 (323)
T ss_pred             ccccccc-cCcCCCCccchHHh-ccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence              34433 233322 2222222 23345799999999999999999999999999999998665433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-48  Score=355.97  Aligned_cols=230  Identities=32%  Similarity=0.528  Sum_probs=191.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ..+.+.++.||+|+.|+||+|+++.|++.+|+|++..+     .+...+|+++++..+||+|.                 
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            34678889999999999999999999999999999432     34456899999999999981                 


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                                .....+++++.....++.++++||.|||.+++||||||||+|||++..| .|||||||.++..... ...
T Consensus       158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvnS-~a~  235 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVNS-IAN  235 (364)
T ss_pred             hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhhh-hcc
Confidence                      1122366899999999999999999999558999999999999999988 6999999999887665 557


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----CcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGE-----SGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      +++||..|||||.+.+.. |+.++||||||++++||.+|+.||...     +..+.+..|..   .|++           
T Consensus       236 tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP-----------  300 (364)
T KOG0581|consen  236 TFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPP-----------  300 (364)
T ss_pred             cccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCC-----------
Confidence            899999999999998865 999999999999999999999999774     22333333332   1111           


Q ss_pred             cccCCcccCCCcccccCCC-CChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                                    .++.. +|+++++||..||++||.+|+|+.|+++|||+.+....+
T Consensus       301 --------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  301 --------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             --------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence                          12332 799999999999999999999999999999998876544

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-48  Score=374.81  Aligned_cols=228  Identities=32%  Similarity=0.509  Sum_probs=203.3

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCce------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      -|++++.||.|+-|.|.+|++..||+.+|||++.+.       .....+|+.||+.+.|||+                  
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            499999999999999999999999999999999766       3456799999999999998                  


Q ss_pred             --------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          147 --------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       147 --------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                              .+....+++++..+.+++.||+.|+.|+| ..+|+||||||+|+|||.+++ |||+|||+|..-..+.-..+
T Consensus        93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH-~~~icHRDLKpENlLLd~~~n-IKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCH-AFNICHRDLKPENLLLDVKNN-IKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh-hhcceeccCCchhhhhhcccC-EeeeccceeecccCCccccc
Confidence                    23345688999999999999999999999 899999999999999999885 99999999988877777788


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      .||+|+|.|||++.|.++.+.++||||+|||||.||+|+.||.+.+-...+.++.+                 ..|.   
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~-----------------G~f~---  230 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR-----------------GVFE---  230 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-----------------Cccc---
Confidence            99999999999999999889999999999999999999999998776666666554                 1222   


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                               ++..++.++++||++||..||++|+|.+|+++|||+.......
T Consensus       231 ---------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  231 ---------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             ---------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence                     3456899999999999999999999999999999998876543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-47  Score=365.99  Aligned_cols=226  Identities=35%  Similarity=0.521  Sum_probs=195.0

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhHHHHHHHHHhcC-CCce------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLD-HPNV------------  146 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~-h~ni------------  146 (395)
                      ..+.|.+.+.||+|+||+|++|++..+++.||+|++.+.         .....+|+.+++.+. ||||            
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            345799999999999999999999999999999976553         224458999999999 9998            


Q ss_pred             --------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC-CCceEEeecCCcccc-
Q 016085          147 --------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVL-  210 (395)
Q Consensus       147 --------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~-~~~ikl~DFG~a~~~-  210 (395)
                                    .++...+++.+..++.++.||+.|++||| ++||+||||||+|||++.+ + .+||+|||++... 
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H-~~gi~HRDLK~ENilld~~~~-~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH-SRGIVHRDLKPENILLDGNEG-NLKLSDFGLSAISP  172 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH-hCCEeeCCCCHHHEEecCCCC-CEEEeccccccccC
Confidence                          11223578999999999999999999999 8999999999999999998 6 6999999999887 


Q ss_pred             ccCCCcccccccccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          211 VKGEPNISYICSRYYRAPELIFGAT-EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      ..+....+.+||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||.+.+.......|.+               
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~---------------  237 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK---------------  237 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc---------------
Confidence            4556677899999999999998866 557999999999999999999999999777777666554               


Q ss_pred             CCccccCCcccCCCcccccCCCC-ChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRM-PPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                        ..+.            ++..+ |+++.+||++||..||.+|+|+.+++.||||+.
T Consensus       238 --~~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  238 --GEFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             --CCcc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence              1222            23336 999999999999999999999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-47  Score=339.65  Aligned_cols=214  Identities=31%  Similarity=0.544  Sum_probs=179.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeec------chhhHHHHHHHHHhcCCCce------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      .+|.|+++||+|+||.||++++..+|..||.|.+.-      .....-.|+.+|++|+||||                  
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            369999999999999999999999999999998852      23344579999999999998                  


Q ss_pred             --------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcC--CC--eeeccCCCCceEEcCCCCceEEeecCCcc
Q 016085          147 --------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG--IG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAK  208 (395)
Q Consensus       147 --------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~g--iiHrDlKp~Nill~~~~~~ikl~DFG~a~  208 (395)
                                    ++....+.+++..++.++.|+|.||..+| +  ..  |+||||||.||+|+.+| .+||+|||+++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH-~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL~r  176 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCH-SKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGLGR  176 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHh-ccccccceeeccCcchheEEcCCC-ceeeccchhHh
Confidence                          33445678999999999999999999999 5  34  99999999999999888 69999999999


Q ss_pred             ccccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 016085          209 VLVKGEP-NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  287 (395)
Q Consensus       209 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  287 (395)
                      ....... ..+++|||+||+||.+.+.+ |+++|||||+||++|||+.-++||.|.+-.....+|... ..         
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~---------  245 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DY---------  245 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CC---------
Confidence            8754433 45789999999999998866 999999999999999999999999999665555555442 11         


Q ss_pred             CCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCH
Q 016085          288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA  334 (395)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~  334 (395)
                               +.++        ..-.|.++..||..|++.||+.||+.
T Consensus       246 ---------~~~p--------~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  246 ---------PPLP--------DEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             ---------CCCc--------HHHhhhHHHHHHHHHccCCcccCCCc
Confidence                     1110        01268899999999999999999985

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.4e-47  Score=364.91  Aligned_cols=262  Identities=30%  Similarity=0.451  Sum_probs=211.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCce------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+..      ....+|++|++.|+||||                  
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            36999999999999999999999999999999986543      335689999999999998                  


Q ss_pred             -------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccc
Q 016085          147 -------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NIS  218 (395)
Q Consensus       147 -------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~  218 (395)
                             .+....+.++++.++.++++++.||.||| +.+|+|||+||.|||++..+ .+|+||||+|+.+..+.. .++
T Consensus        82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh-s~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLH-SNRILHRDMKPQNILLEKGG-TLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH-hcCcccccCCcceeeecCCC-ceeechhhhhhhcccCceeeee
Confidence                   23345788999999999999999999999 88999999999999999888 599999999998866543 346


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      ..|||.|||||++.+.+ |+..+|+||||||+|||++|++||....-...+..|.+-                 +..   
T Consensus       160 ikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d-----------------~v~---  218 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD-----------------PVK---  218 (808)
T ss_pred             ccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-----------------CCC---
Confidence            78999999999998765 999999999999999999999999876655555555431                 111   


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCChhhhccCCHHHH
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELL  378 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (395)
                               .+..++..+.+||..+|.+||.+|+|+.+++.|||.+.--.............+..+..|.+.+..+.+.-
T Consensus       219 ---------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spftn~~Ppe~kek~~kq~  289 (808)
T KOG0597|consen  219 ---------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFTNNTPPEYKEKDRKQG  289 (808)
T ss_pred             ---------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccccCCChHHHHhhhccc
Confidence                     22357999999999999999999999999999999976433322222222334555556777776666655


Q ss_pred             HhhchH
Q 016085          379 SKLIPE  384 (395)
Q Consensus       379 ~~~~~~  384 (395)
                      ++..++
T Consensus       290 srqa~~  295 (808)
T KOG0597|consen  290 SRQAEN  295 (808)
T ss_pred             CcccCC
Confidence            555444

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.8e-46  Score=344.41  Aligned_cols=248  Identities=28%  Similarity=0.439  Sum_probs=206.8

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCce--------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNV--------------  146 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni--------------  146 (395)
                      ....+|++++.||+|.-|+||+|+...++..+|+|++.+..       ...+.|.+||+.++||.+              
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            34457999999999999999999999999999999996542       334569999999999997              


Q ss_pred             --------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          147 --------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       147 --------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                    ...+....+++..+++|+.+++.||+||| -.|||+||||||||||-++|| |.|+||.++.....
T Consensus       154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH-mlGivYRDLKPENILvredGH-IMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH-MLGIVYRDLKPENILVREDGH-IMLSDFDLSLRCPV  231 (459)
T ss_pred             EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH-hhceeeccCCcceeEEecCCc-EEeeeccccccCCC
Confidence                          22355678999999999999999999999 899999999999999999996 99999998643210


Q ss_pred             ---------------------------------C------------------------CCcccccccccccccccccCCC
Q 016085          213 ---------------------------------G------------------------EPNISYICSRYYRAPELIFGAT  235 (395)
Q Consensus       213 ---------------------------------~------------------------~~~~~~~gt~~y~aPE~~~~~~  235 (395)
                                                       .                        ....+++||-.|+|||++.|..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0                        0112467899999999999866


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChh
Q 016085          236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPE  315 (395)
Q Consensus       236 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  315 (395)
                       ++.++|||+|||++||||.|..||.|.+..+.+.+|+..                 +..+|..          ..++..
T Consensus       312 -HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~----------~~vs~~  363 (459)
T KOG0610|consen  312 -HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE----------PEVSSA  363 (459)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC----------CcchhH
Confidence             899999999999999999999999999999999988762                 2233332          136789


Q ss_pred             HHHHHHhhccCCCCCCCC----HHHHhcCCcccCCCCCCCCCCCCCCCCCCCCC
Q 016085          316 AVDLVSRLLQYSPNLRCT----ALEACIHPFFDELRDPNARLPNGRPFPPLFNF  365 (395)
Q Consensus       316 ~~~ll~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  365 (395)
                      ++|||+++|.+||++|+.    |+||.+||||+.++|...+-...+.+|...+.
T Consensus       364 akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~  417 (459)
T KOG0610|consen  364 AKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG  417 (459)
T ss_pred             HHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence            999999999999999998    99999999999999987665555555554444

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-48  Score=336.30  Aligned_cols=229  Identities=33%  Similarity=0.463  Sum_probs=193.2

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeec------chhhHHHHHHHHHhcCCCceEee--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVHYS--------------  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l~h~ni~~~--------------  149 (395)
                      .+.|.+.++||+|.|+.|+++.+..||+.+|+|++.-      +.+..++|++|-+.|+||||...              
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            3469999999999999999999999999999998742      34567799999999999998111              


Q ss_pred             -c-----------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC--CCceEEeecCCccccccCCC
Q 016085          150 -R-----------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH--THQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       150 -~-----------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~--~~~ikl~DFG~a~~~~~~~~  215 (395)
                       .           ...-+++..+-.++.||+.||.|+| ..||||||+||+|+|+-+.  +--+||+|||+|.....+..
T Consensus        90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH-~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~  168 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCH-SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA  168 (355)
T ss_pred             ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-hcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence             0           1123466667788999999999999 8899999999999999543  22599999999999886666


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      -...+|||.|||||++...+ |+..+||||.||+||-|+.|.+||.+.+......+|++.                 .+.
T Consensus       169 ~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g-----------------~yd  230 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG-----------------AYD  230 (355)
T ss_pred             cccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc-----------------ccC
Confidence            67789999999999997655 999999999999999999999999999999988888873                 122


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      ++.        .....+++++++|+++||..||.+|+|+.|+|+|||+.+
T Consensus       231 ~~~--------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  231 YPS--------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             CCC--------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            221        123458999999999999999999999999999999965

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=347.81  Aligned_cols=235  Identities=29%  Similarity=0.462  Sum_probs=196.1

Q ss_pred             CCCCCccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------------------hhHHHHHHHHHhcCCC
Q 016085           83 RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------------RYKNRELQTMRLLDHP  144 (395)
Q Consensus        83 ~~~~~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------------------~~~~~E~~~l~~l~h~  144 (395)
                      ......+.++|++.+.||+|.||+|-+|++..+++.||||++.+..                  +...+|+.||++|.|+
T Consensus        89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~  168 (576)
T KOG0585|consen   89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP  168 (576)
T ss_pred             CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence            3344567789999999999999999999999999999999985432                  2345899999999999


Q ss_pred             ceE---------------------------eeccCCC-CcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC
Q 016085          145 NVH---------------------------YSRASQR-MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT  196 (395)
Q Consensus       145 ni~---------------------------~~~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~  196 (395)
                      ||.                           ....... +.+.+++.|+..++.||+||| .+|||||||||+|+||++++
T Consensus       169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH-~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH-YQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             CeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH-hcCeeccccchhheEEcCCC
Confidence            981                           1112234 889999999999999999999 88999999999999999998


Q ss_pred             CceEEeecCCccccccCCC------cccccccccccccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016085          197 HQVKLCDFGSAKVLVKGEP------NISYICSRYYRAPELIFG---ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD  267 (395)
Q Consensus       197 ~~ikl~DFG~a~~~~~~~~------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  267 (395)
                       .+||+|||.+.....+..      ....+|||.|+|||.+.+   ....+.+.||||+||+||.|+.|+.||-+....+
T Consensus       248 -~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~  326 (576)
T KOG0585|consen  248 -TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE  326 (576)
T ss_pred             -cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence             699999999876633311      234789999999999976   3446889999999999999999999999998888


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       268 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      ...+|..                 ....+|..          +.+.+.++|||.+||++||++|++..++..|||...-
T Consensus       327 l~~KIvn-----------------~pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  327 LFDKIVN-----------------DPLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHHhc-----------------CcccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            8888876                 22333332          2368899999999999999999999999999998654

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.4e-45  Score=344.93  Aligned_cols=250  Identities=33%  Similarity=0.632  Sum_probs=203.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY-----------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~-----------------  148 (395)
                      ++|.+.+.||.|+||.||+|++..+++.||+|++...     .....+|+.+++.++|+||..                 
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            4699999999999999999999999999999988632     123458999999999999810                 


Q ss_pred             --------e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccc
Q 016085          149 --------S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNIS  218 (395)
Q Consensus       149 --------~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~  218 (395)
                              . .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...... ....
T Consensus        85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~~~~~~~  162 (288)
T cd07871          85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH-KRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVPTKTYSN  162 (288)
T ss_pred             CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCC-CEEECcCcceeeccCCCccccC
Confidence                    0 11234678888999999999999999 89999999999999999887 69999999997643222 2234


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCccccC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~  296 (395)
                      ..+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.|+.+.|....  ..+....+
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd07871         163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF  242 (288)
T ss_pred             ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence            5679999999998775668999999999999999999999999999999999999999999988776543  22333333


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      +.....++.. ....++.++.+||++||++||.+|+|+.|+|+||||
T Consensus       243 ~~~~~~~~~~-~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         243 PQYRAQPLIN-HAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CccCCCchHH-hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            3332222221 234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-46  Score=346.59  Aligned_cols=229  Identities=33%  Similarity=0.530  Sum_probs=186.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceEe------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVHY------------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~~------------------  148 (395)
                      .+|...+.||+|+||.||++.++++|+.+|||.+...    .....+|+.+|+.|+|+||..                  
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            3589999999999999999999999999999998665    455689999999999999811                  


Q ss_pred             ----------eccCC-CCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC-CCCceEEeecCCcccccc----
Q 016085          149 ----------SRASQ-RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVLVK----  212 (395)
Q Consensus       149 ----------~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~-~~~~ikl~DFG~a~~~~~----  212 (395)
                                ....+ .+++..++.+..||+.||.||| ++||+||||||+|||++. ++ .+||+|||+++....    
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH-s~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH-SKGIVHCDIKPANILLDPSNG-DVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeccCcccceEEEeCCCC-eEEeccCcccccccccccc
Confidence                      01112 6899999999999999999999 899999999999999998 46 699999999987653    


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      ........||+.|||||++......+.++|||||||++.||+||.+||... ...+.+..|...                
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~----------------  238 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE----------------  238 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc----------------
Confidence            122346789999999999975322345999999999999999999999773 333333333221                


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                 .....++..+|+++++||.+||.+||++||||.++|+|||......
T Consensus       239 -----------~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  239 -----------DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -----------CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                       0011355668999999999999999999999999999999976544

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=340.61  Aligned_cols=228  Identities=30%  Similarity=0.517  Sum_probs=194.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCce-----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNV-----------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni-----------------  146 (395)
                      .++|.+.+.||+|+||+||+|+++.++..||||.+.+.      ......|+.+|+.++|+||                 
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            45799999999999999999999999999999988654      2344689999999999998                 


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC-C----CceEEeecCCcccccc
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-T----HQVKLCDFGSAKVLVK  212 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~-~----~~ikl~DFG~a~~~~~  212 (395)
                               .|++..+++++..++.++.||+.||++|| +++||||||||.||||+.. +    -.+||+|||+|+....
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~-~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH-ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence                     34455678999999999999999999999 8899999999999999764 2    2599999999999987


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      +....+.||+|.|||||++.... |+.++|+||+|+++|+|++|++||...+..+.+..+.+..                
T Consensus       168 ~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~----------------  230 (429)
T KOG0595|consen  168 GSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN----------------  230 (429)
T ss_pred             hhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc----------------
Confidence            77777899999999999996544 9999999999999999999999999888877766544311                


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                                .....++..++..+.+|+...|+.+|..|.+..+-+.|++...
T Consensus       231 ----------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  231 ----------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             ----------cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                      1112233446778889999999999999999999999998854

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3e-44  Score=340.92  Aligned_cols=256  Identities=32%  Similarity=0.549  Sum_probs=196.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      ++|.+.+.||+|+||.||+|++..+++.||||++....     ....+|+.+++.++|+||.                  
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            46999999999999999999999999999999986432     2345799999999999981                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNIS  218 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~  218 (395)
                              .......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++..... .....
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~  162 (303)
T cd07869          85 VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH-QRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSVPSHTYSN  162 (303)
T ss_pred             CCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEECCCCcceeccCCCccCCC
Confidence                    0112345788899999999999999999 88999999999999999887 6999999998754322 22234


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcCC--CCcccc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNP--NYTEFK  295 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~  295 (395)
                      ..+|+.|+|||++.+...++.++|||||||++|+|++|..||.+... .+.+..+....+.+....+.....  .+....
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (303)
T cd07869         163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER  242 (303)
T ss_pred             CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence            56799999999987766689999999999999999999999987544 456677777777777655543211  111111


Q ss_pred             CCcccCCCccccc-CCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          296 FPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       296 ~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      +.......+...+ ....+..+.+||.+||++||++|+|+.++++||||+++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence            1111111111111 1135678999999999999999999999999999988753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.3e-44  Score=342.90  Aligned_cols=256  Identities=39%  Similarity=0.689  Sum_probs=199.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEee----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYS----------------  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~----------------  149 (395)
                      +|++.++||+|+||.||+|++..+++.||||++...      .....+|+.+++.++|+||...                
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            499999999999999999999999999999988532      2234579999999999998210                


Q ss_pred             --------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          150 --------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       150 --------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                    .....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.......
T Consensus        81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-cEEEccCccccccccccC
Confidence                          11235788889999999999999999 88999999999999999887 699999999976432221


Q ss_pred             ----cccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          216 ----NISYICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       216 ----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                          .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.|+...+......
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                1245789999999988542 34899999999999999999999999999888888888888888877655432211


Q ss_pred             Cc-cc--cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          291 YT-EF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       291 ~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                      -. .+  .........+... ...+++.+.+||.+||+.||++|||+.++++||||+.+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~  300 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE  300 (338)
T ss_pred             hHHHHHHhhcccCCCchHHh-cCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence            00 00  0000000111111 124678899999999999999999999999999999877653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=348.22  Aligned_cols=226  Identities=31%  Similarity=0.479  Sum_probs=195.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCce--------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNV--------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni--------------------  146 (395)
                      ..|....+||+|+-|.||.|+...+++.||||.+...    ++..-+|+.+|+.++|+||                    
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            3688999999999999999999999999999998643    3455689999999999998                    


Q ss_pred             -----EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccccc
Q 016085          147 -----HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYI  220 (395)
Q Consensus       147 -----~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~  220 (395)
                           ........++|.++..++.+++.||+||| .+||+|||||.+|||++.++ .+||+|||+|..+.... ...+.+
T Consensus       353 ~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH-~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~~~KR~TmV  430 (550)
T KOG0578|consen  353 EGGSLTDVVTKTRMTEGQIAAICREILQGLKFLH-ARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEEQSKRSTMV  430 (550)
T ss_pred             CCCchhhhhhcccccHHHHHHHHHHHHHHHHHHH-hcceeeeccccceeEeccCC-cEEEeeeeeeeccccccCcccccc
Confidence                 11122345889999999999999999999 88999999999999999998 59999999998876554 456789


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      |||+|||||++..+. |++++||||||+++.||+-|++||-.++....++.|.. .|+|..                   
T Consensus       431 GTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~l-------------------  489 (550)
T KOG0578|consen  431 GTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKL-------------------  489 (550)
T ss_pred             CCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCc-------------------
Confidence            999999999997655 99999999999999999999999998888888887754 233322                   


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                            ..+..+|+.+++||.+||+.|+++|++|.|+|+||||+.
T Consensus       490 ------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  490 ------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             ------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence                  134458999999999999999999999999999999944

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=326.47  Aligned_cols=228  Identities=29%  Similarity=0.440  Sum_probs=197.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCce----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNV----------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni----------------  146 (395)
                      -++|..+++||+|.||+|.+++.+.+++.||||+++++.       .....|-++|+..+||.+                
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            357999999999999999999999999999999987653       233468889999999986                


Q ss_pred             ----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-CCC
Q 016085          147 ----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEP  215 (395)
Q Consensus       147 ----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-~~~  215 (395)
                                ........+++..+++|..+|+.||.||| +.+||+||||.+|+|+|.+|| |||+|||+|+.... +..
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH-s~~ivYRDlKLENLlLDkDGH-IKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH-SRNIVYRDLKLENLLLDKDGH-IKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh-hCCeeeeechhhhheeccCCc-eEeeecccchhcccccce
Confidence                      11233567899999999999999999999 789999999999999999996 99999999987654 445


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ..++||||.|+|||++... .|+.++|||.+||+||||++|+.||...+....+..|+..                 +. 
T Consensus       325 ~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----------------d~-  385 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----------------DL-  385 (516)
T ss_pred             eccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------------hc-
Confidence            6678999999999999765 5999999999999999999999999988877777666652                 11 


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  349 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  349 (395)
                                 .|+..++++++.||..+|.+||.+|+.     +.|+.+|+||..+.|.
T Consensus       386 -----------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~  433 (516)
T KOG0690|consen  386 -----------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE  433 (516)
T ss_pred             -----------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence                       255669999999999999999999984     7899999999999885

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.8e-43  Score=332.52  Aligned_cols=249  Identities=39%  Similarity=0.707  Sum_probs=198.1

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      +|++.+.||+|+||.||+|+++.+++.||+|++...      .....+|+.+++.++|+||.                  
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            699999999999999999999999999999988643      23345799999999999980                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--Ccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--PNI  217 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--~~~  217 (395)
                              +......+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.......  ...
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH-KNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-cEEEeeccCccccccccccccc
Confidence                    0112346888899999999999999999 88999999999999999887 69999999998754322  122


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCcccc
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFK  295 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~  295 (395)
                      ...||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....+..+...+....  +.+....
T Consensus       160 ~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         160 EYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             ccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence            456899999999997755 8999999999999999999999999988888888888877777665554322  1111111


Q ss_pred             CCccc-CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          296 FPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       296 ~~~~~-~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      .+... ...+.......++.++.+||++||++||++|+|+.++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            11111 1111222334578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.2e-43  Score=343.67  Aligned_cols=260  Identities=33%  Similarity=0.546  Sum_probs=204.1

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEeec-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYSR-------------  150 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~~-------------  150 (395)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++...      .....+|+.+++.++|+||....             
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            35799999999999999999999999999999998642      23345799999999999982110             


Q ss_pred             ----------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          151 ----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       151 ----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                      ....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||+++......
T Consensus       103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~  180 (364)
T cd07875         103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF  180 (364)
T ss_pred             eEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHh-hCCeecCCCCHHHEEECCCC-cEEEEeCCCccccCCCC
Confidence                            0123567778889999999999999 88999999999999999887 69999999998765444


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC----
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN----  290 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~----  290 (395)
                      ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..++...+.|..+.+..+...    
T Consensus       181 ~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (364)
T cd07875         181 MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY  259 (364)
T ss_pred             cccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHH
Confidence            444567899999999997754 899999999999999999999999999999999999999888877654433211    


Q ss_pred             ------CccccCCccc---CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCC
Q 016085          291 ------YTEFKFPQIK---AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  352 (395)
Q Consensus       291 ------~~~~~~~~~~---~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  352 (395)
                            +..+.+....   ..++........+..+++||.+||++||.+|||+.++|+||||..+.++...
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~  330 (364)
T cd07875         260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEA  330 (364)
T ss_pred             HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccC
Confidence                  1111110000   0011111222346789999999999999999999999999999887666443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.5e-43  Score=355.92  Aligned_cols=256  Identities=24%  Similarity=0.395  Sum_probs=192.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCc------eE-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPN------VH-------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~n------i~-------------  147 (395)
                      .++|++.++||+|+||+||+|.+..+++.||||++....   .....|+.+++.+.|.+      +.             
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~  207 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM  207 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence            467999999999999999999999999999999986432   23456888888886654      20             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC---------------ce
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---------------QV  199 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~---------------~i  199 (395)
                                   +......+++..++.++.||+.||+|||++.|||||||||+|||++.++.               .+
T Consensus       208 ~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v  287 (467)
T PTZ00284        208 CIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV  287 (467)
T ss_pred             EEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence                         01123457888899999999999999993269999999999999986542               49


Q ss_pred             EEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016085          200 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  279 (395)
Q Consensus       200 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  279 (395)
                      ||+|||.+...  .......+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+.+.+|.+
T Consensus       288 kl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~  364 (467)
T PTZ00284        288 RICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL  364 (467)
T ss_pred             EECCCCccccC--ccccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence            99999988543  22334578899999999998765 9999999999999999999999999999889999999988887


Q ss_pred             CHHHHhhcCCC-----Ccccc--CCcccCCCcccc-----c-CCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          280 TREEIKCMNPN-----YTEFK--FPQIKAHPWHKI-----F-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       280 ~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~-----~-~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      +..........     +....  .+......+...     + ....++.+.|||.+||++||++|+|+.|+|+||||...
T Consensus       365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence            76543211000     00000  000000000000     0 00124668899999999999999999999999999876


Q ss_pred             CC
Q 016085          347 RD  348 (395)
Q Consensus       347 ~~  348 (395)
                      ..
T Consensus       445 ~~  446 (467)
T PTZ00284        445 YP  446 (467)
T ss_pred             CC
Confidence            44

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-43  Score=340.45  Aligned_cols=255  Identities=36%  Similarity=0.632  Sum_probs=203.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEee---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHYS---------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~~---------------  149 (395)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++|+||...               
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            46999999999999999999999999999999986432      234479999999999997110               


Q ss_pred             ---------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          150 ---------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       150 ---------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                     .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....  
T Consensus        95 ~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~--  170 (343)
T cd07878          95 VYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQADD--  170 (343)
T ss_pred             EEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecccCChhhEEECCCC-CEEEcCCccceecCC--
Confidence                           11246888999999999999999999 88999999999999999887 699999999986533  


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+..........
T Consensus       171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07878         171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK  250 (343)
T ss_pred             CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence            23456789999999999775568999999999999999999999999988888899999888888776554332211100


Q ss_pred             ---cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          295 ---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       295 ---~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                         ..+......+... ....++.+.+||.+||++||.+|||+.|+|+||||.....+.
T Consensus       251 ~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         251 YIQSLPHMPQQDLKKI-FRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             HhhccccccchhHHHh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence               1111111111111 123577899999999999999999999999999999877654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.7e-43  Score=343.86  Aligned_cols=257  Identities=32%  Similarity=0.550  Sum_probs=201.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEeec--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYSR--------------  150 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~~--------------  150 (395)
                      .+|++.+.||+|+||.||+|++..+|+.||+|++...      .....+|+.+++.++|+||....              
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            5799999999999999999999999999999998542      23345799999999999982110              


Q ss_pred             ---------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          151 ---------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       151 ---------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                     ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.......
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~  178 (359)
T cd07876         101 VYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFM  178 (359)
T ss_pred             eEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCC-CEEEecCCCccccccCcc
Confidence                           0123577788899999999999999 88999999999999999888 699999999976544444


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-------
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-------  288 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-------  288 (395)
                      .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.|....+....       
T Consensus       179 ~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (359)
T cd07876         179 MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV  257 (359)
T ss_pred             CCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            45567899999999997754 8999999999999999999999999998888889999988888765443221       


Q ss_pred             ---CCCccccCCccc-CC--CcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          289 ---PNYTEFKFPQIK-AH--PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       289 ---~~~~~~~~~~~~-~~--~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                         +.+....+.... ..  +.........+..+.+||.+||++||++|||+.|+|+||||.....+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~  325 (359)
T cd07876         258 ENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA  325 (359)
T ss_pred             hhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence               111111100000 00  000011223567899999999999999999999999999998765553

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.6e-43  Score=331.92  Aligned_cols=247  Identities=36%  Similarity=0.612  Sum_probs=193.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcC-CCcEEEEEEeecch------hhHHHHHHHHHhc---CCCceEee------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVHYS------------  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~~~~~~------~~~~~E~~~l~~l---~h~ni~~~------------  149 (395)
                      +|++.+.||+|+||.||+|++.. +++.||+|.+....      ....+|+.+++.+   +|+||...            
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            69999999999999999999864 46889999885321      2334677777766   69997211            


Q ss_pred             --------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          150 --------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       150 --------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                          .....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH-~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  159 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSG-QIKLADFGLARI  159 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEEcCCC-CEEEccccceEe
Confidence                                01234678889999999999999999 88999999999999999887 699999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          210 LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      ...........||+.|+|||.+.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....+.|....+.....
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         160 YSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             ccCCcccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            65444444567899999999997654 89999999999999999999999999999999999999888877665532111


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                       .....+.......+. .+...++..+.+||.+||++||++|||+.++|+||||
T Consensus       239 -~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         239 -LPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             -ccchhccCCCCCCHH-HHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence             111111111111111 1234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=298.41  Aligned_cols=253  Identities=35%  Similarity=0.633  Sum_probs=211.5

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      .|.-.++||+|.||+||+|++.++++.||+|.++-+.      ....||+.+++.|+|.||.                  
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4777889999999999999999999999999986542      3456999999999999981                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NIS  218 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~  218 (395)
                              +....+.+....++.++.|++.||.|+| +++++||||||.|+||+.+| .+||+|||+++...-.-. ...
T Consensus        83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch-shnvlhrdlkpqnllin~ng-elkladfglarafgipvrcysa  160 (292)
T KOG0662|consen   83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH-SHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVRCYSA  160 (292)
T ss_pred             hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh-hhhhhhccCCcceEEeccCC-cEEecccchhhhcCCceEeeec
Confidence                    1123466788889999999999999999 88999999999999999998 699999999987754432 223


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      .+.|..|++|.++.|..-|+.+.|+||.|||+.|+. .|++.|+|.+-.+++.+|+..+|.|.++.|..+..--+-..+|
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp  240 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP  240 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence            466999999999999988999999999999999999 5999999999999999999999999999998776322222233


Q ss_pred             cccCC-CcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          298 QIKAH-PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       298 ~~~~~-~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      .++.. .|.+. -++++..-+||++++|.-+|.+|++++++++||||.+..
T Consensus       241 ~ypattswsqi-vp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  241 IYPATTSWSQI-VPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CccccchHHHH-hhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            33222 23333 345677889999999999999999999999999998753

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.3e-43  Score=334.64  Aligned_cols=255  Identities=35%  Similarity=0.658  Sum_probs=204.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------------e
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      .+|.+.+.||+|+||.||+|++..+++.||+|.+....     ....+|+.+++.++|+||.                 +
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46999999999999999999999999999999886432     2345799999999999981                 0


Q ss_pred             ---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccc
Q 016085          149 ---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NIS  218 (395)
Q Consensus       149 ---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~  218 (395)
                               ......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....... ...
T Consensus        86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~  163 (309)
T cd07872          86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH-RRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPTKTYSN  163 (309)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEECccccceecCCCcccccc
Confidence                     011234678888999999999999999 88999999999999999887 699999999876433222 223


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~  296 (395)
                      ..+|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+....|.....  .+....+
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07872         164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF  243 (309)
T ss_pred             ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence            46789999999987666689999999999999999999999999998899999999999998877755432  1222233


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      +......+.. ....+++++.+||.+||++||.+|+|+.|+++||||+.+..
T Consensus       244 ~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         244 PKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             CccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence            3222222211 22357899999999999999999999999999999988753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-43  Score=340.26  Aligned_cols=226  Identities=30%  Similarity=0.416  Sum_probs=186.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++|+||.               
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            347999999999999999999999999999999986532       2345799999999999981               


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                                 .......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.....  .
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~--~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH-SKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPDR--T  172 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCCC--c
Confidence                       1112356788899999999999999999 88999999999999999888 6999999999865332  3


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...                 ..  
T Consensus       173 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-----------------~~--  232 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG-----------------RL--  232 (329)
T ss_pred             ceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------------Cc--
Confidence            3467899999999997755 899999999999999999999999887765555444321                 00  


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  349 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  349 (395)
                                .++..++..+.+||.+||+.||.+|++     +.++++||||.+..+.
T Consensus       233 ----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        233 ----------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             ----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence                      122336889999999999999999997     7999999999886554

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4e-43  Score=340.64  Aligned_cols=257  Identities=33%  Similarity=0.561  Sum_probs=202.1

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEeec-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYSR-------------  150 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~~-------------  150 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||.+...      .....+|+.+++.++|+||....             
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            35799999999999999999999999999999988642      12345799999999999981100             


Q ss_pred             ----------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          151 ----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       151 ----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                      ....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||+++......
T Consensus        96 ~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDikp~Nill~~~~-~~kl~Dfg~~~~~~~~~  173 (355)
T cd07874          96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF  173 (355)
T ss_pred             eeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHHEEECCCC-CEEEeeCcccccCCCcc
Confidence                            0123567778889999999999999 88999999999999999887 69999999998765444


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC----
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN----  290 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~----  290 (395)
                      ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.+..+.+..+...    
T Consensus       174 ~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (355)
T cd07874         174 MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY  252 (355)
T ss_pred             ccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence            445567899999999997754 899999999999999999999999999988899999998888876655433221    


Q ss_pred             ------CccccCCcccC---CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          291 ------YTEFKFPQIKA---HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       291 ------~~~~~~~~~~~---~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                            +....++....   .+.........+..+.+||.+||+.||++|||+.|+|+||||+...++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence                  11111111100   001111223356789999999999999999999999999999876554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-43  Score=331.82  Aligned_cols=229  Identities=23%  Similarity=0.387  Sum_probs=185.0

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------e
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      |++.+.||+|+||.||+|.+..+++.||+|.+.+..       ....+|+.+++.++|+|+.                 +
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            889999999999999999999999999999886432       2245799999999999981                 0


Q ss_pred             e-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          149 S-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       149 ~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                      .           .....+++..+..++.|++.||+||| +.||+||||||+|||++.++ .+||+|||++..........
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ-RERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCCCeec
Confidence            0           11235788899999999999999999 88999999999999999877 69999999998765444444


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ...||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.......                  
T Consensus       160 ~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------------  220 (285)
T cd05631         160 GRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED------------------  220 (285)
T ss_pred             CCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc------------------
Confidence            567899999999997654 8999999999999999999999998765433333322211100                  


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  349 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  349 (395)
                             ...++..++..+.+||++||+.||.+|++     ++++++||||..+.+.
T Consensus       221 -------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         221 -------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             -------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence                   01133457899999999999999999997     8999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-43  Score=347.83  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=191.2

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceE----------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVH----------------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~----------------------  147 (395)
                      ..+|.+.+.||+|+||.||+|++..+++.||||....  ....+|+.+++.|+|+||.                      
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~  168 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD  168 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCC
Confidence            3469999999999999999999999999999997543  3456899999999999981                      


Q ss_pred             ---eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC--CCccccccc
Q 016085          148 ---YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICS  222 (395)
Q Consensus       148 ---~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~--~~~~~~~gt  222 (395)
                         +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|+.....  ......+||
T Consensus       169 L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH-~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~gt  246 (391)
T PHA03212        169 LYCYLAAKRNIAICDILAIERSVLRAIQYLH-ENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINANKYYGWAGT  246 (391)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHhEEEcCCC-CEEEEeCCcccccccccccccccccCc
Confidence               0112346788889999999999999999 88999999999999999887 6999999999754322  222346789


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHHHHHHhCCCCHHHHhhcCCCCcc--
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGE-------SGVDQLVEIIKVLGTPTREEIKCMNPNYTE--  293 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--  293 (395)
                      +.|+|||++.+.. ++.++|||||||++|+|++|..||.+.       ....++..++...|.++.+...........  
T Consensus       247 ~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~  325 (391)
T PHA03212        247 IATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIY  325 (391)
T ss_pred             cCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHH
Confidence            9999999997654 899999999999999999999887543       234567778777776553321000000000  


Q ss_pred             ------ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          294 ------FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       294 ------~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                            ..........|..  ...++.++.+||.+||++||++|||+.|+|+||||+.+..+
T Consensus       326 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        326 IGLAKKSSRKPGSRPLWTN--LYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             HHHHhccCCCCCCCCCHHH--HhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence                  0000000001111  12357789999999999999999999999999999886544

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-43  Score=331.62  Aligned_cols=224  Identities=27%  Similarity=0.401  Sum_probs=187.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCce------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      +|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++|+||                  
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            699999999999999999999999999999998642       2334579999999999997                  


Q ss_pred             --------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          147 --------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       147 --------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                              .+......+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.....  ...
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~--~~~  157 (291)
T cd05612          82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH-SKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRDR--TWT  157 (291)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEECCCC-CEEEEecCcchhccCC--ccc
Confidence                    01123356788889999999999999999 88999999999999999887 6999999999865432  234


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      .+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...                 ..    
T Consensus       158 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-----------------~~----  215 (291)
T cd05612         158 LCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-----------------KL----  215 (291)
T ss_pred             ccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------Cc----
Confidence            57899999999997654 899999999999999999999999887766655555431                 00    


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCCC
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  349 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  349 (395)
                              .++..++..+.+||++||+.||.+|++     +.++++||||..+.+.
T Consensus       216 --------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         216 --------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             --------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence                    123346889999999999999999995     9999999999887664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-42  Score=327.19  Aligned_cols=247  Identities=32%  Similarity=0.564  Sum_probs=194.2

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhc---CCCceEee-------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVHYS-------------  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l---~h~ni~~~-------------  149 (395)
                      +|++.+.||+|+||.||+|+++.+++.||+|.+....      ....+|+.+++.+   +|+||...             
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4899999999999999999999999999999886421      2334677777665   79997110             


Q ss_pred             -------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          150 -------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       150 -------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                                         .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~~~  158 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENILVTSGG-QVKLADFGLARIY  158 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEECccCccccc
Confidence                               01234788899999999999999999 88999999999999999887 6999999999876


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ..........+|..|+|||++.+.. ++.++|||||||++|+|++|++||.+....+.+..+....+.+....+.... .
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  236 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV-T  236 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc-c
Confidence            5444444567899999999997654 8999999999999999999999999988888889999888877665543211 0


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      .....+.......+ ..+...++..+.+||.+||++||++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPV-QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCch-HHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00011111111111 12234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.5e-43  Score=343.23  Aligned_cols=254  Identities=38%  Similarity=0.620  Sum_probs=200.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY-----------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~-----------------  148 (395)
                      +|.+.+.||+|+||.||+|++..+++.||||.+...      .....+|+.+++.++|+||..                 
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            378899999999999999999999999999988542      133457999999999999810                 


Q ss_pred             -------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-
Q 016085          149 -------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-  214 (395)
Q Consensus       149 -------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-  214 (395)
                                   ......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...... 
T Consensus        81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH-SAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChHHEEECCCC-CEEeccccceeecccCcc
Confidence                         012356788899999999999999999 88999999999999999887 69999999997653322 


Q ss_pred             -CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          215 -PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                       ......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+++..|...+|.++.+.+.........
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence             1233567899999999987666899999999999999999999999999999999999999999887765432211000


Q ss_pred             cc--CCc-ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          294 FK--FPQ-IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       294 ~~--~~~-~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      ..  .+. .........+....++++.+||.+||++||++|||+.|+|+||||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            00  000 0000000112344688999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-44  Score=334.43  Aligned_cols=237  Identities=27%  Similarity=0.416  Sum_probs=195.8

Q ss_pred             CCccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCce------------
Q 016085           86 QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNV------------  146 (395)
Q Consensus        86 ~~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni------------  146 (395)
                      ++...+.|+.-++||+||||.||-++...||+.||+|.+.+.       ......|..||++++.+.|            
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            445556799999999999999999999999999999977433       2333479999999998887            


Q ss_pred             ----------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          147 ----------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       147 ----------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                                      .+......+++..+++|+++|+.||++|| +.+||+|||||+|||||..|| ++|+|+|+|..+
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH-~~~iVYRDLKPeNILLDd~Gh-vRISDLGLAvei  337 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH-RRRIVYRDLKPENILLDDHGH-VRISDLGLAVEI  337 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH-hcceeeccCChhheeeccCCC-eEeeccceEEec
Confidence                            12223458999999999999999999999 899999999999999999996 999999999999


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ..+......+||..|||||++.+.. |+.++|||||||++|||+.|+.||.......-...+-+..-.            
T Consensus       338 ~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~------------  404 (591)
T KOG0986|consen  338 PEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE------------  404 (591)
T ss_pred             CCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc------------
Confidence            9888888889999999999997766 999999999999999999999999764332222111111000            


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDPN  350 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  350 (395)
                                   -...++.++|+++++|++.+|+.||++|+     +++++.+||||+++.|..
T Consensus       405 -------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  405 -------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             -------------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence                         01124556899999999999999999998     567999999999998863

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-44  Score=310.93  Aligned_cols=226  Identities=30%  Similarity=0.428  Sum_probs=196.9

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ...++|.+.+.||+|-||.||+|+.++++..||+|++.+..       ....||++|-..|+||||.             
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy   98 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY   98 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence            34567999999999999999999999999999999986542       4456899999999999980             


Q ss_pred             ---------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          148 ---------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 ---------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                     ......++.+..+..|+.|++.||.|+| .++||||||||+|+|++..+ .+||+|||.+-... 
T Consensus        99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h-~k~VIhRdiKpenlLlg~~~-~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH-LKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAP-  175 (281)
T ss_pred             EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc-cCCcccCCCCHHHhccCCCC-CeeccCCCceeecC-
Confidence                           1124567889999999999999999999 89999999999999999988 69999999986654 


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      .....+.|||..|.+||...+.. ++..+|+|++|++.||++.|.+||...+..+...+|.++                 
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-----------------  237 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-----------------  237 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-----------------
Confidence            44556789999999999998765 999999999999999999999999998888888888773                 


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      .+            .++..++.++.|||.+||.++|.+|.+..|++.|||+...
T Consensus       238 ~~------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  238 DL------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             cc------------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            11            2345589999999999999999999999999999998654

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-44  Score=338.65  Aligned_cols=229  Identities=31%  Similarity=0.455  Sum_probs=204.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      =|.+.+.||+|-|..|-+|++.-||+.||||++.+.+      ...-.|++.|+.++||||.                  
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            4999999999999999999999999999999997643      3455899999999999981                  


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                               .......+.+..++.|++||+.|+.|+| +..+|||||||+|+.+.+..+.|||+|||++..+..+....+
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH-qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T  177 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH-QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT  177 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh-hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence                     1123467899999999999999999999 899999999999998776666899999999999999999999


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      .||+..|-|||+++|..+..+++||||||||||.|++|++||...++.+.+..|+.+-.+                 +  
T Consensus       178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt-----------------v--  238 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT-----------------V--  238 (864)
T ss_pred             ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc-----------------C--
Confidence            999999999999999886778999999999999999999999999999999999986322                 2  


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                                +.-++.+++|||.+||..||.+|.+.+||..|+|++....+.
T Consensus       239 ----------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  239 ----------PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             ----------chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence                      223789999999999999999999999999999999887654

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-44  Score=319.41  Aligned_cols=233  Identities=30%  Similarity=0.481  Sum_probs=195.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------------hhhHHHHHHHHHhc-CCCce------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLL-DHPNV------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------------~~~~~~E~~~l~~l-~h~ni------------  146 (395)
                      .|.-.+.||+|..++|.++..+.+|+.+|+|++.-.            .+...+|+.||+++ .||+|            
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            478889999999999999999999999999988321            12234699999887 69998            


Q ss_pred             --------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          147 --------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       147 --------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                    .+....-.+++...+.++.|++.|++||| ..+|+||||||+|||++.+- +|||+|||+|.....
T Consensus        98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH-a~~IVHRDLKpENILlddn~-~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH-ARNIVHRDLKPENILLDDNM-NIKISDFGFACQLEP  175 (411)
T ss_pred             hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH-HhhhhhcccChhheeecccc-ceEEeccceeeccCC
Confidence                          23334456889999999999999999999 88999999999999999877 699999999999999


Q ss_pred             CCCccccccccccccccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 016085          213 GEPNISYICSRYYRAPELIF-----GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  287 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  287 (395)
                      ++.....||||.|+|||.+.     +.+.|+..+|+||+|||||.|+.|.+||......-++..|++..           
T Consensus       176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk-----------  244 (411)
T KOG0599|consen  176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK-----------  244 (411)
T ss_pred             chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc-----------
Confidence            99999999999999999985     34568999999999999999999999998877777777777621           


Q ss_pred             CCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 016085          288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  351 (395)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  351 (395)
                         | .+.-|          -+.+++...+|||.+||+.||++|+|+.|+|.||||..+.....
T Consensus       245 ---y-qF~sp----------eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~  294 (411)
T KOG0599|consen  245 ---Y-QFRSP----------EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQA  294 (411)
T ss_pred             ---c-ccCCc----------chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcc
Confidence               1 11111          12347899999999999999999999999999999987655433

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.7e-42  Score=330.72  Aligned_cols=247  Identities=32%  Similarity=0.530  Sum_probs=185.4

Q ss_pred             eeeeccCCceEEEEEEEc--CCCcEEEEEEeecch--hhHHHHHHHHHhcCCCceEee----------------------
Q 016085           96 ERVVGQGSFGIVFQAKCL--ETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVHYS----------------------  149 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~--~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~ni~~~----------------------  149 (395)
                      .++||+|+||.||+|+++  .+++.||+|.+....  ....+|+.+++.++|+||...                      
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~   85 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD   85 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence            358999999999999965  467899999886532  345689999999999998100                      


Q ss_pred             --------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC---CCCceEEeecCCcccccc
Q 016085          150 --------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       150 --------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~---~~~~ikl~DFG~a~~~~~  212 (395)
                                    .....+++..++.++.||+.||.||| +.||+||||||+|||++.   ....+||+|||+|+....
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07868          86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH-hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence                          01124788889999999999999999 889999999999999942   223699999999976543


Q ss_pred             CC----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHHhCCC
Q 016085          213 GE----PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG---------VDQLVEIIKVLGTP  279 (395)
Q Consensus       213 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~~~~  279 (395)
                      ..    ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+...         ..++..+...+|.|
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07868         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP  244 (317)
T ss_pred             CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCC
Confidence            22    123457799999999998766689999999999999999999999975432         46778888989988


Q ss_pred             CHHHHhhcCCCCc------cccCCcccCCC---cccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          280 TREEIKCMNPNYT------EFKFPQIKAHP---WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       280 ~~~~~~~~~~~~~------~~~~~~~~~~~---~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ....|........      .+.........   +........+..+.+||.+||++||.+|+|+.|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             ChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            8776654321000      00000000000   0001112345679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-43  Score=339.17  Aligned_cols=230  Identities=31%  Similarity=0.508  Sum_probs=188.1

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|.+.+.||+|+||.||+|++..+++.||||++.+..       ....+|+.+++.++|+||.                 
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            6999999999999999999999999999999986432       3345799999999999981                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC----
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE----  214 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~----  214 (395)
                               +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++.......    
T Consensus        82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH-~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH-KLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccCcccc
Confidence                     0112356889999999999999999999 89999999999999999888 69999999997654332    


Q ss_pred             --------------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 016085          215 --------------------------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQ  268 (395)
Q Consensus       215 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  268 (395)
                                                ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                      12345689999999999776 489999999999999999999999998876666


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-HHHHhcCCcccCCC
Q 016085          269 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-ALEACIHPFFDELR  347 (395)
Q Consensus       269 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-~~e~l~hp~f~~~~  347 (395)
                      ...+.....               ...++.          ...+++++.+||.+||. ||.+|++ +.++++||||..+.
T Consensus       239 ~~~i~~~~~---------------~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         239 YNKIINWKE---------------SLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             HHHHhccCC---------------cccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence            555544210               001111          11268999999999998 9999999 99999999999876


Q ss_pred             CCC
Q 016085          348 DPN  350 (395)
Q Consensus       348 ~~~  350 (395)
                      +..
T Consensus       293 ~~~  295 (350)
T cd05573         293 WEN  295 (350)
T ss_pred             HHH
Confidence            643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-43  Score=337.40  Aligned_cols=231  Identities=33%  Similarity=0.547  Sum_probs=195.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcC-CCceEee-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVHYS-------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~-h~ni~~~-------------  149 (395)
                      ..|.+.+.||+|.||.||+|+++.+|+.||+|++.+..       ....+|+.+|+.+. ||||...             
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            46999999999999999999999999999999986543       36679999999999 9998100             


Q ss_pred             -----------ccCC-CCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC---CceEEeecCCccccccCC
Q 016085          150 -----------RASQ-RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT---HQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       150 -----------~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~---~~ikl~DFG~a~~~~~~~  214 (395)
                                 .-.. .+++..+..++.|++.|+.||| +.||+||||||+|+|+....   ..+|++|||++.....+.
T Consensus       115 mEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH-~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~  193 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLH-SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE  193 (382)
T ss_pred             EEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence                       0011 2999999999999999999999 89999999999999996542   269999999999987766


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....+||+.|+|||++.+.. |+..+|+||+||++|.|++|.+||.+.+.......|...-                 +
T Consensus       194 ~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~-----------------~  255 (382)
T KOG0032|consen  194 RLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD-----------------F  255 (382)
T ss_pred             eEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC-----------------C
Confidence            677889999999999996544 9999999999999999999999999999888777666521                 1


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                              .+....+..++..+++||++||..||.+|+|+.++|+|||++....
T Consensus       256 --------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  256 --------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             --------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence                    1111233457999999999999999999999999999999887633

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.3e-43  Score=336.20  Aligned_cols=221  Identities=27%  Similarity=0.424  Sum_probs=181.0

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE----------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH----------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~----------------------  147 (395)
                      ++||+|+||.||+|++..+|+.||||++.+..       ....+|+.+++.++|+||.                      
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999987532       2334689999999999971                      


Q ss_pred             ----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCccccccc
Q 016085          148 ----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICS  222 (395)
Q Consensus       148 ----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~gt  222 (395)
                          +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++..... ......+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLH-SCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCCcccceecC
Confidence                1112356788899999999999999999 88999999999999999887 6999999999764322 233456789


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  302 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (395)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+...                 ..        
T Consensus       159 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~~--------  212 (323)
T cd05571         159 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------EI--------  212 (323)
T ss_pred             ccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------CC--------
Confidence            9999999997654 899999999999999999999999887655444443220                 00        


Q ss_pred             CcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       303 ~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                          .++..+++++.+||.+||+.||++|+     ++.++++||||..+.+.
T Consensus       213 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         213 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                12345789999999999999999999     89999999999887554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=325.61  Aligned_cols=244  Identities=27%  Similarity=0.423  Sum_probs=195.1

Q ss_pred             CCCccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe-----------
Q 016085           85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY-----------  148 (395)
Q Consensus        85 ~~~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~-----------  148 (395)
                      ..+.....|++..+||.|.-++||+|++..+++.||||++.-+     .....+|+..|+.++||||.-           
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            3445556899999999999999999999999999999998543     355678999999999999810           


Q ss_pred             -----------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          149 -----------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       149 -----------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                                       ..-...+.|..+..++.+++.||.||| ..|.||||||+.||||+.+| .|||+|||.+..+.
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH-~~G~IHRdvKAgnILi~~dG-~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH-QNGHIHRDVKAGNILIDSDG-TVKLADFGVSASLF  177 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH-hcCceecccccccEEEcCCC-cEEEcCceeeeeec
Confidence                             112345899999999999999999999 89999999999999999999 69999999876665


Q ss_pred             cCCCc-----ccccccccccccccc-cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 016085          212 KGEPN-----ISYICSRYYRAPELI-FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       212 ~~~~~-----~~~~gt~~y~aPE~~-~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                      .....     ..++||++|||||++ ..-..|+.++||||||++..||.+|..||....+...+-.  +..+.|+.-.. 
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~--tLqn~pp~~~t-  254 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL--TLQNDPPTLLT-  254 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH--HhcCCCCCccc-
Confidence            44321     356899999999995 4445699999999999999999999999988776655433  33344432110 


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                                      ......-.+.++..++.+|..||++||.+||||.++|+|+||+.....
T Consensus       255 ----------------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  255 ----------------SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             ----------------ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence                            011111223467799999999999999999999999999999986554

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=365.51  Aligned_cols=278  Identities=27%  Similarity=0.433  Sum_probs=214.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeec-------chhhHHHHHHHHHhcCCCce----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPNV----------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~-------~~~~~~~E~~~l~~l~h~ni----------------  146 (395)
                      ..+|.++++||+|+||.|.+++.+.|++.||+|++.+       +...+..|..+|..-+.+-|                
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence            3579999999999999999999999999999998865       23455667777765543332                


Q ss_pred             ----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          147 ----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       147 ----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                                .+.....++++..+++|+..|+.||.-|| +.|+|||||||+|||||..|| |||+|||.|-.+..+.. 
T Consensus       154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH-~mgyVHRDiKPDNvLld~~GH-ikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH-SMGYVHRDIKPDNVLLDKSGH-IKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH-hccceeccCCcceeEecccCc-EeeccchhHHhcCCCCcE
Confidence                      11122347999999999999999999999 999999999999999999996 99999999987764433 


Q ss_pred             -ccccccccccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          216 -NISYICSRYYRAPELIF----GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       216 -~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                       ....+|||.|++||++.    +...|+..+||||+||++|||+.|..||...+-.+.+.+|+..-              
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk--------------  297 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK--------------  297 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh--------------
Confidence             33578999999999994    22458999999999999999999999999999999999998741              


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC---HHHHhcCCcccCCCCCCCCCCCCCCCCCCC----
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFDELRDPNARLPNGRPFPPLF----  363 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t---~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~----  363 (395)
                       ..+.||..          ..+|+.+++||.++++ +|+.|++   +.++.+||||.++.|.+.+...++.+|.+.    
T Consensus       298 -~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~D  365 (1317)
T KOG0612|consen  298 -ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDD  365 (1317)
T ss_pred             -hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCc
Confidence             22333321          2389999999999886 5789998   999999999999999877755544333322    


Q ss_pred             --CCChhhhccCCHHHHH-hhchHHHhhhCCCCCC
Q 016085          364 --NFKPQELKGASKELLS-KLIPEHARKQCPFLGF  395 (395)
Q Consensus       364 --~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  395 (395)
                        ||+..+-...-.+.+. ..-+.+...+.||+||
T Consensus       366 TsnFd~~~dd~~~~e~~p~~~~~~f~Gn~LPFIGf  400 (1317)
T KOG0612|consen  366 TSNFDVDEDDLRDAETFPPRIPKAFSGNHLPFIGF  400 (1317)
T ss_pred             cccccccccccchhhccCCCCCCCCcCCcCCeeee
Confidence              2321111111222332 2344566789999998

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.6e-43  Score=337.15  Aligned_cols=227  Identities=27%  Similarity=0.418  Sum_probs=186.6

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCC-cEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~-~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ...+|.+.+.||+|+||.||+|.+..++ ..||+|.+.+..       ....+|+.+++.++||||.             
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3457999999999999999999876655 689999886432       2345799999999999970             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                   +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....  
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~~~~~--  183 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ-SLNIVYRDLKPENLLLDKDG-FIKMTDFGFAKVVDT--  183 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEccCCCHHHEEECCCC-CEEEecCCCCeecCC--
Confidence                         1123456888899999999999999999 88999999999999999887 699999999976532  


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+....                 .
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-----------------~  245 (340)
T PTZ00426        184 RTYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-----------------I  245 (340)
T ss_pred             CcceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-----------------C
Confidence            234567899999999997754 8999999999999999999999998877665555544310                 0


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                                  .++..+++.+.+||++||+.||++|+     |+.++++||||.++.+.
T Consensus       246 ------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        246 ------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             ------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                        12344788999999999999999996     89999999999987654

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=317.26  Aligned_cols=232  Identities=23%  Similarity=0.410  Sum_probs=189.6

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh-------hHHHHHHHHHhc-CCCce-------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLL-DHPNV-------------  146 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~~l~~l-~h~ni-------------  146 (395)
                      ....+|.++++||+|+|++|.+++.++|.+.||+|+++++.-       ..+.|-.+.... +||.+             
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            344579999999999999999999999999999999876532       233455555443 56654             


Q ss_pred             -------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          147 -------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       147 -------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                   ...+.+.+++++++++|..+|+.||+||| ++|||+||||.+|+|||.+|| |||+|+|.|+.....
T Consensus       327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh-~rgiiyrdlkldnvlldaegh-ikltdygmcke~l~~  404 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLH-ERGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHh-hcCeeeeeccccceEEccCCc-eeecccchhhcCCCC
Confidence                         22355778999999999999999999999 899999999999999999996 999999999987554


Q ss_pred             -CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC-------CCCcHHHHHHHHHHhCCCCHHHHh
Q 016085          214 -EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFP-------GESGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       214 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~-------~~~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                       ..+.++||||+|+|||++.|.. |++++|||+|||+|+||+.|+.||.       ..+..+.+.+++-..         
T Consensus       405 gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek---------  474 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK---------  474 (593)
T ss_pred             CcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh---------
Confidence             4455788999999999998865 9999999999999999999999995       234445555544210         


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC------HHHHhcCCcccCCCCCC
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT------ALEACIHPFFDELRDPN  350 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t------~~e~l~hp~f~~~~~~~  350 (395)
                             .            ..++.++|-.+..+|+..|++||.+|+.      .+++..|+||+.+.|..
T Consensus       475 -------q------------iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~  526 (593)
T KOG0695|consen  475 -------Q------------IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL  526 (593)
T ss_pred             -------c------------ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence                   0            1245568889999999999999999974      57899999999988863

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.4e-42  Score=323.70  Aligned_cols=256  Identities=32%  Similarity=0.623  Sum_probs=203.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------------e
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      ++|.+.+.||.|+||.||+|++..+++.||+|.+....     ....+|+.+++.++|+||.                 +
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46999999999999999999999999999999886432     2345799999999999980                 0


Q ss_pred             ---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccc
Q 016085          149 ---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NIS  218 (395)
Q Consensus       149 ---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~  218 (395)
                               ......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++........ ...
T Consensus        86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~  163 (301)
T cd07873          86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH-RRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKTYSN  163 (301)
T ss_pred             cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCCCCCcccc
Confidence                     112345778889999999999999999 88999999999999999887 699999999876433221 223


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~  296 (395)
                      ..+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....|.....  .+.....
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (301)
T cd07873         164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY  243 (301)
T ss_pred             cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence            45688999999987766688999999999999999999999999988888888999888887766654321  1222222


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      +....... ......+++.+.+||.+||++||.+|+|+.|+++||||+.+...
T Consensus       244 ~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         244 PKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             CccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence            22211111 12334578899999999999999999999999999999887643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.6e-43  Score=335.29  Aligned_cols=231  Identities=26%  Similarity=0.444  Sum_probs=186.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|.+.+.||+|+||.||+|++..+++.||||++.+..       ....+|+.+++.++|+||.                 
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            5999999999999999999999999999999987542       2346799999999999971                 


Q ss_pred             ---------ee-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc-
Q 016085          148 ---------YS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-  216 (395)
Q Consensus       148 ---------~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~-  216 (395)
                               +. .....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++......... 
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH-QMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCCcee
Confidence                     00 11256888999999999999999999 88999999999999999887 6999999999876433322 


Q ss_pred             -ccccccccccccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          217 -ISYICSRYYRAPELIFG-----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       217 -~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                       ....||+.|+|||++.+     ...++.++|||||||++|+|++|+.||.+.+....+..++....             
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-------------  226 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR-------------  226 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence             23468999999999863     33478999999999999999999999988776666655543100             


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                        ...++          ....++..+.+||.+||+ ||.+|+|+.++++||||..+.+..
T Consensus       227 --~~~~~----------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~  273 (330)
T cd05601         227 --FLKFP----------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN  273 (330)
T ss_pred             --ccCCC----------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence              00111          112368999999999998 999999999999999999876543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-43  Score=325.96  Aligned_cols=222  Identities=27%  Similarity=0.447  Sum_probs=196.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCce-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNV-----------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni-----------------  146 (395)
                      .+|++.+.||+|.||+|-+|++...|+.||||.+++++       -...||++||..|+||||                 
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            47999999999999999999999999999999987653       345689999999999998                 


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                               .|+...+.+++..++.++.||..|+.|+| ..+++|||||.+|||||.++ .+||+|||++..+....-..
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCH-knrVvHRDLKLENILLD~N~-NiKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCH-KNRVVHRDLKLENILLDQNN-NIKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHh-hccceecccchhheeecCCC-CeeeeccchhhhhccccHHH
Confidence                     23345678999999999999999999999 88999999999999999988 49999999999888887788


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ++||+|-|.+||++.|.++-++.+|.|||||+||.|+.|..||.|.+....+.+|-..                 .+   
T Consensus       211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G-----------------aY---  270 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG-----------------AY---  270 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc-----------------cc---
Confidence            9999999999999999887799999999999999999999999999888777777541                 11   


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                                +.+..+.++..||+-||..||++|.|+.++-.|=|.+
T Consensus       271 ----------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  271 ----------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ----------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                      1223577899999999999999999999999997764

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=331.15  Aligned_cols=223  Identities=28%  Similarity=0.441  Sum_probs=186.5

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCce--------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNV--------------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni--------------------  146 (395)
                      .|+..+.||+|+||.||+|.+..+++.||||++.-+     ....++|+.+|..++++||                    
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            589999999999999999999999999999998533     3456789999999999998                    


Q ss_pred             ------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cccc
Q 016085          147 ------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISY  219 (395)
Q Consensus       147 ------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~  219 (395)
                            ........+.+..+..++.+++.||.||| ..+.+|||||+.|||+..++ .+||+|||.+........ ..++
T Consensus        94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH-~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLH-SEKKIHRDIKAANILLSESG-DVKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             cCcchhhhhccCCCCccceeeeehHHHHHHhhhhh-hcceecccccccceeEeccC-cEEEEecceeeeeechhhccccc
Confidence                  12233444588888899999999999999 88999999999999999987 699999999877654433 3678


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcc
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI  299 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (395)
                      +|||+|||||++.+. .|+.++||||||++.+||++|.+||.+......+..|-+.  .|                    
T Consensus       172 vGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~--~P--------------------  228 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS--AP--------------------  228 (467)
T ss_pred             cccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC--CC--------------------
Confidence            999999999999864 5999999999999999999999999887764444433221  00                    


Q ss_pred             cCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       300 ~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                            ..+...+++.+++|+..||.+||+.||+|.++|+|+|++.
T Consensus       229 ------P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  229 ------PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             ------CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence                  0122347899999999999999999999999999999976

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.1e-42  Score=335.50  Aligned_cols=230  Identities=27%  Similarity=0.396  Sum_probs=184.3

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|++.+.||+|+||+||+|++..+++.||||++.+..       ....+|+.++..++|+||.                 
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            6999999999999999999999999999999986532       2345799999999999971                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC----
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE----  214 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~----  214 (395)
                               +......+++..++.++.|++.||+||| +.||+||||||+|||++.++ .+||+|||+|+......    
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH-~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH-QLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecCCCHHHeEECCCC-CEEEeeccCcccccccccccc
Confidence                     1123456889999999999999999999 89999999999999999888 59999999987542210    


Q ss_pred             --------------------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 016085          215 --------------------------------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPG  262 (395)
Q Consensus       215 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  262 (395)
                                                      .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                            012357899999999997754 89999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCC---CCCHHHHhc
Q 016085          263 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL---RCTALEACI  339 (395)
Q Consensus       263 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~---R~t~~e~l~  339 (395)
                      .+..+....+......               ..+|.          ...+++++.+||.+|+. +|.+   ||++.|+++
T Consensus       239 ~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~  292 (363)
T cd05628         239 ETPQETYKKVMNWKET---------------LIFPP----------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT  292 (363)
T ss_pred             CCHHHHHHHHHcCcCc---------------ccCCC----------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence            8877666666542110               01111          01268899999999876 4554   579999999


Q ss_pred             CCcccCCCCCC
Q 016085          340 HPFFDELRDPN  350 (395)
Q Consensus       340 hp~f~~~~~~~  350 (395)
                      ||||+.+.+..
T Consensus       293 hp~f~~~~~~~  303 (363)
T cd05628         293 NPFFEGVDWEH  303 (363)
T ss_pred             CCCCCCCCHHH
Confidence            99999886643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.5e-43  Score=315.31  Aligned_cols=255  Identities=38%  Similarity=0.642  Sum_probs=199.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCC----cEEEEEEeecch------hhHHHHHHHHHhcCCCce--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETG----ETVAIKKVLQDK------RYKNRELQTMRLLDHPNV--------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~----~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni--------------  146 (395)
                      ..|++...||+|.||.||+|..++++    +.||||.++.++      ...-||+.+++.|+|+|+              
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            36999999999999999999655443    368999987653      334689999999999997              


Q ss_pred             -----------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC----CCceEEeecC
Q 016085          147 -----------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH----THQVKLCDFG  205 (395)
Q Consensus       147 -----------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~----~~~ikl~DFG  205 (395)
                                       +.......++...++.+++||+.|+.||| +.-|+||||||.|||+..+    | .|||+|||
T Consensus       104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH-~NWvlHRDLKPaNIlvmgdgperG-~VKIaDlG  181 (438)
T KOG0666|consen  104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH-SNWVLHRDLKPANILVMGDGPERG-RVKIADLG  181 (438)
T ss_pred             EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh-hhheeeccCCcceEEEeccCCccC-eeEeeccc
Confidence                             11122356788899999999999999999 7789999999999999766    5 79999999


Q ss_pred             CccccccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---------cHHHHHHH
Q 016085          206 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES---------GVDQLVEI  272 (395)
Q Consensus       206 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---------~~~~~~~i  272 (395)
                      +|+.+...-.    ....+.|..|+|||.++|...|+.++|+||+|||+.||+|-++.|.+..         ..+++.+|
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            9998754322    2245679999999999999999999999999999999999999997743         35799999


Q ss_pred             HHHhCCCCHHHHhhcC--CCCc----cccCCcccCCCccccc--CCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          273 IKVLGTPTREEIKCMN--PNYT----EFKFPQIKAHPWHKIF--HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       273 ~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~--~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                      ++++|.|+.+.|..+.  +.|.    .+.........+...+  .+.-++...+||.+||++||.+|+|+.++|+|+||.
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~  341 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT  341 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence            9999999999887543  2220    0111111110011111  122356699999999999999999999999999997


Q ss_pred             CCC
Q 016085          345 ELR  347 (395)
Q Consensus       345 ~~~  347 (395)
                      .-.
T Consensus       342 ~d~  344 (438)
T KOG0666|consen  342 EDP  344 (438)
T ss_pred             cCC
Confidence            753

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-41  Score=325.25  Aligned_cols=288  Identities=37%  Similarity=0.664  Sum_probs=214.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEee----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHYS----------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~~----------------  149 (395)
                      ++|.+.+.||+|+||.||+|++..+|+.||||.+...     .....+|+.+++.++|+||...                
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            4799999999999999999999999999999988532     1234569999999999997110                


Q ss_pred             -------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          150 -------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       150 -------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                                   .....+++..++.++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++........ 
T Consensus        85 lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH-~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~  162 (336)
T cd07849          85 IVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEHDH  162 (336)
T ss_pred             EEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEECCCC-CEEECcccceeeccccccc
Confidence                         11245788899999999999999999 88999999999999999887 699999999876533221 


Q ss_pred             ---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          216 ---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       216 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                         .....+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+...++.+..+.+........
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
T cd07849         163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA  242 (336)
T ss_pred             cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhh
Confidence               12346789999999876655589999999999999999999999999888888888888888887766543321110


Q ss_pred             cc---cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCChhh
Q 016085          293 EF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQE  369 (395)
Q Consensus       293 ~~---~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (395)
                      ..   ..+......+.. .....+.++.+||.+||+.||++|||+.++++||||..+.++........++    .++-++
T Consensus       243 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~----~~~~~~  317 (336)
T cd07849         243 RNYIKSLPFKPKVPWNK-LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPF----PFDFEL  317 (336)
T ss_pred             hhHHhhcCcCCcccHHH-HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCC----Chhhcc
Confidence            00   011111111111 1234688899999999999999999999999999999988764433332222    233333


Q ss_pred             hccCCHHHHHhhchHH
Q 016085          370 LKGASKELLSKLIPEH  385 (395)
Q Consensus       370 ~~~~~~~~~~~~~~~~  385 (395)
                      ....-++.+..++-++
T Consensus       318 ~~~~~~~~~~~~~~~~  333 (336)
T cd07849         318 FDDLPKEKLKELIFEE  333 (336)
T ss_pred             ccccCHHHHHHHHHHH
Confidence            4444455555554443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.9e-41  Score=318.13  Aligned_cols=250  Identities=35%  Similarity=0.565  Sum_probs=195.3

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE-----------------e
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+....      ....+|+.+++.++|+|+.                 +
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4899999999999999999999999999999886431      2345799999999999971                 0


Q ss_pred             ---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccc
Q 016085          149 ---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NIS  218 (395)
Q Consensus       149 ---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~  218 (395)
                               ......+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+++....... ...
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH-SHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCCCCcCC
Confidence                     112456889999999999999999999 88999999999999999887 699999999976533221 223


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..+++.|+|||.+.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....+......-....++
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            45688999999987766679999999999999999998877 56667777888888888887766554332111111111


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      .......-......+++++.+||++||+.||.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            1111111011234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-42  Score=334.20  Aligned_cols=229  Identities=30%  Similarity=0.465  Sum_probs=184.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|++.+.||+|+||.||+|++..+++.||||++.+..       ....+|+.+++.++|+||.                 
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            6999999999999999999999999999999986532       2345799999999999971                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC---
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---  215 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---  215 (395)
                               +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.......   
T Consensus        82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH-KLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEECCCC-CEEEeecccceeccccccccc
Confidence                     1122356889999999999999999999 88999999999999999888 699999999875422110   


Q ss_pred             ------------------------------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 016085          216 ------------------------------------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPL  259 (395)
Q Consensus       216 ------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  259 (395)
                                                          ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCCC
Confidence                                                11246899999999987654 89999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC---HHH
Q 016085          260 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALE  336 (395)
Q Consensus       260 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t---~~e  336 (395)
                      |.+.+..+....+.....               ...++.          ...+++.+.+||.+||. +|.+|++   +.+
T Consensus       239 f~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~  292 (364)
T cd05599         239 FCSDNPQETYRKIINWKE---------------TLQFPD----------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNE  292 (364)
T ss_pred             CCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence            998877666555543110               001111          11368999999999997 9999998   999


Q ss_pred             HhcCCcccCCCCC
Q 016085          337 ACIHPFFDELRDP  349 (395)
Q Consensus       337 ~l~hp~f~~~~~~  349 (395)
                      +++||||....+.
T Consensus       293 ll~h~~~~~~~~~  305 (364)
T cd05599         293 IKSHPFFKGVDWE  305 (364)
T ss_pred             HhcCCCcCCCCHH
Confidence            9999999887653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-42  Score=328.81  Aligned_cols=232  Identities=29%  Similarity=0.428  Sum_probs=188.5

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|++.+.||+|+||.||+|++..+++.||||++.+..       ....+|+.+++.++|+||.                 
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            6999999999999999999999999999999986532       2345799999999999971                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                               +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++.....  ....
T Consensus        82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~--~~~~  157 (333)
T cd05600          82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH-ELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT--YANS  157 (333)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc--ccCC
Confidence                     1122346788899999999999999999 88999999999999999887 699999999976533  3345


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......               ...+.
T Consensus       158 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------~~~~~  221 (333)
T cd05600         158 VVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET---------------LQRPV  221 (333)
T ss_pred             cccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc---------------ccCCC
Confidence            6789999999999776 4899999999999999999999999988776666555432110               00010


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      ..      .....++.++.+||.+||..+|.+|+++.++++||||..+.+.
T Consensus       222 ~~------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~  266 (333)
T cd05600         222 YD------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN  266 (333)
T ss_pred             CC------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence            00      0012468999999999999999999999999999999987553

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.5e-42  Score=333.09  Aligned_cols=232  Identities=27%  Similarity=0.421  Sum_probs=184.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceEe--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVHY--------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~~--------------  148 (395)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|+.+++.++|+||..              
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            34699999999999999999999999999999998642       223457999999999999810              


Q ss_pred             ---e--------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--
Q 016085          149 ---S--------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       149 ---~--------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                         .        .....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|........  
T Consensus       122 ~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH-~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         122 MEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH-SMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEECCCC-CEEEEecccceecccCCcee
Confidence               0        11235788889999999999999999 89999999999999999888 699999999987543221  


Q ss_pred             cccccccccccccccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          216 NISYICSRYYRAPELIFGAT---EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      ....+||+.|+|||++.+..   .++.++|||||||++|+|++|+.||.+.+....+..|+.....              
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~--------------  265 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS--------------  265 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc--------------
Confidence            23567899999999986532   3788999999999999999999999988776666665542110              


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCC--CCCHHHHhcCCcccCCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRD  348 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~e~l~hp~f~~~~~  348 (395)
                       ..++.          ...++..+.+||.+||+.++.+  |+|+.++++||||+...+
T Consensus       266 -~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         266 -LNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             -cCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence             11111          1236889999999999866544  889999999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-41  Score=333.32  Aligned_cols=230  Identities=29%  Similarity=0.445  Sum_probs=181.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .|++++.||+|+||+||+|++..+++.||||++.+..       ....+|+.+++.++|+||.                 
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            4999999999999999999999999999999986532       2345799999999999981                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC----
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE----  214 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~----  214 (395)
                               +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++......    
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH-~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH-KMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCcHHHEEECCCC-CEEEeeCcCCccccccccccc
Confidence                     1122356788899999999999999999 88999999999999999887 69999999975321000    


Q ss_pred             --------------------------------------------CcccccccccccccccccCCCCCCCcchHHHHHHHH
Q 016085          215 --------------------------------------------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVL  250 (395)
Q Consensus       215 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il  250 (395)
                                                                  ...+.+||+.|+|||++.+.. ++.++|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il  238 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVIL  238 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHH
Confidence                                                        012357899999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccC--CC
Q 016085          251 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY--SP  328 (395)
Q Consensus       251 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~--dP  328 (395)
                      |||++|+.||.+.+..+....+......               ..++          ....+++++.+||.+||..  +|
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~dli~~ll~~~~~~  293 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIP----------PQVKLSPEAVDLITKLCCSAEER  293 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCC----------CCCCCCHHHHHHHHHHccCcccc
Confidence            9999999999887766555554431100               0111          1123689999999997655  44


Q ss_pred             CCCCCHHHHhcCCcccCCCCC
Q 016085          329 NLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       329 ~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      ..|+++.++++||||..+.+.
T Consensus       294 ~~R~~~~~~l~hp~f~~~~~~  314 (381)
T cd05626         294 LGRNGADDIKAHPFFSEVDFS  314 (381)
T ss_pred             cCCCCHHHHhcCcccCCCChh
Confidence            459999999999999987653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.2e-42  Score=333.33  Aligned_cols=232  Identities=25%  Similarity=0.391  Sum_probs=186.6

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceEe--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVHY--------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~~--------------  148 (395)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++|+||..              
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            457999999999999999999999999999999986431       23457999999999999810              


Q ss_pred             ---e--------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--C
Q 016085          149 ---S--------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--P  215 (395)
Q Consensus       149 ---~--------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--~  215 (395)
                         .        .....+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++.......  .
T Consensus       122 ~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         122 MEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEcCCC-CEEEEeccceeeccCCCccc
Confidence               0        01235788889999999999999999 88999999999999999888 69999999997654322  1


Q ss_pred             cccccccccccccccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          216 NISYICSRYYRAPELIFGAT---EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      ....+||+.|+|||++.+..   .++.++|||||||++|+|++|+.||.+.+....+..|.....               
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------------  264 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN---------------  264 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC---------------
Confidence            23457899999999986532   378999999999999999999999998877666665543110               


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCC--CCCHHHHhcCCcccCCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRD  348 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~e~l~hp~f~~~~~  348 (395)
                      ...++.          ...++.++.+||.+||+.+|.+  |+|+.++++||||+...+
T Consensus       265 ~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         265 SLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             cCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence            011111          1236899999999999999988  999999999999987554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.9e-42  Score=326.69  Aligned_cols=226  Identities=28%  Similarity=0.396  Sum_probs=183.2

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh-------hHHHHHHHHHhcC-CCceE----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLLD-HPNVH----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~~l~~l~-h~ni~----------------  147 (395)
                      +|.+.+.||+|+||.||+|++..+++.||||++.+...       ....|..++..+. |++|.                
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            48999999999999999999999999999999875421       2235667777664 66651                


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-CCCc
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPN  216 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-~~~~  216 (395)
                                +......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCCCcc
Confidence                      0112346788889999999999999999 88999999999999999888 699999999975432 2223


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+....                    
T Consensus       159 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--------------------  217 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------------------  217 (323)
T ss_pred             ccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------------
Confidence            3567899999999997755 8999999999999999999999999887766666555410                    


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  349 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  349 (395)
                               ..++..++.++.+||.+||+.||.+|++     ..++++||||+.+.+.
T Consensus       218 ---------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         218 ---------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                     0123457899999999999999999997     4899999999987664

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-41  Score=330.78  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=184.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceE-----------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVH-----------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~-----------------------  147 (395)
                      .+|++.+.||+|+||.||+|++..+++.||+|+....  ....|+.+++.++|+||.                       
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l  143 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDL  143 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCcH
Confidence            4699999999999999999999999999999976443  234699999999999981                       


Q ss_pred             ---eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccccccccc
Q 016085          148 ---YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY  224 (395)
Q Consensus       148 ---~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~  224 (395)
                         .......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++............||+.
T Consensus       144 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~  221 (357)
T PHA03209        144 YTYLTKRSRPLPIDQALIIEKQILEGLRYLH-AQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVE  221 (357)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEEecCccccccccCccccccccccc
Confidence               0122456889999999999999999999 88999999999999999887 699999999976544444445678999


Q ss_pred             ccccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCc---------HHHHHHHHHHhCCCCHHHHhhcCCCCcc-
Q 016085          225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESG---------VDQLVEIIKVLGTPTREEIKCMNPNYTE-  293 (395)
Q Consensus       225 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~-  293 (395)
                      |+|||++.+.. ++.++|||||||++|||+++. ++|.+...         ...+..++..++..+............. 
T Consensus       222 y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  300 (357)
T PHA03209        222 TNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRG  300 (357)
T ss_pred             ccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHH
Confidence            99999997755 899999999999999999854 44443221         2344455555544332211000000000 


Q ss_pred             -ccCCcccCCCc---ccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          294 -FKFPQIKAHPW---HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       294 -~~~~~~~~~~~---~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                       .........++   ...-...++.++.+||.+||++||.+|||+.|+|+||||+++
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        301 FIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             HHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence             00000000000   011122467889999999999999999999999999999864

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-42  Score=335.55  Aligned_cols=229  Identities=29%  Similarity=0.448  Sum_probs=181.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|++.+.||+|+||.||+|++..+++.||||++.+..       ....+|+.+++.++|+||.                 
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            6999999999999999999999999999999986532       2345799999999999981                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC----
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE----  214 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~----  214 (395)
                               +......+++..++.++.|++.||+||| +.||+||||||+|||++.++ .+||+|||+++......    
T Consensus        82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH-~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH-KLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEECCCC-CEEEeeccccccccccccccc
Confidence                     0112356788899999999999999999 89999999999999999887 69999999986321100    


Q ss_pred             --------------------------------------------CcccccccccccccccccCCCCCCCcchHHHHHHHH
Q 016085          215 --------------------------------------------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVL  250 (395)
Q Consensus       215 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il  250 (395)
                                                                  .....+||+.|+|||++.+.. ++.++|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil  238 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIM  238 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchhh
Confidence                                                        001246899999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCC
Q 016085          251 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL  330 (395)
Q Consensus       251 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~  330 (395)
                      |||++|..||.+.+..+.+..+.....               ...++.          ...++.++.+||.+||+ +|.+
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli~~lL~-~~~~  292 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLIRRLIT-NAEN  292 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHHHHHhc-CHhh
Confidence            999999999988777666655543110               011111          11368899999999998 7777


Q ss_pred             C---CCHHHHhcCCcccCCCCC
Q 016085          331 R---CTALEACIHPFFDELRDP  349 (395)
Q Consensus       331 R---~t~~e~l~hp~f~~~~~~  349 (395)
                      |   +|+.++++||||..+.+.
T Consensus       293 r~~r~~~~~~l~hp~~~~~~~~  314 (377)
T cd05629         293 RLGRGGAHEIKSHPFFRGVDWD  314 (377)
T ss_pred             cCCCCCHHHHhcCCCcCCCCHH
Confidence            6   599999999999877553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-41  Score=325.43  Aligned_cols=226  Identities=28%  Similarity=0.422  Sum_probs=184.2

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCc-eE----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPN-VH----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~n-i~----------------  147 (395)
                      +|++.+.||+|+||.||+|++..+++.||||++.+..       .....|..++..+.|++ |.                
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4899999999999999999999999999999987532       23346888888888765 40                


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-CCCc
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPN  216 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-~~~~  216 (395)
                                +......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCCCce
Confidence                      0112345788889999999999999999 88999999999999999887 699999999875422 2223


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....                    
T Consensus       159 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--------------------  217 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--------------------  217 (324)
T ss_pred             eeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence            3567899999999997755 8999999999999999999999999887766665554310                    


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCH-----HHHhcCCcccCCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFDELRDP  349 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  349 (395)
                               ..++..++..+.+||++||..||.+|+++     .++++||||..+.+.
T Consensus       218 ---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~  266 (324)
T cd05587         218 ---------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE  266 (324)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                     01233478999999999999999999976     899999999987653

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.7e-42  Score=327.53  Aligned_cols=220  Identities=25%  Similarity=0.404  Sum_probs=179.3

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE----------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH----------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~----------------------  147 (395)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++|+||.                      
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999986532       2345789999999999971                      


Q ss_pred             ----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCccccccc
Q 016085          148 ----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICS  222 (395)
Q Consensus       148 ----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~gt  222 (395)
                          .......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++..... ......+||
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLH-SGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcccccccccCC
Confidence                0112346788899999999999999999 88999999999999999887 6999999998764322 222346789


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  302 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (395)
                      +.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...                 ..        
T Consensus       159 ~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~~--------  212 (328)
T cd05593         159 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------DI--------  212 (328)
T ss_pred             cCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------Cc--------
Confidence            9999999997654 899999999999999999999999877655444333210                 00        


Q ss_pred             CcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCC
Q 016085          303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  348 (395)
Q Consensus       303 ~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  348 (395)
                          .++..++.++.+||++||+.||++|+     ++.++++||||....+
T Consensus       213 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         213 ----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             ----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                12345789999999999999999997     8999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=324.86  Aligned_cols=218  Identities=32%  Similarity=0.508  Sum_probs=178.7

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE------------------------
Q 016085           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH------------------------  147 (395)
Q Consensus        99 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~------------------------  147 (395)
                      ||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++|+||.                        
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999999999999999986432       2334799999999999981                        


Q ss_pred             --eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccccccccc
Q 016085          148 --YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRY  224 (395)
Q Consensus       148 --~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~gt~~  224 (395)
                        +......+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++...... .....+||+.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLH-KFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccCCcc
Confidence              1123456888999999999999999999 89999999999999999888 69999999997643322 2334678999


Q ss_pred             ccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCc
Q 016085          225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW  304 (395)
Q Consensus       225 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (395)
                      |+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...                 ..          
T Consensus       159 y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~~----------  210 (312)
T cd05585         159 YLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------PL----------  210 (312)
T ss_pred             cCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------CC----------
Confidence            99999997754 899999999999999999999999887765555444321                 00          


Q ss_pred             ccccCCCCChhHHHHHHhhccCCCCCCC---CHHHHhcCCcccCCCC
Q 016085          305 HKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFFDELRD  348 (395)
Q Consensus       305 ~~~~~~~~s~~~~~ll~~~L~~dP~~R~---t~~e~l~hp~f~~~~~  348 (395)
                        .++..+++.+.+||.+||..||.+|+   ++.++++||||....+
T Consensus       211 --~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         211 --RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             --CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence              12345789999999999999999997   5899999999988643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-41  Score=333.63  Aligned_cols=229  Identities=28%  Similarity=0.453  Sum_probs=182.6

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .|+++++||+|+||.||+|++..+++.||||++.+..       ....+|+.+++.++|+||.                 
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5999999999999999999999999999999986532       2445799999999999980                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-----
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-----  213 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-----  213 (395)
                               +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|......     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH-~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH-KMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEEeECCCCccccccccccc
Confidence                     1112345788899999999999999999 88999999999999999888 5999999997532100     


Q ss_pred             -------------------------------------------CCcccccccccccccccccCCCCCCCcchHHHHHHHH
Q 016085          214 -------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVL  250 (395)
Q Consensus       214 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il  250 (395)
                                                                 ......+||+.|+|||++.+.. ++.++|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil  238 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVIL  238 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHH
Confidence                                                       0012346899999999997755 89999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCC
Q 016085          251 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL  330 (395)
Q Consensus       251 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~  330 (395)
                      |||++|++||.+.+..+....+......               ..++          ....+++++.+||.+|+ .+|.+
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~~li~~l~-~~p~~  292 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIP----------PQAKLSPEASDLIIKLC-RGPED  292 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCC----------CcccCCHHHHHHHHHHc-cCHhH
Confidence            9999999999987766655554431100               0011          11347899999999986 59999


Q ss_pred             CCC---HHHHhcCCcccCCCCC
Q 016085          331 RCT---ALEACIHPFFDELRDP  349 (395)
Q Consensus       331 R~t---~~e~l~hp~f~~~~~~  349 (395)
                      |++   +.++++||||+.+.+.
T Consensus       293 R~~~~~~~ei~~hp~f~~~~~~  314 (382)
T cd05625         293 RLGKNGADEIKAHPFFKTIDFS  314 (382)
T ss_pred             cCCCCCHHHHhcCCCcCCcChH
Confidence            997   9999999999887553

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-41  Score=326.21  Aligned_cols=221  Identities=30%  Similarity=0.507  Sum_probs=179.5

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc-CCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~ni~---------------------  147 (395)
                      +.||+|+||.||+|+++.+++.||||++.+..       ....+|..++..+ +|+||.                     
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999986532       2234677777765 699971                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCcccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~g  221 (395)
                           +......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..... .......|
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH-~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLH-DKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCCCccccccc
Confidence                 1123456888999999999999999999 89999999999999999888 6999999998764322 22334678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...                 ..       
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-----------------~~-------  213 (320)
T cd05590         159 TPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-----------------EV-------  213 (320)
T ss_pred             CccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------CC-------
Confidence            99999999997654 899999999999999999999999988776665555431                 00       


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCH------HHHhcCCcccCCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFDELRDP  349 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~------~e~l~hp~f~~~~~~  349 (395)
                           .++..++.++.+||++||+.||.+|+++      .++++||||..+.+.
T Consensus       214 -----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~  262 (320)
T cd05590         214 -----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE  262 (320)
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence                 1223478899999999999999999998      899999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=317.63  Aligned_cols=268  Identities=30%  Similarity=0.555  Sum_probs=202.3

Q ss_pred             CCcccceEEeecCCCCCCCccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhH---HHHHHHHHhcCC--
Q 016085           69 GTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDH--  143 (395)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~---~~E~~~l~~l~h--  143 (395)
                      +...|+++......      ...+|.+++.+|+|.||+|..+.|.+++..||||+++.-....   .-|+++|+++++  
T Consensus        73 dD~dGH~v~~~gD~------l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~D  146 (415)
T KOG0671|consen   73 DDKDGHYVYQVGDI------LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESD  146 (415)
T ss_pred             CCCCceEEEEeccc------cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcC
Confidence            44557676654322      2457999999999999999999999999999999987654433   348888888843  


Q ss_pred             Cc-------------------e------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE
Q 016085          144 PN-------------------V------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV  192 (395)
Q Consensus       144 ~n-------------------i------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill  192 (395)
                      |+                   |            .-.....+++..+++.+++|++.+++||| +.+++|-||||+|||+
T Consensus       147 P~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh-~~kl~HTDLKPENILf  225 (415)
T KOG0671|consen  147 PNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH-DLKLTHTDLKPENILF  225 (415)
T ss_pred             CCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH-hcceeecCCChheEEE
Confidence            22                   1            11234567899999999999999999999 8899999999999997


Q ss_pred             cC--------------------CCCceEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHH
Q 016085          193 NP--------------------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAE  252 (395)
Q Consensus       193 ~~--------------------~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~e  252 (395)
                      .+                    +. .|+|+|||.|...  .+.....+.|.+|+|||++++-. ++.++||||+||||+|
T Consensus       226 vss~~~~~~~~k~~~~~~r~~ks~-~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~E  301 (415)
T KOG0671|consen  226 VSSEYFKTYNPKKKVCFIRPLKST-AIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVE  301 (415)
T ss_pred             eccceEEEeccCCccceeccCCCc-ceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEE
Confidence            21                    22 4999999999775  34446778899999999999866 9999999999999999


Q ss_pred             HHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc-CCCCcc---ccCCcccC-----------CCcccccCC--CCChh
Q 016085          253 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTE---FKFPQIKA-----------HPWHKIFHK--RMPPE  315 (395)
Q Consensus       253 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~-----------~~~~~~~~~--~~s~~  315 (395)
                      |+||..+|++.++.+++..+..++|..+...+... ...|..   ...+....           .++...+..  .....
T Consensus       302 lytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~  381 (415)
T KOG0671|consen  302 LYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ  381 (415)
T ss_pred             eeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence            99999999999999999888888997666555443 111110   01111000           000111100  11235


Q ss_pred             HHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          316 AVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       316 ~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      +.|||++||.+||.+|+|+.|+|.||||+.+.
T Consensus       382 LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  382 LFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             HHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            89999999999999999999999999998764

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-41  Score=325.70  Aligned_cols=221  Identities=27%  Similarity=0.417  Sum_probs=180.7

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE----------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH----------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~----------------------  147 (395)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||.                      
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999986532       2234699999999999981                      


Q ss_pred             ----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccccccc
Q 016085          148 ----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICS  222 (395)
Q Consensus       148 ----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~gt  222 (395)
                          +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...... ......||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCCccccccCC
Confidence                0112345788999999999999999999 88999999999999999887 69999999987643222 22346789


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  302 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (395)
                      +.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...                 ..        
T Consensus       159 ~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~~--------  212 (323)
T cd05595         159 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------EI--------  212 (323)
T ss_pred             cCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------CC--------
Confidence            9999999997654 899999999999999999999999887765554444321                 00        


Q ss_pred             CcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       303 ~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                          .++..+++.+.+||.+||+.||.+|+     ++.++++|+||....+.
T Consensus       213 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~  260 (323)
T cd05595         213 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  260 (323)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence                12345789999999999999999998     89999999999887653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=319.75  Aligned_cols=231  Identities=28%  Similarity=0.410  Sum_probs=194.7

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhh-------HHHHHHHHHhcCCCce--------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-------KNRELQTMRLLDHPNV--------------  146 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~~l~~l~h~ni--------------  146 (395)
                      ....+|..+.+||+|+||+|.+|..+.+.+.||||+++++.-.       ...|-++|.....|-.              
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            3445799999999999999999999999999999998765311       1235555554443321              


Q ss_pred             -------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          147 -------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       147 -------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                   ..+++.+++.+..+.+|+.+|+-||=||| ++|||+||||.+||+|+.+|| |||+|||+|+....+
T Consensus       426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh-~kgIiYRDLKLDNvmLd~eGH-iKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIFD  503 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh-cCCeeeeeccccceEeccCCc-eEeeecccccccccC
Confidence                         12345678999999999999999999999 899999999999999999996 999999999986544


Q ss_pred             -CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          214 -EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       214 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                       ..+.+++|||.|+|||++.-++ |+.++||||+||+||||+.|++||.|.+..+.++.|++..                
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn----------------  566 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN----------------  566 (683)
T ss_pred             CcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc----------------
Confidence             4455789999999999997655 9999999999999999999999999999999999998741                


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCH-----HHHhcCCcccCCCCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFDELRDPN  350 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~~  350 (395)
                                   -.+++.+|.++.++++..|...|.+|+..     .++..||||+.+.|..
T Consensus       567 -------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  567 -------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             -------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence                         12566799999999999999999999864     5789999999998863

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-41  Score=329.46  Aligned_cols=255  Identities=23%  Similarity=0.329  Sum_probs=191.1

Q ss_pred             ccceeeeeeeccCCceEEEEEEEc--CCCcEEEEEEeecchhhHHHHHHHHHhcCCCceEe-------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCL--ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHY-------------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~--~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~~-------------------  148 (395)
                      ..+|.+.+.||+|+||.||+|...  .+++.||+|.+... ....+|+.+|+.++|+||..                   
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  169 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK  169 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence            347999999999999999999764  45678999988654 34468999999999999810                   


Q ss_pred             ------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC---cccc
Q 016085          149 ------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISY  219 (395)
Q Consensus       149 ------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---~~~~  219 (395)
                            ......+++..++.++.||+.||.||| ++||+||||||+|||++.++ .++|+|||++........   ....
T Consensus       170 ~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH-~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~~~~~~~~~  247 (392)
T PHA03207        170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH-GRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHPDTPQCYGW  247 (392)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEcCCC-CEEEccCccccccCccccccccccc
Confidence                  123456889999999999999999999 88999999999999999887 699999999976543322   2245


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCCHHHHhhcCC----CCc
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCMNP----NYT  292 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~----~~~  292 (395)
                      .||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+..   ....+..+.+.++..+.+.......    .+.
T Consensus       248 ~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  326 (392)
T PHA03207        248 SGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFK  326 (392)
T ss_pred             ccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHH
Confidence            7899999999997654 8999999999999999999999997643   4566777777766544321110000    000


Q ss_pred             cccCCcccCCCcccc-cCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          293 EFKFPQIKAHPWHKI-FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~-~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      .+.........+... ....++.++.+||.+||.+||++|||+.|+|+||||.+...
T Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        327 QYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             hhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence            011000000011111 11245778999999999999999999999999999977543

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.5e-41  Score=323.22  Aligned_cols=220  Identities=29%  Similarity=0.472  Sum_probs=179.3

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc-CCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~ni~---------------------  147 (395)
                      +.||+|+||+||+|++..+++.||||++.+..       ....+|..+++.+ +|+||.                     
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999987542       2334688888877 699981                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCcccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~g  221 (395)
                           .......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..... ......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH-ERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCCCcccceec
Confidence                 0112346889999999999999999999 88999999999999999887 6999999998754222 22334578


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+.......+...                 .        
T Consensus       159 ~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------~--------  212 (318)
T cd05570         159 TPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------E--------  212 (318)
T ss_pred             CccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------C--------
Confidence            99999999997755 899999999999999999999999887765554444321                 0        


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCH-----HHHhcCCcccCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFDELRD  348 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~  348 (395)
                          ..++..++..+.+||.+||+.||.+|+|+     .++++||||..+.+
T Consensus       213 ----~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         213 ----VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             ----CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                01233478999999999999999999999     99999999988765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.4e-41  Score=323.14  Aligned_cols=220  Identities=30%  Similarity=0.501  Sum_probs=175.8

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHh-cCCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~-l~h~ni~---------------------  147 (395)
                      ++||+|+||.||+|+++.+|+.||+|++.+..       .....|..++.. ++|+||.                     
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999999999999999987542       223457777765 4899871                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCcccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~g  221 (395)
                           +......+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++..... ......+|
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH-SKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCCCceeccCC
Confidence                 0112346788899999999999999999 88999999999999999887 6999999998754222 22345678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...  .                  +    
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~------------------~----  213 (316)
T cd05620         159 TPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--T------------------P----  213 (316)
T ss_pred             CcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C------------------C----
Confidence            99999999997754 899999999999999999999999887765544443221  0                  0    


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCH-HHHhcCCcccCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-LEACIHPFFDELRD  348 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-~e~l~hp~f~~~~~  348 (395)
                           .++..++.++.+||.+||..||++|+++ .++++||||..+.+
T Consensus       214 -----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         214 -----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence                 1223368899999999999999999998 58889999988765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.3e-41  Score=319.18  Aligned_cols=245  Identities=32%  Similarity=0.546  Sum_probs=182.7

Q ss_pred             eeeccCCceEEEEEEEcC--CCcEEEEEEeecch--hhHHHHHHHHHhcCCCceEee-----------------------
Q 016085           97 RVVGQGSFGIVFQAKCLE--TGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVHYS-----------------------  149 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~--~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~ni~~~-----------------------  149 (395)
                      .+||+|+||.||+|++..  ++..||+|.+....  ....+|+.+++.++|+||...                       
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l   86 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDL   86 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCcH
Confidence            589999999999999654  56889999886542  345689999999999998100                       


Q ss_pred             -------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc----CCCCceEEeecCCcccccc
Q 016085          150 -------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       150 -------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~----~~~~~ikl~DFG~a~~~~~  212 (395)
                                   .....+++..++.++.||+.||.||| +.||+||||||+|||+.    .++ .+||+|||+++....
T Consensus        87 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~~~~~  164 (317)
T cd07867          87 WHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNS  164 (317)
T ss_pred             HHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH-hCCEEcCCCCHHHEEEccCCCCCC-cEEEeeccceeccCC
Confidence                         01124678888999999999999999 88999999999999993    334 699999999986543


Q ss_pred             CC----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHHhCCC
Q 016085          213 GE----PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG---------VDQLVEIIKVLGTP  279 (395)
Q Consensus       213 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~~~~  279 (395)
                      ..    ......+|+.|+|||++.+...++.++|||||||++|+|+||++||.....         ..++..+...++.+
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07867         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP  244 (317)
T ss_pred             CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence            22    123456799999999997766689999999999999999999999975432         35677788888887


Q ss_pred             CHHHHhhcCC--CCcccc----CCcccCCC---cccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          280 TREEIKCMNP--NYTEFK----FPQIKAHP---WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       280 ~~~~~~~~~~--~~~~~~----~~~~~~~~---~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ....|.....  .+....    ........   .........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             ChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            7766643221  110000    00000000   0011122346679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.6e-41  Score=328.89  Aligned_cols=232  Identities=27%  Similarity=0.397  Sum_probs=183.6

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceEe--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVHY--------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~~--------------  148 (395)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|+.+++.++|+||..              
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            35799999999999999999999999999999998642       123457899999999999710              


Q ss_pred             ---e--------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--
Q 016085          149 ---S--------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       149 ---~--------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                         .        .....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+++.......  
T Consensus       122 ~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~~~~~~~~~  199 (371)
T cd05622         122 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVR  199 (371)
T ss_pred             EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH-HCCEEeCCCCHHHEEECCCC-CEEEEeCCceeEcCcCCccc
Confidence               0        11235788889999999999999999 89999999999999999888 599999999986543221  


Q ss_pred             cccccccccccccccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          216 NISYICSRYYRAPELIFGAT---EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      ....+||+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......|+....               
T Consensus       200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------  264 (371)
T cd05622         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN---------------  264 (371)
T ss_pred             ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence            23567899999999986532   378999999999999999999999998877666665543211               


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCC--CCCHHHHhcCCcccCCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRD  348 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~e~l~hp~f~~~~~  348 (395)
                      ...++          ....++..+.+||.+||..++.+  |+++.++++|+||.+..+
T Consensus       265 ~~~~~----------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         265 SLTFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             cccCC----------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence            01111          11247899999999999844433  779999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3e-41  Score=323.46  Aligned_cols=225  Identities=27%  Similarity=0.425  Sum_probs=182.2

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHH---HhcCCCceEe--------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTM---RLLDHPNVHY--------------  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l---~~l~h~ni~~--------------  148 (395)
                      |++.+.||+|+||.||+|++..+++.||||++.+..       ....+|++++   +.++|+||..              
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            788999999999999999999999999999986532       2233455554   5668999710              


Q ss_pred             -----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCc
Q 016085          149 -----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPN  216 (395)
Q Consensus       149 -----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~  216 (395)
                                 ......+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++..... ...
T Consensus        81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH-~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLH-ENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCCCCcc
Confidence                       012346889999999999999999999 88999999999999999888 6999999998754322 223


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...+||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....                    
T Consensus       159 ~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--------------------  217 (324)
T cd05589         159 STFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--------------------  217 (324)
T ss_pred             cccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------------
Confidence            3567899999999997654 8999999999999999999999999887766655554310                    


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                               ..++..++..+.+||.+||+.||.+|+     ++.++++||||..+.+.
T Consensus       218 ---------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         218 ---------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence                     012344789999999999999999999     69999999999887543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1e-40  Score=313.08  Aligned_cols=248  Identities=35%  Similarity=0.660  Sum_probs=194.5

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------e
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      +|++.+.||+|+||.||+|++..+++.||||.+...      .....+|+.+++.++|+|+.                 +
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            489999999999999999999999999999987532      13456799999999999980                 0


Q ss_pred             -----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-c
Q 016085          149 -----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-N  216 (395)
Q Consensus       149 -----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~  216 (395)
                                 ......+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++........ .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH-SRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCcccc
Confidence                       011245788999999999999999999 88999999999999999887 699999999876532211 2


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccc
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEF  294 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~  294 (395)
                      ....+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+.+..+...++.+....|.....  ++.. 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN-  237 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh-
Confidence            2345688999999987666678999999999999999999999999888888888888877776655532211  1100 


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      .++....... ......+++++.+||++||+.||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         238 TFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            0111111111 11233478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-40  Score=320.34  Aligned_cols=288  Identities=38%  Similarity=0.664  Sum_probs=217.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      .+|.+.+.||+|+||.||+|++..+++.||||.+...      .....+|+.+++.++|+||..                
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            3699999999999999999999999999999987542      223457999999999999811                


Q ss_pred             --------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-
Q 016085          149 --------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  213 (395)
Q Consensus       149 --------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-  213 (395)
                                    ......+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||+++..... 
T Consensus        85 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          85 YIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH-SANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCC-CEEECcCccccccCCCc
Confidence                          012356789999999999999999999 88999999999999999887 6999999999765433 


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC-c
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY-T  292 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~  292 (395)
                      .......++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+....+.+....+....... .
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence            222345678899999998654458999999999999999999999999988888888888888888776553222110 0


Q ss_pred             cc--cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCChhhh
Q 016085          293 EF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQEL  370 (395)
Q Consensus       293 ~~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (395)
                      .+  ..+......+ ......+++++.+||++||+.||++|||+.++++||||..+.++......  +.+..+++...+ 
T Consensus       243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~--~~~~~~~~~~~~-  318 (337)
T cd07858         243 RYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVC--QTPFSFDFEEDA-  318 (337)
T ss_pred             HHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccC--CCccchhhhhhh-
Confidence            00  0011111111 11234578999999999999999999999999999999998887654322  223334444333 


Q ss_pred             ccCCHHHHHhhchHHH
Q 016085          371 KGASKELLSKLIPEHA  386 (395)
Q Consensus       371 ~~~~~~~~~~~~~~~~  386 (395)
                        .+++.+..++-.++
T Consensus       319 --~~~~~~~~~~~~~~  332 (337)
T cd07858         319 --LTEEDIKELIYNEM  332 (337)
T ss_pred             --cCHHHHHHHHHHHH
Confidence              56666666555443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-41  Score=315.64  Aligned_cols=230  Identities=24%  Similarity=0.387  Sum_probs=185.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .|++.++||+|+||.||++.+..+++.||+|++....       ....+|+.+++.++|+||.                 
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3899999999999999999999999999999986432       2345799999999999981                 


Q ss_pred             e-----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          148 Y-----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 ~-----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                      +           ......+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH-RERIVYRDLKPENILLDDYG-HIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCHHHEEECCCC-CEEEeeCCCceecCCCCcc
Confidence            0           011245788999999999999999999 88999999999999999877 6999999999876444444


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....||+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+.......+.......                 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  220 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED-----------------  220 (285)
T ss_pred             ccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc-----------------
Confidence            4567899999999997654 8999999999999999999999998766544333333211000                 


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                              ...++..++..+.+||.+||..||.+|+     ++.++++||||....+.
T Consensus       221 --------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         221 --------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             --------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence                    0012334788999999999999999999     89999999999886554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2e-41  Score=331.30  Aligned_cols=228  Identities=27%  Similarity=0.418  Sum_probs=181.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|++++.||+|+||.||+|++..+++.||||++.+.       .....+|+.+|+.++|+||.                 
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            599999999999999999999999999999998643       23345799999999999981                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-----
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-----  213 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-----  213 (395)
                               +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|......     
T Consensus        82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH-KMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHEEECCCC-CEEEEeCCCCccccccccccc
Confidence                     1122345788889999999999999999 88999999999999999887 6999999997532100     


Q ss_pred             ---------------------------------------CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHH
Q 016085          214 ---------------------------------------EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL  254 (395)
Q Consensus       214 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  254 (395)
                                                             ......+||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyell  238 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEML  238 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeehh
Confidence                                                   0011347899999999997654 899999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC--
Q 016085          255 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC--  332 (395)
Q Consensus       255 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~--  332 (395)
                      +|+.||.+.+..+....+.....               ...++          ....+++.+.+||.+|+ .+|.+|+  
T Consensus       239 ~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~----------~~~~~s~~~~~li~~l~-~~p~~R~~~  292 (376)
T cd05598         239 VGQPPFLADTPAETQLKVINWET---------------TLHIP----------SQAKLSREASDLILRLC-CGAEDRLGK  292 (376)
T ss_pred             hCCCCCCCCCHHHHHHHHhccCc---------------cccCC----------CCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence            99999998776655544432100               00000          11247899999999976 5999999  


Q ss_pred             -CHHHHhcCCcccCCCC
Q 016085          333 -TALEACIHPFFDELRD  348 (395)
Q Consensus       333 -t~~e~l~hp~f~~~~~  348 (395)
                       |+.++++||||+.+..
T Consensus       293 ~t~~ell~h~~~~~~~~  309 (376)
T cd05598         293 NGADEIKAHPFFKGIDF  309 (376)
T ss_pred             CCHHHHhCCCCcCCCCH
Confidence             9999999999988654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.9e-40  Score=320.42  Aligned_cols=234  Identities=27%  Similarity=0.360  Sum_probs=180.4

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe---------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY---------------  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~---------------  148 (395)
                      ...+|.+.+.||+|+||.||+|++..+++.||||++...     .....+|+.+++.++|+||..               
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            345799999999999999999999999999999998543     234568999999999999810               


Q ss_pred             --e-----ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccccc
Q 016085          149 --S-----RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYI  220 (395)
Q Consensus       149 --~-----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~  220 (395)
                        .     .......+..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...... ......
T Consensus       152 e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~  229 (353)
T PLN00034        152 EFMDGGSLEGTHIADEQFLADVARQILSGIAYLH-RRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSV  229 (353)
T ss_pred             ecCCCCcccccccCCHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCC-CEEEcccccceecccccccccccc
Confidence              0     11223567778889999999999999 88999999999999999887 69999999998654332 223567


Q ss_pred             ccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          221 CSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       221 gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ||..|+|||.+..    ....+.++|||||||++|+|++|+.||......+....+.......                 
T Consensus       230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  292 (353)
T PLN00034        230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-----------------  292 (353)
T ss_pred             cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-----------------
Confidence            8999999998743    1234678999999999999999999997433222211111110000                 


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                              .......++.++.+||.+||+.||++|||+.|+++||||..-...
T Consensus       293 --------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        293 --------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             --------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence                    001233478899999999999999999999999999999886443

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.6e-41  Score=324.87  Aligned_cols=230  Identities=30%  Similarity=0.437  Sum_probs=179.8

Q ss_pred             ceeeeeeeccCCceEEEEEEEc---CCCcEEEEEEeecch--------hhHHHHHHHHHhcC-CCceE------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLLD-HPNVH------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~--------~~~~~E~~~l~~l~-h~ni~------------  147 (395)
                      +|++.+.||+|+||.||+|++.   .+++.||+|++.+..        ....+|+.+++.++ |+||.            
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4899999999999999999864   578999999986432        23456899999994 88871            


Q ss_pred             --------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 --------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 --------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                    +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~~~  158 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH-KLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCHHHeEECCCC-CEEEeeCcCCcccccc
Confidence                          0112356888999999999999999999 88999999999999999888 6999999999765333


Q ss_pred             C--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          214 E--PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       214 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      .  .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||...........+......             
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------------  225 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-------------  225 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-------------
Confidence            2  2234678999999999977655889999999999999999999999754322211111111000             


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  348 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  348 (395)
                                  ....++..+++.+.+||.+||+.||++|+     ++.++++||||+...+
T Consensus       226 ------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         226 ------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             ------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                        00113345789999999999999999999     7889999999998755

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.8e-41  Score=325.14  Aligned_cols=222  Identities=28%  Similarity=0.418  Sum_probs=179.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE----------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH----------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~----------------------  147 (395)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|+++++.++|+||.                      
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999986532       2334688999999999970                      


Q ss_pred             ----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCccccccc
Q 016085          148 ----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICS  222 (395)
Q Consensus       148 ----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~gt  222 (395)
                          +......+++..++.++.||+.||.|||+..||+||||||+|||++.++ .+||+|||+++..... .......||
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCcccccccCC
Confidence                0112346788999999999999999999337999999999999999887 6999999998764322 223346789


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  302 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (395)
                      +.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...                 ..        
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~~--------  213 (325)
T cd05594         160 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------EI--------  213 (325)
T ss_pred             cccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------CC--------
Confidence            9999999997654 899999999999999999999999887665544443221                 00        


Q ss_pred             CcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       303 ~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                          .++..+++++.+||.+||++||++|+     ++.++++||||..+.+.
T Consensus       214 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         214 ----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence                12344789999999999999999997     89999999999987554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.4e-41  Score=322.46  Aligned_cols=252  Identities=32%  Similarity=0.564  Sum_probs=200.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhH---HHHHHHHHhcCC------------------Cc-e--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDH------------------PN-V--  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~---~~E~~~l~~l~h------------------~n-i--  146 (395)
                      .+|.|....|+|-||+|.+|.|...|..||||+|.++....   .+|++||++|+.                  .| +  
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl  511 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL  511 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence            47999999999999999999999999999999998775433   478888888742                  22 1  


Q ss_pred             Ee-------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          147 HY-------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       147 ~~-------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                      .+             ....-.+....++.|+.|++.||..|- .+||+|.||||+|||++...+.+||||||.|.....+
T Consensus       512 VFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK-~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en  590 (752)
T KOG0670|consen  512 VFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK-KCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN  590 (752)
T ss_pred             EehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH-hcCeeecccCccceEeccCcceeeeccCccccccccc
Confidence            11             122345677788999999999999999 9999999999999999998889999999999887655


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-----
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-----  288 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-----  288 (395)
                      + .+.+..+..|.|||+++|.+ |+...|+||+||+||||+||+..|+|.++++++...+.+-|..+...++...     
T Consensus       591 e-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqH  668 (752)
T KOG0670|consen  591 E-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQH  668 (752)
T ss_pred             c-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhh
Confidence            4 45677899999999999977 9999999999999999999999999999999999999999988877664211     


Q ss_pred             ----CCCccccCCcccCCCccccc----C-----------CCCC-------hhHHHHHHhhccCCCCCCCCHHHHhcCCc
Q 016085          289 ----PNYTEFKFPQIKAHPWHKIF----H-----------KRMP-------PEAVDLVSRLLQYSPNLRCTALEACIHPF  342 (395)
Q Consensus       289 ----~~~~~~~~~~~~~~~~~~~~----~-----------~~~s-------~~~~~ll~~~L~~dP~~R~t~~e~l~hp~  342 (395)
                          -+|.......+........+    +           ..++       ..+.+||.+||..||++|.|..++|.|||
T Consensus       669 FD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpF  748 (752)
T KOG0670|consen  669 FDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPF  748 (752)
T ss_pred             cccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCc
Confidence                12222222222221111110    0           0122       35899999999999999999999999999


Q ss_pred             ccC
Q 016085          343 FDE  345 (395)
Q Consensus       343 f~~  345 (395)
                      |+.
T Consensus       749 i~~  751 (752)
T KOG0670|consen  749 ITE  751 (752)
T ss_pred             ccC
Confidence            964

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-42  Score=304.14  Aligned_cols=253  Identities=33%  Similarity=0.535  Sum_probs=207.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--h----hhHHHHHHHHHhcCCCce-------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--K----RYKNRELQTMRLLDHPNV-------------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~----~~~~~E~~~l~~l~h~ni-------------------  146 (395)
                      .|.-..+||+|.||.||+|+.+++|+.||+|++.-+  +    ....+|+++|..|+|+|+                   
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            588889999999999999999999999999976432  1    234589999999999997                   


Q ss_pred             ---------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          147 ---------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       147 ---------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                                     .+.....+++..++..++.+++.||.|+| +..|+|||+|++|+||+.++ .+||+|||+++.+.
T Consensus        98 t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH-r~kilHRDmKaaNvLIt~dg-ilklADFGlar~fs  175 (376)
T KOG0669|consen   98 TFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH-RNKILHRDMKAANVLITKDG-ILKLADFGLARAFS  175 (376)
T ss_pred             eeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH-HhhHHhhcccHhhEEEcCCc-eEEeecccccccee
Confidence                           22334468899999999999999999999 88999999999999999988 79999999997765


Q ss_pred             cCCC-----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 016085          212 KGEP-----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       212 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  286 (395)
                      ....     .+..+.|..|++||.++|...|+.+.|||..||||.||+||.+.|.+.+...++..|....|..+.+.|..
T Consensus       176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~  255 (376)
T KOG0669|consen  176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN  255 (376)
T ss_pred             cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence            4322     23456699999999999999999999999999999999999999999999999999999999999888865


Q ss_pred             cC--CCCccccCCcccCCCcc---ccc-CCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          287 MN--PNYTEFKFPQIKAHPWH---KIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       287 ~~--~~~~~~~~~~~~~~~~~---~~~-~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      +.  +-|...+.+.+.....+   ... +---.+++.||+.++|.+||.+|+++.++|+|.||..-
T Consensus       256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence            43  12233322222222111   111 11125689999999999999999999999999999653

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-40  Score=319.40  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=183.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      ++|++.+.||+|+||.||+|++..++..||+|.+...     .....+|+++|+.++|+||.                  
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            4799999999999999999999999999999988643     23456899999999999981                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY  219 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~  219 (395)
                              +......+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++...... .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~~~~~  162 (331)
T cd06649          85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MANSF  162 (331)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccccccc-ccccC
Confidence                    1112345788889999999999999999434799999999999999887 6999999999765432 23456


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh----hcCCCCcc--
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK----CMNPNYTE--  293 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----~~~~~~~~--  293 (395)
                      .||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+. ..+   ++.+......    ........  
T Consensus       163 ~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         163 VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EAI---FGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             CCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH---hcccccccccCCccccCccccccc
Confidence            7899999999997754 89999999999999999999999977654332 222   2221110000    00000000  


Q ss_pred             -----ccCC------------cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          294 -----FKFP------------QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       294 -----~~~~------------~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                           ....            .+............+++++.+||.+||++||++|||+.++++||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                 0000            00000000011224688999999999999999999999999999997643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.5e-40  Score=320.90  Aligned_cols=258  Identities=33%  Similarity=0.582  Sum_probs=200.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEeec--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYSR--------------  150 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~~--------------  150 (395)
                      .+|++.+.||+|+||.||+|++..+++.||||.+.+.      .....+|+.+++.++|+||....              
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            4799999999999999999999999999999988542      12344799999999999972100              


Q ss_pred             ---------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          151 ---------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       151 ---------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                     ....+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||+++.......
T Consensus        96 ~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH-~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~  173 (353)
T cd07850          96 VYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFM  173 (353)
T ss_pred             EEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEECCCC-CEEEccCccceeCCCCCC
Confidence                           0113677788889999999999999 88999999999999999888 699999999987644433


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc-
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-  294 (395)
                      .....+|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+...++.|+.+...........+ 
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (353)
T cd07850         174 MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYV  252 (353)
T ss_pred             CCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHh
Confidence            34456789999999997754 8999999999999999999999999998888899999999988776544322111100 


Q ss_pred             -cCCcccCCCcccc------------cCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 016085          295 -KFPQIKAHPWHKI------------FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  351 (395)
Q Consensus       295 -~~~~~~~~~~~~~------------~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  351 (395)
                       ..+......+...            .....+..+.+||.+||++||++|||+.|+|.||||+.+.++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~  322 (353)
T cd07850         253 ENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE  322 (353)
T ss_pred             hcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence             0000000011111            02234667999999999999999999999999999987666543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.8e-41  Score=320.63  Aligned_cols=221  Identities=29%  Similarity=0.470  Sum_probs=179.5

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc-CCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~ni~---------------------  147 (395)
                      ++||+|+||.||+|++..+++.||||++.+..       .....|.+++..+ +|+||.                     
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999987542       2234577888765 799970                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCcccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~g  221 (395)
                           .......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..... .......|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH-RHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCC-CEEEeecccceecccCCcccccccc
Confidence                 1122346788889999999999999999 88999999999999999888 6999999998764322 22334678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...                 ..       
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-----------------~~-------  213 (321)
T cd05591         159 TPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-----------------DV-------  213 (321)
T ss_pred             CccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------CC-------
Confidence            99999999987654 899999999999999999999999988876666655431                 00       


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCC-------CHHHHhcCCcccCCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-------TALEACIHPFFDELRDP  349 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-------t~~e~l~hp~f~~~~~~  349 (395)
                           .++..++.++.+||.+||+.||++|+       ++.++++||||..+.+.
T Consensus       214 -----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         214 -----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             -----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence                 12233688999999999999999999       89999999999887653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.5e-40  Score=313.73  Aligned_cols=257  Identities=35%  Similarity=0.563  Sum_probs=200.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEe---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHY---------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~---------------  148 (395)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++|+|+..               
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            347999999999999999999999999999999886332      12347999999999999710               


Q ss_pred             -------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-
Q 016085          149 -------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-  214 (395)
Q Consensus       149 -------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-  214 (395)
                                   ......+++..+..++.||+.||.||| +.|++||||||+||+++.++ .+||+|||++....... 
T Consensus        86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH-ENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLPAK  163 (309)
T ss_pred             EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEECccceeeecCCccC
Confidence                         001245788888999999999999999 88999999999999999887 69999999998764332 


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NYT  292 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~  292 (395)
                      ......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+.....  ...
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence            222334578899999987766689999999999999999999999999999999999999888887665532211  111


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      .+..+......+... ....++.+.+||.+||++||++|||+.+++.||||.+..-+
T Consensus       244 ~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         244 KFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            111111111111111 12258899999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.6e-41  Score=326.31  Aligned_cols=230  Identities=27%  Similarity=0.413  Sum_probs=184.3

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|++.+.||+|+||.||+|+++.+++.||||++....       ....+|+.++..++|+||.                 
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            5999999999999999999999999999999986432       2345799999999999981                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC----
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE----  214 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~----  214 (395)
                               +......+++..++.++.|++.||+||| +.||+||||||+|||++.++ .+||+|||+++......    
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH-~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH-QLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEccCCCHHHEEECCCC-CEEEeeccCCccccccccccc
Confidence                     1123456889999999999999999999 89999999999999999888 69999999987542110    


Q ss_pred             --------------------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 016085          215 --------------------------------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPG  262 (395)
Q Consensus       215 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  262 (395)
                                                      .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCCC
Confidence                                            012357899999999997755 89999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC---CHHHHhc
Q 016085          263 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEACI  339 (395)
Q Consensus       263 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~---t~~e~l~  339 (395)
                      .+.......++....               ...++.          ...+++++.+||.+|+ .||.+|+   ++.++++
T Consensus       239 ~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         239 ETPQETYRKVMNWKE---------------TLVFPP----------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCHHHHHHHHHcCCC---------------ceecCC----------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            877666655543110               001110          0126889999999987 4999998   4799999


Q ss_pred             CCcccCCCCCC
Q 016085          340 HPFFDELRDPN  350 (395)
Q Consensus       340 hp~f~~~~~~~  350 (395)
                      ||||+.+.+..
T Consensus       293 hp~f~~~~~~~  303 (360)
T cd05627         293 HPFFEGVDWGH  303 (360)
T ss_pred             CCCCCCCCHHH
Confidence            99999987643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-40  Score=329.11  Aligned_cols=249  Identities=27%  Similarity=0.366  Sum_probs=183.5

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceEe---------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHY---------------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~~---------------------  148 (395)
                      ...|.+.+.||+|+||.||+|++..+++.||||....  ....+|+++|+.|+|+||..                     
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~  245 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD  245 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCC
Confidence            4479999999999999999999999999999996432  23458999999999999810                     


Q ss_pred             -----eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC---ccccc
Q 016085          149 -----SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYI  220 (395)
Q Consensus       149 -----~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---~~~~~  220 (395)
                           ......+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+++.......   .....
T Consensus       246 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~  323 (461)
T PHA03211        246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIH-GEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIA  323 (461)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCEEECcCCHHHEEECCCC-CEEEcccCCceecccccccccccccC
Confidence                 011245889999999999999999999 88999999999999999887 699999999976533221   12356


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC-CCC------CcHHHHHHHHHHhCCCCHHH--------Hh
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF-PGE------SGVDQLVEIIKVLGTPTREE--------IK  285 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~------~~~~~~~~i~~~~~~~~~~~--------~~  285 (395)
                      ||+.|+|||++.+.. ++.++|||||||+||||++|..++ ...      ....++.+++...+......        ..
T Consensus       324 GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~  402 (461)
T PHA03211        324 GTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVS  402 (461)
T ss_pred             CCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHH
Confidence            899999999997755 899999999999999999987554 322      12345556655543321110        00


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      ...........+......|...  ..++.++.+||.+||++||.+|||+.|+|+||||+.
T Consensus       403 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        403 QYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            0000000001111111122221  135778999999999999999999999999999964

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4e-40  Score=316.99  Aligned_cols=273  Identities=37%  Similarity=0.689  Sum_probs=212.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEe----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      .+|.+.+.||.|+||.||+|.+..+++.||+|++....      ....+|+.+++.++|+||..                
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            46999999999999999999999999999999886431      23457999999999999711                


Q ss_pred             -------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 -------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 -------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                   ......+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++........
T Consensus        85 lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          85 VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH-SANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-cEEecccccceeecccCc
Confidence                         112456899999999999999999999 88999999999999999888 699999999976543221


Q ss_pred             -----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          216 -----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       216 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                           .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+...++..+....|.|+...+......
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence                 123467889999999866555899999999999999999999999999988899999999998887665432211


Q ss_pred             Cccc---cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCCh
Q 016085          291 YTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKP  367 (395)
Q Consensus       291 ~~~~---~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  367 (395)
                      ....   .++......+.. +....+.++.+||.+||+.+|.+|||+.+++.||||.....+....    ...+.++++-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~  317 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEP----TCPPPFDFDF  317 (334)
T ss_pred             hHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccc----cCCCCCCCCh
Confidence            1000   111111112211 2234689999999999999999999999999999999887765432    2234455555


Q ss_pred             hhh
Q 016085          368 QEL  370 (395)
Q Consensus       368 ~~~  370 (395)
                      +..
T Consensus       318 ~~~  320 (334)
T cd07855         318 EAI  320 (334)
T ss_pred             hhh
Confidence            444

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-40  Score=319.30  Aligned_cols=220  Identities=30%  Similarity=0.489  Sum_probs=178.3

Q ss_pred             eeeccCCceEEEEEEEc---CCCcEEEEEEeecch--------hhHHHHHHHHHhcCCCceE------------------
Q 016085           97 RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~--------~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      +.||+|+||.||+|++.   .+++.||+|++....        ....+|+.+|+.++|+||.                  
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999864   478899999986432        2235799999999999981                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNIS  218 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~  218 (395)
                              .......+.+..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..... .....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~  159 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH-QQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGTVTHT  159 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCCcccc
Confidence                    0112345678888899999999999999 88999999999999999887 6999999998754332 22334


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      ..||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+...                 ..    
T Consensus       160 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-----------------~~----  217 (323)
T cd05584         160 FCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-----------------KL----  217 (323)
T ss_pred             cCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------CC----
Confidence            67899999999997654 899999999999999999999999887766555554431                 00    


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCC
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  348 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  348 (395)
                              .++..+++.+.+||++||+.||++|+     ++.++++||||....+
T Consensus       218 --------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         218 --------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             --------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                    12344789999999999999999999     8999999999987644

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.9e-40  Score=311.32  Aligned_cols=223  Identities=24%  Similarity=0.360  Sum_probs=176.8

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------e------
Q 016085           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------Y------  148 (395)
Q Consensus        99 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------~------  148 (395)
                      ||+|+||+||+|.+..+++.||+|.+.+..       .....|+.+++.++|+||.                 +      
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999999999999999986432       2234699999999999971                 0      


Q ss_pred             -------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccccc
Q 016085          149 -------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYI  220 (395)
Q Consensus       149 -------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~~  220 (395)
                             ......+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++........ .....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH-QRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCccccccC
Confidence                   012345788999999999999999999 88999999999999999877 699999999976544322 23457


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      ||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||...........+.......                     
T Consensus       159 g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------------  216 (280)
T cd05608         159 GTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND---------------------  216 (280)
T ss_pred             CCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc---------------------
Confidence            899999999997754 8999999999999999999999997654332222222110000                     


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                          ...++..++..+.+|+.+||+.||++|+     |+.++++||||+.+.+.
T Consensus       217 ----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         217 ----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             ----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence                0012344789999999999999999999     88999999999987665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6e-41  Score=321.27  Aligned_cols=220  Identities=29%  Similarity=0.459  Sum_probs=176.3

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecchh-------hHHHHH-HHHHhcCCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNREL-QTMRLLDHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~-~~l~~l~h~ni~---------------------  147 (395)
                      +.||+|+||+||+|++..+|+.||||++.+...       ...+|. .+++.++|+||.                     
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            479999999999999999999999999865321       112333 356789999981                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~g  221 (395)
                           +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++...... .....+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH-SLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCCCccccccC
Confidence                 1122346788899999999999999999 88999999999999999887 69999999987643322 2334578


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...   +                      
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~----------------------  212 (323)
T cd05575         159 TPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P----------------------  212 (323)
T ss_pred             ChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C----------------------
Confidence            99999999997754 899999999999999999999999887765555554431   0                      


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCH----HHHhcCCcccCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFDELRD  348 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~e~l~hp~f~~~~~  348 (395)
                          ..++..++..+.+||.+||+.||.+|+++    .++++||||..+.+
T Consensus       213 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         213 ----LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence                01233468999999999999999999987    69999999988765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-40  Score=319.46  Aligned_cols=222  Identities=24%  Similarity=0.445  Sum_probs=175.5

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc-CCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~ni~---------------------  147 (395)
                      ++||+|+||.||+|++..+++.||||++++..       ....+|..+++.+ +|+||.                     
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999999999999999997532       2345788888888 799981                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-CCCcccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-~~~~~~~~g  221 (395)
                           +......+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++.... .......+|
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLH-ERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEECCCC-CEEECcCccccccccCCCccccccC
Confidence                 1122457899999999999999999999 88999999999999999887 699999999975322 223345678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      |+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.....        .+.+.+.+..                ..
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----------------~~  221 (329)
T cd05588         159 TPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE----------------KQ  221 (329)
T ss_pred             CccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc----------------CC
Confidence            99999999997754 89999999999999999999999963211        1111111110                00


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC------HHHHhcCCcccCCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT------ALEACIHPFFDELRDP  349 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t------~~e~l~hp~f~~~~~~  349 (395)
                                  ..++..++..+.+||++||+.||.+|+|      +.++++||||..+.+.
T Consensus       222 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~  271 (329)
T cd05588         222 ------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD  271 (329)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence                        0123457899999999999999999987      7899999999887653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2e-40  Score=316.79  Aligned_cols=220  Identities=31%  Similarity=0.506  Sum_probs=176.0

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHh-cCCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~-l~h~ni~---------------------  147 (395)
                      ++||+|+||.||+|++..+++.||||+++...       .....|..++.. .+|+||.                     
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999987542       122345566654 4899981                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~g  221 (395)
                           +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...... .....+|
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLH-KKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCCCccccccC
Confidence                 0112356888899999999999999999 88999999999999999887 69999999997653322 2334678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....                         
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------------------------  212 (316)
T cd05592         159 TPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR-------------------------  212 (316)
T ss_pred             CccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence            99999999997755 8999999999999999999999999887665555443210                         


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCH-HHHhcCCcccCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-LEACIHPFFDELRD  348 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-~e~l~hp~f~~~~~  348 (395)
                          ..++..++.++.+||.+||+.||.+|+++ .++++||||..+.+
T Consensus       213 ----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         213 ----PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence                01233478899999999999999999986 48889999988755

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.8e-40  Score=315.73  Aligned_cols=221  Identities=29%  Similarity=0.516  Sum_probs=176.8

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHh-cCCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~-l~h~ni~---------------------  147 (395)
                      +.||+|+||.||+|++..+++.||||++....       .....|..++.. ++||||.                     
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999987542       223356777765 5899971                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCcccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~g  221 (395)
                           +......+++..+..++.|++.||+||| +.||+||||||+|||++.++ .+||+|||+++..... .......|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH-~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH-SKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCCCceeeecC
Confidence                 0112346788889999999999999999 88999999999999999887 6999999998754322 22345678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...  .                       
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~-----------------------  212 (316)
T cd05619         159 TPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--N-----------------------  212 (316)
T ss_pred             CccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C-----------------------
Confidence            99999999997654 899999999999999999999999887765544443221  0                       


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHH-HHhcCCcccCCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL-EACIHPFFDELRDP  349 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~-e~l~hp~f~~~~~~  349 (395)
                          ..++..++.++.+||.+||+.||++|+++. ++++||||..+.+.
T Consensus       213 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         213 ----PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             ----CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence                012233688999999999999999999996 89999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.9e-40  Score=316.56  Aligned_cols=225  Identities=28%  Similarity=0.417  Sum_probs=182.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCC-ceE----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHP-NVH----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~-ni~----------------  147 (395)
                      +|.+.+.||+|+||.||+|+++.+++.||||++.+..       .....|..+++.+.|+ +|.                
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3788999999999999999999999999999987542       2234678888887654 440                


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cc
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PN  216 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~  216 (395)
                                +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH-~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH-RRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCCccc
Confidence                      0112356889999999999999999999 88999999999999999888 59999999987643222 23


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+....                 .  
T Consensus       159 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------------~--  218 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------------V--  218 (323)
T ss_pred             cCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------C--
Confidence            3456899999999997654 8999999999999999999999999887766666555410                 0  


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRD  348 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  348 (395)
                                .++..++.++.+|+.+||+.||.+|++     ..++++||||..+.+
T Consensus       219 ----------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         219 ----------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             ----------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence                      123347889999999999999999997     478999999998765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=298.06  Aligned_cols=255  Identities=37%  Similarity=0.588  Sum_probs=206.2

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCce-------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNV-------------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni-------------------  146 (395)
                      +-.-.+-||.|+||.||.++|.++|+.||+|++..-      ....-+|+++|..++|.|+                   
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            345557899999999999999999999999988542      2334589999999999997                   


Q ss_pred             -----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          147 -----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       147 -----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                 ..+...+.++.++++.+.+||+.||.||| +.||+||||||.|+|+++++ .+||||||+|+.....+.
T Consensus       134 V~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH-sA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  134 VLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH-TANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHh-hcchhhccCCCccEEeccCc-eEEecccccccccchhhh
Confidence                       33455678899999999999999999999 88999999999999999998 799999999987644332


Q ss_pred             --cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          216 --NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       216 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                        .+..+.|.+|+|||++.|...|+.++||||+|||+.||+.++..|...+..+++..|...+|+|+.+.++........
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence              344567999999999999999999999999999999999999999999999999999999999999988754432221


Q ss_pred             ccCCcccCCCc---cccc--CCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          294 FKFPQIKAHPW---HKIF--HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       294 ~~~~~~~~~~~---~~~~--~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      .-.......+-   ...+  +..-..+..+++.++|.+||.+|.+.++++.|++..+.+-
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL  351 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence            11100000000   0001  1122347889999999999999999999999999987654

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.6e-40  Score=310.29  Aligned_cols=229  Identities=26%  Similarity=0.420  Sum_probs=180.9

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------e
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      |++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+|+.                 +
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            788899999999999999999999999999885431       2344699999999999971                 0


Q ss_pred             e-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          149 S-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       149 ~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                      .           .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++..........
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-QERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQTIK  159 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCcccc
Confidence            0           11235788888999999999999999 89999999999999999887 69999999987654444334


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ...||..|+|||++.+.. ++.++||||+||++|+|++|+.||.+................                   
T Consensus       160 ~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-------------------  219 (285)
T cd05630         160 GRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-------------------  219 (285)
T ss_pred             CCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-------------------
Confidence            457899999999997655 899999999999999999999999765432111111110000                   


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  349 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  349 (395)
                            ....++..+++++.+||.+||+.||++|+|     +.|+++||||..+.+.
T Consensus       220 ------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         220 ------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             ------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence                  000123346889999999999999999999     9999999999886553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-39  Score=313.18  Aligned_cols=259  Identities=39%  Similarity=0.711  Sum_probs=206.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      +|++.+.||.|+||.||+|++..+++.||||.+....      ....+|+.+++.++|+||.                  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4899999999999999999999999999999886532      3456799999999999970                  


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-  214 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-  214 (395)
                                  .......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .++|+|||++....... 
T Consensus        81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH-~~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH-SANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEcccCceEeeccccc
Confidence                        0112236788888999999999999999 88999999999999999887 69999999998765443 


Q ss_pred             ---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          215 ---PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       215 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                         ......+|+.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+.+..++...+.+....+.......
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence               23345678999999999876468999999999999999999999999999999999999999988876654221110


Q ss_pred             -ccc--cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCC
Q 016085          292 -TEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL  353 (395)
Q Consensus       292 -~~~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~  353 (395)
                       ..+  ..+......+.. ....++..+.+||.+||+++|.+|||+.+++.||||+.+..+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~  302 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSK-LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEP  302 (330)
T ss_pred             hhhHHhhcccCCcchhHH-hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCC
Confidence             000  011111111111 2334789999999999999999999999999999999988765443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-39  Score=305.99  Aligned_cols=250  Identities=42%  Similarity=0.775  Sum_probs=200.8

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE-----------------e
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      +|++.+.||.|+||.||+|++..+|+.||+|++....      ....+|+.+++.++|+|+.                 +
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4899999999999999999999999999999986432      3456899999999999970                 0


Q ss_pred             ---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--cc
Q 016085          149 ---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--NI  217 (395)
Q Consensus       149 ---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--~~  217 (395)
                               ......+++..++.++.||+.||+||| +.||+|+||||+||+++.++ .++|+|||++........  ..
T Consensus        81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH-ANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCcCHHHEEEcCCC-cEEEeeeeecccccCCCCCccc
Confidence                     012345788899999999999999999 88999999999999999877 699999999877644321  23


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCcccc
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFK  295 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~  295 (395)
                      ...++..|+|||.+.+...++.++||||+||++|+|++|.+||.+.+....+..+....+.+....+....  .++....
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            45678999999998766667999999999999999999999999988888899999988888776665432  1222222


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                      ++......+.. ...+.+..+.+||.+||.+||++|||+.++++||||.
T Consensus       239 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         239 FPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            22222222221 2234678999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-40  Score=315.01  Aligned_cols=232  Identities=28%  Similarity=0.433  Sum_probs=182.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++|+||.                 
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            6999999999999999999999999999999986421       2345788999999999970                 


Q ss_pred             e---------e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc-
Q 016085          148 Y---------S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-  216 (395)
Q Consensus       148 ~---------~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~-  216 (395)
                      +         . .....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||++......... 
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH-QLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCCCcc
Confidence            0         1 11346788999999999999999999 89999999999999999888 6999999998765433222 


Q ss_pred             -ccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          217 -ISYICSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       217 -~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                       ...+||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+.+..+....+.....              
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~--------------  225 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--------------  225 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence             22468999999999863    23478899999999999999999999988776665555543110              


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCC--CCCHHHHhcCCcccCCCCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRDP  349 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~  349 (395)
                       .+.++.         ....++..+.+||++||+.++++  |+++.++++||||..+.+.
T Consensus       226 -~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~  275 (331)
T cd05597         226 -HFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD  275 (331)
T ss_pred             -cccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence             000110         11237899999999999765544  7899999999999887654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.7e-41  Score=290.07  Aligned_cols=258  Identities=31%  Similarity=0.627  Sum_probs=212.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-hhhHHHHHHHHHhcC-CCceE--------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVH--------------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~-h~ni~--------------------  147 (395)
                      .++|.+.+++|+|-|+.||.|.+..+++.++||+++.- +....||+.||+.|. |+||.                    
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~  116 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY  116 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence            45799999999999999999999999999999998764 345679999999997 99981                    


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS  222 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt  222 (395)
                           +..-...++...++.++.|++.||.|+| +.||.|||+||.|++||.....++|+|+|+|.+...+......+.+
T Consensus       117 v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCH-S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVAS  195 (338)
T KOG0668|consen  117 VNNTDFKQLYPTLTDYDIRYYIYELLKALDYCH-SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS  195 (338)
T ss_pred             hccccHHHHhhhhchhhHHHHHHHHHHHHhHHH-hcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeeh
Confidence                 2222356777788999999999999999 8999999999999999988778999999999998777766677789


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHHH-Hh----hcCCCCccccC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF-PGESGVDQLVEIIKVLGTPTREE-IK----CMNPNYTEFKF  296 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~-~~----~~~~~~~~~~~  296 (395)
                      ++|--||.+.....|+.+-|+|||||+|..|++.+-|| .|.++.+++.+|.+++|+-.... +.    .+++.|... .
T Consensus       196 RyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i-~  274 (338)
T KOG0668|consen  196 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDI-L  274 (338)
T ss_pred             hhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhH-h
Confidence            99999999988888999999999999999999988775 78889999999999999743211 11    122333321 1


Q ss_pred             CcccCCCcccccCC----CCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          297 PQIKAHPWHKIFHK----RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       297 ~~~~~~~~~~~~~~----~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      ....+.+|..+++.    -+++++.|||.++|.+|-.+|+||.|++.||||..+...
T Consensus       275 ~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  275 GRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             hccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence            22334455555543    256899999999999999999999999999999877654

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.7e-39  Score=313.75  Aligned_cols=258  Identities=31%  Similarity=0.541  Sum_probs=195.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceEeec----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVHYSR----------------  150 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~~~~----------------  150 (395)
                      .+|.+.+.||.|+||.||+|++..+++.||+|.+...    .....+|+.+++.++|+||....                
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            4799999999999999999999999999999988543    23456799999999999972100                


Q ss_pred             ----------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcc
Q 016085          151 ----------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  208 (395)
Q Consensus       151 ----------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~  208 (395)
                                            ....+++..++.++.||+.||.||| +.||+||||||+||+++.++..+||+|||+++
T Consensus        85 ~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~givH~dikp~Nili~~~~~~~kl~dfg~~~  163 (342)
T cd07854          85 LTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH-SANVLHRDLKPANVFINTEDLVLKIGDFGLAR  163 (342)
T ss_pred             ccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEcCCCceEEECCcccce
Confidence                                  1235788899999999999999999 88999999999999998666579999999987


Q ss_pred             ccccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          209 VLVKGEP----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       209 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                      .......    .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+......+.....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07854         164 IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR  243 (342)
T ss_pred             ecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            6432111    122356889999998866556889999999999999999999999998888877777766555444322


Q ss_pred             hhcCCCCccccC--CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          285 KCMNPNYTEFKF--PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       285 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                      ............  ......+. ..+...++.++.+||.+||+.||.+|||+.++++||||+.+..+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~  310 (342)
T cd07854         244 NELLNVIPSFVRNDGGEPRRPL-RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF  310 (342)
T ss_pred             hhhhhhhhhhhhhcccccCCCH-HHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence            211110000000  00001111 112335788999999999999999999999999999999876554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.8e-40  Score=331.20  Aligned_cols=226  Identities=27%  Similarity=0.367  Sum_probs=184.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEee---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYS---------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~---------------  149 (395)
                      .+|.+.+.||+|+||+||+|++..+++.||||++...      .....+|+.++..++|+|+...               
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            4799999999999999999999999999999998543      2334578899999999886210               


Q ss_pred             -----------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCC
Q 016085          150 -----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  206 (395)
Q Consensus       150 -----------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~  206 (395)
                                             .....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH-~~~IiHrDLKP~NILl~~~~-~vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH-SKHMIHRDIKSANILLCSNG-LVKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence                                   01234678888999999999999999 88999999999999999887 699999999


Q ss_pred             ccccccC---CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 016085          207 AKVLVKG---EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  283 (395)
Q Consensus       207 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  283 (395)
                      ++.....   ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....       
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-------  261 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-------  261 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-------
Confidence            9765332   1223467899999999997754 8999999999999999999999998877655554443210       


Q ss_pred             HhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          284 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                             +              ..++..+++++.+||.+||+.||.+||++.++++|||++.+.
T Consensus       262 -------~--------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        262 -------Y--------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             -------C--------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                   0              013345789999999999999999999999999999987643

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.2e-40  Score=308.63  Aligned_cols=251  Identities=37%  Similarity=0.623  Sum_probs=200.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEee---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHYS---------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~~---------------  149 (395)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.++...      ....+|+.+++.++|+||...               
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46999999999999999999999999999999886432      123479999999999998110               


Q ss_pred             -------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CC
Q 016085          150 -------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP  215 (395)
Q Consensus       150 -------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~  215 (395)
                                   .....+++..++.++.||+.||+||| +.||+||||||+||+++.++ .++|+|||++...... ..
T Consensus        85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH-DNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHHHEEECCCC-cEEEeecCceeeccCCccc
Confidence                         01234788899999999999999999 88999999999999999887 6999999999876543 22


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCcc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NYTE  293 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~  293 (395)
                      .....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+..++...+.|....|.....  ....
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
T cd07843         163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK  242 (293)
T ss_pred             cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence            23456788999999987665578999999999999999999999999998888999999888888776653221  1111


Q ss_pred             ccCCcccCCCcccccCCC-CChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          294 FKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ..........+...++.. +++.+.+||++||+.||++|||+.|++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            111112222233334444 68899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.5e-39  Score=303.68  Aligned_cols=250  Identities=35%  Similarity=0.654  Sum_probs=192.2

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      +|++.+.||+|+||.||+|++..+++.||+|++....      ....+|+.+++.++|+|+.                  
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            6999999999999999999999999999999875432      2345799999999999971                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNIS  218 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~  218 (395)
                              .......+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++....... ....
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH-KHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCChhhEEEcCCC-cEEECccccceecCCCcccccC
Confidence                    0112346889999999999999999999 89999999999999999887 69999999998764433 2234


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCccccC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~  296 (395)
                      ..++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+.+..+....+...........  ..+.....
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            5678899999998775558899999999999999999999999888877777777665544332211111  00111111


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      +..............++..+.+||.+||+.||++|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            11110000011123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.9e-40  Score=315.87  Aligned_cols=221  Identities=25%  Similarity=0.456  Sum_probs=173.4

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc-CCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~ni~---------------------  147 (395)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|+.++..+ +|+||.                     
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999987532       2234677777766 899970                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-CCCcccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-~~~~~~~~g  221 (395)
                           +......+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++.... ........|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCCCccccccC
Confidence                 0122356889999999999999999999 88999999999999999888 599999999976432 222345678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--------cHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES--------GVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      |+.|+|||++.+.. ++.++|||||||++|+|++|+.||....        ....+...+..                ..
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~----------------~~  221 (329)
T cd05618         159 TPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----------------KQ  221 (329)
T ss_pred             CccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc----------------CC
Confidence            99999999997754 8999999999999999999999995311        11111111110                00


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC------HHHHhcCCcccCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT------ALEACIHPFFDELRD  348 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t------~~e~l~hp~f~~~~~  348 (395)
                                  ..++..++..+.+||.+||+.||.+|+|      ..++++||||..+.+
T Consensus       222 ------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         222 ------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                        0134457899999999999999999998      579999999988755

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-39  Score=304.76  Aligned_cols=248  Identities=38%  Similarity=0.701  Sum_probs=194.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCce-----------------Ee
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV-----------------HY  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni-----------------~~  148 (395)
                      +|++.+.||.|+||.||+|++..+++.||||.+....      ....+|+++++.++|+||                 .+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            3899999999999999999999999999999885432      245679999999999997                 01


Q ss_pred             e----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cc
Q 016085          149 S----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NI  217 (395)
Q Consensus       149 ~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~  217 (395)
                      .          .....+++..+..++.|++.||+||| +.|++||||+|+||+++.++ .+||+|||++........ ..
T Consensus        81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCccccc
Confidence            1          11345788899999999999999999 88999999999999999887 699999999876533221 22


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCcccc
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFK  295 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~  295 (395)
                      ...++..|+|||.+.+...++.++|||||||++|+|+||+.||.+.+..+.+.++.+..+.+....+.....  .+.. .
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  237 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP-S  237 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh-h
Confidence            345688899999987765578999999999999999999999999888888888888888776554322110  0000 1


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ++......... ....++.++.+||.+||+.||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         238 FPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            11111111111 123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.5e-39  Score=304.61  Aligned_cols=247  Identities=38%  Similarity=0.650  Sum_probs=193.5

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcC-CCceEe------------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVHY------------------  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~-h~ni~~------------------  148 (395)
                      |++.+.||+|+||.||+|.+..+++.||+|++.+..     ....+|+.+++++. |+|+..                  
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            788999999999999999999999999999886532     12236888888885 999710                  


Q ss_pred             -e---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          149 -S---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       149 -~---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                       .         .....+++..++.++.|++.||.||| +.||+||||||+||+++. + .+||+|||+++..........
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~~~~~~~  157 (282)
T cd07831          81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH-RNGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYSKPPYTE  157 (282)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCceecccCHHHEEEcC-C-CeEEEecccccccccCCCcCC
Confidence             0         01245788899999999999999999 889999999999999998 5 699999999987654444445


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC-CccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-YTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~  297 (395)
                      ..++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+........... ...+.++
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP  237 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence            567899999998755455789999999999999999999999999988888888888888776543322111 1111222


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ......+ ..+...++..+.+||.+||.+||++|||+.++++||||
T Consensus       238 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         238 SKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            2111111 11233578999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.2e-40  Score=317.58  Aligned_cols=220  Identities=30%  Similarity=0.470  Sum_probs=176.1

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHH-HHHHhcCCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNREL-QTMRLLDHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~-~~l~~l~h~ni~---------------------  147 (395)
                      +.||+|+||+||+|++..+|+.||+|++.+..       ....+|. .+++.++|+||.                     
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999986532       1122333 356789999971                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCcccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~g  221 (395)
                           +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++..... ......+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH-~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH-SINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCCCCcccccC
Confidence                 1122456889999999999999999999 88999999999999999888 6999999998754322 22345678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...                 .        
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----------------~--------  212 (325)
T cd05604         159 TPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----------------P--------  212 (325)
T ss_pred             ChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------C--------
Confidence            99999999997754 899999999999999999999999887766555544331                 0        


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCH----HHHhcCCcccCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFDELRD  348 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~e~l~hp~f~~~~~  348 (395)
                          ..++...+..+.++|++||+.||.+|+++    .++++||||..+.+
T Consensus       213 ----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         213 ----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             ----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence                01223468899999999999999999976    59999999988654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.4e-39  Score=306.26  Aligned_cols=229  Identities=25%  Similarity=0.394  Sum_probs=184.8

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------e
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      |+..+.||+|+||+||+|.+..+++.||+|.+....       ....+|+.+++.++|+|+.                 +
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            788899999999999999999999999999885432       2345799999999999971                 0


Q ss_pred             e-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          149 S-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       149 ~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                      .           .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++..........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH-~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-RENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEGESIR  159 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCCCccc
Confidence            0           11235788899999999999999999 88999999999999999887 69999999997654433334


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ...|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.........+........                 
T Consensus       160 ~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-----------------  221 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-----------------  221 (285)
T ss_pred             CCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc-----------------
Confidence            567899999999997654 89999999999999999999999987665444444333211000                 


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  349 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  349 (395)
                              ..+...++..+.+|+.+||+.||++|+|     +.+++.|+||......
T Consensus       222 --------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         222 --------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             --------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence                    0123447889999999999999999999     8899999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.1e-39  Score=311.68  Aligned_cols=260  Identities=39%  Similarity=0.672  Sum_probs=202.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCC--CcEEEEEEeecc------hhhHHHHHHHHHhc-CCCceEe--------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLET--GETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVHY--------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~--~~~vAiK~~~~~------~~~~~~E~~~l~~l-~h~ni~~--------------  148 (395)
                      +|++.+.||+|+||.||+|++..+  +..||||.+...      .....+|+.+++.+ +|+||..              
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            489999999999999999999888  899999987642      12345799999988 5998710              


Q ss_pred             ---------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          149 ---------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       149 ---------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                     ......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus        81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH-SANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHeEEcCCC-CEEeCcCCCceecccc
Confidence                           012345788889999999999999999 88999999999999999887 6999999999765432


Q ss_pred             CC-----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          214 EP-----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       214 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ..     .....+|..|+|||.+.+...++.++||||+||++|+|++|.+||.+.+....+..++..+|.+..+.+..+.
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            21     2235689999999988765568999999999999999999999999998889999999999988776554332


Q ss_pred             CCCc-c--ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCC
Q 016085          289 PNYT-E--FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP  354 (395)
Q Consensus       289 ~~~~-~--~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~  354 (395)
                      .... .  ..........+.. .....+..+.+||.+||++||++|||+.+++.||||..++++.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~  306 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPV  306 (332)
T ss_pred             hhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccccc
Confidence            1100 0  0011111111111 12345789999999999999999999999999999999987754433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.5e-40  Score=316.33  Aligned_cols=233  Identities=26%  Similarity=0.384  Sum_probs=183.1

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceEe----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      +|++.+.||+|+||.||++++..+++.||+|++.+..       ....+|..++..++|+||..                
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            6999999999999999999999999999999986521       22456888999999999710                


Q ss_pred             ----------e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc-
Q 016085          149 ----------S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-  216 (395)
Q Consensus       149 ----------~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~-  216 (395)
                                . .....+++..++.++.|++.||+||| +.||+||||||+|||++.++ .+||+|||+++........ 
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH-~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH-QLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCCcee
Confidence                      0 11356788899999999999999999 89999999999999999887 6999999999766433221 


Q ss_pred             -ccccccccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          217 -ISYICSRYYRAPELIFGA----TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       217 -~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                       ....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....              
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--------------  225 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE--------------  225 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC--------------
Confidence             235689999999998642    2478899999999999999999999988776655555443110              


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCC--CCCHHHHhcCCcccCCCCCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~~  350 (395)
                       ...++.         ....++.++.+||.+||+.++.+  |+++.++++||||+.+.+..
T Consensus       226 -~~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~  276 (331)
T cd05624         226 -RFQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN  276 (331)
T ss_pred             -cccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence             001111         11236899999999999976655  46899999999999876643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.1e-39  Score=306.01  Aligned_cols=255  Identities=36%  Similarity=0.636  Sum_probs=197.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+.+++.++|+|+..                
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            3699999999999999999999999999999987542      134557999999999999810                


Q ss_pred             -e----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cc
Q 016085          149 -S----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PN  216 (395)
Q Consensus       149 -~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~  216 (395)
                       .          .....+++..++.++.||+.||+||| +.||+||||||+||+++.++..+||+|||++....... ..
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH-SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence             0          01123467788899999999999999 88999999999999998665579999999997653322 12


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccc
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEF  294 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~  294 (395)
                      ....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+.+++...+.|....|.....  .+. .
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  239 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK-S  239 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh-h
Confidence            3346688999999987655588999999999999999999999999888888888888888887665542111  110 0


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      .++..... ........+++.+.++|.+||+.+|++||++.++++||||.++..
T Consensus       240 ~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        240 AFPKWPPK-DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hcccCCCC-CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            01110000 011123457889999999999999999999999999999988653

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-39  Score=310.87  Aligned_cols=255  Identities=37%  Similarity=0.620  Sum_probs=200.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEee---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYS---------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~---------------  149 (395)
                      .+|.+.+.||+|+||.||+|++..+|+.||||.+...      .....+|+.+++.++|+||...               
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            3699999999999999999999999999999988642      1234579999999999997100               


Q ss_pred             --------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          150 --------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       150 --------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                    .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||+++....  .
T Consensus        95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~~~~--~  170 (342)
T cd07879          95 FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH-SAGIIHRDLKPGNLAVNEDC-ELKILDFGLARHADA--E  170 (342)
T ss_pred             EEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEeeCCCCcCCCC--C
Confidence                          01235788889999999999999999 88999999999999999887 699999999876432  2


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC-cc-
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY-TE-  293 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~-  293 (395)
                      .....+|..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..++...+.+....+....... .. 
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (342)
T cd07879         171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY  250 (342)
T ss_pred             CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHH
Confidence            2345678899999998765558999999999999999999999999988888888888888877766554332110 00 


Q ss_pred             -ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          294 -FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       294 -~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                       ...+......+.. ..+..+..+.+||.+||+.||++||++.+++.||||..+++..
T Consensus       251 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         251 IKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             HhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence             0111111111111 1234678899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.5e-40  Score=315.52  Aligned_cols=220  Identities=27%  Similarity=0.426  Sum_probs=175.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecchh-------hHHHH-HHHHHhcCCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRE-LQTMRLLDHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E-~~~l~~l~h~ni~---------------------  147 (395)
                      +.||+|+||.||+|++..+++.||+|++.+...       ...+| ..+++.++|+||.                     
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999999999999999999865321       11223 3356789999981                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCcccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~g  221 (395)
                           +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..... ......+|
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH-~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLH-SLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCCCCcccccC
Confidence                 1112345778889999999999999999 88999999999999999887 6999999999764322 22345678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+...   +                      
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~----------------------  212 (325)
T cd05602         159 TPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P----------------------  212 (325)
T ss_pred             CccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C----------------------
Confidence            99999999997754 899999999999999999999999987766655555431   0                      


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHH----HHhcCCcccCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL----EACIHPFFDELRD  348 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~----e~l~hp~f~~~~~  348 (395)
                          ..+...++..+.+||.+||+.||.+|+++.    ++++|+||..+.+
T Consensus       213 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         213 ----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             ----cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence                012234789999999999999999999875    8999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.3e-39  Score=304.49  Aligned_cols=251  Identities=36%  Similarity=0.637  Sum_probs=193.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcC-CCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLD-HPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~-h~ni~-----------------  147 (395)
                      +|++.+.||+|+||.||+|++..+++.||+|.+....      ....+|+.+++.+. |+|+.                 
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            5999999999999999999999999999999875432      23457999999995 58870                 


Q ss_pred             ee-----c-------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          148 YS-----R-------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       148 ~~-----~-------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      +.     .             ....+++..++.++.||+.||.||| +.||+||||||+||+++.+...+||+|||+++.
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH-KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            00     0             0234688899999999999999999 889999999999999998344799999999876


Q ss_pred             cccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          210 LVKGE-PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       210 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ..... ......+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+....+..+....+.+....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            53221 12233568889999998765568999999999999999999999999988888888888888777765543221


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                      .......++....... ....+.++..+.+||.+||.+||.+|||+.+++.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDL-SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhH-HHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            1111111111111111 112235789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-39  Score=313.43  Aligned_cols=232  Identities=25%  Similarity=0.414  Sum_probs=183.1

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|++.++||+|+||.||+++++.+++.||+|++.+..       ....+|+.++..++|+||.                 
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            6999999999999999999999999999999986422       2245788899999999971                 


Q ss_pred             e---------e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--
Q 016085          148 Y---------S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       148 ~---------~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                      +         . .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++........  
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH-~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEECCCC-CEEEeecchheecccCCcce
Confidence            0         1 11346788899999999999999999 89999999999999999887 699999999876533322  


Q ss_pred             cccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          216 NISYICSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      ....+||+.|+|||++.+    ...++.++|||||||++|||++|+.||.+.+..+.+..+.....              
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--------------  225 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--------------  225 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc--------------
Confidence            123578999999999852    33478999999999999999999999988776666655543100              


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCC--CCCHHHHhcCCcccCCCCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRDP  349 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~  349 (395)
                       ...++.         ....+++++.+||++||+.++.+  |+++.++++||||..+.+.
T Consensus       226 -~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~  275 (332)
T cd05623         226 -RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD  275 (332)
T ss_pred             -cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence             001111         11347899999999999776555  6899999999999987654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-39  Score=311.02  Aligned_cols=257  Identities=36%  Similarity=0.595  Sum_probs=201.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEee---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYS---------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~---------------  149 (395)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++...      .....+|+.+++.++|+||...               
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            4699999999999999999999999999999988643      1234579999999999997110               


Q ss_pred             ---------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          150 ---------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       150 ---------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                     .....+++..++.++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++.....  
T Consensus        97 ~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~~~~--  172 (345)
T cd07877          97 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDD--  172 (345)
T ss_pred             EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChHHEEEcCCC-CEEEecccccccccc--
Confidence                           01135788889999999999999999 88999999999999999887 699999999876432  


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+...............
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (345)
T cd07877         173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  252 (345)
T ss_pred             cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence            23445778999999998765558999999999999999999999999888888888888888877766554332211000


Q ss_pred             ---cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCC
Q 016085          295 ---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  352 (395)
Q Consensus       295 ---~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  352 (395)
                         ..+......+.. .....++.+.+||.+||+.||.+|+|+.++++||||.+...+...
T Consensus       253 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~  312 (345)
T cd07877         253 YIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE  312 (345)
T ss_pred             HHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcc
Confidence               011111111111 112357889999999999999999999999999999987766543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-40  Score=317.50  Aligned_cols=220  Identities=29%  Similarity=0.467  Sum_probs=179.5

Q ss_pred             eeeccCCceEEEEEEEc---CCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE--------------------
Q 016085           97 RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH--------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~--------------------  147 (395)
                      +.||+|+||.||++++.   .+|+.||+|++.+..      ....+|+.+++.++|+||.                    
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            67999999999999863   578999999987532      2334699999999999981                    


Q ss_pred             ------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCccccc
Q 016085          148 ------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYI  220 (395)
Q Consensus       148 ------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~  220 (395)
                            +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..... .......
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~  159 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFC  159 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCCCceeccc
Confidence                  0112345788999999999999999999 88999999999999999887 6999999999765443 2233567


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      ||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...                 ..      
T Consensus       160 g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~-----------------~~------  215 (318)
T cd05582         160 GTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA-----------------KL------  215 (318)
T ss_pred             CChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-----------------CC------
Confidence            899999999997654 899999999999999999999999887766665554431                 00      


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCC
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRD  348 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  348 (395)
                            .++..+++.+.+||++||+.||++|++     +.++++||||..+.+
T Consensus       216 ------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         216 ------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence                  123347899999999999999999999     778999999988654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.1e-39  Score=305.63  Aligned_cols=224  Identities=24%  Similarity=0.385  Sum_probs=174.7

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceEe-----------------e-----
Q 016085           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVHY-----------------S-----  149 (395)
Q Consensus        99 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~~-----------------~-----  149 (395)
                      ||+|+||.||+++++.+|+.||+|.+....       .....|+++++.++|+||..                 .     
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999999999999999885421       22346999999999999810                 0     


Q ss_pred             ------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccccc
Q 016085          150 ------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR  223 (395)
Q Consensus       150 ------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~  223 (395)
                            .....+++..+..++.||+.||+||| +.||+||||||+||+++.++ .++|+|||++.............+|.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH-SMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH-HCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCceeeccCCCC
Confidence                  11224677778889999999999999 88999999999999999887 69999999998765444444567899


Q ss_pred             cccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCC
Q 016085          224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP  303 (395)
Q Consensus       224 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (395)
                      .|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.........+....-          ..   ...        
T Consensus       159 ~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~----------~~---~~~--------  216 (277)
T cd05607         159 GYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL----------ED---EVK--------  216 (277)
T ss_pred             CccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh----------cc---ccc--------
Confidence            999999997765 99999999999999999999999976543222222211100          00   000        


Q ss_pred             cccccCCCCChhHHHHHHhhccCCCCCCCCH----HHHhcCCcccCCCCC
Q 016085          304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFDELRDP  349 (395)
Q Consensus       304 ~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~e~l~hp~f~~~~~~  349 (395)
                         .....++.++.+||.+||+.||++|+++    .++++|+||+.+.++
T Consensus       217 ---~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~  263 (277)
T cd05607         217 ---FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP  263 (277)
T ss_pred             ---cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence               0112468899999999999999999999    678899999987664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-39  Score=312.10  Aligned_cols=256  Identities=37%  Similarity=0.660  Sum_probs=201.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      ++|.+.+.||+|+||.||+|++..+++.||||++...      .....+|+.+++.++|+|+..                
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            4699999999999999999999999999999987542      123347999999999999710                


Q ss_pred             --------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          149 --------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       149 --------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                    ......+++..++.++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++...... 
T Consensus        95 ~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH-~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~-  171 (343)
T cd07851          95 VYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH-SAGIIHRDLKPSNIAVNEDC-ELKILDFGLARHTDDE-  171 (343)
T ss_pred             EEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-CEEEcccccccccccc-
Confidence                          011236788899999999999999999 88999999999999999877 6999999999765332 


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc-
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-  293 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-  293 (395)
                       .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..++...+.++...+......... 
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07851         172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN  250 (343)
T ss_pred             -ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHH
Confidence             344567889999999866545889999999999999999999999998888888888888888776655433211100 


Q ss_pred             c--cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 016085          294 F--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  351 (395)
Q Consensus       294 ~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  351 (395)
                      +  ..+......+.. .....++.+.+||.+||+.||++|||+.++++||||.+...+..
T Consensus       251 ~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~  309 (343)
T cd07851         251 YIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED  309 (343)
T ss_pred             HHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence            0  011111111111 12346889999999999999999999999999999998876643

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9e-41  Score=319.41  Aligned_cols=225  Identities=28%  Similarity=0.446  Sum_probs=196.4

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ++|.+++++|+|+||.+++++++..++.|++|.+.-.      ......|+.+++++.||||.                 
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            4699999999999999999999999999999988532      33556899999999999981                 


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-  214 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-  214 (395)
                                  ......-+++..+..|+.|++.|++||| +.+|+|||||+.|||++.++ .|||+|||+|+...... 
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH-~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH-ENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-hhhhhcccchhhhhhccccC-ceeecchhhhhhcCCchh
Confidence                        0122356899999999999999999999 88999999999999999988 58999999999987665 


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ...+.+||++||+||++.+.+ |+.++|||||||++|||++-+++|.+.+-...+.+|+.....|               
T Consensus       162 ~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P---------------  225 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP---------------  225 (426)
T ss_pred             hhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC---------------
Confidence            556789999999999998866 9999999999999999999999999999888888888754333               


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                   ++...+.+++.||+.||..+|..||++.++|.+|.....
T Consensus       226 -------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  226 -------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             -------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence                         233468999999999999999999999999999988643

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-39  Score=303.39  Aligned_cols=250  Identities=35%  Similarity=0.652  Sum_probs=192.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEe-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY-----------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~-----------------  148 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||.+....     ....+|+.+++.++|+||..                 
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            46999999999999999999999999999999886432     23457999999999999810                 


Q ss_pred             ---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccc
Q 016085          149 ---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNIS  218 (395)
Q Consensus       149 ---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~  218 (395)
                               ......+++..++.++.|++.||.||| +.||+||||||+||+++.++ .+||+|||+++...... ....
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH-QRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecccCCHHHEEEcCCC-CEEECccccccccCCCCccccc
Confidence                     011235788889999999999999999 88999999999999999887 69999999987543221 1122


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhcCCC--Ccccc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNPN--YTEFK  295 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~  295 (395)
                      ..++..|+|||.+.+...++.++||||+||++|+|++|+.||.+.. ..+++..+.+.++.+....+......  +....
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS  242 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence            3468889999998765568999999999999999999999998765 55677777788888777665433221  11111


Q ss_pred             CCcccCCCcccccCCCCC--hhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          296 FPQIKAHPWHKIFHKRMP--PEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s--~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      .+..........+ ..++  ..+.++|.+||++||++|||+.+++.||||
T Consensus       243 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         243 FPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            1111111111111 1234  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5e-39  Score=303.90  Aligned_cols=256  Identities=38%  Similarity=0.642  Sum_probs=199.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh---------hHHHHHHHHHhcCCCceE---------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---------YKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---------~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      +|.+.+.||+|+||.||+|.+..+++.||||.+.....         ....|+.+++.++|+||.               
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            48899999999999999999999999999999865421         234689999999999971               


Q ss_pred             ----------eeccCC-CCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-C
Q 016085          148 ----------YSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-P  215 (395)
Q Consensus       148 ----------~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~  215 (395)
                                +..... .+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++....... .
T Consensus        81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH-SNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCChhhEEEcCCC-CEEEccceeeeeccCCCcc
Confidence                      011222 6889999999999999999999 88999999999999999887 69999999997764432 2


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      .....+++.|+|||.+.+...++.++|+|||||++|+|++|.++|.+.+..+.+..+....+.+....+......-....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE  238 (298)
T ss_pred             ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence            22345678899999986655689999999999999999999999999888888888888877777665532211100000


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                      ......... .......+..+.+||.+||++||++|||+.+++.|+||.+...+.
T Consensus       239 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         239 FKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccCCcch-hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            000011111 112344678999999999999999999999999999998876553

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-40  Score=317.54  Aligned_cols=220  Identities=27%  Similarity=0.454  Sum_probs=174.2

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecchh-------hHHHHHHHHHhc---CCCceE---------------------
Q 016085           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLL---DHPNVH---------------------  147 (395)
Q Consensus        99 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~~l~~l---~h~ni~---------------------  147 (395)
                      ||+|+||+||+|++..+++.||||++.+...       ....|..++..+   .|+||.                     
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999999999999999864321       122456666555   688871                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCcccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~g  221 (395)
                           +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++..... ......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH-~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLH-KYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCCCCccCccC
Confidence                 1122356889999999999999999999 88999999999999999887 6999999998764332 22335678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+...                 ...++    
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------~~~~~----  217 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-----------------KVRFP----  217 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------CCCCC----
Confidence            999999999976656899999999999999999999999887665544443321                 00111    


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCC----CHHHHhcCCcccCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC----TALEACIHPFFDELRD  348 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~----t~~e~l~hp~f~~~~~  348 (395)
                             ...+++++.+||++||+.||.+|+    ++.++++||||....+
T Consensus       218 -------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         218 -------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             -------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence                   123688999999999999999998    7899999999987653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.5e-40  Score=301.89  Aligned_cols=227  Identities=36%  Similarity=0.575  Sum_probs=180.7

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhh------HHHHHHHHHhcCCCce--------------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY------KNRELQTMRLLDHPNV--------------------  146 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~~l~~l~h~ni--------------------  146 (395)
                      |++.+.||+|+||+||+|++..+++.||+|++......      ..+|+.+++.++|+||                    
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            88999999999999999999999999999998654321      2348999999999998                    


Q ss_pred             ------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc-ccCCCcccc
Q 016085          147 ------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISY  219 (395)
Q Consensus       147 ------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~-~~~~~~~~~  219 (395)
                            .+......+++..+..++.||+.||.+|| +.||+||||||+||+++.++ .++|+|||.+... .........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh-~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLH-SKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHH-HTTEEESSBSGGGEEESTTS-EEEESSGTTTEESTSTTSEBSSS
T ss_pred             ccccccccccccccccccccccccccccccccccc-cccccccccccccccccccc-ccccccccccccccccccccccc
Confidence                  01123567889999999999999999999 78999999999999999777 6999999999763 222333456


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcc
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI  299 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (395)
                      .+|..|+|||++.....++.++|+||||+++|+|++|..||......+....+.+...........              
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------------  224 (260)
T PF00069_consen  159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ--------------  224 (260)
T ss_dssp             SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT--------------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc--------------
Confidence            779999999998723458999999999999999999999998875445444444432221111100              


Q ss_pred             cCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       300 ~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                              .....+..+.+||.+||+.||++|||+.++++||||
T Consensus       225 --------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 --------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             --------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             --------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                    000123789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-39  Score=312.59  Aligned_cols=222  Identities=24%  Similarity=0.430  Sum_probs=175.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc-CCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~ni~---------------------  147 (395)
                      +.||+|+||+||+|++..+++.||+|++.+..       ....+|..++..+ +|+||.                     
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999997542       2244788888877 689871                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-CCCcccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-~~~~~~~~g  221 (395)
                           +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLH-ERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCCCceecccC
Confidence                 0112356889999999999999999999 88999999999999999888 599999999975432 223345678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      |+.|+|||++.+.. ++.++|||||||++|+|++|+.||....      ..+.+..++..  .              .  
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~--------------~--  219 (327)
T cd05617         159 TPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K--------------P--  219 (327)
T ss_pred             CcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------------C--
Confidence            99999999997654 8999999999999999999999996422      11222222210  0              0  


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC------HHHHhcCCcccCCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT------ALEACIHPFFDELRDP  349 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t------~~e~l~hp~f~~~~~~  349 (395)
                                ..++..++..+.++|.+||+.||.+|++      ..++++||||..+.+.
T Consensus       220 ----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         220 ----------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence                      0123447899999999999999999998      4699999999988654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.8e-39  Score=304.82  Aligned_cols=250  Identities=36%  Similarity=0.634  Sum_probs=194.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEee--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHYS--------------  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~~--------------  149 (395)
                      .++|++.+.||.|+||.||+|.+..+++.||||.+....      ....+|+++++.++|+||...              
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            457999999999999999999999999999999875321      234579999999999998110              


Q ss_pred             --------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          150 --------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       150 --------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                          .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++..
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~  164 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH-ENHILHRDIKAANILIDNQG-ILKIADFGLARP  164 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEECcCccchh
Confidence                                11346889999999999999999999 88999999999999999888 699999999876


Q ss_pred             cccCCC------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 016085          210 LVKGEP------------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  277 (395)
Q Consensus       210 ~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  277 (395)
                      ......            .....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+....+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            533211            12235688899999987655589999999999999999999999999998888888888887


Q ss_pred             CCCHHHHhhcC--CCCcc-ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          278 TPTREEIKCMN--PNYTE-FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       278 ~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      .+....+....  +.... ....... ..+.. ....+++.+.+||.+||+.||.+|||+.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYP-RTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCC-ccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            77665443211  00000 0000000 01111 112356789999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.5e-39  Score=308.63  Aligned_cols=256  Identities=37%  Similarity=0.659  Sum_probs=200.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEee---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYS---------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~---------------  149 (395)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++|+||...               
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            4699999999999999999999999999999988542      1234579999999999997100               


Q ss_pred             ---------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          150 ---------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       150 ---------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                     .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++.....  
T Consensus        95 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~--  170 (343)
T cd07880          95 FYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQTDS--  170 (343)
T ss_pred             EEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEeeccccccccc--
Confidence                           01246788999999999999999999 88999999999999999887 699999999976533  


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc-
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-  293 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-  293 (395)
                      ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+++..+.++.+........... 
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07880         171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN  250 (343)
T ss_pred             CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHH
Confidence            2234567899999999876445889999999999999999999999988888888888887777665544332211000 


Q ss_pred             --ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 016085          294 --FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  351 (395)
Q Consensus       294 --~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  351 (395)
                        ...+......+ ..+...++..+.++|.+||+.||++|||+.+++.||||+.......
T Consensus       251 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~  309 (343)
T cd07880         251 YVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED  309 (343)
T ss_pred             HHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence              00111111111 1123457889999999999999999999999999999998876543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1e-39  Score=312.37  Aligned_cols=221  Identities=29%  Similarity=0.434  Sum_probs=174.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecchh-------hHHHHH-HHHHhcCCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNREL-QTMRLLDHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~-~~l~~l~h~ni~---------------------  147 (395)
                      ++||+|+||.||+|++..+++.||+|++.+...       ...+|. .+++.++|+||.                     
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999864321       122333 467889999981                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYIC  221 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~g  221 (395)
                           .......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...... .....+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLH-SLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCCCccccccC
Confidence                 0112345788889999999999999999 88999999999999999888 69999999987643222 2334678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...   +              .       
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~--------------~-------  213 (321)
T cd05603         159 TPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P--------------L-------  213 (321)
T ss_pred             CcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C--------------C-------
Confidence            99999999997654 899999999999999999999999887655544443320   0              0       


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCH----HHHhcCCcccCCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFDELRDP  349 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~e~l~hp~f~~~~~~  349 (395)
                           .++...+..+.++|.+||+.||.+|+++    .++++|+||..+.+.
T Consensus       214 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~  260 (321)
T cd05603         214 -----QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD  260 (321)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence                 1233467899999999999999999875    599999999877653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.4e-39  Score=301.12  Aligned_cols=251  Identities=36%  Similarity=0.639  Sum_probs=189.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------------e
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++|+||.                 +
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            46999999999999999999999999999999885432     2345799999999999981                 0


Q ss_pred             ---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccc
Q 016085          149 ---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNIS  218 (395)
Q Consensus       149 ---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~  218 (395)
                               ......+++..++.++.|++.||.||| +.||+||||||+|||++.++ .++|+|||+++...... ....
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          85 MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH-GQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             ccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHHEEEcCCC-cEEEeccccccccCCCCCCCCC
Confidence                     011234677788899999999999999 88999999999999999887 69999999987643221 2233


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcC--CCCcccc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN--PNYTEFK  295 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~  295 (395)
                      ..+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+. .+.+..+....+.|....+....  +.+....
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW  242 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence            45688999999987655578899999999999999999999976543 45666677777777665543221  1121111


Q ss_pred             CCcccCCCccccc-CCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          296 FPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       296 ~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      .+........... ....+..+.+||.+||+.||++|||+.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            1111000010000 01236789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.7e-39  Score=304.23  Aligned_cols=252  Identities=31%  Similarity=0.517  Sum_probs=191.2

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEee--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHYS--------------  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~~--------------  149 (395)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+....      ....+|+.+++.++|+||...              
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            347999999999999999999999999999999885431      123479999999999997100              


Q ss_pred             --------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          150 --------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       150 --------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                          .....+++..++.++.||+.||+||| +.|++|+||||+||+++.++ .+||+|||++..
T Consensus        91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~  168 (310)
T cd07865          91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH-RNKILHRDMKAANILITKDG-ILKLADFGLARA  168 (310)
T ss_pred             CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEECCCC-cEEECcCCCccc
Confidence                                01125788899999999999999999 88999999999999999887 699999999976


Q ss_pred             cccCCCc-----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          210 LVKGEPN-----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       210 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                      .......     ....++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+....+..+....+..+...+
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW  248 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            5432211     23456788999999877655789999999999999999999999988887777777777776555433


Q ss_pred             hhcC--CCCccccCCcccCCCccccc-CCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          285 KCMN--PNYTEFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       285 ~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ....  ..+.....+..........+ ....+..+.+||.+||+.||.+|||++++++||||
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            2211  00111111111111111111 11246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-39  Score=305.71  Aligned_cols=250  Identities=39%  Similarity=0.644  Sum_probs=190.1

Q ss_pred             ceeeeeeeccCCceEEEEEEEcC--CCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE---------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLE--TGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~--~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      +|.+.+.||+|+||.||+|.+..  +++.||+|.+....       ....+|+.+++.++|+||.               
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48999999999999999999988  89999999987632       3445799999999999970               


Q ss_pred             ----e-------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC----CCCceEEeecCC
Q 016085          148 ----Y-------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP----HTHQVKLCDFGS  206 (395)
Q Consensus       148 ----~-------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~----~~~~ikl~DFG~  206 (395)
                          +             ......+++..++.++.||+.||.||| +.||+||||||+||+++.    ++ .+||+|||+
T Consensus        81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~Dfg~  158 (316)
T cd07842          81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH-SNWVLHRDLKPANILVMGEGPERG-VVKIGDLGL  158 (316)
T ss_pred             EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH-hCCEeeCCCCHHHEEEcCCCCccc-eEEECCCcc
Confidence                0             001125788889999999999999999 889999999999999998    66 699999999


Q ss_pred             ccccccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------HHHHHHH
Q 016085          207 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV---------DQLVEII  273 (395)
Q Consensus       207 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~i~  273 (395)
                      +........    .....+|..|+|||.+.+...++.++|+|||||++|+|++|++||.+....         ..+..++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            886543322    223467889999999877666899999999999999999999999865432         3566777


Q ss_pred             HHhCCCCHHHHhhcC--CCCcc----ccCCcccCCCcccccC--CCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          274 KVLGTPTREEIKCMN--PNYTE----FKFPQIKAHPWHKIFH--KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       274 ~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~--~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ..++.+....+....  +.+..    ..............+.  ...+..+.++|.+||++||++|||+.|+++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            777777665443211  11111    0000011011111111  1567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=309.97  Aligned_cols=218  Identities=30%  Similarity=0.459  Sum_probs=177.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcE-EEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGET-VAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~-vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ...+.+.||+|+||+||+|..  .|.. ||+|++...      ...+.+|+.+|.+|+||||.                 
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            456667799999999999987  4555 999998653      23667899999999999981                 


Q ss_pred             ----------eec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCC-eeeccCCCCceEEcCCCCceEEeecCCccccccC-
Q 016085          148 ----------YSR--ASQRMPLIYVKLYTYQICRALAYIHGGIG-VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  213 (395)
Q Consensus       148 ----------~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~g-iiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-  213 (395)
                                +..  ....++...+..++.||+.|++||| +++ ||||||||+|||++.+.-.+||+|||+++..... 
T Consensus       120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH-~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH-SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh-cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence                      111  3578899999999999999999999 889 9999999999999988535999999999877554 


Q ss_pred             CCcccccccccccccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          214 EPNISYICSRYYRAPELIFG-ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      ...+...||+.|||||++.+ ...|+.++||||||++||||+||+.||.+.........+.....+|             
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp-------------  265 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP-------------  265 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-------------
Confidence            34445789999999999984 2459999999999999999999999999988744444443321111             


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                    .++...++.+..|+.+||..||.+||+..+++.
T Consensus       266 --------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  266 --------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             --------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                          233447899999999999999999999988754

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=297.74  Aligned_cols=230  Identities=30%  Similarity=0.478  Sum_probs=182.6

Q ss_pred             cceeee-eeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHh-cCCCceE---------------------
Q 016085           91 ISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-LDHPNVH---------------------  147 (395)
Q Consensus        91 ~~y~~~-~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~-l~h~ni~---------------------  147 (395)
                      ++|.+. ++||-|-.|+|..+.++.|++.+|+|++... ....||+++--. -.|+||.                     
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE  139 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME  139 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence            356665 5899999999999999999999999987644 344567765433 3688871                     


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC--CceEEeecCCccccccCC
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~--~~ikl~DFG~a~~~~~~~  214 (395)
                                 ..+..+.+.+..+..++.||+.|+.||| +.+|.||||||+|+|....+  -.+||+|||+|+......
T Consensus       140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH-~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~  218 (400)
T KOG0604|consen  140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH-SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG  218 (400)
T ss_pred             cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH-hcchhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence                       1133466999999999999999999999 89999999999999985432  269999999999987666


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV----DQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ...+.+.||+|.|||++ |...|+...|+||+||+||-||+|.+||......    .+-.+|...               
T Consensus       219 ~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g---------------  282 (400)
T KOG0604|consen  219 DLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG---------------  282 (400)
T ss_pred             cccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc---------------
Confidence            77788899999999988 4455999999999999999999999999765432    233333332               


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                        .+.||.   ..     +..+|+.++|+|+++|..+|++|+|+.++++|||+.+...
T Consensus       283 --qy~FP~---pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  283 --QYEFPE---PE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             --CccCCC---hh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence              122222   11     1237999999999999999999999999999999987543

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.8e-39  Score=299.83  Aligned_cols=248  Identities=35%  Similarity=0.656  Sum_probs=196.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe-----------------e
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY-----------------S  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~-----------------~  149 (395)
                      +|++.+.||.|+||.||+|++..+|+.||||.+...     .....+|+.+++.++|+|+..                 .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            489999999999999999999999999999988643     233457999999999999710                 0


Q ss_pred             -----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cc
Q 016085          150 -----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NI  217 (395)
Q Consensus       150 -----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~  217 (395)
                                 .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++........ ..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH-ENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCccccc
Confidence                       01135789999999999999999999 88999999999999999887 699999999976533221 22


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc--cc
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE--FK  295 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~  295 (395)
                      ...++..|++||.+.+...++.++|+|||||++|+|++|+.||.+.+..+.+..++.....|....+..+. ....  ..
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  237 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QLPEYKPT  237 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cCchhccc
Confidence            34568899999998776667999999999999999999999999999888899999888888776665332 1111  11


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ++....... ..+....+..+.++|.+||+.||.+||++.++++||||
T Consensus       238 ~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            111111111 11223468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=285.73  Aligned_cols=235  Identities=26%  Similarity=0.405  Sum_probs=188.2

Q ss_pred             CCCccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhh--HH---HHHHHHHh-cCCCce------------
Q 016085           85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY--KN---RELQTMRL-LDHPNV------------  146 (395)
Q Consensus        85 ~~~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--~~---~E~~~l~~-l~h~ni------------  146 (395)
                      ......++.+.+..||.|+.|.|++++.+.+|...|||.+......  ..   ..+.++.. .+.|.|            
T Consensus        86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            3444556788889999999999999999999999999999754322  22   23333322 235666            


Q ss_pred             --------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          147 --------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       147 --------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                    .+.+..++++|..+-++...++.||.||...+||+|||+||+|||+|..| .|||||||++.+..+
T Consensus       166 V~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  166 VFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecccccceeec
Confidence                          22344677899999999999999999999888999999999999999988 599999999999888


Q ss_pred             CCCccccccccccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          213 GEPNISYICSRYYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      ....+...|-+.|||||.+-  ..+.|+.++||||||++++||.||+.||.+. .+.+.+..|...  .|+.        
T Consensus       245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP~--------  314 (391)
T KOG0983|consen  245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPPL--------  314 (391)
T ss_pred             ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCCC--------
Confidence            87777788899999999983  2456999999999999999999999999985 455666666552  1110        


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                               +       .....+|+.+.+|+..||++|+.+||.-.++|+|||+...
T Consensus       315 ---------L-------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  315 ---------L-------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             ---------C-------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence                     0       0123379999999999999999999999999999998764

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-40  Score=313.00  Aligned_cols=230  Identities=27%  Similarity=0.390  Sum_probs=201.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCce-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNV-----------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni-----------------  146 (395)
                      .+..++..||-||||.|-++..+.....+|+|++++.       .+....|.+||.....+.|                 
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            4578888999999999999988766667999988653       2344578999999888887                 


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                               ...+..+.+....+++|+..++.|++||| ++|||+|||||+|++|+.+| .+||.|||+|+....+..+.
T Consensus       500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH-~k~iIYRDLKPENllLd~~G-y~KLVDFGFAKki~~g~KTw  577 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH-RKGIIYRDLKPENLLLDNRG-YLKLVDFGFAKKIGSGRKTW  577 (732)
T ss_pred             HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH-hcCceeccCChhheeeccCC-ceEEeehhhHHHhccCCcee
Confidence                     23455678999999999999999999999 89999999999999999988 69999999999999999999


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ++||||.|.|||+++.+. ++.++|.||||+++|||++|.+||.+.+.....+.|++.+.               .+   
T Consensus       578 TFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid---------------~i---  638 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID---------------KI---  638 (732)
T ss_pred             eecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh---------------hh---
Confidence            999999999999999865 89999999999999999999999999999999999987431               11   


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDPN  350 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~~  350 (395)
                               .+|..++..+.+||+++...+|.+|+.     +.++.+|.||..+.|..
T Consensus       639 ---------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg  687 (732)
T KOG0614|consen  639 ---------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG  687 (732)
T ss_pred             ---------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence                     245568899999999999999999986     78999999999998864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.7e-39  Score=309.52  Aligned_cols=252  Identities=26%  Similarity=0.418  Sum_probs=181.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      ++|++.+.||.|+||.||+|++..++..||+|.+...     .....+|+++++.++|+||.                  
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            4799999999999999999999999999999987643     13456899999999999980                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY  219 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~  219 (395)
                              +......+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++...... .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~-~~~~~  162 (333)
T cd06650          85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MANSF  162 (333)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhhhh-ccccC
Confidence                    1122345778888999999999999999435899999999999999887 5999999998765332 22345


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH--hCCCCHHHHhhcC-------CC
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV--LGTPTREEIKCMN-------PN  290 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~-------~~  290 (395)
                      .+|..|+|||.+.+.. ++.++|+|||||++|+|++|+.||......+.. .++..  .+.+.........       ..
T Consensus       163 ~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (333)
T cd06650         163 VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPRPPGRPLSS  240 (333)
T ss_pred             CCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccCCccchhhh
Confidence            7899999999997654 899999999999999999999999765543322 21110  0111100000000       00


Q ss_pred             CccccCCc---------ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          291 YTEFKFPQ---------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       291 ~~~~~~~~---------~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      +.....+.         +............++.++.+||.+||++||++|||+.|++.||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence            00000000         000000000112357889999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-39  Score=296.13  Aligned_cols=222  Identities=29%  Similarity=0.459  Sum_probs=178.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhHHHHHHHHHhcCCCceE---------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+...         .....+|+.+++.++|+||.               
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            599999999999999999999999999999987532         12345799999999999981               


Q ss_pred             --e---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          148 --Y---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 --~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                        +         ......+++..+..++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||+++........
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH-SNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEeecccceeccccccc
Confidence              0         011235677888999999999999999 88999999999999999877 6999999998765322111


Q ss_pred             ----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          217 ----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       217 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                          ....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.......+....                
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------------  223 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP----------------  223 (263)
T ss_pred             cccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC----------------
Confidence                2345788999999997755 8999999999999999999999997765544433322210                


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                                 ....++..++..+.+||++||..+|.+|||+.++++|+||
T Consensus       224 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 -----------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             -----------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                       0112334578999999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.9e-39  Score=299.78  Aligned_cols=250  Identities=37%  Similarity=0.683  Sum_probs=192.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE-----------------e
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++|+||.                 +
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            5999999999999999999999899999999875422      2345799999999999970                 0


Q ss_pred             ---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccc
Q 016085          149 ---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NIS  218 (395)
Q Consensus       149 ---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~  218 (395)
                               ......+++..+..++.||+.||.||| +.||+||||+|+||+++.++ .++|+|||++........ ...
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH-SHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCccccCc
Confidence                     112235788999999999999999999 88999999999999999887 699999999876543322 233


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCccccC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~  296 (395)
                      ..++..|+|||.+.+...++.++|||||||++|+|++|++||.+....+.+..+....+...........  ........
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            5678899999998765557899999999999999999999999888778878887776654332211111  00111112


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      +............+.++..+.+|+.+||..+|++|||+.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            22211111112234678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=298.12  Aligned_cols=247  Identities=36%  Similarity=0.689  Sum_probs=193.7

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE-----------------e-
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH-----------------Y-  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~-----------------~-  148 (395)
                      |++.+.||.|++|.||+|.+..+|..||+|++..+.      ....+|+.+++.++|+|+.                 + 
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            678899999999999999999999999999886432      3355799999999999971                 0 


Q ss_pred             -------eccC--CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccc
Q 016085          149 -------SRAS--QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNIS  218 (395)
Q Consensus       149 -------~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~  218 (395)
                             ....  ..+++..+..++.|++.||+||| +.|++||||+|+||+++.++ .++|+|||++....... ....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH-~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH-SHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCCCccccCc
Confidence                   0111  25789999999999999999999 88999999999999999877 69999999997653222 1123


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~  296 (395)
                      ..++..|+|||++.+...++.++|+|||||++|+|++|++||.+.+....+..+.+..+.|....+.....  ++.. .+
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  237 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP-TF  237 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh-hc
Confidence            35688899999887655578999999999999999999999999888888888888888887765532211  1100 11


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      +....... ......++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         238 PKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            11111111 11234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=293.05  Aligned_cols=251  Identities=34%  Similarity=0.572  Sum_probs=202.5

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEeec---------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYSR---------------  150 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~~---------------  150 (395)
                      +|.-++.+|.|.- .|..|.|.-+++.||+|++...      .+...+|..++..++|+|+....               
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            6888899999998 8889999999999999987432      34556899999999999982110               


Q ss_pred             --------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          151 --------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       151 --------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                                    ....+.-..+..+++|+++|+.||| +.||+||||||+||+++.++ .+||.|||+|+.....-..
T Consensus        97 y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lh-s~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e~~~~~m  174 (369)
T KOG0665|consen   97 YLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLH-SAGIIHRDLKPSNIVVNSDC-TLKILDFGLARTEDTDFMM  174 (369)
T ss_pred             HHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHH-hcceeecccCcccceecchh-heeeccchhhcccCccccc
Confidence                          0123455567889999999999999 89999999999999999998 6999999999887655556


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC-------
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-------  289 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-------  289 (395)
                      +.++.|++|+|||++.+.. |...+||||+||++.||++|+..|+|.+..++..+|.+.+|+|.+.....+.+       
T Consensus       175 tpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~  253 (369)
T KOG0665|consen  175 TPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE  253 (369)
T ss_pred             CchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence            7889999999999999876 99999999999999999999999999999999999999999999987765442       


Q ss_pred             ---CCccccCCcc-cCCCccccc--CCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          290 ---NYTEFKFPQI-KAHPWHKIF--HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       290 ---~~~~~~~~~~-~~~~~~~~~--~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                         .|..+.+... +...|....  ++.-+..+++|+.+||..||++|.++.++|+||||+-+
T Consensus       254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence               2222211111 111111111  11234568999999999999999999999999999944

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=298.07  Aligned_cols=250  Identities=38%  Similarity=0.704  Sum_probs=197.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+++++.++|+||.                  
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            699999999999999999999999999999987542      23456899999999999971                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--Ccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--PNI  217 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--~~~  217 (395)
                              +......+++..+..++.||+.||.||| +.|++||||+|+||+++.++ .+||+|||++.......  ...
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH-SHNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-CEEEEeeecccccCCCcccccc
Confidence                    0112345788899999999999999999 88999999999999999877 69999999988765443  233


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCcccc
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFK  295 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~  295 (395)
                      ...++..|+|||++.+...++.++|+|||||++|+|++|++||.+.+..+.+..+....+...........  ..+....
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            45678899999999876468999999999999999999999999888888888877777766554333221  1111111


Q ss_pred             CCcccC-CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          296 FPQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       296 ~~~~~~-~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      .+.... ..+...++..++..+.+||++||..+|++|||+.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            211111 111222344568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=302.27  Aligned_cols=232  Identities=30%  Similarity=0.490  Sum_probs=187.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCce-----------------E
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNV-----------------H  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni-----------------~  147 (395)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+++++.++|+||                 .
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            6999999999999999999999999999999886432       234579999999999997                 0


Q ss_pred             e---------e--ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          148 Y---------S--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       148 ~---------~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                      +         .  .....+++..++.++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++........ 
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH-LLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH-HCCeeccCCChHHeEEcCCC-CEEEeecchhhcccccccc
Confidence            0         0  11246788899999999999999999 88999999999999999887 699999999875432211 


Q ss_pred             -----------------------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH
Q 016085          216 -----------------------------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV  266 (395)
Q Consensus       216 -----------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  266 (395)
                                                   .....||..|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence                                         11236788899999997754 899999999999999999999999887766


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC----HHHHhcCCc
Q 016085          267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT----ALEACIHPF  342 (395)
Q Consensus       267 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t----~~e~l~hp~  342 (395)
                      ..+..+...                 ...++          ....++..+.+||.+||+.||++|||    +.++|+|||
T Consensus       239 ~~~~~~~~~-----------------~~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~  291 (316)
T cd05574         239 ETFSNILKK-----------------EVTFP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF  291 (316)
T ss_pred             HHHHHHhcC-----------------CccCC----------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence            655544321                 00000          01126899999999999999999999    999999999


Q ss_pred             ccCCCCCCCCC
Q 016085          343 FDELRDPNARL  353 (395)
Q Consensus       343 f~~~~~~~~~~  353 (395)
                      |+...++..+.
T Consensus       292 ~~~~~~~~~~~  302 (316)
T cd05574         292 FRGVNWALIRH  302 (316)
T ss_pred             hhcCChhhccc
Confidence            99998877665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-38  Score=307.31  Aligned_cols=263  Identities=38%  Similarity=0.682  Sum_probs=204.6

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhc-CCCceEee-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVHYS-------------  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l-~h~ni~~~-------------  149 (395)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+.+.      .....+|+.+++.+ +|+||...             
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            35799999999999999999999999999999987532      22345799999999 99998110             


Q ss_pred             -------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--
Q 016085          150 -------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--  214 (395)
Q Consensus       150 -------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--  214 (395)
                                   .....+.+..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.......  
T Consensus        86 lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          86 LVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIH-SGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEEN  163 (337)
T ss_pred             EEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-cEEEeeccchhcccccccc
Confidence                         00125677788889999999999999 88999999999999999888 69999999987654332  


Q ss_pred             ----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          215 ----PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       215 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                          ......+|..|+|||.+.+...++.++|+|||||++|+|++|+.||.+....+....+....+.+..+.+..+...
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP  243 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence                1223567899999998876566889999999999999999999999999888888888888888776655443221


Q ss_pred             CccccC---CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCC
Q 016085          291 YTEFKF---PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPN  355 (395)
Q Consensus       291 ~~~~~~---~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  355 (395)
                      +.....   .......... ..+.++.++.+||.+||+.||++|||+.++++||||+.+..+......
T Consensus       244 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~  310 (337)
T cd07852         244 FAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVL  310 (337)
T ss_pred             hHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCC
Confidence            111111   1111111111 223378999999999999999999999999999999998776544433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=319.90  Aligned_cols=228  Identities=25%  Similarity=0.369  Sum_probs=186.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCce---------------E----
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNV---------------H----  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni---------------~----  147 (395)
                      +.|.|+..||.|+||+||+|.++.++-..|.|++....    ....-|+.||..++||+|               .    
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            35999999999999999999999998888999874322    223359999999999998               1    


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc-cCCCccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNIS  218 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~-~~~~~~~  218 (395)
                              ...-...+.+..++.+++|+|.||+||| +.+|||||||..|||+..+| .|+|+|||.+.... ......+
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH-s~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH-SQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh-hcchhhhhccccceEEEecC-cEeeecccccccchhHHhhhcc
Confidence                    1122467899999999999999999999 88999999999999999999 69999999875442 2234457


Q ss_pred             ccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          219 YICSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      +.|||+|||||++..    ...|++++||||||++|.||..+.+|-...+....+.+|.+.-  |+              
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--PP--------------  253 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP--------------  253 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--CC--------------
Confidence            899999999999842    3459999999999999999999999998888877777765521  11              


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                ...-+...+..+.|||.+||..||..||+++++|+||||+++
T Consensus       254 ----------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  254 ----------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             ----------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence                      001122346789999999999999999999999999999854

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=298.06  Aligned_cols=248  Identities=41%  Similarity=0.759  Sum_probs=198.3

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE-----------------e-
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH-----------------Y-  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~-----------------~-  148 (395)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+....      ....+|+.+++.++|+|+.                 + 
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            677899999999999999999999999999885432      2345799999999999970                 0 


Q ss_pred             --------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccccc
Q 016085          149 --------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISY  219 (395)
Q Consensus       149 --------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~  219 (395)
                              ......+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||.+....... .....
T Consensus        81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-SHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH-HCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCCCcccccCc
Confidence                    011246788899999999999999999 88999999999999999877 69999999987764433 22234


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCC
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFP  297 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~  297 (395)
                      .++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+.+..+...++.+....+.....  .+....++
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            5788899999987764689999999999999999999999999998899999988888887766654433  11222222


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ....... ......++.++.+||.+||++||.+||++.++++||||
T Consensus       239 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         239 KKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            2111111 11234578999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.8e-38  Score=302.60  Aligned_cols=258  Identities=38%  Similarity=0.724  Sum_probs=202.2

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEee--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYS--------------  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~--------------  149 (395)
                      +++|.+.+.||.|+||.||+|++..+++.||||++.+.      .....+|+.+++.++|||+...              
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv   88 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV   88 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence            45799999999999999999999999999999987532      2345579999999999998110              


Q ss_pred             -----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          150 -----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       150 -----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                                 .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++.....  ....
T Consensus        89 ~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH-~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~~~--~~~~  164 (328)
T cd07856          89 TELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH-SAGVVHRDLKPSNILINENC-DLKICDFGLARIQDP--QMTG  164 (328)
T ss_pred             eehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEeECCCC-CEEeCccccccccCC--CcCC
Confidence                       01245677788889999999999999 88999999999999999877 699999999875422  2234


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc-cc--c
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT-EF--K  295 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~--~  295 (395)
                      ..++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......+.+.++.++.+........-. .+  .
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (328)
T cd07856         165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS  244 (328)
T ss_pred             CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence            56788999999886645589999999999999999999999999888888888888888888766543221100 00  0


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  352 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  352 (395)
                      .+.....+.. .....++..+.++|.+||+.+|++|||+.+++.||||...+.+...
T Consensus       245 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~  300 (328)
T cd07856         245 LPKREPVPFS-EKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE  300 (328)
T ss_pred             ccccCCCcHH-HHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence            0000001111 1123468899999999999999999999999999999988877544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=299.57  Aligned_cols=275  Identities=27%  Similarity=0.451  Sum_probs=206.2

Q ss_pred             CCCcccceEEeecCCCCCCCccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHH---HHHHHHHhcC--
Q 016085           68 NGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLD--  142 (395)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~---~E~~~l~~l~--  142 (395)
                      .....|.+....+|.    ....++|.+.++||.|-|++||+|.|..+.+.||+|+++....+.+   .||++|+.++  
T Consensus        59 ~dY~kGGYHpV~IGD----~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~  134 (590)
T KOG1290|consen   59 EDYRKGGYHPVRIGD----VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG  134 (590)
T ss_pred             hhhhcCCCceeeccc----cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence            344556666665554    4455789999999999999999999999999999999987655443   6899998873  


Q ss_pred             ---CCc---e-------------------------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccC
Q 016085          143 ---HPN---V-------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI  185 (395)
Q Consensus       143 ---h~n---i-------------------------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDl  185 (395)
                         |++   |                               ......+.++...++.|++||+.||.|||.++||||-||
T Consensus       135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDl  214 (590)
T KOG1290|consen  135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDL  214 (590)
T ss_pred             CCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCC
Confidence               222   1                               112345789999999999999999999999999999999


Q ss_pred             CCCceEEc------------------------------------------------------------------------
Q 016085          186 KPQNLLVN------------------------------------------------------------------------  193 (395)
Q Consensus       186 Kp~Nill~------------------------------------------------------------------------  193 (395)
                      ||+|||+.                                                                        
T Consensus       215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~  294 (590)
T KOG1290|consen  215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI  294 (590)
T ss_pred             CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence            99999971                                                                        


Q ss_pred             ------------------------------------------CC---------------------------C--------
Q 016085          194 ------------------------------------------PH---------------------------T--------  196 (395)
Q Consensus       194 ------------------------------------------~~---------------------------~--------  196 (395)
                                                                ..                           .        
T Consensus       295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~  374 (590)
T KOG1290|consen  295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI  374 (590)
T ss_pred             cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence                                                      00                           0        


Q ss_pred             ------------C----ceEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 016085          197 ------------H----QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF  260 (395)
Q Consensus       197 ------------~----~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  260 (395)
                                  .    ++||+|||.|.+..  ...+.-+.|+.|+|||++.|.. |++.+||||++|++|||+||..+|
T Consensus       375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLF  451 (590)
T KOG1290|consen  375 ASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLF  451 (590)
T ss_pred             ccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceee
Confidence                        0    36777777776642  2334556799999999999976 999999999999999999999999


Q ss_pred             CC------CCcHHHHHHHHHHhCCCCHHHHhhcCC--CCcc-----ccCCcccCCCcccc------cCCCCChhHHHHHH
Q 016085          261 PG------ESGVDQLVEIIKVLGTPTREEIKCMNP--NYTE-----FKFPQIKAHPWHKI------FHKRMPPEAVDLVS  321 (395)
Q Consensus       261 ~~------~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~------~~~~~s~~~~~ll~  321 (395)
                      .-      ..+.+.+..|++.+|..++.....-..  +|..     ..+..++..++...      ++..-..++.+||.
T Consensus       452 ePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~  531 (590)
T KOG1290|consen  452 EPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLS  531 (590)
T ss_pred             cCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHH
Confidence            52      235789999999999988876643221  1110     11112222222211      22233457899999


Q ss_pred             hhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          322 RLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       322 ~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      -||+++|++|+||+++|+|||++.+..+
T Consensus       532 PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  532 PMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HHHhcCccccccHHHHhcCccccCCCCC
Confidence            9999999999999999999999887654

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=320.98  Aligned_cols=224  Identities=29%  Similarity=0.403  Sum_probs=182.5

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCC-CcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-----------------ee
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLET-GETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-----------------YS  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~-~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-----------------~~  149 (395)
                      .|.+.+.||+|+||.||+|.+..+ ++.||+|.+...    .....+|+.+|+.++|+||.                 +.
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            499999999999999999998877 788999976432    23445799999999999981                 00


Q ss_pred             -------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          150 -------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       150 -------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                                   .....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....... 
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH-SRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-hCCEEECCcCHHhEEECCCC-cEEEEeCcCceecCCcccc
Confidence                         11235778889999999999999999 88999999999999999887 699999999987643321 


Q ss_pred             --cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          216 --NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       216 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                        ....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....              +. 
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~--------------~~-  289 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK--------------YD-  289 (478)
T ss_pred             ccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------CC-
Confidence              33457899999999987654 8999999999999999999999998877665555544310              00 


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                   .++..++.++.+||.+||..||++||++.+++.|+|++.+
T Consensus       290 -------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        290 -------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                         1223478899999999999999999999999999998654

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.6e-38  Score=298.02  Aligned_cols=230  Identities=27%  Similarity=0.444  Sum_probs=179.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEe-----------------e
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY-----------------S  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~-----------------~  149 (395)
                      +|.+.++||+|+||.||+|.+..+++.||+|.+..+.     ....+|+.+++.++|+|+..                 .
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            5889999999999999999999999999999886431     23457999999999999811                 0


Q ss_pred             c-----cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccccccccc
Q 016085          150 R-----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY  224 (395)
Q Consensus       150 ~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~  224 (395)
                      .     ....+++..+..++.|++.||.||| +.||+|+||||+|||++.++ .++|+|||++...... .....++|..
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~  158 (279)
T cd06619          82 DGGSLDVYRKIPEHVLGRIAVAVVKGLTYLW-SLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNS-IAKTYVGTNA  158 (279)
T ss_pred             CCCChHHhhcCCHHHHHHHHHHHHHHHHHHH-HCCEeeCCCCHHHEEECCCC-CEEEeeCCcceecccc-cccCCCCChh
Confidence            0     1234678888999999999999999 89999999999999999888 6999999999765432 2334678999


Q ss_pred             ccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQ---LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       225 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+|||.+.+.. ++.++|+|||||++|+|++|+.||........   ............               .+    
T Consensus       159 y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------~~----  218 (279)
T cd06619         159 YMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---------------PP----  218 (279)
T ss_pred             hcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------------CC----
Confidence            99999997654 89999999999999999999999965322110   001111100000               00    


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                          .......++++.+||.+||+.||.+||++.++++||||.....
T Consensus       219 ----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         219 ----VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             ----CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence                0012236789999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-38  Score=295.75  Aligned_cols=249  Identities=35%  Similarity=0.633  Sum_probs=194.5

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE-----ee------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH-----YS------------  149 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~-----~~------------  149 (395)
                      |.+.+.||.|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++|+|+.     ..            
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999999999999999987542      2345799999999999971     00            


Q ss_pred             -----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--Cc
Q 016085          150 -----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--PN  216 (395)
Q Consensus       150 -----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--~~  216 (395)
                                 .....+++..++.++.||+.||+||| +.|++|+||||+||+++.++ .++|+|||++.......  ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH-~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH-SNGILHRDIKGSNILINNDG-VLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCcHHHeEEcCCC-CEEEccccceeeccCCCcccc
Confidence                       11146788899999999999999999 88999999999999999887 69999999998764432  12


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC--Cccc
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--YTEF  294 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~  294 (395)
                      ....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+....+..+....+.+....+......  +...
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            33456888999998876556899999999999999999999999998888888888888887776655432211  0000


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      .............+...++..+.++|++||++||.+||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            0000000111112222248899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3e-38  Score=297.76  Aligned_cols=224  Identities=29%  Similarity=0.458  Sum_probs=185.5

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...       .....+|+++++.++|+||.                 
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            599999999999999999999999999999988643       23345799999999999970                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                               +......+++..+..++.||+.||.||| +.||+||||+|+|||++.++ .+||+|||++......  ...
T Consensus        82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH-~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~--~~~  157 (290)
T cd05580          82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH-SLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR--TYT  157 (290)
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC--CCC
Confidence                     1122356888899999999999999999 89999999999999999887 6999999999876443  334


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      ..+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+...  .                    
T Consensus       158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~--------------------  214 (290)
T cd05580         158 LCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K--------------------  214 (290)
T ss_pred             CCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C--------------------
Confidence            56789999999987654 889999999999999999999999877654444443320  0                    


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                             ..++..++..+.++|.+||+.||.+|+     ++.++++||||+.+.+.
T Consensus       215 -------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         215 -------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             -------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence                   012334688999999999999999999     89999999999988764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.5e-38  Score=304.50  Aligned_cols=253  Identities=38%  Similarity=0.559  Sum_probs=195.5

Q ss_pred             ccee-eeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh------------------hHHHHHHHHHhcCCCceE----
Q 016085           91 ISYM-AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------------------YKNRELQTMRLLDHPNVH----  147 (395)
Q Consensus        91 ~~y~-~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------------------~~~~E~~~l~~l~h~ni~----  147 (395)
                      .+|. +.+.||.|+||.||+|.+..+++.||||++.....                  ...+|+.+++.++|+||.    
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3565 45789999999999999999999999998854321                  245799999999999971    


Q ss_pred             ---------------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCC
Q 016085          148 ---------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  206 (395)
Q Consensus       148 ---------------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~  206 (395)
                                           +......+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||+
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH-~~~i~H~dl~~~nill~~~~-~~kl~dfg~  165 (335)
T PTZ00024         88 VYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLH-KWYFMHRDLSPANIFINSKG-ICKIADFGL  165 (335)
T ss_pred             EEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeecccccHHHeEECCCC-CEEECCccc
Confidence                                 0112346788899999999999999999 89999999999999999887 699999999


Q ss_pred             ccccccC---------------CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 016085          207 AKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVE  271 (395)
Q Consensus       207 a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  271 (395)
                      +......               .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            8765411               1112234578899999997765579999999999999999999999999998888999


Q ss_pred             HHHHhCCCCHHHHhhcC--CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          272 IIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       272 i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      +...++.|....|....  +.+..+.  ....... .......+..+.+||.+||+.+|++|||+.++|.||||+....
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~  321 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFT--PRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL  321 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccC--cCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence            99988888765443221  1111110  0000001 1122346889999999999999999999999999999986543

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.8e-38  Score=330.89  Aligned_cols=232  Identities=29%  Similarity=0.410  Sum_probs=184.0

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe--------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY--------------  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~--------------  148 (395)
                      ...+|++++.||+|+||.||+|++..+++.||+|++...      ...+.+|+.+|+.|+|+||..              
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            345799999999999999999999999999999988532      234557999999999999710              


Q ss_pred             -----e-------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCC-------CeeeccCCCCceEEcCCC-------
Q 016085          149 -----S-------------RASQRMPLIYVKLYTYQICRALAYIHGGI-------GVCHRDIKPQNLLVNPHT-------  196 (395)
Q Consensus       149 -----~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-------giiHrDlKp~Nill~~~~-------  196 (395)
                           .             .....+++..++.|+.||+.||.||| +.       +||||||||+||||+...       
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH-s~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH-NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-hcccccccCCceeccCcHHHeEeecCcccccccc
Confidence                 0             01245888899999999999999999 53       599999999999996421       


Q ss_pred             ---------CceEEeecCCccccccCCCcccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH
Q 016085          197 ---------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLFPGESGV  266 (395)
Q Consensus       197 ---------~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  266 (395)
                               ..+||+|||++............+||+.|+|||++.+. ..++.++||||||||||+|++|..||...+..
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~  249 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF  249 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence                     14899999999876444444456789999999998643 34789999999999999999999999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       267 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      ..+...+...  +                  ..        .....+.++.+||.+||.++|.+||++.++|.|+||..+
T Consensus       250 ~qli~~lk~~--p------------------~l--------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        250 SQLISELKRG--P------------------DL--------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHHHHHHhcC--C------------------CC--------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            5444333210  0                  00        012257899999999999999999999999999999877


Q ss_pred             CCC
Q 016085          347 RDP  349 (395)
Q Consensus       347 ~~~  349 (395)
                      ..+
T Consensus       302 ~~p  304 (1021)
T PTZ00266        302 GPP  304 (1021)
T ss_pred             CCC
Confidence            554

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-39  Score=323.43  Aligned_cols=255  Identities=22%  Similarity=0.276  Sum_probs=174.5

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCc-EEEEE------------------Eeecc---hhhHHHHHHHHHhcCCCceE
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGE-TVAIK------------------KVLQD---KRYKNRELQTMRLLDHPNVH  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~-~vAiK------------------~~~~~---~~~~~~E~~~l~~l~h~ni~  147 (395)
                      ..+|++++.||+|+||+||+|..+.... .++.|                  .+...   .....+|+.+|+.++|+||.
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3579999999999999999987653322 22222                  11111   22346899999999999981


Q ss_pred             ee------------------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC
Q 016085          148 YS------------------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH  197 (395)
Q Consensus       148 ~~------------------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~  197 (395)
                      ..                              ..........++.++.||+.||.||| ++||+||||||+|||++.++ 
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH-~~gIiHrDLKP~NILl~~~~-  304 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH-DKKLIHRDIKLENIFLNCDG-  304 (501)
T ss_pred             cEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-
Confidence            10                              00112234567789999999999999 88999999999999999887 


Q ss_pred             ceEEeecCCccccccCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCC--CCcHHHHHHH
Q 016085          198 QVKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPL-FPG--ESGVDQLVEI  272 (395)
Q Consensus       198 ~ikl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~--~~~~~~~~~i  272 (395)
                      .+||+|||+++.......  ....+||+.|+|||++.+.. ++.++|||||||++|||++|..+ |.+  .....++.++
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            699999999987643322  22467899999999997754 89999999999999999998754 432  2344566666


Q ss_pred             HHHhCCCCHHHHhh---cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          273 IKVLGTPTREEIKC---MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       273 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      +..++.+..+....   +........+...............++.++.++|.+||++||.+|||+.|+|.||||....
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence            66554332221000   0000000000000000000011224677899999999999999999999999999997753

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=317.84  Aligned_cols=222  Identities=30%  Similarity=0.490  Sum_probs=181.2

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCce---------------------------
Q 016085           98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNV---------------------------  146 (395)
Q Consensus        98 ~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni---------------------------  146 (395)
                      +||+|.||+||-|+|+.|....|||.+...    ......|+.+-+.|.|.||                           
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            799999999999999999999999988533    3455689999999999998                           


Q ss_pred             EeeccCCCC--cHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc-ccccccc
Q 016085          147 HYSRASQRM--PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSR  223 (395)
Q Consensus       147 ~~~~~~~~~--~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~-~~~~gt~  223 (395)
                      .+....+++  .+..+-+|..||++||.||| ...|||||||-+|+|++...+.+||+|||-+++...-.+. .++.||.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH-en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTL  740 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH-ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTL  740 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh-hcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccch
Confidence            111234556  78889999999999999999 8899999999999999988779999999999987654443 4677899


Q ss_pred             cccccccc-cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCC
Q 016085          224 YYRAPELI-FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  302 (395)
Q Consensus       224 ~y~aPE~~-~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (395)
                      .|||||++ .|...|+.++|||||||++.||.||++||.......  ..++++ |               -        .
T Consensus       741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkV-G---------------m--------y  794 (1226)
T KOG4279|consen  741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKV-G---------------M--------Y  794 (1226)
T ss_pred             hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhh-c---------------c--------e
Confidence            99999999 455679999999999999999999999996432211  112221 0               0        0


Q ss_pred             CcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       303 ~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      +....++..++.+++.||.+|+.+||.+||+|.++|..||++.-
T Consensus       795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            11223556688999999999999999999999999999999765

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=311.39  Aligned_cols=222  Identities=31%  Similarity=0.461  Sum_probs=186.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .|.-++.||.|+||.||-|+|..+.+.||||++....       ..+..|+..|+.|+|||+.                 
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3888899999999999999999999999999985332       3345799999999999971                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                               ......++-+..+..|+.+.+.||.||| +.+.||||||..||||+..| .|||+|||.|....   +..+
T Consensus       107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH-S~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~---PAns  181 (948)
T KOG0577|consen  107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-SHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMA---PANS  181 (948)
T ss_pred             HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH-HhhHHhhhccccceEecCCC-eeeeccccchhhcC---chhc
Confidence                     1123467888889999999999999999 89999999999999999888 79999999997653   3468


Q ss_pred             cccccccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          219 YICSRYYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ++|||+|||||+++  ....|+-++||||||++..||.-+++|+...+....++.|... ..                  
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-es------------------  242 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ES------------------  242 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CC------------------
Confidence            99999999999995  3345999999999999999999999999888888888777552 11                  


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      |.+...        .-|..+..|+.+||++-|.+|||++++|+|+|+..
T Consensus       243 PtLqs~--------eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  243 PTLQSN--------EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             CCCCCc--------hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence            111111        23788999999999999999999999999999865

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.1e-38  Score=295.40  Aligned_cols=231  Identities=27%  Similarity=0.395  Sum_probs=182.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceEe------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVHY------------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~~------------------  148 (395)
                      +.|++.+.||.|+||.||+|++..+++.||+|.+....    ....+|+.+++.++|+|+..                  
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            46999999999999999999999999999999986432    23456999999999999811                  


Q ss_pred             ---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccc
Q 016085          149 ---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNIS  218 (395)
Q Consensus       149 ---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~  218 (395)
                               ......+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++....... ....
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~  169 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH-SMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDS  169 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh-cCCeeecCCCcceEEEcCCC-CEEEccCccceeccccccccce
Confidence                     011345788899999999999999999 88999999999999999877 69999999987543221 1234


Q ss_pred             ccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          219 YICSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ..+++.|+|||.+.+    ...++.++|+|||||++|+|++|..||...+.......+...   ..              
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~--------------  232 (292)
T cd06644         170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EP--------------  232 (292)
T ss_pred             ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CC--------------
Confidence            567889999999852    233688999999999999999999999776654433333210   00              


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                        +       ....+..++.++.+||.+||..||++||++.++++||||..+...
T Consensus       233 --~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         233 --P-------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             --c-------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence              0       001123467899999999999999999999999999999887654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-38  Score=292.68  Aligned_cols=248  Identities=41%  Similarity=0.733  Sum_probs=196.1

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcC-CCce-----------------Ee-
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNV-----------------HY-  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~-h~ni-----------------~~-  148 (395)
                      |++.+.||+|+||+||+|++..+++.||||.+....     ....+|+..++.+. |+|+                 .+ 
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            678899999999999999999899999999876432     13346889999999 9997                 00 


Q ss_pred             -------ecc--CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccc
Q 016085          149 -------SRA--SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY  219 (395)
Q Consensus       149 -------~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~  219 (395)
                             ...  ...+++..+..++.|++.+|.||| +.|++|+||+|+||+++.++ .++|+|||++............
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh-~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~  158 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH-KHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDY  158 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEEcCCC-CEEEeecccceeccCCCCcCCC
Confidence                   011  136788999999999999999999 88999999999999999877 6999999999876544444456


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCC
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFP  297 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~  297 (395)
                      .++..|+|||++.+...++.++|+||||+++++|++|++||.+.+..+.+..+...++.+....+.....  ......++
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07830         159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP  238 (283)
T ss_pred             CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence            6788999999886655589999999999999999999999999999999999999888887655432211  11111222


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ..........++ ..+..+.+||++||+.||++|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         239 QFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            222111111122 237889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.6e-38  Score=292.57  Aligned_cols=222  Identities=29%  Similarity=0.455  Sum_probs=174.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhHHHHHHHHHhcCCCceEe--------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVHY--------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~ni~~--------------  148 (395)
                      +|.+.+.||+|+||.||+|.+..++..||+|.+...         .....+|+.+++.++|+||..              
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            599999999999999999999999999999987532         134567999999999999810              


Q ss_pred             --------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-
Q 016085          149 --------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  213 (395)
Q Consensus       149 --------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-  213 (395)
                                    ......+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||+++..... 
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH-~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH-SNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEECCCC-CEEEccCCCcccccccc
Confidence                          011234677788889999999999999 89999999999999999877 6999999998764321 


Q ss_pred             ---CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          214 ---EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       214 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                         .......++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||........+..+...   +.          
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~----------  226 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT----------  226 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC----------
Confidence               1112345788999999997654 899999999999999999999999766544333322210   00          


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                                    ...++..+++.+.+|| +||..+|++||++.|+++||||+
T Consensus       227 --------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 --------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             --------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                          0112334678899999 68889999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.6e-38  Score=293.80  Aligned_cols=225  Identities=25%  Similarity=0.404  Sum_probs=176.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhc-CCCceEe-----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVHY-----------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l-~h~ni~~-----------------  148 (395)
                      .+.|++.+.||+|+||.||+|++..+++.||+|.+...   .....+|+.+++.+ +|+|+..                 
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            34699999999999999999999999999999998643   33456788999888 6998710                 


Q ss_pred             ------e---------c--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          149 ------S---------R--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       149 ------~---------~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                            .         .  ....+++..+..++.|++.||.||| ++||+||||||+||+++.++ .++|+|||++....
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH-~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~~  162 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-QHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHEEECCCC-CEEEccCCCceecc
Confidence                  0         0  1235788888999999999999999 88999999999999999887 69999999987653


Q ss_pred             cCC-CcccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 016085          212 KGE-PNISYICSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       212 ~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  286 (395)
                      ... ......|+..|+|||++.+    ...++.++|+||+||++|+|++|..||...........+...           
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~-----------  231 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-----------  231 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC-----------
Confidence            221 2234567899999999853    224788999999999999999999999765443332222110           


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                                      .........++..+.+||.+||..||.+|||+.++++||||
T Consensus       232 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         232 ----------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ----------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                            00001123467899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.2e-37  Score=287.77  Aligned_cols=221  Identities=29%  Similarity=0.455  Sum_probs=178.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEee----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYS----------------  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~----------------  149 (395)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+.+++.++|+|+...                
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            499999999999999999999999999999988532      2234579999999999997100                


Q ss_pred             -------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          150 -------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       150 -------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                                   .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++........ 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH-~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH-EKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCchhEEEecCC-cEEEecccceEEecccCCc
Confidence                         01234688888999999999999999 88999999999999999877 699999999976643222 


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      .....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+.......+....                   
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-------------------  218 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-------------------  218 (257)
T ss_pred             cccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------------
Confidence            23356789999999987654 8899999999999999999999998776555444433210                   


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      .+         ..+..+++.+.+||.+||+.||++|||+.++++||||
T Consensus       219 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 LP---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CC---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00         1123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.6e-38  Score=296.59  Aligned_cols=233  Identities=23%  Similarity=0.374  Sum_probs=180.6

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcC-CCceEe-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLD-HPNVHY-----------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~-h~ni~~-----------------  148 (395)
                      +|...+.||+|+||.||++.+..+++.||+|.+...     .....+|+.++.++. |+||..                 
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            577888999999999999999999999999988643     223457888898886 999810                 


Q ss_pred             -------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 -------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 -------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                   ......+++..+..++.|++.||+|||++.||+||||||+||+++.++ .+||+|||+++.......
T Consensus        85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~  163 (288)
T cd06616          85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLVDSIA  163 (288)
T ss_pred             ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHhccCCc
Confidence                         001345788889999999999999999446999999999999999877 699999999976654444


Q ss_pred             cccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          216 NISYICSRYYRAPELIFGA--TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      .....++..|+|||.+.+.  ..++.++|||||||++|+|++|+.||.....  ....+.+.....              
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~--------------  227 (288)
T cd06616         164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGD--------------  227 (288)
T ss_pred             cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCC--------------
Confidence            4445678999999998765  3589999999999999999999999976541  222222211100              


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                        .+..     ....+..++..+.+||.+||+.||++|||+.++++||||.....
T Consensus       228 --~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         228 --PPIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             --CCcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence              0000     00112347889999999999999999999999999999987553

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-37  Score=292.97  Aligned_cols=231  Identities=27%  Similarity=0.452  Sum_probs=181.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCce-----------------Ee-
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNV-----------------HY-  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni-----------------~~-  148 (395)
                      +|++++.||+|+||.||+|++..+++.||+|.+...     .....+|+.+++.++|+||                 .+ 
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            589999999999999999999999999999987643     1234579999999999997                 00 


Q ss_pred             --------ecc---CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          149 --------SRA---SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       149 --------~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                              ...   ...+++..+..++.|++.||.|||++.||+||||||+||+++.++ .+||+|||++...... ...
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~-~~~  159 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVAS-LAK  159 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccCC-ccc
Confidence                    011   236889999999999999999999446999999999999999877 6999999998765332 223


Q ss_pred             cccccccccccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          218 SYICSRYYRAPELIFGAT-----EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      ...+++.|+|||.+.+..     .++.++|+|||||++|+|++|+.||...........+........            
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------  227 (286)
T cd06622         160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------------  227 (286)
T ss_pred             cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC------------
Confidence            446788999999885432     358899999999999999999999976554333333222111000            


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                                   ..++..++.++.+||.+||+.+|.+||++.++++||||......
T Consensus       228 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         228 -------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             -------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                         01233478999999999999999999999999999999887654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-39  Score=312.20  Aligned_cols=232  Identities=28%  Similarity=0.422  Sum_probs=198.5

Q ss_pred             CccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCce--------------
Q 016085           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV--------------  146 (395)
Q Consensus        87 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni--------------  146 (395)
                      ....+.|.+.+.||+|.|++|.+|++.-|+..||||++.+..      ....+|+++|+.|+||||              
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            344557999999999999999999999999999999986542      335689999999999998              


Q ss_pred             ------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          147 ------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       147 ------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                  .+.....++.+..++.++.|++.|++||| +++|+|||||.+||||+.+. .+||+|||++..+..+.
T Consensus       132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH-~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH-SKNIVHRDLKAENILLDENM-NIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHh-hcceeccccchhhccccccc-ceeeeccccceeecccc
Confidence                        23345678888999999999999999999 88999999999999999888 49999999999988777


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ...+++|++.|.|||++.|..+.++.+|+||+|+++|.|+.|..||.|.+-...-...+.                 ..+
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-----------------gk~  272 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR-----------------GKY  272 (596)
T ss_pred             cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-----------------eee
Confidence            788999999999999999988889999999999999999999999998764322111111                 011


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                                  .++..++.++.+||+++|..+|.+|++..++.+|.|.......
T Consensus       273 ------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  273 ------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             ------------cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                        1334488999999999999999999999999999999876654

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-40  Score=310.92  Aligned_cols=221  Identities=33%  Similarity=0.566  Sum_probs=185.9

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeec------chhhHHHHHHHHHhcCCCce-----------------------
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNV-----------------------  146 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l~h~ni-----------------------  146 (395)
                      .++||+|.||+||-|.++++|+.||||++.+      ......+|+.||+.+.||.|                       
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            3699999999999999999999999999854      34566789999999999987                       


Q ss_pred             ----EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC--ceEEeecCCccccccCCCccccc
Q 016085          147 ----HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYI  220 (395)
Q Consensus       147 ----~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~--~ikl~DFG~a~~~~~~~~~~~~~  220 (395)
                          .+....+++++...+++..||+.||.||| -++|+|+||||+|||+.+...  ++||||||+|+.+.+..-..+.+
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH-~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV  727 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH-FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV  727 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh-hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence                12234678999999999999999999999 899999999999999975432  79999999999998777777899


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI  299 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (395)
                      |||.|+|||++..+. |...-|+||+|||+|.-|.|..||.. ++..+++++.                    .|-+   
T Consensus       728 GTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA--------------------aFMy---  783 (888)
T KOG4236|consen  728 GTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA--------------------AFMY---  783 (888)
T ss_pred             CCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchhHHhhcc--------------------cccc---
Confidence            999999999998755 99999999999999999999999954 3333443321                    1111   


Q ss_pred             cCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       300 ~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      +..+|     ..+++.+.|||..+|+..-.+|.+....|.|||+++.
T Consensus       784 Pp~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  784 PPNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             CCCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            12233     3479999999999999999999999999999999864

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=290.33  Aligned_cols=248  Identities=40%  Similarity=0.725  Sum_probs=198.9

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE---------------e---
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH---------------Y---  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~---------------~---  148 (395)
                      |++.+.||+|+||.||+|++..+++.||+|.+....      ....+|+.+++.++|+|+.               +   
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            677889999999999999999999999999886532      2345799999999999970               0   


Q ss_pred             -------ecc-CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccccc
Q 016085          149 -------SRA-SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISY  219 (395)
Q Consensus       149 -------~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~  219 (395)
                             ... ...+++..+..++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||+++...... .....
T Consensus        81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH-SHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChheEEEcCCC-CEEEecCCcccccCCCccccCcc
Confidence                   011 146788999999999999999999 88999999999999999877 69999999987654332 22234


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC-CccccCCc
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-YTEFKFPQ  298 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~  298 (395)
                      .++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+....+..+....+.+....|...... +....++.
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            45788999999877646899999999999999999999999999988999999999998888777544322 12223333


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      .........+ +.++..+.++|++||..||++||++.++++||||
T Consensus       239 ~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            3333332222 2358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6e-38  Score=300.98  Aligned_cols=249  Identities=23%  Similarity=0.368  Sum_probs=176.2

Q ss_pred             eeeeeccC--CceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------ee
Q 016085           95 AERVVGQG--SFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------YS  149 (395)
Q Consensus        95 ~~~~lG~G--~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------~~  149 (395)
                      ++++||+|  +||+||++++..+|+.||+|.+...      .....+|+.+++.++|+||.                 +.
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  7899999999999999999998643      23456799999999999981                 00


Q ss_pred             -----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC---
Q 016085          150 -----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---  215 (395)
Q Consensus       150 -----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---  215 (395)
                                 .....+++..++.++.|++.||.||| +.||+||||||+|||++.++ .++++|||.+........   
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH-HMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCChhhEEEecCC-cEEEcccchhhcccccccccc
Confidence                       11234788899999999999999999 88999999999999999887 699999986543321111   


Q ss_pred             -----cccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC---------
Q 016085          216 -----NISYICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT---------  280 (395)
Q Consensus       216 -----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------  280 (395)
                           .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+............  +..+         
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~  237 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchh
Confidence                 1123457779999998653 3489999999999999999999999987554433322221  1111         


Q ss_pred             HHHHhhcC------CCCccccC----CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          281 REEIKCMN------PNYTEFKF----PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       281 ~~~~~~~~------~~~~~~~~----~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      .+.+....      ..+.....    ...............+++.+.+||.+||++||++|||+.++++||||+.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            00000000      00000000    000000001112345678999999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.7e-38  Score=290.80  Aligned_cols=227  Identities=27%  Similarity=0.485  Sum_probs=179.1

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----------hhHHHHHHHHHhcCCCceE--------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----------~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      +|+..+.||+|+||.||+|.+..+++.||+|++....          ....+|+.+++.++|+|+.              
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            3888899999999999999999999999999886422          3445799999999999970              


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                  +......+++..+..++.||+.||.||| +.|++||||||+||+++.+++.+||+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH-~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH-ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence                        1112346788889999999999999999 889999999999999987776799999999876643211


Q ss_pred             -----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          216 -----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       216 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                           .....+|..|+|||.+.+.. ++.++|+|||||++|+|++|..||...........+......            
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------  226 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA------------  226 (268)
T ss_pred             cCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc------------
Confidence                 12345688999999987654 899999999999999999999999765443333322221000            


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                                  .....++..+++++.+++.+||..+|.+|||+.++++||||+
T Consensus       227 ------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 ------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                        000113344788999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.9e-38  Score=290.08  Aligned_cols=221  Identities=31%  Similarity=0.521  Sum_probs=177.3

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------------hhHHHHHHHHHhcCCCceE-----------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------------~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+....             ....+|+.+++.++|+||.           
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4888999999999999999999999999999875321             2345799999999999971           


Q ss_pred             ------e---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          148 ------Y---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 ------~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                            +         ......+++..+..++.|++.||+||| +.|++||||+|+||+++.++ .++|+|||+++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH-~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH-NRGIIHRDIKGANILVDNKG-GIKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHH-hcCcccccCCHHHEEEcCCC-CEEecccCCCccccc
Confidence                  0         112345788888999999999999999 88999999999999999887 699999999877642


Q ss_pred             CCC-------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 016085          213 GEP-------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       213 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                      ...       .....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||.+.+....+..+...          
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------  227 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN----------  227 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc----------
Confidence            211       11245788899999987654 889999999999999999999999876554443332220          


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                               ..         ..++..++..+.++|++||+.||.+||++.++++||||
T Consensus       228 ---------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 ---------AS---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ---------CC---------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                     00         01233478899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.9e-38  Score=302.25  Aligned_cols=221  Identities=27%  Similarity=0.412  Sum_probs=169.0

Q ss_pred             cccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecc-----hhhHHHHHHHHHhc-CCCceEeec-------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVHYSR-------  150 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~ni~~~~-------  150 (395)
                      ..++|++.+.||+|+||.||+|.+.     .+++.||+|++...     .....+|+.+++.+ +|+||....       
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3457999999999999999999752     44578999998643     23355799999999 899981100       


Q ss_pred             --------------------c-----------------------------------------------------------
Q 016085          151 --------------------A-----------------------------------------------------------  151 (395)
Q Consensus       151 --------------------~-----------------------------------------------------------  151 (395)
                                          .                                                           
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence                                0                                                           


Q ss_pred             ---CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC---cccccccccc
Q 016085          152 ---SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYY  225 (395)
Q Consensus       152 ---~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y  225 (395)
                         ...+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.......   .....+++.|
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLA-SRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHH-HCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCccc
Confidence               123566677889999999999999 88999999999999999877 699999999976533221   1123446789


Q ss_pred             cccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCc
Q 016085          226 RAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW  304 (395)
Q Consensus       226 ~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (395)
                      +|||++.+.. ++.++|||||||++|||++ |..||.+......+...+.. +.              .           
T Consensus       243 ~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~--------------~-----------  295 (338)
T cd05102         243 MAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GT--------------R-----------  295 (338)
T ss_pred             cCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CC--------------C-----------
Confidence            9999997654 8999999999999999997 99999876544433332221 00              0           


Q ss_pred             ccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       305 ~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                       ...+...++.+.+|+.+||+.||.+|||+.++++
T Consensus       296 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         296 -MRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             0112346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.2e-37  Score=290.24  Aligned_cols=227  Identities=29%  Similarity=0.455  Sum_probs=175.2

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHH-HHHhcCCCceEe-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQ-TMRLLDHPNVHY-----------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~-~l~~l~h~ni~~-----------------  148 (395)
                      +|++.+.||+|+||.||+|+++.+|+.||||.+....     .....|+. .++.++|+|+..                 
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            6999999999999999999999999999999886432     12223444 467789999710                 


Q ss_pred             ------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCC-CeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 ------------SRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 ------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                  ......+++..+..++.||+.||.||| +. +++||||||+||+++.++ .+||+|||++........
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~  159 (283)
T cd06617          82 MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVA  159 (283)
T ss_pred             hcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCeecCCCCHHHEEECCCC-CEEEeecccccccccccc
Confidence                        012245788999999999999999999 65 999999999999999887 699999999987644333


Q ss_pred             cccccccccccccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          216 NISYICSRYYRAPELIFGA---TEYTTAVDIWSVGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      .....++..|+|||.+.+.   ..++.++|+|||||++|+|++|+.||... ...+.+..+...  ..            
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------------  225 (283)
T cd06617         160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PS------------  225 (283)
T ss_pred             cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CC------------
Confidence            3335678899999988542   33688999999999999999999999643 222333332220  00            


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                           +.        .....++.++.+||.+||..+|.+|||+.++++||||....
T Consensus       226 -----~~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         226 -----PQ--------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             -----CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                 00        01123688999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3e-37  Score=292.17  Aligned_cols=251  Identities=31%  Similarity=0.510  Sum_probs=194.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEee--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHYS--------------  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~~--------------  149 (395)
                      ..+|.+.+.||.|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++|+|+...              
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            346999999999999999999999999999999986432      234579999999999998210              


Q ss_pred             ----------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCc
Q 016085          150 ----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  207 (395)
Q Consensus       150 ----------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a  207 (395)
                                            .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~i~H~dl~p~nili~~~~-~~kl~dfg~~  163 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH-KKNFLHRDIKCSNILLNNKG-QIKLADFGLA  163 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-cEEeCccccc
Confidence                                  01235788899999999999999999 88999999999999999887 6999999999


Q ss_pred             cccccCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 016085          208 KVLVKGEP--NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       208 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                      ........  .....++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+..+.+....+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP  243 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            76543321  1223457789999988665557899999999999999999999999888888888888887777665443


Q ss_pred             hcCC--CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          286 CMNP--NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       286 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ....  .+............+. .....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            2211  1110000000001111 1223468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.7e-37  Score=293.85  Aligned_cols=229  Identities=30%  Similarity=0.448  Sum_probs=184.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceEe-----------------e
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVHY-----------------S  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~~-----------------~  149 (395)
                      .+|.+.+.||.|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++|+|+..                 .
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4699999999999999999999999999999988543    234457999999999999810                 0


Q ss_pred             --------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccccc
Q 016085          150 --------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYI  220 (395)
Q Consensus       150 --------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~~  220 (395)
                              .....+++..+..++.|++.||+||| +.|++||||||+||+++.++ .+||+|||++........ .....
T Consensus        99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH-~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  176 (296)
T cd06655          99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH-ANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMV  176 (296)
T ss_pred             CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEccCccchhcccccccCCCcC
Confidence                    11235788999999999999999999 88999999999999999877 699999999876543322 22346


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      ++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||.+.+....+..+... +.+.                    
T Consensus       177 ~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~--------------------  234 (296)
T cd06655         177 GTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------------------  234 (296)
T ss_pred             CCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc--------------------
Confidence            788999999987654 899999999999999999999999887765554443221 0000                    


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                           ...+..+++.+.+||++||..||++|||+.+++.||||+....
T Consensus       235 -----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         235 -----LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             -----cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence                 0112347889999999999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=291.33  Aligned_cols=226  Identities=28%  Similarity=0.428  Sum_probs=182.8

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------------ee
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------------YS  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------------~~  149 (395)
                      +|.+.+.||.|+||.||+|++..+++.||+|.+....     ....+|+.+++.++|+|+.                 +.
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            6999999999999999999999999999999886432     3456799999999999971                 00


Q ss_pred             --------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCccccc
Q 016085          150 --------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYI  220 (395)
Q Consensus       150 --------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~  220 (395)
                              .....+++..+..++.|++.||.||| +.|++||||+|+||+++.++ .++|+|||+++..... .......
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~  159 (274)
T cd06609          82 GGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH-EEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRNTFV  159 (274)
T ss_pred             CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCC-CEEEcccccceeeccccccccccc
Confidence                    01236889999999999999999999 88999999999999999887 6999999999876543 2223456


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      +++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+.......+....                   .+   
T Consensus       160 ~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------------~~---  216 (274)
T cd06609         160 GTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-------------------PP---  216 (274)
T ss_pred             CCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-------------------CC---
Confidence            788999999997755 8999999999999999999999997766444333322210                   00   


Q ss_pred             CCCcccccCC-CCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          301 AHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       301 ~~~~~~~~~~-~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                            .+.. .++.++.++|.+||..+|++|||+.++++||||.....
T Consensus       217 ------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         217 ------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             ------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence                  0111 16789999999999999999999999999999977543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.8e-37  Score=284.89  Aligned_cols=222  Identities=30%  Similarity=0.459  Sum_probs=181.3

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------e
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+.+++.++|+|+.                 +
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            489999999999999999999999999999988542      23456799999999999971                 0


Q ss_pred             e-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          149 S-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       149 ~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                      .           .....+++..+..++.|++.||+||| ++||+||||||+||+++.++..+||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH-TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            0           01234788889999999999999999 88999999999999998766578999999998765544444


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ...++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+.......+.....                    
T Consensus       160 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~--------------------  218 (256)
T cd08220         160 TVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF--------------------  218 (256)
T ss_pred             ccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC--------------------
Confidence            567789999999997654 88999999999999999999999987765544444332100                    


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                              ..++..++..+.+++.+||..||.+|||+.++++||||
T Consensus       219 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         219 --------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             --------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                    01223468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-37  Score=291.99  Aligned_cols=227  Identities=26%  Similarity=0.370  Sum_probs=181.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceE-----------------e--
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVH-----------------Y--  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~-----------------~--  148 (395)
                      -|++.+.||.|+||.||+|.+..++..+|+|.+....    ....+|+.+++.++|+|+.                 +  
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3789999999999999999999999999999885432    2345799999999999981                 0  


Q ss_pred             --------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccccc
Q 016085          149 --------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISY  219 (395)
Q Consensus       149 --------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~  219 (395)
                              ......+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++....... .....
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH-ENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCcccEEEccCC-CEEEccccccccccccccccccc
Confidence                    012356788899999999999999999 88999999999999999887 69999999987653322 12345


Q ss_pred             cccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          220 ICSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       220 ~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      .+|+.|+|||++..    ...++.++|+||+||++|+|++|++||...+..+....+......              .  
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--------------~--  227 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--------------T--  227 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC--------------C--
Confidence            67899999998842    234778999999999999999999999887765555544331100              0  


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                ...+..++..+.+||.+||+.||.+|||+.++++||||...
T Consensus       228 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         228 ----------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                      01123467899999999999999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=274.80  Aligned_cols=225  Identities=30%  Similarity=0.417  Sum_probs=172.3

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCce------------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      ...+|++.+.||.|||+.||+++...+++.||+|++.-.    .+...+|++..++++|||+                  
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            345899999999999999999999999999999988533    3445689999999999997                  


Q ss_pred             -----------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCC--eeeccCCCCceEEcCCCCceEEeecCCc
Q 016085          147 -----------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSA  207 (395)
Q Consensus       147 -----------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlKp~Nill~~~~~~ikl~DFG~a  207 (395)
                                       .....+..+++..+..|+.+|+.||++|| +..  +.||||||.|||+...+ .++|.|||.+
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH-~~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~  176 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH-EKEPPYAHRDIKPANILLSDSG-LPVLMDLGSA  176 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh-ccCCcccccCCCcceeEecCCC-ceEEEeccCc
Confidence                             01123446899999999999999999999 777  99999999999999877 7999999998


Q ss_pred             cccccCCC----------cccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 016085          208 KVLVKGEP----------NISYICSRYYRAPELIFG--ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV  275 (395)
Q Consensus       208 ~~~~~~~~----------~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  275 (395)
                      ....-.-.          -....||..|+|||.+.-  ....+.++|||||||+||+|+.|..||..         +.+.
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~~  247 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQQ  247 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------Hhhc
Confidence            76421110          113457999999998832  23368899999999999999999999942         1111


Q ss_pred             hCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .|....      .-....+.+|.-          ..+|+.+.+||+.||+.||.+||++.+++.+
T Consensus       248 GgSlaL------Av~n~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  248 GGSLAL------AVQNAQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             CCeEEE------eeeccccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            111000      000011222221          2278999999999999999999999999864

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.1e-37  Score=289.96  Aligned_cols=227  Identities=25%  Similarity=0.375  Sum_probs=178.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhc-CCCceEe-----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVHY-----------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l-~h~ni~~-----------------  148 (395)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+...   .....+|+.+++.+ +|+|+..                 
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            45799999999999999999999999999999988643   23455789999988 8999711                 


Q ss_pred             -----e-------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          149 -----S-------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       149 -----~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                           .             .....+++..++.++.|++.||+||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~  178 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH-NNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence                 0             01245688888999999999999999 88999999999999999887 6999999998765


Q ss_pred             ccCC-CcccccccccccccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 016085          211 VKGE-PNISYICSRYYRAPELIFGAT----EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       211 ~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                      .... ......++..|+|||.+....    .++.++|||||||++|+|++|++||...+....+..+.+.   +.     
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~-----  250 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PP-----  250 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CC-----
Confidence            4322 122346788999999875432    2688999999999999999999999876654444333220   00     


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                                 +.       ...+...+..+.+||.+||+.||++||++.++++||||+
T Consensus       251 -----------~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 -----------PT-------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             -----------CC-------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                       00       001223567899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.3e-37  Score=292.80  Aligned_cols=228  Identities=28%  Similarity=0.410  Sum_probs=181.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceEe-----------------e
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVHY-----------------S  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~~-----------------~  149 (395)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.+.|+|+..                 .
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4699999999999999999999999999999988643    234557999999999999810                 0


Q ss_pred             --------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccccc
Q 016085          150 --------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYI  220 (395)
Q Consensus       150 --------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~~  220 (395)
                              .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++........ .....
T Consensus       100 ~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH-~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  177 (296)
T cd06654         100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMV  177 (296)
T ss_pred             CCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEcCCC-CEEECccccchhccccccccCccc
Confidence                    01234677788899999999999999 88999999999999999877 699999999876533222 22346


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      +++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||.+.+....+..+.. .+.+.                    
T Consensus       178 ~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~--------------------  235 (296)
T cd06654         178 GTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE--------------------  235 (296)
T ss_pred             CCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCC--------------------
Confidence            789999999987644 88999999999999999999999987665443332221 00000                    


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                           ...+..++..+.+||.+||..||++|||+.++++||||...+
T Consensus       236 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         236 -----LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             -----CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence                 011234678999999999999999999999999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.1e-37  Score=287.71  Aligned_cols=222  Identities=29%  Similarity=0.444  Sum_probs=176.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----------hhHHHHHHHHHhcCCCceE--------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----------~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      +|++.+.||+|+||.||+|.+ .+++.+|+|.+....          ....+|+.+++.++|+||.              
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            488999999999999999986 578899999875321          3356799999999999971              


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC--
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--  213 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~--  213 (395)
                                  +......+++..+..++.|++.||+||| +.||+|+||+|+||+++.++ .++|+|||++......  
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH-NNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhccc
Confidence                        1112346788889999999999999999 88999999999999999887 6999999998764211  


Q ss_pred             -----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          214 -----EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       214 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                           .......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+....+.          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------  226 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL----------  226 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----------
Confidence                 1122346788999999987654 899999999999999999999999776544433332221000          


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                                      ...++..++..+.+||++||..+|.+|||+.++++||||
T Consensus       227 ----------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 ----------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ----------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                            011234478899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.2e-37  Score=286.12  Aligned_cols=227  Identities=28%  Similarity=0.422  Sum_probs=180.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY------------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~------------------  148 (395)
                      +|++.+.||.|+||.||+|.+..++..||+|++...     .....+|+.+++.++|+|+..                  
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   81 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL   81 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence            699999999999999999999889999999988543     244568999999999999810                  


Q ss_pred             --------ecc---CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc-
Q 016085          149 --------SRA---SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-  216 (395)
Q Consensus       149 --------~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~-  216 (395)
                              ...   ...+++..++.++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++......... 
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh-~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH-SNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhccCcccc
Confidence                    001   135788889999999999999999 89999999999999999887 6999999998776543222 


Q ss_pred             ----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          217 ----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       217 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                          ....++..|+|||.+.....++.++|+|||||++|+|++|+.||...+....+..+...   .+.           
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~-----------  225 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPP-----------  225 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCC-----------
Confidence                23467889999999876545899999999999999999999999876655444433321   000           


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      .  .+.       ......+++.+.+||.+||..||++|||+.++++||||
T Consensus       226 ~--~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         226 S--LET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             C--cCC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            0  000       00013468899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.8e-37  Score=293.88  Aligned_cols=252  Identities=25%  Similarity=0.403  Sum_probs=180.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-------------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-------------------  147 (395)
                      +|++.+.||+|+||.||+|.+..++..||+|.+....     ....+|+++++.++|+||.                   
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            5999999999999999999999999999999876431     2345799999999999981                   


Q ss_pred             -------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccccc
Q 016085          148 -------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI  220 (395)
Q Consensus       148 -------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~  220 (395)
                             +......+++..+..++.|++.||.|||+..+++||||||+|||++.++ .+||+|||++...... ......
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~-~~~~~~  159 (308)
T cd06615          82 DGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MANSFV  159 (308)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccccc-ccccCC
Confidence                   1112355788889999999999999999436999999999999999887 6999999998765332 223467


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH-HHH-hhcCCCCcc----c
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR-EEI-KCMNPNYTE----F  294 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~-~~~~~~~~~----~  294 (395)
                      +++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+... ...+......... ... .........    .
T Consensus       160 ~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         160 GTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCCCCCccchh
Confidence            899999999987654 8999999999999999999999997665322 2222211100000 000 000000000    0


Q ss_pred             cC----CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          295 KF----PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       295 ~~----~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      ..    ...........-...++.++.+|+.+||..||++|||+.++++||||....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence            00    000000000000113678899999999999999999999999999997653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3e-37  Score=286.82  Aligned_cols=222  Identities=29%  Similarity=0.467  Sum_probs=175.3

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhHHHHHHHHHhcCCCceEe--------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVHY--------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~ni~~--------------  148 (395)
                      +|++.+.||+|+||.||+|++..+++.||||.+...         .....+|+.+++.+.|+||..              
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            599999999999999999999999999999987521         124457999999999999710              


Q ss_pred             --------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-
Q 016085          149 --------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  213 (395)
Q Consensus       149 --------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-  213 (395)
                                    ......+++..+..++.|++.||+||| +.||+|+||||+||+++.++ .++|+|||++...... 
T Consensus        83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH-SNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEecCCC-CEEECcCcccccccccc
Confidence                          011234677778899999999999999 88999999999999999877 6999999998764321 


Q ss_pred             ---CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          214 ---EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       214 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                         .......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||.+......+..+..   .+.          
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~----------  226 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT----------  226 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC----------
Confidence               1122345788999999987654 89999999999999999999999977654443332221   110          


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                                    ....+..++..+.++|++||. +|++||++.++++|||+.
T Consensus       227 --------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 --------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             --------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                          011233467889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-37  Score=287.94  Aligned_cols=246  Identities=36%  Similarity=0.637  Sum_probs=188.8

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhc---CCCceE----------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVH----------------  147 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l---~h~ni~----------------  147 (395)
                      |++.+.||+|+||.||+|++..+++.||+|.+....      ....+|+.+++.+   +|+|+.                
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            778999999999999999998889999999986321      2234677777666   599870                


Q ss_pred             e--------------e--ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          148 Y--------------S--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       148 ~--------------~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                      .              .  .....+++..++.++.|++.||.||| +.|++|+||+|+||+++.++ .+||+|||++....
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH-~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH-SHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCChhhEEEccCC-CEEEeccCcceecc
Confidence            0              0  01124788899999999999999999 88999999999999999887 69999999997765


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          212 KGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      .........++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+.+..+.+.++....+.+....+..... .
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  236 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS-L  236 (287)
T ss_pred             CCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc-c
Confidence            444434456788999999997755 89999999999999999999999999988888888888766655433221100 0


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ....++....... ......++..+.+||.+||+.||.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            0001111111111 11223467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.3e-37  Score=286.35  Aligned_cols=221  Identities=29%  Similarity=0.456  Sum_probs=180.3

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|.+.+.||.|+||.||+|++..+++.||+|.+.+.       .....+|+.+++.++|+||.                 
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            489999999999999999999999999999988643       23445799999999999970                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                               +......+++..+..++.||+.||.||| +.|++|+||+|+||+++.++ .++|+|||++...........
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH-SKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCccccc
Confidence                     0111247889999999999999999999 88999999999999999888 699999999877654433445


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ..++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+..  +.+.....   .                  
T Consensus       159 ~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~------------------  216 (258)
T cd05578         159 TSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---T------------------  216 (258)
T ss_pred             cCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc---c------------------
Confidence            66788999999987655 899999999999999999999999876642  22211111   0                  


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCH--HHHhcCCcc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA--LEACIHPFF  343 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~--~e~l~hp~f  343 (395)
                             ....++..++..+.++|.+||..||.+|+++  .++++||||
T Consensus       217 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 -------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             -------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                   0111334468999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.9e-37  Score=289.56  Aligned_cols=224  Identities=27%  Similarity=0.406  Sum_probs=175.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhc-CCCceEee-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVHYS-----------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l-~h~ni~~~-----------------  149 (395)
                      +.|++.+.||.|+||.||+|++..+++.||+|++....   .....|+.+++.+ +|+|+...                 
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            46999999999999999999999999999999885442   3345688888888 69987110                 


Q ss_pred             -----------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          150 -----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       150 -----------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                       .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++.....
T Consensus        96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~~~  173 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH-AHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEeeCcchhhhhc
Confidence                             01234677778889999999999999 88999999999999999887 699999999876532


Q ss_pred             C-CCcccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 016085          213 G-EPNISYICSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  287 (395)
Q Consensus       213 ~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  287 (395)
                      . .......+++.|+|||.+..    ...++.++|+|||||++|+|++|..||........+..+...   ..       
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~-------  243 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP-------  243 (282)
T ss_pred             cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC-------
Confidence            2 12234568899999998852    234788999999999999999999999765543333222110   00       


Q ss_pred             CCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                                       .......++..+.+||++||..||.+|||+.|+++||||
T Consensus       244 -----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 -----------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -----------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                             001123468899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-37  Score=293.79  Aligned_cols=229  Identities=29%  Similarity=0.425  Sum_probs=181.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceEe-----------------e
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVHY-----------------S  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~~-----------------~  149 (395)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++|+|+..                 .
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            4699999999999999999999999999999988542    234457899999999999810                 0


Q ss_pred             --------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccccc
Q 016085          150 --------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYI  220 (395)
Q Consensus       150 --------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~~  220 (395)
                              .....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .++|+|||++........ .....
T Consensus        99 ~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH-~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~  176 (297)
T cd06656          99 AGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMV  176 (297)
T ss_pred             CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEECcCccceEccCCccCcCccc
Confidence                    01234677888999999999999999 88999999999999999877 699999999876533322 22346


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      +++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+....+..+.. .+.+.                    
T Consensus       177 ~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~--------------------  234 (297)
T cd06656         177 GTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------------------  234 (297)
T ss_pred             CCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC--------------------
Confidence            788999999987644 89999999999999999999999977654333222111 00000                    


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                           ...+..++..+.+||.+||..||++||++.++++||||...+.
T Consensus       235 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         235 -----LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             -----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence                 0122346788999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.4e-37  Score=289.20  Aligned_cols=226  Identities=27%  Similarity=0.397  Sum_probs=176.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceE-------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVH-------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~-------------------  147 (395)
                      ++|.+.+.||+|+||.||+|++..+++.||+|.+....    ....+|+.+++.++|+||.                   
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            47999999999999999999999999999999886432    2345799999999999971                   


Q ss_pred             -------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccccc
Q 016085          148 -------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISY  219 (395)
Q Consensus       148 -------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~  219 (395)
                             +......+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||++....... .....
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06645          89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH-SKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCcccccccc
Confidence                   0112356788999999999999999999 88999999999999999887 69999999987653322 12345


Q ss_pred             ccccccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          220 ICSRYYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       220 ~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      .|+..|+|||.+.  ....++.++|+|||||++|+|++|..||........+..+...              .+.   .+
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--------------~~~---~~  229 (267)
T cd06645         167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--------------NFQ---PP  229 (267)
T ss_pred             cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--------------CCC---CC
Confidence            7899999999874  2234788999999999999999999999765543333222110              000   00


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  342 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~  342 (395)
                      ..     .  ....++..+.+||.+||+.||++|||+.++++|||
T Consensus       230 ~~-----~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         230 KL-----K--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             cc-----c--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            00     0  01135788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-38  Score=301.99  Aligned_cols=228  Identities=26%  Similarity=0.430  Sum_probs=168.5

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcC-CCceE---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVH---------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~-h~ni~---------------  147 (395)
                      ...|+++++||+||-++||++.. ...+.||+|.+...      ......|+..|.+|+ |.+|.               
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            34699999999999999999985 34466777765321      233457999999996 45550               


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                                 +......++...+++|..|++.|+.++| ..||||.||||.|+|+-. | .+||+|||+|..+..+.. 
T Consensus       439 mE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH-~~gIVHSDLKPANFLlVk-G-~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  439 MECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH-QHGIVHSDLKPANFLLVK-G-RLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             eecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH-HhceeecCCCcccEEEEe-e-eEEeeeechhcccCccccc
Confidence                       1112233444588999999999999999 899999999999999873 5 699999999988755433 


Q ss_pred             --cccccccccccccccccCCC----------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 016085          216 --NISYICSRYYRAPELIFGAT----------EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  283 (395)
Q Consensus       216 --~~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  283 (395)
                        ..+.+||+.||+||.+....          ..++++||||||||||+|+.|++||....  ..+.++... -.|.   
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI-~~P~---  589 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAI-TDPN---  589 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhh-cCCC---
Confidence              23578999999999995321          25789999999999999999999995321  122222221 1111   


Q ss_pred             HhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          284 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                              .+..+|.+..           ..++.++++.||++||.+|||+.++|+|||.+-.
T Consensus       590 --------~~Iefp~~~~-----------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  590 --------HEIEFPDIPE-----------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             --------ccccccCCCC-----------chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence                    2234444321           2349999999999999999999999999998764

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-37  Score=289.08  Aligned_cols=226  Identities=28%  Similarity=0.385  Sum_probs=175.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceEe------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVHY------------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~~------------------  148 (395)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++|+|+..                  
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4699999999999999999999999999999988643    234567999999999999710                  


Q ss_pred             --------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccccc
Q 016085          149 --------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISY  219 (395)
Q Consensus       149 --------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~  219 (395)
                              ......+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++....... .....
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06646          89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH-SKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEECCCC-CEEECcCccceeecccccccCcc
Confidence                    112345678888999999999999999 88999999999999999887 59999999998654322 12345


Q ss_pred             cccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          220 ICSRYYRAPELIFG--ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       220 ~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      .++..|+|||.+.+  ...++.++|+||+||++|+|++|+.||...........+...              .+   ..+
T Consensus       167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~--------------~~---~~~  229 (267)
T cd06646         167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS--------------NF---QPP  229 (267)
T ss_pred             ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC--------------CC---CCC
Confidence            67899999998742  234788999999999999999999999655433222111110              00   000


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  342 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~  342 (395)
                      ..       .....++..+.+||++||+.||++|||+.++++|+|
T Consensus       230 ~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         230 KL-------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CC-------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            00       012246789999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8.1e-37  Score=281.82  Aligned_cols=221  Identities=25%  Similarity=0.401  Sum_probs=178.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------e
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      +|.+.+.||+|+||.||+|.+..+++.|++|.+...      .....+|+.+++.++|+|+.                 +
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            488999999999999999999999999999987532      23445789999999999981                 0


Q ss_pred             e-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-c
Q 016085          149 S-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-N  216 (395)
Q Consensus       149 ~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~  216 (395)
                      .           .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||+++....... .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH-~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH-SKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccchh
Confidence            0           01345778888899999999999999 88999999999999999887 699999999886644322 2


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||...+.......+....                   .
T Consensus       159 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~  218 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-------------------F  218 (256)
T ss_pred             hccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------------C
Confidence            2346788999999997654 8999999999999999999999998777544444433210                   0


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      +         .++..++..+.++|.+||+.+|++||++.++++|||+
T Consensus       219 ~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         219 P---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             C---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            0         1122368899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.1e-37  Score=285.29  Aligned_cols=220  Identities=30%  Similarity=0.449  Sum_probs=177.0

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE------------------------
Q 016085           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH------------------------  147 (395)
Q Consensus        99 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~------------------------  147 (395)
                      ||.|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++|+||.                        
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999999999999999986432       3456799999999999981                        


Q ss_pred             --eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccccccc
Q 016085          148 --YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY  225 (395)
Q Consensus       148 --~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y  225 (395)
                        +......+++..+..++.||+.||.||| +.|++|+||+|+||+++.++ .++|+|||++.............+++.|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLH-NRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCcccccccccCCcCc
Confidence              1112345788889999999999999999 88999999999999999887 6999999999876544333445678999


Q ss_pred             cccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCC
Q 016085          226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP  303 (395)
Q Consensus       226 ~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (395)
                      +|||.+.+.. ++.++|+|||||++|+|++|..||....  .......+....               .           
T Consensus       159 ~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~-----------  211 (262)
T cd05572         159 VAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------------G-----------  211 (262)
T ss_pred             cChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC---------------C-----------
Confidence            9999986644 8999999999999999999999998765  333333322100               0           


Q ss_pred             cccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCC
Q 016085          304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRD  348 (395)
Q Consensus       304 ~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  348 (395)
                       ...++...+.++.++|.+||+.||.+|+|     +.|+++||||+++.+
T Consensus       212 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         212 -KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             -CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence             00122335789999999999999999999     999999999998765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.4e-37  Score=284.37  Aligned_cols=224  Identities=29%  Similarity=0.429  Sum_probs=179.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch--hhHHHHHHHHHhcCCCceEe--------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVHY--------------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~ni~~--------------------  148 (395)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+....  ....+|+.+++.++|+|+..                    
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            46999999999999999999998889999999986543  45668999999999999810                    


Q ss_pred             -------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccccc
Q 016085          149 -------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYI  220 (395)
Q Consensus       149 -------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~  220 (395)
                             ......+++..++.++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||++....... ......
T Consensus        83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh-~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~  160 (256)
T cd06612          83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH-SNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRNTVI  160 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEECCCC-cEEEcccccchhcccCcccccccc
Confidence                   012346788999999999999999999 88999999999999999887 69999999998764433 222345


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      ++..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+...   .           ..        
T Consensus       161 ~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~-----------~~--------  217 (256)
T cd06612         161 GTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---P-----------PP--------  217 (256)
T ss_pred             CCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---C-----------CC--------
Confidence            788999999987654 899999999999999999999999765543322221110   0           00        


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                          ....+..++..+.+||.+||+.||++|||+.+++.||||
T Consensus       218 ----~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         218 ----TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ----CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                000123367899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.4e-37  Score=283.13  Aligned_cols=223  Identities=35%  Similarity=0.546  Sum_probs=178.8

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---------hhHHHHHHHHHhcCCCceE---------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      +|+..+.||+|+||+||+|.+..+++.||+|.+....         ....+|+.+++.++|+|+.               
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4888899999999999999998899999999875422         3456799999999999970               


Q ss_pred             --e---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          148 --Y---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 --~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                        +         ......+++..+..++.||+.||.||| +.||+|+||+|+||+++.++ .+||+|||++.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH-DRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFSFA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEccCccceeccccccc
Confidence              1         112334788888899999999999999 88999999999999999887 6999999998776444333


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....++..|+|||.+.....++.++|+|||||++|+|++|+.||...........+.....                  .
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------------------~  220 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE------------------L  220 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc------------------C
Confidence            4566789999999986543478999999999999999999999976654333333221100                  0


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                               ..++..+++.+.+|+.+||+.+|.+|||+.+++.|||+
T Consensus       221 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         221 ---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                     01233478999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-37  Score=289.58  Aligned_cols=229  Identities=27%  Similarity=0.382  Sum_probs=181.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceEe-----------------e
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVHY-----------------S  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~~-----------------~  149 (395)
                      ++|.+.+.||.|+||.||+|.+..++..||+|.+....    ....+|+.+++.++|+|+..                 .
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            46999999999999999999998899999999886432    23457999999999999810                 0


Q ss_pred             ----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccc
Q 016085          150 ----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNIS  218 (395)
Q Consensus       150 ----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~  218 (395)
                                .....+++..++.++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++....... ....
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH-SHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEECCCC-CEEEccCccchhhcccccccce
Confidence                      11245889999999999999999999 88999999999999999887 69999999886543222 2234


Q ss_pred             ccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          219 YICSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ..+|+.|+|||.+..    ...++.++|+|||||++|+|++|+.||.+.+....+..+...  .+               
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------------  225 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EP---------------  225 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CC---------------
Confidence            567999999998742    223678999999999999999999999876654443333210  00               


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                        +..       ..+..++.++.+||.+||+.+|.+||++.++++||||....
T Consensus       226 --~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         226 --PTL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             --CCc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence              000       01233678999999999999999999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-38  Score=315.52  Aligned_cols=215  Identities=29%  Similarity=0.518  Sum_probs=171.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcC-CCceE-------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLD-HPNVH-------------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~-h~ni~-------------------  147 (395)
                      +++|.++|.+|||+.||+|++...|..||+|++.-.    .....+|+++|+.|+ |+||.                   
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            699999999999999999999988899999988543    234568999999997 99981                   


Q ss_pred             -----e-----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCC--eeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          148 -----Y-----------SRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       148 -----~-----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                           |           .+...++.+.++..|++|+++|+.+|| .+.  |||||||-|||||+.++ ..||||||.|..
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g-~~KLCDFGSatt  195 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADG-NYKLCDFGSATT  195 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCC-CEEeCccccccc
Confidence                 0           012345899999999999999999999 777  99999999999999988 599999999865


Q ss_pred             cccCCCcc----------cccccccccccccc--cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 016085          210 LVKGEPNI----------SYICSRYYRAPELI--FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  277 (395)
Q Consensus       210 ~~~~~~~~----------~~~gt~~y~aPE~~--~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  277 (395)
                      ........          ....|+.|+|||++  ......+.++|||||||+||-|+....||.+.....    |+    
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Il----  267 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----IL----  267 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EE----
Confidence            43332111          23459999999998  233348999999999999999999999997653211    11    


Q ss_pred             CCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                +.   .|.+|..          +..+..+.+||+.||+.||.+||++.+++.
T Consensus       268 ----------ng---~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  268 ----------NG---NYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             ----------ec---cccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence                      11   2233331          347899999999999999999999998875

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.7e-37  Score=288.27  Aligned_cols=224  Identities=27%  Similarity=0.379  Sum_probs=169.7

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHh---cCCCceE--------------------
Q 016085           98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL---LDHPNVH--------------------  147 (395)
Q Consensus        98 ~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~---l~h~ni~--------------------  147 (395)
                      .||+|+||.||+|.+..+++.||+|.+.+..       ....+|..+++.   ..|+|+.                    
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999885432       122234433333   4688871                    


Q ss_pred             ------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccc
Q 016085          148 ------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC  221 (395)
Q Consensus       148 ------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~g  221 (395)
                            +......+++..+..++.|++.||.||| +.||+||||||+|||++.++ .++|+|||++....... .....|
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH-~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~~-~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH-NRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK-PHASVG  157 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcCCCCCCHHHEEECCCC-CEEEccCCcceeccccC-ccCcCC
Confidence                  0112345788899999999999999999 88999999999999999887 69999999986543322 234568


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |..|+|||.+.+...++.++|+||+||++|+|++|..||.+....... .+.....                        
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~------------------------  212 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL------------------------  212 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh------------------------
Confidence            999999999864445899999999999999999999999764322111 1111000                        


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDPN  350 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  350 (395)
                       .....++..++.++.++|.+||..||.+|+     |+.++++||||+.+.+..
T Consensus       213 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         213 -TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             -cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence             001113345789999999999999999999     699999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.3e-37  Score=286.09  Aligned_cols=224  Identities=30%  Similarity=0.501  Sum_probs=177.8

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------------ee
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------------YS  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------------~~  149 (395)
                      +|++.+.||+|+||.||+|.++.+++.||+|.+....     ....+|+.+++.++|+||.                 +.
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5889999999999999999999999999999886542     2345799999999999971                 00


Q ss_pred             ---------cc-CCCCcHHHHHHHHHHHHHHHHHHHcC-CCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          150 ---------RA-SQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       150 ---------~~-~~~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                               .. ...+++..+..++.|++.||+||| + .|++||||||+||+++.++ .++|+|||.+........ ..
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~-~~  158 (265)
T cd06605          82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLA-KT  158 (265)
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc-CCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHHHh-hc
Confidence                     11 156788889999999999999999 7 8999999999999999877 699999999876543222 22


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES-----GVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      ..++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+     ..+.+..+..   .+.             
T Consensus       159 ~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~-------------  221 (265)
T cd06605         159 FVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPP-------------  221 (265)
T ss_pred             ccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCC-------------
Confidence            6678899999999775 48999999999999999999999996542     1112222111   000             


Q ss_pred             ccCCcccCCCcccccCCC-CChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          294 FKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                         +         .++.. ++..+.+||.+||..||++|||+.+++.||||+...
T Consensus       222 ---~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         222 ---P---------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             ---C---------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence               0         01111 688999999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-38  Score=305.59  Aligned_cols=219  Identities=32%  Similarity=0.460  Sum_probs=177.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHH-hcCCCceEe--------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-LLDHPNVHY--------------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~-~l~h~ni~~--------------------  148 (395)
                      ...|.+...+|.|+|+.|-.+.+..+++.+++|++.+......+|+.++. .-+|+|+.-                    
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g  400 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG  400 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence            45799999999999999999999999999999999888666677885554 458999810                    


Q ss_pred             -----eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE-cCCCCceEEeecCCccccccCCCccccccc
Q 016085          149 -----SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICS  222 (395)
Q Consensus       149 -----~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill-~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt  222 (395)
                           .....+.....+..|++||+.|+.||| ++|+|||||||+|||+ +..+ .++|+|||.++.....  ..+.+-|
T Consensus       401 ~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH-~~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~~--~~tp~~t  476 (612)
T KOG0603|consen  401 GELLRRIRSKPEFCSEASQWAAELVSAVDYLH-EQGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELERS--CDTPALT  476 (612)
T ss_pred             cHHHHHHHhcchhHHHHHHHHHHHHHHHHHHH-hcCeeecCCChhheeecCCCC-cEEEEEechhhhCchh--hcccchh
Confidence                 011222333677789999999999999 7999999999999999 5666 5999999999876433  3344668


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  302 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (395)
                      ..|.|||++.. ..|+.++||||||++||+||+|+.||......   ..|...++.+.                      
T Consensus       477 ~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~----------------------  530 (612)
T KOG0603|consen  477 LQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK----------------------  530 (612)
T ss_pred             hcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc----------------------
Confidence            89999999975 55999999999999999999999999765544   23333333322                      


Q ss_pred             CcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       303 ~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                           +...+|..+++||++||+.||.+|+++.+++.||||
T Consensus       531 -----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 -----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -----cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                 113489999999999999999999999999999999

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-38  Score=305.54  Aligned_cols=235  Identities=28%  Similarity=0.447  Sum_probs=185.4

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCce-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNV-----------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni-----------------  146 (395)
                      .-|..++.||-|+||+|.+++...|...||+|.+.+..       ...+.|..||...+.+-|                 
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            35999999999999999999999999999999886543       334578899988877665                 


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc------
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV------  211 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~------  211 (395)
                               .++...+-|+|..+++|++++.+|+++.| ..|+|||||||+|||||.+|| |||+|||+|.-+.      
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH-kmGFIHRDiKPDNILIDrdGH-IKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH-KMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH-hccceecccCccceEEccCCc-eeeeeccccccceeccccc
Confidence                     11234467899999999999999999999 999999999999999999996 9999999985321      


Q ss_pred             ---cCCC----------------------------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHH
Q 016085          212 ---KGEP----------------------------------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL  254 (395)
Q Consensus       212 ---~~~~----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  254 (395)
                         .+..                                  ..+.+||+.|+|||++... .|+..+||||.|||||||+
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHHHh
Confidence               0000                                  0246789999999999764 4999999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-
Q 016085          255 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-  333 (395)
Q Consensus       255 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-  333 (395)
                      .|++||...+..+...+|+.+.             ++            +.-....+++.++.+||.++. -+++.|+. 
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~-------------~~------------l~~~~~~~ls~e~~~li~kLc-~sad~RLGk  919 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWR-------------NF------------LHIPYQGNLSKEALDLIQKLC-CSADSRLGK  919 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehh-------------hc------------cccccccccCHHHHHHHHHHh-cChhhhhcc
Confidence            9999998877665555544421             00            011123468999999999864 56789984 


Q ss_pred             --HHHHhcCCcccCCCCCCCCCC
Q 016085          334 --ALEACIHPFFDELRDPNARLP  354 (395)
Q Consensus       334 --~~e~l~hp~f~~~~~~~~~~~  354 (395)
                        ++++..||||+.+.....+..
T Consensus       920 ng~d~vKaHpfFkgIDfsslRkq  942 (1034)
T KOG0608|consen  920 NGADQVKAHPFFKGIDFSSLRKQ  942 (1034)
T ss_pred             cchhhhhcCccccccchHhhhhc
Confidence              678999999999877654433

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-37  Score=283.84  Aligned_cols=228  Identities=29%  Similarity=0.440  Sum_probs=179.3

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhc-CCCceE-----ee---------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVH-----YS---------  149 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l-~h~ni~-----~~---------  149 (395)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...   .....+|+.+++.+ +|+||.     +.         
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            3456899999999999999999999999999999988653   23456899999998 799870     00         


Q ss_pred             ---------c-------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCc
Q 016085          150 ---------R-------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  207 (395)
Q Consensus       150 ---------~-------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a  207 (395)
                               .             ....+++..++.++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH-~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~  160 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH-ENKVIHRDIKGQNILLTKNA-EVKLVDFGVS  160 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHHHEEEccCC-eEEECCCccc
Confidence                     0             0245788888999999999999999 88999999999999999887 6999999998


Q ss_pred             cccccCCC-cccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 016085          208 KVLVKGEP-NISYICSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  282 (395)
Q Consensus       208 ~~~~~~~~-~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  282 (395)
                      ........ .....++..|+|||.+.+    ...++.++|||||||++|+|++|+.||........+..+...   +.  
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~--  235 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PP--  235 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CC--
Confidence            76533221 234567899999998753    234678999999999999999999999766554444443221   00  


Q ss_pred             HHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                                    +..       ......+..+.+||.+||..||++|||+.++++|||+
T Consensus       236 --------------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 --------------PTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             --------------CCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                          000       0112357899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.2e-37  Score=286.78  Aligned_cols=224  Identities=27%  Similarity=0.400  Sum_probs=176.7

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------e------
Q 016085           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------Y------  148 (395)
Q Consensus        99 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------~------  148 (395)
                      ||+|+||+||+|.+..+|+.||+|.+....       ....+|+++++.++|+|+.                 +      
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999999999999999885421       2234799999999999971                 0      


Q ss_pred             ---ec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccccc
Q 016085          149 ---SR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR  223 (395)
Q Consensus       149 ---~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~  223 (395)
                         ..  ....+++..+..++.|++.||.||| +.|++||||+|+||+++.++ .++|+|||++.............++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH-QRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCccccccCCC
Confidence               01  1126888899999999999999999 88999999999999999887 69999999987654433334456788


Q ss_pred             cccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCC
Q 016085          224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP  303 (395)
Q Consensus       224 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (395)
                      .|+|||.+.+.. ++.++|+|||||++|+|++|+.||...........+.....                         .
T Consensus       159 ~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------------~  212 (277)
T cd05577         159 GYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-------------------------E  212 (277)
T ss_pred             CcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-------------------------c
Confidence            999999987755 89999999999999999999999976554222222211000                         0


Q ss_pred             cccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCCC
Q 016085          304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDPN  350 (395)
Q Consensus       304 ~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  350 (395)
                      ....++..+++.+.++|.+||+.||.+|+     ++.++++||||..+.+..
T Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence            00112344689999999999999999999     899999999999887754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=282.15  Aligned_cols=226  Identities=29%  Similarity=0.426  Sum_probs=180.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-------------------  147 (395)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++...    .....+|+.+++.++|+|+.                   
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            4699999999999999999999999999999988643    34456899999999999970                   


Q ss_pred             -------eecc-CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccc
Q 016085          148 -------YSRA-SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNIS  218 (395)
Q Consensus       148 -------~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~  218 (395)
                             +... ...+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .+||+|||++....... ....
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH-ETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCChhhEEECCCC-CEEECccccchhhhhhhhcccc
Confidence                   0111 256888999999999999999999 88999999999999999887 59999999987654322 2234


Q ss_pred             ccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          219 YICSRYYRAPELIFGA--TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ..++..|+|||.+.+.  ..++.++|+|||||++|+|++|.+||.+.+.......+....-.+                 
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-----------------  223 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-----------------  223 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-----------------
Confidence            5678899999998654  247889999999999999999999998876555444333210000                 


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  342 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~  342 (395)
                      +.       .......+.++.+||.+||..||.+|||+.+++.|+|
T Consensus       224 ~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         224 PK-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             cc-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            00       0011235778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-36  Score=285.71  Aligned_cols=227  Identities=25%  Similarity=0.346  Sum_probs=176.7

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhc-CCCceEee---------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVHYS---------------  149 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l-~h~ni~~~---------------  149 (395)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++...   .....+|+.+++.+ +|+|+...               
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            445799999999999999999999999999999987542   23456799999999 69998110               


Q ss_pred             --------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          150 --------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       150 --------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                          .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||++..
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~  173 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH-VNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQ  173 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH-hCCccccCCCHHhEEECCCC-CEEEccCCceee
Confidence                                11234677778889999999999999 88999999999999999887 599999999876


Q ss_pred             cccCC-CcccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          210 LVKGE-PNISYICSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       210 ~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                      ..... ......|++.|+|||++..    ...++.++|||||||++|+|++|+.||........+..+...   .     
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~-----  245 (286)
T cd06638         174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---P-----  245 (286)
T ss_pred             cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---C-----
Confidence            54322 2234468999999998743    133788999999999999999999999766543332221110   0     


Q ss_pred             hhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                                 .+       ....+...+..+.+||.+||+.||++|||+.|+++|+||
T Consensus       246 -----------~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 -----------PP-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             -----------CC-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                       00       001122357789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.7e-37  Score=289.61  Aligned_cols=230  Identities=30%  Similarity=0.435  Sum_probs=182.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCce-----------------Eee-
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNV-----------------HYS-  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni-----------------~~~-  149 (395)
                      .|.....||.|+||.||++.+..++..||||.+...    .....+|+.+++.++|+|+                 .+. 
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            466678899999999999999999999999987543    2345579999999999997                 000 


Q ss_pred             -------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccccccc
Q 016085          150 -------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYIC  221 (395)
Q Consensus       150 -------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~g  221 (395)
                             .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++....... ......+
T Consensus       103 ~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~  180 (292)
T cd06658         103 GGALTDIVTHTRMNEEQIATVCLSVLRALSYLH-NQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVG  180 (292)
T ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccccccCceeec
Confidence                   11245788899999999999999999 88999999999999999887 69999999987543222 1234567


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      +..|+|||.+.+.. ++.++|+|||||++|+|++|+.||.+.+....+..+.......                .     
T Consensus       181 ~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------~-----  238 (292)
T cd06658         181 TPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR----------------V-----  238 (292)
T ss_pred             CccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc----------------c-----
Confidence            89999999986654 8999999999999999999999998776655444332211000                0     


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                           .....++..+.+||.+||..||++|||+.++++||||.....+.
T Consensus       239 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         239 -----KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             -----ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence                 01123678999999999999999999999999999998876654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.6e-36  Score=280.17  Aligned_cols=221  Identities=28%  Similarity=0.453  Sum_probs=178.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE---------------e--
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH---------------Y--  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~---------------~--  148 (395)
                      +|++.+.||+|+||.||++++..+++.||+|.+...      .....+|+.+++.++|+||.               +  
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            489999999999999999999999999999987532      22456799999999999970               0  


Q ss_pred             e-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-c
Q 016085          149 S-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-N  216 (395)
Q Consensus       149 ~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~  216 (395)
                      .           .....+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||++........ .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchhhh
Confidence            0           01224678888999999999999999 88999999999999999877 699999999976543222 1


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+...  ..                 
T Consensus       159 ~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~-----------------  218 (256)
T cd08218         159 RTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SY-----------------  218 (256)
T ss_pred             hhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--CC-----------------
Confidence            2345788899999987655 889999999999999999999999876655555444321  00                 


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      +         ..+..++.++.++|.+||+.+|.+||++.++++||||
T Consensus       219 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 P---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             C---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            0         1223468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.2e-36  Score=287.21  Aligned_cols=228  Identities=29%  Similarity=0.490  Sum_probs=179.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +|.+.+.||+|+||.||+|++..+++.||+|.+....       ....+|+++++.++|+||.                 
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            5999999999999999999999999999999886432       2334789999999999981                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC----
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE----  214 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~----  214 (395)
                               +......+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||+++......    
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH-NYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCccccc
Confidence                     0112345788888999999999999999 88999999999999999877 69999999986421110    


Q ss_pred             ------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 016085          215 ------------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  282 (395)
Q Consensus       215 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  282 (395)
                                  ......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+..+.+..+....      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~------  232 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD------  232 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------
Confidence                        001235678899999987654 8999999999999999999999998776555444433210      


Q ss_pred             HHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC---HHHHhcCCcccCCCC
Q 016085          283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFDELRD  348 (395)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t---~~e~l~hp~f~~~~~  348 (395)
                                 ...+.         ....++.++.+||.+||+.||++||+   +.++++||||....+
T Consensus       233 -----------~~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         233 -----------IEWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             -----------cCCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence                       00000         01236889999999999999999997   789999999977654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.2e-36  Score=279.02  Aligned_cols=222  Identities=28%  Similarity=0.442  Sum_probs=178.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------e
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      +|.+.+.||+|+||.||+|.++.++..||+|.+...      .....+|+.+++.++|+|+.                 +
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            489999999999999999999999999999988542      23456899999999999970                 0


Q ss_pred             e-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc-
Q 016085          149 S-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-  216 (395)
Q Consensus       149 ~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~-  216 (395)
                      .           .....+++..+..++.|++.||.||| +.|++|+||||+||+++.++..+||+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH-DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            0           01224688889999999999999999 8899999999999999987656799999998765433221 


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+...              .     .
T Consensus       160 ~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------~-----~  219 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG--------------Y-----F  219 (257)
T ss_pred             cccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------c-----C
Confidence            2345788999999886654 899999999999999999999999876654443332210              0     0


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      +         .....++..+.++|.+||..+|++|||+.++++||||
T Consensus       220 ~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         220 A---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             C---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            0         1123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-36  Score=282.26  Aligned_cols=227  Identities=31%  Similarity=0.530  Sum_probs=176.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch--------------hhHHHHHHHHHhcCCCceE----------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------------RYKNRELQTMRLLDHPNVH----------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--------------~~~~~E~~~l~~l~h~ni~----------  147 (395)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+....              ....+|+.+++.++|+|+.          
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5899999999999999999999999999999875311              2345699999999999970          


Q ss_pred             ----------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          148 ----------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       148 ----------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                                      +......+++..++.++.||+.||.||| +.|++||||+|+||+++.++ .++|+|||+++...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH-SKGILHRDLKADNLLVDADG-ICKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh-hCCeeecCCChhhEEEcCCC-eEEEeecccccccc
Confidence                            0112356788889999999999999999 88999999999999999887 69999999987653


Q ss_pred             cCC---CcccccccccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 016085          212 KGE---PNISYICSRYYRAPELIFGAT-EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  287 (395)
Q Consensus       212 ~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  287 (395)
                      ...   ......++..|+|||.+.+.. .++.++|+|||||++|+|++|..||........+..+....           
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  228 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR-----------  228 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc-----------
Confidence            221   122345788999999986543 47899999999999999999999997654433332221100           


Q ss_pred             CCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                          ..        ..+.......++..+.+||.+||..+|.+|||+.++++||||
T Consensus       229 ----~~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 ----SA--------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ----cC--------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                00        000111223468999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2e-36  Score=283.78  Aligned_cols=223  Identities=27%  Similarity=0.382  Sum_probs=170.1

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHH---HHHHhcCCCceE--------------------
Q 016085           98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNREL---QTMRLLDHPNVH--------------------  147 (395)
Q Consensus        98 ~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~---~~l~~l~h~ni~--------------------  147 (395)
                      +||+|+||.||+|++..+++.||+|.+.+..       .....|.   .+++...|+|+.                    
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999999999999999885431       1122233   344445788871                    


Q ss_pred             ------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccc
Q 016085          148 ------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC  221 (395)
Q Consensus       148 ------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~g  221 (395)
                            +......+++..++.++.|++.||.||| +.+|+||||||+||+++.++ .++|+|||++...... ......|
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~-~~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-KPHASVG  157 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc-CCcCcCC
Confidence                  0112345788999999999999999999 88999999999999999887 6999999998755332 2234578


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      +..|+|||.+.+...++.++||||+||++|+|++|+.||.+........ +......                       
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~-----------------------  213 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT-----------------------  213 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhc-----------------------
Confidence            9999999998755458999999999999999999999997653221111 1010000                       


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                        ....++..++..+.++|.+||..+|.+|+     ++.++++||||....+.
T Consensus       214 --~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~  264 (278)
T cd05606         214 --MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ  264 (278)
T ss_pred             --cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence              00112334689999999999999999999     99999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=279.95  Aligned_cols=221  Identities=28%  Similarity=0.461  Sum_probs=176.3

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhHHHHHHHHHhcCCCceE---------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      +|++.+.||+|+||.||+|++..+++.||+|.+...         .....+|+.+++.++|+||.               
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            699999999999999999999999999999987421         12445799999999999971               


Q ss_pred             ----e---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-
Q 016085          148 ----Y---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  213 (395)
Q Consensus       148 ----~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-  213 (395)
                          +         ......+++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||+++..... 
T Consensus        83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH-~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH-SNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCC-CEEECcccccccccccc
Confidence                0         011234678888899999999999999 88999999999999999877 6999999999765321 


Q ss_pred             ---CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          214 ---EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       214 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                         .......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||.+......+.++.   ..+.          
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~----------  226 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPT----------  226 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCC----------
Confidence               1122356788999999997654 8999999999999999999999997765444333322   1111          


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                                    ...++..+++.+.++|.+||. +|.+|||+.+++.|||.
T Consensus       227 --------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 --------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             --------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                          112345578999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4e-36  Score=278.03  Aligned_cols=222  Identities=28%  Similarity=0.465  Sum_probs=177.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY-----------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~-----------------  148 (395)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+...      ......|+.+++.++|+|+..                 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            489999999999999999999999999999988532      223456899999999999810                 


Q ss_pred             --e-------------ccCCCCcHHHHHHHHHHHHHHHHHHH----cCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          149 --S-------------RASQRMPLIYVKLYTYQICRALAYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       149 --~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                        .             .....+++..++.++.||+.||.|||    .+.+|+|+||||+||+++.++ .+||+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEeccccccc
Confidence              0             01245677888999999999999999    124799999999999999877 699999999987


Q ss_pred             cccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          210 LVKGEP-NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       210 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ...... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+.......+...             
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------  225 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG-------------  225 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-------------
Confidence            654432 33456899999999997654 899999999999999999999999887643333322210             


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                            ..         ..++...+..+.+|+.+||+.+|.+|||+.++++|||+
T Consensus       226 ------~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 ------KF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ------CC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                  00         01233468899999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2e-36  Score=286.56  Aligned_cols=229  Identities=31%  Similarity=0.453  Sum_probs=181.5

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-----------------ee--
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-----------------YS--  149 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-----------------~~--  149 (395)
                      |.....||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++|+|+.                 +.  
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            55667899999999999999999999999988532    23455799999999999970                 00  


Q ss_pred             ------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccccccc
Q 016085          150 ------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICS  222 (395)
Q Consensus       150 ------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~gt  222 (395)
                            .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++....... ......++
T Consensus       103 ~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~  180 (297)
T cd06659         103 GALTDIVSQTRLNEEQIATVCESVLQALCYLH-SQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGT  180 (297)
T ss_pred             CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHeEEccCC-cEEEeechhHhhcccccccccceecC
Confidence                  11245788889999999999999999 88999999999999999887 69999999987543322 12345678


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  302 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (395)
                      ..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+....+..+...   +..                     
T Consensus       181 ~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~---------------------  235 (297)
T cd06659         181 PYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP---------------------  235 (297)
T ss_pred             ccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC---------------------
Confidence            9999999997654 899999999999999999999999876655544433210   000                     


Q ss_pred             CcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       303 ~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                      .  ......++..+.++|++||+.+|.+||++.++++||||.+...+.
T Consensus       236 ~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~  281 (297)
T cd06659         236 K--LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPE  281 (297)
T ss_pred             C--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcc
Confidence            0  001223678999999999999999999999999999998766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=279.96  Aligned_cols=221  Identities=33%  Similarity=0.512  Sum_probs=171.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecchh-------hHHHHHHH-HHhcCCCceEe--------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVHY--------------------  148 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~~-l~~l~h~ni~~--------------------  148 (395)
                      +.||.|+||.||+|.+..+++.||+|.+.+...       ....|..+ ...++|+|+..                    
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            579999999999999999999999999864321       11234333 34558998711                    


Q ss_pred             ------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccccccc
Q 016085          149 ------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS  222 (395)
Q Consensus       149 ------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt  222 (395)
                            ......+++..+..++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||+++....   .....++
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~---~~~~~~~  156 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH-QRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE---NKKFVGT  156 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-cEEEeecccceeccc---cccCCCC
Confidence                  112346788999999999999999999 88999999999999999877 699999999876433   2334678


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  302 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (395)
                      ..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+....            ..            
T Consensus       157 ~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------~~------------  211 (260)
T cd05611         157 PDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR------------IN------------  211 (260)
T ss_pred             cCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc------------cC------------
Confidence            8999999997765 8999999999999999999999998776655444433210            00            


Q ss_pred             CcccccCCCCChhHHHHHHhhccCCCCCCCC---HHHHhcCCcccCCCC
Q 016085          303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFDELRD  348 (395)
Q Consensus       303 ~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t---~~e~l~hp~f~~~~~  348 (395)
                       +.......+++.+.++|.+||+.||++|++   +.|+++||||.++.|
T Consensus       212 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         212 -WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             -CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence             011122247899999999999999999995   479999999988765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.2e-36  Score=278.89  Aligned_cols=225  Identities=34%  Similarity=0.530  Sum_probs=181.6

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------------e-
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------------Y-  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------------~-  148 (395)
                      +|.+.+.||.|+||.||+|++..+++.||+|++...     .....+|+.+++.++|+|+.                 + 
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            589999999999999999999999999999988654     34456899999999999981                 0 


Q ss_pred             --------eccCCCCcHHHHHHHHHHHHHHHHHHHcC-CCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc-c
Q 016085          149 --------SRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-S  218 (395)
Q Consensus       149 --------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~-~  218 (395)
                              ......+++..+..++.|++.||.||| + .|++||||+|+||+++.++ .++|+|||++.......... .
T Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh-~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~~~~  159 (264)
T cd06623          82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH-TKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNT  159 (264)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh-ccCCCccCCCCHHHEEECCCC-CEEEccCccceecccCCCcccc
Confidence                    112356788889999999999999999 7 8999999999999999887 69999999998764433322 4


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.....   .+....+..   ..                
T Consensus       160 ~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~----------------  219 (264)
T cd06623         160 FVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP----------------  219 (264)
T ss_pred             eeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC----------------
Confidence            5678899999998765 489999999999999999999999977642   222222211   00                


Q ss_pred             CCcccCCCcccccCCC-CChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          296 FPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      .         ..++.. ++..+.++|.+||..+|++|||+.++++||||+..+
T Consensus       220 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         220 P---------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             C---------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            0         011223 688999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-36  Score=284.73  Aligned_cols=233  Identities=29%  Similarity=0.427  Sum_probs=177.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      .+|++.+.||+|+||+||+|.+..+++.||+|++...     .....+|+++++.++|+||.                  
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            4699999999999999999999999999999987543     23456799999999999971                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY  219 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~  219 (395)
                              +....+.+++..++.++.|++.||.|||+..|++||||||+||+++.++ .++|+|||++...... .....
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~~~-~~~~~  162 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINS-IADTF  162 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchhhh-ccCcc
Confidence                    0112345788889999999999999999446999999999999999877 6999999998654322 22345


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      .++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.......    ....+....        ......    .
T Consensus       163 ~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~----~  229 (284)
T cd06620         163 VGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL--------QQIVQE----P  229 (284)
T ss_pred             ccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH--------HHHhhc----c
Confidence            789999999998765 48999999999999999999999998654321    111111100        000000    0


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      .+.        .....++..+.+||.+||+.||.+|||+.|+++|+||.+-
T Consensus       230 ~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         230 PPR--------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             CCC--------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            000        0011257889999999999999999999999999999664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=324.32  Aligned_cols=229  Identities=30%  Similarity=0.492  Sum_probs=185.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeec------chhhHHHHHHHHHhcCCCceE-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      -+|.-...||.|.||.||.|.+..+|+..|+|.++-      ......+|..++..|+|||++                 
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            367778899999999999999999999999997742      233456899999999999981                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC----
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE----  214 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~----  214 (395)
                               ....+...++...+.|..|++.|+.||| +.|||||||||.||||+.+| .||++|||.|.....+.    
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH-~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLH-EHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHH-hcCceecCCCccceeeecCC-cEEeecccceeEecCchhcCC
Confidence                     1223445677778889999999999999 88999999999999999888 79999999998875442    


Q ss_pred             -CcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          215 -PNISYICSRYYRAPELIFGA--TEYTTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                       ......||+.|||||++.+.  ...+.+.|||||||++.||+||+.||...+.+ ..++.+-. .              
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-g-------------- 1457 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-G-------------- 1457 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-c--------------
Confidence             12357899999999999653  24678999999999999999999999765443 33333221 1              


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                          ..|+         +|.++|.+..|||.+||..||++|+++.|+|.|.|-+.-.+.
T Consensus      1458 ----h~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1458 ----HKPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             ----CCCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence                1122         344589999999999999999999999999999997665543

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.4e-36  Score=275.74  Aligned_cols=221  Identities=34%  Similarity=0.511  Sum_probs=180.3

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------e
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      +|++.++||.|+||.||.+++..+++.|++|.+...      .....+|+.+++.++|+||.                 +
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            499999999999999999999999999999987532      13345799999999999981                 0


Q ss_pred             e-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cc
Q 016085          149 S-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PN  216 (395)
Q Consensus       149 ~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~  216 (395)
                      .           .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH-KAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCChHhEEEeCCC-CEEECcCcceEEcccccccc
Confidence            0           01245788889999999999999999 88999999999999999887 69999999997654333 22


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+..+....+...  ...                
T Consensus       159 ~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~----------------  219 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT----------------  219 (256)
T ss_pred             cccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC----------------
Confidence            3456789999999987654 889999999999999999999999887665555554321  000                


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                                .....++.++.++|.+||..+|.+||++.++++|+|+
T Consensus       220 ----------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         220 ----------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             ----------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                      0113368899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.4e-36  Score=284.77  Aligned_cols=224  Identities=29%  Similarity=0.417  Sum_probs=178.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceEe----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+|+..                
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            5999999999999999999999999999999885321       23457999999999999711                


Q ss_pred             ----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          149 ----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       149 ----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                                ......+++..+..++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||++......   ..
T Consensus        96 ~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH-~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~~~---~~  170 (307)
T cd06607          96 YCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH-SHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPA---NS  170 (307)
T ss_pred             hhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcccEEECCCC-CEEEeecCcceecCCC---CC
Confidence                      012345788889999999999999999 88999999999999999887 6999999998764322   34


Q ss_pred             ccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          219 YICSRYYRAPELIFG--ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ..+++.|+|||++.+  ...++.++|||||||++|+|++|+.||.+.+.......+...  .                 .
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~-----------------~  231 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--D-----------------S  231 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--C-----------------C
Confidence            567889999998842  244788999999999999999999999876654443332210  0                 0


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      +..        .....+..+.+||.+||+.||++||++.+++.||||..-.
T Consensus       232 ~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         232 PTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             CCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            000        0122578899999999999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=276.73  Aligned_cols=231  Identities=27%  Similarity=0.453  Sum_probs=177.9

Q ss_pred             eeee-eeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhc-CCCce--------------------
Q 016085           93 YMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLL-DHPNV--------------------  146 (395)
Q Consensus        93 y~~~-~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l-~h~ni--------------------  146 (395)
                      |++. +.||+|+|+.|--+....+|..||||++.+..    ...-||++++... .|+||                    
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm  158 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM  158 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence            5554 58999999999999999999999999997653    3345899988887 58897                    


Q ss_pred             ------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC--ceEEeecCCccccccCC----
Q 016085          147 ------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGE----  214 (395)
Q Consensus       147 ------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~--~ikl~DFG~a~~~~~~~----  214 (395)
                            ..+.....+++..+..+...|+.||.||| .+||.||||||+|||...-.+  -||||||.++.-.....    
T Consensus       159 ~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH-~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  159 RGGPLLSHIQKRKHFNEREASRVVKDIASALDFLH-TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             cCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHh-hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence                  11233456899999999999999999999 899999999999999864332  49999998865432221    


Q ss_pred             ----Cccccccccccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------------HHHHH
Q 016085          215 ----PNISYICSRYYRAPELIF----GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV---------------DQLVE  271 (395)
Q Consensus       215 ----~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------------~~~~~  271 (395)
                          ...+.+|+..|||||++.    ....|+.+.|.||||||||-||.|.+||.|.-+.               ..+..
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes  317 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES  317 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence                123567888999999872    2345899999999999999999999999874321               12222


Q ss_pred             HHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       272 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      |.+.                 .++||.   ..     +..+|.+++||++.+|..|+.+|.++.++++|||++.+...
T Consensus       318 IQEG-----------------kYeFPd---kd-----WahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  318 IQEG-----------------KYEFPD---KD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             Hhcc-----------------CCcCCh---hh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            2221                 122222   11     22379999999999999999999999999999999987654

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.5e-36  Score=278.28  Aligned_cols=224  Identities=29%  Similarity=0.470  Sum_probs=170.4

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceEe--------------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVHY--------------------  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~~--------------------  148 (395)
                      ......||+|+||.||+|++..++..||+|.+...    .....+|+.+++.++|+||..                    
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   89 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG   89 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence            33446899999999999999999999999987543    234568999999999999710                    


Q ss_pred             ------ec-cCCCC--cHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccc
Q 016085          149 ------SR-ASQRM--PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NIS  218 (395)
Q Consensus       149 ------~~-~~~~~--~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~  218 (395)
                            .. ....+  ++..+..++.||+.||.||| +.||+||||||+||+++.+...++|+|||++........ ...
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~  168 (268)
T cd06624          90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH-DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET  168 (268)
T ss_pred             CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcccc
Confidence                  00 11234  67778889999999999999 889999999999999987444799999999876533222 223


Q ss_pred             ccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..+++.|+|||.+.+. ..++.++|+||+||++|+|++|+.||................                     
T Consensus       169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  227 (268)
T cd06624         169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF---------------------  227 (268)
T ss_pred             CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh---------------------
Confidence            4578899999998543 347899999999999999999999996543221111000000                     


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                           .....++..+++++.+|+.+||+.+|.+|||+.+++.||||
T Consensus       228 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         228 -----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                 00011234478899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-36  Score=284.96  Aligned_cols=225  Identities=28%  Similarity=0.398  Sum_probs=179.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------------ee
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------------YS  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------------~~  149 (395)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++|+||.                 +.
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4888999999999999999999999999999876332     2456899999999999980                 00


Q ss_pred             --------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccccc
Q 016085          150 --------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYI  220 (395)
Q Consensus       150 --------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~~  220 (395)
                              .....+++..++.++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||++........ .....
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06642          85 GGGSALDLLKPGPLEETYIATILREILKGLDYLH-SERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             CCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh-cCCeeccCCChheEEEeCCC-CEEEccccccccccCcchhhhccc
Confidence                    12245788889999999999999999 88999999999999999877 699999999876543321 12345


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      ++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...........+...                   ..    
T Consensus       163 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-------------------~~----  218 (277)
T cd06642         163 GTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN-------------------SP----  218 (277)
T ss_pred             CcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC-------------------CC----
Confidence            788999999997654 899999999999999999999999765443322221110                   00    


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                           ..+....+..+.+||.+||+.+|.+|||+.++++||||..+.
T Consensus       219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         219 -----PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             -----CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                 012234678899999999999999999999999999997754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.3e-36  Score=291.73  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=173.7

Q ss_pred             eeeccC--CceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEe--------------------
Q 016085           97 RVVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHY--------------------  148 (395)
Q Consensus        97 ~~lG~G--~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~--------------------  148 (395)
                      ..||+|  +||+||+|++..+|+.||+|++....      ....+|+.+++.++|+||..                    
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  99999999999999999999986422      34467889999999999810                    


Q ss_pred             ------ec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc---
Q 016085          149 ------SR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---  217 (395)
Q Consensus       149 ------~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~---  217 (395)
                            ..  ....+++..+..++.|++.||+||| +.||+||||||+|||++.++ .++++||+.+..........   
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH-~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH-QNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccCcccccc
Confidence                  00  1234788888899999999999999 88999999999999999887 69999998654332111100   


Q ss_pred             -----cccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH---------
Q 016085          218 -----SYICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---------  282 (395)
Q Consensus       218 -----~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------  282 (395)
                           ...++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..++......+..         
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence                 11235669999998653 347899999999999999999999998876555444433311111100         


Q ss_pred             HHhhcCCCCc----cccC-----CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          283 EIKCMNPNYT----EFKF-----PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       283 ~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      .+......+.    ....     .......+.......++..+.+||++||++||++|||+.++|+||||..+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence            0000000000    0000     00000011111223467789999999999999999999999999999887654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.7e-36  Score=287.09  Aligned_cols=219  Identities=24%  Similarity=0.361  Sum_probs=169.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcE----EEEEEeecc-----hhhHHHHHHHHHhcCCCceEe-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGET----VAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY-------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~----vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~-------------  148 (395)
                      .+|++.+.||+|+||.||+|++..+++.    ||+|.+...     .....+|+.+++.++|+||..             
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v   86 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   86 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence            4699999999999999999998766654    899988543     233457899999999999810             


Q ss_pred             -------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 -------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 -------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                   ......++...+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.......
T Consensus        87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~  164 (316)
T cd05108          87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-ERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEK  164 (316)
T ss_pred             eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH-hcCeeccccchhheEecCCC-cEEEccccccccccCCCc
Confidence                         011234677788899999999999999 88999999999999999887 599999999987643332


Q ss_pred             cc---cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          216 NI---SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       216 ~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      ..   ...++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+ +..+......             
T Consensus       165 ~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~-------------  229 (316)
T cd05108         165 EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGER-------------  229 (316)
T ss_pred             ceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCC-------------
Confidence            21   223366799999987654 8999999999999999997 999998765443 2333321000             


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                          .          ..+...+..+.+++.+||..||.+|||+.+++.+
T Consensus       230 ----~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         230 ----L----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ----C----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                0          0122357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.6e-36  Score=277.58  Aligned_cols=220  Identities=33%  Similarity=0.557  Sum_probs=175.4

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------e------
Q 016085           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------Y------  148 (395)
Q Consensus        99 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------~------  148 (395)
                      ||.|+||.||+|++..+++.||+|.+....       ....+|+++++.++|+|+.                 +      
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999999999999999886432       2345789999999999970                 0      


Q ss_pred             ---eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC---------Cc
Q 016085          149 ---SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---------PN  216 (395)
Q Consensus       149 ---~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~---------~~  216 (395)
                         ......+++..+..++.||+.||.||| +.|++||||+|+||+++.++ .++|+|||++.......         ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH-~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLH-SNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCcccccccccccc
Confidence               111246788899999999999999999 88999999999999999888 69999999987654332         11


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...........+...                 ....
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~~~~  220 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG-----------------KIEW  220 (265)
T ss_pred             cCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------CcCC
Confidence            2345688899999987655 899999999999999999999999877655544443220                 0001


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCH---HHHhcCCcccCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA---LEACIHPFFDELRD  348 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~---~e~l~hp~f~~~~~  348 (395)
                      +.          ...++..+.+||.+||+.+|.+|||+   .++|+||||+++.|
T Consensus       221 ~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         221 PE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             Cc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            10          01148899999999999999999999   99999999988754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.1e-36  Score=282.51  Aligned_cols=219  Identities=23%  Similarity=0.304  Sum_probs=172.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCC-----cEEEEEEeecch-----hhHHHHHHHHHhcCCCceEe------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~------------  148 (395)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.+....     ....+|+.+++.++|+||..            
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            46999999999999999999876555     689999886432     23467999999999999710            


Q ss_pred             -----e---------cc----------------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCc
Q 016085          149 -----S---------RA----------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ  198 (395)
Q Consensus       149 -----~---------~~----------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~  198 (395)
                           .         ..                ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH-~~~i~H~dlkp~Nil~~~~~-~  162 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS-SHHFVHRDLAARNCLVGEGL-T  162 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccccceEEEcCCC-c
Confidence                 0         00                034667788899999999999999 88999999999999999877 6


Q ss_pred             eEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 016085          199 VKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIK  274 (395)
Q Consensus       199 ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  274 (395)
                      ++|+|||+++.......   .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS  241 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999876533221   22345578899999987654 8999999999999999998 9999988776554444332


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          275 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ..                   .         ...+..++.++.+|+.+||+.||.+||++.+++++
T Consensus       242 ~~-------------------~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         242 RQ-------------------L---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CC-------------------c---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            10                   0         01234478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=9.4e-36  Score=280.21  Aligned_cols=229  Identities=31%  Similarity=0.470  Sum_probs=181.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceEee------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVHYS------------------  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~~~------------------  149 (395)
                      .|...+.||.|++|.||+|.+..+++.||+|.+...    .....+|+.+++.++|+|+...                  
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            366668999999999999999999999999987532    2234579999999999997100                  


Q ss_pred             -------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cccccc
Q 016085          150 -------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYIC  221 (395)
Q Consensus       150 -------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~~g  221 (395)
                             ....++++..+..++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||.+........ .....+
T Consensus       100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~  177 (285)
T cd06648         100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLH-AQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRRKSLVG  177 (285)
T ss_pred             CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCCcccccccC
Confidence                   01245778888999999999999999 88999999999999999887 699999998875533221 223467


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      +..|+|||.+.+.. ++.++|+|||||++|+|++|+.||.+.+....+..+... ..                  +..  
T Consensus       178 ~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~------------------~~~--  235 (285)
T cd06648         178 TPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LP------------------PKL--  235 (285)
T ss_pred             CccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CC------------------CCC--
Confidence            89999999987655 899999999999999999999999876655544443321 00                  000  


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                           .....++..+.+||++||+++|++|||+.++++||||....++
T Consensus       236 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         236 -----KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             -----cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence                 0112367899999999999999999999999999999987754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.3e-36  Score=276.67  Aligned_cols=218  Identities=28%  Similarity=0.473  Sum_probs=175.1

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------------ee
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------------YS  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------------~~  149 (395)
                      +|.+.+.||.|+||.||++++..+++.||+|.+...     .....+|+.+++.++|+|+.                 +.
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            489999999999999999999999999999987532     23445789999999999970                 10


Q ss_pred             -----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cc
Q 016085          150 -----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NI  217 (395)
Q Consensus       150 -----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~  217 (395)
                                 .....+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||++........ ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH-EKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCcceEEECCCC-cEEEcccCcceeecccccccc
Confidence                       11234688889999999999999999 88999999999999999887 699999999876543222 23


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ...+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+...              .+.     
T Consensus       159 ~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--------------~~~-----  218 (255)
T cd08219         159 TYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG--------------SYK-----  218 (255)
T ss_pred             cccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC--------------CCC-----
Confidence            456788999999987654 899999999999999999999999876655444443221              000     


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                               .++..++..+.+||.+||+.||++|||+.++++-
T Consensus       219 ---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 ---------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                     1223467889999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.7e-36  Score=285.32  Aligned_cols=225  Identities=19%  Similarity=0.226  Sum_probs=161.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCC---CcEEEEEEeecchhhHH---------------HHHHHHHhcCCCceEe----
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDKRYKN---------------RELQTMRLLDHPNVHY----  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~---~~~vAiK~~~~~~~~~~---------------~E~~~l~~l~h~ni~~----  148 (395)
                      .+|++.++||+|+||.||+|++..+   +..+|+|+.........               .+...+..+.|+|+..    
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4699999999999999999998877   67788886432221111               1223445567877510    


Q ss_pred             -------------------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEee
Q 016085          149 -------------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  203 (395)
Q Consensus       149 -------------------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~D  203 (395)
                                               .......++..++.++.|++.||+||| +.||+||||||+|||++.++ .++|+|
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~iiHrDiKp~Nill~~~~-~~~l~D  169 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH-EHGISHGDIKPENIMVDGNN-RGYIID  169 (294)
T ss_pred             eeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-cEEEEE
Confidence                                     001123567778889999999999999 88999999999999999877 699999


Q ss_pred             cCCccccccCC--------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 016085          204 FGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV  275 (395)
Q Consensus       204 FG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  275 (395)
                      ||+|+......        ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+......+....+.
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~  248 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC  248 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence            99997653221        112346899999999987655 899999999999999999999999876433322222111


Q ss_pred             hCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                            ..+..+..       +        .......++.+.++++.|+..+|++||+..++++
T Consensus       249 ------~~~~~~~~-------~--------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        249 ------DFIKRLHE-------G--------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             ------HHHHHhhh-------h--------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                  00000000       0        0011235788999999999999999999999864

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.2e-36  Score=283.77  Aligned_cols=230  Identities=29%  Similarity=0.423  Sum_probs=180.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceEe-----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVHY-----------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~~-----------------  148 (395)
                      .++|.+.+.||+|+||.||++.+..++..||+|.+...    .....+|+.+++.++|+|+..                 
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            35799999999999999999999889999999987532    233457899999999999710                 


Q ss_pred             e--------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cccc
Q 016085          149 S--------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISY  219 (395)
Q Consensus       149 ~--------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~  219 (395)
                      .        .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++........ ....
T Consensus        98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH-~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~~~~~~~  175 (293)
T cd06647          98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTM  175 (293)
T ss_pred             CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH-hCCEeeccCCHHHEEEcCCC-CEEEccCcceecccccccccccc
Confidence            0        01234677888999999999999999 88999999999999999877 699999998865533322 2234


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcc
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI  299 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (395)
                      .+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+....+..+.. .+.+.                   
T Consensus       176 ~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~-------------------  234 (293)
T cd06647         176 VGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE-------------------  234 (293)
T ss_pred             cCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC-------------------
Confidence            6788999999987654 89999999999999999999999987655433222211 00000                   


Q ss_pred             cCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       300 ~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                            ...+..++..+.+||++||+.+|++||++.+++.|+||+..+.
T Consensus       235 ------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         235 ------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             ------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence                  0012236788999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.2e-36  Score=276.73  Aligned_cols=225  Identities=32%  Similarity=0.556  Sum_probs=176.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++|+||.                  
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4899999999999999999999999999999986432      3445799999999999970                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc--
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--  217 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~--  217 (395)
                              +......+++..++.++.|++.||.||| +.||+|+||+|+||+++.++ .+||+|||++..........  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH-SHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEcccccccccCCCCCcccc
Confidence                    0112244788889999999999999999 88999999999999999877 69999999987764332211  


Q ss_pred             ---cccccccccccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          218 ---SYICSRYYRAPELIFGAT--EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       218 ---~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                         ...++..|+|||.+.+..  .++.++|+|||||++|+|++|+.||.+............. +.++            
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~------------  225 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP------------  225 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC------------
Confidence               245688999999986532  3788999999999999999999999765433222221111 1000            


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                        .++.          ...+++.+.+||.+||+.+|.+|||+.+++.|||+
T Consensus       226 --~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 --PIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             --CCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence              0110          12358899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-36  Score=280.80  Aligned_cols=227  Identities=30%  Similarity=0.489  Sum_probs=178.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcC---CCceEe---------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLD---HPNVHY---------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~---h~ni~~---------------  148 (395)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+...     .....+|+.+++.+.   |+|+..               
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            488899999999999999999999999999987542     234567999999987   998710               


Q ss_pred             --e--------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cc
Q 016085          149 --S--------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NI  217 (395)
Q Consensus       149 --~--------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~  217 (395)
                        .        .....+++..+..++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||++........ ..
T Consensus        82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh-~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06917          82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH-KVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKRS  159 (277)
T ss_pred             ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCCCccccc
Confidence              0        11236788889999999999999999 88999999999999999877 699999999977644322 23


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ...|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+..                   ...+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------------------~~~~  220 (277)
T cd06917         160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-------------------SKPP  220 (277)
T ss_pred             cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-------------------CCCC
Confidence            456788999999987655579999999999999999999999976543322211100                   0000


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      ..        .....+.++.+|+.+||+.||.+|||+.++++|+||++..
T Consensus       221 ~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         221 RL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             CC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            00        0112678999999999999999999999999999997754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.9e-36  Score=291.96  Aligned_cols=221  Identities=23%  Similarity=0.343  Sum_probs=169.0

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCC-----CcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceEeec-------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVHYSR-------  150 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~~~~-------  150 (395)
                      ..++|.+.+.||+|+||.||+|++..+     +..||+|.+....     ....+|+.+++.+ +|+||....       
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            345799999999999999999986543     3579999986432     2345799999999 899981100       


Q ss_pred             --------------------------------------------------------------------------------
Q 016085          151 --------------------------------------------------------------------------------  150 (395)
Q Consensus       151 --------------------------------------------------------------------------------  150 (395)
                                                                                                      
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence                                                                                            


Q ss_pred             ---------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc---c
Q 016085          151 ---------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---S  218 (395)
Q Consensus       151 ---------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~---~  218 (395)
                               ...++++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++.........   .
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA-SKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH-HCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcceeeccC
Confidence                     0123677788999999999999999 88999999999999999777 69999999997654332211   1


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..++..|+|||++.+.. ++.++|||||||++|+|++ |+.||........+..+.....                    
T Consensus       274 ~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~--------------------  332 (374)
T cd05106         274 ARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY--------------------  332 (374)
T ss_pred             CCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc--------------------
Confidence            23456799999997654 8999999999999999997 9999987654443333332100                    


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                             ....+...++++.++|.+||+.||.+|||+.++++
T Consensus       333 -------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         333 -------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             -------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   00112236889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-35  Score=302.62  Aligned_cols=248  Identities=21%  Similarity=0.293  Sum_probs=162.3

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCC----CcEEEEEEeecchhhHHHHHHHHHhcC---------------------C
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLET----GETVAIKKVLQDKRYKNRELQTMRLLD---------------------H  143 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~----~~~vAiK~~~~~~~~~~~E~~~l~~l~---------------------h  143 (395)
                      ..++|.+.+.||+|+||.||+|++..+    +..||+|++......   |..+...+.                     +
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            456899999999999999999999988    999999987543211   111111110                     0


Q ss_pred             -Cce--Eeecc-------------------------------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCc
Q 016085          144 -PNV--HYSRA-------------------------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  189 (395)
Q Consensus       144 -~ni--~~~~~-------------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~N  189 (395)
                       ..+  .+...                               ........+..++.||+.||.||| +.||+||||||+|
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH-~~gIiHRDLKP~N  285 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH-STGIVHRDVKPQN  285 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH-HCCEEeCcCCHHH
Confidence             000  00000                               001123346679999999999999 8899999999999


Q ss_pred             eEEcCCCCceEEeecCCccccccCC--CcccccccccccccccccCCC---------------------CCCCcchHHHH
Q 016085          190 LLVNPHTHQVKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT---------------------EYTTAVDIWSV  246 (395)
Q Consensus       190 ill~~~~~~ikl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~DiwSl  246 (395)
                      ||++.+...+||+|||+|+....+.  .....++|+.|+|||.+....                     .++.++|||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            9998654479999999997653322  223567899999999763211                     23456799999


Q ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccC
Q 016085          247 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY  326 (395)
Q Consensus       247 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~  326 (395)
                      ||+||||+++..++  .+....+..++...+.............+    .+.... .+  .........+.+||.+||++
T Consensus       366 GviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~----~~~~~~-~~--~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        366 GLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVEPRA----SPDLRR-GF--EVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhcccc----chhhhh-hh--hhccccchHHHHHHHHHccC
Confidence            99999999976543  34444555555544433222111111110    000000 00  00111245677999999999


Q ss_pred             CCCCCCCHHHHhcCCcccCCCCC
Q 016085          327 SPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       327 dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      ||++|||+.++|+||||+.....
T Consensus       437 dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCCCcc
Confidence            99999999999999999876543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.8e-36  Score=281.06  Aligned_cols=211  Identities=16%  Similarity=0.180  Sum_probs=167.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceEee--------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVHYS--------------------  149 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~~~--------------------  149 (395)
                      ..||+|++|.||+|..  +|+.||||.+....       ....+|+.+|++++|+||...                    
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5799999999999987  78999999886432       334589999999999998111                    


Q ss_pred             ----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccc
Q 016085          150 ----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY  219 (395)
Q Consensus       150 ----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~  219 (395)
                                .....+++.....++.|++.||.|||...+++||||||+|||++.++ .+||+|||+++.....  ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~--~~~~  180 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP--PFKN  180 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc--cccc
Confidence                      11235677788899999999999999435999999999999999887 6999999999765332  2345


Q ss_pred             cccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          220 ICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      .+|..|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+....+......+                   
T Consensus       181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------  241 (283)
T PHA02988        181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL-------------------  241 (283)
T ss_pred             cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Confidence            678999999998652 348999999999999999999999998877665555444311100                   


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                              .++...++.+.+||.+||+.||++|||+.++++
T Consensus       242 --------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 --------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             --------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                    122246889999999999999999999999974

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-35  Score=280.64  Aligned_cols=232  Identities=27%  Similarity=0.401  Sum_probs=175.4

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceE---------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVH---------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~---------------  147 (395)
                      ..++|++.+.||+|+||.||+|.+..+++.||||.+....     ....+|+.++..+ .|+||.               
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            3457999999999999999999999889999999986432     1223466655555 499870               


Q ss_pred             --ee---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          148 --YS---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 --~~---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                        +.         .....+++..+..++.|++.||.|||+..||+||||+|+||+++.++ .+||+|||++.........
T Consensus        93 ~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~~~~~~~~  171 (296)
T cd06618          93 MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGRLVDSKAK  171 (296)
T ss_pred             eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchhccCCCcc
Confidence              00         01245788888899999999999999436999999999999999877 6999999999766443333


Q ss_pred             ccccccccccccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          217 ISYICSRYYRAPELIFGA---TEYTTAVDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      ....++..|+|||.+.+.   ..++.++|||||||++|+|++|+.||..... .+.+..+...              .  
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------------~--  235 (296)
T cd06618         172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE--------------E--  235 (296)
T ss_pred             cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC--------------C--
Confidence            344578889999998643   2378899999999999999999999965332 2222222210              0  


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                         .+..       .....++.++.+||.+||..||.+||++.+++.||||....
T Consensus       236 ---~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         236 ---PPSL-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             ---CCCC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence               0000       00113678999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.2e-36  Score=281.78  Aligned_cols=218  Identities=21%  Similarity=0.245  Sum_probs=171.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCC-----CcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEee-----------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHYS-----------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~~-----------  149 (395)
                      .+|++.+.||+|+||.||+|++..+     ++.||||++....     ....+|+.+++.++|+||...           
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            4699999999999999999987543     5789999986432     335578999999999997100           


Q ss_pred             ----c---------------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCc
Q 016085          150 ----R---------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ  198 (395)
Q Consensus       150 ----~---------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~  198 (395)
                          .                           ....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH-~~gi~H~dlkp~Nil~~~~~-~  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS-SHHVVHKDLATRNVLVFDKL-N  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-HcCccccccchhheEecCCC-c
Confidence                0                           0124677778899999999999999 88999999999999999877 6


Q ss_pred             eEEeecCCccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 016085          199 VKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIK  274 (395)
Q Consensus       199 ikl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  274 (395)
                      +||+|||+++........   ....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+.+..+..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN  241 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999998765433221   1234577899999987655 8999999999999999998 8899988766555554433


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          275 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ...                            ..++..++..+.+|+.+||+.+|.+||++.+++.
T Consensus       242 ~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         242 RQV----------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             CCc----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            100                            0123457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.1e-36  Score=281.26  Aligned_cols=225  Identities=27%  Similarity=0.391  Sum_probs=179.1

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------------ee
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------------YS  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------------~~  149 (395)
                      .|...+.||.|+||.||+|.+..++..||+|.+....     ....+|+.+++.+.|+|+.                 +.
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4889999999999999999999999999999886432     2345799999999999971                 00


Q ss_pred             --------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccccc
Q 016085          150 --------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYI  220 (395)
Q Consensus       150 --------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~~  220 (395)
                              .....+++..+..++.|++.||+||| +.|++|+||+|+||+++.++ .++|+|||++........ .....
T Consensus        85 ~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh-~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06640          85 GGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH-SEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCcccccccc
Confidence                    12245778888899999999999999 88999999999999999877 699999999976543322 22345


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      ++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+.......+..  +.                 .    
T Consensus       163 ~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~-----------------~----  218 (277)
T cd06640         163 GTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NN-----------------P----  218 (277)
T ss_pred             CcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CC-----------------C----
Confidence            688899999987654 89999999999999999999999987654433322211  00                 0    


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                           ..+...++..+.+||.+||..+|++||++.++++|+||....
T Consensus       219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         219 -----PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             -----CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                 012234678899999999999999999999999999996643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.2e-36  Score=288.29  Aligned_cols=220  Identities=26%  Similarity=0.392  Sum_probs=169.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceEe-----------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVHY-----------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~~-----------  148 (395)
                      ++|++.+.||+|+||.||+|++.     .+++.||+|++....     ....+|+.+++.+ +|+||..           
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            47999999999999999999754     345789999886321     2344699999999 8998710           


Q ss_pred             -------ec---------c-------------------------------------------------------------
Q 016085          149 -------SR---------A-------------------------------------------------------------  151 (395)
Q Consensus       149 -------~~---------~-------------------------------------------------------------  151 (395)
                             ..         .                                                             
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence                   00         0                                                             


Q ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC---ccccccccccccc
Q 016085          152 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAP  228 (395)
Q Consensus       152 ~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aP  228 (395)
                      ...+++..+..++.||+.||+||| +.||+||||||+|||++.++ .++|+|||+++.......   .....++..|+||
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH-~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA-SRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence            125677888999999999999999 88999999999999999877 699999999987543221   1223456789999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccc
Q 016085          229 ELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI  307 (395)
Q Consensus       229 E~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (395)
                      |.+.+.. ++.++|||||||++|+|++ |..||.+....+.+...+... .                 .         ..
T Consensus       245 E~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~-----------------~---------~~  296 (337)
T cd05054         245 ESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-T-----------------R---------MR  296 (337)
T ss_pred             HHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc-C-----------------C---------CC
Confidence            9997755 8999999999999999998 999998755444433332210 0                 0         01


Q ss_pred             cCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          308 FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       308 ~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .+...++++.+++.+||+.+|++||++.++++|
T Consensus       297 ~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            123367899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-35  Score=275.59  Aligned_cols=218  Identities=23%  Similarity=0.355  Sum_probs=172.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCceE-----------------ee-
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVH-----------------YS-  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni~-----------------~~-  149 (395)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+..+.   ....+|+++++.++|+|+.                 +. 
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            35999999999999999999999999999999986543   2345799999999999970                 00 


Q ss_pred             ----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc--
Q 016085          150 ----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--  217 (395)
Q Consensus       150 ----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~--  217 (395)
                                .....+++..++.++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++..........  
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~~~~~~  163 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHA  163 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccCcceEEEcCCC-cEEeCCCccccccccceeeccC
Confidence                      11234778888999999999999999 88999999999999999877 69999999997754332111  


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...               +     
T Consensus       164 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---------------~-----  222 (263)
T cd05052         164 GAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---------------Y-----  222 (263)
T ss_pred             CCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---------------C-----
Confidence            122356799999887654 8999999999999999998 99999887654443333210               0     


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                              ....+..++..+.+||.+||+.||++|||+.++++
T Consensus       223 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 --------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                    00123457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.7e-35  Score=272.48  Aligned_cols=221  Identities=33%  Similarity=0.543  Sum_probs=178.8

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------e
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++...      .....+|+++++.++|+|+.                 +
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            489999999999999999999999999999998643      23455799999999999970                 0


Q ss_pred             e----------cc---CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-
Q 016085          149 S----------RA---SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-  214 (395)
Q Consensus       149 ~----------~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-  214 (395)
                      .          ..   ...+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||.+....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-SRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH-hCCEecccCChHHeEEcCCC-cEEECCccceeecccCcc
Confidence            0          00   256788899999999999999999 78999999999999999877 69999999987654432 


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+....                  
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  219 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ------------------  219 (258)
T ss_pred             eecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC------------------
Confidence            223356788999999987654 8999999999999999999999997766444333322200                  


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                       .+         .++..++..+.+++.+||..+|++|||+.++|+||||
T Consensus       220 -~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 -YP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             -CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence             00         1223468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9e-37  Score=295.18  Aligned_cols=220  Identities=21%  Similarity=0.284  Sum_probs=171.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      +...+...||+|.||+||+|++..   .||||++.-.      .+.++.|+.++++-+|.||.                 
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqw  468 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQW  468 (678)
T ss_pred             HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehh
Confidence            457788999999999999999744   5999998532      35567899999999999982                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC---CC
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG---EP  215 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~---~~  215 (395)
                               ......++.....+.|+.||++|+.||| .++|||||||..||||.+++ .|||+|||++......   ..
T Consensus       469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH-AK~IIHrDLKSnNIFl~~~~-kVkIgDFGLatvk~~w~g~~q  546 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH-AKNIIHRDLKSNNIFLHEDL-KVKIGDFGLATVKTRWSGEQQ  546 (678)
T ss_pred             ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh-hhhhhhhhccccceEEccCC-cEEEecccceeeeeeeccccc
Confidence                     2233456777788899999999999999 88999999999999999876 7999999998653221   12


Q ss_pred             cccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          216 NISYICSRYYRAPELIFGA--TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      .....|...|||||++..+  -.|++.+|||||||++|||+||..||...+....+..+-+..+.|..            
T Consensus       547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~------------  614 (678)
T KOG0193|consen  547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL------------  614 (678)
T ss_pred             cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc------------
Confidence            2234567889999999532  34899999999999999999999999866555444433221111111            


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                  .....+.+.++++|+..||.+++++||+..++|.
T Consensus       615 ------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  615 ------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                        1123446789999999999999999999999875

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.8e-37  Score=314.24  Aligned_cols=225  Identities=29%  Similarity=0.438  Sum_probs=169.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCce-------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNV-------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni-------------------  146 (395)
                      .+|+.++.||+||||.||+++++-+|+.||||++.-.     .....+|+.+|.+|+||||                   
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            4688999999999999999999999999999998543     2334589999999999998                   


Q ss_pred             --------------------------------------------------------------------------------
Q 016085          147 --------------------------------------------------------------------------------  146 (395)
Q Consensus       147 --------------------------------------------------------------------------------  146 (395)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             --------------------------------Eeec-------------cCCCC--cHHHHHHHHHHHHHHHHHHHcCCC
Q 016085          147 --------------------------------HYSR-------------ASQRM--PLIYVKLYTYQICRALAYIHGGIG  179 (395)
Q Consensus       147 --------------------------------~~~~-------------~~~~~--~~~~~~~~~~qi~~aL~~LH~~~g  179 (395)
                                                      .|++             ....+  ....++.++.||++||.|+| +.|
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH-~~g  717 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH-DQG  717 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-hCc
Confidence                                            0000             00111  24557889999999999999 889


Q ss_pred             eeeccCCCCceEEcCCCCceEEeecCCccccc-------------------cCCCcccccccccccccccccCCC--CCC
Q 016085          180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-------------------KGEPNISYICSRYYRAPELIFGAT--EYT  238 (395)
Q Consensus       180 iiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~--~~~  238 (395)
                      ||||||||.||+|++++ .|||+|||+|....                   .....++.+||.-|+|||++.+..  .|+
T Consensus       718 iIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             eeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999999888 59999999998721                   111345678999999999996655  599


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHH
Q 016085          239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVD  318 (395)
Q Consensus       239 ~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  318 (395)
                      .++|+||||+||+||+.-   |.-  ..+-... +..+..+               .+|.-      ..|...--+.-..
T Consensus       797 ~KiDmYSLGIVlFEM~yP---F~T--sMERa~i-L~~LR~g---------------~iP~~------~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLYP---FGT--SMERASI-LTNLRKG---------------SIPEP------ADFFDPEHPEEAS  849 (1351)
T ss_pred             chhhhHHHHHHHHHHhcc---CCc--hHHHHHH-HHhcccC---------------CCCCC------cccccccchHHHH
Confidence            999999999999999853   532  2222222 2211111               11110      1112223456788


Q ss_pred             HHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          319 LVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       319 ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                      +|+.||+.||++||||.|+|++.||.
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhhccCCC
Confidence            99999999999999999999999986

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-35  Score=281.66  Aligned_cols=224  Identities=20%  Similarity=0.262  Sum_probs=167.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcC----------------CCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEee
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLE----------------TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHYS  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~----------------~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~~  149 (395)
                      ++|++.+.||+|+||.||+|++..                ++..||+|.+....     ....+|+.+++.++|+||...
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            479999999999999999998642                34479999886532     235579999999999997110


Q ss_pred             ----------------cc-----------------------------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeecc
Q 016085          150 ----------------RA-----------------------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD  184 (395)
Q Consensus       150 ----------------~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrD  184 (395)
                                      ..                             ...+++..+..++.||+.||.||| +.||+|||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~ivH~d  163 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS-SLNFVHRD  163 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH-HCCccccC
Confidence                            00                             012455677889999999999999 88999999


Q ss_pred             CCCCceEEcCCCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh--CCCC
Q 016085          185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL--GQPL  259 (395)
Q Consensus       185 lKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~--g~~p  259 (395)
                      |||+|||++.++ .+||+|||+++.......   .....++..|+|||++.+.. ++.++|||||||++|+|++  |..|
T Consensus       164 lkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         164 LATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999887 699999999976533321   11234477899999987655 8999999999999999986  6678


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          260 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       260 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                      |.+.+..+.+..+.........           .          .....+..++..+.+|+.+||..||++|||+.++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~-----------~----------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGR-----------Q----------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccc-----------c----------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            8876665555444332110000           0          00011234678999999999999999999999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-37  Score=299.13  Aligned_cols=223  Identities=28%  Similarity=0.436  Sum_probs=181.4

Q ss_pred             eeeeeeccCCceEEEEEEEcCCCcEEEEEEee------cc--hhhHHHHHHHHHhcCCCce-------------------
Q 016085           94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QD--KRYKNRELQTMRLLDHPNV-------------------  146 (395)
Q Consensus        94 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~------~~--~~~~~~E~~~l~~l~h~ni-------------------  146 (395)
                      +...+||+|+|-+||+|.|..+|..||.-.++      ..  ...+..|+.+|+.|+|+||                   
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44578999999999999999999999875432      22  2456689999999999998                   


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHc-CCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                               .|....+++....++.|+.||+.||.|||+ .--|||||||.+||+|+.+.+.|||+|+|+|....... .
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-a  201 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-A  201 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-c
Confidence                     233455778888899999999999999994 23599999999999999988899999999998765443 3


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      .+.+|||.|||||++.  ..|+..+||||||..|.||+|+..||..-....++++-+-. |..+..              
T Consensus       202 ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~s--------------  264 (632)
T KOG0584|consen  202 KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAA--------------  264 (632)
T ss_pred             ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHH--------------
Confidence            4579999999999985  46999999999999999999999999877766666553321 222221              


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                 |.+=-.+++++||.+||.. .++|+|+.|+|+||||..-
T Consensus       265 -----------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  265 -----------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             -----------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                       1111368999999999999 8999999999999999763

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.6e-36  Score=278.11  Aligned_cols=220  Identities=33%  Similarity=0.600  Sum_probs=179.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcC-CCce-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLD-HPNV-----------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~-h~ni-----------------  146 (395)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++.+.       .....+|..+++.+. |+||                 
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            699999999999999999999999999999988642       133457889999998 9998                 


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                               .+......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||++........  
T Consensus        82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh-~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH-SKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEECCCC-CEEecCCccccccCCccccc
Confidence                     01122346889999999999999999999 88999999999999999887 599999999876533221  


Q ss_pred             -------------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 016085          216 -------------------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL  276 (395)
Q Consensus       216 -------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  276 (395)
                                         .....++..|+|||.+.+.. ++.++|+|||||++++|++|+.||...+....+..+... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-  237 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL-  237 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-
Confidence                               11235688899999887654 899999999999999999999999877654444443321 


Q ss_pred             CCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCH----HHHhcCCcc
Q 016085          277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFF  343 (395)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~e~l~hp~f  343 (395)
                                                  ...++..+++.+.+||.+||+.||.+|||+    .++++||||
T Consensus       238 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 ----------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             ----------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence                                        011233468899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=295.78  Aligned_cols=211  Identities=27%  Similarity=0.413  Sum_probs=176.5

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceE--------------------------e
Q 016085           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVH--------------------------Y  148 (395)
Q Consensus        95 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~--------------------------~  148 (395)
                      -++.||.|+.|.||+|+.  .++.||||+++.   ..+.+++-|++|+|+||.                          .
T Consensus       128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            357899999999999987  678999998864   344689999999999981                          1


Q ss_pred             eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccccccccccccc
Q 016085          149 SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP  228 (395)
Q Consensus       149 ~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aP  228 (395)
                      ++....+.......|..+|+.|++||| .+.|||||||.-||||+-+. .|||+|||-++...+..+..+++||..||||
T Consensus       203 Lka~~~itp~llv~Wsk~IA~GM~YLH-~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFaGTVaWMAP  280 (904)
T KOG4721|consen  203 LKAGRPITPSLLVDWSKGIAGGMNYLH-LHKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFAGTVAWMAP  280 (904)
T ss_pred             HhccCccCHHHHHHHHHHhhhhhHHHH-HhhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhhhhHhhhCH
Confidence            234566777788889999999999999 88999999999999999777 7999999999988777777789999999999


Q ss_pred             ccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCccccc
Q 016085          229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF  308 (395)
Q Consensus       229 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (395)
                      |++...+ .+.++|||||||+|||||||..||.+-+....                           +..+....+....
T Consensus       281 EvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------------------IwGVGsNsL~Lpv  332 (904)
T KOG4721|consen  281 EVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------------------IWGVGSNSLHLPV  332 (904)
T ss_pred             HHhhcCC-cccccceehhHHHHHHHHhcCCCccccchhee---------------------------EEeccCCcccccC
Confidence            9998765 99999999999999999999999976443211                           1112222333345


Q ss_pred             CCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          309 HKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       309 ~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      +...++.++=||+.||+-.|.+||++.++|.|
T Consensus       333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             cccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            66789999999999999999999999999988

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=285.99  Aligned_cols=226  Identities=29%  Similarity=0.410  Sum_probs=184.2

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeec--chhhHHHHHHHHHhcCCCce-----------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLDHPNV-----------------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~--~~~~~~~E~~~l~~l~h~ni-----------------------  146 (395)
                      -|.++.+||+|+||.||+|.++++|..+|||.+.-  +......|+.||++++.+++                       
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            39999999999999999999999999999999854  34556689999999998887                       


Q ss_pred             ----EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccccccc
Q 016085          147 ----HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYIC  221 (395)
Q Consensus       147 ----~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~g  221 (395)
                          ........+.+..+..++...+.||+||| ...-||||||..||||+.+|+ .||+|||.|....+.- ...+..|
T Consensus       114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH-~~~KIHRDIKAGNILLNT~G~-AKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T KOG0574|consen  114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLH-DLKKIHRDIKAGNILLNTDGI-AKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T ss_pred             cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH-HHHHHHhhcccccEEEcccch-hhhhhccccchhhhhHHhhCcccc
Confidence                11224577899999999999999999999 778899999999999999995 9999999997664432 2346789


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      ||.|||||++... .|+..+||||||++..||.-|++||.+..+...+..|-.   .|+.        .   |.      
T Consensus       192 TPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT---~PPP--------T---F~------  250 (502)
T KOG0574|consen  192 TPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT---KPPP--------T---FK------  250 (502)
T ss_pred             CcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC---CCCC--------C---CC------
Confidence            9999999999654 499999999999999999999999987655433322211   1111        0   00      


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                            -+..-|.++.||+++||.++|++|.||.++++|||+++.
T Consensus       251 ------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  251 ------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             ------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence                  112247889999999999999999999999999999763

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-35  Score=275.74  Aligned_cols=217  Identities=22%  Similarity=0.296  Sum_probs=168.5

Q ss_pred             eeeeeeeccCCceEEEEEEEcC---CCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEee--------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHYS--------------  149 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~~--------------  149 (395)
                      |++.+.||+|+||.||+|....   ++..||+|.+....      ....+|+.+++.++|+|+...              
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6788999999999999998765   34789999886432      234579999999999997110              


Q ss_pred             ------------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecC
Q 016085          150 ------------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  205 (395)
Q Consensus       150 ------------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG  205 (395)
                                              .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS-NRNFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH-hCCeeccccchheEEECCCC-eEEECCcc
Confidence                                    01135678888999999999999999 88999999999999999877 69999999


Q ss_pred             CccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 016085          206 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  281 (395)
Q Consensus       206 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  281 (395)
                      +++........   ....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+....+.+..+...  .   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~---  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG--N---  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--C---
Confidence            99876433211   112346679999998654 48999999999999999999 99999877655444333220  0   


Q ss_pred             HHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          282 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                             ....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       233 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 -----------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             -----------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   001223468899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.5e-35  Score=270.11  Aligned_cols=222  Identities=30%  Similarity=0.511  Sum_probs=178.8

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceE-----------------ee-
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVH-----------------YS-  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~-----------------~~-  149 (395)
                      +|.+.+.||+|+||.||+|.+..+++.|++|++....    ....+|+.+++.++|+|+.                 +. 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4889999999999999999999899999999986543    4566899999999999971                 00 


Q ss_pred             --------cc-CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccccc
Q 016085          150 --------RA-SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI  220 (395)
Q Consensus       150 --------~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~  220 (395)
                              .. ...+++..+..++.|++.||.||| +.|++||||+|+||+++.++ .++|+|||.+.............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH-SNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh-cCCEecCCCCHHHEEEccCC-eEEEeecccccccccccccccee
Confidence                    01 146788899999999999999999 79999999999999999877 69999999998765443234556


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      ++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+....+..+.. ...+                  .. 
T Consensus       159 ~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~------------------~~-  217 (253)
T cd05122         159 GTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPP------------------GL-  217 (253)
T ss_pred             cCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCC------------------Cc-
Confidence            788999999987654 89999999999999999999999987654444433222 0000                  00 


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCc
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  342 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~  342 (395)
                            .....++..+.++|.+||+.||++|||+.++++|||
T Consensus       218 ------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         218 ------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                  001114789999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-35  Score=276.55  Aligned_cols=217  Identities=22%  Similarity=0.290  Sum_probs=167.2

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCc--EEEEEEeecc------hhhHHHHHHHHHhcCCCceEee---------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYS---------------  149 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~--~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~---------------  149 (395)
                      |.+.+.||+|+||.||+|++..++.  .||+|.+...      .....+|+.+++.++|+||...               
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999877765  6999987532      2334578999999999997110               


Q ss_pred             -----------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCC
Q 016085          150 -----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  206 (395)
Q Consensus       150 -----------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~  206 (395)
                                             .....+++..+..++.|++.||.||| ++||+||||||+|||++.++ .+||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS-SKSFIHRDLAARNCMLNENM-NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhheEEcCCC-CEEECCCCc
Confidence                                   01123577888999999999999999 88999999999999999877 699999999


Q ss_pred             ccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 016085          207 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  282 (395)
Q Consensus       207 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  282 (395)
                      ++.......   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |+.||.+....+....+... ..    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~----  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-NR----  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CC----
Confidence            987643321   1122346789999998765 48999999999999999999 89999876654433333210 00    


Q ss_pred             HHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                             ...+..++..+.++|.+||+.||++|||+.+++++
T Consensus       233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 -----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                   01123467889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1e-35  Score=310.23  Aligned_cols=116  Identities=25%  Similarity=0.426  Sum_probs=100.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      .+|.+.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++|+||.                
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            46999999999999999999999999999999986532       4556899999999999971                


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcc
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  208 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~  208 (395)
                                ++.....+++..++.++.||+.||.||| .+||+||||||+||||+.++ .+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH-~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH-RHGIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence                      0112245678889999999999999999 88999999999999999887 69999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-35  Score=276.94  Aligned_cols=222  Identities=27%  Similarity=0.379  Sum_probs=169.1

Q ss_pred             ceeeeeee--ccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhc-CCCceE---------------------
Q 016085           92 SYMAERVV--GQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVH---------------------  147 (395)
Q Consensus        92 ~y~~~~~l--G~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l-~h~ni~---------------------  147 (395)
                      .|.+.+.+  |.|+||.||+++++.+++.+|+|.+..... ...|..+...+ +|+|+.                     
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~   93 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKD   93 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCC
Confidence            46666665  999999999999999999999999865421 11234333333 699871                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccccccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS  222 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt  222 (395)
                           +......+++..+..++.|++.||.||| +.|++||||||+||+++.++..++|+|||++......   ....++
T Consensus        94 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~  169 (267)
T PHA03390         94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGT  169 (267)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCCC
Confidence                 0112347899999999999999999999 8899999999999999987746999999998765322   234678


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      ..|+|||++.+.. ++.++|+||+||++|+|++|..||........ ...+......              .        
T Consensus       170 ~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------~--------  226 (267)
T PHA03390        170 LDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK--------------K--------  226 (267)
T ss_pred             CcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--------------c--------
Confidence            9999999997654 89999999999999999999999986543321 1111111000              0        


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCC-HHHHhcCCcccC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-ALEACIHPFFDE  345 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-~~e~l~hp~f~~  345 (395)
                          ......+++.+.+||.+||+.||.+|++ ..++|+||||..
T Consensus       227 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        227 ----LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             ----CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                0112247899999999999999999996 599999999963

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-35  Score=279.66  Aligned_cols=231  Identities=28%  Similarity=0.447  Sum_probs=178.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEc---CCCcEEEEEEeecch--------hhHHHHHHHHHhc-CCCceE------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVH------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~--------~~~~~E~~~l~~l-~h~ni~------------  147 (395)
                      +|++.+.||.|+||.||+|++.   .+|+.||+|++....        ....+|+.+++.+ +|+||.            
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            3889999999999999999875   478999999986421        3345799999999 588871            


Q ss_pred             --------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 --------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 --------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                    +......+++..+..++.|++.||.||| +.|++||||||+|||++.++ .+||+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~  158 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH-KLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeEECCCC-CEEEeeCccceecccc
Confidence                          0112345788888899999999999999 89999999999999999887 6999999999765432


Q ss_pred             C--CcccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          214 E--PNISYICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       214 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      .  ......++..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+.......           
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------  227 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-----------  227 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-----------
Confidence            2  12245678899999998643 246889999999999999999999996543322222222211000           


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                                    ...++..+++.+.+|+.+||+.||++|+     ++.+++.||||+.+.+.
T Consensus       228 --------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         228 --------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             --------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence                          0012344788999999999999999997     88999999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.7e-35  Score=280.94  Aligned_cols=223  Identities=30%  Similarity=0.428  Sum_probs=178.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .|...+.||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++|+|+.                 
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            3777789999999999999999999999999885321       2345799999999999970                 


Q ss_pred             e---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          148 Y---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       148 ~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                      +         ......+++..+..++.||+.||.||| +.||+||||+|+||+++.++ .+||+|||++.....   ...
T Consensus       102 ~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH-~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~~---~~~  176 (313)
T cd06633         102 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-SHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSSP---ANS  176 (313)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCChhhEEECCCC-CEEEeecCCCcccCC---CCC
Confidence            0         012345788889999999999999999 88999999999999999887 699999999865322   234


Q ss_pred             ccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          219 YICSRYYRAPELIFG--ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ..++..|+|||.+.+  ...++.++|+|||||++|+|++|..||.+.+....+..+... .                  .
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~------------------~  237 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-D------------------S  237 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-C------------------C
Confidence            567889999999842  234788999999999999999999999887665555544321 0                  0


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      +.        ......+..+.+||.+||+++|.+||++.++++||||...
T Consensus       238 ~~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         238 PT--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            00        0112356789999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.5e-35  Score=275.85  Aligned_cols=219  Identities=20%  Similarity=0.235  Sum_probs=170.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEc---CCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ..+|++.+.||+|+||.||+|.++   ..+..||+|.+....     ....+|+.+++.++|+||.              
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            346999999999999999999865   346689999886542     2345799999999999970              


Q ss_pred             ------------ee-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 ------------YS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 ------------~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                  +. .....+++..++.++.||+.||+||| +.|++||||||+|||++.++ .++++|||.+.......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH-~~~iiH~dikp~nili~~~~-~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS-EMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeeccccHhhEEEcCCC-cEEECCCcccccccccc
Confidence                        01 11346788999999999999999999 88999999999999999887 69999999876542221


Q ss_pred             Ccc--cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          215 PNI--SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       215 ~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      ...  ...++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+.+..+....               
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~---------------  225 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF---------------  225 (266)
T ss_pred             hhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC---------------
Confidence            111  223467899999987654 8999999999999999875 999998877655544432210               


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                         ..          ..+..++..+.+++.+||+.+|.+||++.++++
T Consensus       226 ---~~----------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         226 ---RL----------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ---CC----------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence               00          122346889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.9e-35  Score=288.94  Aligned_cols=221  Identities=24%  Similarity=0.367  Sum_probs=169.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEE-----cCCCcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceEeec--------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVHYSR--------  150 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~-----~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~~~~--------  150 (395)
                      ..+|++.+.||+|+||.||+|++     ..++..||+|+++...     ....+|+.+++.+ +||||....        
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34799999999999999999974     3467789999986432     2345799999999 899982110        


Q ss_pred             --------------------------------------------------------------------------------
Q 016085          151 --------------------------------------------------------------------------------  150 (395)
Q Consensus       151 --------------------------------------------------------------------------------  150 (395)
                                                                                                      
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence                                                                                            


Q ss_pred             -------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc-
Q 016085          151 -------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-  216 (395)
Q Consensus       151 -------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~-  216 (395)
                                   ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++........ 
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA-SKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCchhhEEEECCC-cEEEecCccceeccCccccc
Confidence                         0113667788899999999999999 88999999999999999776 6999999999765433221 


Q ss_pred             --ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          217 --ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       217 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                        ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+......+..++...              +. 
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~--------------~~-  335 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG--------------YR-  335 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC--------------cc-
Confidence              1123456799999997754 8999999999999999998 899998765544433333210              00 


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                  ...+...+.++.+||.+||+.||++|||+.++++.
T Consensus       336 ------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         336 ------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                        00122357899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-35  Score=277.94  Aligned_cols=233  Identities=27%  Similarity=0.442  Sum_probs=175.6

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEee-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHYS-----------------  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~~-----------------  149 (395)
                      +|...+.||.|+||.||+|.+..+++.||+|.+...     .....+|+++++.++|+||...                 
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            589999999999999999999999999999988643     2345689999999999998110                 


Q ss_pred             ---------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          150 ---------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       150 ---------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                     .....+++..+..++.||+.||.||| +.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH-~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH-SRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNSL  159 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEecCC-eEEEeeccccccccccc
Confidence                           01234677778899999999999999 88999999999999999887 69999999987653322


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      . ....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.....  .... ...........           
T Consensus       160 ~-~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~-----------  225 (287)
T cd06621         160 A-GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLSYIVNMPN-----------  225 (287)
T ss_pred             c-ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HHHHHHhcCCc-----------
Confidence            1 234568889999998664 489999999999999999999999976521  0111 11111110000           


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                          +......   ......++.+.+||.+||.+||.+|||+.|++.||||....
T Consensus       226 ----~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         226 ----PELKDEP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             ----hhhccCC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence                0000000   00012467899999999999999999999999999996543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.2e-35  Score=276.48  Aligned_cols=219  Identities=22%  Similarity=0.297  Sum_probs=169.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCc----EEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~------------  148 (395)
                      ..+|++.+.||+|+||.||+|++..+++    .||+|.+...     .....+|+.+++.++|+||..            
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l   85 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL   85 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence            3479999999999999999999877766    4899987543     223457889999999999710            


Q ss_pred             -------------e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          149 -------------S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       149 -------------~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                   . .....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||+++......
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE-EVRLVHRDLAARNVLVKSPN-HVKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccccceEEEcCCC-cEEECCCCceeeccccc
Confidence                         0 11345788899999999999999999 88999999999999998777 59999999998764332


Q ss_pred             Ccc---cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          215 PNI---SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       215 ~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ...   ...+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.......... ++.....+           
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~-----------  230 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERL-----------  230 (279)
T ss_pred             ceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcC-----------
Confidence            211   123367899999997654 8999999999999999998 999997655433322 22211000           


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                      ..+...+..+.+++.+||+.||++||++.+++.
T Consensus       231 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         231 ----------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ----------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            012236789999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.4e-35  Score=276.64  Aligned_cols=229  Identities=25%  Similarity=0.332  Sum_probs=173.7

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEee---------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHYS---------  149 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~~---------  149 (395)
                      ..++|++.+.||+|+||.||+|.++.     .+..||+|.+....     ....+|+.+++.++|+||...         
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            34579999999999999999997652     35589999875432     223468899999999998100         


Q ss_pred             ------c-----------c----------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEe
Q 016085          150 ------R-----------A----------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  202 (395)
Q Consensus       150 ------~-----------~----------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~  202 (395)
                            .           .          ........+..++.|++.||.||| +.||+||||||+|||++.++ .++|+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dikp~nili~~~~-~~~L~  161 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN-AKKFVHRDLAARNCMVAHDF-TVKIG  161 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcCCCCChheEEEcCCC-cEEEC
Confidence                  0           0          112344567789999999999999 88999999999999999877 69999


Q ss_pred             ecCCccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 016085          203 DFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  278 (395)
Q Consensus       203 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  278 (395)
                      |||+++........   ....++..|+|||.+.+.. ++.++|+|||||++|||++ |..||.+.+..+....+...   
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---  237 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG---  237 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---
Confidence            99998765332211   1223467799999987654 8999999999999999998 78999876655544433220   


Q ss_pred             CCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc------CCcccCCCC
Q 016085          279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI------HPFFDELRD  348 (395)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~------hp~f~~~~~  348 (395)
                                 .+     +         ..+...++.+.+++.+||+.||++|||+.++++      ||||..+.+
T Consensus       238 -----------~~-----~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         238 -----------GY-----L---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             -----------CC-----C---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence                       00     0         012335789999999999999999999999877      999988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.4e-36  Score=283.70  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=171.6

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------ee
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------YS  149 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------~~  149 (395)
                      |.+.+.+|  ++|.||++++..+++.||||++...      .....+|+.+++.++|+||.                 +.
T Consensus         4 ~~i~~~~~--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           4 TLIGKCFE--DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             hhhhHhhc--CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence            33444444  4455666666779999999998643      13456899999999999970                 00


Q ss_pred             -----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC---
Q 016085          150 -----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---  215 (395)
Q Consensus       150 -----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---  215 (395)
                                 .....+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||.+........   
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH-~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH-SKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCcceEEEecCC-ceEEecCccceeecccccccc
Confidence                       11235788889999999999999999 88999999999999999877 699999998865532211   


Q ss_pred             -----cccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH----HHh
Q 016085          216 -----NISYICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE----EIK  285 (395)
Q Consensus       216 -----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~  285 (395)
                           .....++..|+|||++.+. ..++.++|+||+||++|+|++|..||........+.....  +.....    ...
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~  237 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCccccccCchh
Confidence                 1233457789999998653 3488999999999999999999999987654443322211  111100    000


Q ss_pred             hcCCCCcc----ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          286 CMNPNYTE----FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       286 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      ........    ...+ .............++.++.+|+++||++||++|||+.++|+||||+.++..
T Consensus       238 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~  304 (314)
T cd08216         238 LYEDSMSQSRSSNEHP-NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR  304 (314)
T ss_pred             hhcCCcCccccccccc-chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence            00000000    0000 000111112233456789999999999999999999999999999987643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=271.05  Aligned_cols=221  Identities=36%  Similarity=0.605  Sum_probs=179.5

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      +|++.+.||+|+||.||+|++..+++.||+|.+....      ....+|+++++.++|+|+.                  
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4889999999999999999999999999999885443      2456799999999999971                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NIS  218 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~  218 (395)
                              +......+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++........ ...
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH-EQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCcccccc
Confidence                    0112246788899999999999999999 88999999999999999877 699999999987654332 123


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      ..++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+...              .        
T Consensus       159 ~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------~--------  215 (254)
T cd06627         159 VVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--------------D--------  215 (254)
T ss_pred             cccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------C--------
Confidence            46788999999987655 899999999999999999999999776543333332210              0        


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                            ...++..++..+.++|.+||..+|++|||+.+++.||||
T Consensus       216 ------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         216 ------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                  011234578899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-35  Score=276.84  Aligned_cols=223  Identities=28%  Similarity=0.409  Sum_probs=178.6

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------------ee-
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------------YS-  149 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------------~~-  149 (395)
                      |++.+.||+|+||.||+|.+..+++.||||.+....     ....+|+.+++.++|+|+.                 +. 
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            888999999999999999999999999999875322     3455799999999999971                 00 


Q ss_pred             -------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cccccc
Q 016085          150 -------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYIC  221 (395)
Q Consensus       150 -------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~~g  221 (395)
                             .....+++..+..++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||++........ .....+
T Consensus        86 ~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~  163 (277)
T cd06641          86 GGSALDLLEPGPLDETQIATILREILKGLDYLH-SEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVG  163 (277)
T ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHc-cCCeecCCCCHHhEEECCCC-CEEEeecccceecccchhhhccccC
Confidence                   11345788889999999999999999 88999999999999999887 699999999876543221 123457


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      +..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+... +                  .     
T Consensus       164 ~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~------------------~-----  218 (277)
T cd06641         164 TPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-N------------------P-----  218 (277)
T ss_pred             CccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-C------------------C-----
Confidence            88899999987644 789999999999999999999999766544333332110 0                  0     


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                          ..+...++.++.++|.+||..+|.+||++.++++||||...
T Consensus       219 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         219 ----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ----CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                01223468899999999999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2e-35  Score=308.18  Aligned_cols=221  Identities=24%  Similarity=0.364  Sum_probs=168.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceEee--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVHYS--------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~~~--------------  149 (395)
                      ++|++.++||+|+||.||+|++..+++.||||++..+       .....+|+.+++.++||||...              
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            4699999999999999999999999999999998643       1234579999999999998100              


Q ss_pred             --cc---------------------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCC
Q 016085          150 --RA---------------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  206 (395)
Q Consensus       150 --~~---------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~  206 (395)
                        ..                     ...++...+..++.||+.||+||| +.||+||||||+|||++.++ .++|+|||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH-s~GIIHRDLKPeNILLd~dg-~vKLiDFGL  159 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH-SKGVLHRDLKPDNILLGLFG-EVVILDWGA  159 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH-HCCccccCCchheEEEcCCC-CEEEEecCc
Confidence              00                     112334556778999999999999 88999999999999999887 599999999


Q ss_pred             ccccccCC-------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016085          207 AKVLVKGE-------------------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD  267 (395)
Q Consensus       207 a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  267 (395)
                      ++......                   .....+||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.+.....
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            97652110                   011246899999999997755 8999999999999999999999997754432


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       268 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ....  .....|..              .          .-...+++.+.+++.+||+.||++|++..+.+.+
T Consensus       239 i~~~--~~i~~P~~--------------~----------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        239 ISYR--DVILSPIE--------------V----------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhh--hhccChhh--------------c----------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2211  10000000              0          0012468899999999999999999987776654

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.3e-35  Score=276.12  Aligned_cols=218  Identities=24%  Similarity=0.359  Sum_probs=171.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      .+|.+.+.||+|+||.||+|++..     +++.||+|.+...     .....+|+++++.++|+|+.             
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            469999999999999999998753     4678999998643     23456899999999999970             


Q ss_pred             --e--e-----------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceE
Q 016085          148 --Y--S-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK  200 (395)
Q Consensus       148 --~--~-----------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ik  200 (395)
                        +  .                       .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+|
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~h~dlkp~nili~~~~-~~k  162 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA-SQHFVHRDLATRNCLVGYDL-VVK  162 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh-hCCeeccccccceEEEcCCC-eEE
Confidence              0  0                       01234677888999999999999999 88999999999999999887 699


Q ss_pred             EeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 016085          201 LCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVL  276 (395)
Q Consensus       201 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  276 (395)
                      |+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+... 
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~-  240 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG-  240 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-
Confidence            999999876432221   12334577899999997655 8999999999999999998 99999877665544443320 


Q ss_pred             CCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                       ..                          ...+...+..+.+||++||+.||++|||+.|+++
T Consensus       241 -~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         241 -RL--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             -Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             00                          0112346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2e-35  Score=279.59  Aligned_cols=219  Identities=22%  Similarity=0.294  Sum_probs=168.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCc--EEEEEEeecc-----hhhHHHHHHHHHhc-CCCceE---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVH---------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~--~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~ni~---------------  147 (395)
                      ++|++.++||+|+||.||+|.+..++.  .+|+|.++..     .....+|+.++.++ +|+||.               
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            369999999999999999999877765  4688877632     13355799999888 799971               


Q ss_pred             --eec-------------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceE
Q 016085          148 --YSR-------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK  200 (395)
Q Consensus       148 --~~~-------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ik  200 (395)
                        +..                         ....+++..++.++.|++.||+||| +.||+||||||+|||++.++ .+|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH-~~~ivH~dlkp~Nill~~~~-~~k  159 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS-EKQFIHRDLAARNVLVGENL-ASK  159 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCcCCcceEEECCCC-eEE
Confidence              000                         0124677888999999999999999 88999999999999999877 699


Q ss_pred             EeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 016085          201 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  279 (395)
Q Consensus       201 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  279 (395)
                      |+|||++.............++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....   
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~---  235 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---  235 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC---
Confidence            99999986432211111122355699999987654 8999999999999999997 999998877655544432210   


Q ss_pred             CHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                               ....+..++..+.+||.+||+.+|.+|||++++++.
T Consensus       236 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 -------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     001223478899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.6e-35  Score=270.15  Aligned_cols=223  Identities=35%  Similarity=0.537  Sum_probs=178.6

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEe-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHY-----------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~-----------------  148 (395)
                      +|++.+.||+|++|.||+|.+..+++.|++|++....      ....+|+.+++.++|+|+..                 
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4889999999999999999999999999999886543      34568999999999999810                 


Q ss_pred             -----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--
Q 016085          149 -----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       149 -----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                                 ......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH-SNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEcCCC-CEEEcccccEEecccccccc
Confidence                       011226778888999999999999999 79999999999999999877 699999999987655442  


Q ss_pred             -cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          216 -NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       216 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                       .....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||......  ...+.....                 
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~-----------------  218 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGS-----------------  218 (260)
T ss_pred             cccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhccc-----------------
Confidence             33456788999999987654 899999999999999999999999876521  111111100                 


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                             ......++...+..+.+||.+||+.||.+||++.++++||||
T Consensus       219 -------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 -------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             -------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                   000111334468999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.3e-35  Score=278.65  Aligned_cols=229  Identities=32%  Similarity=0.462  Sum_probs=180.1

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-----------------ee--
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-----------------YS--  149 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-----------------~~--  149 (395)
                      |.....||+|+||.||++.+..+++.||||.+...    .....+|+.+++.++|+|+.                 +.  
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            44457899999999999999999999999987532    23345799999999999970                 00  


Q ss_pred             ------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccccccc
Q 016085          150 ------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICS  222 (395)
Q Consensus       150 ------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~~gt  222 (395)
                            .....+++..++.++.|++.||+||| +.|++||||+|+||+++.++ .++|+|||++........ .....++
T Consensus       102 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH-~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         102 GALTDIVTHTRMNEEQIAAVCLAVLKALSVLH-AQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEEcccccceecccccccccccccC
Confidence                  11245788889999999999999999 88999999999999999887 699999999876543221 2235678


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  302 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (395)
                      +.|+|||.+.+.. ++.++|+||+||++|+|++|..||.+......+..+.....  .              .+      
T Consensus       180 ~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~--~--------------~~------  236 (292)
T cd06657         180 PYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--P--------------KL------  236 (292)
T ss_pred             ccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC--c--------------cc------
Confidence            9999999886544 89999999999999999999999987765554443322110  0              00      


Q ss_pred             CcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       303 ~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                          .....++..+.++|.+||..||.+||++.++++||||.....+.
T Consensus       237 ----~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         237 ----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             ----CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence                01123678999999999999999999999999999998876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.9e-35  Score=273.44  Aligned_cols=220  Identities=30%  Similarity=0.452  Sum_probs=170.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||.+...       .....+|+.+++.++|+|+.                
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            3699999999999999999999999999999976431       12345799999999999971                


Q ss_pred             -ee-------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 -YS-------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 -~~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                       +.             .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~~~  159 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH-SRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCCHHHEEEcCCC-CEEECccccceeccch
Confidence             00             01234678888999999999999999 88999999999999999887 6999999998765432


Q ss_pred             CC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          214 EP-NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       214 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      .. .....+++.|+|||.+.+.. ++.++|+||+||++|+|++|+.||...... ..+...+...+.++           
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------  227 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP-----------  227 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC-----------
Confidence            21 12346788999999987654 899999999999999999999999654321 12222211111110           


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                     ......+..+.+||.+||+.+|++||++.++++
T Consensus       228 ---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         228 ---------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             ---------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                           011235788999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=288.25  Aligned_cols=215  Identities=27%  Similarity=0.388  Sum_probs=175.6

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCce----------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNV----------------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni----------------------  146 (395)
                      .+++++.||+|.||.||.|+... ...||+|.++..   ...+.+|+.+|+.|+|+||                      
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            46778899999999999999843 347999988653   3456689999999999998                      


Q ss_pred             ----Eeec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccc-
Q 016085          147 ----HYSR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-  219 (395)
Q Consensus       147 ----~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~-  219 (395)
                          .+++  ....+.......++.|||+|++||+ ++++|||||...|||++.+. .+||+|||+|+...++...... 
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe-s~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~~Y~~~~~  363 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE-SKNYIHRDLAARNILVDEDL-VVKISDFGLARLIGDDEYTASEG  363 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH-hCCccchhhhhhheeeccCc-eEEEcccccccccCCCceeecCC
Confidence                1122  3567788889999999999999999 89999999999999999887 7999999999955444332221 


Q ss_pred             -cccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          220 -ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       220 -~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                       .-...|.|||.+.-.. ++.+||||||||+||||+| |+.||.+.+..+.+..+.+...                  .|
T Consensus       364 ~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR------------------lp  424 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR------------------LP  424 (468)
T ss_pred             CCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc------------------CC
Confidence             1256699999997655 9999999999999999997 9999999998888887765221                  11


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                                -|..+|+++.+++..||..+|++|||...+.
T Consensus       425 ----------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  425 ----------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             ----------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                      2345899999999999999999999998664

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.8e-35  Score=271.74  Aligned_cols=220  Identities=25%  Similarity=0.469  Sum_probs=173.3

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhHHHHHHHHHhcCCCce----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNV----------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~ni----------------  146 (395)
                      +|.+.+.||+|+||.||++++..++..+++|+++..         .....+|+.+++.++|+|+                
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            489999999999999999999888777777765421         1234568899999999997                


Q ss_pred             -Eee-------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          147 -HYS-------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       147 -~~~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                       .+.             .....+++..++.++.|++.||.||| +.|++|+||||+||+++. + .++|+|||+++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~h~~l~~~nili~~-~-~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-QRRILHRDLKAKNIFLKN-N-LLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH-HcCccccCCChhheEeec-C-CEeecccCceeecCC
Confidence             000             12345788889999999999999999 889999999999999985 3 599999999877643


Q ss_pred             CCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          213 GEP-NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       213 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      ... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+.......+..  +.             
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~-------------  221 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GP-------------  221 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CC-------------
Confidence            322 22345788999999886544 78899999999999999999999976654443333221  00             


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                          .         ..++..++.++.++|.+||..||++||++.++++||||
T Consensus       222 ----~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 ----T---------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ----C---------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                0         01223467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.7e-35  Score=279.56  Aligned_cols=220  Identities=23%  Similarity=0.311  Sum_probs=167.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcE--EEEEEeecc-----hhhHHHHHHHHHhc-CCCceE--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQD-----KRYKNRELQTMRLL-DHPNVH--------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~--vAiK~~~~~-----~~~~~~E~~~l~~l-~h~ni~--------------  147 (395)
                      ..+|.+.+.||+|+||.||+|++..++..  +|+|.+...     .....+|+.++..+ +|+||.              
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            35799999999999999999998877764  577766532     12345799999999 899971              


Q ss_pred             ---eec-------------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCce
Q 016085          148 ---YSR-------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV  199 (395)
Q Consensus       148 ---~~~-------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~i  199 (395)
                         +..                         ....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~gi~H~dlkp~Nili~~~~-~~  163 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENY-VA  163 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH-hCCccccccchheEEecCCC-cE
Confidence               000                         0124678889999999999999999 89999999999999999887 69


Q ss_pred             EEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 016085          200 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  278 (395)
Q Consensus       200 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  278 (395)
                      ||+|||+++............++..|+|||.+.+.. ++.++|||||||++|+|+| |..||.+.+..+....+...   
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---  239 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---  239 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC---
Confidence            999999986432211111223356799999886654 8999999999999999998 99999876654433322110   


Q ss_pred             CCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                  +             ....+..++..+.+||.+||+.+|++||++.+++.+
T Consensus       240 ------------~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 ------------Y-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             ------------C-------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                        0             000122367899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.2e-35  Score=273.73  Aligned_cols=221  Identities=20%  Similarity=0.282  Sum_probs=170.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEe-----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY-----------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~-----------  148 (395)
                      .++|.+.+.||+|+||.||+|.+..     ++..||+|.+....     ....+|+.+++.++|+||..           
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            3579999999999999999999987     77889999875332     23557999999999999810           


Q ss_pred             ------e---------c-------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC--CceEEeec
Q 016085          149 ------S---------R-------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDF  204 (395)
Q Consensus       149 ------~---------~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~--~~ikl~DF  204 (395)
                            .         .       ....+++..+..++.||+.||+||| +.|++||||||+|||++.++  ..+||+||
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~nil~~~~~~~~~~kl~df  163 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE-ENHFIHRDIAARNCLLTCKGPGRVAKIADF  163 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccchheEEEeccCCCcceEeccC
Confidence                  0         0       0124677888899999999999999 88999999999999998653  25999999


Q ss_pred             CCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016085          205 GSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  280 (395)
Q Consensus       205 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  280 (395)
                      |+++.......   ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+.......+... ..  
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~--  239 (277)
T cd05036         164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR--  239 (277)
T ss_pred             ccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc--
Confidence            99986532211   11222356799999997655 8999999999999999997 99999877655443332210 00  


Q ss_pred             HHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          281 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                               ...+..++..+.+|+.+||+.+|++|||+.++++|
T Consensus       240 -------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 -------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                     01233468899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5e-35  Score=273.76  Aligned_cols=221  Identities=25%  Similarity=0.319  Sum_probs=168.7

Q ss_pred             cccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEe----------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY----------  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~----------  148 (395)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|.+....     ....+|+.+++.++|+||..          
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3457999999999999999999865     245679999875422     23457999999999999810          


Q ss_pred             -------e---------cc----------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEe
Q 016085          149 -------S---------RA----------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  202 (395)
Q Consensus       149 -------~---------~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~  202 (395)
                             .         ..          ...++...+..++.|++.||.||| +.|++||||||+||+++.++ .++|+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~vH~dlkp~Nil~~~~~-~~~l~  161 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDF-TVKIG  161 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCcchheEEEcCCC-CEEEC
Confidence                   0         00          012345667888999999999999 88999999999999999887 69999


Q ss_pred             ecCCccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 016085          203 DFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  278 (395)
Q Consensus       203 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  278 (395)
                      |||+++........   ....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+....+..+... +.
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~  239 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-GL  239 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence            99998765332211   1224467899999987654 8999999999999999998 78999877665544433321 00


Q ss_pred             CCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                        +         .++...+..+.+|+.+||+.||++|||+.|++++
T Consensus       240 ------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 ------------------L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             ------------------C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                              0         1123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.4e-35  Score=279.54  Aligned_cols=225  Identities=29%  Similarity=0.415  Sum_probs=178.6

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .|...+.||+|+||.||+|++..+++.||+|.+...       .....+|+.+++.++|+|+.                 
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            488889999999999999999999999999987532       12334799999999999970                 


Q ss_pred             e---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          148 Y---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       148 ~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                      +         ......+++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++.....   ...
T Consensus        96 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~---~~~  170 (308)
T cd06634          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP---ANX  170 (308)
T ss_pred             ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHhEEECCCC-cEEECCcccceeecC---ccc
Confidence            0         112345788889999999999999999 88999999999999999877 699999999876532   234


Q ss_pred             ccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          219 YICSRYYRAPELIFG--ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ..+++.|+|||.+.+  ...++.++|||||||++|+|++|..||...+.......+....                   .
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------------~  231 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-------------------S  231 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-------------------C
Confidence            567889999999852  2347889999999999999999999997765544444332210                   0


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      +.        ......+..+.+||.+||+.+|++||++.++++|||+.....
T Consensus       232 ~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         232 PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             CC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence            00        012236788999999999999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.2e-35  Score=268.22  Aligned_cols=220  Identities=28%  Similarity=0.446  Sum_probs=177.2

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------e
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      +|++.+.||+|+||.||++.++.+++.||+|.+...      .....+|+.+++.++|+||.                 +
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            489999999999999999999999999999988642      22334789999999999981                 0


Q ss_pred             e-------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 S-------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 ~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                      .             .....+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .+||+|||++...... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh-~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~-~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH-EQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKN-M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCcceEEEecCC-cEEEeeccchhhhccC-C
Confidence            0             01245677888999999999999999 88999999999999999877 6999999999776544 2


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+...                   .
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~  217 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG-------------------K  217 (256)
T ss_pred             cccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------C
Confidence            23356788999999997654 889999999999999999999999877654433332210                   0


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ++.         .....+.++.++|.+||+.+|++|||+.++++||++
T Consensus       218 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         218 YPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            010         122367899999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.6e-35  Score=271.96  Aligned_cols=217  Identities=26%  Similarity=0.333  Sum_probs=169.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCceEe----------------e--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVHY----------------S--  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni~~----------------~--  149 (395)
                      ++|++.++||+|+||.||+|++..+ ..||+|.+....   ....+|+.+++.++|+||..                .  
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~   84 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK   84 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence            4699999999999999999988665 469999886532   34568999999999999710                0  


Q ss_pred             ---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc--cc
Q 016085          150 ---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--IS  218 (395)
Q Consensus       150 ---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~--~~  218 (395)
                               .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||.+.........  ..
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~~~~~~~~~  162 (262)
T cd05071          85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQG  162 (262)
T ss_pred             CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH-HCCccccccCcccEEEcCCC-cEEeccCCceeeccccccccccC
Confidence                     01234677888999999999999999 88999999999999999887 6999999999765433221  12


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..++..|+|||...+.. ++.++|+|||||++|+|++ |..||.+.........+.....                  . 
T Consensus       163 ~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~------------------~-  222 (262)
T cd05071         163 AKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------------M-  222 (262)
T ss_pred             CcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC------------------C-
Confidence            33567799999886654 8999999999999999999 8899987765544443322100                  0 


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                               .....++..+.+|+.+||+.||++||++.++++
T Consensus       223 ---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 ---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ---------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                     012346889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.1e-35  Score=271.36  Aligned_cols=211  Identities=24%  Similarity=0.342  Sum_probs=164.2

Q ss_pred             eeccCCceEEEEEEE--cCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE----------------------
Q 016085           98 VVGQGSFGIVFQAKC--LETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH----------------------  147 (395)
Q Consensus        98 ~lG~G~fg~V~~a~~--~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~----------------------  147 (395)
                      .||+|+||.||+|.+  ..++..||+|++....      ....+|+.+++.++|+||.                      
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   81 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP   81 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence            589999999999964  4677899999885432      2345789999999999971                      


Q ss_pred             ---eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc----cccc
Q 016085          148 ---YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN----ISYI  220 (395)
Q Consensus       148 ---~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~----~~~~  220 (395)
                         +......+++..+..++.|++.||+||| +.||+||||||.||+++.++ .+||+|||++.........    ....
T Consensus        82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLE-ETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeecCCCC
Confidence               0112345788889999999999999999 88999999999999999877 6999999999765433221    1223


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI  299 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (395)
                      ++..|+|||.+.+. .++.++|+|||||++|||++ |..||.+.+.......+.+..                       
T Consensus       160 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-----------------------  215 (257)
T cd05116         160 WPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-----------------------  215 (257)
T ss_pred             CCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-----------------------
Confidence            35789999988654 48999999999999999998 999998776654444332200                       


Q ss_pred             cCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       300 ~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                           ....+..+++++.+||.+||+.||++||++.++..
T Consensus       216 -----~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         216 -----RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                 00123347899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.4e-35  Score=270.89  Aligned_cols=218  Identities=24%  Similarity=0.313  Sum_probs=170.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceEe-----------------e
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVHY-----------------S  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~~-----------------~  149 (395)
                      ..+|++.+.||+|+||.||+|.+. ++..||+|.+...   .....+|+.+++.++|+||..                 .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            357999999999999999999864 5677999987643   234567999999999999810                 0


Q ss_pred             -----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc--
Q 016085          150 -----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--  216 (395)
Q Consensus       150 -----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~--  216 (395)
                                 .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++.........  
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH-~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE-RKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYTAR  161 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhhEEecCCC-cEEECCCccceecCCCceecc
Confidence                       11244677778889999999999999 88999999999999999877 6999999999775432211  


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+.......+....                  .
T Consensus       162 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------------~  222 (261)
T cd05072         162 EGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY------------------R  222 (261)
T ss_pred             CCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC------------------C
Confidence            1233466799999987654 8999999999999999998 999998776555444432210                  0


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      .          .....++.++.+|+.+||..+|++|||+.++++
T Consensus       223 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 M----------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             C----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            0          011236889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8e-35  Score=274.13  Aligned_cols=217  Identities=25%  Similarity=0.370  Sum_probs=169.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      .+|.+.+.||+|+||.||++.+.     .++..||+|.+...    .....+|+.+++.++|+|+.              
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            36999999999999999999863     34567999988643    23456799999999999980              


Q ss_pred             ---ee---------c-------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEe
Q 016085          148 ---YS---------R-------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  202 (395)
Q Consensus       148 ---~~---------~-------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~  202 (395)
                         +.         .             ....+++..+..++.|++.||+||| +.|++||||||+|||++.++ .+||+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~  162 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVGENL-LVKIG  162 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccCcceEEEccCC-cEEec
Confidence               00         0             1124788899999999999999999 88999999999999999887 69999


Q ss_pred             ecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 016085          203 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  278 (395)
Q Consensus       203 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  278 (395)
                      |||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+.+..+...  .
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~--~  239 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG--R  239 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--C
Confidence            9999976533221   1123346789999998764 48999999999999999998 99999877765554444321  0


Q ss_pred             CCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                      .                 .         ..+...+..+.+|+.+||+.||.+|||+.+++
T Consensus       240 ~-----------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~  273 (288)
T cd05093         240 V-----------------L---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH  273 (288)
T ss_pred             c-----------------C---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            0                 0         01223678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.9e-35  Score=270.17  Aligned_cols=217  Identities=24%  Similarity=0.316  Sum_probs=170.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCceEe-------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVHY-------------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni~~-------------------  148 (395)
                      .+|++.++||+|+||.||+|.+. +++.||+|.+....   ....+|+.+++.++|+|+..                   
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~   84 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN   84 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence            46999999999999999999864 56889999886533   34568999999999999710                   


Q ss_pred             --------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc--cc
Q 016085          149 --------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--IS  218 (395)
Q Consensus       149 --------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~--~~  218 (395)
                              ......+++..+..++.|++.||+||| +.|++||||||+||+++.++ .++|+|||++.........  ..
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH-~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~  162 (260)
T cd05067          85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE-RKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYTAREG  162 (260)
T ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh-cCCeecccccHHhEEEcCCC-CEEEccCcceeecCCCCcccccC
Confidence                    011235677888899999999999999 89999999999999999887 6999999999765422211  12


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+......                   
T Consensus       163 ~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  222 (260)
T cd05067         163 AKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-------------------  222 (260)
T ss_pred             CcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-------------------
Confidence            34467899999986644 8999999999999999998 99999887665544443221000                   


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                               ..+...+.++.+||.+||+.+|++|||+.++++
T Consensus       223 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 ---------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                     112336789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.9e-35  Score=269.55  Aligned_cols=217  Identities=21%  Similarity=0.310  Sum_probs=170.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE-----------------ee-
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH-----------------YS-  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~-----------------~~-  149 (395)
                      .+|++.+.||+|+||.||+|+.+ .+..+|+|.+...   .....+|+.+++.++|+||.                 +. 
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            46999999999999999999875 4568999987643   23456799999999999971                 00 


Q ss_pred             ---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc--cc
Q 016085          150 ---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--IS  218 (395)
Q Consensus       150 ---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~--~~  218 (395)
                               .....+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||.++........  ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE-RNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH-HCCccccccCcceEEEcCCC-eEEECCCCCccccCCCceeccCC
Confidence                     11234788889999999999999999 88999999999999999877 6999999998765332221  12


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..++..|+|||.+.+.. ++.++|+|||||++|+|++ |+.||.+.+..+.+..+.....                .   
T Consensus       161 ~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~----------------~---  220 (256)
T cd05114         161 AKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR----------------L---  220 (256)
T ss_pred             CCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------------C---
Confidence            23456799999987654 8999999999999999999 9999988776655555433100                0   


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                               ..+...+..+.+|+.+||+.||.+||++.++++
T Consensus       221 ---------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 ---------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                     011225778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.6e-35  Score=269.89  Aligned_cols=216  Identities=24%  Similarity=0.332  Sum_probs=170.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE----------------ee--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH----------------YS--  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~----------------~~--  149 (395)
                      ++|++.+.||+|+||.||+|.+. .+..||+|.+...   .....+|+.+++.++|+|+.                +.  
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~   84 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK   84 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence            46999999999999999999865 5667999988653   23456899999999999971                00  


Q ss_pred             ---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc--cc
Q 016085          150 ---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--IS  218 (395)
Q Consensus       150 ---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~--~~  218 (395)
                               .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++.........  ..
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~  162 (260)
T cd05070          85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE-RMNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYTARQG  162 (260)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCccceEEEeCCc-eEEeCCceeeeeccCcccccccC
Confidence                     01234788889999999999999999 88999999999999999877 6999999999765433211  12


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..++..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||.+.+..+....+.....                    
T Consensus       163 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------------  221 (260)
T cd05070         163 AKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR--------------------  221 (260)
T ss_pred             CCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence            23456799999986654 8999999999999999999 8999988766555444322100                    


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                              ...+...+..+.+|+.+||..||.+|||+.++.
T Consensus       222 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         222 --------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             --------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                    011234678999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.2e-35  Score=271.25  Aligned_cols=221  Identities=30%  Similarity=0.467  Sum_probs=170.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||.+...       .....+|+.+++.++|+|+.                
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3699999999999999999999999999999987532       12345799999999999970                


Q ss_pred             -ee-------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 -YS-------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 -~~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                       +.             .....+++..++.++.||+.||.||| +.|++|+||||+||+++.++ .++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~  159 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-CEEECcchhhhccccC
Confidence             00             11345788889999999999999999 88999999999999999877 6999999998765433


Q ss_pred             CC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          214 EP-NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       214 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      .. .....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.....  ..+.+...               
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~---------------  221 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIE---------------  221 (267)
T ss_pred             CcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhhhh---------------
Confidence            22 22356789999999987654 8899999999999999999999997644221  11111100               


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ....+.        ......+..+.+||.+||+.||++|||+.++++
T Consensus       222 ~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         222 QCDYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             cCCCCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            000000        011236789999999999999999999997753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9e-35  Score=272.89  Aligned_cols=219  Identities=21%  Similarity=0.310  Sum_probs=169.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEc----CCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      .+|++.+.||+|+||.||+|.+.    .++..||+|.+....     ....+|+.+++.++|+||.              
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            46999999999999999999853    456789999886421     3456799999999999981              


Q ss_pred             ---eecc--------------------------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCc
Q 016085          148 ---YSRA--------------------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ  198 (395)
Q Consensus       148 ---~~~~--------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~  198 (395)
                         +...                          ...+++..+..++.|++.||.||| +.||+||||||+|||++.++ .
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~nili~~~~-~  162 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS-SHFFVHKDLAARNILIGEQL-H  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hcCeehhccccceEEEcCCC-c
Confidence               0000                          123567778889999999999999 88999999999999999877 6


Q ss_pred             eEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 016085          199 VKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIK  274 (395)
Q Consensus       199 ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  274 (395)
                      +||+|||+++.......   .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.+.......+..
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  241 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK  241 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999976543221   12334467799999987654 8999999999999999998 9999987665444333322


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          275 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      . ..                           ...+..+++.+.+++.+||+.||++||++.+++++
T Consensus       242 ~-~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         242 R-QL---------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             C-Cc---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            0 00                           01223468899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.8e-35  Score=268.82  Aligned_cols=212  Identities=22%  Similarity=0.314  Sum_probs=163.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------------e------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------------Y------  148 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------------~------  148 (395)
                      +.||+|+||.||+|++..+++.||+|.+...     .....+|+++++.++|+||.                 +      
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3689999999999999999999999987543     23456799999999999980                 0      


Q ss_pred             ---e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc---cccc
Q 016085          149 ---S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYIC  221 (395)
Q Consensus       149 ---~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~---~~~g  221 (395)
                         . .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++..........   ...+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE-SKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccchheEEEcCCC-cEEECccccCcccccccccccCCCCCC
Confidence               0 11235788889999999999999999 88999999999999999887 69999999987643221111   1112


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      +..|+|||.+.+.. ++.++|+|||||++|+|++ |..||...+.......+....                        
T Consensus       159 ~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~------------------------  213 (252)
T cd05084         159 PVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV------------------------  213 (252)
T ss_pred             ceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC------------------------
Confidence            45699999987654 8999999999999999997 899997655443322222100                        


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                          ....+...+..+.+|+.+||+.||++|||+.++++
T Consensus       214 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         214 ----RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ----CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                00122346889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1e-34  Score=277.30  Aligned_cols=223  Identities=30%  Similarity=0.427  Sum_probs=178.5

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .|...+.||+|+||.||+|++..++..||+|.+....       ....+|+.+++.++|+|+.                 
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4889999999999999999999999999999885321       2345799999999999971                 


Q ss_pred             e---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          148 Y---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       148 ~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                      +         ......+++..+..++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||++.....   ...
T Consensus       106 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~~---~~~  180 (317)
T cd06635         106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-SHNMIHRDIKAGNILLTEPG-QVKLADFGSASIASP---ANS  180 (317)
T ss_pred             CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcccEEECCCC-CEEEecCCCccccCC---ccc
Confidence            0         012345778888999999999999999 88999999999999999887 699999999875432   234


Q ss_pred             ccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          219 YICSRYYRAPELIFG--ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ..+++.|+|||.+.+  ...++.++|+|||||++|+|++|..||.+.+....+..+......+                 
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  243 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-----------------  243 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC-----------------
Confidence            567889999998742  2347899999999999999999999998776555555444311000                 


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                ......++.+.+||.+||+.+|.+||++.++++|+|+...
T Consensus       244 ----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         244 ----------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ----------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                      0112357889999999999999999999999999999553

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-34  Score=268.13  Aligned_cols=217  Identities=25%  Similarity=0.337  Sum_probs=169.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCceE----------------ee--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVH----------------YS--  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni~----------------~~--  149 (395)
                      ++|.+.+.||+|+||.||+|.+..+ ..||+|.+....   ....+|+.+++.++|+|+.                +.  
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence            4699999999999999999987654 469999876432   3446799999999999971                00  


Q ss_pred             ---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc--cc
Q 016085          150 ---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--IS  218 (395)
Q Consensus       150 ---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~--~~  218 (395)
                               .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++.........  ..
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~  162 (260)
T cd05069          85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE-RMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTARQG  162 (260)
T ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccCcceEEEcCCC-eEEECCCccceEccCCcccccCC
Confidence                     01123677888899999999999999 88999999999999999887 6999999999765333211  12


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+....+....+.... .                   
T Consensus       163 ~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~-------------------  221 (260)
T cd05069         163 AKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-R-------------------  221 (260)
T ss_pred             CccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-------------------
Confidence            33467799999886654 8999999999999999999 999998876655444332210 0                   


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                              ...+...+..+.+|+.+||+.||++||++.++++
T Consensus       222 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         222 --------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             --------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                    0122346889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.7e-35  Score=274.15  Aligned_cols=225  Identities=19%  Similarity=0.229  Sum_probs=170.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCC----------------cEEEEEEeecch-----hhHHHHHHHHHhcCCCceEee
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETG----------------ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHYS  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~----------------~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~~  149 (395)
                      .+|++.+.||+|+||.||+|.+..++                ..||+|.+....     ....+|+++++.++|+|+...
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            46999999999999999999876544                468999886542     334579999999999997110


Q ss_pred             --------------------------ccC-----------CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE
Q 016085          150 --------------------------RAS-----------QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV  192 (395)
Q Consensus       150 --------------------------~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill  192 (395)
                                                ...           ..+++..++.++.|++.||.||| +.||+||||||+||++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH-~~~i~H~dlkp~Nili  163 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-SLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH-HcCccccccchhceee
Confidence                                      011           15788889999999999999999 8899999999999999


Q ss_pred             cCCCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHH
Q 016085          193 NPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL--GQPLFPGESGVD  267 (395)
Q Consensus       193 ~~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~  267 (395)
                      +.++ .++|+|||+++.......   .....++..|+|||.+.+.. ++.++|||||||++|+|++  |..||...+..+
T Consensus       164 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         164 GKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             cCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            9887 699999999876533321   12334577899999987654 8999999999999999998  778887766555


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       268 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      .+..+........               .      ......+...+.++.+|+.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~---------------~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         242 VIENAGHFFRDDG---------------R------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHhcccccc---------------c------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            5444433211000               0      0000112346789999999999999999999999963

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-34  Score=268.01  Aligned_cols=218  Identities=19%  Similarity=0.275  Sum_probs=170.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE-----------------e--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH-----------------Y--  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~-----------------~--  148 (395)
                      .+|++.+.||+|+||.||+|++.. +..||+|.+...   .....+|+.+++.++|+||.                 +  
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            469999999999999999998643 456999988643   23456799999999999981                 0  


Q ss_pred             -------e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc--c
Q 016085          149 -------S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--S  218 (395)
Q Consensus       149 -------~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~--~  218 (395)
                             . .....+++..+..++.||+.||.||| +.|++|+||||+||+++.++ .+||+|||.++.........  .
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE-SKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccCcceEEEcCCC-CEEECCCccceecCCCceeecCC
Confidence                   0 11235788899999999999999999 88999999999999999877 69999999987654332211  2


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||...+..+....+......                   
T Consensus       161 ~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  220 (256)
T cd05113         161 SKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-------------------  220 (256)
T ss_pred             CccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-------------------
Confidence            23456799999997654 8999999999999999998 99999876655544444321000                   


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                               ..+...+..+.+++.+||+.||.+|||+.+++.+
T Consensus       221 ---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 ---------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                     0112357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-35  Score=266.91  Aligned_cols=213  Identities=35%  Similarity=0.566  Sum_probs=172.9

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE------------------------
Q 016085           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH------------------------  147 (395)
Q Consensus        99 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~------------------------  147 (395)
                      ||.|+||.||++.+..+++.||+|.+.+..       ....+|+.+++.++|+|+.                        
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999998889999999886532       2456799999999999970                        


Q ss_pred             --eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCccccccccc
Q 016085          148 --YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRY  224 (395)
Q Consensus       148 --~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~gt~~  224 (395)
                        +......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||.+...... .......++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh-~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLH-SLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCcccCCcCCcc
Confidence              1112335788899999999999999999 79999999999999999887 6999999998776443 22334567889


Q ss_pred             ccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCc
Q 016085          225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW  304 (395)
Q Consensus       225 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (395)
                      |+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+..  +               .           
T Consensus       159 ~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~---------------~-----------  209 (250)
T cd05123         159 YLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D---------------P-----------  209 (250)
T ss_pred             ccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C---------------C-----------
Confidence            99999987654 78999999999999999999999977665333333322  0               0           


Q ss_pred             ccccCCCCChhHHHHHHhhccCCCCCCCCH---HHHhcCCcc
Q 016085          305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTA---LEACIHPFF  343 (395)
Q Consensus       305 ~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~---~e~l~hp~f  343 (395)
                       ..++..++..+.++|++||..||++|||+   .++++||||
T Consensus       210 -~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         210 -LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence             01233468899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-34  Score=266.44  Aligned_cols=217  Identities=24%  Similarity=0.337  Sum_probs=170.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE-----------------e--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH-----------------Y--  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~-----------------~--  148 (395)
                      .+|++.+.||+|+||.||+|.+. +++.||+|.+...   .....+|+.+++.++|+|+.                 +  
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            46999999999999999999875 4578999998653   23456799999999999981                 0  


Q ss_pred             -------ec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc--
Q 016085          149 -------SR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--  217 (395)
Q Consensus       149 -------~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~--  217 (395)
                             ..  ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||+++.........  
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE-AQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKEDIYEARE  162 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCcceEEEcCCC-CEEECCcceEEEccCCcccccC
Confidence                   01  1235788889999999999999999 88999999999999999887 69999999998764322111  


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....+..|+|||.+.+.. ++.++|+|||||++|+|++ |+.||.+.+....+..+.....                  .
T Consensus       163 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------~  223 (261)
T cd05068         163 GAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------------------M  223 (261)
T ss_pred             CCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------C
Confidence            112245799999887654 8999999999999999999 9999988765554444332100                  0


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus       224 ----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 ----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                      012336789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.7e-35  Score=269.71  Aligned_cols=217  Identities=24%  Similarity=0.352  Sum_probs=173.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceE-----------------e-
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVH-----------------Y-  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~-----------------~-  148 (395)
                      .+|++.++||.|+||.||+|.+.. ++.+|+|.+....    ....+|+.+++.++|+|+.                 + 
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            469999999999999999999877 8899999986543    3456799999999999970                 0 


Q ss_pred             ----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cc
Q 016085          149 ----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NI  217 (395)
Q Consensus       149 ----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~  217 (395)
                                ......+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++........ ..
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE-EQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccCcceEEEcCCc-eEEEccccchhhcCCcccccc
Confidence                      012345788889999999999999999 88999999999999999887 699999999976533221 11


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||.+.+..+.+..+.....                   
T Consensus       163 ~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------------  222 (261)
T cd05148         163 DKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-------------------  222 (261)
T ss_pred             CCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-------------------
Confidence            233467899999986654 8999999999999999998 8999988776555554442100                   


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                               ...+...++.+.+++.+||+.||.+|||+.++++
T Consensus       223 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         223 ---------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                     0112346889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=267.22  Aligned_cols=213  Identities=27%  Similarity=0.413  Sum_probs=171.7

Q ss_pred             eeeccCCceEEEEEEEcCC---CcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------------e---
Q 016085           97 RVVGQGSFGIVFQAKCLET---GETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------------Y---  148 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~---~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------------~---  148 (395)
                      +.||+|+||.||+|.+...   +..||+|.+...     .....+|+.+++.++|+|+.                 +   
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999999866   889999988654     23456799999999999970                 0   


Q ss_pred             ------ecc---------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          149 ------SRA---------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       149 ------~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                            ...         ...+++..++.++.|++.||+||| +.||+||||||+||+++.++ .++|+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA-SKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH-cCCcccCccCcceEEECCCC-cEEEcccccccccccc
Confidence                  111         266899999999999999999999 89999999999999999887 6999999999876543


Q ss_pred             C---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          214 E---PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       214 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      .   ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+...              
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------------  223 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--------------  223 (262)
T ss_pred             cccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Confidence            2   12344568899999998765 48999999999999999999 69999887655544443320              


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                    .....+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       224 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 --------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                          0011233468999999999999999999999999865

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=269.45  Aligned_cols=219  Identities=25%  Similarity=0.300  Sum_probs=170.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCC---CcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~---~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      ++|++.+.||+|+||.||+|++..+   ...||||.+....     ....+|+.+++.++|+||.               
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            4699999999999999999998654   4579999876432     2345699999999999971               


Q ss_pred             --ee----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 --YS----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 --~~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                        +.          .....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .++|+|||+++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh-~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS-EMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEcCCC-CEEECccchhhccccccc
Confidence              00          11235788889999999999999999 89999999999999999887 699999999987642211


Q ss_pred             c-c--cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          216 N-I--SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       216 ~-~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      . .  ...++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.....              
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------  226 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR--------------  226 (266)
T ss_pred             ceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence            1 1  123457899999987654 8999999999999999997 9999977665444443322100              


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                          .          ..+...+..+.+|+.+||+.+|++||++.+++++
T Consensus       227 ----~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         227 ----L----------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ----C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                0          0122368899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.5e-34  Score=267.24  Aligned_cols=214  Identities=23%  Similarity=0.339  Sum_probs=168.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch--hhHHHHHHHHHhcCCCceEe------------------e-
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVHY------------------S-  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~ni~~------------------~-  149 (395)
                      .+|.+.+.||+|+||.||++..  .+..||+|.+....  ....+|+.+++.++|+|+..                  . 
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            3699999999999999999976  57889999886543  34568999999999999710                  0 


Q ss_pred             ----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccc
Q 016085          150 ----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY  219 (395)
Q Consensus       150 ----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~  219 (395)
                                .....+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||+++......  ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~--~~~  159 (256)
T cd05082          84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-ANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ--DTG  159 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeccccchheEEEcCCC-cEEecCCccceeccccC--CCC
Confidence                      01123677888999999999999999 88999999999999999887 69999999987653322  233


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      .++..|+|||++.+.. ++.++|||||||++|+|++ |+.||...+..+....+.+.               +       
T Consensus       160 ~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~---------------~-------  216 (256)
T cd05082         160 KLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---------------Y-------  216 (256)
T ss_pred             ccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---------------C-------
Confidence            4466799999986644 8999999999999999997 99999876554443333210               0       


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                            .......+++.+.+++.+||+.+|++|||+.++++
T Consensus       217 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 ------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                  00122346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-34  Score=272.32  Aligned_cols=228  Identities=32%  Similarity=0.464  Sum_probs=181.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCceEe-------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVHY-------------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni~~-------------------  148 (395)
                      ..|.+.+.||.|+||.||+|.+..++..||+|++....   ....+|+.+++.++|+|+..                   
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   98 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD   98 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence            45999999999999999999999899999999987543   34567999999999999711                   


Q ss_pred             -------eccCC-CCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cccc
Q 016085          149 -------SRASQ-RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISY  219 (395)
Q Consensus       149 -------~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~  219 (395)
                             ..... .++...+..++.|++.||.||| +.||+|+||+|+||+++.++ .++|+|||++........ ....
T Consensus        99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH-~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~  176 (286)
T cd06614          99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH-SQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKEKSKRNSV  176 (286)
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCChhhEEEcCCC-CEEECccchhhhhccchhhhccc
Confidence                   01112 6888889999999999999999 89999999999999999887 699999998865433221 1234


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcc
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI  299 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (395)
                      .++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+.......+... +.+.                  .
T Consensus       177 ~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~------------------~  236 (286)
T cd06614         177 VGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP------------------L  236 (286)
T ss_pred             cCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC------------------C
Confidence            5688899999987654 899999999999999999999999876655444433221 0000                  0


Q ss_pred             cCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       300 ~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                             .....++..+.+||.+||+.+|.+|||+.++++|+||....
T Consensus       237 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         237 -------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             -------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence                   01122678999999999999999999999999999998843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-34  Score=269.03  Aligned_cols=219  Identities=26%  Similarity=0.328  Sum_probs=170.1

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCC-----CcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEee----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHYS----------  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~~----------  149 (395)
                      ..+|++.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.++|+|+...          
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            34799999999999999999988644     4789999986432     234579999999999998100          


Q ss_pred             -----c---------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEee
Q 016085          150 -----R---------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  203 (395)
Q Consensus       150 -----~---------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~D  203 (395)
                           .                     ....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~di~p~nill~~~~-~~kl~d  162 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA-AKKFVHRDLAARNCMVAEDL-TVKIGD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccChheEEEcCCC-CEEECC
Confidence                 0                     0112466678889999999999999 88999999999999999888 699999


Q ss_pred             cCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 016085          204 FGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  279 (395)
Q Consensus       204 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  279 (395)
                      ||+++.......   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+.......+.. .+. 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~-  239 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GGH-  239 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CCC-
Confidence            999876543321   12334578899999986654 8999999999999999998 9999987765544433321 000 


Q ss_pred             CHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                                ..++...+..+.+||.+||+.+|++|||+.++++
T Consensus       240 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         240 --------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                      0122335889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.6e-34  Score=270.98  Aligned_cols=218  Identities=20%  Similarity=0.298  Sum_probs=166.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCc----EEEEEEeecch-----hhHHHHHHHHHhcCCCceEe-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY-------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~-------------  148 (395)
                      .+|++.+.||+|+||.||+|.+..+++    .||+|.+....     .....|+.+++.++|+||..             
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i   86 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV   86 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence            469999999999999999999887776    47777764321     23345777888999999710             


Q ss_pred             -------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 -------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 -------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                   ......+++..+..++.||+.||.||| +.|++||||||+|||++.++ .+||+|||+++.......
T Consensus        87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp~nili~~~~-~~kl~Dfg~~~~~~~~~~  164 (279)
T cd05111          87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE-EHRMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDK  164 (279)
T ss_pred             EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-HCCEeccccCcceEEEcCCC-cEEEcCCccceeccCCCc
Confidence                         012345788889999999999999999 88999999999999999877 699999999986543321


Q ss_pred             ---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          216 ---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       216 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                         .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+...... ..++.....+.           
T Consensus       165 ~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~-----------  231 (279)
T cd05111         165 KYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLA-----------  231 (279)
T ss_pred             ccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCC-----------
Confidence               12234567899999987654 8999999999999999998 9999987654332 22222100000           


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                      .+...+..+.+++.+||..||++|||+.|+++
T Consensus       232 ----------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         232 ----------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                            11224678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.7e-35  Score=272.97  Aligned_cols=230  Identities=26%  Similarity=0.328  Sum_probs=166.4

Q ss_pred             eeeeeeeccCCceEEEEEE----EcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEee--------------
Q 016085           93 YMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHYS--------------  149 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~----~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~~--------------  149 (395)
                      |.+.+.||+|+||+||++.    ...+++.||+|.+...     .....+|+.+++.++|+||...              
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            4999999999999998865    3357889999988643     2334579999999999997110              


Q ss_pred             -------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          150 -------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       150 -------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                                   .....+++..++.++.|++.||.||| +.||+||||||+|||++.++ .++|+|||+++........
T Consensus        86 v~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  163 (283)
T cd05080          86 IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH-SQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEY  163 (283)
T ss_pred             EecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccChheEEEcCCC-cEEEeecccccccCCcchh
Confidence                         01235788889999999999999999 88999999999999999887 6999999999876433221


Q ss_pred             ----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCCHHHHhhcCCCC
Q 016085          217 ----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPTREEIKCMNPNY  291 (395)
Q Consensus       217 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~  291 (395)
                          ....++..|+|||.+.+.. ++.++|||||||++|+|++|..||......  +..+... .+......+.      
T Consensus       164 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~------  234 (283)
T cd05080         164 YRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLI------  234 (283)
T ss_pred             hccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhh------
Confidence                1223466799999987654 899999999999999999999998654321  1111110 0000000000      


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                            ...........+...+..+.+|+.+||+.||++|||+.++++
T Consensus       235 ------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         235 ------ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             ------hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                  000000011123457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=268.04  Aligned_cols=218  Identities=21%  Similarity=0.299  Sum_probs=169.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceEee------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVHYS------------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~~~------------------  149 (395)
                      .+|++.+.||+|+||.||+|++. ++..+|+|.+.+.   .....+|+.+++.++|+||...                  
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35899999999999999999875 5678999988643   2345679999999999998110                  


Q ss_pred             ---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc--c
Q 016085          150 ---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--S  218 (395)
Q Consensus       150 ---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~--~  218 (395)
                               .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||+++.........  .
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE-SNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-HCCcccccccHhhEEECCCC-cEEECCcccceecccccccccCC
Confidence                     11235678888999999999999999 88999999999999999887 69999999987654322111  1


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.+..+....+....                     
T Consensus       161 ~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------------  218 (256)
T cd05059         161 TKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---------------------  218 (256)
T ss_pred             CCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence            12345799999987654 8999999999999999998 899998766554443332210                     


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                             ....+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       219 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         219 -------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                   001123368899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-34  Score=266.54  Aligned_cols=212  Identities=25%  Similarity=0.365  Sum_probs=164.6

Q ss_pred             eeeccCCceEEEEEEEcCCC---cEEEEEEeecchh-----hHHHHHHHHHhcCCCceE---------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETG---ETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVH---------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~---~~vAiK~~~~~~~-----~~~~E~~~l~~l~h~ni~---------------------  147 (395)
                      ++||+|+||.||+|.+..++   ..||+|.+.....     ...+|+.+++.++|+|+.                     
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG   80 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence            47999999999999876555   7899998864432     345799999999999971                     


Q ss_pred             ----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc----cc
Q 016085          148 ----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SY  219 (395)
Q Consensus       148 ----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~----~~  219 (395)
                          +......+++..+..++.|++.||.||| ..|++||||||+|||++.++ .+||+|||+++.........    ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~  158 (257)
T cd05060          81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLE-SKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRATTAG  158 (257)
T ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh-hcCeeccCcccceEEEcCCC-cEEeccccccceeecCCcccccccCc
Confidence                0112235788899999999999999999 88999999999999999887 69999999998664333211    11


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      .++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+... .               .     
T Consensus       159 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~---------------~-----  216 (257)
T cd05060         159 RWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-E---------------R-----  216 (257)
T ss_pred             cccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-C---------------c-----
Confidence            2245799999986654 8999999999999999998 99999876654443333210 0               0     


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                             ...+...+..+.++|.+||..||++||++.++++
T Consensus       217 -------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 -------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                   0122346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.6e-34  Score=272.73  Aligned_cols=221  Identities=26%  Similarity=0.415  Sum_probs=170.7

Q ss_pred             cccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceE----------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVH----------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~----------  147 (395)
                      ..++|.+.+.||+|+||.||+|.+.     .++..||+|.+....     ....+|+.+++.+ +|+||.          
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3457999999999999999999763     345689999886432     2355799999999 799981          


Q ss_pred             -------ee---------c--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          148 -------YS---------R--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       148 -------~~---------~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                             +.         .  ....+++..+..++.|++.||.||| +.||+|+||||+|||++.++ .++|+|||+++.
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~~l~dfg~~~~  190 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNVLLTHGK-IVKICDFGLARD  190 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeehhhhccceEEEcCCC-eEEECCCccccc
Confidence                   00         0  1122788889999999999999999 88999999999999999776 699999999976


Q ss_pred             cccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 016085          210 LVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       210 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                      ......   .....++..|+|||.+.+.. ++.++||||+||++|+|++ |..||.+......+.......         
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~---------  260 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG---------  260 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC---------
Confidence            543321   11234567899999987655 8999999999999999998 999998776555444433210         


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                           +             ....+...++.+.+|+.+||..+|++|||+.++++
T Consensus       261 -----~-------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 -----Y-------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             -----C-------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                 0             00012236789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2e-34  Score=271.27  Aligned_cols=231  Identities=30%  Similarity=0.461  Sum_probs=175.5

Q ss_pred             ceeeeeeeccCCceEEEEEEEc---CCCcEEEEEEeecch--------hhHHHHHHHHHhc-CCCce-------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLL-DHPNV-------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~--------~~~~~E~~~l~~l-~h~ni-------------  146 (395)
                      +|++.+.||+|+||.||+|++.   .+++.||||.+.+..        ....+|+.+++.+ +|+|+             
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3889999999999999999864   467899999886431        2345789999999 58887             


Q ss_pred             ----Ee---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          147 ----HY---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       147 ----~~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                          .+         ......+++..++.++.|++.||.||| +.|++||||||+||+++.++ .++|+|||+++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH-~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~  158 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH-QLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCC-CEEEEECccccccccc
Confidence                00         012345778889999999999999999 88999999999999999887 6999999998765433


Q ss_pred             CC--cccccccccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          214 EP--NISYICSRYYRAPELIFGAT-EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       214 ~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ..  .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+..-.          . 
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----------~-  227 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK----------S-  227 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc----------c-
Confidence            22  12345788999999986532 3688999999999999999999999644322222222111000          0 


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC---HHHHhcCCcccCCCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFDELRDP  349 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t---~~e~l~hp~f~~~~~~  349 (395)
                                    ....+..++..+.++|.+||+.||++|||   +.++|+||||+.+.+.
T Consensus       228 --------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         228 --------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             --------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                          00123346789999999999999999998   5678999999998774

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.9e-34  Score=271.98  Aligned_cols=218  Identities=25%  Similarity=0.354  Sum_probs=169.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceE--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      .+|.+.+.||+|+||.||+|.+.     .++..+|+|.+....    ....+|+.+++.++|+||.              
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46999999999999999999854     345679999886432    3456899999999999970              


Q ss_pred             ---eec-------------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCce
Q 016085          148 ---YSR-------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV  199 (395)
Q Consensus       148 ---~~~-------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~i  199 (395)
                         +..                         ....+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~Nil~~~~~-~~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGANL-LV  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccCcceEEEccCC-cE
Confidence               000                         1123678889999999999999999 88999999999999999887 69


Q ss_pred             EEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 016085          200 KLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKV  275 (395)
Q Consensus       200 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  275 (395)
                      +|+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+.+..+...
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  241 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG  241 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence            9999999976543221   12344578899999987654 8999999999999999998 99999776655544332210


Q ss_pred             hCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                        .                 .+         ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus       242 --~-----------------~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         242 --R-----------------VL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             --C-----------------CC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence              0                 00         012236789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-34  Score=271.90  Aligned_cols=221  Identities=22%  Similarity=0.347  Sum_probs=171.0

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCC-----cEEEEEEeecch-----hhHHHHHHHHHhc-CCCceEe---------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVHY---------  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~~---------  148 (395)
                      ...+|++.+.||+|+||.||++.....+     ..||+|.+....     ....+|+.+++.+ +|+||..         
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3457999999999999999999876443     789999886432     2345799999999 8999810         


Q ss_pred             --------e-------------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC
Q 016085          149 --------S-------------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH  195 (395)
Q Consensus       149 --------~-------------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~  195 (395)
                              .                         .....+++..+..++.|++.||.||| +.||+||||||+|||++.+
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA-SKKCIHRDLAARNVLVTED  168 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-HCCccccccceeeEEEcCC
Confidence                    0                         12345678888899999999999999 8899999999999999987


Q ss_pred             CCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 016085          196 THQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVE  271 (395)
Q Consensus       196 ~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  271 (395)
                      + .+||+|||+++.......   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+....
T Consensus       169 ~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         169 H-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             C-eEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            7 699999999986543221   11223456799999886644 8999999999999999997 9999987765554443


Q ss_pred             HHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       272 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      +....                            ....+...+..+.+|+.+||..||++|||+.+++++
T Consensus       247 ~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         247 LKEGY----------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHcCC----------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            32200                            001123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.2e-34  Score=264.70  Aligned_cols=221  Identities=31%  Similarity=0.505  Sum_probs=170.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++..       .....+|+.+++.++|+|+.                
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            4699999999999999999999999999999987531       23455799999999999970                


Q ss_pred             -ee-------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 -YS-------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 -~~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                       +.             .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++......
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~  159 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH-SKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH-hCCEecCCcChhhEEECCCC-cEEEeccceeeeccCC
Confidence             00             11234688889999999999999999 88999999999999999887 6999999998765332


Q ss_pred             C-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          214 E-PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       214 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      . ......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||......  ...+.....               
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~---------------  221 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIE---------------  221 (267)
T ss_pred             CcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhh---------------
Confidence            2 123356788999999987654 899999999999999999999999654321  111111100               


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ....+.        ......+..+.++|.+||..+|++|||+.++++
T Consensus       222 ~~~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         222 KCDYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             cCCCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            000000        011246789999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-34  Score=264.74  Aligned_cols=218  Identities=25%  Similarity=0.321  Sum_probs=171.9

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceEe-----------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVHY-----------------  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~~-----------------  148 (395)
                      ..++|++.+.||+|+||.||+|.+. .++.||||.+...   .....+|+.+++.++|+|+..                 
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            3457999999999999999999975 4578999988653   234568999999999999810                 


Q ss_pred             e-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc-
Q 016085          149 S-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-  216 (395)
Q Consensus       149 ~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~-  216 (395)
                      .           .....+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .+||+|||++......... 
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh-~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~  160 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE-SRNYIHRDLAARNILVGENL-VCKIADFGLARLIEDDEYTA  160 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcchheEEEcCCC-CEEECccccceeccchhhhh
Confidence            0           01235788888999999999999999 88999999999999999887 6999999998765432111 


Q ss_pred             -ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          217 -ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       217 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                       ....++..|+|||.+.+.. ++.++|+|||||++|+|++ |+.||.+.+....+..+.....                 
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------------  222 (261)
T cd05034         161 REGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR-----------------  222 (261)
T ss_pred             hhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence             1223356799999997654 8999999999999999998 9999988776555555432110                 


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                                 ...+...+.++.+++.+||+.+|.+||++.+++
T Consensus       223 -----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~  255 (261)
T cd05034         223 -----------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQ  255 (261)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence                       011233578999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-34  Score=264.84  Aligned_cols=215  Identities=26%  Similarity=0.385  Sum_probs=169.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh---hHHHHHHHHHhcCCCceE-----------------ee
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVH-----------------YS  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~~l~~l~h~ni~-----------------~~  149 (395)
                      ..+|++.+.||+|+||.||+|..  .|+.||+|.+.....   ...+|+.+++.++|+|+.                 +.
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            34699999999999999999986  488999999876543   455799999999999971                 00


Q ss_pred             c---------cC--CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          150 R---------AS--QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       150 ~---------~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                      .         ..  ..+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||.++......  ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~~--~~  158 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE-EKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ--DS  158 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccchhcccceEEEeCCC-CEEEccccccccccccc--cc
Confidence            0         11  25788889999999999999999 88999999999999999887 69999999998763222  22


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ...+..|+|||.+.+.. ++.++|+|||||++|+|++ |..||...+..+....+..               .+      
T Consensus       159 ~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---------------~~------  216 (256)
T cd05039         159 GKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK---------------GY------  216 (256)
T ss_pred             CCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc---------------CC------
Confidence            33456799999987654 8899999999999999997 9999977654443332221               00      


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                             ....+...++.+.+||.+||..+|++|||+.++++
T Consensus       217 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 -------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             -------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                   00122346899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=292.12  Aligned_cols=171  Identities=29%  Similarity=0.463  Sum_probs=148.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      .-|...+.||+|+||.||+++++++|+.||||.+++.     ....-+|+++|++|+|+||.                  
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            3478889999999999999999999999999988653     34455899999999999981                  


Q ss_pred             -----------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc--C-CCCceEEeecCCc
Q 016085          148 -----------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN--P-HTHQVKLCDFGSA  207 (395)
Q Consensus       148 -----------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~--~-~~~~ikl~DFG~a  207 (395)
                                       .-.....+++..+..+...+..||.||| ++||+||||||+||++-  . ..+.-||+|||.|
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr-En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR-ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence                             0122457899999999999999999999 89999999999999873  2 2235799999999


Q ss_pred             cccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 016085          208 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPG  262 (395)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  262 (395)
                      +...++....+.+||+.|.+||++..+..|+..+|.|||||++|+++||..||.-
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9999998889999999999999997555699999999999999999999999953

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.5e-34  Score=269.94  Aligned_cols=217  Identities=23%  Similarity=0.378  Sum_probs=166.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEee------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHYS------------  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~~------------  149 (395)
                      +|++.+.||+|+||.||+|++..     ....+|+|.+....     ....+|+.+++.++|+||...            
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            48889999999999999998753     23578999876432     234579999999999997110            


Q ss_pred             -----c---------------------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceE
Q 016085          150 -----R---------------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL  191 (395)
Q Consensus       150 -----~---------------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nil  191 (395)
                           .                                 ....+++..+..++.|++.||.||| +.||+||||||+|||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~ivH~dikp~nil  159 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA-EMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH-HCCeehhhhhhheEE
Confidence                 0                                 0124667788999999999999999 889999999999999


Q ss_pred             EcCCCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 016085          192 VNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVD  267 (395)
Q Consensus       192 l~~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~  267 (395)
                      ++.++ .+||+|||+++.......   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.....
T Consensus       160 l~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         160 VAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99877 699999999976533221   11223467899999986654 8999999999999999998 999998766544


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       268 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ....+.+.               +             ....+..++.++.+|+.+||+.||++||++.++++
T Consensus       238 ~~~~~~~~---------------~-------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 LFNLLKTG---------------Y-------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHhCC---------------C-------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            33322110               0             00122346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.2e-34  Score=267.17  Aligned_cols=219  Identities=21%  Similarity=0.267  Sum_probs=169.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcC----CCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLE----TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~----~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~------------  148 (395)
                      .++|.+.+.||+|+||.||+|.+..    ++..||+|.+...     .....+|+.+++.++|+|+..            
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4579999999999999999999876    3578999988643     233457999999999999700            


Q ss_pred             ---------------ecc--------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecC
Q 016085          149 ---------------SRA--------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  205 (395)
Q Consensus       149 ---------------~~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG  205 (395)
                                     ...        ...+++..+..++.|++.||+||| +.|++||||||+||+++.++ .+||+|||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~di~p~nil~~~~~-~~kl~d~g  162 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-KRGVIHKDIAARNCVIDEEL-QVKITDNA  162 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccCHhhEEEcCCC-cEEECCCC
Confidence                           000        034778888999999999999999 88999999999999999887 69999999


Q ss_pred             CccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 016085          206 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  281 (395)
Q Consensus       206 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  281 (395)
                      +++........   ....++..|+|||.+.+.. ++.++|||||||++|++++ |+.||.+.+..+....+...      
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------  235 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG------  235 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC------
Confidence            99765333211   1233466799999987654 8999999999999999998 99999876554432222110      


Q ss_pred             HHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          282 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                  ...          .....+++.+.+++.+||..||++|||+.++++
T Consensus       236 ------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         236 ------------YRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ------------CCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                        000          011235789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.6e-34  Score=265.98  Aligned_cols=218  Identities=25%  Similarity=0.349  Sum_probs=169.4

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCc---EEEEEEeecc-----hhhHHHHHHHHHhcCCCceE---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~---~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .+|++.+.||+|+||.||+|+++.+++   .||||.+...     .....+|+.+++.++|+||.               
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            359999999999999999999887665   5999988643     23445799999999999980               


Q ss_pred             --e----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 --Y----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 --~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                        +          ......+++..++.++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH-~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS-EMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccChheEEEcCCC-cEEECCCccccccccCcc
Confidence              0          011344678888999999999999999 88999999999999999877 699999999876543222


Q ss_pred             ccc---cc---ccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          216 NIS---YI---CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       216 ~~~---~~---gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ...   ..   .+..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....+....            
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~------------  228 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY------------  228 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC------------
Confidence            111   11   135799999987654 8999999999999999886 999998776655444432210            


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                            ..          ..+..++..+.+++.+||..+|.+||++.+++.
T Consensus       229 ------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         229 ------RL----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ------cC----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                  00          012346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-34  Score=269.90  Aligned_cols=225  Identities=21%  Similarity=0.259  Sum_probs=168.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCC--------------cEEEEEEeecch-----hhHHHHHHHHHhcCCCceEe---
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETG--------------ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY---  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~--------------~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~---  148 (395)
                      .+|++.+.||+|+||.||+|++..++              ..||+|.+....     ....+|+++++.++|+|+..   
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            47999999999999999999875432              359999886532     23457999999999999710   


Q ss_pred             --------------ec---------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc
Q 016085          149 --------------SR---------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  193 (395)
Q Consensus       149 --------------~~---------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~  193 (395)
                                    ..                     ....+++..+..++.|++.||.||| +.|++||||||+||+++
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~Nill~  163 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA-SLNFVHRDLATRNCLVG  163 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH-hcCeeccccChhhEEEc
Confidence                          00                     0013567778889999999999999 88999999999999999


Q ss_pred             CCCCceEEeecCCccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHHH
Q 016085          194 PHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL--GQPLFPGESGVDQ  268 (395)
Q Consensus       194 ~~~~~ikl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~  268 (395)
                      .++ .+||+|||++.........   ....++..|+|||.+.+.. ++.++|+|||||++|+|++  |..||...+..+.
T Consensus       164 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         164 NHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             CCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            877 6999999999765333211   1223467899999987655 8999999999999999998  6788987766555


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          269 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       269 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      +..+.+......            ....         ...+...++.+.+|+.+||++||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~------------~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQG------------RQIY---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhcc------------cccc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            554433210000            0000         0012336789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.3e-34  Score=268.08  Aligned_cols=218  Identities=25%  Similarity=0.372  Sum_probs=169.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      .+|.+.++||+|+||.||+|.+.     .++..+|+|.+...    .....+|+++++.++|+||.              
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46889999999999999999753     35678999987643    23456899999999999970              


Q ss_pred             ---eec---------c---------------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceE
Q 016085          148 ---YSR---------A---------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK  200 (395)
Q Consensus       148 ---~~~---------~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ik  200 (395)
                         +..         .               ...+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~~i~H~dlkp~nil~~~~~-~~k  162 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA-SLHFVHRDLATRNCLVGQGL-VVK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH-HCCeecccccHhhEEEcCCC-CEE
Confidence               000         0               024678888999999999999999 89999999999999999877 699


Q ss_pred             EeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 016085          201 LCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVL  276 (395)
Q Consensus       201 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  276 (395)
                      |+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||......+.+..+....
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR  241 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence            999999876533221   11233467899999987655 8999999999999999998 999997766555444432210


Q ss_pred             CCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                        +                          ...+..+++.+.+||.+||+.||++||++.++++
T Consensus       242 --~--------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         242 --E--------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             --c--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence              0                          0112346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.9e-34  Score=264.39  Aligned_cols=211  Identities=23%  Similarity=0.294  Sum_probs=163.0

Q ss_pred             eeccCCceEEEEEEEc--CCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE----------------ee-----
Q 016085           98 VVGQGSFGIVFQAKCL--ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH----------------YS-----  149 (395)
Q Consensus        98 ~lG~G~fg~V~~a~~~--~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~----------------~~-----  149 (395)
                      .||+|+||.||+|.+.  .++..||+|++....     ....+|+.+++.++|+||.                +.     
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L   81 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL   81 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence            3899999999999765  445679999886432     2355799999999999981                00     


Q ss_pred             -----ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc----cccc
Q 016085          150 -----RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN----ISYI  220 (395)
Q Consensus       150 -----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~----~~~~  220 (395)
                           .....+++..+..++.|++.||.||| ++|++||||||+|||++.++ .+||+|||+++........    ....
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE-GKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccCCCC
Confidence                 12345788899999999999999999 88999999999999999877 6999999999765333211    1122


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI  299 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (395)
                      ++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+....+...  ..                    
T Consensus       160 ~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~--------------------  216 (257)
T cd05115         160 WPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG--KR--------------------  216 (257)
T ss_pred             CCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--CC--------------------
Confidence            356899999987654 8999999999999999996 99999887665544333221  00                    


Q ss_pred             cCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       300 ~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                            ..++...++++.++|.+||..||++||++.++.+
T Consensus       217 ------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                  0122346899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.3e-34  Score=262.85  Aligned_cols=218  Identities=21%  Similarity=0.330  Sum_probs=170.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE-----------------ee-
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH-----------------YS-  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~-----------------~~-  149 (395)
                      .+|++.+.||.|+||.||+|.+. ++..+|+|.+...   .....+|+++++.++|+|+.                 +. 
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            36999999999999999999875 4678999988643   23456899999999999971                 00 


Q ss_pred             ---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc--cc
Q 016085          150 ---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--IS  218 (395)
Q Consensus       150 ---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~--~~  218 (395)
                               .....+++..++.++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++.........  ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE-SSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH-HCCccccccccceEEEcCCC-eEEECCCcceeecccCcccccCC
Confidence                     11234688888999999999999999 88999999999999999777 6999999998765332211  12


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||........+..+.+..                     
T Consensus       161 ~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------------  218 (256)
T cd05112         161 TKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF---------------------  218 (256)
T ss_pred             CccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC---------------------
Confidence            23456899999987654 8999999999999999998 999998766554444432200                     


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                             ....+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus       219 -------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         219 -------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                   001122357899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.2e-34  Score=272.59  Aligned_cols=220  Identities=22%  Similarity=0.338  Sum_probs=167.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcC-------CCcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceEe--------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVHY--------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~-------~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~~--------  148 (395)
                      .++|.+.+.||+|+||.||+|++..       +...||+|.+....     ....+|+.+++.+ +|+||..        
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3579999999999999999998643       23579999886432     2345689999999 7999710        


Q ss_pred             ---------e---------c----------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC
Q 016085          149 ---------S---------R----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP  194 (395)
Q Consensus       149 ---------~---------~----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~  194 (395)
                               .         .                ....+++..+..++.|++.||+||| +.|++||||||+|||++.
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~gi~H~dlkp~Nill~~  175 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTE  175 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH-HCCcccccccHHheEEcC
Confidence                     0         0                0124677888999999999999999 889999999999999998


Q ss_pred             CCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 016085          195 HTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLV  270 (395)
Q Consensus       195 ~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  270 (395)
                      ++ .+||+|||+++.......   .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.+..+...
T Consensus       176 ~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         176 DN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             CC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            87 699999999876543221   11122356899999987654 8999999999999999998 889997765433333


Q ss_pred             HHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       271 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .+.. ..                           ....+...+.++.+||.+||..+|.+|||+.+++++
T Consensus       254 ~~~~-~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         254 LLKE-GH---------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHc-CC---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            2211 00                           001223468899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.2e-34  Score=275.04  Aligned_cols=220  Identities=26%  Similarity=0.390  Sum_probs=166.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceEe-----ecc---
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVHY-----SRA---  151 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~~-----~~~---  151 (395)
                      ++|++.+.||+|+||.||+|.+.     .+++.||||.+....     ....+|+.++..+ +|+||..     ...   
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            47999999999999999999853     467899999986432     2345799999999 6788710     000   


Q ss_pred             --------------------------------------------------------------------------------
Q 016085          152 --------------------------------------------------------------------------------  151 (395)
Q Consensus       152 --------------------------------------------------------------------------------  151 (395)
                                                                                                      
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence                                                                                            


Q ss_pred             ------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc---cccccc
Q 016085          152 ------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICS  222 (395)
Q Consensus       152 ------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~---~~~~gt  222 (395)
                            ...+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++.........   ....++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCCCCCC
Confidence                  012466677889999999999999 88999999999999999877 6999999999765332211   122346


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      ..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+......+...+....               .        
T Consensus       245 ~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------~--------  300 (343)
T cd05103         245 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---------------R--------  300 (343)
T ss_pred             cceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC---------------C--------
Confidence            6799999987654 8999999999999999997 9999977544333322221100               0        


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                          ...+...++++.+++.+||+.||++|||+.++++|
T Consensus       301 ----~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         301 ----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                00122357889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.3e-34  Score=265.28  Aligned_cols=218  Identities=24%  Similarity=0.331  Sum_probs=169.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCc---EEEEEEeecc-----hhhHHHHHHHHHhcCCCceE---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~---~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .+|+..+.||+|+||.||+|++..++.   .||+|.+...     ......|+++++.++|+|+.               
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            469999999999999999999876655   7999988643     22345799999999999970               


Q ss_pred             --e---------e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 --Y---------S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 --~---------~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                        +         . .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS-DMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhhEEEcCCC-cEEECCCccceecccccc
Confidence              0         0 12345788889999999999999999 88999999999999999877 699999999876543221


Q ss_pred             cc----cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          216 NI----SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       216 ~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ..    ....+..|+|||.+.+.. ++.++|||||||++|+|++ |+.||...+..+....+......|           
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~-----------  230 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP-----------  230 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC-----------
Confidence            11    112245799999987644 8999999999999999997 999998776655554443211000           


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                       .....+..+.+|+.+||+.+|++||++.++++
T Consensus       231 -----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 -----------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                             11235789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.5e-34  Score=262.83  Aligned_cols=216  Identities=28%  Similarity=0.409  Sum_probs=170.4

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCC----cEEEEEEeecch-----hhHHHHHHHHHhcCCCceE----------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETG----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~----~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      +.+.+.||.|+||.||+|++..++    ..||+|.+....     .....|+.+++.++|+|+.                
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356789999999999999998766    899999986443     3456799999999999970                


Q ss_pred             -e---------eccCCC--CcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 -Y---------SRASQR--MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 -~---------~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                       +         ......  +++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh-~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE-SKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh-cCCeeecccccceEEEccCC-eEEEcccCCceecccccc
Confidence             0         011122  788899999999999999999 88999999999999999887 699999999977654422


Q ss_pred             cc--cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          216 NI--SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       216 ~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      ..  ...++..|+|||.+.+. .++.++|+|||||++|+|++ |.+||.+.+..+....+....                
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------  221 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY----------------  221 (258)
T ss_pred             cccccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            21  12357889999998554 48999999999999999998 889998766655554443210                


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                         .         ...+...+..+.+++.+||..||++|||+.++++
T Consensus       222 ---~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      222 ---R---------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ---C---------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence               0         0112236889999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.8e-34  Score=270.97  Aligned_cols=219  Identities=22%  Similarity=0.296  Sum_probs=168.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCc----EEEEEEeecch-----hhHHHHHHHHHhcCCCceEe-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY-------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~-------------  148 (395)
                      .+|++.+.||+|+||.||+|.+..+++    .||+|.+....     ....+|+.+++.++|+||..             
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v   86 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV   86 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence            469999999999999999999887776    47888776432     13457899999999999711             


Q ss_pred             ---e----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 ---S----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 ---~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                         .          .....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||+++.......
T Consensus        87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~  164 (303)
T cd05110          87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEK  164 (303)
T ss_pred             ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh-hcCeeccccccceeeecCCC-ceEEccccccccccCccc
Confidence               0          11224677888999999999999999 88999999999999998877 699999999986543322


Q ss_pred             ---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          216 ---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       216 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                         .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+..... +..+......+            
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~------------  230 (303)
T cd05110         165 EYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERL------------  230 (303)
T ss_pred             ccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCC------------
Confidence               11233467899999987654 8999999999999999997 999997765333 22222211000            


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                     ..+...+..+.+++.+||..+|++||++.++++.
T Consensus       231 ---------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         231 ---------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           0112357789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.7e-34  Score=265.19  Aligned_cols=218  Identities=27%  Similarity=0.351  Sum_probs=169.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCc---EEEEEEeecc-----hhhHHHHHHHHHhcCCCceE---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~---~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .+|++.+.||+|+||.||+|+++.++.   .||+|.+...     .....+|+.+++.++|+||.               
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            479999999999999999999875543   7999987543     23456799999999999981               


Q ss_pred             --ee----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 --YS----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 --~~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                        +.          .....+++..+..++.|++.||.||| +.|++||||||+|||++.++ .++|+|||++........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeehhhchhcEEECCCC-eEEeCCCCcccccccccc
Confidence              00          11235688888999999999999999 89999999999999999887 699999999987643321


Q ss_pred             c----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          216 N----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       216 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      .    ....++..|+|||.+.+.. ++.++|+|||||++|++++ |..||.+.+..+....+.+...             
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-------------  227 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-------------  227 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-------------
Confidence            1    1112256799999997654 8999999999999999886 9999987765554444432100             


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                           .          ..+..+++.+.+++.+||+.+|.+||++.++++
T Consensus       228 -----~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 -----L----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -----C----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                 0          012236789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.3e-34  Score=262.79  Aligned_cols=214  Identities=24%  Similarity=0.362  Sum_probs=168.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCCCceE----------------ee---
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVH----------------YS---  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~ni~----------------~~---  149 (395)
                      .+|++.+.||+|+||.||++..  +++.||+|.+...  .....+|+.+++.++|+|+.                +.   
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~   83 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG   83 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence            4699999999999999999864  7889999988643  23456799999999999970                00   


Q ss_pred             --------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccc
Q 016085          150 --------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC  221 (395)
Q Consensus       150 --------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~g  221 (395)
                              .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++.......  .....
T Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~~--~~~~~  159 (254)
T cd05083          84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE-SKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMGV--DNSKL  159 (254)
T ss_pred             CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccCcceEEEcCCC-cEEECCCccceeccccC--CCCCC
Confidence                    11234678888999999999999999 88999999999999999887 69999999987643221  22334


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      +..|+|||.+.+.. ++.++|+|||||++|+|++ |+.||.+.+..+....+.+.               +   .     
T Consensus       160 ~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---------------~---~-----  215 (254)
T cd05083         160 PVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---------------Y---R-----  215 (254)
T ss_pred             CceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC---------------C---C-----
Confidence            56799999986654 8999999999999999997 99999877654433332210               0   0     


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                           ......++..+.+|+.+||+.+|.+||++.+++.
T Consensus       216 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 -----MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -----CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                 0012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-34  Score=265.50  Aligned_cols=218  Identities=25%  Similarity=0.334  Sum_probs=169.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCc----EEEEEEeecch-----hhHHHHHHHHHhcCCCceEe-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY-------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~-------------  148 (395)
                      .+|++.+.||+|+||.||+|.++.+|+    .||+|.+....     ....+|+.+++.++|+|+..             
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v   86 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI   86 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence            469999999999999999999877665    58999876542     33457999999999999710             


Q ss_pred             -------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 -------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 -------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                   ......+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||+++.......
T Consensus        87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~~~~~~~~  164 (279)
T cd05057          87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE-EKRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLDVDEK  164 (279)
T ss_pred             EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-hCCEEecccCcceEEEcCCC-eEEECCCcccccccCccc
Confidence                         011235788899999999999999999 89999999999999999877 699999999987643322


Q ss_pred             ccc---ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          216 NIS---YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       216 ~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      ...   ..++..|+|||.+.... ++.++|+|||||++|||++ |+.||.+....+....+... ..             
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~-------------  229 (279)
T cd05057         165 EYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ER-------------  229 (279)
T ss_pred             ceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CC-------------
Confidence            211   12256799999886544 8999999999999999998 99999887655443333221 00             


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                        .            ..+...+..+.+++.+||..||.+|||+.++++
T Consensus       230 --~------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         230 --L------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             --C------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              0            012235788999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-34  Score=265.06  Aligned_cols=203  Identities=27%  Similarity=0.329  Sum_probs=158.6

Q ss_pred             CCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceE-----------------e---------eccCCCC
Q 016085          102 GSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVH-----------------Y---------SRASQRM  155 (395)
Q Consensus       102 G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~-----------------~---------~~~~~~~  155 (395)
                      |.||+||+|++..+++.||+|.+..... ..+|...+....|+|+.                 +         ......+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l   82 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNI   82 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCC
Confidence            8999999999999999999999976543 34555666666788871                 0         1122357


Q ss_pred             cHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccccccccccccccCCC
Q 016085          156 PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT  235 (395)
Q Consensus       156 ~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  235 (395)
                      ++..+..++.|++.||+||| +.||+||||||+||+++.++ .++|+|||.+......  .....++..|+|||.+.+..
T Consensus        83 ~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~  158 (237)
T cd05576          83 PEECVKRWAAEMVVALDALH-REGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISE  158 (237)
T ss_pred             CHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCccccCCcccCCCC
Confidence            88889999999999999999 88999999999999999888 5999999988665332  22345577899999886544


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChh
Q 016085          236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPE  315 (395)
Q Consensus       236 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  315 (395)
                       ++.++|+||+||++|+|++|+.||......     +.                ....            ..++..+++.
T Consensus       159 -~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~----------------~~~~------------~~~~~~~~~~  204 (237)
T cd05576         159 -ETEACDWWSLGAILFELLTGKTLVECHPSG-----IN----------------THTT------------LNIPEWVSEE  204 (237)
T ss_pred             -CCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc----------------cccc------------cCCcccCCHH
Confidence             889999999999999999999887432110     00                0000            0123447889


Q ss_pred             HHHHHHhhccCCCCCCCCH-----HHHhcCCcc
Q 016085          316 AVDLVSRLLQYSPNLRCTA-----LEACIHPFF  343 (395)
Q Consensus       316 ~~~ll~~~L~~dP~~R~t~-----~e~l~hp~f  343 (395)
                      +.+||.+||+.||++|+|+     .++++||||
T Consensus       205 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            9999999999999999986     899999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.3e-34  Score=267.13  Aligned_cols=232  Identities=25%  Similarity=0.344  Sum_probs=166.1

Q ss_pred             cceeeeeeeccCCceEEEEEE----EcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceEe--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVHY--------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~----~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~~--------------  148 (395)
                      .+|++.+.||+|+||.||+|.    +..+++.||+|.+....    ....+|+.+++.++|+|+..              
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            369999999999999999997    44678899999986432    24568999999999999710              


Q ss_pred             --------------e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          149 --------------S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       149 --------------~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                    . .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH-~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~  161 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG-SKRYVHRDLATRNILVESEN-RVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCHhhEEECCCC-eEEECCCcccccccCC
Confidence                          0 11234678888899999999999999 88999999999999999887 6999999999876433


Q ss_pred             CCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCCHHHH-hhc
Q 016085          214 EPN----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-TPTREEI-KCM  287 (395)
Q Consensus       214 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~-~~~  287 (395)
                      ...    ....++..|+|||.+.+.. ++.++|||||||++|||++|..++..... .....+..... ......+ ..+
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHHHHHH
Confidence            221    1122345699999987654 89999999999999999999877643321 11110000000 0000000 000


Q ss_pred             CCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ...             ........++..+.+||.+||..+|++|||+.++++
T Consensus       240 ~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         240 KNN-------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             hcC-------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            000             000123457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.2e-33  Score=261.89  Aligned_cols=217  Identities=26%  Similarity=0.374  Sum_probs=168.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCceE----------------ee--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVH----------------YS--  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni~----------------~~--  149 (395)
                      ++|++.+.||+|+||.||+|.+. .+..||+|.+....   ....+|+.+++.++|+|+.                +.  
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~   84 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK   84 (260)
T ss_pred             cceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence            47999999999999999999854 45679999886543   3455799999999999971                00  


Q ss_pred             ---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc--cc
Q 016085          150 ---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--IS  218 (395)
Q Consensus       150 ---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~--~~  218 (395)
                               .....++...+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||.+.........  ..
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~  162 (260)
T cd05073          85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREG  162 (260)
T ss_pred             CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH-hCCccccccCcceEEEcCCC-cEEECCCcceeeccCCCcccccC
Confidence                     01234567778889999999999999 88999999999999999887 6999999998765432211  12


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.+..+....+...               +   .. 
T Consensus       163 ~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---------------~---~~-  222 (260)
T cd05073         163 AKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---------------Y---RM-  222 (260)
T ss_pred             CcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---------------C---CC-
Confidence            23456799999987644 8999999999999999998 99999877655444433211               0   00 


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                               ......+..+.+++.+||+.+|++||++.++++
T Consensus       223 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         223 ---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ---------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                     012346889999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-33  Score=268.47  Aligned_cols=221  Identities=24%  Similarity=0.346  Sum_probs=168.9

Q ss_pred             cccceeeeeeeccCCceEEEEEEEc-------CCCcEEEEEEeecc-----hhhHHHHHHHHHhc-CCCceEe-------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCL-------ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVHY-------  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~ni~~-------  148 (395)
                      ...+|.+.+.||+|+||.||+|++.       ..+..||+|.+...     .....+|+.+++.+ +|+||..       
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3457999999999999999999753       23457999988643     23456799999999 8999700       


Q ss_pred             ----------e---------c----------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc
Q 016085          149 ----------S---------R----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  193 (395)
Q Consensus       149 ----------~---------~----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~  193 (395)
                                .         .                ....++...+..++.||+.||.||| +.||+||||||+|||++
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-~~givH~dlkp~Nili~  171 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA-SQKCIHRDLAARNVLVT  171 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH-HCCeeecccccceEEEc
Confidence                      0         0                0124566778889999999999999 88999999999999999


Q ss_pred             CCCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016085          194 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQL  269 (395)
Q Consensus       194 ~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  269 (395)
                      .++ .+||+|||+++.......   .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus       172 ~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  249 (304)
T cd05101         172 ENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  249 (304)
T ss_pred             CCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            877 699999999986643221   11233467899999987654 8999999999999999998 88999877655544


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          270 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       270 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ..+....                            ....+...+..+.+||.+||..+|.+|||+.++++.
T Consensus       250 ~~~~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         250 KLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            4332100                            001123468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-33  Score=269.25  Aligned_cols=219  Identities=22%  Similarity=0.326  Sum_probs=167.2

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcC-------CCcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceEee-------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVHYS-------  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~-------~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~~~-------  149 (395)
                      .++|.+.+.||+|+||.||+|++..       ....||+|.+....     ....+|+.+++.+ +|+||...       
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            3579999999999999999998642       34579999886432     2345799999999 69998100       


Q ss_pred             ----------c-------------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC
Q 016085          150 ----------R-------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP  194 (395)
Q Consensus       150 ----------~-------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~  194 (395)
                                .                         ....+++..+..++.||+.||.||| +.||+||||||+|||++.
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~gi~H~dlkp~Nill~~  169 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE-SRRCIHRDLAARNVLVTE  169 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH-HCCeeeccccceeEEEcC
Confidence                      0                         0123677778889999999999999 889999999999999998


Q ss_pred             CCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 016085          195 HTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLV  270 (395)
Q Consensus       195 ~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  270 (395)
                      ++ .+||+|||+++.......   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+...
T Consensus       170 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         170 DN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             CC-cEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            87 699999999976543211   11122346799999987654 8999999999999999999 899998776554444


Q ss_pred             HHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       271 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      .+...  .                          ....+..++..+.+|+.+||..||++|||+.++++
T Consensus       248 ~~~~~--~--------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         248 LLREG--H--------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHcC--C--------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            33220  0                          00112346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-33  Score=277.57  Aligned_cols=220  Identities=27%  Similarity=0.414  Sum_probs=167.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCC-----CcEEEEEEeecc-----hhhHHHHHHHHHhcC-CCceE-----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQD-----KRYKNRELQTMRLLD-HPNVH-----------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~-----~~~~~~E~~~l~~l~-h~ni~-----------  147 (395)
                      .++|++.+.||+|+||.||+|.+...     +..||||++...     .....+|+.+|+.+. ||||.           
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            45799999999999999999987533     347999988643     234557999999996 99981           


Q ss_pred             ------eec-----------------------------------------------------------------------
Q 016085          148 ------YSR-----------------------------------------------------------------------  150 (395)
Q Consensus       148 ------~~~-----------------------------------------------------------------------  150 (395)
                            +..                                                                       
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence                  000                                                                       


Q ss_pred             ----------------------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC
Q 016085          151 ----------------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT  196 (395)
Q Consensus       151 ----------------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~  196 (395)
                                                        ....+++..+..++.||+.||.||| +.||+||||||+|||++.++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivH~dikp~Nill~~~~  274 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA-SKNCVHRDLAARNVLLAQGK  274 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChHhEEEeCCC
Confidence                                              0123667777889999999999999 88999999999999999877


Q ss_pred             CceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 016085          197 HQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEI  272 (395)
Q Consensus       197 ~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i  272 (395)
                       .+||+|||+++.......   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+......+...
T Consensus       275 -~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~  352 (400)
T cd05105         275 -IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK  352 (400)
T ss_pred             -EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence             699999999976543222   12334577899999997654 8999999999999999997 99999875443333332


Q ss_pred             HHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          273 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      +...                 ..          ...+..++..+.+++.+||+.||++|||+.++.+
T Consensus       353 ~~~~-----------------~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         353 IKSG-----------------YR----------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HhcC-----------------CC----------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            2210                 00          0112346889999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-33  Score=266.29  Aligned_cols=218  Identities=25%  Similarity=0.312  Sum_probs=168.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEee-----------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHYS-----------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~~-----------  149 (395)
                      ++|++.+.||+|+||.||+|.+..     ++..||+|.+...     .....+|+.+++.++|+|+...           
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            469999999999999999998753     6789999988643     2345579999999999997100           


Q ss_pred             ------c-------------------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE
Q 016085          150 ------R-------------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV  192 (395)
Q Consensus       150 ------~-------------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill  192 (395)
                            .                               ....+++..+..++.|++.||.||| +.|++||||||+||++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH-~~~i~H~dl~p~nil~  163 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS-ERKFVHRDLATRNCLV  163 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hCCeecccccHhheEe
Confidence                  0                               0123567778899999999999999 8899999999999999


Q ss_pred             cCCCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 016085          193 NPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQ  268 (395)
Q Consensus       193 ~~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  268 (395)
                      +.++ .++|+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+.
T Consensus       164 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~  241 (288)
T cd05050         164 GENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV  241 (288)
T ss_pred             cCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9888 699999999875432211   11223466799999987654 8999999999999999997 8889987766554


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          269 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       269 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ...+...              +     ..         ..+..++..+.+||.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~--------------~-----~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         242 IYYVRDG--------------N-----VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHhcC--------------C-----CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            4433220              0     00         012346789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.1e-34  Score=264.27  Aligned_cols=216  Identities=24%  Similarity=0.337  Sum_probs=165.6

Q ss_pred             eeeeeeeccCCceEEEEEEEc---CCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEeec-------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHYSR-------------  150 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~~~-------------  150 (395)
                      |++.++||+|+||.||+|.+.   .+++.||||.+..+.      ....+|+.+++.++|+|+....             
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999865   357899999886432      2345799999999999971000             


Q ss_pred             -------------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecC
Q 016085          151 -------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  205 (395)
Q Consensus       151 -------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG  205 (395)
                                               ....++...+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS-SKNFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccchhhEEEcCCC-CEEECccc
Confidence                                     0013566778899999999999999 88999999999999999877 69999999


Q ss_pred             CccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 016085          206 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  281 (395)
Q Consensus       206 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  281 (395)
                      +++.......   .....+++.|++||.+.+.. ++.++|||||||++|+|++ |++||.+.+..+....+... .    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~----  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-N----  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-C----
Confidence            9986543221   12233467899999986654 8999999999999999999 89999876654433333220 0    


Q ss_pred             HHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          282 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                 ..            ......+..+.+++.+||+.+|.+||++.+++.
T Consensus       233 -----------~~------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         233 -----------RL------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             -----------cC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       00            011236789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-33  Score=272.03  Aligned_cols=219  Identities=23%  Similarity=0.342  Sum_probs=167.4

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCC-------CcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceEe---------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLET-------GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVHY---------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~-------~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~~---------  148 (395)
                      .+|++.+.||+|+||.||+|++...       +..||+|.+....     ....+|+.+++.+ +|+||..         
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            4699999999999999999986532       2369999876432     3455799999999 8999810         


Q ss_pred             --------e---------c----------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC
Q 016085          149 --------S---------R----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH  195 (395)
Q Consensus       149 --------~---------~----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~  195 (395)
                              .         .                ....++...+..++.|++.||.||| +.||+||||||+|||++.+
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~givH~dlkp~Nill~~~  170 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA-SQKCIHRDLAARNVLVTED  170 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH-HCCeeccccccceEEEcCC
Confidence                    0         0                0123566677889999999999999 8899999999999999988


Q ss_pred             CCceEEeecCCccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 016085          196 THQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVE  271 (395)
Q Consensus       196 ~~~ikl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  271 (395)
                      + .+||+|||+++........   ....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....
T Consensus       171 ~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         171 N-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             C-cEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            7 6999999999765432211   1222356799999997654 8999999999999999998 8899988765554443


Q ss_pred             HHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       272 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      +....                            ....+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus       249 ~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         249 LKEGH----------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHcCC----------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            32200                            001123467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-33  Score=260.39  Aligned_cols=211  Identities=24%  Similarity=0.345  Sum_probs=163.4

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------------ee-----
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------------YS-----  149 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------------~~-----  149 (395)
                      ++||.|+||.||+|.+.. ++.||+|.+...     .....+|+++++.++|+||.                 +.     
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            469999999999999877 999999987643     23456799999999999971                 00     


Q ss_pred             -----ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc---ccccc
Q 016085          150 -----RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYIC  221 (395)
Q Consensus       150 -----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~---~~~~g  221 (395)
                           .....++...+..++.|++.||.||| +.|++||||||+|||++.++ .++|+|||++.........   .....
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH-~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE-SKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceeccccCcc
Confidence                 11234677888899999999999999 88999999999999999887 6999999998765322111   11223


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      +..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.........+....                        
T Consensus       158 ~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~------------------------  212 (251)
T cd05041         158 PIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY------------------------  212 (251)
T ss_pred             eeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC------------------------
Confidence            56699999987654 8999999999999999998 889997766543333322100                        


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                          ....+..++..+.+|+.+||+.+|.+|||+.|+++
T Consensus       213 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         213 ----RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             ----CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                00112346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.3e-33  Score=262.99  Aligned_cols=218  Identities=28%  Similarity=0.380  Sum_probs=169.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCC---CcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEe--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY--------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~---~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~--------------  148 (395)
                      .+|.+.+.||+|+||.||+|.+...   ...||||......     ....+|+.+++.++|+|+..              
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~   85 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM   85 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence            4699999999999999999987644   3569999875432     24557999999999999810              


Q ss_pred             -----------e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          149 -----------S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       149 -----------~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                                 . .....+++..+..++.|++.||+||| +.|++||||||+||+++.++ .++|+|||+++........
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  163 (270)
T cd05056          86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE-SKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLEDESYY  163 (270)
T ss_pred             EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccChheEEEecCC-CeEEccCceeeecccccce
Confidence                       0 11235788889999999999999999 88999999999999999877 6999999998765433211


Q ss_pred             --ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          217 --ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       217 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                        ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+....                 
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-----------------  225 (270)
T cd05056         164 KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-----------------  225 (270)
T ss_pred             ecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence              122234679999988654 48999999999999999996 999998877655544432210                 


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                 ....+..++..+.+||.+||..+|.+|||+.+++.
T Consensus       226 -----------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         226 -----------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             -----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       00123447889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-33  Score=262.96  Aligned_cols=212  Identities=23%  Similarity=0.322  Sum_probs=160.4

Q ss_pred             eeeccCCceEEEEEEEcCCCc--EEEEEEeecc-----hhhHHHHHHHHHhc-CCCceEe-----------------ec-
Q 016085           97 RVVGQGSFGIVFQAKCLETGE--TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVHY-----------------SR-  150 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~--~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~ni~~-----------------~~-  150 (395)
                      +.||+|+||.||+|++..++.  .+|+|.+...     .....+|+.+++.+ +|+||..                 .. 
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999988776  4688877642     12345799999999 8999710                 00 


Q ss_pred             ------------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCC
Q 016085          151 ------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  206 (395)
Q Consensus       151 ------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~  206 (395)
                                              ....+++..+..++.|++.||+||| +.|++||||||+|||++.++ .+||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH-~~~i~H~dikp~nili~~~~-~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENY-VAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccccceEEEcCCC-eEEECCCCC
Confidence                                    0123678888999999999999999 88999999999999999887 699999999


Q ss_pred             ccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 016085          207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                      +..............+..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.+..+....+...          
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~----------  227 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----------  227 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC----------
Confidence            86432111111122356799999886644 8999999999999999997 99999876654443332110          


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                           +             ....+..++..+.+|+.+||+.||.+|||+.+++.
T Consensus       228 -----~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         228 -----Y-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -----C-------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                 0             00012236789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-33  Score=261.07  Aligned_cols=213  Identities=26%  Similarity=0.350  Sum_probs=166.4

Q ss_pred             eeeccCCceEEEEEEEcC-CCc--EEEEEEeecchh-----hHHHHHHHHHhcCCCceEee-------------------
Q 016085           97 RVVGQGSFGIVFQAKCLE-TGE--TVAIKKVLQDKR-----YKNRELQTMRLLDHPNVHYS-------------------  149 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~-~~~--~vAiK~~~~~~~-----~~~~E~~~l~~l~h~ni~~~-------------------  149 (395)
                      +.||+|+||.||+|.+.. .++  .||||.+.....     ...+|+.+++.++|+||...                   
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG   80 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence            468999999999999865 333  699999865433     45579999999999997100                   


Q ss_pred             -------ccC-CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC----cc
Q 016085          150 -------RAS-QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP----NI  217 (395)
Q Consensus       150 -------~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~----~~  217 (395)
                             ... ..+++..++.++.|++.||.||| +.|++||||||+||+++.++ .+||+|||+++.......    ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE-SKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH-hCCccccccCcccEEEecCC-EEEeccccccccccccccceeccc
Confidence                   011 35788889999999999999999 88999999999999999887 699999999987644221    11


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.....               .   
T Consensus       159 ~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------~---  219 (257)
T cd05040         159 HLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE---------------R---  219 (257)
T ss_pred             CCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------------c---
Confidence            234577899999986654 8999999999999999998 9999987776665555433100               0   


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                               ...+...+..+.+++.+||+.+|++|||+.++++
T Consensus       220 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 ---------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ---------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                     0012336789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-33  Score=264.03  Aligned_cols=220  Identities=24%  Similarity=0.307  Sum_probs=170.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      .+|.+.+.||+|+||.||+|+.+.     +.+.||+|.+....     ....+|+++++.++|+|+.             
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            469999999999999999999754     34679999875432     2356899999999999970             


Q ss_pred             -------------eeccCC---------CCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecC
Q 016085          148 -------------YSRASQ---------RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  205 (395)
Q Consensus       148 -------------~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG  205 (395)
                                   +.....         .+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH-~~~i~H~dlkp~Nili~~~~-~~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS-NARFVHRDLAARNCLVSSQR-EVKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh-hcCcccCcCccceEEEeCCC-cEEEcccc
Confidence                         001112         5789999999999999999999 88999999999999999887 59999999


Q ss_pred             CccccccCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 016085          206 SAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  282 (395)
Q Consensus       206 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  282 (395)
                      +++......  ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+......+..+...       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~-------  234 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG-------  234 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC-------
Confidence            987543221  122335577899999987654 7899999999999999998 88999776554443332210       


Q ss_pred             HHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                .          +.......++..+.+++.+||+.||++|||+.+++++
T Consensus       235 ----------~----------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 ----------K----------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             ----------C----------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                      0          0001223478899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-33  Score=266.34  Aligned_cols=225  Identities=20%  Similarity=0.273  Sum_probs=166.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcC----------------CCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLE----------------TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH--  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~----------------~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~--  147 (395)
                      ++|++.+.||+|+||.||+|++..                ++..||+|.+....     ....+|+.+++.++|+||.  
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            469999999999999999986542                34579999886432     3456799999999999971  


Q ss_pred             ---------------eec--------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE
Q 016085          148 ---------------YSR--------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV  192 (395)
Q Consensus       148 ---------------~~~--------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill  192 (395)
                                     +..                    ....+++..+..++.|++.||+||| +.||+||||||+|||+
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dlkp~Nili  163 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS-SLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH-HCCeecccCChheEEE
Confidence                           000                    0112456678999999999999999 8899999999999999


Q ss_pred             cCCCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHH
Q 016085          193 NPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL--GQPLFPGESGVD  267 (395)
Q Consensus       193 ~~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~  267 (395)
                      +.++ .++|+|||+++.......   .....++..|+|||...+.. ++.++|+|||||++|||++  |..||...+..+
T Consensus       164 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         164 GKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             cCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            9877 699999999976533221   11223357899999887654 8999999999999999998  778997766555


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       268 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      .+.........           .......          ..+...+..+.+|+.+||+.||.+||++.++++
T Consensus       242 ~~~~~~~~~~~-----------~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRD-----------QGRQVYL----------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhh-----------ccccccC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            44332221100           0000000          012336789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.9e-34  Score=265.07  Aligned_cols=210  Identities=20%  Similarity=0.295  Sum_probs=159.1

Q ss_pred             eeeccCCceEEEEEEEcCCCc-------EEEEEEeecch----hhHHHHHHHHHhcCCCceE------------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGE-------TVAIKKVLQDK----RYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~-------~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      +.||+|+||.||+|.+...+.       .||+|.+....    ....+|..+++.++|+|+.                  
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999998865544       48888875432    2345788999999999970                  


Q ss_pred             --------ee-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCc-------eEEeecCCccccc
Q 016085          148 --------YS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-------VKLCDFGSAKVLV  211 (395)
Q Consensus       148 --------~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~-------ikl~DFG~a~~~~  211 (395)
                              +. .....+++..+..++.||+.||+||| ++||+||||||+||+++.++..       ++++|||++....
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE-DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence                    01 11235788888999999999999999 8999999999999999876532       7999999986543


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          212 KGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      .   .....++..|+|||.+.+...++.++|||||||++|+|++|. .||...+...... +...               
T Consensus       160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~---------------  220 (258)
T cd05078         160 P---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED---------------  220 (258)
T ss_pred             C---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc---------------
Confidence            2   223467888999999976555899999999999999999984 6665544332221 1110               


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                        .            ..++...+.++.+||.+||+.||++|||+.++++.
T Consensus       221 --~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 --R------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             --c------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence              0            01222356789999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-33  Score=265.26  Aligned_cols=228  Identities=25%  Similarity=0.366  Sum_probs=166.0

Q ss_pred             ceeeeeeeccCCceEEEEEEE----cCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEee-------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKC----LETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHYS-------------  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~----~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~~-------------  149 (395)
                      -|++++.||+|+||.||+|+.    ..+++.||+|.+...     .....+|+.+++.++|+|+...             
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            489999999999999999974    457889999998633     2345689999999999997100             


Q ss_pred             ----------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          150 ----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       150 ----------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                      .....+++..+..++.|++.||+||| +.||+||||||+||+++.++ .++|+|||++......
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH-~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~  162 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETD  162 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccchheEEEcCCC-CEEECCCccccccccC
Confidence                            11124678888999999999999999 88999999999999999877 6999999999866433


Q ss_pred             CCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC----H-HHH
Q 016085          214 EPN----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT----R-EEI  284 (395)
Q Consensus       214 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~-~~~  284 (395)
                      ...    ....++..|+|||.+.+.. ++.++|||||||++|+|+++..|+.....  .   ..+..+...    . ...
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMT--L---FLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccc--h---hhhhcccccccccHHHHH
Confidence            221    1234567799999987654 89999999999999999998766533211  0   011111000    0 000


Q ss_pred             hhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ......             .....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         237 RVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            000000             0001233478999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-33  Score=261.70  Aligned_cols=210  Identities=18%  Similarity=0.221  Sum_probs=156.8

Q ss_pred             eeeccCCceEEEEEEEcC------------CCcEEEEEEeecch----hhHHHHHHHHHhcCCCceEe------------
Q 016085           97 RVVGQGSFGIVFQAKCLE------------TGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVHY------------  148 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~------------~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~~------------  148 (395)
                      +.||+|+||.||+|+...            ....||+|.+....    ....+|+.+++.++||||..            
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999997432            23358889875432    23456888999999999810            


Q ss_pred             ---------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC------ceEEeecCCc
Q 016085          149 ---------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH------QVKLCDFGSA  207 (395)
Q Consensus       149 ---------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~------~ikl~DFG~a  207 (395)
                                     ......+++..+..++.||+.||.||| +.||+||||||+|||++.++.      .++++|||++
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~  159 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE-DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP  159 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh-hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence                           012345788889999999999999999 889999999999999976542      2899999998


Q ss_pred             cccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 016085          208 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  286 (395)
                      ......   ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||.+....+.. .+..            
T Consensus       160 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~------------  223 (262)
T cd05077         160 ITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYE------------  223 (262)
T ss_pred             ccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHh------------
Confidence            654322   23457888999998865456899999999999999998 588888765432211 1111            


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                        ..+               ......+.++.+||.+||+.||.+||++.+++++
T Consensus       224 --~~~---------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         224 --GQC---------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             --cCc---------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence              000               0011235789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-33  Score=261.95  Aligned_cols=220  Identities=22%  Similarity=0.391  Sum_probs=170.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcC-CCcEEEEEEeecch--------------hhHHHHHHHHH-hcCCCceE--------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQDK--------------RYKNRELQTMR-LLDHPNVH--------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~~~~~~--------------~~~~~E~~~l~-~l~h~ni~--------  147 (395)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....              ....+|+.++. .++|+|+.        
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            38899999999999999999987 78899999874211              12335777665 47999971        


Q ss_pred             ---------e-------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecC
Q 016085          148 ---------Y-------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  205 (395)
Q Consensus       148 ---------~-------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG  205 (395)
                               +             ......+++..++.++.|++.||.|||+..|++||||||+||+++.++ .++|+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~dfg  159 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITDFG  159 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEeccc
Confidence                     0             012345788888999999999999999447899999999999999887 69999999


Q ss_pred             CccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 016085          206 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                      ++.............++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+.......+......+      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------  232 (269)
T cd08528         160 LAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP------  232 (269)
T ss_pred             ceeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc------
Confidence            998765443334566788999999997654 8999999999999999999999997665444433332211000      


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                           ......++.+.+||.+||+.||++||++.|+..+
T Consensus       233 ---------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 ---------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ---------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                 0112367899999999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.8e-33  Score=260.71  Aligned_cols=212  Identities=24%  Similarity=0.362  Sum_probs=157.6

Q ss_pred             eeeccCCceEEEEEEEcC---CCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe-----e--------------
Q 016085           97 RVVGQGSFGIVFQAKCLE---TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY-----S--------------  149 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~-----~--------------  149 (395)
                      +.||+|+||.||+|.+..   .+..||||.+...     .....+|+.+++.++|+|+..     .              
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998754   3457999987432     234457899999999999710     0              


Q ss_pred             ---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-----
Q 016085          150 ---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-----  215 (395)
Q Consensus       150 ---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-----  215 (395)
                               ..........+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||+++.......     
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA-SKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccCcceEEEcCCC-cEEECCccccccccCCcceeecc
Confidence                     01123455667788899999999999 88999999999999999887 699999999975532211     


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....++..|+|||.+.+.. ++.++|||||||++|||++ |.+||...+..+....+..  +.+               
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~--~~~---------------  220 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRR---------------  220 (262)
T ss_pred             cccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc--CCC---------------
Confidence            11233467899999987654 8999999999999999999 5677876554443332211  000               


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                        +         ..+...+..+.+++.+||..+|++||++.++++
T Consensus       221 --~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         221 --L---------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             --C---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              0         012235788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.1e-33  Score=257.33  Aligned_cols=211  Identities=23%  Similarity=0.362  Sum_probs=162.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------------e------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------------Y------  148 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------------~------  148 (395)
                      ++||+|+||.||+|.. .++..||+|.+....     ....+|+.+++.++|+|+.                 +      
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            3689999999999985 468899999876432     2345799999999999971                 0      


Q ss_pred             ----eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc--ccccc
Q 016085          149 ----SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--SYICS  222 (395)
Q Consensus       149 ----~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~--~~~gt  222 (395)
                          ......+.+..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++..........  ...++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLE-SKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccChheEEEcCCC-eEEECCCccceeccccccccCCCCCCc
Confidence                011234678888999999999999999 88999999999999999877 69999999987543322111  12335


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      ..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.........+....                         
T Consensus       158 ~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-------------------------  211 (250)
T cd05085         158 IKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-------------------------  211 (250)
T ss_pred             ccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence            6799999986644 8999999999999999998 999998776554433332100                         


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                         ....+..++..+.+|+.+||+.+|++||++.++++
T Consensus       212 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 ---RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence               00122346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=260.24  Aligned_cols=234  Identities=25%  Similarity=0.347  Sum_probs=177.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh-----hHHHHHH-HHHhcCCCce------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQ-TMRLLDHPNV------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~-~l~~l~h~ni------------------  146 (395)
                      .+.+-+..||.|+||+|++..++.+|+..|||.++....     .+..|.. +++.-+.|||                  
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            345556789999999999999999999999999864322     1223333 3444567776                  


Q ss_pred             ------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          147 ------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       147 ------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                  .+......++|..+-.+..-++.||+||-....|||||+||+||||+..| .|||||||+|....+.-
T Consensus       144 LMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  144 LMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLVDSI  222 (361)
T ss_pred             HHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHHHHH
Confidence                        22334566777777777778899999999888999999999999999988 59999999997766555


Q ss_pred             CcccccccccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCCHHHHhhcCCCCc
Q 016085          215 PNISYICSRYYRAPELIFGAT-EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPTREEIKCMNPNYT  292 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~  292 (395)
                      ..+.-.|-..|||||.+.... .|+.++|+||||++|||+.||..|+.+-+.  .+.++..+ .|-|+.-....      
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~------  294 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDK------  294 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCcc------
Confidence            455567778899999995443 389999999999999999999999977543  33333332 23333211000      


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                     -.-..+..+..||..||.+|-..||...+++++||+.....
T Consensus       295 ---------------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  295 ---------------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             ---------------cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence                           01126889999999999999999999999999999976543

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.9e-33  Score=274.28  Aligned_cols=222  Identities=24%  Similarity=0.363  Sum_probs=169.6

Q ss_pred             cccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhHHHHHHHHHhcC-CCceEee--------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVHYS--------  149 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~-h~ni~~~--------  149 (395)
                      ...+|.+.+.||+|+||.||+|++.     .+++.||+|++....     ....+|+.+|..+. |+||...        
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3457899999999999999999853     355789999986432     23457999999998 9998100        


Q ss_pred             ---------c----------------------------------------------------------------------
Q 016085          150 ---------R----------------------------------------------------------------------  150 (395)
Q Consensus       150 ---------~----------------------------------------------------------------------  150 (395)
                               .                                                                      
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence                     0                                                                      


Q ss_pred             -------------------------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc
Q 016085          151 -------------------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  193 (395)
Q Consensus       151 -------------------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~  193 (395)
                                                           ....+++..+..++.||+.||.||| +.||+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA-SKNCVHRDLAARNVLIC  273 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh-cCCcCcccCCcceEEEe
Confidence                                                 0012455667788999999999999 88999999999999999


Q ss_pred             CCCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016085          194 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQL  269 (395)
Q Consensus       194 ~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  269 (395)
                      .++ .+||+|||+++.......   .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||......+.+
T Consensus       274 ~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         274 EGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             CCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            876 699999999976533221   12345678899999997654 8999999999999999998 89999776555544


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          270 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       270 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ...+... .                          ....+..++.++.+||.+||..+|.+||++.++++.
T Consensus       352 ~~~~~~~-~--------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         352 YNAIKRG-Y--------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHcC-C--------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4333210 0                          001223468899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6e-33  Score=258.42  Aligned_cols=217  Identities=22%  Similarity=0.300  Sum_probs=158.0

Q ss_pred             eeeccCCceEEEEEEEcC--CCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEe-----------------e---
Q 016085           97 RVVGQGSFGIVFQAKCLE--TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY-----------------S---  149 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~--~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~-----------------~---  149 (395)
                      +.||+|+||.||+|....  ....+|+|.+....     ....+|+.+++.++|+||..                 .   
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999996543  34578999775332     23457899999999999810                 0   


Q ss_pred             ------c-----cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC---
Q 016085          150 ------R-----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---  215 (395)
Q Consensus       150 ------~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---  215 (395)
                            .     .....++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++........   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH-hcCEecccccHhheEecCCC-cEEEeccccccccccchheec
Confidence                  0     0112356677889999999999999 88999999999999999887 699999999865432211   


Q ss_pred             cccccccccccccccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          216 NISYICSRYYRAPELIFG------ATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      .....++..|+|||++..      ...++.++|||||||++|+|++ |..||......+.+..+.......         
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---------  229 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK---------  229 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc---------
Confidence            122344677999998742      2346889999999999999998 889998776655555443321100         


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                             .+       ...+...++..+.+++..|+ .||++|||+.++++
T Consensus       230 -------~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         230 -------LP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             -------CC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                   00       01123347888999999998 59999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.7e-33  Score=261.15  Aligned_cols=209  Identities=19%  Similarity=0.234  Sum_probs=157.1

Q ss_pred             eeccCCceEEEEEEEcCC------------------------CcEEEEEEeecch----hhHHHHHHHHHhcCCCceE--
Q 016085           98 VVGQGSFGIVFQAKCLET------------------------GETVAIKKVLQDK----RYKNRELQTMRLLDHPNVH--  147 (395)
Q Consensus        98 ~lG~G~fg~V~~a~~~~~------------------------~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~--  147 (395)
                      .||+|+||.||+|....+                        ...||+|.+....    ..+.+|+.+++.++|+||.  
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999974321                        2358899885432    2345688899999999981  


Q ss_pred             ------------------------ee-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC-----
Q 016085          148 ------------------------YS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-----  197 (395)
Q Consensus       148 ------------------------~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~-----  197 (395)
                                              +. .....+++..+..++.||+.||+||| +.||+||||||+|||++..+.     
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp~Nill~~~~~~~~~~  160 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE-DKNLVHGNVCAKNILLARLGLAEGTS  160 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-cCCccCCCCCcccEEEeccCcccCcc
Confidence                                    00 12356788889999999999999999 889999999999999975431     


Q ss_pred             -ceEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHH
Q 016085          198 -QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKV  275 (395)
Q Consensus       198 -~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~  275 (395)
                       .+||+|||++......   ....++..|+|||.+.+...++.++|||||||++|||+ +|+.||.+....+... ....
T Consensus       161 ~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~  236 (274)
T cd05076         161 PFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYEK  236 (274)
T ss_pred             ceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHHh
Confidence             3899999988654222   22356788999998876555899999999999999995 6999998765433222 1110


Q ss_pred             hCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .                 .            .++...++.+.+||.+||+.+|++|||+.+++++
T Consensus       237 ~-----------------~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         237 K-----------------H------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             c-----------------c------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            0                 0            0112245789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.6e-33  Score=257.19  Aligned_cols=209  Identities=20%  Similarity=0.213  Sum_probs=158.8

Q ss_pred             eeeccCCceEEEEEEEcCCC----------cEEEEEEeecch---hhHHHHHHHHHhcCCCceEe---------------
Q 016085           97 RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDK---RYKNRELQTMRLLDHPNVHY---------------  148 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~----------~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni~~---------------  148 (395)
                      +.||+|+||.||+|.+..++          ..|++|.+....   ....+|+.+++.++|+|+..               
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e   80 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE   80 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence            46899999999999998776          358888765433   34568999999999999810               


Q ss_pred             ----------ecc-CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC------ceEEeecCCccccc
Q 016085          149 ----------SRA-SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH------QVKLCDFGSAKVLV  211 (395)
Q Consensus       149 ----------~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~------~ikl~DFG~a~~~~  211 (395)
                                ... ...++...+..++.||+.||.||| +.||+||||||+|||++.++.      .+||+|||++....
T Consensus        81 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037          81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             cCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh-hCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence                      011 125788888999999999999999 889999999999999987651      39999999997654


Q ss_pred             cCCCcccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          212 KGEPNISYICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      .   .....++..|+|||.+.+. ..++.++|||||||++|+|++ |..||...+..........              .
T Consensus       160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~--------------~  222 (259)
T cd05037         160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD--------------Q  222 (259)
T ss_pred             c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc--------------C
Confidence            3   2234567789999998765 358999999999999999999 5788866543221111110              0


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                      ...+......+.+||.+||..+|.+|||+.++++
T Consensus       223 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 ----------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ----------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                            0001112378999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-33  Score=260.07  Aligned_cols=215  Identities=26%  Similarity=0.394  Sum_probs=166.1

Q ss_pred             eeeeeeccCCceEEEEEEEc----CCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           94 MAERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        94 ~~~~~lG~G~fg~V~~a~~~----~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .+.+.||.|.||.||+|...    ..+..|+||.+...     .....+|++.++.++|+||.                 
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            46789999999999999987    45678999999542     24456799999999999981                 


Q ss_pred             ---------eecc--CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          148 ---------YSRA--SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 ---------~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                               +...  ...++......++.||+.||.||| +.+|+|++|+++|||++.++ .+||+|||++.........
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh-~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH-SNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH-HTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccc-ccccccccccccccccccc
Confidence                     0111  357888999999999999999999 78999999999999999887 7999999999776322211


Q ss_pred             ---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          217 ---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       217 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                         ....+...|+|||.+.+.. ++.++||||||+++|||++ |+.||.+.+..+....+.+..                
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~----------------  222 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ----------------  222 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE----------------
T ss_pred             cccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc----------------
Confidence               2234577899999997655 8999999999999999999 789998887666555553210                


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                  ....+..++..+.++|.+||..||++|||+.++++
T Consensus       223 ------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  223 ------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                        00123346889999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-32  Score=255.39  Aligned_cols=217  Identities=20%  Similarity=0.243  Sum_probs=157.0

Q ss_pred             eeeccCCceEEEEEEEc--CCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEee-----------------c--
Q 016085           97 RVVGQGSFGIVFQAKCL--ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHYS-----------------R--  150 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~--~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~~-----------------~--  150 (395)
                      +.||+|+||.||+|...  .++..+|+|.+....     ....+|+.+++.++|+||...                 .  
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999764  355689999886432     244579999999999998100                 0  


Q ss_pred             ------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC---
Q 016085          151 ------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---  215 (395)
Q Consensus       151 ------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---  215 (395)
                                  .....+...+..++.|++.||+||| +.|++||||||+||+++.++ .+||+|||+++.......   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-KNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH-HCCEeccccCcceEEEcCCC-cEEECCccccccccCcceeec
Confidence                        0112345566788999999999999 88999999999999999877 699999999875432221   


Q ss_pred             cccccccccccccccccCCC------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          216 NISYICSRYYRAPELIFGAT------EYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      .....++..|+|||++.+..      .++.++|+|||||++|+|++ |+.||......+...........          
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------  228 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL----------  228 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC----------
Confidence            11234678899999885321      25789999999999999996 99999876654433322211000          


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                          .  .+       ...+....++.+.+++.+|+ .+|++|||+.+++.
T Consensus       229 ----~--~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 ----K--LP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ----C--CC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                0  00       00112235788999999998 68999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.1e-33  Score=257.66  Aligned_cols=213  Identities=23%  Similarity=0.356  Sum_probs=162.0

Q ss_pred             eeeccCCceEEEEEEEcCCC------cEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe-----------------
Q 016085           97 RVVGQGSFGIVFQAKCLETG------ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY-----------------  148 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~------~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~-----------------  148 (395)
                      +.||+|+||.||+|++....      +.||||.+...     .....+|+.+++.++|+||..                 
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999986544      68999987543     234457999999999999810                 


Q ss_pred             ec----------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC----CceEEeecCCcc
Q 016085          149 SR----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT----HQVKLCDFGSAK  208 (395)
Q Consensus       149 ~~----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~----~~ikl~DFG~a~  208 (395)
                      ..                ....+++..+..++.|++.||.||| +.|++|+||||+||+++.++    ..++|+|||+++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE-QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH-hCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            00                1123566778889999999999999 88999999999999998754    259999999987


Q ss_pred             ccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          209 VLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       209 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                      .......   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+... .       
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~-------  230 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G-------  230 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C-------
Confidence            6533221   11234467899999997654 8999999999999999998 99999876655443332110 0       


Q ss_pred             hhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                          ....+..++..+.+||.+||+.+|.+||++.++++
T Consensus       231 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 --------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             --------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                00122346789999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-33  Score=269.43  Aligned_cols=233  Identities=27%  Similarity=0.369  Sum_probs=167.2

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceE-----------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .+++|.-...||+|+||.||+|... ++..||||++....    ..+.+|+.++.+++|+|+.                 
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            3457888899999999999999864 44899999886432    4478999999999999981                 


Q ss_pred             -----------eeccCC-CCcHHHHHHHHHHHHHHHHHHHcCCC--eeeccCCCCceEEcCCCCceEEeecCCcccccc-
Q 016085          148 -----------YSRASQ-RMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  212 (395)
Q Consensus       148 -----------~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-  212 (395)
                                 +..... .++|.....|+.+++.||+|||..+.  |||||||++|||||.+. ..||+|||+|+.... 
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCcccCCcc
Confidence                       001112 77999999999999999999996453  99999999999999888 699999999977654 


Q ss_pred             CCCcccc-cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHH-HHhCCCCHHHHhhcC
Q 016085          213 GEPNISY-ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG--VDQLVEII-KVLGTPTREEIKCMN  288 (395)
Q Consensus       213 ~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~-~~~~~~~~~~~~~~~  288 (395)
                      ....... .||..|+|||.+... ..+.++|||||||+|.||+||+.+......  ...+.... ..+...         
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---------  300 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG---------  300 (361)
T ss_pred             ccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---------
Confidence            3222223 799999999999764 489999999999999999999988764321  11111111 111110         


Q ss_pred             CCCccccCCcccCCCcccccCC-CCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                       .+.++--+.+..    ..+.. ..-..+..+..+|++.+|.+||+..|++
T Consensus       301 -~~~eiiD~~l~~----~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv  346 (361)
T KOG1187|consen  301 -KLREIVDPRLKE----GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV  346 (361)
T ss_pred             -chhheeCCCccC----CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence             111111111110    00000 1123467888999999999999999874

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.3e-32  Score=272.81  Aligned_cols=239  Identities=22%  Similarity=0.304  Sum_probs=160.1

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEc----------------CCCcEEEEEEeecchh------------------hHHH
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCL----------------ETGETVAIKKVLQDKR------------------YKNR  133 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~----------------~~~~~vAiK~~~~~~~------------------~~~~  133 (395)
                      ...++|.+.++||+|+||.||+|.+.                ..++.||||.+.....                  ....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            34668999999999999999999752                3456799999854321                  1123


Q ss_pred             HHHHHHhcCCCce----------------------------Eeec-----------------------------------
Q 016085          134 ELQTMRLLDHPNV----------------------------HYSR-----------------------------------  150 (395)
Q Consensus       134 E~~~l~~l~h~ni----------------------------~~~~-----------------------------------  150 (395)
                      |+.++.+++|.++                            .+..                                   
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6666666766543                            0000                                   


Q ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccc--ccccccccc
Q 016085          151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--ICSRYYRAP  228 (395)
Q Consensus       151 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~--~gt~~y~aP  228 (395)
                      ....+++..++.++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||++.....+......  .+|+.|+||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH-~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            0012345667889999999999999 88999999999999999887 6999999999765433322222  347899999


Q ss_pred             ccccCCCC-------------------C--CCcchHHHHHHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 016085          229 ELIFGATE-------------------Y--TTAVDIWSVGCVLAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       229 E~~~~~~~-------------------~--~~~~DiwSlG~il~ell~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~  286 (395)
                      |.+.....                   |  ....|+||+||++|+|++|.. ||.+.......   .+... .....|+.
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~~-~~~~~~r~  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQYD-NDLNRWRM  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhcc-chHHHHHh
Confidence            98853210                   1  234799999999999999985 77543221111   01000 00011111


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCC---CCCCCHHHHhcCCccc
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP---NLRCTALEACIHPFFD  344 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP---~~R~t~~e~l~hp~f~  344 (395)
                      ...            ..+.-......++.+.||+.+||..+|   .+|+|+.|+|+||||.
T Consensus       456 ~~~------------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        456 YKG------------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             hcc------------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            000            000111223468999999999999876   6899999999999995

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-32  Score=256.16  Aligned_cols=231  Identities=26%  Similarity=0.359  Sum_probs=166.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEc----CCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEee------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHYS------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~~------------  149 (395)
                      .+|++.+.||+|+||.||+|+..    .+++.||+|.+....     ....+|+.+++.+.|+||...            
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            36889999999999999999864    357899999986543     345689999999999997100            


Q ss_pred             -----------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          150 -----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       150 -----------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                       .....+++..+..++.|++.||+||| +.||+||||||+||+++.++ .++|+|||++.....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~  161 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG-SQRYIHRDLAARNILVESED-LVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHhEEEcCCC-CEEEccccccccccc
Confidence                             00123677788899999999999999 88999999999999999887 699999999987653


Q ss_pred             CCCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCCHHHHh-h
Q 016085          213 GEPN----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPTREEIK-C  286 (395)
Q Consensus       213 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~-~  286 (395)
                      ....    ....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.........  +... .+......+. .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccHHHHHHH
Confidence            2221    1123456699999987654 899999999999999999999998654321100  0000 0000000000 0


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      +... .            ....+...+..+.+|+.+||+.+|.+|||+.++++
T Consensus       239 ~~~~-~------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         239 LKEG-E------------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHcC-C------------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000 0            00012235788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=264.62  Aligned_cols=238  Identities=26%  Similarity=0.410  Sum_probs=183.6

Q ss_pred             CCCccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----------hhHHHHHHHHHhcCCCce-------
Q 016085           85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNV-------  146 (395)
Q Consensus        85 ~~~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----------~~~~~E~~~l~~l~h~ni-------  146 (395)
                      ..+...++|-++++||+|||+.||+|.|....+.||+|+-.-++           ...-||.+|-+.|+|+.|       
T Consensus       457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf  536 (775)
T KOG1151|consen  457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF  536 (775)
T ss_pred             cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence            44556678999999999999999999999999999999742211           223479999999999998       


Q ss_pred             --------------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHc-CCCeeeccCCCCceEEcCC--CCceEEee
Q 016085          147 --------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNPH--THQVKLCD  203 (395)
Q Consensus       147 --------------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlKp~Nill~~~--~~~ikl~D  203 (395)
                                          .|+....-+++..++.|+-||+.||.||.. +..|||-||||.||||-..  ++.|||+|
T Consensus       537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence                                233455678999999999999999999994 3469999999999998432  23699999


Q ss_pred             cCCccccccCCC--------ccccccccccccccccc-C--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 016085          204 FGSAKVLVKGEP--------NISYICSRYYRAPELIF-G--ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEI  272 (395)
Q Consensus       204 FG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  272 (395)
                      ||+++.+.+...        +....||.+|++||.+. +  .+..+.++||||+|||+|.++.|+.||...-..   +.|
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---QdI  693 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---QDI  693 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---HHH
Confidence            999998754432        22467899999999884 3  345789999999999999999999999543322   122


Q ss_pred             HHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          273 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      +...-          -.+..++.||.-          +-++.++.+||++||++.-++|....++..||||.-
T Consensus       694 LqeNT----------IlkAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  694 LQENT----------ILKATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             Hhhhc----------hhcceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            22100          011123334332          237899999999999999999999999999999954

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.2e-33  Score=261.96  Aligned_cols=259  Identities=30%  Similarity=0.474  Sum_probs=189.6

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcC---CCcEEEEEEeec--chhhHHHHHHHHHhcC-CCce-----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQ--DKRYKNRELQTMRLLD-HPNV-----------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~--~~~~~~~E~~~l~~l~-h~ni-----------------  146 (395)
                      ...|+++++||.|.|++||+|.+..   .++.||+|.+..  .......|+++|..+. +.||                 
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl  114 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL  114 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence            3469999999999999999999887   788999998854  3455678999998874 3333                 


Q ss_pred             ------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc---------
Q 016085          147 ------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---------  211 (395)
Q Consensus       147 ------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~---------  211 (395)
                            .+..-...++...++.|++.++.||.++| ..|||||||||.|+|.+...+.-.|+|||+|....         
T Consensus       115 p~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h-~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~  193 (418)
T KOG1167|consen  115 PYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLH-KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSR  193 (418)
T ss_pred             cccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhh-ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhh
Confidence                  11111245678889999999999999999 89999999999999999988888999999987210         


Q ss_pred             --------c--CCC--------------------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh
Q 016085          212 --------K--GEP--------------------------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL  255 (395)
Q Consensus       212 --------~--~~~--------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~  255 (395)
                              .  +..                          .-...||++|+|||++...+..+.++||||.|||+.-+++
T Consensus       194 ~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls  273 (418)
T KOG1167|consen  194 SYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLS  273 (418)
T ss_pred             hhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhc
Confidence                    0  000                          0124689999999999888888999999999999999999


Q ss_pred             CCCCCC-CCCcHHHHHHHHHHhCCCCHHHHhhcCCC------------------CccccCCcccC-C---CcccccCCCC
Q 016085          256 GQPLFP-GESGVDQLVEIIKVLGTPTREEIKCMNPN------------------YTEFKFPQIKA-H---PWHKIFHKRM  312 (395)
Q Consensus       256 g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~-~---~~~~~~~~~~  312 (395)
                      ++.||- ..++.+.+.+|...+|.........+...                  |.......... .   .+......-.
T Consensus       274 ~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~  353 (418)
T KOG1167|consen  274 RRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVF  353 (418)
T ss_pred             cccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccc
Confidence            999974 45666677777766664332222111111                  11110000000 0   1222233345


Q ss_pred             ChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          313 PPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       313 s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      +..+.+||++||..||.+|.||+++|+||||......
T Consensus       354 ~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~  390 (418)
T KOG1167|consen  354 PALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT  390 (418)
T ss_pred             cHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence            5689999999999999999999999999999866543

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.5e-31  Score=249.26  Aligned_cols=216  Identities=21%  Similarity=0.304  Sum_probs=155.2

Q ss_pred             eeccCCceEEEEEEEcCC--CcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------------ee----
Q 016085           98 VVGQGSFGIVFQAKCLET--GETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------------YS----  149 (395)
Q Consensus        98 ~lG~G~fg~V~~a~~~~~--~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------------~~----  149 (395)
                      .||+|+||.||+|+....  ...+++|.+...     .....+|+.+++.++|+|+.                 +.    
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999975433  335677766533     23455788899999999981                 00    


Q ss_pred             -----c----cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC---Ccc
Q 016085          150 -----R----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNI  217 (395)
Q Consensus       150 -----~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~---~~~  217 (395)
                           .    .....++..++.++.||+.||+||| +.+|+||||||+|||++.++ .++|+|||++.......   ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-KHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH-HCCeeccCCccceEEEcCCc-cEEecccccccccCcchhhhccc
Confidence                 0    0123455567788999999999999 88999999999999999887 59999999986432211   112


Q ss_pred             cccccccccccccccCC------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          218 SYICSRYYRAPELIFGA------TEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ...++..|+|||++.+.      ..++.++|||||||++|||++ |..||...+..+.+..+......            
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------------  227 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV------------  227 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc------------
Confidence            34678899999987431      235789999999999999997 57888776665555554331110            


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                        ..         +...+...+++.+.+++..|| .+|.+||++.++++
T Consensus       228 --~~---------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         228 --KL---------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             --cc---------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence              00         001122336788999999999 68999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.1e-33  Score=278.54  Aligned_cols=215  Identities=25%  Similarity=0.344  Sum_probs=175.3

Q ss_pred             ceeeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE--------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      +-...+.||+|+||+||+|+...     ....||||.++...     ..++||+++|..|+|+||.              
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            45667899999999999998653     34579999987543     4567999999999999980              


Q ss_pred             ----------------------eeccCC----CCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEE
Q 016085          148 ----------------------YSRASQ----RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  201 (395)
Q Consensus       148 ----------------------~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl  201 (395)
                                            ......    .++..+...++.||+.|++||- ++.+|||||...|+||+++. .|||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs-~~~FVHRDLATRNCLVge~l-~VKI  644 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS-SHHFVHRDLATRNCLVGENL-VVKI  644 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCcccccchhhhhceeccce-EEEe
Confidence                                  011222    3788899999999999999999 88999999999999999887 6999


Q ss_pred             eecCCccccccCCCcc---cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 016085          202 CDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  277 (395)
Q Consensus       202 ~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  277 (395)
                      +|||+++.....+...   ...-...|||||.|+-.. ++..|||||+||+|||+++ |..||.|.++.+.+..|.+.. 
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~-  722 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ-  722 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC-
Confidence            9999998765443221   112256799999997655 9999999999999999996 999999999988888776510 


Q ss_pred             CCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHH
Q 016085          278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA  337 (395)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~  337 (395)
                                                . ..-+.+.|.++.+|+..||+.+|.+||++.||
T Consensus       723 --------------------------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  723 --------------------------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             --------------------------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence                                      0 12345689999999999999999999999987

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-32  Score=264.01  Aligned_cols=218  Identities=25%  Similarity=0.379  Sum_probs=170.0

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCc---E-EEEEEeecc-------hhhHHHHHHHHHhcCCCceE-------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGE---T-VAIKKVLQD-------KRYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~---~-vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      +-.+.++||+|+||.||+|+.+..+.   . ||+|..+.+       ...+-+|+++|+.++|+||.             
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            34556899999999999998875432   3 899987641       23344799999999999981             


Q ss_pred             -------------eeccCC-CCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 -------------YSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 -------------~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                   +.+... .++......++.+.+.||+||| ++++|||||-..|+|++.++ .+||+|||+++....-
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh-~k~~IHRDIAARNcL~~~~~-~vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH-SKNCIHRDIAARNCLYSKKG-VVKISDFGLSRAGSQY  315 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH-HCCCcchhHhHHHheecCCC-eEEeCccccccCCcce
Confidence                         122223 4888889999999999999999 89999999999999999876 5899999998765311


Q ss_pred             CCcc-cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          214 EPNI-SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       214 ~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      .... ...-...|+|||.+... .|+.++||||+||++||+++ |..||.+....+....|....               
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~---------------  379 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG---------------  379 (474)
T ss_pred             eeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC---------------
Confidence            1111 11235679999999765 59999999999999999998 889999998887777774411               


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                  +....+...+..+..++.+|+..||++|+|..++.+
T Consensus       380 ------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  380 ------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             ------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                        011123346889999999999999999999988753

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=6e-31  Score=239.22  Aligned_cols=213  Identities=39%  Similarity=0.640  Sum_probs=167.7

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE---------------e-----------ecc
Q 016085          103 SFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH---------------Y-----------SRA  151 (395)
Q Consensus       103 ~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~---------------~-----------~~~  151 (395)
                      +||.||+|.+..+++.||+|++...     .....+|+..++.++|+|+.               +           ...
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            6899999999888999999998643     34566899999999999970               0           011


Q ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccccccccccccc
Q 016085          152 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI  231 (395)
Q Consensus       152 ~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~  231 (395)
                      ...++...+..++.+++.++.||| +.||+|+||+|+||+++.++ .++|+|||.+.............++..|++||.+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLH-SNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHH-HcCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            122677888899999999999999 78999999999999999887 6999999999877554444556778899999998


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCC
Q 016085          232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR  311 (395)
Q Consensus       232 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (395)
                      .+.. ++.++|+||||+++++|++|..||........+...........                         ......
T Consensus       159 ~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~  212 (244)
T smart00220      159 LGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-------------------------PPPEWK  212 (244)
T ss_pred             ccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------------------------cccccc
Confidence            7544 78899999999999999999999977443333333222100000                         000111


Q ss_pred             CChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          312 MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       312 ~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ++..+.+++.+||..+|++||++.++++||||
T Consensus       213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      213 ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            67899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=275.22  Aligned_cols=218  Identities=21%  Similarity=0.360  Sum_probs=174.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCc-----EEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~-----~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ..-++.+.||+|.||.||.|.......     .||||.+.+.     ...+.+|..+|+.++||||.             
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            457788999999999999998764333     4999988654     34556899999999999981             


Q ss_pred             -------------eec-------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCc
Q 016085          148 -------------YSR-------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  207 (395)
Q Consensus       148 -------------~~~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a  207 (395)
                                   +++       ....+.......++.||++|++||+ ++++|||||...|+||+... .+||+|||+|
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe-~~~fvHRDLAaRNCLL~~~r-~VKIaDFGlA  849 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE-SKHFVHRDLAARNCLLDERR-VVKIADFGLA  849 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH-hCCCcCcchhhhheeecccC-cEEEcccchh
Confidence                         111       1345677788899999999999999 89999999999999999886 7999999999


Q ss_pred             cccccCCCccc-c--cccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 016085          208 KVLVKGEPNIS-Y--ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  283 (395)
Q Consensus       208 ~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  283 (395)
                      +.+...+.... .  .-...|||||.+.... ++.++|||||||+|||+++ |..||.+.++.+.+.-.++.-       
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-------  921 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-------  921 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-------
Confidence            95543332211 1  1145799999998755 9999999999999999997 899999988877766555421       


Q ss_pred             HhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          284 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                 ..          ..+..++..+.+++..||+.+|++||+...+++
T Consensus       922 -----------RL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 -----------RL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -----------cc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                       01          123458899999999999999999999998876

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=266.73  Aligned_cols=231  Identities=28%  Similarity=0.421  Sum_probs=187.1

Q ss_pred             CccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhc-CCCceE---------------
Q 016085           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVH---------------  147 (395)
Q Consensus        87 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l-~h~ni~---------------  147 (395)
                      +...+.|++.++||.|.||.||+++.+++++..|+|++...   ....+.|+++|+.+ .|||+.               
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            44456799999999999999999999999999999988644   34456788888877 678870               


Q ss_pred             ------------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          148 ------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       148 ------------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                        .-....++.|..+..+++.++.||.+|| +..++|||||-.|||++.++ .|||+|||.+..
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH-~nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH-NNKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  172 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh-hcceeeecccCceEEEeccC-cEEEeeeeeeee
Confidence                              0012678999999999999999999999 88999999999999999998 599999999866


Q ss_pred             cccC-CCcccccccccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          210 LVKG-EPNISYICSRYYRAPELIFGA----TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       210 ~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                      .... ....+.+|||+|||||++...    ..|+..+|+||||++..||--|.+|+-+..+...+..|..   .|+..  
T Consensus       173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPPk--  247 (953)
T KOG0587|consen  173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPK--  247 (953)
T ss_pred             eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCcc--
Confidence            5332 334567899999999999542    3478899999999999999999999988776655554432   22221  


Q ss_pred             hhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                                           ..-+.+-+.++.+||..||..|-++||+..++|+|||+.+
T Consensus       248 ---------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  248 ---------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             ---------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence                                 1113345789999999999999999999999999999974

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=256.68  Aligned_cols=214  Identities=33%  Similarity=0.493  Sum_probs=171.0

Q ss_pred             eeeeeeeccCCceEEEEEEEcCC--Cc--EEEEEEeecc-----hhhHHHHHHHHHhcCCCce-----------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLET--GE--TVAIKKVLQD-----KRYKNRELQTMRLLDHPNV-----------------  146 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~--~~--~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni-----------------  146 (395)
                      -++.++||.|.||.||.|.....  |+  -||||..+.+     .+.+..|.-+|+.++||||                 
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmE  470 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVME  470 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEe
Confidence            44557899999999999987532  33  4899988764     3455679999999999998                 


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                               .+......++......|++||+.||.||| +..+|||||...|||+.+.. .|||+|||+++...+.....
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe-SkrfVHRDIAaRNiLVsSp~-CVKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE-SKRFVHRDIAARNILVSSPQ-CVKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH-hhchhhhhhhhhheeecCcc-eeeecccchhhhccccchhh
Confidence                     11234567788888999999999999999 88999999999999999877 69999999999886665544


Q ss_pred             cccc--cccccccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          218 SYIC--SRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       218 ~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ...|  ..-|||||.+. -..++.++|||-|||.|||++ .|..||.|-.+.+.+..|.+.                   
T Consensus       549 aS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-------------------  608 (974)
T KOG4257|consen  549 ASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG-------------------  608 (974)
T ss_pred             ccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-------------------
Confidence            4444  45699999984 455999999999999999988 599999987665554433221                   


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHH
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA  337 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~  337 (395)
                               -+...++++++.+..|+.+||+++|.+||+..++
T Consensus       609 ---------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  609 ---------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             ---------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence                     0112466789999999999999999999998765

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=265.48  Aligned_cols=221  Identities=33%  Similarity=0.495  Sum_probs=165.1

Q ss_pred             eeeeeeeccCCceE-EEEEEEcCCCcEEEEEEeecchh-hHHHHHHHHHhc-CCCceEee--------------------
Q 016085           93 YMAERVVGQGSFGI-VFQAKCLETGETVAIKKVLQDKR-YKNRELQTMRLL-DHPNVHYS--------------------  149 (395)
Q Consensus        93 y~~~~~lG~G~fg~-V~~a~~~~~~~~vAiK~~~~~~~-~~~~E~~~l~~l-~h~ni~~~--------------------  149 (395)
                      |.-.+++|.|+-|+ ||+|..  .|+.||||.+..+.. ..+||+..|+.- +|+||...                    
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~s  588 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACS  588 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhh
Confidence            44557899999986 699986  789999999877654 778999999877 69998111                    


Q ss_pred             -----ccC----CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC---CC-CceEEeecCCccccccCCCc
Q 016085          150 -----RAS----QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HT-HQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       150 -----~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~---~~-~~ikl~DFG~a~~~~~~~~~  216 (395)
                           ...    ........+.+..|++.||++|| +.+||||||||.||||+.   ++ -+++|+|||+|+....+...
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH-sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS  667 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH-SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS  667 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHH-hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence                 110    00111345778899999999999 899999999999999976   23 36999999999998655432


Q ss_pred             ----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          217 ----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       217 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                          ....||-+|+|||++.... -+.++||+||||++|+.++| ..||.+.-  +.-.+|+.              .++
T Consensus       668 ~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~--------------~~~  730 (903)
T KOG1027|consen  668 FSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILT--------------GNY  730 (903)
T ss_pred             hhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--Hhhhhhhc--------------Ccc
Confidence                2346799999999997655 67899999999999999986 89995432  22223322              111


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      .-...            .+....++.|||.+||+++|..||+|.++|.||||-.
T Consensus       731 ~L~~L------------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  731 TLVHL------------EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             ceeee------------ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            11111            1111228999999999999999999999999999964

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=255.04  Aligned_cols=223  Identities=24%  Similarity=0.316  Sum_probs=177.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCC-Cc--EEEEEEeecc-----hhhHHHHHHHHHhcCCCceEee------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLET-GE--TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHYS------------  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~-~~--~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~~------------  149 (395)
                      .++-++.++||+|.||.|++|.+... |+  .||||.++.+     ...+.+|+.+|.+|+|+|+..+            
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV  188 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMV  188 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHH
Confidence            34577889999999999999988643 33  5899998654     3456799999999999997211            


Q ss_pred             ---------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          150 ---------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       150 ---------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                     .....+.......|+.||+.|+.||. .+++|||||...|+||-... .|||+|||+.+....++
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe-skrlvHRDLAARNlllaspr-tVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE-SKRLVHRDLAARNLLLASPR-TVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhhhheecccc-eeeeecccceeccCCCC
Confidence                           12344566667789999999999999 88999999999999998766 79999999999887776


Q ss_pred             Ccccccc----cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          215 PNISYIC----SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       215 ~~~~~~g----t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      .......    ...|.|||.+.... ++.++|+|++||++|||++ |+.||.|....+.+.+|-+.-.            
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er------------  333 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER------------  333 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc------------
Confidence            5443222    45699999997654 9999999999999999996 8999999998887777643100            


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                                      ..-++.+++++.+++..||+.+|++|||+..|...-+.
T Consensus       334 ----------------LpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  334 ----------------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             ----------------CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence                            01245589999999999999999999999887644343

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=222.52  Aligned_cols=186  Identities=25%  Similarity=0.452  Sum_probs=146.1

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh-----hHHHHHHHH-HhcCCCce---------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTM-RLLDHPNV---------------  146 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~~l-~~l~h~ni---------------  146 (395)
                      ...+....+..||+|+||.|-+.++..+|...|+|.+.....     ...+|+.+. +...+|.+               
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            333456666789999999999999999999999998864322     222344433 23345554               


Q ss_pred             --------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          147 --------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       147 --------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                    ......+.++|..+-+++..++.||.|||++..+||||+||+|||||.+| ++|+||||++....+
T Consensus       123 cME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  123 CMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLVD  201 (282)
T ss_pred             eHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccceeehh
Confidence                          12345678899999999999999999999888999999999999999998 699999999987655


Q ss_pred             CCCccccccccccccccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHH
Q 016085          213 GEPNISYICSRYYRAPELIF---GATEYTTAVDIWSVGCVLAELLLGQPLFPG-ESGVDQLVEIIK  274 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~  274 (395)
                      .-..+-..|-..|||||.+.   .+..|+.++||||||+++.||.+++.||.. .++.+++.++.+
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            54434355667799999984   233589999999999999999999999964 667777777765

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.8e-30  Score=246.54  Aligned_cols=214  Identities=24%  Similarity=0.385  Sum_probs=169.1

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCce------------Eeec------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNV------------HYSR------  150 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni------------~~~~------  150 (395)
                      +....++||.|.||.||.+.+++-...||||.++.+.   ..+..|..+|+.++|||+            .|+.      
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y  347 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY  347 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence            3455679999999999999999999999999998764   455689999999999997            1111      


Q ss_pred             ----------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccccc
Q 016085          151 ----------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI  220 (395)
Q Consensus       151 ----------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~  220 (395)
                                ....++......++.||..|++||. .+++|||||...|+|+.++. .||++|||+++.+..+ ..+...
T Consensus       348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE-kknFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgD-TYTAHA  424 (1157)
T KOG4278|consen  348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENH-IVKVADFGLSRLMTGD-TYTAHA  424 (1157)
T ss_pred             ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH-Hhhhhhhhhhhhhccccccc-eEEeeccchhhhhcCC-ceeccc
Confidence                      1223444556678899999999999 88999999999999999765 8999999999987543 333444


Q ss_pred             c---cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          221 C---SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       221 g---t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      |   ..-|.|||.+.-.. ++.++|||+|||+|||+.| |..||+|.+..+.+..+.+-                  +..
T Consensus       425 GAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg------------------yRM  485 (1157)
T KOG4278|consen  425 GAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG------------------YRM  485 (1157)
T ss_pred             CccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc------------------ccc
Confidence            4   45699999885444 8999999999999999996 99999998755444333221                  111


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHH
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA  337 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~  337 (395)
                                .-+..+++.+.+|++.||+|+|.+||+.+|+
T Consensus       486 ----------~~PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  486 ----------DGPEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             ----------cCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence                      1245589999999999999999999999876

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-29  Score=241.11  Aligned_cols=223  Identities=22%  Similarity=0.277  Sum_probs=172.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEee----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHYS----------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~~----------------  149 (395)
                      ..-.+.++||+|-||.|.++.- ..+..||+|.++..     ...+.+|+++|.+|+||||...                
T Consensus       538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            3578889999999999999984 44789999998754     2456689999999999998111                


Q ss_pred             ----------ccC--CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          150 ----------RAS--QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       150 ----------~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                                ...  ....-.....++.||+.|++||. +.++|||||.+.|+|++.+. .+||+|||.++....+....
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe-s~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE-SLNFVHRDLATRNCLVDGEF-TIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH-hhchhhccccccceeecCcc-cEEecCcccccccccCCcee
Confidence                      111  11122334558999999999999 89999999999999999998 59999999998765544322


Q ss_pred             ---cccccccccccccccCCCCCCCcchHHHHHHHHHHHH--hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          218 ---SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL--LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       218 ---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                         ..+-...|||+|.++-.+ ++.++|+|++|++|||++  +...||...++.+.+.+....+..+.....        
T Consensus       695 vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~--------  765 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV--------  765 (807)
T ss_pred             eecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee--------
Confidence               223367899999997655 999999999999999986  688999888877776666554433332110        


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                                   ...+.-++..+.+||.+||.+|-++||+.+++-
T Consensus       766 -------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  766 -------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             -------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence                         112344788999999999999999999999874

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=258.86  Aligned_cols=218  Identities=27%  Similarity=0.373  Sum_probs=182.4

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCc---EEEEEEeecc-----hhhHHHHHHHHHhcCCCceE---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~---~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      ..-+|.++||.|.||.|++|+.+..|+   .||||.++..     ...+..|+.||-+++||||.               
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            356788999999999999999886664   6999999754     34455799999999999981               


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                  +....+.+...+...+++.|+.|++||- +.|+|||||...|||+|++- ..|++|||+++...++..
T Consensus       709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs-dm~YVHRDLAARNILVNsnL-vCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS-DMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh-hcCchhhhhhhhheeeccce-EEEeccccceeecccCCC
Confidence                        2234456788888899999999999999 89999999999999999988 799999999998755542


Q ss_pred             -cccccc---cccccccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          216 -NISYIC---SRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       216 -~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                       ..+..|   ...|.|||.+.-. .++.++|+||+|++|||.+ .|..||.+.++.+.+..|.+-.+.|++         
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---------  856 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---------  856 (996)
T ss_pred             ccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC---------
Confidence             222222   4679999999654 4999999999999999988 599999999999999999876555543         


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                         .++|..+..|+.-||++|-.+||+..++++
T Consensus       857 -------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  857 -------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             -------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                               347899999999999999999999999876

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=4.5e-29  Score=271.96  Aligned_cols=231  Identities=21%  Similarity=0.299  Sum_probs=161.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceEe---------------ec-c----
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHY---------------SR-A----  151 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~~---------------~~-~----  151 (395)
                      .|...++||+|+||.||+|++..++..||||.+.........|+.+++.++||||..               .. .    
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L  770 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL  770 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence            467778999999999999999999999999998765555567899999999999810               00 0    


Q ss_pred             ---CCCCcHHHHHHHHHHHHHHHHHHHc--CCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccccccccccc
Q 016085          152 ---SQRMPLIYVKLYTYQICRALAYIHG--GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR  226 (395)
Q Consensus       152 ---~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~  226 (395)
                         -..+++..+..++.|++.||+|||.  +.+|+||||||+||+++.++ ..++. ||.......   .....+|+.|+
T Consensus       771 ~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~---~~~~~~t~~y~  845 (968)
T PLN00113        771 SEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT---DTKCFISSAYV  845 (968)
T ss_pred             HHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-ecccccccc---CCCcccccccc
Confidence               1236778889999999999999993  24899999999999999776 46654 665543321   12346789999


Q ss_pred             ccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcc
Q 016085          227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH  305 (395)
Q Consensus       227 aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (395)
                      |||++.+.. ++.++|||||||++|||+||+.||...... ..+....+......         ....+..+.....   
T Consensus       846 aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~---  912 (968)
T PLN00113        846 APETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC---------HLDMWIDPSIRGD---  912 (968)
T ss_pred             CcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc---------chhheeCccccCC---
Confidence            999987654 999999999999999999999999542211 11111111100000         0000000000000   


Q ss_pred             cccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          306 KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       306 ~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .........++.+++.+||+.||++|||+.|+++.
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            00011123467889999999999999999999854

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-30  Score=251.55  Aligned_cols=230  Identities=27%  Similarity=0.368  Sum_probs=187.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCce-------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNV-------------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni-------------------  146 (395)
                      .++|.++..+|.|.||.||+|+|+.+++..|+|+++-.    ....+.|+-+++..+|+||                   
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            35799999999999999999999999999999998743    3456789999999999998                   


Q ss_pred             -------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCccc
Q 016085          147 -------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNIS  218 (395)
Q Consensus       147 -------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~  218 (395)
                             ......+.+++.++..++.+.+.+|+||| +.|-+|||||-.|||++..+ .+|++|||.+..+... ....+
T Consensus        94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylh-s~gk~hRdiKGanilltd~g-DvklaDfgvsaqitati~Krks  171 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH-SQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITATIAKRKS  171 (829)
T ss_pred             cCCCcccceeeecccchhHHHHHHHhhhhccchhhh-cCCcccccccccceeecccC-ceeecccCchhhhhhhhhhhhc
Confidence                   23345678999999999999999999999 88999999999999999988 5999999997655322 33457


Q ss_pred             cccccccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          219 YICSRYYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      +.||++|||||+..  .+..|...+|||++|++..|+---++|-.+......+..+.+..-.|+.              .
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~--------------l  237 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT--------------L  237 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc--------------c
Confidence            89999999999872  2345899999999999999998888887665555555554443222221              1


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      .          -...-++.+-+|++.+|..+|++|||+..+|.|||...
T Consensus       238 k----------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  238 K----------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             c----------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            1          11234778999999999999999999999999999864

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=243.62  Aligned_cols=173  Identities=28%  Similarity=0.437  Sum_probs=151.8

Q ss_pred             CCccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhH------------HHHHHHHHhcC---CCce----
Q 016085           86 QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK------------NRELQTMRLLD---HPNV----  146 (395)
Q Consensus        86 ~~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~------------~~E~~~l~~l~---h~ni----  146 (395)
                      ......+|...+.||.|+||.|++|.++++...|+||.+.+++-..            --|+.||..|+   |+||    
T Consensus       556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL  635 (772)
T KOG1152|consen  556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL  635 (772)
T ss_pred             eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence            3445567999999999999999999999999999999987765332            25999999998   9998    


Q ss_pred             -----------------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEee
Q 016085          147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  203 (395)
Q Consensus       147 -----------------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~D  203 (395)
                                             .++....++.|..+..++.|+..|+++|| +.||||||||-+|+.++.+| .+||+|
T Consensus       636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh-~~~ivhrdikdenvivd~~g-~~klid  713 (772)
T KOG1152|consen  636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH-DQGIVHRDIKDENVIVDSNG-FVKLID  713 (772)
T ss_pred             heeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc-ccCceecccccccEEEecCC-eEEEee
Confidence                                   23445678999999999999999999999 89999999999999999999 599999


Q ss_pred             cCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 016085          204 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFP  261 (395)
Q Consensus       204 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  261 (395)
                      ||.|.... ..+...++||..|.|||++.|.++.+..-|||+||++||.++....||.
T Consensus       714 fgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99987654 3455678999999999999998888999999999999999999999985

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.5e-28  Score=226.83  Aligned_cols=224  Identities=24%  Similarity=0.345  Sum_probs=158.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-hhhHHHHHHHHH--hcCCCce---------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMR--LLDHPNV---------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~--~l~h~ni---------------------  146 (395)
                      .+-.+.+.||+|-||.||+|+.  .|+.||||++... .....||.+|.+  .|+|+||                     
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT  288 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT  288 (513)
T ss_pred             heeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence            4688999999999999999988  6899999999654 344456777775  5799998                     


Q ss_pred             Eee--------ccCCCCcHHHHHHHHHHHHHHHHHHHc-------CCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          147 HYS--------RASQRMPLIYVKLYTYQICRALAYIHG-------GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       147 ~~~--------~~~~~~~~~~~~~~~~qi~~aL~~LH~-------~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                      .|.        .....++...+..++..++.||++||.       +..|.|||||..|||+.+++ ..-|+|+|+|-...
T Consensus       289 dYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLGLAv~h~  367 (513)
T KOG2052|consen  289 DYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHD  367 (513)
T ss_pred             ecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeeceeeEEec
Confidence            111        123567788889999999999999992       34599999999999999988 69999999997654


Q ss_pred             cCC-----CcccccccccccccccccCCCCC----C-CcchHHHHHHHHHHHHhC----------CCCCCCCCc----HH
Q 016085          212 KGE-----PNISYICSRYYRAPELIFGATEY----T-TAVDIWSVGCVLAELLLG----------QPLFPGESG----VD  267 (395)
Q Consensus       212 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~----~-~~~DiwSlG~il~ell~g----------~~pf~~~~~----~~  267 (395)
                      ...     .....+||..|||||++-...+.    + ..+||||||.++||+..+          ++||.+-.+    .+
T Consensus       368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e  447 (513)
T KOG2052|consen  368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE  447 (513)
T ss_pred             ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence            432     23457899999999999543221    1 259999999999999853          477765322    12


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       268 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                      .+.+++-.                 ....|.++ ..|.   ....-..+..|++.||..||.-|.||..+.
T Consensus       448 eMrkVVCv-----------------~~~RP~ip-nrW~---s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  448 EMRKVVCV-----------------QKLRPNIP-NRWK---SDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             HHhcceee-----------------cccCCCCC-cccc---cCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence            22221110                 00011110 1111   111123567899999999999999997765

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-28  Score=230.57  Aligned_cols=236  Identities=25%  Similarity=0.318  Sum_probs=164.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeec-chhhHHHHHHHHHh--cCCCceE--------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKNRELQTMRL--LDHPNVH--------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~-~~~~~~~E~~~l~~--l~h~ni~--------------------  147 (395)
                      ..-.+.++||+|.||.||+|+.  +++.||||++.. ++.....|.+|.+.  ++|+||.                    
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            3467788999999999999987  669999999864 45566677777765  6899981                    


Q ss_pred             -e--------eccCCCCcHHHHHHHHHHHHHHHHHHHc--------CCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          148 -Y--------SRASQRMPLIYVKLYTYQICRALAYIHG--------GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       148 -~--------~~~~~~~~~~~~~~~~~qi~~aL~~LH~--------~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                       +        ......+++....+++..+++||+|||.        +..|+|||||..||||..+. ...|+|||+|..+
T Consensus       288 ~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGLAl~~  366 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGLALRL  366 (534)
T ss_pred             eeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccceeEEe
Confidence             0        0123456777888999999999999994        23699999999999999888 6999999999887


Q ss_pred             ccCC---CcccccccccccccccccCCCCCC-----CcchHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCCH
Q 016085          211 VKGE---PNISYICSRYYRAPELIFGATEYT-----TAVDIWSVGCVLAELLLGQPLFP-GESGVDQLVEIIKVLGTPTR  281 (395)
Q Consensus       211 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwSlG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~  281 (395)
                      ..+.   +....+||..|||||++.|..++.     .+.||||+|.+||||+++-.-+. +..+..++---.++...|+.
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            5443   234578999999999997765554     47999999999999998754432 33222222211222333444


Q ss_pred             HHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHH
Q 016085          282 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL  335 (395)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~  335 (395)
                      +.+...-..  ....|.++. .|..   ..-..-+.+.+.-||..||+-|+||.
T Consensus       447 e~mq~~VV~--kK~RP~~p~-~W~~---h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  447 EEMQELVVR--KKQRPKIPD-AWRK---HAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HHHHHHHHh--hccCCCChh-hhhc---CccHHHHHHHHHHHcCCchhhhhhhH
Confidence            433321100  011111111 1111   11245688999999999999999985

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-27  Score=235.76  Aligned_cols=215  Identities=26%  Similarity=0.345  Sum_probs=167.4

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCc----EEEEEEeecc-----hhhHHHHHHHHHhcCCCce-----------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNV-----------------  146 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni-----------------  146 (395)
                      .+..++||+|+||+||+|...-.|+    +||||++...     ...+.+|+-+|..|+|+|+                 
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq  777 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQ  777 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHH
Confidence            5667899999999999998765454    6899987543     3345579999999999997                 


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                               .......++.......|..||++|+.||| .++++||||-..|||+.+-. .+||+|||+|+.........
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe-~qrlVHrdLaaRNVLVksP~-hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE-EQRLVHRDLAARNVLVKSPN-HVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-hcchhhhhhhhhheeecCCC-eEEEEecchhhccCcccccc
Confidence                     12234456677778889999999999999 88999999999999999877 49999999999876555433


Q ss_pred             cccc---cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          218 SYIC---SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       218 ~~~g---t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      ...+   .+-|||-|.+.-. .|+.++||||+||++||++| |..|+.+....+.-..+.+-    .            .
T Consensus       856 ~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g----e------------R  918 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG----E------------R  918 (1177)
T ss_pred             cccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc----c------------c
Confidence            3322   5669999998654 49999999999999999996 99999887654432222110    0            0


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                      .            .-++..+.++.-++.+||..|+..||++.++-
T Consensus       919 L------------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  919 L------------SQPPICTIDVYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             C------------CCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence            0            12344788999999999999999999998764

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.1e-27  Score=255.13  Aligned_cols=164  Identities=18%  Similarity=0.219  Sum_probs=119.9

Q ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC------------------CceEEeecCCccccccC
Q 016085          152 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT------------------HQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       152 ~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~------------------~~ikl~DFG~a~~~~~~  213 (395)
                      ...+++..++.++.||+.||.||| ++||+||||||+||||+..+                  ..+||+|||+++.....
T Consensus        74 ~~~~~~~~~~~i~~qi~~al~~lH-~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~  152 (793)
T PLN00181         74 DRSVDAFECFHVFRQIVEIVNAAH-SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEIL  152 (793)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHH-hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccc
Confidence            345899999999999999999999 89999999999999996432                  24667777776542110


Q ss_pred             C-----------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 016085          214 E-----------------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL  276 (395)
Q Consensus       214 ~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  276 (395)
                      .                 .....+||+.|||||++.+.. |+.++|||||||+||||++|.+|+....  ..+..+... 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~-  228 (793)
T PLN00181        153 SERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR-  228 (793)
T ss_pred             cccchhhhhccccCCCcccccccCCCcceEChhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh-
Confidence            0                 001245789999999998765 8999999999999999999998875321  111111110 


Q ss_pred             CCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      ..|+.                          . ....+...+++.+||++||.+||++.|+++||||....
T Consensus       229 ~~~~~--------------------------~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        229 VLPPQ--------------------------I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             hcChh--------------------------h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            00000                          0 00134567899999999999999999999999998753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2e-27  Score=207.20  Aligned_cols=156  Identities=22%  Similarity=0.183  Sum_probs=118.5

Q ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccccccccccccc
Q 016085          152 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI  231 (395)
Q Consensus       152 ~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~  231 (395)
                      ...+++..++.++.||+.||.||| +.+      ||+|||++.++ .+|+  ||+++.....    ...||+.|+|||++
T Consensus        11 ~~~l~~~~~~~i~~qi~~~L~~lH-~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~~~g~~~y~aPE~~   76 (176)
T smart00750       11 GRPLNEEEIWAVCLQCLRALRELH-RQA------KSGNILLTWDG-LLKL--DGSVAFKTPE----QSRVDPYFMAPEVI   76 (176)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHH-hcC------CcccEeEcCcc-ceee--ccceEeeccc----cCCCcccccChHHh
Confidence            346899999999999999999999 666      99999999887 5888  9999765332    23689999999999


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCC
Q 016085          232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK  310 (395)
Q Consensus       232 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (395)
                      .+.. ++.++|||||||++|||++|+.||....... .+..+.........            ..          .....
T Consensus        77 ~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~----------~~~~~  133 (176)
T smart00750       77 QGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP------------RD----------RSNLE  133 (176)
T ss_pred             cCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc------------cc----------cccHH
Confidence            7755 8999999999999999999999997654332 22222221100000            00          00011


Q ss_pred             CCCh--hHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          311 RMPP--EAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       311 ~~s~--~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                      .++.  .+.+||.+||..||.+|||+.++++|+|+.
T Consensus       134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            1233  699999999999999999999999999975

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.8e-28  Score=214.34  Aligned_cols=230  Identities=23%  Similarity=0.305  Sum_probs=162.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhc-CCCce--------------Eee---
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNV--------------HYS---  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l-~h~ni--------------~~~---  149 (395)
                      +.|.|.+.||.|-||++.+|+++.++..+++|.+.+..   ..+.+|..---.| .|.||              .+.   
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            36999999999999999999999999999999886543   3344555433333 35555              111   


Q ss_pred             ---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE-cCCCCceEEeecCCccccccCCCcccc
Q 016085          150 ---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISY  219 (395)
Q Consensus       150 ---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill-~~~~~~ikl~DFG~a~~~~~~~~~~~~  219 (395)
                               .....+.+...+.++.|+++|++||| ++++||||||.+|||| +.+..+|||||||..+.....-  ...
T Consensus       104 aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMH-sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV--~~~  180 (378)
T KOG1345|consen  104 APRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMH-SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV--KYL  180 (378)
T ss_pred             CccchhhhhcCcccccHHHHHHHHHHHHHHHHHhh-ccchhhcccccceEEEecCCccEEEeeecccccccCcee--hhh
Confidence                     11245677888999999999999999 8899999999999998 5555589999999986642211  112


Q ss_pred             cccccccccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          220 ICSRYYRAPELIFGAT----EYTTAVDIWSVGCVLAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      --+..|.+||.+....    ...+.+|+|.||+++|.++||.+||......+ ...+.++..+.-..             
T Consensus       181 ~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-------------  247 (378)
T KOG1345|consen  181 EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-------------  247 (378)
T ss_pred             hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-------------
Confidence            2256699999874322    24778999999999999999999997433222 22333333222111             


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCC---CCHHHHhcCCcccC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR---CTALEACIHPFFDE  345 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R---~t~~e~l~hp~f~~  345 (395)
                      ..|        . ....+++.+..+.++-|..+|++|   .+++...+..|...
T Consensus       248 ~~P--------~-~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  248 ALP--------K-KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             cCc--------h-hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            001        0 112368999999999999999999   56666666677644

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.94  E-value=1.4e-27  Score=244.05  Aligned_cols=220  Identities=29%  Similarity=0.496  Sum_probs=171.3

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCce-----EeeccCCCCcHHHHHHH
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV-----HYSRASQRMPLIYVKLY  163 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni-----~~~~~~~~~~~~~~~~~  163 (395)
                      .-.+|..++.|-.|+||.||+++++.+.+.+|+|+ .++.-...+   ++.....|.+     ......+.++..     
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilRn---ilt~a~npfvvgDc~tllk~~g~lPvd-----  151 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILRN---ILTFAGNPFVVGDCATLLKNIGPLPVD-----  151 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhhc---cccccCCcceechhhhhcccCCCCcch-----
Confidence            34579999999999999999999999999999954 333222211   5555566655     222233344433     


Q ss_pred             HHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC----------------cccccccccccc
Q 016085          164 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP----------------NISYICSRYYRA  227 (395)
Q Consensus       164 ~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~----------------~~~~~gt~~y~a  227 (395)
                         ++.+++||| +.||+|||+||+|++|..-|+ +|++|||+.+.......                ....+|||.|+|
T Consensus       152 ---mvla~Eylh-~ygivhrdlkpdnllIT~mGh-iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyia  226 (1205)
T KOG0606|consen  152 ---MVLAVEYLH-SYGIVHRDLKPDNLLITSMGH-IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIA  226 (1205)
T ss_pred             ---hhHHhHhhc-cCCeecCCCCCCcceeeeccc-ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccC
Confidence               378999999 999999999999999999985 99999999876532211                123578999999


Q ss_pred             cccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccc
Q 016085          228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI  307 (395)
Q Consensus       228 PE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (395)
                      ||++..+. |+..+|||++|+|+||.+-|..||.|.+.++.+..++.-.                 +.++.        .
T Consensus       227 PeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-----------------i~wpE--------~  280 (1205)
T KOG0606|consen  227 PEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-----------------IEWPE--------E  280 (1205)
T ss_pred             hhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh-----------------ccccc--------c
Confidence            99998755 9999999999999999999999999999988887776521                 11111        1


Q ss_pred             cCCCCChhHHHHHHhhccCCCCCCC---CHHHHhcCCcccCCCCC
Q 016085          308 FHKRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFFDELRDP  349 (395)
Q Consensus       308 ~~~~~s~~~~~ll~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~  349 (395)
                       ...++++++++|.++|+.+|..|.   .+.++.+|+||+.+.|.
T Consensus       281 -dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  281 -DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             -CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence             123689999999999999999996   46688999999999886

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-26  Score=236.81  Aligned_cols=216  Identities=27%  Similarity=0.440  Sum_probs=162.4

Q ss_pred             eeeeeeeccCCceEEEEEEEcC-------CCcEEEEEEeecc-----hhhHHHHHHHHHhc-CCCce-------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNV-------------  146 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~-------~~~~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~ni-------------  146 (395)
                      ..+.+.||+|.||.|++|....       ....||||.++..     ......|+++|+.+ .|+|+             
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~  377 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL  377 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence            3566799999999999997541       1456999987643     34556899999888 59997             


Q ss_pred             -------------EeeccC----------------CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC
Q 016085          147 -------------HYSRAS----------------QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH  197 (395)
Q Consensus       147 -------------~~~~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~  197 (395)
                                   .+.+..                ..++......+++||+.|++||+ +..+|||||-..|||+..+. 
T Consensus       378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~-~~~~vHRDLAaRNVLi~~~~-  455 (609)
T KOG0200|consen  378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA-SVPCVHRDLAARNVLITKNK-  455 (609)
T ss_pred             EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh-hCCccchhhhhhhEEecCCC-
Confidence                         001111                13788888999999999999999 88999999999999999876 


Q ss_pred             ceEEeecCCccccccCCCcc--cccc--cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 016085          198 QVKLCDFGSAKVLVKGEPNI--SYIC--SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEI  272 (395)
Q Consensus       198 ~ikl~DFG~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i  272 (395)
                      .+||+|||+|+.........  ...+  ...|||||.+.. ..|+.++||||+||+|||+++ |..||.+-.....+.+.
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~  534 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF  534 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence            79999999998654443322  1122  345999999977 459999999999999999997 88999885423333322


Q ss_pred             HHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          273 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                      ++. |..                          -..+...++++.++++.||+.+|++||+..++.
T Consensus       535 l~~-G~r--------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  535 LKE-GNR--------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             Hhc-CCC--------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            221 100                          012334689999999999999999999999876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=1.5e-25  Score=198.55  Aligned_cols=181  Identities=35%  Similarity=0.605  Sum_probs=150.4

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE---------------e--ec------
Q 016085           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH---------------Y--SR------  150 (395)
Q Consensus        99 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~---------------~--~~------  150 (395)
                      ||.|++|.||++++..+++.+++|++....     ....+|+..++.+.|+++.               +  ..      
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999998889999999987654     4577899999999999871               0  00      


Q ss_pred             ---cC-CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC-CCCceEEeecCCccccccCC-Cccccccccc
Q 016085          151 ---AS-QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVLVKGE-PNISYICSRY  224 (395)
Q Consensus       151 ---~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~-~~~~ikl~DFG~a~~~~~~~-~~~~~~gt~~  224 (395)
                         .. ..++...+..++.+++.+|.+|| +.|++|+||+|.||+++. ++ .++|+|||.+....... ......+...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH-SNGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchhhcccCCCC
Confidence               01 25778888899999999999999 889999999999999998 55 69999999997654332 1233456888


Q ss_pred             ccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCc
Q 016085          225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW  304 (395)
Q Consensus       225 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (395)
                      |++||.+.....++.++|+|++|+++++|                                                   
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------------  187 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------------  187 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------------
Confidence            99999986643588999999999999999                                                   


Q ss_pred             ccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCC
Q 016085          305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP  341 (395)
Q Consensus       305 ~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp  341 (395)
                               ..+.+++.+||+.||++|+++.++++|+
T Consensus       188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                     2467899999999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=2.4e-25  Score=200.57  Aligned_cols=172  Identities=36%  Similarity=0.611  Sum_probs=141.3

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe-------------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY-------------------  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~-------------------  148 (395)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+...     .....+|+..++.++|+|+..                   
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            67789999999999999999888999999998653     345567999999999998700                   


Q ss_pred             -------eccCCC-CcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--Cccc
Q 016085          149 -------SRASQR-MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--PNIS  218 (395)
Q Consensus       149 -------~~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--~~~~  218 (395)
                             ...... +++..+..++.|++.+|.+|| +.|++|+||+|+||+++.++ .++|+|||++.......  ....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH-SLGIVHRDLKPENILLGMDG-LVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEecCcccccccc
Confidence                   011123 778888999999999999999 78999999999999999876 69999999998765442  2334


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCcH
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPG-ESGV  266 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~  266 (395)
                      ..++..|++||.+.+...++.++|+||||+++++|++|+.||.+ .+..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            56788899999883334478899999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-25  Score=208.18  Aligned_cols=218  Identities=22%  Similarity=0.298  Sum_probs=165.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecchhhH-----HHHHHHHHhcCCCceE-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~~~~-----~~E~~~l~~l~h~ni~-------------  147 (395)
                      .++++..++-+|.||.||+|...+     +.+.|-+|.+++.....     ..|...+.-+.|+|+.             
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P  363 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP  363 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence            468888899999999999996543     23456777776654433     3677788888999970             


Q ss_pred             ---e-------------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecC
Q 016085          148 ---Y-------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  205 (395)
Q Consensus       148 ---~-------------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG  205 (395)
                         +                   -...+.+.-.+...++.|+..|++||| +.||||.||...|++|++.- ++||+|=.
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh-~~~ViHkDiAaRNCvIdd~L-qVkltDsa  441 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH-NHGVIHKDIAARNCVIDDQL-QVKLTDSA  441 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH-hcCcccchhhhhcceehhhe-eEEeccch
Confidence               0                   011233455566778999999999999 89999999999999999776 79999999


Q ss_pred             CccccccCCCcc---cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 016085          206 SAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  281 (395)
Q Consensus       206 ~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  281 (395)
                      +++.........   .......||+||.+... .|+.++|+|||||+||||+| |+.|+..-++.++..-+.+.      
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG------  514 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG------  514 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc------
Confidence            988765443221   11125669999999765 49999999999999999997 99999888877665444331      


Q ss_pred             HHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          282 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                  +.        +.  -+.++|+++..++.-||+.+|++||+.+++..
T Consensus       515 ------------yR--------la--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  515 ------------YR--------LA--QPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ------------ce--------ec--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                        00        11  13458999999999999999999999998753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.9e-26  Score=225.68  Aligned_cols=211  Identities=30%  Similarity=0.434  Sum_probs=170.5

Q ss_pred             eeccCCceEEEEEEE---cCCCcEEEEEEeecc------hhhHHHHHHHHHhcC-CCce---------------------
Q 016085           98 VVGQGSFGIVFQAKC---LETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNV---------------------  146 (395)
Q Consensus        98 ~lG~G~fg~V~~a~~---~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~-h~ni---------------------  146 (395)
                      ++|.|.||.|++++.   ...|..||+|+.++.      +.....|..++..++ |+.+                     
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            479999999998753   246778999987543      223345778888776 6665                     


Q ss_pred             -----EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccc
Q 016085          147 -----HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC  221 (395)
Q Consensus       147 -----~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~g  221 (395)
                           ........+.+...+.+...++.+++++| +.||+|||+|++||+++.+|| +++.|||+++.....+..   ||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh-~l~iiyrd~k~enilld~~Gh-i~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLH-KLGIAYRDYKLENVLLLLEGH-IKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcc-hhHHHHhcccccceeecccCc-cccCCchhhhHhHhhhhc---cc
Confidence                 11223455678888999999999999999 899999999999999999996 999999999887665443   89


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |..|||||++.   .+..++|+||+|+++++|++|..||.+    +....|.+.-                         
T Consensus       156 t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-------------------------  203 (612)
T KOG0603|consen  156 TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-------------------------  203 (612)
T ss_pred             chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-------------------------
Confidence            99999999996   378899999999999999999999987    5666666521                         


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCH-----HHHhcCCcccCCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFDELRDP  349 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  349 (395)
                          -.++..++..+.++++.++..+|.+|...     .|+++|+||+.+.|.
T Consensus       204 ----~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  204 ----LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             ----cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence                01334478899999999999999999854     699999999999886

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=7.5e-26  Score=230.73  Aligned_cols=234  Identities=24%  Similarity=0.330  Sum_probs=172.1

Q ss_pred             eeeeeeccCCceEEEEEEEcCCCcEEEEEEee----cchhh------HHHHHHHHHhcCCCce---------------E-
Q 016085           94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRY------KNRELQTMRLLDHPNV---------------H-  147 (395)
Q Consensus        94 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~----~~~~~------~~~E~~~l~~l~h~ni---------------~-  147 (395)
                      ....++|.|+||.|+.+......+.++.|.+.    .....      ...|+.+-..|.|+|+               . 
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999999998887777777777543    11111      2245556677889986               0 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC---
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---  215 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---  215 (395)
                               +......+....+..++.|++.||+||| ..||.|||||++|+++..++ .+||+|||.+.....+..   
T Consensus       401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h-~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH-SMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHH-hcCceeccCccccEEEecCC-ceEEeecCcceeeccCcchhh
Confidence                     0111236777888999999999999999 89999999999999999888 799999999876643322   


Q ss_pred             --cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          216 --NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       216 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                        ....+|+..|+|||++.+...-...+||||.|++++.|++|+.||.-....+....-.               .....
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~---------------~~~~~  543 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN---------------NYSDQ  543 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh---------------ccccc
Confidence              2357789999999999887756778999999999999999999996544332221000               00000


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      .....     -...+...++...+.+|.+||++||.+|+|+.+|++.+||+.+...
T Consensus       544 ~~~~~-----~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  544 RNIFE-----GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             ccccc-----ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence            00000     0111233478899999999999999999999999999999987653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-24  Score=189.06  Aligned_cols=177  Identities=27%  Similarity=0.374  Sum_probs=145.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch--hhHHHHHHHHHhcCC----Cce-----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDH----PNV-----------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h----~ni-----------------  146 (395)
                      .+.|++++.||+|+||.+|+|....+|+.||||.-.+..  .....|..+.+.|++    |+|                 
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL   93 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL   93 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence            346999999999999999999999999999999876543  345678888888865    333                 


Q ss_pred             ------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc--CCCCceEEeecCCccccccCCC---
Q 016085          147 ------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN--PHTHQVKLCDFGSAKVLVKGEP---  215 (395)
Q Consensus       147 ------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~--~~~~~ikl~DFG~a~~~~~~~~---  215 (395)
                            .+.....+++..++.-++-|++.-++|+| .+++|||||||+|+|..  ...+.+.|+|||+|+...+...   
T Consensus        94 GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH-~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H  172 (341)
T KOG1163|consen   94 GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH-LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH  172 (341)
T ss_pred             CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH-hhccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence                  12234567788888889999999999999 89999999999999974  4455799999999998754432   


Q ss_pred             -----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 016085          216 -----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQ  268 (395)
Q Consensus       216 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  268 (395)
                           .....||..|.+--...+.. .+.+.|+-|+|.+|..+..|..||.|......
T Consensus       173 Ipyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk  229 (341)
T KOG1163|consen  173 IPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATK  229 (341)
T ss_pred             CccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence                 23467899999988887755 79999999999999999999999998654433

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=9.5e-24  Score=192.01  Aligned_cols=193  Identities=25%  Similarity=0.364  Sum_probs=155.0

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEe--ecchhhHHHHHHHHHhcCC----Cce---------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLLDH----PNV---------------  146 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~--~~~~~~~~~E~~~l~~l~h----~ni---------------  146 (395)
                      .....|+|.++||+|+||..+.|.+.-+++.||||.-  +.+......|.+..+.|.+    |++               
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3444799999999999999999999999999999975  3344556678888888864    333               


Q ss_pred             --------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc----CCCCceEEeecCCccccccCC
Q 016085          147 --------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       147 --------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~----~~~~~ikl~DFG~a~~~~~~~  214 (395)
                              .+.....+++...+..++.|++.-++|+| ++.+|+|||||+|+||.    .+.+.|.|+|||+|+.+.+..
T Consensus       105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH-~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH-EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH-hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence                    23345788999999999999999999999 88999999999999995    344579999999999886654


Q ss_pred             Cc--------ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHHHhCCCCHH
Q 016085          215 PN--------ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGE---SGVDQLVEIIKVLGTPTRE  282 (395)
Q Consensus       215 ~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~  282 (395)
                      +.        .+.-||..||+-...+|.. .+.+.|+-|||-+++..|.|..||.|.   +..+-.++|-+.-...+.+
T Consensus       184 TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE  261 (449)
T ss_pred             ccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence            32        3566899999999999866 899999999999999999999999984   3344445554443333333

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=2.6e-22  Score=192.20  Aligned_cols=222  Identities=21%  Similarity=0.230  Sum_probs=164.2

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCC-cEEEEEEeecchh----hHHHHHHHHHhcCC----Cce---E----------e-
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQDKR----YKNRELQTMRLLDH----PNV---H----------Y-  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~-~~vAiK~~~~~~~----~~~~E~~~l~~l~h----~ni---~----------~-  148 (395)
                      +|++.+.||+|+||.||+|.+..++ ..+|+|.......    ....|..++..+..    .++   .          + 
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            6999999999999999999998774 6899998765321    46678899988872    111   0          0 


Q ss_pred             --------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC----CceEEeecCCcc--
Q 016085          149 --------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT----HQVKLCDFGSAK--  208 (395)
Q Consensus       149 --------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~----~~ikl~DFG~a~--  208 (395)
                                    ....+.++..++..++.|++.+|++|| +.|++||||||+|+++....    +.+.|.|||+|+  
T Consensus        99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH-~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH-SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH-hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence                          012468899999999999999999999 89999999999999997653    469999999998  


Q ss_pred             ccccCC--------C-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016085          209 VLVKGE--------P-NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  279 (395)
Q Consensus       209 ~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  279 (395)
                      ......        . .....||..|.++.+..+.. .+.+.|+||++.++.+|+.|..||.+.........+.+.....
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~  256 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL  256 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence            322111        1 12355999999999998765 8999999999999999999999997766443333332211000


Q ss_pred             CHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                     ....         +....+..+..++..+-..+...+|....+..
T Consensus       257 ---------------~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  257 ---------------LTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             ---------------cccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence                           0000         12224567888888888888899998765543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=7.4e-22  Score=185.77  Aligned_cols=232  Identities=34%  Similarity=0.479  Sum_probs=175.3

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCC-ceE-----------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHP-NVH-----------------  147 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~-ni~-----------------  147 (395)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+...       .....+|+.+++.+.|+ ++.                 
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999986   78999988543       23456788999999988 560                 


Q ss_pred             ---------eeccC---CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-
Q 016085          148 ---------YSRAS---QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-  214 (395)
Q Consensus       148 ---------~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-  214 (395)
                               +....   ..+....+..++.|++.++.|+| +.|++|||+||+||+++..+..++++|||.++...... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H-~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH-SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence                     00111   26888899999999999999999 88999999999999999876459999999997554332 


Q ss_pred             ------CcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCC-CHH
Q 016085          215 ------PNISYICSRYYRAPELIFGA--TEYTTAVDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTP-TRE  282 (395)
Q Consensus       215 ------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~-~~~  282 (395)
                            ......||..|+|||.+.+.  ..++...|+||+|++++++++|..||.....   .......+.....+ .. 
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  236 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA-  236 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc-
Confidence                  23567789999999999763  4589999999999999999999999877664   34444444432222 00 


Q ss_pred             HHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                   .+..      ..........+.+++.+++..+|..|.+..+...++|......
T Consensus       237 -------------~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         237 -------------SPLS------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             -------------cccC------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence                         0000      0000112367999999999999999999999888877655443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2e-22  Score=193.63  Aligned_cols=141  Identities=20%  Similarity=0.318  Sum_probs=107.2

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcC-CCcEEEEEEeecc---------hhhHHHHHHHHHhcCCCceE--e---------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVH--Y---------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~ni~--~---------  148 (395)
                      .++|.+.++||+|+||+||+|++.. +++.||||++...         ...+.+|+++|+.++|+|+.  +         
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~LV   96 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGLV   96 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEEE
Confidence            3469999999999999999999876 6778899986422         23467899999999999971  0         


Q ss_pred             -e-ccCCCCcHH---HHHHHHHHHHHHHHHHHcCCCeeeccC-CCCceEEcCCCCceEEeecCCccccccCCC-------
Q 016085          149 -S-RASQRMPLI---YVKLYTYQICRALAYIHGGIGVCHRDI-KPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-------  215 (395)
Q Consensus       149 -~-~~~~~~~~~---~~~~~~~qi~~aL~~LH~~~giiHrDl-Kp~Nill~~~~~~ikl~DFG~a~~~~~~~~-------  215 (395)
                       . .....+...   ....++.|++.||.||| +.||+|||| ||+|||++.++ .+||+|||+|+.......       
T Consensus        97 mE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH-~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA~~~~~~~~~~~~~~~  174 (365)
T PRK09188         97 RGWTEGVPLHLARPHGDPAWFRSAHRALRDLH-RAGITHNDLAKPQNWLMGPDG-EAAVIDFQLASVFRRRGALYRIAAY  174 (365)
T ss_pred             EEccCCCCHHHhCccchHHHHHHHHHHHHHHH-HCCCeeCCCCCcceEEEcCCC-CEEEEECccceecccCcchhhhhhh
Confidence             0 011111110   12467899999999999 889999999 99999998777 699999999986643321       


Q ss_pred             --ccccccccccccccccc
Q 016085          216 --NISYICSRYYRAPELIF  232 (395)
Q Consensus       216 --~~~~~gt~~y~aPE~~~  232 (395)
                        .....+++.|+|||.+.
T Consensus       175 ~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        175 EDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             hhhhhhhccCccCCcccCC
Confidence              12445688899999884

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=2.4e-22  Score=185.53  Aligned_cols=203  Identities=29%  Similarity=0.365  Sum_probs=127.8

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCC-Cc------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDH-PN------------------  145 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h-~n------------------  145 (395)
                      .....+.||.|+|+.||.++|.+||+.+|+|++....       ....+|.-....+.+ .|                  
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4778899999999999999999999999999874322       111222222222111 00                  


Q ss_pred             ---------------e------Eeec-----------------cCCCC-cHHHH-HHHHHHHHHHHHHHHcCCCeeeccC
Q 016085          146 ---------------V------HYSR-----------------ASQRM-PLIYV-KLYTYQICRALAYIHGGIGVCHRDI  185 (395)
Q Consensus       146 ---------------i------~~~~-----------------~~~~~-~~~~~-~~~~~qi~~aL~~LH~~~giiHrDl  185 (395)
                                     +      ....                 ..... ....+ ..+..|++..+++|| +.||+|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh-~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH-SYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH-HTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh-hcceEeccc
Confidence                           0      0000                 00101 11222 344589999999999 889999999


Q ss_pred             CCCceEEcCCCCceEEeecCCccccccCCCcccccccccccccccccCC-------CCCCCcchHHHHHHHHHHHHhCCC
Q 016085          186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTTAVDIWSVGCVLAELLLGQP  258 (395)
Q Consensus       186 Kp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~ell~g~~  258 (395)
                      ||+|++++.+| .+.|+||+........  ......+..|.+||.....       ..++.+.|.|+||+++|.|++|..
T Consensus       172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDG-GVFLGDFSSLVRAGTR--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS--EEE--GGGEEETTEE--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCC-CEEEcChHHHeecCce--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999998 6999999987654322  1113346779999977331       237889999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCC
Q 016085          259 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR  331 (395)
Q Consensus       259 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R  331 (395)
                      ||..........           .       .|.              ... ++++.++.||..+|++||.+|
T Consensus       249 Pf~~~~~~~~~~-----------~-------~f~--------------~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPE-----------W-------DFS--------------RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSG-----------G-------GGT--------------TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCcccccc-----------c-------cch--------------hcC-CcCHHHHHHHHHHccCCcccC
Confidence            997543211000           0       000              112 579999999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=2.1e-21  Score=199.47  Aligned_cols=216  Identities=31%  Similarity=0.424  Sum_probs=149.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch--------hhHHHHHHHHHhcCCCceE----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--------~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      +|...+.||++-|=+|.+|++.+ | .|+||++.+..        ....+|++ ...+++||+.                
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            48888999999999999998743 3 49999885543        12223555 6677899971                


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc--
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--  216 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~--  216 (395)
                               ......-+...+.+.|+.||+.||.-+| +.||+|+|||.+||||++=. .+.|+||..-+...-.++.  
T Consensus       101 qyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH-~~gVcHGDIKsENILiTSWN-W~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  101 QYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCH-KLGVCHGDIKSENILITSWN-WLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHH-HcCccccccccceEEEeeec-hhhhhcccccCCccCCCCCcc
Confidence                     1111223456667888999999999999 89999999999999999654 6999999876654222221  


Q ss_pred             --cccc----ccccccccccccCC----------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 016085          217 --ISYI----CSRYYRAPELIFGA----------TEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  279 (395)
Q Consensus       217 --~~~~----gt~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  279 (395)
                        .-++    .-.+|+|||.+...          +..+++-||||+||+++||++ |++||.-    .++...... +.-
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~-~~~  253 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSG-NAD  253 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhcc-Ccc
Confidence              1111    13579999988431          125778999999999999997 7999942    111111110 000


Q ss_pred             CHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ..+.                       .+..--+..+++||..|++.||++|.+|++.|+.
T Consensus       254 ~~e~-----------------------~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQ-----------------------LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CHHH-----------------------HHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1100                       0111124579999999999999999999999874

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=2.1e-20  Score=173.88  Aligned_cols=154  Identities=23%  Similarity=0.321  Sum_probs=111.0

Q ss_pred             CCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC---CCceEEeecCCccccccCC-------Ccccccccc
Q 016085          154 RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH---THQVKLCDFGSAKVLVKGE-------PNISYICSR  223 (395)
Q Consensus       154 ~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~---~~~ikl~DFG~a~~~~~~~-------~~~~~~gt~  223 (395)
                      ..+....+.++.|+++|+.||| ++||.|||+|.+|||+.-+   .-.+.|+|||+|-......       .....-|..
T Consensus       337 ~~s~r~~~~~laQlLEav~hL~-~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa  415 (598)
T KOG4158|consen  337 HRSYRTGRVILAQLLEAVTHLH-KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNA  415 (598)
T ss_pred             CCchHHHHHHHHHHHHHHHHHH-HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcc
Confidence            3455566778999999999999 8999999999999998322   2268899999985432211       112334577


Q ss_pred             cccccccccCCCCC-----CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          224 YYRAPELIFGATEY-----TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       224 ~y~aPE~~~~~~~~-----~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      ..||||+....+..     =.++|.|+.|.+.||+++...||.+......                  ...+|.+-..|.
T Consensus       416 ~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L------------------~~r~Yqe~qLPa  477 (598)
T KOG4158|consen  416 KLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL------------------DTRTYQESQLPA  477 (598)
T ss_pred             eecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee------------------chhhhhhhhCCC
Confidence            78999998543321     1378999999999999999999977321100                  012233333433


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHH
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL  335 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~  335 (395)
                               ++..+++.+++|+..+|+.||++|+++.
T Consensus       478 ---------lp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  478 ---------LPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             ---------CcccCChHHHHHHHHHhcCCccccCCcc
Confidence                     4556899999999999999999999853

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=6.5e-21  Score=183.72  Aligned_cols=150  Identities=34%  Similarity=0.525  Sum_probs=108.6

Q ss_pred             HHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-------Ccccccccccccccc
Q 016085          157 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------PNISYICSRYYRAPE  229 (395)
Q Consensus       157 ~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-------~~~~~~gt~~y~aPE  229 (395)
                      ......++.|+..|++|    +|.+|||+||.||+...+. .+||.|||+........       ..+..+||..||+||
T Consensus       358 ~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~-q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPE  432 (516)
T KOG1033|consen  358 LSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDD-QLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPE  432 (516)
T ss_pred             hhHHHHHHHhhccchhh----ccchhhhccccccccccch-hhhhhhhhheeecccCCcccchhhhhhhcccccccCCHH
Confidence            33455677889999988    6999999999999998777 79999999987765554       345678999999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCccccc
Q 016085          230 LIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF  308 (395)
Q Consensus       230 ~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (395)
                      .+.+.. |+.++||||||++|+||++ =...|.-   ...+..+..  |..++                         .+
T Consensus       433 Qi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~--g~ip~-------------------------~~  481 (516)
T KOG1033|consen  433 QIRGQQ-YSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRD--GIIPP-------------------------EF  481 (516)
T ss_pred             HHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhc--CCCCh-------------------------HH
Confidence            998865 9999999999999999997 2222211   111111110  11111                         11


Q ss_pred             CCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          309 HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       309 ~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                      ..+ -+.-.+||..||...|.+||++.+.--|+|.
T Consensus       482 ~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  482 LQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            111 2455689999999999999988877667664

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=8.7e-20  Score=161.17  Aligned_cols=111  Identities=15%  Similarity=0.235  Sum_probs=88.5

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecchh------------------------------hHHHHHHHHHhcCCCc
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------------------------------YKNRELQTMRLLDHPN  145 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------------------------------~~~~E~~~l~~l~h~n  145 (395)
                      ...||+|+||.||+|.+. +|+.||||+++....                              ...+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999986 899999999865421                              1124889999887554


Q ss_pred             e---------------Eee---------ccCCCCcHHHHHHHHHHHHHHHHHH-HcCCCeeeccCCCCceEEcCCCCceE
Q 016085          146 V---------------HYS---------RASQRMPLIYVKLYTYQICRALAYI-HGGIGVCHRDIKPQNLLVNPHTHQVK  200 (395)
Q Consensus       146 i---------------~~~---------~~~~~~~~~~~~~~~~qi~~aL~~L-H~~~giiHrDlKp~Nill~~~~~~ik  200 (395)
                      +               .+.         .....++...+..++.|++.+|.|| | +.||+||||||+|||++. + .++
T Consensus        81 v~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H-~~giiHrDlkP~NIli~~-~-~v~  157 (190)
T cd05147          81 IPCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ-DCRLVHADLSEYNLLYHD-G-KLY  157 (190)
T ss_pred             CCCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEEC-C-cEE
Confidence            3               011         1234677888999999999999999 7 789999999999999984 4 699


Q ss_pred             EeecCCcccc
Q 016085          201 LCDFGSAKVL  210 (395)
Q Consensus       201 l~DFG~a~~~  210 (395)
                      |+|||+|...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=7.5e-19  Score=155.42  Aligned_cols=112  Identities=17%  Similarity=0.236  Sum_probs=89.6

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecch------------------------------hhHHHHHHHHHhcCCCc
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------------------------RYKNRELQTMRLLDHPN  145 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------------------------------~~~~~E~~~l~~l~h~n  145 (395)
                      .+.||+|+||.||+|++. +|+.||||++....                              ....+|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            568999999999999987 89999999986431                              11246888898888776


Q ss_pred             e---------------Eee---------ccCCCCcHHHHHHHHHHHHHHHHHHHcC-CCeeeccCCCCceEEcCCCCceE
Q 016085          146 V---------------HYS---------RASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVK  200 (395)
Q Consensus       146 i---------------~~~---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlKp~Nill~~~~~~ik  200 (395)
                      +               .+.         .....++...+..++.|++.+|.+|| + .||+||||||+|||++ ++ .++
T Consensus        81 i~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH-~~~givHrDlkP~NIll~-~~-~~~  157 (190)
T cd05145          81 VPVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLY-QEAGLVHGDLSEYNILYH-DG-KPY  157 (190)
T ss_pred             CCCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHH-HhCCEecCCCChhhEEEE-CC-CEE
Confidence            4               111         11234566788899999999999999 6 8999999999999998 55 699


Q ss_pred             EeecCCccccc
Q 016085          201 LCDFGSAKVLV  211 (395)
Q Consensus       201 l~DFG~a~~~~  211 (395)
                      |+|||+|....
T Consensus       158 liDFG~a~~~~  168 (190)
T cd05145         158 IIDVSQAVELD  168 (190)
T ss_pred             EEEcccceecC
Confidence            99999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=9.4e-19  Score=154.11  Aligned_cols=167  Identities=17%  Similarity=0.092  Sum_probs=117.7

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh--------hHHHHHHHHHhcCC-Cce---E-----ee----cc
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR--------YKNRELQTMRLLDH-PNV---H-----YS----RA  151 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~E~~~l~~l~h-~ni---~-----~~----~~  151 (395)
                      +.+...|++|+||+|+++..  .+..++.+.+.....        ...+|+++|++|.| +++   .     +.    ..
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~   81 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLA   81 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeec
Confidence            34668999999999998865  778888776654322        45789999999964 333   1     00    01


Q ss_pred             CCCCcH---HHHHHHHHHHHHHHHHHHcCCCeeeccC-CCCceEEcCCCCceEEeecCCccccccCCCc-----------
Q 016085          152 SQRMPL---IYVKLYTYQICRALAYIHGGIGVCHRDI-KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----------  216 (395)
Q Consensus       152 ~~~~~~---~~~~~~~~qi~~aL~~LH~~~giiHrDl-Kp~Nill~~~~~~ikl~DFG~a~~~~~~~~~-----------  216 (395)
                      ...+..   .....++.|++.+|.++| +.||+|||| ||+|||++.++ .++|+|||+|.........           
T Consensus        82 G~~L~~~~~~~~~~~~~qi~~~L~~lH-~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~  159 (218)
T PRK12274         82 GAAMYQRPPRGDLAYFRAARRLLQQLH-RCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRLLAREDLRH  159 (218)
T ss_pred             CccHHhhhhhhhHHHHHHHHHHHHHHH-HCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHHHHHHHHHH
Confidence            111110   112457889999999999 899999999 79999999877 5999999999854332210           


Q ss_pred             ---ccccccccccccccccCCCCCC-CcchHHHHHHHHHHHHhCCCCCCCC
Q 016085          217 ---ISYICSRYYRAPELIFGATEYT-TAVDIWSVGCVLAELLLGQPLFPGE  263 (395)
Q Consensus       217 ---~~~~gt~~y~aPE~~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~  263 (395)
                         .....++.|++|+...-....+ ...+|++.|+-+|.++||..++.+.
T Consensus       160 llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        160 LLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence               0112477788887653222233 5689999999999999999887544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1e-18  Score=182.50  Aligned_cols=167  Identities=23%  Similarity=0.400  Sum_probs=127.3

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhH-HHHHHHHHhcC----C-------------Cce---
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-NRELQTMRLLD----H-------------PNV---  146 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~-~~E~~~l~~l~----h-------------~ni---  146 (395)
                      ..+..|.|.+.||+|+||+||+|...+ |+.||+|+-+...... .=-.+++.+|+    +             ..+   
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            445679999999999999999999876 9999999754321100 00011222222    1             001   


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc------CCCCceEEeecCCccccc
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN------PHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~------~~~~~ikl~DFG~a~~~~  211 (395)
                               .+....+.+++..+.++..|++.-++.|| .+||||+||||+|+||.      .+...++|+|||.+.-+.
T Consensus       774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH-~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLH-AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHH-hcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence                     34456788999999999999999999999 89999999999999983      222259999999986542


Q ss_pred             ---cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 016085          212 ---KGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ  257 (395)
Q Consensus       212 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~  257 (395)
                         ++......++|-.+-++|+..|.+ +++.+|.|.|+.+++.||+|+
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence               333344566788899999998866 999999999999999999997

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.77  E-value=1e-18  Score=156.90  Aligned_cols=148  Identities=11%  Similarity=0.106  Sum_probs=106.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hh---------HHHHHHHHHhcCCCce----Ee-e-c
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RY---------KNRELQTMRLLDHPNV----HY-S-R  150 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~---------~~~E~~~l~~l~h~ni----~~-~-~  150 (395)
                      .++|++.++||.|+||.||++.+  ++..+|||++....    ..         ..+|+..+.++.|++|    .+ . .
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            35799999999999999999865  46789999985321    11         4688889999999987    11 0 0


Q ss_pred             c----------------CCCCcHHHH----HHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          151 A----------------SQRMPLIYV----KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       151 ~----------------~~~~~~~~~----~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                      .                -...+....    .....+++.+|..|| +.|++|||+||+||++++++  ++|+|||.....
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH-~~gi~H~Dikp~Nili~~~g--i~liDfg~~~~~  184 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLH-QHGMVSGDPHKGNFIVSKNG--LRIIDLSGKRCT  184 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHH-HcCCccCCCChHHEEEeCCC--EEEEECCCcccc
Confidence            0                001111111    234669999999999 89999999999999999766  999999988654


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHH
Q 016085          211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL  254 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  254 (395)
                      .......           .+++. ..|+.++|+||||+++..+.
T Consensus       185 ~e~~a~d-----------~~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        185 AQRKAKD-----------RIDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cchhhHH-----------HHHHH-hHhcccccccceeEeehHHH
Confidence            2221110           12333 34778999999999887654

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=4.2e-17  Score=148.96  Aligned_cols=116  Identities=16%  Similarity=0.157  Sum_probs=90.9

Q ss_pred             ceeeeeeeccCCceEEEEEE-EcCCCcEEEEEEeecch----------------------------hhHHHHHHHHHhcC
Q 016085           92 SYMAERVVGQGSFGIVFQAK-CLETGETVAIKKVLQDK----------------------------RYKNRELQTMRLLD  142 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~-~~~~~~~vAiK~~~~~~----------------------------~~~~~E~~~l~~l~  142 (395)
                      -|.+.+.||+|+||.||+|. +..+|+.||||++....                            ....+|+.+++.+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 66789999999886431                            12357999998887


Q ss_pred             CCce-------------E--e---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCC-eeeccCCCCceEEcCCCC
Q 016085          143 HPNV-------------H--Y---------SRASQRMPLIYVKLYTYQICRALAYIHGGIG-VCHRDIKPQNLLVNPHTH  197 (395)
Q Consensus       143 h~ni-------------~--~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g-iiHrDlKp~Nill~~~~~  197 (395)
                      +..+             .  +         ......+....+..++.||+.+|.+|| ..| |+||||||+||+++ ++ 
T Consensus       109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~g~iiH~Dikp~NIli~-~~-  185 (237)
T smart00090      109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLY-KEGELVHGDLSEYNILVH-DG-  185 (237)
T ss_pred             hcCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHH-hcCCEEeCCCChhhEEEE-CC-
Confidence            5332             0  0         011223445556789999999999999 889 99999999999999 55 


Q ss_pred             ceEEeecCCcccc
Q 016085          198 QVKLCDFGSAKVL  210 (395)
Q Consensus       198 ~ikl~DFG~a~~~  210 (395)
                      .++|+|||.|...
T Consensus       186 ~i~LiDFg~a~~~  198 (237)
T smart00090      186 KVVIIDVSQSVEL  198 (237)
T ss_pred             CEEEEEChhhhcc
Confidence            6999999998653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=1.4e-17  Score=170.34  Aligned_cols=231  Identities=25%  Similarity=0.350  Sum_probs=171.4

Q ss_pred             cceeeeeeeccCCceEEEEEEEcC-CCcEEEEEEeecc---h---hhHHHHHHHHHhcC-CCce----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQD---K---RYKNRELQTMRLLD-HPNV----------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~~~~~---~---~~~~~E~~~l~~l~-h~ni----------------  146 (395)
                      ..|.+.+.||+|+|+.|-++.... +...+|.|.+...   .   .....|..+-+.+. |.|+                
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            359999999999999999887643 4455777765322   1   12224666666666 8887                


Q ss_pred             ----------Eee-ccCC-CCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-C
Q 016085          147 ----------HYS-RASQ-RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-G  213 (395)
Q Consensus       147 ----------~~~-~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-~  213 (395)
                                ... .... .++...+..++.|+..++.|+|...++.||||||+|.+++..+..+++.|||+|..... .
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence                      111 1222 56677789999999999999996679999999999999998773599999999987755 2


Q ss_pred             CC---cccccc-cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          214 EP---NISYIC-SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       214 ~~---~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      ..   ....+| ++.|+|||...+....+...|+||+|+++.-+++|..||......+..                    
T Consensus       180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------------------  239 (601)
T KOG0590|consen  180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------------------  239 (601)
T ss_pred             CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------------
Confidence            22   234678 999999999987666789999999999999999999999654332210                    


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                       |..+  ... ...........++....+++.++|..+|..|.+..++..++|+..
T Consensus       240 -~~~~--~~~-~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  240 -YSSW--KSN-KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             -ceee--ccc-ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence             0000  000 011122234567899999999999999999999999999999988

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.61  E-value=2.4e-15  Score=133.82  Aligned_cols=115  Identities=17%  Similarity=0.154  Sum_probs=87.6

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch--------------------------hhHHHHHHHHHhcCCCce
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------------------------RYKNRELQTMRLLDHPNV  146 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--------------------------~~~~~E~~~l~~l~h~ni  146 (395)
                      |.+.+.||+|+||.||+|... +|+.||||++....                          ....+|+.++..+.|.++
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888899999999999999864 79999999865321                          123468888888877643


Q ss_pred             -------------Eee-ccCC---CCcH-HHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcc
Q 016085          147 -------------HYS-RASQ---RMPL-IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  208 (395)
Q Consensus       147 -------------~~~-~~~~---~~~~-~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~  208 (395)
                                   ... ....   .+.. .....++.+++.++.++| +.||+||||||+||+++.++ .++|+|||.|.
T Consensus        96 ~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh-~~gi~H~Dl~p~Nill~~~~-~~~liDfg~~~  173 (198)
T cd05144          96 PVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAY-KHGIIHGDLSEFNILVDDDE-KIYIIDWPQMV  173 (198)
T ss_pred             CCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHH-HCCCCcCCCCcccEEEcCCC-cEEEEECCccc
Confidence                         000 0111   1111 345678899999999999 89999999999999999876 69999999996


Q ss_pred             cc
Q 016085          209 VL  210 (395)
Q Consensus       209 ~~  210 (395)
                      ..
T Consensus       174 ~~  175 (198)
T cd05144         174 ST  175 (198)
T ss_pred             cC
Confidence            54

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.59  E-value=1.2e-15  Score=136.06  Aligned_cols=214  Identities=16%  Similarity=0.209  Sum_probs=147.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeec------chhhHHHHHHHHHhcCCCceE-------------e---
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVH-------------Y---  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l~h~ni~-------------~---  148 (395)
                      .+..+..+|....-|..|+++.  .|..+++|++.-      ..+.++.|.-.|+.+.||||.             .   
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence            3456677899999999999987  444566676532      234566788899999999981             1   


Q ss_pred             ------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeee-ccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 ------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH-RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 ------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiH-rDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                  ....-.....++..++..++.|+.|||+-..++- --|....++||++- ..+|. .+-+++..   .
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-taris-mad~kfsf---q  342 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARIS-MADTKFSF---Q  342 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhhee-cccceeee---e
Confidence                        1112223455678899999999999995333333 35777888998765 34442 11122211   1


Q ss_pred             cccccccccccccccccCCCCC--CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          216 NISYICSRYYRAPELIFGATEY--TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      .......|.||+||.+..++..  -.++|+|||++++|||.|+..||.+-.+.+.--+|.                    
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------------------  402 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------------------  402 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--------------------
Confidence            1223347899999999765432  347999999999999999999998876654322221                    


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                             -.-++..+++.++..+..|+.-|++-||.+||....+.
T Consensus       403 -------leglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  403 -------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             -------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                   11223346777899999999999999999999876553

>PRK10345 hypothetical protein; Provisional

Probab=99.59  E-value=5.8e-15  Score=131.95  Aligned_cols=107  Identities=21%  Similarity=0.264  Sum_probs=77.4

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhc-----CCCceE---------------e--
Q 016085           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL-----DHPNVH---------------Y--  148 (395)
Q Consensus        95 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l-----~h~ni~---------------~--  148 (395)
                      -.+.||+|+||.||.  +..++.. +||++...    .....+|+.+++.+     +|+||.               +  
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            347899999999995  6666665 69988643    34567899999999     568870               1  


Q ss_pred             eccC--------------CCCcHHHHHHHHHHHHHHH-HHHHcCCCeeeccCCCCceEEcCCC---CceEEeecCCc
Q 016085          149 SRAS--------------QRMPLIYVKLYTYQICRAL-AYIHGGIGVCHRDIKPQNLLVNPHT---HQVKLCDFGSA  207 (395)
Q Consensus       149 ~~~~--------------~~~~~~~~~~~~~qi~~aL-~~LH~~~giiHrDlKp~Nill~~~~---~~ikl~DFG~a  207 (395)
                      ....              ..+++.  ..++.|++.++ +||| +.+|+||||||+|||++..+   ..++|+||+-+
T Consensus        83 I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh-~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLL-DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            0110              112222  34578888888 9999 88999999999999997432   26999995444

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.53  E-value=4.2e-14  Score=124.42  Aligned_cols=112  Identities=22%  Similarity=0.234  Sum_probs=80.1

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecchhh----------------------------HHHHHHHHHhcCCCce-
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY----------------------------KNRELQTMRLLDHPNV-  146 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----------------------------~~~E~~~l~~l~h~ni-  146 (395)
                      .+.||+|+||.||+|.+. +++.||||++......                            ...|...+..+.+..+ 
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            468999999999999976 8999999987643210                            0234555555433321 


Q ss_pred             ------------Eeec-cC-----CC---CcH-HHHHHHHHHHHHHHHHHHcC-CCeeeccCCCCceEEcCCCCceEEee
Q 016085          147 ------------HYSR-AS-----QR---MPL-IYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCD  203 (395)
Q Consensus       147 ------------~~~~-~~-----~~---~~~-~~~~~~~~qi~~aL~~LH~~-~giiHrDlKp~Nill~~~~~~ikl~D  203 (395)
                                  .+.. ..     ..   ... ..++.++.+++.++.++| . .||+||||||+||+++ ++ .++|+|
T Consensus        81 ~~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh-~~~~ivH~Dl~p~Nili~-~~-~~~liD  157 (187)
T cd05119          81 VPKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLY-REAGLVHGDLSEYNILVD-DG-KVYIID  157 (187)
T ss_pred             CCceEecCCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHh-hccCcCcCCCChhhEEEE-CC-cEEEEE
Confidence                        1111 11     01   111 567889999999999999 6 9999999999999999 55 699999


Q ss_pred             cCCccccc
Q 016085          204 FGSAKVLV  211 (395)
Q Consensus       204 FG~a~~~~  211 (395)
                      ||.+....
T Consensus       158 fg~a~~~~  165 (187)
T cd05119         158 VPQAVEID  165 (187)
T ss_pred             Cccccccc
Confidence            99996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.52  E-value=8.4e-14  Score=123.79  Aligned_cols=108  Identities=19%  Similarity=0.308  Sum_probs=80.6

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecc------------hhhHHHHHHHHHhcCCCce-----Eee-----------
Q 016085           98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLLDHPNV-----HYS-----------  149 (395)
Q Consensus        98 ~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------------~~~~~~E~~~l~~l~h~ni-----~~~-----------  149 (395)
                      .||+|+||.||+|..  ++..|++|.....            .....+|+++++.+.|+++     ...           
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  6788999985431            1223479999999987764     000           


Q ss_pred             ccCCCCcHHHHH---HHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          150 RASQRMPLIYVK---LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       150 ~~~~~~~~~~~~---~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                      ..+..+......   .++.|++.+|.+|| +.|++|||++|.||+++ ++ .++++|||++...
T Consensus        79 ~~g~~l~~~~~~~~~~~~~~i~~~l~~lH-~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGNDELLREIGRLVGKLH-KAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcHHHHHHHHHHHHHHHH-HCCeecCCCCcceEEEE-CC-cEEEEECCCCcCC
Confidence            112222222222   68999999999999 89999999999999998 55 6999999998663

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.51  E-value=2.8e-14  Score=140.22  Aligned_cols=164  Identities=27%  Similarity=0.385  Sum_probs=114.8

Q ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC---CCccccccccccccc
Q 016085          152 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG---EPNISYICSRYYRAP  228 (395)
Q Consensus       152 ~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~---~~~~~~~gt~~y~aP  228 (395)
                      ...++......++..|+.||+|||.+....|+.|+..|+++|... .+||+|||+.......   .......-...|.||
T Consensus        42 ~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aP  120 (484)
T KOG1023|consen   42 DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAP  120 (484)
T ss_pred             ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCH
Confidence            456677777888999999999999654459999999999999876 7999999998765321   111111224559999


Q ss_pred             ccccCCC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          229 ELIFGAT------EYTTAVDIWSVGCVLAELLLGQPLFPGESGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       229 E~~~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      |.+.+..      ..+.+.|+||+|++++|+++...||......    +.+..+.+ .+.              ....|.
T Consensus       121 ellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-~~~--------------~~~rP~  185 (484)
T KOG1023|consen  121 ELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-GGS--------------NPFRPS  185 (484)
T ss_pred             HHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-cCC--------------CCcCcc
Confidence            9996531      1467899999999999999999999763322    22222222 111              011111


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                      +..      .. .+.+++..+++.||.-+|.+||++.++-
T Consensus       186 i~~------~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  186 IEL------LN-ELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             hhh------hh-hcchHHHHHHHHhcccChhhCccHHHHH
Confidence            110      11 3566899999999999999999998874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.51  E-value=1.2e-14  Score=150.12  Aligned_cols=244  Identities=25%  Similarity=0.288  Sum_probs=175.4

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE--------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ..+.+.+.+-+-+|+++.++.+.-..+|...++|.....       .+...++..++-...+|.+.              
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            445788888999999999999987778877777754322       11112222332222333331              


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC--
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--  213 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~--  213 (395)
                                  ........+...++-+...+..+++||| ...+.|||++|.|+|+..+++ .+++|||.......-  
T Consensus       882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~-s~~r~h~~~~p~~~l~~~~gh-~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLH-SSLRKHRDLKPDSLLIAYDGH-RPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccc-cchhhcccccccchhhcccCC-cccCccccccccccccC
Confidence                        1111233555667788889999999999 656999999999999998885 999999843322100  


Q ss_pred             ------------------------------CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 016085          214 ------------------------------EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGE  263 (395)
Q Consensus       214 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  263 (395)
                                                    .......+|+.|.+||...+.. .+..+|||++|++++|.++|.+||...
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                          0012346799999999998866 899999999999999999999999988


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHH---HHhcC
Q 016085          264 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL---EACIH  340 (395)
Q Consensus       264 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~---e~l~h  340 (395)
                      .....+..|....                         .+|. .-+...+..+.+++.+.|..+|.+|.++.   +.-.|
T Consensus      1039 tpq~~f~ni~~~~-------------------------~~~p-~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~ 1092 (1205)
T KOG0606|consen 1039 TPQQIFENILNRD-------------------------IPWP-EGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGH 1092 (1205)
T ss_pred             chhhhhhccccCC-------------------------CCCC-CCccccChhhhhhhhhhhccCchhccCcccccccccC
Confidence            8776665554310                         0110 01233688999999999999999999887   88899


Q ss_pred             CcccCCCCCCCCCCCCCCCCC
Q 016085          341 PFFDELRDPNARLPNGRPFPP  361 (395)
Q Consensus       341 p~f~~~~~~~~~~~~~~~~~~  361 (395)
                      +||+...|.+.......++|.
T Consensus      1093 ~~~~~~~~~~l~~q~~~~~p~ 1113 (1205)
T KOG0606|consen 1093 PFFQDVDWENLALQKAEFVPQ 1113 (1205)
T ss_pred             CccCCCCccccccccCccCCC
Confidence            999999998777666655543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.51  E-value=1.1e-13  Score=124.10  Aligned_cols=108  Identities=19%  Similarity=0.307  Sum_probs=81.8

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecc------------hhhHHHHHHHHHhcCCCce-----E----------ee
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLLDHPNV-----H----------YS  149 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------------~~~~~~E~~~l~~l~h~ni-----~----------~~  149 (395)
                      +.||+|++|.||+|+.  .|..|++|+....            .....+|+.++..+.|+++     .          ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  7788999975421            1234578999999988775     1          00


Q ss_pred             -ccCCCCcHH------HHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          150 -RASQRMPLI------YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       150 -~~~~~~~~~------~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                       ..+..+...      ....++.+++.+|.+|| +.|++|||++|.|||++ ++ .++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGMEELELSREIGRLVGKLH-SAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHH-hCCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence             111112111      34588899999999999 88999999999999999 45 699999999865

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.46  E-value=2.4e-13  Score=139.00  Aligned_cols=114  Identities=17%  Similarity=0.270  Sum_probs=82.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEee-cc-----------hhhHHHHHHHHHhcCCCceEe----e------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-QD-----------KRYKNRELQTMRLLDHPNVHY----S------  149 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~-~~-----------~~~~~~E~~~l~~l~h~ni~~----~------  149 (395)
                      .|...+.||+|+||.||++....  ..+++|+.. +.           .....+|+++++.++|+++..    .      
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            45678999999999999998743  344444321 10           123457999999999988611    0      


Q ss_pred             ------ccCCCCcHH--HHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          150 ------RASQRMPLI--YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       150 ------~~~~~~~~~--~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                            .....+...  ....++.|++.+|.+|| +.||+||||||+|||++ ++ .++|+|||+|+..
T Consensus       412 ~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH-~~giiHrDlkp~NILl~-~~-~~~liDFGla~~~  477 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLH-KAGIVHGDLTTSNFIVR-DD-RLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHH-hCCCccCCCChHHEEEE-CC-cEEEEeCcccccC
Confidence                  112223222  25678899999999999 89999999999999994 44 6999999999763

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.38  E-value=3.5e-12  Score=116.71  Aligned_cols=110  Identities=20%  Similarity=0.283  Sum_probs=79.2

Q ss_pred             eeec-cCCceEEEEEEEcCCCcEEEEEEeecc-----------------hhhHHHHHHHHHhcCCCceE-----------
Q 016085           97 RVVG-QGSFGIVFQAKCLETGETVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        97 ~~lG-~G~fg~V~~a~~~~~~~~vAiK~~~~~-----------------~~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      ..|| .||.|+||.+..  .+..++||.+...                 .....+|+.++..|.|+++.           
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4677 899999999876  4788999977421                 12345799999999887740           


Q ss_pred             --------eec--cCCCCcHHH-------HHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          148 --------YSR--ASQRMPLIY-------VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       148 --------~~~--~~~~~~~~~-------~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                              +..  ..+..+...       ....+.||+.+|.+|| +.||+||||||+|||++.++ .++|+|||.+...
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH-~~GI~HrDlkp~NILv~~~~-~v~LIDfg~~~~~  192 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFH-DAGVYHADLNAHNILLDPDG-KFWLIDFDRGELR  192 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHH-HCCCCCCCCCchhEEEcCCC-CEEEEECCCcccC
Confidence                    000  011111111       1234678999999999 89999999999999999876 6999999998653

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.35  E-value=4.3e-12  Score=106.46  Aligned_cols=112  Identities=20%  Similarity=0.250  Sum_probs=84.9

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEeecch--hhHHHHHHHHHhcCCC--ce---E------------ee-ccCCC
Q 016085           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHP--NV---H------------YS-RASQR  154 (395)
Q Consensus        95 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~--ni---~------------~~-~~~~~  154 (395)
                      +.+.||+|.++.||++.+.  +..+++|......  ....+|+.+++.+.|.  ++   .            .. .....
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4578999999999999974  3789999986654  3567899999999764  32   0            00 01111


Q ss_pred             C---cHHHHHHHHHHHHHHHHHHHcC--CCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          155 M---PLIYVKLYTYQICRALAYIHGG--IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       155 ~---~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      +   +......++.+++.+|.+||..  .+++|+|++|+||+++..+ .++++|||.+..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            2   3356677889999999999932  3799999999999999755 699999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=1.5e-12  Score=128.25  Aligned_cols=223  Identities=26%  Similarity=0.301  Sum_probs=159.9

Q ss_pred             cceeeeeeecc--CCceEEEEEEE--cCCCcEEEEEEeec------chhhHHHHHHHHHhc-CCCce------------E
Q 016085           91 ISYMAERVVGQ--GSFGIVFQAKC--LETGETVAIKKVLQ------DKRYKNRELQTMRLL-DHPNV------------H  147 (395)
Q Consensus        91 ~~y~~~~~lG~--G~fg~V~~a~~--~~~~~~vAiK~~~~------~~~~~~~E~~~l~~l-~h~ni------------~  147 (395)
                      ..+.+.+.+|.  |.+|.||.+++  .+++..+|+|.-+.      ......+|+...+.+ .|+|.            .
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            35778889999  99999999999  88999999996321      122223444443333 23332            0


Q ss_pred             e-------------e-ccCCCCcHHHHHHHHHHHHH----HHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          148 Y-------------S-RASQRMPLIYVKLYTYQICR----ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       148 ~-------------~-~~~~~~~~~~~~~~~~qi~~----aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      +             . .....++...++.+..+...    ||.++| +.+++|-|+||+||++..+....+++|||+...
T Consensus       194 fiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h-s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~  272 (524)
T KOG0601|consen  194 FIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH-SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK  272 (524)
T ss_pred             eeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC-CCcccccccchhheecccccceeecCCcceeEE
Confidence            1             1 11223677778888888888    999999 889999999999999998833699999999888


Q ss_pred             cccCCCcc------cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHHHhCCCCH
Q 016085          210 LVKGEPNI------SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGE--SGVDQLVEIIKVLGTPTR  281 (395)
Q Consensus       210 ~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~  281 (395)
                      +..+.-..      ...+...|++||...+  .++...|++|+|.+..+..+|..++...  +.+.++..+.        
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--------  342 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--------  342 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--------
Confidence            76554221      1245677999998854  3899999999999999999988766543  2222221111        


Q ss_pred             HHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          282 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                            ....+-...+.++...+..|+..+|..|+++..+++|+++...
T Consensus       343 ----------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  343 ----------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             ----------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence                                  1111222346677779999999999999999999999998643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=1.7e-12  Score=129.75  Aligned_cols=233  Identities=19%  Similarity=0.230  Sum_probs=146.6

Q ss_pred             CCCCccccceeeeeeeccCCce---EEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceEeeccCCCCcHHHH
Q 016085           84 NGQPKQTISYMAERVVGQGSFG---IVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYV  160 (395)
Q Consensus        84 ~~~~~~~~~y~~~~~lG~G~fg---~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~  160 (395)
                      ...+....+|++.+.+|..+-|   ++|.+....++.....|..-  ....+....-++++.|.      ..-...-+.+
T Consensus        30 l~~~~~~~~~~~~~~~~~~g~g~~~~ly~~~~~~sk~~~~~~s~~--~~~ld~~~~~~~~lr~~------~~vs~aTe~~  101 (700)
T KOG2137|consen   30 LPGPKESQSYRSLNQVGSAGPGDAWKLYAGKKSGSKAPTLKKSAV--VWMLDKRASSLQQLRGL------DGVSKATEDG  101 (700)
T ss_pred             cCCcccccccccccceeecCCCchhhhhhhhccCccCccccceee--eeecChhhhHHHHHhcc------cchhhcccHh
Confidence            3344555678888888775544   56666555444443222110  00011112233444441      1111122222


Q ss_pred             HHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--------cccc--ccccccccccc
Q 016085          161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--------NISY--ICSRYYRAPEL  230 (395)
Q Consensus       161 ~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--------~~~~--~gt~~y~aPE~  230 (395)
                      ..=+.++..|+.|+|.+.++||+.|.|++|.++..+ ..||+.|+++.....+..        ....  .-...|.|||.
T Consensus       102 f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~  180 (700)
T KOG2137|consen  102 FANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY  180 (700)
T ss_pred             hhhhhcccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence            233345669999999889999999999999999988 699999998765433111        0111  12456999999


Q ss_pred             ccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccC
Q 016085          231 IFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH  309 (395)
Q Consensus       231 ~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (395)
                      +.+. ..+.++|++|+||++|.+. .|+..+.+.........-....             +..            .....
T Consensus       181 ~~~~-~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~-------------~~~------------~~~~s  234 (700)
T KOG2137|consen  181 LLGT-TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL-------------NAG------------AFGYS  234 (700)
T ss_pred             hccc-cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc-------------ccc------------ccccc
Confidence            9774 4799999999999999999 6776665543222111110000             000            01123


Q ss_pred             CCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 016085          310 KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  351 (395)
Q Consensus       310 ~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  351 (395)
                      .+++.++++=|.++|..++..||++.+++..|||++..-...
T Consensus       235 ~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~aL  276 (700)
T KOG2137|consen  235 NNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKAL  276 (700)
T ss_pred             ccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchhhhh
Confidence            568999999999999999999999999999999988655443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.10  E-value=4.8e-10  Score=96.69  Aligned_cols=109  Identities=15%  Similarity=0.221  Sum_probs=78.6

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCce----Eeec-----------cCCCCcH
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNV----HYSR-----------ASQRMPL  157 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni----~~~~-----------~~~~~~~  157 (395)
                      .+.|+.|.++.||+++.  .++.|++|......   ....+|+.+++.+.+.++    ....           ....+..
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLT   80 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccc
Confidence            35789999999999986  47889999875543   335688999988865432    1110           1111211


Q ss_pred             --HHHHHHHHHHHHHHHHHHcCCC-----eeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          158 --IYVKLYTYQICRALAYIHGGIG-----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       158 --~~~~~~~~qi~~aL~~LH~~~g-----iiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                        .....+..+++.+|..|| +.+     ++|+|++|.||+++ ++ .++++|||.+..
T Consensus        81 ~~~~~~~~~~~l~~~l~~LH-~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~~  136 (170)
T cd05151          81 EDFSDPENLEKIAKLLKKLH-SSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAGM  136 (170)
T ss_pred             ccccCHHHHHHHHHHHHHHh-CCCCCCceeecCCCCcCcEEEE-CC-eEEEEecccccC
Confidence              123456789999999999 667     49999999999999 44 599999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.09  E-value=4.6e-11  Score=117.95  Aligned_cols=224  Identities=23%  Similarity=0.219  Sum_probs=148.5

Q ss_pred             cccceeeeeeeccCCceEEEEEEEc-CCCcEEEEEEeecchhhH------HHHHHHHHhc-CCCce--------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCL-ETGETVAIKKVLQDKRYK------NRELQTMRLL-DHPNV--------------  146 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~~~~------~~E~~~l~~l-~h~ni--------------  146 (395)
                      -..+|..+..||.|.|+.|+.+... .++..|++|.+.+.....      -.|+.+...+ .|.++              
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            3457999999999999999987654 678899999876543222      1233333332 22222              


Q ss_pred             ------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          147 ------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       147 ------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                  ........+.+...+.+..|++.++.++| +..++|+|+||+||++..++..-++.|||++....-. 
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~-s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-  420 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH-SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-  420 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc-chhhhcccccccceeeccchhhhhcccccccccccee-
Confidence                        00011223455556778899999999999 8999999999999999876446899999998652111 


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .......+..|-..|++.....+..++|++|||..+.+.++|.+.-.....   ...|+..                   
T Consensus       421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~-------------------  478 (524)
T KOG0601|consen  421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSG-------------------  478 (524)
T ss_pred             cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecc-------------------
Confidence            111122244442355555555689999999999999999999844322211   1111110                   


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      ..+          ........+..+.+.+...++..|+.+.++..|.=|...
T Consensus       479 ~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  479 DTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             ccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence            000          112234788899999999999999999998888766443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.06  E-value=1.4e-09  Score=108.21  Aligned_cols=48  Identities=25%  Similarity=0.359  Sum_probs=39.5

Q ss_pred             HHHHHHHH-HHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          162 LYTYQICR-ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       162 ~~~~qi~~-aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                      .++.+++. .+..+| ..|++|+|++|.||+++.++ .++|+|||++....
T Consensus       260 ~ia~~~~~~~l~ql~-~~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       260 ALAENLARSFLNQVL-RDGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHHHH-hCCceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            35555555 467889 88999999999999998877 69999999997653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.99  E-value=2.1e-09  Score=94.73  Aligned_cols=112  Identities=14%  Similarity=0.228  Sum_probs=79.1

Q ss_pred             eeeeccCCceEEEEEEEcC------CCcEEEEEEeecc--------------h------------h----hHHHHHHHHH
Q 016085           96 ERVVGQGSFGIVFQAKCLE------TGETVAIKKVLQD--------------K------------R----YKNRELQTMR  139 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~------~~~~vAiK~~~~~--------------~------------~----~~~~E~~~l~  139 (395)
                      ..+||.|-=+.||.|....      .+..+|||+.+..              .            .    ...+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999997643      3578999976311              0            0    1126888888


Q ss_pred             hcCCCce---------------Eeecc---------CCCCcHHHHHHHHHHHHHHHHHH-HcCCCeeeccCCCCceEEcC
Q 016085          140 LLDHPNV---------------HYSRA---------SQRMPLIYVKLYTYQICRALAYI-HGGIGVCHRDIKPQNLLVNP  194 (395)
Q Consensus       140 ~l~h~ni---------------~~~~~---------~~~~~~~~~~~~~~qi~~aL~~L-H~~~giiHrDlKp~Nill~~  194 (395)
                      ++....+               .+...         ...++...+..+..|++.+|..| | +.||+|+||++.|||++.
T Consensus        82 rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H-~~glVHGDLs~~NIL~~~  160 (197)
T cd05146          82 RMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYK-ECNLVHADLSEYNMLWHD  160 (197)
T ss_pred             HHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEEC
Confidence            8754332               11111         11233445667789999999998 8 889999999999999974


Q ss_pred             CCCceEEeecCCcccc
Q 016085          195 HTHQVKLCDFGSAKVL  210 (395)
Q Consensus       195 ~~~~ikl~DFG~a~~~  210 (395)
                       + .+.|+|||.|-..
T Consensus       161 -~-~v~iIDF~qav~~  174 (197)
T cd05146         161 -G-KVWFIDVSQSVEP  174 (197)
T ss_pred             -C-cEEEEECCCceeC
Confidence             4 5999999988554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.94  E-value=1.6e-08  Score=101.26  Aligned_cols=159  Identities=21%  Similarity=0.289  Sum_probs=108.5

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCce------------EeeccCCCCc
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNV------------HYSRASQRMP  156 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni------------~~~~~~~~~~  156 (395)
                      |.+ ...+-++.+..-.|..+.++.+|.|...+...    ....+.++-|+.|+||||            .|+......|
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P   93 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP   93 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc
Confidence            555 33333333322245667788888888775432    345678899999999998            2332222223


Q ss_pred             ---------HHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-ccccccccccc
Q 016085          157 ---------LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYR  226 (395)
Q Consensus       157 ---------~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~~gt~~y~  226 (395)
                               ...+..-++||+.||.|||..++++|++|.-+.|+++..| ..||++|-++........ .....---.|.
T Consensus        94 l~~~lk~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~  172 (690)
T KOG1243|consen   94 LETVLKELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFD  172 (690)
T ss_pred             HHHHHHHhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhccc
Confidence                     3344556889999999998789999999999999999998 599999988755432221 11111223366


Q ss_pred             ccccccCCCCCCCcchHHHHHHHHHHHHhC
Q 016085          227 APELIFGATEYTTAVDIWSVGCVLAELLLG  256 (395)
Q Consensus       227 aPE~~~~~~~~~~~~DiwSlG~il~ell~g  256 (395)
                      .|+.+-.   -+-..|.|-|||++++++.|
T Consensus       173 ~P~~~~~---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  173 DPEEIDP---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence            7775522   12568999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.91  E-value=1.7e-09  Score=109.24  Aligned_cols=35  Identities=20%  Similarity=0.306  Sum_probs=30.5

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD  127 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~  127 (395)
                      .|.. +.||+|++|.||+|+.+.+|+.||||+.+..
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~  155 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPD  155 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcc
Confidence            4666 7899999999999999888999999998644

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.83  E-value=4.7e-09  Score=96.67  Aligned_cols=160  Identities=21%  Similarity=0.171  Sum_probs=105.1

Q ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHc-CCCeeeccCCCCceEEcCCCCceEEeecCCccccccC--------CCccccccc
Q 016085          152 SQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--------EPNISYICS  222 (395)
Q Consensus       152 ~~~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~--------~~~~~~~gt  222 (395)
                      ...+.....++|+-||+.||.|||+ ..-|+|+++..+-|++..++ .||+.   +.......        .......+-
T Consensus       170 ~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig---~~ap~s~h~s~~~~~~~Ek~~~~~~  245 (458)
T KOG1266|consen  170 QKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIG---SVAPDSTHPSVNSTREAEKSVNTSL  245 (458)
T ss_pred             hhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEec---ccCccccchhhhhhhHhhhhccccC
Confidence            3456666778899999999999994 23599999999999999776 57764   22111000        001112346


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF-PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      ++|.|||.=.. .+.+.++|||++|....+|..|..-- .+.+....-..|...                          
T Consensus       246 ~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~--------------------------  298 (458)
T KOG1266|consen  246 PGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV--------------------------  298 (458)
T ss_pred             CccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh--------------------------
Confidence            78999986533 33677999999999999999887432 222211111111110                          


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                            +-..-...-++++.+||+-.|+.||++.+++.||..-+++.
T Consensus       299 ------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs  339 (458)
T KOG1266|consen  299 ------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS  339 (458)
T ss_pred             ------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence                  00001223467899999999999999999999999766543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.80  E-value=1.5e-07  Score=89.78  Aligned_cols=171  Identities=19%  Similarity=0.254  Sum_probs=111.0

Q ss_pred             CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccccccccccccccccc
Q 016085          153 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF  232 (395)
Q Consensus       153 ~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  232 (395)
                      ..+.+..+...+..|+.+..-|| ..|.+-+|+.++|+|++.++ .|.|.|-..-.....+......+|...|.+||.-.
T Consensus       112 P~~~w~fllrvaRnlA~aFA~lH-~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~  189 (637)
T COG4248         112 PHCAWDFLLRVARNLASAFATLH-EHGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQT  189 (637)
T ss_pred             CccccHHHHHHHHHHHHHHHHHH-hcCCcccccCccceeeecCc-eEEEEcccceeeccCCceEecccCccccCCHHHhc
Confidence            44677888899999999999999 88999999999999999877 68888744322223333344567889999999653


Q ss_pred             -C---CCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCC--HHHHhhcCCCCccccCCcccCCCcc
Q 016085          233 -G---ATEYTTAVDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPT--REEIKCMNPNYTEFKFPQIKAHPWH  305 (395)
Q Consensus       233 -~---~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  305 (395)
                       +   .-.-+...|.|.||+++++++.| +.||.|...         ....|+  +..+....-.|.....+.....+..
T Consensus       190 ~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~---------~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~  260 (637)
T COG4248         190 LPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL---------ISDAPNPLETDIAHGRFAYASDQRRGLKPPPRS  260 (637)
T ss_pred             cccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc---------cCCCCCcchhhhhcceeeechhccCCCCCCCCC
Confidence             1   12246789999999999999986 999987321         111111  1122111111111111111111111


Q ss_pred             cccCCCCChhHHHHHHhhccC--CCCCCCCHH
Q 016085          306 KIFHKRMPPEAVDLVSRLLQY--SPNLRCTAL  335 (395)
Q Consensus       306 ~~~~~~~s~~~~~ll~~~L~~--dP~~R~t~~  335 (395)
                      .. ...+++++..|..+|+.-  ++.-|||++
T Consensus       261 ~P-~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         261 IP-LSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             CC-hhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            11 123688999999999974  467899874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.52  E-value=6.1e-07  Score=76.86  Aligned_cols=113  Identities=19%  Similarity=0.290  Sum_probs=79.2

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEee-cc-----------hhhHHHHHHHHHhcCC-----CceEe---------
Q 016085           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVL-QD-----------KRYKNRELQTMRLLDH-----PNVHY---------  148 (395)
Q Consensus        95 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~-~~-----------~~~~~~E~~~l~~l~h-----~ni~~---------  148 (395)
                      ....|-+|+-+.|+++.+  .|+.+.||.-. +.           .....+|+++|.++.-     |-+.+         
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            567888999999999976  78888888532 11           2233468888887643     22211         


Q ss_pred             ec---c-----------CCCCcHHH-HHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCce--EEeecCCcccc
Q 016085          149 SR---A-----------SQRMPLIY-VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV--KLCDFGSAKVL  210 (395)
Q Consensus       149 ~~---~-----------~~~~~~~~-~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~i--kl~DFG~a~~~  210 (395)
                      ..   .           ...-.+.. ...++.+|-..+.-|| ..+|||+||..+||+|.++++++  .|+|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH-~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH-DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh-hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            10   0           01111112 2567788889999999 88999999999999998887765  89999998653

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.50  E-value=9e-07  Score=76.06  Aligned_cols=109  Identities=16%  Similarity=0.273  Sum_probs=71.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEe-ecc-----------hhhHHHHHHHHHhcCCCc-----e----------Eee
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKV-LQD-----------KRYKNRELQTMRLLDHPN-----V----------HYS  149 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~-~~~-----------~~~~~~E~~~l~~l~h~n-----i----------~~~  149 (395)
                      ..+++|+=+.++.+..  -|..+.+|.- .+.           .....+|++++..+.-..     +          ...
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            3578999999999865  4455677742 221           122346888888774322     2          111


Q ss_pred             cc-CCCCcHHHH---HHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          150 RA-SQRMPLIYV---KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       150 ~~-~~~~~~~~~---~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                      .- ...+....-   ..++..+-.-+.-|| ..||+|+||.++||+++..  .+.++|||++...
T Consensus        80 ~I~G~~lkd~l~~~~~~~~r~vG~~vg~lH-~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEARPDLLREVGRLVGKLH-KAGIVHGDLTTSNIILSGG--RIYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhcchHHHHHHHHHHHHHH-hcCeecCCCccceEEEeCC--cEEEEECCccccc
Confidence            11 111111111   246677778889999 8899999999999999854  3999999999753

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.42  E-value=3.3e-06  Score=75.78  Aligned_cols=112  Identities=18%  Similarity=0.259  Sum_probs=79.5

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCc-----eEeecc---------------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPN-----VHYSRA---------------  151 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~n-----i~~~~~---------------  151 (395)
                      +.||.|.++.||++... +|+.|++|.....     .....+|..+++.+.+.+     +.....               
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            56899999999999863 3688999987653     245678999999886532     211000               


Q ss_pred             -C---------CCCcHHHHHHHHHHHHHHHHHHHc---------------------------------------------
Q 016085          152 -S---------QRMPLIYVKLYTYQICRALAYIHG---------------------------------------------  176 (395)
Q Consensus       152 -~---------~~~~~~~~~~~~~qi~~aL~~LH~---------------------------------------------  176 (395)
                       +         ..++......++.+++.+|..||+                                             
T Consensus        83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (223)
T cd05154          83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR  162 (223)
T ss_pred             CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence             0         124455666777888888888872                                             


Q ss_pred             ----------CCCeeeccCCCCceEEcCC-CCceEEeecCCccc
Q 016085          177 ----------GIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV  209 (395)
Q Consensus       177 ----------~~giiHrDlKp~Nill~~~-~~~ikl~DFG~a~~  209 (395)
                                ...++|+|+.+.||+++.+ ...+.|+||+.+..
T Consensus       163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      1347999999999999873 22588999998854

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.38  E-value=1.3e-05  Score=78.71  Aligned_cols=134  Identities=21%  Similarity=0.324  Sum_probs=100.5

Q ss_pred             eEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCce----------------------------------
Q 016085          105 GIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNV----------------------------------  146 (395)
Q Consensus       105 g~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni----------------------------------  146 (395)
                      .+.|+|....+|..|++|++.-++    ...-.-++..+++.|.|+                                  
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            467999999999999999983221    112245778899999997                                  


Q ss_pred             ------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          147 ------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       147 ------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                  .+.......++..+|.|+.|+..||.++| +.|+.-+-|.|.+||++.+- +|+|.-.|+......+.
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH-ssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH-SSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQEDP  447 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH-hcCceeecccHhHeEeeCcc-eEEEecccceeeecCCC
Confidence                        11223456788999999999999999999 78999999999999999765 68888777655443222


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ  257 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~  257 (395)
                                 .  |-+.+    -.+-|.=.||.+++.|.||.
T Consensus       448 -----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  448 -----------T--EPLES----QQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             -----------C--cchhH----HhhhhHHHHHHHHHHHhhcc
Confidence                       1  11211    23568999999999999996

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.35  E-value=2.1e-06  Score=75.31  Aligned_cols=101  Identities=26%  Similarity=0.363  Sum_probs=65.0

Q ss_pred             EEEEEEEcCCCcEEEEEEeecc------------------------------hhhHHHHHHHHHhcCCCce---------
Q 016085          106 IVFQAKCLETGETVAIKKVLQD------------------------------KRYKNRELQTMRLLDHPNV---------  146 (395)
Q Consensus       106 ~V~~a~~~~~~~~vAiK~~~~~------------------------------~~~~~~E~~~l~~l~h~ni---------  146 (395)
                      .||.|.. ..|..+|+|+.+..                              .....+|.+.|.++....+         
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3899986 45779999976321                              0122469999999876543         


Q ss_pred             ------Eeecc-CC---CC-----cHHHHHHHHHHHHHHHHH-HHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          147 ------HYSRA-SQ---RM-----PLIYVKLYTYQICRALAY-IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       147 ------~~~~~-~~---~~-----~~~~~~~~~~qi~~aL~~-LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                            .++.. +.   .+     .......++.+++..+.. +| +.||+|+||.+.|||++.+  .+.|+|||.+...
T Consensus        80 ~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~-~~givHGDLs~~NIlv~~~--~~~iIDf~qav~~  156 (188)
T PF01163_consen   80 RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLH-KAGIVHGDLSEYNILVDDG--KVYIIDFGQAVDS  156 (188)
T ss_dssp             TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHH-CTTEEESS-STTSEEEETT--CEEE--GTTEEET
T ss_pred             CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHH-hcCceecCCChhhEEeecc--eEEEEecCcceec
Confidence                  12220 11   11     122356677888885555 67 8999999999999999965  5999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.23  E-value=2.8e-07  Score=92.11  Aligned_cols=218  Identities=18%  Similarity=0.136  Sum_probs=144.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceEe-----------------eccCC-
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHY-----------------SRASQ-  153 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~~-----------------~~~~~-  153 (395)
                      -|...+.+++|+++++++.+...+...+ .+.+... ....-++++|.+++|||..+                 +.... 
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r  320 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR  320 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence            3667788999999999999987665555 7777655 33445899999999999310                 00001 


Q ss_pred             ------CCcH-----HHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccccccc
Q 016085          154 ------RMPL-----IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS  222 (395)
Q Consensus       154 ------~~~~-----~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt  222 (395)
                            ..++     .........-+.+|++|| +.-=+|||    ||+..+.  ..+.+||+............+..+|
T Consensus       321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~-~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~~t~~~~  393 (829)
T KOG0576|consen  321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELH-SSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKPRTAIGT  393 (829)
T ss_pred             cccccCChhhHhhhhhhhhhhhhhhcccccccc-cccccCcc----ccccccc--ccccccccCCcccCcccccccCCCC
Confidence                  1111     122233445567899999 54458888    8888764  4899999998776555555677889


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC-
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA-  301 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  301 (395)
                      +.++|||+..... +....|.||+|+-..+|--|-+|-....                .....-.    .....+.... 
T Consensus       394 ~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~----------------~~~~~~g----~~p~s~~L~~~  452 (829)
T KOG0576|consen  394 PEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPP----------------AVLPMIG----NGPNSPMLTDK  452 (829)
T ss_pred             CCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCc----------------cccCCCC----CCCCccccchh
Confidence            9999999887655 8999999999988777877777654311                1000000    0000011111 


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      ..|...+.       .++...|+..-|..|++..+++.|.+|+..
T Consensus       453 ~aw~~~~~-------~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  453 SAWSPVFH-------RDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             hhcCcccc-------cCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            12222111       257788999999999999999999999764

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.18  E-value=1.1e-05  Score=73.49  Aligned_cols=114  Identities=19%  Similarity=0.169  Sum_probs=80.1

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEee----------cc----------------hhhHHHHHHHHHhcCCC--
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----------QD----------------KRYKNRELQTMRLLDHP--  144 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~----------~~----------------~~~~~~E~~~l~~l~h~--  144 (395)
                      +.+...||-|-=|.||.|.+. .|..+|||.=+          ..                ....++|.++|+.|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            667789999999999999875 68999999421          11                12235799999988543  


Q ss_pred             ce------------Eeec-----cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCc
Q 016085          145 NV------------HYSR-----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  207 (395)
Q Consensus       145 ni------------~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a  207 (395)
                      .+            +-..     ..-++....+..++..|+.-+.-+- +.||||+|+.+-||+++.+| .+.++||--+
T Consensus       172 ~VP~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~-~~GiVHGDlSefNIlV~~dg-~~~vIDwPQ~  249 (304)
T COG0478         172 KVPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAY-RRGIVHGDLSEFNILVTEDG-DIVVIDWPQA  249 (304)
T ss_pred             CCCCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHH-HcCccccCCchheEEEecCC-CEEEEeCccc
Confidence            11            1000     0111134455566666776666666 67999999999999999988 5999999766


Q ss_pred             cc
Q 016085          208 KV  209 (395)
Q Consensus       208 ~~  209 (395)
                      ..
T Consensus       250 v~  251 (304)
T COG0478         250 VP  251 (304)
T ss_pred             cc
Confidence            43

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.14  E-value=1.4e-05  Score=74.34  Aligned_cols=52  Identities=15%  Similarity=0.280  Sum_probs=43.4

Q ss_pred             HHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC------CCceEEeecCCccc
Q 016085          157 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH------THQVKLCDFGSAKV  209 (395)
Q Consensus       157 ~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~------~~~ikl~DFG~a~~  209 (395)
                      ......++.++...+.-|| ..||+|+|+++.|||++.+      ...+.|+||+.+..
T Consensus       137 ~~~~~~ll~~la~~i~~LH-~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        137 PRLKRMLIKRVATMVRDMH-AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHH-HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            3455678889999999999 8999999999999999752      23699999998853

>PRK09902 hypothetical protein; Provisional

Probab=98.00  E-value=4.1e-05  Score=67.93  Aligned_cols=109  Identities=11%  Similarity=0.125  Sum_probs=77.1

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeec----------chhhHHHHHHHHHhcCCCce---------------------E
Q 016085           99 VGQGSFGIVFQAKCLETGETVAIKKVLQ----------DKRYKNRELQTMRLLDHPNV---------------------H  147 (395)
Q Consensus        99 lG~G~fg~V~~a~~~~~~~~vAiK~~~~----------~~~~~~~E~~~l~~l~h~ni---------------------~  147 (395)
                      -|+||.+.|++...  .|+.|-+|.-..          ....+.+|+..|+.|..-++                     .
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            36789999998764  444678885421          23456789999998865544                     0


Q ss_pred             eeccC--------------CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC-ceEEeecCCcccc
Q 016085          148 YSRAS--------------QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVL  210 (395)
Q Consensus       148 ~~~~~--------------~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~-~ikl~DFG~a~~~  210 (395)
                      ...-.              .+.+...-..++.++...+.-|| ..|+.|+|+-+.|||++.++. .++++||--++..
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH-~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH-SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            00011              12233444688999999999999 899999999999999985552 4999999876543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.94  E-value=5e-05  Score=81.09  Aligned_cols=174  Identities=23%  Similarity=0.352  Sum_probs=117.0

Q ss_pred             HHHHHHHHHhcCCCce------------------------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCe
Q 016085          131 KNRELQTMRLLDHPNV------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV  180 (395)
Q Consensus       131 ~~~E~~~l~~l~h~ni------------------------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~gi  180 (395)
                      ..-|+..+..+.|.|+                              .........+...++.+..+++.||.|+| +...
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h-~~~l  307 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH-SLSL  307 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH-Hhcc
Confidence            3457778888999997                              11223456778888999999999999999 5544


Q ss_pred             eeccCCCC---ceEEcCCCCceEEe--ecCCccccccCCCcccccccccccccccccCCCCCCC--cchHHHHHHHHHHH
Q 016085          181 CHRDIKPQ---NLLVNPHTHQVKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT--AVDIWSVGCVLAEL  253 (395)
Q Consensus       181 iHrDlKp~---Nill~~~~~~ikl~--DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwSlG~il~el  253 (395)
                      .|.-|..+   +--.+.++ .+.++  ||+..+.............+..+.++|...... +..  ..|+|.+|..+..+
T Consensus       308 ~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCcccccccccccccc-chhhhhhHHHHHHHHHhhh
Confidence            44433333   22233444 35555  888888776665555556677788888775432 333  47999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC
Q 016085          254 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT  333 (395)
Q Consensus       254 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t  333 (395)
                      ..|..+-.-.   .....++                                   .........+++.+|+.-++++|++
T Consensus       386 ~~~~~i~~~~---~~~~~~l-----------------------------------~~~~~~~~~d~~~~~~~~~~~~Rl~  427 (1351)
T KOG1035|consen  386 SQGEDISEKS---AVPVSLL-----------------------------------DVLSTSELLDALPKCLDEDSEERLS  427 (1351)
T ss_pred             hhcCcccccc---cchhhhh-----------------------------------ccccchhhhhhhhhhcchhhhhccc
Confidence            9886432110   0001100                                   0111126888999999999999999


Q ss_pred             HHHHhcCCcccC
Q 016085          334 ALEACIHPFFDE  345 (395)
Q Consensus       334 ~~e~l~hp~f~~  345 (395)
                      +.+++.|+|.+.
T Consensus       428 ~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  428 ALELLTHPFLRF  439 (1351)
T ss_pred             hhhhhhchhccc
Confidence            999999999754

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.83  E-value=0.00015  Score=65.53  Aligned_cols=110  Identities=17%  Similarity=0.229  Sum_probs=76.2

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecchhh----------------------------HHHHHHHHHhcCCC-----
Q 016085           98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY----------------------------KNRELQTMRLLDHP-----  144 (395)
Q Consensus        98 ~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----------------------------~~~E~~~l~~l~h~-----  144 (395)
                      .|..|--+.||+|.. .++..||+|+++.....                            ..+|+.-|+++...     
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            566777778999974 56889999988543211                            12477777766432     


Q ss_pred             -------ceE---eec----cC-----CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecC
Q 016085          145 -------NVH---YSR----AS-----QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  205 (395)
Q Consensus       145 -------ni~---~~~----~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG  205 (395)
                             |+.   ++.    ..     -.+....+..+..+++..+.-|-...|+||+||..=|||+. ++ .+.|+|||
T Consensus       134 ~Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~-~p~iID~~  211 (268)
T COG1718         134 EPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG-EPYIIDVS  211 (268)
T ss_pred             CceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-eEEEEECc
Confidence                   221   111    11     12223357888889999998888448999999999999999 44 59999999


Q ss_pred             Ccccc
Q 016085          206 SAKVL  210 (395)
Q Consensus       206 ~a~~~  210 (395)
                      -|-..
T Consensus       212 QaV~~  216 (268)
T COG1718         212 QAVTI  216 (268)
T ss_pred             ccccc
Confidence            88554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.82  E-value=4.4e-05  Score=68.24  Aligned_cols=53  Identities=25%  Similarity=0.429  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC--CceEEeecCCcccc
Q 016085          157 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVL  210 (395)
Q Consensus       157 ~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~--~~ikl~DFG~a~~~  210 (395)
                      ......++.++...+.-|| ..||+|+|+++.|||++.+.  ..+.|+||+.++..
T Consensus       117 ~~~~~~ll~~l~~~i~~lH-~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  117 PSQRRELLRALARLIAKLH-DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hhhHHHHHHHHHHHHHHHH-HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            4455678889999999999 89999999999999998765  24899999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.80  E-value=8.2e-05  Score=75.04  Aligned_cols=33  Identities=36%  Similarity=0.514  Sum_probs=29.4

Q ss_pred             CCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                      .|+.|.|..|.||+++.++ .+.+.|||+.....
T Consensus       284 dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~  316 (517)
T COG0661         284 DGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLD  316 (517)
T ss_pred             cCccccCCCccceEEecCC-cEEEEcCcceecCC
Confidence            4999999999999999998 69999999987653

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.67  E-value=0.00023  Score=60.99  Aligned_cols=113  Identities=21%  Similarity=0.359  Sum_probs=75.6

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCCCce---Ee----------eccCCCCcH
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNV---HY----------SRASQRMPL  157 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~ni---~~----------~~~~~~~~~  157 (395)
                      -++.+.||+|.+|.||++..  .|..+|+|+-+.+  ......|.++|..++-.++   .+          ...+.++..
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~  101 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGK  101 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhh
Confidence            45567899999999999987  6679999976544  4556789999999987665   11          111222322


Q ss_pred             HHH---HHHHHHHHHHHHHHHcCCCeeeccCCC--CceEEcCCCCceEEeecCCcccc
Q 016085          158 IYV---KLYTYQICRALAYIHGGIGVCHRDIKP--QNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       158 ~~~---~~~~~qi~~aL~~LH~~~giiHrDlKp--~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                      ...   +.-...++.+---|- ..||-|..|.-  .||+++ ++ .+.|+||..|+.-
T Consensus       102 ~~~~~~rk~l~~vlE~a~~LD-~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At~k  156 (201)
T COG2112         102 LEIGGDRKHLLRVLEKAYKLD-RLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSATFK  156 (201)
T ss_pred             hhhcccHHHHHHHHHHHHHHH-HhccchhhhcCCceeEEec-CC-cEEEEEccchhhc
Confidence            222   333444555533344 78999999864  356665 44 5999999998743

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.64  E-value=0.00054  Score=61.17  Aligned_cols=114  Identities=17%  Similarity=0.207  Sum_probs=72.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHH-------------HHHHHHHhcCCCce----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------------RELQTMRLLDHPNV----------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~-------------~E~~~l~~l~h~ni----------  146 (395)
                      ..+|.+.+++-......|.+..-  .|+.+.+|..+......+             +++..+..+....+          
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            34688889998888888887764  678899997754432211             23332323211110          


Q ss_pred             ------------Eee--ccCCCCcHHH--HHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcc
Q 016085          147 ------------HYS--RASQRMPLIY--VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  208 (395)
Q Consensus       147 ------------~~~--~~~~~~~~~~--~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~  208 (395)
                                  ...  ..+..+....  -..+...+..++.-|| ..|+.|+|..|.|++++.++  ++++||+..+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH-~~G~~HGD~hpgNFlv~~~~--i~iID~~~k~  182 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLH-KHGFYHGDPHPGNFLVSNNG--IRIIDTQGKR  182 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHH-HcCCccCCCCcCcEEEECCc--EEEEECcccc
Confidence                        000  1122222111  1134456778899999 89999999999999999554  9999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.44  E-value=0.001  Score=59.79  Aligned_cols=45  Identities=18%  Similarity=0.137  Sum_probs=34.7

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcC
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLD  142 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~  142 (395)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.|.
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~   48 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLA   48 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHH
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHH
Confidence            4678999999999998643  58999987655  345567888887774

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.15  E-value=0.0044  Score=54.70  Aligned_cols=108  Identities=25%  Similarity=0.293  Sum_probs=70.7

Q ss_pred             cceeeeeeeccCCc-eEEEEEEEcCCCcEEEEEEeec----------------c---------hhhHHHHHHHHHhcCC-
Q 016085           91 ISYMAERVVGQGSF-GIVFQAKCLETGETVAIKKVLQ----------------D---------KRYKNRELQTMRLLDH-  143 (395)
Q Consensus        91 ~~y~~~~~lG~G~f-g~V~~a~~~~~~~~vAiK~~~~----------------~---------~~~~~~E~~~l~~l~h-  143 (395)
                      .+++.++.||.|.- |.||+++.  .|+.||+|.+..                .         ...+..|.+...+|+. 
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            36899999999999 99999987  788999998321                0         0122345555555532 


Q ss_pred             --CceEeeccC--CCCc-------------------------------HHHHHHHHHHHHHHHHHHHcCCCeeeccCCCC
Q 016085          144 --PNVHYSRAS--QRMP-------------------------------LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQ  188 (395)
Q Consensus       144 --~ni~~~~~~--~~~~-------------------------------~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~  188 (395)
                        .++...+..  -.++                               ......-+.+|..-+..+| ..||+-+|+|+.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~-k~gI~~~Dv~~~  193 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILH-KLGIVPRDVKPR  193 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHH-HCCeeeccCccc
Confidence              222000000  0001                               0112234568889999999 899999999999


Q ss_pred             ceEEcCCCCceEEeecCCc
Q 016085          189 NLLVNPHTHQVKLCDFGSA  207 (395)
Q Consensus       189 Nill~~~~~~ikl~DFG~a  207 (395)
                      |..   +   -||+|||.+
T Consensus       194 ny~---~---G~lvDfs~~  206 (207)
T PF13095_consen  194 NYR---G---GKLVDFSSS  206 (207)
T ss_pred             ccc---C---CEEEecccC
Confidence            976   2   379999965

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.14  E-value=0.0037  Score=56.68  Aligned_cols=43  Identities=19%  Similarity=0.180  Sum_probs=31.2

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCC
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDH  143 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h  143 (395)
                      ..||+|..+.||+.    .+..+++|.....  .....+|.++++.+..
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~   51 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFS   51 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHH
Confidence            57899999999974    2556788987543  2345789999887753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.84  E-value=0.0058  Score=61.80  Aligned_cols=34  Identities=35%  Similarity=0.571  Sum_probs=28.5

Q ss_pred             CCeeeccCCCCceEEcC---CCCceEEeecCCccccc
Q 016085          178 IGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~---~~~~ikl~DFG~a~~~~  211 (395)
                      .|++|+|-.|.||++.+   .+..+.+.|||+.....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            48999999999999984   24479999999987653

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.61  E-value=0.016  Score=55.56  Aligned_cols=112  Identities=17%  Similarity=0.261  Sum_probs=80.6

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------------------------------hhhHHHHHHHHHhcCCC
Q 016085           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------------------------------KRYKNRELQTMRLLDHP  144 (395)
Q Consensus        95 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------------------------------~~~~~~E~~~l~~l~h~  144 (395)
                      +..+|..|--+.||.|. ..+|..+|||+++..                              +.....|++-|++|...
T Consensus       148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            34567778888899997 467888999976421                              01234688888888654


Q ss_pred             ce---------------Eee---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceE
Q 016085          145 NV---------------HYS---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK  200 (395)
Q Consensus       145 ni---------------~~~---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ik  200 (395)
                      .|               .++         .....++...++.+-.|++.-+.-|-..+++||.||.-=|+|+- +| .+.
T Consensus       227 GIP~PePIlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG-~ly  304 (520)
T KOG2270|consen  227 GIPCPEPILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG-KLY  304 (520)
T ss_pred             CCCCCCceeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC-EEE
Confidence            43               111         11234666678888888888888777689999999999999997 35 599


Q ss_pred             EeecCCccc
Q 016085          201 LCDFGSAKV  209 (395)
Q Consensus       201 l~DFG~a~~  209 (395)
                      |+|.+-+-.
T Consensus       305 iIDVSQSVE  313 (520)
T KOG2270|consen  305 IIDVSQSVE  313 (520)
T ss_pred             EEEcccccc
Confidence            999887644

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.55  E-value=0.015  Score=52.72  Aligned_cols=32  Identities=31%  Similarity=0.539  Sum_probs=26.2

Q ss_pred             CCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      .+++|+|+.+.|||++.++..+.|+||-.|..
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            46999999999999997322699999987743

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.49  E-value=0.0025  Score=70.36  Aligned_cols=151  Identities=17%  Similarity=0.006  Sum_probs=96.4

Q ss_pred             HHHHHHHHHHHcCCC----eeeccCCCCceEEcCCCCceEEeecCCccc-cccCCCcccccccccccccccccCCCCCCC
Q 016085          165 YQICRALAYIHGGIG----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGATEYTT  239 (395)
Q Consensus       165 ~qi~~aL~~LH~~~g----iiHrDlKp~Nill~~~~~~ikl~DFG~a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  239 (395)
                      .+.+.+..-+|+..+    .+|++||+-|.+|..+. .+|+.++|+.+. ..........+|++.|+++++... ..++.
T Consensus      1342 kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~ 1419 (2724)
T KOG1826|consen 1342 KVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTK 1419 (2724)
T ss_pred             HHHHhccchhhhcccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-Hhhhh
Confidence            343566666563222    68999999999998776 599999999983 222222234567899999997744 44788


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHH
Q 016085          240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDL  319 (395)
Q Consensus       240 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  319 (395)
                      ++|+|..|+.+|+...|..+|.     ..++.+++.           .-.+-..++++.            -.|.++-..
T Consensus      1420 rsdilr~s~~ly~rs~~n~~fi-----~flq~~Lkg-----------iidn~tf~sIe~------------l~pgdaNve 1471 (2724)
T KOG1826|consen 1420 RSDILRRSLSLYLRSDGNAYFI-----FFLQPALKG-----------IIDNHTFFSIEK------------LKPGDANVE 1471 (2724)
T ss_pred             HHHHHHHHHHHHHHhcccHHHH-----HHHHHHHcC-----------cccccccccccc------------cCCCcccHH
Confidence            8999999999999999988772     222222221           111111222221            123444445


Q ss_pred             HHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          320 VSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       320 l~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      ...+|-+.-..||.-...+.-+.|..
T Consensus      1472 ~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1472 ALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred             HHHHHHHHhhhcchhhhhcccccccc
Confidence            55555566678888888777776643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.49  E-value=0.011  Score=54.44  Aligned_cols=29  Identities=34%  Similarity=0.493  Sum_probs=25.4

Q ss_pred             CeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       179 giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      .++|+|+.|.||+++.++  +.|+||..|..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC--CEEEeccccCc
Confidence            589999999999999765  78999998854

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=96.38  E-value=0.014  Score=55.64  Aligned_cols=31  Identities=29%  Similarity=0.268  Sum_probs=25.6

Q ss_pred             CCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      .|+||+|+.|.||+++.+. ..-|+||+.|..
T Consensus       187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence            4899999999999998543 457999998743

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.36  E-value=0.012  Score=55.47  Aligned_cols=30  Identities=30%  Similarity=0.315  Sum_probs=25.6

Q ss_pred             CCeeeccCCCCceEEcCCCCceEEeecCCcc
Q 016085          178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  208 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~~~~~ikl~DFG~a~  208 (395)
                      .++||+|+.|.||+++.++ .+.|+||+.|.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            4799999999999999754 46899999774

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.31  E-value=0.044  Score=51.77  Aligned_cols=32  Identities=31%  Similarity=0.523  Sum_probs=26.4

Q ss_pred             CCCeeeccCCCCceEEcCC---CCceEEeecCCcc
Q 016085          177 GIGVCHRDIKPQNLLVNPH---THQVKLCDFGSAK  208 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~---~~~ikl~DFG~a~  208 (395)
                      ..+++|+|+.+.|||++.+   .+.+.|+||..|.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            3478999999999999874   2269999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.23  E-value=0.017  Score=54.75  Aligned_cols=31  Identities=32%  Similarity=0.389  Sum_probs=26.6

Q ss_pred             CCCeeeccCCCCceEEcCCCCceEEeecCCcc
Q 016085          177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  208 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~  208 (395)
                      ..++||+|+.+.||+++.++ .+.|+||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence            36899999999999998765 46899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02876 acyl-CoA dehydrogenase

Probab=96.21  E-value=0.056  Score=58.53  Aligned_cols=51  Identities=24%  Similarity=0.320  Sum_probs=35.1

Q ss_pred             eeeeccCCceEEEEEEEcCCC--cEEEEEEeec-----chhhHHHHHHHHHhcC-CCce
Q 016085           96 ERVVGQGSFGIVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTMRLLD-HPNV  146 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~--~~vAiK~~~~-----~~~~~~~E~~~l~~l~-h~ni  146 (395)
                      .+.|+.|.+..+|+......+  ..+++|+...     ......+|+++|+.|. |.++
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~v  101 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDV  101 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCC
Confidence            467889999999988764332  4677776532     2345678999999885 5554

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=95.84  E-value=0.094  Score=47.81  Aligned_cols=31  Identities=29%  Similarity=0.407  Sum_probs=25.7

Q ss_pred             CCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ..++|+|+.|.|||++.++ .+.|+||+.|..
T Consensus       163 ~~l~HgD~~~~Nil~~~~~-~~~iIDwe~a~~  193 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGK-FSGFIDLGRLGV  193 (244)
T ss_pred             eEEECCCCCCccEEEeCCc-EEEEEEcccccc
Confidence            3489999999999999754 578999997743

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.72  E-value=0.017  Score=54.48  Aligned_cols=114  Identities=13%  Similarity=0.147  Sum_probs=73.1

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEe----------ecch----------------hhHHHHHHHHHhcCCCc-
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----------LQDK----------------RYKNRELQTMRLLDHPN-  145 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~----------~~~~----------------~~~~~E~~~l~~l~h~n-  145 (395)
                      |.+.+.||-|--+.||.+-+ ..|...++|.=          +.+.                -...+|...|+.|.... 
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            77889999999999999986 45888999832          1111                11235888887774311 


Q ss_pred             -----------e--EeeccCCCC----cHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcc
Q 016085          146 -----------V--HYSRASQRM----PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  208 (395)
Q Consensus       146 -----------i--~~~~~~~~~----~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~  208 (395)
                                 +  +-.....++    ....+..+...+..-+--|. +.|+||+|+.-=||++..++ .++++||--+-
T Consensus       173 pVPkpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la-~~GlIHgDFNEFNimv~dd~-~i~vIDFPQmv  250 (465)
T KOG2268|consen  173 PVPKPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLA-NHGLIHGDFNEFNIMVKDDD-KIVVIDFPQMV  250 (465)
T ss_pred             CCCCcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHH-HcCceecccchheeEEecCC-CEEEeechHhh
Confidence                       1  001111111    01122334445555556676 78999999999999999777 59999997654


Q ss_pred             c
Q 016085          209 V  209 (395)
Q Consensus       209 ~  209 (395)
                      .
T Consensus       251 S  251 (465)
T KOG2268|consen  251 S  251 (465)
T ss_pred             c
Confidence            3

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.57  E-value=0.0055  Score=60.89  Aligned_cols=91  Identities=21%  Similarity=0.294  Sum_probs=67.8

Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHH
Q 016085          239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVD  318 (395)
Q Consensus       239 ~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  318 (395)
                      +++||||+|.++.++.-|...|......+++..+.+..-.+.....-.+..                 .+...++..+..
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~-----------------~~~~~~d~~~~~  172 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEH-----------------LIQLLADKKRLP  172 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH-----------------HHHHhhhHhHHH
Confidence            599999999999999999999887777777777766433222211111000                 122235778899


Q ss_pred             HHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          319 LVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       319 ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      ++.+|+-..|..||...++.+++-|.++
T Consensus       173 ~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  173 LLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HhccCCccccccccchhHHhcCccHHHH
Confidence            9999999999999999999999999775

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.47  E-value=0.12  Score=49.69  Aligned_cols=30  Identities=23%  Similarity=0.411  Sum_probs=25.6

Q ss_pred             eeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       180 iiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ++|.|+-+.|||++++++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975544699999998854

>PLN02236 choline kinase

Probab=95.18  E-value=0.12  Score=50.03  Aligned_cols=32  Identities=28%  Similarity=0.670  Sum_probs=26.7

Q ss_pred             CCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ..++|+|+++.|||++.+...+.|+||..|..
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            36899999999999986434699999998854

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=95.09  E-value=0.12  Score=45.89  Aligned_cols=103  Identities=21%  Similarity=0.290  Sum_probs=61.5

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecch--------------------hhHHHHHHHHHhcC-CCce---------
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------------------RYKNRELQTMRLLD-HPNV---------  146 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--------------------~~~~~E~~~l~~l~-h~ni---------  146 (395)
                      ..||+|+.=.||.--   .+...+||++....                    ....+|+.-...+. ..++         
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            578999999999653   34567889886554                    34456777777776 4433         


Q ss_pred             --------------EeeccCCCCc--HHHHH-------HHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC--C-ceE
Q 016085          147 --------------HYSRASQRMP--LIYVK-------LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--H-QVK  200 (395)
Q Consensus       147 --------------~~~~~~~~~~--~~~~~-------~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~--~-~ik  200 (395)
                                    ......+..+  .....       .+...+-.-..||- ..+|+.+||+|.||++....  . .+.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~-~~~Iv~~dl~~~NIv~~~~~~~~~~lv  162 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLL-DHHIVIRDLNPHNIVVQRRDSGEFRLV  162 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHH-HcCCeecCCCcccEEEEecCCCceEEE
Confidence                          1111122211  11111       12222333445676 67999999999999995432  2 477


Q ss_pred             Eee
Q 016085          201 LCD  203 (395)
Q Consensus       201 l~D  203 (395)
                      |+|
T Consensus       163 lID  165 (199)
T PF10707_consen  163 LID  165 (199)
T ss_pred             EEe
Confidence            777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=94.63  E-value=0.45  Score=46.88  Aligned_cols=31  Identities=19%  Similarity=0.230  Sum_probs=26.1

Q ss_pred             CCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ...++|||+.+.||++..+  .++++||-+|..
T Consensus       222 ~~~l~HgDl~~gni~~~~~--~~~viD~E~a~~  252 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE--ETKVIDPEFAFY  252 (401)
T ss_pred             CCceeeccCCcccEEeeCC--CcEEEecccccc
Confidence            4579999999999999865  489999987754

>PRK10593 hypothetical protein; Provisional

Probab=94.00  E-value=1  Score=42.56  Aligned_cols=45  Identities=4%  Similarity=0.034  Sum_probs=32.1

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeec--chhhHHHHHHHHHhcC
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLD  142 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~--~~~~~~~E~~~l~~l~  142 (395)
                      .+.||.|..+.||+..+  .+..+.+|..+.  ......+|...|+.|.
T Consensus        19 ~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~   65 (297)
T PRK10593         19 VECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLA   65 (297)
T ss_pred             eeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHc
Confidence            35799999999999864  223577777544  2346778988888774

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=93.75  E-value=0.14  Score=44.97  Aligned_cols=55  Identities=22%  Similarity=0.161  Sum_probs=46.1

Q ss_pred             CCcHHHHHHHHHHHHHHHHHHHc--CCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          154 RMPLIYVKLYTYQICRALAYIHG--GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       154 ~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ..++.....++.+++..+++|+.  ...+.-.|++++|+-++.++ ++|++|...+..
T Consensus        55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~  111 (188)
T PF12260_consen   55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFV  111 (188)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCC-cEEEEechhcch
Confidence            45788889999999999999993  03477899999999999877 699999987644

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.60  E-value=0.15  Score=48.21  Aligned_cols=31  Identities=29%  Similarity=0.547  Sum_probs=26.0

Q ss_pred             CCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ..++||+|+.+.||+++. + .+.|+||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-N-EVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-C-cEEEEECccccc
Confidence            358999999999999986 4 489999997643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=93.55  E-value=0.087  Score=47.85  Aligned_cols=32  Identities=34%  Similarity=0.403  Sum_probs=25.6

Q ss_pred             CCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ..+++|+|+.+.||+++.++ ..-|+||+.|..
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~~  194 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGR-LSAVIDFGCLGV  194 (235)
T ss_pred             CceEEeCCCCCCcEEEECCC-EEEEEeCcccCc
Confidence            45699999999999998543 456999998743

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.44  E-value=0.11  Score=45.49  Aligned_cols=29  Identities=24%  Similarity=0.324  Sum_probs=24.9

Q ss_pred             CeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       179 giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      -.+|+|+.|.||+++.++  ++|+||+.|..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            469999999999998654  89999998854

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=92.39  E-value=0.16  Score=48.42  Aligned_cols=35  Identities=31%  Similarity=0.423  Sum_probs=23.1

Q ss_pred             HHHHHHHHHHHHHHH---HHcCCCeeeccCCCCceEEc
Q 016085          159 YVKLYTYQICRALAY---IHGGIGVCHRDIKPQNLLVN  193 (395)
Q Consensus       159 ~~~~~~~qi~~aL~~---LH~~~giiHrDlKp~Nill~  193 (395)
                      .+++++.||+.-.--   |-+....+|-||||+|||+-
T Consensus       276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  313 (434)
T PF05445_consen  276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIF  313 (434)
T ss_pred             HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEe
Confidence            356667776553311   22234699999999999984

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=92.28  E-value=0.15  Score=45.50  Aligned_cols=31  Identities=42%  Similarity=0.741  Sum_probs=20.4

Q ss_pred             CCeeeccCCCCceEE-cCCCCceEEeecCCccc
Q 016085          178 IGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       178 ~giiHrDlKp~Nill-~~~~~~ikl~DFG~a~~  209 (395)
                      ..++|.||.+.|||+ +.++ .++|+||-.|..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDG-EVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSS-CEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCC-eEEEecHHHHhh
Confidence            468999999999999 4444 699999998865

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=91.91  E-value=1.2  Score=43.12  Aligned_cols=31  Identities=23%  Similarity=0.261  Sum_probs=26.1

Q ss_pred             CCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ...++|+||.+.||+++.++  ++++|+.++..
T Consensus       191 ~~~llHGDl~~gNi~~~~~~--~~~iD~e~~~~  221 (370)
T TIGR01767       191 AETLLHGDLHSGSIFVSEHE--TKVIDPEFAFY  221 (370)
T ss_pred             cceeeeccCCcccEEEcCCC--CEEEcCccccc
Confidence            55799999999999998654  88999987754

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.69  E-value=0.44  Score=42.03  Aligned_cols=33  Identities=21%  Similarity=0.231  Sum_probs=26.6

Q ss_pred             CCCeeeccCCCCceEEcCCCC----ceEEeecCCccc
Q 016085          177 GIGVCHRDIKPQNLLVNPHTH----QVKLCDFGSAKV  209 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~~~----~ikl~DFG~a~~  209 (395)
                      ...++|||+.+.||++..++.    .+.|+||..+..
T Consensus       119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             ceEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            347999999999999975432    589999998754

subfamily of choline kinases

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=91.60  E-value=0.35  Score=46.59  Aligned_cols=53  Identities=17%  Similarity=0.245  Sum_probs=42.9

Q ss_pred             cHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          156 PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       156 ~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                      ...++..++++.+.-+.-+...-.+-|||+..+||||+ +| .|.|+||-+|+..
T Consensus       319 ~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDfklsRl~  371 (488)
T COG5072         319 RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDFKLSRLS  371 (488)
T ss_pred             cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEeeeeecc
Confidence            35566777778777777776566789999999999999 77 5999999999854

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=91.51  E-value=0.15  Score=47.74  Aligned_cols=32  Identities=28%  Similarity=0.508  Sum_probs=26.0

Q ss_pred             CCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ..++|+|+.|.|||++.++...-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999996553456999998854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=91.16  E-value=1.7  Score=42.78  Aligned_cols=35  Identities=17%  Similarity=0.276  Sum_probs=27.8

Q ss_pred             HHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       173 ~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      |+-....++|+||.|.||+++.++  +|++|.-+|-.
T Consensus       222 F~~~~~aLlHGDlHtGSI~v~~~~--~kvIDpEFAfy  256 (409)
T PRK12396        222 FMTNAQALIHGDLHTGSVFVKNDS--TKVIDPEFAFY  256 (409)
T ss_pred             HHhcchhhccCcCCCCCEEecCCc--eEEEccccccc
Confidence            343455799999999999999764  89999877744

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=91.11  E-value=0.4  Score=44.64  Aligned_cols=46  Identities=28%  Similarity=0.426  Sum_probs=34.3

Q ss_pred             HHHHHHHHHHHHHcC-CCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          163 YTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       163 ~~~qi~~aL~~LH~~-~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      .+..+-.++.-.+.. .-++|+|+.|+|+|.++.+ .++|+||-.|..
T Consensus       137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~  183 (269)
T COG0510         137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence            344555556666522 3599999999999999866 599999988754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=91.02  E-value=0.36  Score=46.30  Aligned_cols=29  Identities=31%  Similarity=0.564  Sum_probs=25.1

Q ss_pred             eeeccCCCCceEEcCCCCceEEeecCCcc
Q 016085          180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAK  208 (395)
Q Consensus       180 iiHrDlKp~Nill~~~~~~ikl~DFG~a~  208 (395)
                      +||+|+.|+||+++.+...+.++||+-|.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            99999999999999775338899999774

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=90.95  E-value=0.31  Score=46.22  Aligned_cols=32  Identities=13%  Similarity=0.170  Sum_probs=27.4

Q ss_pred             CCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ..++||+|+.++|+|++.++ .+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETR-GGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence            34899999999999998776 589999988754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=90.91  E-value=2.7  Score=41.30  Aligned_cols=30  Identities=27%  Similarity=0.370  Sum_probs=24.8

Q ss_pred             CCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ..++|.|+-+.||+.+.+  .+.++||-.|..
T Consensus       227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEecCC--CEEEEEeccccC
Confidence            468999999999998754  499999987743

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=90.80  E-value=0.24  Score=44.41  Aligned_cols=39  Identities=23%  Similarity=0.302  Sum_probs=32.9

Q ss_pred             HHHHHHHH-cCCCeeeccCCCCceEEcCCCCceEEeecCCc
Q 016085          168 CRALAYIH-GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  207 (395)
Q Consensus       168 ~~aL~~LH-~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a  207 (395)
                      +.+|.-.| ++.+.+|+|-.|+||+-|+.| .+||.|=+..
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G-~lKlVDP~~L  190 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFG-YLKLVDPVCL  190 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCC-CEEecChhhh
Confidence            46788888 466899999999999999999 5999997653

The function of this family is unknown.

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=89.54  E-value=0.18  Score=40.72  Aligned_cols=44  Identities=25%  Similarity=0.290  Sum_probs=32.3

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecchh-hHHHHHHHHHhc
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-YKNRELQTMRLL  141 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-~~~~E~~~l~~l  141 (395)
                      +-||.|+.|.||+|+.+ +|+.||||+.+.... .....+.+|+.+
T Consensus        17 ~PlasASiaQVh~a~l~-~g~~VaVKV~rP~i~~~i~~Dl~~l~~~   61 (119)
T PF03109_consen   17 EPLASASIAQVHRARLK-DGEEVAVKVQRPGIEEQIEADLRILRRL   61 (119)
T ss_pred             chhhheehhhheeeeec-ccchhhhhhcchHHHHHHHHHHHHHHHH
Confidence            57999999999999864 499999999876543 334455555443

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PHA03111 Ser/Thr kinase; Provisional

Probab=89.05  E-value=0.92  Score=43.18  Aligned_cols=37  Identities=30%  Similarity=0.339  Sum_probs=25.9

Q ss_pred             HHHHHHHHHHHHHHHHHH---cCCCeeeccCCCCceEEcC
Q 016085          158 IYVKLYTYQICRALAYIH---GGIGVCHRDIKPQNLLVNP  194 (395)
Q Consensus       158 ~~~~~~~~qi~~aL~~LH---~~~giiHrDlKp~Nill~~  194 (395)
                      ..+++++.||+.-.-.+-   ....++|-||||+|||+-+
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd  318 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD  318 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence            346777888876553332   1236999999999999843

>PTZ00296 choline kinase; Provisional

Probab=87.36  E-value=4.6  Score=40.49  Aligned_cols=30  Identities=27%  Similarity=0.535  Sum_probs=24.5

Q ss_pred             CCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ..++|.|+-+.|||.+.+  .++|+||-.|..
T Consensus       284 ~VfCHNDl~~~NiL~~~~--~l~LIDfEYAg~  313 (442)
T PTZ00296        284 IVFCHNDLQENNIINTNK--CLRLIDFEYSGY  313 (442)
T ss_pred             eeEEeCCCCccceeecCC--CEEEEeeccccc
Confidence            358999999999998744  399999987743

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	395
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-125
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-125
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-125
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-125
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-125
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-125
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-125
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-124
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-124
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-124
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-124
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-124
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-124
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-123
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-123
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-123
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-123
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-123
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-122
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-122
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-120
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-115
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-74
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-71
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-43
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-43
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-42
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-41
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-41
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-41
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-41
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-40
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-40
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-40
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-40
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-40
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-40
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-40
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-40
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-40
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-40
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-40
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-40
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-40
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-40
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-40
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-40
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-40
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-40
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-40
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-40
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-40
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-40
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-40
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-40
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-40
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-40
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-40
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-40
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-40
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-40
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-40
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-40
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-40
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-40
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-40
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-40
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-40
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-40
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-40
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-40
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-40
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-40
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-40
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-39
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-39
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-39
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-39
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-39
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-39
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-39
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-39
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-39
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-39
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-39
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-39
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-39
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-39
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-39
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-38
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-38
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-38
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-38
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-38
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-38
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-38
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-38
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-38
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-37
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-37
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-36
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-36
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-36
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-35
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-35
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-35
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-35
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-35
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-35
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-35
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-35
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-35
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-35
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-35
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-35
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-35
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-35
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-35
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-35
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-35
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-35
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-35
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-35
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-35
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-35
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-35
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-35
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-35
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-35
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-35
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-35
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-35
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-35
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-35
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-35
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-35
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-35
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-35
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-35
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-35
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-35
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-35
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-35
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-35
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-35
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-35
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-35
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-35
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-35
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-35
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-35
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-35
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-35
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-35
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-34
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-34
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-34
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-34
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-34
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-34
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-34
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-34
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-34
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-34
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-34
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-31
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-31
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-30
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-30
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-30
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-30
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-30
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-30
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-30
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-30
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-30
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-30
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-30
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		5e-30
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-30
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		8e-30
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-29
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-29
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-29
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-29
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-29
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-29
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-29
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-29
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-29
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-29
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-29
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-29
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-29
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-29
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-29
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-29
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-29
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-29
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-29
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-28
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-28
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-28
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-28
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-27
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-27
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-27
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-27
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-27
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-27
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-27
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-27
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-27
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-27
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-27
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-27
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-27
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-27
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-27
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-27
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-27
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-27
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-27
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-27
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-27
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-27
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-27
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-26
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-26
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-26
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-26
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-25
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-25
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-25
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-24
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-24
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-24
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-23
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-23
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-23
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-23
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-23
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-23
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-23
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-23
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-23
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-23
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-23
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-23
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-21
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-21
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-21
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-21
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-21
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-21
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-21
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-21
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-20
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-20
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-20
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-20
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-20
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-20
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-20
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-20
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-20
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-20
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-20
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-20
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-20
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-20
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-20
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-20
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-20
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-20
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-20
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-19
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-18
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-18
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-17
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-16
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-16
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-16
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		7e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-16
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-15
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-15
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-15
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-15
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-15
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-15
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-15
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-14
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-14
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-14
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-14
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-14
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-13
3soa_A	444	Full-Length Human Camkii Length = 444		3e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-13
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-13
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-12
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-12
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		8e-12
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-12
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-12
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-11
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		9e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-10
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-10
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-10
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-09
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-08
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-08
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-08
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-07
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-07
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-06
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-06
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-06
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-06
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-06
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-06
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-06
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-06
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-06
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-06
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-06
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-06
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-06
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-06
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-06
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-06
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-05
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-04
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-04
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		1e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-04
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-04
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-04
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-04

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  446 bits (1147), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 219/359 (61%), Positives = 261/359 (72%), Gaps = 39/359 (10%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 25  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 82
Query: 126 QDKRYKNRELQTMRLLDHPNV-----------------------------------HYSR 150
           QDKR+KNRELQ MR LDH N+                                   HYSR
Sbjct: 83  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 142
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 210
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 143 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLV 270
           V+GEPN+SYICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 321
Query: 331 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q
Sbjct: 322 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQ 379

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  446 bits (1146), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 219/359 (61%), Positives = 261/359 (72%), Gaps = 39/359 (10%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 126 QDKRYKNRELQTMRLLDHPNV-----------------------------------HYSR 150
           QDKR+KNRELQ MR LDH N+                                   HYSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 210
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLV 270
           V+GEPN+SYICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 331 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQ 385

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  446 bits (1146), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 219/360 (60%), Positives = 261/360 (72%), Gaps = 39/360 (10%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 33  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 90
Query: 126 QDKRYKNRELQTMRLLDHPNV-----------------------------------HYSR 150
           QDKR+KNRELQ MR LDH N+                                   HYSR
Sbjct: 91  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 150
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 210
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 151 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLV 270
           V+GEPN+SYICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 329
Query: 331 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 330 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 388

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  445 bits (1145), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 219/360 (60%), Positives = 261/360 (72%), Gaps = 39/360 (10%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 76  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 133
Query: 126 QDKRYKNRELQTMRLLDHPNV-----------------------------------HYSR 150
           QDKR+KNRELQ MR LDH N+                                   HYSR
Sbjct: 134 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 193
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 210
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 194 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLV 270
           V+GEPN+SYICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 372
Query: 331 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 373 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 431

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  445 bits (1145), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 219/360 (60%), Positives = 261/360 (72%), Gaps = 39/360 (10%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 35  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 92
Query: 126 QDKRYKNRELQTMRLLDHPNV-----------------------------------HYSR 150
           QDKR+KNRELQ MR LDH N+                                   HYSR
Sbjct: 93  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 152
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 210
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 153 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLV 270
           V+GEPN+SYICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 331
Query: 331 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 332 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 390

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  444 bits (1142), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 219/359 (61%), Positives = 261/359 (72%), Gaps = 39/359 (10%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 126 QDKRYKNRELQTMRLLDHPNV-----------------------------------HYSR 150
           QDKR+KNRELQ MR LDH N+                                   HYSR
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 210
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLV 270
           V+GEPN+SYICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 331 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q
Sbjct: 307 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQ 364

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  444 bits (1141), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 220/352 (62%), Positives = 257/352 (73%), Gaps = 40/352 (11%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 8   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 67
Query: 134 ELQTMRLLDHPNV-----------------------------------HYSRASQRMPLI 158
           ELQ MR LDH N+                                   HYSRA Q +P+I
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 127
Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 218
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 128 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 186
Query: 219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
           YICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 187 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 246
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 247 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 306
Query: 339 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 390
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 307 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 357

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  443 bits (1139), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 218/359 (60%), Positives = 260/359 (72%), Gaps = 39/359 (10%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 126 QDKRYKNRELQTMRLLDHPNV-----------------------------------HYSR 150
           QDKR+KNRELQ MR LDH N+                                   HYSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 210
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLV 270
           V+GEPN+S ICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 331 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQ 385

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  442 bits (1136), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 220/375 (58%), Positives = 266/375 (70%), Gaps = 46/375 (12%)
Query: 51  IKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQA 110
           ++G +V +       D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QA
Sbjct: 1   MRGSKVSR-------DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQA 51
Query: 111 KCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV------------------------ 146
           K  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+                        
Sbjct: 52  KLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 111
Query: 147 -----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH 195
                      HYSRA Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P 
Sbjct: 112 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPD 170
Query: 196 THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL 255
           T  +KLCDFGSAK LV+GEPN+S ICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLL
Sbjct: 171 TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 230
Query: 256 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPE 315
           GQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPE
Sbjct: 231 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE 290
Query: 316 AVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASK 375
           A+ L SRLL+Y+P  R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++ 
Sbjct: 291 AIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNP 349
Query: 376 ELLSKLIPEHARKQC 390
            L + LIP HAR Q 
Sbjct: 350 PLATILIPPHARIQA 364

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  441 bits (1135), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 218/359 (60%), Positives = 260/359 (72%), Gaps = 39/359 (10%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 126 QDKRYKNRELQTMRLLDHPNV-----------------------------------HYSR 150
           QDKR+KNRELQ MR LDH N+                                   HYSR
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 210
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLV 270
           V+GEPN+S ICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 331 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q
Sbjct: 313 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQ 370

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  441 bits (1134), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 218/360 (60%), Positives = 260/360 (72%), Gaps = 39/360 (10%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 126 QDKRYKNRELQTMRLLDHPNV-----------------------------------HYSR 150
           QDKR+KNRELQ MR LDH N+                                   HYSR
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 210
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLV 270
           V+GEPN+S ICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 331 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 364

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  441 bits (1134), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 218/359 (60%), Positives = 260/359 (72%), Gaps = 39/359 (10%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 126 QDKRYKNRELQTMRLLDHPNV-----------------------------------HYSR 150
           QDKR+KNRELQ MR LDH N+                                   HYSR
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 210
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLV 270
           V+GEPN+S ICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 331 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q
Sbjct: 302 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQ 359

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  440 bits (1132), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 219/349 (62%), Positives = 256/349 (73%), Gaps = 40/349 (11%)
Query: 77  VTTIGGRNGQ---PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 134 ELQTMRLLDHPNV-----------------------------------HYSRASQRMPLI 158
           ELQ MR LDH N+                                   HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 218
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
           YICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 339 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 387
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 349

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  438 bits (1127), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 219/351 (62%), Positives = 256/351 (72%), Gaps = 40/351 (11%)
Query: 77  VTTIGGRNGQ---PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 134 ELQTMRLLDHPNV-----------------------------------HYSRASQRMPLI 158
           ELQ MR LDH N+                                   HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 218
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            ICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 339 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQ 351

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  437 bits (1125), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 218/349 (62%), Positives = 255/349 (73%), Gaps = 40/349 (11%)
Query: 77  VTTIGGRNGQ---PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 4   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 63
Query: 134 ELQTMRLLDHPNV-----------------------------------HYSRASQRMPLI 158
           ELQ MR LDH N+                                   HYSRA Q +P+I
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 123
Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 218
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 124 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 182
Query: 219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            ICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 183 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 242
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 243 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 302
Query: 339 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 387
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 303 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 350

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  437 bits (1124), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 218/349 (62%), Positives = 255/349 (73%), Gaps = 40/349 (11%)
Query: 77  VTTIGGRNGQ---PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 134 ELQTMRLLDHPNV-----------------------------------HYSRASQRMPLI 158
           ELQ MR LDH N+                                   HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 218
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            ICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 339 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 387
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 349

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  437 bits (1124), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 218/349 (62%), Positives = 255/349 (73%), Gaps = 40/349 (11%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 7   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 66
Query: 134 ELQTMRLLDHPNV-----------------------------------HYSRASQRMPLI 158
           ELQ MR LDH N+                                   HYSRA Q +P+I
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 126
Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 218
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 127 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 185
Query: 219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            ICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 186 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 245
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 246 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 305
Query: 339 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 387
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 306 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 353

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  437 bits (1124), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 218/349 (62%), Positives = 255/349 (73%), Gaps = 40/349 (11%)
Query: 77  VTTIGGRNGQ---PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 134 ELQTMRLLDHPNV-----------------------------------HYSRASQRMPLI 158
           ELQ MR LDH N+                                   HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 218
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            ICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 339 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 387
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 349

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  434 bits (1117), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 217/349 (62%), Positives = 254/349 (72%), Gaps = 40/349 (11%)
Query: 77  VTTIGGRNGQ---PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 134 ELQTMRLLDHPNV-----------------------------------HYSRASQRMPLI 158
           ELQ MR LDH N+                                   HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 218
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
           YICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 339 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 387
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 349

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  434 bits (1115), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 217/351 (61%), Positives = 254/351 (72%), Gaps = 40/351 (11%)
Query: 77  VTTIGGRNGQ---PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 134 ELQTMRLLDHPNV-----------------------------------HYSRASQRMPLI 158
           ELQ MR LDH N+                                   HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 218
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
           YICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
           PTRE+I+ MNPNYTEF FPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 339 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQ 351

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  429 bits (1104), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 215/349 (61%), Positives = 252/349 (72%), Gaps = 40/349 (11%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 134 ELQTMRLLDHPNV-----------------------------------HYSRASQRMPLI 158
           ELQ MR LDH N+                                   HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI 122
Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 218
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            ICSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
           PTRE+I+ MNPNYTEF FPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 339 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 387
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 349

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  413 bits (1061), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 201/350 (57%), Positives = 254/350 (72%), Gaps = 39/350 (11%)
Query: 75  IIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE 134
           I V    G+ G+ ++ I+Y   +V+G GSFG+VFQAK +E+ E VAIKKVLQDKR+KNRE
Sbjct: 25  IKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 135 LQTMRLLDHPNV-----------------------------------HYSRASQRMPLIY 159
           LQ MR++ HPNV                                   HY++  Q MP++ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           +KLY YQ+ R+LAYIH  IG+CHRDIKPQNLL++P +  +KL DFGSAK+L+ GEPN+S 
Sbjct: 143 IKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
           ICSRYYRAPELIFGAT YTT +DIWS GCV+AEL+ GQPLFPGESG+DQLVEIIKVLGTP
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
           +RE+IK MNPNY E KFPQI+ HP+ K+F  R PP+A+DL+SRLL+Y+P+ R TA+EA  
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 340 HPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
           HPFFDELR   AR+PNGR  PPLFN+  +EL     +L+S+L+P+HA  +
Sbjct: 322 HPFFDELRTGEARMPNGRELPPLFNWTKEEL-SVRPDLISRLVPQHAEAE 370

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  276 bits (706), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 148/339 (43%), Positives = 200/339 (58%), Gaps = 44/339 (12%)
Query: 88  KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR---LLDHP 144
           K+   +  ER+ GQG+FG V   K   TG +VAIKKV+QD R++NRELQ M+   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 145 NV------------------------------------HYSRASQRMPLIYVKLYTYQIC 168
           N+                                    +Y R     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 169 RALAYIH-GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 227
           R++  +H   + VCHRDIKP N+LVN     +KLCDFGSAK L   EPN++YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 287
           PELIFG   YTTAVDIWSVGC+ AE++LG+P+F G++   QL EI++VLG P+RE ++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 288 NPNYTEFKFPQIKAHPWHKIFHK---RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
           NP++T+      K  PW  +F     +   EA DL+S LLQY P  R    EA  HP+FD
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 345 ELRDPNARLPNGRPFP-PLFNFKPQELKGASKELLSKLI 382
           EL DP  +LPN +  P  LF F P E++  S+   +KL+
Sbjct: 320 ELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV 358

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  266 bits (679), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 121/247 (48%), Positives = 176/247 (71%), Gaps = 10/247 (4%)
Query: 148 YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 207
           + R+ + +P+  + +Y YQ+ RA+ +IH  +G+CHRDIKPQNLLVN   + +KLCDFGSA
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCDFGSA 189
Query: 208 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
           K L+  EP+++ ICSR+YRAPEL+ GATEYT ++D+WS+GCV  EL+LG+PLF GE+ +D
Sbjct: 190 KKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID 249
Query: 268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 327
           QLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI  +  P  A+DL+ ++L+Y 
Sbjct: 250 QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309
Query: 328 PNLRCTALEACIHPFFDELRDP-------NARLPNG--RPFPPLFNFKPQELKGASKELL 378
           P+LR    EA  HPFFD LR+        N+  P+G  +  P LFNF P EL      +L
Sbjct: 310 PDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVL 369
Query: 379 SKLIPEH 385
           ++++P++
Sbjct: 370 NRILPKN 376

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 102/321 (31%), Positives = 168/321 (52%), Gaps = 53/321 (16%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLLDH------ 143
            +  + ++G+G++G+V  A    TGE VAIKK+       +  R L+ +++L H      
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 144 --------------------------PNVHYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
                                      ++H   ++Q +   +++ + YQ  RA+  +HG 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----------YICSRYYR 226
             V HRD+KP NLL+N +   +K+CDFG A+++ +   + S           Y+ +R+YR
Sbjct: 132 -NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYR 189
Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIK 285
           APE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +  +++
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 286 CM-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EA  HP+
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 343 FDELRDPNARLPNGRPFPPLF 363
                DPN   P G P PP F
Sbjct: 309 LQTYHDPNDE-PEGEPIPPSF 328

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 102/321 (31%), Positives = 169/321 (52%), Gaps = 53/321 (16%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLLDH------ 143
            +  + ++G+G++G+V  A    TGE VAIKK+       +  R L+ +++L H      
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 144 --------------------------PNVHYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
                                      ++H   ++Q +   +++ + YQ  RA+  +HG 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-----EPN------ISYICSRYYR 226
             V HRD+KP NLL+N +   +K+CDFG A+++ +      EP       + ++ +R+YR
Sbjct: 132 -NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIK 285
           APE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +  +++
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 286 CM-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EA  HP+
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 343 FDELRDPNARLPNGRPFPPLF 363
                DPN   P G P PP F
Sbjct: 309 LQTYHDPNDE-PEGEPIPPSF 328

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 101/321 (31%), Positives = 167/321 (52%), Gaps = 53/321 (16%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLLDH------ 143
            +  + ++G+G++G+V  A    TGE VAIKK+       +  R L+ +++L H      
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 144 --------------------------PNVHYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
                                      ++H   ++Q +   +++ + YQ  RA+  +HG 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----------YICSRYYR 226
             V HRD+KP NLL+N +   +K+CDFG A+++ +   + S            + +R+YR
Sbjct: 132 -NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYR 189
Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIK 285
           APE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +  +++
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 286 CM-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EA  HP+
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 343 FDELRDPNARLPNGRPFPPLF 363
                DPN   P G P PP F
Sbjct: 309 LQTYHDPNDE-PEGEPIPPSF 328

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 114/340 (33%), Positives = 174/340 (51%), Gaps = 52/340 (15%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y   + +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H NV 
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 148 YSR-----------------------------ASQRMPLIYVKLYTYQICRALAYIHGGI 178
             R                              SQ++   ++  + YQI R L YIH   
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSA- 163
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGA 234
            V HRD+KP NLL+N  T  +K+CDFG A++      +  +    + +R+YRAPE++  +
Sbjct: 164 NVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNS 222
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPN 290
             YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      N
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARN 282
Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           Y +   P      W K+F K    +A+DL+ R+L ++PN R T  EA  HP+ ++  DP 
Sbjct: 283 YLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPT 340
Query: 351 ARLPNGRPFPPLFNFKPQELKGASKELLSKLI-PEHARKQ 389
                  P    F F   EL    KE L +LI  E AR Q
Sbjct: 341 DEPVAEEP----FTFA-MELDDLPKERLKELIFQETARFQ 375

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 106/310 (34%), Positives = 162/310 (52%), Gaps = 52/310 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------REL 135
           G  G P+   ++     +G+G++G+V++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 136 QTMRLLDHPNV---------------------------HYSRASQRMPLIYVKLYTYQIC 168
             ++ L+HPN+                             + A   +PL  +K Y +Q+ 
Sbjct: 61  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYY 225
           + LA+ H    V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +Y
Sbjct: 121 QGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWY 176
Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
           RAPE++ G   Y+TAVDIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP      
Sbjct: 177 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 236
Query: 286 CMN--PNYTEFKFPQIKAHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACI 339
            +   P+Y    FP+     W  + F K +PP   D   L+S++L Y PN R +A  A  
Sbjct: 237 GVTSMPDYKP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 290
Query: 340 HPFFDELRDP 349
           HPFF ++  P
Sbjct: 291 HPFFQDVTKP 300

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 106/310 (34%), Positives = 162/310 (52%), Gaps = 52/310 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------REL 135
           G  G P+   ++     +G+G++G+V++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 136 QTMRLLDHPNV---------------------------HYSRASQRMPLIYVKLYTYQIC 168
             ++ L+HPN+                             + A   +PL  +K Y +Q+ 
Sbjct: 61  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYY 225
           + LA+ H    V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +Y
Sbjct: 121 QGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWY 176
Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
           RAPE++ G   Y+TAVDIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP      
Sbjct: 177 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 236
Query: 286 CMN--PNYTEFKFPQIKAHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACI 339
            +   P+Y    FP+     W  + F K +PP   D   L+S++L Y PN R +A  A  
Sbjct: 237 GVTSMPDYKP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 290
Query: 340 HPFFDELRDP 349
           HPFF ++  P
Sbjct: 291 HPFFQDVTKP 300

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  164 bits (414), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 106/302 (35%), Positives = 159/302 (52%), Gaps = 52/302 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 75  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 133
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 134 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 190
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 191 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 247
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNG 356
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P   L   
Sbjct: 248 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRLE 304
Query: 357 RP 358
           RP
Sbjct: 305 RP 306

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 147
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 148 NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 264 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 322 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 360

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 129
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVD 186
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 187 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 243
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 244 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 73  IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 131
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 132 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 188
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 189 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 245
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 246 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 74  IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 132
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 133 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 189
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 190 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 246
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 247 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 158/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 147 ------------HYSRASQR---------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                       H  +  ++         +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 74  IHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 132
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 133 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 189
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 190 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 246
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 247 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 105/293 (35%), Positives = 157/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN------- 145
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN       
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 146 -------------VHY-------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                        VH        + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 70  IHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 128
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 129 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 186 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 242
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 243 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 73  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 131
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 132 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 188
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 189 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 245
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 246 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 72  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 131 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 187
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 188 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 244
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 245 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 72  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 131 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 187
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 188 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 244
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 245 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 129
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 187 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 243
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 244 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 128
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 129 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 186 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 242
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 243 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 74  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 132
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 133 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 189
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 190 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 246
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 247 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 73  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 131
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 132 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 188
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 189 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 245
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 246 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 129
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 187 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 243
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 244 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 129
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 187 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 243
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 244 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 129
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 187 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 243
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 244 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 74  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 132
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 133 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 189
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 190 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 246
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 247 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 128
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 129 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 186 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 242
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 243 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 74  IHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 132
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 133 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 189
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 190 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 246
Query: 301 AHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 247 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 128
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 129 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 186 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 242
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 243 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 128
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 129 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 186 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 242
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 243 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 129
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 187 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 243
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 244 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 72  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 131 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 187
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 188 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 244
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 245 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 75  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 133
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 134 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 190
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 191 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 247
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 248 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 143
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 144 NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 259
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 260 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 318 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 356

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 163
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 164 NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 279
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 280 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 337
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 338 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 376

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 147
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 148 NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 264 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 322 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 360

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 72  IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 131 KPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 187
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 188 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 244
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 245 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + L++ H    V HRD+
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH-RVLHRDL 129
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 187 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 243
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 244 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 74  IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 132
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 133 KPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 189
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 190 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 246
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 247 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 145
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 146 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 261
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 262 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 319
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 320 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 358

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 143
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 144 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 259
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 260 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 318 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 356

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 151
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 152 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 207
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 208 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 267
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 268 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 325
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 326 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 364

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 143
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 144 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 259
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 260 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 318 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 356

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 72  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 131 KPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 187
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 188 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 244
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 245 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 73  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 131
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 132 KPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 188
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 189 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 245
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 246 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 163
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 164 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 279
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 280 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 337
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 338 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 376

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 156/293 (53%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 71  IHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 129
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 130 KPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 187 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 243
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 244 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 141
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 142 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 257
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 258 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 315
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 316 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 354

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 148
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 149 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 204
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 264
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 265 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 322
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 323 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 361

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 149
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 150 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 205
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 206 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 265
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 266 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 323
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 324 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 362

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 140
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 141 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 196
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 197 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 256
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 257 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 314
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 315 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 353

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 147
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 148 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 264 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 322 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 360

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/289 (35%), Positives = 154/289 (53%), Gaps = 52/289 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+      
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 129
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 187 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 243
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDE 345
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF +
Sbjct: 244 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA- 147
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 148 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 264 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 322 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 360

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 155/293 (52%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+      
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 129
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 187 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 243
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 244 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 155/293 (52%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+      
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  + A   +PL  +K Y +Q+ + LA+ H    V HRD+
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDL 128
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVD 242
           KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G   Y+TAVD
Sbjct: 129 KPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK 300
           IWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y    FP+  
Sbjct: 186 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPK-- 242
Query: 301 AHPW-HKIFHKRMPPEAVD---LVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              W  + F K +PP   D   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 243 ---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 107/343 (31%), Positives = 170/343 (49%), Gaps = 55/343 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 145
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 146 NVLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC---MN 288
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C   + 
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLK 261
Query: 289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 348
                   P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+  +  D
Sbjct: 262 ARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320
Query: 349 PNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           P+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 321 PSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 358

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 172/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 145
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 146 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 261
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+  +  
Sbjct: 262 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYY 319
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 320 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 358

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 172/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 141
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 142 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P +E++ C+    
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLK 257
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 258 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 315
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 316 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 354

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 108/344 (31%), Positives = 173/344 (50%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAI+K+   + + Y  R L+ +++L    H N+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 147
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 148 NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+    
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 264 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 322 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 360

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 103/307 (33%), Positives = 155/307 (50%), Gaps = 45/307 (14%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDHP---- 144
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R  + + LL H     
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 145 -----NVHYSRASQR--------MPLIYVKL---------------YTYQICRALAYIHG 176
                +V    +S R        MP +   L                 YQ+ + L YIH 
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS 162
Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGAT 235
             GV HRD+KP NL VN    ++K+ DFG A+     +  ++ Y+ +R+YRAPE+I    
Sbjct: 163 A-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPEVILSWM 217
Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 294
            Y   VDIWSVGC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +N    +  
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 277
Query: 295 --KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 352
               PQ     + ++F  R  P+A DL+ ++L+   + R TA +A  HPFF+  RDP   
Sbjct: 278 IQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE 336
Query: 353 LPNGRPF 359
               +PF
Sbjct: 337 TEAQQPF 343

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/308 (33%), Positives = 157/308 (50%), Gaps = 47/308 (15%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDHP---- 144
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R  + + LL H     
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 145 -----NVHYSRASQR--------MPLIYVKL---------------YTYQICRALAYIHG 176
                +V    +S R        MP +   L                 YQ+ + L YIH 
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS 144
Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGAT 235
             GV HRD+KP NL VN    ++K+ DFG A+     +  ++ Y+ +R+YRAPE+I    
Sbjct: 145 A-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPEVILSWM 199
Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN----PNY 291
            Y   VDIWSVGC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +N     +Y
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 259
Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
            +   PQ     + ++F  R  P+A DL+ ++L+   + R TA +A  HPFF+  RDP  
Sbjct: 260 IQ-SLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE 317
Query: 352 RLPNGRPF 359
                +PF
Sbjct: 318 ETEAQQPF 325

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 171/344 (49%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 143
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 144 NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCM 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I   
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLK 259
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 260 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 318 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 356

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 50/298 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN- 145
           Y     VG+G++G+V++AK    G  VA+K++  D   +       RE+  ++ L HPN 
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 146 ------VHYSRASQRMPLIY----------------------VKLYTYQICRALAYIHGG 177
                 +H  R    + L++                      +K+Y YQ+ R +A+ H  
Sbjct: 82  VSLIDVIHSERC---LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 234
             + HRD+KPQNLL+N     +KL DFG A+    G P  SY   + + +YRAP+++ G+
Sbjct: 139 -RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYT 292
            +Y+T+VDIWS+GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + 
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           +  F   +  PW  I       E +DL+S +L + PN R +A +A  HP+F +L DP 
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 50/298 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN- 145
           Y     VG+G++G+V++AK    G  VA+K++  D   +       RE+  ++ L HPN 
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 146 ------VHYSRASQRMPLIY----------------------VKLYTYQICRALAYIHGG 177
                 +H  R    + L++                      +K+Y YQ+ R +A+ H  
Sbjct: 82  VSLIDVIHSERC---LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 234
             + HRD+KPQNLL+N     +KL DFG A+    G P  SY   + + +YRAP+++ G+
Sbjct: 139 -RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYT 292
            +Y+T+VDIWS+GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + 
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           +  F   +  PW  I       E +DL+S +L + PN R +A +A  HP+F +L DP 
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 107/341 (31%), Positives = 171/341 (50%), Gaps = 51/341 (14%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 147
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGA 234
            V HRD+KP NLL+N  T  +K+CDFG A+V      +  +    + +R+YRAPE++  +
Sbjct: 148 NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 206
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPN 290
             YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      N
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           Y     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  DP+
Sbjct: 267 YL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 351 ARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
                  PF   F+    EL    KE L +LI E   +  P
Sbjct: 325 DEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 360

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 107/341 (31%), Positives = 171/341 (50%), Gaps = 51/341 (14%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 148
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGA 234
            V HRD+KP NLL+N  T  +K+CDFG A+V      +  +    + +R+YRAPE++  +
Sbjct: 149 NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 207
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPN 290
             YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      N
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 267
Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           Y     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  DP+
Sbjct: 268 YL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 325
Query: 351 ARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
                  PF   F+    EL    KE L +LI E   +  P
Sbjct: 326 DEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 361

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 101/337 (29%), Positives = 166/337 (49%), Gaps = 48/337 (14%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDHPNV----- 146
            +G G++G+V  A+   TG+ VAIKK      V+ + +   REL+ ++   H N+     
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 147 --------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                                         +SQ + L +V+ + YQ+ R L Y+H    V
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA-QV 179
Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELIFGAT 235
            HRD+KP NLLVN +  ++K+ DFG A+ L             Y+ +R+YRAPEL+    
Sbjct: 180 IHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH 238
Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 294
           EYT A+D+WSVGC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +        
Sbjct: 239 EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAY 298
Query: 295 --KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 352
               P  +  PW  ++      +A+ L+ R+L++ P+ R +A  A  HPF  +  DP+  
Sbjct: 299 IQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDE 357
Query: 353 LPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
                PF   F+ +    +   + +++++   HAR++
Sbjct: 358 PDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARRE 394

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 109/312 (34%), Positives = 153/312 (49%), Gaps = 49/312 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNV--- 146
           +G+G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN+   
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 147 -----HYSRASQRMPLI------------------YVKLYTYQICRALAYIHGGIGVCHR 183
                H S  S     +                  ++K Y     + L Y+H    + HR
Sbjct: 78  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHR 136
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTA 240
           D+KP NLL++     +KL DFG AK    G PN +Y   + +R+YRAPEL+FGA  Y   
Sbjct: 137 DLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELLFGARMYGVG 193
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNYTEFK-FP 297
           VD+W+VGC+LAELLL  P  PG+S +DQL  I + LGTPT E+    C  P+Y  FK FP
Sbjct: 194 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 253
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
            I   P H IF      + +DL+  L  ++P  R TA +A    +F     P       R
Sbjct: 254 GI---PLHHIFSA-AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 309
Query: 358 PFPPLFNFKPQE 369
           P  P+   K Q 
Sbjct: 310 PNCPVETLKEQS 321

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/301 (31%), Positives = 153/301 (50%), Gaps = 37/301 (12%)
Query: 78  TTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYK 131
             +G  N   +    Y    +VG+GS+G+V + +  +TG  VAIKK L+       K+  
Sbjct: 12  VDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA 71
Query: 132 NRELQTMRLLDHPNV----HYSRASQRMPLIY----------------------VKLYTY 165
            RE++ ++ L H N+       +  +R  L++                      V+ Y +
Sbjct: 72  MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF 131
Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRY 224
           QI   + + H    + HRDIKP+N+LV+  +  VKLCDFG A+ L   GE     + +R+
Sbjct: 132 QIINGIGFCHSH-NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRW 189
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTRE 282
           YRAPEL+ G  +Y  AVD+W++GC++ E+ +G+PLFPG+S +DQL  I+  LG   P  +
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249
Query: 283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           E+   NP +   + P+IK     +  + ++    +DL  + L   P+ R    E   H F
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
Query: 343 F 343
           F
Sbjct: 310 F 310

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 103/337 (30%), Positives = 167/337 (49%), Gaps = 48/337 (14%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDH-------- 143
            +G G++G+V  A+   TG+ VAIKK      V+ + +   REL+ ++   H        
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 144 ---PNVHYSR--------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
              P V Y                      +SQ + L +V+ + YQ+ R L Y+H    V
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA-QV 180
Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELIFGAT 235
            HRD+KP NLLVN +  ++K+ DFG A+ L             Y+ +R+YRAPEL+    
Sbjct: 181 IHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH 239
Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 294
           EYT A+D+WSVGC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +        
Sbjct: 240 EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAY 299
Query: 295 --KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 352
               P  +  PW  ++      +A+ L+ R+L++ P+ R +A  A  HPF  +  DP+  
Sbjct: 300 IQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDE 358
Query: 353 LPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
                PF   F+ +    +   + +++++   HAR++
Sbjct: 359 PDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARRE 395

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 151/287 (52%), Gaps = 50/287 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV----HY 148
           +G+G++G+V++A+    GET A+KK+  +K  +       RE+  ++ L H N+      
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 149 SRASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHRDIK 186
               +R+ L++                       K +  Q+   +AY H    V HRD+K
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLK 127
Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVDI 243
           PQNLL+N    ++K+ DFG A+    G P   Y   I + +YRAP+++ G+ +Y+T +DI
Sbjct: 128 PQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-----KFPQ 298
           WSVGC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      PN TE       F  
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW----PNVTELPKYDPNFTV 240
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
            +  PW   F K +    +DL+S++L+  PN R TA +A  H +F E
Sbjct: 241 YEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 96/287 (33%), Positives = 151/287 (52%), Gaps = 50/287 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV----HY 148
           +G+G++G+V++A+    GET A+KK+  +K  +       RE+  ++ L H N+      
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 149 SRASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHRDIK 186
               +R+ L++                       K +  Q+   +AY H    V HRD+K
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLK 127
Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVDI 243
           PQNLL+N    ++K+ DFG A+    G P   Y   + + +YRAP+++ G+ +Y+T +DI
Sbjct: 128 PQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-----KFPQ 298
           WSVGC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      PN TE       F  
Sbjct: 185 WSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNW----PNVTELPKYDPNFTV 240
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
            +  PW   F K +    +DL+S++L+  PN R TA +A  H +F E
Sbjct: 241 YEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 96/287 (33%), Positives = 151/287 (52%), Gaps = 50/287 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV----HY 148
           +G+G++G+V++A+    GET A+KK+  +K  +       RE+  ++ L H N+      
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 149 SRASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHRDIK 186
               +R+ L++                       K +  Q+   +AY H    V HRD+K
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLK 127
Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVDI 243
           PQNLL+N    ++K+ DFG A+    G P   Y   + + +YRAP+++ G+ +Y+T +DI
Sbjct: 128 PQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-----KFPQ 298
           WSVGC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      PN TE       F  
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW----PNVTELPKYDPNFTV 240
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
            +  PW   F K +    +DL+S++L+  PN R TA +A  H +F E
Sbjct: 241 YEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 98/331 (29%), Positives = 162/331 (48%), Gaps = 75/331 (22%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTM-RLLDHPN 145
           Y   + +G+G++GIV+++    TGE VA+KK+        D +   RE+  +  L  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 146 V----HYSRASQRMPLIYVKLY----------------------TYQICRALAYIHGGIG 179
           +    +  RA     +  V  Y                       YQ+ + + Y+H G G
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG-G 129
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK---------------------GEPNIS 218
           + HRD+KP N+L+N   H VK+ DFG ++  V                       +P ++
Sbjct: 130 LLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 219 -YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 277
            Y+ +R+YRAPE++ G+T+YT  +D+WS+GC+L E+L G+P+FPG S ++QL  II V+ 
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID 248
Query: 278 TPTREEIKCMNPNYTEFKFPQIKAH-------------PWHKIFHKRMPP-----EAVDL 319
            P+ E+++ +   + +     +K                W  +  K  P      EA+DL
Sbjct: 249 FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL 308
Query: 320 VSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           + +LLQ++PN R +A +A  HPF     +PN
Sbjct: 309 LDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 108/344 (31%), Positives = 170/344 (49%), Gaps = 57/344 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVH 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N+ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 148 YSRASQRMPLI-----------------------------YVKLYTYQICRALAYIHGGI 178
                 R P I                             ++  + YQI R L YIH   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 143
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELI 231
            V HRD+KP NLL+N  T  +K+ DFG A+V    +P+         Y+ +R+YRAPE++
Sbjct: 144 NVLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCM 287
             +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I   
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLK 259
Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  
Sbjct: 260 ARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 348 DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 318 DPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 356

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/314 (31%), Positives = 151/314 (48%), Gaps = 45/314 (14%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV---- 146
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV    
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 147 ----------HYSRA----------------SQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                      +S                  SQ +   +V+   YQ+ R L YIH   G+
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA-GI 152
Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
            HRD+KP N+ VN  + ++++ DFG A+     E    Y+ +R+YRAPE++     Y   
Sbjct: 153 IHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFP 297
           VDIWSVGC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +        P
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
            +       IF +   P A+DL+ R+L    + R +A EA  H +F +  DP    P   
Sbjct: 270 PMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE-PEAE 327
Query: 358 PFPPLFNFKPQELK 371
           P+      K + L+
Sbjct: 328 PYDESVEAKERTLE 341

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 154/287 (53%), Gaps = 41/287 (14%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNV----HY 148
           +G+GS+G+VF+ +  +TG+ VAIKK L+       K+   RE++ ++ L HPN+      
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 149 SRASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHRDIK 186
            R  +R+ L++                      VK  T+Q  +A+ + H      HRD+K
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVK 129
Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVDI 243
           P+N+L+  H+  +KLCDFG A++L    P+  Y   + +R+YR+PEL+ G T+Y   VD+
Sbjct: 130 PENILITKHS-VIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVGDTQYGPPVDV 186
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTEFKFPQIKA 301
           W++GCV AELL G PL+PG+S VDQL  I K LG   P  +++   N  ++  K P  + 
Sbjct: 187 WAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPED 246
Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 348
               ++    +   A+ L+   L   P  R T  +   HP+F+ +R+
Sbjct: 247 MEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 101/314 (32%), Positives = 154/314 (49%), Gaps = 49/314 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  +  +++G  +A+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 176
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 177 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNMTV 233
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   ++QL +I+++ GTP    I  M      NY     P
Sbjct: 234 DIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYIN-SLP 292
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA EA  HP+F +  DP+   P   
Sbjct: 293 QMPKRNFADVF-IGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDE-PESE 350
Query: 358 PFPPLFNFKPQELK 371
           P+   F  +  E++
Sbjct: 351 PYDQSFESRQLEIE 364

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/314 (31%), Positives = 150/314 (47%), Gaps = 45/314 (14%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV---- 146
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV    
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 147 ----------HYSRA----------------SQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                      +S                   Q +   +V+   YQ+ R L YIH   G+
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA-GI 152
Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
            HRD+KP N+ VN  + ++++ DFG A+     E    Y+ +R+YRAPE++     Y   
Sbjct: 153 IHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFP 297
           VDIWSVGC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +        P
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
            +       IF +   P A+DL+ R+L    + R +A EA  H +F +  DP    P   
Sbjct: 270 PMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE-PEAE 327
Query: 358 PFPPLFNFKPQELK 371
           P+      K + L+
Sbjct: 328 PYDESVEAKERTLE 341

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 102/306 (33%), Positives = 152/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++  A  Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNAMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 152/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 153
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN  + ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 154 HRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 269
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 270 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 327
Query: 358 PFPPLF 363
           P+   F
Sbjct: 328 PYDQSF 333

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/313 (30%), Positives = 148/313 (47%), Gaps = 43/313 (13%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV---- 146
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV    
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 147 ----------HYSRA----------------SQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                      +S                   Q +   +V+   YQ+ R L YIH   G+
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA-GI 144
Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
            HRD+KP N+ VN    ++++ DFG A+     E    Y+ +R+YRAPE++     Y   
Sbjct: 145 IHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
           VDIWSVGC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +       + 
Sbjct: 202 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 261
Query: 301 AHPWHKI--FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRP 358
             P   +    +   P A+DL+ R+L    + R +A EA  H +F +  DP    P   P
Sbjct: 262 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE-PEAEP 320
Query: 359 FPPLFNFKPQELK 371
           +      K + L+
Sbjct: 321 YDESVEAKERTLE 333

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 152/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 149
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN  + ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 150 HRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 265
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 266 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 323
Query: 358 PFPPLF 363
           P+   F
Sbjct: 324 PYDQSF 329

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 92/301 (30%), Positives = 157/301 (52%), Gaps = 43/301 (14%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
           +Y+    +G+G++  V++ K   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 147 ----HYSRASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGV 180
                     + + L++                      VKL+ +Q+ R LAY H    V
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ-KV 121
Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEY 237
            HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+++ G+T+Y
Sbjct: 122 LHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 295
           +T +D+W VGC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  N  +  + 
Sbjct: 179 STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238
Query: 296 FPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 354
           +P+ +A     + H  R+  +  DL+++LLQ+    R +A +A  HPFF  L +   +LP
Sbjct: 239 YPKYRAEAL--LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLP 296
Query: 355 N 355
           +
Sbjct: 297 D 297

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 102/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           PF   F
Sbjct: 322 PFDQSF 327

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLA 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 153
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 154 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLA 269
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 270 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 327
Query: 358 PFPPLF 363
           P+   F
Sbjct: 328 PYDQSF 333

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 166
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 167 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 223
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 224 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLA 282
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 283 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 340
Query: 358 PFPPLF 363
           P+   F
Sbjct: 341 PYDQSF 346

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 157
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 158 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 214
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 215 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLA 273
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 274 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 331
Query: 358 PFPPLF 363
           P+   F
Sbjct: 332 PYDQSF 337

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDX-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 167
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 168 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 224
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLA 283
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 284 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 341
Query: 358 PFPPLF 363
           P+   F
Sbjct: 342 PYDQSF 347

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 158
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 159 HRDLKPSNLAVNEDX-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 215
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 216 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 274
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 275 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 332
Query: 358 PFPPLF 363
           P+   F
Sbjct: 333 PYDQSF 338

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 152
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 153 HRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 268
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 269 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 326
Query: 358 PFPPLF 363
           P+   F
Sbjct: 327 PYDQSF 332

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 143
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 144 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLA 259
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 260 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 317
Query: 358 PFPPLF 363
           P+   F
Sbjct: 318 PYDQSF 323

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 154
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 155 HRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 270
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 271 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 328
Query: 358 PFPPLF 363
           P+   F
Sbjct: 329 PYDQSF 334

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 100/302 (33%), Positives = 151/302 (50%), Gaps = 49/302 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRA-------SQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A       SQ++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN  + ++K+ DFG  +     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PF 359
           P+
Sbjct: 322 PY 323

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 153
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 154 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 269
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 270 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 327
Query: 358 PFPPLF 363
           P+   F
Sbjct: 328 PYDQSF 333

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 159
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 160 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 216
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 217 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 275
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 276 QMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 333
Query: 358 PFPPLF 363
           P+   F
Sbjct: 334 PYDQSF 339

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 159
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 160 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 216
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 217 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 275
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 276 QMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 333
Query: 358 PFPPLF 363
           P+   F
Sbjct: 334 PYDQSF 339

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 159
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 160 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 216
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 217 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 275
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 276 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 333
Query: 358 PFPPLF 363
           P+   F
Sbjct: 334 PYDQSF 339

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 153
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 154 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 269
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 270 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 327
Query: 358 PFPPLF 363
           P+   F
Sbjct: 328 PYDQSF 333

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           +G G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 152
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 153 HRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 268
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 269 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 326
Query: 358 PFPPLF 363
           P+   F
Sbjct: 327 PYDQSF 332

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 158
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 159 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 215
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 216 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 274
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 275 QMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 332
Query: 358 PFPPLF 363
           P+   F
Sbjct: 333 PYDQSF 338

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 154
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 155 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 270
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 271 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 328
Query: 358 PFPPLF 363
           P+   F
Sbjct: 329 PYDQSF 334

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 167
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 168 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 224
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 283
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 284 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 341
Query: 358 PFPPLF 363
           P+   F
Sbjct: 342 PYDQSF 347

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 149
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 150 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 265
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 266 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 323
Query: 358 PFPPLF 363
           P+   F
Sbjct: 324 PYDQSF 329

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 170
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 171 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 227
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 228 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 286
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 287 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 344
Query: 358 PFPPLF 363
           P+   F
Sbjct: 345 PYDQSF 350

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 149
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 150 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 265
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 266 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 323
Query: 358 PFPPLF 363
           P+   F
Sbjct: 324 PYDQSF 329

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 152
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 153 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 268
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 269 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 326
Query: 358 PFPPLF 363
           P+   F
Sbjct: 327 PYDQSF 332

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 146
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 147 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 203
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 204 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 262
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 263 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 320
Query: 358 PFPPLF 363
           P+   F
Sbjct: 321 PYDQSF 326

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 100/302 (33%), Positives = 150/302 (49%), Gaps = 49/302 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 154
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 155 HRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 270
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 271 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 328
Query: 358 PF 359
           P+
Sbjct: 329 PY 330

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 152
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 153 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 268
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 269 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 326
Query: 358 PFPPLF 363
           P+   F
Sbjct: 327 PYDQSF 332

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 170
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 171 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNWMHYNQTV 227
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 228 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 286
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 287 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 344
Query: 358 PFPPLF 363
           P+   F
Sbjct: 345 PYDQSF 350

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 166
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 167 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 223
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 224 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 282
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 283 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 340
Query: 358 PFPPLF 363
           P+   F
Sbjct: 341 PYDQSF 346

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 100/302 (33%), Positives = 150/302 (49%), Gaps = 49/302 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 154
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 155 HRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 270
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 271 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 328
Query: 358 PF 359
           P+
Sbjct: 329 PY 330

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 149
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 150 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 265
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 266 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 323
Query: 358 PFPPLF 363
           P+   F
Sbjct: 324 PYDQSF 329

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    ++ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLA 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 145
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 146 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 202
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 203 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 261
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 262 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 319
Query: 358 PFPPLF 363
           P+   F
Sbjct: 320 PYDQSF 325

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 144
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 145 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 201
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 202 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 260
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 261 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 318
Query: 358 PFPPLF 363
           P+   F
Sbjct: 319 PYDQSF 324

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 144
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 145 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 201
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 202 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 260
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 261 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 318
Query: 358 PFPPLF 363
           P+   F
Sbjct: 319 PYDQSF 324

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    ++ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 143
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 144 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 259
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 260 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 317
Query: 358 PFPPLF 363
           P+   F
Sbjct: 318 PYDQSF 323

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 98/293 (33%), Positives = 147/293 (50%), Gaps = 48/293 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 98/293 (33%), Positives = 147/293 (50%), Gaps = 48/293 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+
Sbjct: 264 QMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 98/293 (33%), Positives = 147/293 (50%), Gaps = 48/293 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 143
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    ++ +R+YRAPE++     Y   V
Sbjct: 144 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMHYNQTV 200
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLA 259
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 260 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 317
Query: 358 PFPPLF 363
           P+   F
Sbjct: 318 PYDQSF 323

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  144 bits (363), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 147 --HYSRASQRMPLIY-----------------------VKLYTYQICRALAYIHGGIGVC 181
               +R+ +    +Y                       V+   YQI R L YIH    + 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA-DII 143
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 144 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLA 259
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 260 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 317
Query: 358 PFPPLF 363
           P+   F
Sbjct: 318 PYDQSF 323

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 151/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ D+G A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 102/316 (32%), Positives = 151/316 (47%), Gaps = 55/316 (17%)
Query: 82  GRNGQPKQTISYMAERV---------VGQGSFGIVFQAKCLETGETVAIKKV---LQDKR 129
            R+G  +Q ++  A  V         VG G++G V  A    TG  VAIKK+    Q + 
Sbjct: 7   ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 66
Query: 130 YKNRELQTMRLLDH---PNV--------------HYSRASQRMPLI-------------- 158
           +  R  + +RLL H    NV               ++     MP +              
Sbjct: 67  FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG 126
Query: 159 --YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 216
              ++   YQ+ + L YIH   G+ HRD+KP NL VN    ++K+ DFG A+        
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--ADSEM 182
Query: 217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 276
              + +R+YRAPE+I     YT  VDIWSVGC++AE++ G+ LF G   +DQL EI+KV 
Sbjct: 183 XGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 242
Query: 277 GTPTREEIKCMNP----NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 332
           GTP  E ++ +      NY +   P+++   +  I      P AV+L+ ++L      R 
Sbjct: 243 GTPPAEFVQRLQSDEAKNYMK-GLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRV 300
Query: 333 TALEACIHPFFDELRD 348
           TA EA  HP+F+ L D
Sbjct: 301 TAGEALAHPYFESLHD 316

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 150/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DF  A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 150/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 167
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +     + +R+YRAPE++     Y   V
Sbjct: 168 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNWMHYNQTV 224
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLA 283
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 284 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 341
Query: 358 PFPPLF 363
           P+   F
Sbjct: 342 PYDQSF 347

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 150/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+  FG A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 95/293 (32%), Positives = 149/293 (50%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV----HY 148
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+      
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 149 SRASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHRDIK 186
             + +++ L++                      VK + +Q+ + L + H    V HRD+K
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLK 128
Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVDI 243
           PQNLL+N    ++KL +FG A+    G P   Y   + + +YR P+++FGA  Y+T++D+
Sbjct: 129 PQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 244 WSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E+   M       K P  K +
Sbjct: 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------KLPDYKPY 239
Query: 303 PWHKIFHK------RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
           P +           ++     DL+  LL+ +P  R +A EA  HP+F +   P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 150/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ D G A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 150/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ DFG A+     +     + +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 95/293 (32%), Positives = 148/293 (50%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV----HY 148
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+      
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 149 SRASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHRDIK 186
             + +++ L++                      VK + +Q+ + L + H    V HRD+K
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLK 128
Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVDI 243
           PQNLL+N    ++KL DFG A+    G P   Y   + + +YR P+++FGA  Y+T++D+
Sbjct: 129 PQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 244 WSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M       K P  K +
Sbjct: 186 WSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------KLPDYKPY 239
Query: 303 PWHKIFHK------RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
           P +           ++     DL+  LL+ +P  R +A EA  HP+F +   P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 150/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ D G A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 150/306 (49%), Gaps = 49/306 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNV----- 146
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV     
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 147 ------------------HYSRAS-------QRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                             H   A        Q++   +V+   YQI R L YIH    + 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DII 147
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP NL VN    ++K+ D G A+     +    Y+ +R+YRAPE++     Y   V
Sbjct: 148 HRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFKFP 297
           DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +    
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLT 263
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   P   
Sbjct: 264 QMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-PVAD 321
Query: 358 PFPPLF 363
           P+   F
Sbjct: 322 PYDQSF 327

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 149/293 (50%), Gaps = 52/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV----HYS 149
           +G G++  V++     TG  VA+K+V  D          RE+  M+ L H N+       
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 150 RASQRMPLIY---------------------------VKLYTYQICRALAYIHGGIGVCH 182
               ++ L++                           VK + +Q+ + LA+ H    + H
Sbjct: 73  HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILH 131
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           RD+KPQNLL+N    Q+KL DFG A+   +      S + + +YRAP+++ G+  Y+T++
Sbjct: 132 RDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI 190
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-KF-PQI 299
           DIWS GC+LAE++ G+PLFPG +  +QL  I  ++GTP     + + P+ T+  K+ P I
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN----ESLWPSVTKLPKYNPNI 246
Query: 300 KAHPWHKIF-----HKRMPPEA--VDLVSRLLQYSPNLRCTALEACIHPFFDE 345
           +  P   +      H + P +   +D +  LLQ +P++R +A +A  HP+F E
Sbjct: 247 QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/306 (29%), Positives = 149/306 (48%), Gaps = 64/306 (20%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNV-- 146
           YM  + +G G  G+VF A   +  + VAIKK++    Q  ++  RE++ +R LDH N+  
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 147 ----------------------------------HYSRASQRMPLI--YVKLYTYQICRA 170
                                               +   ++ PL+  + +L+ YQ+ R 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRG 132
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-------ICSR 223
           L YIH    V HRD+KP NL +N     +K+ DFG A+++   +P+ S+       + ++
Sbjct: 133 LKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKGHLSEGLVTK 188
Query: 224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQL---VEIIKVLGTPT 280
           +YR+P L+     YT A+D+W+ GC+ AE+L G+ LF G   ++Q+   +E I V+    
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 281 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEA 337
           R+E+  + P Y      +      HK   + +P    EAVD + ++L +SP  R TA EA
Sbjct: 249 RQELLSVIPVYIRNDMTEP-----HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303
Query: 338 CIHPFF 343
             HP+ 
Sbjct: 304 LSHPYM 309

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 54/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------------LQDKRYKNRELQTMRL 140
           Y  +R +  GS+G V  A     G  VAIK+V            L D     R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 141 LDH---PN--------VHYSR-ASQRMPLI----------------------YVKLYTYQ 166
           L+H   PN        VH+   A  ++ L+                      +++ + Y 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 226
           I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+  R+YR
Sbjct: 143 ILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVTHRWYR 200
Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
           APEL+     +T  VD+WS GCV+AE+   + LF G +  +QL +I++V+GTP  E++  
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 287 MNP----NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
            +     +Y       + A  W  +      P A+DL++++L+++P  R +  +A  HP+
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVV-PTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319
Query: 343 FDELRDP 349
           F+ L DP
Sbjct: 320 FESLFDP 326

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 54/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------------LQDKRYKNRELQTMRL 140
           Y  +R +  GS+G V  A     G  VAIK+V            L D     R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 141 LDH---PN--------VHYSR-ASQRMPLI----------------------YVKLYTYQ 166
           L+H   PN        VH+   A  ++ L+                      +++ + Y 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 226
           I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+  R+YR
Sbjct: 143 ILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVTHRWYR 200
Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
           APEL+     +T  VD+WS GCV+AE+   + LF G +  +QL +I++V+GTP  E++  
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 287 MNP----NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
            +     +Y       + A  W  +      P A+DL++++L+++P  R +  +A  HP+
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVV-PTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319
Query: 343 FDELRDP 349
           F+ L DP
Sbjct: 320 FESLFDP 326

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 114/203 (56%), Gaps = 22/203 (10%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           ++ Y Y++ +AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 148 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 206
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 278
           + SRY++ PEL+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 207 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 266
Query: 279 PTREEIKCMNPNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLL 324
                   +N    +++    PQ++A        PW K  +      + PEA+D + +LL
Sbjct: 267 ------DGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 320
Query: 325 QYSPNLRCTALEACIHPFFDELR 347
           +Y    R TALEA  HP+F ++R
Sbjct: 321 RYDHQERLTALEAMTHPYFQQVR 343

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 139/289 (48%), Gaps = 39/289 (13%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-NRELQTMR----------- 139
            Y   R +G+G +  VF+A  +   E V +K +   K+ K  RE++ +            
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 140 --------------LLDH-PNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
                         + +H  N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRD 156
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
           +KP N++++    +++L D+G A+    G+     + SRY++ PEL+     Y  ++D+W
Sbjct: 157 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMW 216
Query: 245 SVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQ 298
           S+GC+LA ++   +P F G    DQLV I KVLGT    +        ++P + +    +
Sbjct: 217 SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGR 275
Query: 299 IKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                W +  H      + PEA+D + +LL+Y    R TA EA  HP+F
Sbjct: 276 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 114/203 (56%), Gaps = 22/203 (10%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           ++ Y Y++ +AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 128 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 278
           + SRY++ PEL+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 187 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246
Query: 279 PTREEIKCMNPNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLL 324
                   +N    +++    PQ++A        PW K  +      + PEA+D + +LL
Sbjct: 247 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 325 QYSPNLRCTALEACIHPFFDELR 347
           +Y    R TALEA  HP+F ++R
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVR 323

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 114/203 (56%), Gaps = 22/203 (10%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           ++ Y Y++ +AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 278
           + SRY++ PEL+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 279 PTREEIKCMNPNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLL 324
                   +N    +++    PQ++A        PW K  +      + PEA+D + +LL
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 325 QYSPNLRCTALEACIHPFFDELR 347
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 114/203 (56%), Gaps = 22/203 (10%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           ++ Y Y++ +AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 278
           + SRY++ PEL+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 279 PTREEIKCMNPNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLL 324
                   +N    +++    PQ++A        PW K  +      + PEA+D + +LL
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 325 QYSPNLRCTALEACIHPFFDELR 347
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 114/203 (56%), Gaps = 22/203 (10%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           ++ Y Y++ +AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 278
           + SRY++ PEL+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 279 PTREEIKCMNPNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLL 324
                   +N    +++    PQ++A        PW K  +      + PEA+D + +LL
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 325 QYSPNLRCTALEACIHPFFDELR 347
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 114/203 (56%), Gaps = 22/203 (10%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           ++ Y Y++ +AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 278
           + SRY++ PEL+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 279 PTREEIKCMNPNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLL 324
                   +N    +++    PQ++A        PW K  +      + PEA+D + +LL
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 325 QYSPNLRCTALEACIHPFFDELR 347
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 114/203 (56%), Gaps = 22/203 (10%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           ++ Y Y++ +AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 128 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 278
           + SRY++ PEL+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 187 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246
Query: 279 PTREEIKCMNPNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLL 324
                   +N    +++    PQ++A        PW K  +      + PEA+D + +LL
Sbjct: 247 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 325 QYSPNLRCTALEACIHPFFDELR 347
           +Y    R TALEA  HP+F ++R
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVR 323

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 114/203 (56%), Gaps = 22/203 (10%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           ++ Y Y++ +AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 129 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 187
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 278
           + SRY++ PEL+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 188 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 247
Query: 279 PTREEIKCMNPNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLL 324
                   +N    +++    PQ++A        PW K  +      + PEA+D + +LL
Sbjct: 248 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 301
Query: 325 QYSPNLRCTALEACIHPFFDELR 347
           +Y    R TALEA  HP+F ++R
Sbjct: 302 RYDHQERLTALEAMTHPYFQQVR 324

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 114/203 (56%), Gaps = 22/203 (10%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           ++ Y Y++ +AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 278
           + SRY++ PEL+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 279 PTREEIKCMNPNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLL 324
                   +N    +++    PQ++A        PW K  +      + PEA+D + +LL
Sbjct: 246 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 325 QYSPNLRCTALEACIHPFFDELR 347
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 114/203 (56%), Gaps = 22/203 (10%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
           ++ Y Y++ +AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 278
           + SRY++ PEL+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 279 PTREEIKCMNPNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLL 324
                   +N    +++    PQ++A        PW K  +      + PEA+D + +LL
Sbjct: 246 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 325 QYSPNLRCTALEACIHPFFDELR 347
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N+L++    +++L D+
Sbjct: 118 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVLIDHEHRKLRLIDW 176
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 177 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 295
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
           EA+D + +LL+Y    R TA EA  HP+F  +    AR+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARM 334

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 118 NTDFKQLRQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 176
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 177 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 295
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
           EA+D + +LL+Y    R TA EA  HP+F  +    AR+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARM 334

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 117 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 175
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 176 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 236 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 294
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
           EA+D + +LL+Y    R TA EA  HP+F  +    AR+
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARM 333

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 118 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 176
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 177 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 295
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
           EA+D + +LL+Y    R TA EA  HP+F  +    AR+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARM 334

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 118 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 176
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 177 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 295
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
           EA+D + +LL+Y    R TA EA  HP+F  +    AR+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARM 334

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 118 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 176
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 177 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 295
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
           EA+D + +LL+Y    R TA EA  HP+F  +    AR+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARM 334

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 118 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 176
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 177 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 295
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
           EA+D + +LL+Y    R TA EA  HP+F  +    AR+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARM 334

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 123 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 181
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 182 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 241
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 242 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 300
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
           EA+D + +LL+Y    R TA EA  HP+F  +    AR+
Sbjct: 301 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARM 339

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 118 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 176
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 177 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 295
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
           EA+D + +LL+Y    R TA EA  HP+F  +    AR+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARM 334

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 143/290 (49%), Gaps = 47/290 (16%)
Query: 99  VGQGSFGIVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNV-- 146
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNV  
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 147 -----HYSRASQ--RMPLIY-----------------------VKLYTYQICRALAYIHG 176
                  SR  +  ++ L++                       +K   +Q+ R L ++H 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 236
              V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++  ++ 
Sbjct: 139 H-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS- 195
Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           Y T VD+WSVGC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +       F
Sbjct: 196 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALPRQAF 254
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
               A P  K F   +     DL+ + L ++P  R +A  A  HP+F +L
Sbjct: 255 HSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 143/290 (49%), Gaps = 47/290 (16%)
Query: 99  VGQGSFGIVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNV-- 146
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNV  
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 147 -----HYSRASQ--RMPLIY-----------------------VKLYTYQICRALAYIHG 176
                  SR  +  ++ L++                       +K   +Q+ R L ++H 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 236
              V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++  ++ 
Sbjct: 139 H-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS- 195
Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           Y T VD+WSVGC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +       F
Sbjct: 196 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALPRQAF 254
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
               A P  K F   +     DL+ + L ++P  R +A  A  HP+F +L
Sbjct: 255 HSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 118 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 176
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 177 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 295
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           EA+D + +LL+Y    R TA EA  HP+F
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 118 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 176
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 177 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 295
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           EA+D + +LL+Y    R TA EA  HP+F
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 116 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 174
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 175 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 293
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           EA+D + +LL+Y    R TA EA  HP+F
Sbjct: 294 EALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 117 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 175
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 176 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 236 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 294
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           EA+D + +LL+Y    R TA EA  HP+F
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 113/212 (53%), Gaps = 18/212 (8%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y++ +AL Y H   G+ HRD+KP N++++    +++L D+
Sbjct: 119 NTDFKQLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDW 177
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+     +     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G+
Sbjct: 178 GLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQ 237
Query: 264 SGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAHPWHKIFHKR---- 311
              DQLV I KVLGT   EE+          ++P++ +    Q     W    H      
Sbjct: 238 DNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHL 293
Query: 312 MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + PEA+DL+ +LL+Y    R TA EA  HP+F
Sbjct: 294 VSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+
Sbjct: 118 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDW 176
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G 
Sbjct: 177 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236
Query: 264 SGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPP 314
              DQLV I KVLGT    +        ++P + +    +     W +  H      + P
Sbjct: 237 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSP 295
Query: 315 EAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           EA+D + +LL+Y    R TA EA  HP+F
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 113/212 (53%), Gaps = 18/212 (8%)
Query: 145 NVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 204
           N  + +  Q +    ++ Y Y++ +AL Y H   G+ HRD+KP N++++    +++L D+
Sbjct: 124 NTDFKQLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDW 182
Query: 205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGE 263
           G A+     +     + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G+
Sbjct: 183 GLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQ 242
Query: 264 SGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAHPWHKIFHKR---- 311
              DQLV I KVLGT   EE+          ++P++ +    Q     W    H      
Sbjct: 243 DNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHL 298
Query: 312 MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + PEA+DL+ +LL+Y    R TA EA  HP+F
Sbjct: 299 VSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 148/285 (51%), Gaps = 44/285 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVHYSRA- 151
           +G+G++G V++A    T ETVAIK++  +   +       RE+  ++ L H N+   ++ 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 152 ---SQRMPLIY---------------------VKLYTYQICRALAYIHGGIGVCHRDIKP 187
              + R+ LI+                     +K + YQ+   + + H      HRD+KP
Sbjct: 102 IHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKP 160
Query: 188 QNLLVN----PHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTA 240
           QNLL++      T  +K+ DFG A+    G P   +   I + +YR PE++ G+  Y+T+
Sbjct: 161 QNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEILLGSRHYSTS 218
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQ 298
           VDIWS+ C+ AE+L+  PLFPG+S +DQL +I +VLG P       +   P++ +  FP+
Sbjct: 219 VDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ-SFPK 277
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            +     ++    +  E +DL++ +L+  P  R +A  A  HP+F
Sbjct: 278 FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 90/287 (31%), Positives = 141/287 (49%), Gaps = 47/287 (16%)
Query: 99  VGQGSFGIVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNV-- 146
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNV  
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 147 -----HYSRASQ--RMPLIY-----------------------VKLYTYQICRALAYIHG 176
                  SR  +  ++ L++                       +K   +Q+ R L ++H 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 236
              V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++  ++ 
Sbjct: 139 H-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS- 195
Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           Y T VD+WSVGC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +       F
Sbjct: 196 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALPRQAF 254
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
               A P  K F   +     DL+ + L ++P  R +A  A  HP+F
Sbjct: 255 HSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/307 (29%), Positives = 145/307 (47%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VDIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 295 KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F           +K    +A DL+S++L    + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 91/307 (29%), Positives = 145/307 (47%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VDIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 295 KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F           +K    +A DL+S++L    + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV------ 146
           +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M++++H N+      
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 147 --------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGGIGVCHR 183
                    +      M L+   L                 YQ+   + ++H   G+ HR
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSA-GIIHR 150
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           D+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y   VDI
Sbjct: 151 DLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDI 208
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEFKFPQIK 300
           WSVG ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E + P+  
Sbjct: 209 WSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR-PKYA 267
Query: 301 AHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
            + + K+F           +K    +A DL+S++L    + R +  EA  HP+ +   DP
Sbjct: 268 GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 327
Query: 350 N 350
           +
Sbjct: 328 S 328

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 91/307 (29%), Positives = 144/307 (46%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VDIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 295 KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F           +K    +A DL+S++L    + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKLYT---------------YQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322
Query: 345 ELRDP 349
              DP
Sbjct: 323 VWYDP 327

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 91/307 (29%), Positives = 144/307 (46%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VDIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 295 KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F           +K    +A DL+S++L    + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV------ 146
           +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M++++H N+      
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 147 --------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGGIGVCHR 183
                    +      M L+   L                 YQ+   + ++H   G+ HR
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSA-GIIHR 150
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           D+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y   VDI
Sbjct: 151 DLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDI 208
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEFKFPQIK 300
           WSVG ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E + P+  
Sbjct: 209 WSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR-PKYA 267
Query: 301 AHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
            + + K+F           +K    +A DL+S++L    + R +  EA  HP+ +   DP
Sbjct: 268 GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 327
Query: 350 N 350
           +
Sbjct: 328 S 328

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 91/307 (29%), Positives = 144/307 (46%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VDIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 295 KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F           +K    +A DL+S++L    + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKLYT---------------YQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322
Query: 345 ELRDP 349
              DP
Sbjct: 323 VWYDP 327

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 147 --------------HYSRASQRMPLIYVKLYT---------------YQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSA 138
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 139 -GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 195
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315
Query: 345 ELRDP 349
              DP
Sbjct: 316 VWYDP 320

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 97/337 (28%), Positives = 152/337 (45%), Gaps = 64/337 (18%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 147 ----------------------------------HYSRASQRMPLIYVKLYTYQICRALA 172
                                             H     +RM  +      YQ+   + 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL-----LYQMLCGIK 140
Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 232
           ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 198
Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 289
           G   Y   VDIWSVGC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   
Sbjct: 199 GMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVR 257
Query: 290 NYTEF--KFPQIK--------AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
           NY E   K+P IK          P      K    +A DL+S++L   P+ R +  EA  
Sbjct: 258 NYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALR 317
Query: 340 HPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKE 376
           HP+     DP        P P +++ + +E + A +E
Sbjct: 318 HPYITVWYDPAEA---EAPPPQIYDAQLEEREHAIEE 351

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/307 (29%), Positives = 144/307 (46%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 88  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 147
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+        + ++ +RYYRAPE+I G   Y
Sbjct: 148 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG-Y 204
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VDIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 205 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 264
Query: 295 KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F           +K    +A DL+S++L    + R +  EA  HP+ 
Sbjct: 265 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 323
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 324 NVWYDPS 330

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV------ 146
           +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+      
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 147 --------HYSRASQRMPLIYVKLYT---------------YQICRALAYIHGGIGVCHR 183
                    +      M L+   L                 YQ+   + ++H   G+ HR
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHSA-GIIHR 150
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           D+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y   VDI
Sbjct: 151 DLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDI 208
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE------- 293
           WSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E       
Sbjct: 209 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG 268
Query: 294 FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
             FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +   DP
Sbjct: 269 LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 327

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/307 (29%), Positives = 143/307 (46%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 146
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 147 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 203
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VDIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 204 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 263
Query: 295 KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F           +K    +A DL+S++L    + R +  EA  HP+ 
Sbjct: 264 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 323 NVWYDPS 329

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/307 (29%), Positives = 143/307 (46%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VDIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 295 KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F           +K    +A DL+S++L    + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 183
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 184 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 240
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 301 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360
Query: 345 ELRDP 349
              DP
Sbjct: 361 VWYDP 365

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 108/402 (26%), Positives = 159/402 (39%), Gaps = 121/402 (30%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNV 146
           Y    ++G GS+G V +A        VAIKK+L+      D +   RE+  +  L+H +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 147 ------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
                                            R    +  +++K   Y +   + Y+H 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS 174
Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS------------------ 218
             G+ HRD+KP N LVN     VK+CDFG A+ +   E   S                  
Sbjct: 175 A-GILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 219 ----------YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-----------GQ 257
                     ++ +R+YRAPELI     YT A+D+WS+GC+ AELL              
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292
Query: 258 PLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
           PLFPG S                      DQL  I  +LGTP+ E+I+ +          
Sbjct: 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE------- 345
Query: 298 QIKAHPWHKIFHKR-----------MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
              A  + +IF KR              +A+ L+ R+L ++PN R T  E   HPFF E+
Sbjct: 346 --DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403
Query: 347 R----DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPE 384
           R    + NA      PF    N    +L+ A  + + +  PE
Sbjct: 404 RIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 146
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 147 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 203
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 263
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 264 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 323
Query: 345 ELRDP 349
              DP
Sbjct: 324 VWYDP 328

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 183
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 184 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 240
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 301 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360
Query: 345 ELRDP 349
              DP
Sbjct: 361 VWYDP 365

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322
Query: 345 ELRDP 349
              DP
Sbjct: 323 VWYDP 327

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322
Query: 345 ELRDP 349
              DP
Sbjct: 323 VWYDP 327

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 146
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 147 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 203
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 263
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 264 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 323
Query: 345 ELRDP 349
              DP
Sbjct: 324 VWYDP 328

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 84
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 85  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 144
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 145 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 201
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 202 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 261
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 262 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 321
Query: 345 ELRDP 349
              DP
Sbjct: 322 VWYDP 326

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 139
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 140 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 196
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 256
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 257 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 316
Query: 345 ELRDP 349
              DP
Sbjct: 317 VWYDP 321

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 139
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 140 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 196
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 256
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 257 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 316
Query: 345 ELRDP 349
              DP
Sbjct: 317 VWYDP 321

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 51/305 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 139 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 195
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 293
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 294 ------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315
Query: 345 ELRDP 349
              DP
Sbjct: 316 VWYDP 320

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 94/338 (27%), Positives = 153/338 (45%), Gaps = 66/338 (19%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 147 ----------------------------------HYSRASQRMPLIYVKLYTYQICRALA 172
                                             H     +RM  +      YQ+   + 
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL-----LYQMLCGIK 138
Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 232
           ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 139 HLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVIL 196
Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 289
           G   Y   VDIWSVGC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   
Sbjct: 197 GMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVR 255
Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEAC 338
           NY E + P      + ++F   + P           +A DL+S++L   P+ R +  EA 
Sbjct: 256 NYVENR-PAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 314
Query: 339 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKE 376
            HP+     DP        P P +++ + +E + A +E
Sbjct: 315 RHPYITVWYDPAEA---EAPPPQIYDAQLEEREHAIEE 349

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 136/294 (46%), Gaps = 51/294 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV------ 146
           +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+      
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 147 --------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGGIGVCHR 183
                    +      M L+   L                 YQ+   + ++H   G+ HR
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA-GIIHR 150
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           D+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y   VDI
Sbjct: 151 DLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDI 208
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE------- 293
           WSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E       
Sbjct: 209 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG 268
Query: 294 FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
             FP++      P     +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 269 LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 143/307 (46%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 91  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 150
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 151 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 207
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VD+WSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 208 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 267
Query: 295 KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F           +K    +A DL+S++L    + R +  EA  HP+ 
Sbjct: 268 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 326
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 327 NVWYDPS 333

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 143/307 (46%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 80  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 139
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 140 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 196
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VD+WSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 197 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 256
Query: 295 KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F           +K    +A DL+S++L    + R +  EA  HP+ 
Sbjct: 257 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 315
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 316 NVWYDPS 322

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 90/307 (29%), Positives = 142/307 (46%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VDIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 295 KFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F   + P           +A DL+S++L    + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 95/349 (27%), Positives = 156/349 (44%), Gaps = 99/349 (28%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDHPNVHY 148
           +Y+ + ++G+GS+G V+ A    T + VAIKKV    +D     R L+ + +L+     Y
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 149 S-----------------------------RASQRMPLI----YVKLYTYQICRALAYIH 175
                                         +   + P+     ++K   Y +     +IH
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146
Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNI----------------- 217
              G+ HRD+KP N L+N     VK+CDFG A+ +  + + NI                 
Sbjct: 147 ES-GIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 218 -----SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQ----------PLFP 261
                S++ +R+YRAPELI     YT ++DIWS GC+ AELL + Q          PLFP
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 262 G-----------------ESGVDQLVEIIKVLGTPTREEIKCMN-PNYTEFKFPQIKAHP 303
           G                 +S  DQL  I  ++GTPT +++K +N P   ++    IK  P
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY----IKLFP 320
Query: 304 WHKIFHKR-----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
             K  + +     +  + ++L+  +L+++PN R T  +A  HP+  ++R
Sbjct: 321 HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 142/307 (46%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP    +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVEN 262
Query: 295 KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F           +K    +A DL+S++L    + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 142/307 (46%), Gaps = 53/307 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 --------------HYSRASQRMPLIYVKL---------------YTYQICRALAYIHGG 177
                          +      M L+   L                 YQ+   + ++H  
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-Y 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 294
              VD+WSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 203 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 295 KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + P+   + + K+F           +K    +A DL+S++L    + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 344 DELRDPN 350
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 89/329 (27%), Positives = 148/329 (44%), Gaps = 79/329 (24%)
Query: 87  PKQTISYMAE--RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 144
           P   ++Y  E  +V+G+GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 145 N----------VHY--------------------------SRASQRMPLIYVKLYTYQIC 168
                      +H                               Q   L  V+ + + I 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSRYYRA 227
           + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR+YRA
Sbjct: 211 QCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRA 267
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 287
           PE+I GA  Y   +D+WS+GC+LAELL G PL PGE   DQL  +I++LG P++   K +
Sbjct: 268 PEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLL 323
Query: 288 NPNYTEFKFPQIKAHPWH------------------KIFHKRMPPEA------------- 316
           + +     F   K +P +                  +    R PPE+             
Sbjct: 324 DASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 317 --VDLVSRLLQYSPNLRCTALEACIHPFF 343
             +D + + L++ P +R T  +A  HP+ 
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 89/329 (27%), Positives = 148/329 (44%), Gaps = 79/329 (24%)
Query: 87  PKQTISYMAE--RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 144
           P   ++Y  E  +V+G+GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 145 N----------VHY--------------------------SRASQRMPLIYVKLYTYQIC 168
                      +H                               Q   L  V+ + + I 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSRYYRA 227
           + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR+YRA
Sbjct: 211 QCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRA 267
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 287
           PE+I GA  Y   +D+WS+GC+LAELL G PL PGE   DQL  +I++LG P++   K +
Sbjct: 268 PEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLL 323
Query: 288 NPNYTEFKFPQIKAHPWH------------------KIFHKRMPPEA------------- 316
           + +     F   K +P +                  +    R PPE+             
Sbjct: 324 DASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 317 --VDLVSRLLQYSPNLRCTALEACIHPFF 343
             +D + + L++ P +R T  +A  HP+ 
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 94/354 (26%), Positives = 146/354 (41%), Gaps = 100/354 (28%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDHPNVHY 148
           +Y  + ++G+GS+G V+ A      + VAIKKV    +D     R L+ + +L+     Y
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 149 S-----------------------------RASQRMPLI----YVKLYTYQICRALAYIH 175
                                         +   + P+     +VK   Y +     +IH
Sbjct: 89  IIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIH 148
Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI------------------ 217
              G+ HRD+KP N L+N     VK+CDFG A+  +  + +I                  
Sbjct: 149 ES-GIIHRDLKPANCLLNQDC-SVKICDFGLART-INSDKDIHIVNDLEEKEENEEPGPH 205
Query: 218 ---------SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ----------- 257
                    S++ +R+YRAPELI     YT ++DIWS GC+ AELL              
Sbjct: 206 NKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRF 265
Query: 258 PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMNPN----YTEFKF 296
           PLFPG                 +S  DQL  I  V+GTP  E++KC+       Y +  F
Sbjct: 266 PLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKL-F 324
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           P        K +   +  E +DL+  +L+++   R T  +A  HP+  ++R  N
Sbjct: 325 PTRDGIDLSKKY-SSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKEN 377

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 119/235 (50%), Gaps = 42/235 (17%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 142
           +NG+ K    Y  + ++G+GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 143 HPN----------VHYSRA---SQRMPLIYVKL-----------------------YTYQ 166
             N          VH  R       + L++  L                       +  Q
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 167 ICRALAYIHG-GIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 224
           +C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+     I SR+
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRF 223
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
           YR+PE++ G   Y  A+D+WS+GC+L E+  G+PLF G + VDQ+ +I++VLG P
Sbjct: 224 YRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 93/341 (27%), Positives = 145/341 (42%), Gaps = 81/341 (23%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 142
           +NG+ K    Y  + ++G+GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 28  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 143 HPNVHYSRAS------------------------------------QRMPLIYVKLYTYQ 166
             N H +                                       + + L   + +  Q
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 146
Query: 167 ICRALAYIHG-GIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 224
           +C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+     I SR+
Sbjct: 147 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRF 204
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           YR+PE++ G   Y  A+D+WS+GC+L E+  G+PLF G + VDQ+ +I++VLG P    I
Sbjct: 205 YRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHI 262
Query: 285 KCMNPNYTEFKFPQIKAHPWH----------------KIFHKRMPPEA------------ 316
               P   +F F ++    W+                +  H  +  E             
Sbjct: 263 LDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESG 321
Query: 317 ---------VDLVSRLLQYSPNLRCTALEACIHPFFDELRD 348
                     DL+ R+L Y P  R     A  H FF +  D
Sbjct: 322 HTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 362

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 119/235 (50%), Gaps = 42/235 (17%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 142
           +NG+ K    Y  + ++G+GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 143 HPN----------VHYSRA---SQRMPLIYVKL-----------------------YTYQ 166
             N          VH  R       + L++  L                       +  Q
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 167 ICRALAYIHG-GIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 224
           +C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+     I SR+
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIYQXIQSRF 223
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
           YR+PE++ G   Y  A+D+WS+GC+L E+  G+PLF G + VDQ+ +I++VLG P
Sbjct: 224 YRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 131/290 (45%), Gaps = 54/290 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 145
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 146 V-------HYSRASQRMPLIYV------KLYTY-------------------QICRALAY 173
           V         SR  + + +  V       L TY                   Q  R L +
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
           +H    + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE++  
Sbjct: 128 LHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQ 185
Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
           +T Y T VD+WSVGC+ AE+   +PLF G S  DQL +I  ++G P  ++    + +   
Sbjct: 186 ST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPR 243
Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
             FP     P   +    M      L+  +L ++P+ R +A  A  H + 
Sbjct: 244 GAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 50/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV      
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 147 ------HYSRASQRMPLIY---------------VKLYTYQICRALAYIHGGI------G 179
                  Y+R    + L++               VK    +I R +  +  G+       
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 145
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAPELIFGA 234
           + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR PEL+ G 
Sbjct: 146 ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGE 204
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
            +Y   +D+W  GC++AE+    P+  G +   QL  I ++ G+ T E    ++ NY  +
Sbjct: 205 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYELY 263
Query: 295 KFPQIKAHPWHKIFHKRMP----PEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           +  ++      K+  +       P A+DL+ +LL   P  R  + +A  H FF
Sbjct: 264 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 50/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVH----- 147
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV      
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 148 -------YSRASQRMPLIY---------------VKLYTYQICRALAYIHGGI------G 179
                  Y+R    + L++               VK    +I R +  +  G+       
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 145
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAPELIFGA 234
           + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR PEL+ G 
Sbjct: 146 ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGE 204
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
            +Y   +D+W  GC++AE+    P+  G +   QL  I ++ G+ T E    ++ NY  +
Sbjct: 205 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYELY 263
Query: 295 KFPQIKAHPWHKIFHKRMP----PEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           +  ++      K+  +       P A+DL+ +LL   P  R  + +A  H FF
Sbjct: 264 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 131/290 (45%), Gaps = 54/290 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 145
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 146 V-------HYSRASQRMPLIYV------KLYTY-------------------QICRALAY 173
           V         SR  + + +  V       L TY                   Q  R L +
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
           +H    + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE++  
Sbjct: 128 LHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQ 185
Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
           +T Y T VD+WSVGC+ AE+   +PLF G S  DQL +I  ++G P  ++    + +   
Sbjct: 186 ST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPR 243
Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
             FP     P   +    M      L+  +L ++P+ R +A  A  H + 
Sbjct: 244 GAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 50/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVH----- 147
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV      
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 148 -------YSRASQRMPLIY---------------VKLYTYQICRALAYIHGGI------G 179
                  Y+R    + L++               VK    +I R +  +  G+       
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 145
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAPELIFGA 234
           + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR PEL+ G 
Sbjct: 146 ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGE 204
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
            +Y   +D+W  GC++AE+    P+  G +   QL  I ++ G+ T E    ++ NY  +
Sbjct: 205 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYELY 263
Query: 295 KFPQIKAHPWHKIFHKRMP----PEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           +  ++      K+  +       P A+DL+ +LL   P  R  + +A  H FF
Sbjct: 264 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 50/293 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVH----- 147
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV      
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 148 -------YSRASQRMPLIY---------------VKLYTYQICRALAYIHGGI------G 179
                  Y+R    + L++               VK    +I R +  +  G+       
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 144
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAPELIFGA 234
           + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR PEL+ G 
Sbjct: 145 ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGE 203
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
            +Y   +D+W  GC++AE+    P+  G +   QL  I ++ G+ T E    ++ NY  +
Sbjct: 204 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYELY 262
Query: 295 KFPQIKAHPWHKIFHKRMP----PEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           +  ++      K+  +       P A+DL+ +LL   P  R  + +A  H FF
Sbjct: 263 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 131/290 (45%), Gaps = 54/290 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 145
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 146 V-------HYSRASQRMPLIYV------KLYTY-------------------QICRALAY 173
           V         SR  + + +  V       L TY                   Q  R L +
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
           +H    + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE++  
Sbjct: 128 LHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQ 185
Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
           +T Y T VD+WSVGC+ AE+   +PLF G S  DQL +I  ++G P  ++    + +   
Sbjct: 186 ST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPR 243
Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
             FP     P   +    M      L+  +L ++P+ R +A  A  H + 
Sbjct: 244 GAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 88/329 (26%), Positives = 145/329 (44%), Gaps = 79/329 (24%)
Query: 87  PKQTISYMAE--RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 144
           P   ++Y  E  +V+G+G FG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 145 N----------VHY--------------------------SRASQRMPLIYVKLYTYQIC 168
                      +H                               Q   L  V+ + + I 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSRYYRA 227
           + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +     I SR+YRA
Sbjct: 211 QCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRA 267
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 287
           PE+I GA  Y   +D+WS+GC+LAELL G PL PGE   DQL  +I++LG P +   K +
Sbjct: 268 PEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ---KLL 323
Query: 288 NPNYTEFKFPQIKAHPWH------------------KIFHKRMPPEA------------- 316
           + +     F   K +P +                  +    R PPE+             
Sbjct: 324 DASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 317 --VDLVSRLLQYSPNLRCTALEACIHPFF 343
             +D + + L++ P +R T  +A  HP+ 
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 131/293 (44%), Gaps = 57/293 (19%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------------RELQTMRLLD--- 142
           +G G++G V++A+   +G  VA+K V    R  N             RE+  +R L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 143 HPNV-------HYSRASQRMPLIYV------KLYTY-------------------QICRA 170
           HPNV         SR  + + +  V       L TY                   Q  R 
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 230
           L ++H    + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE+
Sbjct: 133 LDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEV 190
Query: 231 IFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 290
           +  +T Y T VD+WSVGC+ AE+   +PLF G S  DQL +I  ++G P  ++    + +
Sbjct: 191 LLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVS 248
Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                FP     P   +    M      L+  +L ++P+ R +A  A  H + 
Sbjct: 249 LPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/238 (33%), Positives = 117/238 (49%), Gaps = 40/238 (16%)
Query: 146 VHYSRASQ------RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHT 196
           + + RAS+      ++P   VK   YQI   + Y+H    V HRD+KP N+LV    P  
Sbjct: 110 IKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPER 168
Query: 197 HQVKLCDFGSAKVL---VKGEPNIS-YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAE 252
            +VK+ D G A++    +K   ++   + + +YRAPEL+ GA  YT A+DIW++GC+ AE
Sbjct: 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 228
Query: 253 LLLGQPLF---------PGESGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFKFPQ-- 298
           LL  +P+F               DQL  I  V+G P     E+IK M  + T  K  +  
Sbjct: 229 LLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRN 288
Query: 299 -------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
                  IK    HK+   +   +A  L+ +LL   P  R T+ +A   P+F  L DP
Sbjct: 289 TYTNCSLIKYMEKHKV---KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF--LEDP 341

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 63/285 (22%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 145
           Y  +RV+G+GSFG V   K   TG+  A+K + +       DK    RE+Q ++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 146 VH------------------YSRASQRMPLIYVKLYT--------YQICRALAYIHGGIG 179
           +                   Y+       +I  K ++         Q+   + Y+H    
Sbjct: 112 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN-K 170
Query: 180 VCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
           + HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE++ G   Y
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--Y 228
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
               D+WS G +L  LL G P F G +  D L ++ K                YT F+ P
Sbjct: 229 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------GKYT-FELP 273
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           Q     W     K++   A DL+ ++L Y P++R +A +A  H +
Sbjct: 274 Q-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 63/285 (22%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 145
           Y  +RV+G+GSFG V   K   TG+  A+K + +       DK    RE+Q ++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 146 VH------------------YSRASQRMPLIYVKLYT--------YQICRALAYIHGGIG 179
           +                   Y+       +I  K ++         Q+   + Y+H    
Sbjct: 111 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN-K 169
Query: 180 VCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
           + HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE++ G   Y
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--Y 227
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
               D+WS G +L  LL G P F G +  D L ++ K                YT F+ P
Sbjct: 228 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------GKYT-FELP 272
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           Q     W     K++   A DL+ ++L Y P++R +A +A  H +
Sbjct: 273 Q-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 63/285 (22%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 145
           Y  +RV+G+GSFG V   K   TG+  A+K + +       DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 146 VH------------------YSRASQRMPLIYVKLYT--------YQICRALAYIHGGIG 179
           +                   Y+       +I  K ++         Q+   + Y+H    
Sbjct: 88  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN-K 146
Query: 180 VCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
           + HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE++ G   Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--Y 204
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
               D+WS G +L  LL G P F G +  D L ++ K                YT F+ P
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------GKYT-FELP 249
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           Q     W     K++   A DL+ ++L Y P++R +A +A  H +
Sbjct: 250 Q-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 100/355 (28%), Positives = 150/355 (42%), Gaps = 79/355 (22%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-------------- 130
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y              
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 131 ---KNRELQTM------RLLDHPN------VHY---------------SRASQR-MPLIY 159
               N +  +M      +LLDH N      VH                 +   R +PLIY
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 132
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-----PHTHQVKLCDFGSAKVLVKGE 214
           VK  + Q+   L Y+H   G+ H DIKP+N+L+       +  Q+K+ D G+A      E
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190
Query: 215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG------VDQ 268
              + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D 
Sbjct: 191 HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
Query: 269 LVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FHKRMPPE 315
           + +II++LG            T T    + +  N ++ KF  ++     K  F K    E
Sbjct: 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309
Query: 316 AVDLVSRLLQYSPNLRCTALEACIHPFF------DELRDPNARL-PNGRPFPPLF 363
             D +S +LQ  P  R  A     HP+       +E+R P+  L  +G   P  F
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 100/355 (28%), Positives = 150/355 (42%), Gaps = 79/355 (22%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-------------- 130
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y              
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 131 ---KNRELQTM------RLLDHPN------VHY---------------SRASQR-MPLIY 159
               N +  +M      +LLDH N      VH                 +   R +PLIY
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 132
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-----PHTHQVKLCDFGSAKVLVKGE 214
           VK  + Q+   L Y+H   G+ H DIKP+N+L+       +  Q+K+ D G+A      E
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190
Query: 215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG------VDQ 268
              + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D 
Sbjct: 191 HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
Query: 269 LVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FHKRMPPE 315
           + +II++LG            T T    + +  N ++ KF  ++     K  F K    E
Sbjct: 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309
Query: 316 AVDLVSRLLQYSPNLRCTALEACIHPFF------DELRDPNARL-PNGRPFPPLF 363
             D +S +LQ  P  R  A     HP+       +E+R P+  L  +G   P  F
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 157
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+   TE +  
Sbjct: 158 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL---TEKSAC 213
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 214 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 254
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 255 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 302

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 153
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+   TE +  
Sbjct: 154 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL---TEKSAC 209
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 210 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 250
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 251 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 298

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 139/298 (46%), Gaps = 78/298 (26%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 156
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTTA 240
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   +   ++
Sbjct: 157 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSS 215
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
            D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ FP+
Sbjct: 216 -DLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL-----------------EYDFPE 255
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
                  K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 256 -------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 63/285 (22%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 145
           Y  +RV+G+GSFG V   K   TG+  A+K + +       DK    RE+Q ++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 146 VH------------------YSRASQRMPLIYVKLYT--------YQICRALAYIHGGIG 179
           +                   Y+       +I  K ++         Q+   + Y+H    
Sbjct: 94  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN-K 152
Query: 180 VCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
           + HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE++ G   Y
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--Y 210
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
               D+WS G +L  LL G P F G +  D L ++ K                YT F+ P
Sbjct: 211 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------GKYT-FELP 255
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           Q     W     K++   A DL+ ++L Y P++R +A +A  H +
Sbjct: 256 Q-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 141/300 (47%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 154
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K     +++ +  Y +PEL+   TE +  
Sbjct: 155 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL---TEKSAC 210
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 211 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 251
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 252 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 299

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 141/298 (47%), Gaps = 78/298 (26%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 145 --------NVHY--SRASQRMPLIYVK-----------LYTYQICRALAYIHGGIGVCHR 183
                    +++  S A     L Y++            YT +I  AL Y+HG  G+ HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 156
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTTA 240
           D+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+   +  + +
Sbjct: 157 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-SKS 214
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
            D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ FP+
Sbjct: 215 SDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDFPE 255
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
                  K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 256 -------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 154
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   TE +  
Sbjct: 155 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSAC 210
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 211 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 251
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 252 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 299

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 154
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   TE +  
Sbjct: 155 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSAC 210
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 211 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 251
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 252 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 299

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 156
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   TE +  
Sbjct: 157 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSAC 212
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 213 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 253
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 254 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 156
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   TE +  
Sbjct: 157 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSAC 212
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 213 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 253
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 254 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 156
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   TE +  
Sbjct: 157 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSAC 212
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 213 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 253
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 254 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 156
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   TE +  
Sbjct: 157 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSAC 212
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 213 KSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL-----------------EYDF 253
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 254 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 157
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   TE +  
Sbjct: 158 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSAC 213
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 214 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 254
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 255 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 302

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 153
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   TE +  
Sbjct: 154 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSAC 209
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 210 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 250
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 251 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 298

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 139/298 (46%), Gaps = 78/298 (26%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 132
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTTA 240
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   +   ++
Sbjct: 133 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 191
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
            D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ FP+
Sbjct: 192 -DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDFPE 231
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
                  K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 232 -------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 124/285 (43%), Gaps = 63/285 (22%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 145
           Y  +RV+G+GSFG V   K   TG+  A+K + +       DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 146 VH------------------YSRASQRMPLIYVKLYT--------YQICRALAYIHGGIG 179
           +                   Y+       +I  K ++         Q+   + Y H    
Sbjct: 88  IXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKN-K 146
Query: 180 VCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
           + HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE++ G   Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT--Y 204
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
               D+WS G +L  LL G P F G +  D L ++ K                YT F+ P
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------GKYT-FELP 249
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           Q     W     K++   A DL+ + L Y P+ R +A +A  H +
Sbjct: 250 Q-----W-----KKVSESAKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 139/298 (46%), Gaps = 78/298 (26%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 133
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTTA 240
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   +   ++
Sbjct: 134 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 192
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
            D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ FP+
Sbjct: 193 -DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDFPE 232
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
                  K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 233 -------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 278

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 103 YFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 161
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   TE +  
Sbjct: 162 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSAC 217
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 218 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 258
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 259 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 306

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 139/298 (46%), Gaps = 78/298 (26%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 138
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTTA 240
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   +   ++
Sbjct: 139 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 197
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
            D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ FP+
Sbjct: 198 -DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDFPE 237
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
                  K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 238 -------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 283

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 139/298 (46%), Gaps = 78/298 (26%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 134
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTTA 240
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   +   ++
Sbjct: 135 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 193
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
            D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ FP+
Sbjct: 194 -DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDFPE 233
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
                  K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 234 -------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 279

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 139/298 (46%), Gaps = 78/298 (26%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 131
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTTA 240
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   +   ++
Sbjct: 132 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 190
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
            D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ FP+
Sbjct: 191 -DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDFPE 230
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
                  K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 231 -------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 276

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 139/300 (46%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF     A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 154
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   TE +  
Sbjct: 155 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSAC 210
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 211 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 251
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P+       K F     P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 252 PE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 299

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 137/300 (45%), Gaps = 82/300 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHP----- 144
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP     
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 145 ------------NVHYSRASQRMPLIY---------VKLYTYQICRALAYIHGGIGVCHR 183
                        + Y++  + +  I           + YT +I  AL Y+HG  G+ HR
Sbjct: 101 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHR 159
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTT- 239
           D+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+   TE +  
Sbjct: 160 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSAC 215
Query: 240 -AVDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKF 296
            + D+W++GC++ +L+ G P  P  +G + L+  +IIK+                 E+ F
Sbjct: 216 KSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-----------------EYDF 256
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFDELRDPN 350
           P                P+A DLV +L  L  +  L C  +E       HPFF+ +   N
Sbjct: 257 PAA------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 304

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/329 (24%), Positives = 138/329 (41%), Gaps = 92/329 (27%)
Query: 98  VVGQGSFGIVFQAKCLET---GETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQR 154
            +G+G+FG V +  C++    G  VA+K V    RY       +++L+H N     ++ R
Sbjct: 21  TLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 155 ------------------------------------MPLIYVKLYTYQICRALAYIHGGI 178
                                                 L +++   YQIC+++ ++H   
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN- 137
Query: 179 GVCHRDIKPQNLL---------------------VNPHTHQVKLCDFGSAKVLVKGEPNI 217
            + H D+KP+N+L                     +NP    +K+ DFGSA      E + 
Sbjct: 138 KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHHS 192
Query: 218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 277
           + + +R+YRAPE+I  A  ++   D+WS+GC+L E  LG  +FP     + L  + ++LG
Sbjct: 193 TLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILG 251
Query: 278 ---------TPTREEIKCMNPNYTEF----KFPQIKAHPWHKIF------HKRMPPEAVD 318
                    T  R+       ++ E     ++      P  +        H+R+     D
Sbjct: 252 PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL----FD 307
Query: 319 LVSRLLQYSPNLRCTALEACIHPFFDELR 347
           L+ ++L+Y P  R T  EA  HPFFD L+
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFFDLLK 336

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/329 (24%), Positives = 137/329 (41%), Gaps = 92/329 (27%)
Query: 98  VVGQGSFGIVFQAKCLET---GETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQR 154
            +G+G+FG V +  C++    G  VA+K V    RY       +++L+H N     ++ R
Sbjct: 21  TLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 155 ------------------------------------MPLIYVKLYTYQICRALAYIHGGI 178
                                                 L +++   YQIC+++ ++H   
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN- 137
Query: 179 GVCHRDIKPQNLL---------------------VNPHTHQVKLCDFGSAKVLVKGEPNI 217
            + H D+KP+N+L                     +NP    +K+ DFGSA      E + 
Sbjct: 138 KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHHS 192
Query: 218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 277
           + +  R+YRAPE+I  A  ++   D+WS+GC+L E  LG  +FP     + L  + ++LG
Sbjct: 193 TLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILG 251
Query: 278 ---------TPTREEIKCMNPNYTEF----KFPQIKAHPWHKIF------HKRMPPEAVD 318
                    T  R+       ++ E     ++      P  +        H+R+     D
Sbjct: 252 PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL----FD 307
Query: 319 LVSRLLQYSPNLRCTALEACIHPFFDELR 347
           L+ ++L+Y P  R T  EA  HPFFD L+
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFFDLLK 336

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 126/299 (42%), Gaps = 65/299 (21%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVH--- 147
           ++G+GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN+    
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 148 ---------------YSRASQRMPLIYVKLYT-YQICRALAYIHGGI------GVCHRDI 185
                          Y+       +I  K ++ +   R +  +  GI       + HRD+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 186 KPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           KP+N+L+        +K+ DFG +    +       I + YY APE++ G   Y    D+
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDV 205
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS G +L  LL G P F G++  D L               K +      F  PQ     
Sbjct: 206 WSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAFDLPQ----- 245
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPL 362
           W  I       +A DL+ ++L + P+LR TA +   HP+   ++  ++  P     P L
Sbjct: 246 WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW---IQKYSSETPTISDLPSL 296

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 106/228 (46%), Gaps = 49/228 (21%)
Query: 81  GGRN-GQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE--- 134
           GGR+   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNRE   
Sbjct: 2   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60
Query: 135 --LQTMRLLDHPNVHYSR---------ASQRMPLIY------------------------ 159
             +Q M+ L+HPNV  +R         A   +PL+                         
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 160 --VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV--KLCDFGSAKVLVKGEP 215
             ++     I  AL Y+H    + HRD+KP+N+++ P   ++  K+ D G AK L +GE 
Sbjct: 121 GPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLG-QPLFPG 262
              ++ +  Y APEL+    +YT  VD WS G +  E + G +P  P 
Sbjct: 180 CTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 62/279 (22%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVH--- 147
           ++G+GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN+    
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 148 ---------------YSRASQRMPLIYVKLYT-YQICRALAYIHGGI------GVCHRDI 185
                          Y+       +I  K ++ +   R +  +  GI       + HRD+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 186 KPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           KP+N+L+        +K+ DFG +    +       I + YY APE++ G   Y    D+
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDV 205
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS G +L  LL G P F G++  D L               K +      F  PQ     
Sbjct: 206 WSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAFDLPQ----- 245
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           W  I       +A DL+ ++L + P+LR TA +   HP+
Sbjct: 246 WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 106/228 (46%), Gaps = 49/228 (21%)
Query: 81  GGRN-GQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE--- 134
           GGR+   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNRE   
Sbjct: 3   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 61
Query: 135 --LQTMRLLDHPNVHYSR---------ASQRMPLIY------------------------ 159
             +Q M+ L+HPNV  +R         A   +PL+                         
Sbjct: 62  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 121
Query: 160 --VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV--KLCDFGSAKVLVKGEP 215
             ++     I  AL Y+H    + HRD+KP+N+++ P   ++  K+ D G AK L +GE 
Sbjct: 122 GPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLG-QPLFPG 262
              ++ +  Y APEL+    +YT  VD WS G +  E + G +P  P 
Sbjct: 181 CTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 62/279 (22%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVH--- 147
           ++G+GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN+    
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 148 ---------------YSRASQRMPLIYVKLYT-YQICRALAYIHGGI------GVCHRDI 185
                          Y+       +I  K ++ +   R +  +  GI       + HRD+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 186 KPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           KP+N+L+        +K+ DFG +    +       I + YY APE++ G   Y    D+
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDV 205
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS G +L  LL G P F G++  D L               K +      F  PQ     
Sbjct: 206 WSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAFDLPQ----- 245
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           W  I       +A DL+ ++L + P+LR TA +   HP+
Sbjct: 246 WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 62/281 (22%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYK---NRELQTMRLLDHPN-VHYSRAS 152
           V+G+G++GIV+  + L     +AIK++ + D RY    + E+   + L H N V Y  + 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 153 QRMPLI----------------------------YVKLYTYQICRALAYIHGGIGVCHRD 184
                I                             +  YT QI   L Y+H    + HRD
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRD 147
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIF-GATEYTTAVD 242
           IK  N+L+N ++  +K+ DFG++K L    P   ++  +  Y APE+I  G   Y  A D
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 207
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           IWS+GC + E+  G+P F                        +   P    FK    K H
Sbjct: 208 IWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKVGMFKVH 244
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           P      + M  EA   + +  +  P+ R  A +  +  F 
Sbjct: 245 PE---IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 62/281 (22%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYK---NRELQTMRLLDHPN-VHYSRAS 152
           V+G+G++GIV+  + L     +AIK++ + D RY    + E+   + L H N V Y  + 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 153 QRMPLI----------------------------YVKLYTYQICRALAYIHGGIGVCHRD 184
                I                             +  YT QI   L Y+H    + HRD
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRD 133
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIF-GATEYTTAVD 242
           IK  N+L+N ++  +K+ DFG++K L    P   ++  +  Y APE+I  G   Y  A D
Sbjct: 134 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 193
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           IWS+GC + E+  G+P F                        +   P    FK    K H
Sbjct: 194 IWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKVGMFKVH 230
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           P      + M  EA   + +  +  P+ R  A +  +  F 
Sbjct: 231 PE---IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 39/225 (17%)
Query: 153 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---------NPHTH------ 197
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 150 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 208
Query: 198 ---QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL 254
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS+GC+L E  
Sbjct: 209 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 265
Query: 255 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKA 301
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 266 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 325
Query: 302 HPWHKIFHKRMPPEAV---DLVSRLLQYSPNLRCTALEACIHPFF 343
            P  K +  +   E V   DL+ R+L++ P  R T  EA +HPFF
Sbjct: 326 KPL-KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 39/225 (17%)
Query: 153 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---------NPH-------- 195
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 127 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 185
Query: 196 -THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL 254
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS+GC+L E  
Sbjct: 186 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYY 242
Query: 255 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKA 301
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 243 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 302
Query: 302 HPWHKIFHKRMPPEAV---DLVSRLLQYSPNLRCTALEACIHPFF 343
            P  K +  +   E V   DL+ R+L++ P  R T  EA +HPFF
Sbjct: 303 KPL-KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 39/225 (17%)
Query: 153 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---------NPHTH------ 197
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 198 ---QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL 254
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS+GC+L E  
Sbjct: 177 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYY 233
Query: 255 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKA 301
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 302 HPWHKIFHKRMPPEAV---DLVSRLLQYSPNLRCTALEACIHPFF 343
            P  K +  +   E V   DL+ R+L++ P  R T  EA +HPFF
Sbjct: 294 KPL-KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 41/210 (19%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 144
           ++  E+ +G+G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 145 NV------------------------------HYSRASQRMPLIYVKLYTYQICRALAYI 174
           NV                              H+ +  + +P   V  Y  Q+C AL ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFG 233
           H    V HRDIKP N+ +   T  VKL D G  +    K     S + + YY +PE I  
Sbjct: 153 HSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 209
Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGE 263
              Y    DIWS+GC+L E+   Q  F G+
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 89/190 (46%), Gaps = 33/190 (17%)
Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSR- 223
           QI  AL Y+H   G+CHRDIKP+N L + + + ++KL DFG +K   K      Y  +  
Sbjct: 176 QIFSALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234
Query: 224 ----YYRAPELIFGATE-YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
               Y+ APE++    E Y    D WS G +L  LL+G   FPG +  D + +++     
Sbjct: 235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN---- 290
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
              +++   NPNY                    + P A DL+S LL  + + R  A+ A 
Sbjct: 291 ---KKLCFENPNYN------------------VLSPLARDLLSNLLNRNVDERFDAMRAL 329
Query: 339 IHPFFDELRD 348
            HP+  +  D
Sbjct: 330 QHPWISQFSD 339

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 133/313 (42%), Gaps = 67/313 (21%)
Query: 88  KQTISYMAERV--VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMR 139
           K  +S M +RV  +G G++G V   +   T    AIK + +     +       E+  ++
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK 91
Query: 140 LLDHPNVH------------------------YSRASQRMPL--IYVKLYTYQICRALAY 173
           LLDHPN+                         +     RM    +   +   Q+   + Y
Sbjct: 92  LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 231
           +H    + HRD+KP+NLL+        +K+ DFG + V    +     + + YY APE++
Sbjct: 152 LHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL 210
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
               +Y    D+WS+G +L  LL G P F G++  DQ  EI++          K     Y
Sbjct: 211 --RKKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR----------KVEKGKY 254
Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
           T F  P+     W     K +   A DL+ ++LQ+    R +A +A  HP+  E+    +
Sbjct: 255 T-FDSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM---CS 300
Query: 352 RLPNGRPFPPLFN 364
           +  +G   P L N
Sbjct: 301 KKESGIELPSLAN 313

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 39/237 (16%)
Query: 156 PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ----------------- 198
           P+  V+   +Q+C+A+ ++H    + H D+KP+N+L     ++                 
Sbjct: 135 PIHQVRHMAFQLCQAVKFLHDN-KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKST 193
Query: 199 -VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ 257
            V++ DFGSA      E + + + +R+YRAPE+I     ++   D+WS+GC++ E  +G 
Sbjct: 194 AVRVVDFGSATF--DHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGF 250
Query: 258 PLFPGESGVDQLVEIIKVLG-TPTREEIKC------------MNPNYTEFKFPQIKAHPW 304
            LF      + L  + ++LG  P+R   K              + N +  ++ +    P 
Sbjct: 251 TLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPL 310
Query: 305 HKIFHKRMPP--EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD--PNARLPNGR 357
            +          +  DL+  +L+Y P  R T  EA  HPFF  LR   PN    + R
Sbjct: 311 RRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSR 367

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 33/201 (16%)
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAK 208
            ++R+     KLY YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 209 VLVKGEPNI-SYICSR-YYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
           +L  GE ++   +C    Y APE++   G   Y  AVD WS+G +L   L G P F    
Sbjct: 166 IL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223
Query: 265 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 324
               L           +++I     N+     P++    W ++  K     A+DLV +LL
Sbjct: 224 TQVSL-----------KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLL 259
Query: 325 QYSPNLRCTALEACIHPFFDE 345
              P  R T  EA  HP+  +
Sbjct: 260 VVDPKARFTTEEALRHPWLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 33/201 (16%)
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAK 208
            ++R+     KLY YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 209 VLVKGEPNI-SYICSR-YYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
           +L  GE ++   +C    Y APE++   G   Y  AVD WS+G +L   L G P F    
Sbjct: 166 IL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223
Query: 265 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 324
               L           +++I     N+     P++    W ++  K     A+DLV +LL
Sbjct: 224 TQVSL-----------KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLL 259
Query: 325 QYSPNLRCTALEACIHPFFDE 345
              P  R T  EA  HP+  +
Sbjct: 260 VVDPKARFTTEEALRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 33/201 (16%)
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAK 208
            ++R+     KLY YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K
Sbjct: 106 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 164
Query: 209 VLVKGEPNI-SYICSR-YYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
           +L  GE ++   +C    Y APE++   G   Y  AVD WS+G +L   L G P F    
Sbjct: 165 IL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 222
Query: 265 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 324
               L           +++I     N+     P++    W ++  K     A+DLV +LL
Sbjct: 223 TQVSL-----------KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLL 258
Query: 325 QYSPNLRCTALEACIHPFFDE 345
              P  R T  EA  HP+  +
Sbjct: 259 VVDPKARFTTEEALRHPWLQD 279

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 33/201 (16%)
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAK 208
            ++R+     KLY YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 209 VLVKGEPNI-SYICSR-YYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
           +L  GE ++   +C    Y APE++   G   Y  AVD WS+G +L   L G P F    
Sbjct: 166 IL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223
Query: 265 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 324
               L           +++I     N+     P++    W ++  K     A+DLV +LL
Sbjct: 224 TQVSL-----------KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLL 259
Query: 325 QYSPNLRCTALEACIHPFFDE 345
              P  R T  EA  HP+  +
Sbjct: 260 VVDPKARFTTEEALRHPWLQD 280

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 33/201 (16%)
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAK 208
            ++R+     KLY YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K
Sbjct: 113 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 171
Query: 209 VLVKGEPNI-SYICSR-YYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
           +L  GE ++   +C    Y APE++   G   Y  AVD WS+G +L   L G P F    
Sbjct: 172 IL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229
Query: 265 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 324
               L           +++I     N+     P++    W ++  K     A+DLV +LL
Sbjct: 230 TQVSL-----------KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLL 265
Query: 325 QYSPNLRCTALEACIHPFFDE 345
              P  R T  EA  HP+  +
Sbjct: 266 VVDPKARFTTEEALRHPWLQD 286

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 34/205 (16%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 144
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 145 NV--HYSRASQRMPLIYV------KLYTY-----------------QICRALAYIHGGIG 179
           ++   Y     +  +I V      +L+ Y                 QI  A+ Y H    
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH-K 133
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+I G      
Sbjct: 134 IVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 240 AVDIWSVGCVLAELLLGQPLFPGES 264
            VD+WS G +L  +L  +  F  ES
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 34/205 (16%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 144
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 145 NV--HYSRASQRMPLIYV------KLYTY-----------------QICRALAYIHGGIG 179
           ++   Y     +  +I V      +L+ Y                 QI  A+ Y H    
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH-K 127
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+I G      
Sbjct: 128 IVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 240 AVDIWSVGCVLAELLLGQPLFPGES 264
            VD+WS G +L  +L  +  F  ES
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 34/205 (16%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 144
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 145 NV--HYSRASQRMPLIYV------KLYTY-----------------QICRALAYIHGGIG 179
           ++   Y     +  +I V      +L+ Y                 QI  A+ Y H    
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH-K 123
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+I G      
Sbjct: 124 IVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 240 AVDIWSVGCVLAELLLGQPLFPGES 264
            VD+WS G +L  +L  +  F  ES
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 33/201 (16%)
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAK 208
            ++R+     KLY YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K
Sbjct: 232 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290
Query: 209 VLVKGEPNI-SYICSR-YYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
           +L  GE ++   +C    Y APE++   G   Y  AVD WS+G +L   L G P F    
Sbjct: 291 IL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348
Query: 265 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 324
               L           +++I     N+     P++    W ++  K     A+DLV +LL
Sbjct: 349 TQVSL-----------KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLL 384
Query: 325 QYSPNLRCTALEACIHPFFDE 345
              P  R T  EA  HP+  +
Sbjct: 385 VVDPKARFTTEEALRHPWLQD 405

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 34/205 (16%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 144
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 145 NV--HYSRASQRMPLIYV------KLYTY-----------------QICRALAYIHGGIG 179
           ++   Y     +  +I V      +L+ Y                 QI  A+ Y H    
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH-K 132
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+I G      
Sbjct: 133 IVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 240 AVDIWSVGCVLAELLLGQPLFPGES 264
            VD+WS G +L  +L  +  F  ES
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 33/201 (16%)
Query: 151 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAK 208
            ++R+     KLY YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K
Sbjct: 246 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 304
Query: 209 VLVKGEPNI-SYICSR-YYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
           +L  GE ++   +C    Y APE++   G   Y  AVD WS+G +L   L G P F    
Sbjct: 305 IL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 362
Query: 265 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 324
               L           +++I     N+     P++    W ++  K     A+DLV +LL
Sbjct: 363 TQVSL-----------KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLL 398
Query: 325 QYSPNLRCTALEACIHPFFDE 345
              P  R T  EA  HP+  +
Sbjct: 399 VVDPKARFTTEEALRHPWLQD 419

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 125/286 (43%), Gaps = 62/286 (21%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----RELQTMRLLDHPNV- 146
           +++   V+G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H N+ 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 147 ----------HYSRASQRMP-------LIYVKLYT--------YQICRALAYIHGGIGVC 181
                     HY    Q +        ++   +YT         Q+  A+ Y+H   G+ 
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN-GIV 128
Query: 182 HRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYT 238
           HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C    Y APE +     Y+
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPE-VLAQKPYS 185
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
            AVD WS+G +   LL G P F  E+   +L E IK                Y EF+ P 
Sbjct: 186 KAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK--------------EGYYEFESP- 229
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                    F   +   A D +  LL+  PN R T  +A  HP+ D
Sbjct: 230 ---------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 3/108 (2%)
Query: 150 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 209
           + ++R+P   +   +  + R LAY+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 106 KEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 164
Query: 210 LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ 257
           L+    N S++ +R Y APE + G T Y+   DIWS+G  L EL +G+
Sbjct: 165 LIDSMAN-SFVGTRSYMAPERLQG-THYSVQSDIWSMGLSLVELAVGR 210

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 65/283 (22%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYKNRELQ-TMRLLDHP-NVHYSRA 151
           +G+G++G+V + + + +G+ +A+K++      Q+++    +L  +MR +D P  V +  A
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 152 SQRMPLIYV----------KLY------------------TYQICRALAYIHGGIGVCHR 183
             R   +++          K Y                     I +AL ++H  + V HR
Sbjct: 119 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR 178
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI---FGATEYTTA 240
           D+KP N+L+N    QVK+CDFG +  LV           + Y APE I        Y+  
Sbjct: 179 DVKPSNVLINA-LGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVK 237
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
            DIWS+G  + EL + +  FP +S            GTP ++               Q+ 
Sbjct: 238 SDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------------LKQVV 271
Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
             P  ++   +   E VD  S+ L+ +   R T  E   HPFF
Sbjct: 272 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 40/220 (18%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAI--KKVLQDKRYKNRELQTMRL-------LDHP--- 144
           +V+GQGSFG VF  K +   +   +   KVL+    K R+    ++       ++HP   
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 145 NVHYSRASQ-RMPLIY----------------------VKLYTYQICRALAYIHGGIGVC 181
            +HY+  ++ ++ LI                       VK Y  ++  AL ++H  +G+ 
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGII 148
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATEYTTA 240
           +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++     +T +
Sbjct: 149 YRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQS 206
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 279
            D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 118/288 (40%), Gaps = 63/288 (21%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVHYSRAS 152
           +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  MR   H NV     S
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 216
Query: 153 -------------------------QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 187
                                     RM    +      + +AL+ +H   GV HRDIK 
Sbjct: 217 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKS 275
Query: 188 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVDIWSV 246
            ++L+  H  +VKL DFG    + K  P    +  + Y+ APELI     Y   VDIWS+
Sbjct: 276 DSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGPEVDIWSL 333
Query: 247 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 306
           G ++ E++ G+P +  E               P  + +K +  N            P  K
Sbjct: 334 GIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----------PRLK 368
Query: 307 IFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 354
             HK + P     + RLL   P  R TA E   HPF  +   P + +P
Sbjct: 369 NLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 415

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 118/288 (40%), Gaps = 63/288 (21%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVHYSRAS 152
           +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  MR   H NV     S
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 139
Query: 153 -------------------------QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 187
                                     RM    +      + +AL+ +H   GV HRDIK 
Sbjct: 140 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKS 198
Query: 188 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVDIWSV 246
            ++L+  H  +VKL DFG    + K  P    +  + Y+ APELI     Y   VDIWS+
Sbjct: 199 DSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGPEVDIWSL 256
Query: 247 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 306
           G ++ E++ G+P +  E               P  + +K +  N            P  K
Sbjct: 257 GIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----------PRLK 291
Query: 307 IFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 354
             HK + P     + RLL   P  R TA E   HPF  +   P + +P
Sbjct: 292 NLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 338

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 60/285 (21%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNV-H 147
           Y  E  +G+GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN+  
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 148 YSRASQRMPLIYVKL-------------------------YTYQICRALAYIHGGIGVCH 182
                +    IY+ +                             +  A+AY H  + V H
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK-LNVAH 129
Query: 183 RDIKPQNLL--VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
           RD+KP+N L   +     +KL DFG A     G+   + + + YY +P+++ G   Y   
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPE 187
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
            D WS G ++  LL G P F   +  + +++I +  GT               F FP+  
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT---------------FTFPE-- 228
Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
              W  +      P+A  L+ RLL  SP  R T+L+A  H +F++
Sbjct: 229 -KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 125/303 (41%), Gaps = 67/303 (22%)
Query: 85  GQPKQTISYMAERV-VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 137
           G P+   SY+   + +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 27  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 81
Query: 138 MRLLDHPNVHYSRAS-------------------------QRMPLIYVKLYTYQICRALA 172
           MR   H NV     S                          RM    +      + +AL+
Sbjct: 82  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALS 141
Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 231
            +H   GV HRDIK  ++L+  H  +VKL DFG    + K  P    +  + Y+ APELI
Sbjct: 142 VLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 199
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
                Y   VDIWS+G ++ E++ G+P +  E               P  + +K +  N 
Sbjct: 200 -SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNL 243
Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
                      P  K  HK + P     + RLL   P  R TA E   HPF  +   P +
Sbjct: 244 P----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 292
Query: 352 RLP 354
            +P
Sbjct: 293 IVP 295

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 126/306 (41%), Gaps = 67/306 (21%)
Query: 85  GQPKQTISYMAERV-VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 137
           G P+   SY+   + +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 25  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 79
Query: 138 MRLLDHPNVHYSRAS-------------------------QRMPLIYVKLYTYQICRALA 172
           MR   H NV     S                          RM    +      + +AL+
Sbjct: 80  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALS 139
Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 231
            +H   GV HRDIK  ++L+  H  +VKL DFG    + K  P    +  + Y+ APELI
Sbjct: 140 VLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 197
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
                Y   VDIWS+G ++ E++ G+P +  E               P  + +K +  N 
Sbjct: 198 -SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNL 241
Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
                      P  K  HK + P     + RLL   P  R TA E   HPF  +   P +
Sbjct: 242 P----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 290
Query: 352 RLPNGR 357
            +P  R
Sbjct: 291 IVPLMR 296

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 125/306 (40%), Gaps = 67/306 (21%)
Query: 85  GQPKQTISYMAERV-VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 137
           G P+   SY+   + +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 16  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 70
Query: 138 MRLLDHPNVHYSRAS-------------------------QRMPLIYVKLYTYQICRALA 172
           MR   H NV     S                          RM    +      + +AL+
Sbjct: 71  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALS 130
Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 231
            +H   GV HRDIK  ++L+  H  +VKL DFG    + K  P    +    Y+ APELI
Sbjct: 131 VLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 188
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
                Y   VDIWS+G ++ E++ G+P +  E               P  + +K +  N 
Sbjct: 189 -SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNL 232
Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
                      P  K  HK + P     + RLL   P  R TA E   HPF  +   P +
Sbjct: 233 P----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 281
Query: 352 RLPNGR 357
            +P  R
Sbjct: 282 IVPLMR 287

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 125/306 (40%), Gaps = 67/306 (21%)
Query: 85  GQPKQTISYMAERV-VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 137
           G P+   SY+   + +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 20  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 74
Query: 138 MRLLDHPNVHYSRAS-------------------------QRMPLIYVKLYTYQICRALA 172
           MR   H NV     S                          RM    +      + +AL+
Sbjct: 75  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALS 134
Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 231
            +H   GV HRDIK  ++L+  H  +VKL DFG    + K  P    +    Y+ APELI
Sbjct: 135 VLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 192
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
                Y   VDIWS+G ++ E++ G+P +  E               P  + +K +  N 
Sbjct: 193 -SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNL 236
Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
                      P  K  HK + P     + RLL   P  R TA E   HPF  +   P +
Sbjct: 237 P----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 285
Query: 352 RLPNGR 357
            +P  R
Sbjct: 286 IVPLMR 291

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 40/220 (18%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAI--KKVLQDKRYKNRELQTMRL-------LDHP--- 144
           +V+GQGSFG VF  K +   +   +   KVL+    K R+    ++       ++HP   
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 145 NVHYSRASQ-RMPLIY----------------------VKLYTYQICRALAYIHGGIGVC 181
            +HY+  ++ ++ LI                       VK Y  ++  AL ++H  +G+ 
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGII 149
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATEYTTA 240
           +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++     +T +
Sbjct: 150 YRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQS 207
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 279
            D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 208 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 40/220 (18%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAI--KKVLQDKRYKNRELQTMRL-------LDHP--- 144
           +V+GQGSFG VF  K +   +   +   KVL+    K R+    ++       ++HP   
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 145 NVHYSRASQ-RMPLIY----------------------VKLYTYQICRALAYIHGGIGVC 181
            +HY+  ++ ++ LI                       VK Y  ++  AL ++H  +G+ 
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGII 148
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATEYTTA 240
           +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++     +T +
Sbjct: 149 YRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQS 206
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 279
            D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 60/285 (21%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNV-H 147
           Y  E  +G+GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN+  
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 148 YSRASQRMPLIYVKL-------------------------YTYQICRALAYIHGGIGVCH 182
                +    IY+ +                             +  A+AY H  + V H
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK-LNVAH 146
Query: 183 RDIKPQNLL--VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
           RD+KP+N L   +     +KL DFG A     G+   + + + YY +P+++ G   Y   
Sbjct: 147 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPE 204
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
            D WS G ++  LL G P F   +  + +++I +  GT               F FP+  
Sbjct: 205 CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT---------------FTFPE-- 245
Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
              W  +      P+A  L+ RLL  SP  R T+L+A  H +F++
Sbjct: 246 -KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 38/208 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DH 143
            ++  +++G+GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 144 PNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
           P +                          ++ ++  +  L     Y  +I   L ++H  
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATE 236
            G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G  +
Sbjct: 138 -GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QK 194
Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGES 264
           Y  +VD WS G +L E+L+GQ  F G+ 
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 38/207 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y  ++ +G+G+F  V  A+ + TG  VA+K +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 144 PNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
           PN+                           Y  A  RM     +    QI  A+ Y H  
Sbjct: 74  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 133
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
             + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G    
Sbjct: 134 Y-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGES 264
              VD+WS+G +L  L+ G   F G++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+   +   +A+K + + +  K        RE++    L HPN+   
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   S R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 74  YGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-KVIHR 132
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 133 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-HDEKVDL 189
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  D    I +V                 EF FP      
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EFTFPDF---- 228
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 125/288 (43%), Gaps = 63/288 (21%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNV-----H 147
           +G+GS GIV  A+   +G  VA+K  + D R + R      E+  MR   H NV      
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 148 YSRASQRMPLI-------------YVKLYTYQIC-------RALAYIHGGIGVCHRDIKP 187
           Y    +   L+              V+L   QI        +ALAY+H   GV HRDIK 
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKS 169
Query: 188 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVDIWSV 246
            ++L+     +VKL DFG    + K  P    +    Y+ APE+I   + Y T VDIWS+
Sbjct: 170 DSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLYATEVDIWSL 227
Query: 247 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 306
           G ++ E++ G+P +  +S V  +            + ++   P       P++K    HK
Sbjct: 228 GIMVIEMVDGEPPYFSDSPVQAM------------KRLRDSPP-------PKLKNS--HK 266
Query: 307 IFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 354
           +      P   D + R+L   P  R TA E   HPF  +   P   +P
Sbjct: 267 V-----SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 124/301 (41%), Gaps = 77/301 (25%)
Query: 87  PKQTI-SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTM 138
           PK ++  +   R +G GSFG V   +    G   A+K +       L+   + N E   +
Sbjct: 1   PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 139 RLLDHPNV--------------------------HYSRASQRMPLIYVKLYTYQICRALA 172
            ++ HP +                             R SQR P    K Y  ++C AL 
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120
Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSR-YYRAPEL 230
           Y+H    + +RD+KP+N+L++ + H +K+ DFG AK +    P+++Y +C    Y APE+
Sbjct: 121 YLHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEV 174
Query: 231 IFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 290
           +     Y  ++D WS G ++ E+L G   F   + +    +I+                 
Sbjct: 175 V-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---------------- 217
Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL-----QYSPNLRCTALEACIHPFFDE 345
             E +FP                 +  DL+SRL+     Q   NL+    +   HP+F E
Sbjct: 218 -AELRFPPF------------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
Query: 346 L 346
           +
Sbjct: 265 V 265

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 124/290 (42%), Gaps = 64/290 (22%)
Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDH 143
           T  Y     +G+G+F +V +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 144 PNV---HYSRASQRMPLIYVKLYT-----------------------YQICRALAYIHGG 177
           PN+   H S + +    +   L T                        QI  ++ + H  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 178 IGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFG 233
            G+ HRD+KP+NLL+   +    VKL DFG A + V+G+      +  +  Y +PE +  
Sbjct: 123 -GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLR 179
Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
              Y   VD+W+ G +L  LL+G P F  E    +L + IK                   
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GA 222
Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + FP   +  W  +      PEA DL++++L  +P  R TA EA  HP+ 
Sbjct: 223 YDFP---SPEWDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 123/291 (42%), Gaps = 68/291 (23%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNV- 146
           ++ +R +G G+FG V   +   +G    IK + +D+          E++ ++ LDHPN+ 
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 147 --------------------------HYSRASQRMPLI---YVKLYTYQICRALAYIHGG 177
                                         A  R   +   YV     Q+  ALAY H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 178 IGVCHRDIKPQNLL---VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 234
             V H+D+KP+N+L    +PH+  +K+ DFG A++    E + +   +  Y APE+    
Sbjct: 144 -HVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF--K 199
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
            + T   DIWS G V+  LL G   F G S    L E+        +++     PNY   
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKEPNYA-- 245
Query: 295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
               ++  P        + P+AVDL+ ++L   P  R +A +   H +F +
Sbjct: 246 ----VECRP--------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 67/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYKNRELQ-TMRLLDHP-NVHYSRA 151
           +G+G++G+V + + + +G+ +A+K++      Q+++    +L  +MR +D P  V +  A
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 152 SQRMPLIYV----------KLY------------------TYQICRALAYIHGGIGVCHR 183
             R   +++          K Y                     I +AL ++H  + V HR
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR 134
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGATEYTT 239
           D+KP N+L+N    QVK+CDFG +  LV     +I   C + Y APE I        Y+ 
Sbjct: 135 DVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGC-KPYMAPERINPELNQKGYSV 192
Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
             DIWS+G  + EL + +  FP +S            GTP ++               Q+
Sbjct: 193 KSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------------LKQV 226
Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
              P  ++   +   E VD  S+ L+ +   R T  E   HPFF
Sbjct: 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 135/306 (44%), Gaps = 84/306 (27%)
Query: 94  MAERVVGQGSFG-IVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNV-- 146
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++LL    DHPNV  
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 91
Query: 147 -HYSRASQRMPLIYVKLYTY-----------------------------QICRALAYIHG 176
            + S  + R   I ++L                                QI   +A++H 
Sbjct: 92  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 177 GIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNISYIC--- 221
            + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+          
Sbjct: 152 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 222 --SRYYRAPELIFGATE--YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 277
             +  +RAPEL+  +T+   T ++DI+S+GCV    +L +   P      +   II+  G
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNIIR--G 267
Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 337
             + +E+KC++                     + +  EA DL+S+++ + P  R TA++ 
Sbjct: 268 IFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPTAMKV 307
Query: 338 CIHPFF 343
             HP F
Sbjct: 308 LRHPLF 313

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 40/197 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVHYS 149
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN    
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 150 RAS------------------------QRMPL--IYVKLYTYQICRALAYIHGGIGVCHR 183
           R                           + PL  + +   T+   + LAY+H    + HR
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHR 178
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--YTTAV 241
           D+K  N+L++     VKL DFGSA ++    P   ++ + Y+ APE+I    E  Y   V
Sbjct: 179 DVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMDEGQYDGKV 234
Query: 242 DIWSVGCVLAELLLGQP 258
           D+WS+G    EL   +P
Sbjct: 235 DVWSLGITCIELAERKP 251

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 124/290 (42%), Gaps = 64/290 (22%)
Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDH 143
           T  Y     +G+G+F +V +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 144 PNV---HYSRASQRMPLIYVKLYT-----------------------YQICRALAYIHGG 177
           PN+   H S + +    +   L T                        QI  ++ + H  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 178 IGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFG 233
            G+ HRD+KP+NLL+   +    VKL DFG A + V+G+      +  +  Y +PE +  
Sbjct: 123 -GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLR 179
Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
              Y   VD+W+ G +L  LL+G P F  E    +L + IK                   
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GA 222
Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + FP   +  W  +      PEA DL++++L  +P  R TA EA  HP+ 
Sbjct: 223 YDFP---SPEWDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 100 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 158
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 159 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 215
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 216 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 254
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 255 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 91  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 149
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 150 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 206
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 207 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 245
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 246 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 122/281 (43%), Gaps = 64/281 (22%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV---HYS 149
           +G+G+F +V +   +  G+  A K +       +D +   RE +  RLL HPN+   H S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 150 RASQRMPLIYVKLYT-----------------------YQICRALAYIHGGIGVCHRDIK 186
            + +    +   L T                        QI  A+ + H  +GV HRD+K
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ-MGVVHRDLK 148
Query: 187 PQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTAVD 242
           P+NLL+        VKL DFG A + V+GE      +  +  Y +PE +     Y   VD
Sbjct: 149 PENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLRKDPYGKPVD 206
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +W+ G +L  LL+G P F  E    +L + IK                   + FP  +  
Sbjct: 207 LWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAYDFPSPE-- 247
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            W  +      PEA DL++++L  +P+ R TA EA  HP+ 
Sbjct: 248 -WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 38/207 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 144 PNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
           PN+                           Y  A  RM     +    QI  A+ Y H  
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
             + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G    
Sbjct: 133 F-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGES 264
              VD+WS+G +L  L+ G   F G++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 38/207 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 144 PNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
           PN+                           Y  A  RM     +    QI  A+ Y H  
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
             + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G    
Sbjct: 133 F-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGES 264
              VD+WS+G +L  L+ G   F G++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 135/306 (44%), Gaps = 84/306 (27%)
Query: 94  MAERVVGQGSFG-IVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNV-- 146
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++LL    DHPNV  
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 91
Query: 147 -HYSRASQRMPLIYVKLYTY-----------------------------QICRALAYIHG 176
            + S  + R   I ++L                                QI   +A++H 
Sbjct: 92  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 177 GIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNISYIC--- 221
            + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+          
Sbjct: 152 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 222 --SRYYRAPELIFGATE--YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 277
             +  +RAPEL+  +T+   T ++DI+S+GCV    +L +   P      +   II+  G
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNIIR--G 267
Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 337
             + +E+KC++                     + +  EA DL+S+++ + P  R TA++ 
Sbjct: 268 IFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPTAMKV 307
Query: 338 CIHPFF 343
             HP F
Sbjct: 308 LRHPLF 313

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 38/203 (18%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNV-- 146
           +++G+GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                   ++ ++  +  L     Y  +I   L ++H   G+ +
Sbjct: 84  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-GIVY 142
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAV 241
           RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G  +Y  +V
Sbjct: 143 RDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSV 200
Query: 242 DIWSVGCVLAELLLGQPLFPGES 264
           D WS G +L E+L+GQ  F G+ 
Sbjct: 201 DWWSFGVLLYEMLIGQSPFHGQD 223

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK-RVIHR 136
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+  +  ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 137 DIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 193
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G P F   +  +    I +V                 EF FP      
Sbjct: 194 WSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EFTFPDF---- 232
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++ + R T  E   HP+
Sbjct: 233 --------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 79  YGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 137
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 138 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 194
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 233
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 234 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 137
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 138 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 194
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 233
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 234 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 40/197 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVHYS 149
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN    
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 150 RAS------------------------QRMPL--IYVKLYTYQICRALAYIHGGIGVCHR 183
           R                           + PL  + +   T+   + LAY+H    + HR
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHR 139
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--YTTAV 241
           D+K  N+L++     VKL DFGSA ++    P   ++ + Y+ APE+I    E  Y   V
Sbjct: 140 DVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 242 DIWSVGCVLAELLLGQP 258
           D+WS+G    EL   +P
Sbjct: 196 DVWSLGITCIELAERKP 212

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 135
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 136 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 192
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 231
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 232 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 39/217 (17%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------R 133
           G + QP    +Y   + +G+G+F  V  A+ + TG  VAIK +  DK   N        R
Sbjct: 4   GSDEQP-HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFR 60
Query: 134 ELQTMRLLDHPNV--------------------------HYSRASQRMPLIYVKLYTYQI 167
           E++ M++L+HPN+                           Y  A  RM     +    QI
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 120
Query: 168 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 227
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 121 VSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDTFCGSPPYAA 178
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
           PEL  G       VD+WS+G +L  L+ G   F G++
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 136
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 137 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 193
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 194 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 232
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 233 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 120/294 (40%), Gaps = 63/294 (21%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHP---NVHYS-R 150
           +G G+FG+V +     TG   A K V+     DK    +E+QTM +L HP   N+H +  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 151 ASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVCHRDIKP 187
               M +IY  +                       Y  Q+C+ L ++H      H D+KP
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKP 283
Query: 188 QNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTAVDIWS 245
           +N++     ++++KL DFG    L   +       +  + APE+  G    Y T  D+WS
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT--DMWS 341
Query: 246 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           VG +   LL G   F GE+  + L              +K  + N  +  F  I      
Sbjct: 342 VGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSGISE---- 385
Query: 306 KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP--NARLPNGR 357
                    +  D + +LL   PN R T  +A  HP+      P  ++++P+ R
Sbjct: 386 ---------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSR 430

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 135
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 136 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 192
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 231
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 232 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 73  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 131
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 132 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 188
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 189 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 227
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 228 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 79  YGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 137
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G   +   VD+
Sbjct: 138 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRM-HDEKVDL 194
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 233
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 234 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 120/294 (40%), Gaps = 63/294 (21%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHP---NVHYS-R 150
           +G G+FG+V +     TG   A K V+     DK    +E+QTM +L HP   N+H +  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 151 ASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVCHRDIKP 187
               M +IY  +                       Y  Q+C+ L ++H      H D+KP
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKP 177
Query: 188 QNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTAVDIWS 245
           +N++     ++++KL DFG    L   +       +  + APE+  G    Y T  D+WS
Sbjct: 178 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT--DMWS 235
Query: 246 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           VG +   LL G   F GE+  + L              +K  + N  +  F  I      
Sbjct: 236 VGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSGISE---- 279
Query: 306 KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP--NARLPNGR 357
                    +  D + +LL   PN R T  +A  HP+      P  ++++P+ R
Sbjct: 280 ---------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSR 324

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 40/220 (18%)
Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV- 146
           +V+GQGSFG VF  + +   ++G   A+K +      ++D+     E   +  ++HP V 
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 147 --HYSRASQ-RMPLIY----------------------VKLYTYQICRALAYIHGGIGVC 181
             HY+  ++ ++ LI                       VK Y  ++   L ++H  +G+ 
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS-LGII 152
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATEYTTA 240
           +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++     ++ +
Sbjct: 153 YRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV-NRQGHSHS 210
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 279
            D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 211 ADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 115/300 (38%), Gaps = 73/300 (24%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR--------- 133
           R  + K   SY   R +G G++G V   K        AIK + + +  K R         
Sbjct: 28  RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIE 87
Query: 134 --------ELQTMRLLDHPNV-HYSRASQRMPLIYVKLYTY------------------- 165
                   E+  ++ LDHPN+       +     Y+    Y                   
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 166 ------QICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNI 217
                 QI   + Y+H    + HRDIKP+N+L+        +K+ DFG +    K     
Sbjct: 148 AANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 277
             + + YY APE++    +Y    D+WS G ++  LL G P F G++  D + ++ K   
Sbjct: 207 DRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK--- 261
Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 337
                        Y +F       + W     K +  EA +L+  +L Y  N RCTA EA
Sbjct: 262 ----------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYDYNKRCTAEEA 299

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 38/207 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 144 PNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
           PN+                           Y  A  RM     +    QI  A+ Y H  
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
             + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G    
Sbjct: 133 F-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGES 264
              VD+WS+G +L  L+ G   F G++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 34/203 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
           Y+    +G+GSFG V  A   +T + VA+K + +    K+       RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 146 V-------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
           +                          Y    +RM     + +  QI  A+ Y H    +
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH-KI 129
Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
            HRD+KP+NLL++ + + VK+ DFG + ++  G    +   S  Y APE+I G       
Sbjct: 130 VHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE 188
Query: 241 VDIWSVGCVLAELLLGQPLFPGE 263
           VD+WS G VL  +L+G+  F  E
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 132
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 133 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 189
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 228
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 137
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G   +   VD+
Sbjct: 138 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-HDEKVDL 194
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 233
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 234 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 100 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 158
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G   +   VD+
Sbjct: 159 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM-HDEKVDL 215
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 216 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 254
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 255 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 38/207 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 144 PNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
           PN+                           Y  A  RM     +    QI  A+ Y H  
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
             + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G    
Sbjct: 133 F-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGES 264
              VD+WS+G +L  L+ G   F G++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 121/286 (42%), Gaps = 62/286 (21%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVA-----IKKVLQDKRYKNRELQTMRLLDHPNV- 146
           YM    +G+G FGIV   +C+ET          +K    D+    +E+  + +  H N+ 
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 147 --HYSRAS-QRMPLIY-----------------------VKLYTYQICRALAYIHGGIGV 180
             H S  S + + +I+                       +  Y +Q+C AL ++H    +
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH-NI 123
Query: 181 CHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
            H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE +      +T
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE-VHQHDVVST 182
Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           A D+WS+G ++  LL G   F  E+   Q++E I             MN  YT       
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAEYT------- 221
Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
               + +   K +  EA+D V RLL      R TA EA  HP+  +
Sbjct: 222 ----FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK-RVIHR 136
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+  +  ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 137 DIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM-HDEKVDL 193
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G P F   +  +    I +V                 EF FP      
Sbjct: 194 WSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EFTFPDF---- 232
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++ + R T  E   HP+
Sbjct: 233 --------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 133
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G   +   VD+
Sbjct: 134 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-HDEKVDL 190
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 229
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 230 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 132
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G   +   VD+
Sbjct: 133 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-HDEKVDL 189
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 228
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 132
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G   +   VD+
Sbjct: 133 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-HDEKVDL 189
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 228
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 132
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 133 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-HDEKVDL 189
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 228
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 135
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 136 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-HDEKVDL 192
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 231
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 232 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 132
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G   +   VD+
Sbjct: 133 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGRM-HDEKVDL 189
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 228
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 133
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 134 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM-HDEKVDL 190
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 229
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 230 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 76  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 134
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G   +   VD+
Sbjct: 135 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-HDEKVDL 191
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 230
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 231 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/316 (25%), Positives = 121/316 (38%), Gaps = 72/316 (22%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 138
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 139 RLLDHPNV----------------------------HYSRASQRMPLIYVKLYTYQICRA 170
           + LD+P+V                            H  R +   P    + +  Q  + 
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP--EARYFMRQTIQG 154
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPE 229
           + Y+H    V HRD+K  NL +N     VK+ DFG A K+   GE   +   +  Y APE
Sbjct: 155 VQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKTLCGTPNYIAPE 212
Query: 230 LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
            +     ++  VDIWS+GC+L  LL+G+P F                      E  C+  
Sbjct: 213 -VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETSCLKE 249
Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
            Y   K  +    P H      + P A  L+ R+L   P LR +  E     FF     P
Sbjct: 250 TYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP 302
Query: 350 NARLPNG-RPFPPLFN 364
             RLP      PP F+
Sbjct: 303 -MRLPTSCLTVPPRFS 317

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 137
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE I G   +   VD+
Sbjct: 138 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRX-HDEKVDL 194
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 233
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 234 --------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 38/207 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 144 PNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
           PN+                           Y  A  RM     +    QI  A+ Y H  
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
             + HRD+K +NLL++   + +K+ DFG +     G     +  S  Y APEL  G    
Sbjct: 133 F-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD 190
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGES 264
              VD+WS+G +L  L+ G   F G++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 132
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G   +   VD+
Sbjct: 133 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGRM-HDEKVDL 189
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 228
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY 219
           + Y  QI     Y+H    V HRD+K  NL +N    +VK+ DFG A KV   GE   + 
Sbjct: 120 RYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTL 177
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
             +  Y APE +     ++  VD+WS+GC++  LL+G+P F                   
Sbjct: 178 CGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------------------- 217
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
              E  C+   Y      +IK + +     K + P A  L+ ++LQ  P  R T  E   
Sbjct: 218 ---ETSCLKETYL-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLN 267
Query: 340 HPFFDELRDPNARLP-NGRPFPPLFNFKPQELKGASKELLSKL 381
             FF     P ARLP      PP F+  P  L  ++++ L+ L
Sbjct: 268 DEFFTSGYIP-ARLPITCLTIPPXFSIAPSSLDPSNRKPLTVL 309

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 135
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G   +   VD+
Sbjct: 136 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-HDEKVDL 192
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 231
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 232 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 122/306 (39%), Gaps = 69/306 (22%)
Query: 79  TIGGRNGQPKQTISYMAERV---------VGQGSFGIVFQAKCLETGETVAIK----KVL 125
           ++   NG+   +    AE +         +G G+F  V  A+   TG+  A+K    K L
Sbjct: 1   SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 126 QDKRYK-NRELQTMRLLDHPNV-----------HYSRASQRMP-------LIYVKLYT-- 164
           + K      E+  +R + H N+           H     Q +        ++    YT  
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEK 120
Query: 165 ------YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL--CDFGSAKVLVKGEPN 216
                  Q+  A+ Y+H  +G+ HRD+KP+NLL      + K+   DFG +K+  KG+  
Sbjct: 121 DASTLIRQVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVM 179
Query: 217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 276
            +   +  Y APE +     Y+ AVD WS+G +   LL G P F  E+      +I+K  
Sbjct: 180 STACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKA- 237
Query: 277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 336
                           EF  P      W  I        A D +  L++  PN R T  +
Sbjct: 238 --------------EYEFDSPY-----WDDI-----SDSAKDFIRNLMEKDPNKRYTCEQ 273
Query: 337 ACIHPF 342
           A  HP+
Sbjct: 274 AARHPW 279

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/316 (25%), Positives = 120/316 (37%), Gaps = 72/316 (22%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 138
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 139 RLLDHPNV----------------------------HYSRASQRMPLIYVKLYTYQICRA 170
           + LD+P+V                            H  R +   P    + +  Q  + 
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP--EARYFMRQTIQG 154
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPE 229
           + Y+H    V HRD+K  NL +N     VK+ DFG A K+   GE       +  Y APE
Sbjct: 155 VQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE 212
Query: 230 LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
            +     ++  VDIWS+GC+L  LL+G+P F                      E  C+  
Sbjct: 213 -VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETSCLKE 249
Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
            Y   K  +    P H      + P A  L+ R+L   P LR +  E     FF     P
Sbjct: 250 TYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP 302
Query: 350 NARLPNG-RPFPPLFN 364
             RLP      PP F+
Sbjct: 303 -MRLPTSCLTVPPRFS 317

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/316 (25%), Positives = 120/316 (37%), Gaps = 72/316 (22%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 138
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 21  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 80
Query: 139 RLLDHPNV----------------------------HYSRASQRMPLIYVKLYTYQICRA 170
           + LD+P+V                            H  R +   P    + +  Q  + 
Sbjct: 81  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP--EARYFMRQTIQG 138
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPE 229
           + Y+H    V HRD+K  NL +N     VK+ DFG A K+   GE       +  Y APE
Sbjct: 139 VQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE 196
Query: 230 LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
            +     ++  VDIWS+GC+L  LL+G+P F                      E  C+  
Sbjct: 197 -VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETSCLKE 233
Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
            Y   K  +    P H      + P A  L+ R+L   P LR +  E     FF     P
Sbjct: 234 TYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP 286
Query: 350 NARLPNG-RPFPPLFN 364
             RLP      PP F+
Sbjct: 287 -MRLPTSCLTVPPRFS 301

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 132
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G   +   VD+
Sbjct: 133 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-HDEKVDL 189
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 228
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 121/286 (42%), Gaps = 80/286 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 133
Query: 184 DIKPQNLLVNPHTHQVKLCDFG-------SAKVLVKGEPNISYICSRYYRAPELIFGATE 236
           DIKP+NLL+     ++K+ DFG       S +  + G  +        Y  PE+I G   
Sbjct: 134 DIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLPPEMIEGRM- 183
Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           +   VD+WS+G +  E L+G+P F   +  +    I +V                 EF F
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTF 226
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           P              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 227 PDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  +    +A+K + + +  K        RE++    L HPN+   
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 71  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 129
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 130 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 186
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 187 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 225
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 226 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY 219
           + Y  QI     Y+H    V HRD+K  NL +N    +VK+ DFG A KV   GE   + 
Sbjct: 120 RYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTL 177
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
             +  Y APE +     ++  VD+WS+GC++  LL+G+P F                   
Sbjct: 178 CGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------------------- 217
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
              E  C+   Y      +IK + +     K + P A  L+ ++LQ  P  R T  E   
Sbjct: 218 ---ETSCLKETYL-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLN 267
Query: 340 HPFFDELRDPNARLP-NGRPFPPLFNFKPQELKGASKELLSKL 381
             FF     P ARLP      PP F+  P  L  ++++ L+ L
Sbjct: 268 DEFFTSGYIP-ARLPITCLTIPPRFSIAPSSLDPSNRKPLTVL 309

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 135
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G   +   VD+
Sbjct: 136 DIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM-HDEKVDL 192
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 231
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 232 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 82/316 (25%), Positives = 120/316 (37%), Gaps = 72/316 (22%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 138
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 139 RLLDHPNV----------------------------HYSRASQRMPLIYVKLYTYQICRA 170
           + LD+P+V                            H  R +   P    + +  Q  + 
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP--EARYFMRQTIQG 154
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPE 229
           + Y+H    V HRD+K  NL +N     VK+ DFG A K+   GE       +  Y APE
Sbjct: 155 VQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKXLCGTPNYIAPE 212
Query: 230 LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
            +     ++  VDIWS+GC+L  LL+G+P F                      E  C+  
Sbjct: 213 -VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETSCLKE 249
Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
            Y   K  +    P H      + P A  L+ R+L   P LR +  E     FF     P
Sbjct: 250 TYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP 302
Query: 350 NARLPNG-RPFPPLFN 364
             RLP      PP F+
Sbjct: 303 -MRLPTSCLTVPPRFS 317

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 58/273 (21%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHP---NV 146
           R +G+GSFG V   +  +T +  A+K     K ++    +N  +ELQ M+ L+HP   N+
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 147 HYS-RASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCHR 183
            YS +  + M ++                       VKL+  ++  AL Y+     + HR
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ-RIIHR 139
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTTAV 241
           D+KP N+L++ H H V + DF  A +L +     +   ++ Y APE+        Y+ AV
Sbjct: 140 DMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAV 198
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP--------TREEI----KCMNP 289
           D WS+G    ELL G+  +   S      EI+    T         ++E +    K + P
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQEMVSLLKKLLEP 257
Query: 290 N----YTEF----KFPQIKAHPWHKIFHKRMPP 314
           N    +++      FP +    W  +F KR+ P
Sbjct: 258 NPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 38/207 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 144 PNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
           PN+                           Y  A  RM     +    QI  A+ Y H  
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
             + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G    
Sbjct: 134 -RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGES 264
              VD+WS+G +L  L+ G   F G++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY 219
           + Y  QI     Y+H    V HRD+K  NL +N    +VK+ DFG A KV   GE   + 
Sbjct: 124 RYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTL 181
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
             +  Y APE +     ++  VD+WS+GC++  LL+G+P F                   
Sbjct: 182 CGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------------------- 221
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
              E  C+   Y      +IK + +     K + P A  L+ ++LQ  P  R T  E   
Sbjct: 222 ---ETSCLKETYL-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLN 271
Query: 340 HPFFDELRDPNARLP-NGRPFPPLFNFKPQELKGASKELLSKL 381
             FF     P ARLP      PP F+  P  L  ++++ L+ L
Sbjct: 272 DEFFTSGYIP-ARLPITCLTIPPRFSIAPSSLDPSNRKPLTVL 313

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 121/298 (40%), Gaps = 65/298 (21%)
Query: 82  GRNGQPKQTISYMAERV--VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ 133
           GR     Q +S   +RV  +G G++G V   K   TG   AIK + +             
Sbjct: 10  GRENLYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL 69
Query: 134 -ELQTMRLLDHPNV-----------HYSRA---------------SQRMPLIYVKLYTYQ 166
            E+  ++ LDHPN+           +Y                   Q+   +   +   Q
Sbjct: 70  DEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQ 129
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           +     Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G      + + Y
Sbjct: 130 VLSGTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAY 188
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE++    +Y    D+WS G +L  LL G P F G++  DQ     ++L    + + 
Sbjct: 189 YIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----EILKRVEKGKF 239
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
               P++T+                  +  EA  LV  +L Y P+ R +A EA  HP+
Sbjct: 240 SFDPPDWTQ------------------VSDEAKQLVKLMLTYEPSKRISAEEALNHPW 279

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 76  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 134
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ +FG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 135 DIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 191
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 230
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 231 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 122/289 (42%), Gaps = 64/289 (22%)
Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDH 143
           T  Y     +G+G+F +V +   L TG   A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 144 PNV---HYSRASQRMPLIYVKLYT-----------------------YQICRALAYIHGG 177
            N+   H S + +    +   L T                        QI  A+ + H  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ- 121
Query: 178 IGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFG 233
           +GV HRD+KP+NLL+        VKL DFG A + V+G+      +  +  Y +PE +  
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLR 179
Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
              Y   VDIW+ G +L  LL+G P F  E    +L + IK                   
Sbjct: 180 KEAYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----------------GA 222
Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           + FP   +  W  +      PEA +L++++L  +P  R TA EA  HP+
Sbjct: 223 YDFP---SPEWDTV-----TPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN+   
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 147 -HYSRASQRMPLI---------YVKL-------------YTYQICRALAYIHGGIGVCHR 183
             Y   + R+ LI         Y +L             Y  ++  AL+Y H    V HR
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHR 135
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ +FG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 136 DIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDL 192
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           WS+G +  E L+G+P F   +  +    I +V                 EF FP      
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF---- 231
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 232 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 122/280 (43%), Gaps = 64/280 (22%)
Query: 99  VGQGSFGIVFQ-AKCLETGETVAI-----KKVLQDKRYKNRELQTMRLLDHPNV---HYS 149
           +G+G+F +V +  K L   E  A+     K   +D +   RE +  RLL HPN+   H S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 150 RASQRMPLIYVKLYT-----------------------YQICRALAYIHGGIGVCHRDIK 186
            + +    +   L T                        QI  A+ + H  +GV HR++K
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLK 137
Query: 187 PQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTAVD 242
           P+NLL+        VKL DFG A + V+GE      +  +  Y +PE +     Y   VD
Sbjct: 138 PENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLRKDPYGKPVD 195
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +W+ G +L  LL+G P F  E    +L + IK                   + FP  +  
Sbjct: 196 LWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAYDFPSPE-- 236
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
            W  +      PEA DL++++L  +P+ R TA EA  HP+
Sbjct: 237 -WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPW 270

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 119/287 (41%), Gaps = 66/287 (22%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 144
           Y+    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 145 N------VHYSRASQRMPLIYV---KLYTYQIC-----------RALAYIHGGIGVCHR- 183
           +      V  + +   M + YV   +L+ Y IC           R    I  G+  CHR 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDY-ICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 184 -----DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
                D+KP+N+L++ H +  K+ DFG + ++  GE       S  Y APE+I G     
Sbjct: 136 MVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAG 194
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
             VDIWS G +L  LL G   F  +               PT  +  C    YT    PQ
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFDDDH-------------VPTLFKKICDGIFYT----PQ 237
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
                        + P  + L+  +LQ  P  R T  +   H +F +
Sbjct: 238 Y------------LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 68/124 (54%), Gaps = 3/124 (2%)
Query: 150 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 209
           + + R+P   +   +  + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 115 KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 173
Query: 210 LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQL 269
           L+    N S++ +R Y +PE + G T Y+   DIWS+G  L E+ +G+      SG   +
Sbjct: 174 LIDSMAN-SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAI 231
Query: 270 VEII 273
            E++
Sbjct: 232 FELL 235

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 62/108 (57%), Gaps = 3/108 (2%)
Query: 150 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 209
           + + R+P   +   +  + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 158 KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 216
Query: 210 LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ 257
           L+    N S++ +R Y +PE + G T Y+   DIWS+G  L E+ +G+
Sbjct: 217 LIDSMAN-SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGR 262

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 85/314 (27%), Positives = 135/314 (42%), Gaps = 76/314 (24%)
Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIK-----------KVLQDKRYKNRELQTMR--- 139
           +V+G G++G VF  + +   +TG+  A+K           K  +  R + + L+ +R   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 140 -----------------LLDHPN-----VHYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
                            +LD+ N      H S+  +R     V++Y  +I  AL ++H  
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHK- 177
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELIFGA- 234
           +G+ +RDIK +N+L++ + H V L DFG +K  V  E   +Y  C    Y AP+++ G  
Sbjct: 178 LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 236
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
           + +  AVD WS+G ++ ELL G   F  +   +   EI       +R  +K   P     
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKSEPP----- 284
Query: 295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELR-D 348
            +PQ             M   A DL+ RLL   P  R       A E   H FF ++  D
Sbjct: 285 -YPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331
Query: 349 PNARLPNGRPFPPL 362
             A      PF P+
Sbjct: 332 DLAAKKVPAPFKPV 345

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 134/310 (43%), Gaps = 88/310 (28%)
Query: 94  MAERVVGQGSFG-IVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNV-- 146
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++LL    DHPNV  
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 147 -HYSRASQRMPLIYVKLYTY-----------------------------QICRALAYIHG 176
            + S  + R   I ++L                                QI   +A++H 
Sbjct: 74  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 177 GIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNISYIC--- 221
            + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+ +        
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 222 --SRYYRAPELIFGATEYTT------AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
             +  +RAPEL+  +    T      ++DI+S+GCV    +L +   P      +   II
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNII 251
Query: 274 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           +  G  + +E+KC++                     + +  EA DL+S+++ + P  R T
Sbjct: 252 R--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPT 289
Query: 334 ALEACIHPFF 343
           A++   HP F
Sbjct: 290 AMKVLRHPLF 299

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 62/108 (57%), Gaps = 3/108 (2%)
Query: 150 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 209
           + + R+P   +   +  + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 123 KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 181
Query: 210 LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ 257
           L+    N S++ +R Y +PE + G T Y+   DIWS+G  L E+ +G+
Sbjct: 182 LIDSMAN-SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 41/212 (19%)
Query: 85  GQPKQTISYMAERV-VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 137
           G P++   Y+A  + +G+GS GIV  A    TG+ VA+KK+  D R + R      E+  
Sbjct: 41  GDPRE---YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVI 95
Query: 138 MRLLDHPNV--HYSR-----------------------ASQRMPLIYVKLYTYQICRALA 172
           MR   H NV   YS                           RM    +      + RAL+
Sbjct: 96  MRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALS 155
Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 231
           Y+H   GV HRDIK  ++L+     ++KL DFG    + K  P    +    Y+ APE+I
Sbjct: 156 YLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVI 213
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGE 263
                Y T VDIWS+G ++ E++ G+P +  E
Sbjct: 214 -SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 244

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 68/120 (56%), Gaps = 4/120 (3%)
Query: 150 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 209
           + + R+P   +   +  + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 96  KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 154
Query: 210 LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQ 268
           L+    N S++ +R Y +PE + G T Y+   DIWS+G  L E+ +G+ P+ P ++  D 
Sbjct: 155 LIDSMAN-SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDS 212

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 38/207 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 144 PNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
           PN+                           Y  A   M     +    QI  A+ Y H  
Sbjct: 66  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK 125
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
             + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G    
Sbjct: 126 F-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGES 264
              VD+WS+G +L  L+ G   F G++
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 39/212 (18%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNV-- 146
           RV+G+GSFG V  A+  ETG+  A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                    + + S+R      + Y  +I  AL ++H   G+ +
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK-GIIY 147
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y APE I     Y  AV
Sbjct: 148 RDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQEMLYGPAV 205
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
           D W++G +L E+L G   F  E+  D L E I
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 236

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 122/290 (42%), Gaps = 75/290 (25%)
Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIK--------KVLQDKRYKNRELQTMRLLDHPN 145
           RV+G+G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 146 -VHYSRASQRMPLIYVKL-------------------------YTYQICRALAYIHGGIG 179
            V    A Q    +Y+ L                         Y  +I  AL ++H   G
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK-G 141
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFGATEYT 238
           + +RD+KP+N+++N H   VKL DFG  K  +  G    ++  +  Y APE++   + + 
Sbjct: 142 IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM-RSGHN 199
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
            AVD WS+G ++ ++L G P F GE+    + +I+K          K   P Y       
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---------KLNLPPY------- 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 343
                        +  EA DL+ +LL+ +   R       A E   HPFF
Sbjct: 244 -------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY 219
           + Y  QI     Y+H    V HRD+K  NL +N    +VK+ DFG A KV   GE     
Sbjct: 144 RYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVL 201
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
             +  Y APE +     ++  VD+WS+GC++  LL+G+P F                   
Sbjct: 202 CGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------------------- 241
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
              E  C+   Y      +IK + +     K + P A  L+ ++LQ  P  R T  E   
Sbjct: 242 ---ETSCLKETYL-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLN 291
Query: 340 HPFFDELRDPNARLP-NGRPFPPLFNFKPQELKGASKELLSKL 381
             FF     P ARLP      PP F+  P  L  ++++ L+ L
Sbjct: 292 DEFFTSGYIP-ARLPITCLTIPPRFSIAPSSLDPSNRKPLTVL 333

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY 219
           + Y  QI     Y+H    V HRD+K  NL +N    +VK+ DFG A KV   GE     
Sbjct: 142 RYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVL 199
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
             +  Y APE +     ++  VD+WS+GC++  LL+G+P F                   
Sbjct: 200 CGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------------------- 239
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
              E  C+   Y      +IK + +     K + P A  L+ ++LQ  P  R T  E   
Sbjct: 240 ---ETSCLKETYL-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLN 289
Query: 340 HPFFDELRDPNARLP-NGRPFPPLFNFKPQELKGASKELLSKL 381
             FF     P ARLP      PP F+  P  L  ++++ L+ L
Sbjct: 290 DEFFTSGYIP-ARLPITCLTIPPRFSIAPSSLDPSNRKPLTVL 331

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 126/292 (43%), Gaps = 60/292 (20%)
Query: 84  NGQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYKNRELQTMR 139
           +G  +  +S  +  E  +G+G+  IV++ K   T +  A+K  K   DK+    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 140 LLDHPNVHYSRASQRMPL---IYVKLYT-----------------------YQICRALAY 173
            L HPN+   +     P    + ++L T                        QI  A+AY
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 174 IHGGIGVCHRDIKPQNLL-VNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSR-YYRAPEL 230
           +H   G+ HRD+KP+NLL   P     +K+ DFG +K+ V+ +  +  +C    Y APE+
Sbjct: 164 LHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVCGTPGYCAPEI 221
Query: 231 IFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 290
           + G   Y   VD+WSVG +   LL G   F  E G DQ +          R  + C    
Sbjct: 222 LRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------FRRILNC---- 266
Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             E+ F      PW       +   A DLV +L+   P  R T  +A  HP+
Sbjct: 267 --EYYF----ISPW----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 62/108 (57%), Gaps = 3/108 (2%)
Query: 150 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 209
           + + R+P   +   +  + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 96  KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 154
Query: 210 LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ 257
           L+    N S++ +R Y +PE + G T Y+   DIWS+G  L E+ +G+
Sbjct: 155 LIDSMAN-SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 115/285 (40%), Gaps = 63/285 (22%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-------ELQTMRLLDHPN 145
           Y   + +G G++G V   K   TG   AIK + +              E+  ++ LDHPN
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 146 V-----------HYSRA---------------SQRMPLIYVKLYTYQICRALAYIHGGIG 179
           +           +Y                   Q+   +   +   Q+     Y+H    
Sbjct: 66  IMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH-N 124
Query: 180 VCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
           + HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE++    +Y
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RKKY 182
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
               D+WS G +L  LL G P F G++  DQ     ++L    + +     P++T+    
Sbjct: 183 DEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----EILKRVEKGKFSFDPPDWTQ---- 231
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                         +  EA  LV  +L Y P+ R +A EA  HP+
Sbjct: 232 --------------VSDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 62/108 (57%), Gaps = 3/108 (2%)
Query: 150 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 209
           + + R+P   +   +  + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 96  KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 154
Query: 210 LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ 257
           L+    N S++ +R Y +PE + G T Y+   DIWS+G  L E+ +G+
Sbjct: 155 LIDSMAN-SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 133/310 (42%), Gaps = 88/310 (28%)
Query: 94  MAERVVGQGSFG-IVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNV-- 146
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++LL    DHPNV  
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 147 -HYSRASQRMPLIYVKLYTY-----------------------------QICRALAYIHG 176
            + S  + R   I ++L                                QI   +A++H 
Sbjct: 74  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 177 GIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNISYIC--- 221
            + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+          
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 192
Query: 222 --SRYYRAPELIFGATEYTT------AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
             +  +RAPEL+  +    T      ++DI+S+GCV    +L +   P      +   II
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNII 251
Query: 274 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           +  G  + +E+KC++                     + +  EA DL+S+++ + P  R T
Sbjct: 252 R--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPT 289
Query: 334 ALEACIHPFF 343
           A++   HP F
Sbjct: 290 AMKVLRHPLF 299

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 64/272 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVHYSR 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 151 ASQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +R                          MP    + + +Q+   + Y+HG IG+ HRD
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 129
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAV 241
           IKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   V
Sbjct: 130 IKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D+WS G VL  +L G+   P +   D   E                   Y+++K  +   
Sbjct: 189 DVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYL 227
Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           +PW KI         + L+ ++L  +P+ R T
Sbjct: 228 NPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 84/183 (45%), Gaps = 32/183 (17%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 226
           +  A++++H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE       +  Y 
Sbjct: 209 LLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYL 266
Query: 227 APELIFGATE-----YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 281
           APE++  + +     Y   VD+W+ G +L  LL G P F     +  L  I         
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--------- 317
Query: 282 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 341
                M   Y +F  P+     W             DL+SRLLQ  P  R TA +A  HP
Sbjct: 318 -----MEGQY-QFSSPE-----WDD-----RSSTVKDLISRLLQVDPEARLTAEQALQHP 361
Query: 342 FFD 344
           FF+
Sbjct: 362 FFE 364

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 37/205 (18%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 144
           Y+    +G G+FG V   +   TG  VA+ K+L  ++ ++        RE+Q ++L  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAV-KILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 145 NV--HYSRASQ----RMPLIYV---KLYTY-----------------QICRALAYIHGGI 178
           ++   Y   S      M + YV   +L+ Y                 QI  A+ Y H  +
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
            V HRD+KP+N+L++ H    K+ DFG + ++  GE   +   S  Y APE+I G     
Sbjct: 132 -VVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 189
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGE 263
             VDIWS G +L  LL G   F  E
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 62/108 (57%), Gaps = 3/108 (2%)
Query: 150 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 209
           + + R+P   +   +  + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 96  KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 154
Query: 210 LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ 257
           L+    N S++ +R Y +PE + G T Y+   DIWS+G  L E+ +G+
Sbjct: 155 LIDSMAN-SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 62/108 (57%), Gaps = 3/108 (2%)
Query: 150 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 209
           + + R+P   +   +  + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 96  KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 154
Query: 210 LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ 257
           L+    N S++ +R Y +PE + G T Y+   DIWS+G  L E+ +G+
Sbjct: 155 LIDSMAN-SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 119/290 (41%), Gaps = 75/290 (25%)
Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIK--------KVLQDKRYKNRELQTMRLLDHPN 145
           RV+G+G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 146 -VHYSRASQRMPLIYVKL-------------------------YTYQICRALAYIHGGIG 179
            V    A Q    +Y+ L                         Y  +I  AL ++H   G
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK-G 141
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATEYT 238
           + +RD+KP+N+++N H   VKL DFG  K  +         C    Y APE++   + + 
Sbjct: 142 IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM-RSGHN 199
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
            AVD WS+G ++ ++L G P F GE+    + +I+K          K   P Y       
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---------KLNLPPY------- 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 343
                        +  EA DL+ +LL+ +   R       A E   HPFF
Sbjct: 244 -------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 109/249 (43%), Gaps = 51/249 (20%)
Query: 68  NGTETGHIIVTTIGGRNGQPK-QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ 126
           +G +TG++   TIGG+  Q +   +  + E  +G G+ G V++ +  +TG  +A+K++  
Sbjct: 6   SGKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM-- 58
Query: 127 DKRYKNRELQTMRLLDHPNVHYS-------------------------------RASQRM 155
            +R  N+E     L+D   V  S                               +  +RM
Sbjct: 59  -RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRM 117
Query: 156 ----PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 211
               P   +   T  I +AL Y+    GV HRD+KP N+L++    Q+KLCDFG +  LV
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLV 176
Query: 212 KGEPNISYICSRYYRAPELIF----GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
             +          Y APE I        +Y    D+WS+G  L EL  GQ  FP ++   
Sbjct: 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FPYKNCKT 234
Query: 268 QLVEIIKVL 276
               + KVL
Sbjct: 235 DFEVLTKVL 243

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 123/281 (43%), Gaps = 67/281 (23%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-------LLDHPNV---- 146
           ++G+GSF  V++A+ + TG  VAIK + +   YK   +Q ++        L HP++    
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 147 HYSRASQRMPLI-----------YVK------------LYTYQICRALAYIHGGIGVCHR 183
           +Y   S  + L+           Y+K             + +QI   + Y+H   G+ HR
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH-GILHR 136
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTTAVD 242
           D+   NLL+  +   +K+ DFG A  L +  E + +   +  Y +PE I   + +    D
Sbjct: 137 DLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRSAHGLESD 194
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS+GC+   LL+G+P F  ++  + L +++                   +++ P     
Sbjct: 195 VWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-----------------LADYEMPSF--- 234
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                    +  EA DL+ +LL+ +P  R +      HPF 
Sbjct: 235 ---------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 37/205 (18%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 144
           Y+    +G G+FG V   +   TG  VA+ K+L  ++ ++        RE+Q ++L  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAV-KILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 145 NV--HYSRASQ----RMPLIYV---KLYTY-----------------QICRALAYIHGGI 178
           ++   Y   S      M + YV   +L+ Y                 QI  A+ Y H  +
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
            V HRD+KP+N+L++ H    K+ DFG + ++  GE       S  Y APE+I G     
Sbjct: 132 -VVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAG 189
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGE 263
             VDIWS G +L  LL G   F  E
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 122/305 (40%), Gaps = 64/305 (20%)
Query: 74  HIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKR 129
           H IVT    + G      +     ++G G FG V + +   TG  +A K +    ++DK 
Sbjct: 75  HRIVT---AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 130 YKNRELQTMRLLDHPNV------HYSRASQRMPLIYVK---------------------L 162
               E+  M  LDH N+        S+    + + YV                      L
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL 191
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYIC 221
           +  QIC  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+     E       
Sbjct: 192 FMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250
Query: 222 SRYYRAPELI-FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 280
           +  + APE++ +    + T  D+WSVG +   LL G   F G++  + L  I+       
Sbjct: 251 TPEFLAPEVVNYDFVSFPT--DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308
Query: 281 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 340
            EE                          + +  EA + +S+LL    + R +A EA  H
Sbjct: 309 DEEF-------------------------QDISEEAKEFISKLLIKEKSWRISASEALKH 343
Query: 341 PFFDE 345
           P+  +
Sbjct: 344 PWLSD 348

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN- 145
           Y+  + +G+GSFG     K  E G    IK++       +++    RE+  +  + HPN 
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 146 VHYSRASQRMPLIYVKL---------------------------YTYQICRALAYIHGGI 178
           V Y  + +    +Y+ +                           +  QIC AL ++H   
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR- 144
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEY 237
            + HRDIK QN+ +      V+L DFG A+VL    E   + I + YY +PE I     Y
Sbjct: 145 KILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPE-ICENKPY 202
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
               DIW++GCVL EL   +  F   S  + +++II
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 64/272 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVHYSR 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 151 ASQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +R                          MP    + + +Q+   + Y+HG IG+ HRD
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 130
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAV 241
           IKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   V
Sbjct: 131 IKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D+WS G VL  +L G+   P +   D   E                   Y+++K  +   
Sbjct: 190 DVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYL 228
Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           +PW KI         + L+ ++L  +P+ R T
Sbjct: 229 NPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 118/295 (40%), Gaps = 63/295 (21%)
Query: 84  NGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM----- 138
           N   K + +Y  +  +G+G+F +V +     TG   A  K++  K+   R+ Q +     
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREAR 80
Query: 139 --RLLDHPNV---HYSRASQRMPLIYVKLYT-----------------------YQICRA 170
             R L HPN+   H S   +    +   L T                        QI  +
Sbjct: 81  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 140
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAP 228
           +AY H   G+ HR++KP+NLL+        VKL DFG A  +   E    +  +  Y +P
Sbjct: 141 IAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199
Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 288
           E +     Y+  VDIW+ G +L  LL+G P F  E    +L   IK              
Sbjct: 200 E-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA------------- 244
Query: 289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                + +P   +  W  +      PEA  L+  +L  +P  R TA +A   P+ 
Sbjct: 245 ---GAYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 62/271 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVHYSRA 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV     
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 152 SQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
            +R                          MP    + + +Q+   + Y+HG IG+ HRDI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDI 131
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAVD 242
           KP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   VD
Sbjct: 132 KPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS G VL  +L G+   P +   D   E                   Y+++K  +   +
Sbjct: 191 VWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYLN 229
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           PW KI         + L+ ++L  +P+ R T
Sbjct: 230 PWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 62/271 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVHYSRA 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV     
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 152 SQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
            +R                          MP    + + +Q+   + Y+HG IG+ HRDI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDI 131
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAVD 242
           KP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   VD
Sbjct: 132 KPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS G VL  +L G+   P +   D   E                   Y+++K  +   +
Sbjct: 191 VWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYLN 229
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           PW KI         + L+ ++L  +P+ R T
Sbjct: 230 PWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 62/271 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVHYSRA 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV     
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 152 SQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
            +R                          MP    + + +Q+   + Y+HG IG+ HRDI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDI 131
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAVD 242
           KP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   VD
Sbjct: 132 KPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS G VL  +L G+   P +   D   E                   Y+++K  +   +
Sbjct: 191 VWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYLN 229
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           PW KI         + L+ ++L  +P+ R T
Sbjct: 230 PWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 62/271 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVHYSRA 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV     
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 152 SQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
            +R                          MP    + + +Q+   + Y+HG IG+ HRDI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDI 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAVD 242
           KP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   VD
Sbjct: 131 KPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS G VL  +L G+   P +   D   E                   Y+++K  +   +
Sbjct: 190 VWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYLN 228
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           PW KI         + L+ ++L  +P+ R T
Sbjct: 229 PWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 62/271 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVHYSRA 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV     
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 152 SQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
            +R                          MP    + + +Q+   + Y+HG IG+ HRDI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDI 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAVD 242
           KP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   VD
Sbjct: 131 KPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS G VL  +L G+   P +   D   E                   Y+++K  +   +
Sbjct: 190 VWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYLN 228
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           PW KI         + L+ ++L  +P+ R T
Sbjct: 229 PWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 64/272 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVHYSR 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NV    
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 151 ASQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +R                          MP    + + +Q+   + Y+HG IG+ HRD
Sbjct: 70  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 128
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAV 241
           IKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   V
Sbjct: 129 IKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D+WS G VL  +L G+   P +   D   E                   Y+++K  +   
Sbjct: 188 DVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYL 226
Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           +PW KI         + L+ ++L  +P+ R T
Sbjct: 227 NPWKKI-----DSAPLALLHKILVENPSARIT 253

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 64/272 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVHYSR 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 151 ASQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +R                          MP    + + +Q+   + Y+HG IG+ HRD
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 130
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAV 241
           IKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   V
Sbjct: 131 IKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D+WS G VL  +L G+   P +   D   E                   Y+++K  +   
Sbjct: 190 DVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYL 228
Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           +PW KI         + L+ ++L  +P+ R T
Sbjct: 229 NPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 67/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHP-NVHYSRA 151
           +G+G++G+V + + + +G+  A+K++       + KR       + R +D P  V +  A
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 152 SQRMPLIYV----------KLY------------------TYQICRALAYIHGGIGVCHR 183
             R   +++          K Y                     I +AL ++H  + V HR
Sbjct: 102 LFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR 161
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGATEYTT 239
           D+KP N+L+N    QVK CDFG +  LV     +I   C + Y APE I        Y+ 
Sbjct: 162 DVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGC-KPYXAPERINPELNQKGYSV 219
Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
             DIWS+G    EL + +  FP +S            GTP ++               Q+
Sbjct: 220 KSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ-------------LKQV 253
Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
              P  ++   +   E VD  S+ L+ +   R T  E   HPFF
Sbjct: 254 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 127/296 (42%), Gaps = 64/296 (21%)
Query: 77  VTTIGGRNGQPKQTISYMAERV-----VGQGSFGIVFQAKCLETGETVAIKKVLQ--DKR 129
           + + G     P+Q   + AE +     +G+G++G V +     +G+ +A+K++    D++
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62
Query: 130 YKNRELQ----TMRLLDHPN-VHYSRASQR----------MPLIYVKLYTY--------- 165
            + + L      MR  D P  V +  A  R          M   + K Y Y         
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVI 122
Query: 166 ----------QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 215
                        +AL ++   + + HRDIKP N+L++  +  +KLCDFG +  LV    
Sbjct: 123 PEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIA 181
Query: 216 NISYICSRYYRAPELIFGATE---YTTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVE 271
                  R Y APE I  +     Y    D+WS+G  L EL  G+  +P  + V DQL +
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ 241
Query: 272 IIKVLGTP---TREEIKCMNPNYTEF-------------KFPQIKAHPWHKIFHKR 311
           ++K  G P   +  E +  +P++  F             K+ ++  HP+  ++ +R
Sbjct: 242 VVK--GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 64/272 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVHYSR 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 151 ASQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +R                          MP    + + +Q+   + Y+HG IG+ HRD
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 129
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAV 241
           IKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   V
Sbjct: 130 IKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D+WS G VL  +L G+   P +   D   E                   Y+++K  +   
Sbjct: 189 DVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYL 227
Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           +PW KI         + L+ ++L  +P+ R T
Sbjct: 228 NPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 62/271 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVHYSRA 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV     
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 152 SQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
            +R                          MP    + + +Q+   + Y+HG IG+ HRDI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDI 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAVD 242
           KP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   VD
Sbjct: 131 KPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS G VL  +L G+   P +   D   E                   Y+++K  +   +
Sbjct: 190 VWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYLN 228
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           PW KI         + L+ ++L  +P+ R T
Sbjct: 229 PWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 62/271 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVHYSRA 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV     
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 152 SQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
            +R                          MP    + + +Q+   + Y+HG IG+ HRDI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDI 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAVD 242
           KP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   VD
Sbjct: 131 KPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS G VL  +L G+   P +   D   E                   Y+++K  +   +
Sbjct: 190 VWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYLN 228
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           PW KI         + L+ ++L  +P+ R T
Sbjct: 229 PWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 62/271 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVHYSRA 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV     
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 152 SQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
            +R                          MP    + + +Q+   + Y+HG IG+ HRDI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDI 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAVD 242
           KP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   VD
Sbjct: 131 KPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS G VL  +L G+   P +   D   E                   Y+++K  +   +
Sbjct: 190 VWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYLN 228
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           PW KI         + L+ ++L  +P+ R T
Sbjct: 229 PWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/283 (22%), Positives = 118/283 (41%), Gaps = 64/283 (22%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM------------- 138
            +   R++G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+             
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 139 -----------------------RLLDHPNVHYSRASQRM-PLIYVKLYTYQICRALAYI 174
                                   L++  ++HY  +   +     ++ Y  +I   L ++
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 234
           H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  Y APE++   
Sbjct: 309 HNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLF-----PGESGVDQLVEIIKV-------------- 275
             Y ++ D +S+GC+L +LL G   F       +  +D++   + V              
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 276 ---LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 314
              L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 120/287 (41%), Gaps = 61/287 (21%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH 143
           QP++    + +  +G+GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D 
Sbjct: 26  QPEEVFDVLEK--LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS 83
Query: 144 PNV-----------------HYSRASQRMPLIYVKLYTY----------QICRALAYIHG 176
           P+V                  Y  A     +I ++  T              + L Y+H 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGAT 235
            +   HRDIK  N+L+N   H  KL DFG A  L       +  I + ++ APE+I    
Sbjct: 144 -MRKIHRDIKAGNILLNTEGH-AKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI-QEI 200
Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 295
            Y    DIWS+G    E+  G+P +        +  +  +   PT       NP  T F+
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYA------DIHPMRAIFMIPT-------NPPPT-FR 246
Query: 296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
            P++    W   F         D V + L  SP  R TA +   HPF
Sbjct: 247 KPEL----WSDNF--------TDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/283 (22%), Positives = 118/283 (41%), Gaps = 64/283 (22%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM------------- 138
            +   R++G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+             
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 139 -----------------------RLLDHPNVHYSRASQRM-PLIYVKLYTYQICRALAYI 174
                                   L++  ++HY  +   +     ++ Y  +I   L ++
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 307
Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 234
           H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  Y APE++   
Sbjct: 308 HNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 364
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLF-----PGESGVDQLVEIIKV-------------- 275
             Y ++ D +S+GC+L +LL G   F       +  +D++   + V              
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 424
Query: 276 ---LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 314
              L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 425 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 467

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 102/244 (41%), Gaps = 60/244 (24%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK----------V 209
           V+ Y   + +AL  IH   G+ HRD+KP N L N    +  L DFG A+           
Sbjct: 119 VREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177
Query: 210 LVKGEP-------NISYIC-SRY-----------YRAPELIFGATEYTTAVDIWSVGCVL 250
            V+ E        N   IC SR            +RAPE++      TTA+D+WS G + 
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 251 AELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK-----------------------C 286
             LL G+ P +     +  L +I+ + G  +RE I+                       C
Sbjct: 238 LSLLSGRYPFYKASDDLTALAQIMTIRG--SRETIQAAKTFGKSILCSKEVPAQDLRKLC 295
Query: 287 MNPNYTEFKFPQ----IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                 +   P+    I+ H  +      +P EA DL+ +LL  +P  R TA EA +HPF
Sbjct: 296 ERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355
Query: 343 FDEL 346
           F ++
Sbjct: 356 FKDM 359

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 62/271 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVHYSRA 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV     
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 152 SQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
            +R                          MP    + + +Q+   + Y+HG IG+ HRDI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDI 131
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAVD 242
           KP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   VD
Sbjct: 132 KPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS G VL  +L G+   P +   D   E                   Y+++K  +   +
Sbjct: 191 VWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYLN 229
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           PW KI         + L+ ++L  +P+ R T
Sbjct: 230 PWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/283 (22%), Positives = 118/283 (41%), Gaps = 64/283 (22%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM------------- 138
            +   R++G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+             
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 139 -----------------------RLLDHPNVHYSRASQRM-PLIYVKLYTYQICRALAYI 174
                                   L++  ++HY  +   +     ++ Y  +I   L ++
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 234
           H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  Y APE++   
Sbjct: 309 HNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLF-----PGESGVDQLVEIIKV-------------- 275
             Y ++ D +S+GC+L +LL G   F       +  +D++   + V              
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 276 ---LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 314
              L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/283 (22%), Positives = 118/283 (41%), Gaps = 64/283 (22%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM------------- 138
            +   R++G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+             
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 139 -----------------------RLLDHPNVHYSRASQRM-PLIYVKLYTYQICRALAYI 174
                                   L++  ++HY  +   +     ++ Y  +I   L ++
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 234
           H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  Y APE++   
Sbjct: 309 HNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLF-----PGESGVDQLVEIIKV-------------- 275
             Y ++ D +S+GC+L +LL G   F       +  +D++   + V              
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 276 ---LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 314
              L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 113/283 (39%), Gaps = 60/283 (21%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYK-NRELQTMRLLDHPNV- 146
           Y    V+G G+F  V  A+   T + VAIK    K L+ K      E+  +  + HPN+ 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 147 ----------HYSRASQRMP-------LIYVKLYT--------YQICRALAYIHGGIGVC 181
                     H     Q +        ++    YT        +Q+  A+ Y+H  +G+ 
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIV 138
Query: 182 HRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +     Y+ 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKPYSK 197
Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           AVD WS+G +   LL G P F  E+      +I+K                  EF  P  
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------------EYEFDSPY- 241
Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
               W  I        A D +  L++  P  R T  +A  HP+
Sbjct: 242 ----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K +E    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 68/274 (24%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVHYSR 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 151 ASQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +R                          MP    + + +Q+   + Y+HG IG+ HRD
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 130
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTT 239
           IKP+NLL++   + +K+ DFG A V      N   + ++      Y APEL+     +  
Sbjct: 131 IKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLKRREFHAE 187
Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
            VD+WS G VL  +L G+   P +   D   E                   Y+++K  + 
Sbjct: 188 PVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKT 226
Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
             +PW KI         + L+ ++L  +P+ R T
Sbjct: 227 YLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 38/207 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++  ++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 144 PNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
           PN+                           Y  A  R      +    QI  A+ Y H  
Sbjct: 73  PNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQK 132
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
             + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G    
Sbjct: 133 F-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGES 264
              VD+WS+G +L  L+ G   F G++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 61/108 (56%), Gaps = 3/108 (2%)
Query: 150 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 209
           + + R+P   +   +  + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 99  KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 157
Query: 210 LVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ 257
           L+    N  ++ +R Y +PE + G T Y+   DIWS+G  L E+ +G+
Sbjct: 158 LIDEMAN-EFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 115/271 (42%), Gaps = 62/271 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVHYSRA 151
           + +G+G++G V  A    T E VA+K V   +         +E+    +L+H NV     
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 152 SQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
            +R                          MP    + + +Q+   + Y+HG IG+ HRDI
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDI 131
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAVD 242
           KP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   VD
Sbjct: 132 KPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS G VL  +L G+   P +   D   E                   Y+++K  +   +
Sbjct: 191 VWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYLN 229
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           PW KI         + L+ ++L  +P+ R T
Sbjct: 230 PWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 68/274 (24%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVHYSR 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 151 ASQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +R                          MP    + + +Q+   + Y+HG IG+ HRD
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 129
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTT 239
           IKP+NLL++   + +K+ DFG A V      N   + ++      Y APEL+     +  
Sbjct: 130 IKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
            VD+WS G VL  +L G+   P +   D   E                   Y+++K  + 
Sbjct: 187 PVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKT 225
Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
             +PW KI         + L+ ++L  +P+ R T
Sbjct: 226 YLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 84/190 (44%), Gaps = 34/190 (17%)
Query: 164 TYQICRALAYIHGGI---GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
           T +I RAL  +   +    + HRD+KP+N+L++   + +KL DFG +  L  GE   S  
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLRSVC 184
Query: 221 CSRYYRAPELIFGATE-----YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 275
            +  Y APE+I  +       Y   VD+WS G ++  LL G P F     +  L  I   
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--- 241
Query: 276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 335
                      M+ NY +F  P+   +               DLVSR L   P  R TA 
Sbjct: 242 -----------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQKRYTAE 279
Query: 336 EACIHPFFDE 345
           EA  HPFF +
Sbjct: 280 EALAHPFFQQ 289

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 70/286 (24%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK--------------------KVLQDKRY------ 130
           +++G+G+FG V   K   TG   A+K                    +VLQ+ R+      
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 131 ------KNRELQTMRLLDHPNVHYSRASQRM-PLIYVKLYTYQICRALAYIHGGIGVCHR 183
                  +R    M   +   + +  + +R+      + Y  +I  AL Y+H    V +R
Sbjct: 217 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 276
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    +Y  AVD
Sbjct: 277 DLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 334
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
            W +G V+ E++ G+  F  +   ++L E+I +                 E +FP+    
Sbjct: 335 WWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM----------------EEIRFPRT--- 374
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 343
                    + PEA  L+S LL+  P  R       A E   H FF
Sbjct: 375 ---------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 123/294 (41%), Gaps = 74/294 (25%)
Query: 90  TISYMAERVVGQGSFGIV-----------FQAKCLETGETVAIKKVLQDKRYKNRELQTM 138
           T  Y     +G+G+F +V           + AK + T +  A     +D +   RE +  
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA-----RDHQKLEREARIC 84
Query: 139 RLLDHPNV---HYSRASQRMPLIYVKLYT-----------------------YQICRALA 172
           RLL HPN+   H S + +    +   L T                       +QI  ++ 
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVN 144
Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAP 228
           +IH    + HRD+KP+NLL+        VKL DFG A + V+GE      +  +  Y +P
Sbjct: 145 HIHQH-DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLSP 202
Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 288
           E +     Y   VDIW+ G +L  LL+G P F  E    +L + IK              
Sbjct: 203 E-VLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA------------- 247
Query: 289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                + FP   +  W  +      PEA +L++++L  +P  R TA +A  HP+
Sbjct: 248 ---GAYDFP---SPEWDTV-----TPEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 124/297 (41%), Gaps = 62/297 (20%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----RELQTM-RLLDHPNV-- 146
           +   ++G+G++  V  A  L+ G+  A+K + +   +      RE++T+ +   + N+  
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 147 --HYSRASQRMPLIYVKL----------------------YTYQICRALAYIHGGIGVCH 182
              +     R  L++ KL                          +  AL ++H   G+ H
Sbjct: 76  LIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTK-GIAH 134
Query: 183 RDIKPQNLLVNP--HTHQVKLCDF--GSAKVLVKG-----EPNISYIC-SRYYRAPELI- 231
           RD+KP+N+L         VK+CDF  GS   L         P ++  C S  Y APE++ 
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 232 ---FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIK 285
                AT Y    D+WS+G VL  +L G P F G  G D      E+ +V      E I+
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 254
Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                  +++FP      W  I       EA DL+S+LL      R +A +   HP+
Sbjct: 255 -----EGKYEFPD---KDWAHI-----SSEAKDLISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 70/286 (24%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK--------------------KVLQDKRY------ 130
           +++G+G+FG V   K   TG   A+K                    +VLQ+ R+      
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 131 ------KNRELQTMRLLDHPNVHYSRASQRM-PLIYVKLYTYQICRALAYIHGGIGVCHR 183
                  +R    M   +   + +  + +R+      + Y  +I  AL Y+H    V +R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    +Y  AVD
Sbjct: 274 DLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 331
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
            W +G V+ E++ G+  F  +   ++L E+I +                 E +FP+    
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM----------------EEIRFPRT--- 371
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 343
                    + PEA  L+S LL+  P  R       A E   H FF
Sbjct: 372 ---------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 118/286 (41%), Gaps = 70/286 (24%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK--------------------KVLQDKRY------ 130
           +++G+G+FG V   K   TG   A+K                    +VLQ+ R+      
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 75
Query: 131 ------KNRELQTMRLLDHPNVHYSRASQRM-PLIYVKLYTYQICRALAYIHGGIGVCHR 183
                  +R    M   +   + +  + +R+      + Y  +I  AL Y+H    V +R
Sbjct: 76  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 135
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    +Y  AVD
Sbjct: 136 DLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVD 193
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
            W +G V+ E++ G+  F  +   ++L E+I +      EEI+                 
Sbjct: 194 WWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR----------------- 229
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 343
                F + + PEA  L+S LL+  P  R       A E   H FF
Sbjct: 230 -----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 118/286 (41%), Gaps = 70/286 (24%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK--------------------KVLQDKRY------ 130
           +++G+G+FG V   K   TG   A+K                    +VLQ+ R+      
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 74
Query: 131 ------KNRELQTMRLLDHPNVHYSRASQRM-PLIYVKLYTYQICRALAYIHGGIGVCHR 183
                  +R    M   +   + +  + +R+      + Y  +I  AL Y+H    V +R
Sbjct: 75  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 134
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    +Y  AVD
Sbjct: 135 DLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVD 192
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
            W +G V+ E++ G+  F  +   ++L E+I +      EEI+                 
Sbjct: 193 WWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR----------------- 228
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 343
                F + + PEA  L+S LL+  P  R       A E   H FF
Sbjct: 229 -----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 115/271 (42%), Gaps = 62/271 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVHYSRA 151
           + +G+G+ G V  A    T E VA+K V   +         +E+   ++L+H NV     
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 152 SQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
            +R                          MP    + + +Q+   + Y+HG IG+ HRDI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDI 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIFGATEYTTAVD 242
           KP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+     +   VD
Sbjct: 131 KPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +WS G VL  +L G+   P +   D   E                   Y+++K  +   +
Sbjct: 190 VWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTYLN 228
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           PW KI         + L+ ++L  +P+ R T
Sbjct: 229 PWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 89/210 (42%), Gaps = 35/210 (16%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY 219
           + Y  QI     Y+H    V HRD+K  NL +N    +VK+ DFG A KV   GE     
Sbjct: 118 RYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVL 175
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
             +  Y APE +     ++  VD+WS+GC++  LL+G+P F                   
Sbjct: 176 CGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------------------- 215
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
              E  C+   Y      +IK + +     K + P A  L+ ++LQ  P  R T  E   
Sbjct: 216 ---ETSCLKETYL-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLN 265
Query: 340 HPFFDELRDPNARLP-NGRPFPPLFNFKPQ 368
             FF     P ARLP      PP F+  P 
Sbjct: 266 DEFFTSGYIP-ARLPITCLTIPPRFSIAPS 294

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 118/286 (41%), Gaps = 70/286 (24%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK--------------------KVLQDKRY------ 130
           +++G+G+FG V   K   TG   A+K                    +VLQ+ R+      
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 73
Query: 131 ------KNRELQTMRLLDHPNVHYSRASQRM-PLIYVKLYTYQICRALAYIHGGIGVCHR 183
                  +R    M   +   + +  + +R+      + Y  +I  AL Y+H    V +R
Sbjct: 74  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 133
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    +Y  AVD
Sbjct: 134 DLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVD 191
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
            W +G V+ E++ G+  F  +   ++L E+I +      EEI+                 
Sbjct: 192 WWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR----------------- 227
Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 343
                F + + PEA  L+S LL+  P  R       A E   H FF
Sbjct: 228 -----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 79/333 (23%), Positives = 134/333 (40%), Gaps = 88/333 (26%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLD 142
           +++  R +G G+FG V   + ++  +  A+K V   K+Y           +++Q   + +
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 143 HPNVHYS---RASQRMPLIY-----------------------VKLYTYQICRALAYIHG 176
           +  V Y         M LI+                       +KLY  +I +AL Y+  
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155
Query: 177 GIGVCHRDIKPQNLLVN-PHTHQ-----------------------VKLCDFGSAKVLVK 212
            + + H D+KP+N+L++ P+  +                       +KL DFG A    K
Sbjct: 156 -MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF--K 212
Query: 213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 272
            + + S I +R YRAPE+I     +  + D+WS GCVLAEL  G  LF     ++ L  +
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271
Query: 273 IKVL----------GTPTREEIKCMNPNYTEFKFPQ-----------IKAHPWHKIFHKR 311
             ++           T T    K +N +  +  +P+            K  P +KI    
Sbjct: 272 ESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330
Query: 312 MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
           +     D +  +LQ  P LR +  E   H F +
Sbjct: 331 L---FCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y A
Sbjct: 153 LTFEYLHS-LDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLA 207
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 208 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y A
Sbjct: 153 LTFEYLHS-LDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLA 207
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 208 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 51/229 (22%)
Query: 85  GQPKQTISYMAER-----VVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYK 131
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 132 NRELQTMRLLDHPNVH--YSRASQRMP--------LIYVKLYTYQ--------------- 166
            RE Q    L+HP +   Y       P        + YV   T +               
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 167 -----ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---- 217
                 C+AL + H   G+ HRD+KP N+L++  T+ VK+ DFG A+ +     ++    
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNSVXQTA 177
Query: 218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
           + I +  Y +PE   G +      D++S+GCVL E+L G+P F G+S V
Sbjct: 178 AVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 68/274 (24%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVHYSR 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 151 ASQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +R                          MP    + + +Q+   + Y+HG IG+ HRD
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 129
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTT 239
           IKP+NLL++   + +K+ DFG A V      N   + ++      Y APEL+     +  
Sbjct: 130 IKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
            VD+WS G VL  +L G+   P +   D   E                   Y+++K  + 
Sbjct: 187 PVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE-------------------YSDWKEKKT 225
Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
             +PW KI         + L+ ++L  +P+ R T
Sbjct: 226 YLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K +E    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 44/212 (20%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ------ 136
           P Q  +++ +    R +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 137 --------------TMRLLDHPNVH-------------YSRASQRMPLIYVKLYTYQICR 169
                              D+ N++             + R   R    + + Y  QI  
Sbjct: 94  RIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAP 228
              Y+H  + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y AP
Sbjct: 154 TFEYLHS-LDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLAP 208
Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           E+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 209 EIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIV 152
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y A
Sbjct: 153 LTFEYLHS-LDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLA 207
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 208 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 68/274 (24%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVHYSR 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 151 ASQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
             +R                          MP    + + +Q+   + Y+HG IG+ HRD
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 129
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTT 239
           IKP+NLL++   + +K+ DFG A V      N   + ++      Y APEL+     +  
Sbjct: 130 IKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
            VD+WS G VL  +L G+   P +   D   E                   Y+++K  + 
Sbjct: 187 PVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKT 225
Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
             +PW KI         + L+ ++L  +P+ R T
Sbjct: 226 YLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 62/223 (27%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRLLD-HPNV----- 146
           RV+ +G F  V++A+ + +G   A+K++L ++  KNR    E+  M+ L  HPN+     
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 147 -----------------------------HYSRASQRMPL---IYVKLYTYQICRALAYI 174
                                           +   R PL     +K++ YQ CRA+ ++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF-YQTCRAVQHM 152
Query: 175 HGGIG-VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---------- 223
           H     + HRD+K +NLL++ +   +KLCDFGSA   +   P+ S+   R          
Sbjct: 153 HRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATT-ISHYPDYSWSAQRRALVEEEITR 210
Query: 224 ----YYRAPELIFGATEYTTA--VDIWSVGCVLAELLLGQPLF 260
                YR PE+I   + +      DIW++GC+L  L   Q  F
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           Y++Q+ R + ++     + HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 204 YSFQVARGMEFLSSRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 223 RY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 278
           R    + APE IF    Y+T  D+WS G +L E+  LG   +PG       V++ +   +
Sbjct: 262 RLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDFCS 313
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 323
             RE ++   P Y+  +  QI    WH+   +R  P   +LV +L
Sbjct: 314 RLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELVEKL 356

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 117/290 (40%), Gaps = 63/290 (21%)
Query: 88  KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RL 140
           K + +Y  +  +G+G+F +V +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 141 LDHPNV---HYSRASQRMPLIYVKLYT-----------------------YQICRALAYI 174
           L HPN+   H S   +    +   L T                        QI  ++AY 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 175 HGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 232
           H   G+ HR++KP+NLL+        VKL DFG A  +   E    +  +  Y +PE + 
Sbjct: 122 HSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VL 179
Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 292
               Y+  VDIW+ G +L  LL+G P F  E    +L   IK                  
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA----------------G 222
Query: 293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
            + +P  +   W  +      PEA  L+  +L  +P  R TA +A   P+
Sbjct: 223 AYDYPSPE---WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 66/273 (24%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVHYSRA 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV     
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 152 SQR--------------------------MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
            +R                          MP    + + +Q+   + Y+HG IG+ HRDI
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDI 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTTA 240
           KP+NLL++   + +K+ DFG A V      N   + ++      Y APEL+     +   
Sbjct: 131 KPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
           VD+WS G VL  +L G+   P +   D   E                   Y+++K  +  
Sbjct: 188 VDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWKEKKTY 226
Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
            +PW KI         + L+ ++L  +P+ R T
Sbjct: 227 LNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 42/212 (19%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 228
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  Y AP
Sbjct: 153 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCGTPEYLAP 208
Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           E+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 209 EIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 153 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLA 207
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 208 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 60/283 (21%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNV- 146
           Y    V+G G+F  V  A+   T + VAIK + ++     +     E+  +  + HPN+ 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 147 ----------HYSRASQRMP-------LIYVKLYT--------YQICRALAYIHGGIGVC 181
                     H     Q +        ++    YT        +Q+  A+ Y+H  +G+ 
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIV 138
Query: 182 HRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +     Y+ 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKPYSK 197
Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           AVD WS+G +   LL G P F  E+      +I+K                  E++F   
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK-----------------AEYEF--- 237
Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
            +  W  I        A D +  L++  P  R T  +A  HP+
Sbjct: 238 DSPYWDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 113/283 (39%), Gaps = 60/283 (21%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKR-YKNRELQTMRLLDHPNV- 146
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+ 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 147 ----------HYSRASQRMP-------LIYVKLYT--------YQICRALAYIHGGIGVC 181
                     H     Q +        ++    YT        +Q+  A+ Y+H  +G+ 
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIV 138
Query: 182 HRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +     Y+ 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKPYSK 197
Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           AVD WS+G +   LL G P F  E+      +I+K                  EF  P  
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------------EYEFDSPY- 241
Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
               W  I        A D +  L++  P  R T  +A  HP+
Sbjct: 242 ----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 83/190 (43%), Gaps = 34/190 (17%)
Query: 164 TYQICRALAYIHGGI---GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
           T +I RAL  +   +    + HRD+KP+N+L++   + +KL DFG +  L  GE      
Sbjct: 113 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVC 171
Query: 221 CSRYYRAPELIFGATE-----YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 275
            +  Y APE+I  +       Y   VD+WS G ++  LL G P F     +  L  I   
Sbjct: 172 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--- 228
Query: 276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 335
                      M+ NY +F  P+   +               DLVSR L   P  R TA 
Sbjct: 229 -----------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQKRYTAE 266
Query: 336 EACIHPFFDE 345
           EA  HPFF +
Sbjct: 267 EALAHPFFQQ 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 113/283 (39%), Gaps = 60/283 (21%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKR-YKNRELQTMRLLDHPNV- 146
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+ 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 147 ----------HYSRASQRMP-------LIYVKLYT--------YQICRALAYIHGGIGVC 181
                     H     Q +        ++    YT        +Q+  A+ Y+H  +G+ 
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIV 138
Query: 182 HRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +     Y+ 
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKPYSK 197
Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           AVD WS+G +   LL G P F  E+      +I+K                  EF  P  
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------------EYEFDSPY- 241
Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
               W  I        A D +  L++  P  R T  +A  HP+
Sbjct: 242 ----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 51/229 (22%)
Query: 85  GQPKQTISYMAER-----VVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYK 131
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 132 NRELQTMRLLDHPNVHYSRASQRM-----PLIYVKL------------------------ 162
            RE Q    L+HP +    A+        PL Y+ +                        
Sbjct: 61  -REAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 163 -YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--- 218
                 C+AL + H   G+ HRD+KP N++++  T+ VK+ DFG A+ +     +++   
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 219 -YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
             I +  Y +PE   G +      D++S+GCVL E+L G+P F G+S V
Sbjct: 178 AVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 117/290 (40%), Gaps = 63/290 (21%)
Query: 88  KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RL 140
           K + +Y  +  +G+G+F +V +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 141 LDHPNV---HYSRASQRMPLIYVKLYT-----------------------YQICRALAYI 174
           L HPN+   H S   +    +   L T                        QI  ++AY 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 175 HGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 232
           H   G+ HR++KP+NLL+        VKL DFG A  +   E    +  +  Y +PE + 
Sbjct: 122 HSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VL 179
Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 292
               Y+  VDIW+ G +L  LL+G P F  E    +L   IK                  
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA----------------G 222
Query: 293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
            + +P  +   W  +      PEA  L+  +L  +P  R TA +A   P+
Sbjct: 223 AYDYPSPE---WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 51/229 (22%)
Query: 85  GQPKQTISYMAER-----VVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYK 131
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 132 NRELQTMRLLDHPNVH--YSRASQRMP--------LIYVKLYTYQ--------------- 166
            RE Q    L+HP +   Y       P        + YV   T +               
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 167 -----ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--- 218
                 C+AL + H   G+ HRD+KP N++++  T+ VK+ DFG A+ +     +++   
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 219 -YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
             I +  Y +PE   G +      D++S+GCVL E+L G+P F G+S V
Sbjct: 178 AVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 117/290 (40%), Gaps = 63/290 (21%)
Query: 88  KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RL 140
           K + +Y  +  +G+G+F +V +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 60
Query: 141 LDHPNV---HYSRASQRMPLIYVKLYT-----------------------YQICRALAYI 174
           L HPN+   H S   +    +   L T                        QI  ++AY 
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 175 HGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 232
           H   G+ HR++KP+NLL+        VKL DFG A  +   E    +  +  Y +PE + 
Sbjct: 121 HSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VL 178
Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 292
               Y+  VDIW+ G +L  LL+G P F  E    +L   IK                  
Sbjct: 179 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA----------------G 221
Query: 293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
            + +P  +   W  +      PEA  L+  +L  +P  R TA +A   P+
Sbjct: 222 AYDYPSPE---WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 263

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 152
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 153 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLA 207
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 208 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 83/190 (43%), Gaps = 34/190 (17%)
Query: 164 TYQICRALAYIHGGI---GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
           T +I RAL  +   +    + HRD+KP+N+L++   + +KL DFG +  L  GE      
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVC 184
Query: 221 CSRYYRAPELIFGATE-----YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 275
            +  Y APE+I  +       Y   VD+WS G ++  LL G P F     +  L  I   
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--- 241
Query: 276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 335
                      M+ NY +F  P+   +               DLVSR L   P  R TA 
Sbjct: 242 -----------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQKRYTAE 279
Query: 336 EACIHPFFDE 345
           EA  HPFF +
Sbjct: 280 EALAHPFFQQ 289

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 42/212 (19%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 18  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 77
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 78  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 137
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 228
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  Y AP
Sbjct: 138 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCGTPEYLAP 193
Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           E+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 194 EIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 113/240 (47%), Gaps = 36/240 (15%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 141 LDHPN-VHYSRASQRMPLIYVKL--------------------YTYQICR----ALAYIH 175
             +PN V+Y  +      ++V +                        +CR    AL ++H
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 234
               V HRDIK  N+L+      VKL DFG  A++  +     + + + Y+ APE++   
Sbjct: 134 SN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
             Y   VDIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  + ++  + +F
Sbjct: 192 A-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 249

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 51/227 (22%)
Query: 85  GQPKQTISYMAER-----VVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYK 131
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 132 NRELQTMRLLDHPNVH--YSRASQRMP--------LIYVKLYTYQ--------------- 166
            RE Q    L+HP +   Y       P        + YV   T +               
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 167 -----ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--- 218
                 C+AL + H   G+ HRD+KP N++++  T+ VK+ DFG A+ +     +++   
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 219 -YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
             I +  Y +PE   G +      D++S+GCVL E+L G+P F G+S
Sbjct: 178 AVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 119/279 (42%), Gaps = 66/279 (23%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   VA+K + + +  K        RE++    L HPN+   
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 147 ---HYSRASQRMPLIYV---KLY-----------------TYQICRALAYIHGGIGVCHR 183
               Y R    + L Y    +LY                   ++  AL Y HG   V HR
Sbjct: 89  YNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGK-KVIHR 147
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G   +   VD+
Sbjct: 148 DIKPENLLLGLKG-ELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRM-HNEKVDL 204
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           W +G +  ELL+G P F   S  +    I+KV                 + KFP      
Sbjct: 205 WCIGVLCYELLVGNPPFESASHNETYRRIVKV-----------------DLKFP------ 241
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                   +P  A DL+S+LL+++P+ R    +   HP+
Sbjct: 242 ------ASVPTGAQDLISKLLRHNPSERLPLAQVSAHPW 274

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 38/199 (19%)
Query: 97  RVVGQGSFGIVFQAK--------CLETGETVAIKKVLQDKRYKNRELQTMRLLDHP---N 145
           +V+G+GSFG V  A+         ++  +  AI K  ++K   +     ++ + HP    
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 146 VHYS-RASQRMPLIY----------------------VKLYTYQICRALAYIHGGIGVCH 182
           +H+S + + ++  +                        + Y  +I  AL Y+H  + + +
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIVY 162
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAV 241
           RD+KP+N+L++   H V L DFG  K  ++     S  C +  Y APE +     Y   V
Sbjct: 163 RDLKPENILLDSQGHIV-LTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTV 220
Query: 242 DIWSVGCVLAELLLGQPLF 260
           D W +G VL E+L G P F
Sbjct: 221 DWWCLGAVLYEMLYGLPPF 239

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 47/201 (23%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPN-VHYS------- 149
           ++G G FG VF+AK    G+T  IK+V  +     RE++ +  LDH N VHY+       
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 150 ------------------------------------RASQRMPLIYVKLYTYQICRALAY 173
                                               R  +++  +       QI + + Y
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDY 137
Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
           IH    + +RD+KP N+ +   T QVK+ DFG    L           +  Y +PE I  
Sbjct: 138 IHSK-KLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI-S 194
Query: 234 ATEYTTAVDIWSVGCVLAELL 254
           + +Y   VD++++G +LAELL
Sbjct: 195 SQDYGKEVDLYALGLILAELL 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 51/229 (22%)
Query: 85  GQPKQTISYMAER-----VVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYK 131
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 132 NRELQTMRLLDHPNVH--YSRASQRMP--------LIYVKLYTYQ--------------- 166
            RE Q    L+HP +   Y       P        + YV   T +               
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 167 -----ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--- 218
                 C+AL + H   G+ HRD+KP N++++  T+ VK+ DFG A+ +     +++   
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 219 -YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
             I +  Y +PE   G +      D++S+GCVL E+L G+P F G+S V
Sbjct: 178 AVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 112/240 (46%), Gaps = 36/240 (15%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 141 LDHPN-VHYSRASQRMPLIYVKL--------------------YTYQICR----ALAYIH 175
             +PN V+Y  +      ++V +                        +CR    AL ++H
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 234
               V HRDIK  N+L+      VKL DFG  A++  +       + + Y+ APE++   
Sbjct: 134 SN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRK 191
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
             Y   VDIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  + ++  + +F
Sbjct: 192 A-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 249

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 112/240 (46%), Gaps = 36/240 (15%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 141 LDHPN-VHYSRASQRMPLIYVKL--------------------YTYQICR----ALAYIH 175
             +PN V+Y  +      ++V +                        +CR    AL ++H
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 134
Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 234
               V HRDIK  N+L+      VKL DFG  A++  +       + + Y+ APE++   
Sbjct: 135 SN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRK 192
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
             Y   VDIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  + ++  + +F
Sbjct: 193 A-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 250

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 44/212 (20%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 139 RLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQICR 169
           R+L                D+ N++             + R   R    + + Y  QI  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAP 228
              Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y AP
Sbjct: 154 TFEYLHS-LDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAP 208
Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           E+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 209 EIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 112/240 (46%), Gaps = 36/240 (15%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 141 LDHPN-VHYSRASQRMPLIYVKL--------------------YTYQICR----ALAYIH 175
             +PN V+Y  +      ++V +                        +CR    AL ++H
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 234
               V HRDIK  N+L+      VKL DFG  A++  +       + + Y+ APE++   
Sbjct: 134 SN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRK 191
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
             Y   VDIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  + ++  + +F
Sbjct: 192 A-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 249

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 61/103 (59%), Gaps = 7/103 (6%)
Query: 168 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSR 223
           C+AL + H   G+ HRD+KP N++++  T+ VK+ DFG A+ +     +++     I + 
Sbjct: 143 CQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
            Y +PE   G +      D++S+GCVL E+L G+P F G+S V
Sbjct: 201 QYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 44/213 (20%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQIC 168
            R+L                D+ N++             + R   R    + + Y  QI 
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRA 227
               Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y A
Sbjct: 152 LTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLA 206
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           PE+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 44/212 (20%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 54  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 139 RLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQICR 169
           R+L                D+ N++             + R   R    + + Y  QI  
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 173
Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAP 228
              Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP
Sbjct: 174 TFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAP 228
Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           E+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 229 EIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 44/212 (20%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 139 RLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQICR 169
           R+L                D+ N++             + R   R    + + Y  QI  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAP 228
              Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP
Sbjct: 154 TFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAP 208
Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           E+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 209 EIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 44/212 (20%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 139 RLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQICR 169
           R+L                D+ N++             + R   R    + + Y  QI  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAP 228
              Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP
Sbjct: 154 TFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAP 208
Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           E+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 209 EIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 44/212 (20%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 139 RLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQICR 169
           R+L                D+ N++             + R   R    + + Y  QI  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAP 228
              Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP
Sbjct: 154 TFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAP 208
Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           E+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 209 EIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 82/322 (25%), Positives = 136/322 (42%), Gaps = 73/322 (22%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAI--------------------KKVL 125
           QP    ++   RV+G+G FG V   +   TG+  A                     K++L
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 126 Q--DKRY----------KNRELQTMRLLDHPNVH---YSRASQRMPLIYVKLYTYQICRA 170
           +  + R+          K+     + L++  ++    Y       P      Y  +IC  
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 230
           L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE+
Sbjct: 299 LEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 231 IFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 290
           +     YT + D W++GC+L E++ GQ  F       Q  + IK      REE++ +   
Sbjct: 357 V-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL--- 400
Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDE 345
                   +K  P  + + +R  P+A  L S+LL   P  R      +A E   HP F +
Sbjct: 401 --------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
Query: 346 LRDPNARLPNGRPFPPLFNFKP 367
           L     RL  G   PP   FKP
Sbjct: 451 LN--FKRLGAGMLEPP---FKP 467

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 44/212 (20%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 139 RLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQICR 169
           R+L                D+ N++             + R   R    + + Y  QI  
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 145
Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAP 228
              Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP
Sbjct: 146 TFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAP 200
Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           E+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 201 EIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 114/294 (38%), Gaps = 64/294 (21%)
Query: 99  VGQGSFGIVFQAKCLE--TGETVAIKKVLQ----DKRYKNRELQTMRLLDHP---NVH-- 147
           +G G+FG+V   +C+E  TG     K +      DK     E+  M  L HP   N+H  
Sbjct: 59  LGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 148 -------------------YSRASQ---RMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                              + R +    +M    V  Y  Q C  L ++H    + H DI
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDI 175
Query: 186 KPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
           KP+N++        VK+ DFG A  L   E       +  + APE++          D+W
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFYTDMW 234
Query: 245 SVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 304
           ++G +   LL G   F GE  ++ L            + +K  +  + E  F  +     
Sbjct: 235 AIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDAFSSVS---- 278
Query: 305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD-ELRDPNARLPNGR 357
                    PEA D +  LLQ  P  R T  +A  HP+   +  +  +R+P+ R
Sbjct: 279 ---------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 323

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/317 (23%), Positives = 127/317 (40%), Gaps = 60/317 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNV--------- 146
           +G G+FG+    +  ++ E VA+K + + ++      RE+   R L HPN+         
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 --------HYSRASQ---------RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 189
                    Y+   +         R      + +  Q+   ++Y H  + VCHRD+K +N
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLEN 145
Query: 190 LLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGC 248
            L++     ++K+CDFG +K  V      S + +  Y APE++          D+WS G 
Sbjct: 146 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGV 205
Query: 249 VLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 307
            L  +L+G  P    E   +    I ++L       ++   P+Y                
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILN------VQYAIPDYV--------------- 244
Query: 308 FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKP 367
               + PE   L+SR+    P  R +  E   H +F  L++  A L N       F+   
Sbjct: 245 ---HISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDNTMTTQFDESD 299
Query: 368 QELKGASKELLSKLIPE 384
           Q   G S E + ++I E
Sbjct: 300 Q--PGQSIEEIMQIIAE 314

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 82/322 (25%), Positives = 136/322 (42%), Gaps = 73/322 (22%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAI--------------------KKVL 125
           QP    ++   RV+G+G FG V   +   TG+  A                     K++L
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 126 Q--DKRY----------KNRELQTMRLLDHPNVH---YSRASQRMPLIYVKLYTYQICRA 170
           +  + R+          K+     + L++  ++    Y       P      Y  +IC  
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 230
           L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE+
Sbjct: 299 LEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 231 IFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 290
           +     YT + D W++GC+L E++ GQ  F       Q  + IK      REE++ +   
Sbjct: 357 V-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL--- 400
Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDE 345
                   +K  P  + + +R  P+A  L S+LL   P  R      +A E   HP F +
Sbjct: 401 --------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
Query: 346 LRDPNARLPNGRPFPPLFNFKP 367
           L     RL  G   PP   FKP
Sbjct: 451 LN--FKRLGAGMLEPP---FKP 467

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 113/240 (47%), Gaps = 36/240 (15%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 141 LDHPN-VHYSRASQRMPLIYVKL--------------------YTYQICR----ALAYIH 175
             +PN V+Y  +      ++V +                        +CR    AL ++H
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 134
Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 234
               V HR+IK  N+L+      VKL DFG  A++  +     + + + Y+ APE++   
Sbjct: 135 SN-QVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 192
Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
             Y   VDIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  + ++  + +F
Sbjct: 193 A-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 250

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/109 (38%), Positives = 66/109 (60%), Gaps = 11/109 (10%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---- 218
           +T QI   + + H  + + HRDIKPQN+L++ +   +K+ DFG AK L   E +++    
Sbjct: 116 FTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGIAKAL--SETSLTQTNH 171
Query: 219 YICSRYYRAPELIFG-ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
            + +  Y +PE   G AT+  T  DI+S+G VL E+L+G+P F GE+ V
Sbjct: 172 VLGTVQYFSPEQAKGEATDECT--DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK         +   + Y
Sbjct: 176 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 234
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE + G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +
Sbjct: 235 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 287
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 288 -------GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK         +   + Y
Sbjct: 170 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE + G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +
Sbjct: 229 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 281
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 282 -------GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 44/212 (20%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 139 RLL----------------DHPNVH-------------YSRASQRMPLIYVKLYTYQICR 169
           R+L                D+ N++             + R   R    + + Y  QI  
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 145
Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAP 228
              Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP
Sbjct: 146 TFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAP 200
Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
           E+I  +  Y  AVD W++G ++ E+  G P F
Sbjct: 201 EIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK         +   + Y
Sbjct: 126 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE + G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +
Sbjct: 185 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 237
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 238 -------GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK         +   + Y
Sbjct: 132 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 190
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE + G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +
Sbjct: 191 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 243
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 244 -------GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK         +   + Y
Sbjct: 140 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 198
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE + G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +
Sbjct: 199 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 251
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 252 -------GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 10/155 (6%)
Query: 124 VLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
             QD +Y    ++ M   D  N+    ++  +P  + K YT ++  AL  IH  +G+ HR
Sbjct: 143 AFQDDKYLYMVMEYMPGGDLVNL---MSNYDVPEKWAKFYTAEVVLALDAIHS-MGLIHR 198
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNI-SYICSRYYRAPELI---FGATEYT 238
           D+KP N+L++ H H +KL DFG+  K+   G  +  + + +  Y +PE++    G   Y 
Sbjct: 199 DVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYG 257
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
              D WSVG  L E+L+G   F  +S V    +I+
Sbjct: 258 RECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK         +   + Y
Sbjct: 131 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 189
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE + G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +
Sbjct: 190 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 242
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 243 -------GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 122/301 (40%), Gaps = 74/301 (24%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  +    +A+K + + +  K        RE++    L HPN+   
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 147 -HYSRASQRMPL---------IYVKL-------------YTYQICRALAYIHGGIGVCHR 183
            +Y    +R+ L         +Y +L             +  ++  AL Y H    V HR
Sbjct: 81  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER-KVIHR 139
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+  +  ++K+ DFG + V            +  Y  PE+I G T +   VD+
Sbjct: 140 DIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-HDEKVDL 196
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           W  G +  E L+G P F   S  +    I+ V                 + KFP      
Sbjct: 197 WCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DLKFPPF---- 235
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLF 363
                   +   + DL+S+LL+Y P  R        HP+       N+R    R  PP++
Sbjct: 236 --------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV----KANSR----RVLPPVY 279
Query: 364 N 364
Sbjct: 280 Q 280

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK         +   + Y
Sbjct: 130 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 188
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE + G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +
Sbjct: 189 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 241
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 242 -------GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK         +   + Y
Sbjct: 126 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE + G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +
Sbjct: 185 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 237
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 238 -------GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 122/301 (40%), Gaps = 74/301 (24%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  +    +A+K + + +  K        RE++    L HPN+   
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 147 -HYSRASQRMPL---------IYVKL-------------YTYQICRALAYIHGGIGVCHR 183
            +Y    +R+ L         +Y +L             +  ++  AL Y H    V HR
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER-KVIHR 138
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIKP+NLL+  +  ++K+ DFG + V            +  Y  PE+I G T +   VD+
Sbjct: 139 DIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-HDEKVDL 195
Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           W  G +  E L+G P F   S  +    I+ V                 + KFP      
Sbjct: 196 WCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DLKFPPF---- 234
Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLF 363
                   +   + DL+S+LL+Y P  R        HP+       N+R    R  PP++
Sbjct: 235 --------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV----KANSR----RVLPPVY 278
Query: 364 N 364
Sbjct: 279 Q 279

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/317 (23%), Positives = 126/317 (39%), Gaps = 60/317 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNV--------- 146
           +G G+FG+    +  ++ E VA+K + + ++      RE+   R L HPN+         
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 147 --------HYSRASQ---------RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 189
                    Y+   +         R      + +  Q+   ++Y H  + VCHRD+K +N
Sbjct: 86  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLEN 144
Query: 190 LLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGC 248
            L++     ++K+CDFG +K  V      S + +  Y APE++          D+WS G 
Sbjct: 145 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGV 204
Query: 249 VLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 307
            L  +L+G  P    E   +    I ++L       ++   P+Y                
Sbjct: 205 TLYVMLVGAYPFEDPEEPKNFRKTIHRILN------VQYAIPDYV--------------- 243
Query: 308 FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKP 367
               + PE   L+SR+    P  R +  E   H +F  L++  A L N       F    
Sbjct: 244 ---HISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDNTMTTQFAASD 298
Query: 368 QELKGASKELLSKLIPE 384
           Q   G S E + ++I E
Sbjct: 299 Q--PGQSIEEIMQIIAE 313

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK         +   + Y
Sbjct: 125 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 183
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE + G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +
Sbjct: 184 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 236
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 237 -------GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK         +   + Y
Sbjct: 124 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 182
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE + G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +
Sbjct: 183 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 235
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 236 -------GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 89/340 (26%), Positives = 136/340 (40%), Gaps = 76/340 (22%)
Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNV-H 147
           T  Y  +  +G GS+ +  +     T    A+K + + KR    E++ + R   HPN+  
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 148 YSRASQRMPLIYV-----------------KLYT--------YQICRALAYIHGGIGVCH 182
                     +YV                 K ++        + I + + Y+H   GV H
Sbjct: 81  LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ-GVVH 139
Query: 183 RDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATE 236
           RD+KP N+L      NP +  +++CDFG AK L      +   C +  + APE +     
Sbjct: 140 RDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLERQG 196
Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           Y  A DIWS+G +L  +L G   F      D   EI+  +G+                KF
Sbjct: 197 YDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSG---------------KF 240
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF---FDELRDPNARL 353
             +    W+ +        A DLVS++L   P+ R TA     HP+   +D+L  P  +L
Sbjct: 241 -SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL--PQYQL 292
Query: 354 PNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFL 393
            N +  P L       +KGA     S L     R Q P L
Sbjct: 293 -NRQDAPHL-------VKGAMAATYSAL----NRNQSPVL 320

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 46/213 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKN--RELQTMRLLDHPNV- 146
           E ++G G FG V++A  +  G+ VA+K    D      +  +N  +E +   +L HPN+ 
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 147 ----------------HYSR--------ASQRMPLIYVKLYTYQICRALAYIH--GGIGV 180
                            ++R        + +R+P   +  +  QI R + Y+H    + +
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 181 CHRDIKPQNLLV-------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
            HRD+K  N+L+       +     +K+ DFG A+   +    +S   +  + APE+I  
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAYAWMAPEVI-R 187
Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
           A+ ++   D+WS G +L ELL G+  F G  G+
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 61/274 (22%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLD-HPNV--- 146
           + ++ +G+GSF I    KC+      A    +  KR +    +E+  ++L + HPN+   
Sbjct: 14  LKDKPLGEGSFSIC--RKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 147 HYSRASQRMPLIYVKLYT-----------------------YQICRALAYIHGGIGVCHR 183
           H     Q    + ++L                          ++  A++++H  +GV HR
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD-VGVVHR 130
Query: 184 DIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTA 240
           D+KP+NLL        ++K+ DFG A++       +   C + +Y APEL+     Y  +
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGYDES 189
Query: 241 VDIWSVGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
            D+WS+G +L  +L GQ  F            VEI+K +                +F F 
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK-------------GDFSF- 235
Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 331
             +   W     K +  EA DL+  LL   PN R
Sbjct: 236 --EGEAW-----KNVSQEAKDLIQGLLTVDPNKR 262

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV---KLCDFG-SAKVLVKGE------PN 216
           +  AL ++H   G+ HRD+KP+N+L   H +QV   K+CDFG  + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 217 ISYIC-SRYYRAPELIFGATE----YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVE 271
           +   C S  Y APE++   +E    Y    D+WS+G +L  LL G P F G  G D   +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 331
             +    P  + +   +    +++FP      W  I        A DL+S+LL      R
Sbjct: 238 --RGEACPACQNMLFESIQEGKYEFPD---KDWAHI-----SCAAKDLISKLLVRDAKQR 287
Query: 332 CTALEACIHPF 342
            +A +   HP+
Sbjct: 288 LSAAQVLQHPW 298

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 78/179 (43%), Gaps = 25/179 (13%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK             + Y
Sbjct: 124 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPY 182
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE + G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +
Sbjct: 183 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 235
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 236 -------GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 38/197 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 186
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           D+KP+NLL++   + +++ DFG AK  VKG    +   +  Y APE+I  +  Y  AVD 
Sbjct: 187 DLKPENLLIDQQGY-IQVTDFGFAK-RVKG-ATWTLCGTPEYLAPEIIL-SKGYNKAVDW 242
Query: 244 WSVGCVLAELLLGQPLF 260
           W++G ++ E+  G P F
Sbjct: 243 WALGVLIYEMAAGYPPF 259

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 49/203 (24%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNV----HYS 149
           V+G+G FG   +    ETGE + +K+++    + +R   +E++ MR L+HPNV       
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 150 RASQRMPLI--YVK---------------------LYTYQICRALAYIHGGIGVCHRDIK 186
              +R+  I  Y+K                      +   I   +AY+H  + + HRD+ 
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH-SMNIIHRDLN 135
Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLV--KGEP-------------NISYICSRYYRAPELI 231
             N LV  + + V + DFG A+++V  K +P               + + + Y+ APE+I
Sbjct: 136 SHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 232 FGATEYTTAVDIWSVGCVLAELL 254
            G + Y   VD++S G VL E++
Sbjct: 195 NGRS-YDEKVDVFSFGIVLCEII 216

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 88/216 (40%), Gaps = 54/216 (25%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNV-- 146
           Y+  + +G+G F  V   + L  G   A+K++L    QD+    RE    RL +HPN+  
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 147 --------HYSRASQRMPLIYVKLYTYQ------------------------ICRALAYI 174
                     ++    + L + K  T                          ICR L  I
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS---AKVLVKGEPNISYI-------CSRY 224
           H   G  HRD+KP N+L+      V L D GS   A + V+G      +       C+  
Sbjct: 151 HAK-GYAHRDLKPTNILLGDEGQPV-LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 225 YRAPELIFGATEYTTA---VDIWSVGCVLAELLLGQ 257
           YRAPEL F    +       D+WS+GCVL  ++ G+
Sbjct: 209 YRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 108 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 166
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 167 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL-SKGYNKAVD 221
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 222 WWALGVLIYEMAAGYPPF 239

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           D+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  Y  AVD 
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLAGTPEYLAPEIIL-SKGYNKAVDW 221
Query: 244 WSVGCVLAELLLGQPLF 260
           W++G ++ E+  G P F
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 61/284 (21%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNV----- 146
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+     
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 147 ------HYSRASQRM-------PLIYVKLYT--------YQICRALAYIHGGIGVCHRDI 185
                 H    ++ M        ++  K ++        + I + + Y+H   GV HRD+
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ-GVVHRDL 147
Query: 186 KPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTT 239
           KP N+L      NP    +++CDFG AK L      +   C +  + APE +     Y  
Sbjct: 148 KPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLKRQGYDE 204
Query: 240 AVDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
             DIWS+G +L  +L G  P   G S  D   EI+  +G+                KF  
Sbjct: 205 GCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG---------------KFT- 246
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           +    W+ +        A DLVS++L   P+ R TA +   HP+
Sbjct: 247 LSGGNWNTV-----SETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 94  EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 152
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 153 DLKPENLLIDEQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL-SKGYNKAVD 207
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 208 WWALGVLIYEMAAGYPPF 225

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 61/287 (21%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNV----- 146
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+     
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 147 ------HYSRASQRM-------PLIYVKLYT--------YQICRALAYIHGGIGVCHRDI 185
                 H    ++ M        ++  K ++        + I + + Y+H   GV HRD+
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ-GVVHRDL 147
Query: 186 KPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTT 239
           KP N+L      NP    +++CDFG AK L      +   C +  + APE +     Y  
Sbjct: 148 KPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLKRQGYDE 204
Query: 240 AVDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
             DIWS+G +L  +L G  P   G S  D   EI+  +G+                KF  
Sbjct: 205 GCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG---------------KF-T 246
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
           +    W+ +        A DLVS++L   P+ R TA +   HP+  +
Sbjct: 247 LSGGNWNTV-----SETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           D+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  Y  AVD 
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLXGTPEYLAPEIIL-SKGYNKAVDW 221
Query: 244 WSVGCVLAELLLGQPLF 260
           W++G ++ E+  G P F
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYR 186
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 187 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVD 241
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 242 WWALGVLIYEMAAGYPPF 259

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 91/323 (28%), Positives = 131/323 (40%), Gaps = 79/323 (24%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNV-- 146
           V+G+G+F +V +    ETG+  A+K V   K   +         RE     +L HP++  
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 147 -HYSRASQRMPLIYVKL---------------------------YTYQICRALAYIHGGI 178
              + +S  M  +  +                            Y  QI  AL Y H   
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN- 149
Query: 179 GVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFG 233
            + HRD+KP+N+L+    ++  VKL DFG A  L  GE  +     + + ++ APE++  
Sbjct: 150 NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPHFMAPEVV-K 206
Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
              Y   VD+W  G +L  LL G   F G    ++L E I       + + K MNP    
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGKYK-MNPR--- 254
Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA-- 351
                     W  I        A DLV R+L   P  R T  EA  HP+  E RD  A  
Sbjct: 255 ---------QWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPWLKE-RDRYAYK 299
Query: 352 -RLPNGRPFPPLFNFKPQELKGA 373
             LP        FN + ++LKGA
Sbjct: 300 IHLPETVEQLRKFNAR-RKLKGA 321

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 89/340 (26%), Positives = 134/340 (39%), Gaps = 76/340 (22%)
Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNV-H 147
           T  Y  +  +G GS+ +  +     T    A+K + + KR    E++ + R   HPN+  
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 148 YSRASQRMPLIYV-----------------KLYT--------YQICRALAYIHGGIGVCH 182
                     +YV                 K ++        + I + + Y+H   GV H
Sbjct: 81  LKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ-GVVH 139
Query: 183 RDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATE 236
           RD+KP N+L      NP +  +++CDFG AK L      +   C +  + APE +     
Sbjct: 140 RDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLXTPCYTANFVAPE-VLERQG 196
Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           Y  A DIWS+G +L   L G   F      D   EI+  +G+                KF
Sbjct: 197 YDAACDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGSG---------------KF 240
Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF---FDELRDPNARL 353
             +    W+ +        A DLVS+ L   P+ R TA     HP+   +D+L  P  +L
Sbjct: 241 -SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQL--PQYQL 292
Query: 354 PNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFL 393
            N +  P L       +KGA     S L     R Q P L
Sbjct: 293 -NRQDAPHL-------VKGAXAATYSAL----NRNQSPVL 320

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 102 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYR 160
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 161 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL-SKGYNKAVD 215
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 216 WWALGVLIYEMAAGYPPF 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 39/211 (18%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHP----NV 146
           V+G+GSFG V  A    T E  AIK + +D   ++ +++        + LLD P     +
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 147 HYS-RASQRMPLI--YVK--------------------LYTYQICRALAYIHGGIGVCHR 183
           H   +   R+  +  YV                      Y  +I   L ++H   G+ +R
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKR-GIIYR 144
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGATEYTTAVD 242
           D+K  N++++   H +K+ DFG  K  ++ G     +  +  Y APE+I     Y  +VD
Sbjct: 145 DLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-AYQPYGKSVD 202
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            W+ G +L E+L GQP F GE   D+L + I
Sbjct: 203 WWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 74/130 (56%), Gaps = 12/130 (9%)
Query: 153 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 212
           +++P  + + Y+ +I  AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++
Sbjct: 148 RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLR 205
Query: 213 -GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF--------PGE 263
            G+   ++  +  Y APE++ G  +Y  +VD W++G ++ E++ G+  F        P +
Sbjct: 206 PGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
Query: 264 SGVDQLVEII 273
           +  D L ++I
Sbjct: 265 NTEDYLFQVI 274

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 42/213 (19%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQT 137
           R+  P +    + E  +G G+FG V++AK  ETG  +A  KV++ K  +  E     ++ 
Sbjct: 5   RDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEI 61
Query: 138 MRLLDHPNV------HYSRASQRMPLIY---------------------VKLYTYQICRA 170
           +   DHP +      +Y      + + +                     +++   Q+  A
Sbjct: 62  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 121
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPE 229
           L ++H    + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE
Sbjct: 122 LNFLHSK-RIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 179
Query: 230 LIF----GATEYTTAVDIWSVGCVLAELLLGQP 258
           ++       T Y    DIWS+G  L E+   +P
Sbjct: 180 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 212

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           +P+  +K     +  + +YIH    +CHRD+KP N+L++ +  +VKL DFG ++ +V  +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDKK 206
Query: 215 PNISYICSRYYRAPELIFGATEYTTA-VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
              S   +  +  PE     + Y  A VDIWS+G  L  +      F  +     LVE+ 
Sbjct: 207 IKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS---LVELF 262
Query: 274 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR-------MPPEAVDLVSRLLQY 326
             + T   E             +P  + H  + + +K+       +  E +D +   L+ 
Sbjct: 263 NNIRTKNIE-------------YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309
Query: 327 SPNLRCTALEACIHPFF-----DELRDPNARLPNGR 357
           +P  R T+ +A  H +      ++LR+ +  L   R
Sbjct: 310 NPAERITSEDALKHEWLADTNIEDLREFSKELYKKR 345

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 42/213 (19%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQT 137
           R+  P +    + E  +G G+FG V++AK  ETG  +A  KV++ K  +  E     ++ 
Sbjct: 13  RDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEI 69
Query: 138 MRLLDHPNV------HYSRASQRMPLIY---------------------VKLYTYQICRA 170
           +   DHP +      +Y      + + +                     +++   Q+  A
Sbjct: 70  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPE 229
           L ++H    + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE
Sbjct: 130 LNFLHSK-RIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 230 LIF----GATEYTTAVDIWSVGCVLAELLLGQP 258
           ++       T Y    DIWS+G  L E+   +P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 43/215 (20%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
            + Y  +I  AL Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +  
Sbjct: 112 ARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKX 169
Query: 220 ICSR-YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            C    Y APE +    +Y  AVD W +G V+ E++ G+  F  +   ++L E+I +   
Sbjct: 170 FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM--- 224
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CT 333
              EEI+                      F + + PEA  L++ LL+  P  R       
Sbjct: 225 ---EEIR----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 259
Query: 334 ALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQ 368
           A E   H FF  +   +  +   +  PP   FKPQ
Sbjct: 260 AKEVMEHRFFLSINWQD--VVQKKLLPP---FKPQ 289

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 56/276 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNV--------- 146
           +G G+FG+    +   T E VA+K + +         RE+   R L HPN+         
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 147 --------HYSRASQ---------RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 189
                    Y+   +         R      + +  Q+   ++Y H  + +CHRD+K +N
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH-SMQICHRDLKLEN 146
Query: 190 LLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGC 248
            L++     ++K+CDFG +K  V      S + +  Y APE++          D+WS G 
Sbjct: 147 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206
Query: 249 VLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 307
            L  +L+G  P    E   D    I ++L                ++  P          
Sbjct: 207 TLYVMLVGAYPFEDPEEPRDYRKTIQRILS--------------VKYSIPD--------- 243
Query: 308 FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
              R+ PE   L+SR+    P  R +  E   H +F
Sbjct: 244 -DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 26/168 (15%)
Query: 119 VAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
           V +    QD RY    ++ M   D  N+    ++  +P  + + YT ++  AL  IH  +
Sbjct: 137 VQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDAIHS-M 192
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYICSRYYRAP 228
           G  HRD+KP N+L++   H +KL DFG+   + K          G P+        Y +P
Sbjct: 193 GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD--------YISP 243
Query: 229 ELI---FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
           E++    G   Y    D WSVG  L E+L+G   F  +S V    +I+
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 26/168 (15%)
Query: 119 VAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
           V +    QD RY    ++ M   D  N+    ++  +P  + + YT ++  AL  IH  +
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDAIHS-M 187
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYICSRYYRAP 228
           G  HRD+KP N+L++   H +KL DFG+   + K          G P+        Y +P
Sbjct: 188 GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD--------YISP 238
Query: 229 ELI---FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
           E++    G   Y    D WSVG  L E+L+G   F  +S V    +I+
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 76/181 (41%), Gaps = 25/181 (13%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK         +   + Y
Sbjct: 170 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE + G  +Y  + D WS+G +   LL G P F    G      +    G  TR   
Sbjct: 229 YVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHG------LAISPGXKTR--- 278
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
             +     EF  P+     W ++       E   L+  LL+  P  R T  E   HP+  
Sbjct: 279 --IRXGQYEFPNPE-----WSEV-----SEEVKXLIRNLLKTEPTQRXTITEFXNHPWIX 326
Query: 345 E 345
           +
Sbjct: 327 Q 327

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 43/215 (20%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
            + Y  +I  AL Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +  
Sbjct: 107 ARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKX 164
Query: 220 ICSR-YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            C    Y APE +    +Y  AVD W +G V+ E++ G+  F  +   ++L E+I +   
Sbjct: 165 FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM--- 219
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CT 333
              EEI+                      F + + PEA  L++ LL+  P  R       
Sbjct: 220 ---EEIR----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 334 ALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQ 368
           A E   H FF  +   +  +   +  PP   FKPQ
Sbjct: 255 AKEVMEHRFFLSINWQD--VVQKKLLPP---FKPQ 284

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 71/130 (54%), Gaps = 12/130 (9%)
Query: 153 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 212
           +++P  + + Y+ +I  AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++
Sbjct: 116 RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLR 173
Query: 213 GEPNISYICSR-YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF--------PGE 263
                S  C    Y APE++ G  +Y  +VD W++G ++ E++ G+  F        P +
Sbjct: 174 PGDTTSXFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 232
Query: 264 SGVDQLVEII 273
           +  D L ++I
Sbjct: 233 NTEDYLFQVI 242

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 26/168 (15%)
Query: 119 VAIKKVLQDKRYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
           V +    QD RY    ++ M   D  N+    ++  +P  + + YT ++  AL  IH  +
Sbjct: 137 VQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDAIHS-M 192
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYICSRYYRAP 228
           G  HRD+KP N+L++   H +KL DFG+   + K          G P+        Y +P
Sbjct: 193 GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD--------YISP 243
Query: 229 ELI---FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
           E++    G   Y    D WSVG  L E+L+G   F  +S V    +I+
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 166 DLKPENLIIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIII-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 43/215 (20%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
            + Y  +I  AL Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +  
Sbjct: 107 ARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKX 164
Query: 220 ICSR-YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            C    Y APE +    +Y  AVD W +G V+ E++ G+  F  +   ++L E+I +   
Sbjct: 165 FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM--- 219
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CT 333
              EEI+                      F + + PEA  L++ LL+  P  R       
Sbjct: 220 ---EEIR----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 334 ALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQ 368
           A E   H FF  +   +  +   +  PP   FKPQ
Sbjct: 255 AKEVMEHRFFLSINWQD--VVQKKLLPP---FKPQ 284

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 43/214 (20%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
           + Y  +I  AL Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +   
Sbjct: 108 RFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTF 165
Query: 221 CSR-YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
           C    Y APE +    +Y  AVD W +G V+ E++ G+  F  +   ++L E+I +    
Sbjct: 166 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM---- 219
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTA 334
             EEI+                      F + + PEA  L++ LL+  P  R       A
Sbjct: 220 --EEIR----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 335 LEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQ 368
            E   H FF  +   +  +   +  PP   FKPQ
Sbjct: 256 KEVMEHRFFLSINWQD--VVQKKLLPP---FKPQ 284

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y  AVD
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPEIIL-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ ++  G P F
Sbjct: 221 WWALGVLIYQMAAGYPPF 238

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 71/130 (54%), Gaps = 12/130 (9%)
Query: 153 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 212
           +++P  + + Y+ +I  AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++
Sbjct: 101 RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLR 158
Query: 213 GEPNISYICSR-YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF--------PGE 263
                S  C    Y APE++ G  +Y  +VD W++G ++ E++ G+  F        P +
Sbjct: 159 PGDTTSXFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 217
Query: 264 SGVDQLVEII 273
           +  D L ++I
Sbjct: 218 NTEDYLFQVI 227

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 43/215 (20%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
            + Y  +I  AL Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +  
Sbjct: 110 ARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKT 167
Query: 220 ICSR-YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            C    Y APE +    +Y  AVD W +G V+ E++ G+  F  +   ++L E+I +   
Sbjct: 168 FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM--- 222
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CT 333
              EEI+                      F + + PEA  L++ LL+  P  R       
Sbjct: 223 ---EEIR----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 257
Query: 334 ALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQ 368
           A E   H FF  +   +  +   +  PP   FKPQ
Sbjct: 258 AKEVMEHRFFLSINWQD--VVQKKLLPP---FKPQ 287

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 43/215 (20%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
            + Y  +I  AL Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +  
Sbjct: 107 ARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKX 164
Query: 220 ICSR-YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            C    Y APE +    +Y  AVD W +G V+ E++ G+  F  +   ++L E+I +   
Sbjct: 165 FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM--- 219
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CT 333
              EEI+                      F + + PEA  L++ LL+  P  R       
Sbjct: 220 ---EEIR----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 334 ALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQ 368
           A E   H FF  +   +  +   +  PP   FKPQ
Sbjct: 255 AKEVMEHRFFLSINWQD--VVQKKLLPP---FKPQ 284

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 71/130 (54%), Gaps = 12/130 (9%)
Query: 153 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 212
           +++P  + + Y+ +I  AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++
Sbjct: 105 RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLR 162
Query: 213 GEPNISYICSR-YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF--------PGE 263
                S  C    Y APE++ G  +Y  +VD W++G ++ E++ G+  F        P +
Sbjct: 163 PGDTTSXFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221
Query: 264 SGVDQLVEII 273
           +  D L ++I
Sbjct: 222 NTEDYLFQVI 231

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 85/191 (44%), Gaps = 34/191 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNV--HYSRA 151
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V  +Y   
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 152 SQRMPLIYVKLYT-----------------------YQICRALAYIHGGIGVCHRDIKPQ 188
            +   L  +  Y                         +I + L Y+H    + HRDIK  
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI-HRDIKAA 153
Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAVDIWSVG 247
           N+L++ H  +VKL DFG A  L   +    +++ + ++ APE+I   + Y +  DIWS+G
Sbjct: 154 NVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLG 211
Query: 248 CVLAELLLGQP 258
               EL  G+P
Sbjct: 212 ITAIELARGEP 222

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 36/190 (18%)
Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNV------- 146
           E VVG+G+FG+V +AK     + VAIK++  +   K    EL+ +  ++HPN+       
Sbjct: 14  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 147 ---------------HYSRASQRMPLIYVKL-----YTYQICRALAYIHG--GIGVCHRD 184
                           Y+      PL Y        +  Q  + +AY+H      + HRD
Sbjct: 72  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
           +KP NLL+      +K+CDFG+A  +     N     S  + APE +F  + Y+   D++
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSNYSEKCDVF 188
Query: 245 SVGCVLAELL 254
           S G +L E++
Sbjct: 189 SWGIILWEVI 198

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 85/191 (44%), Gaps = 34/191 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNV--HYSRA 151
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V  +Y   
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 152 SQRMPLIYVKLYT-----------------------YQICRALAYIHGGIGVCHRDIKPQ 188
            +   L  +  Y                         +I + L Y+H    + HRDIK  
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI-HRDIKAA 133
Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAVDIWSVG 247
           N+L++ H  +VKL DFG A  L   +    +++ + ++ APE+I   + Y +  DIWS+G
Sbjct: 134 NVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLG 191
Query: 248 CVLAELLLGQP 258
               EL  G+P
Sbjct: 192 ITAIELARGEP 202

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/317 (23%), Positives = 126/317 (39%), Gaps = 60/317 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNV--------- 146
           +G G+FG+    +  ++ E VA+K + + ++      RE+   R L HPN+         
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 --------HYSRASQ---------RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 189
                    Y+   +         R      + +  Q+   ++Y H  + VCHRD+K +N
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLEN 145
Query: 190 LLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGC 248
            L++     ++K+C FG +K  V      S + +  Y APE++          D+WS G 
Sbjct: 146 TLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGV 205
Query: 249 VLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 307
            L  +L+G  P    E   +    I ++L       ++   P+Y                
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILN------VQYAIPDYV--------------- 244
Query: 308 FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKP 367
               + PE   L+SR+    P  R +  E   H +F  L++  A L N       F+   
Sbjct: 245 ---HISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDNTMTTQFDESD 299
Query: 368 QELKGASKELLSKLIPE 384
           Q   G S E + ++I E
Sbjct: 300 Q--PGQSIEEIMQIIAE 314

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 43/215 (20%)
Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
            + Y  +I  AL Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +  
Sbjct: 107 ARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKT 164
Query: 220 ICSR-YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            C    Y APE +    +Y  AVD W +G V+ E++ G+  F  +   ++L E+I +   
Sbjct: 165 FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM--- 219
Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CT 333
              EEI+                      F + + PEA  L++ LL+  P  R       
Sbjct: 220 ---EEIR----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 334 ALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQ 368
           A E   H FF  +   +  +   +  PP   FKPQ
Sbjct: 255 AKEVMEHRFFLSINWQD--VVQKKLLPP---FKPQ 284

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 46/222 (20%)
Query: 85  GQPKQTIS---YMAERVVGQGSFGIVFQAKCLE-TGE--TVAIKKVLQDKRYKNRE---- 134
           G P+  I+    +  R++G+G FG V++       GE   VA+K   +D    N+E    
Sbjct: 15  GSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 74
Query: 135 -LQTMRLLDHPNV-------------------------HY-SRASQRMPLIYVKLYTYQI 167
               M+ LDHP++                         HY  R    + ++ + LY+ QI
Sbjct: 75  EAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 134
Query: 168 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--- 224
           C+A+AY+   I   HRDI  +N+LV      VKL DFG ++  ++ E       +R    
Sbjct: 135 CKAMAYLE-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIK 191
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLL--GQPLFPGES 264
           + +PE I     +TTA D+W     + E+L    QP F  E+
Sbjct: 192 WMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 232

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 36/190 (18%)
Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNV------- 146
           E VVG+G+FG+V +AK     + VAIK++  +   K    EL+ +  ++HPN+       
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 147 ---------------HYSRASQRMPLIYVKL-----YTYQICRALAYIHGG--IGVCHRD 184
                           Y+      PL Y        +  Q  + +AY+H      + HRD
Sbjct: 71  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
           +KP NLL+      +K+CDFG+A  +     N     S  + APE +F  + Y+   D++
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSNYSEKCDVF 187
Query: 245 SVGCVLAELL 254
           S G +L E++
Sbjct: 188 SWGIILWEVI 197

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 43/207 (20%)
Query: 97  RVVGQGSFGIVFQAKCLE-TGE--TVAIKKVLQDKRYKNRE-----LQTMRLLDHPNV-- 146
           R++G+G FG V++       GE   VA+K   +D    N+E        M+ LDHP++  
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 147 -----------------------HY-SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                  HY  R    + ++ + LY+ QIC+A+AY+   I   H
Sbjct: 74  LIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE-SINCVH 132
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTT 239
           RDI  +N+LV      VKL DFG ++  ++ E       +R    + +PE I     +TT
Sbjct: 133 RDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESI-NFRRFTT 189
Query: 240 AVDIWSVGCVLAELLL--GQPLFPGES 264
           A D+W     + E+L    QP F  E+
Sbjct: 190 ASDVWMFAVCMWEILSFGKQPFFWLEN 216

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 34/191 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNV--HYSRA 151
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V  +Y   
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 152 SQRMPLIYVKLYT-----------------------YQICRALAYIHGGIGVCHRDIKPQ 188
            +   L  +  Y                         +I + L Y+H    + HRDIK  
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI-HRDIKAA 148
Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAVDIWSVG 247
           N+L++ H  +VKL DFG A  L   +     ++ + ++ APE+I   + Y +  DIWS+G
Sbjct: 149 NVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDSKADIWSLG 206
Query: 248 CVLAELLLGQP 258
               EL  G+P
Sbjct: 207 ITAIELARGEP 217

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 43/207 (20%)
Query: 97  RVVGQGSFGIVFQAKCLE-TGE--TVAIKKVLQDKRYKNRE-----LQTMRLLDHPNV-- 146
           R++G+G FG V++       GE   VA+K   +D    N+E        M+ LDHP++  
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 147 -----------------------HY-SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                  HY  R    + ++ + LY+ QIC+A+AY+   I   H
Sbjct: 78  LIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE-SINCVH 136
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTT 239
           RDI  +N+LV      VKL DFG ++  ++ E       +R    + +PE I     +TT
Sbjct: 137 RDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESI-NFRRFTT 193
Query: 240 AVDIWSVGCVLAELLL--GQPLFPGES 264
           A D+W     + E+L    QP F  E+
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLEN 220

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 34/191 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNV--HYSRA 151
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V  +Y   
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 152 SQRMPLIYVKLYT-----------------------YQICRALAYIHGGIGVCHRDIKPQ 188
            +   L  +  Y                         +I + L Y+H    + HRDIK  
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI-HRDIKAA 133
Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAVDIWSVG 247
           N+L++ H  +VKL DFG A  L   +     ++ + ++ APE+I   + Y +  DIWS+G
Sbjct: 134 NVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDSKADIWSLG 191
Query: 248 CVLAELLLGQP 258
               EL  G+P
Sbjct: 192 ITAIELARGEP 202

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 27/191 (14%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV---KLCDFG-SAKVLVKGE------PN 216
           +  AL ++H   G+ HRD+KP+N+L   H +QV   K+CDF   + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 217 ISYIC-SRYYRAPELIFGATE----YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVE 271
           +   C S  Y APE++   +E    Y    D+WS+G +L  LL G P F G  G D   +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 331
             +    P  + +   +    +++FP      W  I        A DL+S+LL      R
Sbjct: 238 --RGEACPACQNMLFESIQEGKYEFPD---KDWAHI-----SCAAKDLISKLLVRDAKQR 287
Query: 332 CTALEACIHPF 342
            +A +   HP+
Sbjct: 288 LSAAQVLQHPW 298

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP +I  +  Y  AVD
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEYLAPAIIL-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 102/243 (41%), Gaps = 66/243 (27%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHY--------- 148
           V+GQG+FG V +A+        AIKK+   +   +  L  + LL   N  Y         
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 149 SRASQRMPLIYVK----------------LYTY------------------QICRALAYI 174
            R +   P+  VK                LY                    QI  AL+YI
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI 132
Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEPNI--------SY 219
           H   G+ HRD+KP N+ ++  +  VK+ DFG AK       +L     N+        S 
Sbjct: 133 HSQ-GIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
           I +  Y A E++ G   Y   +D++S+G +  E+     ++P  +G+++ V I+K L + 
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNILKKLRSV 244
Query: 280 TRE 282
           + E
Sbjct: 245 SIE 247

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 102/243 (41%), Gaps = 66/243 (27%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHY--------- 148
           V+GQG+FG V +A+        AIKK+   +   +  L  + LL   N  Y         
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 149 SRASQRMPLIYVK----------------LYTY------------------QICRALAYI 174
            R +   P+  VK                LY                    QI  AL+YI
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYI 132
Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEPNI--------SY 219
           H   G+ HRD+KP N+ ++  +  VK+ DFG AK       +L     N+        S 
Sbjct: 133 HSQ-GIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
           I +  Y A E++ G   Y   +D++S+G +  E+     ++P  +G+++ V I+K L + 
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNILKKLRSV 244
Query: 280 TRE 282
           + E
Sbjct: 245 SIE 247

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/317 (22%), Positives = 125/317 (39%), Gaps = 60/317 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNV--------- 146
           +G G+FG+    +  ++ E VA+K + + ++      RE+   R L HPN+         
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 --------HYSRASQ---------RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 189
                    Y+   +         R      + +  Q+   ++Y H  + VCHRD+K +N
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLEN 145
Query: 190 LLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGC 248
            L++     ++K+C FG +K  V        + +  Y APE++          D+WS G 
Sbjct: 146 TLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGV 205
Query: 249 VLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 307
            L  +L+G  P    E   +    I ++L       ++   P+Y                
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILN------VQYAIPDYV--------------- 244
Query: 308 FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKP 367
               + PE   L+SR+    P  R +  E   H +F  L++  A L N       F+   
Sbjct: 245 ---HISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDNTMTTQFDESD 299
Query: 368 QELKGASKELLSKLIPE 384
           Q   G S E + ++I E
Sbjct: 300 Q--PGQSIEEIMQIIAE 314

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++     + HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 40/198 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL----------- 141
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L           
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 142 -----DHPNVH-------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                D+ N++             + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYR 165
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+KP+NLL++   + +++ DFG AK  VKG      +C      APE+I  +  Y  AVD
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK-RVKGRT--WXLCGTPEALAPEIIL-SKGYNKAVD 220
Query: 243 IWSVGCVLAELLLGQPLF 260
            W++G ++ E+  G P F
Sbjct: 221 WWALGVLIYEMAAGYPPF 238

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 88/221 (39%), Gaps = 45/221 (20%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRL 140
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 141 LDHPNV--HYSRASQRMPLIYVKLYTY------------------------------QIC 168
           L HPN+  +Y R   R       +  Y                              Q+ 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 169 RALAYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSR 223
            AL   H    GG  V HRD+KP N+ ++     VKL DFG A++L   E     ++ + 
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDEDFAKEFVGTP 180
Query: 224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
           YY +PE +     Y    DIWS+GC+L EL    P F   S
Sbjct: 181 YYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 32/205 (15%)
Query: 148 YSRASQRMPLIYVKLYTYQICR----ALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKL 201
           +SR  +R    + +    +I R    A+ ++H    + HRD+KP+NLL         +KL
Sbjct: 114 FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 202 CDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
            DFG AK   +    +   C + YY APE + G  +Y  + D+WS+G ++  LL G P F
Sbjct: 173 TDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229
Query: 261 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLV 320
              +G        + +    +  I+       ++ FP  +   W ++       +A  L+
Sbjct: 230 YSNTG--------QAISPGMKRRIRL-----GQYGFPNPE---WSEV-----SEDAKQLI 268
Query: 321 SRLLQYSPNLRCTALEACIHPFFDE 345
             LL+  P  R T  +   HP+ ++
Sbjct: 269 RLLLKTDPTERLTITQFMNHPWINQ 293

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 197 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 254
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 255 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 306
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 307 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 341

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 195 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 252
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 253 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 304
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 305 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 339

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 32/205 (15%)
Query: 148 YSRASQRMPLIYVKLYTYQICR----ALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKL 201
           +SR  +R    + +    +I R    A+ ++H    + HRD+KP+NLL         +KL
Sbjct: 95  FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKL 153
Query: 202 CDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
            DFG AK   +    +   C + YY APE + G  +Y  + D+WS+G ++  LL G P F
Sbjct: 154 TDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF 210
Query: 261 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLV 320
              +G        + +    +  I+       ++ FP  +   W ++       +A  L+
Sbjct: 211 YSNTG--------QAISPGMKRRIRL-----GQYGFPNPE---WSEV-----SEDAKQLI 249
Query: 321 SRLLQYSPNLRCTALEACIHPFFDE 345
             LL+  P  R T  +   HP+ ++
Sbjct: 250 RLLLKTDPTERLTITQFMNHPWINQ 274

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDP 193
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDP 193
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 190 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 247
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 299
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 300 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 202
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 188 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 245
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 246 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 297
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 298 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 332

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++     + HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 198
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 199 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 250
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 251 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 285

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 147 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 204
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 205 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 256
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 257 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 291

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 193
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 202
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/317 (22%), Positives = 124/317 (39%), Gaps = 60/317 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNV--------- 146
           +G G+FG+    +  +  E VA+K + + ++      RE+   R L HPN+         
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 --------HYSRASQ---------RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 189
                    Y+   +         R      + +  Q+   ++Y H  + V HRD+K +N
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAH-AMQVAHRDLKLEN 145
Query: 190 LLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGC 248
            L++     ++K+ DFG +K  V      S + +  Y APE++          D+WS G 
Sbjct: 146 TLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGV 205
Query: 249 VLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 307
            L  +L+G  P    E   +    I ++L       ++   P+Y                
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILN------VQYAIPDYV--------------- 244
Query: 308 FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKP 367
               + PE   L+SR+    P  R +  E   H +F  L++  A L N       F+   
Sbjct: 245 ---HISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDNTMTTQFDESD 299
Query: 368 QELKGASKELLSKLIPE 384
           Q   G S E + ++I E
Sbjct: 300 Q--PGQSIEEIMQIIAE 314

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 182 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 239
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 240 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 291
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 292 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 326

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 147
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 265
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 193
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 146
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 264
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 146
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 264
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 147
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 265
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 134
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 135 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 192
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 252
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 253 HLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 146
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 264
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 35  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 94  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 153
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 154 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 211
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 74  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 133
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 134 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 191
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 192 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 251
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 252 HLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 88/221 (39%), Gaps = 45/221 (20%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRL 140
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 141 LDHPNV--HYSRASQRMPLIYVKLYTY------------------------------QIC 168
           L HPN+  +Y R   R       +  Y                              Q+ 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 169 RALAYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSR 223
            AL   H    GG  V HRD+KP N+ ++     VKL DFG A++L        +++ + 
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTP 180
Query: 224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
           YY +PE +     Y    DIWS+GC+L EL    P F   S
Sbjct: 181 YYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 102 PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 161
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 88/221 (39%), Gaps = 45/221 (20%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRL 140
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 141 LDHPNV--HYSRASQRMPLIYVKLYTY------------------------------QIC 168
           L HPN+  +Y R   R       +  Y                              Q+ 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 169 RALAYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSR 223
            AL   H    GG  V HRD+KP N+ ++     VKL DFG A++L        +++ + 
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTP 180
Query: 224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
           YY +PE +     Y    DIWS+GC+L EL    P F   S
Sbjct: 181 YYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 5/145 (3%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 119 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 176
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 177 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 236
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 50/200 (25%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL------DHP 144
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L       + 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 145 NVHYS--RASQRMPLIYVK---------------------LYTYQICRALAYIHGGIGVC 181
            V Y   R S R+ + Y+                      LY+ QIC+ + Y+ G     
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL-GSRRCV 136
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPELIFGA 234
           HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE +   
Sbjct: 137 HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPESL-SD 191
Query: 235 TEYTTAVDIWSVGCVLAELL 254
             ++   D+WS G VL EL 
Sbjct: 192 NIFSRQSDVWSFGVVLYELF 211

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 5/145 (3%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 118 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 175
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 176 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 235
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 236 HLIRWCLALRPSDRPTFEEIQNHPW 260

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 5/145 (3%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 5/145 (3%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 46/210 (21%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGET---VAIKKV-----LQDKRYKNRELQTM 138
           P + +   ++RV+G+G FG+V+  + ++  +     AIK +     +Q      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 139 RLLDHPNV---------------------------HYSRASQRMPLIYVKL-YTYQICRA 170
           R L+HPNV                            + R+ QR P +   + +  Q+ R 
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 230
           + Y+       HRD+  +N +++  +  VK+ DFG A+ ++  E   S    R+ R P +
Sbjct: 137 MEYL-AEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQHRHARLP-V 192
Query: 231 IFGATE------YTTAVDIWSVGCVLAELL 254
            + A E      +TT  D+WS G +L ELL
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 34/191 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNV-----HY 148
           +G+GSFG V++     T E VAIK +       +     +E+  +   D P +      Y
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 149 SRASQRMPLI--------------------YVKLYTYQICRALAYIHGGIGVCHRDIKPQ 188
            ++++   ++                    Y+     +I + L Y+H    + HRDIK  
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI-HRDIKAA 145
Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAVDIWSVG 247
           N+L++     VKL DFG A  L   +     ++ + ++ APE+I   + Y    DIWS+G
Sbjct: 146 NVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDFKADIWSLG 203
Query: 248 CVLAELLLGQP 258
               EL  G+P
Sbjct: 204 ITAIELAKGEP 214

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 5/145 (3%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 5/145 (3%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 5/145 (3%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 119 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 176
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 177 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 236
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 50/200 (25%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL------DHP 144
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L       + 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 145 NVHYS--RASQRMPLIYVK---------------------LYTYQICRALAYIHGGIGVC 181
            V Y   R S R+ + Y+                      LY+ QIC+ + Y+ G     
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL-GSRRCV 137
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPELIFGA 234
           HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE +   
Sbjct: 138 HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPESL-SD 192
Query: 235 TEYTTAVDIWSVGCVLAELL 254
             ++   D+WS G VL EL 
Sbjct: 193 NIFSRQSDVWSFGVVLYELF 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 50/200 (25%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL------DHP 144
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L       + 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 145 NVHYS--RASQRMPLIYVK---------------------LYTYQICRALAYIHGGIGVC 181
            V Y   R S R+ + Y+                      LY+ QIC+ + Y+ G     
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL-GSRRCV 149
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPELIFGA 234
           HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE +   
Sbjct: 150 HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPESL-SD 204
Query: 235 TEYTTAVDIWSVGCVLAELL 254
             ++   D+WS G VL EL 
Sbjct: 205 NIFSRQSDVWSFGVVLYELF 224

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 5/145 (3%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 232
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 5/145 (3%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 232
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 146
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +    +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQ 264
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 147
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +    +
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQ 265
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 147
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +    +
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQ 265
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 48  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 106
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 107 PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 166
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 167 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 224
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +    +
Sbjct: 225 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 284
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 285 HLIRWCLALRPSDRPTFEEIQNHPW 309

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 134
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 135 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 192
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +    +
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 252
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 253 HLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 74  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 133
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 134 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 191
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +    +
Sbjct: 192 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 251
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 252 HLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 45/265 (16%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 102 PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 161
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +    +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 279
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 42/215 (19%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL------ 135
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 136 ---------------QTMRLLD---HPNVH-------------YSRASQRMPLI--YVKL 162
                            +RLLD    P+               +   ++R  L     + 
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 134
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 135 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 192
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ 257
           R Y  PE I     +  +  +WS+G +L +++ G 
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 73/145 (50%), Gaps = 5/145 (3%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHN-XGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +    +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 232
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 100/259 (38%), Gaps = 72/259 (27%)
Query: 153 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN----------------------- 189
           Q +P+  VK    Q+ + L Y+H    + H DIKP+N                       
Sbjct: 135 QGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKA 194
Query: 190 -----------------LLVNP------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 226
                            LLVNP         +VK+ D G+A  + K       I +R YR
Sbjct: 195 GAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQYR 252
Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPT 280
           + E++ GA  Y+T  DIWS  C+  EL  G  LF   SG       D +  II++LG+  
Sbjct: 253 SIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIP 311
Query: 281 REEIKCMNPNYTEFKFPQ-------IKAHPW---HKIFHKRMPP-----EAVDLVSRLLQ 325
           R     ++  Y+   F +        K  PW     +  K   P     +  D +  +L+
Sbjct: 312 RH--FALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLE 369
Query: 326 YSPNLRCTALEACIHPFFD 344
             P  R +A E   HP+ +
Sbjct: 370 MVPEKRASAGECLRHPWLN 388

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 73/145 (50%), Gaps = 5/145 (3%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 142 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 199
Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 281
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +    +
Sbjct: 200 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 259
Query: 282 EEIK-CMNPNYTEF-KFPQIKAHPW 304
             I+ C+    ++   F +I+ HPW
Sbjct: 260 HLIRWCLALRPSDRPTFEEIQNHPW 284

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/294 (22%), Positives = 113/294 (38%), Gaps = 68/294 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F IV + +   TG+  A  K ++ +R  +           RE+  +R + HPN+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H    + 
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK-RIA 130
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE++       
Sbjct: 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV-NYEPLG 189
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F GE+  + L  I              +N ++ E  F  
Sbjct: 190 LEADMWSIGVITYILLSGASPFLGETKQETLTNI------------SAVNYDFDEEYFSN 237
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 352
                            A D + RLL   P  R T  ++  H +   +R  N R
Sbjct: 238 -------------TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR 278

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 86/200 (43%), Gaps = 50/200 (25%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL------DHP 144
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L       + 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 145 NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
            V Y                        R   R+    + LY+ QIC+ + Y+ G     
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL-GSRRCV 133
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPELIFGA 234
           HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE +   
Sbjct: 134 HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVREPGQSPI---FWYAPESL-SD 188
Query: 235 TEYTTAVDIWSVGCVLAELL 254
             ++   D+WS G VL EL 
Sbjct: 189 NIFSRQSDVWSFGVVLYELF 208

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 45/200 (22%)
Query: 97  RVVGQGSFGIV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
           R +G+G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+ 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 147 ----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                       +  +   ++ L     Y  QIC+ + Y+ G  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL-GSR 145
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPELIFGA 234
              HRD+  +N+LV    HQVK+ DFG  K +   +   +    R    ++ APE +   
Sbjct: 146 QYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM-Q 203
Query: 235 TEYTTAVDIWSVGCVLAELL 254
           +++  A D+WS G  L ELL
Sbjct: 204 SKFYIASDVWSFGVTLHELL 223

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 42/213 (19%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQT 137
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +  E     +  
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 138 MRLLDHPNV-------HYSRA------------------SQRMPLI--YVKLYTYQICRA 170
           +   DHPN+       +Y                         PL    +++   Q   A
Sbjct: 88  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 147
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPE 229
           L Y+H    + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE
Sbjct: 148 LNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPE 205
Query: 230 LIFGATE----YTTAVDIWSVGCVLAELLLGQP 258
           ++   T     Y    D+WS+G  L E+   +P
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 42/213 (19%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQT 137
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +  E     +  
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 138 MRLLDHPNV-------HYSRA------------------SQRMPLI--YVKLYTYQICRA 170
           +   DHPN+       +Y                         PL    +++   Q   A
Sbjct: 88  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 147
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPE 229
           L Y+H    + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE
Sbjct: 148 LNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 205
Query: 230 LIFGATE----YTTAVDIWSVGCVLAELLLGQP 258
           ++   T     Y    D+WS+G  L E+   +P
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 97/261 (37%), Gaps = 74/261 (28%)
Query: 153 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV-------------------- 192
           Q +PL  VK    Q+ + L Y+H    + H DIKP+N+L+                    
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200
Query: 193 ----------------------------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 224
                                       N    +VK+ D G+A  + K       I +R 
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQ 258
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGT 278
           YR+ E++ G+  Y T  DIWS  C+  EL  G  LF   SG       D +  II++LG 
Sbjct: 259 YRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 317
Query: 279 PTREEIKCMNPNYTEFKFPQ-------IKAHPWHKI--------FHKRMPPEAVDLVSRL 323
             R+ I  +   Y++  F +        K  PW           + +       D +  +
Sbjct: 318 VPRKLI--VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPM 375
Query: 324 LQYSPNLRCTALEACIHPFFD 344
           L+  P  R TA E   HP+ +
Sbjct: 376 LELIPEKRATAAECLRHPWLN 396

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 45/200 (22%)
Query: 97  RVVGQGSFGIV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
           R +G+G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+ 
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 147 ----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                       +  +   ++ L     Y  QIC+ + Y+ G  
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL-GSR 133
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPELIFGA 234
              HRD+  +N+LV    HQVK+ DFG  K +   +   +    R    ++ APE +   
Sbjct: 134 QYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM-Q 191
Query: 235 TEYTTAVDIWSVGCVLAELL 254
           +++  A D+WS G  L ELL
Sbjct: 192 SKFYIASDVWSFGVTLHELL 211

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 8/132 (6%)
Query: 149 SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA- 207
           S+   R+P    + Y  ++  A+  +H  +   HRDIKP N+L++ + H ++L DFGS  
Sbjct: 166 SKFEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCL 223
Query: 208 KVLVKGEPNISY-ICSRYYRAPELI----FGATEYTTAVDIWSVGCVLAELLLGQPLFPG 262
           K++  G    S  + +  Y +PE++     G   Y    D WS+G  + E+L G+  F  
Sbjct: 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283
Query: 263 ESGVDQLVEIIK 274
           ES V+   +I+ 
Sbjct: 284 ESLVETYGKIMN 295

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 34/191 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNV-----HY 148
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D   V      Y
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 149 SRASQRM------------------PLIYVKLYTY--QICRALAYIHGGIGVCHRDIKPQ 188
            + S+                    P    ++ T   +I + L Y+H    + HRDIK  
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI-HRDIKAA 149
Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAVDIWSVG 247
           N+L++     VKL DFG A  L   +    +++ + ++ APE+I   + Y +  DIWS+G
Sbjct: 150 NVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKADIWSLG 207
Query: 248 CVLAELLLGQP 258
               EL  G+P
Sbjct: 208 ITAIELAKGEP 218

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 97/261 (37%), Gaps = 74/261 (28%)
Query: 153 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV-------------------- 192
           Q +PL  VK    Q+ + L Y+H    + H DIKP+N+L+                    
Sbjct: 125 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 184
Query: 193 ----------------------------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 224
                                       N    +VK+ D G+A  + K       I +R 
Sbjct: 185 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQ 242
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGT 278
           YR+ E++ G+  Y T  DIWS  C+  EL  G  LF   SG       D +  II++LG 
Sbjct: 243 YRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 301
Query: 279 PTREEIKCMNPNYTEFKFPQ-------IKAHPWHKI--------FHKRMPPEAVDLVSRL 323
             R+ I  +   Y++  F +        K  PW           + +       D +  +
Sbjct: 302 VPRKLI--VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPM 359
Query: 324 LQYSPNLRCTALEACIHPFFD 344
           L+  P  R TA E   HP+ +
Sbjct: 360 LELIPEKRATAAECLRHPWLN 380

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 45/198 (22%)
Query: 97  RVVGQGSFGIVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNV-- 146
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++  
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 147 -----------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                   + +  +  + L  + LY YQ+  ALAY+     V H
Sbjct: 456 LIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV-H 514
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATEY 237
           RDI  +N+LV+  T  VKL DFG ++ +   E +  Y  S+      + APE I     +
Sbjct: 515 RDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI-NFRRF 569
Query: 238 TTAVDIWSVGCVLAELLL 255
           T+A D+W  G  + E+L+
Sbjct: 570 TSASDVWMFGVCMWEILM 587

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 39/211 (18%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLLDHPN-----VHY 148
           V+G+GSFG V  ++   T E  A+K + +D   ++ +++ TM   R+L  P         
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 149 SRASQRMPLIYVKL-------------------------YTYQICRALAYIHGGIGVCHR 183
               Q M  +Y  +                         Y  +I   L ++    G+ +R
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYR 145
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+K  N++++   H +K+ DFG  K  +         C    Y APE+I     Y  +VD
Sbjct: 146 DLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQPYGKSVD 203
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 204 WWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 233

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 155 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+ DFG A+ + K  
Sbjct: 141 LTLEHLIXYSFQVAKGMEFL-ASRKXIHRDLAARNILLS-EKNVVKIXDFGLARDIYKDP 198
Query: 215 PNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLV 270
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 199 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 250
Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 305
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 251 KIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWH 285

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 15/120 (12%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 215
           ++YQ+ + +A++       HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 166 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
            +       + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK
Sbjct: 224 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 278

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 84/212 (39%), Gaps = 53/212 (25%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-KNRELQTMRLLDHPNV----------- 146
           +G GS+G VF+ +  E G   A+K+ +   R  K+R  +   +  H  V           
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                H       +P   V  Y      ALA++H   G+ H D+
Sbjct: 125 AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDV 183
Query: 186 KPQNLLVNPHTHQVKLCDFG--------SAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
           KP N+ + P   + KL DFG         A  + +G+P         Y APEL+ G+  Y
Sbjct: 184 KPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPELLQGS--Y 232
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQL 269
            TA D++S+G  + E+     L  G  G  QL
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 123/294 (41%), Gaps = 65/294 (22%)
Query: 91  ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNV-- 146
           IS+  + V+G G+ G +      +  + VA+K++L +   + +RE+Q +R  D HPNV  
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 147 HYSRASQR------MPLIYVKLYTY------------------QICRALAYIHGGIGVCH 182
           ++     R      + L    L  Y                  Q    LA++H  + + H
Sbjct: 83  YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH-SLNIVH 141
Query: 183 RDIKPQNLLVN-PHTH---QVKLCDFGSAKVLVKGEPNISYIC----SRYYRAPELIFGA 234
           RD+KP N+L++ P+ H   +  + DFG  K L  G  + S       +  + APE++   
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 235 TEY--TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 292
            +   T  VDI+S GCV    ++ +   P    + +   I+  LG  +   + C++P   
Sbjct: 202 CKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL--LGACS---LDCLHPEKH 255
Query: 293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
           E                      A +L+ +++   P  R +A     HPFF  L
Sbjct: 256 EDVI-------------------ARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ERV+G G FG V   +    G+    VAIK +      K R     E   M   DHPN+ 
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
           +     ++  P++ V  Y                    Q+   L  I  G+      G  
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV 146
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + APE I    +
Sbjct: 147 HRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAPEAI-AFRK 203
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G V+ E++
Sbjct: 204 FTSASDVWSYGIVMWEVV 221

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 84/198 (42%), Gaps = 45/198 (22%)
Query: 97  RVVGQGSFGIVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNV-- 146
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++  
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                           + L  + LY YQ+  ALAY+     V H
Sbjct: 76  LIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV-H 134
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATEY 237
           RDI  +N+LV+  T  VKL DFG ++ +   E +  Y  S+      + APE I     +
Sbjct: 135 RDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI-NFRRF 189
Query: 238 TTAVDIWSVGCVLAELLL 255
           T+A D+W  G  + E+L+
Sbjct: 190 TSASDVWMFGVCMWEILM 207

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 15/120 (12%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 215
           ++YQ+ + +A++       HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 168 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
            +       + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK
Sbjct: 226 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 280

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 15/120 (12%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 215
           ++YQ+ + +A++       HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 150 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
            +       + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK
Sbjct: 208 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 82/213 (38%), Gaps = 58/213 (27%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPN-VHY-------- 148
           ++G G FG VF+AK    G+T  I++V  +     RE++ +  LDH N VHY        
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 78
Query: 149 -----------------------SRASQRMPLIYV------------------KLYTYQI 167
                                  SR+  +   I +                  KL     
Sbjct: 79  YDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 138
Query: 168 CRALAYIHGGIGVCH------RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 221
                 I  G+   H      RD+KP N+ +   T QVK+ DFG    L           
Sbjct: 139 LELFEQITKGVDYIHSKKLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTRSKG 197
Query: 222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELL 254
           +  Y +PE I  + +Y   VD++++G +LAELL
Sbjct: 198 TLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 15/120 (12%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 215
           ++YQ+ + +A++       HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 173 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
            +       + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK
Sbjct: 231 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 2/97 (2%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
           + +  Q+  A+ + H   GV HRDIK +N+L++      KL DFGS   L+  EP   + 
Sbjct: 142 RCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD 199
Query: 221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ 257
            +R Y  PE I     +     +WS+G +L +++ G 
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 15/120 (12%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 215
           ++YQ+ + +A++       HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 173 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
            +       + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK
Sbjct: 231 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 39/211 (18%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLLDHPN-----VHY 148
           V+G+GSFG V  ++   T E  A+K + +D   ++ +++ TM   R+L  P         
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 149 SRASQRMPLIYVKL-------------------------YTYQICRALAYIHGGIGVCHR 183
               Q M  +Y  +                         Y  +I   L ++    G+ +R
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYR 466
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTTAVD 242
           D+K  N++++   H +K+ DFG  K  +         C    Y APE+I     Y  +VD
Sbjct: 467 DLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQPYGKSVD 524
Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 525 WWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 120/318 (37%), Gaps = 83/318 (26%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----------------- 139
           +V+G+G+F  V   K  +TG+  A+K + +    K  E+   R                 
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 140 --LLDHPNVHY---------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                  N  Y               S+  +R+P    + Y  +I  A+  +H  +G  H
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR-LGYVH 185
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGE-PNISYICSRYYRAPELIFGATEYTTA 240
           RDIKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +PE++         
Sbjct: 186 RDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 241 V------DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
                  D W++G    E+  GQ  F  +S  +   +I+                     
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV--------------------- 283
Query: 295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFF-----DEL 346
                K H    +  + +P EA D + RLL   P  R     A +   HPFF     D L
Sbjct: 284 ---HYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAGDFRTHPFFFGLDWDGL 339
Query: 347 RDPNARLPNGRPFPPLFN 364
           RD    +P   PF P F 
Sbjct: 340 RDS---VP---PFTPDFE 351

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 128/314 (40%), Gaps = 100/314 (31%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL---------QTMRLLDHPN-VHY 148
           +G+G FG+VF+AK        AIK++    R  NREL         + +  L+HP  V Y
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 149 SRA------SQRMPLIYVKLYTY---QICR------------------------------ 169
             A      ++++     K+Y Y   Q+CR                              
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 170 -ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------PNISY-- 219
            A+ ++H   G+ HRD+KP N+        VK+ DFG    + + E       P  +Y  
Sbjct: 129 EAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 220 ----ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 275
               + ++ Y +PE I G + Y+  VDI+S+G +L EL     L+P  + ++++  +  V
Sbjct: 187 HTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLTDV 240
Query: 276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 335
                              KFP         +F ++ P E V +V  +L  SP  R  A+
Sbjct: 241 ----------------RNLKFP--------PLFTQKYPCEYV-MVQDMLSPSPMERPEAI 275
Query: 336 EACIHPFFDELRDP 349
               +  F++L  P
Sbjct: 276 NIIENAVFEDLDFP 289

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 42/213 (19%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQT 137
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +  E     +  
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 138 MRLLDHPNV-------HYSRA------------------SQRMPLI--YVKLYTYQICRA 170
           +   DHPN+       +Y                         PL    +++   Q   A
Sbjct: 88  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 147
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPE 229
           L Y+H    + HRD+K  N+L       +KL DFG SAK     +    +I + Y+ APE
Sbjct: 148 LNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPE 205
Query: 230 LIFGATE----YTTAVDIWSVGCVLAELLLGQP 258
           ++   T     Y    D+WS+G  L E+   +P
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 89/323 (27%), Positives = 127/323 (39%), Gaps = 79/323 (24%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNV-- 146
           V+G+G F +V +    ETG+  A+K V   K   +         RE     +L HP++  
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 147 -HYSRASQRMPLIYVKL---------------------------YTYQICRALAYIHGGI 178
              + +S  M  +  +                            Y  QI  AL Y H   
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN- 151
Query: 179 GVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFG 233
            + HRD+KP  +L+    ++  VKL  FG A  L  GE  +     + + ++ APE++  
Sbjct: 152 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPEVV-K 208
Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
              Y   VD+W  G +L  LL G   F G    ++L E I       + + K MNP    
Sbjct: 209 REPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGKYK-MNPR--- 256
Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA-- 351
                     W  I        A DLV R+L   P  R T  EA  HP+  E RD  A  
Sbjct: 257 ---------QWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPWLKE-RDRYAYK 301
Query: 352 -RLPNGRPFPPLFNFKPQELKGA 373
             LP        FN + ++LKGA
Sbjct: 302 IHLPETVEQLRKFNAR-RKLKGA 323

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 70/139 (50%), Gaps = 24/139 (17%)
Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLV 211
           Y +L+  QI  AL+YIH   G+ HR++KP N+ ++  +  VK+ DFG AK       +L 
Sbjct: 118 YWRLFR-QILEALSYIHSQ-GIIHRNLKPXNIFIDE-SRNVKIGDFGLAKNVHRSLDILK 174
Query: 212 KGEPNI--------SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGE 263
               N+        S I +  Y A E++ G   Y   +D +S+G +  E      ++P  
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFS 229
Query: 264 SGVDQLVEIIKVLGTPTRE 282
           +G ++ V I+K L + + E
Sbjct: 230 TGXER-VNILKKLRSVSIE 247

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 49/206 (23%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYK-NRELQTMRLLDHPN--------- 145
           +VG G++G V++ + ++TG+  AIK   V  D+  +  +E+  ++   H           
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 146 ---------------VHYSRASQRMPLI-----------YVKLYTYQICRALAYIHGGIG 179
                          + +  A     LI           ++     +I R L+++H    
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-K 149
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF----- 232
           V HRDIK QN+L+  +  +VKL DFG +  L +  G  N ++I + Y+ APE+I      
Sbjct: 150 VIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDENP 207
Query: 233 GATEYTTAVDIWSVGCVLAELLLGQP 258
            AT Y    D+WS+G    E+  G P
Sbjct: 208 DAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 89/323 (27%), Positives = 127/323 (39%), Gaps = 79/323 (24%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNV-- 146
           V+G+G F +V +    ETG+  A+K V   K   +         RE     +L HP++  
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 147 -HYSRASQRMPLIYVKL---------------------------YTYQICRALAYIHGGI 178
              + +S  M  +  +                            Y  QI  AL Y H   
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN- 149
Query: 179 GVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFG 233
            + HRD+KP  +L+    ++  VKL  FG A  L  GE  +     + + ++ APE++  
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPEVV-K 206
Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
              Y   VD+W  G +L  LL G   F G    ++L E I       + + K MNP    
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGKYK-MNPR--- 254
Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA-- 351
                     W  I        A DLV R+L   P  R T  EA  HP+  E RD  A  
Sbjct: 255 ---------QWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPWLKE-RDRYAYK 299
Query: 352 -RLPNGRPFPPLFNFKPQELKGA 373
             LP        FN + ++LKGA
Sbjct: 300 IHLPETVEQLRKFNAR-RKLKGA 321

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 45/198 (22%)
Query: 97  RVVGQGSFGIVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNV-- 146
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++  
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 147 -----------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                   + +  +  + L  + LY YQ+  ALAY+     V H
Sbjct: 456 LIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV-H 514
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATEY 237
           RDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + APE I     +
Sbjct: 515 RDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI-NFRRF 569
Query: 238 TTAVDIWSVGCVLAELLL 255
           T+A D+W  G  + E+L+
Sbjct: 570 TSASDVWMFGVCMWEILM 587

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 45/198 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNV-- 146
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++  
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                           + L  + LY YQ+  ALAY+     V H
Sbjct: 73  LIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV-H 131
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATEY 237
           RDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + APE I     +
Sbjct: 132 RDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI-NFRRF 186
Query: 238 TTAVDIWSVGCVLAELLL 255
           T+A D+W  G  + E+L+
Sbjct: 187 TSASDVWMFGVCMWEILM 204

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/294 (21%), Positives = 112/294 (38%), Gaps = 68/294 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F IV + +   TG+  A  K ++ +R  +           RE+  +R + HPN+ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H    + 
Sbjct: 93  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK-RIA 151
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE++       
Sbjct: 152 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV-NYEPLG 210
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F GE+  + L  I              +N ++ E  F  
Sbjct: 211 LEADMWSIGVITYILLSGASPFLGETKQETLTNI------------SAVNYDFDEEYFSN 258
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 352
                            A D + RLL   P  R    ++  H +   +R  N R
Sbjct: 259 -------------TSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRNVR 299

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 45/198 (22%)
Query: 97  RVVGQGSFGIVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNV-- 146
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++  
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                           + L  + LY YQ+  ALAY+     V H
Sbjct: 76  LIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV-H 134
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATEY 237
           RDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + APE I     +
Sbjct: 135 RDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI-NFRRF 189
Query: 238 TTAVDIWSVGCVLAELLL 255
           T+A D+W  G  + E+L+
Sbjct: 190 TSASDVWMFGVCMWEILM 207

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 45/198 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNV-- 146
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++  
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                           + L  + LY YQ+  ALAY+     V H
Sbjct: 79  LIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV-H 137
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATEY 237
           RDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + APE I     +
Sbjct: 138 RDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI-NFRRF 192
Query: 238 TTAVDIWSVGCVLAELLL 255
           T+A D+W  G  + E+L+
Sbjct: 193 TSASDVWMFGVCMWEILM 210

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 112/302 (37%), Gaps = 66/302 (21%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            Y  + V+G G+  +V  A C    E VAIK++  +K   +     +E+Q M    HPN+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 147 --HYSRASQRMPLIYV-KLYT-------------------------------YQICRALA 172
             +Y+    +  L  V KL +                                ++   L 
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG------EPNISYICSRYYR 226
           Y+H   G  HRD+K  N+L+      V++ DFG +  L  G      +   +++ +  + 
Sbjct: 136 YLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
           APE++     Y    DIWS G    EL  G    P        V ++ +   P       
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDP------- 244
Query: 287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
                     P ++     K   K+       ++S  LQ  P  R TA E   H FF + 
Sbjct: 245 ----------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294
Query: 347 RD 348
           ++
Sbjct: 295 KN 296

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 45/198 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNV-- 146
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++  
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                           + L  + LY YQ+  ALAY+     V H
Sbjct: 78  LIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV-H 136
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATEY 237
           RDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + APE I     +
Sbjct: 137 RDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI-NFRRF 191
Query: 238 TTAVDIWSVGCVLAELLL 255
           T+A D+W  G  + E+L+
Sbjct: 192 TSASDVWMFGVCMWEILM 209

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 45/198 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNV-- 146
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++  
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                           + L  + LY YQ+  ALAY+     V H
Sbjct: 104 LIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV-H 162
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATEY 237
           RDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + APE I     +
Sbjct: 163 RDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI-NFRRF 217
Query: 238 TTAVDIWSVGCVLAELLL 255
           T+A D+W  G  + E+L+
Sbjct: 218 TSASDVWMFGVCMWEILM 235

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/131 (33%), Positives = 67/131 (51%), Gaps = 19/131 (14%)
Query: 153 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-- 210
           Q++P+     Y  +I  AL+Y+H  IG+ + D+KP+N+++     Q+KL D G+   +  
Sbjct: 177 QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINS 233
Query: 211 ---VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
              + G P         ++APE++   T  T A DI++VG  LA L L  P   G   VD
Sbjct: 234 FGYLYGTPG--------FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VD 282
Query: 268 QLVEIIKVLGT 278
            L E   VL T
Sbjct: 283 GLPEDDPVLKT 293

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 45/198 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNV-- 146
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++  
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                           + L  + LY YQ+  ALAY+     V H
Sbjct: 76  LIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV-H 134
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATEY 237
           RDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + APE I     +
Sbjct: 135 RDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI-NFRRF 189
Query: 238 TTAVDIWSVGCVLAELLL 255
           T+A D+W  G  + E+L+
Sbjct: 190 TSASDVWMFGVCMWEILM 207

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 84/198 (42%), Gaps = 45/198 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNV-- 146
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++  
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                           + L  + LY YQ+  ALAY+     V H
Sbjct: 81  LIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV-H 139
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATEY 237
           RDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + APE I     +
Sbjct: 140 RDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI-NFRRF 194
Query: 238 TTAVDIWSVGCVLAELLL 255
           T+A D+W  G  + E+L+
Sbjct: 195 TSASDVWMFGVCMWEILM 212

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 43/215 (20%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMR 139
           G+  Q  S M+   +G G+FG V+ A   E  + V +K     KVL+D   ++ +L  + 
Sbjct: 20  GEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77
Query: 140 L-------LDHPNV-------------------HYSRAS-----QRMPLIYVKLYTY--- 165
           L       ++H N+                   H S         R P +   L +Y   
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 225
           Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+   ++  +  Y
Sbjct: 138 QLVSAVGYLRLK-DIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLF 260
            APE++ G       +++WS+G  L  L+  +  F
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 149 SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA- 207
           S+   ++P    + Y  ++  A+  IH  +   HRDIKP N+L++ + H ++L DFGS  
Sbjct: 182 SKFEDKLPEDMARFYIGEMVLAIDSIHQ-LHYVHRDIKPDNVLLDVNGH-IRLADFGSCL 239
Query: 208 KVLVKGEPNISY-ICSRYYRAPELI----FGATEYTTAVDIWSVGCVLAELLLGQPLFPG 262
           K+   G    S  + +  Y +PE++     G  +Y    D WS+G  + E+L G+  F  
Sbjct: 240 KMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 299
Query: 263 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIFHKRMPPEAVDLVS 321
           ES V+   +I+                N+ E F+FP   +H         +  EA DL+ 
Sbjct: 300 ESLVETYGKIM----------------NHEERFQFP---SHV------TDVSEEAKDLIQ 334
Query: 322 RLL-QYSPNLRCTALEAC-IHPFFDELRDPNAR 352
           RL+      L    +E    H FF+ L   N R
Sbjct: 335 RLICSRERRLGQNGIEDFKKHAFFEGLNWENIR 367

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 8/132 (6%)
Query: 149 SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA- 207
           S+   ++P    + Y  ++  A+  IH  +   HRDIKP N+L++ + H ++L DFGS  
Sbjct: 166 SKFEDKLPEDMARFYIGEMVLAIDSIHQ-LHYVHRDIKPDNVLLDVNGH-IRLADFGSCL 223
Query: 208 KVLVKGEPNISY-ICSRYYRAPELI----FGATEYTTAVDIWSVGCVLAELLLGQPLFPG 262
           K+   G    S  + +  Y +PE++     G  +Y    D WS+G  + E+L G+  F  
Sbjct: 224 KMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 283
Query: 263 ESGVDQLVEIIK 274
           ES V+   +I+ 
Sbjct: 284 ESLVETYGKIMN 295

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 51/202 (25%)
Query: 97  RVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           R +G+G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 37  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 147 --------HYSRASQRMPLIYVKL-------------------YTYQICRALAYIHGGIG 179
                       AS ++ + YV L                   +  QIC  +AY+H    
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHY 155
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPELIF 232
           + HRD+  +N+L++ +   VK+ DFG AK + +G       E   S +   ++ APE + 
Sbjct: 156 I-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV---FWYAPECL- 209
Query: 233 GATEYTTAVDIWSVGCVLAELL 254
              ++  A D+WS G  L ELL
Sbjct: 210 KEYKFYYASDVWSFGVTLYELL 231

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 111/301 (36%), Gaps = 66/301 (21%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            Y  + V+G G+  +V  A C    E VAIK++  +K   +     +E+Q M    HPN+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 147 --HYSRASQRMPLIYV-KLYT-------------------------------YQICRALA 172
             +Y+    +  L  V KL +                                ++   L 
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 130
Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG------EPNISYICSRYYR 226
           Y+H   G  HRD+K  N+L+      V++ DFG +  L  G      +   +++ +  + 
Sbjct: 131 YLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 188
Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
           APE++     Y    DIWS G    EL  G    P        V ++ +   P       
Sbjct: 189 APEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDP------- 239
Query: 287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
                     P ++     K   K+       ++S  LQ  P  R TA E   H FF + 
Sbjct: 240 ----------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 289
Query: 347 R 347
           +
Sbjct: 290 K 290

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV- 146
           ERV+G G FG V   +    G+    VAIK +      K R     E   M   DHPNV 
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 147 HYSRASQR-MPLIYV------------------KLYTYQICRALAYIHGGI------GVC 181
           H      R  P++ V                  +    Q+   L  I  G+      G  
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYV 167
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +       + APE I    +
Sbjct: 168 HRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTAPEAI-QYRK 224
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G V+ E++
Sbjct: 225 FTSASDVWSYGIVMWEVM 242

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 20  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 75
Query: 147 --------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                               H+  AS+ +  +  +     Q  R + Y+H    + HRD+
Sbjct: 76  YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDL 134
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF--GATEYTTA 240
           K  N+ ++   + VK+ DFG A V  +   +  +     S  + APE+I    +  Y+  
Sbjct: 135 KSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 194 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----H 147
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 87
Query: 148 YSRASQRMPL--------IYVKLYTY--------------QICRALAYIHGGIGVCHRDI 185
           YS A Q   +        +Y  L+                Q  R + Y+H    + HRD+
Sbjct: 88  YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDL 146
Query: 186 KPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF--GATEYTTA 240
           K  N+ ++   + VK+ DFG A  K    G      +  S  + APE+I    +  Y+  
Sbjct: 147 KSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           + YQ+ + + ++     V HRD+  +N+LV  H   VK+CDFG A+ ++     +    +
Sbjct: 177 FAYQVAKGMEFLEFKSCV-HRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNA 234
Query: 223 RY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
           R    + APE +F    YT   D+WS G +L E+  LG   +PG
Sbjct: 235 RLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 136
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 195
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 244 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 136
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 195
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 244 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 135
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 194
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 195 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 242
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 243 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 135
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 194
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 195 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 242
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 243 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 136
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 195
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 244 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 51/201 (25%)
Query: 97  RVVGQGSFGIVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNV-- 146
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++  
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 147 -----------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                   + +  +  + L  + LY YQ+  ALAY+     V H
Sbjct: 76  LIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV-H 134
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVL--------VKGEPNISYICSRYYRAPELIFGA 234
           RDI  +N+LV+ +   VKL DFG ++ +         KG+  I ++      APE I   
Sbjct: 135 RDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTXXKASKGKLPIKWM------APESI-NF 186
Query: 235 TEYTTAVDIWSVGCVLAELLL 255
             +T+A D+W  G  + E+L+
Sbjct: 187 RRFTSASDVWMFGVCMWEILM 207

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 136
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 195
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 244 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 136
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 195
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 244 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 136
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 195
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 244 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 46/217 (21%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVH 147
           ++   ++GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+ 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 148 YSRASQRMPLIYVKLYTYQIC------------------------RALAYIHGGI----- 178
              A +       K+   + C                          L  + GG+     
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 179 -GVCHRDIKPQNLL--VNPHTHQV-KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 234
            G+ HR+IKP N++  +      V KL DFG+A+ L   E  +S   +  Y  P++   A
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 235 T-------EYTTAVDIWSVGCVLAELLLGQ-PLFPGE 263
                   +Y   VD+WS+G        G  P  P E
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 136
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 195
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 244 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 52/203 (25%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNV------ 146
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+      
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG-GIGVCH 182
                                  H S A +++         Y + + + Y+H     + H
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATE 236
           RD+K  NLLV+   + VK+CDFG +++         ++ S+       + APE++     
Sbjct: 163 RDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWMAPEVLRDEPS 216
Query: 237 YTTAVDIWSVGCVLAEL-LLGQP 258
              + D++S G +L EL  L QP
Sbjct: 217 NEKS-DVYSFGVILWELATLQQP 238

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/322 (21%), Positives = 119/322 (36%), Gaps = 91/322 (28%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-------- 133
           G +G   Q   Y  +  +G+GS+G+V  A   E   T    KVL  K+   +        
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYN-ENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 134 -----------------------ELQTMRLLDHPNV-------------HYSRASQRM-- 155
                                  E+  ++ LDHPNV             H     + +  
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 156 -PLIYV-----------KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 203
            P++ V           + Y   + + + Y+H    + HRDIKP NLLV    H +K+ D
Sbjct: 123 GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGH-IKIAD 180
Query: 204 FGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEYTT--AVDIWSVGCVLAELLLGQPLF 260
           FG +      +  +S  + +  + APE +    +  +  A+D+W++G  L   + GQ  F
Sbjct: 181 FGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 261 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLV 320
                                E I C++         +IK+          +  +  DL+
Sbjct: 241 -------------------MDERIMCLH--------SKIKSQALEFPDQPDIAEDLKDLI 273
Query: 321 SRLLQYSPNLRCTALEACIHPF 342
           +R+L  +P  R    E  +HP+
Sbjct: 274 TRMLDKNPESRIVVPEIKLHPW 295

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 44/199 (22%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNV---- 146
           +G+G FG+V++     T  TVA+KK+         + K+  ++E++ M    H N+    
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHG------------------GIGVCH------ 182
            +S     + L+YV +    +   L+ + G                  GI   H      
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTT 239
           RDIK  N+L++      K+ DFG A+   K    +     + +  Y APE + G  E T 
Sbjct: 157 RDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRG--EITP 213
Query: 240 AVDIWSVGCVLAELLLGQP 258
             DI+S G VL E++ G P
Sbjct: 214 KSDIYSFGVVLLEIITGLP 232

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 44/199 (22%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNV---- 146
           +G+G FG+V++     T  TVA+KK+         + K+  ++E++ M    H N+    
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHG------------------GIGVCH------ 182
            +S     + L+YV +    +   L+ + G                  GI   H      
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTT 239
           RDIK  N+L++      K+ DFG A+   K    +     + +  Y APE + G  E T 
Sbjct: 157 RDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRG--EITP 213
Query: 240 AVDIWSVGCVLAELLLGQP 258
             DI+S G VL E++ G P
Sbjct: 214 KSDIYSFGVVLLEIITGLP 232

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 136
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 195
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 244 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 39/199 (19%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPN-VHYSRASQR 154
           +G G FG V++    +   TVA+K + +D        +E   M+ + HPN V       R
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 155 MPLIYV--KLYTY-------------------------QICRALAYIHGGIGVCHRDIKP 187
            P  Y+  +  TY                         QI  A+ Y+       HRD+  
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAA 137
Query: 188 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAVDIW 244
           +N LV  + H VK+ DFG ++ L+ G+   ++  +++   + APE +    +++   D+W
Sbjct: 138 RNCLVGEN-HLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 194
Query: 245 SVGCVLAEL-LLGQPLFPG 262
           + G +L E+   G   +PG
Sbjct: 195 AFGVLLWEIATYGMSPYPG 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 87
Query: 147 --------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                               H+  AS+ +  +  +     Q  R + Y+H    + HRD+
Sbjct: 88  YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDL 146
Query: 186 KPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF--GATEYTTA 240
           K  N+ ++   + VK+ DFG A  K    G      +  S  + APE+I    +  Y+  
Sbjct: 147 KSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 136
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 195
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 244 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 136
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIV-NYEPLG 195
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 244 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H  + + 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 136
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 195
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 244 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 44/199 (22%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNV---- 146
           +G+G FG+V++     T  TVA+KK+         + K+  ++E++ M    H N+    
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHG------------------GIGV------CH 182
            +S     + L+YV +    +   L+ + G                  GI         H
Sbjct: 91  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 150
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTT 239
           RDIK  N+L++      K+ DFG A+   K    +     + +  Y APE + G  E T 
Sbjct: 151 RDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG--EITP 207
Query: 240 AVDIWSVGCVLAELLLGQP 258
             DI+S G VL E++ G P
Sbjct: 208 KSDIYSFGVVLLEIITGLP 226

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 147 -HYSRASQRMPLIYV-------KLYTY-----------------QICRALAYIHGGIGVC 181
             +     +  +I +       +L+ +                 QI   + Y+H  + + 
Sbjct: 78  TLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIA 136
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE++       
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLG 195
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F G++  + L  +              +N  + +  F  
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNYEFEDEYFSN 243
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             A              A D + RLL   P  R T  ++  HP+
Sbjct: 244 TSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
                 ++  P++ V  Y                    Q+   L  I  G+      G  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y          + +PE I    +
Sbjct: 170 HRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 226
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 227 FTSASDVWSYGIVLWEVM 244

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 33/189 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPN-VHYSRASQRMPL 157
           +G+GSFG V + +  +TG   A+KKV + + ++  EL     L  P  V    A +  P 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAVREGPW 159
Query: 158 IYV-----------KLYTYQIC----RALAYIHGGIG---------VCHRDIKPQNLLVN 193
           + +           +L   Q C    RAL Y+   +          + H D+K  N+L++
Sbjct: 160 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 219
Query: 194 PHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEYTTAVDIWSVG 247
                  LCDFG A  L       S +   Y      + APE++ G +     VD+WS  
Sbjct: 220 SDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSSC 278
Query: 248 CVLAELLLG 256
           C++  +L G
Sbjct: 279 CMMLHMLNG 287

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 31/216 (14%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISY 219
           +  QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G    + 
Sbjct: 120 FIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
             +  + APE++          D+WS+G +   LL G   F G++  + L  I  V    
Sbjct: 179 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV---- 233
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
                                ++ + + F  +    A D + +LL      R T  EA  
Sbjct: 234 ---------------------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 340 HPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASK 375
           HP+   + +  A +        L NF+ Q ++  SK
Sbjct: 273 HPWITPVDNQQA-MVRRESVVNLENFRKQYVRRRSK 307

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 74/176 (42%), Gaps = 30/176 (17%)
Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPH--THQVKLCDFGSAKVLVKGEPNISYICSR 223
           QI   + Y+H    + H D+KPQN+L++       +K+ DFG ++ +         + + 
Sbjct: 139 QILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 283
            Y APE I      TTA D+W++G +   LL     F GE   +  + I +V        
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-------- 248
Query: 284 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
               N +Y+E  F  +                A D +  LL  +P  R TA E C+
Sbjct: 249 ----NVDYSEETFSSVSQL-------------ATDFIQSLLVKNPEKRPTA-EICL 286

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVH 147
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN+ 
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
           +     ++  P++ +  Y                    Q+   L  I  G+         
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAV 153
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + APE I    +
Sbjct: 154 HRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAPEAI-AYRK 210
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G V+ E++
Sbjct: 211 FTSASDVWSYGIVMWEVM 228

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 31/216 (14%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISY 219
           +  QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G    + 
Sbjct: 120 FIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
             +  + APE++          D+WS+G +   LL G   F G++  + L  I  V    
Sbjct: 179 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---- 233
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
                                ++ + + F       A D + +LL      R T  EA  
Sbjct: 234 ---------------------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 340 HPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASK 375
           HP+   + +  A +        L NF+ Q ++  SK
Sbjct: 273 HPWITPVDNQQA-MVRRESVVNLENFRKQYVRRRSK 307

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 77/180 (42%), Gaps = 20/180 (11%)
Query: 149 SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 208
           S   +R P+     Y  Q+   L Y+H   G+ H+DIKP NLL+      +K+   G A+
Sbjct: 100 SVPEKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTT-GGTLKISALGVAE 157
Query: 209 VL---VKGEPNISYICSRYYRAPELIFGATEYTT-AVDIWSVGCVLAELLLGQPLFPGES 264
            L      +   +   S  ++ PE+  G   ++   VDIWS G  L  +  G   F G++
Sbjct: 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
Query: 265 GVDQLVEIIKV--------LGTPTREEIKCM--NPNYTEFKFPQIKAHPWHKIFHKRMPP 314
            + +L E I           G P  + +K M        F   QI+ H W   F K+ PP
Sbjct: 218 -IYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW---FRKKHPP 273

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 78/190 (41%), Gaps = 35/190 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPN-VHYSRASQRMPL 157
           VG+GSFG V + K  +TG   A+KKV + + ++  EL     L  P  V    A +  P 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 124
Query: 158 IYVKL-------------------------YTYQICRALAYIHGGIGVCHRDIKPQNLLV 192
           + + +                         Y  Q    L Y+H    + H D+K  N+L+
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-ILHGDVKADNVLL 183
Query: 193 NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEYTTAVDIWSV 246
           +    +  LCDFG A  L       S +   Y      + APE++ G       VDIWS 
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 242
Query: 247 GCVLAELLLG 256
            C++  +L G
Sbjct: 243 CCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 78/190 (41%), Gaps = 35/190 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPN-VHYSRASQRMPL 157
           VG+GSFG V + K  +TG   A+KKV + + ++  EL     L  P  V    A +  P 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 140
Query: 158 IYVKL-------------------------YTYQICRALAYIHGGIGVCHRDIKPQNLLV 192
           + + +                         Y  Q    L Y+H    + H D+K  N+L+
Sbjct: 141 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-ILHGDVKADNVLL 199
Query: 193 NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEYTTAVDIWSV 246
           +    +  LCDFG A  L       S +   Y      + APE++ G       VDIWS 
Sbjct: 200 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 258
Query: 247 GCVLAELLLG 256
            C++  +L G
Sbjct: 259 CCMMLHMLNG 268

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
                 ++  P++ V  Y                    Q+   L  I  G+      G  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFV 169
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +PE I    +
Sbjct: 170 HRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 226
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 227 FTSASDVWSYGIVLWEVM 244

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 46/217 (21%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVH 147
           ++   ++GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+ 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 148 YSRASQRMPLIYVKLYTYQIC------------------------RALAYIHGGI----- 178
              A +       K+   + C                          L  + GG+     
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 179 -GVCHRDIKPQNLL--VNPHTHQV-KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 234
            G+ HR+IKP N++  +      V KL DFG+A+ L   E  +    +  Y  P++   A
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERA 190
Query: 235 T-------EYTTAVDIWSVGCVLAELLLGQ-PLFPGE 263
                   +Y   VD+WS+G        G  P  P E
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/309 (22%), Positives = 116/309 (37%), Gaps = 67/309 (21%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPN--- 145
           +G G F IV + +   TG   A K  K  Q +  +         RE+  +R + HPN   
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 146 ---VHYSRASQRMPLIYV---KLYTY-----------------QICRALAYIHGGIGVCH 182
              V+ +R    + L  V   +L+ +                 QI   + Y+H    + H
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK-KIAH 138
Query: 183 RDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
            D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE++        
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-NYEPLGL 197
Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
             D+WS+G +   LL G   F G++  + L  I  V                        
Sbjct: 198 EADMWSIGVITYILLSGASPFLGDTKQETLANITAV------------------------ 233
Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPF 359
            ++ + + F  +    A D + +LL      R T  EA  HP+   + D    +      
Sbjct: 234 -SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV-DTQQAMVRRESV 291
Query: 360 PPLFNFKPQ 368
             L NFK Q
Sbjct: 292 VNLENFKKQ 300

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 65/126 (51%), Gaps = 13/126 (10%)
Query: 141 LDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK 200
           LDHP+    RA     LI    + +QI + + Y+   + + HRD+  +N+LV     ++K
Sbjct: 139 LDHPD---ERALTMGDLIS---FAWQISQGMQYL-AEMSLVHRDLAARNILV-AEGRKMK 190
Query: 201 LCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LG 256
           + DFG ++ + + +  +     R    + A E +F    YTT  D+WS G +L E++ LG
Sbjct: 191 ISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLG 249
Query: 257 QPLFPG 262
              +PG
Sbjct: 250 GNPYPG 255

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVH 147
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN+ 
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 148 YSRA--SQRMPLIYVKLYT---------------YQICRALAYIHG-GIGV--------C 181
           +     ++  P++ +  Y                + + + +  + G G G+         
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 138
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + APE I    +
Sbjct: 139 HRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAPEAI-AYRK 195
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G V+ E++
Sbjct: 196 FTSASDVWSYGIVMWEVM 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVH 147
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN+ 
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 148 YSRA--SQRMPLIYVKLYT---------------YQICRALAYIHG-GIGV--------C 181
           +     ++  P++ +  Y                + + + +  + G G G+         
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 132
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + APE I    +
Sbjct: 133 HRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAPEAI-AYRK 189
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G V+ E++
Sbjct: 190 FTSASDVWSYGIVMWEVM 207

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 162 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 220
            YT QI   L ++H    + +RD+KP+N+L++   + V++ D G A  L  G+     Y 
Sbjct: 293 FYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA 350
Query: 221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL 254
            +  + APEL+ G  EY  +VD +++G  L E++
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 162 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 220
            YT QI   L ++H    + +RD+KP+N+L++   + V++ D G A  L  G+     Y 
Sbjct: 293 FYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA 350
Query: 221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL 254
            +  + APEL+ G  EY  +VD +++G  L E++
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 162 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 220
            YT QI   L ++H    + +RD+KP+N+L++   + V++ D G A  L  G+     Y 
Sbjct: 293 FYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA 350
Query: 221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL 254
            +  + APEL+ G  EY  +VD +++G  L E++
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
                 ++  P++ V  Y                    Q+   L  I  G+      G  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +PE I    +
Sbjct: 170 HRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 226
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 227 FTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
                 ++  P++ V  Y                    Q+   L  I  G+      G  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +PE I    +
Sbjct: 170 HRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 226
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 227 FTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
                 ++  P++ V  Y                    Q+   L  I  G+      G  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +PE I    +
Sbjct: 170 HRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 226
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 227 FTSASDVWSYGIVLWEVM 244

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/284 (21%), Positives = 108/284 (38%), Gaps = 68/284 (23%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNV- 146
           +G G F IV + +   TG+  A  K ++ +R  +           RE+  +R + HPN+ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 147 --HYSRASQRMPLIYVKL-----------------------YTYQICRALAYIHGGIGVC 181
             H    ++   ++ ++L                       +  QI   + Y+H    + 
Sbjct: 79  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK-RIA 137
Query: 182 HRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE++       
Sbjct: 138 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV-NYEPLG 196
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G +   LL G   F GE+  + L              I  +N ++ E  F  
Sbjct: 197 LEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNYDFDEEYFSN 244
Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                            A D + RLL   P  R    ++  H +
Sbjct: 245 -------------TSELAKDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 65/126 (51%), Gaps = 13/126 (10%)
Query: 141 LDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK 200
           LDHP+    RA     LI    + +QI + + Y+   + + HRD+  +N+LV     ++K
Sbjct: 139 LDHPD---ERALTMGDLIS---FAWQISQGMQYL-AEMKLVHRDLAARNILV-AEGRKMK 190
Query: 201 LCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LG 256
           + DFG ++ + + +  +     R    + A E +F    YTT  D+WS G +L E++ LG
Sbjct: 191 ISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLG 249
Query: 257 QPLFPG 262
              +PG
Sbjct: 250 GNPYPG 255

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
                 ++  P++ V  Y                    Q+   L  I  G+      G  
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 157
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +PE I    +
Sbjct: 158 HRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 214
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 215 FTSASDVWSYGIVLWEVM 232

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
                 ++  P++ V  Y                    Q+   L  I  G+      G  
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 167
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +PE I    +
Sbjct: 168 HRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 224
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 225 FTSASDVWSYGIVLWEVM 242

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
                 ++  P++ V  Y                    Q+   L  I  G+      G  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +PE I    +
Sbjct: 170 HRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 226
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 227 FTSASDVWSYGIVLWEVM 244

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
                 ++  P++ V  Y                    Q+   L  I  G+      G  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y          + +PE I    +
Sbjct: 170 HRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 226
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 227 FTSASDVWSYGIVLWEVM 244

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 162 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 220
            YT QI   L ++H    + +RD+KP+N+L++   + V++ D G A  L  G+     Y 
Sbjct: 293 FYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA 350
Query: 221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL 254
            +  + APEL+ G  EY  +VD +++G  L E++
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 YSRA--SQRMPLIYV------------------KLYTYQICRALAYIHGGI------GVC 181
                 ++  P++ V                  +    Q+   L  I  G+      G  
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAV 169
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +PE I    +
Sbjct: 170 HRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 226
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 227 FTSASDVWSYGIVLWEVM 244

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 148 YSRA--SQRMPLIYVKLY------------------TYQICRALAYIHGGI------GVC 181
                 ++  P++ V  Y                    Q+   L  I  G+      G  
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 140
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +PE I    +
Sbjct: 141 HRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 197
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 198 FTSASDVWSYGIVLWEVM 215

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 78/190 (41%), Gaps = 35/190 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPN-VHYSRASQRMPL 157
           +G+GSFG V + K  +TG   A+KKV + + ++  EL     L  P  V    A +  P 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 138
Query: 158 IYVKL-------------------------YTYQICRALAYIHGGIGVCHRDIKPQNLLV 192
           + + +                         Y  Q    L Y+H    + H D+K  N+L+
Sbjct: 139 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-ILHGDVKADNVLL 197
Query: 193 NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEYTTAVDIWSV 246
           +    +  LCDFG A  L       S +   Y      + APE++ G       VDIWS 
Sbjct: 198 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 256
Query: 247 GCVLAELLLG 256
            C++  +L G
Sbjct: 257 CCMMLHMLNG 266

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 33/189 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPN-VHYSRASQRMPL 157
           +G+GSFG V + +  +TG   A+KKV + + ++  EL     L  P  V    A +  P 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAVREGPW 140
Query: 158 IYV-----------KLYTYQIC----RALAYIHGGIG---------VCHRDIKPQNLLVN 193
           + +           +L   Q C    RAL Y+   +          + H D+K  N+L++
Sbjct: 141 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 200
Query: 194 PHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEYTTAVDIWSVG 247
                  LCDFG A  L         +   Y      + APE++ G +     VD+WS  
Sbjct: 201 SDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSSC 259
Query: 248 CVLAELLLG 256
           C++  +L G
Sbjct: 260 CMMLHMLNG 268

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 65/126 (51%), Gaps = 13/126 (10%)
Query: 141 LDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK 200
           LDHP+    RA     LI    + +QI + + Y+   + + HRD+  +N+LV     ++K
Sbjct: 139 LDHPD---ERALTMGDLIS---FAWQISQGMQYL-AEMKLVHRDLAARNILV-AEGRKMK 190
Query: 201 LCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LG 256
           + DFG ++ + + +  +     R    + A E +F    YTT  D+WS G +L E++ LG
Sbjct: 191 ISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLG 249
Query: 257 QPLFPG 262
              +PG
Sbjct: 250 GNPYPG 255

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------PNIS 218
           QI  A+ ++H   G+ HRD+KP N+        VK+ DFG    + + E       P  +
Sbjct: 172 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 219 Y------ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL 254
           Y      + ++ Y +PE I G   Y+  VDI+S+G +L ELL
Sbjct: 230 YATHXGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL 270

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 51/202 (25%)
Query: 97  RVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           R +G+G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 147 --------HYSRASQRMPLIYVKL-------------------YTYQICRALAYIHGGIG 179
                        S ++ + YV L                   +  QIC  +AY+H    
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHY 138
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YYRAPELIF 232
           + HR++  +N+L++ +   VK+ DFG AK + +G     Y   R       ++ APE + 
Sbjct: 139 I-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAPECL- 192
Query: 233 GATEYTTAVDIWSVGCVLAELL 254
              ++  A D+WS G  L ELL
Sbjct: 193 KEYKFYYASDVWSFGVTLYELL 214

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 51/202 (25%)
Query: 97  RVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           R +G+G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 147 --------HYSRASQRMPLIYVKL-------------------YTYQICRALAYIHGGIG 179
                        S ++ + YV L                   +  QIC  +AY+H    
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHY 138
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YYRAPELIF 232
           + HR++  +N+L++ +   VK+ DFG AK + +G     Y   R       ++ APE + 
Sbjct: 139 I-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAPECL- 192
Query: 233 GATEYTTAVDIWSVGCVLAELL 254
              ++  A D+WS G  L ELL
Sbjct: 193 KEYKFYYASDVWSFGVTLYELL 214

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 45/85 (52%), Gaps = 4/85 (4%)
Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFG--SAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
            HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T
Sbjct: 156 THRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHAT 213
Query: 239 TAVDIWSVGCVLAELLLGQPLFPGE 263
              DI+++ CVL E L G P + G+
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD 238

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 82/209 (39%), Gaps = 31/209 (14%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISY 219
           +  QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G    + 
Sbjct: 120 FIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
             +  + APE++          D+WS+G +   LL G   F G++  + L  I  V    
Sbjct: 179 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV---- 233
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
                                ++ + + F  +    A D + +LL      R T  EA  
Sbjct: 234 ---------------------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 340 HPFFDELRDPNARLPNGRPFPPLFNFKPQ 368
           HP+   + +  A +        L NF+ Q
Sbjct: 273 HPWITPVDNQQA-MVRRESVVNLENFRKQ 300

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 72/179 (40%), Gaps = 46/179 (25%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRY 224
           I  A+ Y+H  I + HRD+KP+NLL         +KL DFG AK    GE          
Sbjct: 126 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE---------- 173
Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
                      +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +
Sbjct: 174 -----------KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 216
Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 217 -------GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 YSRA--SQRMPLIYV------------------KLYTYQICRALAYIHGGI------GVC 181
                 ++  P++ V                  +    Q+   L  I  G+      G  
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +PE I    +
Sbjct: 170 HRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 226
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 227 FTSASDVWSYGIVLWEVM 244

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 72/183 (39%), Gaps = 30/183 (16%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISY 219
           +  QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G    + 
Sbjct: 120 FIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
             +  + APE++          D+WS+G +   LL G   F G++  + L  I  V    
Sbjct: 179 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---- 233
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
                                ++ + + F       A D + +LL      R T  EA  
Sbjct: 234 ---------------------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 340 HPF 342
           HP+
Sbjct: 273 HPW 275

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 148 YSRA--SQRMPLIYV------------------KLYTYQICRALAYIHGGI------GVC 181
                 ++  P++ V                  +    Q+   L  I  G+      G  
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 140
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE 236
           HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +PE I    +
Sbjct: 141 HRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSPEAI-AYRK 197
Query: 237 YTTAVDIWSVGCVLAELL 254
           +T+A D+WS G VL E++
Sbjct: 198 FTSASDVWSYGIVLWEVM 215

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 81/209 (38%), Gaps = 31/209 (14%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISY 219
           +  QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G    + 
Sbjct: 120 FIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
             +  + APE++          D+WS+G +   LL G   F G++  + L  I  V    
Sbjct: 179 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---- 233
Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
                                ++ + + F       A D + +LL      R T  EA  
Sbjct: 234 ---------------------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 340 HPFFDELRDPNARLPNGRPFPPLFNFKPQ 368
           HP+   + +  A +        L NF+ Q
Sbjct: 273 HPWITPVDNQQA-MVRRESVVNLENFRKQ 300

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 51/204 (25%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNRELQTMRL--LDHPNV-HYSRASQ 153
           V  +G FG V++A+ L   E VA+K   +QDK+    E +   L  + H N+  +  A +
Sbjct: 31  VKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 154 RMPLIYVKLYTY---------------------QIC-------RALAYIHGGI------- 178
           R   + V L+                       ++C       R LAY+H  I       
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 179 --GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFG 233
              + HRDIK +N+L+  +     + DFG A     G+        + +R Y APE++ G
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTAC-IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 234 ATEYTTA----VDIWSVGCVLAEL 253
           A  +       +D++++G VL EL
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 82/199 (41%), Gaps = 42/199 (21%)
Query: 96  ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVH 147
           E+V+G G FG V        G+    VAIK +      K R     E   M   DHPNV 
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 148 YSRA--SQRMPLIYV------------------KLYTYQICRALAYIHGGI------GVC 181
           +     ++  P++ +                  +    Q+   L  I  G+         
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRAPELIFGAT 235
           HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + APE I    
Sbjct: 158 HRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-QYR 215
Query: 236 EYTTAVDIWSVGCVLAELL 254
           ++T+A D+WS G V+ E++
Sbjct: 216 KFTSASDVWSYGIVMWEVM 234

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 51/202 (25%)
Query: 97  RVVGQGSFGIVFQAKCLE-----TGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 146
           R +G+G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 15  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 147 --------HYSRASQRMPLIYVKL-------------------YTYQICRALAYIHGGIG 179
                        S ++ + YV L                   +  QIC  +AY+H    
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHY 133
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YYRAPELIF 232
           + HR +  +N+L++ +   VK+ DFG AK + +G     Y   R       ++ APE + 
Sbjct: 134 I-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAPECL- 187
Query: 233 GATEYTTAVDIWSVGCVLAELL 254
              ++  A D+WS G  L ELL
Sbjct: 188 KECKFYYASDVWSFGVTLYELL 209

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 141
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 142 HRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 199
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 139
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 140 HRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 197
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 198 HQSDVWSYGVTVWELM 213

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 146
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 147 HRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 204
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 205 HQSDVWSYGVTVWELM 220

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 51/202 (25%)
Query: 97  RVVGQGSFGIVFQAKCLE-----TGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 146
           R +G+G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 14  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 147 --------HYSRASQRMPLIYVKL-------------------YTYQICRALAYIHGGIG 179
                        S ++ + YV L                   +  QIC  +AY+H    
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHY 132
Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YYRAPELIF 232
           + HR +  +N+L++ +   VK+ DFG AK + +G     Y   R       ++ APE + 
Sbjct: 133 I-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAPECL- 186
Query: 233 GATEYTTAVDIWSVGCVLAELL 254
              ++  A D+WS G  L ELL
Sbjct: 187 KECKFYYASDVWSFGVTLYELL 208

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 43/205 (20%)
Query: 91  ISYMA-ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLL 141
           +SY+  E V+G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 142 DHPNVHYSRA--SQRMPLIYV------------------KLYTYQICRALAYIHGGI--- 178
           +HPN+       +  MP++ +                  +    Q+   L  I  G+   
Sbjct: 73  EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL 132
Query: 179 ---GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRAPE 229
                 HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S        + APE
Sbjct: 133 AEMSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 230 LIFGATEYTTAVDIWSVGCVLAELL 254
            I    ++T+A D WS G V+ E++
Sbjct: 192 AI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 44/209 (21%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ--------------- 136
           ++  + ++G+G FG V++ + L  G  VA+K+ L+++R +  ELQ               
Sbjct: 31  NFXNKNILGRGGFGKVYKGR-LADGXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 137 -----------TMRLLDHPNVH--------YSRASQRMPLIYVKLYTYQI--CRALAYIH 175
                      T RLL +P +           R   + PL + K     +   R LAY+H
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 176 GGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--YRAPELI 231
                 + HRD+K  N+L++     V + DFG AK++   + ++         + APE +
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYL 207
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLF 260
               + +   D++  G +L EL+ GQ  F
Sbjct: 208 -STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 139
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 140 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 197
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 198 HQSDVWSYGVTVWELM 213

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 82/198 (41%), Gaps = 44/198 (22%)
Query: 100 GQGSFGIVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNV----H 147
           G+G FG+V++     T  TVA+KK+         + K+  ++E++      H N+     
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 148 YSRASQRMPLIYVK------------------LYTYQICRALAYIHGGIGV------CHR 183
           +S     + L+YV                   L  +  C+       GI         HR
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTA 240
           DIK  N+L++      K+ DFG A+   K    +     + +  Y APE + G  E T  
Sbjct: 149 DIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRG--EITPK 205
Query: 241 VDIWSVGCVLAELLLGQP 258
            DI+S G VL E++ G P
Sbjct: 206 SDIYSFGVVLLEIITGLP 223

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 44/209 (21%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ--------------- 136
           ++  + ++G+G FG V++ + L  G  VA+K+ L+++R +  ELQ               
Sbjct: 39  NFSNKNILGRGGFGKVYKGR-LADGTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 137 -----------TMRLLDHPNVH--------YSRASQRMPLIYVKLYTYQI--CRALAYIH 175
                      T RLL +P +           R   + PL + K     +   R LAY+H
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 156
Query: 176 GGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--YRAPELI 231
                 + HRD+K  N+L++     V + DFG AK++   + ++         + APE +
Sbjct: 157 DHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYL 215
Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLF 260
               + +   D++  G +L EL+ GQ  F
Sbjct: 216 -STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--- 223
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S    
Sbjct: 156 IAAGMKYL-ANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKI 212
Query: 224 --YYRAPELIFGATEYTTAVDIWSVGCVLAELL 254
              + APE I    ++T+A D+WS G V+ E++
Sbjct: 213 PIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 142
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 143 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 200
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 201 HQSDVWSYGVTVWELM 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 106 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 164
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 165 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 222
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 223 HQSDVWSYGVTVWELM 238

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 142
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 143 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 200
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 201 HQSDVWSYGVTVWELM 216

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           ++ Q+ + +A++       HRD+  +N+L+  + H  K+ DFG A+ ++     I    +
Sbjct: 165 FSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 223 RY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 223 RLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           ++ Q+ + +A++       HRD+  +N+L+  + H  K+ DFG A+ ++     I    +
Sbjct: 163 FSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNA 220
Query: 223 RY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 221 RLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 14/138 (10%)
Query: 129 RYKNRELQTMRLLDHPNVHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQ 188
           R K+R L+T       N   S AS R  L     ++ Q+ + +A++       HRD+  +
Sbjct: 142 RRKSRVLETDPAFAIAN---STASTRDLL----HFSSQVAQGMAFL-ASKNCIHRDVAAR 193
Query: 189 NLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAVDIWS 245
           N+L+  + H  K+ DFG A+ ++     I    +R    + APE IF    YT   D+WS
Sbjct: 194 NVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWS 251
Query: 246 VGCVLAELL-LGQPLFPG 262
            G +L E+  LG   +PG
Sbjct: 252 YGILLWEIFSLGLNPYPG 269

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 142
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 143 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 200
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 201 HQSDVWSYGVTVWELM 216

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           ++ Q+ + +A++       HRD+  +N+L+  + H  K+ DFG A+ ++     I    +
Sbjct: 157 FSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 223 RY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 215 RLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           ++ Q+ + +A++       HRD+  +N+L+  + H  K+ DFG A+ ++     I    +
Sbjct: 171 FSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNA 228
Query: 223 RY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 229 RLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 91  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 149
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 150 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 207
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 208 HQSDVWSYGVTVWELM 223

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 141
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 142 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 199
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 87  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 145
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 146 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 203
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 204 HQSDVWSYGVTVWELM 219

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 139
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 140 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 197
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 198 HQSDVWSYGVTVWELM 213

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           ++ Q+ + +A++       HRD+  +N+L+  + H  K+ DFG A+ ++     I    +
Sbjct: 169 FSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 223 RY---YRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 227 RLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 146
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 147 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 204
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 205 HQSDVWSYGVTVWELM 220

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNV- 146
           +V+G G+FG V++   +  GETV I    K+L +       ++       M  +DHP++ 
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV              +  QI + + Y+     + 
Sbjct: 104 RLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER-RLV 162
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG A++L   E   +    +    + A E I    ++T
Sbjct: 163 HRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH-YRKFT 220
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 221 HQSDVWSYGVTIWELM 236

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIF 232
           +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +Y  +       + APE I 
Sbjct: 170 LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 233 GATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
             T +++A D+WS G V+ E+L  G+  +   +  D +  +         E  +   P  
Sbjct: 228 FRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEGYRLPAPMG 278
Query: 292 TEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTA 334
                 Q+    WHK   +R    + V ++  L++   +LR TA
Sbjct: 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNV- 146
           +V+G G+FG V++   +  GETV I    K+L +       ++       M  +DHP++ 
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV              +  QI + + Y+     + 
Sbjct: 81  RLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER-RLV 139
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG A++L   E   +    +    + A E I    ++T
Sbjct: 140 HRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH-YRKFT 197
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 198 HQSDVWSYGVTIWELM 213

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----H 147
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 71
Query: 148 YSRASQ----------------------RMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
           YS A Q                      +  +I +     Q  + + Y+H    + HRD+
Sbjct: 72  YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDL 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE--YTTA 240
           K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I    +  Y+  
Sbjct: 131 KSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 75  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 133
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 134 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 191
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 192 HQSDVWSYGVTVWELM 207

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 139
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 140 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 197
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 198 HQSDVWSYGVTVWELM 213

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   + + R       N+E+      M  +D+P+V 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 115 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 173
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 174 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 231
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 232 HQSDVWSYGVTVWELM 247

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                          Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 83  RLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 141
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 142 HRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 199
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                          Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 83  RLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 141
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 142 HRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 199
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 43/197 (21%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNR------ELQTMRLLDH---- 143
           +V+G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH    
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 144 ------PNVHYSRASQRMPL----IYVKL------------YTYQICRALAYIHGGIGVC 181
                 P       +Q +PL     +V+             +  QI + + Y+    G+ 
Sbjct: 97  RLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH-GMV 155
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI-FGATEY 237
           HR++  +N+L+   + QV++ DFG A +L   +  + Y  ++    + A E I FG  +Y
Sbjct: 156 HRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG--KY 212
Query: 238 TTAVDIWSVGCVLAELL 254
           T   D+WS G  + EL+
Sbjct: 213 THQSDVWSYGVTVWELM 229

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                          Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 85  RLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 143
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 144 HRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 201
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 202 HQSDVWSYGVTVWELM 217

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                          Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 82  RLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 140
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 141 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 198
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 199 HQSDVWSYGVTVWELM 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                          Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 84  RLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 142
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 143 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 200
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 201 HQSDVWSYGVTVWELM 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                          Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 85  RLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 143
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 144 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 201
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 202 HQSDVWSYGVTVWELM 217

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI   + Y+     + 
Sbjct: 78  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR-RLV 136
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 137 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 194
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 195 HQSDVWSYGVTVWELM 210

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 43/197 (21%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNR------ELQTMRLLDH---- 143
           +V+G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH    
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 144 ------PNVHYSRASQRMPL----IYVKL------------YTYQICRALAYIHGGIGVC 181
                 P       +Q +PL     +V+             +  QI + + Y+    G+ 
Sbjct: 79  RLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH-GMV 137
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI-FGATEY 237
           HR++  +N+L+   + QV++ DFG A +L   +  + Y  ++    + A E I FG  +Y
Sbjct: 138 HRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG--KY 194
Query: 238 TTAVDIWSVGCVLAELL 254
           T   D+WS G  + EL+
Sbjct: 195 THQSDVWSYGVTVWELM 211

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                          Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 82  RLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 140
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 141 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 198
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 199 HQSDVWSYGVTVWELM 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                          Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 83  RLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 141
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 142 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 199
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                          Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 81  RLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 139
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 140 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 197
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 198 HQSDVWSYGVTVWELM 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 43  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 98
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                H      +  +I +     Q  + + Y+H    + HRD+
Sbjct: 99  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDL 157
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE--YTTA 240
           K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I    +  Y+  
Sbjct: 158 KSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 217 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 99
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                H      +  +I +     Q  + + Y+H    + HRD+
Sbjct: 100 YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDL 158
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE--YTTA 240
           K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I    +  Y+  
Sbjct: 159 KSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 81/196 (41%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV-------HYS 149
           +V+G G+FG V++   +  GE V I   ++  R          +LD   V       + S
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 150 R------------ASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
           R             +Q MP    L +V+             +  QI + ++Y+   + + 
Sbjct: 83  RLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED-VRLV 141
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG A++L   E        +    + A E I     +T
Sbjct: 142 HRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL-RRRFT 199
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 200 HQSDVWSYGVTVWELM 215

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 76
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                H      +  +I +     Q  + + Y+H    + HRD+
Sbjct: 77  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDL 135
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE--YTTA 240
           K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I    +  Y+  
Sbjct: 136 KSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 195 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 18  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 73
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                H      +  +I +     Q  + + Y+H    + HRD+
Sbjct: 74  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDL 132
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE--YTTA 240
           K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I    +  Y+  
Sbjct: 133 KSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 192 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 76
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                H      +  +I +     Q  + + Y+H    + HRD+
Sbjct: 77  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDL 135
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE--YTTA 240
           K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I    +  Y+  
Sbjct: 136 KSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 195 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 71
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                H      +  +I +     Q  + + Y+H    + HRD+
Sbjct: 72  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDL 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE--YTTA 240
           K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I    +  Y+  
Sbjct: 131 KSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 36  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 91
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                H      +  +I +     Q  + + Y+H    + HRD+
Sbjct: 92  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDL 150
Query: 186 KPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGATE--YTTA 240
           K  N+ ++     VK+ DFG A  K    G      +  S  + APE+I    +  Y+  
Sbjct: 151 KSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 210 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 146
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 147 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 204
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 205 HQSDVWSYGVTVWELM 220

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                         +Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 139
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 140 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 197
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 198 HQSDVWSYGVTVWELM 213

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 99
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                H      +  +I +     Q  + + Y+H    + HRD+
Sbjct: 100 YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDL 158
Query: 186 KPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGATE--YTTA 240
           K  N+ ++     VK+ DFG A  K    G      +  S  + APE+I    +  Y+  
Sbjct: 159 KSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 43/205 (20%)
Query: 91  ISYMA-ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLL 141
           +SY+  E V+G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 142 DHPNVHYSRA--SQRMPLIYV------------------KLYTYQICRALAYIHGGI--- 178
           +HPN+       +  MP++ +                  +    Q+   L  I  G+   
Sbjct: 75  EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL 134
Query: 179 ---GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRAPE 229
                 HRD+  +N+LVN +    K+ DFG ++ L +   + +   S        + APE
Sbjct: 135 AEMSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 230 LIFGATEYTTAVDIWSVGCVLAELL 254
            I    ++T+A D WS G V+ E++
Sbjct: 194 AI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 44/213 (20%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNV----- 146
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+     
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILLFMG 71
Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                H      +  +I +     Q  + + Y+H    + HRD+
Sbjct: 72  YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDL 130
Query: 186 KPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGATE--YTTA 240
           K  N+ ++     VK+ DFG A  K    G      +  S  + APE+I    +  Y+  
Sbjct: 131 KSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
            D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 122/306 (39%), Gaps = 87/306 (28%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNR------------------ 133
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R                  
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 134 ------------ELQTMRLLDHPNV-HYSRASQ--------RMPLIYVKL--YTYQICRA 170
                        L  M L+ H ++  Y R+ +        R P    ++     +I   
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRA 227
           +AY++    V HRD+  +N +V  H   VK+ DFG  + + + +        +    + A
Sbjct: 143 MAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
           PE +     +TT+ D+WS G VL E+  L +  + G S  +Q+++ +             
Sbjct: 201 PESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV------------- 245
Query: 287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC------IH 340
           M+  Y +         P         P    DL+    Q++PN+R T LE        +H
Sbjct: 246 MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLH 291
Query: 341 PFFDEL 346
           P F E+
Sbjct: 292 PSFPEV 297

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIF 232
           +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +   +       + APE I 
Sbjct: 170 LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAXTTTGGKIPIRWTAPEAIA 227
Query: 233 GATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
             T +++A D+WS G V+ E+L  G+  +   +  D +  +         E  +   P  
Sbjct: 228 FRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEGYRLPAPMG 278
Query: 292 TEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTA 334
                 Q+    WHK   +R    + V ++  L++   +LR TA
Sbjct: 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 76/346 (21%), Positives = 130/346 (37%), Gaps = 76/346 (21%)
Query: 98  VVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV--- 146
           V+G+G      V  A+   TGE V ++++  +        +   EL   +L +HPN+   
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 147 ----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                       H+      + + Y+      + +AL YIH  +
Sbjct: 76  RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIHH-M 131
Query: 179 GVCHRDIKPQNLLVNPH--------THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 230
           G  HR +K  ++L++             + +   G  + +V   P  S +    + +PE+
Sbjct: 132 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS-VKVLPWLSPEV 190
Query: 231 IFGATE-YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT--RE 282
           +    + Y    DI+SVG    EL  G   F        L+E +      +L T T   E
Sbjct: 191 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 250
Query: 283 EIKCMNPN------------YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           E+  M+P+             T    P     P H  +H+   P     V + LQ +P+ 
Sbjct: 251 EL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHP-YHRTFSPHFHHFVEQCLQRNPDA 308
Query: 331 RCTALEACIHPFFDEL-RDPNARLPN-GRPFPPLFNFKPQELKGAS 374
           R +A     H FF ++ R  +  LP   RP  P+ NF+  + +  S
Sbjct: 309 RPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHS 354

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 76/346 (21%), Positives = 130/346 (37%), Gaps = 76/346 (21%)
Query: 98  VVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV--- 146
           V+G+G      V  A+   TGE V ++++  +        +   EL   +L +HPN+   
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 147 ----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                       H+      + + Y+      + +AL YIH  +
Sbjct: 92  RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIHH-M 147
Query: 179 GVCHRDIKPQNLLVNPH--------THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 230
           G  HR +K  ++L++             + +   G  + +V   P  S +    + +PE+
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS-VKVLPWLSPEV 206
Query: 231 IFGATE-YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT--RE 282
           +    + Y    DI+SVG    EL  G   F        L+E +      +L T T   E
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266
Query: 283 EIKCMNPN------------YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
           E+  M+P+             T    P     P H  +H+   P     V + LQ +P+ 
Sbjct: 267 EL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHP-YHRTFSPHFHHFVEQCLQRNPDA 324
Query: 331 RCTALEACIHPFFDEL-RDPNARLPN-GRPFPPLFNFKPQELKGAS 374
           R +A     H FF ++ R  +  LP   RP  P+ NF+  + +  S
Sbjct: 325 RPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHS 370

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 36/156 (23%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL----QTMRLL 141
           +P+    +   R +G GSFG ++    ++T E VAIK  L++ + K+ +L    +  R+L
Sbjct: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRIL 59
Query: 142 DH----PNVHY-----------------------SRASQRMPLIYVKLYTYQICRALAYI 174
                 PNV +                       +  S+++ L  V +   Q+   + ++
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 175 HGGIGVCHRDIKPQNLL--VNPHTHQVKLCDFGSAK 208
           H      HRDIKP N L  +    +QV + DFG AK
Sbjct: 120 HSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 82/196 (41%), Gaps = 41/196 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNV- 146
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 147 ---------HYSRASQRMP----LIYVKL------------YTYQICRALAYIHGGIGVC 181
                          Q MP    L YV+             +  QI + + Y+     + 
Sbjct: 88  RLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLV 146
Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 147 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YT 204
Query: 239 TAVDIWSVGCVLAELL 254
              D+WS G  + EL+
Sbjct: 205 HQSDVWSYGVTVWELM 220

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 48/209 (22%)
Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKK-VLQDKRYKN----------RELQTMRLLDHP 144
           E+ +G+G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 145 NV-----------------------HYSRASQRMPLIY-VKL-YTYQICRALAYIHG-GI 178
           N+                       ++    +  P+ + VKL     I   + Y+     
Sbjct: 84  NIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLC----DFGSAKVLVKGEPNISYICSRY-YRAPELIFG 233
            + HRD++  N+ +        +C    DFG+++  V    ++S +   + + APE I G
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLLGNFQWMAPETI-G 199
Query: 234 ATE--YTTAVDIWSVGCVLAELLLGQPLF 260
           A E  YT   D +S   +L  +L G+  F
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 40/216 (18%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNV-- 146
           M    +G GSFG V++ K       V I KV+     Q + ++N E+  +R   H N+  
Sbjct: 39  MLSTRIGSGSFGTVYKGKW-HGDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNILL 96
Query: 147 --------------HYSRASQRMPLIYVKLYTYQI----------CRALAYIHGGIGVCH 182
                          +   S     ++V+   +Q+           + + Y+H    + H
Sbjct: 97  FMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK-NIIH 155
Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISY-ICSRYYRAPELIFGATE--Y 237
           RD+K  N+ ++     VK+ DFG A V  +  G   +     S  + APE+I       +
Sbjct: 156 RDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
           +   D++S G VL EL+ G+  +   +  DQ++ ++
Sbjct: 215 SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 46/211 (21%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 217
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 218 SYICSRYYRAPELIFGATE----------YTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA--VDLVSRLLQ 325
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 326 YSPNLRCTALEACIHPFFDELRDPNARLPNG 356
             P  R +  E   HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 74/315 (23%), Positives = 123/315 (39%), Gaps = 105/315 (33%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNR------------------ 133
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R                  
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 134 ------------ELQTMRLLDHPNV-HYSRASQ--------RMPLIYVKL--YTYQICRA 170
                        L  M L+ H ++  Y R+ +        R P    ++     +I   
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 226
           +AY++    V HR++  +N +V  H   VK+ DFG  + + + +         YYR    
Sbjct: 143 MAYLNAKKFV-HRNLAARNCMV-AHDFTVKIGDFGMTRDIYETD---------YYRKGGK 191
Query: 227 --------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLG 277
                   APE +     +TT+ D+WS G VL E+  L +  + G S  +Q+++ +    
Sbjct: 192 GLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV---- 245
Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 337
                    M+  Y +         P         P    DL+    Q++PN+R T LE 
Sbjct: 246 ---------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLEI 282
Query: 338 C------IHPFFDEL 346
                  +HP F E+
Sbjct: 283 VNLLKDDLHPSFPEV 297

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 74/315 (23%), Positives = 123/315 (39%), Gaps = 105/315 (33%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNR------------------ 133
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R                  
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 134 ------------ELQTMRLLDHPNV-HYSRASQ--------RMPLIYVKL--YTYQICRA 170
                        L  M L+ H ++  Y R+ +        R P    ++     +I   
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 226
           +AY++    V HR++  +N +V  H   VK+ DFG  + + + +         YYR    
Sbjct: 144 MAYLNAKKFV-HRNLAARNCMV-AHDFTVKIGDFGMTRDIYETD---------YYRKGGK 192
Query: 227 --------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLG 277
                   APE +     +TT+ D+WS G VL E+  L +  + G S  +Q+++ +    
Sbjct: 193 GLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV---- 246
Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 337
                    M+  Y +         P         P    DL+    Q++PN+R T LE 
Sbjct: 247 ---------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLEI 283
Query: 338 C------IHPFFDEL 346
                  +HP F E+
Sbjct: 284 VNLLKDDLHPSFPEV 298

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 46/211 (21%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 217
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 218 SYICSRYYRAPELIFGATE----------YTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+  F       
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA--VDLVSRLLQ 325
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 326 YSPNLRCTALEACIHPFFDELRDPNARLPNG 356
             P  R +  E   HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 217
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 218 SYICSRYYRAPELIFGATE----------YTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 327
           Q++  I  L          ++PN+ E +FP I               +  D++   L+  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 308
Query: 328 PNLRCTALEACIHPFFDELRDPNARLPNG 356
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 42/209 (20%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 217
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 186
Query: 218 SYICSRYYRAPELIFGATE----------YTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 327
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 280
Query: 328 PNLRCTALEACIHPFFDELRDPNARLPNG 356
           P  R +  E   HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 42/209 (20%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 217
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 167
Query: 218 SYICSRYYRAPELIFGATE----------YTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+   P +  ++
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 225
Query: 268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 327
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 226 QISKLHAII-----------DPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 261
Query: 328 PNLRCTALEACIHPFFDELRDPNARLPNG 356
           P  R +  E   HP+      P  ++  G
Sbjct: 262 PKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 74/315 (23%), Positives = 122/315 (38%), Gaps = 105/315 (33%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNR------------------ 133
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R                  
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 134 ------------ELQTMRLLDHPNV-HYSRASQ--------RMPLIYVKL--YTYQICRA 170
                        L  M L+ H ++  Y R+ +        R P    ++     +I   
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 226
           +AY++    V HRD+  +N +V  H   VK+ DFG  + + + +         YYR    
Sbjct: 143 MAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD---------YYRKGGK 191
Query: 227 --------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLG 277
                   APE +     +TT+ D+WS G VL E+  L +  + G S  +Q+++ +    
Sbjct: 192 GLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV---- 245
Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 337
                    M+  Y +         P         P    DL+    Q++P +R T LE 
Sbjct: 246 ---------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMRPTFLEI 282
Query: 338 C------IHPFFDEL 346
                  +HP F E+
Sbjct: 283 VNLLKDDLHPSFPEV 297

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 74/315 (23%), Positives = 122/315 (38%), Gaps = 105/315 (33%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNR------------------ 133
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R                  
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 134 ------------ELQTMRLLDHPNV-HYSRASQ--------RMPLIYVKL--YTYQICRA 170
                        L  M L+ H ++  Y R+ +        R P    ++     +I   
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 226
           +AY++    V HRD+  +N +V  H   VK+ DFG  + + +         + YYR    
Sbjct: 142 MAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---------TDYYRKGGK 190
Query: 227 --------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLG 277
                   APE +     +TT+ D+WS G VL E+  L +  + G S  +Q+++ +    
Sbjct: 191 GLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV---- 244
Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 337
                    M+  Y +         P         P    DL+    Q++P +R T LE 
Sbjct: 245 ---------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMRPTFLEI 281
Query: 338 C------IHPFFDEL 346
                  +HP F E+
Sbjct: 282 VNLLKDDLHPSFPEV 296

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 74/315 (23%), Positives = 122/315 (38%), Gaps = 105/315 (33%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNR------------------ 133
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R                  
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 134 ------------ELQTMRLLDHPNV-HYSRASQ--------RMPLIYVKL--YTYQICRA 170
                        L  M L+ H ++  Y R+ +        R P    ++     +I   
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 226
           +AY++    V HRD+  +N +V  H   VK+ DFG  + + +         + YYR    
Sbjct: 143 MAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---------TAYYRKGGK 191
Query: 227 --------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLG 277
                   APE +     +TT+ D+WS G VL E+  L +  + G S  +Q+++ +    
Sbjct: 192 GLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV---- 245
Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 337
                    M+  Y +         P         P    DL+    Q++P +R T LE 
Sbjct: 246 ---------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMRPTFLEI 282
Query: 338 C------IHPFFDEL 346
                  +HP F E+
Sbjct: 283 VNLLKDDLHPSFPEV 297

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 121/306 (39%), Gaps = 87/306 (28%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNR------------------ 133
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R                  
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 134 ------------ELQTMRLLDHPNV-HYSRASQ--------RMPLIYVKL--YTYQICRA 170
                        L  M L+ H ++  Y R+ +        R P    ++     +I   
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRA 227
           +AY++    V HRD+  +N +V  H   VK+ DFG  + + + +        +    + A
Sbjct: 140 MAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
           PE +     +TT+ D+WS G VL E+  L +  + G S  +Q+++ +             
Sbjct: 198 PESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV------------- 242
Query: 287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC------IH 340
           M+  Y +         P         P    DL+    Q++P +R T LE        +H
Sbjct: 243 MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 288
Query: 341 PFFDEL 346
           P F E+
Sbjct: 289 PSFPEV 294

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 121/306 (39%), Gaps = 87/306 (28%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNR------------------ 133
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R                  
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 134 ------------ELQTMRLLDHPNV-HYSRASQ--------RMPLIYVKL--YTYQICRA 170
                        L  M L+ H ++  Y R+ +        R P    ++     +I   
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRA 227
           +AY++    V HRD+  +N +V  H   VK+ DFG  + + + +        +    + A
Sbjct: 143 MAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 228 PELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
           PE +     +TT+ D+WS G VL E+  L +  + G S  +Q+++ +             
Sbjct: 201 PESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV------------- 245
Query: 287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC------IH 340
           M+  Y +         P         P    DL+    Q++P +R T LE        +H
Sbjct: 246 MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 291
Query: 341 PFFDEL 346
           P F E+
Sbjct: 292 PSFPEV 297

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 42/209 (20%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 217
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 218 SYICSRYYRAPELIFGATE----------YTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+   P +  ++
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 228
Query: 268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 327
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 229 QISKLHAII-----------DPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 264
Query: 328 PNLRCTALEACIHPFFDELRDPNARLPNG 356
           P  R +  E   HP+      P  ++  G
Sbjct: 265 PKQRISIPELLAHPYVQIQTHPVNQMAKG 293

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 48/209 (22%)
Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKK-VLQDKRYKN----------RELQTMRLLDHP 144
           E+ +G+G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 145 NV-----------------------HYSRASQRMPLIY-VKL-YTYQICRALAYIHG-GI 178
           N+                       ++    +  P+ + VKL     I   + Y+     
Sbjct: 84  NIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLC----DFGSAKVLVKGEPNISYICSRY-YRAPELIFG 233
            + HRD++  N+ +        +C    DFG ++  V    ++S +   + + APE I G
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETI-G 199
Query: 234 ATE--YTTAVDIWSVGCVLAELLLGQPLF 260
           A E  YT   D +S   +L  +L G+  F
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 42/209 (20%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 217
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 166
Query: 218 SYICSRYYRAPELIFGATE----------YTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+   P +  ++
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 224
Query: 268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 327
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 225 QISKLHAII-----------DPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 260
Query: 328 PNLRCTALEACIHPFFDELRDPNARLPNG 356
           P  R +  E   HP+      P  ++  G
Sbjct: 261 PKQRISIPELLAHPYVQIQTHPVNQMAKG 289

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 60/208 (28%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL---QDKRYKNRELQTMRLLDHPNV--------- 146
           VG+G +G V++   L  GE+VA+K      +   ++  E+    LL H N+         
Sbjct: 16  VGKGRYGEVWRG--LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMT 73
Query: 147 ------------HYSRAS------QRM---PLIYVKLYTYQICRALAYIH-------GGI 178
                       HY          QR    P + ++L     C  LA++H       G  
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAAC-GLAHLHVEIFGTQGKP 132
Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELI-- 231
            + HRD K +N+LV  +  Q  + D G A +  +G       N   + ++ Y APE++  
Sbjct: 133 AIAHRDFKSRNVLVKSNL-QCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDE 191
Query: 232 ------FGATEYTTAVDIWSVGCVLAEL 253
                 F + ++T   DIW+ G VL E+
Sbjct: 192 QIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 83/209 (39%), Gaps = 42/209 (20%)
Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 217
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +      +   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDXXXVVKD 186
Query: 218 SYICSRYYRAPELIFGATE----------YTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 327
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 280
Query: 328 PNLRCTALEACIHPFFDELRDPNARLPNG 356
           P  R +  E   HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	395
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-158
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-27
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-91
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-89
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-88
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-88
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-88
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-87
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-87
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-86
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-86
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-85
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-85
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-85
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-84
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-83
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-83
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-82
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-82
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-81
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-80
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-80
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-80
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-79
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-78
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-78
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-78
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-77
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-71
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-61
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-59
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-58
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-57
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-57
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-55
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-52
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-52
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-52
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-52
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-50
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-46
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-46
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-46
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-46
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-46
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-45
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-45
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-45
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-45
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-45
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-45
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-45
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-44
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-44
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-44
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-44
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-44
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-44
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-43
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-43
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-43
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-43
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-42
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-42
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-42
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-42
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-42
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-42
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-42
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-41
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-41
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-41
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-41
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-41
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-40
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-40
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-40
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-40
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-40
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-40
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-40
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-40
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-40
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-40
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-39
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-39
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-39
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-39
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-39
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-38
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-38
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-37
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-37
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-36
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-36
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-36
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-36
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-35
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-35
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-35
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-35
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-34
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-07
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-34
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-34
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-34
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-34
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-34
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-34
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-34
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-33
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-33
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-33
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-33
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-33
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-33
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-33
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-32
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-32
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-32
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-32
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-32
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-31
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-30
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-30
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-30
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-30
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-30
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-30
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-29
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-29
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-29
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-29
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-29
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-29
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-28
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-28
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-08
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-27
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-27
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-26
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-26
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-26
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-25
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-25
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-25
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-24
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-24
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-23
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-17
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-17
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-17
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-17
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-17
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-16
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-16
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-16
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-15
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-15
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-15
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-14
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-14
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-14
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-13
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-13
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-13
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-12
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-12
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-12
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-12
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-12
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-12
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-11
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-11
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-11
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-09
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-06

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  572 bits (1475), Expect = 0.0
 Identities = 222/398 (55%), Positives = 269/398 (67%), Gaps = 51/398 (12%)

Query: 29  KPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPK 88
           +     ++    + P     MK+              D +G++   ++ T   G+     
Sbjct: 6   RTTSFAESCKPVQQPSAFGSMKVSR------------DKDGSKVTTVVATP--GQGPDRP 51

Query: 89  QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV-- 146
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+  
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 111

Query: 147 ---------------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
                                            HYSRA Q +P+IYVKLY YQ+ R+LAY
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
           IH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFG
Sbjct: 172 IHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
           AT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTE
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290

Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
           FKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC H FFDELRDPN +L
Sbjct: 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 350

Query: 354 PNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           PNGR  P LFNF  QEL  ++  L + LIP HAR Q  
Sbjct: 351 PNGRDTPALFNFTTQELS-SNPPLATILIPPHARIQAA 387

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  564 bits (1456), Expect = 0.0
 Identities = 203/373 (54%), Positives = 259/373 (69%), Gaps = 39/373 (10%)

Query: 57  EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
              +    ++        I V    G+ G+ ++ I+Y   +V+G GSFG+VFQAK +E+ 
Sbjct: 7   NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESD 65

Query: 117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNV------------------------------ 146
           E VAIKKVLQDKR+KNRELQ MR++ HPNV                              
Sbjct: 66  E-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124

Query: 147 -----HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 201
                HY++  Q MP++ +KLY YQ+ R+LAYIH  IG+CHRDIKPQNLL++P +  +KL
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKL 183

Query: 202 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFP 261
            DFGSAK+L+ GEPN+SYICSRYYRAPELIFGAT YTT +DIWS GCV+AEL+ GQPLFP
Sbjct: 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243

Query: 262 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 321
           GESG+DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+ HP+ K+F  R PP+A+DL+S
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303

Query: 322 RLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKL 381
           RLL+Y+P+ R TA+EA  HPFFDELR   AR+PNGR  PPLFN+  +EL     +L+S+L
Sbjct: 304 RLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRL 362

Query: 382 IPEHARKQCPFLG 394
           +P+HA  +    G
Sbjct: 363 VPQHAEAELLSRG 375

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  539 bits (1391), Expect = 0.0
 Identities = 149/358 (41%), Positives = 204/358 (56%), Gaps = 46/358 (12%)

Query: 73  GHIIVTTIGGRNGQP--KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY 130
           G ++         +   K+   +  ER+ GQG+FG V   K   TG +VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 131 KNRELQTMRLL---DHPNV------------------------------------HYSRA 151
           +NRELQ M+ L    HPN+                                    +Y R 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 152 SQRMPLIYVKLYTYQICRALAYIH-GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 210
               P I +K++ +Q+ R++  +H   + VCHRDIKP N+LVN     +KLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLV 270
              EPN++YICSRYYRAPELIFG   YTTAVDIWSVGC+ AE++LG+P+F G++   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK---RMPPEAVDLVSRLLQYS 327
           EI++VLG P+RE ++ +NP++T+      K  PW  +F     +   EA DL+S LLQY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 328 PNLRCTALEACIHPFFDELRDPNARLPNGRPFPP-LFNFKPQELKGASKELLSKLIPE 384
           P  R    EA  HP+FDEL DP  +LPN +  P  LF F P E++  S+   +KL+ +
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  450 bits (1159), Expect = e-158
 Identities = 122/253 (48%), Positives = 177/253 (69%), Gaps = 10/253 (3%)

Query: 147 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
            + R+ + +P+  + +Y YQ+ RA+ +IH  +G+CHRDIKPQNLLVN   + +KLCDFGS
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCDFGS 188

Query: 207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
           AK L+  EP+++YICSR+YRAPEL+ GATEYT ++D+WS+GCV  EL+LG+PLF GE+ +
Sbjct: 189 AKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI 248

Query: 267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
           DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI  +  P  A+DL+ ++L+Y
Sbjct: 249 DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308

Query: 327 SPNLRCTALEACIHPFFDELRDP-------NARLPNG--RPFPPLFNFKPQELKGASKEL 377
            P+LR    EA  HPFFD LR+        N+  P+G  +  P LFNF P EL      +
Sbjct: 309 EPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNV 368

Query: 378 LSKLIPEHARKQC 390
           L++++P++     
Sbjct: 369 LNRILPKNFSPNY 381

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  110 bits (277), Expect = 2e-27
 Identities = 30/63 (47%), Positives = 41/63 (65%)

Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 144
           G    +  Y   + +G GSFGIV +   +E+G+  A+KKVLQD RYKNREL  M++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 145 NVH 147
           N+ 
Sbjct: 61  NII 63

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  275 bits (705), Expect = 7e-91
 Identities = 94/304 (30%), Positives = 148/304 (48%), Gaps = 40/304 (13%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+GS+G+VF+ +  +TG+ VAIKK L+ +          RE++ ++ L HPN+      
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 147 --------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 186
                                  R  + +P   VK  T+Q  +A+ + H      HRD+K
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVK 129

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWS 245
           P+N+L+  H+  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y   VD+W+
Sbjct: 130 PENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWA 188

Query: 246 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFKFPQIK-AH 302
           +GCV AELL G PL+PG+S VDQL  I K LG       +    N  ++  K P  +   
Sbjct: 189 IGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDME 248

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPL 362
           P    F   +   A+ L+   L   P  R T  +   HP+F+ +R+    L      P  
Sbjct: 249 PLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE-DLAKEHDKPAE 306

Query: 363 FNFK 366
             + 
Sbjct: 307 NLYF 310

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  270 bits (693), Expect = 7e-89
 Identities = 82/308 (26%), Positives = 135/308 (43%), Gaps = 54/308 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQD----KR-YKNRELQTMRLLDHPNV 146
           YM  + +G G  G+VF A   +  + VAIKK+ L D    K     RE++ +R LDH N+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 147 --------------------------------------HYSRASQRMPLIYVKLYTYQIC 168
                                                         +   + +L+ YQ+ 
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130

Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRY 224
           R L YIH    V HRD+KP NL +N     +K+ DFG A+++     +       + +++
Sbjct: 131 RGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           YR+P L+     YT A+D+W+ GC+ AE+L G+ LF G   ++Q+  I++ +     E+ 
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249

Query: 285 KCMNPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
           + +      +          P  ++    +  EAVD + ++L +SP  R TA EA  HP+
Sbjct: 250 QELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAEEALSHPY 308

Query: 343 FDELRDPN 350
                 P 
Sbjct: 309 MSIYSFPM 316

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  269 bits (691), Expect = 2e-88
 Identities = 94/321 (29%), Positives = 160/321 (49%), Gaps = 54/321 (16%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLD 142
           +Y+    +G+G++  V++ K   T   VA+K++    R ++         RE+  ++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 143 HPNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
           H N+                          +       + +  VKL+ +Q+ R LAY H 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 233
              V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+++ G
Sbjct: 119 Q-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPDILLG 174

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPN 290
           +T+Y+T +D+W VGC+  E+  G+PLFPG +  +QL  I ++LGTPT E    I      
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN-EE 233

Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
           +  + +P+ +A         R+  +  DL+++LLQ+    R +A +A  HPFF  L +  
Sbjct: 234 FKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292

Query: 351 ARLPNGRPFPPLFNFKPQELK 371
            +LP+      +F  K  +L+
Sbjct: 293 HKLPD---TTSIFALKEIQLQ 310

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  268 bits (688), Expect = 5e-88
 Identities = 90/287 (31%), Positives = 140/287 (48%), Gaps = 39/287 (13%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           VG+GS+G+V + +  +TG  VAIKK L+    K       RE++ ++ L H N+      
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 147 --------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 186
                                       +    V+ Y +QI   + + H    + HRDIK
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIK 151

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWS 245
           P+N+LV+  +  VKLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y  AVD+W+
Sbjct: 152 PENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWA 210

Query: 246 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFKFPQIKAH- 302
           +GC++ E+ +G+PLFPG+S +DQL  I+  LG       E+   NP +   + P+IK   
Sbjct: 211 IGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKERE 270

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
           P  + +  ++    +DL  + L   P+ R    E   H FF      
Sbjct: 271 PLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  268 bits (687), Expect = 7e-88
 Identities = 83/294 (28%), Positives = 135/294 (45%), Gaps = 39/294 (13%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMR-LLDHPNV--- 146
           Y   R +G+G +  VF+A  +   E V +K +  ++ K+ K RE++ +  L   PN+   
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 147 -HYSRASQRMPLIYV---------------------KLYTYQICRALAYIHGGIGVCHRD 184
               +         V                     + Y Y+I +AL Y H   G+ HRD
Sbjct: 97  ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM-GIMHRD 155

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
           +KP N++++    +++L D+G A+    G+     + SRY++ PEL+     Y  ++D+W
Sbjct: 156 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMW 215

Query: 245 SVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNYTEFK--FPQI 299
           S+GC+LA ++   +P F G    DQLV I KVLGT    +   K        F     + 
Sbjct: 216 SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRH 275

Query: 300 KAHPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
               W +  H      + PEA+D + +LL+Y    R TA EA  HP+F  +   
Sbjct: 276 SRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  268 bits (688), Expect = 1e-87
 Identities = 87/340 (25%), Positives = 144/340 (42%), Gaps = 60/340 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------------RELQT 137
           Y  +R +  GS+G V        G  VAIK+V                       RE++ 
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 138 MRLLDHPNV-----------------------------HYSRASQRMPL--IYVKLYTYQ 166
           +    HPN+                                   QR+ +   +++ + Y 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142

Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 226
           I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+  R+YR
Sbjct: 143 ILLGLHVLHEA-GVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYR 200

Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
           APEL+     +T  VD+WS GCV+AE+   + LF G +  +QL +I++V+GTP  E++  
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260

Query: 287 M-NP---NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
             +P   +Y       + A  W  +      P A+DL++++L+++P  R +  +A  HP+
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQALRHPY 319

Query: 343 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 382
           F+ L DP   L  G      F+F            + K+ 
Sbjct: 320 FESLFDPL-DLTEGLSER--FHFDESVT---DVYDMHKIF 353

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  267 bits (684), Expect = 4e-87
 Identities = 104/342 (30%), Positives = 167/342 (48%), Gaps = 59/342 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-----LQD-KR-YKNRELQTMRLLDHPN 145
           +  + ++G+G++G+V  A    TGE VAIKK+          R    RE++ ++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 146 ------VHYSRASQRMPLIY-----------------------VKLYTYQICRALAYIHG 176
                 +    + +    +Y                       ++ + YQ  RA+  +HG
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG 130

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----------YICSRYY 225
              V HRD+KP NLL+N     +K+CDFG A+++ +   + S           ++ +R+Y
Sbjct: 131 S-NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188

Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI- 284
           RAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP  +   
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248

Query: 285 -KCMNPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 341
               +P   E+    P   A P  K+F + + P+ +DL+ R+L + P  R TA EA  HP
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKEALEHP 307

Query: 342 FFDELRDPNARLPNGRPFPPL-FNFKPQELKGASKELLSKLI 382
           +     DPN   P G P PP  F F     +  + + L KLI
Sbjct: 308 YLQTYHDPN-DEPEGEPIPPSFFEFD-HYKEALTTKDLKKLI 347

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  265 bits (679), Expect = 2e-86
 Identities = 104/334 (31%), Positives = 150/334 (44%), Gaps = 51/334 (15%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNV--- 146
           +G+G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN+   
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                                       S  +   ++K Y     + L Y+H    + HR
Sbjct: 78  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHR 136

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTA 240
           D+KP NLL++     +KL DFG AK    G PN +Y   + +R+YRAPEL+FGA  Y   
Sbjct: 137 DLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 193

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---KCMNPNYTEFKFP 297
           VD+W+VGC+LAELLL  P  PG+S +DQL  I + LGTPT EE     C  P+Y    F 
Sbjct: 194 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLPDYVT--FK 250

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
                P H IF      + +DL+  L  ++P  R TA +A    +F     P        
Sbjct: 251 SFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--PGPTPGCQL 307

Query: 358 PFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
           P P       +E    +  +  K      +   P
Sbjct: 308 PRPNCPVETLKEQSNPALAIKRKRTEALEQGGLP 341

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  261 bits (670), Expect = 2e-85
 Identities = 85/304 (27%), Positives = 146/304 (48%), Gaps = 57/304 (18%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G V++A    T ETVAIK++  +   +       RE+  ++ L H N+      
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 147 -------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 187
                               Y   +  + +  +K + YQ+   + + H      HRD+KP
Sbjct: 102 IHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKP 160

Query: 188 QNLLVNPHTH----QVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTA 240
           QNLL++         +K+ DFG A+    G P   +   I + +YR PE++ G+  Y+T+
Sbjct: 161 QNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEILLGSRHYSTS 218

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFP 297
           VDIWS+ C+ AE+L+  PLFPG+S +DQL +I +VLG P       +  + P++ +  FP
Sbjct: 219 VDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL-PDWKQS-FP 276

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           + +     ++    +  E +DL++ +L+  P  R +A  A  HP+F              
Sbjct: 277 KFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN----------- 325

Query: 358 PFPP 361
            F P
Sbjct: 326 DFDP 329

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  261 bits (670), Expect = 7e-85
 Identities = 102/333 (30%), Positives = 166/333 (49%), Gaps = 53/333 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQD----KR-YKNRELQTMRLLDHPN 145
           Y     +G+G++G+V  A        VAIKK+   +     +R    RE++ +    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 146 V-----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
           +                             +    +Q +   ++  + YQI R L YIH 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELIF 232
              V HRD+KP NLL+N  T  +K+CDFG A+V      +      Y+ +R+YRAPE++ 
Sbjct: 147 A-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204

Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNY 291
            +  YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+ N   
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264

Query: 292 TEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
             +    P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  DP
Sbjct: 265 RNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

Query: 350 NARLPNGRPFPPLFNFKPQELKGASKELLSKLI 382
           +   P        F F   EL    KE L +LI
Sbjct: 324 S-DEP---IAEAPFKF-DMELDDLPKEKLKELI 351

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  259 bits (665), Expect = 8e-85
 Identities = 94/286 (32%), Positives = 152/286 (53%), Gaps = 45/286 (15%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           VG+G++G+V++AK    G  VA+K++  D   +       RE+  ++ L HPN+      
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 147 --------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 186
                                       +    +K+Y YQ+ R +A+ H    + HRD+K
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLK 146

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVDI 243
           PQNLL+N     +KL DFG A+    G P  SY   + + +YRAP+++ G+ +Y+T+VDI
Sbjct: 147 PQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDI 203

Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIK 300
           WS+GC+ AE++ G+PLFPG +  DQL +I  +LGTP      +++ + P + +  F   +
Sbjct: 204 WSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWKQRTFQVFE 262

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
             PW  I       E +DL+S +L + PN R +A +A  HP+F +L
Sbjct: 263 KKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  256 bits (656), Expect = 9e-84
 Identities = 92/286 (32%), Positives = 147/286 (51%), Gaps = 46/286 (16%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G+V++A+    GET A+KK+  +K  +       RE+  ++ L H N+      
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 147 --------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 186
                                       +  +  K +  Q+   +AY H    V HRD+K
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLK 127

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVDI 243
           PQNLL+N    ++K+ DFG A+    G P   Y   I + +YRAP+++ G+ +Y+T +DI
Sbjct: 128 PQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184

Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIK 300
           WSVGC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +  + P Y +  F   +
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY-DPNFTVYE 242

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
             PW     K +    +DL+S++L+  PN R TA +A  H +F E 
Sbjct: 243 PLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  255 bits (655), Expect = 3e-83
 Identities = 86/313 (27%), Positives = 144/313 (46%), Gaps = 61/313 (19%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNV--- 146
           +G G++  V++     TG  VA+K+V    +  +         RE+  M+ L H N+   
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 147 ----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                             + + L  VK + +Q+ + LA+ H   
Sbjct: 69  YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN- 127

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 235
            + HRD+KPQNLL+N    Q+KL DFG A+    G P  ++   + + +YRAP+++ G+ 
Sbjct: 128 KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDVLMGSR 184

Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 292
            Y+T++DIWS GC+LAE++ G+PLFPG +  +QL  I  ++GTP       +  + P Y 
Sbjct: 185 TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL-PKY- 242

Query: 293 EFKFPQIKAHPWHKIFHK----RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 348
                Q       ++        +    +D +  LLQ +P++R +A +A  HP+F E   
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302

Query: 349 PNARLPNGRPFPP 361
             A +   R    
Sbjct: 303 H-ASMGGSRSHHH 314

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  257 bits (659), Expect = 3e-83
 Identities = 95/330 (28%), Positives = 152/330 (46%), Gaps = 52/330 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y   + VG G++G V  A    TG  VAIKK+          +   REL+ ++ + H NV
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 147 ------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
                                               +++    ++   YQ+ + L YIH 
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 146

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGAT 235
             G+ HRD+KP NL VN     +K+ DFG A+     +  ++ Y+ +R+YRAPE+I    
Sbjct: 147 A-GIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWM 201

Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF 294
            YT  VDIWSVGC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ + +     +
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261

Query: 295 --KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 352
               P+++   +  I      P AV+L+ ++L      R TA EA  HP+F+ L D    
Sbjct: 262 MKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 320

Query: 353 LPNGRPFPPLFNFKPQELKGASKELLSKLI 382
            P  + +   F     +    + +   ++ 
Sbjct: 321 -PQVQKYDDSF-----DDVDRTLDEWKRVT 344

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  255 bits (653), Expect = 2e-82
 Identities = 104/331 (31%), Positives = 163/331 (49%), Gaps = 54/331 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQD----KR-YKNRELQTMRLLDHP 144
           Y++   VG G++G V  A    +GE VAIKK+    Q     KR Y  REL  ++ + H 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83

Query: 145 NV-------HYSRASQRMPLIY----------------------VKLYTYQICRALAYIH 175
           NV         + + +     Y                      ++   YQ+ + L YIH
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH 143

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGA 234
              GV HRD+KP NL VN     +K+ DFG A+     +  ++ Y+ +R+YRAPE+I   
Sbjct: 144 SA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYRAPEVILSW 198

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTE 293
             Y   VDIWSVGC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ + +     
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258

Query: 294 F--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
           +    PQ     + ++F  R  P+A DL+ ++L+   + R TA +A  HPFF+  RDP  
Sbjct: 259 YIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE 317

Query: 352 RLPNGRPFPPLFNFKPQELKGASKELLSKLI 382
                +PF    + + ++L   + +   + I
Sbjct: 318 ETEAQQPFD--DSLEHEKL---TVDEWKQHI 343

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  251 bits (644), Expect = 7e-82
 Identities = 91/290 (31%), Positives = 145/290 (50%), Gaps = 46/290 (15%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+      
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 147 --------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 186
                               ++   +  +    VK + +Q+ + L + H    V HRD+K
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLK 128

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTTAVDI 243
           PQNLL+N    ++KL +FG A+    G P   Y   + + +YR P+++FGA  Y+T++D+
Sbjct: 129 PQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185

Query: 244 WSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQI 299
           WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E    +  + P+Y  +     
Sbjct: 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDYKPYPMYPA 244

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
                  +   ++     DL+  LL+ +P  R +A EA  HP+F +   P
Sbjct: 245 T-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  252 bits (646), Expect = 3e-81
 Identities = 100/332 (30%), Positives = 158/332 (47%), Gaps = 56/332 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 144
           Y     VG G++G V  A   +TG  VA+KK+ +        KR Y  REL+ ++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 145 NV------------------------------HYSRASQRMPLIYVKLYTYQICRALAYI 174
           NV                              +     Q++   +V+   YQI R L YI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 148

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFG 233
           H    + HRD+KP NL VN    ++K+ DFG A+        ++ Y+ +R+YRAPE++  
Sbjct: 149 HSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYRAPEIMLN 203

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYT 292
              Y   VDIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K + + +  
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263

Query: 293 EF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
            +     Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+
Sbjct: 264 NYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

Query: 351 ARLPNGRPFPPLFNFKPQELKGASKELLSKLI 382
              P   P+    + + ++L     +    L 
Sbjct: 323 DE-PVADPYD--QSLESRDL---LIDEWKSLT 348

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  253 bits (647), Expect = 3e-80
 Identities = 100/386 (25%), Positives = 149/386 (38%), Gaps = 105/386 (27%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 144
           Y    ++G GS+G V +A        VAIKK+L+        KR    RE+  +  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 145 NV------------------------------HYSRASQRMPLIYVKLYTYQICRALAYI 174
           +V                                 R    +  +++K   Y +   + Y+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------------- 218
           H   G+ HRD+KP N LVN     VK+CDFG A+ +   E   S                
Sbjct: 173 HSA-GILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

Query: 219 ------------YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL----------- 255
                       ++ +R+YRAPELI     YT A+D+WS+GC+ AELL            
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

Query: 256 GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCM-NPNYTEF 294
             PLFPG S                      DQL  I  +LGTP+ E+I+ +   +   +
Sbjct: 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY 350

Query: 295 --KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 352
              FP+ +     + F      +A+ L+ R+L ++PN R T  E   HPFF E+R     
Sbjct: 351 IRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVE 409

Query: 353 LPNGRPFPPLFNFKPQELKGASKELL 378
                     FN      +   +   
Sbjct: 410 TNATEKVRLPFNDWMNMDEPQLRYAF 435

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  249 bits (639), Expect = 3e-80
 Identities = 97/340 (28%), Positives = 150/340 (44%), Gaps = 59/340 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQD----KR-YKNRELQTMRLLDHP 144
           Y   + +G G+ GIV  A        VAIKK+    Q+    KR Y  REL  M+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 145 NV---------HYSRASQ------------------RMPL--IYVKLYTYQICRALAYIH 175
           N+           S                      +M L    +    YQ+   + ++H
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 235
              G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G  
Sbjct: 145 SA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-M 201

Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 294
            Y   VDIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    + 
Sbjct: 202 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 261

Query: 295 -KFPQIKAHPWHKIFHKRMP-----------PEAVDLVSRLLQYSPNLRCTALEACIHPF 342
              P+   + + K+F   +             +A DL+S++L    + R +  EA  HP+
Sbjct: 262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321

Query: 343 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 382
            +   DP+       P  P      +E    + E   +LI
Sbjct: 322 INVWYDPS-EAEAPPPKIPDKQLDEREH---TIEEWKELI 357

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  248 bits (636), Expect = 6e-80
 Identities = 85/340 (25%), Positives = 135/340 (39%), Gaps = 65/340 (19%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV------ 146
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV      
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 147 ---HYSRASQRMPLIY-------------------------VKLYTYQICRALAYIHGGI 178
                S  ++    IY                         +K     +   L YIH   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 143

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV--LVKGEPNISY---ICSRYYRAPELIFG 233
            + HRD+K  N+L+      +KL DFG A+   L K      Y   + + +YR PEL+ G
Sbjct: 144 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPN 290
             +Y   +D+W  GC++AE+    P+  G +   QL  I ++ G+ T E    +      
Sbjct: 203 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY-EL 261

Query: 291 YTEFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
           Y + +  + +              P A+DL+ +LL   P  R  + +A  H FF      
Sbjct: 262 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD--- 318

Query: 350 NARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
                   P P            +  E L+   P      
Sbjct: 319 --------PMPSDLKGMLSTHLTSMFEYLAP--PRRKHHH 348

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  249 bits (637), Expect = 1e-79
 Identities = 94/361 (26%), Positives = 162/361 (44%), Gaps = 79/361 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL---QD----KR-YKNRELQTMRLL-DH 143
           Y   + +G+G++GIV+++    TGE VA+KK+    Q+    +R +  RE+  +  L  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 144 PNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
            N+                          H    +  +  ++ +   YQ+ + + Y+H G
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG 128

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS------------------- 218
            G+ HRD+KP N+L+N   H VK+ DFG ++  V      +                   
Sbjct: 129 -GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186

Query: 219 ---YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 275
              Y+ +R+YRAPE++ G+T+YT  +D+WS+GC+L E+L G+P+FPG S ++QL  II V
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246

Query: 276 LGTPTREEIKCM-NPNYTEF--KFPQIKAHPWHKIFHKRMP---------------PEAV 317
           +  P+ E+++ + +P          +                               EA+
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306

Query: 318 DLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKEL 377
           DL+ +LLQ++PN R +A +A  HPF     +PN             N   +      + L
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNL 366

Query: 378 L 378
           +
Sbjct: 367 V 367

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  248 bits (635), Expect = 2e-78
 Identities = 89/323 (27%), Positives = 143/323 (44%), Gaps = 56/323 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 144
           Y   + +G G+ GIV  A        VAIKK+ +        KR Y  REL  M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 145 NV----HYSRASQ-----------------------RMPL--IYVKLYTYQICRALAYIH 175
           N+    +     +                       +M L    +    YQ+   + ++H
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 235
              G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G  
Sbjct: 182 SA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-M 238

Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 294
            Y   VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    + 
Sbjct: 239 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298

Query: 295 -KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
              P+     + K+F           +K    +A DL+S++L   P  R +  +A  HP+
Sbjct: 299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358

Query: 343 FDELRDPNARLP-NGRPFPPLFN 364
            +   DP        + +    +
Sbjct: 359 INVWYDPAEVEAPPPQIYDKQLD 381

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  246 bits (629), Expect = 6e-78
 Identities = 92/382 (24%), Positives = 149/382 (39%), Gaps = 101/382 (26%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQD-KR-YKNRELQTMRLLDHP 144
           Y+ + ++G+GS+G V+ A    T + VAIKKV      L D KR    RE+  +  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 145 NV------------------------------HYSRASQRMPLIYVKLYTYQICRALAYI 174
            +                                 +    +   ++K   Y +     +I
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------------- 218
           H   G+ HRD+KP N L+N     VK+CDFG A+ +   +                    
Sbjct: 146 HES-GIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203

Query: 219 -------YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-----------PLF 260
                  ++ +R+YRAPELI     YT ++DIWS GC+ AELL              PLF
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263

Query: 261 PGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIK 300
           PG S                   DQL  I  ++GTPT +++K +  P   ++   FP  K
Sbjct: 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK 323

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFP 360
                + +   +  + ++L+  +L+++PN R T  +A  HP+  ++R             
Sbjct: 324 PINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLE----NFST 378

Query: 361 PLFNFKPQELKGASKELLSKLI 382
                   +    S+  L  + 
Sbjct: 379 KKIILPFDDWMVLSETQLRYIF 400

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  242 bits (619), Expect = 7e-78
 Identities = 80/302 (26%), Positives = 128/302 (42%), Gaps = 62/302 (20%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RE---LQTMRLLDHPNV 146
           +G G++G V++A+   +G  VA+K V                 RE   L+ +   +HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 147 ------------------------------HY--SRASQRMPLIYVKLYTYQICRALAYI 174
                                          Y        +P   +K    Q  R L ++
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 231
           H    + HRD+KP+N+LV      VKL DFG A++       ++    + + +YRAPE++
Sbjct: 137 HAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPEVL 191

Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
             +T Y T VD+WSVGC+ AE+   +PLF G S  DQL +I  ++G P  ++     P  
Sbjct: 192 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----PRD 246

Query: 292 TE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 348
                  FP     P   +    M      L+  +L ++P+ R +A  A  H +  +  +
Sbjct: 247 VSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD-E 304

Query: 349 PN 350
            N
Sbjct: 305 GN 306

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  242 bits (619), Expect = 1e-77
 Identities = 92/312 (29%), Positives = 143/312 (45%), Gaps = 63/312 (20%)

Query: 99  VGQGSFGIVFQAK-CLETGETVAIKKVLQDKRYKN-------RE---LQTMRLLDHPNV- 146
           +G+G++G VF+A+     G  VA+K+V      +        RE   L+ +   +HPNV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 147 ------HYSRASQR-------------------------MPLIYVKLYTYQICRALAYIH 175
                   SR  +                          +P   +K   +Q+ R L ++H
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 232
               V HRD+KPQN+LV   + Q+KL DFG A++       ++    + + +YRAPE++ 
Sbjct: 138 SH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-MALTSVVVTLWYRAPEVLL 192

Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 292
            ++ Y T VD+WSVGC+ AE+   +PLF G S VDQL +I+ V+G P  E+     P   
Sbjct: 193 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDV 247

Query: 293 E---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
                 F    A P  K     +     DL+ + L ++P  R +A  A  HP+F +L   
Sbjct: 248 ALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306

Query: 350 NARLPNGRPFPP 361
              L +    PP
Sbjct: 307 KENLDS--HLPP 316

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  227 bits (581), Expect = 3e-71
 Identities = 88/358 (24%), Positives = 145/358 (40%), Gaps = 81/358 (22%)

Query: 99  VGQGSFGIVFQAKCLE--TGETVAIKKVLQDKRYKN--RELQTMRLLDHPNV-------- 146
           VG+G++G V++AK  +    +  A+K++       +  RE+  +R L HPNV        
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 147 ----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                         ++   ++P   VK   YQI   + Y+H   
Sbjct: 89  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN- 147

Query: 179 GVCHRDIKPQNLLVN---PHTHQVKLCDFGSAKVLVKGEPNISY------ICSRYYRAPE 229
            V HRD+KP N+LV    P   +VK+ D G A++     P          + + +YRAPE
Sbjct: 148 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYRAPE 205

Query: 230 LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES---------GVDQLVEIIKVLGTPT 280
           L+ GA  YT A+DIW++GC+ AELL  +P+F               DQL  I  V+G P 
Sbjct: 206 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA 265

Query: 281 RE---------EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 331
            +         E   +  ++    +       + +    +   +A  L+ +LL   P  R
Sbjct: 266 DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR 325

Query: 332 CTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 389
            T+ +A   P+F E            P P    F   ++    +E L++  P+    +
Sbjct: 326 ITSEQAMQDPYFLED-----------PLPTSDVFAGCQIPYPKREFLTEEEPDDKGDK 372

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  203 bits (517), Expect = 2e-61
 Identities = 90/373 (24%), Positives = 149/373 (39%), Gaps = 83/373 (22%)

Query: 43  PEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTT---IGGRNGQPKQTISYMAERVV 99
             EI  + +  ++ +         G   + G  +      +  R         Y   +V+
Sbjct: 55  YPEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYR---------YEVLKVI 105

Query: 100 GQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVHY----- 148
           G+GSFG V +A   +  + VA+K V  +KR+        R L+ +R  D  N        
Sbjct: 106 GKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165

Query: 149 -------------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                                        Q   L  V+ + + I + L  +H    + H 
Sbjct: 166 ENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK-NRIIHC 224

Query: 184 DIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVD 242
           D+KP+N LL       +K+ DFGS+      +   +YI SR+YRAPE+I GA  Y   +D
Sbjct: 225 DLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFYRAPEVILGA-RYGMPID 281

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-----------CMNPNY 291
           +WS+GC+LAELL G PL PGE   DQL  +I++LG P+++ +               P Y
Sbjct: 282 MWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRY 341

Query: 292 TEFKF---------------PQIKAHPWHKIFHKRMPPEA----VDLVSRLLQYSPNLRC 332
                                +++  P  + +   +        +D + + L++ P +R 
Sbjct: 342 CTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401

Query: 333 TALEACIHPFFDE 345
           T  +A  HP+   
Sbjct: 402 TPGQALRHPWLRR 414

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  196 bits (500), Expect = 2e-59
 Identities = 94/372 (25%), Positives = 144/372 (38%), Gaps = 88/372 (23%)

Query: 53  GERVEKEMEATVVDGNGTETGHIIVT---TIGGRNGQPKQTISYMAERVVGQGSFGIVFQ 109
                K+      DG   +    IV        R         Y  + ++G+GSFG V +
Sbjct: 22  SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDR---------YEIDSLIGKGSFGQVVK 72

Query: 110 AKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVHY--------------- 148
           A      E VAIK +   K + N      R L+ M   D    +Y               
Sbjct: 73  AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132

Query: 149 ---------------SRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQN-LL 191
                          +   + + L   + +  Q+C AL ++    + + H D+KP+N LL
Sbjct: 133 LVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192

Query: 192 VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLA 251
            NP    +K+ DFGS+     G+    YI SR+YR+PE++ G   Y  A+D+WS+GC+L 
Sbjct: 193 CNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILV 249

Query: 252 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-----------CMNPNYTEFKFPQIK 300
           E+  G+PLF G + VDQ+ +I++VLG P    +              +  +   K    K
Sbjct: 250 EMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGK 309

Query: 301 AH---PWHKIFH-----KRMPPEA----------------VDLVSRLLQYSPNLRCTALE 336
                P  +  H     +   P                   DL+ R+L Y P  R     
Sbjct: 310 REYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369

Query: 337 ACIHPFFDELRD 348
           A  H FF +  D
Sbjct: 370 ALQHSFFKKTAD 381

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  193 bits (492), Expect = 2e-58
 Identities = 77/338 (22%), Positives = 124/338 (36%), Gaps = 74/338 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLL-------- 141
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 142 DHPNVHY----------------------------------SRASQRMPLIYVKLYTYQI 167
           D    ++                                      + +PLIYVK  + Q+
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 168 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-----VKLCDFGSAKVLVKGEPNISYICS 222
              L Y+H   G+ H DIKP+N+L+           +K+ D G+A      E   + I +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSIQT 198

Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVL 276
           R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II++L
Sbjct: 199 REYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 257

Query: 277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP--------------EAVDLVSR 322
           G      ++        F   +       K+    +                E  D +S 
Sbjct: 258 GELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316

Query: 323 LLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFP 360
           +LQ  P  R  A     HP+  +           R   
Sbjct: 317 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  190 bits (484), Expect = 3e-57
 Identities = 74/353 (20%), Positives = 129/353 (36%), Gaps = 92/353 (26%)

Query: 71  ETGHIIV---TTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD 127
           E  H        +            ++  R +G G+FG V   + ++  +  A+K V   
Sbjct: 21  EIVHFSWKKGMLLNNA---------FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI 71

Query: 128 KRYKN------RELQTM-----------RLLDH---------------PNVH-YSRASQR 154
           K+Y          L+ +           +                   P+++     +  
Sbjct: 72  KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNY 131

Query: 155 --MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN-LLVNPHTH-------------- 197
               +  +KLY  +I +AL Y+   + + H D+KP+N LL +P+                
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190

Query: 198 ---------QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGC 248
                     +KL DFG A    K + + S I +R YRAPE+I     +  + D+WS GC
Sbjct: 191 IQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGC 247

Query: 249 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---------KCMNPNYTEFKFPQI 299
           VLAEL  G  LF     ++ L  +  ++    +  +         K +N +  +  +P+ 
Sbjct: 248 VLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPEN 307

Query: 300 KAHPWHKIFHKRMPPEA--------VDLVSRLLQYSPNLRCTALEACIHPFFD 344
            +        K+  P           D +  +LQ  P LR +  E   H F +
Sbjct: 308 ASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  189 bits (481), Expect = 6e-57
 Identities = 77/351 (21%), Positives = 139/351 (39%), Gaps = 86/351 (24%)

Query: 72  TGHIIVTT---IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQD 127
           + H+I  +   +  R         Y     +G+G+FG V +    + G   VA+K V   
Sbjct: 1   SMHLICQSGDVLSAR---------YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV 51

Query: 128 KRYKN------RELQTM------------RLLDH---------------PNVH-YSRASQ 153
            RY        + L+ +            ++L+                 + + + + + 
Sbjct: 52  DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENG 111

Query: 154 R--MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN------------------ 193
                L +++   YQIC+++ ++H    + H D+KP+N+L                    
Sbjct: 112 FLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170

Query: 194 PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAEL 253
                +K+ DFGSA      E + + + +R+YRAPE+I     ++   D+WS+GC+L E 
Sbjct: 171 LINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEY 227

Query: 254 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIK---------CMNPNYTEFKFPQIKAHPW 304
            LG  +FP     + L  + ++LG   +  I+             ++ E           
Sbjct: 228 YLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA 287

Query: 305 HKIFHKRMPPE------AVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
            K   + M  +        DL+ ++L+Y P  R T  EA  HPFFD L+  
Sbjct: 288 CKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  185 bits (472), Expect = 1e-55
 Identities = 79/361 (21%), Positives = 130/361 (36%), Gaps = 86/361 (23%)

Query: 71  ETGHIIVT---TIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQ 126
           + GH++      +  R         Y     +G+G+FG V +      G   VA+K +  
Sbjct: 5   KEGHLVCRIGDWLQER---------YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN 55

Query: 127 DKRYKN------RELQTM------------RLLDH---------------PNVH-YSRAS 152
             +Y+         L+ +             + D                 N   + + +
Sbjct: 56  VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKEN 115

Query: 153 --QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN----------------- 193
             Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L                   
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174

Query: 194 -PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAE 252
                 +++ DFGSA      E + + + +R+YR PE+I     +    D+WS+GC+L E
Sbjct: 175 SVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFE 231

Query: 253 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQIKAHP 303
              G  LF      + LV + K+LG      I               + E          
Sbjct: 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 291

Query: 304 WHKIFHKRMPPEA------VDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
             K     M  ++       DL+ R+L++ P  R T  EA +HPFF  L          R
Sbjct: 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSR 351

Query: 358 P 358
            
Sbjct: 352 N 352

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  176 bits (448), Expect = 2e-52
 Identities = 65/347 (18%), Positives = 115/347 (33%), Gaps = 84/347 (24%)

Query: 56  VEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLET 115
           +      +     GTE  +    ++ GR         Y   + +G G    VFQ    E 
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSVKGRI--------YSILKQIGSGGSSKVFQVLN-EK 51

Query: 116 GETVAIKKV----LQDKRYKN--RELQTMRLLDHPNVH---------------------- 147
            +  AIK V      ++   +   E+  +  L   +                        
Sbjct: 52  KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN 111

Query: 148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 202
                + +  + +     K Y   +  A+  IH   G+ H D+KP N L+      +KL 
Sbjct: 112 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLI--VDGMLKLI 168

Query: 203 DFGSAKVLVKGEPNI---SYICSRYYRAPELIFGA----------TEYTTAVDIWSVGCV 249
           DFG A  +     ++   S + +  Y  PE I             ++ +   D+WS+GC+
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228

Query: 250 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 309
           L  +  G+  F         +  I             ++PN+ E +FP I          
Sbjct: 229 LYYMTYGKTPFQQIINQISKLHAI-------------IDPNH-EIEFPDI---------- 264

Query: 310 KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNG 356
                +  D++   L+  P  R +  E   HP+      P  ++  G
Sbjct: 265 --PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  176 bits (448), Expect = 2e-52
 Identities = 61/293 (20%), Positives = 93/293 (31%), Gaps = 83/293 (28%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL----DHP 144
           S+     +G GS+G VF+ +  E G   A+K+     +  + + R+L  +        HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 145 NV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                       H       +P   V  Y      ALA++H   
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH-SQ 176

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
           G+ H D+KP N+ + P     KL DFG    L              Y APEL+     Y 
Sbjct: 177 GLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGSYG 233

Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
           TA D++S+G  + E+     L  G                                    
Sbjct: 234 TAADVFSLGLTILEVACNMELPHG------------------------------------ 257

Query: 299 IKAHPWHKIFHKRMPP--------EAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                W ++    +PP        E   ++  +L+  P LR TA      P  
Sbjct: 258 --GEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  177 bits (450), Expect = 2e-52
 Identities = 64/344 (18%), Positives = 111/344 (32%), Gaps = 85/344 (24%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 147 H---------------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIG 179
                                       + +  + +     K Y   +  A+  IH   G
Sbjct: 70  KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HG 128

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFG--- 233
           + H D+KP N L+      +KL DFG A  +     ++   S + +  Y  PE I     
Sbjct: 129 IVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 234 -------ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
                   ++ +   D+WS+GC+L  +  G+  F         +  I             
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI------------- 233

Query: 287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
           ++PN+ E +FP I               +  D++   L+  P  R +  E   HP+    
Sbjct: 234 IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ-- 278

Query: 347 RDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 390
                      P   +     +E+K    +L+    P    K  
Sbjct: 279 -------IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAA 315

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  177 bits (451), Expect = 4e-52
 Identities = 64/344 (18%), Positives = 111/344 (32%), Gaps = 85/344 (24%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 147 H---------------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIG 179
                                       + +  + +     K Y   +  A+  IH   G
Sbjct: 117 KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HG 175

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGA-- 234
           + H D+KP N L+      +KL DFG A  +     ++   S + +  Y  PE I     
Sbjct: 176 IVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 235 --------TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
                   ++ +   D+WS+GC+L  +  G+  F         +  I             
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI------------- 280

Query: 287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
           ++PN+ E +FP I               +  D++   L+  P  R +  E   HP+    
Sbjct: 281 IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ-- 325

Query: 347 RDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 390
                      P   +     +E+K    +L+    P    K  
Sbjct: 326 -------IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAA 362

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  172 bits (438), Expect = 2e-50
 Identities = 50/350 (14%), Positives = 86/350 (24%), Gaps = 99/350 (28%)

Query: 83  RNGQPKQTIS--------YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK--- 131
                    S              +  G   +VF  + +E  E  A+K            
Sbjct: 46  PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE 105

Query: 132 ----NRELQTMRLLDHPNVHYSRASQR--------------------------------- 154
               +        L   +   +R  +R                                 
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165

Query: 155 -MPLIYVKL------------------------YTYQICRALAYIHGGIGVCHRDIKPQN 189
            MP   V L                         T Q+ R  A +    G+ H    P N
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ-SKGLVHGHFTPDN 224

Query: 190 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAVDIWSVGC 248
           L + P    + L D  +   +  G    +      Y   E +      +T A++ W +G 
Sbjct: 225 LFIMPDGR-LMLGDVSALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281

Query: 249 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF 308
            +  +      F   +   +       L  P  +                          
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD--------------------SLAFGS 321

Query: 309 HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD-PNARLPNGR 357
              +P     L+ R L +    R   LEA   P F +L++  ++ L  G+
Sbjct: 322 CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  161 bits (409), Expect = 1e-46
 Identities = 63/324 (19%), Positives = 99/324 (30%), Gaps = 86/324 (26%)

Query: 77  VTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKN 132
           +  I  ++        Y+  + +G+G F  V   + L  G   A+K++L    QD+    
Sbjct: 23  MVIIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74

Query: 133 RELQTMRLLDHPNV----------------------------------HYSRASQRMPLI 158
           RE    RL +HPN+                                          +   
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134

Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG----- 213
            +      ICR L  IH   G  HRD+KP N+L+     Q  L D GS            
Sbjct: 135 QILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSR 192

Query: 214 -----EPNISYICSRYYRAPELIFGA--TEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
                +   +  C+  YRAPEL             D+WS+GCVL  ++ G+  +      
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252

Query: 267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 326
              V +  V                 +   PQ            R       L++ ++  
Sbjct: 253 GDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMMTV 286

Query: 327 SPNLRCTALEACIHPFFDELRDPN 350
            P+ R             +   P 
Sbjct: 287 DPHQRPHIPLLLSQLEALQPPAPG 310

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  159 bits (404), Expect = 3e-46
 Identities = 72/299 (24%), Positives = 113/299 (37%), Gaps = 74/299 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRLLDHPNV------ 146
            V+G+G++GIV+  + L     +AIK++  +D RY      E+   + L H N+      
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                     +         I    YT QI   L Y+H    + 
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHDN-QIV 144

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATE-YTT 239
           HRDIK  N+L+N ++  +K+ DFG++K L    P   ++  +  Y APE+I      Y  
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           A DIWS+GC + E+  G+P F       +L E    +                 FK    
Sbjct: 205 AADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------FKVGMF 241

Query: 300 KAHPWHKIFHKRMP----PEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 354
           K HP        +P     EA   + +  +  P+ R  A +  +  F           P
Sbjct: 242 KVHP-------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  163 bits (413), Expect = 3e-46
 Identities = 62/292 (21%), Positives = 108/292 (36%), Gaps = 67/292 (22%)

Query: 91  ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLD-HPNV-- 146
           IS+  + V+G G+ G +   + +     VA+K++L +   + +RE+Q +R  D HPNV  
Sbjct: 24  ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 147 ----------HY--------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                      Y               +       +       Q    LA++H  + + H
Sbjct: 83  YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS-LNIVH 141

Query: 183 RDIKPQNLLVNPH----THQVKLCDFGSAKVLVKGEPNISY---IC-SRYYRAPELIFGA 234
           RD+KP N+L++        +  + DFG  K L  G  + S    +  +  + APE++   
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201

Query: 235 TE--YTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
            +   T  VDI+S GCV   ++  G   F                G   + +   +    
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQRQANILLGAC 245

Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                      P            A +L+ +++   P  R +A     HPFF
Sbjct: 246 -SLDCLH----PEKHE-----DVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  159 bits (405), Expect = 3e-46
 Identities = 54/299 (18%), Positives = 104/299 (34%), Gaps = 51/299 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPN-- 145
           ++   ++GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N  
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 146 ----VHYSRASQRMPLI--YVK---LYTY--------------------QICRALAYIHG 176
               +     ++   LI  +     LYT                      +   + ++  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 177 GIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
             G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P++   
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189

Query: 234 AT-------EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK--VLGTPTREEI 284
           A        +Y   VD+WS+G        G   F    G  +  E++   + G P+    
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249

Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                      +      P      + +      +++ +L+          +       
Sbjct: 250 GVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  163 bits (413), Expect = 4e-46
 Identities = 69/309 (22%), Positives = 120/309 (38%), Gaps = 84/309 (27%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMR-LLDHPNV---- 146
            ++E+++G GS G V   +    G  VA+K++L D       E++ +    DHPNV    
Sbjct: 17  VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY 75

Query: 147 ----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                             +            QI   +A++H  +
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-L 134

Query: 179 GVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGE----PNISYIC- 221
            + HRD+KPQN+LV+  +             ++ + DFG  K L  G+     N++    
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194

Query: 222 SRYYRAPELIFGATE------YTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
           +  +RAPEL+  +         T ++DI+S+GCV   +L  G+  F  +    +   II+
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRESNIIR 252

Query: 275 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 334
                              F   ++K      +       EA DL+S+++ + P  R TA
Sbjct: 253 -----------------GIFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPLKRPTA 290

Query: 335 LEACIHPFF 343
           ++   HP F
Sbjct: 291 MKVLRHPLF 299

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  158 bits (401), Expect = 1e-45
 Identities = 76/323 (23%), Positives = 114/323 (35%), Gaps = 82/323 (25%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKN---RELQTMR 139
           P+    Y+  R +G+G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70

Query: 140 LLDHPNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
            L H +V                             +  + +     + Y  QI     Y
Sbjct: 71  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE--------PNISYICSRY 224
           +H    V HRD+K  NL +N    +VK+ DFG + KV   GE        PN        
Sbjct: 131 LHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPN-------- 180

Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE++     ++  VD+WS+GC++  LL+G+P F      +  + I K          
Sbjct: 181 YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------- 230

Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   E+  P              + P A  L+ ++LQ  P  R T  E     FF 
Sbjct: 231 --------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDEFFT 270

Query: 345 ELRDPNARLPNGRPFPPLFNFKP 367
               P          PP F+  P
Sbjct: 271 SGYIPARLPITCLTIPPRFSIAP 293

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  157 bits (400), Expect = 2e-45
 Identities = 63/309 (20%), Positives = 105/309 (33%), Gaps = 87/309 (28%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV--- 146
           +    V+GQG+FG V +A+        AIKK+   +   +    E+  +  L+H  V   
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 147 -----HYSRASQRMPLIYVKLYTY--------------------------------QICR 169
                      + M  +  K   +                                QI  
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127

Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------ 223
           AL+YIH   G+ HRD+KP N+ ++  +  VK+ DFG AK + +    +            
Sbjct: 128 ALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185

Query: 224 ---------YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 274
                     Y A E++ G   Y   +D++S+G +  E++   P   G       V I+K
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RVNILK 239

Query: 275 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 334
            L +                +FP     P    F          ++  L+ + PN R  A
Sbjct: 240 KLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNKRPGA 278

Query: 335 LEACIHPFF 343
                  + 
Sbjct: 279 RTLLNSGWL 287

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  156 bits (397), Expect = 3e-45
 Identities = 68/296 (22%), Positives = 107/296 (36%), Gaps = 73/296 (24%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 147 --------------------------------HYSRASQRMPLIYVKLYTYQICRALAYI 174
                                             ++  Q +   +V     Q+  AL   
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 175 H----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 229
           H    GG  V HRD+KP N+ ++     VKL DFG A++L            + YY +PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186

Query: 230 LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
            +     Y    DIWS+GC+L EL    P F   S   +L   I+               
Sbjct: 187 QMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR--------------- 229

Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
              E KF +I           R   E  ++++R+L      R +  E   +P   E
Sbjct: 230 ---EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  161 bits (410), Expect = 3e-45
 Identities = 65/304 (21%), Positives = 113/304 (37%), Gaps = 76/304 (25%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 146
           Y   + +G G++G V   +   T    AIK +               E+  ++LLDHPN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 147 ---------------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
                                             ++            +   Q+   + Y
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV-------DAAVIIKQVLSGVTY 151

Query: 174 IHGGIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 231
           +H    + HRD+KP+N LL +      +K+ DFG + V    +     + + YY APE++
Sbjct: 152 LHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL 210

Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
               +Y    D+WS+G +L  LL G P F G++  DQ  EI+         +++     +
Sbjct: 211 RK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEKGKYTF 256

Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
                       W  +        A DL+ ++LQ+    R +A +A  HP+  E+     
Sbjct: 257 DS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKE 303

Query: 352 RLPN 355
               
Sbjct: 304 SGIE 307

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  157 bits (400), Expect = 3e-45
 Identities = 79/337 (23%), Positives = 122/337 (36%), Gaps = 82/337 (24%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKN---RELQTMR 139
           P+    Y+  R +G+G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 37  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96

Query: 140 LLDHPNV--------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
            L H +V                             +  + +     + Y  QI     Y
Sbjct: 97  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE--------PNISYICSRY 224
           +H    V HRD+K  NL +N    +VK+ DFG + KV   GE        PN        
Sbjct: 157 LHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPN-------- 206

Query: 225 YRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 284
           Y APE++     ++  VD+WS+GC++  LL+G+P F      +  + I K          
Sbjct: 207 YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------- 256

Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                   E+  P              + P A  L+ ++LQ  P  R T  E     FF 
Sbjct: 257 --------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDEFFT 296

Query: 345 ELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKL 381
               P          PP F+  P  L  ++++ L+ L
Sbjct: 297 SGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVL 333

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  161 bits (409), Expect = 3e-45
 Identities = 68/304 (22%), Positives = 118/304 (38%), Gaps = 76/304 (25%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 146
           Y    ++G+GSFG V + K   T +  A+K +       +D     RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 147 ---------------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
                                             +S                Q+   + Y
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVFSGITY 136

Query: 174 IHGGIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 231
           +H    + HRD+KP+N LL +      +K+ DFG +    +       I + YY APE++
Sbjct: 137 MHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195

Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
            G   Y    D+WS G +L  LL G P F G++  +   +I+        + ++     +
Sbjct: 196 RG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVETGKYAF 241

Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
                       W  I       +A DL+ ++L + P+LR TA +   HP+  +      
Sbjct: 242 DL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETP 288

Query: 352 RLPN 355
            + +
Sbjct: 289 TISD 292

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  161 bits (408), Expect = 6e-45
 Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 77/293 (26%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHPN 145
           Y  +RV+G+GSFG V   K   TG+  A+K +    ++ K  K    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 146 V---------------------------------HYSRASQRMPLIYVKLYTYQICRALA 172
           +                                  +S                Q+   + 
Sbjct: 88  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQVLSGIT 140

Query: 173 YIHGGIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 230
           Y+H    + HRD+KP+N LL +      +++ DFG +      +     I + YY APE+
Sbjct: 141 YMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 199

Query: 231 IFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 290
           + G   Y    D+WS G +L  LL G P F G +  +   +I+        ++++     
Sbjct: 200 LHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVEKGKYT 245

Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           +            W K+        A DL+ ++L Y P++R +A +A  H + 
Sbjct: 246 FEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  155 bits (394), Expect = 4e-44
 Identities = 69/306 (22%), Positives = 109/306 (35%), Gaps = 67/306 (21%)

Query: 74  HIIVTTIGGRNGQPKQTIS-YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQ 126
           H       G      Q++  Y+  + +G+GSFG     K  E G    IK++       +
Sbjct: 6   HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65

Query: 127 DKRYKNRELQTMRLLDHPN-VHY---------------------------SRASQRMPLI 158
           ++    RE+  +  + HPN V Y                           ++        
Sbjct: 66  EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED 125

Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 218
            +  +  QIC AL ++H    + HRDIK QN+ +      V+L DFG A+VL        
Sbjct: 126 QILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELAR 183

Query: 219 YIC-SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 277
               + YY +PE+      Y    DIW++GCVL EL   +  F   S +  LV  I    
Sbjct: 184 ACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKII--- 238

Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 337
                    ++ +Y                       +   LVS+L + +P  R +    
Sbjct: 239 ---SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRDRPSVNSI 274

Query: 338 CIHPFF 343
               F 
Sbjct: 275 LEKGFI 280

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  158 bits (402), Expect = 6e-44
 Identities = 70/303 (23%), Positives = 111/303 (36%), Gaps = 87/303 (28%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------------REL 135
           Y   R +G G++G V   K        AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 136 QTMRLLDHPNV---------------------------------HYSRASQRMPLIYVKL 162
             ++ LDHPN+                                  +              
Sbjct: 98  SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC-------DAAN 150

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYI 220
              QI   + Y+H    + HRDIKP+N LL N ++   +K+ DFG +    K       +
Sbjct: 151 IMKQILSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209

Query: 221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 280
            + YY APE++    +Y    D+WS G ++  LL G P F G++  DQ  +II       
Sbjct: 210 GTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII------- 256

Query: 281 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 340
            ++++     +          + W  I       EA +L+  +L Y  N RCTA EA   
Sbjct: 257 -KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEEALNS 302

Query: 341 PFF 343
            + 
Sbjct: 303 RWI 305

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  154 bits (391), Expect = 6e-44
 Identities = 62/306 (20%), Positives = 102/306 (33%), Gaps = 64/306 (20%)

Query: 71  ETGHIIVTTIGGRNGQPKQTIS-YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDK 128
             G ++   +   + + ++ +     +  VG+GSFG V + K  +TG   A+KKV L+  
Sbjct: 37  NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV- 95

Query: 129 RYKNRELQTMRLLDHPN-VHY--------------------S-----RASQRMPLIYVKL 162
            ++  EL     L  P  V                      S     +    +P      
Sbjct: 96  -FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY 154

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           Y  Q    L Y+H    + H D+K  N+L++    +  LCDFG A  L       S +  
Sbjct: 155 YLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213

Query: 223 R------YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 276
                   + APE++ G       VDIWS  C++  +L G   +         ++I    
Sbjct: 214 DYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-E 271

Query: 277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 336
             P                  +I              P     +   L+  P  R +A+E
Sbjct: 272 PPPI----------------REIPPS---------CAPLTAQAIQEGLRKEPVHRASAME 306

Query: 337 ACIHPF 342
                 
Sbjct: 307 LRRKVG 312

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  154 bits (391), Expect = 6e-44
 Identities = 72/342 (21%), Positives = 117/342 (34%), Gaps = 95/342 (27%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMR-LLDHPN-V 146
               RV+ +G F  V++A+ + +G   A+K++L    +  R   +E+  M+ L  HPN V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 147 HY-----------------------------------SRASQRMPLIYVKLYTYQICRAL 171
            +                                     +   +    V    YQ CRA+
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 172 AYIHG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------------EPNI 217
            ++H     + HRD+K +NLL++     +KLCDFGSA  +                E  I
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 218 SYICSRYYRAPELI--FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 275
           +   +  YR PE+I  +         DIW++GC+L  L   Q  F   +     + I+  
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRIVNG 264

Query: 276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 335
                            ++  P           H         L+  +LQ +P  R +  
Sbjct: 265 -----------------KYSIPP----------HDTQYTVFHSLIRAMLQVNPEERLSIA 297

Query: 336 EACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKEL 377
           E        E+        N  P  P+     Q     S  L
Sbjct: 298 EVVHQLQ--EIAAA----RNVNPKSPITELLEQNGGYGSATL 333

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  152 bits (387), Expect = 7e-44
 Identities = 69/299 (23%), Positives = 113/299 (37%), Gaps = 80/299 (26%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  ++   +A+K     ++ +        RE++    L HPN+   
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                                     +   +        Y  ++  AL+Y H    V HR
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRVIHR 133

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVK-------GEPNISYICSRYYRAPELIFGATE 236
           DIKP+NLL+      +K+ DFG +            G  +        Y  PE+I G   
Sbjct: 134 DIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YLPPEMIEG-RM 183

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           +   VD+WS+G +  E L+G+P F   +  +    I +V                 EF F
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTF 226

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPN 355
           P      +       +   A DL+SRLL+++P+ R    E   HP+        +   N
Sbjct: 227 P-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 273

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  153 bits (389), Expect = 8e-44
 Identities = 69/297 (23%), Positives = 108/297 (36%), Gaps = 84/297 (28%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPN 145
           +  E+ +G+G F  V++A CL  G  VA+KKV        + +    +E+  ++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 146 V------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIH 175
           V                              H+ +  + +P   V  Y  Q+C AL ++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYICSRYYR 226
               V HRDIKP N+ +      VKL D G  +           + G P        YY 
Sbjct: 154 SR-RVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTP--------YYM 203

Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIK 285
           +PE I     Y    DIWS+GC+L E+   Q  F G+   +  L + I+           
Sbjct: 204 SPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE----------- 251

Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                  +  +P + +             E   LV+  +   P  R           
Sbjct: 252 -------QCDYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  152 bits (386), Expect = 1e-43
 Identities = 61/295 (20%), Positives = 96/295 (32%), Gaps = 80/295 (27%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPN-VHY--- 148
           +    ++G G FG VF+AK    G+T  IK+V  +     RE++ +  LDH N VHY   
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 149 ----------------------------------------SRASQRMPLIYVKLYTYQIC 168
                                                    R  +++  +       QI 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132

Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 228
           + + YIH    + +RD+KP N+ +   T QVK+ DFG    L           +  Y +P
Sbjct: 133 KGVDYIHS-KKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190

Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 288
           E I    +Y   VD++++G +LAELL                ++                
Sbjct: 191 EQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD-------------- 233

Query: 289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                             I       +   L+ +LL   P  R    E       
Sbjct: 234 -----------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  159 bits (402), Expect = 2e-43
 Identities = 77/316 (24%), Positives = 118/316 (37%), Gaps = 51/316 (16%)

Query: 81  GGRNGQPKQTI--SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----R 133
           GGR+          +  +  +G G FG V +    +TGE VAIK+  Q+   KN      
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61

Query: 134 ELQTMRLLDHPNV----------HYSRASQRMPLI--YVK---LYTY------------- 165
           E+Q M+ L+HPNV               +    L   Y +   L  Y             
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121

Query: 166 -------QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPN 216
                   I  AL Y+H    + HRD+KP+N+++ P   +   K+ D G AK L +GE  
Sbjct: 122 PIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180

Query: 217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 276
             ++ +  Y APEL+    +YT  VD WS G +  E + G   F       Q    ++  
Sbjct: 181 TEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR-- 237

Query: 277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 336
              + E I   +      KF  +   P H         +    +  +L +    R T  +
Sbjct: 238 -EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQCMLMWHQRQRGTDPQ 294

Query: 337 ACIHPFFDELRDPNAR 352
                 F  L    + 
Sbjct: 295 NPNVGCFQALDSILSL 310

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  154 bits (390), Expect = 4e-43
 Identities = 57/304 (18%), Positives = 108/304 (35%), Gaps = 56/304 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNV- 146
           ++   ++GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+ 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 147 ----HYSRASQRMPLI---YVK---LYTY--------------------QICRALAYIHG 176
                    + R  ++   +     LYT                      +   + ++  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 177 GIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
             G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P++   
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189

Query: 234 AT-------EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK--VLGTPTREEI 284
           A        +Y   VD+WS+G        G   F    G  +  E++   + G P+    
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249

Query: 285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
                      +      P      + +      +++ +L+          +     FF 
Sbjct: 250 GVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ-----FFA 302

Query: 345 ELRD 348
           E  D
Sbjct: 303 ETSD 306

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  154 bits (391), Expect = 5e-43
 Identities = 79/345 (22%), Positives = 137/345 (39%), Gaps = 76/345 (22%)

Query: 51  IKGERVEKEMEATVVDGN----GTETGHIIVTTIGGRNGQPKQTIS----YMAERVVGQG 102
           +  E V K     + + +          + V      + Q     +    Y+  + +G G
Sbjct: 87  VNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSG 146

Query: 103 SFGIVFQAKCLETGETVAIKKVLQDKRYKN------------RELQTMRLLDHPNV---- 146
           + G V  A   +T + VAI+ + + K                 E++ ++ L+HP +    
Sbjct: 147 ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206

Query: 147 -------HY------------SR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                  +Y             +   ++R+     KLY YQ+  A+ Y+H   G+ HRD+
Sbjct: 207 NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDL 265

Query: 186 KPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATE--YTTA 240
           KP+N+L++       +K+ DFG +K+L +    +  +C +  Y APE++       Y  A
Sbjct: 266 KPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRA 324

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
           VD WS+G +L   L G P F        L + I   G               ++ F    
Sbjct: 325 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG---------------KYNFI--- 365

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
              W ++       +A+DLV +LL   P  R T  EA  HP+  +
Sbjct: 366 PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  149 bits (380), Expect = 7e-43
 Identities = 63/312 (20%), Positives = 122/312 (39%), Gaps = 84/312 (26%)

Query: 85  GQPKQTIS-YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQ 136
               + I  +    ++G+GSF  V++A+ + TG  VAIK + +   YK         E++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 137 TMRLLDHPNV---------------------------HYSRASQRMPLIYVKLYTYQICR 169
               L HP++                           +     +       + + +QI  
Sbjct: 64  IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123

Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE--------PNISYI 220
            + Y+H   G+ HRD+   NLL+  +   +K+ DFG + ++ +  E        PN    
Sbjct: 124 GMLYLH-SHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPN---- 177

Query: 221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 280
               Y +PE+    + +    D+WS+GC+   LL+G+P F  ++  + L +++       
Sbjct: 178 ----YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA----- 227

Query: 281 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 340
                       +++ P      +       +  EA DL+ +LL+ +P  R +      H
Sbjct: 228 ------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263

Query: 341 PFFDELRDPNAR 352
           PF        ++
Sbjct: 264 PFMSRNSSTKSK 275

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  149 bits (377), Expect = 3e-42
 Identities = 55/292 (18%), Positives = 104/292 (35%), Gaps = 80/292 (27%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV----- 146
            +G+GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+     
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG-GIGV 180
                                     Y +  + M +  ++ +  QI + L ++H     +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPELIFG 233
            HRD+K  N+ +   T  VK+ D G A +        V G P         + APE+   
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAPEMY-- 202

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
             +Y  +VD+++ G  + E+   +  +       Q+                        
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------------------------ 238

Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
           ++       P    F K   PE  +++   ++ + + R +  +   H FF E
Sbjct: 239 YRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  148 bits (377), Expect = 3e-42
 Identities = 66/287 (22%), Positives = 105/287 (36%), Gaps = 80/287 (27%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNV--- 146
           R +G+G FG V+ A+  +    +A+K     ++ ++       RE++    L HPN+   
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                                     +   R        +  ++  AL Y H    V HR
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE-RKVIHR 138

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVK-------GEPNISYICSRYYRAPELIFGATE 236
           DIKP+NLL+      +K+ DFG +            G  +        Y  PE+I G   
Sbjct: 139 DIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YLPPEMIEG-KT 188

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           +   VD+W  G +  E L+G P F   S  +    I+ V                 + KF
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DLKF 231

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           P     P+       +   + DL+S+LL+Y P  R        HP+ 
Sbjct: 232 P-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  149 bits (378), Expect = 4e-42
 Identities = 76/334 (22%), Positives = 128/334 (38%), Gaps = 72/334 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKN--------RELQTMRL 140
           Y+  + +G G+ G V  A   +T + VAIK    +       +          E++ ++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 141 LDHPNVHYSRASQRMPLIYV-------------------------KLYTYQICRALAYIH 175
           L+HP +   +        Y+                         KLY YQ+  A+ Y+H
Sbjct: 72  LNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 176 GGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 232
              G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C +  Y APE++ 
Sbjct: 132 E-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLV 189

Query: 233 GATE--YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 290
                 Y  AVD WS+G +L   L G P F        L + I   G             
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG------------- 235

Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
             ++ F       W ++       +A+DLV +LL   P  R T  EA  HP+  +     
Sbjct: 236 --KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD----E 281

Query: 351 ARLPNGRPFPPLFNFKPQELKGASKELLSKLIPE 384
                 +      N      +  ++   S+  P 
Sbjct: 282 DMKRKFQDLLSEENESTALPQVLAQPSTSRKRPR 315

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  148 bits (375), Expect = 4e-42
 Identities = 74/302 (24%), Positives = 118/302 (39%), Gaps = 76/302 (25%)

Query: 85  GQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTM 138
           G  K  I+  Y  E  +G+GS+G V  A    T    A K      ++D     +E++ M
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 139 RLLDHPNV---------------------------------HYSRASQRMPLIYVKLYTY 165
           + LDHPN+                                  +  +              
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-------DAARIMK 113

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSR 223
            +  A+AY H  + V HRD+KP+N L    +    +KL DFG A     G+   + + + 
Sbjct: 114 DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172

Query: 224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 283
           YY +P+++ G   Y    D WS G ++  LL G P F   +  + +++I +         
Sbjct: 173 YYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG-------- 222

Query: 284 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                     F FP      W  +      P+A  L+ RLL  SP  R T+L+A  H +F
Sbjct: 223 ---------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWF 265

Query: 344 DE 345
           ++
Sbjct: 266 EK 267

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  150 bits (380), Expect = 8e-42
 Identities = 68/312 (21%), Positives = 109/312 (34%), Gaps = 60/312 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTMRLLDHPNV-- 146
           Y     +G G+FG+V +     TG     K        DK     E+  M  L HP +  
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 147 ---HYSRASQR---MPLI-------------------YVKLYTYQICRALAYIHGGIGVC 181
               +    +    +  +                    V  Y  Q C  L ++H    + 
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIV 171

Query: 182 HRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
           H DIKP+N++        VK+ DFG A  L   E       +  + APE I         
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVGFY 230

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
            D+W++G +   LL G   F GE  ++ L  + +                  +++F    
Sbjct: 231 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-----------------DWEFD--- 270

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF-DELRDPNARLPNGRPF 359
              +  +      PEA D +  LLQ  P  R T  +A  HP+   +  +  +R+P+ R  
Sbjct: 271 EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYN 325

Query: 360 PPLFNFKPQELK 371
                 K +   
Sbjct: 326 KIRQKIKEKYAD 337

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  147 bits (374), Expect = 8e-42
 Identities = 49/322 (15%), Positives = 85/322 (26%), Gaps = 114/322 (35%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL----DHPN 145
           +     +G G FG VF+      G   AIK+    L     +   L+ +        H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 146 V------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIH 175
           V                                 R         +K    Q+ R L YIH
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 176 GGIGVCHRDIKPQNLLVNPH------------------THQVKLCDFGSAKVL-----VK 212
             + + H DIKP N+ ++                        K+ D G    +      +
Sbjct: 133 S-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191

Query: 213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 272
           G+          + A E++     +    DI+++   +      +PL             
Sbjct: 192 GDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---------- 233

Query: 273 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP-------EAVDLVSRLLQ 325
                                          WH+I   R+P        E  +L+  ++ 
Sbjct: 234 ----------------------------GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIH 265

Query: 326 YSPNLRCTALEACIHPFFDELR 347
             P  R +A+    H       
Sbjct: 266 PDPERRPSAMALVKHSVLLSAS 287

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  149 bits (377), Expect = 9e-42
 Identities = 58/323 (17%), Positives = 113/323 (34%), Gaps = 76/323 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN----------------REL 135
           R + QG F  +   +  +  +  A+K      + + + +                   EL
Sbjct: 37  RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 136 QTMRLLDHPNV----------------------------------HYSRASQRMPLIYVK 161
           Q +  + +                                          +  +P+  +K
Sbjct: 95  QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 162 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 221
                +  + +YIH    +CHRD+KP N+L++ +   VKL DFG ++ +V  +  I    
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK--IKGSR 211

Query: 222 -SRYYRAPELIFGATEY-TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 279
            +  +  PE     + Y    VDIWS+G  L  +      F  +  + +L   I+     
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR----- 266

Query: 280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 339
             + I+   P      F     +      +  +  E +D +   L+ +P  R T+ +A  
Sbjct: 267 -TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322

Query: 340 HPFF-----DELRDPNARLPNGR 357
           H +      ++LR+ +  L   R
Sbjct: 323 HEWLADTNIEDLREFSKELYKKR 345

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  149 bits (378), Expect = 1e-41
 Identities = 66/400 (16%), Positives = 114/400 (28%), Gaps = 135/400 (33%)

Query: 42  LPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAE----- 96
           + E  N +     R   E   +  D         +V+T     GQP +  S + E     
Sbjct: 24  IEELFNRIPQANVRTTSEYMQSAADS--------LVSTSLWNTGQPFRVESELGERPRTL 75

Query: 97  ---RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL----- 141
               V+GQ       +A   ETGE+  +      +R  +        E+  +RLL     
Sbjct: 76  VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135

Query: 142 --------------------DHPNV----------------------------------H 147
                                   +                                   
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195

Query: 148 YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 207
           +S   + +        T Q+ R LA +H   G+ H  ++P +++++     V L  F   
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGG-VFLTGFEHL 253

Query: 208 KVLVKGEPNISYICSRYYRAPELI----------FGATEYTTAVDIWSVGCVLAELLLGQ 257
              V+    +    SR +  PEL              T  T + D W++G V+  +    
Sbjct: 254 ---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 258 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH--KRMPPE 315
                ++ +                                        IF   K +P  
Sbjct: 311 LPITKDAALG-----------------------------------GSEWIFRSCKNIPQP 335

Query: 316 AVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP-NARLP 354
              L+   L+Y    R   L+A   P +++LR   +A LP
Sbjct: 336 VRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  147 bits (374), Expect = 1e-41
 Identities = 68/288 (23%), Positives = 111/288 (38%), Gaps = 74/288 (25%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVA---IKKVLQDKRYKNRELQTMRLLDHPNV--- 146
           YM    +G+G FGIV +     + +T     +K    D+    +E+  + +  H N+   
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 147 -------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIH 175
                                            +          +  Y +Q+C AL ++H
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVCEALQFLH 119

Query: 176 GGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 233
               + H DI+P+N++     +  +K+ +FG A+ L  G+     +  +  Y APE +  
Sbjct: 120 S-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPE-VHQ 176

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
               +TA D+WS+G ++  LL G   F  E+  +Q  +II        E I      + E
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYTFDE 224

Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 341
             F +I               EA+D V RLL      R TA EA  HP
Sbjct: 225 EAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  146 bits (372), Expect = 2e-41
 Identities = 71/303 (23%), Positives = 118/303 (38%), Gaps = 80/303 (26%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----RELQTMRLLDHPNV-- 146
           ++   V+G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H N+  
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 147 -------------------------------HYS--RASQRMPLIYVKLYTYQICRALAY 173
                                           Y+   AS             Q+  A+ Y
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---------VIQQVLSAVKY 121

Query: 174 IHGGIGVCHRDIKPQNLLV-NPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 230
           +H   G+ HRD+KP+NLL   P  + ++ + DFG +K+   G   +S  C +  Y APE 
Sbjct: 122 LHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPE- 177

Query: 231 IFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 290
           +     Y+ AVD WS+G +   LL G P F  E+      +I +                
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG--------------- 222

Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
              ++F    +  W  I        A D +  LL+  PN R T  +A  HP+ D     +
Sbjct: 223 --YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALH 272

Query: 351 ARL 353
             +
Sbjct: 273 RDI 275

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  146 bits (370), Expect = 3e-41
 Identities = 65/317 (20%), Positives = 108/317 (34%), Gaps = 92/317 (29%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYKNRELQTMRLLDHPN-V 146
           +   + +G+G FG+VF+AK        AIK++        +    RE++ +  L+HP  V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 147 HY----------------------------------------SRASQRMPLIYVKLYTYQ 166
            Y                                            +            Q
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 167 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--- 223
           I  A+ ++H   G+ HRD+KP N+        VK+ DFG    + + E   + +      
Sbjct: 127 IAEAVEFLHS-KGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 224 ----------YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
                      Y +PE I G   Y+  VDI+S+G +L ELL   P F  +    + +  +
Sbjct: 185 ARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTDV 240

Query: 274 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           +                    KFP +           +  P    +V  +L  SP  R  
Sbjct: 241 R------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPE 273

Query: 334 ALEACIHPFFDELRDPN 350
           A+    +  F++L  P 
Sbjct: 274 AINIIENAVFEDLDFPG 290

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  145 bits (368), Expect = 5e-41
 Identities = 71/318 (22%), Positives = 114/318 (35%), Gaps = 82/318 (25%)

Query: 74  HIIVTTIGGRNGQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQ 126
           H    + G  N   + TI   ++ +R +G G+FG V   +   +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 127 DKRYKNRELQTMRLLDHPNV-------------------------------------HYS 149
                  E++ ++ LDHPN+                                       S
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS 122

Query: 150 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSA 207
                    YV     Q+  ALAY H    V H+D+KP+N+L    +    +K+ DFG A
Sbjct: 123 EG-------YVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174

Query: 208 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
           ++    E + +   +  Y APE+     + T   DIWS G V+  LL G   F G S  +
Sbjct: 175 ELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE 232

Query: 268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 327
              +                     E  +               + P+AVDL+ ++L   
Sbjct: 233 VQQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLKQMLTKD 266

Query: 328 PNLRCTALEACIHPFFDE 345
           P  R +A +   H +F +
Sbjct: 267 PERRPSAAQVLHHEWFKQ 284

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  147 bits (372), Expect = 5e-41
 Identities = 66/292 (22%), Positives = 108/292 (36%), Gaps = 75/292 (25%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNV----- 146
           Y  +  +G GS+ +  +     T    A+K + + KR    E++ + R   HPN+     
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 147 ----------------------------HYS--RASQRMPLIYVKLYTYQICRALAYIHG 176
                                        +S   AS  +         + I + + Y+H 
Sbjct: 84  VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL---------FTITKTVEYLHA 134

Query: 177 GIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 232
             GV HRD+KP N+L    + +   +++CDFG AK L      +   C +  + APE + 
Sbjct: 135 -QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VL 192

Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKCMNPNY 291
               Y  A DIWS+G +L  +L G   F           + ++  G              
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-------------- 238

Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            +F         W+ +        A DLVS++L   P+ R TA     HP+ 
Sbjct: 239 -KFSLS---GGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  150 bits (380), Expect = 1e-40
 Identities = 74/372 (19%), Positives = 124/372 (33%), Gaps = 75/372 (20%)

Query: 27  PAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQ 86
           P +P         ++      ++  +G+ V  +   +    N                  
Sbjct: 93  PCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLD 142
                 Y     +G G+FG+V +     TG   A K V      DK    +E+QTM +L 
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212

Query: 143 HPNV----------------------------------HYSRASQRMPLIYVKLYTYQIC 168
           HP +                                    S             Y  Q+C
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE-------AVEYMRQVC 265

Query: 169 RALAYIHGGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 227
           + L ++H      H D+KP+N++     ++++KL DFG    L   +       +  + A
Sbjct: 266 KGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 324

Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 287
           PE+  G        D+WSVG +   LL G   F GE+  +            T   +K  
Sbjct: 325 PEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSC 371

Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF--DE 345
           + N  +  F  I               +  D + +LL   PN R T  +A  HP+     
Sbjct: 372 DWNMDDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418

Query: 346 LRDPNARLPNGR 357
               ++++P+ R
Sbjct: 419 APGRDSQIPSSR 430

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (368), Expect = 2e-40
 Identities = 62/321 (19%), Positives = 105/321 (32%), Gaps = 83/321 (25%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 142
           Y     +G G F +V + +   TG   A K          +    +    RE+  ++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 143 HPNV---------------------------------HYSRASQRMPLIYVKLYTYQICR 169
           HPNV                                   +             +  QI  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE-------ATEFLKQILN 125

Query: 170 ALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYY 225
            + Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G      I  +  +
Sbjct: 126 GVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEF 183

Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
            APE I          D+WS+G +   LL G   F G++  + L  +  V          
Sbjct: 184 VAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV---------- 232

Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
                   ++F       +           A D + RLL   P  R T  ++  HP+   
Sbjct: 233 -------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

Query: 346 LRDPNARLPNGRPFPPLFNFK 366
            +D    L        +  FK
Sbjct: 278 -KDTQQALSRKASAVNMEKFK 297

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  144 bits (365), Expect = 2e-40
 Identities = 68/294 (23%), Positives = 113/294 (38%), Gaps = 76/294 (25%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y    ++G+GSFG V + K   T +  A+K + +            RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 147 ---------------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
                                             +S                Q+   + Y
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVFSGITY 136

Query: 174 IHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 231
           +H    + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++
Sbjct: 137 MHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195

Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
            G   Y    D+WS G +L  LL G P F G++  D L  +                   
Sbjct: 196 RG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET----------------- 236

Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
            ++ F       W  I       +A DL+ ++L + P+LR TA +   HP+  +
Sbjct: 237 GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  147 bits (372), Expect = 2e-40
 Identities = 65/384 (16%), Positives = 110/384 (28%), Gaps = 124/384 (32%)

Query: 76  IVTTIGGRNGQPKQTISYMAER--------VVGQGSFGIVFQAKCLETGETVAIKKVLQD 127
           +V+T     GQP +  S + ER        V+GQ       +A   ETGE+  +      
Sbjct: 55  LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 114

Query: 128 KRYKN-------RELQTMRLL-------------------------DHPNVHYSRASQR- 154
           +R  +        E+  +RLL                             +   R  +R 
Sbjct: 115 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 174

Query: 155 ---------MPLIYVKL------------------------YTYQICRALAYIHGGIGVC 181
                     P +   L                         T Q+ R LA +H   G+ 
Sbjct: 175 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLV 233

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY----YRAPELIFGA--- 234
           H  ++P +++++     V L  F        G   +S I   +      A  ++      
Sbjct: 234 HTYLRPVDIVLDQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHH 290

Query: 235 -TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
            T  T A D W++G  +  +         ++ +                           
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------------------------ 326

Query: 294 FKFPQIKAHPWHKIFH--KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD-PN 350
                        IF   K +P     L+   L+Y    R   L+A   P +++LR   +
Sbjct: 327 -----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 375

Query: 351 ARLPNGRPFPPLFNFKPQELKGAS 374
           A LP  +              G S
Sbjct: 376 AALPLYQTDGEPTREGGAPPSGTS 399

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  144 bits (366), Expect = 4e-40
 Identities = 76/300 (25%), Positives = 117/300 (39%), Gaps = 78/300 (26%)

Query: 84  NGQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMR 139
           +G  +  +S  +  E  +G+G+  IV++ K   T +  A+K + +    K    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103

Query: 140 LLDHPNV---------------------------------HYS--RASQRMPLIYVKLYT 164
            L HPN+                                 +YS   A+            
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD---------AV 154

Query: 165 YQICRALAYIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC- 221
            QI  A+AY+H   G+ HRD+KP+NLL   P     +K+ DFG +K++      +  +C 
Sbjct: 155 KQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCG 212

Query: 222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 281
           +  Y APE I     Y   VD+WSVG +   LL G   F  E G   +   I        
Sbjct: 213 TPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL------- 264

Query: 282 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 341
               C      E+ F    +  W ++        A DLV +L+   P  R T  +A  HP
Sbjct: 265 ---NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQHP 307

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  143 bits (362), Expect = 4e-40
 Identities = 64/307 (20%), Positives = 101/307 (32%), Gaps = 82/307 (26%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 142
           Y     +G G F IV + +   TG+  A K          +    +    RE+  +R + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 143 HPNV---------------------------------HYSRASQRMPLIYVKLYTYQICR 169
           HPN+                                   +             +  QI  
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE-------ATQFLKQILD 119

Query: 170 ALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYY 225
            + Y+H    + H D+KP+N+++   N    ++KL DFG A  +  G      I  +  +
Sbjct: 120 GVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEF 177

Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
            APE I          D+WS+G +   LL G   F GE+  + L  I  V          
Sbjct: 178 VAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV---------- 226

Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
                   + F       +           A D + RLL   P  R T  ++  H +   
Sbjct: 227 -------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271

Query: 346 LRDPNAR 352
           +R  N R
Sbjct: 272 IRRRNVR 278

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  144 bits (364), Expect = 6e-40
 Identities = 68/319 (21%), Positives = 120/319 (37%), Gaps = 63/319 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNV-----HYS 149
           ++V+G G  G V +     TG+  A+K +L D     +E+    +    P++      Y 
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILDVYE 92

Query: 150 RASQRMPLIYV-------------------KLYT--------YQICRALAYIHGGIGVCH 182
                   + +                   + +T          I  A+ ++H    + H
Sbjct: 93  NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAH 151

Query: 183 RDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTT 239
           RD+KP+NLL  +      +KL DFG AK   +    +   C + YY APE + G  +Y  
Sbjct: 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGPEKYDK 208

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           + D+WS+G ++  LL G P F   +G      + +         I+       ++ FP  
Sbjct: 209 SCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-----QYGFP-- 253

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF-DELRDPNARLPNGRP 358
               W ++       +A  L+  LL+  P  R T  +   HP+    +  P   L   R 
Sbjct: 254 -NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARV 307

Query: 359 FPPLFNFKPQELKGASKEL 377
                +   +  +  +  L
Sbjct: 308 LQEDKDHWDEVKEEMTSAL 326

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  145 bits (368), Expect = 6e-40
 Identities = 77/326 (23%), Positives = 125/326 (38%), Gaps = 64/326 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNV----- 146
            +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++     
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVD 122

Query: 147 HYSRASQRMPLIYV-------------------KLYT--------YQICRALAYIHGGIG 179
            Y         + +                   + +T          I  A+ Y+H  I 
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-IN 181

Query: 180 VCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
           + HRD+KP+NLL  +   +  +KL DFG AK         +   + YY APE + G  +Y
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKY 240

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
             + D+WS+G ++  LL G P F    G+     +           I+       +++FP
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MGQYEFP 287

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD-PNARLPNG 356
                 W ++       E   L+  LL+  P  R T  E   HP+  +    P   L   
Sbjct: 288 ---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 339

Query: 357 RPFPPLFNFKPQELKGASKELLSKLI 382
           R        + +++K   +E+ S L 
Sbjct: 340 RVL-KEDKERWEDVK---EEMTSALA 361

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  144 bits (365), Expect = 8e-40
 Identities = 67/321 (20%), Positives = 102/321 (31%), Gaps = 83/321 (25%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 142
           Y     +G G F IV + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 143 HPNV---------------------------------HYSRASQRMPLIYVKLYTYQICR 169
           HPN+                                   S             +  QI  
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFIKQILD 126

Query: 170 ALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYY 225
            + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G      I  +  +
Sbjct: 127 GVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184

Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
            APE I          D+WS+G +   LL G   F G++  + L  I  V          
Sbjct: 185 VAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV---------- 233

Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
                   + F       + +         A D + +LL      R T  EA  HP+   
Sbjct: 234 -------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

Query: 346 LRDPNARLPNGRPFPPLFNFK 366
             D    +        L NFK
Sbjct: 279 -VDTQQAMVRRESVVNLENFK 298

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  143 bits (362), Expect = 9e-40
 Identities = 66/321 (20%), Positives = 100/321 (31%), Gaps = 83/321 (25%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 142
           Y     +G G F IV + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 143 HPNV---------------------------------HYSRASQRMPLIYVKLYTYQICR 169
           H NV                                   S             +  QI  
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFIKQILD 126

Query: 170 ALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYY 225
            + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G      I  +  +
Sbjct: 127 GVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184

Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
            APE I          D+WS+G +   LL G   F G++  + L  I  V          
Sbjct: 185 VAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---------- 233

Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
                   + F       +           A D + +LL      R T  EA  HP+   
Sbjct: 234 -------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

Query: 346 LRDPNARLPNGRPFPPLFNFK 366
             D    +        L NF+
Sbjct: 279 -VDNQQAMVRRESVVNLENFR 298

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  143 bits (362), Expect = 1e-39
 Identities = 63/293 (21%), Positives = 120/293 (40%), Gaps = 69/293 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-NRELQTMRLLD-HPNV---- 146
            + ++ +G+GSF I  +    ++ +  A+K + +       +E+  ++L + HPN+    
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 147 -----------------------------HYS--RASQRMPLIYVKLYTYQICRALAYIH 175
                                        H+S   AS  M          ++  A++++H
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM---------RKLVSAVSHMH 123

Query: 176 GGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 232
             +GV HRD+KP+NLL  + + + ++K+ DFG A++       +   C + +Y APE + 
Sbjct: 124 D-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LL 181

Query: 233 GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 292
               Y  + D+WS+G +L  +L GQ  F            ++++     ++IK       
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG----- 231

Query: 293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
           +F F       W  +       EA DL+  LL   PN R        + +  +
Sbjct: 232 DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  145 bits (368), Expect = 1e-39
 Identities = 73/297 (24%), Positives = 111/297 (37%), Gaps = 80/297 (26%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y     +G+G+F +V +   +  G+  A   +   K          RE +  RLL HPN+
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 147 ---------------------------------HYS--RASQRMPLIYVKLYTYQICRAL 171
                                            +YS   AS             QI  A+
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---------CIQQILEAV 123

Query: 172 AYIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 228
            + H  +GV HR++KP+NLL  +      VKL DFG A  +   +        +  Y +P
Sbjct: 124 LHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182

Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 288
           E +     Y   VD+W+ G +L  LL+G P F  E       +I                
Sbjct: 183 E-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA-------------- 227

Query: 289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
                + FP   +  W  +      PEA DL++++L  +P+ R TA EA  HP+   
Sbjct: 228 ---GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  143 bits (362), Expect = 2e-39
 Identities = 82/324 (25%), Positives = 114/324 (35%), Gaps = 71/324 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDH 143
           Y    V+G+G F +V +    ETG+  A+K V   K   +         RE     +L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 144 PNV-----HYS---------------------RASQRMPLIY----VKLYTYQICRALAY 173
           P++      YS                             +Y       Y  QI  AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 174 IHGGIGVCHRDIKPQN-LLVNPH-THQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 230
            H    + HRD+KP   LL +   +  VKL  FG A  L +          + ++ APE 
Sbjct: 146 CHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE- 203

Query: 231 IFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 290
           +     Y   VD+W  G +L  LL G   F G    ++L E I                 
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII---------------- 245

Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 350
             ++K        W  I        A DLV R+L   P  R T  EA  HP+  E     
Sbjct: 246 KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297

Query: 351 ARLPNGRPFPPLFNFKPQ-ELKGA 373
            ++        L  F  + +LKGA
Sbjct: 298 YKIHLPETVEQLRKFNARRKLKGA 321

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  140 bits (356), Expect = 3e-39
 Identities = 72/295 (24%), Positives = 107/295 (36%), Gaps = 81/295 (27%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y  +  +G+G+F +V +     TG   A K +   K          RE +  R L HPN+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 147 ---------------------------------HYS--RASQRMPLIYVKLYTYQICRAL 171
                                             YS   AS  +          QI  ++
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI---------QQILESI 118

Query: 172 AYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 228
           AY H   G+ HR++KP+NLL+        VKL DFG A  +   E        +  Y +P
Sbjct: 119 AYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYLSP 176

Query: 229 ELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 288
           E +     Y+  VDIW+ G +L  LL+G P F  E       +I                
Sbjct: 177 E-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------------- 222

Query: 289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                + +P   +  W  +      PEA  L+  +L  +P  R TA +A   P+ 
Sbjct: 223 ----AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  142 bits (360), Expect = 4e-39
 Identities = 78/325 (24%), Positives = 117/325 (36%), Gaps = 80/325 (24%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y  +  +G+G+F +V +     TG   A K +   K          RE +  R L HPN+
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 147 ---------------------------------HYS--RASQRMPLIYVKLYTYQICRAL 171
                                             YS   AS             QI  ++
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---------CIQQILESI 141

Query: 172 AYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 229
           AY H   G+ HR++KP+NLL+        VKL DFG A  +   E    +  +  Y +PE
Sbjct: 142 AYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 200

Query: 230 LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
            +     Y+  VDIW+ G +L  LL+G P F  E       +I                 
Sbjct: 201 -VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-------------- 245

Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
               + +P   +  W  +      PEA  L+  +L  +P  R TA +A   P+       
Sbjct: 246 ---AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 294

Query: 350 NARLPNGRPFPPLFNFKP-QELKGA 373
            + +        L  F   ++LKGA
Sbjct: 295 ASAIHRQDTVDCLKKFNARRKLKGA 319

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  139 bits (353), Expect = 3e-38
 Identities = 63/302 (20%), Positives = 110/302 (36%), Gaps = 49/302 (16%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQTMRLLDHPN-VHY--- 148
            +G G+ G+VF+     +G  +A K +   ++        RELQ +   + P  V +   
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 149 ----------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 186
                                  + + R+P   +   +  + + L Y+     + HRD+K
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 159

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSV 246
           P N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G   Y+   DIWS+
Sbjct: 160 PSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGTH-YSVQSDIWSM 216

Query: 247 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 306
           G  L E+ +G+   P     +  +     +     E                + + P   
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276

Query: 307 IF---------------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
           IF                     E  D V++ L  +P  R    +  +H F         
Sbjct: 277 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 336

Query: 352 RL 353
             
Sbjct: 337 DF 338

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  139 bits (353), Expect = 5e-38
 Identities = 66/295 (22%), Positives = 112/295 (37%), Gaps = 61/295 (20%)

Query: 80  IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNREL 135
           +  + G      +     ++G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 136 QTMRLLDHPNV-----HYSRASQRMPLI-----------------------YVKLYTYQI 167
             M  LDH N+      +  +   + L+                          L+  QI
Sbjct: 138 SVMNQLDHANLIQLYDAFE-SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196

Query: 168 CRALAYIHGGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 226
           C  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+     E       +  + 
Sbjct: 197 CEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFL 255

Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
           APE +      +   D+WSVG +   LL G   F G++  + L  I+             
Sbjct: 256 APE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC----------- 303

Query: 287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 341
                  +         +  I       EA + +S+LL    + R +A EA  HP
Sbjct: 304 ------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEALKHP 344

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  136 bits (345), Expect = 1e-37
 Identities = 69/308 (22%), Positives = 113/308 (36%), Gaps = 92/308 (29%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK------------KVLQDKRYK-NRELQTMR 139
           Y  + ++G+G   +V +     T +  A+K            + +Q+ R    +E+  +R
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 140 LLD-HPNV---------------------------------HYS--RASQRMPLIYVKLY 163
            +  HPN+                                   S     + M        
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM-------- 130

Query: 164 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 222
              +   +  +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE  +  +C +
Sbjct: 131 -RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LREVCGT 186

Query: 223 RYYRAPELIFGATE-----YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 277
             Y APE+I  +       Y   VD+WS G ++  LL G P F     +  L  I+    
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-- 244

Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 337
                           ++F    +  W             DLVSR L   P  R TA EA
Sbjct: 245 ---------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAEEA 281

Query: 338 CIHPFFDE 345
             HPFF +
Sbjct: 282 LAHPFFQQ 289

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  135 bits (341), Expect = 8e-37
 Identities = 72/305 (23%), Positives = 114/305 (37%), Gaps = 80/305 (26%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTM-RLLDHPNV---- 146
           E V+G+G+   V     L T +  A+K    +    +    RE++ + +   H NV    
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 147 -----------------------------HYS--RASQRMPLIYVKLYTYQICRALAYIH 175
                                        H++   AS  +           +  AL ++H
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV---------QDVASALDFLH 128

Query: 176 GGIGVCHRDIKPQNLL-VNP-HTHQVKLCDFGSAKVLVKGE-------PNISYIC-SRYY 225
              G+ HRD+KP+N+L  +P     VK+CDF     +           P +   C S  Y
Sbjct: 129 N-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 226 RAPELI----FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 281
            APE++      A+ Y    D+WS+G +L  LL G P F G  G D   +  +       
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247

Query: 282 ---EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
              E I+       +++FP      W  I        A DL+S+LL      R +A +  
Sbjct: 248 MLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRLSAAQVL 294

Query: 339 IHPFF 343
            HP+ 
Sbjct: 295 QHPWV 299

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  135 bits (341), Expect = 1e-36
 Identities = 61/299 (20%), Positives = 104/299 (34%), Gaps = 66/299 (22%)

Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 146
           +  + +G+G F +V Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 147 ------------HY----------------SRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                            ++ +    V     QI   + Y+H   
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-N 150

Query: 179 GVCHRDIKPQN-LLVNPH-THQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT 235
            + H D+KPQN LL + +    +K+ DFG ++ +      +  I  +  Y APE I    
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPE-ILNYD 208

Query: 236 EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 295
             TTA D+W++G +   LL     F GE   +  + I +V                    
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-----------------NVD 251

Query: 296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 354
           +       +  +        A D +  LL  +P  R TA     H +  +    N   P
Sbjct: 252 YS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHP 302

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  134 bits (339), Expect = 1e-36
 Identities = 72/315 (22%), Positives = 116/315 (36%), Gaps = 75/315 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN---RELQTMRLLDHP 144
           Y+   ++G+GS+G V +    ET    A+K     K+ +    +    +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 145 N------VHYSRASQRMPLI--YVK-----LYTY----------------QICRALAYIH 175
           N      V Y+   Q+M ++  Y       +                   Q+   L Y+H
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAPELIF 232
              G+ H+DIKP NLL+      +K+   G A+ L     +        S  ++ PE+  
Sbjct: 127 -SQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 233 GATEYT-TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
           G   ++   VDIWS G  L  +  G   F G++        I  L     E I       
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FENIG-----K 227

Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
             +  P                P   DL+  +L+Y P  R +  +   H +F +   P  
Sbjct: 228 GSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE 275

Query: 352 RLPNGRPFPPLFNFK 366
                 P PP  + K
Sbjct: 276 APV---PIPPSPDTK 287

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  134 bits (338), Expect = 5e-36
 Identities = 69/305 (22%), Positives = 115/305 (37%), Gaps = 91/305 (29%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------------RELQTMRL 140
           Y  + V+G+G   +V +     TG   A+K +       +            RE   +R 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 141 L-DHPNV---------------------------------HYS--RASQRMPLIYVKLYT 164
           +  HP++                                   S       M         
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM--------- 206

Query: 165 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SR 223
             +  A++++H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  +C + 
Sbjct: 207 RSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LRELCGTP 263

Query: 224 YYRAPELIFGATE-----YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
            Y APE++  + +     Y   VD+W+ G +L  LL G P F     +  L  I++    
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG--- 320

Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
                         +++F    +  W             DL+SRLLQ  P  R TA +A 
Sbjct: 321 --------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTAEQAL 358

Query: 339 IHPFF 343
            HPFF
Sbjct: 359 QHPFF 363

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  133 bits (338), Expect = 7e-36
 Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 68/288 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHP---NV 146
           R +G+GSFG V   +  +T +  A+K     K ++    R   +ELQ M+ L+HP   N+
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 147 HYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
            YS                       + +       VKL+  ++  AL Y+     + HR
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN-QRIIHR 139

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF--GATEYTTAV 241
           D+KP N+L++ H H V + DF  A +L +     +   ++ Y APE+        Y+ AV
Sbjct: 140 DMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAV 198

Query: 242 DIWSVGCVLAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           D WS+G    ELL G+  +   S     ++V   +                 T   +P  
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----------------TTVVTYPS- 241

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-HPFFDEL 346
                          E V L+ +LL+ +P+ R + L      P+ +++
Sbjct: 242 -----------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  131 bits (333), Expect = 1e-35
 Identities = 72/298 (24%), Positives = 118/298 (39%), Gaps = 86/298 (28%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHP---NV 146
           +++G+GSF  V  A+ L T    AIK      ++++    Y  RE   M  LDHP    +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 147 HYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
           +++                       R          + YT +I  AL Y+HG  G+ HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHR 154

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------YICSRYYRAPELIFGA 234
           D+KP+N+L+N   H +++ DFG+AKVL                 Y+      +PEL+   
Sbjct: 155 DLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV------SPELLTE- 206

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 294
                + D+W++GC++ +L+ G P F   +    + + I                   E+
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII----------------KLEY 249

Query: 295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP------NLRCTALEACIHPFFDEL 346
            FP            ++  P+A DLV +LL                     HPFF+ +
Sbjct: 250 DFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  132 bits (333), Expect = 2e-35
 Identities = 64/284 (22%), Positives = 106/284 (37%), Gaps = 60/284 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNV- 146
           Y   + +G G+FG+    +   T E VA+K       + +     RE+   R L HPN+ 
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                         + R      + +  Q+   ++Y H  + +C
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS-MQIC 138

Query: 182 HRDIKPQNLLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT-T 239
           HRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE++    EY   
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-QEYDGK 197

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
             D+WS G  L  +L+G   F                   T + I  +     ++  P  
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-----KYSIPD- 243

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                      R+ PE   L+SR+    P  R +  E   H +F
Sbjct: 244 ---------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  130 bits (329), Expect = 3e-35
 Identities = 66/322 (20%), Positives = 111/322 (34%), Gaps = 80/322 (24%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNV----- 146
            +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++     
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 147 HYSRASQRMPLIYV-------------------KLYT--------YQICRALAYIHGGIG 179
            Y         + +                   + +T          I  A+ Y+H  I 
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-IN 137

Query: 180 VCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
           + HRD+KP+NLL  +   +  +KL DFG AK     +                      Y
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK----------------------Y 175

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
             + D+WS+G ++  LL G P F    G+     +           I+       +++FP
Sbjct: 176 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MGQYEFP 222

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
                 W ++       E   L+  LL+  P  R T  E   HP+  +         +  
Sbjct: 223 ---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 274

Query: 358 PFPPLFNFKPQELKGASKELLS 379
                   + +++K      L+
Sbjct: 275 RVLKEDKERWEDVKEEMTSALA 296

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  130 bits (329), Expect = 4e-35
 Identities = 60/311 (19%), Positives = 106/311 (34%), Gaps = 81/311 (26%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN-----RELQTMRLLD 142
           Y    ++G G FG V+    +     VAIK     ++       N      E+  ++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 143 H--PNV---------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
                V                            +      +     + + +Q+  A+ +
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 232
            H   GV HRDIK +N+L++ +  ++KL DFGS  +L       +    +R Y  PE I 
Sbjct: 165 CHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIR 221

Query: 233 GATEYT-TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
               Y   +  +WS+G +L +++ G   F  +       EII+                 
Sbjct: 222 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR----------------- 257

Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
            +  F             +R+  E   L+   L   P+ R T  E   HP+  ++  P  
Sbjct: 258 GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 305

Query: 352 RLP-NGRPFPP 361
               +     P
Sbjct: 306 TAEIHLHSLSP 316

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  129 bits (327), Expect = 1e-34
 Identities = 56/198 (28%), Positives = 86/198 (43%), Gaps = 33/198 (16%)

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 221
              QI  AL Y+H   G+CHRDIKP+N L     + ++KL DFG +K   K      Y  
Sbjct: 173 IMRQIFSALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231

Query: 222 -----SRYYRAPELIFGATE-YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 275
                + Y+ APE++    E Y    D WS G +L  LL+G   FPG +  D + +++  
Sbjct: 232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN- 290

Query: 276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 335
                            +  F       ++ +      P A DL+S LL  + + R  A+
Sbjct: 291 ----------------KKLCFE---NPNYNVL-----SPLARDLLSNLLNRNVDERFDAM 326

Query: 336 EACIHPFFDELRDPNARL 353
            A  HP+  +  D   ++
Sbjct: 327 RALQHPWISQFSDKIYKM 344

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 19/63 (30%), Positives = 30/63 (47%), Gaps = 9/63 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL---------QDKRYKNRELQTMRLLDH 143
           Y  +  +GQGS+G+V  A   +T    AIK +          +D      E++ M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 144 PNV 146
           PN+
Sbjct: 88  PNI 90

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  128 bits (323), Expect = 1e-34
 Identities = 65/286 (22%), Positives = 114/286 (39%), Gaps = 64/286 (22%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
           +   + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                            MP    + + +Q+   + Y+HG IG+ 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGIT 127

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAPELIFGATEYT 238
           HRDIKP+NLL++     +K+ DFG A V         ++ +C +  Y APEL+    E+ 
Sbjct: 128 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-REFH 185

Query: 239 -TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
              VD+WS G VL  +L G+  +      DQ  +  +       ++              
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN---------- 229

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                PW K     +    + L+ ++L  +P+ R T  +     ++
Sbjct: 230 -----PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  128 bits (324), Expect = 2e-34
 Identities = 66/313 (21%), Positives = 106/313 (33%), Gaps = 82/313 (26%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN-----RELQTMRLLD 142
           Y    ++G+G FG VF    L     VAIK     +VL      +      E+  +  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 143 ----HPNV---------------------------HYSRASQRMPLIYVKLYTYQICRAL 171
               HP V                            Y      +     + +  Q+  A+
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152

Query: 172 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 230
            + H   GV HRDIK +N+L++      KL DFGS  +L       +    +R Y  PE 
Sbjct: 153 QHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEW 209

Query: 231 IFGATEYT-TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
           I    +Y      +WS+G +L +++ G   F  +       EI++               
Sbjct: 210 ISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA-------------- 248

Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
              E  FP              + P+   L+ R L   P+ R +  E  + P+     + 
Sbjct: 249 ---ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293

Query: 350 NARLPNGRPFPPL 362
               P+     PL
Sbjct: 294 VPLNPSKGGPAPL 306

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  133 bits (337), Expect = 2e-34
 Identities = 76/351 (21%), Positives = 124/351 (35%), Gaps = 88/351 (25%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----------LQTMRLLDHP- 144
           R++G+G FG V+  +  +TG+  A+K  L  KR K ++           L  +   D P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 145 --NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIG 179
              + Y+                                 ++ Y  +I   L ++H    
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RF 312

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           V +RD+KP N+L++ H H V++ D G A    K +P+ + + +  Y APE++     Y +
Sbjct: 313 VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVAYDS 370

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           + D +S+GC+L +LL G   F      D             + EI               
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI-----------DRMT 406

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--CT---ALEACIHPFFDELRDPN-ARL 353
                         PE   L+  LLQ   N R  C    A E    PFF  L   +   +
Sbjct: 407 LTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL---DWQMV 461

Query: 354 PNGRPFPPLFNFKPQELKGASKELL---------SKLIPEHARKQCPFLGF 395
              +  PP     P   +  + +           +K I      Q  +  F
Sbjct: 462 FLQKYPPP---LIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNF 509

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  131 bits (330), Expect = 2e-34
 Identities = 78/354 (22%), Positives = 129/354 (36%), Gaps = 87/354 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHP---NV 146
           +V+G+G+FG V   K     +  A+K     ++L+         E   +   D      +
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 147 HYS------------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
           HY+                        +   R+P    + Y  ++  A+  +H  +   H
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH-QLHYVH 198

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELI----FGATE 236
           RDIKP N+L++ + H ++L DFGS   L++     S        Y +PE++     G   
Sbjct: 199 RDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           Y    D WS+G  + E+L G+  F  ES + +    I             MN     F+F
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------MNHK-ERFQF 302

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN-LRCT-ALEACIHPFF-----DELRDP 349
           P              +   A DL+ RL+    + L      +   HPFF     D +R+ 
Sbjct: 303 PT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNC 353

Query: 350 NARLPNGRPFPP-------LFNFKPQELKGASKE-LLSKLIPEHARKQCPFLGF 395
            A      P+ P         NF   +    + E +        +    PF+GF
Sbjct: 354 EA------PYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGF 401

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  128 bits (324), Expect = 2e-34
 Identities = 73/308 (23%), Positives = 123/308 (39%), Gaps = 71/308 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 144
           Y   + +G+G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 145 NV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
           N+                           Y  A  RM     +    QI  A+ Y H   
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ-K 133

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 237
            + HRD+K +NLL++     +K+ DFG +     G   +   C +  Y APEL  G  +Y
Sbjct: 134 RIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAAPELFQG-KKY 190

Query: 238 T-TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
               VD+WS+G +L  L+ G   F G++ + +L E +                   +++ 
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL----------------RGKYRI 233

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNG 356
           P      +       M  +  +L+ R L  +P  R T  +     + +   + +   P  
Sbjct: 234 P-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFV 281

Query: 357 RPFPPLFN 364
            P   + +
Sbjct: 282 EPELDISD 289

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  128 bits (323), Expect = 4e-34
 Identities = 68/303 (22%), Positives = 121/303 (39%), Gaps = 64/303 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
           +   + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 147 --HYSRASQRMPLI---YVK---LYTY-----------------QICRALAYIHGGIGVC 181
             +  R    +  +   Y     L+                   Q+   + Y+HG IG+ 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGIT 127

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAPELIFGATEYT 238
           HRDIKP+NLL++     +K+ DFG A V         ++ +C +  Y APEL+    E+ 
Sbjct: 128 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-REFH 185

Query: 239 -TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
              VD+WS G VL  +L G+  +      DQ  +  +       ++              
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN---------- 229

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
                PW K     +    + L+ ++L  +P+ R T  +     ++++     A+ P   
Sbjct: 230 -----PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVT 279

Query: 358 PFP 360
              
Sbjct: 280 SGG 282

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  127 bits (321), Expect = 5e-34
 Identities = 63/311 (20%), Positives = 108/311 (34%), Gaps = 89/311 (28%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--------------- 132
           Y  +  +G+GS+G+V  A         A+K     K+++   +                 
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 133 ----------RELQTMRLLDHPNV--------HYSRASQRMPLIYVK------------- 161
                     +E+  ++ LDHPNV          +     M    V              
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134

Query: 162 ------LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 215
                  Y   + + + Y+H    + HRDIKP NLLV      +K+ DFG +      + 
Sbjct: 135 SEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDA 192

Query: 216 NISYIC-SRYYRAPELIFGAT-EYT-TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 272
            +S    +  + APE +      ++  A+D+W++G  L   + GQ  F  E  +  L   
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLHSK 251

Query: 273 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 332
           IK                    +FP              +  +  DL++R+L  +P  R 
Sbjct: 252 IK----------------SQALEFPD----------QPDIAEDLKDLITRMLDKNPESRI 285

Query: 333 TALEACIHPFF 343
              E  +HP+ 
Sbjct: 286 VVPEIKLHPWV 296

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  125 bits (316), Expect = 1e-33
 Identities = 73/297 (24%), Positives = 114/297 (38%), Gaps = 66/297 (22%)

Query: 81  GGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------R 133
           G ++    +   Y+    +G G+FG V   +   TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 134 ELQTMRLLDHPNV--------------------------HYSRASQRMPLIYVKLYTYQI 167
           E+Q ++L  HP++                           Y     R+  +  +    QI
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120

Query: 168 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYR 226
             A+ Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +   C S  Y 
Sbjct: 121 LSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-LRTSCGSPNYA 177

Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
           APE+I G       VDIWS G +L  LL G   F  E         +  L     ++I+ 
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTL----FKKIR- 224

Query: 287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                  F  P      +       +      L+  +LQ  P  R T  +   H +F
Sbjct: 225 ----GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  128 bits (323), Expect = 2e-33
 Identities = 81/368 (22%), Positives = 126/368 (34%), Gaps = 108/368 (29%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKK-----VLQDKR--YKNRELQTMRLLDHP---NV 146
           +V+G+G+F  V   K  +TG+  A+K      +L+         E   +   D      +
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 147 HYS------------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
           H++                        +  +R+P    + Y  +I  A+  +H  +G  H
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH-RLGYVH 185

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--------YICSRYYRAPELI--- 231
           RDIKP N+L++   H ++L DFGS   L       S        Y+      +PE++   
Sbjct: 186 RDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL------SPEILQAV 238

Query: 232 ---FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 288
               G   Y    D W++G    E+  GQ  F  +S   +    I             ++
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI-------------VH 284

Query: 289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR---CTALEACIHPFF-- 343
                   P            + +P EA D + RLL   P  R     A +   HPFF  
Sbjct: 285 YK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333

Query: 344 ---DELRDPNARLPNGRPFPPLF-------NF------KPQELKGASKELLSKLIPEHAR 387
              D LRD         PF P F       NF          + G  + L          
Sbjct: 334 LDWDGLRDSVP------PFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLG 387

Query: 388 KQCPFLGF 395
              PF+G+
Sbjct: 388 VHLPFVGY 395

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  127 bits (320), Expect = 3e-33
 Identities = 73/361 (20%), Positives = 122/361 (33%), Gaps = 112/361 (31%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLL-----DHP 144
           Y   R +G G F  V+ +  ++  + VA+K V   + Y      E++ ++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 145 NVHYSRA----------------------------------SQRMPLIYVKLYTYQICRA 170
           N                                         Q +PL  VK    Q+ + 
Sbjct: 99  NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158

Query: 171 LAYIHGGIGVCHRDIKPQNLLV-------------------------------------- 192
           L Y+H    + H DIKP+N+L+                                      
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 193 ----------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVD 242
                     N    +VK+ D G+A  +   +     I +R YR+ E++ G+  Y T  D
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNTPAD 275

Query: 243 IWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI-------KCMNP 289
           IWS  C+  EL  G  LF   SG       D +  II++LG   R+ I       +    
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335

Query: 290 NYTEFKFPQIKAHPWHKIFHKRMP------PEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                   ++K     ++  ++            D +  +L+  P  R TA E   HP+ 
Sbjct: 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395

Query: 344 D 344
           +
Sbjct: 396 N 396

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  127 bits (322), Expect = 4e-33
 Identities = 85/372 (22%), Positives = 144/372 (38%), Gaps = 86/372 (23%)

Query: 43  PEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTIS---YMAERVV 99
            E    ++   + ++K+  A +   +G+ + +     +     +PK  ++   +   +++
Sbjct: 97  EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLL 156

Query: 100 GQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHP---NV 146
           G+G+FG V   K   TG   A+K      ++           NR LQ  R   HP    +
Sbjct: 157 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTAL 213

Query: 147 HYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
            YS                          +       + Y  +I  AL Y+H    V +R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVD 242
           D+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE++    +Y  AVD
Sbjct: 274 DLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVD 331

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
            W +G V+ E++ G+  F  +   ++L E+I                   E +FP     
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------MEEIRFP----- 369

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELRDPN-ARLPNG 356
                  + + PEA  L+S LL+  P  R       A E   H FF          +   
Sbjct: 370 -------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF---AGIVWQHVYEK 419

Query: 357 RPFPPLFNFKPQ 368
           +  PP   FKPQ
Sbjct: 420 KLSPP---FKPQ 428

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  125 bits (316), Expect = 4e-33
 Identities = 61/293 (20%), Positives = 100/293 (34%), Gaps = 64/293 (21%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQT-MRLLDHPNV----- 146
            +G G+ G V++ +  +TG  +A+K++      +  K    +L   ++  D P +     
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                   R    +P   +   T  I +AL Y+    GV HRD+
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDV 151

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI----FGATEYTTAV 241
           KP N+L++    Q+KLCDFG +  LV  +          Y APE I        +Y    
Sbjct: 152 KPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRA 210

Query: 242 DIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
           D+WS+G  L EL  GQ  +       + L ++++    P                 P + 
Sbjct: 211 DVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP-----------------PLLP 251

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
                   H     +    V   L      R    +   H F          +
Sbjct: 252 G-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDV 297

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  124 bits (313), Expect = 4e-33
 Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 65/284 (22%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQ-TMRLLDHPNV----- 146
            +G+G++G+V + + + +G+ +A+K++   +  +  K    +L  +MR +D P       
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                         Q +P   +      I +AL ++H  + V H
Sbjct: 74  ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 133

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG---ATEYTT 239
           RD+KP N+L+N    QVK+CDFG +  LV           + Y APE I        Y+ 
Sbjct: 134 RDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSV 192

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
             DIWS+G  + EL + +  +       Q ++ + V                     PQ+
Sbjct: 193 KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS-----------------PQL 234

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            A  +          E VD  S+ L+ +   R T  E   HPFF
Sbjct: 235 PADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  125 bits (315), Expect = 7e-33
 Identities = 71/284 (25%), Positives = 115/284 (40%), Gaps = 65/284 (22%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 145
           Y+    +G+GSFG V  A   +T + VA+K      + +   +    RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 146 V-------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
           +                          Y    +RM     + +  QI  A+ Y H    +
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR-HKI 129

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTT 239
            HRD+KP+NLL++ +   VK+ DFG + ++  G   +   C S  Y APE+I G      
Sbjct: 130 VHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPEVINGKLYAGP 187

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
            VD+WS G VL  +L+G+  F  E  +  L + +                    +  P  
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN----------------SCVYVMP-- 228

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
               +       + P A  L+ R++   P  R T  E    P+F
Sbjct: 229 ---DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  128 bits (323), Expect = 1e-32
 Identities = 80/314 (25%), Positives = 125/314 (39%), Gaps = 77/314 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHP---N 145
           RV+G+G FG V   +   TG+  A K  L+ KR K R        E Q +  ++     +
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 146 VHYS-------------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
           + Y+                               P      Y  +IC  L  +H    +
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR-ERI 307

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
            +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++     YT +
Sbjct: 308 VYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFS 365

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
            D W++GC+L E++ GQ  F                    REE+              +K
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRK------------KKIKREEV-----------ERLVK 402

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELRDPN-ARLP 354
             P  + + +R  P+A  L S+LL   P  R      +A E   HP F   +  N  RL 
Sbjct: 403 EVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF---KKLNFKRLG 457

Query: 355 NGRPFPPLFNFKPQ 368
            G   PP   FKP 
Sbjct: 458 AGMLEPP---FKPD 468

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  124 bits (313), Expect = 1e-32
 Identities = 63/298 (21%), Positives = 107/298 (35%), Gaps = 80/298 (26%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN-------RELQTMRL 140
           Y     +G G+FG V+ A   E  + V +K     KVL+D   ++        E+  +  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 141 LDHPNV---------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
           ++H N+                            +     R+          Q+  A+ Y
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGY 145

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 232
           +     + HRDIK +N+++      +KL DFGSA  L +G+      C +  Y APE++ 
Sbjct: 146 LRLK-DIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCGTIEYCAPEVLM 202

Query: 233 GATEYT-TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
           G   Y    +++WS+G  L  L+  +  F       +L E ++                 
Sbjct: 203 G-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE----------------- 238

Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
                P              +  E + LVS LLQ  P  R T  +    P+  +  + 
Sbjct: 239 AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNL 284

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  122 bits (309), Expect = 3e-32
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 36/207 (17%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNV------- 146
           E VVG+G+FG+V +AK     + VAIK++  +   K    EL+ +  ++HPN+       
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 147 --------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG--GIGVCHRD 184
                               H +         +   +  Q  + +AY+H      + HRD
Sbjct: 71  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIW 244
           +KP NLL+      +K+CDFG+A          +   S  + APE+  G + Y+   D++
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SNYSEKCDVF 187

Query: 245 SVGCVLAELLLGQPLFPGESGVDQLVE 271
           S G +L E++  +  F    G    + 
Sbjct: 188 SWGIILWEVITRRKPFDEIGGPAFRIM 214

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  125 bits (316), Expect = 6e-32
 Identities = 69/317 (21%), Positives = 113/317 (35%), Gaps = 80/317 (25%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHP---N 145
           RV+G+G FG VF  +   TG+  A K  L  KR K R        E + +  +      +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 146 VHYS---------------------------RASQRMPLIYVKLYTYQICRALAYIHGGI 178
           + Y+                             +          YT QI   L ++H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-R 308

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 237
            + +RD+KP+N+L++   + V++ D G A  L  G+        +  + APEL+ G  EY
Sbjct: 309 NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
             +VD +++G  L E++  +  F                     +E+             
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARG------------EKVENKEL-----------KQ 403

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELRDPN-A 351
           ++        +  +  P + D    LLQ  P  R      +      HP F   RD +  
Sbjct: 404 RVLEQAVT--YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF---RDISWR 458

Query: 352 RLPNGRPFPPLFNFKPQ 368
           +L  G   PP   F P 
Sbjct: 459 QLEAGMLTPP---FVPD 472

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  121 bits (306), Expect = 1e-31
 Identities = 73/312 (23%), Positives = 121/312 (38%), Gaps = 78/312 (25%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHP---NV 146
           +++G+G+FG V   +   TG   A+K      ++      +   E + ++   HP    +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 147 HYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
            Y+                          +       + Y  +I  AL Y+H    V +R
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYR 129

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATEYTTAVD 242
           DIK +NL+++   H +K+ DFG  K  +     +   C    Y APE++    +Y  AVD
Sbjct: 130 DIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVD 187

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
            W +G V+ E++ G+  F  +   ++L E+I                   E +FP     
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------MEEIRFP----- 225

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELRDPN-ARLPNG 356
                  + + PEA  L++ LL+  P  R       A E   H FF      N   +   
Sbjct: 226 -------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF---LSINWQDVVQK 275

Query: 357 RPFPPLFNFKPQ 368
           +  PP   FKPQ
Sbjct: 276 KLLPP---FKPQ 284

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  121 bits (306), Expect = 1e-31
 Identities = 67/295 (22%), Positives = 111/295 (37%), Gaps = 63/295 (21%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQT-MRLLDHPNV----- 146
            +G+G++G V +     +G+ +A+K++   + +K  K    +L   MR  D P +     
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                     YS     +P   +   T    +AL ++   + + 
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKII 148

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE---YT 238
           HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +     Y 
Sbjct: 149 HRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYD 207

Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+WS+G  L EL  G+  +P  + V   +  + V G P                 PQ
Sbjct: 208 VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP-----------------PQ 249

Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
           +      + F     P  ++ V+  L    + R    E   HPF     +    +
Sbjct: 250 LSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  120 bits (303), Expect = 6e-31
 Identities = 57/313 (18%), Positives = 100/313 (31%), Gaps = 64/313 (20%)

Query: 93  YMAERVVGQG--SFGIVFQAKCLETGETVAIKKV----LQDKRYKN--RELQTMRLLDHP 144
           Y    V+G+G      V  A+   TGE V ++++      ++       EL   +L +HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 145 NV-HY---------------------------SRASQRMPLIYVKLYTYQICRALAYIHG 176
           N+  Y                           +     M  + +      + +AL YIH 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--------KVLVKGEPNISYICSRYYRAP 228
            +G  HR +K  ++L++    +V L    S         +  V  +     +    + +P
Sbjct: 147 -MGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

Query: 229 ELIF-GATEYTTAVDIWSVGCVLAELLLGQP----------LF-------PGESGVDQLV 270
           E++      Y    DI+SVG    EL  G            L        P       + 
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264

Query: 271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 330
                +          ++ + T               +H+   P     V + LQ +P+ 
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324

Query: 331 RCTALEACIHPFF 343
           R +A     H FF
Sbjct: 325 RPSASTLLNHSFF 337

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  121 bits (305), Expect = 1e-30
 Identities = 73/285 (25%), Positives = 108/285 (37%), Gaps = 66/285 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 145
           Y+    +G G+FG V   K   TG  VA+K     K+          RE+Q ++L  HP+
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 146 V--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 179
           +                           Y   + R+     +    QI   + Y H    
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR-HM 136

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYT 238
           V HRD+KP+N+L++ H    K+ DFG + ++  GE  +   C S  Y APE+I G     
Sbjct: 137 VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAPEVISGRLYAG 194

Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
             VDIWS G +L  LL G   F  +  V  L + I                    F  P 
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC----------------DGIFYTP- 236

Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                +       + P  + L+  +LQ  P  R T  +   H +F
Sbjct: 237 ----QY-------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  117 bits (295), Expect = 2e-30
 Identities = 46/214 (21%), Positives = 77/214 (35%), Gaps = 44/214 (20%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHP 144
           E+ +G+G FG+V + + ++    VAIK ++                  RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 145 N-VHYSRASQRMPLI---YVK---LYTY------------------QICRALAYIHG-GI 178
           N V         P +   +V    LY                     I   + Y+     
Sbjct: 84  NIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143

Query: 179 GVCHRDIKPQNLLVNPHTHQ----VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 234
            + HRD++  N+ +           K+ DFG ++           + +  + APE I   
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPETIGAE 201

Query: 235 TE-YTTAVDIWSVGCVLAELLLGQPLFPGESGVD 267
            E YT   D +S   +L  +L G+  F   S   
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  117 bits (295), Expect = 4e-30
 Identities = 74/314 (23%), Positives = 121/314 (38%), Gaps = 80/314 (25%)

Query: 97  RVVGQGSFGIVFQAK---CLETGETVAIKKVLQDKRYKNRELQTM---RLL---DHP--- 144
           +V+GQGSFG VF  K     +  +  A+K + +        ++T     +L   +HP   
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 145 NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
            +HY+                                 VK Y  ++  AL ++H  +G+ 
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGII 148

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTA 240
           +RD+KP+N+L++   H +KL DFG +K  +  E      C +  Y APE++     +T +
Sbjct: 149 YRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQS 206

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
            D WS G ++ E+L G   F G+    + + +I                   +   PQ  
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL----------------KAKLGMPQ-- 247

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELRDPN-ARLP 354
                      + PEA  L+  L + +P  R         E   H FF      +  +L 
Sbjct: 248 ----------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF---STIDWNKLY 294

Query: 355 NGRPFPPLFNFKPQ 368
                PP   FKP 
Sbjct: 295 RREIHPP---FKPA 305

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  118 bits (296), Expect = 4e-30
 Identities = 33/310 (10%), Positives = 84/310 (27%), Gaps = 88/310 (28%)

Query: 92  SYMAERVVGQGSFGIVFQAKC-----LETGETVAIK----KVLQDKRYKNRELQTMRLLD 142
                 ++G+G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 143 HPNV-------------------------------HYSRASQRMPLIYVKLYTYQICRAL 171
                                              + +   + MP   V  +  ++   +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 172 AYIHGGIGVCHRDIKPQNLLVNPHTHQ----------VKLCDFGSA---KVLVKGEPNIS 218
             +H    + H DIKP N ++     +          + L D G +   K+  KG    +
Sbjct: 186 EQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
              +  ++  E++     +   +D + V   +  +L G  +     G             
Sbjct: 245 KCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG------------- 290

Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 338
               + + +                W++ FH             +L         +L+  
Sbjct: 291 -GECKPEGLFRRL-------PHLDMWNEFFHV------------MLNIPDCHHLPSLDLL 330

Query: 339 IHPFFDELRD 348
                   + 
Sbjct: 331 RQKLKKVFQQ 340

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (293), Expect = 5e-30
 Identities = 66/305 (21%), Positives = 106/305 (34%), Gaps = 70/305 (22%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
           Y  + V+G G+  +V  A C    E VAIK++  +K   +     +E+Q M    HPN+ 
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 147 ---------------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
                                                 S  +    +     ++   L Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSR-------YY 225
           +H   G  HRD+K  N+L+      V++ DFG SA +   G+   +    R        +
Sbjct: 137 LHK-NGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFVGTPCW 192

Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
            APE++     Y    DIWS G    EL  G   +     +  L+  ++           
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ----------- 241

Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
             N        P ++     K   K+       ++S  LQ  P  R TA E   H FF +
Sbjct: 242 --ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

Query: 346 LRDPN 350
            ++  
Sbjct: 294 AKNKE 298

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  117 bits (296), Expect = 5e-30
 Identities = 74/313 (23%), Positives = 114/313 (36%), Gaps = 80/313 (25%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKNRELQ-TM-------RLLDHP--- 144
           +V+G+GSFG V  A+        A+K VLQ     K +E +  M       + + HP   
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 145 NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
            +H+S                       +  +       + Y  +I  AL Y+H  + + 
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIV 161

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATEYTTA 240
           +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE++     Y   
Sbjct: 162 YRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRT 219

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
           VD W +G VL E+L G P F   +   ++ + I                     +     
Sbjct: 220 VDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL----------------NKPLQLK--- 259

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR----CTALEACIHPFFDELRDPN-ARLPN 355
                      +   A  L+  LLQ     R       +E   H FF      N   L N
Sbjct: 260 ---------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF---SLINWDDLIN 307

Query: 356 GRPFPPLFNFKPQ 368
            +  PP   F P 
Sbjct: 308 KKITPP---FNPN 317

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  118 bits (297), Expect = 8e-30
 Identities = 80/356 (22%), Positives = 124/356 (34%), Gaps = 95/356 (26%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHP---NV 146
           +V+G+G+FG V   +   T +  A+K     ++++     +   E   M   + P    +
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 147 HYS----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
            Y+                       ++  +P  + + YT ++  AL  IH  +G  HRD
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS-MGFIHRD 193

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--------YICSRYYRAPELIF---G 233
           +KP N+L++   H +KL DFG+   + K              YI      +PE++    G
Sbjct: 194 VKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI------SPEVLKSQGG 246

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
              Y    D WSVG  L E+L+G   F  +S    LV              K MN     
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS----------KIMNHK-NS 291

Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFDEL--RD 348
             FP              +  EA +L+   L     +R       E   H FF       
Sbjct: 292 LTFP----------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAW 340

Query: 349 PNAR--LPNGRPFPPLF-------NFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
              R  +    P  P         NF   E     +E    +       Q PF+GF
Sbjct: 341 ETLRDTVA---PVVPDLSSDIDTSNFDDLEED-KGEEETFPIPKAFVGNQLPFVGF 392

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  116 bits (293), Expect = 9e-30
 Identities = 78/313 (24%), Positives = 127/313 (40%), Gaps = 83/313 (26%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 144
           +++G+GSFG VF A+  +T +  AIK      VL D   +     TM   R+L    +HP
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLAWEHP 78

Query: 145 ---NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGI 178
              ++  +                       ++  +  L     Y  +I   L ++H   
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-K 137

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATEY 237
           G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G  +Y
Sbjct: 138 GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKY 195

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
             +VD WS G +L E+L+GQ  F G+   ++L   I+                     +P
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR----------------MDNPFYP 238

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA-CIHPFFDELRDPN-ARLPN 355
                       + +  EA DL+ +L    P  R         HP F   R+ N   L  
Sbjct: 239 ------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF---REINWEELER 283

Query: 356 GRPFPPLFNFKPQ 368
               PP   F+P+
Sbjct: 284 KEIDPP---FRPK 293

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  116 bits (293), Expect = 1e-29
 Identities = 78/316 (24%), Positives = 124/316 (39%), Gaps = 84/316 (26%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHP-- 144
           RV+G+GSFG V  A+  ETG+  A+K      +LQD   +      R L   R  +HP  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 86

Query: 145 -NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
             +                          + S+R      + Y  +I  AL ++H   G+
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK-GI 145

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATEYTT 239
            +RD+K  N+L++   H  KL DFG  K  +      +  C    Y APE++     Y  
Sbjct: 146 IYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE-MLYGP 203

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           AVD W++G +L E+L G   F  E+  D L E I                   E  +P  
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------NDEVVYP-- 244

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR------CTALEACIHPFFDELRDPN-AR 352
                       +  +A  ++   +  +P +R              HPFF   ++ + A+
Sbjct: 245 ----------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF---KEIDWAQ 291

Query: 353 LPNGRPFPPLFNFKPQ 368
           L + +  PP   F+P+
Sbjct: 292 LNHRQIEPP---FRPR 304

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  116 bits (293), Expect = 1e-29
 Identities = 73/315 (23%), Positives = 111/315 (35%), Gaps = 83/315 (26%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHP-- 144
            V+G+GSFG V  ++   T E  A+K      V+QD   +      R L        P  
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 83

Query: 145 -NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
             +H                         +   R    +   Y  +I   L ++    G+
Sbjct: 84  TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGI 142

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATEYTT 239
            +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I     Y  
Sbjct: 143 IYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGK 200

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           +VD W+ G +L E+L GQ  F GE   D+L + I                      +P  
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EHNVAYP-- 241

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELRDPN-ARL 353
                     K M  EAV +   L+   P  R         +   H FF   R  +  +L
Sbjct: 242 ----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---RYIDWEKL 288

Query: 354 PNGRPFPPLFNFKPQ 368
                 PP   +KP+
Sbjct: 289 ERKEIQPP---YKPK 300

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  115 bits (291), Expect = 1e-29
 Identities = 80/318 (25%), Positives = 125/318 (39%), Gaps = 86/318 (27%)

Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQ----DKRYKNRELQTM---RLL---DH 143
           RV+G+G +G VFQ + +    TG+  A+K VL+     +  K+    T     +L    H
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTA-HTKAERNILEEVKH 80

Query: 144 P---NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGG 177
           P   ++ Y+                                    Y  +I  AL ++H  
Sbjct: 81  PFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ- 139

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIFGATE 236
            G+ +RD+KP+N+++N   H VKL DFG  K  +         C    Y APE++   + 
Sbjct: 140 KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SG 197

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           +  AVD WS+G ++ ++L G P F GE+   + ++ I                   +   
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL----------------KCKLNL 240

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELRDPN- 350
           P              +  EA DL+ +LL+ +   R       A E   HPFF   R  N 
Sbjct: 241 P------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF---RHINW 285

Query: 351 ARLPNGRPFPPLFNFKPQ 368
             L   +  PP   FKP 
Sbjct: 286 EELLARKVEPP---FKPL 300

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  115 bits (290), Expect = 2e-29
 Identities = 75/317 (23%), Positives = 122/317 (38%), Gaps = 91/317 (28%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHP---NV 146
           R +G GSFG V   +    G   A+K      V++ K   + N E   + ++ HP    +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 147 HYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
             +                       R SQR P    K Y  ++C AL Y+H    + +R
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH-SKDIIYR 130

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYYRAPELIFGATEY 237
           D+KP+N+L++ + H +K+ DFG AK +        G P+        Y APE++     Y
Sbjct: 131 DLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIAPEVVST-KPY 180

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
             ++D WS G ++ E+L G   F   +   +  E I                   E +FP
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL----------------NAELRFP 223

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP-----NLRCTALEACIHPFFDELRDPN-A 351
                            +  DL+SRL+         NL+    +   HP+F E+      
Sbjct: 224 ------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV---VWE 268

Query: 352 RLPNGRPFPPLFNFKPQ 368
           +L +     P   ++P 
Sbjct: 269 KLLSRNIETP---YEPP 282

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  114 bits (288), Expect = 2e-29
 Identities = 65/292 (22%), Positives = 107/292 (36%), Gaps = 62/292 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
           +     +G+GSFG VF+     T + VAIK +  ++         +E+  +   D P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 147 ----HYSRASQ--------------------RMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                Y + ++                     +    +     +I + L Y+H      H
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS-EKKIH 142

Query: 183 RDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           RDIK  N+L++    +VKL DFG + ++        +++ + ++ APE+I  +  Y +  
Sbjct: 143 RDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKA 200

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           DIWS+G    EL  G+P       +  L  I K    PT E                   
Sbjct: 201 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEG------------------ 241

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
             + K           + V   L   P+ R TA E   H F        + L
Sbjct: 242 -NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYL 284

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  115 bits (289), Expect = 3e-29
 Identities = 66/294 (22%), Positives = 111/294 (37%), Gaps = 84/294 (28%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHP---NV 146
           + +G GSFG V   K  E+G   A+K     KV++ K   +   E + ++ ++ P    +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 147 HYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
            +S                       R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYR 165

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYYRAPELIFGATEY 237
           D+KP+NLL++   + +++ DFG AK +        G P           APE+I     Y
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALAPEIILS-KGY 215

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
             AVD W++G ++ E+  G P F  +    Q+ E I          +        + +FP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI----------VSG------KVRFP 258

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP-----NLRCTALEACIHPFFDEL 346
                            +  DL+  LLQ        NL+    +   H +F   
Sbjct: 259 ------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  115 bits (289), Expect = 4e-29
 Identities = 81/319 (25%), Positives = 129/319 (40%), Gaps = 80/319 (25%)

Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDKRYKNREL--QTM---RLL----DHP 144
           +V+G G++G VF  + +   +TG+  A+K + +    +  +    T    ++L      P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 145 ---NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGI 178
               +HY+                          +R     V++Y  +I  AL ++H  +
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-L 178

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-IC-SRYYRAPELIFGATE 236
           G+ +RDIK +N+L++ + H V L DFG +K  V  E   +Y  C +  Y AP+++ G   
Sbjct: 179 GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 237

Query: 237 -YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 295
            +  AVD WS+G ++ ELL G   F  +   +   EI           I       +E  
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL-----KSEPP 284

Query: 296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELRDPN 350
           +PQ             M   A DL+ RLL   P  R       A E   H FF   +  N
Sbjct: 285 YPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF---QKIN 329

Query: 351 -ARLPNGRPFPPLFNFKPQ 368
              L   +   P   FKP 
Sbjct: 330 WDDLAAKKVPAP---FKPV 345

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  113 bits (284), Expect = 7e-29
 Identities = 70/290 (24%), Positives = 111/290 (38%), Gaps = 61/290 (21%)

Query: 84  NGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMR 139
            G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++       K     E+  MR
Sbjct: 15  VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 140 LLDHPNV-----HYSRASQ--------------------RMPLIYVKLYTYQICRALAYI 174
              +PN+      Y    +                     M    +     +  +AL ++
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFG 233
           H    V HRDIK  N+L+      VKL DFG    +   +    + + + Y+ APE++  
Sbjct: 133 HSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
              Y   VDIWS+G +  E++ G+P +  E+ +  L  I    GTP  +           
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN---------- 238

Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                        IF         D ++R L+     R +A E   H F 
Sbjct: 239 -------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  111 bits (279), Expect = 2e-28
 Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 46/209 (22%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHPN-V 146
           E ++G G FG V++A  +  G+ VA+K    D             +E +   +L HPN +
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 147 HYSRASQRMPLIYV--------KLYTY----------------QICRALAYIH--GGIGV 180
                  + P + +         L                   QI R + Y+H    + +
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 181 CHRDIKPQNLLVN-------PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
            HRD+K  N+L+             +K+ DFG A+   +    +S   +  + APE+I  
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRA 188

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPG 262
           +  ++   D+WS G +L ELL G+  F G
Sbjct: 189 SM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  112 bits (282), Expect = 3e-28
 Identities = 70/286 (24%), Positives = 112/286 (39%), Gaps = 67/286 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
           +   R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 146 V-----HYSRASQ---------------------RMPLIYVKLYTYQICRALAYIHGGIG 179
                  Y R                         +  + +   T+   + LAY+H    
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HN 174

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--Y 237
           + HRD+K  N+L++     VKL DFGSA ++       S++ + Y+ APE+I    E  Y
Sbjct: 175 MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQY 230

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
              VD+WS+G    EL   +P     + +  L  I +                      P
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------NES-------P 271

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
            +++  W + F         + V   LQ  P  R T+     H F 
Sbjct: 272 ALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFV 309

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  112 bits (282), Expect = 3e-28
 Identities = 66/318 (20%), Positives = 120/318 (37%), Gaps = 79/318 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 144
           RV+G+GS+  V   +  +T    A+K      V  D+              +     +HP
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID----WVQTEKHVFEQASNHP 70

Query: 145 ---NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGI 178
               +H                         +  +++P  + + Y+ +I  AL Y+H   
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-R 129

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 237
           G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G  +Y
Sbjct: 130 GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDY 187

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
             +VD W++G ++ E++ G+  F      D   +        T + +           F 
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-----------FQ 229

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR------CTALEACIHPFFDELRDPN- 350
            I          + +  +A  ++   L   P  R          +   HPFF   R+ + 
Sbjct: 230 VILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF---RNVDW 284

Query: 351 ARLPNGRPFPPLFNFKPQ 368
             +   +  PP   FKP 
Sbjct: 285 DMMEQKQVVPP---FKPN 299

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  111 bits (279), Expect = 5e-28
 Identities = 66/289 (22%), Positives = 107/289 (37%), Gaps = 59/289 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNV---- 146
           +     +G+GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D P+V    
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 147 -HYSRASQ----------------------RMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
             Y + +                        +    +        + L Y+H      HR
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM-RKIHR 149

Query: 184 DIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVD 242
           DIK  N+L+N      KL DFG + ++        + I + ++ APE+I     Y    D
Sbjct: 150 DIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNCVAD 207

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           IWS+G    E+  G+P +     +  +  I      PT  +                   
Sbjct: 208 IWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK-----------------PE 249

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
            W   F         D V + L  SP  R TA +   HPF    +  + 
Sbjct: 250 LWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  111 bits (279), Expect = 5e-28
 Identities = 72/281 (25%), Positives = 113/281 (40%), Gaps = 59/281 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNV-- 146
             +   +G+GS GIV  A+   +G  VA+K +     Q +     E+  MR   H NV  
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 147 ---HYSRASQ--------------------RMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
               Y    +                    R+    +      + +ALAY+H   GV HR
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ-GVIHR 165

Query: 184 DIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVD 242
           DIK  ++L+     +VKL DFG  A++        S + + Y+ APE+I   + Y T VD
Sbjct: 166 DIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVD 223

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           IWS+G ++ E++ G+P +  +S V  +  +      P  +                  +H
Sbjct: 224 IWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN-----------------SH 265

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
               +          D + R+L   P  R TA E   HPF 
Sbjct: 266 KVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  111 bits (279), Expect = 5e-28
 Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 41/204 (20%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV--- 146
           +  +G GSFG V +A+    G  VA+K +++   +        RE+  M+ L HPN+   
Sbjct: 42  KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 147 --------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG-GIG 179
                                     H S A +++         Y + + + Y+H     
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYT 238
           + HR++K  NLLV+   + VK+CDFG +++      +  S   +  + APE++       
Sbjct: 160 IVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSN 217

Query: 239 TAVDIWSVGCVLAELLLGQPLFPG 262
              D++S G +L EL   Q  +  
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGN 241

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  110 bits (277), Expect = 1e-27
 Identities = 46/197 (23%), Positives = 78/197 (39%), Gaps = 46/197 (23%)

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL------------ 210
              QI  A+ ++H   G+ HRD+KP N+        VK+ DFG    +            
Sbjct: 169 IFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTP 226

Query: 211 -VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQL 269
                 +   + ++ Y +PE I G   Y+  VDI+S+G +L ELL               
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQM------ 277

Query: 270 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 329
            E ++++      +++         KFP         +F ++ P E   +V  +L  SP 
Sbjct: 278 -ERVRII-----TDVR-------NLKFP--------LLFTQKYPQEH-MMVQDMLSPSPT 315

Query: 330 LRCTALEACIHPFFDEL 346
            R  A +   +  F+ L
Sbjct: 316 ERPEATDIIENAIFENL 332

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 52.6 bits (126), Expect = 7e-08
 Identities = 17/59 (28%), Positives = 30/59 (50%), Gaps = 5/59 (8%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
           +   + +G+G FG+VF+AK        AIK++    R        RE++ +  L+HP +
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  110 bits (278), Expect = 2e-27
 Identities = 66/318 (20%), Positives = 120/318 (37%), Gaps = 79/318 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 144
           RV+G+GS+  V   +  +T    A++      V  D+              +     +HP
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID----WVQTEKHVFEQASNHP 113

Query: 145 ---NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGI 178
               +H                         +  +++P  + + Y+ +I  AL Y+H   
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-R 172

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 237
           G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G  +Y
Sbjct: 173 GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDY 230

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
             +VD W++G ++ E++ G+  F      D   +        T + +           F 
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-----------FQ 272

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--CTALEACI----HPFFDELRDPN- 350
            I          + +  +A  ++   L   P  R  C           HPFF   R+ + 
Sbjct: 273 VILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF---RNVDW 327

Query: 351 ARLPNGRPFPPLFNFKPQ 368
             +   +  PP   FKP 
Sbjct: 328 DMMEQKQVVPP---FKPN 342

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  113 bits (283), Expect = 2e-27
 Identities = 73/315 (23%), Positives = 112/315 (35%), Gaps = 83/315 (26%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHP-- 144
            V+G+GSFG V  ++   T E  A+K      V+QD   +      R L        P  
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 404

Query: 145 -NVHYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
             +H                         +   R    +   Y  +I   L ++    G+
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGI 463

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTT 239
            +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE+I     Y  
Sbjct: 464 IYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGK 521

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           +VD W+ G +L E+L GQ  F GE   D+L + I                      +P  
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EHNVAYP-- 562

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELRDPN-ARL 353
                     K M  EAV +   L+   P  R         +   H FF   R  +  +L
Sbjct: 563 ----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---RYIDWEKL 609

Query: 354 PNGRPFPPLFNFKPQ 368
                 PP   +KP+
Sbjct: 610 ERKEIQPP---YKPK 621

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  108 bits (272), Expect = 3e-27
 Identities = 67/295 (22%), Positives = 111/295 (37%), Gaps = 64/295 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNV-- 146
           +     +G G+FG V++AK  ETG   A K +     ++      E++ +   DHP +  
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 147 ---HYSRASQ----------------------RMPLIYVKLYTYQICRALAYIHGGIGVC 181
               Y    +                       +    +++   Q+  AL ++H    + 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK-RII 139

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGAT----E 236
           HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++   T     
Sbjct: 140 HRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           Y    DIWS+G  L E+   +P     + +  L++I K    PT                
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT------------- 244

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
                  W   F         D +   L  +P  R +A +   HPF   +    A
Sbjct: 245 ----PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  108 bits (272), Expect = 4e-27
 Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 49/213 (23%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ--DKRYKN--RELQTMRLLDHPN-VHYSR 150
             V+G+G FG   +    ETGE + +K++++  ++  +   +E++ MR L+HPN + +  
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 151 ASQRMPLIYV--------KLYTY------------------QICRALAYIHGGIGVCHRD 184
              +   +           L                      I   +AY+H  + + HRD
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRD 133

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---------------YYRAPE 229
           +   N LV      V + DFG A+++V  +     + S                Y+ APE
Sbjct: 134 LNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192

Query: 230 LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPG 262
           +I G   Y   VD++S G VL E++      P 
Sbjct: 193 MING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  106 bits (266), Expect = 3e-26
 Identities = 54/210 (25%), Positives = 82/210 (39%), Gaps = 44/210 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYK---NRELQTMRLLDHP 144
           Y   R+VG+G  G V++A+       VA+K ++      D  ++    RE +T   L  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 145 NV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
           +V                             R    +          QI  AL   H   
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYYRAPELIFGA 234
           G  HRD+KP+N+LV+       L DFG A      +  +    + + + YY APE    +
Sbjct: 154 GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSES 210

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
              T   DI+++ CVL E L G P + G+ 
Sbjct: 211 -HATYRADIYALTCVLYECLTGSPPYQGDQ 239

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  106 bits (266), Expect = 5e-26
 Identities = 40/208 (19%), Positives = 75/208 (36%), Gaps = 52/208 (25%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPN-VHYSRA 151
            + +G+G +G V+  K    GE VA+K     ++    RE  +    L+ H N + +  A
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 152 SQRMPLIYVK------------LYTY----------------QICRALAYIHGGI----- 178
             +    + +            LY Y                     L ++H  I     
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159

Query: 179 --GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----RYYRAPELI 231
              + HRD+K +N+LV  +     + D G A   +     +    +     + Y  PE++
Sbjct: 160 KPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218

Query: 232 FGAT-----EYTTAVDIWSVGCVLAELL 254
             +      +     D++S G +L E+ 
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVA 246

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  109 bits (273), Expect = 5e-26
 Identities = 52/229 (22%), Positives = 84/229 (36%), Gaps = 66/229 (28%)

Query: 78  TTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQD-------KR 129
             + G+         Y  +  +  G  G ++ A      G  V +K  L           
Sbjct: 76  DIVAGQ---------YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAM 125

Query: 130 YKNRELQTMRLLDHPNV--------HYSRASQRMPLI---YVK----------------- 161
               E Q +  + HP++        H  R    +  I   YV                  
Sbjct: 126 AM-AERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEA 184

Query: 162 -LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-----VKGEP 215
             Y  +I  AL+Y+H  IG+ + D+KP+N+++     Q+KL D G+   +     + G P
Sbjct: 185 IAYLLEILPALSYLH-SIGLVYNDLKPENIMLTE--EQLKLIDLGAVSRINSFGYLYGTP 241

Query: 216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES 264
                    ++APE++      T A DI++VG  LA L L  P   G  
Sbjct: 242 --------GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  104 bits (262), Expect = 8e-26
 Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 42/215 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV--- 146
            + +G GSFG V++ K       VA+K +               E+  +R   H N+   
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85

Query: 147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                                  H   +  +  +  +     Q  R + Y+H    + HR
Sbjct: 86  MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA-KSIIHR 144

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE--YT 238
           D+K  N+ ++   + VK+ DFG A    +   +  +     S  + APE+I       Y+
Sbjct: 145 DLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203

Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 273
              D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  104 bits (262), Expect = 9e-26
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 52/208 (25%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNV------ 146
              VG+G +G V++      GE VA+K    +D++   RE  L    +L H N+      
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 147 --HYSRASQRMPLI--YVK---LYTY----------------QICRALAYIHGGI----- 178
                 +S ++ LI  Y +   LY Y                 I   LA++H  I     
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130

Query: 179 --GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----RYYRAPELI 231
              + HRD+K +N+LV  +     + D G A +  +    +    +     + Y APE++
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189

Query: 232 -----FGATEYTTAVDIWSVGCVLAELL 254
                    +    VDIW+ G VL E+ 
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (263), Expect = 1e-25
 Identities = 63/305 (20%), Positives = 112/305 (36%), Gaps = 72/305 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMR-LLDHPN-VH 147
           +    +VG G++G V++ + ++TG+  AIK +     ++    +E+  ++    H N   
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 148 Y---------------------------------SRASQRMPLIYVKLYTYQICRALAYI 174
           Y                                 +     +   ++     +I R L+++
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI-- 231
           H    V HRDIK QN+L+     +VKL DFG SA++        ++I + Y+ APE+I  
Sbjct: 146 HQH-KVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203

Query: 232 --FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
                  Y    D+WS+G    E+  G P       +  L  I +             NP
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------------NP 250

Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
                  P++K+  W K F           +   L  + + R    +   HPF  +  + 
Sbjct: 251 ------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296

Query: 350 NARLP 354
                
Sbjct: 297 RQVRI 301

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  104 bits (261), Expect = 2e-25
 Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 55/231 (23%)

Query: 78  TTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYKN 132
           + +  R         Y    ++G G    V  A+ L     VA+K VL     +D  +  
Sbjct: 8   SHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYL 57

Query: 133 R---ELQTMRLLDHPNV------------------------------HYSRASQRMPLIY 159
           R   E Q    L+HP +                                      M    
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117

Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
                   C+AL + H   G+ HRD+KP N++++  T+ VK+ DFG A+ +     +++ 
Sbjct: 118 AIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQ 175

Query: 220 ----ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
               I +  Y +PE   G +      D++S+GCVL E+L G+P F G+S V
Sbjct: 176 TAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  103 bits (260), Expect = 2e-25
 Identities = 60/232 (25%), Positives = 94/232 (40%), Gaps = 55/232 (23%)

Query: 74  HIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------ 127
           H+I   I  R         Y     +G G    V+ A+       VAIK  +        
Sbjct: 3   HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52

Query: 128 ---KRYKNRELQTMRLLDHPNV--------------------------HYSRASQRMPLI 158
              KR++ RE+     L H N+                           Y  +   + + 
Sbjct: 53  ETLKRFE-REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVD 111

Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 218
               +T QI   + + H  + + HRDIKPQN+L++     +K+ DFG AK L   E +++
Sbjct: 112 TAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGIAKAL--SETSLT 167

Query: 219 Y----ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV 266
                + +  Y +PE   G        DI+S+G VL E+L+G+P F GE+ V
Sbjct: 168 QTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  101 bits (254), Expect = 2e-24
 Identities = 45/208 (21%), Positives = 79/208 (37%), Gaps = 52/208 (25%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPN-VHYSRA 151
           +  +G+G FG V++ K    GE VA+K    +++R   RE  +    +L H N + +  A
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 152 SQRMPLIYVK------------LYTY----------------QICRALAYIH-------G 176
             +    + +            L+ Y                     LA++H       G
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 164

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----RYYRAPELI 231
              + HRD+K +N+LV  +     + D G A         I    +     + Y APE++
Sbjct: 165 KPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 232 FGAT-----EYTTAVDIWSVGCVLAELL 254
             +      E     DI+++G V  E+ 
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIA 251

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  101 bits (253), Expect = 2e-24
 Identities = 60/326 (18%), Positives = 110/326 (33%), Gaps = 95/326 (29%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN-VHY 148
             ++G+G FG V+  +       VAI+ +  ++  ++      RE+   R   H N V +
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 149 SRASQRMPLIYV--------KLYTY------------------QICRALAYIHGGIGVCH 182
             A    P + +         LY+                   +I + + Y+H   G+ H
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA-KGILH 153

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--------YRAPELIFGA 234
           +D+K +N+  +     V + DFG   +   G         +         + APE+I   
Sbjct: 154 KDLKSKNVFYDNGK--VVITDFGLFSI--SGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 235 TE--------YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
           +         ++   D++++G +  EL   +  F  +        II  +GT  +  +  
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMGTGMKPNL-- 263

Query: 287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
                                    M  E  D++     +    R         P F +L
Sbjct: 264 --SQIG-------------------MGKEISDILLFCWAFEQEER---------PTFTKL 293

Query: 347 RDPNARLP--NGRPFPPLFNFKPQEL 370
            D   +LP  N R   P   +K  EL
Sbjct: 294 MDMLEKLPKRNRRLSHPGHFWKSAEL 319

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 98.5 bits (246), Expect = 9e-24
 Identities = 28/206 (13%), Positives = 65/206 (31%), Gaps = 46/206 (22%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPN-VHY 148
              + +   G +++ +    G  + +K +          R  N E   +R+  HPN +  
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 149 SRASQRMPLI-------YVK---LYTY-------------------QICRALAYIHG-GI 178
             A Q  P         ++    LY                      + R +A++H    
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATE 236
            +    +  ++++++      ++                  + +  + APE +       
Sbjct: 133 LIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMYAPAWVAPEALQKKPEDT 187

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPG 262
              + D+WS   +L EL+  +  F  
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFAD 213

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 98.3 bits (245), Expect = 3e-23
 Identities = 54/247 (21%), Positives = 95/247 (38%), Gaps = 57/247 (23%)

Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNV 146
           ++      V  +G FG V++A+     E VA+K    QDK+    E  + ++  + H N+
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 147 --------HYSRASQRMPLI--YVK---LYTY----------------QICRALAYIHGG 177
                     +     + LI  + +   L  +                 + R LAY+H  
Sbjct: 81  LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHED 140

Query: 178 I---------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---- 224
           I          + HRDIK +N+L+  +     + DFG A      E   S   +      
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAGDTHGQVGT 196

Query: 225 --YRAPELIFGA----TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
             Y APE++ GA     +    +D++++G VL EL        G      L    ++   
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256

Query: 279 PTREEIK 285
           P+ E+++
Sbjct: 257 PSLEDMQ 263

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 62/327 (18%), Positives = 115/327 (35%), Gaps = 68/327 (20%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNRELQTMRL--LDHPN-VHYSRA 151
             ++G+G +G V++         VA+K     +++    E    R+  ++H N   +   
Sbjct: 18  LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 152 SQRMP--------LI-----------YVKLYT----------YQICRALAYIHGGI---- 178
            +R+         L+           Y+ L+T          + + R LAY+H  +    
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGD 135

Query: 179 ----GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---------Y 225
                + HRD+  +N+LV        + DFG +  L                       Y
Sbjct: 136 HYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194

Query: 226 RAPELIFGA------TEYTTAVDIWSVGCVLAELLLG-QPLFPGESGVD-QLVEIIKVLG 277
            APE++ GA            VD++++G +  E+ +    LFPGES  + Q+    +V  
Sbjct: 195 MAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN 254

Query: 278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 337
            PT E+++ +     E + P+     W +  +        + +          R TA   
Sbjct: 255 HPTFEDMQVL--VSREKQRPKFPEA-WKE--NSLAVRSLKETIEDCWDQDAEARLTAQ-- 307

Query: 338 CIHPFFDELRDPNARLPNGRPFPPLFN 364
                  EL     R  +  P     +
Sbjct: 308 XAEERMAELMMIWERNKSVSPTAHHHH 334

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 53/228 (23%), Positives = 87/228 (38%), Gaps = 66/228 (28%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 147 -------------------------HYSRASQ-RMPLIYVKLYTYQICRALAYI--HGGI 178
                                     Y R  +  +   Y+  +  QI + + Y+     +
Sbjct: 80  CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------A 227
              HRD+  +N+LV      VK+ DFG AK+L   E          Y            A
Sbjct: 140 ---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMA 187

Query: 228 PE-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 271
            E ++     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 188 LESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 39/340 (11%), Positives = 66/340 (19%), Gaps = 100/340 (29%)

Query: 55  RVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLE 114
           R      +   D      G        GR         Y      G       +QA    
Sbjct: 7   REPDRESSAPPDDVQLVPGA---RIANGR---------YRLLIFHGGVPPLQFWQALDTA 54

Query: 115 TGETVAIKKVL----QDKRYKNR---ELQTMRLLDHPNV------------HY------- 148
               VA+  V                    +  +D P V                     
Sbjct: 55  LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIR 114

Query: 149 -----SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 203
                  A      +        +  A    H   GV      P  + V+     V L  
Sbjct: 115 GGSLQEVADTSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-DGDVVLAY 172

Query: 204 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGE 263
                                                 DI  +G  L  LL+ +   P  
Sbjct: 173 PA-------------------TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEA 205

Query: 264 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 323
                L    +        E   ++ +                     +P +   + +R 
Sbjct: 206 GVRSGLAPAERDTAGQPI-EPADIDRD---------------------IPFQISAVAARS 243

Query: 324 LQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLF 363
           +Q    +R  +         + ++   A         P+ 
Sbjct: 244 VQGDGGIRSASTLL------NLMQQATAVADRTEVLGPID 277

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 82.3 bits (204), Expect = 8e-18
 Identities = 45/221 (20%), Positives = 84/221 (38%), Gaps = 59/221 (26%)

Query: 94  MAERVVGQGSFGIVFQAKCLETGET--VAIKKV---LQDKRYKN---RELQTMRLLDHPN 145
           + ++ +G G+FG V +           VA+K +     D   K+    E   M+ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 146 V-------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
           +                          Y + ++ +    +    +Q+   + Y+      
Sbjct: 80  IVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESNF 138

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------------AP 228
            HRD+  +N+L+    H  K+ DFG +K L   E         YY+            AP
Sbjct: 139 VHRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQTHGKWPVKWYAP 189

Query: 229 E-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
           E + +   ++++  D+WS G ++ E    GQ  + G  G +
Sbjct: 190 ECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 56/227 (24%), Positives = 87/227 (38%), Gaps = 62/227 (27%)

Query: 96  ERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            R +G+G FG V           TGE VA+K +  D   ++     +E+  +R L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 147 ----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                        Y      + L  + L+  QIC  +AY+H   
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHA-Q 153

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------------ 226
              HRD+  +N+L++ +   VK+ DFG AK + +G          YYR            
Sbjct: 154 HYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDGDSPVFWY 204

Query: 227 APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEI 272
           APE +     +  A D+WS G  L ELL          +   +L+ I
Sbjct: 205 APECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 62/209 (29%)

Query: 96  ERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPN- 145
            + +G+G+FG V   +       TGE VA+KK LQ    ++     RE++ ++ L H N 
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 146 -----VHYSRASQRMPLI-----------YVK------------LYTYQICRALAYIHGG 177
                V YS   + + LI           Y++             YT QIC+ + Y+   
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT- 132

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----------- 226
               HRD+  +N+LV    ++VK+ DFG  KVL + +         +++           
Sbjct: 133 KRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKE--------FFKVKEPGESPIFW 183

Query: 227 -APELIFGATEYTTAVDIWSVGCVLAELL 254
            APE +   ++++ A D+WS G VL EL 
Sbjct: 184 YAPESLT-ESKFSVASDVWSFGVVLYELF 211

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 44/218 (20%), Positives = 72/218 (33%), Gaps = 59/218 (27%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV---- 146
              +G+G+FG VF  +       VA+K   +      +     E + ++   HPN+    
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 147 ----------------------HYSRASQRMPLIYVKL-YTYQICRALAYIHGGIGVCHR 183
                                  + R       +   L         + Y+       HR
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES-KCCIHR 237

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------------APE-L 230
           D+  +N LV    + +K+ DFG ++    G          Y              APE L
Sbjct: 238 DLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLRQVPVKWTAPEAL 287

Query: 231 IFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
            +G   Y++  D+WS G +L E   LG   +P  S   
Sbjct: 288 NYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 48/216 (22%), Positives = 83/216 (38%), Gaps = 47/216 (21%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------ 146
           +  +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+      
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 147 --------------------HYSRASQRMPLIYVKL--YTYQICRALAYIHGGIGVCHRD 184
                                Y R   R  +  V L     QI  A+ Y+       HR+
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRN 343

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APELIFGATEYT 238
           +  +N LV    H VK+ DFG ++++        Y      +      APE +     ++
Sbjct: 344 LAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPESLAYNK-FS 397

Query: 239 TAVDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 271
              D+W+ G +L E+   G   +PG       +L+E
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 81.0 bits (200), Expect = 6e-17
 Identities = 52/215 (24%), Positives = 80/215 (37%), Gaps = 47/215 (21%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------ 146
           E  +GQG FG V+      T   VAIK +           +E Q M+ L H  +      
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 147 -------------------HYSRASQRMPLIYVKL--YTYQICRALAYIHGGIGVCHRDI 185
                               + +      L   +L     QI   +AY+   +   HRD+
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDL 306

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APELIFGATEYTT 239
           +  N+LV  +    K+ DFG A+++   E    Y   +  +      APE       +T 
Sbjct: 307 RAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEAALYGR-FTI 360

Query: 240 AVDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 271
             D+WS G +L EL   G+  +PG    +    VE
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 79.6 bits (197), Expect = 6e-17
 Identities = 48/206 (23%), Positives = 82/206 (39%), Gaps = 47/206 (22%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------ 146
           +  +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+      
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 147 --------------------HYSRASQRMPLIYVKL--YTYQICRALAYIHGGIGVCHRD 184
                                Y R   R  +  V L     QI  A+ Y+       HRD
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNFIHRD 136

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE-LIFGATEY 237
           +  +N LV  + H VK+ DFG ++++        Y      +      APE L +   ++
Sbjct: 137 LAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPESLAYN--KF 189

Query: 238 TTAVDIWSVGCVLAELL-LGQPLFPG 262
           +   D+W+ G +L E+   G   +PG
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPG 215

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 60/208 (28%)

Query: 96  ERVVGQGSFGIVFQAKCL----ETGETVAIK--KVLQDKRYKN--RELQTMRLLDHPN-V 146
            + +G+G+FG V   +       TGE VA+K  +   ++  ++  RE++ ++ L H N V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 147 HY---SRASQRMPLI----YVK---------------------LYTYQICRALAYIHGGI 178
            Y     ++ R  L     Y+                       YT QIC+ + Y+    
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT-K 164

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------------ 226
              HRD+  +N+LV    ++VK+ DFG  KVL + +         YY+            
Sbjct: 165 RYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKEPGESPIFWY 215

Query: 227 APELIFGATEYTTAVDIWSVGCVLAELL 254
           APE +   ++++ A D+WS G VL EL 
Sbjct: 216 APESLT-ESKFSVASDVWSFGVVLYELF 242

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 52/215 (24%), Positives = 80/215 (37%), Gaps = 47/215 (21%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------ 146
           E  +GQG FG V+      T   VAIK +           +E Q M+ L H  +      
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 147 -------------------HYSRASQRMPLIYVKL--YTYQICRALAYIHGGIGVCHRDI 185
                               + +      L   +L     QI   +AY+   +   HRD+
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDL 389

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APELIFGATEYTT 239
           +  N+LV  +    K+ DFG A+++   E    Y   +  +      APE       +T 
Sbjct: 390 RAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEAALYGR-FTI 443

Query: 240 AVDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 271
             D+WS G +L EL   G+  +PG    +    VE
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 54/209 (25%), Positives = 79/209 (37%), Gaps = 62/209 (29%)

Query: 96  ERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPN- 145
              +G+G+FG V   +       TG  VA+K  LQ           RE+Q ++ L     
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 146 VHY---SRASQRMPLI-------------YVK------------LYTYQICRALAYIHGG 177
           V Y   S    R  L              +++            LY+ QIC+ + Y+   
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS- 145

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----------- 226
               HRD+  +N+LV      VK+ DFG AK+L   +         YY            
Sbjct: 146 RRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVREPGQSPIFW 196

Query: 227 -APELIFGATEYTTAVDIWSVGCVLAELL 254
            APE +     ++   D+WS G VL EL 
Sbjct: 197 YAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 52/209 (24%), Positives = 80/209 (38%), Gaps = 61/209 (29%)

Query: 96  ERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPN- 145
            R +G+G FG V   +       TGE VA+K +  +    +     +E++ +R L H N 
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 146 -----VHYSRASQRMPLI--YVKL---------------------YTYQICRALAYIHGG 177
                +        + LI  ++                       Y  QIC+ + Y+   
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS- 144

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----------- 226
               HRD+  +N+LV    HQVK+ DFG  K +   +         YY            
Sbjct: 145 RQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKDDRDSPVFW 195

Query: 227 -APELIFGATEYTTAVDIWSVGCVLAELL 254
            APE +  +  +  A D+WS G  L ELL
Sbjct: 196 YAPECLMQSK-FYIASDVWSFGVTLHELL 223

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 45/220 (20%), Positives = 82/220 (37%), Gaps = 50/220 (22%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            +V+G G FG V +   +  GE     V IK +      ++       +  +  LDH ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 147 -------------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGV 180
                                     + R  +  +    +  +  QI + + Y+    G+
Sbjct: 78  VRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-EHGM 136

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APELIFGA 234
            HR++  +N+L+     QV++ DFG A +L   +     +     +      A E I   
Sbjct: 137 VHRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQLLYSEAKTPIKWMALESIHFG 192

Query: 235 TEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 271
             YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 193 K-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 49/221 (22%), Positives = 83/221 (37%), Gaps = 59/221 (26%)

Query: 94  MAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 147 -------------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGV 180
                                     +    +  +P+  V    +Q+   + Y+      
Sbjct: 73  VRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKNF 131

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------------AP 228
            HRD+  +N+L+  + H  K+ DFG +K L   +         YY             AP
Sbjct: 132 VHRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARSAGKWPLKWYAP 182

Query: 229 E-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
           E + F   ++++  D+WS G  + E L  GQ  +    G +
Sbjct: 183 ECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 54/227 (23%), Positives = 86/227 (37%), Gaps = 64/227 (28%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 147 -------------------------HYSRASQ-RMPLIYVKLYTYQICRALAYI--HGGI 178
                                     Y R  +  +   Y+  +  QI + + Y+     +
Sbjct: 80  CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------A 227
              HRD+  +N+LV      VK+ DFG AK+L   E          Y            A
Sbjct: 140 ---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMA 187

Query: 228 PELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 271
            E I     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 51/221 (23%), Positives = 85/221 (38%), Gaps = 59/221 (26%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------ 146
           E+ +G G FG V+ A   +    VA+K +            E   M+ L H  +      
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 147 -------------------HYSRASQRMPLIYVKL--YTYQICRALAYIHGGIGVCHRDI 185
                               + ++ +       KL  ++ QI   +A+I       HRD+
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRNYIHRDL 310

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------APE-LIFG 233
           +  N+LV+      K+ DFG A+V+   E         Y             APE + FG
Sbjct: 311 RAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPIKWTAPEAINFG 360

Query: 234 ATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 271
              +T   D+WS G +L E++  G+  +PG S  +  + +E
Sbjct: 361 --SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 50/221 (22%), Positives = 81/221 (36%), Gaps = 59/221 (26%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------ 146
              +G G FG V+          VA+K + Q     +    E   M+ L H  +      
Sbjct: 18  VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 147 -------------------HYSRASQRMPLIYVKL--YTYQICRALAYIHGGIGVCHRDI 185
                               + +    + L   KL     QI   +A+I       HRD+
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERNYIHRDL 135

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------APE-LIFG 233
           +  N+LV+      K+ DFG A+++   E         Y             APE + +G
Sbjct: 136 RAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPIKWTAPEAINYG 185

Query: 234 ATEYTTAVDIWSVGCVLAELL-LGQPLFPGESG--VDQLVE 271
              +T   D+WS G +L E++  G+  +PG +   V Q +E
Sbjct: 186 --TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 78.2 bits (193), Expect = 6e-16
 Identities = 48/206 (23%), Positives = 76/206 (36%), Gaps = 53/206 (25%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNV------- 146
            + +G+G FG V        G  VA+K +  D   +    E   M  L H N+       
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 147 --------------------HYSRASQRMPLIYVKL--YTYQICRALAYIHGGIGVCHRD 184
                                Y R+  R  L    L  ++  +C A+ Y+  G    HRD
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNFVHRD 314

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE-LIFGATEY 237
           +  +N+LV+   +  K+ DFG  K                 +      APE L     ++
Sbjct: 315 LAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEALREK--KF 363

Query: 238 TTAVDIWSVGCVLAELL-LGQPLFPG 262
           +T  D+WS G +L E+   G+  +P 
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPR 389

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 76.6 bits (189), Expect = 6e-16
 Identities = 46/215 (21%), Positives = 77/215 (35%), Gaps = 61/215 (28%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH----PNV 146
           Y   R +G+GSFG++F+   L   + VAIK   +         E +T +LL      PNV
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 147 HYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
           +Y                           ++  +  V +   Q+   +  IH    + +R
Sbjct: 72  YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-EKSLVYR 130

Query: 184 DIKPQNLLV----NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGA 234
           DIKP N L+    + + + + + DFG  K          Y          YR  + + G 
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVK---------FYRDPVTKQHIPYREKKNLSGT 181

Query: 235 TEYTTAV------------DIWSVGCVLAELLLGQ 257
             Y  ++            D+ ++G V    L G 
Sbjct: 182 ARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 76.1 bits (188), Expect = 7e-16
 Identities = 49/211 (23%), Positives = 77/211 (36%), Gaps = 53/211 (25%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNV------- 146
            + +G+G FG V        G  VA+K +  D   +    E   M  L H N+       
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 147 --------------------HYSRASQRMPLIYVKL--YTYQICRALAYIHGGIGVCHRD 184
                                Y R+  R  L    L  ++  +C A+ Y+  G    HRD
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRD 142

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE-LIFGATEY 237
           +  +N+LV+   +  K+ DFG  K                 +      APE L     ++
Sbjct: 143 LAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEALREK--KF 191

Query: 238 TTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
           +T  D+WS G +L E+   G+  +P     D
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 59/221 (26%)

Query: 94  MAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 147 -------------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGV 180
                                     +    +  +P+  V    +Q+   + Y+      
Sbjct: 399 VRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKNF 457

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------------AP 228
            HR++  +N+L+  + H  K+ DFG +K L   +         YY             AP
Sbjct: 458 VHRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARSAGKWPLKWYAP 508

Query: 229 E-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
           E + F   ++++  D+WS G  + E L  GQ  +    G +
Sbjct: 509 ECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 71/236 (30%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTM 138
           P + +   ++RV+G+G FG+V+  + ++  +     AIK    + + +      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76

Query: 139 RLLDHPNV---------------------------HYSRASQRMP----LIYVKLYTYQI 167
           R L+HPNV                            + R+ QR P    LI    +  Q+
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS---FGLQV 133

Query: 168 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR- 226
            R + Y+       HRD+  +N +++  +  VK+ DFG A+ ++  E         YY  
Sbjct: 134 ARGMEYLAE-QKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDRE---------YYSV 182

Query: 227 -------------APE-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
                        A E L      +TT  D+WS G +L ELL  G P +      D
Sbjct: 183 QQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 78.0 bits (192), Expect = 1e-15
 Identities = 59/225 (26%), Positives = 86/225 (38%), Gaps = 62/225 (27%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV- 146
            R +G+G FG V Q   +        VAIK          R     E  TMR  DHP++ 
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 147 ------------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                    + +  +  + L  + LY YQ+  ALAY+       
Sbjct: 455 KLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES-KRFV 513

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------APE- 229
           HRDI  +N+LV+ +   VKL DFG ++ +             YY+           APE 
Sbjct: 514 HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKGKLPIKWMAPES 563

Query: 230 LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESG--VDQLVE 271
           + F    +T+A D+W  G  + E+L  G   F G     V   +E
Sbjct: 564 INFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 49/224 (21%), Positives = 81/224 (36%), Gaps = 65/224 (29%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTMRLLDHPNV- 146
             V+G+G FG V+    L+        A+K    + D    +    E   M+   HPNV 
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 147 --------------------------HYSRASQRMPLIYVKL-YTYQICRALAYIHGGIG 179
                                     ++ R     P +   + +  Q+ + + Y+     
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS-KK 148

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------------- 226
             HRD+  +N +++     VK+ DFG A+ +   E         YY              
Sbjct: 149 FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSVHNKTGAKLPVKW 198

Query: 227 -APE-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
            A E L     ++TT  D+WS G +L EL+  G P +P  +  D
Sbjct: 199 MALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 75.3 bits (186), Expect = 1e-15
 Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 64/221 (28%)

Query: 96  ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV- 146
            R++G+G FG V++            VA+K   +D    N+     E   M+ LDHP++ 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 147 ------------------------HYSRASQ-RMPLIYVKLYTYQICRALAYI--HGGIG 179
                                   HY   ++  + ++ + LY+ QIC+A+AY+     + 
Sbjct: 77  KLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV- 135

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------AP 228
             HRDI  +N+LV      VKL DFG ++ +   +         YY+           +P
Sbjct: 136 --HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVTRLPIKWMSP 183

Query: 229 E-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
           E + F    +TTA D+W     + E+L  G+  F      D
Sbjct: 184 ESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 75.3 bits (186), Expect = 1e-15
 Identities = 58/219 (26%), Positives = 84/219 (38%), Gaps = 60/219 (27%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV- 146
            R +G+G FG V Q   +        VAIK          R     E  TMR  DHP++ 
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 147 ------------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                    + +  +  + L  + LY YQ+  ALAY+       
Sbjct: 80  KLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFV 138

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------APE- 229
           HRDI  +N+LV+ +   VKL DFG ++ +             YY+           APE 
Sbjct: 139 HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKGKLPIKWMAPES 188

Query: 230 LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
           + F    +T+A D+W  G  + E+L  G   F G    D
Sbjct: 189 INFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 48/233 (20%), Positives = 79/233 (33%), Gaps = 74/233 (31%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
            R++G+G FG V +A+  +       VA+K +  D    +      RE   M+  DHP+V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 147 --------------------------------HYSRAS----QRMPLIYVKL--YTYQIC 168
                                            +  AS        L    L  +   I 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 169 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 226
             + Y+       HRD+  +N ++      V + DFG ++ +  G+         YYR  
Sbjct: 148 CGMEYL-SSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGD---------YYRQG 196

Query: 227 ----------APE-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
                     A E L      YT   D+W+ G  + E++  GQ  + G    +
Sbjct: 197 CASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 37/224 (16%), Positives = 69/224 (30%), Gaps = 62/224 (27%)

Query: 96  ERVVGQGSFGIVFQAKCLETGET-------VAIKKVLQDKRYKN----RELQTMRLLDHP 144
              +GQG+F  +F+    E G+        V +K + +  R  +         M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 145 NV--------------------------HYSRASQRMPLIYVKL-YTYQICRALAYIHGG 177
           ++                           Y + ++    I  KL    Q+  A+ ++   
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE- 131

Query: 178 IGVCHRDIKPQNLLVNPHTHQ-------VKLCDFGSAKVLVKGEPNISYICSRYYR---- 226
             + H ++  +N+L+     +       +KL D G +  ++  +           +    
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---------ILQERIP 182

Query: 227 --APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
              PE I        A D WS G  L E+   G           
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 33/149 (22%), Positives = 55/149 (36%), Gaps = 34/149 (22%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYKNRELQTMRLLDH----PNV 146
           +   + +G G+FG +   K L T E VAIK   +       + E +  + L      P V
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 147 HYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
           +Y                           +   L  V +   Q+   + Y+H    + +R
Sbjct: 71  YYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH-SKNLIYR 129

Query: 184 DIKPQNLLV----NPHTHQVKLCDFGSAK 208
           D+KP+N L+    N     + + DF  AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 48/222 (21%), Positives = 84/222 (37%), Gaps = 61/222 (27%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------ 146
            + +G G FG+V   K       VA+K + +    ++   +E QTM  L HP +      
Sbjct: 13  LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 147 --------------------HYSRASQRMPLIYVKL--YTYQICRALAYIHGGIGVCHRD 184
                               +Y R S    L   +L    Y +C  +A++       HRD
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL-ESHQFIHRD 129

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------APE-LIF 232
           +  +N LV+     VK+ DFG  + ++  +         Y             APE   +
Sbjct: 130 LAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPVKWSAPEVFHY 179

Query: 233 GATEYTTAVDIWSVGCVLAELL-LGQPLFPGESG--VDQLVE 271
              +Y++  D+W+ G ++ E+  LG+  +   +   V   V 
Sbjct: 180 F--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 53/230 (23%), Positives = 83/230 (36%), Gaps = 68/230 (29%)

Query: 96  ERVVGQGSFGIVFQAKC-LETGET--VAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
              +G GSFG+V + +    +G+T  VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 146 V-------------------------HYSRASQ-RMPLIYVKLYTYQICRALAYI--HGG 177
           +                            R  Q    L  +  Y  Q+   + Y+     
Sbjct: 83  LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----------- 226
           I   HRD+  +NLL+      VK+ DFG  + L + +         +Y            
Sbjct: 143 I---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQEHRKVPFAW 190

Query: 227 -APE-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 271
            APE L      ++ A D W  G  L E+   GQ  + G +G      ++
Sbjct: 191 CAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 51/238 (21%), Positives = 87/238 (36%), Gaps = 74/238 (31%)

Query: 97  RVVGQGSFGIVFQAKCLETGE-----TVAIKKV-----LQDKRYKNRELQTMRLLDHPNV 146
           R +GQGSFG+V++       +      VAIK V     ++++     E   M+  +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 147 ----------------------------------HYSRASQRMPLIYVKL--YTYQICRA 170
                                               +      P    K+     +I   
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 226
           +AY++      HRD+  +N +V      VK+ DFG  + + + +         YYR    
Sbjct: 151 MAYLNA-NKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETD---------YYRKGGK 199

Query: 227 --------APE-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
                   +PE L  G   +TT  D+WS G VL E+  L +  + G S  +Q++  + 
Sbjct: 200 GLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLRFVM 254

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 51/220 (23%), Positives = 83/220 (37%), Gaps = 59/220 (26%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV- 146
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN+ 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 147 -------------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIGV 180
                                     + R    +  +I +      I   + Y+   +G 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL-SDMGY 168

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------APE 229
            HRD+  +N+L+N +    K+ DFG  +VL              Y            +PE
Sbjct: 169 VHRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRGGKIPIRWTSPE 220

Query: 230 -LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
            + +   ++T+A D+WS G VL E++  G+  +   S  D
Sbjct: 221 AIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 47/221 (21%), Positives = 79/221 (35%), Gaps = 61/221 (27%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV- 146
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN+ 
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 147 -------------------------HYSRASQRMPLIYVKL-YTYQICRALAYIHGGIGV 180
                                     + R       I   +     +   + Y+   +G 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDLGY 172

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------------AP 228
            HRD+  +N+LV+ +    K+ DFG ++VL                            AP
Sbjct: 173 VHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTTGGKIPIRWTAP 223

Query: 229 E-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
           E + F    +++A D+WS G V+ E+L  G+  +   +  D
Sbjct: 224 EAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 74.0 bits (182), Expect = 8e-15
 Identities = 48/224 (21%), Positives = 81/224 (36%), Gaps = 65/224 (29%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTMRLLDHPNV- 146
             V+G+G FG V+    L+        A+K    + D    +    E   M+   HPNV 
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 147 --------------------------HYSRASQRMP----LIYVKLYTYQICRALAYIHG 176
                                     ++ R     P    LI    +  Q+ + + ++  
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFLAS 210

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 226
                HRD+  +N +++     VK+ DFG A+ +   E +        +           
Sbjct: 211 -KKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNKTGAKLPVKW 262

Query: 227 -APE-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
            A E L     ++TT  D+WS G +L EL+  G P +P  +  D
Sbjct: 263 MALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 73.5 bits (181), Expect = 8e-15
 Identities = 45/232 (19%), Positives = 74/232 (31%), Gaps = 73/232 (31%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
            +++G+G FG V +    +       VA+K +  D   +        E   M+   HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 147 -------------------------------HYSRAS----QRMPLIYVKL--YTYQICR 169
                                           Y   S        +    L  +   I  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 226
            + Y+       HRD+  +N ++      V + DFG +K +  G+         YYR   
Sbjct: 159 GMEYL-SNRNFLHRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---------YYRQGR 207

Query: 227 ---------APE-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
                    A E L      YT+  D+W+ G  + E+   G   +PG    +
Sbjct: 208 IAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 72.6 bits (179), Expect = 1e-14
 Identities = 46/216 (21%), Positives = 78/216 (36%), Gaps = 59/216 (27%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------ 146
            + +G G FG+V     L   + VAIK + +    +     E + M  L HP +      
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 147 --------------------HYSRASQRMPLIYVKL--YTYQICRALAYIHGGIGVCHRD 184
                                Y R +QR       L      +C  +AY+     V HRD
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL-EEACVIHRD 129

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------APE-LIF 232
           +  +N LV  +   +K+ DFG  + ++  +         Y             +PE   F
Sbjct: 130 LAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPVKWASPEVFSF 179

Query: 233 GATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
               Y++  D+WS G ++ E+   G+  +   S  +
Sbjct: 180 S--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 36/147 (24%), Positives = 56/147 (38%), Gaps = 32/147 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH----PNV 146
           Y   R +G GSFG ++    +  GE VAIK      ++     E +  +++      P +
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 147 HYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
            +                          S++  L  V L   Q+   + YIH      HR
Sbjct: 71  RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-SKNFIHR 129

Query: 184 DIKPQNLLV--NPHTHQVKLCDFGSAK 208
           D+KP N L+      + V + DFG AK
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 51/213 (23%), Positives = 79/213 (37%), Gaps = 59/213 (27%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH----PNV 146
           +   R +G GSFG ++    ++T E VAIK      ++     E +  R+L      PNV
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 147 HYS-----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
            +                          S+++ L  V +   Q+   + ++H      HR
Sbjct: 69  RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHR 127

Query: 184 DIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATE 236
           DIKP N L+      +QV + DFG AK          Y  +       YR  + + G   
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK---------KYRDTSTHQHIPYRENKNLTGTAR 178

Query: 237 YTTAV------------DIWSVGCVLAELLLGQ 257
           Y  +V            D+ S+G VL   L G 
Sbjct: 179 Y-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 49/208 (23%), Positives = 82/208 (39%), Gaps = 57/208 (27%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT----MRLLDHPN----VH 147
           + ++G G FG V++   L  G  VA+K+   +      E +T    +    HP+    + 
Sbjct: 44  KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 148 YSRASQRMPLIY---------VKLYT-------------YQIC----RALAYIHGGIGVC 181
           +      M LIY           LY               +IC    R L Y+H    + 
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-AII 161

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATE 236
           HRD+K  N+L++ +    K+ DFG +K   + +   +++ +       Y  P       E
Sbjct: 162 HRDVKSINILLDENFV-PKITDFGISKKGTELDQ--THLSTVVKGTLGYIDP-------E 211

Query: 237 Y------TTAVDIWSVGCVLAELLLGQP 258
           Y      T   D++S G VL E+L  + 
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 46/221 (20%), Positives = 79/221 (35%), Gaps = 60/221 (27%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           ++V+G G FG V++     +       VAIK +      K R     E   M    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 147 --------------------------HYSRASQ-RMPLIYVKLYTYQICRALAYIHGGIG 179
                                      + R       ++ +      I   + Y+   + 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-MN 167

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------AP 228
             HRD+  +N+LVN +    K+ DFG ++VL              Y            AP
Sbjct: 168 YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP-------EATYTTSGGKIPIRWTAP 219

Query: 229 E-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
           E + +    +T+A D+WS G V+ E++  G+  +   S  +
Sbjct: 220 EAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 70.7 bits (174), Expect = 6e-14
 Identities = 44/215 (20%), Positives = 79/215 (36%), Gaps = 57/215 (26%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------ 146
            + +G G FG+V   K       VAIK + +    ++    E + M  L H  +      
Sbjct: 29  LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 147 --------------------HYSRASQRMPLIYVKLY-TYQICRALAYIHGGIGVCHRDI 185
                               +Y R  +        L     +C A+ Y+       HRD+
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQFLHRDL 146

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----------APE-LIFG 233
             +N LVN     VK+ DFG ++ ++  E         Y              PE L++ 
Sbjct: 147 AARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPVRWSPPEVLMYS 196

Query: 234 ATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
             ++++  DIW+ G ++ E+  LG+  +   +  +
Sbjct: 197 --KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 54/247 (21%), Positives = 88/247 (35%), Gaps = 80/247 (32%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTM-RLLDHP 144
            + +G G+FG V +A        +   TVA+K +     L ++     EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 145 NV--------------------------HYSRAS----------------QRMPLIYVKL 162
           N+                          ++ R                    + L    L
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 163 YT--YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
            +  YQ+ + +A++       HRD+  +N+L+       K+CDFG A+ +          
Sbjct: 148 LSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDS------ 199

Query: 221 CSRYYR------------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
               Y             APE IF    YT   D+WS G  L EL  LG   +PG     
Sbjct: 200 ---NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255

Query: 268 QLVEIIK 274
           +  ++IK
Sbjct: 256 KFYKMIK 262

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 51/244 (20%), Positives = 88/244 (36%), Gaps = 80/244 (32%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE-----TVAIKKV----LQDKRYKNRELQTMRLLDHPNV 146
           +  +G+G+FG VF A+C           VA+K +       ++   RE + + +L H ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 147 ---------------------------------------HYSRASQRMPLIYVKL--YTY 165
                                                           PL   +L     
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 225
           Q+   + Y+  G+   HRD+  +N LV      VK+ DFG ++ +   +         YY
Sbjct: 166 QVAAGMVYL-AGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD---------YY 214

Query: 226 R------------APE-LIFGATEYTTAVDIWSVGCVLAELL-LG-QPLFPGESGVDQLV 270
           R             PE +++   ++TT  D+WS G VL E+   G QP +   S   + +
Sbjct: 215 RVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS-NTEAI 270

Query: 271 EIIK 274
           + I 
Sbjct: 271 DCIT 274

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 55/254 (21%), Positives = 93/254 (36%), Gaps = 83/254 (32%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGE-----TVAIKKV----LQDKRYKNRELQT 137
            ++ I     R +G+G+FG VF A+C           VA+K +    L  ++   RE + 
Sbjct: 13  KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 138 MRLLDHPNV--------------------------HYSRASQRMPLIYVKLYT------- 164
           +  L H ++                           + RA     +I V           
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 165 ---------YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 215
                     QI   + Y+       HRD+  +N LV  +   VK+ DFG ++ +   + 
Sbjct: 131 GLSQMLHIASQIASGMVYL-ASQHFVHRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTD- 187

Query: 216 NISYICSRYYR------------APE-LIFGATEYTTAVDIWSVGCVLAELL-LG-QPLF 260
                   YYR             PE +++   ++TT  D+WS G +L E+   G QP +
Sbjct: 188 --------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP-W 236

Query: 261 PGESGVDQLVEIIK 274
              S   +++E I 
Sbjct: 237 FQLS-NTEVIECIT 249

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 68.2 bits (167), Expect = 7e-13
 Identities = 50/238 (21%), Positives = 81/238 (34%), Gaps = 72/238 (30%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
            R +G G+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 146 V-------------------------------HYSRASQRMPLIYVKL--YTYQICRALA 172
           +                                  R SQ   L  + L      I     
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYR---- 226
           Y+       HRDI  +N L+         K+ DFG A+ + +           YYR    
Sbjct: 196 YL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---------YYRKGGC 245

Query: 227 --------APE-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
                    PE  + G   +T+  D WS G +L E+  LG   +P +S   +++E + 
Sbjct: 246 AMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 300

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 50/238 (21%), Positives = 81/238 (34%), Gaps = 72/238 (30%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
            R +G G+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 146 V-------------------------------HYSRASQRMPLIYVKL--YTYQICRALA 172
           +                                  R SQ   L  + L      I     
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYR---- 226
           Y+       HRDI  +N L+         K+ DFG A+ + +           YYR    
Sbjct: 155 YL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---------YYRKGGC 204

Query: 227 --------APE-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 274
                    PE  + G   +T+  D WS G +L E+  LG   +P +S   +++E + 
Sbjct: 205 AMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 259

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 55/245 (22%), Positives = 91/245 (37%), Gaps = 79/245 (32%)

Query: 97  RVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLD-HPN 145
           + +G+G+FG V +A         T  TVA+K +       + R    EL+ +  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 146 V---------------------------HYSRAS--------------QRMPLIYVKL-- 162
           V                            Y R+                +  L    L  
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K          
Sbjct: 153 YSFQVAKGMEFL-ASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP-------- 202

Query: 223 RYYR------------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQL 269
             Y             APE IF    YT   D+WS G +L E+  LG   +PG    ++ 
Sbjct: 203 -DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260

Query: 270 VEIIK 274
              +K
Sbjct: 261 CRRLK 265

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 42/245 (17%), Positives = 70/245 (28%), Gaps = 73/245 (29%)

Query: 72  TGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIK--------- 122
            G ++    G +         ++  + +G G FG+++ A      E  A           
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 123 -------KVLQ-----DKRYKNRELQTMRLLDHPNVHYS--------------------- 149
                  K  Q     D   K  E + +  L  P  + S                     
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 150 -----RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQVKLCD 203
                  +       V     ++   L YIH      H DIK  NLL+   +  QV L D
Sbjct: 138 LQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPDQVYLAD 196

Query: 204 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV-----------DIWSVGCVLAE 252
           +G +        +  Y         +   G  E+T+             D+  +G  +  
Sbjct: 197 YGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR 252

Query: 253 LLLGQ 257
            L G+
Sbjct: 253 WLCGK 257

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 51/253 (20%), Positives = 96/253 (37%), Gaps = 88/253 (34%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
            + +G+G FG V +A            TVA+K +       + R    E   ++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 146 V--------------------------HYSRASQRMPLIYVKL----------------- 162
           V                           + R S+++   Y+                   
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 163 -------YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 215
                  + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + + 
Sbjct: 148 TMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNILVAEG-RKMKISDFGLSRDVYEED- 204

Query: 216 NISYICSRYYR------------APELIFGATEYTTAVDIWSVGCVLAELL-LG-QPLFP 261
                    Y             A E +F    YTT  D+WS G +L E++ LG  P +P
Sbjct: 205 --------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP-YP 254

Query: 262 GESGVDQLVEIIK 274
           G    ++L  ++K
Sbjct: 255 GIP-PERLFNLLK 266

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 46/206 (22%), Positives = 90/206 (43%), Gaps = 52/206 (25%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV---- 146
           + ++G+G FG V++ + L  G  VA+K++ +++          E++ + +  H N+    
Sbjct: 35  KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 147 -HYSRASQRMPLIY---------VKLYT-------------YQIC----RALAYIHGGIG 179
                 ++R+ L+Y           L                +I     R LAY+H    
Sbjct: 94  GFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152

Query: 180 VC--HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE-LI 231
               HRD+K  N+L++    +  + DFG AK++   +   +++ +       + APE L 
Sbjct: 153 PKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEYLS 208

Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQ 257
            G +  +   D++  G +L EL+ GQ
Sbjct: 209 TGKS--SEKTDVFGYGVMLLELITGQ 232

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 52/244 (21%), Positives = 86/244 (35%), Gaps = 78/244 (31%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE-----TVAIKKV-----LQDKRYKNRELQTM-RLLDHP 144
            + +G G+FG V +A     G+      VA+K +       +K     EL+ M  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 145 NV--------------------------HYSRASQRMPLIYVKLYT-------------- 164
           N+                          ++ R   R+                       
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 165 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 224
            Q+ + +A++       HRD+  +N+L+    H  K+ DFG A+ ++             
Sbjct: 171 SQVAQGMAFL-ASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS---------N 219

Query: 225 YR------------APELIFGATEYTTAVDIWSVGCVLAELL-LG-QPLFPGESGVDQLV 270
           Y             APE IF    YT   D+WS G +L E+  LG  P +PG     +  
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKFY 277

Query: 271 EIIK 274
           +++K
Sbjct: 278 KLVK 281

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 64.9 bits (159), Expect = 5e-12
 Identities = 51/246 (20%), Positives = 82/246 (33%), Gaps = 82/246 (33%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
              +G+  FG V++         E  + VAIK +        +     E      L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 146 V----------------------------------------HYSRASQRMPLIYVKL--Y 163
           V                                             + +  L        
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 164 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 223
             QI   + Y+     V H+D+  +N+LV      VK+ D G  + +   +         
Sbjct: 134 VAQIAAGMEYL-SSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAAD--------- 182

Query: 224 YYR------------APE-LIFGATEYTTAVDIWSVGCVLAELL-LG-QPLFPGESGVDQ 268
           YY+            APE +++G  +++   DIWS G VL E+   G QP + G S    
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCGYS-NQD 238

Query: 269 LVEIIK 274
           +VE+I+
Sbjct: 239 VVEMIR 244

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 54/247 (21%), Positives = 91/247 (36%), Gaps = 81/247 (32%)

Query: 96  ERVVGQGSFGIVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 142
            + +G+G+FG V  A+ +            VA+K +      +D      E++ M  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 143 HPNV--------------------------HYSRAS--------------QRMPLIYVKL 162
           H N+                           Y +A                   L    L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 163 --YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
               YQ+ R + Y+       HRD+  +N+LV    + +K+ DFG A+ +   +      
Sbjct: 194 VSCAYQVARGMEYL-ASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHID------ 245

Query: 221 CSRYYR------------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
              YY+            APE +F    YT   D+WS G +L E+  LG   +PG   V+
Sbjct: 246 ---YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VE 300

Query: 268 QLVEIIK 274
           +L +++K
Sbjct: 301 ELFKLLK 307

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 81/247 (32%)

Query: 96  ERVVGQGSFGIVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 142
            + +G+G FG V  A+ +       +   TVA+K +      +D      E++ M  +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 143 HPNV--------------------------HYSRAS--------------QRMPLIYVKL 162
           H N+                           Y RA                   + +  L
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 163 --YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
              TYQ+ R + Y+       HRD+  +N+LV  + + +K+ DFG A+ +   +      
Sbjct: 206 VSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID------ 257

Query: 221 CSRYYR------------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
              YY+            APE +F    YT   D+WS G ++ E+  LG   +PG   V+
Sbjct: 258 ---YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VE 312

Query: 268 QLVEIIK 274
           +L +++K
Sbjct: 313 ELFKLLK 319

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 55/247 (22%), Positives = 96/247 (38%), Gaps = 81/247 (32%)

Query: 96  ERVVGQGSFGIVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 142
            + +G+G+FG V  A+ +       +   TVA+K +      +D      E++ M  +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 143 HPNV--------------------------HYSRAS--------------QRMPLIYVKL 162
           H N+                           Y RA                   + +  L
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 163 --YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
              TYQ+ R + Y+       HRD+  +N+LV  + + +K+ DFG A+ +   +      
Sbjct: 160 VSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID------ 211

Query: 221 CSRYYR------------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVD 267
              YY+            APE +F    YT   D+WS G ++ E+  LG   +PG   V+
Sbjct: 212 ---YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VE 266

Query: 268 QLVEIIK 274
           +L +++K
Sbjct: 267 ELFKLLK 273

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 62.6 bits (153), Expect = 4e-11
 Identities = 50/207 (24%), Positives = 79/207 (38%), Gaps = 58/207 (28%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK----NRELQT----MRLLDHPN---- 145
            +G+G FG+V++   +    TVA+KK+            ++       M    H N    
Sbjct: 38  KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 146 VHYSRASQRMPLIY---------VKLYT------------YQIC----RALAYIHGGIGV 180
           + +S     + L+Y          +L               +I       + ++H     
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN-HH 154

Query: 181 CHRDIKPQNLLV----NPHTHQVKLCDFGSAKVLVKGEPNISYICSR----Y-YRAPELI 231
            HRDIK  N+L+           K+ DFG A+   K     + + SR      Y APE +
Sbjct: 155 IHRDIKSANILLDEAFTA-----KISDFGLARASEKFA--QTVMTSRIVGTTAYMAPEAL 207

Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQP 258
            G  E T   DI+S G VL E++ G P
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLP 232

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 39/211 (18%), Positives = 61/211 (28%), Gaps = 61/211 (28%)

Query: 49  MKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVF 108
           M++K  +  ++  A          G II                +     +GQG FG ++
Sbjct: 2   MRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAA---------WKVGLPIGQGGFGCIY 52

Query: 109 QA-----KCLETGETVAIKKVLQDKRYKNRELQTMRLLDH------------------PN 145
            A     + + +     +K    D      EL+  +                      P 
Sbjct: 53  LADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112

Query: 146 VHYS---------------------------RASQRMPLIYVKLYTYQICRALAYIHGGI 178
              S                             ++R     V   + +I   L YIH   
Sbjct: 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE-H 171

Query: 179 GVCHRDIKPQNLLVNP-HTHQVKLCDFGSAK 208
              H DIK  NLL+N  +  QV L D+G A 
Sbjct: 172 EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 52/254 (20%), Positives = 86/254 (33%), Gaps = 89/254 (35%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTM-RLLDHP 144
            +V+G G+FG V  A             VA+K +       ++     EL+ M +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 145 NV--------------------------HYSRASQRMPLIYVKLYT-------------- 164
           N+                          +Y R+  R      ++                
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK-REKFSEDEIEYENQKRLEEEEDLNV 168

Query: 165 ----------YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 214
                     YQ+ + + ++       HRD+  +N+LV      VK+CDFG A+ ++   
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDS 226

Query: 215 PNISYICSRYYR------------APELIFGATEYTTAVDIWSVGCVLAEL--LLGQPLF 260
                     Y             APE +F    YT   D+WS G +L E+  L   P +
Sbjct: 227 ---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP-Y 275

Query: 261 PGESGVDQLVEIIK 274
           PG        ++I+
Sbjct: 276 PGIPVDANFYKLIQ 289

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 33/249 (13%), Positives = 72/249 (28%), Gaps = 78/249 (31%)

Query: 72  TGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG--------ETVAIK- 122
           TG ++    G +         +  +    + + GI+++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 123 -----------KVLQD--KRYKNRELQTMRLLDH---PNVHYS----------------- 149
                         Q   K  +  + + +        P                      
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR 142

Query: 150 ------RASQR--MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQVK 200
                   S +  +    V     ++  AL ++H      H ++  +N+ V+P    QV 
Sbjct: 143 SLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVDPEDQSQVT 201

Query: 201 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV------------DIWSVGC 248
           L  +G A        +++Y             G  E+  ++            D+ S+G 
Sbjct: 202 LAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQSLGY 256

Query: 249 VLAELLLGQ 257
            + + L G 
Sbjct: 257 CMLKWLYGF 265

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.2 bits (150), Expect = 7e-11
 Identities = 28/195 (14%), Positives = 60/195 (30%), Gaps = 34/195 (17%)

Query: 160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 219
            K   +Q+  +LA     +   HRD+   N+L+   +   KL    +             
Sbjct: 163 AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSL-KKLHYTLN------------- 208

Query: 220 ICSRYYRAPE--LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 277
              +    P   L     +YT +        V  ++ + + LF G+   D   +I +++ 
Sbjct: 209 --GKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG--DYQFDIYRLMK 264

Query: 278 TPTREEIKCMNP-------NYTEFKFPQIKAHPWHKIF--HKRMPPEAVDLVSRLLQYSP 328
                     +P       +Y   K  +             K++  +  +    +L +S 
Sbjct: 265 KENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS- 323

Query: 329 NLRCTALEACIHPFF 343
               +A +       
Sbjct: 324 ----SATDLLCQHSL 334

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 49/231 (21%), Positives = 82/231 (35%), Gaps = 80/231 (34%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE--TVAIKKV-----LQDKRYKNRELQTM-RLLDHPNV- 146
           + V+G+G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN+ 
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 147 -------------------------HYSRASQRMPLIYVKLYT----------------Y 165
                                     + R S+ +                          
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 225
            + R + Y+       HRD+  +N+LV  + +  K+ DFG ++                Y
Sbjct: 150 DVARGMDYL-SQKQFIHRDLAARNILVGEN-YVAKIADFGLSRG------------QEVY 195

Query: 226 R------------APE-LIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPG 262
                        A E L +    YTT  D+WS G +L E++ LG   + G
Sbjct: 196 VKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 25/125 (20%)

Query: 163 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 222
           Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K          
Sbjct: 198 YSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP-------- 247

Query: 223 RYYR------------APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQL 269
             Y             APE IF    YT   D+WS G +L E+  LG   +PG    ++ 
Sbjct: 248 -DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305

Query: 270 VEIIK 274
              +K
Sbjct: 306 CRRLK 310

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 55/263 (20%), Positives = 92/263 (34%), Gaps = 92/263 (34%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQ 136
           P+  I Y+  R +G+G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 137 TM---------RLL---------------------------------------DHPNVHY 148
            M         +LL                                       D      
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 149 SRASQRMPLIYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 206
             +    PL   +      Q+   +AY+       HRD+  +N LV  +   VK+ DFG 
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHRDLATRNCLVGEN-MVVKIADFGL 220

Query: 207 AKVLVKGEPNISYICSRYYR------------APE-LIFGATEYTTAVDIWSVGCVLAEL 253
           ++ +   +         YY+             PE + +    YTT  D+W+ G VL E+
Sbjct: 221 SRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEI 269

Query: 254 L-LG-QPLFPGESGVDQLVEIIK 274
              G QP + G +  ++++  ++
Sbjct: 270 FSYGLQP-YYGMA-HEEVIYYVR 290

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 7e-06
 Identities = 58/371 (15%), Positives = 96/371 (25%), Gaps = 144/371 (38%)

Query: 122 KKVLQDKRYK------NRELQTMRLLD------------------HPNVHYS------RA 151
           K +L  +         +    T+RL                      N  Y       + 
Sbjct: 43  KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN--YKFLMSPIKT 100

Query: 152 SQRMPLIYVKLYT---------------YQICR---------AL------AYI--HG--G 177
            QR P +  ++Y                Y + R         AL        +   G  G
Sbjct: 101 EQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160

Query: 178 IG-------VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--------EPNISYICS 222
            G       VC    K Q  +       + L +  S + +++         +PN +    
Sbjct: 161 SGKTWVALDVC-LSYKVQCKMDF-KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218

Query: 223 RYYRAPELI----------FGATEYTTAV----DIWSVGCVLAELLLGQPLFPGESGVDQ 268
                   I            +  Y   +    ++ +     A        F        
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA--------FNLSC---- 266

Query: 269 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM---PPEAVDLVSRLLQ 325
                K+L T TR          T+F       H    + H  M   P E   L+ + L 
Sbjct: 267 -----KILLT-TR------FKQVTDFLSAATTTHI--SLDHHSMTLTPDEVKSLLLKYL- 311

Query: 326 YSPNLRCTAL--EAC-IHPFF-----DELRDPNARLPNGRPFPPLFNFKPQELKGASKEL 377
              + R   L  E    +P       + +RD  A   N +      +    +L    +  
Sbjct: 312 ---DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK------HVNCDKLTTIIESS 362

Query: 378 LSKLIPEHARK 388
           L+ L P   RK
Sbjct: 363 LNVLEPAEYRK 373

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	395
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.59
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.78
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.61
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.58
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.53
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.91
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.34
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.21
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.17
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.16
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.91
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.83
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	96.81
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.65
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.52
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.32
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.02
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	94.64
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	94.55
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	94.49
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.35
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	91.5
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	91.03
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	90.69
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.14
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	88.7
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.48
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	80.82

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-57  Score=440.95  Aligned_cols=287  Identities=35%  Similarity=0.627  Sum_probs=223.4

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.      .....+|+.+|+.|+||||.                 
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            4799999999999999999999999999999998643      23345899999999999981                 


Q ss_pred             --------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 --------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 --------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                    ++...+.+++..++.++.||+.||+||| ++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus       134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH-~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH-SAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTS  211 (398)
T ss_dssp             EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCcCcCCCcCccccccCCCC-CEEEeecceeeecccC
Confidence                          1123567999999999999999999999 88999999999999999888 5999999999875332


Q ss_pred             -----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          214 -----EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       214 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                           ....+.+||+.|||||++.+...|+.++||||+||++|||++|++||.+.+..+++..|+...|.|+...+....
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                 234467899999999999887778999999999999999999999999999999999999999999877654332


Q ss_pred             CCCcc---ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCC
Q 016085          289 PNYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNF  365 (395)
Q Consensus       289 ~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  365 (395)
                      .....   ..++.....+|... .+.+++++.|||.+||++||++|+|+.|+|+||||++..++......    .+.+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~----~~~~~~  366 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETV-YPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDC----APPFDF  366 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCC----SSCCCC
T ss_pred             hhhhhhhhhcCCCcCCCCHHHh-CCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCC----CCCCCC
Confidence            21111   11222222233332 34579999999999999999999999999999999998876544222    223333


Q ss_pred             ChhhhccCCHHHHHhhchHH
Q 016085          366 KPQELKGASKELLSKLIPEH  385 (395)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~  385 (395)
                      .. +....+.+.+..++-++
T Consensus       367 ~~-~~~~~~~~~~k~~i~~e  385 (398)
T 4b99_A          367 AF-DREALTRERIKEAIVAE  385 (398)
T ss_dssp             HH-HHSCCCHHHHHHHHHHH
T ss_pred             cc-chhhcCHHHHHHHHHHH
Confidence            32 22334555555444333

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-57  Score=429.55  Aligned_cols=229  Identities=34%  Similarity=0.581  Sum_probs=197.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCce-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNV-----------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni-----------------  146 (395)
                      ++|++.++||+|+||+||+|+++.+|+.||||++.+.       .....+|+++|+.|+||||                 
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4699999999999999999999999999999999643       2345689999999999998                 


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC---
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---  214 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~---  214 (395)
                               .++...+.+++..++.|+.||+.||+||| ++||+||||||+||||+.++ .+||+|||+|+......   
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH-~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH-GKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTTTTCC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCCCCcc
Confidence                     11233467999999999999999999999 88999999999999999888 59999999998764332   


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ...+.+||+.|||||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+.+|.+.                 .+
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-----------------~~  251 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-----------------EY  251 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----------------CC
T ss_pred             cccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------CC
Confidence            244678999999999998765 899999999999999999999999998888887777652                 11


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHH------HhcCCcccCCCCCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE------ACIHPFFDELRDPNA  351 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e------~l~hp~f~~~~~~~~  351 (395)
                      .            ++..+|+++++||.+||++||++|+|+.|      +++||||+++.|...
T Consensus       252 ~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          252 D------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             C------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             C------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence            1            23457999999999999999999999987      589999999988654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.4e-57  Score=420.62  Aligned_cols=225  Identities=31%  Similarity=0.459  Sum_probs=179.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCce----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNV----------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni----------------  146 (395)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++||||                
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            35799999999999999999999999999999998643       2345689999999999998                


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                               .+......+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+.........
T Consensus        92 mEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH-~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~~~~~  169 (275)
T 3hyh_A           92 IEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-RHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLK  169 (275)
T ss_dssp             EECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCTTTEEECTTC-CEEECCSSCC----------
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCChHHeEECCCC-CEEEeecCCCeecCCCCccC
Confidence                     11234568999999999999999999999 88999999999999999888 59999999998876665566


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      +.+||+.|||||++.+...++.++|||||||++|+|+||+.||.+.+....+..|...                 ..   
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~-----------------~~---  229 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG-----------------VY---  229 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----------------CC---
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-----------------CC---
Confidence            7899999999999988775678999999999999999999999988777666666541                 01   


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                               .++..+|+++.+||.+||+.||++|||+.|+++||||+.
T Consensus       230 ---------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          230 ---------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                     123457999999999999999999999999999999964

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.3e-56  Score=425.11  Aligned_cols=229  Identities=31%  Similarity=0.432  Sum_probs=194.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-----------------e-
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-----------------Y-  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-----------------~-  148 (395)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+|+.++||||.                 + 
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            3699999999999999999999999999999998543    34567899999999999981                 0 


Q ss_pred             -------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCccccc
Q 016085          149 -------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYI  220 (395)
Q Consensus       149 -------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~  220 (395)
                             .....++++..++.|+.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+..... ....+.+
T Consensus       154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~  231 (346)
T 4fih_A          154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH-AQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLV  231 (346)
T ss_dssp             TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCCCcccccc
Confidence                   012357999999999999999999999 88999999999999999888 5999999999876543 3345789


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      ||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..|.....  +              ..    
T Consensus       232 GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--~--------------~~----  290 (346)
T 4fih_A          232 GTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--P--------------RL----  290 (346)
T ss_dssp             SCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC--C--------------CC----
T ss_pred             cCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC--C--------------CC----
Confidence            999999999997655 99999999999999999999999999888887777654210  0              00    


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                            ..+..+|+++.+||.+||++||++|+|+.|+|+||||++...
T Consensus       291 ------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          291 ------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             ------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence                  112347999999999999999999999999999999987543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.8e-56  Score=424.34  Aligned_cols=224  Identities=29%  Similarity=0.425  Sum_probs=185.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.      .....+|+.+|+.|+||||.                 
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5799999999999999999999999999999998643      23456899999999999980                 


Q ss_pred             ---------ee--ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-C
Q 016085          148 ---------YS--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-P  215 (395)
Q Consensus       148 ---------~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~  215 (395)
                               ++  .....+++..++.|+.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+...... .
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-HTTCEETTCCGGGEEECTTC-CEEECSTTEESCCCHHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHHHEEECCCC-CEEEcccccceeecCCccc
Confidence                     11  12345689999999999999999999 88999999999999999888 59999999998764332 2


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ..+.+||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.+..+.+.+|....                   
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-------------------  241 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-------------------  241 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-------------------
T ss_pred             ccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------------
Confidence            34568999999999998765 9999999999999999999999999998888887776521                   


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      ++         .++..+|+++.+||.+||+.||++|||+.|+|+||||++
T Consensus       242 ~~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          242 FP---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             CC---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            01         123457999999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.6e-55  Score=426.85  Aligned_cols=228  Identities=31%  Similarity=0.441  Sum_probs=194.4

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-----------------e-
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-----------------Y-  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-----------------~-  148 (395)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+|+.|+||||.                 + 
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            4699999999999999999999999999999998532    34567999999999999980                 0 


Q ss_pred             -------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCccccc
Q 016085          149 -------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYI  220 (395)
Q Consensus       149 -------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~~~~  220 (395)
                             .....++++..++.|+.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+..... ....+.+
T Consensus       231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH-~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~  308 (423)
T 4fie_A          231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH-AQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLV  308 (423)
T ss_dssp             TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSCCCBCCCE
T ss_pred             CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHH-HCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCCccccccc
Confidence                   012357999999999999999999999 88999999999999999988 5999999999876543 3345789


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      ||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..|....  ++                 .  
T Consensus       309 GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~-----------------~--  366 (423)
T 4fie_A          309 GTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--PP-----------------R--  366 (423)
T ss_dssp             ECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC-----------------C--
T ss_pred             cCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--CC-----------------C--
Confidence            999999999997755 9999999999999999999999999988888777765421  00                 0  


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                           ......+|+++.+||.+||+.||++|+|+.|+|+||||++..
T Consensus       367 -----~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          367 -----LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             -----CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             -----CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                 012234799999999999999999999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.6e-55  Score=407.46  Aligned_cols=222  Identities=23%  Similarity=0.356  Sum_probs=182.9

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-------------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-------------------  147 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-------------------  147 (395)
                      |++.++||+|+||+||+|+++.+++.||+|++...      ...+.+|+.+|+.|+||||.                   
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            47888999999999999999999999999998643      23456899999999999981                   


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCC--eeeccCCCCceEEcC-CCCceEEeecCCccccccC
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlKp~Nill~~-~~~~ikl~DFG~a~~~~~~  213 (395)
                                 +......+++..++.++.||+.||+||| ++|  ||||||||+||||+. ++ .+||+|||+|+... .
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH-~~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~~~~-~  184 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKR-A  184 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGGGCC-T
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCCEEecccChhheeEECCCC-CEEEEeCcCCEeCC-C
Confidence                       0112356899999999999999999999 778  999999999999985 45 69999999997643 3


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      ....+.+||+.|||||++.+ . |+.++|||||||+||||+||+.||.+.+....+...+.....|              
T Consensus       185 ~~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~--------------  248 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------------  248 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--------------
T ss_pred             CccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC--------------
Confidence            34557789999999998864 4 9999999999999999999999998876665554433211000              


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                                  ..++...++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       249 ------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 ------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                        1123447889999999999999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.5e-54  Score=426.07  Aligned_cols=296  Identities=71%  Similarity=1.207  Sum_probs=260.5

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceEee------------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYS------------------  149 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~~~------------------  149 (395)
                      ....+|++.++||+|+||.||+|++..+|+.||||++........+|+.+|+.++|+||...                  
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            34457999999999999999999999999999999998877777799999999999998100                  


Q ss_pred             -----------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          150 -----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       150 -----------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                       .....+++..++.++.||+.||.||| +.||+||||||+|||++.++..+||+|||+++....
T Consensus       131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence                             12356888889999999999999999 899999999999999997765789999999988766


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      .......+||+.|+|||++.+...++.++|||||||++|||++|+.||.+.+..+++..|++.+|.|..+.+..+++++.
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66666788999999999998765699999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCChhhhcc
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKG  372 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (395)
                      .+.++.+....|...++..+++++.+||.+||++||.+|+|+.|+++||||+.++++....+.....+..+++...++..
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSS  369 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTT
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHhcc
Confidence            99999998889988888899999999999999999999999999999999999998877777777778889998887742


Q ss_pred             CCHHHHHhhchHH
Q 016085          373 ASKELLSKLIPEH  385 (395)
Q Consensus       373 ~~~~~~~~~~~~~  385 (395)
                       ...+...++|+.
T Consensus       370 -~~~~~~~~~~~~  381 (420)
T 1j1b_A          370 -NPPLATILIPPH  381 (420)
T ss_dssp             -CGGGHHHHSCTT
T ss_pred             -ChhHHHhhCCHh
Confidence             334444444443

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.4e-55  Score=413.69  Aligned_cols=228  Identities=27%  Similarity=0.427  Sum_probs=188.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEc---CCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCce--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNV--------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni--------------  146 (395)
                      ..+|++++.||+|+||+||+|++.   .+++.||||++.+.      .....+|+.+|+.++||||              
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            357999999999999999999884   46889999998543      2345689999999999998              


Q ss_pred             ------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-
Q 016085          147 ------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  213 (395)
Q Consensus       147 ------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-  213 (395)
                                  .+......+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+..... 
T Consensus       103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCCGGGEEECTTS-CEEEESSEEEEC-----
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHHHeEEcCCC-CEEecccccceeccCCC
Confidence                        11223467999999999999999999999 88999999999999999988 5999999999875443 


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      ....+.+||+.|||||++.+.. |+.++|||||||++|||+||+.||.+.+..+.+..|.+.                 .
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-----------------~  242 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-----------------K  242 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------C
T ss_pred             ccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-----------------C
Confidence            3345678999999999998755 999999999999999999999999999888888777652                 0


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  349 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  349 (395)
                      .            .++..+|+++.+||.+||+.||++|+|     +.|+++||||+++.|.
T Consensus       243 ~------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          243 L------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             C------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence            1            123457999999999999999999998     4799999999998764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.9e-55  Score=416.50  Aligned_cols=232  Identities=25%  Similarity=0.360  Sum_probs=192.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCce-----------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV-----------------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni-----------------------  146 (395)
                      ...|++.++||+|+||+||+|+++.+|+.||||++..+. ...+|+.+|+.|+||||                       
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            346999999999999999999999999999999997653 33579999999999998                       


Q ss_pred             ---EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC------cc
Q 016085          147 ---HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP------NI  217 (395)
Q Consensus       147 ---~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~------~~  217 (395)
                         .++.....+++..++.|+.||+.||+||| ++|||||||||+||||+.++..+||+|||+|+.......      ..
T Consensus       136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~  214 (336)
T 4g3f_A          136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD  214 (336)
T ss_dssp             BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------C
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCC
Confidence               11123467999999999999999999999 899999999999999998875699999999987643321      12


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..+||+.|||||++.+.. |+.++|||||||+||||+||++||.+.+....+..|...  .++                 
T Consensus       215 ~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~-----------------  274 (336)
T 4g3f_A          215 YIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP-----------------  274 (336)
T ss_dssp             CCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG-----------------
T ss_pred             ccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC-----------------
Confidence            357999999999998765 999999999999999999999999988776666666541  000                 


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHH-------------hcCCcccCCCCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA-------------CIHPFFDELRDPN  350 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~-------------l~hp~f~~~~~~~  350 (395)
                             ...++..+++.+.+||.+||++||++|||+.|+             |+|||+.+...|.
T Consensus       275 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          275 -------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             -------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             -------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                   012345689999999999999999999999997             6799999887664

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.7e-53  Score=416.31  Aligned_cols=293  Identities=67%  Similarity=1.178  Sum_probs=261.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceEe---------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHY---------------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~~---------------------  148 (395)
                      ..+|++.++||+|+||.||+|++..+++ ||+|++.+......+|+.+|+.++|+||..                     
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            4579999999999999999999887765 999998887777779999999999999810                     


Q ss_pred             --------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc-CCCCceEEeecCCccccccC
Q 016085          149 --------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-PHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       149 --------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~-~~~~~ikl~DFG~a~~~~~~  213 (395)
                                    ......+++..++.++.||+.||.||| +.||+||||||+|||++ .++ .+||+|||+|+.....
T Consensus       118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIAG  195 (394)
T ss_dssp             ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCTT
T ss_pred             eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccCC
Confidence                          011456888999999999999999999 88999999999999999 455 7999999999887666


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+++.+|.|..+.+..++.++..
T Consensus       196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  275 (394)
T 4e7w_A          196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME  275 (394)
T ss_dssp             CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred             CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence            66677889999999999987667999999999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCChhhhccC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGA  373 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (395)
                      ..++......+...++..+++++.+||.+||++||.+|||+.|+++||||+++++.....+.....++++++...++. .
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  354 (394)
T 4e7w_A          276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-V  354 (394)
T ss_dssp             SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHHHH-T
T ss_pred             hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHHhh-c
Confidence            899998888888888889999999999999999999999999999999999999988777777788999999988875 4


Q ss_pred             CHHHHHhhchHHH
Q 016085          374 SKELLSKLIPEHA  386 (395)
Q Consensus       374 ~~~~~~~~~~~~~  386 (395)
                      ..+++..++|...
T Consensus       355 ~~~~~~~~~~~~~  367 (394)
T 4e7w_A          355 RPDLISRLVPQHA  367 (394)
T ss_dssp             CGGGHHHHSCGGG
T ss_pred             CHHHHHhhccHhh
Confidence            5577777777654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-53  Score=414.76  Aligned_cols=297  Identities=51%  Similarity=0.987  Sum_probs=255.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceEee--------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHYS--------------------  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~~~--------------------  149 (395)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++..+.....+|+.+|+.++|+||...                    
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            457999999999999999999999999999999998887777899999999999998110                    


Q ss_pred             -----------------------------------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeee
Q 016085          150 -----------------------------------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCH  182 (395)
Q Consensus       150 -----------------------------------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiH  182 (395)
                                                                     .....+++..++.++.||+.||.||| +.||+|
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~gi~H  164 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICH  164 (383)
T ss_dssp             ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEEC
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCcCcc
Confidence                                                           11256788889999999999999999 899999


Q ss_pred             ccCCCCceEEcCCCCceEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 016085          183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPG  262 (395)
Q Consensus       183 rDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  262 (395)
                      |||||+|||++.+.+.+||+|||+|+............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+
T Consensus       165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  244 (383)
T 3eb0_A          165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG  244 (383)
T ss_dssp             SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence            99999999998544479999999998876666666788999999999998766699999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCc
Q 016085          263 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  342 (395)
Q Consensus       263 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~  342 (395)
                      .+..+++..+++.+|.|+.+.+..+++.+....++......|...++..+++++.+||.+||++||++|||+.|+|+|||
T Consensus       245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (383)
T 3eb0_A          245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF  324 (383)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCC-------CCCCCCCC--CCCCCCCCCChhhhccCCHHHHHhhchHHHh
Q 016085          343 FDELRD-------PNARLPNG--RPFPPLFNFKPQELKGASKELLSKLIPEHAR  387 (395)
Q Consensus       343 f~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (395)
                      |+.+++       ....++.+  .+.|.++++++.++.....+++.+++|+...
T Consensus       325 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  378 (383)
T 3eb0_A          325 FDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFS  378 (383)
T ss_dssp             GHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC---
T ss_pred             HHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhc
Confidence            988755       23333444  5678899999999988789999999987654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8e-54  Score=414.34  Aligned_cols=257  Identities=28%  Similarity=0.451  Sum_probs=194.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEc---CCCcEEEEEEeecch--hhHHHHHHHHHhc-CCCceE----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--RYKNRELQTMRLL-DHPNVH----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~--~~~~~E~~~l~~l-~h~ni~----------------  147 (395)
                      .++|++.+.||+|+||+||+|+++   .+++.||||++.+..  ....+|+++|+.+ +||||.                
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm   99 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM   99 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence            346999999999999999999875   467899999886543  3456899999988 699981                


Q ss_pred             -ee------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC------
Q 016085          148 -YS------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE------  214 (395)
Q Consensus       148 -~~------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~------  214 (395)
                       +.      ..-..+++..++.++.||+.||+||| ++||+||||||+|||++.+.+.+||+|||+|+......      
T Consensus       100 E~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH-~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~  178 (361)
T 4f9c_A          100 PYLEHESFLDILNSLSFQEVREYMLNLFKALKRIH-QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKF  178 (361)
T ss_dssp             ECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGG
T ss_pred             eCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccc
Confidence             11      01146899999999999999999999 88999999999999999875579999999997543221      


Q ss_pred             -----------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC-CCCcHHHHH
Q 016085          215 -----------------------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFP-GESGVDQLV  270 (395)
Q Consensus       215 -----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~-~~~~~~~~~  270 (395)
                                             ...+.+||+.|+|||++.+...|+.++||||+||++|||++|+.||. +.+..+++.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~  258 (361)
T 4f9c_A          179 VQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALA  258 (361)
T ss_dssp             C--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence                                   12345799999999999887779999999999999999999999984 567788999


Q ss_pred             HHHHHhCCCCHHHHhhcCCC-------C--------------ccccCCcc----cCCCcccccCCCCChhHHHHHHhhcc
Q 016085          271 EIIKVLGTPTREEIKCMNPN-------Y--------------TEFKFPQI----KAHPWHKIFHKRMPPEAVDLVSRLLQ  325 (395)
Q Consensus       271 ~i~~~~~~~~~~~~~~~~~~-------~--------------~~~~~~~~----~~~~~~~~~~~~~s~~~~~ll~~~L~  325 (395)
                      .|+..+|.+....+......       +              .....+..    ............+|+++.|||++||+
T Consensus       259 ~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~  338 (361)
T 4f9c_A          259 QIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLD  338 (361)
T ss_dssp             HHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTC
T ss_pred             HHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCc
Confidence            99999887554333211100       0              00000000    00011112234689999999999999


Q ss_pred             CCCCCCCCHHHHhcCCcccCCC
Q 016085          326 YSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       326 ~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      +||++|+|+.|+|+||||+++.
T Consensus       339 ~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          339 LNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             SCTTTSCCHHHHHTSGGGTTC-
T ss_pred             CChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999998863

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.5e-52  Score=391.41  Aligned_cols=227  Identities=27%  Similarity=0.463  Sum_probs=166.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      .+|++++.||+|+||+||+|+++.+|+.||||++...     .....+|+.+|+.|+||||.                  
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            3699999999999999999999999999999998642     23456899999999999981                  


Q ss_pred             ------ee--------------ccC---CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeec
Q 016085          148 ------YS--------------RAS---QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  204 (395)
Q Consensus       148 ------~~--------------~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DF  204 (395)
                            +.              ...   .......++.++.||+.||+||| ++||+||||||+||||+.++ .+||+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH-~~~IiHRDlKp~NILl~~~~-~vKl~DF  162 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDD-VVKVGDF  162 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH-HCcCccccCcHHHeEECCCC-cEEEccC
Confidence                  00              001   12334568889999999999999 88999999999999999888 6999999


Q ss_pred             CCccccccCCC-------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 016085          205 GSAKVLVKGEP-------------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVE  271 (395)
Q Consensus       205 G~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  271 (395)
                      |+|+.......             ..+.+||+.|||||++.+.. |+.++|||||||++|||++   ||.+.  .+....
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~  236 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQ--MERVRT  236 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence            99987643321             23457999999999998765 9999999999999999996   77543  223333


Q ss_pred             HHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       272 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                      +........                |.         .....++.+.+||.+||+.||++|||+.|+|+||||+++.++.
T Consensus       237 ~~~~~~~~~----------------p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          237 LTDVRNLKF----------------PP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHTTCC----------------CH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHhcCCC----------------CC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            332211111                00         0112467789999999999999999999999999999987654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.1e-52  Score=422.87  Aligned_cols=231  Identities=26%  Similarity=0.368  Sum_probs=188.7

Q ss_pred             CccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHH---HHHHHhcCCCceE---------
Q 016085           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRE---LQTMRLLDHPNVH---------  147 (395)
Q Consensus        87 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E---~~~l~~l~h~ni~---------  147 (395)
                      +...++|+++++||+|+||+||+|+++.+|+.||||++.+..       ....+|   +.+++.++||||.         
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            445568999999999999999999999999999999996532       122233   5566677999981         


Q ss_pred             -----------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          148 -----------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       148 -----------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                                       ++.....+++..++.|+.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+..
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH-~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~  342 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHG-HVRISDLGLACDF  342 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCchHHeEEeCCC-CEEecccceeeec
Confidence                             1123467999999999999999999999 89999999999999999998 4999999999876


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCCHHHHhhc
Q 016085          211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCM  287 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~  287 (395)
                      ... ...+.+||+.|||||++.+...|+.++|||||||+||||++|++||.+.+..+   ....+...            
T Consensus       343 ~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~------------  409 (689)
T 3v5w_A          343 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------------  409 (689)
T ss_dssp             SSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC------------
T ss_pred             CCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC------------
Confidence            543 34567999999999999755569999999999999999999999998754322   22222210            


Q ss_pred             CCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCCC
Q 016085          288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  349 (395)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  349 (395)
                           .            ..++..+|+++.+||.+||+.||++|++     +.|+++||||+++.|.
T Consensus       410 -----~------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          410 -----A------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             -----C------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             -----C------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence                 0            1134558999999999999999999998     7999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.7e-51  Score=418.22  Aligned_cols=234  Identities=27%  Similarity=0.398  Sum_probs=199.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+|+.|+||||.                  
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            35799999999999999999999999999999998653    33456899999999999981                  


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC-CCceEEeecCCccccccCCCcc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~-~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                               +......+++..++.|+.||+.||+||| ++||+||||||+|||++.+ .+.+||+|||+|+.........
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH-~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~  314 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  314 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence                     0123457899999999999999999999 8899999999999999864 2369999999999886666666


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..+||+.|||||++.+.. |+.++|||||||+||+|++|++||.+.+..+.+..|......++                 
T Consensus       315 ~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~-----------------  376 (573)
T 3uto_A          315 VTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-----------------  376 (573)
T ss_dssp             EECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-----------------
T ss_pred             eeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC-----------------
Confidence            789999999999998765 99999999999999999999999999998888887765321111                 


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                              ......+|+++.+||.+||++||.+|+|+.|+|+||||+...++.
T Consensus       377 --------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          377 --------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             --------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             --------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence                    112345799999999999999999999999999999999877654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.1e-49  Score=392.15  Aligned_cols=295  Identities=33%  Similarity=0.551  Sum_probs=209.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY---------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~---------------  148 (395)
                      .++|++.+.||+|+||+||+|++..+++.||||++...      .....+|+.+|+.++|+||..               
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            35799999999999999999999999999999998642      234558999999999999811               


Q ss_pred             ---------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          149 ---------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       149 ---------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                     ......+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+|+.....
T Consensus       132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH-SAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCTTSC
T ss_pred             EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHH-hCCcCCCCCChhhEEECCCC-CEeecccccchhccCc
Confidence                           112346899999999999999999999 88999999999999999988 6999999999875422


Q ss_pred             C----------------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh----------
Q 016085          214 E----------------------------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL----------  255 (395)
Q Consensus       214 ~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~----------  255 (395)
                      .                            .....+||+.|+|||++.+...|+.++|||||||+||||++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                            22356789999999987665669999999999999999998          


Q ss_pred             -CCCCCCCCC--------------------cHHHHHHHHHHhCCCCHHHHhhcCCCCcc---ccCCcccCCCcccccCCC
Q 016085          256 -GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKIFHKR  311 (395)
Q Consensus       256 -g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  311 (395)
                       |+++|.|.+                    ..+++..|++.+|.|+.+.+.........   ..++......+... ...
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  368 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER-FPA  368 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG-STT
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH-CCC
Confidence             788887765                    36788999999999999877654321100   01122222222222 244


Q ss_pred             CChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCChhhhccCCHHHHHhhchHHHhhhCC
Q 016085          312 MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP  391 (395)
Q Consensus       312 ~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (395)
                      .++++.+||++||++||++|+|+.|+|+||||+.++++........+..  ..+.  +....+.+.+...+.+++..-+|
T Consensus       369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~e~~~~~~  444 (458)
T 3rp9_A          369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVR--LPFN--DWMNMDEPQLRYAFVKEIQRYHP  444 (458)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCC--CSSC--TTSCCCHHHHHHHHHHHHTTTCT
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCC--CCcc--ccccCCHHHHHHHHHHHHHHhCc
Confidence            6899999999999999999999999999999999988654332222211  1111  22345555555555555554443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.7e-49  Score=393.94  Aligned_cols=258  Identities=32%  Similarity=0.550  Sum_probs=203.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY---------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~---------------  148 (395)
                      .++|++++.||+|+||+||+|++..+++.||||++...      .....+|+.+|+.++|+||..               
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            35799999999999999999999999999999998643      234458999999999999810               


Q ss_pred             ---e-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          149 ---S-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       149 ---~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                         .           .....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|+......
T Consensus       141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH-~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~  218 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF  218 (464)
T ss_dssp             EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCCCC-----CC
T ss_pred             eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChHhEEEeCCC-CEEEEEEEeeeecCCCc
Confidence               0           01234788999999999999999999 88999999999999999888 69999999998876655


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+..+++..|++.+|.|..+.+.........+
T Consensus       219 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~  297 (464)
T 3ttj_A          219 MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY  297 (464)
T ss_dssp             CC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred             ccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhH
Confidence            566788999999999998764 9999999999999999999999999999999999999999999988775543211111


Q ss_pred             --cCCcccCCCcccccCCC-----------CChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          295 --KFPQIKAHPWHKIFHKR-----------MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       295 --~~~~~~~~~~~~~~~~~-----------~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                        ..+......+...++..           .++++.+||.+||++||++|||+.|+|+||||+.+.++.
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~  366 (464)
T 3ttj_A          298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA  366 (464)
T ss_dssp             HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHH
T ss_pred             hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcc
Confidence              11111111111112111           156799999999999999999999999999999876653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.6e-48  Score=383.59  Aligned_cols=295  Identities=31%  Similarity=0.509  Sum_probs=218.6

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||++...      .....+|+.+|+.++|+||.                
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            35799999999999999999999999999999998643      23456899999999999981                


Q ss_pred             --------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 --------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 --------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                    +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|+.....
T Consensus       105 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          105 LYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH-ESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC---
T ss_pred             EEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCHHHeEECCCC-CEEEccCCCccccccc
Confidence                          0112345899999999999999999999 88999999999999999888 6999999999876433


Q ss_pred             C-----------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-----------CCCC
Q 016085          214 E-----------------------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-----------GQPL  259 (395)
Q Consensus       214 ~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-----------g~~p  259 (395)
                      .                       .....+||+.|+|||++.+...++.++|||||||++|||++           |.++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            2                       12567889999999997666669999999999999999998           5666


Q ss_pred             CCCCC-----------------cHHHHHHHHHHhCCCCHHHHhhcCCCCccc---cCCcccCCCcccccCCCCChhHHHH
Q 016085          260 FPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKAHPWHKIFHKRMPPEAVDL  319 (395)
Q Consensus       260 f~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~l  319 (395)
                      |.+.+                 ..+++..|+..+|.|+.+.+..........   ..+......+.. ..+.+++++.+|
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dL  341 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQ-KYPSISDDGINL  341 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHH
Confidence            66654                 368899999999999998876543211000   111111111111 224579999999


Q ss_pred             HHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCChhhhccCCHHHHHhhchHHHhhhCC
Q 016085          320 VSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP  391 (395)
Q Consensus       320 l~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (395)
                      |.+||++||++|||+.|+|+||||++++++........+..  ..+.  +....+.+.+..++-+++..-+|
T Consensus       342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~e~~~~~~  409 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKII--LPFD--DWMVLSETQLRYIFLKEVQSFHP  409 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCC--CSSC--TTCCCCHHHHHHHHHHHHHHHCT
T ss_pred             HHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCC--CChh--hcccCCHHHHHHHHHHHHHHhCc
Confidence            99999999999999999999999999988754432222221  1121  22335555555555555554443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.1e-49  Score=383.13  Aligned_cols=260  Identities=34%  Similarity=0.658  Sum_probs=199.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcC-CCceE-----ee---------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVH-----YS---------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~-h~ni~-----~~---------  149 (395)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.+. |+||.     +.         
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            4799999999999999999999999999999988532      233457999999997 99981     00         


Q ss_pred             ------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC----
Q 016085          150 ------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG----  213 (395)
Q Consensus       150 ------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~----  213 (395)
                                  .....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|+.....    
T Consensus        89 v~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~  166 (388)
T 3oz6_A           89 VFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLH-SGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRVT  166 (388)
T ss_dssp             EEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEESSSCCCCC
T ss_pred             EecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHeEEcCCC-CEEecCCccccccccccccc
Confidence                        01245788889999999999999999 88999999999999999888 6999999999765321    


Q ss_pred             ------------------CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 016085          214 ------------------EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV  275 (395)
Q Consensus       214 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  275 (395)
                                        ......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..|+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  246 (388)
T 3oz6_A          167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV  246 (388)
T ss_dssp             CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence                              11234688999999999987666999999999999999999999999999999999999999


Q ss_pred             hCCCCHHHHhhcCCCCccccCC------cccCCCcccc------------cCCCCChhHHHHHHhhccCCCCCCCCHHHH
Q 016085          276 LGTPTREEIKCMNPNYTEFKFP------QIKAHPWHKI------------FHKRMPPEAVDLVSRLLQYSPNLRCTALEA  337 (395)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~------------~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~  337 (395)
                      ++.|..+.+......+......      ......+...            ....+++++.+||.+||++||++|||+.|+
T Consensus       247 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~  326 (388)
T 3oz6_A          247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDA  326 (388)
T ss_dssp             HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHH
Confidence            9999988776544332110000      0000011111            112578999999999999999999999999


Q ss_pred             hcCCcccCCCCCCCC
Q 016085          338 CIHPFFDELRDPNAR  352 (395)
Q Consensus       338 l~hp~f~~~~~~~~~  352 (395)
                      |+||||+.+.++...
T Consensus       327 l~Hp~~~~~~~~~~~  341 (388)
T 3oz6_A          327 LKHPFVSIFHNPNEE  341 (388)
T ss_dssp             TTSTTTTTTCCGGGC
T ss_pred             hCCHHHHHhcCCccC
Confidence            999999998876544

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.7e-49  Score=369.40  Aligned_cols=224  Identities=23%  Similarity=0.292  Sum_probs=175.9

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE--------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ....++++.+.||+|+||+||+|+..   ..||||+++..      ...+.+|+.+|+.++||||.              
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iV  109 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIV  109 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEE
Confidence            34457999999999999999999853   35999998532      23456899999999999981              


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-  214 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-  214 (395)
                                  +......+++..+..++.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+...... 
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH-AKNIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCCSSSEEEETTE-EEEECCCSSCBC------
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCccCHHHEEECCCC-cEEEeeccCceecccCCc
Confidence                        1123457899999999999999999999 78999999999999999887 69999999998754322 


Q ss_pred             --CcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          215 --PNISYICSRYYRAPELIFGA--TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       215 --~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                        .....+||+.|||||++.+.  ..|+.++|||||||+||||+||+.||.+.+....+..++.....            
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~------------  255 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA------------  255 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC------------
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC------------
Confidence              23456899999999999643  24899999999999999999999999988777666655542111            


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                           .|..      ..++..+++.+.+||.+||+.||++|||+.|+++
T Consensus       256 -----~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          256 -----SPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             -----CCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             -----CCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                 1110      1234457899999999999999999999988754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.1e-48  Score=362.45  Aligned_cols=255  Identities=34%  Similarity=0.554  Sum_probs=205.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .+|++.+.||+|+||+||+|++..+++.||||++....      ....+|+.+++.++|+||.                 
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46999999999999999999999999999999986432      3455899999999999980                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNI  217 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~  217 (395)
                               +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...... ...
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH-~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCCSCCC
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCcccccc
Confidence                     1112467899999999999999999999 88999999999999999888 69999999998764332 234


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....|............
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence            567899999999998766689999999999999999987766 6777888889999999999887766543321111112


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      +..............+++.+.+||.+||++||++|||+.|+|+||||+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            222222222234456899999999999999999999999999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.1e-48  Score=366.55  Aligned_cols=225  Identities=24%  Similarity=0.363  Sum_probs=181.5

Q ss_pred             ccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ..+|.+.+.||+|+||+||+|++.     .++..||||++...    ...+.+|+++|++|+||||.             
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            357999999999999999999875     35789999998643    23456899999999999980             


Q ss_pred             ----e---------e-------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEE
Q 016085          148 ----Y---------S-------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  201 (395)
Q Consensus       148 ----~---------~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl  201 (395)
                          +         .             .....+++..+..++.||+.||+||| +++||||||||+||||+.++ .+||
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHRDlKp~NILl~~~~-~~Ki  169 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVGENL-LVKI  169 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCccCHhhEEECCCC-cEEE
Confidence                0         0             11246899999999999999999999 88999999999999999887 6999


Q ss_pred             eecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 016085          202 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  277 (395)
Q Consensus       202 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  277 (395)
                      +|||+|+.......   .....||+.|||||++.+.. |+.++|||||||+||||+| |+.||.+.+..+.+..+...  
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~--  246 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG--  246 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT--
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--
Confidence            99999986543322   12346899999999998765 9999999999999999998 99999998877776666541  


Q ss_pred             CCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      ..                          ...+..+|+++.+||.+||+.||++|||+.++  |+|++++.
T Consensus       247 ~~--------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          247 RV--------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             CC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             CC--------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            00                          01234579999999999999999999999998  46776553

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.3e-48  Score=368.62  Aligned_cols=220  Identities=24%  Similarity=0.363  Sum_probs=173.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ..+|.+.++||+|+||+||+|++.     .+++.||||++...    ...+.+|+++|+.|+||||.             
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            357999999999999999999865     36889999998643    23456899999999999980             


Q ss_pred             ----e---------e---------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCce
Q 016085          148 ----Y---------S---------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV  199 (395)
Q Consensus       148 ----~---------~---------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~i  199 (395)
                          +         .               .....+++..+..++.||+.||+||| +++||||||||+||||+.++ .+
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHRDLKp~NILl~~~~-~~  197 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQGL-VV  197 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEETTT-EE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh-cCCeecccccHhhEEECCCC-cE
Confidence                0         0               01245889999999999999999999 88999999999999999887 69


Q ss_pred             EEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 016085          200 KLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKV  275 (395)
Q Consensus       200 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  275 (395)
                      ||+|||+|+.......   ....+||+.|||||++.+.. |+.++|||||||+||||+| |+.||.+.+..+.+..+.+.
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g  276 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG  276 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999987643322   23467899999999998765 9999999999999999998 99999998877776666541


Q ss_pred             hCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .  .                          ...+..+++++.+||.+||+.||++|||+.|++++
T Consensus       277 ~--~--------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          277 R--E--------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             C--C--------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             C--C--------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            1  0                          01234579999999999999999999999999753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-47  Score=371.00  Aligned_cols=290  Identities=48%  Similarity=0.858  Sum_probs=226.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh---hHHHHHHHHHhcCCCceEe-------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVHY-------------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~~l~~l~h~ni~~-------------------  148 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....   ...+++..++.++|+||..                   
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  102 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN  102 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence            479999999999999999999999999999999865533   3345677778889999810                   


Q ss_pred             -----------------eccCCCCcHHHHHHHHHHHHHHHHHHHc-CCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          149 -----------------SRASQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       149 -----------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                                       ......+++..++.++.||+.||.|||. +.||+||||||+|||++...+.+||+|||+++..
T Consensus       103 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~  182 (360)
T 3e3p_A          103 VVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL  182 (360)
T ss_dssp             EEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred             EEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence                             0123456788889999999999999993 4699999999999999973337999999999887


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ..........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.+..+.++.+.+....+.
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3e3p_A          183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPS  262 (360)
T ss_dssp             CTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT
T ss_pred             CCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccc
Confidence            66655666788999999999977666899999999999999999999999999999999999999999999988887766


Q ss_pred             CccccCCcccCCCcccccCC---CCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCC-CCCCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHK---RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFP-PLFNFK  366 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~---~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~-~~~~~~  366 (395)
                      .............|...+..   ..++.+.+||.+||++||.+|||+.|+|+||||+++.++..........+ .+..+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  342 (360)
T 3e3p_A          263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFL  342 (360)
T ss_dssp             CCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCCGGGGCCC
T ss_pred             hhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCCcHHHHcC
Confidence            65555554444444444332   35789999999999999999999999999999999988876665555555 556667


Q ss_pred             hhhhccCCHHHHHh
Q 016085          367 PQELKGASKELLSK  380 (395)
Q Consensus       367 ~~~~~~~~~~~~~~  380 (395)
                      +.+.+..+.+...+
T Consensus       343 ~~~~~~~~~~~~~~  356 (360)
T 3e3p_A          343 PNEIEVMSEAQKAK  356 (360)
T ss_dssp             HHHHHHSCHHHHHH
T ss_pred             chHHHHHHHHHhhh
Confidence            77766666555443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-47  Score=369.83  Aligned_cols=256  Identities=36%  Similarity=0.634  Sum_probs=203.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----ee----------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----YS----------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----~~----------  149 (395)
                      .+|++.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++|+||.     +.          
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4699999999999999999999999999999998542      23345899999999999981     00          


Q ss_pred             ---------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          150 ---------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       150 ---------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                     .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....  
T Consensus       105 ~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~--  180 (367)
T 1cm8_A          105 FYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADS--  180 (367)
T ss_dssp             CEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCS--
T ss_pred             EEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCcCHHHEEEcCCC-CEEEEeeeccccccc--
Confidence                           01245788899999999999999999 88999999999999999888 699999999987532  


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc-
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-  293 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-  293 (395)
                      .....++|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..|++..|.|+.+.+..+...... 
T Consensus       181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  260 (367)
T 1cm8_A          181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  260 (367)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence            3456788999999999987556999999999999999999999999999999999999999999998877654321100 


Q ss_pred             --ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 016085          294 --FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  351 (395)
Q Consensus       294 --~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  351 (395)
                        ...+......+.. +....++.+.+||.+||++||.+|+|+.++|+||||+.+.++..
T Consensus       261 ~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~  319 (367)
T 1cm8_A          261 YMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  319 (367)
T ss_dssp             HHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             HHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence              0122222223322 23457999999999999999999999999999999999887654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.8e-47  Score=364.54  Aligned_cols=231  Identities=27%  Similarity=0.420  Sum_probs=195.9

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE---------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++.+..      ....+|+.+|+.++|+||.               
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            3457999999999999999999999999999999986532      2345899999999999980               


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                                 +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++........
T Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~  170 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH-QKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKL  170 (328)
T ss_dssp             ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSSSCGG
T ss_pred             EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCCCCcc
Confidence                       1112356889999999999999999999 88999999999999999888 5999999999877666666


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+...                 .+  
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------------~~--  231 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-----------------KY--  231 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CC--
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------CC--
Confidence            67789999999999988764568999999999999999999999998877766666541                 01  


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                                .++..+++++.+||++||+.||.+|||+.|+++||||+...+..
T Consensus       232 ----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~  275 (328)
T 3fe3_A          232 ----------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED  275 (328)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTC
T ss_pred             ----------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCccc
Confidence                      12234789999999999999999999999999999998766543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-47  Score=370.88  Aligned_cols=289  Identities=32%  Similarity=0.526  Sum_probs=209.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++|+||..                
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4699999999999999999999999999999998542      234458999999999999810                


Q ss_pred             --------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          149 --------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       149 --------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                    ......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....  
T Consensus       109 ~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~~--  184 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTAD--  184 (367)
T ss_dssp             CEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECC-----------
T ss_pred             EEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHhhEEECCCC-CEEEeeccccccccc--
Confidence                          011246899999999999999999999 88999999999999999888 699999999977533  


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc-
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-  293 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-  293 (395)
                      .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..|++.+|.|..+.+......... 
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~  264 (367)
T 2fst_X          185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  264 (367)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred             cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence            2345788999999999987566999999999999999999999999999999999999999999998877654321100 


Q ss_pred             --ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCChhhhc
Q 016085          294 --FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELK  371 (395)
Q Consensus       294 --~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (395)
                        ...+......+... ....++.+.+||.+||++||++|||+.++|+||||+.+.++......     ..+.+..+ ..
T Consensus       265 ~~~~~~~~~~~~~~~~-~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~-----~~~~~~~~-~~  337 (367)
T 2fst_X          265 YIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-----DPYDQSLE-SR  337 (367)
T ss_dssp             HHHTSCCCCCCCHHHH-TTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCC-----CCCCGGGS-SC
T ss_pred             HHhccCCCCCCCHHHH-CCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCC-----CCCCcchh-hc
Confidence              01122222222222 23578999999999999999999999999999999998876543211     12222221 12


Q ss_pred             cCCHHHHHhhchHHHhhhC
Q 016085          372 GASKELLSKLIPEHARKQC  390 (395)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~  390 (395)
                      ....+.+..++-+++..-+
T Consensus       338 ~~~~~~~~~~~~~e~~~~~  356 (367)
T 2fst_X          338 DLLIDEWKSLTYDEVISFV  356 (367)
T ss_dssp             CCCHHHHHHHHHHHHHHCC
T ss_pred             cCCHHHHHHHHHHHHHHhc
Confidence            3455556665555555433

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.5e-48  Score=363.96  Aligned_cols=220  Identities=22%  Similarity=0.263  Sum_probs=179.1

Q ss_pred             ccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~------------  147 (395)
                      ..++++.+.||+|+||+||+|+..     .+++.||||+++..     ...+.+|+.+|++|+||||.            
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            346899999999999999999853     46789999998643     34567899999999999980            


Q ss_pred             --------------eec----------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC
Q 016085          148 --------------YSR----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH  197 (395)
Q Consensus       148 --------------~~~----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~  197 (395)
                                    ++.                ....+++..+..++.||+.||+||| +++||||||||+||||+.++ 
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHRDLK~~NILl~~~~-  182 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS-SHHVVHKDLATRNVLVYDKL-  182 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH-hCCCCCCCccccceEECCCC-
Confidence                          010                1235788899999999999999999 88999999999999999888 


Q ss_pred             ceEEeecCCccccccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 016085          198 QVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII  273 (395)
Q Consensus       198 ~ikl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~  273 (395)
                      .+||+|||+|+......   .....+||+.|||||++.+.. |+.++|||||||+||||+| |+.||.+.+..+.+..|.
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~  261 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR  261 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            69999999998764332   233467899999999998765 9999999999999999998 899999988776666554


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          274 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ... .                           ...+..+++++.+|+.+||+.||++|||+.|++++
T Consensus       262 ~~~-~---------------------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          262 NRQ-V---------------------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             TTC-C---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCC-C---------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            310 0                           01234578999999999999999999999999764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.2e-47  Score=361.36  Aligned_cols=255  Identities=35%  Similarity=0.662  Sum_probs=202.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....      ....+|+.+++.++|+||.                
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            357999999999999999999985 58999999986432      3456899999999999981                


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCc
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPN  216 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~  216 (395)
                                .......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..... ...
T Consensus        99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~  176 (311)
T 3niz_A           99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH-QHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVRSY  176 (311)
T ss_dssp             ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEETTSCCC--
T ss_pred             cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCchHhEEECCCC-CEEEccCcCceecCCCcccc
Confidence                      1122345899999999999999999999 88999999999999999888 6999999999876433 223


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC--Cccc
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--YTEF  294 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~  294 (395)
                      ....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+......  +...
T Consensus       177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  256 (311)
T 3niz_A          177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR  256 (311)
T ss_dssp             -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred             cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence            44578999999999977666899999999999999999999999999999999999999998876655432210  0011


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      .+.......+. .+...+++++.+||.+||++||++|||+.|+|+||||+++..
T Consensus       257 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          257 TFQVFEKKPWS-SIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             CCCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             ccccccCCcHH-HhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            11111111222 234457899999999999999999999999999999998753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.3e-47  Score=362.22  Aligned_cols=228  Identities=27%  Similarity=0.407  Sum_probs=192.5

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+++.++||||.               
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            357999999999999999999999999999999986532       3456799999999999981               


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-CCC
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEP  215 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-~~~  215 (395)
                                 +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCcCCHHHEEECCCC-CEEEeeccchhhcccCCCc
Confidence                       0112346889999999999999999999 88999999999999999888 599999999986432 334


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......|...                 .. 
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------------~~-  222 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------EI-  222 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CC-
T ss_pred             ccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------CC-
Confidence            45678999999999997754 899999999999999999999999988776666665541                 01 


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                                 .++..+++++.+||.+||+.||++|+     ++.++++||||..+.+.
T Consensus       223 -----------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          223 -----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             -----------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence                       12345799999999999999999999     89999999999988663

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.9e-47  Score=355.15  Aligned_cols=251  Identities=36%  Similarity=0.685  Sum_probs=197.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ++|++.+.||+|+||.||+|++ .+++.||+|++....      ....+|+.+++.++|+||.                 
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            4699999999999999999998 678999999985432      3456899999999999981                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCcc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNI  217 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~  217 (395)
                               .......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..... ....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~  158 (288)
T 1ob3_A           81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYT  158 (288)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC------
T ss_pred             ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-CEEEeECccccccCccccccc
Confidence                     0112356889999999999999999999 88999999999999999888 6999999999765432 2233


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCcccc
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFK  295 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~  295 (395)
                      ...+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+....  ..+.. .
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  237 (288)
T 1ob3_A          159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP-N  237 (288)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-T
T ss_pred             cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc-c
Confidence            45789999999999776668999999999999999999999999999999999999988887665443221  11110 1


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      +.......+. .+...+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       238 ~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          238 FTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccCccHH-HHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            1111111221 2345689999999999999999999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.9e-47  Score=365.95  Aligned_cols=293  Identities=34%  Similarity=0.617  Sum_probs=224.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEee----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHYS----------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~~----------------  149 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++....     ....+|+.+++.++|+||...                
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            47999999999999999999999999999999986422     344589999999999998100                


Q ss_pred             -------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          150 -------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       150 -------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                                   .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....... 
T Consensus       107 iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~  184 (364)
T 3qyz_A          107 IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDH  184 (364)
T ss_dssp             EEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGCB
T ss_pred             EEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCChHhEEECCCC-CEEEEeCcceEecCCCCCc
Confidence                         01245888999999999999999999 88999999999999999887 699999999987643321 


Q ss_pred             ---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          216 ---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       216 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                         ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|..+.+........
T Consensus       185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  264 (364)
T 3qyz_A          185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA  264 (364)
T ss_dssp             CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence               23457899999999987666689999999999999999999999999999999999999999999887754321100


Q ss_pred             ---cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCChhh
Q 016085          293 ---EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQE  369 (395)
Q Consensus       293 ---~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (395)
                         ....+......+. .+...+++++.+||.+||++||++|||+.|+|+||||++...+........    .+.++ .+
T Consensus       265 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~----~~~~~-~~  338 (364)
T 3qyz_A          265 RNYLLSLPHKNKVPWN-RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA----PFKFD-ME  338 (364)
T ss_dssp             HHHHHTSCCCCCCCHH-HHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS----CCCCC---
T ss_pred             HHHHHhcCCccCCCHH-HhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC----cCCcc-cc
Confidence               0011111112222 233457899999999999999999999999999999999866543322221    12222 23


Q ss_pred             hccCCHHHHHhhchHHHhhhCC
Q 016085          370 LKGASKELLSKLIPEHARKQCP  391 (395)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~  391 (395)
                      +....++.+..++.+++..-.|
T Consensus       339 ~~~~~~~~~~~~~~~e~~~~~~  360 (364)
T 3qyz_A          339 LDDLPKEKLKELIFEETARFQP  360 (364)
T ss_dssp             ---CCHHHHHHHHHHHTGGGCC
T ss_pred             cccCCHHHHHHHHHHHHHHhhh
Confidence            4556677777777776655443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.8e-47  Score=357.59  Aligned_cols=253  Identities=32%  Similarity=0.540  Sum_probs=201.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---------hhHHHHHHHHHhcC---CCceEe---------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLD---HPNVHY---------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~E~~~l~~l~---h~ni~~---------  148 (395)
                      .++|++.+.||+|+||+||+|++..+++.||||++....         ....+|+.+++.++   |+||..         
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            457999999999999999999999999999999986322         34557888877765   999810         


Q ss_pred             ---------------------ec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecC
Q 016085          149 ---------------------SR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  205 (395)
Q Consensus       149 ---------------------~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG  205 (395)
                                           ..  ....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg  165 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENILVTSGG-TVKLADFG  165 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCTTTEEECTTS-CEEECSCS
T ss_pred             CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEcCCC-CEEEeeCc
Confidence                                 00  1123899999999999999999999 88999999999999999887 69999999


Q ss_pred             CccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 016085          206 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                      +++............||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.++...|.
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             cccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            998776555566778999999999997755 8999999999999999999999999999999999999999988776543


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      .... .....++......+ ......+++.+.+||.+||++||++|||+.|+|+||||++..
T Consensus       245 ~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          245 RDVS-LPRGAFPPRGPRPV-QSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             SSCS-SCGGGSCCCCCCCH-HHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             chhh-ccccccCCCCCCcH-HHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            2111 11111111111111 223456899999999999999999999999999999998643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-46  Score=364.83  Aligned_cols=231  Identities=25%  Similarity=0.367  Sum_probs=195.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----------hhHHHHHHHHHhcCCCce-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNV-------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----------~~~~~E~~~l~~l~h~ni-------------  146 (395)
                      .++|.+.+.||+|+||.||+|+++.+|+.||+|++.+..          ....+|+.+|+.++||||             
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            357999999999999999999999999999999986532          345789999999999998             


Q ss_pred             -------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC---ceEEeecCCcccc
Q 016085          147 -------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKLCDFGSAKVL  210 (395)
Q Consensus       147 -------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~---~ikl~DFG~a~~~  210 (395)
                                   .+......+++..++.++.||+.||.||| +.||+||||||+|||++.++.   .+||+|||+++..
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence                         11123456899999999999999999999 889999999999999987653   5999999999887


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      .........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..|.......+.         
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------  239 (361)
T 2yab_A          170 EDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE---------  239 (361)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH---------
T ss_pred             CCCCccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc---------
Confidence            6655556778999999999997654 899999999999999999999999998887777776553211111         


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                                      .+...+++.+.+||.+||..||.+|||+.|+|+||||+.+.
T Consensus       240 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          240 ----------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             ----------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             ----------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence                            12234789999999999999999999999999999998654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=363.58  Aligned_cols=263  Identities=33%  Similarity=0.622  Sum_probs=204.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh-----hHHHHHHHHHhcCCCceE------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....     ...+|+.+++.++|+||.                  
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            469999999999999999999999999999999864432     223699999999999981                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNIS  218 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~  218 (395)
                              .......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...... ....
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH-RQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH-HTTEEESSCCGGGEEECTTC-CEEECSSSEEECC---------
T ss_pred             cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCcccccc
Confidence                    0112345889999999999999999999 88999999999999999888 69999999997654332 2334


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC--CccccC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--YTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~  296 (395)
                      ..||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.|....|......  +..+.+
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY  239 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence            578999999999987666899999999999999999999999999999999999999999887655432211  111122


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNG  356 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~  356 (395)
                      +......+ ......+++++.+||.+||++||.+|||+.|+|+||||.++.......+..
T Consensus       240 ~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~  298 (324)
T 3mtl_A          240 PKYRAEAL-LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDT  298 (324)
T ss_dssp             CCCCCCCH-HHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTT
T ss_pred             ccccchhh-hhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCC
Confidence            22211111 112345789999999999999999999999999999999987765444433

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9.6e-47  Score=358.90  Aligned_cols=258  Identities=32%  Similarity=0.581  Sum_probs=192.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------------e
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      .+|++.+.||+|+||.||+|++..+|+.||+|++....     ....+|+.+++.++|+||.                 +
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   84 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF   84 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence            46999999999999999999999999999999986432     3456899999999999981                 0


Q ss_pred             e--------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-
Q 016085          149 S--------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  213 (395)
Q Consensus       149 ~--------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-  213 (395)
                      .              .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..... 
T Consensus        85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           85 MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH-ENKILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             CCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCSSCEETTSCC
T ss_pred             cCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCChHHeEEcCCC-CEEECcCccceecCCCc
Confidence            0              01135788999999999999999999 88999999999999999888 6999999999876433 


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CC
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NY  291 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~  291 (395)
                      .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....|.....  .+
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  242 (317)
T 2pmi_A          163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY  242 (317)
T ss_dssp             CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred             ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence            2234567899999999997755689999999999999999999999999999999999999999887665543221  11


Q ss_pred             ccccCCcccCCCc----ccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 016085          292 TEFKFPQIKAHPW----HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  351 (395)
Q Consensus       292 ~~~~~~~~~~~~~----~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  351 (395)
                      .. .+.......+    .......++.++.+||.+||++||++|||+.|+|+||||++......
T Consensus       243 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  305 (317)
T 2pmi_A          243 NP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS  305 (317)
T ss_dssp             CT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred             cc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence            10 0111111111    11223457899999999999999999999999999999999876643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3e-47  Score=367.91  Aligned_cols=230  Identities=29%  Similarity=0.477  Sum_probs=188.9

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc-CCCceE------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVH------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~ni~------------  147 (395)
                      ...++|++.++||+|+||+||+|+++.+++.||||++.+..       ....+|..+++.+ +||||.            
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            34457999999999999999999999999999999997542       3345789999988 799981            


Q ss_pred             --------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-
Q 016085          148 --------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  212 (395)
Q Consensus       148 --------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-  212 (395)
                                    +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|+.... 
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH-DKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC-
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCHHHEEECCCC-CEEEccccceeecccC
Confidence                          1112356899999999999999999999 88999999999999999888 599999999986432 


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      .......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..|...                 
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------  239 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-----------------  239 (353)
T ss_dssp             --------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------
T ss_pred             CccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            23345678999999999997654 899999999999999999999999999888877777651                 


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCH------HHHhcCCcccCCCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFDELRDP  349 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~------~e~l~hp~f~~~~~~  349 (395)
                      ..            .++..+++.+.+||++||++||++|+++      .++++||||+++.|.
T Consensus       240 ~~------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          240 EV------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             CC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             CC------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence            11            1233478999999999999999999998      899999999998764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.4e-47  Score=364.66  Aligned_cols=220  Identities=26%  Similarity=0.391  Sum_probs=179.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCC-----CcEEEEEEeecc-----hhhHHHHHHHHHhcCC-CceE------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQD-----KRYKNRELQTMRLLDH-PNVH------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h-~ni~------------  147 (395)
                      ++|++.+.||+|+||+||+|++..+     ++.||||.+...     ...+.+|+.+|+.+.| |||.            
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            5799999999999999999997654     367999998643     2345689999999976 8870            


Q ss_pred             ---------------eec----------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC
Q 016085          148 ---------------YSR----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT  196 (395)
Q Consensus       148 ---------------~~~----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~  196 (395)
                                     ++.                ....+++..+..++.||+.||+||| +++||||||||+|||++.++
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH-~~~iiHRDLK~~NILl~~~~  222 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKN  222 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh-hCCeecCccCccceeeCCCC
Confidence                           000                1234788999999999999999999 88999999999999999887


Q ss_pred             CceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 016085          197 HQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEI  272 (395)
Q Consensus       197 ~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i  272 (395)
                       .+||+|||+|+.......   ....+||+.|||||++.+.. |+.++|||||||+||||+| |+.||.+.+..+.+..+
T Consensus       223 -~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~  300 (353)
T 4ase_A          223 -VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  300 (353)
T ss_dssp             -CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred             -CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             699999999987654432   22457899999999998765 9999999999999999998 99999987766655555


Q ss_pred             HHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          273 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      +.....+                           ..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       301 i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          301 LKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4421111                           1234578999999999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.1e-46  Score=362.31  Aligned_cols=263  Identities=37%  Similarity=0.643  Sum_probs=208.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++|+||.                 
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            4799999999999999999999999999999998653      23445899999999999981                 


Q ss_pred             -ee-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 -YS-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 -~~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                       +.           .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....  .
T Consensus       122 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~--~  197 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADA--E  197 (371)
T ss_dssp             CEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECSTTCC--------
T ss_pred             EEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCcCHHHeEECCCC-CEEEEecCccccccc--C
Confidence             00           11245889999999999999999999 88999999999999999888 699999999976532  3


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc-
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-  294 (395)
                      .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+..+....... 
T Consensus       198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  277 (371)
T 4exu_A          198 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY  277 (371)
T ss_dssp             --CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHH
T ss_pred             cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhh
Confidence            3456789999999999875569999999999999999999999999999999999999999999887665443211110 


Q ss_pred             --cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCC
Q 016085          295 --KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRP  358 (395)
Q Consensus       295 --~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~  358 (395)
                        ..+......+. .+...+++.+.+||.+||++||++|||+.|+|+||||+.+..+........+
T Consensus       278 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~  342 (371)
T 4exu_A          278 IQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQP  342 (371)
T ss_dssp             HHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSC
T ss_pred             hhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccC
Confidence              11111111111 1234578999999999999999999999999999999998776544333333

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9.2e-47  Score=360.88  Aligned_cols=260  Identities=31%  Similarity=0.557  Sum_probs=203.5

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE--------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ...++|++.+.||+|+||.||+|++..+++.||||++....      ....+|+.+++.++|+||.              
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34468999999999999999999999999999999986432      2335899999999999981              


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC----CceEEeecCCcccccc
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT----HQVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~----~~ikl~DFG~a~~~~~  212 (395)
                                 +......+++..++.++.||+.||.||| +.||+||||||+|||++.++    ..+||+|||+++....
T Consensus       111 v~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          111 IFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH-SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             EEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence                       1123456899999999999999999999 88999999999999995332    2599999999976543


Q ss_pred             C-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC-C
Q 016085          213 G-EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-N  290 (395)
Q Consensus       213 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~  290 (395)
                      . ......++|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..++...+.|....+..... .
T Consensus       190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (329)
T 3gbz_A          190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP  269 (329)
T ss_dssp             ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence            2 2234457799999999998766689999999999999999999999999999999999999999887665432211 0


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      .....++......+...+...+++++.+||.+||++||++|||+.|+|+||||++..+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            0111233333344444455568899999999999999999999999999999998754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-46  Score=372.41  Aligned_cols=237  Identities=26%  Similarity=0.406  Sum_probs=196.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .++|++.++||+|+||+||+|+++.+++.||||++.+..       ....+|..++..++|+||.               
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            457999999999999999999999999999999986532       2256899999999999980               


Q ss_pred             -----------ee-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 -----------YS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 -----------~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                 +. .....+++..++.++.||+.||+||| +.||+||||||+||||+.++ .+||+|||+|+.......
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSC
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecccCHHHeeEcCCC-CEEEcchhhhhhcccCCC
Confidence                       01 12467899999999999999999999 88999999999999999888 599999999987644433


Q ss_pred             --ccccccccccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          216 --NISYICSRYYRAPELIF----GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       216 --~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                        ....+||+.|+|||++.    +...|+.++|||||||++|||++|+.||.+.+..+....|+....            
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------  298 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------------  298 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH------------
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc------------
Confidence              23468999999999986    234589999999999999999999999999988888887765211            


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCC--CCCHHHHhcCCcccCCCCCCCC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRDPNAR  352 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~~~~  352 (395)
                         .+.+|.         ....+++++.+||++||+.+|++  |+++.|+++||||+.+.|...+
T Consensus       299 ---~~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~  351 (437)
T 4aw2_A          299 ---RFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR  351 (437)
T ss_dssp             ---HCCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred             ---cccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence               011111         11347999999999999999988  9999999999999999887543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=349.82  Aligned_cols=258  Identities=36%  Similarity=0.635  Sum_probs=200.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ++|++.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++|+||.                 
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            4699999999999999999999999999999988543      23345799999999999980                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNI  217 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~  217 (395)
                               +......+++..++.++.|++.||.||| +.||+||||||+|||++.++ .+||+|||++....... ...
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-KHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC-------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCcccccC
Confidence                     1123456899999999999999999999 88999999999999999887 69999999998764332 234


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc--CCCCcccc
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK  295 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~~~  295 (395)
                      ...+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+..........  ...+....
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            5678999999999987666899999999999999999999999999999999999888887766543322  11122222


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                      .+..............++..+.+||.+||++||.+|||+.|+++||||+++.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            2222211111222346889999999999999999999999999999999987653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-46  Score=358.28  Aligned_cols=258  Identities=35%  Similarity=0.584  Sum_probs=203.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---------hhHHHHHHHHHhcCCCceE-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....         ....+|+.+++.++|+||.             
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            347999999999999999999999999999999986421         2345899999999999981             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                   .......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++......
T Consensus        89 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           89 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCC
T ss_pred             EEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH-HCCEECCCCCHHHEEEcCCC-CEEEEecccceeccCCc
Confidence                         0112345788889999999999999999 88999999999999999888 69999999998764332


Q ss_pred             -CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          215 -PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                       .....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+++..+.+....|.........
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  246 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  246 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence             3345678999999999977666899999999999999999999999999999999999999998887665433221111


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                      ..+......++. .+...+++++.+||.+||+.||++|||+.|+|+||||.+...+.
T Consensus       247 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          247 VTFKSFPGIPLH-HIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             CCCCCCCCCCHH-HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             ccccccCCCChH-HhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence            111111111111 12345789999999999999999999999999999998876553

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.2e-46  Score=367.94  Aligned_cols=253  Identities=33%  Similarity=0.577  Sum_probs=202.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhc------CCCceE-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL------DHPNVH-------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l------~h~ni~-------------  147 (395)
                      ..+|++.++||+|+||.||+|++..+++.||||++....   ....+|+.+++.+      +|+||.             
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            457999999999999999999999999999999997654   3345788888887      455760             


Q ss_pred             --e------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC-ceEEeecCCcccccc
Q 016085          148 --Y------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 --~------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~-~ikl~DFG~a~~~~~  212 (395)
                        +            ......+++..++.++.||+.||.||| +.||+||||||+|||++.++. .+||+|||++.... 
T Consensus       176 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~-  253 (429)
T 3kvw_A          176 MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH-KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-  253 (429)
T ss_dssp             EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT-
T ss_pred             EEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEccCCCcceEEeecccceecC-
Confidence              0            011234889999999999999999999 789999999999999998763 29999999997643 


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                       ......+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+++..+++.++.|+...+........
T Consensus       254 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~  331 (429)
T 3kvw_A          254 -QRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN  331 (429)
T ss_dssp             -CCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred             -CcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence             3344678899999999998765 89999999999999999999999999999999999999999999887654321100


Q ss_pred             cc---cCC---------------------------cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCc
Q 016085          293 EF---KFP---------------------------QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  342 (395)
Q Consensus       293 ~~---~~~---------------------------~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~  342 (395)
                      .+   ..+                           ......|...+....++.+.+||.+||++||++|||+.|+|+|||
T Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw  411 (429)
T 3kvw_A          332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPW  411 (429)
T ss_dssp             HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred             ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChh
Confidence            00   000                           011122333344556889999999999999999999999999999


Q ss_pred             ccCC
Q 016085          343 FDEL  346 (395)
Q Consensus       343 f~~~  346 (395)
                      |++.
T Consensus       412 ~~~~  415 (429)
T 3kvw_A          412 LRRR  415 (429)
T ss_dssp             TC--
T ss_pred             hccC
Confidence            9874

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.1e-46  Score=360.89  Aligned_cols=229  Identities=28%  Similarity=0.491  Sum_probs=191.9

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc-CCCceE-------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVH-------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~ni~-------------  147 (395)
                      ..++|.+.++||+|+||+||+|+++.+|+.||||++.+..       ....+|..+++.+ +||||.             
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            3457999999999999999999999999999999997542       3345788888876 999981             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  213 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-  213 (395)
                                   +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|+..... 
T Consensus        95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCChhhEEECCCC-CEEEeEChhhhhcccCC
Confidence                         0112356889999999999999999999 88999999999999999888 5999999999865332 


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..|....                 
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-----------------  234 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-----------------  234 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------------
T ss_pred             CcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence            3345678999999999997755 8999999999999999999999999888777766665410                 


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHH-HHhcCCcccCCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL-EACIHPFFDELRDP  349 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~-e~l~hp~f~~~~~~  349 (395)
                      .            .++..+++++.+||.+||+.||++|+++. ++++||||+.+.|.
T Consensus       235 ~------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          235 P------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             C------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             C------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence            0            12334789999999999999999999998 99999999998763

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.8e-46  Score=364.35  Aligned_cols=230  Identities=24%  Similarity=0.425  Sum_probs=187.8

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc-CCCceE------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVH------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~ni~------------  147 (395)
                      ....+|++.++||+|+||+||+|+++.+++.||||++.+..       ....+|..+++.+ +||||.            
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            44568999999999999999999999999999999987542       2345788998877 899981            


Q ss_pred             --------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc-c
Q 016085          148 --------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-K  212 (395)
Q Consensus       148 --------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~-~  212 (395)
                                    +......+++..++.++.||+.||+||| +.||+||||||+||||+.++ .+||+|||+|+... .
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCT
T ss_pred             EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCEEeccCCHHHEEECCCC-CEEEeecceeeecccC
Confidence                          1112357899999999999999999999 88999999999999999988 59999999998633 3


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--------HHHH-HHHHHHhCCCCHHH
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG--------VDQL-VEIIKVLGTPTREE  283 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--------~~~~-~~i~~~~~~~~~~~  283 (395)
                      .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+...        .+.+ ..+...        
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------  277 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------  277 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--------
T ss_pred             CCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--------
Confidence            34455678999999999998755 89999999999999999999999965321        1112 222210        


Q ss_pred             HhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCH------HHHhcCCcccCCCCC
Q 016085          284 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFDELRDP  349 (395)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~------~e~l~hp~f~~~~~~  349 (395)
                               .            ..++..+++++.+||++||+.||++|+++      .|+++||||+.+.|.
T Consensus       278 ---------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          278 ---------Q------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             ---------C------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             ---------c------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence                     0            01344589999999999999999999985      799999999998764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-46  Score=363.10  Aligned_cols=229  Identities=26%  Similarity=0.393  Sum_probs=192.1

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc-CCCceE-------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVH-------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~ni~-------------  147 (395)
                      ...+|++.++||+|+||+||+|+++.+++.||||++.+..       ....+|..++..+ +|+||.             
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3457999999999999999999999999999999987542       3345788899887 799971             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-C
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-G  213 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-~  213 (395)
                                   +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|+.... .
T Consensus        98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ-SKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCEEeccCCHHHEEEcCCC-cEEEEeCCcccccccCC
Confidence                         1112356889999999999999999999 88999999999999999888 599999999986432 3


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..|...                 .
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------~  237 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-----------------N  237 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------C
T ss_pred             cccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------------C
Confidence            3345678999999999997755 899999999999999999999999998887777777651                 0


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  349 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  349 (395)
                      .            .++..+++++.+||.+||+.||.+|++     +.++++||||+.+.|.
T Consensus       238 ~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          238 V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             C------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             C------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence            1            123457999999999999999999994     6999999999988764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=351.67  Aligned_cols=226  Identities=28%  Similarity=0.474  Sum_probs=193.1

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++||||.               
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            45799999999999999999999999999999998653       23445799999999999981               


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                                 +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++....  ..
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~--~~  160 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH-SKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD--VT  160 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--CB
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChheEEEcCCC-CEEEeecCcceecCC--cc
Confidence                       1122456889999999999999999999 89999999999999999888 599999999987532  33


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......|...                 ..  
T Consensus       161 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------------~~--  220 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-----------------EL--  220 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-----------------CC--
T ss_pred             ccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------CC--
Confidence            4578999999999997754 899999999999999999999999998877777776651                 01  


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                                .++..+++++.+||.+||+.||++|+     ++.++++||||+.+.+.
T Consensus       221 ----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          221 ----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             ----------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence                      12344789999999999999999999     89999999999988764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.9e-46  Score=364.64  Aligned_cols=256  Identities=33%  Similarity=0.560  Sum_probs=192.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEee-----c---------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHYS-----R---------  150 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~~-----~---------  150 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++...      .....+|+.+++.++|+||...     .         
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            4799999999999999999999999999999998642      2334589999999999998110     0         


Q ss_pred             ---------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          151 ---------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       151 ---------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                     ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.......
T Consensus       105 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~  182 (371)
T 2xrw_A          105 VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFM  182 (371)
T ss_dssp             EEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECCCCC---------
T ss_pred             eEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHH-HCCeecccCCHHHEEEcCCC-CEEEEEeecccccccccc
Confidence                           0135788889999999999999999 88999999999999999888 699999999987655444


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc-
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-  294 (395)
                      ....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.|..+.+..+......+ 
T Consensus       183 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  261 (371)
T 2xrw_A          183 MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV  261 (371)
T ss_dssp             -------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHH
T ss_pred             cCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHH
Confidence            45678899999999998754 8999999999999999999999999999999999999999998877665432111000 


Q ss_pred             -cCCcccCCCcccccC-----------CCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          295 -KFPQIKAHPWHKIFH-----------KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       295 -~~~~~~~~~~~~~~~-----------~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                       ..+......+...++           ...+..+.+||.+||++||++|||+.|+|+||||+...++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  328 (371)
T 2xrw_A          262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP  328 (371)
T ss_dssp             HSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCH
T ss_pred             hhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCc
Confidence             001111111111111           1125689999999999999999999999999999987664

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9e-46  Score=361.11  Aligned_cols=231  Identities=27%  Similarity=0.424  Sum_probs=191.0

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ...++|++.+.||+|+||.||+|++..+++.||||++.+..       ....+|+.+|+.++||||.             
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34568999999999999999999999999999999986542       3455899999999999981             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                   +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|+......
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ-NQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLPRET  169 (384)
T ss_dssp             EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCcHHHeEECCCC-CEEEeccceeeeccCCC
Confidence                         1123457899999999999999999999 88999999999999999888 59999999998876666


Q ss_pred             CcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          215 PNISYICSRYYRAPELIFGA--TEYTTAVDIWSVGCVLAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      .....+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||.+.+..  ..+...+...              
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--------------  235 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--------------  235 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--------------
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--------------
Confidence            66678899999999998642  34899999999999999999999999764332  2222211110              


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-HHHHhcCCcccCCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-ALEACIHPFFDELRD  348 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-~~e~l~hp~f~~~~~  348 (395)
                        .            ..++..+++.+.+||.+||+.||.+|++ +.++++||||+.+.|
T Consensus       236 --~------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          236 --V------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             --C------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             --c------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence              0            0123457899999999999999999998 899999999998876

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=351.28  Aligned_cols=231  Identities=23%  Similarity=0.377  Sum_probs=193.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----------hhhHHHHHHHHHhcCCCce-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV-------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----------~~~~~~E~~~l~~l~h~ni-------------  146 (395)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++...          .....+|+.+|+.++||||             
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            45799999999999999999999999999999998643          2446789999999999998             


Q ss_pred             -------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC---ceEEeecCCcccc
Q 016085          147 -------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKLCDFGSAKVL  210 (395)
Q Consensus       147 -------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~---~ikl~DFG~a~~~  210 (395)
                                   .+......+++..++.++.||+.||.||| +.||+||||||+|||++.++.   .+||+|||+++..
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH-HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence                         11123456899999999999999999999 889999999999999987652   5999999999877


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      .........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.........         
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  238 (326)
T 2y0a_A          169 DFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED---------  238 (326)
T ss_dssp             CTTSCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH---------
T ss_pred             CCCCccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc---------
Confidence            5555555678999999999997654 899999999999999999999999988877777666553211111         


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                                      .....++..+.+||.+||+.||++|||+.++|+||||+...
T Consensus       239 ----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          239 ----------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             ----------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             ----------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence                            12234789999999999999999999999999999997643

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=351.50  Aligned_cols=257  Identities=37%  Similarity=0.637  Sum_probs=205.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++|+||..                
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            4699999999999999999999999999999998643      233457999999999999810                


Q ss_pred             --e-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 --S-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 --~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                        .           .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....  .
T Consensus       104 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~--~  179 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADA--E  179 (353)
T ss_dssp             CEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC------
T ss_pred             EEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEeECCCC-cEEEeecccccCCCC--C
Confidence              0           01235789999999999999999999 88999999999999999887 699999999976532  2


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc-
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-  294 (395)
                      .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..|.++.+.+..+....... 
T Consensus       180 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  259 (353)
T 3coi_A          180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY  259 (353)
T ss_dssp             ----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHH
T ss_pred             ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHH
Confidence            3456789999999999775568999999999999999999999999999999999999999999887665443211000 


Q ss_pred             --cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCC
Q 016085          295 --KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  352 (395)
Q Consensus       295 --~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  352 (395)
                        ..+......+. .....+++.+.+||.+||+.||++|||+.++++||||+.+..+...
T Consensus       260 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~  318 (353)
T 3coi_A          260 IQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE  318 (353)
T ss_dssp             HHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred             HHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcccc
Confidence              11111111111 1234578999999999999999999999999999999988776443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-46  Score=353.17  Aligned_cols=230  Identities=28%  Similarity=0.409  Sum_probs=194.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE-------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH-------------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~-------------------  147 (395)
                      .++|++.+.||+|+||.||+|++..+++.||+|.+...   .....+|+.+++.++||||.                   
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            35799999999999999999999999999999998643   23456899999999999980                   


Q ss_pred             -------ee-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC--CCCceEEeecCCccccccCCCcc
Q 016085          148 -------YS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       148 -------~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~--~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                             +. .....+++..++.++.||+.||.||| +.||+||||||+|||++.  ++ .+||+|||+++.........
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH-~~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~~~~~~~~  161 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH-SHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCC-CEEECCCTTCEECCTTCEEE
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeECCCCCccc
Confidence                   01 11246899999999999999999999 889999999999999986  44 69999999998876555555


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ...||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+..........               
T Consensus       162 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------  225 (321)
T 1tki_A          162 LLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE---------------  225 (321)
T ss_dssp             EEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH---------------
T ss_pred             cccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh---------------
Confidence            678899999999997654 8999999999999999999999999988877777776632222221               


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                                ....++.++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       226 ----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          226 ----------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             ----------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             ----------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence                      1234789999999999999999999999999999998643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.5e-45  Score=351.84  Aligned_cols=257  Identities=31%  Similarity=0.559  Sum_probs=198.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-hhhHHHHHHHHHhcC-CCceEe-----------------e--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVHY-----------------S--  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~-h~ni~~-----------------~--  149 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.+. |+||..                 .  
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~  115 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  115 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence            4799999999999999999999999999999998643 455678999999997 999710                 0  


Q ss_pred             ------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccccc
Q 016085          150 ------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR  223 (395)
Q Consensus       150 ------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~  223 (395)
                            .....+++..++.++.||+.||.||| +.||+||||||+|||++.++..+||+|||+++............+|+
T Consensus       116 ~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  194 (330)
T 3nsz_A          116 NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR  194 (330)
T ss_dssp             CCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCG
T ss_pred             CchhHHHHHHhCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccc
Confidence                  01134788899999999999999999 88999999999999999777579999999998776555556678899


Q ss_pred             cccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCCHHHH-hhcCCCCccc---cCCc
Q 016085          224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEI-KCMNPNYTEF---KFPQ  298 (395)
Q Consensus       224 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~---~~~~  298 (395)
                      .|+|||++.+...++.++|||||||++|+|++|+.||. +.+..+.+..+....+.+....+ ..........   ....
T Consensus       195 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (330)
T 3nsz_A          195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR  274 (330)
T ss_dssp             GGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCC
T ss_pred             cccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhh
Confidence            99999999775669999999999999999999999984 45666777777776664432221 1111110000   0000


Q ss_pred             ccCCCcccc----cCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          299 IKAHPWHKI----FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       299 ~~~~~~~~~----~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      .....|...    ....+++++.+||.+||++||++|||+.|+|+||||+.+.+
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          275 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            011111111    12337899999999999999999999999999999998764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=344.64  Aligned_cols=229  Identities=26%  Similarity=0.418  Sum_probs=184.1

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------------------------------hhHHHHHHH
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------------------------RYKNRELQT  137 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------------------------------~~~~~E~~~  137 (395)
                      ...++|++.+.||+|+||.||+|++..+++.||||++....                              ....+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            34567999999999999999999999999999999986432                              235689999


Q ss_pred             HHhcCCCceE---------------------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCce
Q 016085          138 MRLLDHPNVH---------------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNL  190 (395)
Q Consensus       138 l~~l~h~ni~---------------------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Ni  190 (395)
                      ++.++|+||.                           .......+++..++.++.||+.||.||| +.||+||||||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLH-YQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHE
Confidence            9999999980                           0012346899999999999999999999 88999999999999


Q ss_pred             EEcCCCCceEEeecCCccccccCCC-cccccccccccccccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016085          191 LVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATE--YTTAVDIWSVGCVLAELLLGQPLFPGESGVD  267 (395)
Q Consensus       191 ll~~~~~~ikl~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  267 (395)
                      |++.++ .+||+|||+++....... .....||+.|+|||++.+...  ++.++|||||||++|+|++|+.||.+.+...
T Consensus       169 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          169 LVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            999888 699999999987644322 234678999999999966432  4778999999999999999999998876655


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       268 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      ....+...                 ...++          ....+++.+.+||.+||+.||++|||+.|+++||||+.
T Consensus       248 ~~~~~~~~-----------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          248 LHSKIKSQ-----------------ALEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHC-----------------CCCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHhcc-----------------cCCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            44444331                 00011          12347899999999999999999999999999999963

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8e-46  Score=360.41  Aligned_cols=229  Identities=25%  Similarity=0.413  Sum_probs=187.1

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh-------hHHHHHHH-HHhcCCCceE-------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVH-------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~~-l~~l~h~ni~-------------  147 (395)
                      ...+|++.++||+|+||+||+|+++.+++.||||++.+...       ...+|..+ ++.++|+||.             
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            34579999999999999999999999999999999865431       22345554 5678999981             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-C
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-G  213 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-~  213 (395)
                                   +......+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+.... .
T Consensus       116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH-SLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGGBCCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCHHHEEECCCC-CEEEeeCccccccccCC
Confidence                         0112356889999999999999999999 88999999999999999888 599999999986433 3


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+....|...                 .
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------~  255 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-----------------P  255 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-----------------C
T ss_pred             CccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------------c
Confidence            3445678999999999997754 999999999999999999999999998877777777651                 0


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCH----HHHhcCCcccCCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFDELRDP  349 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~e~l~hp~f~~~~~~  349 (395)
                      .            .++..++..+.+||.+||+.||.+|+++    .++++||||+.+.|.
T Consensus       256 ~------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          256 L------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             C------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             c------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence            0            1234578999999999999999999986    699999999988764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.8e-45  Score=353.13  Aligned_cols=230  Identities=24%  Similarity=0.432  Sum_probs=186.5

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc-CCCceE------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVH------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~ni~------------  147 (395)
                      ....+|++.+.||+|+||.||+|+++.+++.||||++.+..       ....+|..+++.+ +||||.            
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            34567999999999999999999999999999999997542       2345799999887 899981            


Q ss_pred             --------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-
Q 016085          148 --------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  212 (395)
Q Consensus       148 --------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-  212 (395)
                                    +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|+.... 
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSCCT
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCHHHEEECCCC-CEEEEeccccccccCC
Confidence                          0112356889999999999999999999 88999999999999999888 599999999986432 


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--------HH-HHHHHHHHhCCCCHHH
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG--------VD-QLVEIIKVLGTPTREE  283 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--------~~-~~~~i~~~~~~~~~~~  283 (395)
                      .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+...        .. ....+...        
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--------  234 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------  234 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--------
T ss_pred             CCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--------
Confidence            33345678999999999997754 89999999999999999999999975211        11 12222210        


Q ss_pred             HhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCH------HHHhcCCcccCCCCC
Q 016085          284 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFDELRDP  349 (395)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~------~e~l~hp~f~~~~~~  349 (395)
                               ..            .++..++..+.+||.+||+.||.+|+++      .++++||||+.+.|.
T Consensus       235 ---------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~  285 (345)
T 3a8x_A          235 ---------QI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  285 (345)
T ss_dssp             ---------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred             ---------CC------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence                     00            1334578999999999999999999995      899999999988763

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.6e-45  Score=353.53  Aligned_cols=258  Identities=30%  Similarity=0.497  Sum_probs=201.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEe---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHY---------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~---------------  148 (395)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....      ....+|+.+++.++|+||..               
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            457999999999999999999999999999999885432      24458999999999999710               


Q ss_pred             -------------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          149 -------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       149 -------------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                         ......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|+.
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~  173 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-RNKILHRDMKAANVLITRDG-VLKLADFGLARA  173 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred             CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCHHHEEEcCCC-CEEEccchhccc
Confidence                               012256899999999999999999999 88999999999999999888 699999999986


Q ss_pred             cccC-----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          210 LVKG-----EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       210 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                      ....     .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.++...+
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            5422     22234678999999999987666899999999999999999999999999999999999998888776544


Q ss_pred             hhcCCC--CccccCCcccCCCccccc-CCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          285 KCMNPN--YTEFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       285 ~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      ......  +................+ ....++.+.+||.+||++||++|||+.|+|+||||.....+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            322110  000000000000000000 01136789999999999999999999999999999875443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.1e-45  Score=353.42  Aligned_cols=227  Identities=26%  Similarity=0.391  Sum_probs=193.0

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ...++|++.+.||+|+||.||+|+++.+|+.||||++.+..       ....+|+.+++.++||||.             
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            34568999999999999999999999999999999986532       3445799999999999981             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                   +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++....  
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~--  193 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS--
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCccceEEECCCC-CEEEcccccceeccC--
Confidence                         0112356889999999999999999999 88999999999999999888 599999999987633  


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....|...                 ..
T Consensus       194 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------------~~  255 (350)
T 1rdq_E          194 RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-----------------KV  255 (350)
T ss_dssp             CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CC
T ss_pred             CcccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-----------------CC
Confidence            234578999999999997754 899999999999999999999999988877777666551                 00


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRD  348 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  348 (395)
                                  .++..++..+.+||.+||+.||.+|++     +.++++||||..+.|
T Consensus       256 ------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          256 ------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             ------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence                        123457899999999999999999998     999999999998765

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.2e-45  Score=356.11  Aligned_cols=230  Identities=30%  Similarity=0.413  Sum_probs=191.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||.                
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            357999999999999999999999999999999986432      3456899999999999981                


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC--CceEEeecCCccccccCCC
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~--~~ikl~DFG~a~~~~~~~~  215 (395)
                                +......+++..+..++.||+.||.||| +.||+||||||+|||++.++  ..+||+|||++........
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence                      1122356789999999999999999999 88999999999999998653  2599999999987765555


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+......                 
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----------------  248 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-----------------  248 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----------------
T ss_pred             cccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence            55678999999999997654 899999999999999999999999988877766666542111                 


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      ++.        .....+++++.+||.+||+.||++|||+.++|+||||...
T Consensus       249 ~~~--------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          249 YPS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             CCT--------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             CCc--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            110        0113378999999999999999999999999999999753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-46  Score=361.12  Aligned_cols=227  Identities=30%  Similarity=0.450  Sum_probs=187.8

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE--------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ..++|++.+.||+|+||.||+|++..+++.||||++.+..       ....+|+.+++.++||||.              
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3457999999999999999999999999999999986432       3456899999999999981              


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                                 +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++.....+...
T Consensus        87 v~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           87 VIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH-RHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTTSBTT
T ss_pred             EEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCchhhEEEcCCC-CEEEEEeccceeccCCccc
Confidence                       1112356899999999999999999999 78999999999999999887 6999999999877666555


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+........                      .   
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------------~---  219 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------------K---  219 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------------C---
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------------H---
Confidence            677899999999999876645889999999999999999999997643211100                      0   


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                        +.  .....++..+++.+.+||++||+.||.+|||+.|+++||||+..
T Consensus       220 --i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          220 --VN--SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             --CC--SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             --HH--cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence              00  00112345589999999999999999999999999999999763

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-45  Score=358.33  Aligned_cols=237  Identities=27%  Similarity=0.430  Sum_probs=193.7

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE--------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ..++|++.++||+|+||+||+|+++.+|+.||||++.+..       ....+|..++..++|+||.              
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            3457999999999999999999999999999999986532       2346799999999999981              


Q ss_pred             ------------ee-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 ------------YS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 ------------~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                  +. .....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|+......
T Consensus       139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH-RLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTS
T ss_pred             EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccCHHHeeecCCC-CEEEeechhheeccCCC
Confidence                        00 11247899999999999999999999 88999999999999999988 59999999998765443


Q ss_pred             C--cccccccccccccccccC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 016085          215 P--NISYICSRYYRAPELIFG------ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       215 ~--~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  286 (395)
                      .  ....+||+.|+|||++.+      ...|+.++|||||||++|||++|+.||.+.+..+....|.....         
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------  287 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE---------  287 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH---------
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------
Confidence            2  234689999999999962      23489999999999999999999999999888887777764210         


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC---CHHHHhcCCcccCCCCCCCC
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFFDELRDPNAR  352 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~~~~  352 (395)
                            ...+|.         +...+++++.+||++||+ +|.+|+   ++.|+++||||+.+.|...+
T Consensus       288 ------~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          288 ------HLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             ------HCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred             ------CcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence                  001110         123479999999999999 999984   89999999999999887554

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.5e-45  Score=344.31  Aligned_cols=229  Identities=28%  Similarity=0.400  Sum_probs=189.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE---------------ee-
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH---------------YS-  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~---------------~~-  149 (395)
                      ..+|++.+.||+|+||.||+|++..+++.||||++...    .....+|+.+++.++||||.               .. 
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            34799999999999999999999999999999998543    34456899999999999981               00 


Q ss_pred             ---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cccc
Q 016085          150 ---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISY  219 (395)
Q Consensus       150 ---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~~~  219 (395)
                               .....+++..++.++.|++.||.||| +.||+||||||+|||++.++ .+||+|||++........ ....
T Consensus        99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~  176 (297)
T 3fxz_A           99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTM  176 (297)
T ss_dssp             CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCC
T ss_pred             CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCcccccCCc
Confidence                     01235788899999999999999999 88999999999999999888 699999999977644332 3456


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcc
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI  299 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (395)
                      +||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+.... .+.                   
T Consensus       177 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~-------------------  235 (297)
T 3fxz_A          177 VGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE-------------------  235 (297)
T ss_dssp             CSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCC-------------------
T ss_pred             cCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCC-------------------
Confidence            7899999999997755 8999999999999999999999999888777666654421 100                   


Q ss_pred             cCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       300 ~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                            ...+..++..+.+||.+||+.||++|||+.|+++||||+...
T Consensus       236 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          236 ------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             ------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence                  011234789999999999999999999999999999998653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.3e-45  Score=361.30  Aligned_cols=234  Identities=27%  Similarity=0.413  Sum_probs=194.1

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE------------e-
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH------------Y-  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~------------~-  148 (395)
                      ..++|.+.++||+|+||+||+|+++.+++.||+|++.+..       ....+|+.+++.++||||.            + 
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l  146 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  146 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            3457999999999999999999999999999999986532       2356899999999999981            0 


Q ss_pred             ------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          149 ------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       149 ------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                                  ......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|+....... 
T Consensus       147 V~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH-~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          147 VMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             EECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSEE
T ss_pred             EEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeeECCCC-CEEEeccceeEeeccCCcc
Confidence                        011246889999999999999999999 88999999999999999888 599999999987644332 


Q ss_pred             -cccccccccccccccccCCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          216 -NISYICSRYYRAPELIFGATE---YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       216 -~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                       ....+||+.|+|||++.+...   ++.++|||||||++|||++|+.||.+.+.......|+....              
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--------------  290 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN--------------  290 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--------------
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--------------
Confidence             235789999999999976432   78999999999999999999999999888888887765310              


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCC--CCCHHHHhcCCcccCCCCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRDP  349 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~  349 (395)
                       ...+|          ....+++++.+||.+||+.+|.+  |+++.|+++||||+.+.|.
T Consensus       291 -~~~~p----------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          291 -SLTFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             -HCCCC----------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             -cccCC----------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence             00111          11247899999999999999998  9999999999999998765

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-44  Score=349.05  Aligned_cols=261  Identities=34%  Similarity=0.674  Sum_probs=202.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEeec--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHYSR--------------  150 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~~~--------------  150 (395)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++....     ....+|+.+++.++|+||....              
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            357999999999999999999999999999999986422     2345899999999999981110              


Q ss_pred             ---------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          151 ---------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       151 ---------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                     ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.......
T Consensus        90 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~  167 (353)
T 2b9h_A           90 YIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH-GSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAA  167 (353)
T ss_dssp             EEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTC-CEEECCCTTCEECC----
T ss_pred             EEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEcCCC-cEEEEecccccccccccc
Confidence                           1245888999999999999999999 88999999999999999887 699999999987543211


Q ss_pred             -----------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          216 -----------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       216 -----------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                                 ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+.....
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T 2b9h_A          168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND  247 (353)
T ss_dssp             ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred             cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence                       123578999999999876556899999999999999999999999999998999999988887763211


Q ss_pred             -hhcCCC-Ccc--ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCC
Q 016085          285 -KCMNPN-YTE--FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL  353 (395)
Q Consensus       285 -~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~  353 (395)
                       .+.... ...  ...+......+ ......+++++.+||.+||+.||++|||+.++++||||+...++....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~  319 (353)
T 2b9h_A          248 LRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEP  319 (353)
T ss_dssp             TTTCCCHHHHHHHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSC
T ss_pred             ccccccchhhHHhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccc
Confidence             100000 000  00111111111 122346899999999999999999999999999999999988876543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=360.27  Aligned_cols=258  Identities=31%  Similarity=0.525  Sum_probs=186.2

Q ss_pred             ceee-eeeeccCCceEEEEEEEc--CCCcEEEEEEeecc--hhhHHHHHHHHHhcCCCceE-----ee------------
Q 016085           92 SYMA-ERVVGQGSFGIVFQAKCL--ETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVH-----YS------------  149 (395)
Q Consensus        92 ~y~~-~~~lG~G~fg~V~~a~~~--~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~ni~-----~~------------  149 (395)
                      .|.+ .++||+|+||.||+|+++  .+++.||||++...  .....+|+.+|+.++|+||.     +.            
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e  100 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD  100 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence            4777 458999999999999966  57899999998654  23566899999999999981     10            


Q ss_pred             -------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE----cCCCCceEEeecCC
Q 016085          150 -------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV----NPHTHQVKLCDFGS  206 (395)
Q Consensus       150 -------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill----~~~~~~ikl~DFG~  206 (395)
                                         .....+++..++.++.||+.||.||| +.||+||||||+||||    +.++ .+||+|||+
T Consensus       101 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivH~Dlkp~NIll~~~~~~~~-~~kl~Dfg~  178 (405)
T 3rgf_A          101 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERG-RVKIADMGF  178 (405)
T ss_dssp             CCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECCSSTTTT-CEEECCTTC
T ss_pred             CCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH-hCCEeCCCcCHHHeEEecCCCCCC-cEEEEECCC
Confidence                               00113888999999999999999999 8899999999999999    5555 699999999


Q ss_pred             ccccccC----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHH
Q 016085          207 AKVLVKG----EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG---------VDQLVEII  273 (395)
Q Consensus       207 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~~~~~~i~  273 (395)
                      |+.....    ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+...         .+++..|+
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~  258 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  258 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence            9876432    1233567899999999998766699999999999999999999999987654         48899999


Q ss_pred             HHhCCCCHHHHhhcCCCCc------cccCCcccCCC---cccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          274 KVLGTPTREEIKCMNPNYT------EFKFPQIKAHP---WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~---~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                      ..+|.|....|........      .+.........   +........++.+.+||.+||++||.+|||+.|+|+||||.
T Consensus       259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~  338 (405)
T 3rgf_A          259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL  338 (405)
T ss_dssp             HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhc
Confidence            9999998766543321000      00000000000   00111223478899999999999999999999999999998


Q ss_pred             CCCCCCC
Q 016085          345 ELRDPNA  351 (395)
Q Consensus       345 ~~~~~~~  351 (395)
                      +...+..
T Consensus       339 ~~~~~~~  345 (405)
T 3rgf_A          339 EDPLPTS  345 (405)
T ss_dssp             SSSCCCS
T ss_pred             cCCCCcc
Confidence            8766543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.4e-45  Score=349.32  Aligned_cols=256  Identities=34%  Similarity=0.618  Sum_probs=204.7

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE---------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....      ....+|+.+++.++|+||.               
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            3457999999999999999999999999999999885432      2345799999999999980               


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CC
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP  215 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~  215 (395)
                                 +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus       103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH-SHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCTTC---------
T ss_pred             EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH-HCCEEccCcChheEEEcCCC-cEEEEeCCCceeecCCccc
Confidence                       1123466899999999999999999999 88999999999999999887 6999999999765433 22


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh--cCCCCcc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC--MNPNYTE  293 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--~~~~~~~  293 (395)
                      .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.........  ..+.+..
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            34567899999999998765689999999999999999999999999999999999999888876654432  2233333


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      ...+..............+++.+.+||.+||++||.+|||+.|+|+||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            34444433333333445689999999999999999999999999999999763

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.5e-44  Score=349.51  Aligned_cols=256  Identities=31%  Similarity=0.615  Sum_probs=197.4

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---------------hhHHHHHHHHHhcCCCceE-----e--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVH-----Y--  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------------~~~~~E~~~l~~l~h~ni~-----~--  148 (395)
                      ++|++.+.||+|+||.||+|.+.. ++.||||++....               ....+|+.+++.++|+||.     +  
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            469999999999999999999855 8999999885421               3456899999999999981     0  


Q ss_pred             ------------------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeec
Q 016085          149 ------------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  204 (395)
Q Consensus       149 ------------------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DF  204 (395)
                                              ......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus       101 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Df  178 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH-EAGVVHRDLHPGNILLADNN-DITICDF  178 (362)
T ss_dssp             CCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECCT
T ss_pred             ccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-HCcCEecCCChHHEEEcCCC-CEEEEec
Confidence                                    012336899999999999999999999 78999999999999999887 6999999


Q ss_pred             CCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       205 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                      |+++............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+
T Consensus       179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (362)
T 3pg1_A          179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV  258 (362)
T ss_dssp             TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence            99986655555556788999999999977556899999999999999999999999999999999999999999887655


Q ss_pred             hhcCCC----CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          285 KCMNPN----YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       285 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                      ......    +............+. ......++.+.+||.+||++||++|||+.|+++||||+.+..+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  327 (362)
T 3pg1_A          259 VMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL  327 (362)
T ss_dssp             HHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence            432210    000011111111221 23445789999999999999999999999999999999987653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.2e-44  Score=348.12  Aligned_cols=250  Identities=26%  Similarity=0.443  Sum_probs=195.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcC-----CCceEe-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----HPNVHY-------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~-----h~ni~~-------------  148 (395)
                      .++|++.++||+|+||.||+|++..+++.||||++....   ....+|+.+++.+.     |+||..             
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l  113 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL  113 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence            347999999999999999999999999999999986533   34457999999997     888710             


Q ss_pred             ------------e--ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC--------------------
Q 016085          149 ------------S--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP--------------------  194 (395)
Q Consensus       149 ------------~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~--------------------  194 (395)
                                  .  .....+++..++.++.||+.||.||| +.||+||||||+|||++.                    
T Consensus       114 v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~  192 (360)
T 3llt_A          114 IFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR-KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ  192 (360)
T ss_dssp             EECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence                        0  11234889999999999999999999 889999999999999975                    


Q ss_pred             -----CCCceEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 016085          195 -----HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQL  269 (395)
Q Consensus       195 -----~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  269 (395)
                           ++ .+||+|||+++....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus       193 ~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  268 (360)
T 3llt_A          193 IYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL  268 (360)
T ss_dssp             EEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence                 44 699999999976433  334567899999999998765 999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccc---------cCCcccCC--------CcccccCCCCChhHHHHHHhhccCCCCCCC
Q 016085          270 VEIIKVLGTPTREEIKCMNPNYTEF---------KFPQIKAH--------PWHKIFHKRMPPEAVDLVSRLLQYSPNLRC  332 (395)
Q Consensus       270 ~~i~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~--------~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~  332 (395)
                      ..+....+.++...+..........         .++.....        .....+....++.+.+||.+||++||++||
T Consensus       269 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  348 (360)
T 3llt_A          269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP  348 (360)
T ss_dssp             HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence            9998888887776554322111000         00000000        000001112347788999999999999999


Q ss_pred             CHHHHhcCCccc
Q 016085          333 TALEACIHPFFD  344 (395)
Q Consensus       333 t~~e~l~hp~f~  344 (395)
                      |+.|+|+||||+
T Consensus       349 ta~elL~hp~f~  360 (360)
T 3llt_A          349 SPAELLKHKFLE  360 (360)
T ss_dssp             CHHHHTTSGGGC
T ss_pred             CHHHHhcCcccC
Confidence            999999999995

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.6e-45  Score=361.69  Aligned_cols=230  Identities=30%  Similarity=0.426  Sum_probs=188.2

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++....      ....+|+.+++.++||||.                
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            357999999999999999999999999999999986432      3456899999999999981                


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC--CCceEEeecCCccccccCCC
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH--THQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~--~~~ikl~DFG~a~~~~~~~~  215 (395)
                                .......+++..+..++.||+.||.||| +.||+||||||+|||++.+  ...+||+|||+++.......
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH-~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence                      1112356889999999999999999999 8899999999999999842  23699999999977654332


Q ss_pred             -cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          216 -NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       216 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                       ....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+......                
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----------------  231 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD----------------  231 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC----------------
T ss_pred             eeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC----------------
Confidence             34568999999999997654 899999999999999999999999998887777776652111                


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                       ++.        .....+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       232 -~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          232 -FPS--------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             -CCT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             -CCc--------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence             110        1123478999999999999999999999999999999753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.9e-44  Score=336.79  Aligned_cols=236  Identities=28%  Similarity=0.380  Sum_probs=193.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++|+||.                
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            457999999999999999999999999999999986532      3455899999999999980                


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC--ceEEeecCCccccccCCC
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~--~ikl~DFG~a~~~~~~~~  215 (395)
                                .......+++..+..++.|++.||.||| +.||+||||||+||+++.++.  .+||+|||++........
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence                      0011245788899999999999999999 889999999999999976542  499999999987765555


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.......+               
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  227 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP---------------  227 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---------------
T ss_pred             ccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC---------------
Confidence            55678899999999997755 89999999999999999999999998887766666554211110               


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  352 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  352 (395)
                        .        .....+++.+.+||.+||+.||++|||+.|+++||||.+.......
T Consensus       228 --~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  274 (284)
T 3kk8_A          228 --S--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA  274 (284)
T ss_dssp             --T--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred             --c--------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence              0        1123478999999999999999999999999999999887665433

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-44  Score=343.77  Aligned_cols=231  Identities=27%  Similarity=0.368  Sum_probs=186.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCce------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||++....     ....+|+.+++.++|+||                  
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            357999999999999999999999999999999985432     345689999999999998                  


Q ss_pred             --------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC---C
Q 016085          147 --------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---P  215 (395)
Q Consensus       147 --------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~---~  215 (395)
                              .+......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++......   .
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH-~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEECC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccccchHHEEEeCCC-CEEEEEeeccceeccCCcccc
Confidence                    11223456899999999999999999999 88999999999999999888 69999999997654322   2


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+...............                
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------  227 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----------------  227 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT----------------
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc----------------
Confidence            3356789999999999876655889999999999999999999998765543322222110000                


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      .          .....+++.+.+||.+||+.||++|||+.|+++||||+....
T Consensus       228 ~----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          228 L----------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             S----------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             C----------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence            0          011337899999999999999999999999999999987544

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-44  Score=362.71  Aligned_cols=227  Identities=30%  Similarity=0.453  Sum_probs=194.0

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCce---------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNV---------------  146 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni---------------  146 (395)
                      ..++|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||               
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3457999999999999999999999999999999986542       345689999999999998               


Q ss_pred             -----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          147 -----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       147 -----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                 .+......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....+..
T Consensus        94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH-RHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH-TTTEECSCCSGGGEEECTTC-CEEECCCSSCEECCTTCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCCcccccHHHEEEecCC-CeEEEeccchhhcccccc
Confidence                       11223467899999999999999999999 88999999999999999888 599999999988766555


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+....                 + 
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------------~-  233 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-----------------F-  233 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-----------------C-
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------------c-
Confidence            5677899999999999876655889999999999999999999999887766666654310                 0 


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                 ..+..+++++.+||++||+.||.+|||+.++++||||+..
T Consensus       234 -----------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          234 -----------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             -----------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                       1223478999999999999999999999999999999764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.7e-44  Score=348.38  Aligned_cols=230  Identities=30%  Similarity=0.396  Sum_probs=185.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhHHHHHHHHHhcCCCceE-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---------~~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      .++|++.+.||+|+||.||+|+++.+++.||||++...         .....+|+.+++.++||||.             
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            35799999999999999999999999999999998542         34467899999999999981             


Q ss_pred             ----ee-------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC--ceEEeecCCcc
Q 016085          148 ----YS-------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAK  208 (395)
Q Consensus       148 ----~~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~--~ikl~DFG~a~  208 (395)
                          +.             .....+++..++.++.||+.||.||| ++||+||||||+|||++.++.  .+||+|||+++
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence                00             01224788899999999999999999 889999999999999986542  49999999998


Q ss_pred             ccccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 016085          209 VLVKGEP-NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  287 (395)
Q Consensus       209 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  287 (395)
                      ....... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. ......+..........     
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~-----  254 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR-----  254 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH-----
T ss_pred             EecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc-----
Confidence            7654332 34567899999999997755 8999999999999999999999998743 33444444321111111     


Q ss_pred             CCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                                          ....+++.+.+||.+||+.||++|||+.++|+||||+...
T Consensus       255 --------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          255 --------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             --------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             --------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence                                1134789999999999999999999999999999998643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-44  Score=351.80  Aligned_cols=231  Identities=27%  Similarity=0.388  Sum_probs=191.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...    .....+|+.+|+.++|+||.                  
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            35799999999999999999999999999999998653    33456899999999999980                  


Q ss_pred             --------ee-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC-CCceEEeecCCccccccCCCcc
Q 016085          148 --------YS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       148 --------~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~-~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                              +. .....+++..++.++.||+.||.||| +.||+||||||+|||++.+ ...+||+|||+++.........
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  208 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  208 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence                    01 12246899999999999999999999 8899999999999999743 2369999999998875555455


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ...||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.....                 .+ 
T Consensus       209 ~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-----------------~~-  269 (387)
T 1kob_A          209 VTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW-----------------EF-  269 (387)
T ss_dssp             EECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC-----------------CC-
T ss_pred             eeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------CC-
Confidence            668899999999997654 89999999999999999999999999887777766654210                 00 


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                             .......+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus       270 -------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          270 -------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             -------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                   0112234789999999999999999999999999999998754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.2e-44  Score=341.82  Aligned_cols=232  Identities=25%  Similarity=0.354  Sum_probs=194.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----------hhhHHHHHHHHHhcCCCceE------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVH------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----------~~~~~~E~~~l~~l~h~ni~------------  147 (395)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++...          .....+|+.+++.++|+||.            
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            35799999999999999999999999999999998643          23467899999999999980            


Q ss_pred             --------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC---ceEEeecCCcccc
Q 016085          148 --------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKLCDFGSAKVL  210 (395)
Q Consensus       148 --------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~---~ikl~DFG~a~~~  210 (395)
                                    +......+++..++.++.||+.||.||| +.||+||||||+|||++.++.   .+||+|||+++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH-~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence                          1122356789999999999999999999 889999999999999987763   5999999999877


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.......+.         
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~---------  239 (321)
T 2a2a_A          170 EDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE---------  239 (321)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH---------
T ss_pred             CccccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh---------
Confidence            6555555677899999999997654 899999999999999999999999988877766665542211111         


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                      .+...++..+.+||.+||+.||++|||+.++++||||..+.+
T Consensus       240 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          240 ----------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             ----------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             ----------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence                            122347899999999999999999999999999999987653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.3e-45  Score=354.72  Aligned_cols=235  Identities=26%  Similarity=0.412  Sum_probs=174.9

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE------------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      ..++|++.+.||+|+||.||+|++..+++.||||++...   .....+|+.+++.++|+||.                  
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            345799999999999999999999999999999998654   24566899999999999980                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC-ceEEeecCCccccccCCCccc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~-~ikl~DFG~a~~~~~~~~~~~  218 (395)
                              +......+++..++.++.||+.||.||| +.||+||||||+|||++.++. .+||+|||+++..........
T Consensus        98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH-~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~  176 (361)
T 3uc3_A           98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  176 (361)
T ss_dssp             CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCC
Confidence                    0112356889999999999999999999 889999999999999986652 499999999986554444556


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      .+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........++.....          .   ...++ 
T Consensus       177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~----------~---~~~~~-  242 (361)
T 3uc3_A          177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS----------V---KYSIP-  242 (361)
T ss_dssp             ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT----------T---CCCCC-
T ss_pred             CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc----------C---CCCCC-
Confidence            789999999999987663445599999999999999999999875543333333221100          0   00111 


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                               ....+++.+.+||.+||++||++|||+.|+++||||....
T Consensus       243 ---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          243 ---------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             ---------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             ---------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence                     1124789999999999999999999999999999996543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.3e-45  Score=350.26  Aligned_cols=231  Identities=27%  Similarity=0.419  Sum_probs=186.5

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhc-CCCceE---------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVH---------------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l-~h~ni~---------------------  147 (395)
                      .++|++.+.||+|+||.||+|+++.+++.||||++.+......+|+.++..+ +||||.                     
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g  100 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG  100 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence            3479999999999999999999999999999999988776677899999888 799980                     


Q ss_pred             -----eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC---ceEEeecCCccccccCC-Cccc
Q 016085          148 -----YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKLCDFGSAKVLVKGE-PNIS  218 (395)
Q Consensus       148 -----~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~---~ikl~DFG~a~~~~~~~-~~~~  218 (395)
                           .......+++..++.++.||+.||+||| +.||+||||||+|||+..+.+   .+||+|||+++...... ....
T Consensus       101 g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH-~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  179 (342)
T 2qr7_A          101 GELLDKILRQKFFSEREASAVLFTITKTVEYLH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT  179 (342)
T ss_dssp             CBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCC
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceec
Confidence                 1123456899999999999999999999 889999999999999854322   49999999998764432 3345


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGE---SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      .+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.   +..+.+..+...                 .+.
T Consensus       180 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-----------------~~~  241 (342)
T 2qr7_A          180 PCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-----------------KFS  241 (342)
T ss_dssp             SSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC-----------------CCC
T ss_pred             cCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC-----------------Ccc
Confidence            67899999999997644 899999999999999999999999863   223333333321                 000


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      +        ....+..+++++.+||++||+.||++|||+.++++||||.+..
T Consensus       242 ~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          242 L--------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             C--------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             c--------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence            0        0112345799999999999999999999999999999997653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-44  Score=345.56  Aligned_cols=230  Identities=28%  Similarity=0.444  Sum_probs=185.1

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEc---CCCcEEEEEEeecch--------hhHHHHHHHHHhcCCCceE---------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVH---------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~--------~~~~~E~~~l~~l~h~ni~---------  147 (395)
                      ....+|++.+.||+|+||.||+|++.   .+++.||||++.+..        ....+|+.+|+.++|+||.         
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            34568999999999999999999985   689999999986532        2345799999999999981         


Q ss_pred             -----------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          148 -----------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       148 -----------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                                       +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~  171 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH-QKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKES  171 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCTTTEEECTTS-CEEECCCSCC---
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCEEcccCCHHHeEECCCC-cEEEEeCCccccc
Confidence                             0112345788899999999999999999 88999999999999999888 6999999999764


Q ss_pred             ccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          211 VKG-EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       211 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      ... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+....             
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-------------  237 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-------------  237 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-------------
T ss_pred             ccCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-------------
Confidence            332 2234567899999999997654 8999999999999999999999999988777777666521             


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                          .            .++..+++.+.+||.+||+.||++||     ++.++++||||+.+.+.
T Consensus       238 ----~------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          238 ----L------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             ----C------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             ----C------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence                0            12334789999999999999999999     89999999999987653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-43  Score=338.06  Aligned_cols=259  Identities=34%  Similarity=0.574  Sum_probs=205.6

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEc-CCCcEEEEEEeecch------hhHHHHHHHHHhc---CCCceEe-----e---
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCL-ETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVHY-----S---  149 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~------~~~~~E~~~l~~l---~h~ni~~-----~---  149 (395)
                      ....+|++.+.||+|+||.||+|++. .+++.||+|++....      ....+|+.+++.+   +|+||..     .   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34467999999999999999999995 678999999886432      2345788888776   8999810     0   


Q ss_pred             ------------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecC
Q 016085          150 ------------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  205 (395)
Q Consensus       150 ------------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG  205 (395)
                                              .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~gi~H~dlkp~Nili~~~~-~~kl~Dfg  165 (326)
T 1blx_A           88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSG-QIKLADFG  165 (326)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred             cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCHHHeEEcCCC-CEEEecCc
Confidence                                    01234889999999999999999999 88999999999999999887 69999999


Q ss_pred             CccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 016085          206 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                      +++............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....|.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          166 LARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             ccccccCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            998765444444567899999999997755 8999999999999999999999999999999999999999888776553


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  351 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  351 (395)
                      ..... ....+..... .....+...++..+.+||.+||+.||.+|||+.++++||||+++.....
T Consensus       245 ~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~  308 (326)
T 1blx_A          245 RDVAL-PRQAFHSKSA-QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE  308 (326)
T ss_dssp             TTCSS-CGGGSCCCCC-CCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             ccccc-chhhhcccCc-chhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence            21110 0011111111 1122345568999999999999999999999999999999998876543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.1e-45  Score=362.09  Aligned_cols=230  Identities=27%  Similarity=0.392  Sum_probs=186.5

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++.+..       ....+|+.+++.++|+||.             
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            34568999999999999999999999999999999987532       2334688999999999981             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcC-CCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                   +......+++..++.++.||+.||+||| + .||+||||||+||||+.++ .+||+|||+|+.....
T Consensus       225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH-HHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTTCC-
T ss_pred             EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hcCCEEECCCCHHHEEECCCC-CEEEccCCCceeccCC
Confidence                         0112346789999999999999999999 6 8999999999999999888 6999999999864332


Q ss_pred             -CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          214 -EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       214 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                       ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...                 
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------------  364 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------  364 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------
T ss_pred             CcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----------------
Confidence             3344678999999999997755 999999999999999999999999988877766666541                 


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                      ..            .++..+++++.+||.+||++||.+||     |+.|+++||||+.+.+.
T Consensus       365 ~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          365 EI------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             CC------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence            01            12345789999999999999999999     99999999999998664

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4e-44  Score=350.23  Aligned_cols=260  Identities=22%  Similarity=0.344  Sum_probs=186.5

Q ss_pred             ccccceeeeeeeccC--CceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE------------
Q 016085           88 KQTISYMAERVVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G--~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~------------  147 (395)
                      ...++|++.+.||+|  +||.||+|++..+++.||||++....      ....+|+.+++.++|+||.            
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            445689999999999  99999999999999999999986542      3455799999999999981            


Q ss_pred             -----ee-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          148 -----YS-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       148 -----~~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                           +.           .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~dfg~~~~~~  179 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH-HMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCGGGCEECE
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEcccccceeec
Confidence                 00           11256899999999999999999999 88999999999999999888 69999999886543


Q ss_pred             cCC--------CcccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC----
Q 016085          212 KGE--------PNISYICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT----  278 (395)
Q Consensus       212 ~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----  278 (395)
                      ...        .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....-.    
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            221        12234789999999999763 35899999999999999999999999987766655544321100    


Q ss_pred             ----CCHHHHhhcCC-----CCcc-----ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          279 ----PTREEIKCMNP-----NYTE-----FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       279 ----~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                          +..........     ....     ...+. ........++..+++.+.+||.+||++||++|||+.|+|+||||+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS-NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccc-cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                00000000000     0000     00000 000111124456889999999999999999999999999999999


Q ss_pred             CCCCCC
Q 016085          345 ELRDPN  350 (395)
Q Consensus       345 ~~~~~~  350 (395)
                      .+....
T Consensus       339 ~~~~~~  344 (389)
T 3gni_B          339 QIKRRA  344 (389)
T ss_dssp             GC---C
T ss_pred             HHhhcc
Confidence            887643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-44  Score=368.40  Aligned_cols=231  Identities=27%  Similarity=0.450  Sum_probs=191.0

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE-------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ...++|++.++||+|+||.||+|+++.+|+.||||++.+.       .....+|+.+|+.++|+||.             
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            4556899999999999999999999999999999998653       23345799999999999980             


Q ss_pred             -------------eec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          148 -------------YSR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 -------------~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                   +..  ....+++..++.++.||+.||+||| +.||+||||||+||||+.++ .+||+|||+|+....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH-~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~~~  338 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH-RERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPE  338 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTS-CEEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeccCCchheEEEeCCC-CeEEEecccceeccc
Confidence                         011  1234899999999999999999999 88999999999999999888 599999999988766


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      .......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.   ...+...+...             
T Consensus       339 ~~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-------------  404 (576)
T 2acx_A          339 GQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------------  404 (576)
T ss_dssp             TCCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-------------
T ss_pred             CccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-------------
Confidence            55556678999999999997754 89999999999999999999999987543   22222222210             


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                                     ...++..+++++.+||.+||+.||.+|+     ++.|+++||||+.+.|.
T Consensus       405 ---------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          405 ---------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             ---------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence                           0012345799999999999999999999     79999999999988763

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2e-44  Score=352.07  Aligned_cols=252  Identities=29%  Similarity=0.448  Sum_probs=194.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcC--------CCceE-----e-----
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD--------HPNVH-----Y-----  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~--------h~ni~-----~-----  148 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.+.        |+||.     +     
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            357999999999999999999999999999999997643   34458999999986        55550     0     


Q ss_pred             ---------------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCC-CeeeccCCCCceEEcCCC----------
Q 016085          149 ---------------------SRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHT----------  196 (395)
Q Consensus       149 ---------------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlKp~Nill~~~~----------  196 (395)
                                           ......+++..++.++.||+.||.||| +. ||+||||||+|||++.++          
T Consensus       116 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH-~~~givHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          116 NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH-HTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-HhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence                                 011246899999999999999999999 76 999999999999998764          


Q ss_pred             --------------------------------------CceEEeecCCccccccCCCcccccccccccccccccCCCCCC
Q 016085          197 --------------------------------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT  238 (395)
Q Consensus       197 --------------------------------------~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  238 (395)
                                                            ..+||+|||++......  ....+||+.|+|||++.+.. ++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~  271 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YN  271 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-CC
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-CC
Confidence                                                  15999999999876432  34567899999999998765 89


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhhcCCCCccc----cCCcccC-CCcc--
Q 016085          239 TAVDIWSVGCVLAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTEF----KFPQIKA-HPWH--  305 (395)
Q Consensus       239 ~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-~~~~--  305 (395)
                      .++|||||||++|+|++|+.||.+.+      ..+.+..+.+.++.++...+.........+    ....+.. .++.  
T Consensus       272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (397)
T 1wak_A          272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF  351 (397)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred             cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence            99999999999999999999998755      467788888999998877654322110000    0000000 0000  


Q ss_pred             ------cccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          306 ------KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       306 ------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                            ..++...+..+.+||.+||++||++|||+.|+|+||||++
T Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                  0012233567899999999999999999999999999974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.6e-44  Score=361.81  Aligned_cols=231  Identities=29%  Similarity=0.472  Sum_probs=190.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      ..+|++.+.||+|+||+||+|++..+++.||||++.+.      .....+|+.+|+.++||||.                
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            35799999999999999999999999999999998532      34556899999999999981                


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC--CceEEeecCCccccccCCC
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~--~~ikl~DFG~a~~~~~~~~  215 (395)
                                .......+++..++.++.||+.||.||| +.||+||||||+|||++..+  ..+||+|||+++.......
T Consensus       101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  179 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (486)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence                      0112356789999999999999999999 88999999999999996432  2699999999987765555


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+||+.|+|||++.+ . ++.++|||||||++|+|++|++||.+.+..+.+..+........               
T Consensus       180 ~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------  242 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRG-T-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD---------------  242 (486)
T ss_dssp             --CCTTGGGGCCGGGGGS-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC---------------
T ss_pred             cCCCcCCCCCCCHHHhCC-C-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence            566789999999999975 3 89999999999999999999999999888777777655211110               


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      .          .....+++.+.+||.+||++||.+|||+.++|+||||+....
T Consensus       243 ~----------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          243 L----------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             S----------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             C----------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            0          012347899999999999999999999999999999987653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.2e-45  Score=343.45  Aligned_cols=225  Identities=20%  Similarity=0.254  Sum_probs=161.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh-h--HHHHHHHHHhcCCCceE----------------ee--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-Y--KNRELQTMRLLDHPNVH----------------YS--  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-~--~~~E~~~l~~l~h~ni~----------------~~--  149 (395)
                      .+|.+.++||+|+||+||+|++  +|+.||||++..... .  .++|+..+..++||||.                ++  
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3699999999999999999987  689999999865432 2  23456666789999981                00  


Q ss_pred             -----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCC--------CeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          150 -----------RASQRMPLIYVKLYTYQICRALAYIHGGI--------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       150 -----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--------giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                                 .....+++..+..++.|++.||+||| +.        +||||||||+||||+.++ .+||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH-~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH-MEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH-CCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCCCCccc
Confidence                       01246788889999999999999999 55        899999999999999888 6999999999876


Q ss_pred             ccCCC-----cccccccccccccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCc--------------H
Q 016085          211 VKGEP-----NISYICSRYYRAPELIFGAT-----EYTTAVDIWSVGCVLAELLLGQPLFPGESG--------------V  266 (395)
Q Consensus       211 ~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~--------------~  266 (395)
                      .....     ....+||+.|||||++.+..     .++.++|||||||+||||+||.+||.....              .
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            54332     22457999999999996542     257799999999999999999877643221              1


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          267 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       267 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      +.+......             ..+    .|.++.    .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~-------------~~~----rp~~p~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          239 EEMRKVVCE-------------QKL----RPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHTT-------------SCC----CCCCCG----GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhc-------------ccC----CCCCCc----cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            111111100             000    011000    00011134578899999999999999999998753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.3e-43  Score=345.95  Aligned_cols=255  Identities=31%  Similarity=0.577  Sum_probs=193.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcC-CCc-----e--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-HPN-----V--------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~-h~n-----i--------------  146 (395)
                      .++|++.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.++ |++     +              
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            457999999999999999999999999999999997654   33456888888885 543     3              


Q ss_pred             -Eee------------ccCCCCcHHHHHHHHHHHHHHHHHHHc-CCCeeeccCCCCceEEcC--CCCceEEeecCCcccc
Q 016085          147 -HYS------------RASQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVL  210 (395)
Q Consensus       147 -~~~------------~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlKp~Nill~~--~~~~ikl~DFG~a~~~  210 (395)
                       .+.            .....+++..++.++.||+.||.|||+ +.||+||||||+|||++.  ++ .+||+|||+++..
T Consensus       133 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~DFG~a~~~  211 (382)
T 2vx3_A          133 LVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVDFGSSCQL  211 (382)
T ss_dssp             EEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECCCTTCEET
T ss_pred             EEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEeccCceec
Confidence             000            112458899999999999999999994 469999999999999953  44 6999999999876


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ..  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++...+......
T Consensus       212 ~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  288 (382)
T 2vx3_A          212 GQ--RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA  288 (382)
T ss_dssp             TC--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred             cc--ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence            33  344678899999999998765 999999999999999999999999999999999999999999887765432110


Q ss_pred             ---Ccc-----cc----------CCcccCCCcccccCC-----------------CCChhHHHHHHhhccCCCCCCCCHH
Q 016085          291 ---YTE-----FK----------FPQIKAHPWHKIFHK-----------------RMPPEAVDLVSRLLQYSPNLRCTAL  335 (395)
Q Consensus       291 ---~~~-----~~----------~~~~~~~~~~~~~~~-----------------~~s~~~~~ll~~~L~~dP~~R~t~~  335 (395)
                         +..     +.          +.......+...+..                 ..++.+.+||.+||++||++|||+.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~  368 (382)
T 2vx3_A          289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY  368 (382)
T ss_dssp             HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence               000     00          000000000000000                 0013789999999999999999999


Q ss_pred             HHhcCCcccCCCC
Q 016085          336 EACIHPFFDELRD  348 (395)
Q Consensus       336 e~l~hp~f~~~~~  348 (395)
                      |+|+||||++..+
T Consensus       369 e~L~hp~f~~~~~  381 (382)
T 2vx3_A          369 YALQHSFFKKTAD  381 (382)
T ss_dssp             HHTTSGGGCC---
T ss_pred             HHhcCcccccCCC
Confidence            9999999987643

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.1e-44  Score=374.13  Aligned_cols=230  Identities=26%  Similarity=0.390  Sum_probs=193.2

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc-CCCceE------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVH------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l-~h~ni~------------  147 (395)
                      ....+|.++++||+|+||+||+|+++.+++.||||++.+..       ....+|..++..+ +|+||.            
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34568999999999999999999999999999999987542       3345788888877 688871            


Q ss_pred             --------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-
Q 016085          148 --------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  212 (395)
Q Consensus       148 --------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-  212 (395)
                                    +......+++..++.|+.||+.||+||| +.||+||||||+||||+.++ .+||+|||+|+.... 
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ-SKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTSEECCCCCSTTEEECSSS-CEEECCCTTCEECCCT
T ss_pred             EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeccCChhhEEEcCCC-cEEEeecceeeccccC
Confidence                          1112356899999999999999999999 88999999999999999988 599999999986432 


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      .......+||+.|+|||++.+.. |+.++|||||||+||||++|+.||.+.+..+.+..|+..                 
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-----------------  557 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-----------------  557 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----------------
T ss_pred             CcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------------
Confidence            33445678999999999997655 899999999999999999999999998888777777641                 


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCH-----HHHhcCCcccCCCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFDELRDP  349 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  349 (395)
                      ..            .++..+++++.+||++||+.||++|+++     .++++||||+.+.|.
T Consensus       558 ~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          558 NV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             CC------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             CC------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence            01            1334589999999999999999999997     999999999998774

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.4e-44  Score=343.31  Aligned_cols=230  Identities=29%  Similarity=0.406  Sum_probs=173.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCCCceE--------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVH--------------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~ni~--------------------  147 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.++|+||.                    
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            45799999999999999999999999999999998754  33456799999999999980                    


Q ss_pred             ------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC---CCCceEEeecCCccccccCCCccc
Q 016085          148 ------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       148 ------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~---~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                            +......+++..++.++.||+.||.||| +.||+||||||+|||++.   ++ .+||+|||+++..........
T Consensus       132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~  209 (349)
T 2w4o_A          132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLH-ENGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIVEHQVLMKT  209 (349)
T ss_dssp             SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEESSSSTTC-CEEECCCC-------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCcccEEEecCCCCC-CEEEccCccccccCccccccc
Confidence                  1122345789999999999999999999 889999999999999975   55 699999999987655444456


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQL-VEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+......+ ..+.....                 .. 
T Consensus       210 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~-----------------~~-  270 (349)
T 2w4o_A          210 VCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY-----------------YF-  270 (349)
T ss_dssp             ---CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC-----------------CC-
T ss_pred             ccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC-----------------cc-
Confidence            77899999999997755 899999999999999999999999877665533 33332100                 00 


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                             .......++..+.+||.+||+.||++|||+.++|+||||....
T Consensus       271 -------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          271 -------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             -------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             -------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                   0112235789999999999999999999999999999998654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.6e-44  Score=354.24  Aligned_cols=232  Identities=30%  Similarity=0.461  Sum_probs=179.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------------hhHHHHHHHHHhcCCCce-----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNV-----------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l~h~ni-----------  146 (395)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.+..            ....+|+.+|+.++||||           
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  213 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED  213 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence            357999999999999999999999999999999986532            134689999999999998           


Q ss_pred             --------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC--ceEEeecCCcccc
Q 016085          147 --------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVL  210 (395)
Q Consensus       147 --------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~--~ikl~DFG~a~~~  210 (395)
                                    .+......+++..++.++.||+.||.||| +.||+||||||+|||++.++.  .+||+|||+|+..
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence                          11223467899999999999999999999 889999999999999975432  5999999999887


Q ss_pred             ccCCCcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          211 VKGEPNISYICSRYYRAPELIFG--ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      .........+||+.|+|||++.+  ...++.++|||||||++|+|++|+.||.+......+...+......         
T Consensus       293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~---------  363 (419)
T 3i6u_A          293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN---------  363 (419)
T ss_dssp             C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC---------
T ss_pred             CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC---------
Confidence            65555556789999999999853  3447889999999999999999999998755433333322211000         


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                     +.......+++.+.+||.+||++||++|||+.|+|+||||++.
T Consensus       364 ---------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          364 ---------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             ---------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             ---------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence                           0011223478999999999999999999999999999999763

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.5e-44  Score=331.67  Aligned_cols=230  Identities=30%  Similarity=0.444  Sum_probs=192.2

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      .++|++.+.||+|+||.||+|++..++..||+|++...    .....+|+.+++.++|+||.                  
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            34799999999999999999999999999999998643    34567899999999999981                  


Q ss_pred             --------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE---cCCCCceEEeecCCccccccCCCc
Q 016085          148 --------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 --------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill---~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                              +......+++..++.++.|++.||.||| +.||+||||||+|||+   +.++ .+||+|||++.........
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~~~~~~~~~~  165 (277)
T 3f3z_A           88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH-KLNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLAARFKPGKMM  165 (277)
T ss_dssp             CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECCTTSCB
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCCCHHHEEEecCCCCC-cEEEEecccceeccCccch
Confidence                    0112345788899999999999999999 8899999999999999   6555 6999999999877655555


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....+|+.|+|||++.+ . ++.++|||||||++|+|++|+.||.+.+..+....+.......+...             
T Consensus       166 ~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------  230 (277)
T 3f3z_A          166 RTKVGTPYYVSPQVLEG-L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD-------------  230 (277)
T ss_dssp             CCCCSCTTTCCHHHHTT-C-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH-------------
T ss_pred             hccCCCCCccChHHhcc-c-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh-------------
Confidence            66788999999999865 3 89999999999999999999999998887777776665322222221             


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                  ...+++.+.+||.+||+.||.+|||+.++|+||||++...
T Consensus       231 ------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          231 ------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             ------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             ------------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence                        1236899999999999999999999999999999976543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8e-44  Score=359.87  Aligned_cols=231  Identities=28%  Similarity=0.428  Sum_probs=191.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----------------hhhHHHHHHHHHhcCCCceE-----
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNVH-----  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----------------~~~~~~E~~~l~~l~h~ni~-----  147 (395)
                      ..+|++.+.||+|+||+||+|+++.+++.||||++.+.                 .....+|+.+|+.++||||.     
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            34799999999999999999999999999999998643                 23456899999999999981     


Q ss_pred             ---------------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC--ceEEeec
Q 016085          148 ---------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDF  204 (395)
Q Consensus       148 ---------------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~--~ikl~DF  204 (395)
                                           .......+++..++.++.||+.||.||| +.||+||||||+|||++.++.  .+||+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH-KHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence                                 0112356889999999999999999999 889999999999999987653  5999999


Q ss_pred             CCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          205 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       205 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                      |+++...........+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+..........  
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  269 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN--  269 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH--
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc--
Confidence            99988766555567789999999999864  38999999999999999999999999988887777776522111111  


Q ss_pred             hhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                             ....+++++.+||++||++||.+|||+.|+|+||||+....
T Consensus       270 -----------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          270 -----------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             -----------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             -----------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence                                   12347899999999999999999999999999999987643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.2e-44  Score=338.83  Aligned_cols=259  Identities=31%  Similarity=0.516  Sum_probs=196.4

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceEee-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVHYS-----------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~~~-----------------  149 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++....    ....+|+.+++.++|+||...                 
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            47999999999999999999999999999999886432    345689999999999998211                 


Q ss_pred             ---------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcc
Q 016085          150 ---------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  208 (395)
Q Consensus       150 ---------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~  208 (395)
                                           .....+++..++.++.||+.||+||| +.||+||||||+|||++.++..+||+|||+++
T Consensus        91 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~  169 (320)
T 2i6l_A           91 LTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLAR  169 (320)
T ss_dssp             CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEETTTTEEEECCCTTCB
T ss_pred             ccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCCCeEEEccCcccc
Confidence                                 01345788999999999999999999 88999999999999998555579999999998


Q ss_pred             ccccC----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          209 VLVKG----EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       209 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                      .....    .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (320)
T 2i6l_A          170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR  249 (320)
T ss_dssp             CC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHH
T ss_pred             ccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhh
Confidence            65322    12234567999999999876556899999999999999999999999999988888888888777666554


Q ss_pred             hhcCCCCccccCCccc-CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          285 KCMNPNYTEFKFPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       285 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                      .........+...... .......+...++.++.+||.+||+.||++|||+.++++||||+....+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             HHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             hhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            4322211110000000 00011123346899999999999999999999999999999999876654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.3e-44  Score=361.96  Aligned_cols=230  Identities=31%  Similarity=0.507  Sum_probs=193.5

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||++...       .....+|+.+++.++||||.               
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            45799999999999999999999999999999998532       34567899999999999981               


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc---CCCCceEEeecCCccccccC
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN---PHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~---~~~~~ikl~DFG~a~~~~~~  213 (395)
                                 .......+++..++.++.||+.||.||| +.||+||||||+|||++   .++ .+||+|||+++.....
T Consensus       105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH-KNKIVHRDLKPENLLLESKSKDA-NIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSTTC-CEEECCTTHHHHBCCC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEEecCCCCC-cEEEEeeeeeEEcccc
Confidence                       1123467899999999999999999999 88999999999999994   444 6999999999877666


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      ......+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+........             
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------------  247 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE-------------  247 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred             cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence            55566789999999999976  389999999999999999999999999888777777655211110             


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                        .          .....+++.+.+||.+||++||.+|||+.++|+||||+....
T Consensus       248 --~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          248 --L----------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             --S----------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             --C----------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence              0          112347899999999999999999999999999999987654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-43  Score=331.60  Aligned_cols=226  Identities=31%  Similarity=0.487  Sum_probs=179.6

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE---------------e-
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH---------------Y-  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~---------------~-  148 (395)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++....     ....+|+.+++.++|+||.               . 
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            457999999999999999999999999999999986543     4567899999999999981               0 


Q ss_pred             -e-------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC---CCCceEEeecCCccccc
Q 016085          149 -S-------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       149 -~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~---~~~~ikl~DFG~a~~~~  211 (395)
                       .             .....+++..++.++.||+.||.||| +.||+||||||+|||++.   ++ .+||+|||++....
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-SQHVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFK  178 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEESSSSTTC-CEEECCCCCCCC--
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH-hCCEEECCCCHHHEEEecCCCCC-CEEEEeeecceecC
Confidence             0             11256888899999999999999999 889999999999999943   34 69999999998765


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          212 KGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      .........||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+....            ..+
T Consensus       179 ~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------------~~~  244 (285)
T 3is5_A          179 SDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE------------PNY  244 (285)
T ss_dssp             --------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------CCC
T ss_pred             CcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC------------ccc
Confidence            5555556788999999998853  48999999999999999999999999877655544433210            000


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      .              .....+++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus       245 ~--------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          245 A--------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             C--------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             c--------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            0              011236899999999999999999999999999999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=348.84  Aligned_cols=227  Identities=28%  Similarity=0.419  Sum_probs=184.0

Q ss_pred             eee--eeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-----------------e-
Q 016085           93 YMA--ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-----------------Y-  148 (395)
Q Consensus        93 y~~--~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-----------------~-  148 (395)
                      |.+  .+.||+|+||.||+|++..+|+.||+|++...    .....+|+.+|+.++|+||.                 + 
T Consensus        89 ~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           89 YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            554  67899999999999999999999999998753    34556899999999999980                 0 


Q ss_pred             ---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE--cCCCCceEEeecCCccccccCCCcc
Q 016085          149 ---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       149 ---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill--~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                               ......+++..++.++.||+.||.||| +.||+||||||+|||+  +.++ .+||+|||+++.........
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~~~~~~~  246 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH-QMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLK  246 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECCTTCBCC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEEecCCCC-cEEEEeCCCceecCCccccc
Confidence                     012245788899999999999999999 8899999999999999  4444 69999999998876555555


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+........                 
T Consensus       247 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~-----------------  308 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE-----------------  308 (373)
T ss_dssp             CCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC-----------------
T ss_pred             cccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-----------------
Confidence            67899999999999765 489999999999999999999999999988888877766321111                 


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                              ......+++++.+||.+||+.||.+|||+.|+|+||||.+..
T Consensus       309 --------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          309 --------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             --------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             --------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                    011234789999999999999999999999999999998753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-43  Score=358.91  Aligned_cols=230  Identities=24%  Similarity=0.376  Sum_probs=188.8

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE-------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ....+|.+.++||+|+||.||+|+++.+|+.||||++.+..       ....+|+.+++.++|+||.             
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            34467999999999999999999999999999999986532       3345799999999999980             


Q ss_pred             ----e---------ec----cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          148 ----Y---------SR----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       148 ----~---------~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                          +         ..    ....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH-~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~~  339 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDG-NVRISDLGLAVEL  339 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH-HcCCcccCCChHHEEEeCCC-CEEEeecceeeec
Confidence                0         00    1236899999999999999999999 88999999999999999988 5999999999876


Q ss_pred             ccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCCHHHHh
Q 016085          211 VKGEP-NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG----VDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       211 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~  285 (395)
                      ..... ....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+.    ......+...          
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~----------  408 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ----------  408 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC----------
T ss_pred             cCCCcccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc----------
Confidence            54433 33458999999999998754 89999999999999999999999987542    2233333320          


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCCC
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  349 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  349 (395)
                             .            ..++..+++++.+||.+||+.||++||+     +.++++||||+.+.|.
T Consensus       409 -------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          409 -------A------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             -------C------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             -------c------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence                   0            0123457999999999999999999995     5899999999987663

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-43  Score=346.77  Aligned_cols=228  Identities=29%  Similarity=0.424  Sum_probs=173.8

Q ss_pred             ccceeee-eeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHH-HhcCCCceE-----e--------------
Q 016085           90 TISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVH-----Y--------------  148 (395)
Q Consensus        90 ~~~y~~~-~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l-~~l~h~ni~-----~--------------  148 (395)
                      .++|.+. ++||+|+||+||+|+++.+++.||||++... ....+|+.++ +.++|+||.     +              
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~  138 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM  138 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence            4468877 7999999999999999999999999998754 3456788887 556899970     0              


Q ss_pred             -----------ec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC---CCCceEEeecCCcccccc
Q 016085          149 -----------SR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       149 -----------~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~---~~~~ikl~DFG~a~~~~~  212 (395)
                                 ..  ....+++..++.++.||+.||.||| +.||+||||||+|||++.   ++ .+||+|||+++....
T Consensus       139 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETTS  216 (400)
T ss_dssp             ECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSTTC-CEEECCCTTCEECC-
T ss_pred             EeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCcCcceEEEecCCCCc-cEEEEecccccccCC
Confidence                       00  1235899999999999999999999 889999999999999987   45 699999999987655


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCCHHHHhhcC
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+...    ....+...             
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~-------------  282 (400)
T 1nxk_A          217 HNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------  282 (400)
T ss_dssp             ----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-------------
T ss_pred             CCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-------------
Confidence            5555567889999999999665 49999999999999999999999998754322    22222210             


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                          .+.++.        .....++.++.+||++||+.||++|||+.++++||||...
T Consensus       283 ----~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          283 ----QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             ----CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ----cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                011110        1123478999999999999999999999999999999764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.5e-43  Score=341.98  Aligned_cols=228  Identities=29%  Similarity=0.433  Sum_probs=188.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------------hhHHHHHHHHHhc-CCCceE----------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLL-DHPNVH----------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l-~h~ni~----------  147 (395)
                      ++|.+.+.||+|+||.||+|++..+|+.||||++....            ....+|+.+++.+ +|+||.          
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            46999999999999999999999999999999986432            2345799999999 899981          


Q ss_pred             ----------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          148 ----------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       148 ----------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                                      +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH-~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH-ANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEEEecCcccccC
Confidence                            0111246788899999999999999999 88999999999999999887 69999999998776


Q ss_pred             cCCCcccccccccccccccccCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 016085          212 KGEPNISYICSRYYRAPELIFGA-----TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  286 (395)
                      ........+||+.|+|||++.+.     ..++.++|||||||++|+|++|+.||.+.+....+..+......+...    
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  327 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP----  327 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH----
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc----
Confidence            65555667899999999998632     247899999999999999999999998887766666665422111111    


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                                           ....++..+.+||.+||+.||++|||+.++|+||||+.
T Consensus       328 ---------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          328 ---------------------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             ---------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ---------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                                 11246889999999999999999999999999999963

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.6e-44  Score=358.79  Aligned_cols=228  Identities=28%  Similarity=0.451  Sum_probs=187.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .+|++.+.||+|+||.||+|+++.+++.||||++.+.      .....+|+.+++.++||||.                 
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            4699999999999999999999999999999998643      24456899999999999981                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC--CceEEeecCCccccccCCCc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~--~~ikl~DFG~a~~~~~~~~~  216 (395)
                               .......+++..++.++.||+.||.||| +.||+||||||+|||++..+  ..+||+|||+++........
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~  195 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH-KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM  195 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence                     0112346788899999999999999999 88999999999999997643  25999999999887665555


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.........               
T Consensus       196 ~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---------------  258 (494)
T 3lij_A          196 KERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS---------------  258 (494)
T ss_dssp             CCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS---------------
T ss_pred             cccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---------------
Confidence            66789999999999853  4899999999999999999999999998887777776652111110               


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                .....+++.+.+||++||++||.+|||+.++|+||||+..
T Consensus       259 ----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          259 ----------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             ----------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             ----------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                      1123478999999999999999999999999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=342.57  Aligned_cols=219  Identities=25%  Similarity=0.377  Sum_probs=183.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------------hhHHHHHHHHHhcCCCceE-----------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++....            ....+|+.+++.++|+||.           
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            47999999999999999999999999999999986542            2345799999999999980           


Q ss_pred             ----------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          148 ----------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       148 ----------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                                      +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR-LKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEEeccCHHHEEEcCCC-cEEEeecccceECC
Confidence                            0112346889999999999999999999 88999999999999999887 69999999998876


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          212 KGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      ........+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....      ..                 
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-----------------  238 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-----------------  238 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-----------------
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-----------------
Confidence            6655566789999999999987664588999999999999999999999652210      00                 


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                  .....+..+++++.+||.+||+.||++|||+.++++||||++.
T Consensus       239 ------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 ------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             ------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             ------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                        0001223478999999999999999999999999999999764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3e-43  Score=336.20  Aligned_cols=232  Identities=25%  Similarity=0.332  Sum_probs=187.2

Q ss_pred             cceeee-eeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcC-CCceE---------------
Q 016085           91 ISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVH---------------  147 (395)
Q Consensus        91 ~~y~~~-~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~-h~ni~---------------  147 (395)
                      ++|.+. +.||+|+||.||+|++..+++.||+|++...      .....+|+.+++.+. |+||.               
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            468887 8999999999999999999999999998643      345568999999985 58870               


Q ss_pred             -----------ee--ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC---CCCceEEeecCCccccc
Q 016085          148 -----------YS--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       148 -----------~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~---~~~~ikl~DFG~a~~~~  211 (395)
                                 +.  .....+++..++.++.||+.||.||| +.||+||||||+|||++.   ++ .+||+|||+++...
T Consensus       108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH-~~givH~Dikp~NIl~~~~~~~~-~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH-QNNIVHLDLKPQNILLSSIYPLG-DIKIVDFGMSRKIG  185 (327)
T ss_dssp             EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEESCBTTBC-CEEECCGGGCEEC-
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-HCCeecCcCChHHEEEecCCCCC-cEEEeeCccccccC
Confidence                       00  11356899999999999999999999 889999999999999987   45 69999999998776


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          212 KGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+........           
T Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-----------  253 (327)
T 3lm5_A          186 HACELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS-----------  253 (327)
T ss_dssp             --------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----------
T ss_pred             CccccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC-----------
Confidence            555555678999999999997654 89999999999999999999999999887777666655321111           


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                                    ......+++.+.+||.+||+.||.+|||+.++|+||||+.+.+..
T Consensus       254 --------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          254 --------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             --------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             --------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence                          112234789999999999999999999999999999999887654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.7e-44  Score=337.93  Aligned_cols=221  Identities=28%  Similarity=0.380  Sum_probs=172.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHH-hcCCCceEe---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMR-LLDHPNVHY---------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~-~l~h~ni~~---------------  148 (395)
                      ++|++.++||+|+||+||+|++..+++.||||++....      ....+|+..+. ..+|+||..               
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999999999999999875421      11223444444 449999810               


Q ss_pred             -----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          149 -----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       149 -----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                                 ......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..........
T Consensus       137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~  214 (311)
T 3p1a_A          137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH-SQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGE  214 (311)
T ss_dssp             ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECGGG-CEEECCCTTCEECC------
T ss_pred             eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEECCCC-CEEEccceeeeecccCCCCc
Confidence                       112346899999999999999999999 78999999999999999887 69999999998775555555


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ...||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....   ..+..  +.                   
T Consensus       215 ~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~--~~-------------------  268 (311)
T 3p1a_A          215 VQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQ--GY-------------------  268 (311)
T ss_dssp             CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTT--TC-------------------
T ss_pred             ccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhc--cC-------------------
Confidence            6678999999999876  4899999999999999999998777553221   11111  00                   


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                            ....++..+++++.+||.+||++||++|||+.|+|+||||++
T Consensus       269 ------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 ------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                  011233457899999999999999999999999999999975

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-43  Score=331.25  Aligned_cols=232  Identities=25%  Similarity=0.388  Sum_probs=187.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----------hhhHHHHHHHHHhcCCCceE-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----------~~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...          .....+|+.+++.++|+||.             
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            4699999999999999999999999999999998643          34567899999999999980             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC---ceEEeecCCccccc
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKLCDFGSAKVLV  211 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~---~ikl~DFG~a~~~~  211 (395)
                                   +......+++..+..++.||+.||.||| +.||+||||||+||+++.++.   .+||+|||++....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence                         1112346788999999999999999999 889999999999999987652   59999999998765


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          212 KGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      .........+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+........           
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  231 (283)
T 3bhy_A          164 AGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-----------  231 (283)
T ss_dssp             --------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-----------
T ss_pred             CCCcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc-----------
Confidence            554455667899999999997654 89999999999999999999999998877666655543211111           


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                                    ......++..+.+||.+||+.||++|||+.++++||||+.++..
T Consensus       232 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          232 --------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             --------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             --------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence                          11223478999999999999999999999999999999887554

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-43  Score=331.62  Aligned_cols=245  Identities=29%  Similarity=0.416  Sum_probs=196.8

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE--------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ..++|.+.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++|+||.              
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            345799999999999999999999999999999998643       23445799999999999981              


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-C
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-E  214 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~  214 (395)
                                  +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++...... .
T Consensus        93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCSTTC
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChHhEEEcCCC-CEEEEeccCceecccCcc
Confidence                        0111246788999999999999999999 88999999999999999887 6999999999876432 2


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+....+...                 ..
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~~  232 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----------------EY  232 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------------CC
T ss_pred             ccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-----------------cC
Confidence            234467899999999997654 899999999999999999999999887766555444321                 00


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNF  365 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  365 (395)
                                  .++..+++.+.+||.+||+.||++|||+.++++||||.....+..........++.+.+
T Consensus       233 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (294)
T 2rku_A          233 ------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSI  291 (294)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCS
T ss_pred             ------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCCccCCCCCCCccc
Confidence                        12334789999999999999999999999999999998876665444344444554444

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.9e-43  Score=336.44  Aligned_cols=233  Identities=31%  Similarity=0.471  Sum_probs=186.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---------hhHHHHHHHHHhcCCCceE--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....         ....+|+.+++.++|+||.              
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            47999999999999999999999999999999986432         3456799999999999981              


Q ss_pred             -eecc---------------------------------------------------CCCCcHHHHHHHHHHHHHHHHHHH
Q 016085          148 -YSRA---------------------------------------------------SQRMPLIYVKLYTYQICRALAYIH  175 (395)
Q Consensus       148 -~~~~---------------------------------------------------~~~~~~~~~~~~~~qi~~aL~~LH  175 (395)
                       ....                                                   ...+++..++.++.||+.||.|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence             0000                                                   112357778899999999999999


Q ss_pred             cCCCeeeccCCCCceEEcCCCC-ceEEeecCCccccccCCC-----cccccccccccccccccCC-CCCCCcchHHHHHH
Q 016085          176 GGIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGA-TEYTTAVDIWSVGC  248 (395)
Q Consensus       176 ~~~giiHrDlKp~Nill~~~~~-~ikl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~  248 (395)
                       +.||+||||||+|||++.++. .+||+|||+++.......     .....||+.|+|||++.+. ..++.++|||||||
T Consensus       186 -~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             -HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             -HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence             789999999999999986552 599999999986543221     2356789999999998642 45899999999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCC
Q 016085          249 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP  328 (395)
Q Consensus       249 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP  328 (395)
                      ++|+|++|+.||.+.+..+.+..+........                         ......+++.+.+||.+||+.||
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFE-------------------------NPNYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT-------------------------SGGGGGSCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccC-------------------------CcccccCCHHHHHHHHHHcCCCh
Confidence            99999999999999888777777665211100                         00112368999999999999999


Q ss_pred             CCCCCHHHHhcCCcccCCCCC
Q 016085          329 NLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       329 ~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      .+|||+.++|+||||+++.+.
T Consensus       320 ~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          320 DERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             TTSCCHHHHHHSHHHHTTSSC
T ss_pred             hHCCCHHHHhcChhhccChHh
Confidence            999999999999999988654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.2e-43  Score=332.48  Aligned_cols=227  Identities=31%  Similarity=0.440  Sum_probs=186.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceEe-------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVHY-------------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~~-------------------  148 (395)
                      .|...+.||+|+||.||+|++..+|+.||||++...    .....+|+.+++.++|+||..                   
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            488889999999999999999999999999998643    244568999999999999810                   


Q ss_pred             ------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccccccc
Q 016085          149 ------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYIC  221 (395)
Q Consensus       149 ------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~g  221 (395)
                            ......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++....... ......|
T Consensus       126 ~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  203 (321)
T 2c30_A          126 GGALTDIVSQVRLNEEQIATVCEAVLQALAYLH-AQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVG  203 (321)
T ss_dssp             SCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCCCS
T ss_pred             CCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCccccccccC
Confidence                  012346889999999999999999999 78999999999999999887 69999999998764432 2345678


Q ss_pred             cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          222 SRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       222 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      |+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+.... .+                  ..  
T Consensus       204 t~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~------------------~~--  261 (321)
T 2c30_A          204 TPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PP------------------KL--  261 (321)
T ss_dssp             CGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CC------------------CC--
T ss_pred             CccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CC------------------Cc--
Confidence            99999999997654 8999999999999999999999998887766655554310 00                  00  


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                           .....+++.+.+||.+||+.||++|||+.++++||||....
T Consensus       262 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          262 -----KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             -----CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                 01223688999999999999999999999999999997643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.3e-43  Score=327.83  Aligned_cols=227  Identities=29%  Similarity=0.443  Sum_probs=186.2

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE--------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++|+||.              
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            456899999999999999999999999999999998643       23456799999999999981              


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                  +......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++...... .
T Consensus        87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~~-~  163 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH-SKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSS-R  163 (279)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-TTTCEECCCCGGGEEECTTS-CEEECSCCEESCC-----
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCEecccCChHhEEEcCCC-CEEEEeccccccCCcc-c
Confidence                        0112256788899999999999999999 88999999999999999888 6999999998654332 2


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....                 . 
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~-  224 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----------------F-  224 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-----------------C-
T ss_pred             ccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-----------------C-
Confidence            34567899999999997754 8999999999999999999999999887766666554411                 0 


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                 .++..+++.+.+||.+||+.||.+|||+.|+++||||+....
T Consensus       225 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          225 -----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             -----------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence                       123347899999999999999999999999999999987543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.1e-43  Score=339.15  Aligned_cols=259  Identities=29%  Similarity=0.477  Sum_probs=195.1

Q ss_pred             CccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcC-----------CCceE-----
Q 016085           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVH-----  147 (395)
Q Consensus        87 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~-----------h~ni~-----  147 (395)
                      +...++|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.+.           |+||.     
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            344568999999999999999999999999999999997543   34567999998886           67760     


Q ss_pred             --------------e----------e--ccCCCCcHHHHHHHHHHHHHHHHHHHcCC-CeeeccCCCCceEEcCCC----
Q 016085          148 --------------Y----------S--RASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHT----  196 (395)
Q Consensus       148 --------------~----------~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlKp~Nill~~~~----  196 (395)
                                    +          .  .....+++..++.++.||+.||.||| +. ||+||||||+|||++.++    
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH-~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH-HTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH-hcCCEEecCCChHHeEEeccCCCcC
Confidence                          0          0  11345889999999999999999999 76 999999999999995322    


Q ss_pred             -CceEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------cHHHH
Q 016085          197 -HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES------GVDQL  269 (395)
Q Consensus       197 -~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~  269 (395)
                       ..+||+|||++......  .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+      ..+.+
T Consensus       174 ~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             EEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             cceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence             26999999999776432  34567899999999998765 8999999999999999999999998654      45678


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCC---cc----ccCCcccCCCcc------cccCCCCChhHHHHHHhhccCCCCCCCCHHH
Q 016085          270 VEIIKVLGTPTREEIKCMNPNY---TE----FKFPQIKAHPWH------KIFHKRMPPEAVDLVSRLLQYSPNLRCTALE  336 (395)
Q Consensus       270 ~~i~~~~~~~~~~~~~~~~~~~---~~----~~~~~~~~~~~~------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e  336 (395)
                      ..+...+|.++...+.......   ..    ............      ..++...+..+.+||.+||++||++|||+.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            8888888988876554321100   00    000000000000      0122335678999999999999999999999


Q ss_pred             HhcCCcccCCCCC
Q 016085          337 ACIHPFFDELRDP  349 (395)
Q Consensus       337 ~l~hp~f~~~~~~  349 (395)
                      +|+||||++....
T Consensus       331 ll~hp~f~~~~~~  343 (373)
T 1q8y_A          331 LVNHPWLKDTLGM  343 (373)
T ss_dssp             HHTCGGGTTCTTC
T ss_pred             HhhChhhhcccCc
Confidence            9999999886543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.2e-43  Score=337.13  Aligned_cols=246  Identities=29%  Similarity=0.423  Sum_probs=196.5

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++|+||.               
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            34799999999999999999999999999999998653       23456799999999999981               


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CC
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP  215 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~  215 (395)
                                 +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++...... ..
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSTTCC
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCCEecCCCchhEEEcCCC-CEEEeeccCceecccCccc
Confidence                       0111246788899999999999999999 88999999999999999887 6999999999876432 23


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+....+...                 .. 
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----------------~~-  258 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----------------EY-  258 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-----------------CC-
T ss_pred             ccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-----------------CC-
Confidence            34567899999999997754 899999999999999999999999887766655554431                 00 


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCCh
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKP  367 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  367 (395)
                                 .++..+++.+.+||.+||+.||++|||+.++++||||.....+..........++.....+
T Consensus       259 -----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (335)
T 2owb_A          259 -----------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAP  319 (335)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCSSC
T ss_pred             -----------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccCCcccccCCCccccCc
Confidence                       1233478999999999999999999999999999999876655433323333344444333

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-43  Score=337.90  Aligned_cols=229  Identities=26%  Similarity=0.442  Sum_probs=163.3

Q ss_pred             ceeee---eeeccCCceEEEEEEEcCCCcEEEEEEeecc-hhhHHHHHHHHHhcC-CCceE-------------------
Q 016085           92 SYMAE---RVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVH-------------------  147 (395)
Q Consensus        92 ~y~~~---~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~-h~ni~-------------------  147 (395)
                      +|.+.   +.||+|+||.||+|++..+++.||||++.+. .....+|+.+++.+. |+||.                   
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~   88 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL   88 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence            57765   7899999999999999999999999999764 345668999999997 99980                   


Q ss_pred             -------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC--ceEEeecCCccccccCC-Ccc
Q 016085          148 -------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGE-PNI  217 (395)
Q Consensus       148 -------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~--~ikl~DFG~a~~~~~~~-~~~  217 (395)
                             +......+++..++.++.||+.||.||| +.||+||||||+|||++.++.  .+||+|||+++...... ...
T Consensus        89 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  167 (325)
T 3kn6_A           89 NGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK  167 (325)
T ss_dssp             CSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccc
Confidence                   1122456899999999999999999999 889999999999999976542  59999999998654332 234


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV-------DQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ..+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..       +.+..+....              
T Consensus       168 ~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~--------------  232 (325)
T 3kn6_A          168 TPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD--------------  232 (325)
T ss_dssp             ----------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC--------------
T ss_pred             ccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC--------------
Confidence            567899999999997654 899999999999999999999999875432       2222221100              


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                         +        .+.......+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       233 ---~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          233 ---F--------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             ---C--------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             ---C--------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence               0        001111234789999999999999999999999999999998754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.6e-43  Score=329.83  Aligned_cols=229  Identities=28%  Similarity=0.414  Sum_probs=170.7

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE---------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....      ....++...++.++|+||.               
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            4468999999999999999999999999999999986432      1223455567889999980               


Q ss_pred             --e------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCC-CeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          148 --Y------------SRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 --~------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                        +            ......+++..++.++.||+.||.||| +. ||+||||||+|||++.++ .+||+|||+++....
T Consensus        85 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYLVD  162 (290)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HHSCCCCCCCSGGGCEECTTC-CEEBCCC--------
T ss_pred             EehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh-hcCCeecCCCCHHHEEECCCC-CEEEeecCCcccccc
Confidence              0            012457899999999999999999999 66 999999999999999887 699999999987755


Q ss_pred             CCCcccccccccccccccc---cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          213 GEPNISYICSRYYRAPELI---FGATEYTTAVDIWSVGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ........||+.|+|||++   .....++.++|||||||++|+|++|+.||.+.. ....+..+.... .          
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~----------  231 (290)
T 3fme_A          163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-S----------  231 (290)
T ss_dssp             -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-C----------
T ss_pred             cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-C----------
Confidence            5545556789999999997   234458999999999999999999999998643 333333333210 0          


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                              +        ......+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       232 --------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          232 --------P--------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             --------C--------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             --------C--------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                    0        01123478999999999999999999999999999999764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.4e-42  Score=322.56  Aligned_cols=230  Identities=27%  Similarity=0.368  Sum_probs=184.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCce-------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNV-------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni-------------------  146 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++....     ....+|+.+++.++|+||                   
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            47999999999999999999999999999999986432     445689999999999998                   


Q ss_pred             -------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC---Cc
Q 016085          147 -------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PN  216 (395)
Q Consensus       147 -------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~---~~  216 (395)
                             .+......+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.......   ..
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCcchhcc
Confidence                   11122356899999999999999999999 88999999999999999887 69999999997654322   23


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+..............  .         .     ..
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------~-----~~  228 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--K---------T-----YL  228 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT--C---------T-----TS
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc--c---------c-----cc
Confidence            346789999999999776545789999999999999999999998765432222211100  0         0     00


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                .....+++.+.+||.+||+.||++|||+.++++||||++...
T Consensus       229 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          229 ----------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             ----------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             ----------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence                      011236899999999999999999999999999999987543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.1e-43  Score=335.38  Aligned_cols=253  Identities=28%  Similarity=0.490  Sum_probs=195.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCC-cEEEEEEeecch---hhHHHHHHHHHhcCCCc------eE-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQDK---RYKNRELQTMRLLDHPN------VH-------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~-~~vAiK~~~~~~---~~~~~E~~~l~~l~h~n------i~-------------  147 (395)
                      ++|++.+.||+|+||.||+|++..++ +.||+|++....   ....+|+.+++.++|++      +.             
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            57999999999999999999998777 689999987542   34557999999987755      30             


Q ss_pred             ----e----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE-------------------cC
Q 016085          148 ----Y----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV-------------------NP  194 (395)
Q Consensus       148 ----~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill-------------------~~  194 (395)
                          +          ......+++..++.++.||+.||.||| +.||+||||||+|||+                   +.
T Consensus        99 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH-~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A           99 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH-ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             EEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             EEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence                0          011246899999999999999999999 8899999999999999                   44


Q ss_pred             CCCceEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 016085          195 HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK  274 (395)
Q Consensus       195 ~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  274 (395)
                      ++ .+||+|||+++....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+
T Consensus       178 ~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (355)
T 2eu9_A          178 NT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK  253 (355)
T ss_dssp             CC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            45 699999999976433  334567899999999997755 89999999999999999999999999998888888888


Q ss_pred             HhCCCCHHHHhhcCCCCccc----cCCcc---------cCCCccc--ccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          275 VLGTPTREEIKCMNPNYTEF----KFPQI---------KAHPWHK--IFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~----~~~~~---------~~~~~~~--~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ..+.++...+..........    .++..         ....+..  ......+..+.+||.+||++||++|||+.|+|+
T Consensus       254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            88888776554322110000    00000         0000000  001112457899999999999999999999999


Q ss_pred             CCcccCCCC
Q 016085          340 HPFFDELRD  348 (395)
Q Consensus       340 hp~f~~~~~  348 (395)
                      ||||+.+.+
T Consensus       334 hp~f~~~~~  342 (355)
T 2eu9_A          334 HPFFAGLTP  342 (355)
T ss_dssp             SGGGGGCCH
T ss_pred             ChhhcCCCh
Confidence            999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.9e-43  Score=334.41  Aligned_cols=231  Identities=31%  Similarity=0.469  Sum_probs=183.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------------hhHHHHHHHHHhcCCCceE-----------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++....            ....+|+.+++.++|+||.           
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   89 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY   89 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence            47999999999999999999999999999999986432            2356899999999999981           


Q ss_pred             --------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC--ceEEeecCCccccc
Q 016085          148 --------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLV  211 (395)
Q Consensus       148 --------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~--~ikl~DFG~a~~~~  211 (395)
                                    +......+++..++.++.||+.||.||| +.||+||||||+|||++.++.  .+||+|||+++...
T Consensus        90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence                          1123456889999999999999999999 889999999999999986542  49999999998764


Q ss_pred             cCCCccccccccccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          212 KGEPNISYICSRYYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      .........||+.|+|||++.  +...++.++|||||||++|+|++|..||.+......+...+......          
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------  238 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN----------  238 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC----------
T ss_pred             cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc----------
Confidence            433334567899999999974  33458999999999999999999999998755433333222211000          


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                    +.......++..+.+||.+||+.||++|||+.++++||||+..
T Consensus       239 --------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          239 --------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             --------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             --------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence                          0011223478999999999999999999999999999999763

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.8e-43  Score=336.85  Aligned_cols=224  Identities=29%  Similarity=0.409  Sum_probs=185.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      ..|.+.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++|+||.                
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            35999999999999999999999999999999986421       2345899999999999981                


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                                .......+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||+++....   ..
T Consensus       134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~---~~  208 (348)
T 1u5q_A          134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP---AN  208 (348)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS---BC
T ss_pred             ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCC---CC
Confidence                      0012456889999999999999999999 78999999999999999887 699999999976532   23


Q ss_pred             cccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          218 SYICSRYYRAPELIFG--ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ...||+.|+|||++.+  ...++.++|||||||++|+|++|+.||.+.+....+..+.... .                 
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-~-----------------  270 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-S-----------------  270 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-C-----------------
T ss_pred             cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C-----------------
Confidence            5678999999999853  3448999999999999999999999999887776666554410 0                 


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                       +.        .....+++.+.+||.+||+.||++|||+.++++||||...
T Consensus       271 -~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          271 -PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             -CC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             -CC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence             00        1123468899999999999999999999999999999764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-42  Score=327.00  Aligned_cols=233  Identities=27%  Similarity=0.378  Sum_probs=189.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------------hhhHHHHHHHHHhcC-CCceE--------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------------KRYKNRELQTMRLLD-HPNVH--------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------------~~~~~~E~~~l~~l~-h~ni~--------  147 (395)
                      ..+|++.+.||+|+||.||+|++..+++.||||++...             .....+|+.+++.+. |+||.        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            45799999999999999999999999999999998543             133457999999995 99981        


Q ss_pred             ------------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          148 ------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       148 ------------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                        +......+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~  173 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQ  173 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEEcCCC-cEEEecccchhh
Confidence                              0112346788899999999999999999 88999999999999999888 699999999987


Q ss_pred             cccCCCccccccccccccccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          210 LVKGEPNISYICSRYYRAPELIF-----GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                      ...........+|+.|+|||++.     ....++.++|||||||++|+|++|+.||.+.+.......+........    
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----  249 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG----  249 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC----
Confidence            76555555677899999999985     234478999999999999999999999988877666665554211100    


Q ss_pred             hhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                                           ......++..+.+||.+||+.||.+|||+.++++||||++....
T Consensus       250 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          250 ---------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             ---------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             ---------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence                                 00112368999999999999999999999999999999887553

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.1e-43  Score=327.17  Aligned_cols=227  Identities=30%  Similarity=0.435  Sum_probs=179.3

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE--------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++|+||.              
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3457999999999999999999999999999999986532       2456899999999999981              


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                  +......+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++........
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH-RHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCCC---
T ss_pred             EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCChhhEEECCCC-CEEEeecccccccCCCcc
Confidence                        0111245788899999999999999999 78999999999999999887 699999999987655444


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      .....+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....                 . 
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~-  228 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-----------------F-  228 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------------C-
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----------------c-
Confidence            4556789999999999776544789999999999999999999998877655555443310                 0 


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                 .++..++..+.+||.+||+.||.+|||+.++++||||++.
T Consensus       229 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          229 -----------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -----------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                       1223468899999999999999999999999999999764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.4e-42  Score=331.29  Aligned_cols=254  Identities=28%  Similarity=0.528  Sum_probs=195.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEE-cCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCc------e-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKC-LETGETVAIKKVLQDK---RYKNRELQTMRLLDHPN------V-------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~-~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~n------i-------------  146 (395)
                      .++|++.+.||+|+||.||+|.+ ..+++.||||++....   ....+|+.+++.++|++      +             
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            34799999999999999999998 5688999999987543   34567999999987765      3             


Q ss_pred             --E--e--------e--ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC------------------
Q 016085          147 --H--Y--------S--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP------------------  194 (395)
Q Consensus       147 --~--~--------~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~------------------  194 (395)
                        .  +        .  .....+++..++.++.||+.||+||| +.||+||||||+|||++.                  
T Consensus        93 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~  171 (339)
T 1z57_A           93 CIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH-SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL  171 (339)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence              0  0        0  11235789999999999999999999 889999999999999986                  


Q ss_pred             -CCCceEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 016085          195 -HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII  273 (395)
Q Consensus       195 -~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  273 (395)
                       ++ .+||+|||+++....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus       172 ~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  247 (339)
T 1z57_A          172 INP-DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME  247 (339)
T ss_dssp             SCC-CEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH
T ss_pred             cCC-CceEeeCcccccCcc--ccccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence             33 599999999976432  334567899999999997754 8999999999999999999999999999888888888


Q ss_pred             HHhCCCCHHHHhhcCCC-Cc---cccCCcc---------cCCCccc--ccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          274 KVLGTPTREEIKCMNPN-YT---EFKFPQI---------KAHPWHK--IFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       274 ~~~~~~~~~~~~~~~~~-~~---~~~~~~~---------~~~~~~~--~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                      ...+..+...+...... +.   ...+...         ....+..  ......++.+.+||.+||+.||.+|||+.|++
T Consensus       248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell  327 (339)
T 1z57_A          248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL  327 (339)
T ss_dssp             HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence            88888777655433211 00   0000000         0000000  01112356789999999999999999999999


Q ss_pred             cCCcccCCCC
Q 016085          339 IHPFFDELRD  348 (395)
Q Consensus       339 ~hp~f~~~~~  348 (395)
                      +||||+.++.
T Consensus       328 ~hp~f~~~~~  337 (339)
T 1z57_A          328 KHPFFDLLKK  337 (339)
T ss_dssp             TSGGGGGGGC
T ss_pred             cCHHHHHHhc
Confidence            9999998754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.9e-43  Score=330.92  Aligned_cols=233  Identities=26%  Similarity=0.388  Sum_probs=174.5

Q ss_pred             ccceeee-eeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHh-cCCCceE----------------
Q 016085           90 TISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRL-LDHPNVH----------------  147 (395)
Q Consensus        90 ~~~y~~~-~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~-l~h~ni~----------------  147 (395)
                      .++|.+. +.||+|+||.||+|++..+++.||||++...    .....+|+.+++. ++|+||.                
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3469985 7899999999999999999999999998653    3455689999988 5799981                


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC--ceEEeecCCccccccCC-
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGE-  214 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~--~ikl~DFG~a~~~~~~~-  214 (395)
                                +......+++..++.++.||+.||.||| +.||+||||||+|||++.++.  .+||+|||++....... 
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH-NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence                      0112346788999999999999999999 789999999999999987653  39999999987653221 


Q ss_pred             -------CcccccccccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------------HH
Q 016085          215 -------PNISYICSRYYRAPELIFGA----TEYTTAVDIWSVGCVLAELLLGQPLFPGESGV---------------DQ  268 (395)
Q Consensus       215 -------~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------------~~  268 (395)
                             .....+||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+....               ..
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  249 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML  249 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence                   12245689999999998641    23789999999999999999999999875431               11


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          269 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       269 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      ...+.....                 .++        ......+++.+.+||.+||+.||.+|||+.|+++||||+....
T Consensus       250 ~~~i~~~~~-----------------~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          250 FESIQEGKY-----------------EFP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHHCCC-----------------CCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             HHHHhccCc-----------------ccC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            222222100                 000        0011347899999999999999999999999999999987654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.2e-43  Score=325.66  Aligned_cols=226  Identities=26%  Similarity=0.442  Sum_probs=162.6

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++|+||.               
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            357999999999999999999999999999999986542       3456899999999999980               


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-  214 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-  214 (395)
                                  .......+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....... 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH-SHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC----
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccCCCC
Confidence                        0012256899999999999999999999 88999999999999999887 69999999998754322 


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+.+..+..                 .. 
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------------~~-  228 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-----------------AD-  228 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----------------SC-
T ss_pred             cceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----------------cc-
Confidence            223467899999999997654 89999999999999999999999987654332221100                 00 


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                                 ..++..++.++.+||.+||+.||++|||+.++++||||....
T Consensus       229 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          229 -----------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             -----------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                       012344789999999999999999999999999999997643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=327.21  Aligned_cols=229  Identities=28%  Similarity=0.411  Sum_probs=188.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch--------hhHHHHHHHHHhcCCCceE-----e---------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVH-----Y---------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--------~~~~~E~~~l~~l~h~ni~-----~---------  148 (395)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....        ....+|+.+++.++|+||.     +         
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            47999999999999999999999999999999986532        3456899999999999980     0         


Q ss_pred             ---------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          149 ---------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       149 ---------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                     ......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++......
T Consensus        85 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           85 MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH-SQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCTT
T ss_pred             EEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCcccEEEcCCC-cEEeeccccccccCcc
Confidence                           012356888999999999999999999 88999999999999999887 6999999999765422


Q ss_pred             ---CCcccccccccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          214 ---EPNISYICSRYYRAPELIFGAT-EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       214 ---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                         .......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+.......+...              
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--------------  228 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--------------  228 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--------------
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--------------
Confidence               1223456899999999986533 2477999999999999999999999987766655554431              


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                         ..            .++..+++.+.+||.+||+.||.+|||+.++++||||+....+.
T Consensus       229 ---~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          229 ---SY------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             ---CC------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             ---CC------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence               00            12344789999999999999999999999999999998876654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-42  Score=331.66  Aligned_cols=223  Identities=26%  Similarity=0.401  Sum_probs=172.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEeec-----c---------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHYSR-----A---------  151 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~~~-----~---------  151 (395)
                      ++|++.+.||+|+||.||+|++..+|+.||||++...     .....+|+.+|+.++||||....     .         
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            4799999999999999999999999999999998632     24456899999999999982110     0         


Q ss_pred             ------------------------------------------------------------------------CCCCcHHH
Q 016085          152 ------------------------------------------------------------------------SQRMPLIY  159 (395)
Q Consensus       152 ------------------------------------------------------------------------~~~~~~~~  159 (395)
                                                                                              .....+..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                                                    01123445


Q ss_pred             HHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-------------Cccccccccccc
Q 016085          160 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------------PNISYICSRYYR  226 (395)
Q Consensus       160 ~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-------------~~~~~~gt~~y~  226 (395)
                      ++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++......             .....+||+.|+
T Consensus       166 ~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHH-hCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            7889999999999999 88999999999999999887 69999999998765432             123457899999


Q ss_pred             ccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCccc
Q 016085          227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK  306 (395)
Q Consensus       227 aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (395)
                      |||++.+.. ++.++|||||||++|+|++|..|+.     +....+..........                        
T Consensus       244 aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~------------------------  293 (332)
T 3qd2_B          244 SPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPL------------------------  293 (332)
T ss_dssp             CHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCH------------------------
T ss_pred             ChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCc------------------------
Confidence            999998755 8999999999999999999876652     1111111111110000                        


Q ss_pred             ccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          307 IFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       307 ~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                       .....++.+.+||.+||+.||++|||+.|+++||||+++
T Consensus       294 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 -LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             -HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             -ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence             011246788999999999999999999999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-42  Score=323.94  Aligned_cols=227  Identities=28%  Similarity=0.419  Sum_probs=188.6

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE-------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ...++|.+.+.||+|+||.||+|++..+++.||||++...       .....+|+.+++.++|+||.             
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence            3446799999999999999999999999999999998643       23456899999999999981             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                   +......+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...... 
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH-ERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSSS-
T ss_pred             EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCHHHEEEcCCC-CEEEecccccccCccc-
Confidence                         0112245788999999999999999999 88999999999999999887 6999999998765332 


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...                 ..
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----------------~~  229 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL  229 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------------CC
T ss_pred             ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-----------------cc
Confidence            234567899999999997754 899999999999999999999999887766655544331                 00


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                                  .++..++..+.+||.+||+.||.+|||+.++++||||+...
T Consensus       230 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          230 ------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             ------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                        12344789999999999999999999999999999998654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.3e-42  Score=322.06  Aligned_cols=224  Identities=22%  Similarity=0.331  Sum_probs=181.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceEe----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      ..|++.+.||+|+||.||+|.+..++..||+|++....      ....+|+.+++.++|+||..                
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            36999999999999999999999999999999986432      33467999999999999810                


Q ss_pred             --------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCC--eeeccCCCCceEEc-CCCCceEEeecCCccccc
Q 016085          149 --------------SRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVN-PHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       149 --------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlKp~Nill~-~~~~~ikl~DFG~a~~~~  211 (395)
                                    ......+++..++.++.||+.||.||| +.|  |+||||||+|||++ .++ .+||+|||++....
T Consensus       106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~~~i~H~dikp~Nil~~~~~~-~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCSCCCGGGEEESSTTS-CEEECCTTGGGGCC
T ss_pred             EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHH-cCCCCEEECCCCHHHEEEECCCC-CEEEeeCCCccccc
Confidence                          011245788889999999999999999 788  99999999999998 455 79999999997543


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          212 KGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      . .......||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.+......+.........             
T Consensus       184 ~-~~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  247 (290)
T 1t4h_A          184 A-SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-------------  247 (290)
T ss_dssp             T-TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-------------
T ss_pred             c-cccccccCCcCcCCHHHHhc-c-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-------------
Confidence            3 23345678999999998864 3 899999999999999999999999886665554433221000             


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                                   ...++...++.+.+||.+||+.||.+|||+.++++||||++
T Consensus       248 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 -------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                         01123446789999999999999999999999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=335.56  Aligned_cols=246  Identities=20%  Similarity=0.317  Sum_probs=182.6

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEe----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      .++|++.++||+|+||.||+|++..+++.||||++....     ....+|+.+++.++|+||..                
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            457999999999999999999999999999999986432     34568999999999999810                


Q ss_pred             ---e---------c---cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE----cCCCCceEEeecCCccc
Q 016085          149 ---S---------R---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       149 ---~---------~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill----~~~~~~ikl~DFG~a~~  209 (395)
                         .         .   ....+++..++.++.||+.||.||| +.||+||||||+|||+    +.++ .+||+|||+++.
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~a~~  165 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAARE  165 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEECTTSCE-EEEECCCTTCEE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEEeccCCCCc-eEEEccCCCcee
Confidence               0         0   1122899999999999999999999 8899999999999998    6555 699999999988


Q ss_pred             cccCCCcccccccccccccccccC-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCC
Q 016085          210 LVKGEPNISYICSRYYRAPELIFG-------ATEYTTAVDIWSVGCVLAELLLGQPLFPGESG----VDQLVEIIKVLGT  278 (395)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~  278 (395)
                      ...........||+.|+|||++.+       ...++.++|||||||++|+|++|+.||.....    .+.+..+...  .
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~  243 (319)
T 4euu_A          166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG--K  243 (319)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH--C
T ss_pred             cCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC--C
Confidence            766655566789999999999852       24589999999999999999999999975433    3344444332  1


Q ss_pred             CCHHHHhhcC-CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCc
Q 016085          279 PTREEIKCMN-PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  342 (395)
Q Consensus       279 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~  342 (395)
                      |.. .+.... .....+.+.  ...+....+...++..+.+||++||++||++|||+.|+|+||-
T Consensus       244 p~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          244 PSG-AISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CTT-CCEEEECSTTCCEEEE--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             Ccc-cchhhhcccCCccccC--ccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            111 110000 000000000  0001111122335568899999999999999999999999874

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-42  Score=327.74  Aligned_cols=228  Identities=28%  Similarity=0.423  Sum_probs=186.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceE-------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVH-------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~-------------------  147 (395)
                      ++|.+.+.||+|+||.||+|++..+|+.||+|++....    ....+|+.+++.++|+||.                   
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            47999999999999999999999999999999986532    3456899999999999981                   


Q ss_pred             -------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE---cCCCCceEEeecCCccccccCCCcc
Q 016085          148 -------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       148 -------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill---~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                             +......+++..+..++.||+.||.||| +.||+||||||+|||+   +.++ .+||+|||+++..... ...
T Consensus        89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~~-~~~  165 (304)
T 2jam_A           89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH-ENGIVHRDLKPENLLYLTPEENS-KIMITDFGLSKMEQNG-IMS  165 (304)
T ss_dssp             CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTTCCCCCB-TTH
T ss_pred             CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEecCCCCC-CEEEccCCcceecCCC-ccc
Confidence                   0111345788889999999999999999 8899999999999999   5555 6999999999764322 234


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ...||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.+....                   
T Consensus       166 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-------------------  225 (304)
T 2jam_A          166 TACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-------------------  225 (304)
T ss_dssp             HHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-------------------
T ss_pred             cccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence            567899999999997654 899999999999999999999999988776666665542100                   


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                            +...+...+++.+.+||.+||+.||++|||+.++++||||+...
T Consensus       226 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          226 ------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             ------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             ------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                  01112345789999999999999999999999999999998753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=340.62  Aligned_cols=235  Identities=28%  Similarity=0.419  Sum_probs=182.9

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEc---CCCcEEEEEEeecc--------hhhHHHHHHHHHhc-CCCceE--------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLL-DHPNVH--------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~--------~~~~~~E~~~l~~l-~h~ni~--------  147 (395)
                      ....+|++.+.||+|+||.||+|++.   .+++.||||++.+.        .....+|+.+++.+ +|+||.        
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            34568999999999999999999984   58999999988542        23345799999999 699971        


Q ss_pred             ------------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          148 ------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       148 ------------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                        +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~  208 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILLDSNG-HVVLTDFGLSKE  208 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEESCSSEEEE
T ss_pred             CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-cEEEeeCCCCee
Confidence                              0112346888999999999999999999 88999999999999999888 699999999986


Q ss_pred             cccCC--CcccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 016085          210 LVKGE--PNISYICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       210 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  286 (395)
                      .....  .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+.....        .
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------~  280 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--------K  280 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--------H
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh--------c
Confidence            53322  22346789999999999753 3478999999999999999999999976433222222222100        0


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                      .                 ...++..++..+.+||.+||+.||.+||     |+.++++||||+.+.+.
T Consensus       281 ~-----------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~  331 (355)
T 1vzo_A          281 S-----------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  331 (355)
T ss_dssp             C-----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             c-----------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence            0                 0012345789999999999999999999     99999999999987653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=333.40  Aligned_cols=228  Identities=24%  Similarity=0.343  Sum_probs=175.1

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCC--CceE--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDH--PNVH--------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h--~ni~--------------  147 (395)
                      ..+|++.+.||+|+||.||+|.+ .+++.||||++....      ....+|+.+|+.++|  +||.              
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            34799999999999999999987 568999999986432      344689999999987  7870              


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                                 +......+++..++.++.||+.||.||| +.||+||||||+|||++ ++ .+||+|||+++....... 
T Consensus        87 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH-~~~iiHrDikp~NIll~-~~-~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           87 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             EECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCCC------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCcceEEEE-CC-cEEEeecccccccCccccc
Confidence                       1122356889999999999999999999 88999999999999997 45 699999999987643322 


Q ss_pred             --cccccccccccccccccC----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHH
Q 016085          216 --NISYICSRYYRAPELIFG----------ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTRE  282 (395)
Q Consensus       216 --~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~  282 (395)
                        ....+||+.|+|||++.+          ...++.++|||||||++|+|++|+.||.+.... ..+..+..   .    
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~----  236 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---P----  236 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---T----
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc---C----
Confidence              235678999999999854          234899999999999999999999999765432 22222211   0    


Q ss_pred             HHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                          .....++...+..+.+||.+||+.||.+|||+.++|+||||+....
T Consensus       237 --------------------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          237 --------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             --------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             --------------------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence                                0011123346789999999999999999999999999999986443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.5e-42  Score=337.97  Aligned_cols=228  Identities=25%  Similarity=0.357  Sum_probs=175.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCC--CceE---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDH--PNVH---------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h--~ni~---------------  147 (395)
                      .+|++.+.||+|+||.||+|.+.. ++.||||++....      ....+|+.+|+.+.|  +||.               
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            469999999999999999999765 8999999986432      345689999999974  8871               


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                                +......+++..++.++.||+.||.||| +.||+||||||+|||++ ++ .+||+|||+++.......  
T Consensus       135 ~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          135 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             EECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH-TTTCCCCCCCGGGEEES-SS-CEEECCCSSSCCC-------
T ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHEEEE-CC-eEEEEecCccccccCCCccc
Confidence                      1122346788889999999999999999 88999999999999996 45 699999999987643322  


Q ss_pred             -cccccccccccccccccCC----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHH
Q 016085          216 -NISYICSRYYRAPELIFGA----------TEYTTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREE  283 (395)
Q Consensus       216 -~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~  283 (395)
                       ....+||+.|+|||++.+.          ..++.++|||||||++|+|++|+.||.+.... ..+..++..        
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~--------  283 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--------  283 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT--------
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc--------
Confidence             2356799999999998651          24899999999999999999999999875432 223322210        


Q ss_pred             HhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          284 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                            . ..            ..++...+..+.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus       284 ------~-~~------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~  330 (390)
T 2zmd_A          284 ------N-HE------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  330 (390)
T ss_dssp             ------T-SC------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred             ------c-cc------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence                  0 00            01223357899999999999999999999999999999865443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.3e-43  Score=340.23  Aligned_cols=234  Identities=17%  Similarity=0.159  Sum_probs=168.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhc--CCCceEe----e--------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL--DHPNVHY----S--------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l--~h~ni~~----~--------  149 (395)
                      .+|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.|  +||||..    .        
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            35999999999999999999999999999999997632       2334675555555  5999421    0        


Q ss_pred             -------------------------cc-------------CCCCcHHHH------HHHHHHHHHHHHHHHcCCCeeeccC
Q 016085          150 -------------------------RA-------------SQRMPLIYV------KLYTYQICRALAYIHGGIGVCHRDI  185 (395)
Q Consensus       150 -------------------------~~-------------~~~~~~~~~------~~~~~qi~~aL~~LH~~~giiHrDl  185 (395)
                                               ..             ...+.....      ..++.||+.||+||| ++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH-~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ-SKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH-HTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH-HCCCccCcC
Confidence                                     00             001122222      455699999999999 889999999


Q ss_pred             CCCceEEcCCCCceEEeecCCccccccCCCcccccccccccccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 016085          186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAVDIWSVGCVLAELLLGQPLFPGES  264 (395)
Q Consensus       186 Kp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  264 (395)
                      ||+|||++.++ .+||+|||+|+...  .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+..
T Consensus       221 kp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          221 TPDNLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             SGGGEEECTTS-CEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CHHHEEECCCC-CEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            99999999888 69999999998653  22225667899999999965 1348999999999999999999999997754


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          265 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       265 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                      ...                    ...+............+.......+++.+.+||.+||++||++|||+.++|+||||+
T Consensus       298 ~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  357 (371)
T 3q60_A          298 PGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL  357 (371)
T ss_dssp             TTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred             ccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence            210                    001111111111111111122346899999999999999999999999999999998


Q ss_pred             CCCC
Q 016085          345 ELRD  348 (395)
Q Consensus       345 ~~~~  348 (395)
                      ++.+
T Consensus       358 ~~~~  361 (371)
T 3q60_A          358 QLQN  361 (371)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.8e-42  Score=324.33  Aligned_cols=230  Identities=29%  Similarity=0.492  Sum_probs=188.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++...      .....+|+.+++.++|+||.                 
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            4799999999999999999999999999999998543      34556899999999999981                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC--ceEEeecCCccccccCCCc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~--~ikl~DFG~a~~~~~~~~~  216 (395)
                               +......+++..++.++.||+.||.||| +.||+||||||+||+++.++.  .+||+|||++.........
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~  180 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM  180 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence                     0111246788899999999999999999 889999999999999976432  5999999999876555444


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....+|+.|+|||++.+ . ++.++|||||||++|+|++|..||.+.+..+.+..+......               ...
T Consensus       181 ~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~  243 (287)
T 2wei_A          181 KDRIGTAYYIAPEVLRG-T-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA---------------FDL  243 (287)
T ss_dssp             SCHHHHHTTCCHHHHTT-C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------CCS
T ss_pred             ccccCcccccChHHhcC-C-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------------CCc
Confidence            55678999999999865 3 899999999999999999999999988776666555441100               000


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                .....+++.+.+||.+||+.||++|||+.++++||||++..+
T Consensus       244 ----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          244 ----------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             ----------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             ----------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                      011347899999999999999999999999999999987644

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.1e-43  Score=331.54  Aligned_cols=231  Identities=26%  Similarity=0.399  Sum_probs=183.2

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++|+||.               
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            457999999999999999999999999999999986532       2345799999999999981               


Q ss_pred             -ee--------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          148 -YS--------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 -~~--------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                       +.              .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEETTS-CEEECCCSCC-----
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCCcCCCCHHHEEEcCCC-CEEEeeccCcccccc
Confidence             11              12346888999999999999999999 88999999999999999887 699999999976543


Q ss_pred             CCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          213 GEP----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       213 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ...    .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+......++.       
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  240 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-------  240 (311)
T ss_dssp             -------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH-------
T ss_pred             cccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc-------
Confidence            321    22456899999999998754 899999999999999999999999988877666655542211111       


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                        .....++.++.+||.+||+.||++||++.+++.|+|++....
T Consensus       241 ------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          241 ------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             ------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             ------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence                              122347899999999999999999999999999999976543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.3e-42  Score=322.45  Aligned_cols=231  Identities=26%  Similarity=0.397  Sum_probs=183.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++|+||.                  
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            45799999999999999999999999999999988543    24456799999999999980                  


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CCcc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNI  217 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~~~  217 (395)
                               .......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++...... ....
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~  175 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRD  175 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHHHHHC--
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHHHEEECCCC-CEEEEECCCCccccccccccc
Confidence                     0012356889999999999999999999 88999999999999999887 6999999987543221 1223


Q ss_pred             ccccccccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          218 SYICSRYYRAPELIF----GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      ...||+.|+|||++.    ....++.++|||||||++|+|++|..||.+.+....+..+....  ++             
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-------------  240 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PP-------------  240 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC-------------
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC--Cc-------------
Confidence            457899999999984    23448999999999999999999999999887766655554310  00             


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                 ....+..++..+.+||.+||+.||.+|||+.++++||||+.+.+
T Consensus       241 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          241 -----------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             -----------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             -----------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence                       00112346889999999999999999999999999999987653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.9e-41  Score=325.67  Aligned_cols=243  Identities=22%  Similarity=0.348  Sum_probs=186.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---------------------hhHHHHHHHHHhcCCCce--
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------------------RYKNRELQTMRLLDHPNV--  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------------------~~~~~E~~~l~~l~h~ni--  146 (395)
                      .++|++.+.||+|+||.||+|++  +++.||||++....                     ....+|+.+++.++|+||  
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            45799999999999999999998  89999999986432                     556789999999999998  


Q ss_pred             ------------------------Ee------ecc--CCCCcHHHHHHHHHHHHHHHHHHHcC-CCeeeccCCCCceEEc
Q 016085          147 ------------------------HY------SRA--SQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVN  193 (395)
Q Consensus       147 ------------------------~~------~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlKp~Nill~  193 (395)
                                              .+      ...  ...+++..++.++.||+.||.||| + .||+||||||+|||++
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMD  186 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH-HTSCEECCCCCGGGEEEC
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh-ccCCEeecCCChHhEEEc
Confidence                                    11      222  467899999999999999999999 6 8999999999999999


Q ss_pred             CCCCceEEeecCCccccccCCCcccccccccccccccccCCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHH
Q 016085          194 PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT-AVDIWSVGCVLAELLLGQPLFPGESG-VDQLVE  271 (395)
Q Consensus       194 ~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~  271 (395)
                      .++ .+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|+.||.+.+. .+....
T Consensus       187 ~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  264 (348)
T 2pml_X          187 KNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN  264 (348)
T ss_dssp             TTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred             CCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            888 6999999999875433 3345678999999999977634655 99999999999999999999988766 444444


Q ss_pred             HHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       272 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      +.......+.        ....+.. ... ..........++..+.+||.+||+.||.+|||+.++++||||++..
T Consensus       265 i~~~~~~~~~--------~~~~~~~-~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          265 IRTKNIEYPL--------DRNHFLY-PLT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HTSCCCCCCC--------SSSSSTT-TTC-C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HhccCcCCcc--------chhhhhc-ccc-ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            3221000000        0000000 000 0000112255889999999999999999999999999999998753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.2e-44  Score=346.44  Aligned_cols=220  Identities=21%  Similarity=0.256  Sum_probs=169.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHH---HHHhcCCCceEee----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQ---TMRLLDHPNVHYS----------  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~---~l~~l~h~ni~~~----------  149 (395)
                      .++|++.+.||+|+||.||+|++..+|+.||||++...       .....+|+.   +++.++||||...          
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45799999999999999999999999999999998632       244568884   5555689997100          


Q ss_pred             -c----------------------------cC----------CCCc-------HHHHHHHHHHHHHHHHHHHcCCCeeec
Q 016085          150 -R----------------------------AS----------QRMP-------LIYVKLYTYQICRALAYIHGGIGVCHR  183 (395)
Q Consensus       150 -~----------------------------~~----------~~~~-------~~~~~~~~~qi~~aL~~LH~~~giiHr  183 (395)
                       .                            ..          ..++       +..+..++.||+.||+||| +.||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH-HTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH-hCCeecC
Confidence             0                            00          1122       3666779999999999999 8899999


Q ss_pred             cCCCCceEEcCCCCceEEeecCCccccccCCCcccccccccccccccccCC----------CCCCCcchHHHHHHHHHHH
Q 016085          184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA----------TEYTTAVDIWSVGCVLAEL  253 (395)
Q Consensus       184 DlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~el  253 (395)
                      ||||+|||++.++ .+||+|||+|+..  +......+| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999887 6999999999863  223345667 999999999765          1489999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC
Q 016085          254 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT  333 (395)
Q Consensus       254 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t  333 (395)
                      ++|+.||.+.+.......+.                                 .....+++++.+||.+||+.||++|||
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIF---------------------------------RSCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHSSCCC------CCSGGGG---------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHCCCCCcccccccchhhhh---------------------------------hhccCCCHHHHHHHHHHcCCCchhCCC
Confidence            99999997644211111000                                 011357899999999999999999999


Q ss_pred             HHHHhcCCcccCCC
Q 016085          334 ALEACIHPFFDELR  347 (395)
Q Consensus       334 ~~e~l~hp~f~~~~  347 (395)
                      +.++++||||+.+.
T Consensus       354 ~~e~l~hp~f~~~~  367 (377)
T 3byv_A          354 PLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHHTSHHHHHHH
T ss_pred             HHHHhhChHHHHHH
Confidence            99999999998764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=320.44  Aligned_cols=228  Identities=29%  Similarity=0.415  Sum_probs=182.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCCCceE-----------------e---
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVH-----------------Y---  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~ni~-----------------~---  148 (395)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++...  .....+|+.+++.++|+||.                 +   
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  108 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA  108 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCC
Confidence            3699999999999999999999999999999998654  34566899999999999980                 0   


Q ss_pred             ------e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccccc
Q 016085          149 ------S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYI  220 (395)
Q Consensus       149 ------~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~  220 (395)
                            . .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....... ......
T Consensus       109 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  186 (314)
T 3com_A          109 GSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH-FMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRNTVI  186 (314)
T ss_dssp             EEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTTBSCBCCCC
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhhccccCccC
Confidence                  0 12456889999999999999999999 88999999999999999887 69999999997664332 233457


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      ||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+....  +.            .+      
T Consensus       187 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------------~~------  245 (314)
T 3com_A          187 GTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--PP------------TF------  245 (314)
T ss_dssp             SCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC------------CC------
T ss_pred             CCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--Cc------------cc------
Confidence            899999999997654 8999999999999999999999998877655544433210  00            00      


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                            ..+..++..+.+||.+||..||.+|||+.++++||||+...
T Consensus       246 ------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          246 ------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             ------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             ------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                  01233688999999999999999999999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2e-42  Score=334.51  Aligned_cols=255  Identities=24%  Similarity=0.394  Sum_probs=183.6

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...     .....+|+.+++.++|+||.                 
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            45799999999999999999999999999999998653     23456899999999999981                 


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCC-CeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                               +......+++..+..++.|++.||.||| +. ||+||||||+|||++.++ .+||+|||++...... ...
T Consensus       112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~~~  188 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MAN  188 (360)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH-C--
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HhCCEEcCCccHHHEEECCCC-CEEEEECCCCcccccc-ccc
Confidence                     0111246788889999999999999999 64 999999999999999888 6999999999765332 234


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCCHHHHhh--cCCCCccc
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKC--MNPNYTEF  294 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~--~~~~~~~~  294 (395)
                      ...||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.... +.+.......  ....+..+
T Consensus       189 ~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (360)
T 3eqc_A          189 SFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF  267 (360)
T ss_dssp             --CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred             CCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence            567899999999997754 8999999999999999999999998876554332221111 1000000000  00000000


Q ss_pred             cCCc------------ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          295 KFPQ------------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       295 ~~~~------------~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      ....            +............++.++.+||.+||++||++|||+.++|+||||+....
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence            0000            00000011122346889999999999999999999999999999987644

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.1e-41  Score=318.24  Aligned_cols=225  Identities=28%  Similarity=0.405  Sum_probs=186.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------------e
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      ..|++.+.||+|+||.||+|++..+++.||||++...     .....+|+.+++.++|+||.                 +
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            4699999999999999999999999999999998643     24567899999999999981                 0


Q ss_pred             --------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccccc
Q 016085          149 --------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISY  219 (395)
Q Consensus       149 --------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~  219 (395)
                              ......+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....... .....
T Consensus       102 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~  179 (303)
T 3a7i_A          102 LGGGSALDLLEPGPLDETQIATILREILKGLDYLH-SEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTF  179 (303)
T ss_dssp             CTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTTBCCBCCC
T ss_pred             CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCChheEEECCCC-CEEEeecccceecCccccccCcc
Confidence                    012356889999999999999999999 88999999999999999887 69999999997764432 23346


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcc
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI  299 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (395)
                      .||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+...  .+                    
T Consensus       180 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------------------  236 (303)
T 3a7i_A          180 VGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP--------------------  236 (303)
T ss_dssp             CSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC--------------------
T ss_pred             CCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC--------------------
Confidence            7899999999997654 899999999999999999999999887765555444321  00                    


Q ss_pred             cCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       300 ~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                            ..+...++..+.+||.+||+.||.+|||+.++++||||...
T Consensus       237 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          237 ------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                  01234578999999999999999999999999999999764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=322.21  Aligned_cols=229  Identities=24%  Similarity=0.402  Sum_probs=179.6

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhc-CCCceE-----ee----------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVH-----YS----------  149 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l-~h~ni~-----~~----------  149 (395)
                      ..++|++.+.||+|+||.||+|++..+++.||||++...   .....+|+.+++.+ +|+||.     +.          
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            345799999999999999999999999999999998543   34567899999998 899981     00          


Q ss_pred             -------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          150 -------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       150 -------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                                         .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++...
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-QHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL  179 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEECTTC-CEEECCCTTTC--
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCcHHHEEEcCCC-CEEEeeCcCceec
Confidence                               01145788889999999999999999 88999999999999999887 6999999998765


Q ss_pred             ccCC-CcccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 016085          211 VKGE-PNISYICSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       211 ~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                      .... ......||+.|+|||++.+    ...++.++|||||||++|+|++|..||.+.+....+..+.... .       
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~-------  251 (326)
T 2x7f_A          180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-A-------  251 (326)
T ss_dssp             -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-C-------
T ss_pred             CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-c-------
Confidence            4322 2334578999999999862    2348999999999999999999999998877666555443310 0       


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                 +        ......++..+.+||.+||..||.+|||+.++++||||++.
T Consensus       252 -----------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          252 -----------P--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             -----------C--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             -----------c--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                       0        01223478999999999999999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.4e-41  Score=317.09  Aligned_cols=223  Identities=21%  Similarity=0.264  Sum_probs=175.6

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhc-CCCceE--------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVH--------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l-~h~ni~--------------  147 (395)
                      ..++|++.+.||+|+||.||+|++..+++.||||++...      .....+|+.++..+ +|+||.              
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            345799999999999999999999999999999998643      23445788888888 999981              


Q ss_pred             -ee-----------c----cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC---------------
Q 016085          148 -YS-----------R----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT---------------  196 (395)
Q Consensus       148 -~~-----------~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~---------------  196 (395)
                       ..           .    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEC------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH-hCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence             00           0    0145789999999999999999999 88999999999999998432               


Q ss_pred             ---CceEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 016085          197 ---HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEII  273 (395)
Q Consensus       197 ---~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  273 (395)
                         ..+||+|||++......   ....||+.|+|||++.+...++.++|||||||++|+|++|.+++.....   ...+.
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~  241 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIR  241 (289)
T ss_dssp             --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHH
T ss_pred             CCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHH
Confidence               25999999999876432   2346899999999997765577899999999999999999987754322   22221


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          274 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      ..                   ..         ..++..+++.+.+||.+||+.||++|||+.++++||||.+.
T Consensus       242 ~~-------------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          242 QG-------------------RL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             TT-------------------CC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             cC-------------------CC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            10                   00         11334578999999999999999999999999999999764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.1e-42  Score=321.47  Aligned_cols=232  Identities=26%  Similarity=0.390  Sum_probs=181.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||.               
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            45799999999999999999999999999999988432       23456899999999999980               


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                                 +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....... 
T Consensus        90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  167 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH-DMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETSLT  167 (294)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC------
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEEeCCCcccccccccc
Confidence                       0112346889999999999999999999 88999999999999999888 699999999987643321 


Q ss_pred             -cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          216 -NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       216 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                       .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+........+.. ..+.              
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~--------------  231 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD-SVPN--------------  231 (294)
T ss_dssp             -------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS-CCCC--------------
T ss_pred             ccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-cCCC--------------
Confidence             23457899999999998755 899999999999999999999999988766554443321 0000              


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                               .....+..+++.+.++|.+||+.||.+||+..+.+.+.|..-+..
T Consensus       232 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          232 ---------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             ---------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             ---------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                     111234557999999999999999999997777777777655543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.7e-42  Score=327.11  Aligned_cols=235  Identities=25%  Similarity=0.392  Sum_probs=160.7

Q ss_pred             ccccceeeee-eeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceE----------------e--
Q 016085           88 KQTISYMAER-VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVH----------------Y--  148 (395)
Q Consensus        88 ~~~~~y~~~~-~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~----------------~--  148 (395)
                      ...++|.+.+ +||+|+||.||+|++..+++.||||++........+....++.+.|+||.                +  
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            3456799965 69999999999999999999999999987766665566677888999970                0  


Q ss_pred             ------------e--ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC--CceEEeecCCcccccc
Q 016085          149 ------------S--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVLVK  212 (395)
Q Consensus       149 ------------~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~--~~ikl~DFG~a~~~~~  212 (395)
                                  .  .....+++..++.++.||+.||.||| +.||+||||||+|||++.++  ..+||+|||+++....
T Consensus       105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH-~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH-SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence                        0  11236899999999999999999999 88999999999999997632  2599999999986543


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          213 GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      . ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+.....             ..
T Consensus       184 ~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------~~  248 (336)
T 3fhr_A          184 N-ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR-------------LG  248 (336)
T ss_dssp             ---------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC--------------------------------
T ss_pred             c-ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh-------------cc
Confidence            2 234567899999999986644 89999999999999999999999977554332211111000             00


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      ...++        ......+++.+.+||.+||+.||++|||+.++++||||++.
T Consensus       249 ~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          249 QYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             --CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             ccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            00000        01123478999999999999999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.8e-42  Score=324.59  Aligned_cols=240  Identities=26%  Similarity=0.390  Sum_probs=167.6

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE---------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      ...++|++.+.||+|+||.||+|++..+++.||||++...     .....+|+.+++.++|+||.               
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            3445799999999999999999999999999999987543     23345789999999999981               


Q ss_pred             --ee-----------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcc
Q 016085          148 --YS-----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  208 (395)
Q Consensus       148 --~~-----------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~  208 (395)
                        +.                 .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~  169 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-KNGQIHRDVKAGNILLGEDG-SVQIADFGVSA  169 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEECTTC-CEEECCCHHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCCCCChhhEEEcCCC-CEEEEeccchh
Confidence              00                 01344889999999999999999999 88999999999999999887 69999999987


Q ss_pred             ccccCC------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 016085          209 VLVKGE------PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  282 (395)
Q Consensus       209 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  282 (395)
                      ......      ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+......+......  .+.  
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~--  245 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN--DPP--  245 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--SCC--
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--CCC--
Confidence            654321      1234578999999999865344899999999999999999999999887765544433221  000  


Q ss_pred             HHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                     ..............++..+.+||.+||+.||.+|||+.++++||||++...
T Consensus       246 ---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          246 ---------------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             ---------------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             ---------------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence                           000000111233457899999999999999999999999999999988654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.3e-42  Score=326.08  Aligned_cols=222  Identities=27%  Similarity=0.420  Sum_probs=180.6

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----------hhHHHHHHHHHhcCC--CceE----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDH--PNVH----------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----------~~~~~E~~~l~~l~h--~ni~----------  147 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||++....          ....+|+.+++.+.|  +||.          
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            457999999999999999999999999999999986542          234579999999975  8870          


Q ss_pred             -----e------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          148 -----Y------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       148 -----~------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                           .            ......+++..++.++.||+.||.||| +.||+||||||+|||++.+.+.+||+|||+++..
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~  200 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  200 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence                 0            012356788899999999999999999 8899999999999999844347999999999876


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+..      .+..  +             
T Consensus       201 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~--~-------------  258 (320)
T 3a99_A          201 KDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--G-------------  258 (320)
T ss_dssp             CSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--C-------------
T ss_pred             ccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc--c-------------
Confidence            433 23456789999999999776645789999999999999999999996532      1111  0             


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                        .            ..++..+++.+.+||.+||+.||++|||+.++++||||++...
T Consensus       259 --~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          259 --Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             --C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             --c------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence              0            0123457899999999999999999999999999999988654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8.3e-41  Score=316.98  Aligned_cols=226  Identities=22%  Similarity=0.325  Sum_probs=172.4

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE--------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ....+|++.+.||+|+||.||+|++  +++.||||++....      ....+|+.+++.++|+||.              
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            4456899999999999999999987  68899999986432      2345899999999999981              


Q ss_pred             -e-----------eccCC---CCcHHHHHHHHHHHHHHHHHHHcCCC--eeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          148 -Y-----------SRASQ---RMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       148 -~-----------~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                       .           .....   .+++..+..++.||+.||.||| +.|  |+||||||+|||++.++ .+||+|||+++..
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~  189 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGLSRLK  189 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH-TSSSCCCCTTCCGGGEEECTTC-CEEECCCC-----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCEECCCCChhhEEEeCCC-cEEECCCCCCccc
Confidence             0           01111   2788889999999999999999 889  99999999999999887 6999999999765


Q ss_pred             ccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          211 VKGE-PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       211 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      .... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.....            
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------------  256 (309)
T 3p86_A          190 ASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK------------  256 (309)
T ss_dssp             ------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC------------
T ss_pred             cccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------
Confidence            4332 233567899999999997755 89999999999999999999999988877665554432110            


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc--CCcccC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFDE  345 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~--hp~f~~  345 (395)
                                     ...++..+++.+.+||.+||+.||.+|||+.++++  +++++.
T Consensus       257 ---------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          257 ---------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ---------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                           01133457899999999999999999999999986  455544

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=317.91  Aligned_cols=231  Identities=26%  Similarity=0.381  Sum_probs=167.5

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE------------e--
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH------------Y--  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~------------~--  148 (395)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++....      ....++..+++.++|+||.            +  
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            4467999999999999999999999999999999986532      2223455578888999981            0  


Q ss_pred             ------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCC-CeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 ------------SRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 ------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                  ......+++..++.++.||+.||.||| +. ||+||||||+|||++.++ .+||+|||++........
T Consensus       103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH-HHHCCCCCCCCGGGEEECTTS-CEEECCCTTC--------
T ss_pred             EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH-hhCCEEeCCCCHHHEEECCCC-CEEEEECCCchhccCCcc
Confidence                        011356889999999999999999999 64 999999999999999887 699999999977655544


Q ss_pred             ccccccccccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          216 NISYICSRYYRAPELIF----GATEYTTAVDIWSVGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      .....+|+.|+|||++.    ....++.++|||||||++|+|++|+.||.+.. ..+.+..+...  .+.          
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~----------  248 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE--EPP----------  248 (318)
T ss_dssp             ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS--CCC----------
T ss_pred             ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc--CCC----------
Confidence            45567899999999985    23448899999999999999999999998744 33444444331  000          


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                          ..          .....+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus       249 ----~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          249 ----LL----------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             ----CC----------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             ----CC----------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                00          01124789999999999999999999999999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5e-41  Score=312.74  Aligned_cols=228  Identities=27%  Similarity=0.397  Sum_probs=184.0

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe-----e--------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY-----S--------  149 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~-----~--------  149 (395)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...      .....+|+.+++.++|+||..     .        
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            345799999999999999999999999999999998642      234568999999999999810     0        


Q ss_pred             -------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCC-----eeeccCCCCceEEcCCCCceEEeecC
Q 016085          150 -------------------RASQRMPLIYVKLYTYQICRALAYIHGGIG-----VCHRDIKPQNLLVNPHTHQVKLCDFG  205 (395)
Q Consensus       150 -------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g-----iiHrDlKp~Nill~~~~~~ikl~DFG  205 (395)
                                         .....+++..++.++.||+.||.||| +.|     |+||||||+|||++.++ .+||+|||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~dfg  161 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH-RRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFG  161 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HHC------CCCCCSGGGEEECSSS-CEEECCCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh-cccCCCCeeEEeccchhhEEEcCCC-CEEEecCc
Confidence                               01123888899999999999999999 778     99999999999999887 69999999


Q ss_pred             CccccccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          206 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       206 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                      +++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+....        
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--------  232 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--------  232 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------
T ss_pred             hheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc--------
Confidence            9976543322 22456899999999997754 8999999999999999999999998877665555544310        


Q ss_pred             hhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          285 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                                 .+         .++..++..+.+||.+||+.||++|||+.++++|+|+..-.
T Consensus       233 -----------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          233 -----------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             -----------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             -----------cc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                       00         12334789999999999999999999999999999997643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-40  Score=313.31  Aligned_cols=226  Identities=25%  Similarity=0.336  Sum_probs=171.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCceEee------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVHYS------------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni~~~------------------  149 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.++|+||...                  
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            47999999999999999999999999999999986543   334579999999999998110                  


Q ss_pred             ----------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCc
Q 016085          150 ----------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  207 (395)
Q Consensus       150 ----------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a  207 (395)
                                            .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~  163 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH-SQGIIHRDLKPMNIFIDESR-NVKIGDFGLA  163 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECCCCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH-hCCeecccCCHHhEEEcCCC-CEEEeeCcch
Confidence                                  01124567788899999999999999 88999999999999999888 6999999999


Q ss_pred             cccccC---------------CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHH
Q 016085          208 KVLVKG---------------EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVE  271 (395)
Q Consensus       208 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~  271 (395)
                      ......               .......||+.|+|||++.+...++.++|||||||++|+|++   ||...... .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~  240 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK  240 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence            765321               122345689999999999766568999999999999999998   55432221 22222


Q ss_pred             HHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       272 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      +...                 ...        +...+....+..+.+||.+||+.||.+|||+.++++||||...
T Consensus       241 ~~~~-----------------~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          241 LRSV-----------------SIE--------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHST-----------------TCC--------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             cccc-----------------ccc--------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            1110                 000        1112334567889999999999999999999999999999653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.4e-40  Score=309.60  Aligned_cols=222  Identities=21%  Similarity=0.301  Sum_probs=177.4

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----------hhHHHHHHHHHhcCCCceE---------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVH---------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----------~~~~~E~~~l~~l~h~ni~---------  147 (395)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....           ....+|+.+++.++|+||.         
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            34468999999999999999999999999999999985321           4456899999999999981         


Q ss_pred             ----------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCC--eeeccCCCCceEEcCCCC----ceEEeecC
Q 016085          148 ----------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTH----QVKLCDFG  205 (395)
Q Consensus       148 ----------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlKp~Nill~~~~~----~ikl~DFG  205 (395)
                                      .......+++..+..++.|++.||.||| +.|  |+||||||+|||++.++.    .+||+|||
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           96 PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH-TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH-hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence                            1123346889999999999999999999 889  999999999999987652    29999999


Q ss_pred             CccccccCCCcccccccccccccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCCHH
Q 016085          206 SAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQ--LVEIIKVLGTPTRE  282 (395)
Q Consensus       206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~  282 (395)
                      +++....  ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+....  ...+.. .+     
T Consensus       175 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~-----  246 (287)
T 4f0f_A          175 LSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EG-----  246 (287)
T ss_dssp             TCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SC-----
T ss_pred             ccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cC-----
Confidence            9975432  3345678999999999842 23478899999999999999999999987654333  222211 11     


Q ss_pred             HHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                           ....++..+++.+.+||.+||+.||.+|||+.++++
T Consensus       247 ---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          247 ---------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             ---------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                 111234457899999999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=311.32  Aligned_cols=230  Identities=27%  Similarity=0.428  Sum_probs=176.2

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-----------------e--
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-----------------Y--  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-----------------~--  148 (395)
                      +|....+||+|+||.||+|++..+++.||||.+...    .....+|+.+++.++|+||.                 +  
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            355556999999999999999999999999998643    24456899999999999980                 0  


Q ss_pred             -------ec---cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccc
Q 016085          149 -------SR---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNI  217 (395)
Q Consensus       149 -------~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~  217 (395)
                             ..   ....+++..++.++.||+.||.||| +.||+||||||+|||++...+.+||+|||++....... ...
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  181 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH-DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE  181 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH-hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence                   00   1124568888999999999999999 88999999999999998733379999999998764322 233


Q ss_pred             cccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          218 SYICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+................                  
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------------  243 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------------  243 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC------------------
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc------------------
Confidence            45789999999998653 23789999999999999999999999765433322111111100                  


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                              ...++..+++.+.+||.+||+.||++|||+.++++||||+....
T Consensus       244 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          244 --------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             --------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence                    01133457899999999999999999999999999999986543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.7e-42  Score=337.40  Aligned_cols=219  Identities=23%  Similarity=0.264  Sum_probs=173.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCC-Cce---------------E
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDH-PNV---------------H  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h-~ni---------------~  147 (395)
                      ..|++.++||+|+||.||+|++..+|+.||||++...       ...+.+|+.+++.+.| .|.               .
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4699999999999999999999999999999988622       2345689999999987 221               0


Q ss_pred             e-------------------------------------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeecc
Q 016085          148 Y-------------------------------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD  184 (395)
Q Consensus       148 ~-------------------------------------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrD  184 (395)
                      .                                           ......+++..+..++.||+.||+||| +.||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH-HTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCC
Confidence            0                                           000223456677788899999999999 88999999


Q ss_pred             CCCCceEEcCCCCceEEeecCCccccccCCCccccccccccccccccc---------CCCCCCCcchHHHHHHHHHHHHh
Q 016085          185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF---------GATEYTTAVDIWSVGCVLAELLL  255 (395)
Q Consensus       185 lKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DiwSlG~il~ell~  255 (395)
                      |||+||||+.++ .+||+|||+++.....  ....+| +.|+|||++.         ....++.++|||||||++|+|++
T Consensus       237 iKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          237 LRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999999988 5999999998765332  345567 9999999983         33347889999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHH
Q 016085          256 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL  335 (395)
Q Consensus       256 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~  335 (395)
                      |+.||.+.+.......+                       +.          ....+++.+.+||.+||+.||++|||+.
T Consensus       313 g~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~  359 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLPL  359 (413)
T ss_dssp             SSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCHH
Confidence            99999765432111100                       00          1124789999999999999999999999


Q ss_pred             HHhcCCcccCCC
Q 016085          336 EACIHPFFDELR  347 (395)
Q Consensus       336 e~l~hp~f~~~~  347 (395)
                      ++++||||+.+.
T Consensus       360 ~~l~~~~~~~~~  371 (413)
T 3dzo_A          360 QAMETPEYEQLR  371 (413)
T ss_dssp             HHTTSHHHHHHH
T ss_pred             HHHhCHHHHHHH
Confidence            999999998753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=315.05  Aligned_cols=227  Identities=26%  Similarity=0.435  Sum_probs=177.5

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-----------------e
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++|+||.                 +
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            45799999999999999999999999999999988542    33456899999999999980                 0


Q ss_pred             ----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc--
Q 016085          149 ----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--  216 (395)
Q Consensus       149 ----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~--  216 (395)
                                ......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++........  
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH-SMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEECTTS-CEEECCCTTCEECC-------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCCcCeEEECCCC-CEEEeecccceeccccccccc
Confidence                      012456889999999999999999999 88999999999999999887 6999999999875433221  


Q ss_pred             -------------ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 016085          217 -------------ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  283 (395)
Q Consensus       217 -------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  283 (395)
                                   ...+||+.|+|||++.+.. ++.++|||||||++|+|++|..||..........             
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-------------  232 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-------------  232 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-------------
T ss_pred             ccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-------------
Confidence                         1457899999999997754 8999999999999999999999986532210000             


Q ss_pred             HhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          284 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                                   ............+..+++.+.+||.+||+.||++|||+.++++  |++.+.
T Consensus       233 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          233 -------------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             -------------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             -------------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence                         0000000011134557899999999999999999999999985  665554

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.8e-40  Score=317.16  Aligned_cols=223  Identities=19%  Similarity=0.222  Sum_probs=175.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhc-CCCceE-----------------ee
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL-DHPNVH-----------------YS  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l-~h~ni~-----------------~~  149 (395)
                      ..+|++.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.+ +|+||.                 +.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            35799999999999999999999999999999998643  34567899999999 999970                 00


Q ss_pred             ---------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC----ceEEeecCCccccccCCC-
Q 016085          150 ---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH----QVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       150 ---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~----~ikl~DFG~a~~~~~~~~-  215 (395)
                               .....+++..++.++.||+.||+||| +.||+||||||+|||++.+++    .+||+|||+++....... 
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~  166 (330)
T 2izr_A           88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH-SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK  166 (330)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence                     11457899999999999999999999 889999999999999987762    199999999987644332 


Q ss_pred             -------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCCHHHHh
Q 016085          216 -------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       216 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~  285 (395)
                             .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..   +.+..+.......+..   
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~---  242 (330)
T 2izr_A          167 KHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE---  242 (330)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH---
T ss_pred             ccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH---
Confidence                   23567899999999998755 899999999999999999999999885433   3333333221111111   


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                           .+....+ ++.+||.+||+.||.+||++.++++
T Consensus       243 ---------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          243 ---------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             ---------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ---------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                                 0112234 9999999999999999999988765

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.3e-40  Score=309.13  Aligned_cols=224  Identities=19%  Similarity=0.232  Sum_probs=177.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhc-CCCceE-----------------e-
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL-DHPNVH-----------------Y-  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l-~h~ni~-----------------~-  148 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.+ +|+|+.                 + 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            34799999999999999999999999999999988643  34567899999999 777760                 0 


Q ss_pred             --------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC----ceEEeecCCccccccCCC-
Q 016085          149 --------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH----QVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       149 --------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~----~ikl~DFG~a~~~~~~~~-  215 (395)
                              ......+++..+..++.||+.||.||| +.||+||||||+|||++.++.    .+||+|||+++....... 
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~  167 (298)
T 1csn_A           89 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  167 (298)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence                    011345899999999999999999999 899999999999999986652    399999999987654322 


Q ss_pred             -------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCCHHHHh
Q 016085          216 -------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       216 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~  285 (395)
                             .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+   ....+..+......++..   
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  243 (298)
T 1csn_A          168 QHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR---  243 (298)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH---
T ss_pred             ccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH---
Confidence                   23457899999999997755 8999999999999999999999998743   333333333321111111   


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                           .+...+++.+.+||.+||+.||++|||+.++++
T Consensus       244 ---------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          244 ---------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             ---------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ---------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence                                 122347899999999999999999999998874

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.6e-40  Score=316.22  Aligned_cols=229  Identities=21%  Similarity=0.282  Sum_probs=165.7

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCc---EEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~---~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      ...++|++.+.||+|+||.||+|++..++.   .||||++...      .....+|+.+++.++|+||.           
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            334579999999999999999999887765   8999988643      23456899999999999981           


Q ss_pred             -------ee---c-----------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceE
Q 016085          148 -------YS---R-----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK  200 (395)
Q Consensus       148 -------~~---~-----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ik  200 (395)
                             +.   .                 ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+|
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~ivH~Dikp~NIli~~~~-~~k  177 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS-SRNFIHRDLAARNCMLAEDM-TVC  177 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTS-CEE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH-cCCcccCCCCcceEEEcCCC-CEE
Confidence                   10   0                 0114788899999999999999999 88999999999999999887 699


Q ss_pred             EeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 016085          201 LCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVL  276 (395)
Q Consensus       201 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  276 (395)
                      |+|||+++.......   .....+|+.|+|||.+.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  256 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN  256 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence            999999987644322   12345578899999997755 8999999999999999999 999999887766655554310


Q ss_pred             CCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-------HHHHhcCCcccCCC
Q 016085          277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-------ALEACIHPFFDELR  347 (395)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-------~~e~l~hp~f~~~~  347 (395)
                      .                            ...+..+++.+.+||.+||+.||++|||       ..+++.|+|+....
T Consensus       257 ~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          257 R----------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             C----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             C----------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            0                            0123457899999999999999999999       67788899997643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-40  Score=316.09  Aligned_cols=234  Identities=26%  Similarity=0.355  Sum_probs=160.3

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHH-HHHhcCCCceEe--------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQ-TMRLLDHPNVHY--------------  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~-~l~~l~h~ni~~--------------  148 (395)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....     ....+|+. +++.++|+||..              
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            3457999999999999999999999999999999986532     12223444 777889999810              


Q ss_pred             ----------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCC-CeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          149 ----------------SRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       149 ----------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                                      ......+++..+..++.|++.||.||| +. ||+||||||+|||++.++ .+||+|||+++...
T Consensus       100 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK-ENLKIIHRDIKPSNILLDRSG-NIKLCDFGISGQLV  177 (327)
T ss_dssp             ECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH-HHHSCCCSCCCGGGEEEETTT-EEEECCCSSSCC--
T ss_pred             EeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh-ccCCEeECCCCHHHEEEcCCC-CEEEccCCCceecc
Confidence                            001456889999999999999999999 77 999999999999999887 69999999998765


Q ss_pred             cCCCccccccccccccccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          212 KGEPNISYICSRYYRAPELIF---GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      .........||+.|+|||++.   ....++.++|||||||++|+|++|+.||.+.+....  .+..              
T Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~--------------  241 (327)
T 3aln_A          178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQ--------------  241 (327)
T ss_dssp             ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CC--------------
T ss_pred             cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HHHH--------------
Confidence            544444557899999999983   223489999999999999999999999976432110  0000              


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                        ......+.     +.......+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       242 --~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          242 --VVKGDPPQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             --CCCSCCCC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             --HhcCCCCC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence              00000010     11112345789999999999999999999999999999997654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=314.79  Aligned_cols=221  Identities=22%  Similarity=0.305  Sum_probs=177.1

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCc---EEEEEEeecc-----hhhHHHHHHHHHhcCCCceE------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~---~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~------------  147 (395)
                      ....+|++.+.||+|+||.||+|++..+++   .||||++...     .....+|+.+++.++|+||.            
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            445689999999999999999999986655   4999998653     23456799999999999980            


Q ss_pred             --------------ee-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          148 --------------YS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 --------------~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                    +. .....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS-DLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCSSCEECC-
T ss_pred             EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCcceEEECCCC-CEEECCCCccccccc
Confidence                          01 12357889999999999999999999 88999999999999999887 699999999987644


Q ss_pred             CCCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 016085          213 GEPN----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  287 (395)
Q Consensus       213 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  287 (395)
                      ....    ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.....          
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----------  272 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR----------  272 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred             CccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC----------
Confidence            3221    1234577899999997654 8999999999999999999 9999988877766655543110          


Q ss_pred             CCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                        ...+..+++.+.+||.+||..||.+|||+.++++
T Consensus       273 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          273 ------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                              0123357899999999999999999999999874

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=322.75  Aligned_cols=227  Identities=19%  Similarity=0.218  Sum_probs=179.9

Q ss_pred             ccccceeeeeeeccCCceEEEEEE-----EcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE----------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAK-----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH----------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~-----~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~----------  147 (395)
                      ....+|++.+.||+|+||.||+|+     +..+++.||||++...     .....+|+.+++.++|+||.          
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            344689999999999999999999     4457789999998542     23355799999999999981          


Q ss_pred             -------ee----------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC--ceEEe
Q 016085          148 -------YS----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLC  202 (395)
Q Consensus       148 -------~~----------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~--~ikl~  202 (395)
                             +.                .....+++..++.++.||+.||.||| +.||+||||||+|||++.++.  .+||+
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence                   00                01135788899999999999999999 889999999999999985442  59999


Q ss_pred             ecCCccccccC---CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 016085          203 DFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  278 (395)
Q Consensus       203 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  278 (395)
                      |||+|+.....   .......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+..... 
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~-  304 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR-  304 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-
Confidence            99999764322   2233456799999999997755 8999999999999999998 9999998877666555443110 


Q ss_pred             CCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                                                 ...+..++..+.+||.+||+.||++|||+.++++|.++-
T Consensus       305 ---------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          305 ---------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                                       012344789999999999999999999999999987763

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.1e-40  Score=312.12  Aligned_cols=229  Identities=24%  Similarity=0.334  Sum_probs=172.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCC--CceE--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDH--PNVH--------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h--~ni~--------------  147 (395)
                      ..+|++.+.||+|+||.||+|++. +++.||||++...      .....+|+.+++.+.|  +||.              
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            346999999999999999999975 5899999998542      2345689999999974  8870              


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                                 +......+++..++.++.||+.||.||| +.||+||||||+|||++. + .+||+|||+++....... 
T Consensus       106 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          106 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-G-MLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEET-T-EEEECCCSSSCC-------
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcccEEEEC-C-eEEEeeccccccccCcccc
Confidence                       1122356788899999999999999999 889999999999999974 4 699999999987643322 


Q ss_pred             --cccccccccccccccccCC----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHH
Q 016085          216 --NISYICSRYYRAPELIFGA----------TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD-QLVEIIKVLGTPTRE  282 (395)
Q Consensus       216 --~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  282 (395)
                        .....||+.|+|||++.+.          ..++.++|||||||++|+|++|+.||.+..... .+..+...       
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-------  255 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-------  255 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT-------
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc-------
Confidence              2245689999999998651          348889999999999999999999997654332 22222110       


Q ss_pred             HHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                             .             ....++...+..+.+||.+||+.||.+|||+.++++||||+....+
T Consensus       256 -------~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          256 -------N-------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             -------T-------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             -------c-------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence                   0             0011233457899999999999999999999999999999875443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.7e-40  Score=320.35  Aligned_cols=221  Identities=26%  Similarity=0.385  Sum_probs=177.3

Q ss_pred             ccceeeeeeeccCCceEEEEEE-----EcCCCcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceE-----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAK-----CLETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVH-----------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~-----~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~-----------  147 (395)
                      .++|++.+.||+|+||.||+|+     +..+++.||||++....     ....+|+.+++.+ +|+||.           
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~  100 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  100 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence            4579999999999999999998     55677899999986532     3456899999999 789980           


Q ss_pred             -------e---------ecc------------------------------------------------------------
Q 016085          148 -------Y---------SRA------------------------------------------------------------  151 (395)
Q Consensus       148 -------~---------~~~------------------------------------------------------------  151 (395)
                             +         ...                                                            
T Consensus       101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (359)
T 3vhe_A          101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  180 (359)
T ss_dssp             CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred             ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence                   0         000                                                            


Q ss_pred             ------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC---ccccccc
Q 016085          152 ------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICS  222 (395)
Q Consensus       152 ------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt  222 (395)
                            ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.......   .....||
T Consensus       181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH-~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t  258 (359)
T 3vhe_A          181 APEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLP  258 (359)
T ss_dssp             ---CTTTTCBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred             cccchhccccCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccccCCC
Confidence                  111888999999999999999999 88999999999999999887 699999999986543322   2245678


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccC
Q 016085          223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  301 (395)
Q Consensus       223 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (395)
                      +.|+|||++.+.. ++.++|||||||++|+|++ |..||.+......+...+.....+                      
T Consensus       259 ~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------  315 (359)
T 3vhe_A          259 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------------------  315 (359)
T ss_dssp             GGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----------------------
T ss_pred             ceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC----------------------
Confidence            9999999997754 8999999999999999998 999999877665555544421110                      


Q ss_pred             CCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       302 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                           ..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       316 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 -----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                 1233478999999999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-41  Score=316.73  Aligned_cols=220  Identities=27%  Similarity=0.425  Sum_probs=176.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----------hhHHHHHHHHHhc----CCCceE---------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLL----DHPNVH---------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----------~~~~~E~~~l~~l----~h~ni~---------  147 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++....          ....+|+.+++.+    +|+||.         
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            36999999999999999999999999999999986432          2234699999999    899980         


Q ss_pred             ------e------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc-CCCCceEEeecCCcc
Q 016085          148 ------Y------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-PHTHQVKLCDFGSAK  208 (395)
Q Consensus       148 ------~------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~-~~~~~ikl~DFG~a~  208 (395)
                            .            ......+++..++.++.||+.||.||| +.||+||||||+||+++ .++ .+||+|||++.
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~-~~kl~dfg~~~  188 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH-SRGVVHRDIKDENILIDLRRG-CAKLIDFGSGA  188 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HHTEECCCCSGGGEEEETTTT-EEEECCCSSCE
T ss_pred             CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChhhEEEeCCCC-eEEEEEcchhh
Confidence                  0            111345889999999999999999999 78999999999999998 555 79999999998


Q ss_pred             ccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          209 VLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ..... ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+..      .+...             
T Consensus       189 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~-------------  248 (312)
T 2iwi_A          189 LLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA-------------  248 (312)
T ss_dssp             ECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT-------------
T ss_pred             hcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh-------------
Confidence            76443 33456789999999998765545668999999999999999999996531      11110             


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                          .            ..++..++..+.+||.+||+.||++|||+.++++||||+....
T Consensus       249 ----~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          249 ----E------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             ----C------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ----c------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                0            0123457899999999999999999999999999999987654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-40  Score=305.94  Aligned_cols=221  Identities=19%  Similarity=0.318  Sum_probs=179.3

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ....+|++.+.||+|+||.||+|++. +++.||+|++...   .....+|+.+++.++|+||.                 
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            34457999999999999999999986 5778999998653   34567899999999999980                 


Q ss_pred             e----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--C
Q 016085          148 Y----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--P  215 (395)
Q Consensus       148 ~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--~  215 (395)
                      +          ......+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||+++......  .
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHS
T ss_pred             eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH-hCCeecCCcchheEEEcCCC-CEEecccccccccccccccc
Confidence            0          012345789999999999999999999 88999999999999999887 69999999997653321  1


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+....                  
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~------------------  224 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------------  224 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------------------
T ss_pred             ccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc------------------
Confidence            22345678899999997655 8999999999999999999 999999887766655554310                  


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                ....+...++.+.+||.+||+.||++|||+.++++|
T Consensus       225 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          225 ----------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                      011233468999999999999999999999999865

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.1e-40  Score=317.93  Aligned_cols=221  Identities=24%  Similarity=0.361  Sum_probs=176.4

Q ss_pred             cccceeeeeeeccCCceEEEEEEEc-------CCCcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceE--------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCL-------ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVH--------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~--------  147 (395)
                      ..++|++.+.||+|+||.||+|++.       .++..||||++....     ....+|+.+|+.+ +||||.        
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            4468999999999999999999875       345679999986532     3456899999999 899980        


Q ss_pred             ---------ee---------c----------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc
Q 016085          148 ---------YS---------R----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  193 (395)
Q Consensus       148 ---------~~---------~----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~  193 (395)
                               +.         .                ....+++..+..++.||+.||+||| ++||+||||||+|||++
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA-SQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEC
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCeeccccchhhEEEC
Confidence                     00         0                0124688889999999999999999 88999999999999999


Q ss_pred             CCCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016085          194 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQL  269 (395)
Q Consensus       194 ~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  269 (395)
                      .++ .+||+|||+++.......   .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+..
T Consensus       238 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          238 ENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             TTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             CCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            888 699999999986543322   23345688999999998755 9999999999999999999 99999887765554


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          270 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       270 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ..+....                            ....+..++.++.+||.+||+.||.+|||+.|++++
T Consensus       316 ~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          316 KLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHTTC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4432210                            001234578999999999999999999999999863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.6e-40  Score=317.34  Aligned_cols=221  Identities=24%  Similarity=0.331  Sum_probs=171.5

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEE----EEEEeecc-----hhhHHHHHHHHHhcCCCceE------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETV----AIKKVLQD-----KRYKNRELQTMRLLDHPNVH------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~v----AiK~~~~~-----~~~~~~E~~~l~~l~h~ni~------------  147 (395)
                      ...+|++.+.||+|+||.||+|++..+++.|    |+|.+...     .....+|+.+++.++|+||.            
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   92 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ   92 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEE
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            3457999999999999999999998887765    77766432     24456899999999999981            


Q ss_pred             --------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 --------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 --------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                    .......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|+.....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEETT-EEEECCTTHHHHHTTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCChheEEECCCC-CEEEccCcceeEccCC
Confidence                          0112456889999999999999999999 88999999999999999887 6999999999876443


Q ss_pred             CCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          214 EPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       214 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      ...   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+.......+.... .           
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~-----------  237 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-R-----------  237 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-C-----------
T ss_pred             cccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-C-----------
Confidence            322   2344588999999998755 8999999999999999999 999998876655433332210 0           


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                      ...+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       238 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          238 ----------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ----------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                            01223468899999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.6e-40  Score=308.09  Aligned_cols=223  Identities=22%  Similarity=0.257  Sum_probs=177.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCCCce------------------Ee-
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNV------------------HY-  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~ni------------------~~-  148 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.++|+++                  .+ 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            35799999999999999999999999999999987543  3456789999999998774                  00 


Q ss_pred             --------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc---CCCCceEEeecCCccccccCCC--
Q 016085          149 --------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN---PHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       149 --------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~---~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                              ......+++..+..++.||+.||.||| +.||+||||||+|||++   .++ .+||+|||+++.......  
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~~~~~~  165 (296)
T 3uzp_A           88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDARTHQ  165 (296)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECBCTTTCC
T ss_pred             CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCccccccccccc
Confidence                    012456899999999999999999999 88999999999999994   555 699999999987654322  


Q ss_pred             ------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCHHHHhh
Q 016085          216 ------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       216 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~  286 (395)
                            .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.   ...+..+.......+.     
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----  239 (296)
T 3uzp_A          166 HIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----  239 (296)
T ss_dssp             BCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----
T ss_pred             ccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-----
Confidence                  23557899999999998755 89999999999999999999999987432   2233333332111111     


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                         ..+...+++.+.+||.+||+.||.+|||+.++++
T Consensus       240 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          240 -------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -------------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                               0122447899999999999999999999998875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.5e-40  Score=315.59  Aligned_cols=222  Identities=21%  Similarity=0.285  Sum_probs=174.5

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcE----EEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGET----VAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~----vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      ....+|++.+.||+|+||.||+|++..+++.    ||+|.+....     ....+|+.+++.++|+||.           
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   89 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSL   89 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSE
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcc
Confidence            3445799999999999999999999888876    6666654321     3345799999999999981           


Q ss_pred             ---------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          148 ---------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 ---------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                     .......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-EHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH-HTTCCCSCCSSTTEEESSSS-CEEECSCSGGGGSCC
T ss_pred             EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH-hCCCCCCccchheEEECCCC-eEEECCCCcccccCc
Confidence                           0011246788889999999999999999 88999999999999999887 599999999987644


Q ss_pred             CCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          213 GEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       213 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ...   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+....+....+....            
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------  234 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE------------  234 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC------------
T ss_pred             ccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC------------
Confidence            332   23455678999999997655 8999999999999999999 999998876655444433210            


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                      ....+..++.++.+||.+||+.||.+|||+.++++|
T Consensus       235 ----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          235 ----------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ----------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ----------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            001223367889999999999999999999999876

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.6e-40  Score=311.58  Aligned_cols=223  Identities=22%  Similarity=0.257  Sum_probs=174.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCCCce----------------E--e-
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNV----------------H--Y-  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~ni----------------~--~-  148 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.++|+++                .  + 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            34799999999999999999999999999999986543  3456789999999998874                0  0 


Q ss_pred             --------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE---cCCCCceEEeecCCccccccCCC--
Q 016085          149 --------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       149 --------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill---~~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                              ......+++..+..++.||+.||.||| +.||+||||||+|||+   +.++ .+||+|||+++.......  
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~~~~~  165 (296)
T 4hgt_A           88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDARTHQ  165 (296)
T ss_dssp             CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECBCTTTCC
T ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeeeeccCCCC-eEEEecCccceeccCcccCc
Confidence                    012456899999999999999999999 8899999999999999   5555 699999999987644322  


Q ss_pred             ------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCCHHHHhh
Q 016085          216 ------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       216 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~  286 (395)
                            .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..   ..+..+.......+.     
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----  239 (296)
T 4hgt_A          166 HIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----  239 (296)
T ss_dssp             BCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----
T ss_pred             cCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-----
Confidence                  22457899999999998755 899999999999999999999999874432   222332221111110     


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                         ..+...+++.+.+||.+||+.||++|||+.++++
T Consensus       240 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          240 -------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                               1122447899999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=330.05  Aligned_cols=243  Identities=21%  Similarity=0.328  Sum_probs=177.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      .++|++.++||+|+||.||+|++..+++.||||++...     .....+|+.+++.++|+||..                
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            45799999999999999999999999999999998643     244568999999999999810                


Q ss_pred             ------------ec---cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE----cCCCCceEEeecCCccc
Q 016085          149 ------------SR---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       149 ------------~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill----~~~~~~ikl~DFG~a~~  209 (395)
                                  ..   ....+++..++.++.||+.||+||| +.||+||||||+|||+    +.++ .+||+|||+++.
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~a~~  165 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAARE  165 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEEECTTSCE-EEEECCGGGCEE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH-HCCEEECCcCHHHEEEeecCCCce-eEEEecCCCceE
Confidence                        00   1122899999999999999999999 8899999999999998    6555 699999999987


Q ss_pred             cccCCCcccccccccccccccccCC-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHhCC
Q 016085          210 LVKGEPNISYICSRYYRAPELIFGA-------TEYTTAVDIWSVGCVLAELLLGQPLFPGES----GVDQLVEIIKVLGT  278 (395)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~  278 (395)
                      ...........||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||.+..    ..+.+..+..  +.
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~  243 (396)
T 4eut_A          166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GK  243 (396)
T ss_dssp             CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--SC
T ss_pred             ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--CC
Confidence            7555555567899999999998541       237889999999999999999999997532    3334444433  22


Q ss_pred             CCHHHHhhcC-CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          279 PTREEIKCMN-PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       279 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      |.. .+.... .....+.+.  ...+....+...++..+.+||++||++||++|+|+.++++
T Consensus       244 p~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          244 PSG-AISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             CTT-CCEEEECSTTCCEEEE--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             Ccc-cchhheeccCCCcccC--ccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            221 111000 000000000  0000111122334567899999999999999999998754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=315.26  Aligned_cols=219  Identities=24%  Similarity=0.332  Sum_probs=169.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEE----EEEEeec-----chhhHHHHHHHHHhcCCCceE-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETV----AIKKVLQ-----DKRYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~v----AiK~~~~-----~~~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ..+|++.+.||+|+||.||+|++..+++.|    |+|.+..     ......+|+.+++.++|+||.             
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL   93 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence            457999999999999999999998888766    5555532     234566899999999999981             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                   .......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++......
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEETT-EEEECCTTC--------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh-hCCCcCCCCCHHHEEEcCCC-CEEEccCcceeEccCcc
Confidence                         0112456889999999999999999999 88999999999999999887 69999999998764332


Q ss_pred             C---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          215 P---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       215 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      .   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....              
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--------------  236 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------------  236 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------------
T ss_pred             ccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            2   22344578899999998755 8999999999999999999 999998877655444333210              


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                    ....+..++.++.+||.+||..||.+|||+.++++
T Consensus       237 --------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          237 --------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             --------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                          00123346889999999999999999999999886

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-39  Score=302.22  Aligned_cols=220  Identities=19%  Similarity=0.284  Sum_probs=177.6

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE---------------ee-
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH---------------YS-  149 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~---------------~~-  149 (395)
                      ..++|++.+.||+|+||.||+|++. ++..||+|++...   .....+|+.+++.++|+||.               .. 
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            4457999999999999999999875 5678999998654   34456899999999999980               00 


Q ss_pred             -----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--c
Q 016085          150 -----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--N  216 (395)
Q Consensus       150 -----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--~  216 (395)
                                 .....+++..++.++.|++.||.||| +.||+||||||+|||++.++ .+||+|||++........  .
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~  162 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE-SHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVSS  162 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH-HTTEEESSCSGGGEEECTTC-CEEECCTTCEEECCTTCEEEC
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCcCcceEEECCCC-CEEEccCccceecchhhhhcc
Confidence                       11234889999999999999999999 88999999999999999887 699999999986644322  1


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....                   
T Consensus       163 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------------  222 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-------------------  222 (268)
T ss_dssp             CSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-------------------
T ss_pred             cCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-------------------
Confidence            2334577899999997654 8999999999999999998 999998887766555543310                   


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                               ....+...++.+.+||.+||+.||++|||+.+++++
T Consensus       223 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          223 ---------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                     001123368899999999999999999999999865

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.2e-39  Score=302.18  Aligned_cols=219  Identities=26%  Similarity=0.417  Sum_probs=168.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--------hhhHHHHHHHHHhcCCCceE--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--------~~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ..+|++.+.||+|+||.||+|++  +++.||||++...        .....+|+.+++.++|+||.              
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            45799999999999999999997  4889999988543        23456899999999999981              


Q ss_pred             ---e--------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCC---eeeccCCCCceEEcCC-------CCceEEeecCC
Q 016085          148 ---Y--------SRASQRMPLIYVKLYTYQICRALAYIHGGIG---VCHRDIKPQNLLVNPH-------THQVKLCDFGS  206 (395)
Q Consensus       148 ---~--------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlKp~Nill~~~-------~~~ikl~DFG~  206 (395)
                         +        ......+++..++.++.|++.||.||| +.|   |+||||||+|||++.+       ...+||+|||+
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH-~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLH-DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH-HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence               0        112467899999999999999999999 778   9999999999999852       23699999999


Q ss_pred             ccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 016085          207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  286 (395)
                      +....... .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+...           
T Consensus       163 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------  229 (271)
T 3dtc_A          163 AREWHRTT-KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN-----------  229 (271)
T ss_dssp             --------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS-----------
T ss_pred             cccccccc-ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC-----------
Confidence            97654332 23567899999999997754 899999999999999999999999987765554443321           


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                      .....++..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       230 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          230 ----------------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ----------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                            00111234578999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.4e-40  Score=306.04  Aligned_cols=223  Identities=29%  Similarity=0.380  Sum_probs=169.1

Q ss_pred             CccccceeeeeeeccCCceEEEEEEEcCC---CcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------
Q 016085           87 PKQTISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        87 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~---~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      ....++|++.+.||+|+||.||+|++..+   +..||+|++...     .....+|+.+++.++||||.           
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV   90 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSC
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCcc
Confidence            34556899999999999999999998654   457999988642     23456899999999999981           


Q ss_pred             -----e----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          148 -----Y----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 -----~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                           +          ......+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||+++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECC---------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecccccHHHEEECCCC-CEEECccccccccCc
Confidence                 0          011235889999999999999999999 88999999999999999877 699999999987644


Q ss_pred             CCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          213 GEP--NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       213 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      ...  .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+.+..+.....            
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~------------  235 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------------  235 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------------
T ss_pred             ccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC------------
Confidence            322  12334578899999997654 8999999999999999996 9999998877666555433100            


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                      ..++..+++.+.+||.+||+.||++|||+.+++++
T Consensus       236 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          236 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                            01234578999999999999999999999998753

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.6e-40  Score=305.54  Aligned_cols=219  Identities=26%  Similarity=0.369  Sum_probs=181.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceEe----------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVHY----------------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~~----------------------  148 (395)
                      .+|++.+.||+|+||.||+|++..+++.||+|++........+|+.+++.++|+||..                      
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   90 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS   90 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence            4799999999999999999999999999999999887777889999999999999810                      


Q ss_pred             ------e----------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCC
Q 016085          149 ------S----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  206 (395)
Q Consensus       149 ------~----------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~  206 (395)
                            .                .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  168 (284)
T 2a19_B           91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH-SKKLINRDLKPSNIFLVDTK-QVKIGDFGL  168 (284)
T ss_dssp             EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred             CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCHHHEEEcCCC-CEEECcchh
Confidence                  0                01245788889999999999999999 88999999999999999877 699999999


Q ss_pred             ccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 016085          207 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  286 (395)
                      +.............+|+.|+|||++.+.. ++.++|||||||++|+|++|..||....  .....+..            
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~------------  233 (284)
T 2a19_B          169 VTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD------------  233 (284)
T ss_dssp             CEESSCCSCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT------------
T ss_pred             heeccccccccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc------------
Confidence            98776555555667899999999997754 8999999999999999999998874211  11111100            


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                                         ..++..++..+.+||.+||..||.+|||+.++++|.|.-.
T Consensus       234 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 -------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             -------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             -------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                               0122346889999999999999999999999999987643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-39  Score=303.60  Aligned_cols=221  Identities=20%  Similarity=0.283  Sum_probs=176.7

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ....+|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+.+++.++|+||.                 
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            44568999999999999999999875 6778999998753   34566899999999999980                 


Q ss_pred             e----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--C
Q 016085          148 Y----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--P  215 (395)
Q Consensus       148 ~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--~  215 (395)
                      +          ......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++......  .
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~  177 (283)
T 3gen_A          100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTS  177 (283)
T ss_dssp             CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCSGGGEEECTTS-CEEECSTTGGGGBCCHHHHS
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCCccceEEEcCCC-CEEEcccccccccccccccc
Confidence            0          011356889999999999999999999 88999999999999999887 69999999997653321  1


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+.....                 
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------------  239 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----------------  239 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-----------------
T ss_pred             ccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC-----------------
Confidence            22344578899999997655 8999999999999999998 9999998877666655543110                 


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                 ...+...++.+.+||.+||+.||.+|||+.++++|
T Consensus       240 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          240 -----------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                       01223468899999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.9e-40  Score=307.43  Aligned_cols=231  Identities=25%  Similarity=0.374  Sum_probs=171.0

Q ss_pred             ccccceeeeeeeccCCceEEEEEE----EcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceEe-----------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVHY-----------  148 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~----~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~~-----------  148 (395)
                      ....+|++.+.||+|+||.||+|+    +..+++.||||++....    ....+|+.+++.++|+||..           
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            345689999999999999999998    56789999999986542    34568999999999999810           


Q ss_pred             --------e----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          149 --------S----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       149 --------~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                              .          .....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL  164 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECCCCSCC--
T ss_pred             ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHhhEEEcCCC-eEEEccCcccccc
Confidence                    0          11234888899999999999999999 88999999999999999887 6999999999876


Q ss_pred             ccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH----
Q 016085          211 VKGEP----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE----  282 (395)
Q Consensus       211 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  282 (395)
                      .....    .....+|..|+|||++.+.. ++.++|||||||++|+|++|..||.....  .   .....+.....    
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~---~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--E---FMRMIGNDKQGQMIV  238 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHH--H---HHHHHCTTCCTHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChH--H---HHhhhcCccccchhH
Confidence            43321    12344678899999997755 89999999999999999999999864321  1   11111111100    


Q ss_pred             --HHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          283 --EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       283 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                        .......             ......+..+++++.+||.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          239 FHLIELLKN-------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHT-------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhc-------------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              0000000             0011124457899999999999999999999999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2e-39  Score=304.11  Aligned_cols=224  Identities=22%  Similarity=0.304  Sum_probs=168.4

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE--------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ...++|++.+.||+|+||.||+|++.   ..||+|++...      .....+|+.+++.++|+||.              
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv   97 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIV   97 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEE
Confidence            44567999999999999999999853   35999998532      23456899999999999981              


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC--
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--  213 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~--  213 (395)
                                  .......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++......  
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH-~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEETTT-EEEECCCC----------
T ss_pred             EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCccceEEECCCC-CEEEccceeccccccccc
Confidence                        0123456888999999999999999999 88999999999999999887 6999999999765322  


Q ss_pred             -CCcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          214 -EPNISYICSRYYRAPELIFG--ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       214 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                       .......||+.|+|||++..  ...++.++|||||||++|+|++|+.||.+....+.+..+......++.         
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  246 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD---------  246 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC---------
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc---------
Confidence             12234568999999999852  234788999999999999999999999987777766665543211110         


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                    ...+...+++.+.+||.+||+.||.+|||+.++++
T Consensus       247 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          247 --------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             --------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                          01123457899999999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.6e-40  Score=316.55  Aligned_cols=240  Identities=21%  Similarity=0.252  Sum_probs=173.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCceE----------------ee-
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVH----------------YS-  149 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni~----------------~~-  149 (395)
                      ..+|++.++||+|+||.||+|++  .++.||||++....   ....+|+.+++.++|+||.                +. 
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            45799999999999999999987  47899999986543   2334688889999999981                00 


Q ss_pred             ------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCC----------CeeeccCCCCceEEcCCCCceEEeecCCc
Q 016085          150 ------------RASQRMPLIYVKLYTYQICRALAYIHGGI----------GVCHRDIKPQNLLVNPHTHQVKLCDFGSA  207 (395)
Q Consensus       150 ------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~----------giiHrDlKp~Nill~~~~~~ikl~DFG~a  207 (395)
                                  .....+++..++.++.||+.||.||| +.          ||+||||||+|||++.++ .+||+|||++
T Consensus       101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH-~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL~DFg~a  178 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH-EDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGLA  178 (322)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHT-CCEEEETTEEECEEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred             EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH-hhccccccccCCCEEeCCCChHhEEECCCC-eEEEccCCcc
Confidence                        01234788899999999999999999 78          999999999999999887 6999999999


Q ss_pred             cccccCCC---cccccccccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016085          208 KVLVKGEP---NISYICSRYYRAPELIFGA----TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  280 (395)
Q Consensus       208 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  280 (395)
                      +.......   .....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+................+.
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            77643322   2346789999999999763    2356688999999999999999999987554322222222223333


Q ss_pred             HHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          281 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ...+......  ....+...    ...-....+..+.+||.+||+.||++|||+.++++
T Consensus       259 ~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          259 LEDMQEVVVH--KKKRPVLR----DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHHHHHHTT--SCCCCCCC----GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhhhhhhc--ccCCCCcc----ccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            3322211000  00000000    00001112456999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.7e-39  Score=314.73  Aligned_cols=228  Identities=19%  Similarity=0.164  Sum_probs=170.5

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCC-----CcEEEEEEeecchhhHHHHHH---------------HHHhcCCCceE--
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDKRYKNRELQ---------------TMRLLDHPNVH--  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~-----~~~vAiK~~~~~~~~~~~E~~---------------~l~~l~h~ni~--  147 (395)
                      .++|++.+.||+|+||.||+|.+..+     ++.||||++........+|+.               .++.++|+||.  
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            34799999999999999999998765     588999998765544444444               44556789871  


Q ss_pred             --------------e--------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc--CCCC
Q 016085          148 --------------Y--------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN--PHTH  197 (395)
Q Consensus       148 --------------~--------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~--~~~~  197 (395)
                                    +              ......+++..++.++.||+.||.||| +.||+||||||+|||++  .++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH-~~~iiHrDlkp~Nill~~~~~~-  191 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH-EHEYVHGDIKASNLLLNYKNPD-  191 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEESSCTT-
T ss_pred             EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCeEEecCCHHHEEEecCCCC-
Confidence                          0              012367899999999999999999999 78999999999999998  666 


Q ss_pred             ceEEeecCCccccccCCC--------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 016085          198 QVKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQL  269 (395)
Q Consensus       198 ~ikl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  269 (395)
                      .+||+|||+|+.......        ....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.......
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            699999999976543221        13345899999999997765 899999999999999999999999864433333


Q ss_pred             HHHHHHhCCCCH-HHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          270 VEIIKVLGTPTR-EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       270 ~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      .........+.. ......                   .....++.++.+||..||..||.+||++.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKC-------------------FPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHH-------------------SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhhhHHHHHHHh-------------------cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            322221111111 110000                   001347899999999999999999999998864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-39  Score=312.82  Aligned_cols=219  Identities=25%  Similarity=0.333  Sum_probs=176.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~------------  147 (395)
                      .++|++.+.||+|+||.||+|++.     .+++.||||++...     .....+|+.+++.++|+||.            
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            457999999999999999999987     45589999998653     23456899999999999980            


Q ss_pred             -----ee---------cc------------------------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCc
Q 016085          148 -----YS---------RA------------------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  189 (395)
Q Consensus       148 -----~~---------~~------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~N  189 (395)
                           +.         ..                        ...+++..++.++.||+.||.||| +.||+||||||+|
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~N  204 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRN  204 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGG
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCcce
Confidence                 00         00                        156888899999999999999999 8899999999999


Q ss_pred             eEEcCCCCceEEeecCCccccccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 016085          190 LLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESG  265 (395)
Q Consensus       190 ill~~~~~~ikl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~  265 (395)
                      ||++.++ .+||+|||+++......   ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+.
T Consensus       205 Il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          205 CLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             EEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             EEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            9999887 69999999997653321   123456789999999997755 8999999999999999999 9999998876


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          266 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       266 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      .+....+....                   .         ..++..++..+.+||.+||+.||.+|||+.++++
T Consensus       283 ~~~~~~~~~~~-------------------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          283 EEVIYYVRDGN-------------------I---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             HHHHHHHHTTC-------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhCCC-------------------c---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            66555443310                   0         0123457899999999999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-39  Score=313.90  Aligned_cols=222  Identities=22%  Similarity=0.338  Sum_probs=178.3

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCC-------CcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceE-------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLET-------GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVH-------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~-------~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~-------  147 (395)
                      ...++|.+.+.||+|+||.||+|++..+       +..||||++....     ....+|+.+++.+ +|+||.       
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            4456899999999999999999997643       3579999986532     3455899999999 999980       


Q ss_pred             ----------ee---------c----------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE
Q 016085          148 ----------YS---------R----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV  192 (395)
Q Consensus       148 ----------~~---------~----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill  192 (395)
                                +.         .                ....+++..++.++.||+.||.||| +.||+||||||+|||+
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCcceEEE
Confidence                      00         0                0134899999999999999999999 8899999999999999


Q ss_pred             cCCCCceEEeecCCccccccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 016085          193 NPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQ  268 (395)
Q Consensus       193 ~~~~~~ikl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  268 (395)
                      +.++ .+||+|||+|+......   ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+.
T Consensus       225 ~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          225 TEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             CTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             cCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9887 69999999998664332   223445688999999998755 8999999999999999999 9999988776555


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          269 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       269 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ...+....                            ....+..+++++.+||.+||+.||++|||+.+++++
T Consensus       303 ~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          303 FKLLKEGH----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHTTC----------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCC----------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            44443210                            001234578999999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-39  Score=308.09  Aligned_cols=221  Identities=22%  Similarity=0.368  Sum_probs=176.4

Q ss_pred             cccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      ...+|.+.+.||+|+||.||+|++.     .+++.||||++....     ....+|+.+++.++||||.           
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            4457999999999999999999984     455899999986532     3455799999999999981           


Q ss_pred             ------ee---------cc------------------------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCC
Q 016085          148 ------YS---------RA------------------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQ  188 (395)
Q Consensus       148 ------~~---------~~------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~  188 (395)
                            +.         ..                        ...+++..++.++.||+.||.||| +.||+||||||+
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dikp~  179 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA-EMKLVHRDLAAR  179 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGG
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH-HCCCcccccchh
Confidence                  00         00                        123788899999999999999999 889999999999


Q ss_pred             ceEEcCCCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 016085          189 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGES  264 (395)
Q Consensus       189 Nill~~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~  264 (395)
                      |||++.++ .+||+|||+++.......   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+
T Consensus       180 NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          180 NILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999877 699999999986643322   12345678899999997754 8999999999999999999 999998877


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          265 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       265 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .......+....                            ....+..+++.+.+||.+||+.||++|||+.+++++
T Consensus       258 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          258 PERLFNLLKTGH----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             GGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhhcCC----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            655444332210                            001234578999999999999999999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-39  Score=310.46  Aligned_cols=222  Identities=23%  Similarity=0.343  Sum_probs=177.0

Q ss_pred             cccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecc-----hhhHHHHHHHHHhc-CCCceE----------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVH----------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~ni~----------  147 (395)
                      ...+|++.+.||+|+||.||+|++.     .+++.||||++...     .....+|+.+++.+ +||||.          
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3457999999999999999999973     45678999998643     23456899999999 999981          


Q ss_pred             -------ee---------ccC-----------------------CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCC
Q 016085          148 -------YS---------RAS-----------------------QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQ  188 (395)
Q Consensus       148 -------~~---------~~~-----------------------~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~  188 (395)
                             +.         ...                       ..+++..++.++.||+.||.||| +.||+||||||+
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~  201 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAAR  201 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH-HTTEEETTCSGG
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChh
Confidence                   00         000                       23688889999999999999999 889999999999


Q ss_pred             ceEEcCCCCceEEeecCCccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 016085          189 NLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGES  264 (395)
Q Consensus       189 Nill~~~~~~ikl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~  264 (395)
                      |||++.++ .+||+|||++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+..
T Consensus       202 NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          202 NVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999887 6999999999876544322   2345688999999997755 8999999999999999998 999998877


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          265 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       265 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ....+..++....                           ....+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       280 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          280 VDANFYKLIQNGF---------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             CSHHHHHHHHTTC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHhcCC---------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            6655555444110                           001233478999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-39  Score=317.37  Aligned_cols=221  Identities=21%  Similarity=0.294  Sum_probs=176.6

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE---------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      ....+|.+.+.||+|+||.||+|++..+++.||||++....     ....+|+.+|+.++||||.               
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            44568999999999999999999999999999999986532     2345799999999999981               


Q ss_pred             --ee----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 --YS----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 --~~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                        +.          .....+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.......
T Consensus       191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVY  268 (377)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCGGGCEECTTSEE
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcCCcccCHHHEEEcCCC-cEEECcCCCceecCCCce
Confidence              00          11235788889999999999999999 88999999999999999887 699999999976433211


Q ss_pred             c---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          216 N---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       216 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      .   ....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+... ..             
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~-------------  333 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GR-------------  333 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-CC-------------
T ss_pred             eecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC-------------
Confidence            1   1123477899999997654 8999999999999999998 99999887765544433221 00             


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                    ...+..+++.+.+||.+||+.||++|||+.++++
T Consensus       334 --------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          334 --------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                          0123447899999999999999999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=325.75  Aligned_cols=228  Identities=26%  Similarity=0.396  Sum_probs=165.9

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-hhhHHHHHHHHHhc-CCCceEe---------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLL-DHPNVHY---------------------  148 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l-~h~ni~~---------------------  148 (395)
                      +|.+.++||+|+||+|+. ....+++.||||++... .....+|+.+|+.+ +||||..                     
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~  103 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT  103 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCC
Confidence            699999999999999764 34568999999998654 24457899999999 7999810                     


Q ss_pred             -----eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC----CceEEeecCCccccccCC----C
Q 016085          149 -----SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT----HQVKLCDFGSAKVLVKGE----P  215 (395)
Q Consensus       149 -----~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~----~~ikl~DFG~a~~~~~~~----~  215 (395)
                           ........+..+..++.||+.||.||| +.||+||||||+|||++.++    ..+||+|||+|+......    .
T Consensus       104 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~  182 (432)
T 3p23_A          104 LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR  182 (432)
T ss_dssp             HHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH-HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---------
T ss_pred             HHHHHHhcCCCccchhHHHHHHHHHHHHHHHH-HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceee
Confidence                 011223444456789999999999999 88999999999999995322    148899999998765432    2


Q ss_pred             cccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          216 NISYICSRYYRAPELIFG--ATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                      ....+||+.|+|||++.+  ...++.++|||||||++|+|++ |..||....... ...+.   +...            
T Consensus       183 ~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~~---~~~~------------  246 (432)
T 3p23_A          183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANILL---GACS------------  246 (432)
T ss_dssp             ---CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHHT---TCCC------------
T ss_pred             ccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHHh---ccCC------------
Confidence            334678999999999964  2347889999999999999999 999996544322 21111   1100            


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                         .....       .....+..+.+||.+||+.||.+|||+.++++||||..+.
T Consensus       247 ---~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          247 ---LDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             ---CTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             ---ccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence               00000       0111355689999999999999999999999999997643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.2e-39  Score=306.48  Aligned_cols=221  Identities=25%  Similarity=0.376  Sum_probs=177.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEE-----cCCCcEEEEEEeecc-----hhhHHHHHHHHHhc-CCCceEe----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVHY----------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~-----~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~ni~~----------  148 (395)
                      .++|++.+.||+|+||.||+|++     ..+++.||||++...     .....+|+.+++.+ +|+||..          
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            45799999999999999999985     457789999998643     24456899999999 9999810          


Q ss_pred             ----------------ecc------------------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC
Q 016085          149 ----------------SRA------------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP  194 (395)
Q Consensus       149 ----------------~~~------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~  194 (395)
                                      ...                  ...+++..++.++.||+.||.||| +.||+||||||+|||++.
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTH  180 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEET
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCccceEEEcC
Confidence                            000                  114889999999999999999999 889999999999999998


Q ss_pred             CCCceEEeecCCccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 016085          195 HTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLV  270 (395)
Q Consensus       195 ~~~~ikl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  270 (395)
                      ++ .+||+|||++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+......+.
T Consensus       181 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          181 GR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             TT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             CC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            77 6999999999876544321   2345678899999997754 8999999999999999998 999998877665555


Q ss_pred             HHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          271 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       271 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .+......                           ...+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          259 KMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhccCCC---------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            55442110                           01223478999999999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.5e-39  Score=301.84  Aligned_cols=223  Identities=28%  Similarity=0.376  Sum_probs=175.3

Q ss_pred             CccccceeeeeeeccCCceEEEEEEEcC---CCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------
Q 016085           87 PKQTISYMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        87 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      ....++|++.+.||+|+||.||+|++..   ++..||+|++...     .....+|+.+++.++|+||.           
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   87 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT   87 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSC
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC
Confidence            3445689999999999999999998754   3446999998653     34456799999999999981           


Q ss_pred             -----e----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          148 -----Y----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 -----~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                           +          ......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++.....
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE-SINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEEEETT-EEEECCCCGGGCC--
T ss_pred             EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCccceEEECCCC-cEEeCccCCCccccc
Confidence                 0          011245888899999999999999999 88999999999999999877 699999999987643


Q ss_pred             CCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          213 GEP--NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       213 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      ...  .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||...+..+....+......           
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-----------  233 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-----------  233 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-----------
T ss_pred             ccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-----------
Confidence            321  22345688899999997654 8999999999999999998 99999877666555444331100           


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                       ..+..+++.+.+||.+||..||++|||+.+++++
T Consensus       234 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          234 -----------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                             1123478999999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.6e-39  Score=302.47  Aligned_cols=221  Identities=22%  Similarity=0.329  Sum_probs=180.1

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCceE-----------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++....   ....+|+.+++.++|+||.                 
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            34567999999999999999999999999999999987543   4456899999999999980                 


Q ss_pred             ee-----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          148 YS-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 ~~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                      +.           .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~  167 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYT  167 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH-HHTCCCSCCSGGGEEECGGG-CEEECCCCGGGTSCSSSSE
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH-HCCccCCCCCcceEEEcCCC-CEEEccCccceeccCCccc
Confidence            00           12345889999999999999999999 78999999999999999887 6999999999876433221


Q ss_pred             --ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          217 --ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       217 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                        ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+.......+....                 
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~-----------------  229 (288)
T 3kfa_A          168 AHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-----------------  229 (288)
T ss_dssp             EETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------------
T ss_pred             cccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC-----------------
Confidence              2344578899999997655 8999999999999999999 999998877655444433210                 


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                 ....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       230 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          230 -----------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                       01123457899999999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.4e-39  Score=304.82  Aligned_cols=222  Identities=27%  Similarity=0.349  Sum_probs=166.6

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE--------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++|+||.              
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3457999999999999999999999999999999986432       3456899999999999981              


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-  214 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-  214 (395)
                                  +......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++....... 
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH-AAGATHRDVKPENILVSADD-FAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECSCCC---------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCcCCcCCCChHHEEEcCCC-CEEEecCccCcccccccc
Confidence                        0112246889999999999999999999 88999999999999999887 69999999997654332 


Q ss_pred             -CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          215 -PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                       ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.. .+...+... .               
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~---------------  251 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQA-I---------------  251 (309)
T ss_dssp             -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSC-C---------------
T ss_pred             ccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccC-C---------------
Confidence             123457899999999997654 899999999999999999999999876543 222222210 0               


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-CHHHHhc
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-TALEACI  339 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-t~~e~l~  339 (395)
                               ......+..++..+.+||.+||+.||++|| |+.++++
T Consensus       252 ---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          252 ---------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ---------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ---------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                     001123455789999999999999999999 6776654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5e-39  Score=309.20  Aligned_cols=228  Identities=15%  Similarity=0.135  Sum_probs=167.2

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcC---CCcEEEEEEeecchhh---------------HHHHHHHHHhcCCCceE----
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDKRY---------------KNRELQTMRLLDHPNVH----  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~~~---------------~~~E~~~l~~l~h~ni~----  147 (395)
                      .++|++.+.||+|+||.||+|++..   ++..||||++......               ..+|+.+++.++|+||.    
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3579999999999999999999987   8889999998654322               23567778888999971    


Q ss_pred             -------------------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC-CceEE
Q 016085          148 -------------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT-HQVKL  201 (395)
Q Consensus       148 -------------------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~-~~ikl  201 (395)
                                               +......+++..++.++.||+.||.||| +.||+||||||+|||++.++ ..+||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH-ENEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             EEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             ccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCcCHHHEEEccCCCCcEEE
Confidence                                     0112336899999999999999999999 88999999999999998664 25999


Q ss_pred             eecCCccccccCCC--------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHH
Q 016085          202 CDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES-GVDQLVEI  272 (395)
Q Consensus       202 ~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i  272 (395)
                      +|||+++.......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.. ....+...
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            99999976533211        13457899999999998754 8999999999999999999999996532 22222222


Q ss_pred             -HHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          273 -IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       273 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                       .......+.......                    -...+++++.+||.+||+.||++|||+.++++
T Consensus       274 ~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          274 KTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence             222211221111100                    01147899999999999999999999999874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=309.54  Aligned_cols=219  Identities=28%  Similarity=0.428  Sum_probs=157.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcC-CCceEee----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLD-HPNVHYS----------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~-h~ni~~~----------------  149 (395)
                      .+|++.++||+|+||.||+|++..+++.||||++....    ....+|+.+++.+. |+||...                
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            37999999999999999999999999999999885432    33457999999996 9998110                


Q ss_pred             --------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCC--eeeccCCCCceEEcCCCCceEEeecCCc
Q 016085          150 --------------------RASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSA  207 (395)
Q Consensus       150 --------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlKp~Nill~~~~~~ikl~DFG~a  207 (395)
                                          .....+++..++.++.||+.||.||| +.|  |+||||||+|||++.++ .+||+|||++
T Consensus       108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~  185 (337)
T 3ll6_A          108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQG-TIKLCDFGSA  185 (337)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH-TSSSCCBCCCCCGGGCEECTTS-CEEBCCCTTC
T ss_pred             eEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCEEEccCCcccEEECCCC-CEEEecCccc
Confidence                                12345889999999999999999999 888  99999999999999887 6999999999


Q ss_pred             cccccCCCc-------------cccccccccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 016085          208 KVLVKGEPN-------------ISYICSRYYRAPELIF--GATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEI  272 (395)
Q Consensus       208 ~~~~~~~~~-------------~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  272 (395)
                      +........             ....||+.|+|||++.  ....++.++|||||||++|+|++|+.||.+......+...
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~  265 (337)
T 3ll6_A          186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK  265 (337)
T ss_dssp             BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc
Confidence            876433221             1456899999999983  2234788999999999999999999999764432211100


Q ss_pred             HHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCc
Q 016085          273 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  342 (395)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~  342 (395)
                                           .          ........+..+.+||.+||+.||.+|||+.++++|-+
T Consensus       266 ---------------------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          266 ---------------------Y----------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ---------------------C----------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             ---------------------c----------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                                 0          00112335778999999999999999999999998743

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.9e-39  Score=305.98  Aligned_cols=221  Identities=26%  Similarity=0.378  Sum_probs=176.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEE-----cCCCcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceEe----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVHY----------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~-----~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~~----------  148 (395)
                      .++|++.+.||+|+||.||+|++     ..+++.||||++....     ....+|+.+++.+ +|+||..          
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            35799999999999999999985     3567899999986532     3455899999999 7899810          


Q ss_pred             -----------------eccC----------------CCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC
Q 016085          149 -----------------SRAS----------------QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH  195 (395)
Q Consensus       149 -----------------~~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~  195 (395)
                                       ....                ..+++..++.++.||+.||.||| +.||+||||||+|||++.+
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEK  184 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGG
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH-hCCcccccCccceEEECCC
Confidence                             0001                12788999999999999999999 8899999999999999987


Q ss_pred             CCceEEeecCCccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 016085          196 THQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVE  271 (395)
Q Consensus       196 ~~~ikl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  271 (395)
                      + .+||+|||+++........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+......+..
T Consensus       185 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~  262 (316)
T 2xir_A          185 N-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  262 (316)
T ss_dssp             G-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             C-CEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence            7 6999999999866443321   2345688999999997755 8999999999999999998 9999988765555444


Q ss_pred             HHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       272 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .+.....                           ...+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       263 ~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          263 RLKEGTR---------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhccCcc---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4332110                           01223478999999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.5e-39  Score=305.95  Aligned_cols=227  Identities=24%  Similarity=0.305  Sum_probs=169.1

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-hhHHHHHHHHHh--cCCCceEe----------------e
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRL--LDHPNVHY----------------S  149 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~--l~h~ni~~----------------~  149 (395)
                      ..++|++.+.||+|+||.||+|++  +++.||||++.... ....+|.+++..  ++|+||..                .
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            345799999999999999999987  78999999986543 334467777766  89999810                0


Q ss_pred             -------------ccCCCCcHHHHHHHHHHHHHHHHHHHc-------CCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          150 -------------RASQRMPLIYVKLYTYQICRALAYIHG-------GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       150 -------------~~~~~~~~~~~~~~~~qi~~aL~~LH~-------~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                   .....+++..+..++.||+.||.|||.       +.||+||||||+|||++.++ .+||+|||+|+.
T Consensus        84 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~  162 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLAVM  162 (301)
T ss_dssp             EECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred             ehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEeeCCCeee
Confidence                         023468889999999999999999993       46999999999999999887 699999999976


Q ss_pred             cccCCCc-----ccccccccccccccccCCC-----CCCCcchHHHHHHHHHHHHhC----------CCCCCCCCc----
Q 016085          210 LVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTTAVDIWSVGCVLAELLLG----------QPLFPGESG----  265 (395)
Q Consensus       210 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~ell~g----------~~pf~~~~~----  265 (395)
                      .......     ....||+.|+|||++.+..     .++.++|||||||++|+|++|          ..||.+...    
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~  242 (301)
T 3q4u_A          163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS  242 (301)
T ss_dssp             EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence            5443322     2347899999999997653     244789999999999999999          888865322    


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          266 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       266 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ...+..+....+.                 .+..    ....+....++.+.+||.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~-----------------~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          243 FEDMRKVVCVDQQ-----------------RPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             HHHHHHHHTTSCC-----------------CCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hhhhhHHHhccCC-----------------CCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            2222222111000                 0000    011122235678999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.8e-39  Score=309.64  Aligned_cols=222  Identities=22%  Similarity=0.302  Sum_probs=176.4

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEE--EEEEeecc-----hhhHHHHHHHHHhc-CCCceE------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETV--AIKKVLQD-----KRYKNRELQTMRLL-DHPNVH------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~v--AiK~~~~~-----~~~~~~E~~~l~~l-~h~ni~------------  147 (395)
                      ...++|++.+.||+|+||.||+|++..++..+  |+|.+...     .....+|+.+++.+ +|+||.            
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            44568999999999999999999999888865  99988642     23456899999999 999981            


Q ss_pred             --------------eec----------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC
Q 016085          148 --------------YSR----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH  197 (395)
Q Consensus       148 --------------~~~----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~  197 (395)
                                    +..                ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ 
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIl~~~~~-  179 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENY-  179 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECGGG-
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCccceEEEcCCC-
Confidence                          000                1136889999999999999999999 88999999999999999887 


Q ss_pred             ceEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 016085          198 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVL  276 (395)
Q Consensus       198 ~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  276 (395)
                      .+||+|||+++............+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+... 
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-  257 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-  257 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-
Confidence            69999999997543333334456688999999997654 8999999999999999998 99999887765544433220 


Q ss_pred             CCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                                 .....+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       258 ---------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          258 ---------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             ---------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                       0001233478999999999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.8e-39  Score=304.05  Aligned_cols=222  Identities=20%  Similarity=0.287  Sum_probs=170.4

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcC---CCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-----------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      ....+|.+.+.||+|+||.||+|++..   +++.||+|++...      .....+|+.+++.++|+||.           
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            344579999999999999999998765   5568999998643      13356799999999999981           


Q ss_pred             ------ee--------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEE
Q 016085          148 ------YS--------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  201 (395)
Q Consensus       148 ------~~--------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl  201 (395)
                            +.                    .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dikp~NIli~~~~-~~kl  188 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS-NRNFLHRDLAARNCMLRDDM-TVCV  188 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH-TTTCCCCCCSGGGEEECTTS-CEEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEcCCC-cEEE
Confidence                  00                    12245888999999999999999999 88999999999999999887 6999


Q ss_pred             eecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 016085          202 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  277 (395)
Q Consensus       202 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  277 (395)
                      +|||+++.......   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+.......+.... 
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-  266 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-  266 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-
Confidence            99999976643321   22345688999999997754 8999999999999999999 999998877666555443310 


Q ss_pred             CCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                                 ....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus       267 ---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 ---------------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ---------------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       001234578999999999999999999999999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=301.84  Aligned_cols=228  Identities=26%  Similarity=0.386  Sum_probs=169.8

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch--hhHHHHHHHHHhcCCCceEe------------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVHY------------------  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~ni~~------------------  148 (395)
                      ...+|++.+.||+|+||.||+|++  .++.||||++....  ....+|+.+++.++|+||..                  
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~   83 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEG   83 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTT
T ss_pred             CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCC
Confidence            345799999999999999999987  47889999986543  44568999999999999810                  


Q ss_pred             ------eccC---CCCcHHHHHHHHHHHHHHHHHHHcC---CCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          149 ------SRAS---QRMPLIYVKLYTYQICRALAYIHGG---IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       149 ------~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                            ....   ..++...+..++.|++.||.||| +   .||+||||||+|||++.++..+||+|||++......  .
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~  160 (307)
T 2eva_A           84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH-SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--M  160 (307)
T ss_dssp             CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH-TCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH-hCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--c
Confidence                  0111   13577888999999999999999 6   799999999999999887755899999999765322  2


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||................+.                  
T Consensus       161 ~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------------  221 (307)
T 2eva_A          161 TNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT------------------  221 (307)
T ss_dssp             ----CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC------------------
T ss_pred             ccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC------------------
Confidence            3456899999999997754 899999999999999999999999764432211111110000                  


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc-----CCcccCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-----HPFFDELRD  348 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~-----hp~f~~~~~  348 (395)
                              ...+...++..+.+||.+||+.||++|||+.++++     ..++.....
T Consensus       222 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  270 (307)
T 2eva_A          222 --------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE  270 (307)
T ss_dssp             --------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred             --------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence                    00123457899999999999999999999999987     355544433

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.4e-39  Score=320.07  Aligned_cols=229  Identities=30%  Similarity=0.433  Sum_probs=164.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-hhHHHHHHHHHhc-CCCceEe---------------ec---
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLL-DHPNVHY---------------SR---  150 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~~l~~l-~h~ni~~---------------~~---  150 (395)
                      +.|.+.++||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +||||..               ..   
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~g   93 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNL   93 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCC
Confidence            357888999999999998764 5679999999987543 3456899999876 8999810               00   


Q ss_pred             -------cCCCC-------cHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC------------CceEEeec
Q 016085          151 -------ASQRM-------PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT------------HQVKLCDF  204 (395)
Q Consensus       151 -------~~~~~-------~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~------------~~ikl~DF  204 (395)
                             .....       .+..+..++.||+.||+||| +.||+||||||+|||++.++            ..+||+||
T Consensus        94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF  172 (434)
T 2rio_A           94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF  172 (434)
T ss_dssp             EHHHHHHTC------------CCHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred             CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH-HCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence                   00111       12234679999999999999 88999999999999997532            26999999


Q ss_pred             CCccccccCCC-----cccccccccccccccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 016085          205 GSAKVLVKGEP-----NISYICSRYYRAPELIFG------ATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEI  272 (395)
Q Consensus       205 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i  272 (395)
                      |+|+.......     ....+||+.|+|||++.+      ...++.++|||||||++|+|++ |..||.+.....  ..+
T Consensus       173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i  250 (434)
T 2rio_A          173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNI  250 (434)
T ss_dssp             TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHH
T ss_pred             ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHH
Confidence            99987654322     224578999999999965      2448999999999999999998 999997654432  223


Q ss_pred             HHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          273 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      ....                 ...+...     ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       251 ~~~~-----------------~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          251 IRGI-----------------FSLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHTC-----------------CCCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hcCC-----------------CCccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            2210                 0011000     0011224678999999999999999999999999999964

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.7e-39  Score=303.87  Aligned_cols=218  Identities=17%  Similarity=0.251  Sum_probs=171.0

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCC-------cEEEEEEeecch----hhHHHHHHHHHhcCCCceE----------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETG-------ETVAIKKVLQDK----RYKNRELQTMRLLDHPNVH----------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~-------~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~----------  147 (395)
                      ..++|.+.+.||+|+||.||+|++..++       ..||+|++....    ....+|+.+++.++|+||.          
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            4568999999999999999999998877       469999986432    3456899999999999981          


Q ss_pred             -------e---------e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCc-------eEEee
Q 016085          148 -------Y---------S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-------VKLCD  203 (395)
Q Consensus       148 -------~---------~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~-------ikl~D  203 (395)
                             +         . .....+++..+..++.||+.||.||| +.||+||||||+|||++.++..       +||+|
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE-ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred             CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh-hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence                   0         0 11223888899999999999999999 8899999999999999877632       99999


Q ss_pred             cCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHH
Q 016085          204 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE  282 (395)
Q Consensus       204 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~  282 (395)
                      ||++.....   .....+|+.|+|||++.+...++.++|||||||++|+|++|. +||...+. .....+....      
T Consensus       165 fg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~~~~~~------  234 (289)
T 4fvq_A          165 PGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYEDR------  234 (289)
T ss_dssp             CCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHTT------
T ss_pred             CcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHHHhhcc------
Confidence            999865422   234567899999999977455899999999999999999955 55544443 3332222210      


Q ss_pred             HHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                             ..++...++++.+||.+||+.||++|||+.++++|
T Consensus       235 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          235 -----------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             -----------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                   01223357889999999999999999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1e-39  Score=310.60  Aligned_cols=236  Identities=21%  Similarity=0.243  Sum_probs=175.0

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ..++|++.+.||+|+||.||+|++ .+++.||||++...    .....+|+.+++.++|+||.                 
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  115 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK  115 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence            445799999999999999999996 46899999987643    24456899999999999980                 


Q ss_pred             e---------ec----cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 Y---------SR----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 ~---------~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                      +         ..    ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++......
T Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  193 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELD  193 (321)
T ss_dssp             CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCSTTEEECTTC-CEEECCCTTCEECSSSS
T ss_pred             cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc-CCCeecCCCCHHHEEECCCC-CEEEeeccccccccccc
Confidence            0         00    1124789999999999999999999 78999999999999999887 69999999997653222


Q ss_pred             ---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          215 ---PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       215 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                         ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+....+...     ...  ..... 
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~--~~~~~-  264 (321)
T 2qkw_B          194 QTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VES--HNNGQ-  264 (321)
T ss_dssp             CCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHH--HTTTC-
T ss_pred             ccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhc--ccccc-
Confidence               123456899999999997755 899999999999999999999999765432211110000     000  00000 


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                          +...........+....+..+.+|+.+||+.||++|||+.++++|
T Consensus       265 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          265 ----LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             ----CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                111111111112233456789999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.1e-39  Score=300.93  Aligned_cols=219  Identities=23%  Similarity=0.290  Sum_probs=174.6

Q ss_pred             ccceeeee-eeccCCceEEEEEEE--cCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE-------------
Q 016085           90 TISYMAER-VVGQGSFGIVFQAKC--LETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        90 ~~~y~~~~-~lG~G~fg~V~~a~~--~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      ..+|.+.+ .||+|+||.||+|.+  ..+++.||||++...      .....+|+.+++.++|+||.             
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l   94 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML   94 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEE
Confidence            35799998 999999999999954  567889999998653      23456899999999999980             


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                  +......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++........
T Consensus        95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCS
T ss_pred             EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHH-hCCeEcCCCCcceEEEeCCC-cEEEccCCcceeeccCCC
Confidence                        1122345889999999999999999999 88999999999999999887 699999999987644332


Q ss_pred             c----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          216 N----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       216 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      .    ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+...  .            
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~------------  237 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--E------------  237 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--C------------
T ss_pred             cccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C------------
Confidence            1    1234578899999997654 8999999999999999999 99999887765544443321  0            


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                           .         ..++..+++.+.+||.+||+.||.+|||+.++++
T Consensus       238 -----~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          238 -----R---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             -----C---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----C---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                 0         0123457899999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.4e-39  Score=310.04  Aligned_cols=236  Identities=21%  Similarity=0.284  Sum_probs=173.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      .++|.+.+.||+|+||.||+|++ .+++.||||++....     ....+|+.+++.++|+||.                 
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  107 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP  107 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred             hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence            45799999999999999999984 468999999986543     2457899999999999980                 


Q ss_pred             e---------e----ccCCCCcHHHHHHHHHHHHHHHHHHHcCC---CeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          148 Y---------S----RASQRMPLIYVKLYTYQICRALAYIHGGI---GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       148 ~---------~----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                      +         .    .....+++..+..++.|++.||.||| +.   ||+||||||+|||++.++ .+||+|||+++...
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  185 (326)
T 3uim_A          108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMD  185 (326)
T ss_dssp             CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH-HSSSSCEECCCCSGGGEEECTTC-CEEECCCSSCEECC
T ss_pred             eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCchhhEEECCCC-CEEeccCccccccC
Confidence            0         0    11234889999999999999999999 77   999999999999999887 69999999998764


Q ss_pred             cCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHHHhCCCCHHHHh
Q 016085          212 KGEP--NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGE----SGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       212 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                      ....  .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...    .....+.....           
T Consensus       186 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  253 (326)
T 3uim_A          186 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-----------  253 (326)
T ss_dssp             SSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT-----------
T ss_pred             cccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH-----------
Confidence            3322  23456899999999997655 899999999999999999999999521    10000111100           


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                         ...................+....+..+.+|+.+||+.||.+|||+.++++|-.-
T Consensus       254 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          254 ---GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             ---TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             ---HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence               0000111111111111112223345789999999999999999999999987543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.9e-39  Score=305.60  Aligned_cols=231  Identities=24%  Similarity=0.293  Sum_probs=182.3

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE----------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH----------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~----------  147 (395)
                      ...++|++.+.||+|+||.||+|++.     .+++.||||++....     ....+|+.+++.++|+||.          
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            33457999999999999999999876     467889999986432     2345799999999999981          


Q ss_pred             -----eecc---------------------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEE
Q 016085          148 -----YSRA---------------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  201 (395)
Q Consensus       148 -----~~~~---------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl  201 (395)
                           ....                     ...+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~NIli~~~~-~~kl  179 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDF-TVKI  179 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCSGGGEEECTTC-CEEE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH-HCCCccCCCccceEEEcCCC-eEEE
Confidence                 0000                     134577888899999999999999 88999999999999999887 6999


Q ss_pred             eecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 016085          202 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  277 (395)
Q Consensus       202 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  277 (395)
                      +|||+++.......   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.... 
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-  257 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-  257 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-
Confidence            99999976543321   12345688999999997655 8999999999999999999 899998877665555443310 


Q ss_pred             CCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC------CcccCCCCC
Q 016085          278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH------PFFDELRDP  349 (395)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h------p~f~~~~~~  349 (395)
                                        .         ...+..++..+.+||.+||+.||.+|||+.++++|      ++|+.+...
T Consensus       258 ------------------~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~  308 (322)
T 1p4o_A          258 ------------------L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY  308 (322)
T ss_dssp             ------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred             ------------------c---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccc
Confidence                              0         01233578999999999999999999999999875      777665443

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.5e-39  Score=324.47  Aligned_cols=224  Identities=21%  Similarity=0.235  Sum_probs=176.7

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCCCce----------------Ee--
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNV----------------HY--  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~ni----------------~~--  148 (395)
                      ..++|++.++||+|+||.||+|++..+++.||||++...  .....+|+.+++.|.|.+.                ..  
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~   84 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL   84 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence            345799999999999999999999999999999987543  3456789999999988542                00  


Q ss_pred             ---------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEE---cCCCCceEEeecCCccccccCCCc
Q 016085          149 ---------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       149 ---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill---~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                               ......+++..++.++.||+.||.||| ++||+||||||+||||   +.++ .+||+|||+++........
T Consensus        85 ~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEECBCTTTC
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccCcceEEEecCCCCC-eEEEEeCCcceeccCCccc
Confidence                     012457899999999999999999999 8899999999999999   4555 6999999999876543321


Q ss_pred             --------ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCCHHHHh
Q 016085          217 --------ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       217 --------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~  285 (395)
                              ....||+.|+|||++.+.. ++.++|||||||+||+|++|+.||.+....   ..+..+.........    
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~----  237 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI----  237 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH----
T ss_pred             cccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH----
Confidence                    2567899999999998765 899999999999999999999999875442   233333321110111    


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                          ..+...++.++.+||.+||+.||++||++.++++
T Consensus       238 --------------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 --------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             --------------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             --------------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                1122347899999999999999999999987654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-39  Score=299.89  Aligned_cols=222  Identities=25%  Similarity=0.287  Sum_probs=177.7

Q ss_pred             ccceeeee-eeccCCceEEEEEEEc--CCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE--------------
Q 016085           90 TISYMAER-VVGQGSFGIVFQAKCL--ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        90 ~~~y~~~~-~lG~G~fg~V~~a~~~--~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||||++...     .....+|+.+++.++|+||.              
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv   87 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV   87 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEE
Confidence            34677777 9999999999999864  46788999998653     23456899999999999981              


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                  .......+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++........
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDS  165 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTTCSC
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH-HCCEeeCCCchheEEEcCCC-CEEECcccceeeeccCcc
Confidence                        0112356899999999999999999999 88999999999999999877 699999999987643322


Q ss_pred             ----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          216 ----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       216 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                          .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+...  .            
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~--~------------  230 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--K------------  230 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--C------------
T ss_pred             eeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC--C------------
Confidence                12334588999999997654 8999999999999999998 99999887776655444321  0            


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  342 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~  342 (395)
                                    ...++..+++.+.+||.+||+.||++|||+.++++|.+
T Consensus       231 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          231 --------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             --------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             --------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                          00123457899999999999999999999999987643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.9e-39  Score=296.17  Aligned_cols=220  Identities=19%  Similarity=0.315  Sum_probs=177.5

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE------------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      ...+|++.+.||+|+||.||+|++. +++.||+|++...   .....+|+.+++.++|+||.                  
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            3457999999999999999999986 6778999998754   34567899999999999980                  


Q ss_pred             ---------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--Cc
Q 016085          148 ---------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--PN  216 (395)
Q Consensus       148 ---------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--~~  216 (395)
                               .......+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++.......  ..
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHST
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCchheEEECCCC-CEEEccccccccccccccccc
Confidence                     0011245788899999999999999999 88999999999999999877 69999999997653221  12


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+....                   
T Consensus       163 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-------------------  222 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-------------------  222 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-------------------
T ss_pred             ccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-------------------
Confidence            2345678899999997654 8999999999999999999 899998877666555543310                   


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                               ....+...+..+.+||.+||+.||++|||+.+++++
T Consensus       223 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          223 ---------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                     001223468899999999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.4e-38  Score=304.46  Aligned_cols=221  Identities=24%  Similarity=0.358  Sum_probs=174.9

Q ss_pred             cccceeeeeeeccCCceEEEEEEEc-------CCCcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceE--------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCL-------ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVH--------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~--------  147 (395)
                      ..++|++.+.||+|+||.||+|++.       .+++.||||++....     ....+|+.+++.+ +|+||.        
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3457999999999999999999976       467789999986532     3356899999999 999981        


Q ss_pred             ---------e---------ecc----------------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc
Q 016085          148 ---------Y---------SRA----------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  193 (395)
Q Consensus       148 ---------~---------~~~----------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~  193 (395)
                               +         ...                ...+++..++.++.||+.||.||| +.||+||||||+|||++
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA-SQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEC
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCccceEEEc
Confidence                     0         000                123788899999999999999999 88999999999999999


Q ss_pred             CCCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016085          194 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQL  269 (395)
Q Consensus       194 ~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  269 (395)
                      .++ .+||+|||+++.......   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus       192 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          192 ENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             TTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             CCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            887 699999999986643322   22345688899999997754 8999999999999999999 99999887766555


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          270 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       270 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ..+.....                            ...+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       270 ~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          270 KLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            44433100                            01234478999999999999999999999999864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.5e-40  Score=338.21  Aligned_cols=251  Identities=27%  Similarity=0.350  Sum_probs=181.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEee----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHYS----------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~~----------------  149 (395)
                      ++|++.+.||+|+||.||+|++..+|+.||||++...     .....+|+.+++.++||||...                
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            5799999999999999999999999999999988643     2345679999999999998100                


Q ss_pred             ----------------c---cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC--ceEEeecCCcc
Q 016085          150 ----------------R---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAK  208 (395)
Q Consensus       150 ----------------~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~--~ikl~DFG~a~  208 (395)
                                      .   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++.  .+||+|||++.
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH-s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH-HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence                            0   0124778889999999999999999 889999999999999987653  38999999998


Q ss_pred             ccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          209 VLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+......+....   ............
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i---~~~~~~~~~~~~  248 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV---REKSNEHIVVYD  248 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC---C------CCSCC
T ss_pred             ccccccccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh---hcccchhhhhhh
Confidence            876665556678999999999997654 8999999999999999999999997754332211100   000000000000


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      .......+..  ..+....+...+++.+.+||.+||++||++|||+.++++||||+.+.+
T Consensus       249 ~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          249 DLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             CCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             hhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence            0000111111  011112233446788999999999999999999999999999987644

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.7e-38  Score=303.43  Aligned_cols=221  Identities=24%  Similarity=0.341  Sum_probs=177.0

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCc-----EEEEEEeecc-----hhhHHHHHHHHHhc-CCCceE----------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVH----------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~-----~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~ni~----------  147 (395)
                      ...+|.+.+.||+|+||.||+|++..+++     .||+|.+...     .....+|+.+++.+ +|+||.          
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            34579999999999999999999977664     7999998653     23456899999999 899981          


Q ss_pred             -----eec-------------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC
Q 016085          148 -----YSR-------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH  197 (395)
Q Consensus       148 -----~~~-------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~  197 (395)
                           ...                         ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ 
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~NIl~~~~~-  201 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNGH-  201 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGCEEEGGG-
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh-cCCcccCCcccceEEECCCC-
Confidence                 000                         1234688889999999999999999 78999999999999999877 


Q ss_pred             ceEEeecCCccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 016085          198 QVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII  273 (395)
Q Consensus       198 ~ikl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~  273 (395)
                      .+||+|||+++........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+......+..+.
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  280 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV  280 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence            6999999999866443321   2345678899999997755 8999999999999999998 999998877666555554


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          274 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      .....+                           ..+...++.+.+||.+||+.||.+|||+.++++
T Consensus       281 ~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          281 KDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            421100                           122336889999999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=310.55  Aligned_cols=226  Identities=13%  Similarity=0.129  Sum_probs=173.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCC--------CcEEEEEEeecchhhHHHHHHHHHhcCCCceEe--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLET--------GETVAIKKVLQDKRYKNRELQTMRLLDHPNVHY--------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~--------~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~~--------------  148 (395)
                      ++|++.+.||+|+||.||+|++..+        ++.||||++... ....+|+.+++.++|+||..              
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            4799999999999999999999874        889999998765 45678999999999987510              


Q ss_pred             ---------------------------ecc--CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC-c
Q 016085          149 ---------------------------SRA--SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-Q  198 (395)
Q Consensus       149 ---------------------------~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~-~  198 (395)
                                                 ...  ...+++..++.++.||+.||.||| +.||+||||||+|||++.++. .
T Consensus       121 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dikp~NIl~~~~~~~~  199 (352)
T 2jii_A          121 TCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH-ENEYVHGNVTAENIFVDPEDQSQ  199 (352)
T ss_dssp             CCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCCGGGEEEETTEEEE
T ss_pred             chhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCCHHHEEEcCCCCce
Confidence                                       011  256899999999999999999999 889999999999999997651 5


Q ss_pred             eEEeecCCccccccCCC--------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHH
Q 016085          199 VKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES-GVDQL  269 (395)
Q Consensus       199 ikl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~  269 (395)
                      +||+|||+++.......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.. ....+
T Consensus       200 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  278 (352)
T 2jii_A          200 VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI  278 (352)
T ss_dssp             EEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             EEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH
Confidence            99999999976543221        13357899999999997754 8999999999999999999999998764 33333


Q ss_pred             HHHHHH-hCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          270 VEIIKV-LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       270 ~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ...... ...+.         .+.        .   .......+++.+.+||.+||+.||++|||+.++++
T Consensus       279 ~~~~~~~~~~~~---------~~~--------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          279 MKQKQKFVDKPG---------PFV--------G---PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHSCC---------CEE--------C---TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhccCChh---------hhh--------h---hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            333221 11110         000        0   00011246899999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.2e-38  Score=295.05  Aligned_cols=220  Identities=23%  Similarity=0.312  Sum_probs=177.0

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE----------------e
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH----------------Y  148 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~----------------~  148 (395)
                      ....+|++.+.||+|+||.||+|++. ++..||+|.+...   .....+|+.+++.++|+||.                +
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~   88 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEY   88 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEec
Confidence            34467999999999999999999974 5678999998653   34566899999999999981                0


Q ss_pred             e---------cc--CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--
Q 016085          149 S---------RA--SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       149 ~---------~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                      .         ..  ...+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||++........  
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~  166 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTA  166 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEEC
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHhhEEEcCCC-CEEECCCcccccccCccccc
Confidence            0         00  115788899999999999999999 88999999999999999887 699999999987643321  


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+.+..+....                  
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------------------  227 (279)
T 1qpc_A          167 REGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------------  227 (279)
T ss_dssp             CTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------------
T ss_pred             ccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc------------------
Confidence            12345678899999997654 8999999999999999999 999999877666555443210                  


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                ....+..+++.+.+||.+||..||++|||+.++++
T Consensus       228 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          228 ----------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                      01123457899999999999999999999999876

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.1e-38  Score=293.15  Aligned_cols=217  Identities=14%  Similarity=0.198  Sum_probs=174.0

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe-------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY-------------  148 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~-------------  148 (395)
                      ....+|++.+.||+|+||.||+|++  +++.||+|++...      .....+|+.+++.++|+||..             
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            3456799999999999999999998  4889999998643      234568999999999999810             


Q ss_pred             ---------------ecc--CCCCcHHHHHHHHHHHHHHHHHHHcCCC--eeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          149 ---------------SRA--SQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       149 ---------------~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                     ...  ...+++..+..++.||+.||.||| +.|  |+||||||+|||++.++ .++|+|||++..
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~~~~  162 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDM-TARISMADVKFS  162 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT-TSSSCCTTCCCSGGGEEECTTS-CEEEEGGGSCCT
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh-cCCCceecCCCccceEEEcCCc-ceeEEeccceee
Confidence                           011  124799999999999999999999 889  99999999999999887 599998888754


Q ss_pred             cccCCCcccccccccccccccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 016085          210 LVKGEPNISYICSRYYRAPELIFGATE--YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  287 (395)
Q Consensus       210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  287 (395)
                      ..    .....+|+.|+|||++.+...  ++.++|||||||++|+|++|+.||.+.+..+....+.....          
T Consensus       163 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------  228 (271)
T 3kmu_A          163 FQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL----------  228 (271)
T ss_dssp             TS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC----------
T ss_pred             ec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC----------
Confidence            32    234578999999999976541  23379999999999999999999998877666555543110          


Q ss_pred             CCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                       ...++..+++.+.+||.+||+.||++|||+.++++
T Consensus       229 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          229 -----------------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                             01133457899999999999999999999999884

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-38  Score=299.93  Aligned_cols=233  Identities=24%  Similarity=0.348  Sum_probs=172.7

Q ss_pred             ccceeeeeeeccCCceEEEEEE----EcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceEe------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVHY------------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~----~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~~------------  148 (395)
                      ..+|++.+.||+|+||.||+|+    +..+++.||+|++....     ....+|+.+++.++|+||..            
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            4469999999999999999998    56789999999986432     45668999999999999800            


Q ss_pred             -------e----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          149 -------S----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       149 -------~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                             .          .....+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++....
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh-cCCcccCCCchheEEEcCCC-CEEECccccccccc
Confidence                   0          12345788899999999999999999 88999999999999999887 69999999998765


Q ss_pred             cCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH-Hhh
Q 016085          212 KGEP----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE-IKC  286 (395)
Q Consensus       212 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~  286 (395)
                      ....    .....+|..|+|||++.+.. ++.++|||||||++|+|++|..|+....     ..+....+...... ...
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~  251 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQMTVTR  251 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGGGHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccccCHHH
Confidence            4432    22356788899999997755 8899999999999999999998864221     11111111111000 000


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      .....         ........+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       252 ~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          252 LVNTL---------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHH---------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHH---------hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            00000         000011134457899999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.4e-39  Score=306.41  Aligned_cols=236  Identities=24%  Similarity=0.304  Sum_probs=175.8

Q ss_pred             CccccceeeeeeeccCCceEEEEEE----EcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceEe----------
Q 016085           87 PKQTISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVHY----------  148 (395)
Q Consensus        87 ~~~~~~y~~~~~lG~G~fg~V~~a~----~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~~----------  148 (395)
                      -....+|++.+.||+|+||.||+|+    +..+++.||||++....    ....+|+.+++.++|+||..          
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            3445689999999999999999999    56789999999986542    33568999999999999810          


Q ss_pred             ---------e----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          149 ---------S----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       149 ---------~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                               .          .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~  176 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEA-HVKIADFGLAKL  176 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECCGGGCEE
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCChhhEEECCCC-CEEEccccccee
Confidence                     0          01234788899999999999999999 88999999999999999887 699999999987


Q ss_pred             cccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCCHHH-
Q 016085          210 LVKGEP----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-TPTREE-  283 (395)
Q Consensus       210 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~-  283 (395)
                      ......    .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||........  ....... .+.... 
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL--RMMGCERDVPALSRL  253 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHCC----CCHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhh--hhcccccccccHHHH
Confidence            643332    22345788899999997754 89999999999999999999999965332110  0000000 000000 


Q ss_pred             HhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          284 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .......             .....+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       254 ~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          254 LELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0000000             0111234578999999999999999999999999653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-38  Score=303.43  Aligned_cols=227  Identities=19%  Similarity=0.228  Sum_probs=175.1

Q ss_pred             ccccceeeeeeeccCCceEEEEEE-----EcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE----------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAK-----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH----------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~-----~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~----------  147 (395)
                      ....+|++.+.||+|+||.||+|+     +..+++.||||++...     .....+|+.+++.++|+||.          
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            345689999999999999999998     5567889999998532     23455799999999999980          


Q ss_pred             -------e---------ec-------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC--CceEEe
Q 016085          148 -------Y---------SR-------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLC  202 (395)
Q Consensus       148 -------~---------~~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~--~~ikl~  202 (395)
                             +         ..       ....+++..++.++.||+.||.||| +.||+||||||+|||++.++  ..+||+
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh-hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence                   0         00       0134788899999999999999999 88999999999999998432  259999


Q ss_pred             ecCCccccccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 016085          203 DFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  278 (395)
Q Consensus       203 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  278 (395)
                      |||++.......   ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.... .
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~  263 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-R  263 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-C
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-C
Confidence            999987553322   123456789999999997655 8999999999999999998 999998877655544443210 0


Q ss_pred             CCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                                                 ...+..++..+.+||.+||+.||.+|||+.++++|.|+-
T Consensus       264 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          264 ---------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                                       012344789999999999999999999999999998864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-38  Score=295.17  Aligned_cols=217  Identities=23%  Similarity=0.315  Sum_probs=170.6

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCc---EEEEEEeecc-----hhhHHHHHHHHHhcCCCceE----------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~---~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      .|.+.++||+|+||.||+|++..+++   .||+|.+...     .....+|+.+++.++|+||.                
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            58888999999999999999766554   7999998642     23445899999999999980                


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC--
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--  213 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~--  213 (395)
                                  .......+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||+++.....  
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA-EQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDREY  179 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTC-CEEECCTTSSCTTTTGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEcCCC-cEEeCcCCCcccccCCcc
Confidence                        0112356788899999999999999999 88999999999999999887 6999999999755322  


Q ss_pred             ---CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          214 ---EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       214 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                         .......+|+.|+|||.+.+.. ++.++|||||||++|+|++| .+||.+.+..+....+.....            
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~------------  246 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR------------  246 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC------------
T ss_pred             cccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC------------
Confidence               1223456788999999997654 89999999999999999995 555655555444433332100            


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                      ...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       247 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          247 ----------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                            0123347899999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.7e-39  Score=310.67  Aligned_cols=221  Identities=25%  Similarity=0.333  Sum_probs=165.5

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEc---CCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~------------  147 (395)
                      ....+|.+.+.||+|+||.||+|++.   .++..||||++...     .....+|+.+++.++|+||.            
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            34457999999999999999999886   46778999998643     23456899999999999980            


Q ss_pred             -----e----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          148 -----Y----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 -----~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                           +          ......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINSNL-VCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCC--------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCcceEEEcCCC-CEEECcCcccccccc
Confidence                 0          012346889999999999999999999 88999999999999999887 699999999987643


Q ss_pred             CCCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 016085          213 GEPN----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  287 (395)
Q Consensus       213 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  287 (395)
                      ....    ....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+.....          
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~----------  268 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR----------  268 (373)
T ss_dssp             --------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE----------
T ss_pred             CCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            3211    1223467899999997655 8999999999999999997 9999988776655544432100          


Q ss_pred             CCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                              .          ..+..++..+.+||.+||+.||++||++.++++
T Consensus       269 --------~----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          269 --------L----------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             --------C----------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------C----------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                    0          112346889999999999999999999998875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.8e-38  Score=314.92  Aligned_cols=217  Identities=24%  Similarity=0.328  Sum_probs=174.1

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch--hhHHHHHHHHHhcCCCceEe-----------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVHY-----------------  148 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~~l~~l~h~ni~~-----------------  148 (395)
                      ....+|++.+.||+|+||.||+|.+  +++.||||+++...  ..+.+|+.+|+.++|+||..                 
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3456899999999999999999987  47899999997543  44568999999999999810                 


Q ss_pred             ----------ec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          149 ----------SR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       149 ----------~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                                ..  ....+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+++.....  .
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~--~  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--Q  343 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTS-CEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHhhEEECCCC-CEEEeeCCCccccccc--c
Confidence                      00  1123688889999999999999999 88999999999999999887 6999999999864322  2


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+....                   
T Consensus       344 ~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-------------------  403 (450)
T 1k9a_A          344 DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------------  403 (450)
T ss_dssp             ---CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-------------------
T ss_pred             cCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence            2345688999999997755 8999999999999999998 999998877655554443210                   


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                               ....+..+++.+.+||.+||+.||++|||+.++++
T Consensus       404 ---------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          404 ---------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                     00123457899999999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-38  Score=321.39  Aligned_cols=220  Identities=21%  Similarity=0.326  Sum_probs=178.6

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE-----------------e
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH-----------------Y  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~-----------------~  148 (395)
                      ...+|++.+.||+|+||.||+|++..++..||||++...   ...+.+|+.+|+.++|+||.                 +
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            345799999999999999999999999999999998754   34566899999999999981                 0


Q ss_pred             ---------e--ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--
Q 016085          149 ---------S--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       149 ---------~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                               .  .....+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+++.......  
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~  375 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMTGDTYTA  375 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECGGG-CEEECCTTCEECCTTCCEEC
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChhhEEECCCC-cEEEeecccceeccCCceee
Confidence                     0  12245788899999999999999999 88999999999999999877 699999999987643321  


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+....                  
T Consensus       376 ~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------------  436 (495)
T 1opk_A          376 HAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------------  436 (495)
T ss_dssp             CTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------------------
T ss_pred             cCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------------
Confidence            12234577899999997654 8999999999999999999 999999877655444332210                  


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                ....+..+++.+.+||.+||+.||++|||+.++++
T Consensus       437 ----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          437 ----------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                      01123457899999999999999999999999974

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.6e-38  Score=317.07  Aligned_cols=220  Identities=25%  Similarity=0.339  Sum_probs=177.2

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceEe----------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      ....+|++.+.||+|+||.||+|++. ++..||||++...   ...+.+|+.+|+.++|+||..                
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~  263 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEF  263 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECC
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEee
Confidence            34568999999999999999999975 4678999998753   345668999999999999810                


Q ss_pred             ---------ec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--C
Q 016085          149 ---------SR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--P  215 (395)
Q Consensus       149 ---------~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--~  215 (395)
                               ..  ....+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+++......  .
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~~~~~~~~  341 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTA  341 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCSGGGEEECTTC-CEEECSTTGGGGBCCHHHHT
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCCHHHEEECCCC-cEEEeeCCCceEcCCCceec
Confidence                     00  0125677788899999999999999 88999999999999999887 69999999998753221  1


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+.+..+......                
T Consensus       342 ~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----------------  404 (454)
T 1qcf_A          342 REGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----------------  404 (454)
T ss_dssp             TCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC----------------
T ss_pred             cCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence            12334578899999997655 8999999999999999999 99999988877666655431100                


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                  ..+..+++.+.+||.+||..||++|||+.++++
T Consensus       405 ------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          405 ------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                        112347899999999999999999999999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.2e-39  Score=304.25  Aligned_cols=221  Identities=25%  Similarity=0.387  Sum_probs=169.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-----ee------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-----YS------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-----~~------------  149 (395)
                      ++|++.+.||+|+||.||+|++..+++.||||++...    .....+|+.+++.++|+||.     +.            
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            4799999999999999999999999999999988543    23456899999999999981     00            


Q ss_pred             -----------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          150 -----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       150 -----------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                       .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++.....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-AKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACI  186 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTS-CEEECCCSSCEESCE
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEcCCC-CEEEEecCcchhccc
Confidence                             01355889999999999999999999 78999999999999999887 699999999876432


Q ss_pred             CCC----------cccccccccccccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCC
Q 016085          213 GEP----------NISYICSRYYRAPELIFGAT--EYTTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTP  279 (395)
Q Consensus       213 ~~~----------~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~  279 (395)
                      ...          .....||+.|+|||++.+..  .++.++|||||||++|+|++|+.||...... ..+......    
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----  262 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN----  262 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC----
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc----
Confidence            111          11345699999999986543  2688999999999999999999999531100 001111100    


Q ss_pred             CHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          280 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                   ....          .....++..+.+||.+||+.||.+|||+.+++++
T Consensus       263 -------------~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 -------------QLSI----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             -------------C--C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------cCCC----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                         0000          1123478999999999999999999999999975

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.4e-38  Score=297.56  Aligned_cols=220  Identities=30%  Similarity=0.471  Sum_probs=161.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      ++|++.+.||+|+||.||+|++..+|+.||||++...       .....+|+.+++.++|+||.                
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            4699999999999999999999999999999998641       23456899999999999980                


Q ss_pred             -ee-------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 -YS-------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 -~~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                       +.             .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++......
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCC---------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCcHHHEEEcCCC-CEEEEeccceeeecCC
Confidence             00             11345788889999999999999999 88999999999999999887 6999999998765433


Q ss_pred             CC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          214 EP-NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       214 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      .. .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.... ..+...+....              
T Consensus       190 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------  254 (310)
T 2wqm_A          190 TTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--------------  254 (310)
T ss_dssp             ---------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--------------
T ss_pred             CccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--------------
Confidence            22 23457899999999997654 899999999999999999999999764322 12222111100              


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                          ++.        .....++.++.+||.+||..||.+|||+.++++
T Consensus       255 ----~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          255 ----YPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             ----SCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                010        112347899999999999999999999999985

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-38  Score=301.51  Aligned_cols=222  Identities=22%  Similarity=0.283  Sum_probs=170.3

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCC----cEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE-----------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETG----ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~----~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      ....+|++.+.||+|+||.||+|++..++    ..||||++...     .....+|+.+++.++|+||.           
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            34457999999999999999999987553    35999998643     23345899999999999980           


Q ss_pred             ----------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          148 ----------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       148 ----------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                                      .......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA-NMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCCCC-----
T ss_pred             cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChheEEECCCC-cEEECCCCcchhhc
Confidence                            0112356889999999999999999999 88999999999999999887 69999999998764


Q ss_pred             cCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 016085          212 KGEP----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       212 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  286 (395)
                      ....    .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+.....         
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---------  268 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---------  268 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---------
T ss_pred             cccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc---------
Confidence            3321    11234578899999997654 8999999999999999998 9999988776655554432100         


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                               .          ..+..++..+.+||.+||+.||++||++.+++++
T Consensus       269 ---------~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          269 ---------L----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ---------C----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------C----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                     0          1123478899999999999999999999998763

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3e-38  Score=296.95  Aligned_cols=218  Identities=22%  Similarity=0.324  Sum_probs=170.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCC---cEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .+|++.+.||+|+||.||+|++..++   ..||+|.+...     .....+|+.+++.++|+||.               
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            36999999999999999999976443   35899988642     23455899999999999980               


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                   .......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++......
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-SKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTC-CEEECSCGGGCCCSCGG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCchheEEECCCC-CEEECcccccccccccc
Confidence                         0012345788899999999999999999 88999999999999999887 69999999997653322


Q ss_pred             -----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          215 -----PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       215 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                           ......+|+.|+|||.+.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+....            
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~------------  249 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------------  249 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC------------
T ss_pred             hhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC------------
Confidence                 123445688999999997755 8999999999999999999 677887766655544443310            


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                      ....+..++..+.+||.+||+.||.+|||+.++++
T Consensus       250 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          250 ----------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            00123347889999999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-38  Score=296.30  Aligned_cols=218  Identities=22%  Similarity=0.328  Sum_probs=168.4

Q ss_pred             CccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCCCceEe-----ec---------
Q 016085           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVHY-----SR---------  150 (395)
Q Consensus        87 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~ni~~-----~~---------  150 (395)
                      .....+|++.+.||+|+||.||+|++  +|+.||||++...  .....+|+.+++.++|+||..     ..         
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            34556899999999999999999987  5889999998754  344568999999999999810     00         


Q ss_pred             --c-------------CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          151 --A-------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       151 --~-------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                        .             ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++......  
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTS-CEEECCCCC---------
T ss_pred             ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCcceEEEeCCC-cEEEeecccccccccc--
Confidence              0             011677778899999999999999 88999999999999999887 6999999999765332  


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+...                   
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-------------------  230 (278)
T 1byg_A          171 QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-------------------  230 (278)
T ss_dssp             -----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-------------------
T ss_pred             ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-------------------
Confidence            23345688999999997654 8999999999999999998 99999887655544433210                   


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                               .....+..+++.+.+||.+||+.||++|||+.++++
T Consensus       231 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          231 ---------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                     001123457899999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.4e-38  Score=297.87  Aligned_cols=225  Identities=25%  Similarity=0.329  Sum_probs=169.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcC-CCc--EEEEEEeecc-------hhhHHHHHHHHHhcCCCceEe-----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLE-TGE--TVAIKKVLQD-------KRYKNRELQTMRLLDHPNVHY-----------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~-~~~--~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~~-----------  148 (395)
                      ..+|++.+.||+|+||.||+|++.. +++  .||||++...       .....+|+.+++.++|+||..           
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK   96 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence            4579999999999999999998643 333  6899988643       234458999999999999810           


Q ss_pred             ---------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          149 ---------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       149 ---------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                     ......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++......
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQN  174 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCC-
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH-hCCcccCCCchheEEEcCCC-CEEEcccccccccccc
Confidence                           011245788899999999999999999 88999999999999999877 6999999999876443


Q ss_pred             CC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          214 EP----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       214 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ..    .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+.+..+......          
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  243 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER----------  243 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC----------
T ss_pred             ccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC----------
Confidence            32    12345678899999997654 8999999999999999999 99999988776665554331000          


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                       ...+..++..+.+||.+||..||.+|||+.++++  +++++
T Consensus       244 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~  282 (291)
T 1u46_A          244 -----------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA  282 (291)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             -----------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence                             0122347899999999999999999999999985  44443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.9e-38  Score=312.75  Aligned_cols=226  Identities=25%  Similarity=0.327  Sum_probs=175.7

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceEe----------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      ....+|++.+.||+|+||.||+|++.. +..||||++...   ...+.+|+.+|+.++|+||..                
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~  259 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEY  259 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehh
Confidence            345679999999999999999999864 467999998753   345678999999999999810                


Q ss_pred             ---------ec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--
Q 016085          149 ---------SR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       149 ---------~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                               ..  ....+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+++.......  
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~  337 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTA  337 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCCCTTC---------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChhhEEECCCC-CEEECCCccceecCCCceec
Confidence                     00  1234788889999999999999999 88999999999999999877 699999999987643321  


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....+|..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+.+..+.....                 
T Consensus       338 ~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-----------------  399 (452)
T 1fmk_A          338 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----------------  399 (452)
T ss_dssp             -----CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------------
T ss_pred             ccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence            12344578899999997654 8999999999999999999 9999998877666555432100                 


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc--CCcccC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFDE  345 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~--hp~f~~  345 (395)
                                 ...+..+++.+.+||.+||+.||++|||+.++++  ..+|..
T Consensus       400 -----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          400 -----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                       0123457899999999999999999999999886  344433

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.6e-38  Score=295.73  Aligned_cols=213  Identities=28%  Similarity=0.408  Sum_probs=161.4

Q ss_pred             cccceeee-eeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHH-HhcCCCceE-----e-------------
Q 016085           89 QTISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVH-----Y-------------  148 (395)
Q Consensus        89 ~~~~y~~~-~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l-~~l~h~ni~-----~-------------  148 (395)
                      ..++|.+. +.||+|+||.||+|++..+++.||||++... ....+|+.++ +.++|+||.     +             
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv   93 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   93 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence            34568887 7899999999999999999999999998754 3456788887 677999970     0             


Q ss_pred             ------------e--ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC---CCCceEEeecCCccccc
Q 016085          149 ------------S--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       149 ------------~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~---~~~~ikl~DFG~a~~~~  211 (395)
                                  .  .....+++..++.++.||+.||.||| +.||+||||||+|||++.   ++ .+||+|||++....
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETT  171 (299)
T ss_dssp             ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECT
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEecCCCCC-cEEEeccccccccc
Confidence                        0  01235899999999999999999999 889999999999999997   45 69999999986431


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          212 KGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                                           + ..++.++|||||||++|+|++|+.||.+.+.......+.               .. 
T Consensus       172 ---------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~---------------~~-  213 (299)
T 3m2w_A          172 ---------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---------------TR-  213 (299)
T ss_dssp             ---------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---------------CS-
T ss_pred             ---------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---------------HH-
Confidence                                 1 237889999999999999999999997654322110000               00 


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                        ..   .....+.......+++++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus       214 --~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          214 --IR---MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             --SC---TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             --Hh---hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence              00   0000111111245789999999999999999999999999999998754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-38  Score=308.05  Aligned_cols=220  Identities=21%  Similarity=0.332  Sum_probs=164.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCC---cEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE--------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ...|.+.+.||+|+||.||+|++..++   ..||+|.+...     .....+|+.+++.++|+||.              
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            346999999999999999999876443   46899988542     23456899999999999981              


Q ss_pred             ----e----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 ----Y----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 ----~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                          +          ......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-SKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCC---------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH-HCCEecCccchheEEECCCC-CEEEeecccccccccc
Confidence                0          011245778889999999999999999 88999999999999999887 6999999999865332


Q ss_pred             CC-----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 016085          214 EP-----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  287 (395)
Q Consensus       214 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  287 (395)
                      ..     .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+...  .         
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--~---------  313 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R---------  313 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--C---------
T ss_pred             ccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--C---------
Confidence            21     12345678899999997655 8999999999999999999 78889876655544443321  0         


Q ss_pred             CCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                       ....+..++..+.+||.+||+.||++|||+.+++++
T Consensus       314 -----------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          314 -----------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                             001233478999999999999999999999998863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-38  Score=300.95  Aligned_cols=224  Identities=21%  Similarity=0.288  Sum_probs=162.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchh-hHHHHHHHHHhc--CCCceEe----------------e--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-YKNRELQTMRLL--DHPNVHY----------------S--  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-~~~~E~~~l~~l--~h~ni~~----------------~--  149 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||++..... ...+|.+++..+  +|+||..                .  
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~  114 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT  114 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence            5799999999999999999987  489999999865432 334566666554  9999810                0  


Q ss_pred             -----------ccCCCCcHHHHHHHHHHHHHHHHHHHcCC--------CeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          150 -----------RASQRMPLIYVKLYTYQICRALAYIHGGI--------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       150 -----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--------giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                                 .....+++..+..++.|++.||.||| +.        ||+||||||+|||++.++ .+||+|||+++..
T Consensus       115 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~  192 (337)
T 3mdy_A          115 DYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLH-TEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVKF  192 (337)
T ss_dssp             CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH-SCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             eccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH-HhhhhhccCCCEEecccchHHEEECCCC-CEEEEeCCCceee
Confidence                       01235788889999999999999999 77        999999999999999887 6999999999765


Q ss_pred             ccCCCc-----ccccccccccccccccCCCCCCCc------chHHHHHHHHHHHHhC----------CCCCCCCCc----
Q 016085          211 VKGEPN-----ISYICSRYYRAPELIFGATEYTTA------VDIWSVGCVLAELLLG----------QPLFPGESG----  265 (395)
Q Consensus       211 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~------~DiwSlG~il~ell~g----------~~pf~~~~~----  265 (395)
                      ......     ....||+.|+|||++.+.. ++..      +|||||||++|||++|          +.||.....    
T Consensus       193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~  271 (337)
T 3mdy_A          193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS  271 (337)
T ss_dssp             C---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence            433221     2457899999999997654 4444      9999999999999999          677754321    


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          266 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       266 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ...+..+.....              ....++       .......+++.+.+||.+||+.||++|||+.++++|
T Consensus       272 ~~~~~~~~~~~~--------------~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          272 YEDMREIVCIKK--------------LRPSFP-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHHHHTTSC--------------CCCCCC-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhhhHHHHhhhc--------------cCcccc-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            122222111000              000000       001112356789999999999999999999999865

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=305.19  Aligned_cols=215  Identities=15%  Similarity=0.185  Sum_probs=164.7

Q ss_pred             ccceeeeeeeccCCceEEEEE-----EEcCCCcEEEEEEeecc-hhhHHHHHHHHHhcC---CCceE-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQA-----KCLETGETVAIKKVLQD-KRYKNRELQTMRLLD---HPNVH-------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a-----~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~---h~ni~-------------  147 (395)
                      ..+|.+.+.||+|+||.||+|     .+..+++.||||++... .....+|+.+++.+.   |+|+.             
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~  143 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV  143 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence            457999999999999999999     46778999999998654 344567888888887   77760             


Q ss_pred             ----e---------ec-----cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC-----------CCCc
Q 016085          148 ----Y---------SR-----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-----------HTHQ  198 (395)
Q Consensus       148 ----~---------~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~-----------~~~~  198 (395)
                          +         ..     ....+++..++.++.||+.||+||| ++||+||||||+|||++.           ++ .
T Consensus       144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH-~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~-~  221 (365)
T 3e7e_A          144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH-DCEIIHGDIKPDNFILGNGFLEQDDEDDLSA-G  221 (365)
T ss_dssp             EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCSGGGEEECGGGTCC------CT-T
T ss_pred             EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh-hCCeecCCCCHHHEEecccccCccccccccC-C
Confidence                0         00     2456899999999999999999999 899999999999999987           56 6


Q ss_pred             eEEeecCCcccccc---CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 016085          199 VKLCDFGSAKVLVK---GEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV  275 (395)
Q Consensus       199 ikl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  275 (395)
                      +||+|||+|+....   .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||......         
T Consensus       222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~---------  291 (365)
T 3e7e_A          222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG---------  291 (365)
T ss_dssp             EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT---------
T ss_pred             EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC---------
Confidence            99999999975432   22234567899999999998765 899999999999999999999999543210         


Q ss_pred             hCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          276 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                       .........       ....++.+.+++.+||+.+|.+|++..+.+.+
T Consensus       292 -----------------~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          292 -----------------ECKPEGLFR-------RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             -----------------EEEECSCCT-------TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             -----------------ceeechhcc-------ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence                             000000000       00136788999999999999999766555554

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.3e-38  Score=297.09  Aligned_cols=228  Identities=23%  Similarity=0.317  Sum_probs=170.6

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--------hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--------~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      |...+.||+|+||.||+|++  +++.||+|++...        .....+|+.+++.++|+||.                 
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            66678999999999999986  6889999998542        23456899999999999980                 


Q ss_pred             e------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 Y------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 ~------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                      +            ......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.......
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSCSS
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEcCCC-cEEEeecccccccccccc
Confidence            0            011245888999999999999999999 88999999999999999887 699999999976543322


Q ss_pred             ---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          216 ---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       216 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                         .....||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......+..+.+...............   
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  263 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK---  263 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS---
T ss_pred             cccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc---
Confidence               223568999999998865  379999999999999999999999987654433333332211110000000000   


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                           ..      ...+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       264 -----~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          264 -----KM------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             -----SC------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----cc------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                 00      00112245679999999999999999999999853

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-37  Score=322.37  Aligned_cols=216  Identities=23%  Similarity=0.309  Sum_probs=171.0

Q ss_pred             eeee-eeeccCCceEEEEEEE--cCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCce-----------------
Q 016085           93 YMAE-RVVGQGSFGIVFQAKC--LETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV-----------------  146 (395)
Q Consensus        93 y~~~-~~lG~G~fg~V~~a~~--~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni-----------------  146 (395)
                      +.+. +.||+|+||.||+|.+  ..+++.||||+++...      ....+|+.+|+.++|+||                 
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E  449 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVME  449 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEE
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4443 4899999999999954  4567899999986532      345689999999999998                 


Q ss_pred             --------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC---
Q 016085          147 --------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---  215 (395)
Q Consensus       147 --------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~---  215 (395)
                              .+......+++..+..++.||+.||+||| +.||+||||||+||||+.++ .+||+|||+|+.......   
T Consensus       450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC------
T ss_pred             ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccccCccccc
Confidence                    11123456889999999999999999999 88999999999999999887 699999999987643322   


Q ss_pred             -cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          216 -NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       216 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                       .....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+....                 
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-----------------  589 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-----------------  589 (635)
T ss_dssp             -------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------------
T ss_pred             cccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence             12334578899999997655 8999999999999999998 999999888766555544310                 


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                 ....+..+++++.+||.+||+.||++|||+.++++
T Consensus       590 -----------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          590 -----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                       00123457899999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9e-38  Score=297.00  Aligned_cols=231  Identities=24%  Similarity=0.322  Sum_probs=168.6

Q ss_pred             eeeeeeeccCCceEEEEEEE----cCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe---------------
Q 016085           93 YMAERVVGQGSFGIVFQAKC----LETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY---------------  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~----~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~---------------  148 (395)
                      |++++.||+|+||.||++..    ..+++.||||++...     .....+|+.+++.++|+||..               
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            59999999999999988753    457899999998754     234568999999999999810               


Q ss_pred             ------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          149 ------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       149 ------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                                  ......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++........ 
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH-~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~  190 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH-AQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEY  190 (318)
T ss_dssp             EECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCGGGCEECCTTCSE
T ss_pred             EEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCchheEEEcCCC-CEEECCccccccccccccc
Confidence                        011234788999999999999999999 88999999999999999887 699999999987654432 


Q ss_pred             ---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          216 ---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       216 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                         .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.......     ....+.........      
T Consensus       191 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~~~------  258 (318)
T 3lxp_A          191 YRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQMTVL------  258 (318)
T ss_dssp             EEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHHHHH------
T ss_pred             cccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccchhHH------
Confidence               22345688899999997755 8899999999999999999999996532110     00111110000000      


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                        ..............+..++..+.+||.+||+.||++|||+.++++
T Consensus       259 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          259 --RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             --HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence              000000000011123457899999999999999999999999984

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.2e-38  Score=301.74  Aligned_cols=242  Identities=22%  Similarity=0.315  Sum_probs=163.8

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-hhHHHHHHH--HHhcCCCceEee---------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQT--MRLLDHPNVHYS---------------  149 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~~--l~~l~h~ni~~~---------------  149 (395)
                      ...++|++.+.||+|+||.||+|++  +++.||||++.... .....|.++  +..++|+||...               
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            3446799999999999999999976  78999999986543 223334444  445899997110               


Q ss_pred             -----c----------cCCCCcHHHHHHHHHHHHHHHHHHHcCC---------CeeeccCCCCceEEcCCCCceEEeecC
Q 016085          150 -----R----------ASQRMPLIYVKLYTYQICRALAYIHGGI---------GVCHRDIKPQNLLVNPHTHQVKLCDFG  205 (395)
Q Consensus       150 -----~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---------giiHrDlKp~Nill~~~~~~ikl~DFG  205 (395)
                           .          .....++..+..++.||+.||.||| +.         ||+||||||+|||++.++ .+||+|||
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH-~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~DFG  165 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLH-TELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFG  165 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH-CCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEECCCT
T ss_pred             EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHH-hhhccccccccceeecccccceEEEcCCC-cEEEeecc
Confidence                 0          1133567778899999999999999 78         999999999999999887 69999999


Q ss_pred             CccccccCC---------CcccccccccccccccccCC------CCCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHHH
Q 016085          206 SAKVLVKGE---------PNISYICSRYYRAPELIFGA------TEYTTAVDIWSVGCVLAELLLGQPLF-PGESGVDQL  269 (395)
Q Consensus       206 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~  269 (395)
                      +++......         .....+||+.|+|||++.+.      ..++.++|||||||++|||++|..|| .+.......
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            998654321         12245789999999999762      23567899999999999999997665 332211111


Q ss_pred             HHHHH-HhCCCCHHHHhhcC-CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          270 VEIIK-VLGTPTREEIKCMN-PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       270 ~~i~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ..+.. ....+....+.... .......++..    +  ......++.+.+||.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA----W--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT----C--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhhcccCCCchHHHHHhhhcccccCCCCCcc----c--ccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            11111 11222222221110 00000011100    0  001113457999999999999999999999954

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=319.05  Aligned_cols=218  Identities=25%  Similarity=0.291  Sum_probs=171.6

Q ss_pred             cceeeee-eeccCCceEEEEEEEc--CCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE---------------
Q 016085           91 ISYMAER-VVGQGSFGIVFQAKCL--ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        91 ~~y~~~~-~lG~G~fg~V~~a~~~--~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .++.+.+ .||+|+||.||+|.+.  .++..||||+++..     ...+.+|+.+|+.++|+||.               
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~  414 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM  414 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEE
Confidence            3466666 8999999999999876  35567999998653     34567899999999999980               


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                                 .......+++..+..++.||+.||+||| ++||+||||||+||||+.++ .+||+|||+++........
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECCCSTTTTCC-----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HCCEEcCcCCHHHEEEcCCC-cEEEeeccCcccccCCCce
Confidence                       0112345899999999999999999999 88999999999999999887 6999999999876433221


Q ss_pred             ----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          217 ----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       217 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                          ....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+....               
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~---------------  556 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---------------  556 (613)
T ss_dssp             ---------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC---------------
T ss_pred             eeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence                1223468899999997654 8999999999999999998 999999988776665554310               


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                   ...++..+++++.+||.+||+.||++|||+.++++
T Consensus       557 -------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          557 -------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             -------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                         00123457899999999999999999999998753

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.7e-37  Score=315.74  Aligned_cols=219  Identities=25%  Similarity=0.327  Sum_probs=176.4

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceEe-----------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVHY-----------------  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~~-----------------  148 (395)
                      ...+|++.+.||+|+||.||+|++.. +..||||++...   ...+.+|+.+|+.|+|+||..                 
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~  343 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM  343 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehh
Confidence            34679999999999999999999864 467999998753   345678999999999999810                 


Q ss_pred             --------ec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--Cc
Q 016085          149 --------SR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--PN  216 (395)
Q Consensus       149 --------~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--~~  216 (395)
                              ..  ....+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+++......  ..
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~  421 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTAR  421 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCTTSTTTCCCHHHHTT
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHhhEEEcCCC-cEEEcccccceecCCCceecc
Confidence                    00  1234788899999999999999999 88999999999999999877 69999999997653221  11


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+|..|+|||++.+.. ++.++|||||||+||||++ |+.||.+....+.+..+.....                  
T Consensus       422 ~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------------  482 (535)
T 2h8h_A          422 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------------  482 (535)
T ss_dssp             CSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred             cCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            2334578899999997654 8999999999999999999 9999998877666555432100                  


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                ...+..++..+.+||.+||+.||++|||+.++++
T Consensus       483 ----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          483 ----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                      0123457899999999999999999999999886

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=294.73  Aligned_cols=231  Identities=26%  Similarity=0.393  Sum_probs=173.4

Q ss_pred             ccccceeeeeeeccCCceEEEEEE----EcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCceEe-----------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVHY-----------  148 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~----~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni~~-----------  148 (395)
                      ....+|++.+.||+|+||.||+|+    +..+++.||||++....    ....+|+.+++.++|+||..           
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            345579999999999999999998    46789999999986532    34568999999999999810           


Q ss_pred             ------------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          149 ------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       149 ------------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                                        ......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++...
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dikp~NIli~~~~-~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL  195 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEEETT-EEEECCCTTCEEC
T ss_pred             ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH-hCCEeccCCCcceEEEcCCC-cEEEecCcchhhc
Confidence                              011245788899999999999999999 88999999999999999877 6999999999876


Q ss_pred             ccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH---
Q 016085          211 VKGEP----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE---  283 (395)
Q Consensus       211 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---  283 (395)
                      .....    .....+|..|+|||++.+.. ++.++|||||||++|+|++|..||....     ....+..+......   
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchhhhH
Confidence            44332    12344677899999997754 8999999999999999999999885421     11111111111000   


Q ss_pred             ---HhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          284 ---IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       284 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                         .......             .....+..+++.+.+||.+||+.||++|||+.++++
T Consensus       270 ~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          270 FHLIELLKNN-------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhhcC-------------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               0000000             000123457899999999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.5e-37  Score=292.29  Aligned_cols=226  Identities=19%  Similarity=0.254  Sum_probs=171.0

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE--------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ...++|++.+.||+|+||.||+|++..   .||+|++....      ....+|+.+++.++|+||.              
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            344579999999999999999998753   49999886431      3345799999999999980              


Q ss_pred             ------------ee-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-
Q 016085          148 ------------YS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  213 (395)
Q Consensus       148 ------------~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-  213 (395)
                                  +. .....+++..++.++.||+.||.||| +.||+||||||+|||++ ++ .+||+|||+++..... 
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH-AKGILHKDLKSKNVFYD-NG-KVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH-HTTCCCCCCCSTTEEEC----CCEECCCSCCC------
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCChhhEEEe-CC-CEEEeecCCcccccccc
Confidence                        01 11235889999999999999999999 88999999999999998 45 6999999998654211 


Q ss_pred             -----CCcccccccccccccccccC--------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016085          214 -----EPNISYICSRYYRAPELIFG--------ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  280 (395)
Q Consensus       214 -----~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  280 (395)
                           .......||+.|+|||++.+        ...++.++|||||||++|+|++|+.||.+.+.......+....    
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----  259 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM----  259 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC----
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC----
Confidence                 12234568999999999864        2347889999999999999999999998877665554443210    


Q ss_pred             HHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          281 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                     .+.        .....++..+.+||.+||..||++|||+.++++  .++.+..
T Consensus       260 ---------------~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~  302 (319)
T 2y4i_B          260 ---------------KPN--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPK  302 (319)
T ss_dssp             ---------------CCC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC--
T ss_pred             ---------------CCC--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHH
Confidence                           000        012246889999999999999999999999985  4444443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.9e-38  Score=303.82  Aligned_cols=219  Identities=17%  Similarity=0.189  Sum_probs=165.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------------hhHHHHHHHHHhcC---------CCceE--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLD---------HPNVH--  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------------~~~~~E~~~l~~l~---------h~ni~--  147 (395)
                      ++|++.+.||+|+||+||+|++  +|+.||||++....            ....+|+.+++.++         |+||.  
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5799999999999999999998  78999999987542            45678999999886         44430  


Q ss_pred             ---------------------------------------------ee--------ccCCCCcHHHHHHHHHHHHHHHHHH
Q 016085          148 ---------------------------------------------YS--------RASQRMPLIYVKLYTYQICRALAYI  174 (395)
Q Consensus       148 ---------------------------------------------~~--------~~~~~~~~~~~~~~~~qi~~aL~~L  174 (395)
                                                                   +.        .....+++..++.++.||+.||.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence                                                         00        0124578999999999999999999


Q ss_pred             HcCCCeeeccCCCCceEEcCCC-------------------CceEEeecCCccccccCCCcccccccccccccccccCCC
Q 016085          175 HGGIGVCHRDIKPQNLLVNPHT-------------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT  235 (395)
Q Consensus       175 H~~~giiHrDlKp~Nill~~~~-------------------~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  235 (395)
                      |.+.||+||||||+|||++.++                   ..+||+|||+|+.....    ..+||+.|+|||++.+..
T Consensus       178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~  253 (336)
T 2vuw_A          178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG  253 (336)
T ss_dssp             HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS
T ss_pred             HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC
Confidence            9336999999999999998765                   16999999999876432    457899999999997643


Q ss_pred             CCCCcchHHHHHHH-HHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCC
Q 016085          236 EYTTAVDIWSVGCV-LAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP  313 (395)
Q Consensus       236 ~~~~~~DiwSlG~i-l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  313 (395)
                        +.++|||||+++ .+++++|..||.+..... ....+......             ..         .........++
T Consensus       254 --~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~---------~~~~~~~~~~s  309 (336)
T 2vuw_A          254 --DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF-------------KT---------KCNTPAMKQIK  309 (336)
T ss_dssp             --SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC-------------SS---------CCCSHHHHHHH
T ss_pred             --ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc-------------Cc---------ccchhhhhhcC
Confidence              889999998777 778889999994421111 11222211000             00         00001223367


Q ss_pred             hhHHHHHHhhccCCCCCCCCHHHHh-cCCccc
Q 016085          314 PEAVDLVSRLLQYSPNLRCTALEAC-IHPFFD  344 (395)
Q Consensus       314 ~~~~~ll~~~L~~dP~~R~t~~e~l-~hp~f~  344 (395)
                      +++.+||++||++|     |+.|+| +||||+
T Consensus       310 ~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          310 RKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             HHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            89999999999987     999999 999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.9e-37  Score=317.41  Aligned_cols=221  Identities=29%  Similarity=0.373  Sum_probs=176.0

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCC---CcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~---~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~------------  147 (395)
                      ....+|++.+.||+|+||.||+|++..+   +..||||.+....     ....+|+.+++.++||||.            
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  466 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW  466 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceE
Confidence            4456899999999999999999998654   4579999886432     3456899999999999981            


Q ss_pred             ----e---------e-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 ----Y---------S-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 ----~---------~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                          +         . .....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDikp~NILl~~~~-~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECCCCCCCSCCC-
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccchHhEEEeCCC-CEEEEecCCCeecCCC
Confidence                0         0 12235788889999999999999999 78999999999999999887 6999999999876433


Q ss_pred             CCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          214 EPN--ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       214 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ...  ....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+.....             
T Consensus       545 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~-------------  610 (656)
T 2j0j_A          545 TYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------------  610 (656)
T ss_dssp             ---------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC-------------
T ss_pred             cceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence            221  2344578999999997654 8999999999999999997 9999998887776666544110             


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                     ..++..+++.+.+||.+||..||.+|||+.++++
T Consensus       611 ---------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          611 ---------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                           0123457899999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.8e-37  Score=293.07  Aligned_cols=226  Identities=21%  Similarity=0.239  Sum_probs=168.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-hhhHHHHHHHHHh--cCCCceEe-----e-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRL--LDHPNVHY-----S-------------  149 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~--l~h~ni~~-----~-------------  149 (395)
                      ++|++.+.||+|+||.||+|++  +++.||||++... .....+|.++++.  ++|+||..     .             
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~  119 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS  119 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence            4799999999999999999987  6899999998654 3344678888887  79999810     0             


Q ss_pred             -----------ccCCCCcHHHHHHHHHHHHHHHHHHHc-------CCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          150 -----------RASQRMPLIYVKLYTYQICRALAYIHG-------GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       150 -----------~~~~~~~~~~~~~~~~qi~~aL~~LH~-------~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                                 .....+++..++.++.||+.||.|||.       +.||+||||||+|||++.++ .+||+|||++....
T Consensus       120 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~  198 (342)
T 1b6c_B          120 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHD  198 (342)
T ss_dssp             CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEECCCTTCEEEE
T ss_pred             eecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEEECCCceecc
Confidence                       011357788899999999999999993       46999999999999999887 69999999998765


Q ss_pred             cCCC-----cccccccccccccccccCCCC-----CCCcchHHHHHHHHHHHHhC----------CCCCCCCCc----HH
Q 016085          212 KGEP-----NISYICSRYYRAPELIFGATE-----YTTAVDIWSVGCVLAELLLG----------QPLFPGESG----VD  267 (395)
Q Consensus       212 ~~~~-----~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~ell~g----------~~pf~~~~~----~~  267 (395)
                      ....     .....||+.|+|||++.+...     ++.++|||||||++|+|++|          +.||.+...    ..
T Consensus       199 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~  278 (342)
T 1b6c_B          199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  278 (342)
T ss_dssp             TTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             ccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHH
Confidence            4432     234578999999999976432     23689999999999999999          788866432    22


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          268 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       268 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .+........              .   .+...    ........+..+.+||.+||+.||++|||+.++++|
T Consensus       279 ~~~~~~~~~~--------------~---~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          279 EMRKVVCEQK--------------L---RPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHHHTTSC--------------C---CCCCC----GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHH--------------h---CCCCc----ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            2222111000              0   00000    000112245679999999999999999999999865

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-36  Score=316.83  Aligned_cols=214  Identities=26%  Similarity=0.372  Sum_probs=172.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcC-CCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      .++|++.+.||+|+||.||+|++.. +++.||||++...     .....+|+.+++.++|+||.                
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3689999999999999999999976 7899999988543     12345899999999999981                


Q ss_pred             -ee------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 -YS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 -~~------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                       ++            .....+++..++.++.||+.||.||| +.||+||||||+|||++.+  .+||+|||+++..... 
T Consensus       159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~-  234 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH-SIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF-  234 (681)
T ss_dssp             EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECSS--CEEECCCTTCEETTCC-
T ss_pred             eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecccChHHeEEeCC--cEEEEecccchhcccC-
Confidence             00            01236889999999999999999999 8899999999999999864  5999999999876432 


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                        ...+||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+....          +                 
T Consensus       235 --~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~-----------------  283 (681)
T 2pzi_A          235 --GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------G-----------------  283 (681)
T ss_dssp             --SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------S-----------------
T ss_pred             --CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------c-----------------
Confidence              456789999999998653  588999999999999999999988652110          0                 


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                       .+   ..    ......++.+.+||.+||+.||.+||+..+++.|+|+..+
T Consensus       284 -~~---~~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          284 -LP---ED----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -CC---TT----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -cc---cc----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence             00   00    0001136789999999999999999999999999998643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.6e-34  Score=269.33  Aligned_cols=197  Identities=16%  Similarity=0.059  Sum_probs=151.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .++|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++|+||.               
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            357999999999999999999999999999999986532       3456899999999999980               


Q ss_pred             --ee-------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          148 --YS-------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       148 --~~-------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                        +.       .-........+..++.||+.||+||| +.||+||||||+|||++.++ .+||+++|             
T Consensus       110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH-~~givH~Dikp~NIll~~~g-~~kl~~~~-------------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAH-RAGVALSIDHPSRVRVSIDG-DVVLAYPA-------------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEEETTS-CEEECSCC-------------
T ss_pred             EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHH-HCCCccCCCCcccEEEcCCC-CEEEEecc-------------
Confidence              00       00122455568889999999999999 88999999999999999887 59987543             


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                            |++        .++.++|||||||++|+|++|+.||.+.+....+...                       ...
T Consensus       175 ------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-----------------------~~~  217 (286)
T 3uqc_A          175 ------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----------------------ERD  217 (286)
T ss_dssp             ------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----------------------CBC
T ss_pred             ------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----------------------HHH
Confidence                  333        2789999999999999999999999876532111000                       000


Q ss_pred             cc-CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          299 IK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       299 ~~-~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      .. .......+...+++.+.+||.+||+.||.+| |+.|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          218 TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            00 0001112345689999999999999999999 9999885

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=1.1e-27  Score=244.47  Aligned_cols=155  Identities=17%  Similarity=0.079  Sum_probs=101.4

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecc--------------hhhHHHHHHHHHhc-CCCce----------------
Q 016085           98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD--------------KRYKNRELQTMRLL-DHPNV----------------  146 (395)
Q Consensus        98 ~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--------------~~~~~~E~~~l~~l-~h~ni----------------  146 (395)
                      .++.|++|.+..++....|+.||+|++.+.              ...+.+|+++|+++ .|+||                
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            466788888888887789999999998643              13356799999999 78887                


Q ss_pred             ----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CC
Q 016085          147 ----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP  215 (395)
Q Consensus       147 ----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~  215 (395)
                                ..+.....+++   ..++.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+..... ..
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH-~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALE-KQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHH-HTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC---CC
T ss_pred             EecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHH-HCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCCcc
Confidence                      11233455654   358899999999999 88999999999999999888 6999999999876443 33


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPL  259 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  259 (395)
                      ..+.+||+.|||||++.+.  +..++|+||+|+++++|.++..+
T Consensus       396 ~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             SHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             ccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence            4567899999999999763  67889999999998887665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.88  E-value=1.3e-23  Score=213.20  Aligned_cols=161  Identities=17%  Similarity=0.230  Sum_probs=115.9

Q ss_pred             eeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------------hhhHHHHHHHHHhcCCCceE--ee----------
Q 016085           94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLLDHPNVH--YS----------  149 (395)
Q Consensus        94 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------------~~~~~~E~~~l~~l~h~ni~--~~----------  149 (395)
                      ...+.||+|+||.||+|.  ..++.+|+|+....            .....+|+++++.++|+||.  ..          
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            446799999999999994  46789999986432            12246899999999999983  10          


Q ss_pred             -cc-CCCCcHHH----HHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--------
Q 016085          150 -RA-SQRMPLIY----VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--------  215 (395)
Q Consensus       150 -~~-~~~~~~~~----~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--------  215 (395)
                       .. -..-+...    +..++.||+.||+||| ++||+||||||+|||++.   .+||+|||+|+.......        
T Consensus       417 VmE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH-~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~~~~~~~  492 (540)
T 3en9_A          417 MMSYINGKLAKDVIEDNLDIAYKIGEIVGKLH-KNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKAVDLIVF  492 (540)
T ss_dssp             EEECCCSEEHHHHSTTCTHHHHHHHHHHHHHH-HTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHHHHHHHH
T ss_pred             EEECCCCCCHHHHHHHHHHHHHHHHHHHHHHH-HCcCccCCCCHHHEEECC---eEEEEECccCEECCCccccccchhhh
Confidence             00 00111111    4588999999999999 889999999999999997   599999999987644322        


Q ss_pred             cccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 016085          216 NISYICSRYYRAPELIFGA-TEYTTAVDIWSVGCVLAELLLGQPLF  260 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf  260 (395)
                      ....+||+.|||||++.+. ..|+..+|+||..+-..+.+.++.+|
T Consensus       493 ~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          493 KKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             hhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1356789999999999641 23788899999999888888877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=2e-21  Score=181.23  Aligned_cols=124  Identities=17%  Similarity=0.146  Sum_probs=96.4

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----------------------hhhHHHHHHHHHhcCCCce----
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------------------KRYKNRELQTMRLLDHPNV----  146 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----------------------~~~~~~E~~~l~~l~h~ni----  146 (395)
                      |.+.+.||+|+||.||+|++ .+|+.||||++...                      .....+|+.+|+.++|.++    
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~  170 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY  170 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEE
Confidence            55669999999999999999 88999999998532                      2235689999999986444    


Q ss_pred             -------Eeec-cCCC---CcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          147 -------HYSR-ASQR---MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       147 -------~~~~-~~~~---~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                             .... ....   +.......++.||+.||.||| +.||+||||||+|||++ ++ .+||+|||+|+.      
T Consensus       171 ~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH-~~giiHrDlkp~NILl~-~~-~vkl~DFG~a~~------  241 (282)
T 1zar_A          171 AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY-HRGIVHGDLSQYNVLVS-EE-GIWIIDFPQSVE------  241 (282)
T ss_dssp             EEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEEE-TT-EEEECCCTTCEE------
T ss_pred             eccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHH-HCCCEeCCCCHHHEEEE-CC-cEEEEECCCCeE------
Confidence                   0000 0111   222446689999999999999 88999999999999999 66 699999999863      


Q ss_pred             ccccccccccccccccc
Q 016085          216 NISYICSRYYRAPELIF  232 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~  232 (395)
                            +..|+|||.+.
T Consensus       242 ------~~~~~a~e~l~  252 (282)
T 1zar_A          242 ------VGEEGWREILE  252 (282)
T ss_dssp             ------TTSTTHHHHHH
T ss_pred             ------CCCCCHHHHHH
Confidence                  34578898874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=6.3e-19  Score=162.19  Aligned_cols=115  Identities=17%  Similarity=0.237  Sum_probs=90.2

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcE--EEEEEeecch----------------------------hhHHHHHHHHHhcC
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQDK----------------------------RYKNRELQTMRLLD  142 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~--vAiK~~~~~~----------------------------~~~~~E~~~l~~l~  142 (395)
                      |.+.+.||+|+||.||+|.+..+|+.  ||||+++...                            ....+|+.+|+.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            88999999999999999998788999  9999864321                            13567999999998


Q ss_pred             CCce---------------EeeccCC----C-------CcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC
Q 016085          143 HPNV---------------HYSRASQ----R-------MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT  196 (395)
Q Consensus       143 h~ni---------------~~~~~~~----~-------~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~  196 (395)
                      |+++               .+....+    .       .++..+..++.||+.||.|||.++||+||||||+|||++.  
T Consensus       129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--  206 (258)
T 1zth_A          129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--  206 (258)
T ss_dssp             HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--
T ss_pred             hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--
Confidence            7653               1111000    1       1133577899999999999995579999999999999986  


Q ss_pred             CceEEeecCCcccc
Q 016085          197 HQVKLCDFGSAKVL  210 (395)
Q Consensus       197 ~~ikl~DFG~a~~~  210 (395)
                       .++|+|||+|...
T Consensus       207 -~~~liDFG~a~~~  219 (258)
T 1zth_A          207 -KVYFIDMGQAVTL  219 (258)
T ss_dssp             -SEEECCCTTCEET
T ss_pred             -cEEEEECcccccC
Confidence             5999999999654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.59  E-value=9.8e-16  Score=147.55  Aligned_cols=115  Identities=15%  Similarity=0.133  Sum_probs=83.8

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch--------------------------hhHHHHHHHHHhcCCCce
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------------------------RYKNRELQTMRLLDHPNV  146 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--------------------------~~~~~E~~~l~~l~h~ni  146 (395)
                      |.+.+.||.|+||.||+|.+ .+|+.||||+++...                          ....+|...|.+|.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            99999999999999999997 469999999864210                          011356777777754433


Q ss_pred             ---------------Eeecc---CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC---------ce
Q 016085          147 ---------------HYSRA---SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---------QV  199 (395)
Q Consensus       147 ---------------~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~---------~i  199 (395)
                                     .+...   ..-.....+..++.||+.+|.||| +.|||||||||.|||++.++.         .+
T Consensus       176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH-~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~  254 (397)
T 4gyi_A          176 PVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLA-KHGLIHGDFNEFNILIREEKDAEDPSSITLTP  254 (397)
T ss_dssp             SCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEEEEEECSSCTTSEEEEE
T ss_pred             CCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHHHEEEeCCCCcccccccccce
Confidence                           00000   011122345678899999999999 889999999999999986652         27


Q ss_pred             EEeecCCccc
Q 016085          200 KLCDFGSAKV  209 (395)
Q Consensus       200 kl~DFG~a~~  209 (395)
                      .|+||+-+-.
T Consensus       255 ~iID~~Q~V~  264 (397)
T 4gyi_A          255 IIIXFPQMVS  264 (397)
T ss_dssp             EECCCTTCEE
T ss_pred             EEEEeCCccc
Confidence            8999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.78  E-value=3.2e-08  Score=90.14  Aligned_cols=114  Identities=16%  Similarity=0.107  Sum_probs=82.1

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeec----chhhHHHHHHHHHhcCC-Cce---E------------eec-
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ----DKRYKNRELQTMRLLDH-PNV---H------------YSR-  150 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~----~~~~~~~E~~~l~~l~h-~ni---~------------~~~-  150 (395)
                      .|++...++.|+.+.||++..  .++.+++|+...    ......+|+.+++.|.. ..+   .            ... 
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            488999999999999999975  468999998864    23457789999998853 222   1            000 


Q ss_pred             cCCCCc-----HHHHHHHHHHHHHHHHHHHcC------------------------------------------------
Q 016085          151 ASQRMP-----LIYVKLYTYQICRALAYIHGG------------------------------------------------  177 (395)
Q Consensus       151 ~~~~~~-----~~~~~~~~~qi~~aL~~LH~~------------------------------------------------  177 (395)
                      .+..+.     ......++.++..+|..|| +                                                
T Consensus        93 ~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  171 (263)
T 3tm0_A           93 DGVLCSEEYEDEQSPEKIIELYAECIRLFH-SIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY  171 (263)
T ss_dssp             SSEEHHHHCCTTTCHHHHHHHHHHHHHHHH-HSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHH
T ss_pred             CCeehhhccCCcccHHHHHHHHHHHHHHHh-CCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHH
Confidence            111111     1123467889999999999 4                                                


Q ss_pred             -----------CCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          178 -----------IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       178 -----------~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                 .+++|+|++|.||+++.++ .+.|+||+.+..
T Consensus       172 ~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~~  213 (263)
T 3tm0_A          172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred             HHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhccc
Confidence                       4599999999999998543 467999997743

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.61  E-value=8.9e-08  Score=86.65  Aligned_cols=115  Identities=17%  Similarity=0.116  Sum_probs=77.4

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-hhhHHHHHHHHHhcCCCce-----Eee-------------ccC
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLDHPNV-----HYS-------------RAS  152 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~h~ni-----~~~-------------~~~  152 (395)
                      .|.+..+.+.|..+.||++.. .+|..|++|+.... .....+|+.+++.+.+.++     ...             ..+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G   99 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   99 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence            366655555667799999964 56778999987553 2345689999988865443     000             011


Q ss_pred             CCCc--HHHHHHHHHHHHHHHHHHHcCCC---------------------------------------------------
Q 016085          153 QRMP--LIYVKLYTYQICRALAYIHGGIG---------------------------------------------------  179 (395)
Q Consensus       153 ~~~~--~~~~~~~~~qi~~aL~~LH~~~g---------------------------------------------------  179 (395)
                      ..+.  ......++.++...|..|| +..                                                   
T Consensus       100 ~~l~~~~~~~~~~~~~l~~~l~~lh-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  178 (264)
T 1nd4_A          100 QDLLSSHLAPAEKVSIMADAMRRLH-TLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM  178 (264)
T ss_dssp             EETTTSCCCHHHHHHHHHHHHHHHT-TSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred             cccCcCcCCHhHHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhc
Confidence            1111  1112367788888899998 433                                                   


Q ss_pred             -------eeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          180 -------VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       180 -------iiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                             ++|+|++|.|||++.++ .+.|+|||.+..
T Consensus       179 ~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~  214 (264)
T 1nd4_A          179 PDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLGV  214 (264)
T ss_dssp             CSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             CCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence                   99999999999998653 467999998743

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.58  E-value=1.9e-07  Score=89.18  Aligned_cols=113  Identities=17%  Similarity=0.183  Sum_probs=81.1

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEee--cc-----hhhHHHHHHHHHhcCCCce-----Ee---------------
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVL--QD-----KRYKNRELQTMRLLDHPNV-----HY---------------  148 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~--~~-----~~~~~~E~~~l~~l~h~ni-----~~---------------  148 (395)
                      .+.|+.|.++.||++..  .+..+++|+..  ..     .....+|..+++.|.+.++     ..               
T Consensus        43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            46789999999999975  35688899775  22     3456789999999874332     00               


Q ss_pred             ec---------cCCCCcHHHHHHHHHHHHHHHHHHHc-------------------------------------------
Q 016085          149 SR---------ASQRMPLIYVKLYTYQICRALAYIHG-------------------------------------------  176 (395)
Q Consensus       149 ~~---------~~~~~~~~~~~~~~~qi~~aL~~LH~-------------------------------------------  176 (395)
                      ..         ....++......++.++...|..||+                                           
T Consensus       121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (359)
T 3dxp_A          121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL  200 (359)
T ss_dssp             ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred             EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence            00         01124567778889999999999994                                           


Q ss_pred             --------------CCCeeeccCCCCceEEcCCCC-ceEEeecCCcccc
Q 016085          177 --------------GIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVL  210 (395)
Q Consensus       177 --------------~~giiHrDlKp~Nill~~~~~-~ikl~DFG~a~~~  210 (395)
                                    ..+++|+|+++.|||++.++. .+.|+||+.|...
T Consensus       201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                          147999999999999987652 3689999998653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.53  E-value=4.8e-08  Score=91.24  Aligned_cols=156  Identities=14%  Similarity=0.202  Sum_probs=97.5

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcC-CCce-----Eee----------------ccC
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLD-HPNV-----HYS----------------RAS  152 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~-h~ni-----~~~----------------~~~  152 (395)
                      +.++.|....||++.     ..+++|+....  .....+|..+|+.+. +..+     ...                ..+
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            458999999999873     45889986543  345678999998873 3222     111                111


Q ss_pred             C--------CCcHHHHHHHHHHHHHHHHHHHc------------------------------------------------
Q 016085          153 Q--------RMPLIYVKLYTYQICRALAYIHG------------------------------------------------  176 (395)
Q Consensus       153 ~--------~~~~~~~~~~~~qi~~aL~~LH~------------------------------------------------  176 (395)
                      .        .++......++.|+...|..||+                                                
T Consensus       101 ~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  180 (304)
T 3sg8_A          101 VPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI  180 (304)
T ss_dssp             EECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred             eECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence            1        12333455777888888888883                                                


Q ss_pred             ---------CCCeeeccCCCCceEEcCC-CCceEEeecCCccccccCCCcccccccccc---ccccccc------CCC--
Q 016085          177 ---------GIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYY---RAPELIF------GAT--  235 (395)
Q Consensus       177 ---------~~giiHrDlKp~Nill~~~-~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y---~aPE~~~------~~~--  235 (395)
                               ...++|+|++|.||+++.+ +..+.|+||+.+......   ........+   ..|+...      +..  
T Consensus       181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~  257 (304)
T 3sg8_A          181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---NDFISLMEDDEEYGMEFVSKILNHYKHKDI  257 (304)
T ss_dssp             HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---HHHHTTCCTTTSCCHHHHHHHHHHHTCSCH
T ss_pred             HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---HHHHHHHhhccccCHHHHHHHHHHcCCCCc
Confidence                     0247999999999999974 435889999998653211   100001111   1222110      000  


Q ss_pred             -----CCCCcchHHHHHHHHHHHHhCCCCC
Q 016085          236 -----EYTTAVDIWSVGCVLAELLLGQPLF  260 (395)
Q Consensus       236 -----~~~~~~DiwSlG~il~ell~g~~pf  260 (395)
                           ......+.|+++.++|.+.+|..+|
T Consensus       258 ~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          258 PTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                 0122368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.34  E-value=0.00078  Score=62.57  Aligned_cols=42  Identities=17%  Similarity=0.149  Sum_probs=31.8

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCC
Q 016085           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDH  143 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h  143 (395)
                      +.++.|....||+.     +..+++|+-...  .....+|..+|+.|.+
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~   68 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVG   68 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTT
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHh
Confidence            46788888899988     567888985432  2456789999999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.17  E-value=0.0023  Score=61.52  Aligned_cols=47  Identities=17%  Similarity=0.183  Sum_probs=32.1

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----------hhhHHHHHHHHHhcC
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----------KRYKNRELQTMRLLD  142 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----------~~~~~~E~~~l~~l~  142 (395)
                      .+.||.|.++.||++.+..+++.|++|.....           .....+|.++|+.+.
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~   92 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQG   92 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHH
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhh
Confidence            45789999999999976666789999975422           122357888888763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.16  E-value=0.002  Score=60.24  Aligned_cols=32  Identities=22%  Similarity=0.438  Sum_probs=27.3

Q ss_pred             CCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ..++||+|+++.|||++.++ .+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENE-QIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGG-CEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCC-cEEEEehhhccc
Confidence            46899999999999997665 599999998743

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.83  E-value=0.0036  Score=59.10  Aligned_cols=31  Identities=16%  Similarity=0.155  Sum_probs=25.9

Q ss_pred             CCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ..++|+|+.+.|||++. +..+.|+||+.|..
T Consensus       222 ~~l~HgDl~~~Nil~~~-~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRD-FQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEET-TEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeC-CcEEEEEccccccc
Confidence            47999999999999984 43578999998854

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=96.81  E-value=0.005  Score=55.51  Aligned_cols=43  Identities=9%  Similarity=0.095  Sum_probs=30.5

Q ss_pred             ccCCc-eEEEEEEEcCCCcEEEEEEeecc-hhhHHHHHHHHHhcC
Q 016085          100 GQGSF-GIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD  142 (395)
Q Consensus       100 G~G~f-g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~  142 (395)
                      ..|.- +.||+......+..+.+|+-... .....+|..+|+.|.
T Consensus        33 ~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~   77 (272)
T 4gkh_A           33 NVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLT   77 (272)
T ss_dssp             ECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHT
T ss_pred             cCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhc
Confidence            33444 46999887777788999986543 334568999998875

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.65  E-value=0.0069  Score=55.77  Aligned_cols=106  Identities=20%  Similarity=0.223  Sum_probs=66.3

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCC----CceE------------eeccCCCCc
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDH----PNVH------------YSRASQRMP  156 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h----~ni~------------~~~~~~~~~  156 (395)
                      .+.|+.|....+|++      ..+++|+.....   ....+|..+++.+..    |.+.            +......+.
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l~   96 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTMS   96 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccCC
Confidence            577888999999988      458888775432   123568887876632    2221            111223333


Q ss_pred             HHHHH---HHHHHHHHHHHHHHcC----------------------------------------------------CCee
Q 016085          157 LIYVK---LYTYQICRALAYIHGG----------------------------------------------------IGVC  181 (395)
Q Consensus       157 ~~~~~---~~~~qi~~aL~~LH~~----------------------------------------------------~gii  181 (395)
                      .....   .+..+++..|.-||+.                                                    ..++
T Consensus        97 ~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~  176 (301)
T 3dxq_A           97 PEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAAC  176 (301)
T ss_dssp             HHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEE
T ss_pred             HhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceee
Confidence            32222   2455666666666621                                                    1279


Q ss_pred             eccCCCCceEEcCCCCceEEeecCCccc
Q 016085          182 HRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       182 HrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      |+|+.+.||+.+ ++ .+.|+||..+..
T Consensus       177 HgDl~~~Nil~~-~~-~~~lID~e~a~~  202 (301)
T 3dxq_A          177 HCDPLCENFLDT-GE-RMWIVDWEYSGM  202 (301)
T ss_dssp             CSCCCGGGEEEC-SS-CEEECCCTTCEE
T ss_pred             ccCCCcCCEEEC-CC-CEEEEecccccC
Confidence            999999999954 45 589999998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.52  E-value=0.03  Score=48.88  Aligned_cols=89  Identities=18%  Similarity=0.081  Sum_probs=55.9

Q ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccccccccccccc
Q 016085          152 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI  231 (395)
Q Consensus       152 ~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~  231 (395)
                      ..++++.++|.++.|.+.+|.-+-.+..-..+=+-|..|+|..+|+ |.+.+ +.+.           .....+.|||..
T Consensus        43 ~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~-V~f~~-~~s~-----------~~~~~~~~pe~~  109 (229)
T 2yle_A           43 NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA-VTLAP-AADD-----------AGEPPPVAGKLG  109 (229)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC-EEECC-C-----------------------CCS
T ss_pred             CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc-eeccc-cccc-----------ccccCCCChhhc
Confidence            4579999999999999999887621111123344568889988884 66553 1110           112346688876


Q ss_pred             cCCCCCCCcchHHHHHHHHHHHHh
Q 016085          232 FGATEYTTAVDIWSVGCVLAELLL  255 (395)
Q Consensus       232 ~~~~~~~~~~DiwSlG~il~ell~  255 (395)
                      .  ...+.+.=|||||+++|.-+-
T Consensus       110 ~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A          110 Y--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             S--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             c--ccchHHHHHHHHHHHHHHHhh
Confidence            3  235788899999999999883

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.32  E-value=0.0068  Score=56.19  Aligned_cols=45  Identities=13%  Similarity=0.053  Sum_probs=28.5

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeec--chhhHHHHHHHHHhcC
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLD  142 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~--~~~~~~~E~~~l~~l~  142 (395)
                      .+.|+.|....+|++...  +..+++|+...  .......|..+++.|.
T Consensus        27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~   73 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLA   73 (322)
T ss_dssp             EEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred             eeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHH
Confidence            456778888999998752  33688998765  3344567888877663

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.02  E-value=0.017  Score=52.78  Aligned_cols=49  Identities=14%  Similarity=0.135  Sum_probs=37.9

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcC
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLD  142 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~  142 (395)
                      ..-++.+|.|..+.||+++. .+|+.|.+|+-...    ...+.+|...|+.|.
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~   69 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLG   69 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence            44567899999999999974 57899999976432    234678999998874

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=94.64  E-value=0.066  Score=52.02  Aligned_cols=47  Identities=15%  Similarity=0.169  Sum_probs=33.0

Q ss_pred             eeeeccCCceEEEEEEEcC-------CCcEEEEEEeec-ch-hhHHHHHHHHHhcC
Q 016085           96 ERVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQ-DK-RYKNRELQTMRLLD  142 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~-------~~~~vAiK~~~~-~~-~~~~~E~~~l~~l~  142 (395)
                      .+.|+.|....||++....       .++.|.+|+... .. ....+|..+++.|.
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~  133 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLS  133 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHH
Confidence            4567888889999997642       257899998744 22 34457888887764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=94.55  E-value=0.14  Score=50.12  Aligned_cols=50  Identities=16%  Similarity=0.187  Sum_probs=33.1

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecchh---hHHHHHHHHHhcCCCc
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPN  145 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~~l~~l~h~n  145 (395)
                      .+.|+.|-...+|++.....+..|++|+......   ...+|..+++.|...+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~g  165 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKN  165 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcC
Confidence            4578888889999998754457899998643221   2257888888886443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=94.49  E-value=0.079  Score=50.58  Aligned_cols=32  Identities=28%  Similarity=0.535  Sum_probs=26.4

Q ss_pred             CCeeeccCCCCceEEcCC---CCceEEeecCCccc
Q 016085          178 IGVCHRDIKPQNLLVNPH---THQVKLCDFGSAKV  209 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~~---~~~ikl~DFG~a~~  209 (395)
                      ..++|+|+.+.||+++.+   ...+.|+||..|..
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            369999999999999876   23699999998854

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.35  E-value=0.039  Score=53.36  Aligned_cols=78  Identities=12%  Similarity=-0.050  Sum_probs=47.9

Q ss_pred             CCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccc--cccccccccccCCC--CCCCcchHHHHHHHHHH
Q 016085          177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGAT--EYTTAVDIWSVGCVLAE  252 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~--~~~~~~DiwSlG~il~e  252 (395)
                      ...++|+|+++.|||++.++  +.|+||+.+.............+  ...|.+|+......  ......++.++...+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            67899999999999998654  99999999876422211111111  23466666553111  01123444577777887


Q ss_pred             HHhC
Q 016085          253 LLLG  256 (395)
Q Consensus       253 ll~g  256 (395)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7765

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=91.50  E-value=0.18  Score=46.55  Aligned_cols=30  Identities=20%  Similarity=0.216  Sum_probs=25.5

Q ss_pred             CCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ...++|+|+++.|||++ +  .+.|+||+.+..
T Consensus       194 ~~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~  223 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D--GPMFVDLDDARN  223 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred             CeeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence            45689999999999998 4  599999998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=91.03  E-value=0.14  Score=47.50  Aligned_cols=34  Identities=38%  Similarity=0.493  Sum_probs=27.8

Q ss_pred             CCCeeeccCCCCceEEcCC---CCceEEeecCCcccc
Q 016085          177 GIGVCHRDIKPQNLLVNPH---THQVKLCDFGSAKVL  210 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~---~~~ikl~DFG~a~~~  210 (395)
                      ...++|+|+.+.||+++.+   ...+.|+||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4589999999999999864   136899999988653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=90.69  E-value=0.19  Score=46.51  Aligned_cols=45  Identities=16%  Similarity=0.157  Sum_probs=34.3

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecc-hhhHHHHHHHHHhcC
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD  142 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~  142 (395)
                      .+.|+.|....+|+...  ++..+++|+.... .....+|...|+.|.
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~   86 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLA   86 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHH
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHH
Confidence            35789999999999975  5678899987543 345678888888774

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.14  E-value=0.16  Score=48.01  Aligned_cols=30  Identities=27%  Similarity=0.548  Sum_probs=25.0

Q ss_pred             CCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       178 ~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      .+++|+|+.+.|||++.+  .+.|+||..|..
T Consensus       212 ~~l~HgDl~~~Nil~~~~--~~~lID~e~a~~  241 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNK--CLRLIDFEYSGF  241 (369)
T ss_dssp             EEEECSCCCGGGEEECC---CEEECCCTTCEE
T ss_pred             eEEEeCCCCcccEEecCC--cEEEEEecCCCC
Confidence            469999999999999854  389999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=88.70  E-value=0.17  Score=47.30  Aligned_cols=33  Identities=24%  Similarity=0.470  Sum_probs=27.5

Q ss_pred             CCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                      ..+++|+|+.+.||+++.++ .+.|+||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEE-SIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGG-CEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCC-eEEEEECCCCeeC
Confidence            35799999999999998665 5999999887653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=80.82  E-value=0.81  Score=43.72  Aligned_cols=31  Identities=26%  Similarity=0.470  Sum_probs=24.8

Q ss_pred             CeeeccCCCCceEEc-----CCCCceEEeecCCccc
Q 016085          179 GVCHRDIKPQNLLVN-----PHTHQVKLCDFGSAKV  209 (395)
Q Consensus       179 giiHrDlKp~Nill~-----~~~~~ikl~DFG~a~~  209 (395)
                      .++|+|+.+.|||+.     .+...+.++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            478999999999993     2334699999998865

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	395
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-111
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-64
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-62
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-60
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-59
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-58
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-58
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-58
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-57
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-57
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-56
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-54
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-54
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-53
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-52
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-52
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-51
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-49
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-48
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-48
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-45
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-44
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-43
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-37
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-36
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-34
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-34
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-33
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-33
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-32
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-32
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-32
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-32
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-31
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-30
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-29
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-29
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-27
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-27
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-27
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-25
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-17

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  328 bits (842), Expect = e-111
 Identities = 218/347 (62%), Positives = 256/347 (73%), Gaps = 38/347 (10%)

Query: 76  IVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL 135
           +V T G    +P Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64

Query: 136 QTMRLLDHPNV-----------------------------------HYSRASQRMPLIYV 160
           Q MR LDH N+                                   HYSRA Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
           KLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 280
           CSRYYRAPELIFGAT+YT+++D+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 281 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 340
           RE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303

Query: 341 PFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 387
            FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELS-SNPPLATILIPPHAR 349

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 5e-64
 Identities = 101/340 (29%), Positives = 165/340 (48%), Gaps = 49/340 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKN---RELQTMRLLDHPNV- 146
           Y     +G+G++G+V  A        VAIKK+   + + Y     RE++ +    H N+ 
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 147 ----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
                                       +    +Q +   ++  + YQI R L YIH   
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 128

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYYRAPELIFGA 234
            V HRD+KP NLL+N  T  +K+CDFG A+V      +      Y+ +R+YRAPE++  +
Sbjct: 129 NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187

Query: 235 TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---NPNY 291
             YT ++DIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+       
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247

Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 351
                P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  D   
Sbjct: 248 YLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD--- 303

Query: 352 RLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 391
             P+  P          EL    KE L +LI E   +  P
Sbjct: 304 --PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 341

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 6e-63
 Identities = 94/296 (31%), Positives = 138/296 (46%), Gaps = 41/296 (13%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNV- 146
             +G+G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN+ 
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                         S  +   ++K Y     + L Y+H    + 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-IL 122

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTA 240
           HRD+KP NLL++ +   +KL DFG AK         ++   +R+YRAPEL+FGA  Y   
Sbjct: 123 HRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
           VD+W+VGC+LAELLL  P  PG+S +DQL  I + LGTPT E+   M        F    
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP--NARLP 354
             P H IF      + +DL+  L  ++P  R TA +A    +F     P    +LP
Sbjct: 242 GIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 3e-62
 Identities = 66/297 (22%), Positives = 114/297 (38%), Gaps = 49/297 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
           +     +G G+ G+VF+     +G  +A K +  + +        RELQ +   + P + 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                       + + R+P   +   +  + + L Y+     + 
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 127

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
           HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R Y +PE + G T Y+   
Sbjct: 128 HRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSVQS 184

Query: 242 DIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYTEFKF---- 296
           DIWS+G  L E+ +G+   P       +L+   +V G       +   P      +    
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244

Query: 297 ----------PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                       I   P  K+       E  D V++ L  +P  R    +  +H F 
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-60
 Identities = 96/300 (32%), Positives = 153/300 (51%), Gaps = 41/300 (13%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           +     +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 147 ---------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 179
                                        + A   +PL  +K Y +Q+ + LA+ H    
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYT 238
           V HRD+KPQNLL+N     +KL DFG A+   V        + + +YRAPE++ G   Y+
Sbjct: 123 VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-CMNPNYTEFKFP 297
           TAVDIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP         +    +  FP
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
           +     + K+    +  +   L+S++L Y PN R +A  A  HPFF ++  P   +P+ R
Sbjct: 242 KWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP---VPHLR 297

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-59
 Identities = 89/291 (30%), Positives = 141/291 (48%), Gaps = 36/291 (12%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y     +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 147 --------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                                     ++   +  +    VK + +Q+ + L + H    V
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SRNV 122

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTT 239
            HRD+KPQNLL+N +    KL +FG A+   +      + + + +YR P+++FGA  Y+T
Sbjct: 123 LHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 240 AVDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
           ++D+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M        +P 
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
             A         ++     DL+  LL+ +P  R +A EA  HP+F +   P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-58
 Identities = 98/331 (29%), Positives = 150/331 (45%), Gaps = 50/331 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y     VG G++G V  A   +TG  VA+KK+      +   +   REL+ ++ + H NV
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 147 ------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
                                         +     Q++   +V+   YQI R L YIH 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 236
              + HRD+KP NL VN      K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMH 195

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-- 294
           Y   VDIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++        
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 295 -KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
               Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+   
Sbjct: 256 QSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD-DE 313

Query: 354 PNGRPFPPLFNFKPQELKGASKELLSKLIPE 384
           P   P+   F     E +    +    L  +
Sbjct: 314 PVADPYDQSF-----ESRDLLIDEWKSLTYD 339

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  191 bits (485), Expect = 2e-58
 Identities = 83/291 (28%), Positives = 138/291 (47%), Gaps = 37/291 (12%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-NRELQTM-RLLDHPNV---- 146
           Y   R +G+G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+    
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                 + +  Q +    ++ Y Y+I +AL Y H  +G+ HRD+
Sbjct: 97  DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDV 155

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWS 245
           KP N++++    +++L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS
Sbjct: 156 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWS 215

Query: 246 VGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI----K 300
           +GC+LA ++  + P F G    DQLV I KVLGT    +         + +F  I     
Sbjct: 216 LGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS 275

Query: 301 AHPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
              W +  H      + PEA+D + +LL+Y    R TA EA  HP+F  + 
Sbjct: 276 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  190 bits (484), Expect = 7e-58
 Identities = 66/302 (21%), Positives = 109/302 (36%), Gaps = 61/302 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNV-- 146
           Y     +G G+FG+V +     TG   A K V+     DK    +E+QTM +L HP +  
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                      +    +M       Y  Q+C+ L ++H      
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN-NYV 146

Query: 182 HRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
           H D+KP+N++     ++++KL DFG    L   +       +  + APE+  G       
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYY 205

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
            D+WSVG +   LL G   F GE+  + L  +                            
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA----------------- 248

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP--NARLPNGRP 358
                      +  +  D + +LL   PN R T  +A  HP+      P  ++++P+ R 
Sbjct: 249 --------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY 300

Query: 359 FP 360
             
Sbjct: 301 TK 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 2e-57
 Identities = 101/330 (30%), Positives = 154/330 (46%), Gaps = 49/330 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y   + VG G++G V  A    TG  VAIKK+ +  + +       REL+ ++ + H NV
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 147 ------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
                                               +++    ++   YQ+ + L YIH 
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH- 138

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 236
             G+ HRD+KP NL VN      K+ DFG A+          Y+ +R+YRAPE+I     
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVILNWMR 195

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-- 294
           YT  VDIWSVGC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ +  +  +   
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 295 -KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 353
              P+++   +  I      P AV+L+ ++L      R TA EA  HP+F+ L D     
Sbjct: 256 KGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE-DE 313

Query: 354 PNGRPFPPLF---NFKPQELKGAS-KELLS 379
           P  + +   F   +    E K  + KE+LS
Sbjct: 314 PQVQKYDDSFDDVDRTLDEWKRVTYKEVLS 343

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 5e-57
 Identities = 79/306 (25%), Positives = 130/306 (42%), Gaps = 50/306 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y     +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 147 ----------------------------------HYSRASQRMPLIYVKLYTYQICRALA 172
                                               S    +  L  +K     +   L 
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 131

Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-----SYICSRYYRA 227
           YIH    + HRD+K  N+L+      +KL DFG A+     + +      + + + +YR 
Sbjct: 132 YIHR-NKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 287
           PEL+ G  +Y   +D+W  GC++AE+    P+  G +   QL  I ++ G+ T E    +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249

Query: 288 NPNYTEFKFPQIKAHP---WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
           +      K   +K        ++      P A+DL+ +LL   P  R  + +A  H FF 
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309

Query: 345 ELRDPN 350
               P+
Sbjct: 310 SDPMPS 315

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  184 bits (467), Expect = 3e-56
 Identities = 88/287 (30%), Positives = 143/287 (49%), Gaps = 38/287 (13%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y     +G+G++G+V++A+    GET A+KK+  +K  +       RE+  ++ L H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 147 --------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                                             +  +  K +  Q+   +AY H    V
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRV 121

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTT 239
            HRD+KPQNLL+N    ++K+ DFG A+   +        I + +YRAP+++ G+ +Y+T
Sbjct: 122 LHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-YTEFKFPQ 298
            +DIWSVGC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +      +  F  
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
            +  PW     K +    +DL+S++L+  PN R TA +A  H +F E
Sbjct: 241 YEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 1e-55
 Identities = 90/297 (30%), Positives = 138/297 (46%), Gaps = 47/297 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLET-GETVAIKKVLQDKRYKN------RELQTMRLL---D 142
           Y     +G+G++G VF+A+ L+  G  VA+K+V      +       RE+  +R L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 143 HPNV--------------------------------HYSRASQRMPLIYVKLYTYQICRA 170
           HPNV                                        +P   +K   +Q+ R 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128

Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 230
           L ++H    V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE+
Sbjct: 129 LDFLHS-HRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186

Query: 231 IFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 290
           +   + Y T VD+WSVGC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +  
Sbjct: 187 LLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVA 244

Query: 291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
                F    A P  K     +     DL+ + L ++P  R +A  A  HP+F +L 
Sbjct: 245 LPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-54
 Identities = 66/287 (22%), Positives = 111/287 (38%), Gaps = 62/287 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
           +   + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NV 
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                            MP    + + +Q+   + Y+HG IG+ 
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGIT 125

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYT 238
           HRDIKP+NLL++   + +K+ DFG A V               +  Y APEL+     + 
Sbjct: 126 HRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184

Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
             VD+WS G VL  +L G+  +   S   Q     K   T                    
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------------ 226

Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
              +PW KI         + L+ ++L  +P+ R T  +     ++++
Sbjct: 227 ---NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  181 bits (459), Expect = 4e-54
 Identities = 71/334 (21%), Positives = 113/334 (33%), Gaps = 62/334 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNV-- 146
           Y     +G G+FG+V +     TG     K +      DK     E+  M  L HP +  
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                      +    +M    V  Y  Q C  L ++H    + 
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIV 149

Query: 182 HRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
           H DIKP+N++        VK+ DFG A  L   E       +  + APE++         
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFY 208

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
            D+W++G +   LL G   F GE  ++ L  + +       +                  
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF---------------- 252

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF-DELRDPNARLPNGRPF 359
                      + PEA D +  LLQ  P  R T  +A  HP+   +  +  +R+P+ R  
Sbjct: 253 ---------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYN 303

Query: 360 PPLFNFKPQELKGASKELLSKLIPEHA--RKQCP 391
                 K +     + +     I   +  RK  P
Sbjct: 304 KIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRP 337

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 4e-54
 Identities = 68/284 (23%), Positives = 112/284 (39%), Gaps = 66/284 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
           +   R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 146 V--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 179
           +                             +   +        Y  ++  AL+Y H    
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-R 126

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           V HRDIKP+NLL+      +K+ DFG +          +   +  Y  PE+I G   +  
Sbjct: 127 VIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG-RMHDE 183

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
            VD+WS+G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP-- 224

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
                       +   A DL+SRLL+++P+ R    E   HP+ 
Sbjct: 225 ----------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 7e-53
 Identities = 65/284 (22%), Positives = 110/284 (38%), Gaps = 58/284 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDHPNV--- 146
           YM    +G+G FGIV +     + +T   K V     D+    +E+  + +  H N+   
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                     + ++  +    +  Y +Q+C AL ++H    + H
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HNIGH 125

Query: 183 RDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAV 241
            DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE+       +TA 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTAT 184

Query: 242 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 301
           D+WS+G ++  LL G   F  E+    +  I+    T   E                   
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF----------------- 227

Query: 302 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
                   K +  EA+D V RLL      R TA EA  HP+  +
Sbjct: 228 --------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  177 bits (448), Expect = 1e-52
 Identities = 88/355 (24%), Positives = 141/355 (39%), Gaps = 83/355 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV--- 146
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 147 ---------------------------------------HYSRASQRMPLIYVKLYTYQI 167
                                                        + +PLIYVK  + Q+
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 168 CRALAYIHGGIGVCHRDIKPQNLLVNPHTH-----QVKLCDFGSAKVLVKGEPNISYICS 222
              L Y+H   G+ H DIKP+N+L+          Q+K+ D G+A      E   + I +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQT 192

Query: 223 RYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVL 276
           R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II++L
Sbjct: 193 REYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251

Query: 277 GTPTREEIKCMNPNYTEF-------KFPQIKAHPWHKI------FHKRMPPEAVDLVSRL 323
           G      ++      T F          ++K  P   +      F K    E  D +S +
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311

Query: 324 LQYSPNLRCTALEACIHPFF------DELRDPNARL-PNGRPFPPLFNFKPQELK 371
           LQ  P  R  A     HP+       +E+R P+  L  +G   P  F    +E++
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF----EEVR 362

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (443), Expect = 3e-52
 Identities = 70/323 (21%), Positives = 116/323 (35%), Gaps = 67/323 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
           +   R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 146 V--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 179
                                            + +  + +   T+   + LAY+H    
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH-SHN 135

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--Y 237
           + HRD+K  N+L++     VKL DFGSA ++    P  S++ + Y+ APE+I    E  Y
Sbjct: 136 MIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDEGQY 191

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
              VD+WS+G    EL   +P     + +  L  I +                       
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----------------------- 228

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
               +    +          + V   LQ  P  R T+     H F    R P   +   +
Sbjct: 229 ----NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284

Query: 358 PFPPLFNFKPQELKGASKELLSK 380
                            K++L +
Sbjct: 285 RTKDAVRELDNLQYRKMKKILFQ 307

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 3e-52
 Identities = 58/287 (20%), Positives = 103/287 (35%), Gaps = 64/287 (22%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNV-- 146
           +     +G G+FG V++A+  ET    A K +     ++      E+  +   DHPN+  
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                          + +    +++   Q   AL Y+H    + 
Sbjct: 74  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN-KII 132

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGAT----E 236
           HRD+K  N+L       +KL DFG +    +  +   S+I + Y+ APE++   T     
Sbjct: 133 HRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           Y    D+WS+G  L E+   +P     + +  L++I                        
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------------------------ 227

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
              K+ P       R      D + + L+ + + R T  +   HPF 
Sbjct: 228 --AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 4e-52
 Identities = 90/338 (26%), Positives = 147/338 (43%), Gaps = 55/338 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+ +  + +       REL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 147 -----------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGG 177
                                                +    +    YQ+   + ++H  
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS- 137

Query: 178 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 237
            G+ HRD+KP N++V       K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGY 195

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF--K 295
              VDIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    +   
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255

Query: 296 FPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 344
            P+     + K+F           +K    +A DL+S++L   P  R +  +A  HP+ +
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315

Query: 345 ELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 382
              DP        P P +++ +  E +  + E   +LI
Sbjct: 316 VWYDPAEVEA---PPPQIYDKQLDERE-HTIEEWKELI 349

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 9e-52
 Identities = 72/330 (21%), Positives = 118/330 (35%), Gaps = 61/330 (18%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNV-------- 146
            +V+G G  G V Q     T E  A+ K+LQD     RE++   R    P++        
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                      R  Q             I  A+ Y+H  I + H
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAH 134

Query: 183 RDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 240
           RD+KP+NLL         +KL DFG AK         +   + YY APE++    +Y  +
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKS 193

Query: 241 VDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 300
            D+WS+G ++  LL G P F    G+     +   +                +++FP  +
Sbjct: 194 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------QYEFPNPE 240

Query: 301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF-DELRDPNARLPNGRPF 359
                      +  E   L+  LL+  P  R T  E   HP+     + P   L   R  
Sbjct: 241 --------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVL 292

Query: 360 PPLFNFKPQELKGASKELLSKLIPEHARKQ 389
                 + +++K      L+ +  ++ + +
Sbjct: 293 KE-DKERWEDVKEEMTSALATMRVDYEQIK 321

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-51
 Identities = 68/292 (23%), Positives = 111/292 (38%), Gaps = 59/292 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNV-- 146
           Y     +GQG+ G V+ A  + TG+ VAI+++       K     E+  MR   +PN+  
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                                          M    +     +  +AL ++H    V HR
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS-NQVIHR 140

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAVD 242
           DIK  N+L+      VKL DFG    +   +   S +  + Y+ APE++     Y   VD
Sbjct: 141 DIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVD 198

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           IWS+G +  E++ G+P +  E+ +  L  I    GTP             E + P     
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP-------------ELQNP----- 239

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 354
                  +++     D ++R L      R +A E   H F    +  ++  P
Sbjct: 240 -------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 5e-51
 Identities = 52/285 (18%), Positives = 104/285 (36%), Gaps = 66/285 (23%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV--- 146
           +  +G+GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+   
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 147 ---------------------------HYSRASQRMPLIYVKLYTYQICRALAYIH-GGI 178
                                       Y +  + M +  ++ +  QI + L ++H    
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 133

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 238
            + HRD+K  N+ +   T  VK+ D G A  L +     + I +  + APE+     +Y 
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE--KYD 190

Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
            +VD+++ G  + E+   +  +       Q+                             
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------------------------- 224

Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 343
           + +      F K   PE  +++   ++ + + R +  +   H FF
Sbjct: 225 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (421), Expect = 4e-49
 Identities = 65/314 (20%), Positives = 107/314 (34%), Gaps = 60/314 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
           Y    V+G G+F  V  A+   T + VAIK + +            E+  +  + HPN+ 
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                                      +Q+  A+ Y+H    + 
Sbjct: 71  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG-IV 129

Query: 182 HRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE++     Y+ 
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSK 188

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           AVD WS+G +   LL G P F  E+      +I+K                         
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP----------------- 231

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPF 359
                   +   +   A D +  L++  P  R T  +A  HP+       +  +      
Sbjct: 232 --------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSE 283

Query: 360 PPLFNFKPQELKGA 373
               NF   + K A
Sbjct: 284 QIKKNFAKSKWKQA 297

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  165 bits (418), Expect = 4e-49
 Identities = 68/298 (22%), Positives = 110/298 (36%), Gaps = 72/298 (24%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-------------LQDKRYKNRELQTMR 139
           Y  + ++G+G   +V +     T +  A+K +              + +    +E+  +R
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 140 LL-DHPNV--------------------------HYSRASQRMPLIYVKLYTYQICRALA 172
            +  HPN+                           Y      +     +     +   + 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 173 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 232
            +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE       +  Y APE+I 
Sbjct: 125 ALH-KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182

Query: 233 GATE-----YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 287
            +       Y   VD+WS G ++  LL G P F     +  L  I              M
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--------------M 228

Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 345
           + NY +F  P+                   DLVSR L   P  R TA EA  HPFF +
Sbjct: 229 SGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 7e-49
 Identities = 65/293 (22%), Positives = 108/293 (36%), Gaps = 73/293 (24%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 146
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 147 --------------------------------HYSRASQRMPLIYVKLYTYQICRALAYI 174
                                             ++  Q +   +V     Q+  AL   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 175 H----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPE 229
           H    GG  V HRD+KP N+ ++   + VKL DFG A++L        +++ + YY +PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184

Query: 230 LIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
            +     Y    DIWS+GC+L EL    P F   S  +   +I                 
Sbjct: 185 QMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR---------------- 227

Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
              E KF +I               E  ++++R+L      R +  E   +P 
Sbjct: 228 ---EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 4e-48
 Identities = 84/321 (26%), Positives = 129/321 (40%), Gaps = 79/321 (24%)

Query: 86  QPKQTI--SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQ 136
           QP++     +   +++G+GSF  V  A+ L T    AIK + +    K        RE  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60

Query: 137 TMRLLDHPNV--------------------------HYSRASQRMPLIYVKLYTYQICRA 170
            M  LDHP                             Y R          + YT +I  A
Sbjct: 61  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120

Query: 171 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 227
           L Y+HG  G+ HRD+KP+N+L+N   H +++ DFG+AKVL          S++ +  Y +
Sbjct: 121 LEYLHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 228 PELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 287
           PEL+        + D+W++GC++ +L+ G P F   +      +IIK+            
Sbjct: 179 PELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------ 225

Query: 288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI------HP 341
                E+ FP+            +  P+A DLV +LL      R    E         HP
Sbjct: 226 -----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268

Query: 342 FFDELRDPNARLPNGRPFPPL 362
           FF+ +      L    P P L
Sbjct: 269 FFESVT--WENLHQQTP-PKL 286

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 4e-48
 Identities = 77/349 (22%), Positives = 133/349 (38%), Gaps = 80/349 (22%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT--------MRLLDHP 144
           ++  +++G+GSFG VF A+  +T +  AIK + +D    + +++             +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 145 NV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
            +                          ++ ++  +  L     Y  +I   L ++H   
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-K 122

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 237
           G+ +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +  Y APE++ G  +Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KY 180

Query: 238 TTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
             +VD WS G +L E+L+GQ  F G+   +                I+  NP Y  +   
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNPFYPRW--- 225

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-HPFFDELRDPNARLPNG 356
                         +  EA DL+ +L    P  R         HP F E+      L   
Sbjct: 226 --------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN--WEELERK 269

Query: 357 R---PFPP-------LFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 395
               PF P         NF  + L    +   +     ++  Q  F  F
Sbjct: 270 EIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNF 318

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 1e-46
 Identities = 60/296 (20%), Positives = 105/296 (35%), Gaps = 76/296 (25%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD 142
           Y    ++G G FG V+    +     VAIK V +D+               E+  ++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 143 --HPNV---------------------------HYSRASQRMPLIYVKLYTYQICRALAY 173
                V                            +      +     + + +Q+  A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 174 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 233
            H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I  
Sbjct: 126 CHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRY 183

Query: 234 ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
              +  +  +WS+G +L +++ G   F  +       EII+                   
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------------- 218

Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
                         F +R+  E   L+   L   P+ R T  E   HP+  ++  P
Sbjct: 219 ----------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (395), Expect = 3e-45
 Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 72/292 (24%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPN 145
           +   R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 146 V--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 179
           +                             R SQR P    K Y  ++C AL Y+H    
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH-SKD 124

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           + +RD+KP+N+L++ + H +K+ DFG AK +   +   +   +  Y APE++     Y  
Sbjct: 125 IIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVST-KPYNK 180

Query: 240 AVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
           ++D WS G ++ E+L G   F   + +    +I+                   E +FP  
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-----------------AELRFP-- 221

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDEL 346
                          +  DL+SRL+    + R         +   HP+F E+
Sbjct: 222 ----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-44
 Identities = 59/316 (18%), Positives = 110/316 (34%), Gaps = 69/316 (21%)

Query: 88  KQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------REL 135
           ++ +   Y     +G G F +V + +   TG   A K + + +   +          RE+
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 136 QTMRLLDHPNV--------------------------HYSRASQRMPLIYVKLYTYQICR 169
             ++ + HPNV                           +    + +       +  QI  
Sbjct: 65  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124

Query: 170 ALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 226
            + Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + 
Sbjct: 125 GVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183

Query: 227 APELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 286
           APE++          D+WS+G +   LL G   F G++  + L  +  V      E    
Sbjct: 184 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---- 238

Query: 287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
                                +       A D + RLL   P  R T  ++  HP+    
Sbjct: 239 ---------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP- 276

Query: 347 RDPNARLPNGRPFPPL 362
           +D    L +    P  
Sbjct: 277 KDTQQALSSAWSHPQF 292

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-44
 Identities = 65/310 (20%), Positives = 111/310 (35%), Gaps = 74/310 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNV--- 146
           +++G+G+FG V   +   TG   A+K + ++             E + ++   HP +   
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                                   +    +       + Y  +I  AL Y+H    V +R
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYR 129

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           DIK +NL+++   H +K+ DFG  K  +     +   C         +    +Y  AVD 
Sbjct: 130 DIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188

Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           W +G V+ E++ G+  F  +        I+                   E +FP      
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIRFP------ 225

Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELRDPNARLPNGRP 358
                 + + PEA  L++ LL+  P  R       A E   H FF  +      +   + 
Sbjct: 226 ------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--WQDVVQKKL 277

Query: 359 FPPLFNFKPQ 368
            PP   FKPQ
Sbjct: 278 LPP---FKPQ 284

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  152 bits (384), Expect = 3e-43
 Identities = 67/317 (21%), Positives = 112/317 (35%), Gaps = 75/317 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD 142
           +   R++G+G FG V+  +  +TG+  A+K + + +            +   L  +   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 143 HPNV----HYSRASQRMPLIY----------------------VKLYTYQICRALAYIHG 176
            P +    +      ++  I                       ++ Y  +I   L ++H 
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH- 124

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 236
              V +RD+KP N+L++ H H V++ D G A    K +P+ S   +  Y APE++     
Sbjct: 125 NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVA 182

Query: 237 YTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           Y ++ D +S+GC+L +LL G   F      D+       L                    
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--------------- 227

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDPNA 351
                            PE   L+  LLQ   N R       A E    PFF  L     
Sbjct: 228 -----------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL--DWQ 274

Query: 352 RLPNGRPFPPLFNFKPQ 368
            +   +  PP     P 
Sbjct: 275 MVFLQKYPPP---LIPP 288

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 8e-42
 Identities = 52/282 (18%), Positives = 96/282 (34%), Gaps = 65/282 (23%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV--- 146
            + +G GSFG V++ K       VA+K +               E+  +R   H N+   
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                                  H      +  +I +     Q  + + Y+H    + HR
Sbjct: 70  MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-SIIHR 128

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG--ATEYT 238
           D+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I       Y+
Sbjct: 129 DLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 239 TAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 298
              D+++ G VL EL+ GQ  +   +  DQ++ ++                    +  P 
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----------------RGYLSPD 230

Query: 299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 340
           +             P     L++  L+   + R    +    
Sbjct: 231 LSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  142 bits (360), Expect = 1e-40
 Identities = 59/291 (20%), Positives = 98/291 (33%), Gaps = 69/291 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
           Y    ++G G    V  A+ L     VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 146 V------------------------------HYSRASQRMPLIYVKLYTYQICRALAYIH 175
           +                                      M            C+AL + H
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYYRAPELI 231
              G+ HRD+KP N++++   + VK+ DFG A+ +     ++    + I +  Y +PE  
Sbjct: 129 -QNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
            G        D++S+GCVL E+L G+P F G+S V    + ++    P            
Sbjct: 187 RGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA--------- 236

Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 342
                            H+ +  +   +V + L  +P  R           
Sbjct: 237 ----------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 8e-40
 Identities = 53/308 (17%), Positives = 95/308 (30%), Gaps = 74/308 (24%)

Query: 80  IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQT 137
           +G R         Y   R +G GSFG ++    +  GE VAIK      ++     E + 
Sbjct: 5   VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55

Query: 138 MRLLDHPNV---------------------------HYSRASQRMPLIYVKLYTYQICRA 170
            +++                                 ++  S++  L  V L   Q+   
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 115

Query: 171 LAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI--------SYI 220
           + YIH      HRD+KP N L+      + V + DFG AK       +         +  
Sbjct: 116 IEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 280
            +  Y +     G  E +   D+ S+G VL    LG   + G     +  +  ++     
Sbjct: 175 GTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233

Query: 281 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA---LEA 337
              I+ +   Y                     P E    ++       + +       + 
Sbjct: 234 STPIEVLCKGY---------------------PSEFATYLNFCRSLRFDDKPDYSYLRQL 272

Query: 338 CIHPFFDE 345
             + F  +
Sbjct: 273 FRNLFHRQ 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (354), Expect = 6e-39
 Identities = 62/310 (20%), Positives = 108/310 (34%), Gaps = 77/310 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNV--- 146
           + +G GSFG V   K  E+G   A+K + + K  K         E + ++ ++ P +   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 147 -----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 183
                                   + R   R    + + Y  QI     Y+H  + + +R
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYR 165

Query: 184 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDI 243
           D+KP+NLL++   + +++ DFG AK         +   +    APE+I     Y  AVD 
Sbjct: 166 DLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-KGYNKAVDW 221

Query: 244 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           W++G ++ E+  G P F  +  +    +I                               
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKI-----------------------------VS 252

Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSP-----NLRCTALEACIHPFFDELRDPNARLPNGRP 358
               F      +  DL+  LLQ        NL+    +   H +F         +   + 
Sbjct: 253 GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT--DWIAIYQRKV 310

Query: 359 FPPLFNFKPQ 368
             P   F P+
Sbjct: 311 EAP---FIPK 317

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  135 bits (341), Expect = 1e-37
 Identities = 45/273 (16%), Positives = 87/273 (31%), Gaps = 53/273 (19%)

Query: 80  IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQT 137
           +G           Y   R +G+GSFG++F+   L   + VAIK   +         E +T
Sbjct: 3   VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53

Query: 138 MRLLDHPNVH---------------------------YSRASQRMPLIYVKLYTYQICRA 170
            +LL                                      ++  +  V +   Q+   
Sbjct: 54  YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 113

Query: 171 LAYIHGGIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAKVLVKGEPNI--------S 218
           +  IH    + +RDIKP N L+      + + + + DFG  K                 +
Sbjct: 114 VQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172

Query: 219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 278
              +  Y +     G  E +   D+ ++G V    L G   + G        +  ++   
Sbjct: 173 LSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231

Query: 279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR 311
                ++ +   + E +F +   +  +  F   
Sbjct: 232 KQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-37
 Identities = 71/322 (22%), Positives = 120/322 (37%), Gaps = 78/322 (24%)

Query: 93  YMAERVVGQGSFGIVFQAKCL---ETGETVAIKKV--------LQDKRYKNRELQTMRLL 141
           +   +V+G G++G VF  + +   +TG+  A+K +         +   +   E Q +  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 142 DHPNV---------------------------HYSRASQRMPLIYVKLYTYQICRALAYI 174
                                            +    +R     V++Y  +I  AL ++
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 145

Query: 175 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI---CSRYYRAPELI 231
           H  +G+ +RDIK +N+L++ + H V L DFG +K  V  E   +Y       Y     + 
Sbjct: 146 H-KLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
            G + +  AVD WS+G ++ ELL G   F  +   +   EI +                 
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------------RI 248

Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDEL 346
            + + P          + + M   A DL+ RLL   P  R       A E   H FF ++
Sbjct: 249 LKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298

Query: 347 RDPNARLPNGRPFPPLFNFKPQ 368
                 L   +   P   FKP 
Sbjct: 299 NW--DDLAAKKVPAP---FKPV 315

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 9e-36
 Identities = 51/276 (18%), Positives = 90/276 (32%), Gaps = 67/276 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNV-------- 146
           + +G+G FG V        G  VA+K +  D   +    E   M  L H N+        
Sbjct: 13  QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                  SR    +    +  ++  +C A+ Y+ G     HRD+
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDL 129

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWS 245
             +N+LV+      K+ DFG  K         +      + APE +    +++T  D+WS
Sbjct: 130 AARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFSTKSDVWS 185

Query: 246 VGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 304
            G +L E+   G+  +P     D +  + K                   +K         
Sbjct: 186 FGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------GYKMD------- 220

Query: 305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 340
                   PP   +++         +R + L+    
Sbjct: 221 ---APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-34
 Identities = 60/289 (20%), Positives = 96/289 (33%), Gaps = 67/289 (23%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------ 146
           E  +GQG FG V+      T   VAIK +           +E Q M+ L H  +      
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 147 ---------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 185
                                      + + L  +     QI   +AY+   +   HRD+
Sbjct: 81  VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDL 139

Query: 186 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATEYTTAVDI 243
           +  N+LV  +    K+ DFG A+++   E            + APE       +T   D+
Sbjct: 140 RAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDV 197

Query: 244 WSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           WS G +L EL   G+  +PG    + L ++ +    P   E                   
Sbjct: 198 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------------------ 239

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA--LEACIHPFFDELRDP 349
                     P    DL+ +  +  P  R T   L+A +  +F      
Sbjct: 240 ----------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 6e-34
 Identities = 51/286 (17%), Positives = 93/286 (32%), Gaps = 67/286 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV--- 146
                 +G G FG V+          VA+K + Q     +    E   M+ L H  +   
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                     + +  ++ +  +     QI   +A+I       H
Sbjct: 74  YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-NYIH 132

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATEYTTA 240
           RD++  N+LV+      K+ DFG A+++   E            + APE I     +T  
Sbjct: 133 RDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIK 190

Query: 241 VDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 299
            D+WS G +L E++  G+  +PG +  + +  + +                         
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------------- 225

Query: 300 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE--ACIHPFF 343
               +  +     P E   L+    +  P  R T     + +  FF
Sbjct: 226 ---GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-33
 Identities = 53/294 (18%), Positives = 103/294 (35%), Gaps = 59/294 (20%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPN-VH 147
           + + +  +G+G FG V++ K    GE VA+K     +    ++  E+    +L H N + 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 148 YSRASQRMPLIYVKLY----------------------------TYQICRALAYIHGGI- 178
           +  A  +    + +L+                                   LA++H  I 
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 179 ------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----YICSRYYRA 227
                  + HRD+K +N+LV        + D G A         I       + ++ Y A
Sbjct: 122 GTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 228 PELIFGA-----TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 282
           PE++  +      E     DI+++G V  E+     +  G     QL     V   P+ E
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVE 239

Query: 283 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 336
           E++ +          +++ +  ++            ++      +   R TAL 
Sbjct: 240 EMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 4e-33
 Identities = 42/276 (15%), Positives = 84/276 (30%), Gaps = 63/276 (22%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------- 146
           + +G G FG+V         + VAIK + +    +     E + M  L HP +       
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 147 --------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 186
                               +            +      +C  +AY+     V HRD+ 
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLA 128

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATEYTTAVDIW 244
            +N LV  +   +K+ DFG  + ++  +   S        + +PE+    + Y++  D+W
Sbjct: 129 ARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVW 186

Query: 245 SVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 304
           S G ++ E+     +        ++VE I                              +
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEVVEDIS---------------------------TGF 219

Query: 305 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 340
                +        +++   +  P  R         
Sbjct: 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 5e-33
 Identities = 63/304 (20%), Positives = 100/304 (32%), Gaps = 71/304 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGET----VAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
           +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 147 -------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 181
                                    +       +   Y+  +  QI + + Y+     + 
Sbjct: 75  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLV 133

Query: 182 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---YYRAPELIFGATEYT 238
           HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E I     YT
Sbjct: 134 HRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYT 191

Query: 239 TAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
              D+WS G  + EL+  G   + G        EI  +L    R                
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILEKGERLPQ------------- 234

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 357
                            +   ++ +      + R    E  I  F    RDP   L    
Sbjct: 235 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDPQRYLVIQG 282

Query: 358 PFPP 361
               
Sbjct: 283 DERM 286

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-32
 Identities = 54/291 (18%), Positives = 94/291 (32%), Gaps = 71/291 (24%)

Query: 97  RVVGQGSFGIVFQAKCLET---GETVAIKKVLQDKRYKN-------RELQTMRLLDHPNV 146
             +G GSFG+V + +         +VA+K +  D   +        RE+  M  LDH N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 147 --------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 180
                                        +      L  +  Y  Q+   + Y+      
Sbjct: 74  IRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-KRF 132

Query: 181 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEY 237
            HRD+  +NLL+      VK+ DFG  + L + + +     +    +            +
Sbjct: 133 IHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 238 TTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 296
           + A D W  G  L E+   GQ  + G +G   L +I K      R E             
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE------------- 238

Query: 297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 347
                           P +  +++ +   + P  R T +   +  F  E +
Sbjct: 239 --------------DCPQDIYNVMVQCWAHKPEDRPTFVA--LRDFLLEAQ 273

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (305), Expect = 1e-32
 Identities = 50/284 (17%), Positives = 103/284 (36%), Gaps = 65/284 (22%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------ 146
           +  +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+      
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 147 ----------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 184
                                       Q +  + +     QI  A+ Y+       HRD
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRD 140

Query: 185 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--YYRAPELIFGATEYTTAVD 242
           +  +N LV  + H VK+ DFG ++++                + APE +    +++   D
Sbjct: 141 LAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSD 198

Query: 243 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 302
           +W+ G +L E+            + Q+ E+++                  +++       
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRME----- 236

Query: 303 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 346
                  +  P +  +L+    Q++P+ R +  E  IH  F+ +
Sbjct: 237 -----RPEGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETM 273

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 2e-32
 Identities = 51/290 (17%), Positives = 96/290 (33%), Gaps = 72/290 (24%)

Query: 96  ERVVGQGSFGIVFQAKC--LETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV- 146
           ++ +G G+FG V +      +  +TVA+K +  +            E   M+ LD+P + 
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                    Y + ++ +    +    +Q+   + Y+       H
Sbjct: 72  RMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES-NFVH 130

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELIFGATEYT 238
           RD+  +N+L+    H  K+ DFG +K L   E              + APE I    +++
Sbjct: 131 RDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFS 188

Query: 239 TAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
           +  D+WS G ++ E    GQ  + G  G +    + K                       
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------------------ 230

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI---HPFFD 344
                          P E  DL++    Y    R       +   + ++D
Sbjct: 231 ----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (305), Expect = 2e-32
 Identities = 60/302 (19%), Positives = 102/302 (33%), Gaps = 74/302 (24%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGET---VAIKKVL-----QDKRYKNRELQTMRLLDH 143
               E+V+G G FG V        G+    VAIK +      + +R    E   M   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 144 PNV---------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHG 176
           PNV                              +   +  +I +      I   + Y+  
Sbjct: 87  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA- 145

Query: 177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRAPEL 230
            +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + APE 
Sbjct: 146 DMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204

Query: 231 IFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 289
           I    ++T+A D+WS G V+ E++  G+  +   +  D +  I +    P   +      
Sbjct: 205 IQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC----- 258

Query: 290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 349
                                  P     L+    Q   N R    +         +R+P
Sbjct: 259 -----------------------PSALHQLMLDCWQKDRNHRPKFGQIVNT-LDKMIRNP 294

Query: 350 NA 351
           N+
Sbjct: 295 NS 296

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 7e-32
 Identities = 46/277 (16%), Positives = 90/277 (32%), Gaps = 65/277 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNV------- 146
           + +G G FG+V   K       VAIK + +    ++    E + M  L H  +       
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 147 --------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 186
                               +      R     +      +C A+ Y+       HRD+ 
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLA 127

Query: 187 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--YICSRYYRAPELIFGATEYTTAVDIW 244
            +N LVN     VK+ DFG ++ ++  E   S        +  PE++   +++++  DIW
Sbjct: 128 ARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIW 185

Query: 245 SVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 303
           + G ++ E+  LG+  +   +  +    I + L                    P +    
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------------RLYRPHL---- 225

Query: 304 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 340
                      +   ++        + R T      +
Sbjct: 226 --------ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 3e-31
 Identities = 56/290 (19%), Positives = 95/290 (32%), Gaps = 72/290 (24%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV-- 146
           +  +G G+FG V Q       +   VAIK + Q     +     RE Q M  LD+P +  
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 182
                                         + +P+  V    +Q+   + Y+       H
Sbjct: 74  LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVH 132

Query: 183 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPELIFGATEYT 238
           RD+  +N+L+    +  K+ DFG +K L   +   +   +      + APE I    +++
Sbjct: 133 RDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFS 190

Query: 239 TAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 297
           +  D+WS G  + E L  GQ  +    G + +  I +        E              
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC------------- 237

Query: 298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI---HPFFD 344
                          PPE   L+S    Y    R   L         ++ 
Sbjct: 238 ---------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 4e-30
 Identities = 54/309 (17%), Positives = 95/309 (30%), Gaps = 94/309 (30%)

Query: 96  ERVVGQGSFGIVFQAKCLETGET-----VAIKKVLQDKRYKN-----RELQTM-RLLDHP 144
            +V+G G+FG V  A      +T     VA+K + +            EL+ M +L  H 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 145 NV-------------------------------------------------HYSRASQRM 155
           N+                                                         +
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161

Query: 156 PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 215
               +  + YQ+ + + ++       HRD+  +N+LV      VK+CDFG A+ ++    
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICDFGLARDIMSDSN 219

Query: 216 NISYICSR---YYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVE 271
            +    +R    + APE +F    YT   D+WS G +L E+  LG   +PG        +
Sbjct: 220 YVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 278

Query: 272 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 331
           +I+               N  +   P                 E   ++     +    R
Sbjct: 279 LIQ---------------NGFKMDQP------------FYATEEIYIIMQSCWAFDSRKR 311

Query: 332 CTALEACIH 340
            +       
Sbjct: 312 PSFPNLTSF 320

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 5e-30
 Identities = 48/298 (16%), Positives = 97/298 (32%), Gaps = 79/298 (26%)

Query: 96  ERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV- 146
             V+G+G FG V+    L+        A+K + +            E   M+   HPNV 
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 147 ---------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 179
                                           +    +  +  +  Q+ + + ++     
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-SKK 150

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGA 234
             HRD+  +N +++     VK+ DFG A+ +   E +  +  +       + A E +   
Sbjct: 151 FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT- 208

Query: 235 TEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 293
            ++TT  D+WS G +L EL+  G P +P  +  D  V +++                   
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------------- 249

Query: 294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFDE 345
                        +  +  P    +++ +       +R +       + A    F  E
Sbjct: 250 ---------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 3e-29
 Identities = 64/285 (22%), Positives = 94/285 (32%), Gaps = 68/285 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKN-----RELQTMRLLDHP 144
               R +G+G FG V Q   +        VAIK               +E  TMR  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 145 NV--------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGI 178
           ++                                  + L  + LY YQ+  ALAY+    
Sbjct: 69  HIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-K 127

Query: 179 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATE 236
              HRDI  +N+LV+ +   VKL DFG ++ +       +        + APE I     
Sbjct: 128 RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RR 185

Query: 237 YTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 295
           +T+A D+W  G  + E+L+ G   F G    D +  I      P                
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC----------- 234

Query: 296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 340
                            PP    L+++   Y P+ R    E    
Sbjct: 235 -----------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 5e-29
 Identities = 48/285 (16%), Positives = 85/285 (29%), Gaps = 70/285 (24%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLD 142
               ++V+G G FG V++     +       VAIK +      K       E   M    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 143 HPNV---------------------------HYSRASQRMPLIYVKLYTYQICRALAYIH 175
           H N+                                     ++ +      I   + Y+ 
Sbjct: 68  HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127

Query: 176 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC----SRYYRAPELI 231
             +   HRD+  +N+LVN +    K+ DFG ++VL                  + APE I
Sbjct: 128 N-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 232 FGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 291
               ++T+A D+WS G V+ E++        E    ++++ I                  
Sbjct: 186 SY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN----------------- 227

Query: 292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 336
                       +        P     L+ +  Q     R    +
Sbjct: 228 ----------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (268), Expect = 4e-27
 Identities = 59/314 (18%), Positives = 96/314 (30%), Gaps = 97/314 (30%)

Query: 97  RVVGQGSFGIVFQAKC-----LETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
           R +G+G+FG VFQA+       E    VA+K + ++          RE   M   D+PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 147 --------------------------------------------------HYSRASQRMP 156
                                                               S     + 
Sbjct: 79  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138

Query: 157 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 216
                    Q+   +AY+       HRD+  +N LV  +   VK+ DFG ++ +   +  
Sbjct: 139 CAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIYSADYY 196

Query: 217 I---SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEI 272
               +      +  PE IF    YTT  D+W+ G VL E+   G   + G +  + +  +
Sbjct: 197 KADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 255

Query: 273 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 332
                                     I A P      +  P E  +L+       P  R 
Sbjct: 256 RD----------------------GNILACP------ENCPLELYNLMRLCWSKLPADRP 287

Query: 333 TALEACIHPFFDEL 346
           +     IH     +
Sbjct: 288 SFCS--IHRILQRM 299

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 4e-27
 Identities = 50/295 (16%), Positives = 95/295 (32%), Gaps = 80/295 (27%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE--TVAIKKV-----LQDKRYKNRELQTM-RLLDHPNV- 146
           + V+G+G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN+ 
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 147 -----------------------------------------HYSRASQRMPLIYVKLYTY 165
                                                      +  +  +    +  +  
Sbjct: 75  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134

Query: 166 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 225
            + R + Y+       HRD+  +N+LV  + +  K+ DFG ++                +
Sbjct: 135 DVARGMDYLSQ-KQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRW 192

Query: 226 RAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
            A E +   + YTT  D+WS G +L E++             +L E +            
Sbjct: 193 MAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP----------- 240

Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 340
                    + P                 E  DL+ +  +  P  R +  +  + 
Sbjct: 241 ----QGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 4e-27
 Identities = 57/300 (19%), Positives = 98/300 (32%), Gaps = 89/300 (29%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRYKN-----RELQTM-RLLDHP 144
            + +G G+FG V +A        +   TVA+K +              EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 145 NV--------------------------------------------HYSRASQRMPLIYV 160
           N+                                                    + L  +
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 161 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 220
             ++YQ+ + +A++       HRD+  +N+L+       K+CDFG A+ +      +   
Sbjct: 148 LSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSNYVVKG 205

Query: 221 CSR---YYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVL 276
            +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK  
Sbjct: 206 NARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK-- 262

Query: 277 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 336
                                      +  +  +  P E  D++       P  R T  +
Sbjct: 263 -------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 1e-25
 Identities = 58/317 (18%), Positives = 100/317 (31%), Gaps = 90/317 (28%)

Query: 93  YMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQD------KRYKNRELQTMRLL 141
               + +G+G+FG V +A         T  TVA+K + +       +   +     + + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 142 DHPNVHY-------------------------------------------SRASQRMPLI 158
            H NV                                                   + L 
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 159 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI- 217
           ++  Y++Q+ + + ++       HRD+  +N+L++     VK+CDFG A+ + K    + 
Sbjct: 135 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVR 192

Query: 218 --SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIK 274
                    + APE IF    YT   D+WS G +L E+       +PG    ++    +K
Sbjct: 193 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 275 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 334
                            T  + P                PE    +       P+ R T 
Sbjct: 252 ---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQRPTF 284

Query: 335 LEACIHPFFDELRDPNA 351
            E   H     L   NA
Sbjct: 285 SELVEH--LGNLLQANA 299

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 3e-25
 Identities = 54/304 (17%), Positives = 99/304 (32%), Gaps = 90/304 (29%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGE-------TVAIKKVLQDKRYKN-----RELQTM-R 139
            +  + +G+G+FG V  A+ +   +        VA+K +  D   K+      E++ M  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 140 LLDHPNVHY------------------------------------------SRASQRMPL 157
           +  H N+                                                +++  
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134

Query: 158 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN- 216
             +    YQ+ R + Y+       HRD+  +N+LV       K+ DFG A+ +   +   
Sbjct: 135 KDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHHIDYYK 192

Query: 217 --ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEII 273
              +      + APE +F    YT   D+WS G +L E+  LG   +PG   V++L +++
Sbjct: 193 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLL 250

Query: 274 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 333
           K                      P                 E   ++       P+ R T
Sbjct: 251 K---------------EGHRMDKP------------SNCTNELYMMMRDCWHAVPSQRPT 283

Query: 334 ALEA 337
             + 
Sbjct: 284 FKQL 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 1e-23
 Identities = 55/307 (17%), Positives = 100/307 (32%), Gaps = 87/307 (28%)

Query: 96  ERVVGQGSFGIVFQAKC-----LETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
            R +GQGSFG+V++         E    VAIK V     ++++     E   M+  +  +
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 146 V------------------------------------HYSRASQRMPLIYVKLYTYQICR 169
           V                                      +       L  +     +I  
Sbjct: 85  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144

Query: 170 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC---SRYYR 226
            +AY++      HRD+  +N +V      VK+ DFG  + + + +             + 
Sbjct: 145 GMAYLN-ANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202

Query: 227 APELIFGATEYTTAVDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIK 285
           +PE +     +TT  D+WS G VL E+  L +  + G S    L  +++           
Sbjct: 203 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME----------- 250

Query: 286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACI 339
                                      P    +L+    QY+P +R +       ++  +
Sbjct: 251 -----------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

Query: 340 HPFFDEL 346
            P F E+
Sbjct: 294 EPGFREV 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.9 bits (191), Expect = 1e-17
 Identities = 31/193 (16%), Positives = 53/193 (27%), Gaps = 44/193 (22%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------------------RYKNRE 134
           +++G+G    VF     E      +K                            R    E
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 135 LQTMRLLDHPNVHYSRASQRMPLI---------------YVKLYTYQICRALAYIHGGIG 179
            + ++ L    V    A +   ++                       I   +A  +    
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG- 123

Query: 180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 239
           + H D+   N+LV      + + DF  +  +  GE     I  R  R     F    Y T
Sbjct: 124 IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNIITYFS-RTYRT 178

Query: 240 AVDIWSVGCVLAE 252
             DI S    + +
Sbjct: 179 EKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	395
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	96.76
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.53
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.24
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	95.94
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	91.78

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-59  Score=445.80  Aligned_cols=293  Identities=72%  Similarity=1.233  Sum_probs=258.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHhcCCCceE-----------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVH-----------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~l~h~ni~-----------------------  147 (395)
                      .+|+.+++||+|+||+||+|+++.+|+.||||++.++.....+|+.+|+.++|+||.                       
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            369999999999999999999999999999999988877778999999999999981                       


Q ss_pred             ------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          148 ------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       148 ------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                  +......+++..++.++.||+.||+||| ++||+||||||+|||++.++..+||+|||+|+.......
T Consensus       100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH-~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~  178 (350)
T d1q5ka_         100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  178 (350)
T ss_dssp             CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred             ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence                        0112446899999999999999999999 899999999999999998876799999999988776666


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ..+.+||+.|+|||.+.+...|+.++||||+||++|||++|++||.+.+..+++..|.+.+|.+..+.+......+....
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~  258 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK  258 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred             cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence            67788999999999998777799999999999999999999999999999999999999999999999998888888888


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCChhhhccCCH
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASK  375 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (395)
                      ++.....++.......+++++.+||.+||++||++|||+.|+|+||||+++.++...++.....+.+.++..+|+. ...
T Consensus       259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~  337 (350)
T d1q5ka_         259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS-SNP  337 (350)
T ss_dssp             CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHT-TCG
T ss_pred             ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhcc-CCc
Confidence            8888888888778888999999999999999999999999999999999999988877777788888899988885 344


Q ss_pred             HHHHhhchHH
Q 016085          376 ELLSKLIPEH  385 (395)
Q Consensus       376 ~~~~~~~~~~  385 (395)
                      ...+.++|++
T Consensus       338 ~~~~~~~p~~  347 (350)
T d1q5ka_         338 PLATILIPPH  347 (350)
T ss_dssp             GGHHHHSCTT
T ss_pred             cccccCCCcc
Confidence            4555666653

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-55  Score=402.60  Aligned_cols=228  Identities=28%  Similarity=0.367  Sum_probs=188.2

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCce------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...     .....+|+.+|+.++||||                  
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            35799999999999999999999999999999998643     2345689999999999998                  


Q ss_pred             --------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC---C
Q 016085          147 --------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---P  215 (395)
Q Consensus       147 --------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~---~  215 (395)
                              .+......+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+......   .
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH-~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETTEECC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCccCcccHHHEEECCCC-CEEEccchhheeeccCCcccc
Confidence                    12344567999999999999999999999 88999999999999999887 69999999998764332   2


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+||+.|||||++.+...++.++|||||||++|+|++|+.||.+.+...............                
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~----------------  225 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----------------  225 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT----------------
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------
Confidence            3457899999999999877656789999999999999999999998766544433333211000                


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                                ......+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       226 ----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         226 ----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             ----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ----------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                      0012347899999999999999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=407.01  Aligned_cols=252  Identities=36%  Similarity=0.596  Sum_probs=205.4

Q ss_pred             eeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---------hhHHHHHHHHHhcCCCce-------------------
Q 016085           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNV-------------------  146 (395)
Q Consensus        95 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~E~~~l~~l~h~ni-------------------  146 (395)
                      .+++||+|+||+||+|+++.+|+.||||++....         ....+|+.+|+.++||||                   
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4689999999999999999999999999985432         234589999999999998                   


Q ss_pred             -------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccc
Q 016085          147 -------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNIS  218 (395)
Q Consensus       147 -------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~  218 (395)
                             ........+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+...... ....
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH-~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCCCCCC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhh-ccceecccCCcceEEecCCC-ccccccCccccccCCCcccccc
Confidence                   11233567899999999999999999999 88999999999999999887 69999999998765433 3345


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      .+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+++..|.+..|.|..+.+...........+..
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS  239 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence            68899999999997766689999999999999999999999999999999999999999998776543332222222222


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      ....++.. ....+++++.+||.+||++||++|||+.|+|+||||++...+
T Consensus       240 ~~~~~~~~-~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         240 FPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             CCCCChHH-hcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            22222222 234578999999999999999999999999999999876544

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=399.83  Aligned_cols=223  Identities=30%  Similarity=0.470  Sum_probs=191.1

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCce----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNV----------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni----------------  146 (395)
                      .++|++.+.||+|+||+||+|+++.+++.||||++.+.       .....+|+.+|+.++||||                
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            35799999999999999999999999999999998643       2345689999999999998                


Q ss_pred             ----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          147 ----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       147 ----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                                .+......+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+..... ..
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH-~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~~-~~  161 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH-SKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSS-RR  161 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCCC-CC
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeeeeccccceecCCC-CEeecccceeeecCCC-cc
Confidence                      11223467899999999999999999999 88999999999999999888 6999999999876433 34


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..+.+.                 ..  
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-----------------~~--  221 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF--  221 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------------CC--
T ss_pred             cccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------CC--
Confidence            5678999999999998765 899999999999999999999999988877766665431                 01  


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                                .++..+|+++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       222 ----------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         222 ----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                      123457999999999999999999999999999999964

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=403.88  Aligned_cols=229  Identities=34%  Similarity=0.579  Sum_probs=192.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCce-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNV-----------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni-----------------  146 (395)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+|+.++||||                 
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            47999999999999999999999999999999986432       345689999999999998                 


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC---
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---  214 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~---  214 (395)
                               .+....+.+++..++.++.|++.||+||| ++||+||||||+|||++.++ .+||+|||+|+......   
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH-~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH-GKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC------
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhc-cccEEcCcCCccccccCCCc-eEEecccccceecccCCccc
Confidence                     11223467899999999999999999999 88999999999999999888 59999999998764332   


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..|.+.                 ..
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-----------------~~  227 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-----------------EY  227 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-----------------CC
T ss_pred             ccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-----------------CC
Confidence            234568999999999998765 899999999999999999999999998877777766541                 01


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHH------HhcCCcccCCCCCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE------ACIHPFFDELRDPNA  351 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e------~l~hp~f~~~~~~~~  351 (395)
                                  .++..+++++.+||.+||+.||++|||+.|      +++||||+++.|...
T Consensus       228 ------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         228 ------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             ------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             ------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence                        123458999999999999999999999987      588999999987643

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=401.28  Aligned_cols=255  Identities=35%  Similarity=0.572  Sum_probs=207.9

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCC-CcEEEEEEeecc------hhhHHHHHHHHHhc---CCCceE------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLET-GETVAIKKVLQD------KRYKNRELQTMRLL---DHPNVH------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~-~~~vAiK~~~~~------~~~~~~E~~~l~~l---~h~ni~------------  147 (395)
                      .++|++++.||+|+||+||+|++..+ ++.||||++...      .....+|+.+|+.|   +||||.            
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            45799999999999999999999765 667999998543      22345788888776   799981            


Q ss_pred             --------------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCc
Q 016085          148 --------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  207 (395)
Q Consensus       148 --------------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a  207 (395)
                                          .......+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH-~~~ivHrDiKp~NILi~~~~-~~kl~dfg~~  163 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSG-QIKLADFGLA  163 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECSCCSC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCEEecCCCccEEEEcCCC-Ceeecchhhh
Confidence                                0113456889999999999999999999 88999999999999999888 6999999999


Q ss_pred             cccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 016085          208 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  287 (395)
Q Consensus       208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  287 (395)
                      +...........+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+++..|++..+.+....+...
T Consensus       164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         164 RIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhhcccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            8766555566788999999999998765 999999999999999999999999999999999999999999887765432


Q ss_pred             CCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          288 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      ..... ..+..... .....+...+++.+.+||.+||++||++|||+.|+|+||||+++...
T Consensus       243 ~~~~~-~~~~~~~~-~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~  302 (305)
T d1blxa_         243 VALPR-QAFHSKSA-QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  302 (305)
T ss_dssp             CSSCG-GGSCCCCC-CCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccchh-hhhccccc-cchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence            21111 11111111 11223456689999999999999999999999999999999988654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-54  Score=402.37  Aligned_cols=226  Identities=28%  Similarity=0.395  Sum_probs=191.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCceE-------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVH-------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni~-------------------  147 (395)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+|+.++||||.                   
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            3699999999999999999999999999999998643    34467899999999999980                   


Q ss_pred             ------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccccc
Q 016085          148 ------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYI  220 (395)
Q Consensus       148 ------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~~~  220 (395)
                            .......+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+...... .....+
T Consensus       100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~~~~~~~~  177 (293)
T d1yhwa1         100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMV  177 (293)
T ss_dssp             TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCCC
T ss_pred             CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCcHHHeEECCCC-cEeeccchhheeeccccccccccc
Confidence                  0112356899999999999999999999 88999999999999999888 59999999998765433 345667


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCccc
Q 016085          221 CSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  300 (395)
Q Consensus       221 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (395)
                      ||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..+.... .+.                    
T Consensus       178 gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~--------------------  235 (293)
T d1yhwa1         178 GTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE--------------------  235 (293)
T ss_dssp             SCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCC--------------------
T ss_pred             cCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCC--------------------
Confidence            999999999998754 8999999999999999999999999988877777665531 110                    


Q ss_pred             CCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          301 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       301 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                           ...+..+++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       236 -----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         236 -----LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             -----CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             -----CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                 0123447899999999999999999999999999999974

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=400.32  Aligned_cols=256  Identities=36%  Similarity=0.650  Sum_probs=208.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCce------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...      .....+|+++|+.++||||                  
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            4799999999999999999999999999999998543      2345689999999999998                  


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cc
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PN  216 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~  216 (395)
                               ........+++..++.++.||+.||+||| ++|||||||||+|||++.++ .+||+|||+|+...... ..
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH-~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCSBCT
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh-cCCEEccccCchheeecccC-cceeccCCcceeccCCcccc
Confidence                     11123567999999999999999999999 88999999999999999887 69999999998765432 33


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC-cccc
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY-TEFK  295 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~  295 (395)
                      ....||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+....... ....
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            456789999999998877767999999999999999999999999999999999999998888765543221100 0011


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      .+......+. .....+++++.+||++||++||++|||+.|+|+||||+++.+|
T Consensus       240 ~~~~~~~~~~-~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         240 FPKWARQDFS-KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             SCCCCCCCHH-HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccchh-hhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            1111111111 1234578999999999999999999999999999999988665

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=404.49  Aligned_cols=227  Identities=27%  Similarity=0.409  Sum_probs=194.8

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCce----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNV----------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni----------------  146 (395)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++||||                
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            35799999999999999999999999999999998753       2345689999999999998                


Q ss_pred             ----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc-CCC
Q 016085          147 ----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEP  215 (395)
Q Consensus       147 ----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~-~~~  215 (395)
                                .+......+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH-~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTTCC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhh-hcCccccccCHHHeEecCCC-CEEEeecccccccccCCcc
Confidence                      11223467899999999999999999999 88999999999999999988 599999999987644 334


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+....+...                 .. 
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-----------------~~-  222 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------EI-  222 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CC-
T ss_pred             cccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-----------------CC-
Confidence            45678999999999998765 899999999999999999999999998877766666541                 11 


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  348 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  348 (395)
                                 .++..+|+++.+||++||++||++|+     ++.|+++||||+++.+
T Consensus       223 -----------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         223 -----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -----------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence                       13445899999999999999999999     4899999999988754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.2e-53  Score=405.30  Aligned_cols=233  Identities=27%  Similarity=0.405  Sum_probs=198.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCce--------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNV--------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni--------------------  146 (395)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+|+.|+||||                    
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            4799999999999999999999999999999998653    2345689999999999998                    


Q ss_pred             ------E-eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC-CCceEEeecCCccccccCCCccc
Q 016085          147 ------H-YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       147 ------~-~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~-~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                            . .......+++..++.++.||+.||+||| ++||+||||||+|||++.+ .+.+||+|||+|+..........
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH-~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  184 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  184 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccce
Confidence                  0 1123456999999999999999999999 8899999999999999643 23699999999988766666667


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      ..||+.|||||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..|......+.                  
T Consensus       185 ~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------------------  245 (350)
T d1koaa2         185 TTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD------------------  245 (350)
T ss_dssp             ECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC------------------
T ss_pred             ecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------------
Confidence            88999999999998765 89999999999999999999999999988888888766322111                  


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCC
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  350 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  350 (395)
                             ......+|+++.+||.+||++||++|||+.|+|+||||+....+.
T Consensus       246 -------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  290 (350)
T d1koaa2         246 -------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  290 (350)
T ss_dssp             -------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred             -------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence                   112234789999999999999999999999999999998876543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.8e-53  Score=394.12  Aligned_cols=251  Identities=34%  Similarity=0.609  Sum_probs=202.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCce------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      ++|+++++||+|+||+||+|+++ +|+.||||++...      .....+|+.+|+.++||||                  
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            47999999999999999999985 7899999998543      2345689999999999998                  


Q ss_pred             --------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Ccc
Q 016085          147 --------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNI  217 (395)
Q Consensus       147 --------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~  217 (395)
                              .+......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|....... ...
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC------
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhc-cCcEEecCCCCceeeEcCCC-CEEecccccceecccCccccc
Confidence                    12244678999999999999999999999 88999999999999999988 59999999998764432 234


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc-cccC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT-EFKF  296 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~  296 (395)
                      ...+|+.|+|||.+.+...++.++|||||||++|||++|+.||.+.+..+++.++.+..+.+....+........ ....
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            557899999999998777789999999999999999999999999999999999999999887665543221100 0111


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      ..... .....+...+++.+.|||++||++||++|||+.|+|+||||++
T Consensus       239 ~~~~~-~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEP-LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCC-CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccC-cchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            11111 1122345568999999999999999999999999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-53  Score=399.64  Aligned_cols=227  Identities=27%  Similarity=0.429  Sum_probs=177.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCce-------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNV-------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni-------------------  146 (395)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++.+..     ....+|+.+|+.++||||                   
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45999999999999999999999999999999986432     234579999999999998                   


Q ss_pred             -------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcC---CCCceEEeecCCccccccCCCc
Q 016085          147 -------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       147 -------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~---~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                             .+......+++..++.++.||+.||+||| ++||+||||||+|||+..   ++ .+||+|||+|+........
T Consensus        89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH-~~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH-DLGIVHRDLKPENLLYYSLDEDS-KIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSTTC-CEEECCC------------
T ss_pred             cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhh-hceeeeEEecccceeecccCCCc-eEEEeccceeEEccCCCee
Confidence                   11234567999999999999999999999 889999999999999953   44 6999999999877666556


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      .+.+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+....|.+....                  
T Consensus       167 ~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~------------------  227 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE------------------  227 (307)
T ss_dssp             ------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC------------------
T ss_pred             eeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC------------------
Confidence            6788999999999997755 999999999999999999999999998877777766542111                  


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                             ........+|+++.+||.+||++||++|||+.|+|+||||+.
T Consensus       228 -------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         228 -------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             -------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             -------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                   011133458999999999999999999999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.5e-53  Score=397.66  Aligned_cols=225  Identities=28%  Similarity=0.481  Sum_probs=194.2

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhHHHHHHHHHhcCCCce-----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNV-----------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni-----------------  146 (395)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++||||                 
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4799999999999999999999999999999998643       2345689999999999998                 


Q ss_pred             ---------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcc
Q 016085          147 ---------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       147 ---------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                               ........+++..++.++.||+.||+||| ++||+||||||+||||+.++ .+||+|||+|+....  ...
T Consensus        84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~--~~~  159 (316)
T d1fota_          84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH-SKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD--VTY  159 (316)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--CBC
T ss_pred             eecCCccccccccccccccccHHHHHHHHHHHhhhhhc-cCcEEccccCchheeEcCCC-CEEEecCccceEecc--ccc
Confidence                     11223466788899999999999999999 89999999999999999888 699999999987643  345


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      +.+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..|...                 ..   
T Consensus       160 ~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-----------------~~---  218 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-----------------EL---  218 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-----------------CC---
T ss_pred             cccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC-----------------CC---
Confidence            678999999999997755 899999999999999999999999998888877777652                 01   


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  349 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  349 (395)
                               .++..+++++.++|.+||++||.+|+     |++++++||||+++.+.
T Consensus       219 ---------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         219 ---------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             ---------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence                     12345789999999999999999996     89999999999998654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-53  Score=394.47  Aligned_cols=227  Identities=25%  Similarity=0.356  Sum_probs=189.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcCCCce--------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNV--------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~h~ni--------------------  146 (395)
                      +.|++++.||+|+||+||+|+++.+|+.||||++...    .....+|+++|+.++||||                    
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            3599999999999999999999999999999998643    2445689999999999998                    


Q ss_pred             ------Ee-eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC-Cccc
Q 016085          147 ------HY-SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNIS  218 (395)
Q Consensus       147 ------~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~-~~~~  218 (395)
                            .+ ......+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+...... ....
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH-~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH-DNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHHHHHTC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCEEEeecChhheeECCCC-CEEEEechhhhccCCCcccccc
Confidence                  01 123456999999999999999999999 88999999999999999888 69999999997653321 2335


Q ss_pred             ccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          219 YICSRYYRAPELIFG----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .+||+.|+|||++.+    ...|+.++|||||||++|+|++|+.||.+.+..+.+..+....  ++            . 
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~------------~-  234 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PP------------T-  234 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CC------------C-
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC------------C-
Confidence            689999999999842    3448999999999999999999999999988888777766521  00            0 


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                                 ...+..+|+++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       235 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         235 -----------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             -----------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             -----------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                       0122347899999999999999999999999999999964

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.2e-52  Score=402.49  Aligned_cols=229  Identities=27%  Similarity=0.377  Sum_probs=195.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----hhHHHHHHHHHhcCCCce--------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNV--------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~~l~~l~h~ni--------------------  146 (395)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....    ....+|+.+|+.|+||||                    
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46999999999999999999999999999999986542    344689999999999998                    


Q ss_pred             -------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc--CCCCceEEeecCCccccccCCCcc
Q 016085          147 -------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN--PHTHQVKLCDFGSAKVLVKGEPNI  217 (395)
Q Consensus       147 -------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~--~~~~~ikl~DFG~a~~~~~~~~~~  217 (395)
                             .......++++..++.++.||+.||+||| ++||+||||||+||||+  .++ .+||+|||+|+.........
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH-~~~iiHRDiKp~NILl~~~~~~-~vkL~DFGla~~~~~~~~~~  186 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVK  186 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTCC-CEEECCCTTCEECCTTSCEE
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccccccccccccCCC-eEEEeecccceecCCCCcee
Confidence                   01122346899999999999999999999 88999999999999997  344 69999999999887666666


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ...||+.|+|||++.+.. |+.++|||||||++|+|+||+.||.+.+..+.+..|......++                 
T Consensus       187 ~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------------  248 (352)
T d1koba_         187 VTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD-----------------  248 (352)
T ss_dssp             EECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC-----------------
T ss_pred             eccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------
Confidence            788999999999997755 99999999999999999999999999988888887766321111                 


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                              ......+|+++.+||.+||++||.+|||+.|+|+||||+...
T Consensus       249 --------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         249 --------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             --------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             --------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence                    112345799999999999999999999999999999998643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.8e-53  Score=404.51  Aligned_cols=225  Identities=25%  Similarity=0.389  Sum_probs=193.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCce----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNV----------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni----------------  146 (395)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+|+.++||||                
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            457999999999999999999999999999999986432       334689999999999998                


Q ss_pred             ----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          147 ----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       147 ----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                                .+......+++..++.++.||+.||.||| ++|||||||||+||||+.++ .+||+|||+|+....  ..
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH-~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~--~~  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKG--RT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS--CB
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCcCCHHHcccCCCC-CEEeeeceeeeeccc--cc
Confidence                      11122357899999999999999999999 88999999999999999888 699999999987643  33


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...+||+.|||||++.+.. |+.++|||||||++|+|+||+.||.+.+....+..|....                 .  
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-----------------~--  255 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----------------V--  255 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------------C--
T ss_pred             ccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-----------------C--
Confidence            4678999999999998765 8999999999999999999999999988877777776521                 0  


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  348 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  348 (395)
                                .++..+++++.+||++||++||.+|+     |+.++++||||+.+.+
T Consensus       256 ----------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         256 ----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             ----------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence                      12345799999999999999999995     8999999999998765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=392.66  Aligned_cols=232  Identities=23%  Similarity=0.376  Sum_probs=195.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----------hhhHHHHHHHHHhcCCCce-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV-------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----------~~~~~~E~~~l~~l~h~ni-------------  146 (395)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.          .....+|+.+|+.++||||             
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            35799999999999999999999999999999998542          2345789999999999998             


Q ss_pred             -------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC---ceEEeecCCcccc
Q 016085          147 -------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKLCDFGSAKVL  210 (395)
Q Consensus       147 -------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~---~ikl~DFG~a~~~  210 (395)
                                   .+......+++..++.++.||+.||+||| +.||+||||||+|||++.++.   .+||+|||+|+..
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH-~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhh-hcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence                         11123457999999999999999999999 889999999999999987653   4999999999887


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016085          211 VKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  290 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  290 (395)
                      ..+.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..|........          
T Consensus       168 ~~~~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~----------  236 (293)
T d1jksa_         168 DFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE----------  236 (293)
T ss_dssp             TTSCBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----------
T ss_pred             CCCccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC----------
Confidence            6666666778999999999997754 89999999999999999999999999888887777655321111          


Q ss_pred             CccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          291 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                                     ...+..+|+++.+||++||+.||++|||+.|+|+||||+...+
T Consensus       237 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         237 ---------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             ---------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             ---------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence                           1223457999999999999999999999999999999987644

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=387.91  Aligned_cols=222  Identities=23%  Similarity=0.363  Sum_probs=181.5

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE-------------------
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH-------------------  147 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~-------------------  147 (395)
                      |++.++||+|+||+||+|++..+++.||+|++....      ....+|+++|+.++||||.                   
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            578889999999999999999999999999986432      3456899999999999981                   


Q ss_pred             -----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCC--eeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 -----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 -----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                 +......+++..++.++.||+.||+||| ++|  |+||||||+|||++.+...+||+|||+|+... ..
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH-~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-~~  168 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS  168 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHH-HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-CC
Confidence                       1112356889999999999999999999 778  99999999999997533369999999997643 33


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....+||+.|+|||++.+ . |+.++|||||||++|||++|+.||.+......+...+.. +.++              
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~--------------  231 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP--------------  231 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC--------------
T ss_pred             ccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC--------------
Confidence            3456789999999999865 3 899999999999999999999999877665554443321 0000              


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                                 ..++...++++.+||.+||++||++|||+.|+|+||||+
T Consensus       232 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 -----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -----------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                       113344789999999999999999999999999999996

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-52  Score=398.57  Aligned_cols=257  Identities=36%  Similarity=0.630  Sum_probs=204.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      ..+|++++.||+|+||+||+|+++.+|+.||||++.+.      .....+|+.+|+.++||||.                
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            34799999999999999999999999999999998643      22345899999999999981                


Q ss_pred             --e------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          148 --Y------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 --~------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                        +            .....++++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+...  
T Consensus        97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~~~--  172 (346)
T d1cm8a_          97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQAD--  172 (346)
T ss_dssp             CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC--
T ss_pred             eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHH-hCCCcccccCcchhhccccc-ccccccccceeccC--
Confidence              0            011357999999999999999999999 88999999999999999888 59999999998763  


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      ...+...||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.+.+.........
T Consensus       173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (346)
T d1cm8a_         173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK  252 (346)
T ss_dssp             SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred             CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence            33456789999999999987776899999999999999999999999999999999999999999988776544321100


Q ss_pred             ---ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 016085          294 ---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  351 (395)
Q Consensus       294 ---~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  351 (395)
                         ...+......+.. ....+++++.+||.+||++||++|||+.|+|+||||+.+.+...
T Consensus       253 ~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~  312 (346)
T d1cm8a_         253 NYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  312 (346)
T ss_dssp             HHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             hhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence               1122222222222 33457899999999999999999999999999999999876543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-52  Score=395.13  Aligned_cols=222  Identities=29%  Similarity=0.413  Sum_probs=188.7

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCce------------------
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      .|++++.||+|+||+||+|++..+|+.||||++....       ....+|+.+|+.++||||                  
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            5999999999999999999999999999999986432       234589999999999998                  


Q ss_pred             --------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          147 --------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       147 --------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                              .+......+++..++.++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+|+....   ...
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH-~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~---~~~  170 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP---ANS  170 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS---BCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeccCCCcceEEECCCC-CEEEeecccccccCC---CCc
Confidence                    11233567999999999999999999999 88999999999999999887 699999999987533   345


Q ss_pred             ccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          219 YICSRYYRAPELIFGA--TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      .+||+.|||||++.+.  ..|+.++|||||||++|||++|+.||.+.+..+.+..+....                   .
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~-------------------~  231 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-------------------S  231 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------------C
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-------------------C
Confidence            7899999999998642  348999999999999999999999999988877777665521                   0


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                      +.        ..+..+|+.+.+||.+||++||++|||+.|+|+||||..
T Consensus       232 ~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         232 PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             CC--------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CC--------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            00        112347899999999999999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=389.47  Aligned_cols=222  Identities=28%  Similarity=0.419  Sum_probs=177.5

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceE--------------e--
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVH--------------Y--  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~--------------~--  148 (395)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...      .....+|+++|+.++||||.              +  
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5799999999999999999999999999999998543      23356899999999999981              0  


Q ss_pred             ----------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCC-----eeeccCCCCceEEcCCCCceEEeecCCc
Q 016085          149 ----------------SRASQRMPLIYVKLYTYQICRALAYIHGGIG-----VCHRDIKPQNLLVNPHTHQVKLCDFGSA  207 (395)
Q Consensus       149 ----------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g-----iiHrDlKp~Nill~~~~~~ikl~DFG~a  207 (395)
                                      ......+++..++.++.||+.||+||| ++|     |+||||||+||||+.++ .+||+|||+|
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH-~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DFG~a  161 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH-RRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLA  161 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HHCC---------CCGGGEEECTTS-CEEECCHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-HhcCCCCCEEeCcCchhhcCcCCCC-cEEEeeccce
Confidence                            012346899999999999999999999 555     99999999999999888 6999999999


Q ss_pred             cccccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 016085          208 KVLVKGE-PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       208 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  286 (395)
                      +...... .....+||+.|+|||++.+.. |+.++|||||||++|||+||+.||.+.+..+....|....          
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~----------  230 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK----------  230 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----------
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC----------
Confidence            8765433 234578899999999997654 9999999999999999999999999988777666665410          


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcc
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  343 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f  343 (395)
                               ++         .++..+|+++.+||.+||+.||++|||+.|+|+|||+
T Consensus       231 ---------~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 ---------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ---------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ---------CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                     00         1234579999999999999999999999999999995

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.5e-52  Score=394.42  Aligned_cols=257  Identities=30%  Similarity=0.551  Sum_probs=205.1

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-hhhHHHHHHHHHhcC-CCce----------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNV----------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~~l~~l~-h~ni----------------------  146 (395)
                      ++|+++++||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.+. |+||                      
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            4799999999999999999999999999999998754 345678999999995 9998                      


Q ss_pred             ---EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCcccccccc
Q 016085          147 ---HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR  223 (395)
Q Consensus       147 ---~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~~~gt~  223 (395)
                         .+....+.+++..++.++.||+.||+||| ++||+||||||+|||++.+++.+||+|||+|+...........++|+
T Consensus       115 ~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH-~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~  193 (328)
T d3bqca1         115 NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR  193 (328)
T ss_dssp             CSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCG
T ss_pred             CCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHh-hcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCc
Confidence               11222457899999999999999999999 89999999999999999777679999999998876666667788999


Q ss_pred             cccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC----Cc
Q 016085          224 YYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF----PQ  298 (395)
Q Consensus       224 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~----~~  298 (395)
                      .|+|||.+.+...++.++||||+||++|+|++|+.||... +..++...+.+.+|.+....+...........+    ..
T Consensus       194 ~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~  273 (328)
T d3bqca1         194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR  273 (328)
T ss_dssp             GGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCC
T ss_pred             cccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhccc
Confidence            9999999988777899999999999999999999999754 455677777777776554433221111000000    00


Q ss_pred             ccCCCccc----ccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCC
Q 016085          299 IKAHPWHK----IFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  348 (395)
Q Consensus       299 ~~~~~~~~----~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~  348 (395)
                      .....+..    .....+++++.|||++||++||++|+|+.|+|+||||+.+.+
T Consensus       274 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         274 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             ccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            01111111    122347889999999999999999999999999999998865

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-53  Score=401.52  Aligned_cols=255  Identities=26%  Similarity=0.416  Sum_probs=185.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCce------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++...     .....+|+.+|+.++||||                  
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            45799999999999999999999999999999998643     2345689999999999998                  


Q ss_pred             --------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCccc
Q 016085          147 --------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       147 --------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                              .+......+++..++.++.||+.||.|||+.+||+||||||+||||+.++ .+||+|||+|+..... ...+
T Consensus        85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~-~~~~  162 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MANS  162 (322)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH-TC--
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccccCCC-cccc
Confidence                    11223457899999999999999999999325999999999999999888 6999999999876443 2346


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhhcCC-----CCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNP-----NYT  292 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~-----~~~  292 (395)
                      .+||+.|+|||++.+.. |+.++||||+||++|||++|+.||.+.+..+. ...+....+.+..........     .+.
T Consensus       163 ~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T d1s9ja_         163 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG  241 (322)
T ss_dssp             -CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred             ccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence            78999999999998865 99999999999999999999999988664432 222222222221111000000     000


Q ss_pred             cccCCc---------ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          293 EFKFPQ---------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       293 ~~~~~~---------~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                      ....+.         .............+|.++.+||.+||++||++|||+.|+|+||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence            000000         0000001111223688999999999999999999999999999998653

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=385.56  Aligned_cols=257  Identities=34%  Similarity=0.560  Sum_probs=208.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCce------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNV------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni------------------  146 (395)
                      ++|++++.||+|+||+||+|+++.+++.||||+++..      .....+|+.+|+.++|+||                  
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            3799999999999999999999999999999998543      2345689999999999998                  


Q ss_pred             --------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-cc
Q 016085          147 --------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NI  217 (395)
Q Consensus       147 --------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-~~  217 (395)
                              .+....+.+++..++.++.|++.||+||| ++||+||||||+|||++.++ .+||+|||.|+....... ..
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH-~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCCSCCC
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhh-cCCEeeecccCcccccccCC-ceeeeecchhhcccCCCccce
Confidence                    12245678899999999999999999999 88999999999999999887 699999999987654432 33


Q ss_pred             cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 016085          218 SYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  296 (395)
Q Consensus       218 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  296 (395)
                      ...+++.|+|||++.+...++.++|||||||++|||++|+.| |.+.+..+++..+....+.+....+............
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            456688999999998776689999999999999999999987 4666777788888888888876655433221111122


Q ss_pred             CcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          297 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       297 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                      +..............+++.+.+||++||++||.+||||.|+|+||||+++.+|
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence            22222222333456688999999999999999999999999999999987653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=393.90  Aligned_cols=293  Identities=34%  Similarity=0.619  Sum_probs=219.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+..     ....+|+.+|+.|+|+||.                  
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            46999999999999999999999999999999986432     2345799999999999971                  


Q ss_pred             ---e--------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--
Q 016085          148 ---Y--------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--  214 (395)
Q Consensus       148 ---~--------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--  214 (395)
                         +        ......+++..++.++.||+.||+||| ++|||||||||+|||++.++ .+||+|||+|+......  
T Consensus        88 l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH-~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~~~~~  165 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDH  165 (345)
T ss_dssp             EEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGCB
T ss_pred             EEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCCCcceEEECCCC-CEEEcccCceeeccCCCcc
Confidence               0        012357899999999999999999999 88999999999999999888 69999999997654332  


Q ss_pred             --CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC-
Q 016085          215 --PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY-  291 (395)
Q Consensus       215 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-  291 (395)
                        .....+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..++...+....+.+............ 
T Consensus       166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T d1pmea_         166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA  245 (345)
T ss_dssp             CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence              23456789999999998666668999999999999999999999999999999999998888888776543221100 


Q ss_pred             --ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCCCCCCCCCCCCCCCCChhh
Q 016085          292 --TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQE  369 (395)
Q Consensus       292 --~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (395)
                        .....+......+.. ....+++++.+||.+||++||.+|||+.|+|+||||+....+......    .....+ ..+
T Consensus       246 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~----~~~~~~-~~~  319 (345)
T d1pmea_         246 RNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA----EAPFKF-DME  319 (345)
T ss_dssp             HHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCC----SSCC------
T ss_pred             hcccccCCccCCCCHHH-hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccc----cCccCC-Chh
Confidence              001122222222222 234578999999999999999999999999999999987765433211    122233 245


Q ss_pred             hccCCHHHHHhhchHHHhhhCC
Q 016085          370 LKGASKELLSKLIPEHARKQCP  391 (395)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~  391 (395)
                      .....++.+..++-+++.+-.|
T Consensus       320 ~~~~~~~~l~~l~~~e~~~~~~  341 (345)
T d1pmea_         320 LDDLPKEKLKELIFEETARFQP  341 (345)
T ss_dssp             ---CCHHHHHHHHHHHSGGGST
T ss_pred             hhhCCHHHHHHHHHHHHHhcCC
Confidence            5567777777777776666555

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=388.36  Aligned_cols=255  Identities=31%  Similarity=0.477  Sum_probs=200.1

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE----------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH----------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~----------------  147 (395)
                      .++|++++.||+|+||+||+|++..+|+.||||++....      ....+|+.+|+.++|+|+.                
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            468999999999999999999999999999999985432      3346899999999999980                


Q ss_pred             ------------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          148 ------------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       148 ------------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                                        .......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|+.
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH-~~~ivHrDlKp~NILl~~~~-~~kl~dfg~~~~  166 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-RNKILHRDMKAANVLITRDG-VLKLADFGLARA  166 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhc-cCCEEecCcCchheeecCCC-cEEeeecceeee
Confidence                              1123457889999999999999999999 88999999999999999988 699999999976


Q ss_pred             cccC-----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 016085          210 LVKG-----EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  284 (395)
Q Consensus       210 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  284 (395)
                      ....     ......+||+.|+|||++.+...|+.++|||||||++|||++|+.||.+.+....+..+.+..+.+..+.+
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            5422     12234678999999999987767999999999999999999999999999999999999999988876544


Q ss_pred             hhcCCCCccccCCccc--CCCcccc-cCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          285 KCMNPNYTEFKFPQIK--AHPWHKI-FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       285 ~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      ......-.........  ....... .....++++.|||.+||++||++|+|+.|+|+||||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            3322111111111000  0000000 011246788999999999999999999999999999753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.8e-52  Score=397.99  Aligned_cols=230  Identities=27%  Similarity=0.370  Sum_probs=185.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHH---HHHHHHhcCCCce-------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNV-------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~---E~~~l~~l~h~ni-------------  146 (395)
                      .++|++.++||+|+||+||+|+++.+|+.||||++.+..       ....+   |+.+++.++||||             
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            357999999999999999999999999999999986432       11223   4666777789998             


Q ss_pred             -------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC
Q 016085          147 -------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       147 -------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~  213 (395)
                                   .++.....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH-~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECSSS-CEEECCCTTCEECSSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHH-HCCccceeeccceeEEcCCC-cEEEeeeceeeecCCC
Confidence                         11123456889999999999999999999 88999999999999999888 5999999999876543


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                       .....+||+.|+|||++.+...|+.++|||||||++|+|+||+.||.+.+..+... +......               
T Consensus       161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~---------------  223 (364)
T d1omwa3         161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT---------------  223 (364)
T ss_dssp             -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSS---------------
T ss_pred             -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccc---------------
Confidence             34467899999999999765568999999999999999999999998765433322 2221100               


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCC-----HHHHhcCCcccCCCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRD  348 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  348 (395)
                                ....++..+|+++.+||.+||++||++|||     +.|+++||||+++.+
T Consensus       224 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         224 ----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             ----------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence                      001234458999999999999999999999     799999999998765

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.2e-51  Score=381.26  Aligned_cols=229  Identities=28%  Similarity=0.390  Sum_probs=194.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------------hhHHHHHHHHHhcC-CCce----------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNV----------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------------~~~~~E~~~l~~l~-h~ni----------  146 (395)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+..             ....+|+.+|+.++ ||||          
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            47999999999999999999999999999999986431             23457999999997 9998          


Q ss_pred             ----------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccc
Q 016085          147 ----------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  210 (395)
Q Consensus       147 ----------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~  210 (395)
                                      .++.....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+..
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~  160 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQL  160 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccccccceEEEcCCC-CeEEccchheeEc
Confidence                            11233567899999999999999999999 88999999999999999888 6999999999987


Q ss_pred             ccCCCcccccccccccccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 016085          211 VKGEPNISYICSRYYRAPELIFG-----ATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  285 (395)
Q Consensus       211 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  285 (395)
                      ..+......+||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+..+....+......++     
T Consensus       161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~-----  235 (277)
T d1phka_         161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG-----  235 (277)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----
T ss_pred             cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence            66666667889999999999853     33478899999999999999999999999988887777766211100     


Q ss_pred             hcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          286 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                                          ......+|+++++||.+||+.||++|||+.|+|+||||++.
T Consensus       236 --------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         236 --------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             --------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             --------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence                                01123479999999999999999999999999999999863

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=384.84  Aligned_cols=220  Identities=26%  Similarity=0.428  Sum_probs=183.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----------hhHHHHHHHHHhcC--CCce------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD--HPNV------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----------~~~~~E~~~l~~l~--h~ni------------  146 (395)
                      ++|++.++||+|+||+||+|++..+|+.||||++.+..          ....+|+.+|+.++  ||||            
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            47999999999999999999999999999999986432          22358999999997  8997            


Q ss_pred             ---------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          147 ---------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       147 ---------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                                     .+......+++..++.++.||+.||+||| ++||+||||||+|||++.+...+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH-~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccCcccceEEecCCCeEEECccccceecc
Confidence                           01123467899999999999999999999 88999999999999998765579999999998654


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          212 KGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                      . ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+      .+.+.                
T Consensus       163 ~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~----------------  219 (273)
T d1xwsa_         163 D-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG----------------  219 (273)
T ss_dssp             S-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC----------------
T ss_pred             c-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc----------------
Confidence            3 334567899999999999876656788999999999999999999997532      12220                


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  347 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~  347 (395)
                       .            ..++..+|+++.+||++||++||++|||+.|+|+||||+++.
T Consensus       220 -~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 -Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             -C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -c------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence             0            013445899999999999999999999999999999998764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-51  Score=391.87  Aligned_cols=256  Identities=36%  Similarity=0.609  Sum_probs=206.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch------hhHHHHHHHHHhcCCCceE-----e-----------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVH-----Y-----------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~~l~~l~h~ni~-----~-----------  148 (395)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..      ....+|+.+|+.++|+|+.     +           
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            47999999999999999999999999999999986432      2345899999999999971     0           


Q ss_pred             --------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          149 --------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       149 --------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                    .....++++..++.++.||+.||+||| ++||+||||||+|||++.++ .+|++|||+|....  .
T Consensus        98 ~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH-~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~~~--~  173 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTD--D  173 (348)
T ss_dssp             CEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECCC----CCT--G
T ss_pred             EEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHH-hCCCcccccCCccccccccc-cccccccchhcccC--c
Confidence                          112457999999999999999999999 88999999999999999888 59999999997653  3


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc-
Q 016085          215 PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-  293 (395)
Q Consensus       215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-  293 (395)
                      ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......|.+..+.+..+........... 
T Consensus       174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  253 (348)
T d2gfsa1         174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  253 (348)
T ss_dssp             GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred             ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence            3445778999999999888776899999999999999999999999999999999999999998887765433211100 


Q ss_pred             --ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCCCC
Q 016085          294 --FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  351 (395)
Q Consensus       294 --~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  351 (395)
                        ...+......+.. ....+++++.+||++||++||++|+|+.|+|+||||+++.++..
T Consensus       254 ~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~  312 (348)
T d2gfsa1         254 YIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  312 (348)
T ss_dssp             HHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred             hhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence              0111122222221 22457899999999999999999999999999999999877654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=389.33  Aligned_cols=229  Identities=28%  Similarity=0.416  Sum_probs=195.2

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCce--------------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNV--------------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~ni--------------------  146 (395)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++....   ....+|+.+|+.++||||                    
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            357999999999999999999999999999999997543   345689999999999998                    


Q ss_pred             ------Eeec-cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC-CceEEeecCCccccccCCCccc
Q 016085          147 ------HYSR-ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT-HQVKLCDFGSAKVLVKGEPNIS  218 (395)
Q Consensus       147 ------~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~-~~ikl~DFG~a~~~~~~~~~~~  218 (395)
                            .++. ....+++..++.++.||+.||+||| ++||+||||||+|||++.++ ..+||+|||+++..........
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH-~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~  162 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL  162 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence                  0111 2346899999999999999999999 88999999999999997543 3699999999988765555566


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      .++|+.|+|||.+.+.. |+.++|||||||++|+|++|..||.+.+..+.+..|.+....++..                
T Consensus       163 ~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~----------------  225 (321)
T d1tkia_         163 LFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE----------------  225 (321)
T ss_dssp             EESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH----------------
T ss_pred             cccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh----------------
Confidence            78899999999997755 8999999999999999999999999999888888887643222222                


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccC
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  345 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~  345 (395)
                               ....+|+++.+||.+||++||++|||+.|+|+||||++
T Consensus       226 ---------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         226 ---------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ---------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ---------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                     22347899999999999999999999999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-51  Score=387.30  Aligned_cols=226  Identities=28%  Similarity=0.506  Sum_probs=189.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHH-HhcCCCce----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTM-RLLDHPNV----------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l-~~l~h~ni----------------  146 (395)
                      ++|++.++||+|+||+||+|+++.+|+.||||++.+..       ....+|..++ +.++||||                
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46999999999999999999999999999999996532       2234566655 47899998                


Q ss_pred             ----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccC-CC
Q 016085          147 ----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP  215 (395)
Q Consensus       147 ----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~-~~  215 (395)
                                .+......+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+..... ..
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH-~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTCC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCcccceeecCCC-ceeccccchhhhccccccc
Confidence                      11223467899999999999999999999 88999999999999999888 5999999999876443 33


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..|...  .+                
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~----------------  220 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP----------------  220 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC----------------
T ss_pred             ccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC----------------
Confidence            44578999999999998765 899999999999999999999999998887777766541  11                


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHH-HHhcCCcccCCCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL-EACIHPFFDELRD  348 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~-e~l~hp~f~~~~~  348 (395)
                                 .++..+|+++.+||++||++||++|||+. ++++||||+++.+
T Consensus       221 -----------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         221 -----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             -----------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence                       12345799999999999999999999995 8999999998754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=389.12  Aligned_cols=256  Identities=32%  Similarity=0.540  Sum_probs=196.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCceEe----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVHY----------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni~~----------------  148 (395)
                      .+|+++++||+|+||+||+|+++.+|+.||||++.+.      .....+|+.+|+.++||||..                
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            4699999999999999999999999999999998643      223568999999999999810                


Q ss_pred             -------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 -------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 -------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                   ......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+|++|||+++.......
T Consensus        97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH-~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~~~~~~  174 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFM  174 (355)
T ss_dssp             EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCCCC---------
T ss_pred             eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhh-hcccccccCCcccccccccc-ceeeechhhhhccccccc
Confidence                         112356899999999999999999999 88999999999999999888 599999999988776666


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....++|+.|+|||++.+.. ++.++||||+||++|+|++|++||.+.+...+...++...+.+..+.+......+..+.
T Consensus       175 ~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  253 (355)
T d2b1pa1         175 MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV  253 (355)
T ss_dssp             ------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHH
T ss_pred             cccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHh
Confidence            66778999999999998754 99999999999999999999999999999999999999999988887764432211100


Q ss_pred             --CCcccCCCcc-----------cccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCCCCC
Q 016085          296 --FPQIKAHPWH-----------KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  349 (395)
Q Consensus       296 --~~~~~~~~~~-----------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  349 (395)
                        .+......+.           .......++++.+||++||++||++||||+|+|+||||+...++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~  320 (355)
T d2b1pa1         254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  320 (355)
T ss_dssp             HTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             hcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence              0000001110           01112246789999999999999999999999999999987654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-50  Score=381.73  Aligned_cols=233  Identities=27%  Similarity=0.381  Sum_probs=183.7

Q ss_pred             ccceeeee-eeccCCceEEEEEEEcCCCcEEEEEEeecchhhHHHHHHHHHh-cCCCceE--------------------
Q 016085           90 TISYMAER-VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-LDHPNVH--------------------  147 (395)
Q Consensus        90 ~~~y~~~~-~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~~l~~-l~h~ni~--------------------  147 (395)
                      .++|.+.. +||+|+||+||+|+++.+++.||||++.+. ....+|+.++.+ ++||||.                    
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm   88 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM   88 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence            45798875 699999999999999999999999998654 446689988654 5899980                    


Q ss_pred             ----------eec--cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC--CceEEeecCCccccccC
Q 016085          148 ----------YSR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVLVKG  213 (395)
Q Consensus       148 ----------~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~--~~ikl~DFG~a~~~~~~  213 (395)
                                +..  ....+++..++.++.||+.||+||| +.||+||||||+|||++.+.  ..+||+|||+|+.....
T Consensus        89 Ey~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH-~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1          89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             ECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             ECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH-HcCCccccccccccccccccccccccccccceeeeccCC
Confidence                      011  1246899999999999999999999 88999999999999998532  25999999999987766


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 016085          214 EPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  293 (395)
Q Consensus       214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  293 (395)
                      ......+||+.|+|||++.+.. |+.++|||||||++|+|+||++||.+.+.......+.....             ...
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~-------------~~~  233 (335)
T d2ozaa1         168 NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-------------MGQ  233 (335)
T ss_dssp             CCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC-------------SCS
T ss_pred             CccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh-------------cCC
Confidence            6667788999999999997654 99999999999999999999999988765544443332110             011


Q ss_pred             ccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          294 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                      +.++.        .....+|+++.+||++||++||++|||+.|+|+||||.+.
T Consensus       234 ~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         234 YEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             SSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            11111        1123478999999999999999999999999999999653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.9e-49  Score=365.19  Aligned_cols=227  Identities=26%  Similarity=0.399  Sum_probs=180.0

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch-------hhHHHHHHHHHhcCCCceE---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVH---------------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~~l~~l~h~ni~---------------  147 (395)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.++.       ....+|+.+|+.++||||.               
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            357999999999999999999999999999999986432       2356899999999999981               


Q ss_pred             ---------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCcccccc
Q 016085          148 ---------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  212 (395)
Q Consensus       148 ---------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~  212 (395)
                                     +......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .++|+|||.++....
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH-~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTS-CEEECCCTTCEECC-
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHH-hCCccCccccCcccccCccc-cceeehhhhhhhhcc
Confidence                           1123457899999999999999999999 88999999999999999888 599999999876533


Q ss_pred             CC----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          213 GE----PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       213 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ..    .....+||+.|+|||++.+.. ++.++|||||||++|+|+||++||.+.+..+.+.+++.....++        
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~--------  234 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--------  234 (277)
T ss_dssp             ---------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG--------
T ss_pred             ccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC--------
Confidence            32    234567999999999997754 89999999999999999999999999888777777665211111        


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCccc
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  344 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~  344 (395)
                                       ......+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus       235 -----------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 -----------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             -----------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -----------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                             123345899999999999999999999655556677753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.6e-48  Score=359.69  Aligned_cols=226  Identities=21%  Similarity=0.306  Sum_probs=181.8

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE------------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      ...+|++.+.||+|+||+||+|+++.+++.||||++..+   ...+.+|+.+|+.++||||.                  
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            345799999999999999999999999999999998654   34566899999999999980                  


Q ss_pred             --------e--eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc-
Q 016085          148 --------Y--SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-  216 (395)
Q Consensus       148 --------~--~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~-  216 (395)
                              +  ......+++..+..++.||+.||+||| ++||+||||||+||||+.++ .+||+|||+|+........ 
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~~~~~~~  172 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTA  172 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCCSSSSEE
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH-HCCcccCccccCeEEECCCC-cEEEccccceeecCCCCcee
Confidence                    0  123457899999999999999999999 88999999999999999888 6999999999876443322 


Q ss_pred             -ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          217 -ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       217 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                       ....||+.|+|||++.+.. |+.++|||||||++|||++|..||........+..++....                  
T Consensus       173 ~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~------------------  233 (287)
T d1opja_         173 HAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------------  233 (287)
T ss_dssp             ETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC------------------
T ss_pred             eccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC------------------
Confidence             2345789999999997765 99999999999999999997666655554454444443100                  


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcCCcccCC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  346 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~hp~f~~~  346 (395)
                               ...++..+++++.+||.+||+.||++|||+.++++  +|+.+
T Consensus       234 ---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         234 ---------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             ---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                     01133457999999999999999999999999975  45443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-48  Score=356.48  Aligned_cols=224  Identities=23%  Similarity=0.294  Sum_probs=177.6

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCce----------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNV----------------  146 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni----------------  146 (395)
                      ..++|++.+.||+|+||+||+|+.   +..||||+++..      ...+.+|+.+|++++||||                
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEE
Confidence            345799999999999999999974   346999998532      2445689999999999998                


Q ss_pred             ---------Eee-ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC--
Q 016085          147 ---------HYS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--  214 (395)
Q Consensus       147 ---------~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~--  214 (395)
                               .+. .....+++..+..++.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+......  
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH-~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEETTS-SEEECCCCCSCC-------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh-cCCEeccccCHHHEEEcCCC-CEEEccccceeeccccCCc
Confidence                     111 23456899999999999999999999 78999999999999999888 69999999998764332  


Q ss_pred             -CcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          215 -PNISYICSRYYRAPELIFGA--TEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       215 -~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                       ......||+.|||||++.+.  ..|+.++|||||||+||||+||+.||.+.+....+..+......++.          
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~----------  230 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD----------  230 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC----------
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc----------
Confidence             23356789999999998643  23789999999999999999999999998877776665543211110          


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                   ...++..+++++.+||.+||+.||++|||+.+++++
T Consensus       231 -------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         231 -------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             -------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                         112345578999999999999999999999999876

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=369.37  Aligned_cols=232  Identities=28%  Similarity=0.437  Sum_probs=186.4

Q ss_pred             ccceeeeeeeccCCceEEEEEEEc---CCCcEEEEEEeecc--------hhhHHHHHHHHHhcCC-Cce-----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLLDH-PNV-----------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~--------~~~~~~E~~~l~~l~h-~ni-----------  146 (395)
                      .++|++++.||+|+||+||+|++.   .+|+.||||++.+.        .....+|+++|++++| |||           
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            467999999999999999999874   47899999988532        2345589999999988 687           


Q ss_pred             ---------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          147 ---------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       147 ---------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                                     .+......+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|+...
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH-~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEESCSSEEEECC
T ss_pred             ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhh-cCCEEeccCCccceeecCCC-CEEEeeccchhhhc
Confidence                           11123456788999999999999999999 88999999999999999887 69999999998764


Q ss_pred             cCC--CcccccccccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          212 KGE--PNISYICSRYYRAPELIFGAT-EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       212 ~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      ...  ......||+.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+.....         
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~---------  251 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---------  251 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC---------
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC---------
Confidence            332  234567899999999997543 47889999999999999999999998876655555554421000         


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCC-----CHHHHhcCCcccCCCC
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  348 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  348 (395)
                                      ...++..+++++.+||.+||++||++|+     |+.|+|+||||+.+.+
T Consensus       252 ----------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         252 ----------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             ----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             ----------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence                            0013345799999999999999999999     5899999999998764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.5e-47  Score=366.14  Aligned_cols=259  Identities=29%  Similarity=0.465  Sum_probs=197.0

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch---hhHHHHHHHHHhcCCCc-----------e-------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPN-----------V-------  146 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~~l~~l~h~n-----------i-------  146 (395)
                      ...++|+++++||+|+||+||+|+++.+|+.||||+++++.   ....+|+.+++.++|+|           |       
T Consensus        10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            34457999999999999999999999999999999997653   34467999999987755           3       


Q ss_pred             ------------------------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCC-----
Q 016085          147 ------------------------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-----  197 (395)
Q Consensus       147 ------------------------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~-----  197 (395)
                                              ........+++..++.++.||+.||+|||+..||+||||||+||||+.++.     
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence                                    001234678899999999999999999995489999999999999986543     


Q ss_pred             ceEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------cHHHHHH
Q 016085          198 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGES------GVDQLVE  271 (395)
Q Consensus       198 ~ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~  271 (395)
                      .++|+|||.+.....  .....+||+.|+|||++.+.. ++.++||||+||++++|++|+.||....      ..+.+..
T Consensus       170 ~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         170 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeeEeeccccccccc--ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            499999999976533  334578899999999998755 8999999999999999999999997543      3467788


Q ss_pred             HHHHhCCCCHHHHhhcCCCC-------ccccCCcccCCCccc------ccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          272 IIKVLGTPTREEIKCMNPNY-------TEFKFPQIKAHPWHK------IFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       272 i~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                      ++..+|.++...+.......       ............+..      .+....++.+.|||.+||++||.+|||+.|+|
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            88889988877654322100       000111111111110      11223467899999999999999999999999


Q ss_pred             cCCcccCCCCC
Q 016085          339 IHPFFDELRDP  349 (395)
Q Consensus       339 ~hp~f~~~~~~  349 (395)
                      +||||+++...
T Consensus       327 ~Hp~f~~~~~~  337 (362)
T d1q8ya_         327 NHPWLKDTLGM  337 (362)
T ss_dssp             TCGGGTTCTTC
T ss_pred             cCcccCCCCCc
Confidence            99999976443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=354.91  Aligned_cols=225  Identities=23%  Similarity=0.316  Sum_probs=181.1

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE----------------e-
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH----------------Y-  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~----------------~-  148 (395)
                      ...+|++.+.||+|+||+||+|+++ +++.||||++...   ...+.+|+.+|++++||||.                + 
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~   89 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYM   89 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeC
Confidence            3457999999999999999999974 5788999998653   34467899999999999981                0 


Q ss_pred             ----------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--c
Q 016085          149 ----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--N  216 (395)
Q Consensus       149 ----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--~  216 (395)
                                ......+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+|+.......  .
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH-~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~~~~~~~  167 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAR  167 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEECC
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCccchhheeeeccc-ceeeccccceEEccCCccccc
Confidence                      011235788999999999999999999 88999999999999999887 699999999987654332  2


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....||+.|+|||++.+.. ++.++|||||||++|||+|| .+||...+..+.+..+....                   
T Consensus       168 ~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-------------------  227 (272)
T d1qpca_         168 EGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-------------------  227 (272)
T ss_dssp             TTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------------------
T ss_pred             cccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-------------------
Confidence            3456799999999997655 89999999999999999995 55666665555544443210                   


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc--CCcccC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFDE  345 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~--hp~f~~  345 (395)
                               ....+..+++++.+||.+||+.||++|||+.++++  |+||..
T Consensus       228 ---------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         228 ---------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                     01123457899999999999999999999999998  788854

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-47  Score=349.46  Aligned_cols=218  Identities=19%  Similarity=0.312  Sum_probs=169.3

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCce---------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNV---------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni---------------------  146 (395)
                      .+|++.+.||+|+||+||+|+++ +++.||||++...   ...+.+|+.+++.++||||                     
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            46999999999999999999975 5678999998653   3456789999999999998                     


Q ss_pred             -----E-eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--ccc
Q 016085          147 -----H-YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--NIS  218 (395)
Q Consensus       147 -----~-~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--~~~  218 (395)
                           . .......+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+|+.......  ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH-~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCTTCSGGGEEECGGG-CEEECSCC---------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh-ccceeecccchhheeecCCC-CeEecccchheeccCCCceeecc
Confidence                 0 1123456789999999999999999999 88999999999999999888 699999999987654332  224


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..||+.|+|||++.+.. |+.++|||||||++|||+| |.+||.+.+..+.+..+.....                    
T Consensus       162 ~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--------------------  220 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------------------  220 (263)
T ss_dssp             ---CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC--------------------
T ss_pred             eecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC--------------------
Confidence            56899999999997765 9999999999999999999 5677776666555555543100                    


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                              ...+...++++.+||.+||+.||++|||+.++++|
T Consensus       221 --------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         221 --------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                    01233468999999999999999999999999876

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-46  Score=353.24  Aligned_cols=219  Identities=25%  Similarity=0.320  Sum_probs=167.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCc---EEEEEEeecc-----hhhHHHHHHHHHhcCCCce----------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNV----------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~---~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni----------------  146 (395)
                      .+|++.++||+|+||+||+|+++.+++   .||||.+...     ...+.+|+.+|++++||||                
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            469999999999999999999987665   5899987542     2345689999999999998                


Q ss_pred             ----------E-eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          147 ----------H-YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       147 ----------~-~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                . .......+++..+..++.||+.||+||| ++||+||||||+||||+.++ .+||+|||+|+.......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA-DMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCC-----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh-hCCCccCccccceEEECCCC-cEEECCcccceEccCCCC
Confidence                      0 1122456899999999999999999999 88999999999999999888 699999999987643322


Q ss_pred             c------ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 016085          216 N------ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  288 (395)
Q Consensus       216 ~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  288 (395)
                      .      ....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+.+..+.....           
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~-----------  251 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR-----------  251 (299)
T ss_dssp             ------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred             cceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            1      1245689999999997755 9999999999999999998 8999998887766655543110           


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                       ...+..+++.+.+||.+||+.||++|||+.|++++
T Consensus       252 -----------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         252 -----------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                             01234578999999999999999999999998764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-47  Score=358.22  Aligned_cols=221  Identities=23%  Similarity=0.340  Sum_probs=178.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCCc-----EEEEEEeecc-----hhhHHHHHHHHHhc-CCCceE-----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVH-----------  147 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~-----~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~ni~-----------  147 (395)
                      .++|++.++||+|+||+||+|++..+++     .||+|.+...     .....+|+.+|+.+ +||||.           
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3579999999999999999999876554     6999988543     23456799999988 899980           


Q ss_pred             ------e---------ec-----------------------cCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCc
Q 016085          148 ------Y---------SR-----------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  189 (395)
Q Consensus       148 ------~---------~~-----------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~N  189 (395)
                            +         +.                       ....+++..++.++.||+.||+||| ++|||||||||+|
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH-~~~IiHRDlKp~N  194 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARN  194 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH-HTTEEETTCSGGG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCchhc
Confidence                  0         00                       0134788899999999999999999 8899999999999


Q ss_pred             eEEcCCCCceEEeecCCccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 016085          190 LLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESG  265 (395)
Q Consensus       190 ill~~~~~~ikl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~  265 (395)
                      ||++.++ .+||+|||+|+........   ....||+.|||||++.+.. |+.++|||||||++|||+| |++||.+.+.
T Consensus       195 ill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         195 VLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             EEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999887 6999999999876554432   2456799999999997755 9999999999999999997 8999998877


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          266 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       266 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      ...+.+++.....                           ...+..+|+++.+||.+||+.||++|||+.|+++|
T Consensus       273 ~~~~~~~~~~~~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         273 DANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             SHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCC---------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7777766552110                           01234578999999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-47  Score=346.59  Aligned_cols=218  Identities=20%  Similarity=0.275  Sum_probs=181.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE--------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH--------------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~--------------------  147 (395)
                      .+|++.++||+|+||+||+|++ ++++.||||++++.   ...+.+|+.++++++||||.                    
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            4799999999999999999997 47789999998753   45567899999999999980                    


Q ss_pred             -------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--ccc
Q 016085          148 -------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--NIS  218 (395)
Q Consensus       148 -------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--~~~  218 (395)
                             .......+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.......  ...
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH-~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH-HTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSSCCCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh-hcCcccccccceeEEEcCCC-cEEECcchhheeccCCCceeecc
Confidence                   1123456788899999999999999999 88999999999999999887 699999999986644332  234


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 016085          219 YICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  297 (395)
Q Consensus       219 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  297 (395)
                      ..||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+...                    
T Consensus       161 ~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~--------------------  219 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------------------  219 (258)
T ss_dssp             SCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC--------------------
T ss_pred             cCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC--------------------
Confidence            56899999999998765 8999999999999999998 8999999887766665543110                    


Q ss_pred             cccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          298 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       298 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                              ...+...++.+.+||.+||+.||++|||+.++++|
T Consensus       220 --------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         220 --------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                    01234478899999999999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=350.58  Aligned_cols=224  Identities=25%  Similarity=0.313  Sum_probs=181.3

Q ss_pred             cceeeeee-eccCCceEEEEEEEcC--CCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCce----------------
Q 016085           91 ISYMAERV-VGQGSFGIVFQAKCLE--TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNV----------------  146 (395)
Q Consensus        91 ~~y~~~~~-lG~G~fg~V~~a~~~~--~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni----------------  146 (395)
                      ++|.+.+. ||+|+||+||+|.++.  ++..||||++...     ...+.+|+++|+.++||||                
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm   87 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM   87 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence            46888885 9999999999998764  4457999998643     2345689999999999998                


Q ss_pred             ---------Ee-eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC-
Q 016085          147 ---------HY-SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  215 (395)
Q Consensus       147 ---------~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~-  215 (395)
                               .+ ......+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+....... 
T Consensus        88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH-~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~  165 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSY  165 (285)
T ss_dssp             ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTTCSCE
T ss_pred             EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCcCchhheeeccCC-ceeeccchhhhcccccccc
Confidence                     11 123457899999999999999999999 88999999999999999887 699999999987644322 


Q ss_pred             ---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          216 ---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       216 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                         .....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+.+..|.+.  ..            
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~--~~------------  230 (285)
T d1u59a_         166 YTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--KR------------  230 (285)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--CC------------
T ss_pred             cccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CC------------
Confidence               22346789999999997655 8999999999999999998 99999988776665555331  00            


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHH---hcCCcccC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA---CIHPFFDE  345 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~---l~hp~f~~  345 (395)
                                    ..++..+|+++.+||.+||+.||++|||+.++   |+|+|+.-
T Consensus       231 --------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         231 --------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                          01345589999999999999999999999877   67888753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-47  Score=351.87  Aligned_cols=217  Identities=24%  Similarity=0.324  Sum_probs=173.9

Q ss_pred             eeeccCCceEEEEEEEc--CCCcEEEEEEeecc------hhhHHHHHHHHHhcCCCce----------------------
Q 016085           97 RVVGQGSFGIVFQAKCL--ETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNV----------------------  146 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~--~~~~~vAiK~~~~~------~~~~~~E~~~l~~l~h~ni----------------------  146 (395)
                      ++||+|+||+||+|.+.  .+++.||||++...      ...+.+|+.+|++++||||                      
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g   92 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG   92 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence            47999999999999764  45678999998543      2345689999999999998                      


Q ss_pred             ---EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc----ccc
Q 016085          147 ---HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN----ISY  219 (395)
Q Consensus       147 ---~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~----~~~  219 (395)
                         .+......+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+........    ...
T Consensus        93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH-~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC----
T ss_pred             cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHH-hCCcccCCCcchhhcccccC-cccccchhhhhhcccccccccccccc
Confidence               12234567899999999999999999999 88999999999999999887 6999999999876443321    234


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCc
Q 016085          220 ICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  298 (395)
Q Consensus       220 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (395)
                      .||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+.  ..                   
T Consensus       171 ~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~~-------------------  228 (277)
T d1xbba_         171 KWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ER-------------------  228 (277)
T ss_dssp             CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CC-------------------
T ss_pred             CCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--CC-------------------
Confidence            6799999999997755 8999999999999999997 89999988766555444321  00                   


Q ss_pred             ccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHH---hcCCccc
Q 016085          299 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA---CIHPFFD  344 (395)
Q Consensus       299 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~---l~hp~f~  344 (395)
                             ..++..+|+++.+||.+||+.||++|||+.++   |+|+|++
T Consensus       229 -------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         229 -------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                   01234578999999999999999999999988   4566654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=355.59  Aligned_cols=219  Identities=24%  Similarity=0.331  Sum_probs=175.4

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCc----EEEEEEeecc-----hhhHHHHHHHHHhcCCCce---------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNV---------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni---------------  146 (395)
                      .+|+++++||+|+||+||+|++..+|+    .||+|.+...     ...+.+|+.+|+.++||||               
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v   88 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   88 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence            369999999999999999999988876    5788877532     2345689999999999998               


Q ss_pred             -----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          147 -----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       147 -----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                 ........+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus        89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH-~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEETT-EEEECCCSHHHHTTTTCC
T ss_pred             EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH-HcCcccCcchhhcceeCCCC-CeEeeccccceecccccc
Confidence                       11123567899999999999999999999 78999999999999999887 699999999987654332


Q ss_pred             ---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          216 ---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       216 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                         .....||+.|+|||++.+.. |+.++|||||||++|||+| |.+||.+.+..+....+.+. ..+            
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-~~~------------  232 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERL------------  232 (317)
T ss_dssp             --------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-CCC------------
T ss_pred             cccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCC------------
Confidence               22346799999999998765 9999999999999999998 89999887766554444331 100            


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                     ..+..+++.+.+||.+||+.||++|||+.|+++|
T Consensus       233 ---------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         233 ---------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ---------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                           1234478999999999999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=343.99  Aligned_cols=218  Identities=22%  Similarity=0.259  Sum_probs=165.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCC----cEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE--------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETG----ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH--------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~----~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~--------------  147 (395)
                      ..|++.++||+|+||+||+|.++.++    ..||||++...     ...+.+|+.+|+.++||||.              
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            46999999999999999999987654    46999998543     22346899999999999980              


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                   .......+++..+..++.||+.||+||| ++||+||||||+||||+.++ .+||+|||+|+......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH-~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA-NMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCCCC--------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc-ccccccCccccceEEECCCC-eEEEcccchhhcccCCC
Confidence                         1123467899999999999999999999 88999999999999999888 69999999998764432


Q ss_pred             C----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          215 P----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       215 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      .    .....||+.|+|||++.+.. ++.++|||||||++|||++|..| |.+.+..+.+..+... .            
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~------------  230 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-F------------  230 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-C------------
T ss_pred             ccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-C------------
Confidence            2    22346799999999997755 99999999999999999996545 5444444433333221 0            


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                                     ....+..++..+.+||.+||+.||++|||+.|+++
T Consensus       231 ---------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         231 ---------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ---------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                           01123457899999999999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=345.93  Aligned_cols=220  Identities=29%  Similarity=0.388  Sum_probs=170.3

Q ss_pred             ccceeeeeeeccCCceEEEEEEEcCCC---cEEEEEEeecc-----hhhHHHHHHHHHhcCCCce---------------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNV---------------  146 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni---------------  146 (395)
                      .++|++.+.||+|+||.||+|++..++   ..||||.+...     .....+|+.+|+.++||||               
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv   85 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII   85 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEE
Confidence            357999999999999999999987543   46899988532     2335689999999999998               


Q ss_pred             -----------EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          147 -----------HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       147 -----------~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                 ........+++..++.++.||+.||+||| ++||+||||||+||+++.++ .+||+|||+|+.......
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH-~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECC------------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc-ccCeeccccchhheeecCCC-cEEEccchhheeccCCcc
Confidence                       01123456899999999999999999999 88999999999999999887 699999999987643322


Q ss_pred             --cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 016085          216 --NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  292 (395)
Q Consensus       216 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  292 (395)
                        .....||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+....                
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~----------------  226 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----------------  226 (273)
T ss_dssp             -------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----------------
T ss_pred             eeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence              23456799999999997655 8999999999999999998 899999888777666654310                


Q ss_pred             cccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          293 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                  ...++..+|+.+.+||.+||+.||++|||+.|+++|
T Consensus       227 ------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         227 ------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                        001345589999999999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-46  Score=344.32  Aligned_cols=228  Identities=25%  Similarity=0.319  Sum_probs=177.8

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCCCceE-----------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVH-----------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h~ni~-----------------  147 (395)
                      ...++|++.+.||+|+||+||+|+++.+ +.||||++...   ...+.+|+.+|++++|+||.                 
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey   92 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEY   92 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECC
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEe
Confidence            3456899999999999999999998655 57999998654   34567899999999999981                 


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                                .......+++..+..++.||+.||+||| +.||+||||||+||||+.++ .+||+|||+|+.......  
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH-~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCCCTTC---------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh-hhheecccccceEEEECCCC-cEEEcccchhhhccCCCcee
Confidence                      0011245899999999999999999999 88999999999999999887 699999999987643332  


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 016085          216 NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  294 (395)
Q Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  294 (395)
                      .....||+.|+|||++.+.. ++.++|||||||++|||++| .+||.+....+.+..+....                  
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~------------------  231 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------------  231 (285)
T ss_dssp             -----CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------------
T ss_pred             eccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------------------
Confidence            23456899999999997755 89999999999999999995 45555555555555443210                  


Q ss_pred             cCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc--CCcccCCC
Q 016085          295 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFDELR  347 (395)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~--hp~f~~~~  347 (395)
                                ....+..+++++.+||.+||+.||++|||+.++++  ++||....
T Consensus       232 ----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         232 ----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ----------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                      00123457899999999999999999999999988  88987653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-45  Score=342.04  Aligned_cols=220  Identities=25%  Similarity=0.364  Sum_probs=165.8

Q ss_pred             cceeeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhHHHHHHHHHhc-CCCceE------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVH------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~------------  147 (395)
                      ++|++.+.||+|+||+||+|++..     +++.||||++....     ....+|..++.++ +|+||.            
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            579999999999999999999754     44689999986432     2334566666666 577760            


Q ss_pred             ------e---------e----------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCC
Q 016085          148 ------Y---------S----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT  196 (395)
Q Consensus       148 ------~---------~----------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~  196 (395)
                            +         .                .....+++..+..++.||+.||+||| ++||+||||||+||||+.++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH-~~~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECGGG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH-hCCCcCCcCCccceeECCCC
Confidence                  0         0                01234788899999999999999999 88999999999999999888


Q ss_pred             CceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHH
Q 016085          197 HQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLG-QPLFPGESGVDQLVEI  272 (395)
Q Consensus       197 ~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i  272 (395)
                       .+||+|||+|+.......   .....||+.|+|||++.+.. ++.++|||||||++|||++| .+||.+.+..+.+..+
T Consensus       172 -~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         172 -VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             -CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             -cEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             699999999986543322   23457899999999998755 89999999999999999986 5789887766666555


Q ss_pred             HHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          273 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      +.....+                           .++..+++++.+||.+||+.||++|||+.|+++|
T Consensus       250 ~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         250 LKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5421111                           1234478999999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-45  Score=343.50  Aligned_cols=229  Identities=22%  Similarity=0.277  Sum_probs=178.6

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCCCce----------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNV----------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~ni----------------------  146 (395)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...  .....+|+++++.++|+|+                      
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~   86 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG   86 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence            4699999999999999999999999999999987643  3456789999999988774                      


Q ss_pred             -----EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC--CCceEEeecCCccccccCCC----
Q 016085          147 -----HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH--THQVKLCDFGSAKVLVKGEP----  215 (395)
Q Consensus       147 -----~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~--~~~ikl~DFG~a~~~~~~~~----  215 (395)
                           ........+++..+..++.|++.||+||| ++||+||||||+|||++..  ...+||+|||+|+.......    
T Consensus        87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~  165 (299)
T d1ckia_          87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI  165 (299)
T ss_dssp             CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBC
T ss_pred             CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccce
Confidence                 11123567899999999999999999999 8899999999999998642  23699999999987654322    


Q ss_pred             ----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC---CCCHHHHhhcC
Q 016085          216 ----NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG---TPTREEIKCMN  288 (395)
Q Consensus       216 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~  288 (395)
                          ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+.....   .++        
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--------  236 (299)
T d1ckia_         166 PYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--------  236 (299)
T ss_dssp             CCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC--------
T ss_pred             eccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC--------
Confidence                23457899999999998755 99999999999999999999999987665544433322110   000        


Q ss_pred             CCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHH---HHhcCCcccC
Q 016085          289 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL---EACIHPFFDE  345 (395)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~---e~l~hp~f~~  345 (395)
                                      ...+...+|+++.+||.+||+.||++||++.   ++|+|+|.+.
T Consensus       237 ----------------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         237 ----------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ----------------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                            0112345789999999999999999999986   4577877543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-45  Score=342.84  Aligned_cols=219  Identities=24%  Similarity=0.298  Sum_probs=175.7

Q ss_pred             ccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecc-----hhhHHHHHHHHHhcCCCceEe-----------
Q 016085           90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVHY-----------  148 (395)
Q Consensus        90 ~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~~-----------  148 (395)
                      .++|++.+.||+|+||+||+|+.+     .+++.||||++...     ...+.+|+.+|+.++|+||..           
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            347999999999999999999875     35678999998643     234578999999999999800           


Q ss_pred             ---------------------------------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCc
Q 016085          149 ---------------------------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  189 (395)
Q Consensus       149 ---------------------------------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~N  189 (395)
                                                             ......+++..+..++.||+.||+||| ++|||||||||+|
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH-~~~ivHrDlKp~N  170 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRN  170 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc-cCCeEeeEEcccc
Confidence                                                   001224788889999999999999999 8899999999999


Q ss_pred             eEEcCCCCceEEeecCCccccccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCc
Q 016085          190 LLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESG  265 (395)
Q Consensus       190 ill~~~~~~ikl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~  265 (395)
                      |||+.++ .+||+|||+|+......   ......+|+.|+|||.+.+.. |+.++|||||||++|||++|. +||.+.+.
T Consensus       171 ILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         171 CLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             EEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             eEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            9999887 59999999998654332   223456789999999998755 999999999999999999985 78888877


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          266 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       266 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      .+.+..+.+..                   .+         .++..+++++.+||.+||+.||++|||+.|+++
T Consensus       249 ~e~~~~v~~~~-------------------~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         249 EEVIYYVRDGN-------------------IL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHTTC-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCC-------------------CC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            77666554310                   00         124457899999999999999999999999863

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=339.59  Aligned_cols=218  Identities=25%  Similarity=0.333  Sum_probs=169.9

Q ss_pred             cceeeeeeeccCCceEEEEEEEcC-CC--cEEEEEEeecc-------hhhHHHHHHHHHhcCCCceE-------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLE-TG--ETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVH-------------  147 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~-~~--~~vAiK~~~~~-------~~~~~~E~~~l~~l~h~ni~-------------  147 (395)
                      .+|++.+.||+|+||.||+|+... ++  ..||||++.+.       ...+.+|+.+|+.++||||.             
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l   87 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM   87 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence            479999999999999999998653 33  36899987542       23456899999999999980             


Q ss_pred             -------------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCC
Q 016085          148 -------------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  214 (395)
Q Consensus       148 -------------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~  214 (395)
                                   .......+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+++......
T Consensus        88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH-~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQND  165 (273)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCC-C
T ss_pred             eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh-hCCEeeeeecHHHhcccccc-ceeeccchhhhhcccCC
Confidence                         1112346899999999999999999999 88999999999999999887 79999999998764443


Q ss_pred             Cc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 016085          215 PN----ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  289 (395)
Q Consensus       215 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  289 (395)
                      ..    ....||..|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+.+..+.+....           
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~-----------  233 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-----------  233 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-----------
T ss_pred             CcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC-----------
Confidence            21    2345688999999998755 8999999999999999998 89999999888877766542100           


Q ss_pred             CCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          290 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                                      ...+..+|+.+.+||.+||+.||++|||+.+++
T Consensus       234 ----------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         234 ----------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ----------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                            012345789999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-45  Score=333.54  Aligned_cols=218  Identities=23%  Similarity=0.351  Sum_probs=172.1

Q ss_pred             ccccceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCCCceE------------------
Q 016085           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        88 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      ...++|++.++||+|+||.||+|++  +|..||||+++++  .+.+.+|++++++++||||.                  
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            3445799999999999999999998  5788999999765  34567899999999999981                  


Q ss_pred             ---------ee--ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCCc
Q 016085          148 ---------YS--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  216 (395)
Q Consensus       148 ---------~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~~  216 (395)
                               +.  .....+++..++.++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||+++.....  .
T Consensus        82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH-~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~~--~  157 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--Q  157 (262)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTS-CEEECCCCC----------
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc-cCceeccccchHhheecCCC-CEeecccccceecCCC--C
Confidence                     00  11124788889999999999999999 78999999999999999988 5999999999875332  3


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 016085          217 ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  295 (395)
Q Consensus       217 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  295 (395)
                      ....+|..|+|||++.+.. ++.++|||||||++|||+| |++||.+.+..+....|.+.                    
T Consensus       158 ~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~--------------------  216 (262)
T d1byga_         158 DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------------  216 (262)
T ss_dssp             ----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------------------
T ss_pred             ccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------------------
Confidence            3456789999999998765 8999999999999999998 78999887776665554321                    


Q ss_pred             CCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          296 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       296 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                              ....++..+++++.+||.+||..||++|||+.+++++
T Consensus       217 --------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         217 --------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                    0112344578999999999999999999999999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=332.83  Aligned_cols=220  Identities=22%  Similarity=0.336  Sum_probs=170.3

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCC-------cEEEEEEeecch-----hhHHHHHHHHHhc-CCCceE--------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETG-------ETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVH--------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~-------~~vAiK~~~~~~-----~~~~~E~~~l~~l-~h~ni~--------  147 (395)
                      ..++|++.+.||+|+||.||+|++..++       ..||||++.++.     ....+|...+.++ +||||.        
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            3458999999999999999999986654       379999986542     3344677888777 899980        


Q ss_pred             ------------------ee----------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc
Q 016085          148 ------------------YS----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  193 (395)
Q Consensus       148 ------------------~~----------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~  193 (395)
                                        ++                .....+++..+..++.||+.||+||| +.|||||||||+|||++
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH-~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEC
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh-hCCEEeeeecccceeec
Confidence                              00                11245899999999999999999999 88999999999999999


Q ss_pred             CCCCceEEeecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016085          194 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQL  269 (395)
Q Consensus       194 ~~~~~ikl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  269 (395)
                      .++ .+||+|||+++.......   .....+|+.|+|||.+.+.. |+.++|||||||++|||++ |.+||.+.+..+..
T Consensus       170 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         170 EDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             TTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             CCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence            888 699999999987654432   33467899999999997755 9999999999999999998 79999887765544


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          270 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       270 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ..+.. ...                           ..++..+++++.+||.+||++||++|||+.|+++
T Consensus       248 ~~i~~-~~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         248 KLLKE-GHR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHT-TCC---------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHc-CCC---------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            33322 000                           0123457899999999999999999999999985

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-44  Score=337.68  Aligned_cols=221  Identities=21%  Similarity=0.266  Sum_probs=177.4

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcCCCcE--EEEEEeecc-----hhhHHHHHHHHHhc-CCCceEe------------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQD-----KRYKNRELQTMRLL-DHPNVHY------------  148 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~--vAiK~~~~~-----~~~~~~E~~~l~~l-~h~ni~~------------  148 (395)
                      ..++|++.++||+|+||+||+|+++.+|..  ||||.+...     .....+|+++|+.+ +||||..            
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            446899999999999999999999888874  677876432     23456899999998 7999800            


Q ss_pred             ------------------------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCc
Q 016085          149 ------------------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ  198 (395)
Q Consensus       149 ------------------------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~  198 (395)
                                                    ......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH-~~~iiHrDlkp~NIL~~~~~-~  165 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENY-V  165 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECGGG-C
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh-cCCccccccccceEEEcCCC-c
Confidence                                          012356899999999999999999999 88999999999999999887 6


Q ss_pred             eEEeecCCccccccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhC
Q 016085          199 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLG  277 (395)
Q Consensus       199 ikl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~  277 (395)
                      +||+|||+|+............||..|+|||.+.+.. ++.++|||||||++|||++|. +||.+.+..+.+..+.+.  
T Consensus       166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~--  242 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG--  242 (309)
T ss_dssp             EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT--
T ss_pred             eEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc--
Confidence            9999999998765555555667899999999997755 899999999999999999965 678777765555444321  


Q ss_pred             CCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          278 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                      .                          ...++..+++++.+||.+||+.||++|||+.|+++|
T Consensus       243 ~--------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 Y--------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             C--------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C--------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            0                          011234578999999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=334.35  Aligned_cols=227  Identities=24%  Similarity=0.303  Sum_probs=181.3

Q ss_pred             cccceeeeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhHHHHHHHHHhcCCCceE-----------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVH-----------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~-----~~~~~E~~~l~~l~h~ni~-----------  147 (395)
                      ..++|++.+.||+|+||+||+|+++.     ++..||||++....     ..+.+|+.++++++|+||.           
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            34579999999999999999998753     45789999986432     2346899999999999980           


Q ss_pred             ----ee---------------------ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEe
Q 016085          148 ----YS---------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  202 (395)
Q Consensus       148 ----~~---------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~  202 (395)
                          ..                     .....+++..+..++.|++.||.||| +++|+||||||+|||++.++ .+||+
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH-~~~ivHrDlk~~NiLld~~~-~~Kl~  175 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDF-TVKIG  175 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCSGGGEEECTTC-CEEEC
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh-hCCeeeceEcCCceeecCCc-eEEEe
Confidence                00                     01123577788899999999999999 78999999999999999888 69999


Q ss_pred             ecCCccccccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCC
Q 016085          203 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGT  278 (395)
Q Consensus       203 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~  278 (395)
                      |||+|+.......   .....+|+.|+|||.+.+.. ++.++|||||||++|||+|| .+||.+.+..+.+..+.+..  
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~--  252 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG--  252 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC--
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC--
Confidence            9999987644322   23346799999999998765 89999999999999999998 58888887777666654310  


Q ss_pred             CCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc------CCcccCC
Q 016085          279 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI------HPFFDEL  346 (395)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~------hp~f~~~  346 (395)
                                       .         ...+..+++.+.+||.+||+.||++|||+.++++      +|+|+++
T Consensus       253 -----------------~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         253 -----------------L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             -----------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             -----------------C---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence                             0         0123457899999999999999999999999987      6666543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3e-43  Score=329.14  Aligned_cols=222  Identities=19%  Similarity=0.247  Sum_probs=175.0

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc--hhhHHHHHHHHHhcCC-Cce---------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDH-PNV---------------------  146 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~--~~~~~~E~~~l~~l~h-~ni---------------------  146 (395)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...  .....+|+++++.|.| +|+                     
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~   84 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG   84 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecC
Confidence            4799999999999999999999999999999988543  3446789999999977 565                     


Q ss_pred             -----EeeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCC----CCceEEeecCCccccccCC---
Q 016085          147 -----HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH----THQVKLCDFGSAKVLVKGE---  214 (395)
Q Consensus       147 -----~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~----~~~ikl~DFG~a~~~~~~~---  214 (395)
                           ........++...+..++.|++.||+||| ++||+||||||+|||++..    .+.+||+|||+|+......   
T Consensus        85 ~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH-~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (293)
T d1csna_          85 PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ  163 (293)
T ss_dssp             CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred             CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH-HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcccc
Confidence                 01123457899999999999999999999 8999999999999999742    2369999999998764321   


Q ss_pred             -----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCCHHHHhh
Q 016085          215 -----PNISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKC  286 (395)
Q Consensus       215 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~  286 (395)
                           .....+||+.|||||++.+.. ++.++|||||||++|||++|+.||.+.....   ....+......++.     
T Consensus       164 ~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-----  237 (293)
T d1csna_         164 HIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-----  237 (293)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH-----
T ss_pred             ceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh-----
Confidence                 123467999999999998755 9999999999999999999999998754332   23333322111111     


Q ss_pred             cCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHh
Q 016085          287 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  338 (395)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l  338 (395)
                                         ..+...+|+++.+|+..|+..+|++||+...+.
T Consensus       238 -------------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         238 -------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             -------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             -------------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence                               112345789999999999999999999977664

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-43  Score=328.37  Aligned_cols=221  Identities=25%  Similarity=0.391  Sum_probs=178.3

Q ss_pred             cccceeeeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecc-----hhhHHHHHHHHHhc-CCCceE----------
Q 016085           89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVH----------  147 (395)
Q Consensus        89 ~~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~-----~~~~~~E~~~l~~l-~h~ni~----------  147 (395)
                      ..++|++.++||+|+||.||+|+..     .+++.||||++...     ...+.+|+.+++.+ +||||.          
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            3458999999999999999999863     46678999998643     23345799999999 699980          


Q ss_pred             -------e---------------------------eccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEc
Q 016085          148 -------Y---------------------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  193 (395)
Q Consensus       148 -------~---------------------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~  193 (395)
                             +                           ......+++..+..++.||+.||+||| ++||+||||||+|||++
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH-~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLT  179 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccccccccccc
Confidence                   0                           011235888999999999999999999 88999999999999999


Q ss_pred             CCCCceEEeecCCccccccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016085          194 PHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLL-GQPLFPGESGVDQL  269 (395)
Q Consensus       194 ~~~~~ikl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  269 (395)
                      .++ .+||+|||+++........   ...+||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+.+
T Consensus       180 ~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         180 HGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             TTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             ccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            887 6999999999876543322   2457799999999997654 8999999999999999998 77778787777777


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          270 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       270 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      .+++.....+                           ..+...++.+.+||.+||++||++|||+.++++
T Consensus       258 ~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         258 YKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            7766531111                           123347899999999999999999999999885

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-42  Score=324.79  Aligned_cols=216  Identities=20%  Similarity=0.287  Sum_probs=165.8

Q ss_pred             eeeeeeccCCceEEEEEEEcCCC---cEEEEEEeecc-----hhhHHHHHHHHHhcCCCceE------------------
Q 016085           94 MAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVH------------------  147 (395)
Q Consensus        94 ~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~~~~~-----~~~~~~E~~~l~~l~h~ni~------------------  147 (395)
                      ...++||+|+||+||+|++..++   ..||||++.+.     ...+.+|+++|++++||||.                  
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            34688999999999999987643   36999998532     23456899999999999980                  


Q ss_pred             ----------eeccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC--
Q 016085          148 ----------YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--  215 (395)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~--  215 (395)
                                ........++..+..++.|++.||.||| +.||+||||||+||||+.++ .+||+|||+++.......  
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH-~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-SKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCTTTTTCCC
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc-ccCcccCCccHHhEeECCCC-CEEEecccchhhcccccccc
Confidence                      1112345677888999999999999999 88999999999999999887 699999999987643322  


Q ss_pred             ---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCCC
Q 016085          216 ---NISYICSRYYRAPELIFGATEYTTAVDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNY  291 (395)
Q Consensus       216 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~  291 (395)
                         .....||+.|+|||.+.+.. ++.++|||||||++|||+||..||...... +....+..  |.             
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~-------------  251 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GR-------------  251 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TC-------------
T ss_pred             ceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CC-------------
Confidence               22356799999999987655 899999999999999999977777554322 22222221  00             


Q ss_pred             ccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhcC
Q 016085          292 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  340 (395)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~h  340 (395)
                                   ....+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       252 -------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 -------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                         001234578999999999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=318.33  Aligned_cols=239  Identities=20%  Similarity=0.200  Sum_probs=161.7

Q ss_pred             cceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecchhh-H--HHHHHHHHhcCCCceEe-------------------
Q 016085           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-K--NRELQTMRLLDHPNVHY-------------------  148 (395)
Q Consensus        91 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-~--~~E~~~l~~l~h~ni~~-------------------  148 (395)
                      .+|.+.+.||+|+||.||+|+.  +|+.||||++...... .  ++|+..+..++||||..                   
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4699999999999999999986  7899999998654322 2  33445556789999800                   


Q ss_pred             ----------eccCCCCcHHHHHHHHHHHHHHHHHHHc-------CCCeeeccCCCCceEEcCCCCceEEeecCCccccc
Q 016085          149 ----------SRASQRMPLIYVKLYTYQICRALAYIHG-------GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  211 (395)
Q Consensus       149 ----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~-------~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~  211 (395)
                                ......+++.....++.|++.||.|||+       ++||+||||||+||||+.++ .+||+|||+++...
T Consensus        81 Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHD  159 (303)
T ss_dssp             ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEEE
T ss_pred             ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCcccccc
Confidence                      0012367888889999999999999993       25999999999999999888 69999999998775


Q ss_pred             cCCC-----cccccccccccccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 016085          212 KGEP-----NISYICSRYYRAPELIFGAT-----EYTTAVDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  281 (395)
Q Consensus       212 ~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  281 (395)
                      ....     .....||+.|+|||++.+..     .++.++|||||||+||||+||..||............ .....+..
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~~~~~  238 (303)
T d1vjya_         160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSDPSV  238 (303)
T ss_dssp             TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCSSCCH
T ss_pred             CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-cccccchH
Confidence            4432     23467899999999986532     1567899999999999999999887432211000000 00000010


Q ss_pred             HHHhhcCCCCccccCCcccCCCcccccCCCCChhHHHHHHhhccCCCCCCCCHHHHhc
Q 016085          282 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  339 (395)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e~l~  339 (395)
                      ........  .....|.+.    ...........+.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~--~~~~~p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         239 EEMRKVVC--EQKLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             HHHHHHHT--TSCCCCCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHh--ccccCCCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            00000000  000001100    00011123346899999999999999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=5.3e-24  Score=185.18  Aligned_cols=150  Identities=17%  Similarity=0.110  Sum_probs=104.8

Q ss_pred             eeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecch----------------------hhHHHHHHHHHhcCCCceEe--
Q 016085           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------------------RYKNRELQTMRLLDHPNVHY--  148 (395)
Q Consensus        93 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----------------------~~~~~E~~~l~~l~h~ni~~--  148 (395)
                      |.+.+.||+|+||.||+|++. +|+.||||+++...                      ....+|...+..+.|.++..  
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568899999999999999984 68999999864211                      11235788889998877610  


Q ss_pred             -----------e--ccCCCCcHHHHHHHHHHHHHHHHHHHcCCCeeeccCCCCceEEcCCCCceEEeecCCccccccCCC
Q 016085          149 -----------S--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  215 (395)
Q Consensus       149 -----------~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~~~~~~~~  215 (395)
                                 .  .....++...+..++.|++.+|.||| ++||+||||||+|||++.+  .++|+|||.|........
T Consensus        81 ~~~~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH-~~giiHrDiKP~NILv~~~--~~~liDFG~a~~~~~~~~  157 (191)
T d1zara2          81 AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY-HRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEEGW  157 (191)
T ss_dssp             EEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEEETT--EEEECCCTTCEETTSTTH
T ss_pred             EecCCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHh-hCCEEEccCChhheeeeCC--CEEEEECCCcccCCCCCc
Confidence                       0  11233556677889999999999999 8899999999999999964  399999999976532211


Q ss_pred             cccccc-cccccccccccCCCCCCCcchHHHHHHHH
Q 016085          216 NISYIC-SRYYRAPELIFGATEYTTAVDIWSVGCVL  250 (395)
Q Consensus       216 ~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwSlG~il  250 (395)
                       ..+.. .... -.+.+ . ..|+..+|+||+.--+
T Consensus       158 -~~~l~rd~~~-~~~~f-~-r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         158 -REILERDVRN-IITYF-S-RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -HHHHHHHHHH-HHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred             -HHHHHHHHHH-HHHHH-c-CCCCCcccHHHHHHHH
Confidence             11100 0000 01222 2 2489999999986443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.91  E-value=0.00059  Score=61.23  Aligned_cols=31  Identities=29%  Similarity=0.259  Sum_probs=26.3

Q ss_pred             CCCeeeccCCCCceEEcCCCCceEEeecCCcc
Q 016085          177 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  208 (395)
Q Consensus       177 ~~giiHrDlKp~Nill~~~~~~ikl~DFG~a~  208 (395)
                      ..|+||+|+.++||+++.+. ..-|+||+.|.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDE-LSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             ccccccCCcchhhhhccccc-ceeEecccccc
Confidence            35899999999999999765 46899999874

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=96.76  E-value=0.0022  Score=55.43  Aligned_cols=49  Identities=18%  Similarity=0.112  Sum_probs=33.5

Q ss_pred             ceeeeeeeccCCceEEEEEEEcCCCcEEEEEEeecc----hhhHHHHHHHHHhcC
Q 016085           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLD  142 (395)
Q Consensus        92 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~~l~~l~  142 (395)
                      .|++.+..+.++-+.||+..  ..++.+.+|+....    .....+|..+++.|.
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~   67 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLE   67 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHT
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHh
Confidence            47777766556667899886  36677888887543    234567888887764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.53  E-value=0.0018  Score=58.36  Aligned_cols=38  Identities=18%  Similarity=0.031  Sum_probs=28.2

Q ss_pred             eEEEEEEEcCCCcEEEEEEeecc---hhhHHHHHHHHHhcCC
Q 016085          105 GIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDH  143 (395)
Q Consensus       105 g~V~~a~~~~~~~~vAiK~~~~~---~~~~~~E~~~l~~l~h  143 (395)
                      -.||+++. ++|..|++|+.+..   ......|...+..|..
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~   76 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVN   76 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHH
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHh
Confidence            47999975 57888999998653   3455678888887753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.24  E-value=0.0067  Score=51.90  Aligned_cols=29  Identities=28%  Similarity=0.292  Sum_probs=24.4

Q ss_pred             eeeccCCCCceEEcCCCCceEEeecCCccc
Q 016085          180 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  209 (395)
Q Consensus       180 iiHrDlKp~Nill~~~~~~ikl~DFG~a~~  209 (395)
                      ++|+|+.|.|||++.++ .+-|+||+.+..
T Consensus       177 liHgD~~~~Nvl~~~~~-~~~iID~~~~~~  205 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGR-FSGFIDCGRLGV  205 (255)
T ss_dssp             EECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             EEeCCCCCcceEEeCCc-eEEEEEchhccc
Confidence            89999999999998654 467999997743

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=95.94  E-value=0.0079  Score=55.51  Aligned_cols=46  Identities=17%  Similarity=0.187  Sum_probs=30.3

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecc-----------hhhHHHHHHHHHhc
Q 016085           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----------KRYKNRELQTMRLL  141 (395)
Q Consensus        96 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-----------~~~~~~E~~~l~~l  141 (395)
                      .+.||.|....||++.+..+++.|.+|.-...           .....+|.++|+.+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~   87 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQ   87 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHH
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHh
Confidence            34689999999999998778889999964321           12234688888766

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=91.78  E-value=0.25  Score=44.83  Aligned_cols=46  Identities=15%  Similarity=0.175  Sum_probs=29.0

Q ss_pred             eeeccCCceEEEEEEEcC-------CCcEEEEEEeecc--hhhHHHHHHHHHhcC
Q 016085           97 RVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQD--KRYKNRELQTMRLLD  142 (395)
Q Consensus        97 ~~lG~G~fg~V~~a~~~~-------~~~~vAiK~~~~~--~~~~~~E~~~l~~l~  142 (395)
                      +.|+.|--=.+|++....       ..+.|.+++.-..  .....+|..+++.+.
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls  102 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLS  102 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHH
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHH
Confidence            467777777888887543       2356777765422  233457888887764